PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Selles, B; Moseler, A; Caubriere, D; Sun, SK; Ziesel, M; Dhalleine, T; Heriche, M; Wirtz, M; Rouhier, N; Couturier, J				Selles, Benjamin; Moseler, Anna; Caubriere, Damien; Sun, Sheng-Kai; Ziesel, Morgane; Dhalleine, Tiphaine; Heriche, Mathilde; Wirtz, Markus; Rouhier, Nicolas; Couturier, Jeremy			The cytosolic Arabidopsis thaliana cysteine desulfurase ABA3 delivers sulfur to the sulfurtransferase STR18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR SULFURASE; FE-S CLUSTER; NIFS-LIKE DOMAIN; ESCHERICHIA-COLI; PROVIDES INSIGHT; OXIDATIVE STRESS; PROTEIN; SUFS; BIOSYNTHESIS; IDENTIFICATION	The biosynthesis of many sulfur-containing molecules depends on cysteine as a sulfur source. Both the cysteine desulfurase (CD) and rhodanese (Rhd) domain-containing protein families participate in the trafficking of sulfur for various metabolic pathways in bacteria and human, but their connection is not yet described in plants. The existence of natural chimeric proteins containing both CD and Rhd domains in specific bacterial genera, however, suggests a general interaction between these proteins. We report here the biochemical relationships between two cytosolic proteins from Arabidopsis thaliana, a Rhd domain-containing protein, the sulfurtransferase 18 (STR18), and a CD isoform referred to as ABA3, and compare these biochemical features to those of a natural CD-Rhd fusion protein from the bacterium Pseudorhodoferax sp. We observed that the bacterial enzyme is bifunctional exhibiting both CD and STR activities using L-cysteine and thiosulfate as sulfur donors but preferentially using L-cysteine to catalyze transpersulfidation reactions. In vitro activity assays and mass spectrometry analyses revealed that STR18 stimulates the CD activity of ABA3 by reducing the intermediate persulfide on its catalytic cysteine, thereby accelerating the overall transfer reaction. We also show that both proteins interact in planta and form an efficient sulfur relay system, whereby STR18 catalyzes transpersulfidation reactions from ABA3 to the model acceptor protein roGFP2. In conclusion, the ABA3- STR18 couple likely represents an uncharacterized pathway of sulfur trafficking in the cytosol of plant cells, independent of ABA3 function in molybdenum cofactor maturation.	[Selles, Benjamin; Moseler, Anna; Caubriere, Damien; Ziesel, Morgane; Dhalleine, Tiphaine; Heriche, Mathilde; Rouhier, Nicolas; Couturier, Jeremy] Univ Lorraine, IAM, INRAE, Nancy, France; [Sun, Sheng-Kai; Wirtz, Markus] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Couturier, Jeremy] Inst Univ France, Paris, France; [Selles, Benjamin] Univ Lorraine, CNRS, IMoPA, F-54000 Nancy, France; [Moseler, Anna] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Chem Sig, D-53113 Bonn, Germany; [Heriche, Mathilde] Univ Bourgogne Franche Comte, INRAE, Univ Bourgogne, Agroecol,AgroSup Dijon,CNRS, F-21000 Dijon, France	INRAE; Universite de Lorraine; Ruprecht Karls University Heidelberg; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Bonn; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Couturier, J (corresponding author), Univ Lorraine, IAM, INRAE, Nancy, France.; Couturier, J (corresponding author), Inst Univ France, Paris, France.	jeremy.couturier@univ-lorraine.fr	Wirtz, Markus/G-5917-2010	Wirtz, Markus/0000-0001-7790-4022; Moseler, Anna/0000-0003-4641-8093; SELLES, Benjamin/0000-0002-9260-9344; Sun, Shengkai/0000-0001-7688-3928; Couturier, Jeremy/0000-0003-3127-2669; Caubriere, Damien/0000-0001-7877-7838	Feodor Lynen Research Fellowship; Alexander von Humboldt Foundation; Lorraine University of Excellence (LUE)	Feodor Lynen Research Fellowship; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Lorraine University of Excellence (LUE)	Funding and additional information-A. M. is recipient of a Feodor Lynen Research Fellowship, and S. K. S. is a recipient of Humboldt Research Fellowship from the Alexander von Humboldt Foundation. The PhD salary of D. C. was provided by a funding from the Lorraine University of Excellence (LUE).	Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Black KA, 2015, BBA-MOL CELL RES, V1853, P1470, DOI 10.1016/j.bbamcr.2014.10.018; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Cheng Hui, 2008, Open Microbiol J, V2, P18, DOI 10.2174/1874285800802010018; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Dahl JU, 2011, J BIOL CHEM, V286, P35801, DOI 10.1074/jbc.M111.282368; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Henne M, 2015, FEBS OPEN BIO, V5, P832, DOI 10.1016/j.fob.2015.10.001; Kambampati R, 2000, J BIOL CHEM, V275, P10727, DOI 10.1074/jbc.275.15.10727; Kaufholdt D, 2016, J PLANT PHYSIOL, V207, P42, DOI 10.1016/j.jplph.2016.10.002; Lehrke M, 2012, BIOCHEM J, V441, P823, DOI 10.1042/BJ20111170; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mao GH, 2011, J BIOL CHEM, V286, P7548, DOI 10.1074/jbc.M110.182865; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marelja Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060869; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Moseler A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100429; Moseler A, 2020, NEW PHYTOL, V226, P967, DOI 10.1111/nph.15870; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Murthy N. M. U., 2007, CHARACTERIZATION ARA; Nakai Y, 2012, J BIOL CHEM, V287, P30874, DOI 10.1074/jbc.M112.350090; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Roret T, 2014, ACTA CRYSTALLOGR F, V70, P1180, DOI 10.1107/S2053230X14017026; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selles B, 2019, J EXP BOT, V70, P4139, DOI 10.1093/jxb/erz213; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; Watanabe S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34862-1; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200; Zannini F, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7100142; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhong R, 2010, PLANT J, V63, P44, DOI 10.1111/j.1365-313X.2010.04220.x	54	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101749	10.1016/j.jbc.2022.101749	http://dx.doi.org/10.1016/j.jbc.2022.101749			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35189141	gold, Green Published, Green Submitted			2022-12-26	WOS:000793502000004
J	Toyoda, S; Shin, J; Fukuhara, A; Otsuki, M; Shimomura, I				Toyoda, Shinichiro; Shin, Jihoon; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro			<p>Transforming growth factor beta 1 signaling links extracellular matrix remodeling to intracellular lipogenesis upon physiological feeding events</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIABETES-MELLITUS; MICE; GLUCOSE; WHITE; LIPODYSTROPHY; KNOCKOUT; LEPTIN	Adipose tissue dynamically changes its mass in response to external nutritional status, which plays an important role in maintaining the lipid homeostasis. Physiologically, feeding events are associated with the expansion of adipose tissue, but little is known about the detailed molecular mechanisms of this expansion. Here, using comprehensive transcriptome analysis, we found that levels of transforming growth factor beta 1 (TGF beta 1), a key regulator of extracellular matrix (ECM) remodeling, were increased in adipose tissue under feeding conditions and associated with the lipogenic pathway. In addition, TGF-beta receptors are highly expressed in adipose tissue, and pharmacological inhibition of TGF-beta 1 reduced adipose tissue mass and caused ectopic lipid accumulation in the liver. This reduced fat mass was associated with decreased gene expression in ECM remodeling and lipogenesis. Furthermore, similar results were observed in the adipose tissue of SMAD family member 3 knockout mice or upon systemic TGF-beta neutralization, with significant reductions in both ECM remodeling and lipogenesis-related genes. Mechanistically, we found that insulin-induced TGF-beta 1 and cell-autonomous action remodels the ECM of adipocytes, which controls the downstream focal adhesion kinase-AKT signaling cascades and enhances the lipogenic pathway. Of note, destruction of collagens or matrix metalloproteinase/a disintegrin and metalloprotease activities, critical components of ECM remodeling, blocked TGF-beta 1-mediated focal adhesion kinase-AKT signaling and the lipogenic pathway. Taken together, this study identifies a previously unknown lipogenic role of TGF-beta 1 by which adipocytes can expand to adapt to physiological feeding events.	[Toyoda, Shinichiro; Shin, Jihoon; Fukuhara, Atsunori; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Shin, Jihoon] Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Suita, Osaka, Japan; [Fukuhara, Atsunori] Osaka Univ, Dept Adipose Management, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Shin, J (corresponding author), Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan.; Shin, J (corresponding author), Osaka Univ, Dept Diabet Care Med, Grad Sch Med, Suita, Osaka, Japan.	shinjihoon0209@endmet.med.osaka-u.ac.jp	Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Shin, Jihoon/0000-0003-1294-0238				A.Feuchtinger, 2020, bioRxiv, DOI 10.1101/2020.06.29.178020; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; BARNARD JA, 1990, BIOCHIM BIOPHYS ACTA, V1032, P79, DOI 10.1016/0304-419X(90)90013-Q; Birsoy K, 2013, J CELL SCI, V126, P1541, DOI 10.1242/jcs.104992; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Cautivo KM, 2016, MOL METAB, V5, P491, DOI 10.1016/j.molmet.2016.05.004; Chitraju C, 2019, J LIPID RES, V60, P1112, DOI 10.1194/jlr.M093112; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Fernandez S, 2019, CELL REP, V27, P2772, DOI 10.1016/j.celrep.2019.04.112; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao HQ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128405; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guilherme A, 2019, NAT REV ENDOCRINOL, V15, P207, DOI 10.1038/s41574-019-0165-y; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Horiguchi M, 2012, J BIOCHEM, V152, P321, DOI 10.1093/jb/mvs089; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Jacquinet A, 2014, EUR J MED GENET, V57, P230, DOI 10.1016/j.ejmg.2014.02.012; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kita S, 2019, J CLIN INVEST, V129, P4041, DOI 10.1172/JCI129193; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Le Dour C, 2017, J LIPID RES, V58, P151, DOI 10.1194/jlr.M071381; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Luk CT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14360; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Nawaz A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00231-1; Norgan NG, 1997, INT J OBESITY, V21, P738, DOI 10.1038/sj.ijo.0800473; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Okuno Y, 2018, DIABETES, V67, P1113, DOI 10.2337/db17-1032; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Petaisto T, 2020, J PHYSIOL-LONDON, V598, P3373, DOI 10.1113/JP279559; Petrus P, 2018, CELL REP, V25, P551, DOI 10.1016/j.celrep.2018.09.069; Roh HC, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101086; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sakaguchi M, 2017, CELL METAB, V25, P448, DOI 10.1016/j.cmet.2016.12.008; Schlaepfer DD, 1996, CELL STRUCT FUNCT, V21, P445, DOI 10.1247/csf.21.445; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Softic S, 2016, DIABETES, V65, P2187, DOI 10.2337/db16-0213; Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Straub LG, 2019, NAT METAB, V1, P334, DOI 10.1038/s42255-019-0041-z; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Vogel P, 2011, VET PATHOL, V48, P642, DOI 10.1177/0300985810383870; Wankhade UD, 2018, MOL METAB, V16, P160, DOI 10.1016/j.molmet.2018.07.008; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013	66	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101748	10.1016/j.jbc.2022.101748	http://dx.doi.org/10.1016/j.jbc.2022.101748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35189145	Green Published, gold, Green Submitted			2022-12-26	WOS:000797895000007
J	Blazanin, M; Lam, WT; Vasen, E; Chan, BK; Turner, PE				Blazanin, Michael; Lam, Wai Tin; Vasen, Emma; Chan, Benjamin K.; Turner, Paul E.			Decay and damage of therapeutic phage OMKO1 by environmental stressors	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; THERMAL INACTIVATION; ANTIBIOTIC STABILITY; BACTERIOPHAGE; TRADEOFFS; EVOLUTION	Antibiotic resistant bacterial pathogens are increasingly prevalent, driving the need for alternative approaches to chemical antibiotics when treating infections. One such approach is bacteriophage therapy: the use of bacteria-specific viruses that lyse (kill) their host cells. Just as the effect of environmental conditions (e.g. elevated temperature) on antibiotic efficacy is well-studied, the effect of environmental stressors on the potency of phage therapy candidates demands examination. Therapeutic phage OMKO1 infects and kills the opportunistic human pathogen Pseudomonas aeruginosa. Here, we used phage OMKO1 as a model to test how environmental stressors can lead to damage and decay of virus particles. We assessed the effects of elevated temperatures, saline concentrations, and urea concentrations. We observed that OMKO1 particles were highly tolerant to different saline concentrations, but decayed more rapidly at elevated temperatures and under high concentrations of urea. Additionally, we found that exposure to elevated temperature reduced the ability of surviving phage particles to suppress the growth of P. aeruginosa, suggesting a temperature-induced damage. Our findings demonstrate that OMKO1 is highly tolerant to a range of conditions that could be experienced inside and outside the human body, while also showing the need for careful characterization of therapeutic phages to ensure that environmental exposure does not compromise their expected potency, dosing, and pharmacokinetics.	[Blazanin, Michael; Lam, Wai Tin; Vasen, Emma; Chan, Benjamin K.; Turner, Paul E.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; [Turner, Paul E.] Yale Sch Med, Program Microbiol, New Haven, CT USA	Yale University; Yale University	Blazanin, M (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA.	mike.blazanin@yale.edu	Blazanin, Michael/ADQ-0878-2022	Blazanin, Michael/0000-0003-4630-6235	Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	We disclose financial support for Wai Tin Lam from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschlimann JR, 2003, PHARMACOTHERAPY, V23, P916, DOI 10.1592/phco.23.7.916.32722; Ahlmann-Eltze C, 2019, GGSIGNIF SIGNIFICANC; ANDERSON TF, 1949, BOT REV, V15, P464, DOI 10.1007/BF02861677; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; BLEICHRODT JF, 1968, VIROLOGY, V36, P343, DOI 10.1016/0042-6822(68)90160-8; Burnet FM, 1933, J PATHOL BACTERIOL, V37, P179, DOI 10.1002/path.1700370203; Chan BK, 2018, EVOL MED PUBLIC HLTH, P60, DOI 10.1093/emph/eoy005; Chan BK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26717; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039; Fazzeli H, 2012, J RES MED SCI, V17, P332; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Goldhill DH, 2014, CURR OPIN VIROL, V8, P79, DOI 10.1016/j.coviro.2014.07.005; Gurney J, 2020, EVOL MED PUBLIC HLTH, P148, DOI 10.1093/emph/eoaa026; Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8; Kortright KE, 2019, CELL HOST MICROBE, V25, P219, DOI 10.1016/j.chom.2019.01.014; LANDERKIN GB, 1957, APPL MICROBIOL, V5, P152, DOI 10.1128/AEM.5.3.152-154.1957; Liu LY, 2012, ANALYST, V137, P595, DOI 10.1039/c2an15780b; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Petrie KL, 2018, SCIENCE, V359, P1542, DOI 10.1126/science.aar1954; POLLARD EC, 1971, BIOPHYS J, V11, P66, DOI 10.1016/S0006-3495(71)86195-7; R Core Team, 2020, R LANG ENV STAT COMP; Remold SK, 2011, MICROB ECOL, V62, P505, DOI 10.1007/s00248-011-9844-5; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; Samara E, 2017, BONE JOINT RES, V6, P296, DOI 10.1302/2046-3758.65.BJR-2017-0276.R1; SATO GH, 1956, SCIENCE, V123, P891, DOI 10.1126/science.123.3203.891; Seaman PF, 2007, FEMS MICROBIOL ECOL, V60, P1, DOI 10.1111/j.1574-6941.2006.00277.x; Seed KD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004847; Singhal S, 2021, EVOLUTION, V75, P1878, DOI 10.1111/evo.14263; Slekovec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049300; Studer RA, 2014, P NATL ACAD SCI USA, V111, P2223, DOI 10.1073/pnas.1310811111; Svahn O, 2015, J CHROMATOGR A, V1415, P73, DOI 10.1016/j.chroma.2015.08.061; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Theuretzbacher U, 2013, J GLOB ANTIMICROB RE, V1, P63, DOI 10.1016/j.jgar.2013.03.010; Turner PE, 2012, J MICROBIOL METH, V88, P117, DOI 10.1016/j.mimet.2011.10.020; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; WHITMAN PA, 1971, APPL MICROBIOL, V22, P463, DOI 10.1177/0038038588022003015; WICK WE, 1964, J BACTERIOL, V87, P1162, DOI 10.1128/JB.87.5.1162-1170.1964; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu ZJ, 2019, EPIDEMICS-NETH, V27, P19, DOI 10.1016/j.epidem.2018.12.003	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263887	10.1371/journal.pone.0263887	http://dx.doi.org/10.1371/journal.pone.0263887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196336	gold, Green Published			2022-12-26	WOS:000835161600020
J	Stangl, AL; Pliakas, T; Izazola-Licea, JA; Ayala, G; Beattie, TS; Ferguson, L; Orza, L; Mathur, S; Pulerwitz, J; Iovita, A; Bendaud, V				Stangl, Anne L.; Pliakas, Triantafyllos; Izazola-Licea, Jose Antonio; Ayala, George; Beattie, Tara S.; Ferguson, Laura; Orza, Luisa; Mathur, Sanyukta; Pulerwitz, Julie; Iovita, Alexandrina; Bendaud, Victoria			Removing the societal and legal impediments to the HIV response: An evidence-based framework for 2025 and beyond	PLOS ONE			English	Article							FEMALE SEX WORKERS; GLOBAL EPIDEMIOLOGY; TRANSGENDER WOMEN; STIGMA; MEN; INTERVENTIONS; INTERRUPTION; INVESTMENT; HIV/AIDS; TRIAL	Societal and legal impediments inhibit quality HIV prevention, care, treatment and support services and need to be removed. The political declaration adopted by UN member countries at the high-level meeting on HIV and AIDS in June 2021, included new societal enabler global targets for achievement by 2025 that will address this gap. Our paper describes how and why UNAIDS arrived at the societal enabler targets adopted. We conducted a scoping review and led a participatory process between January 2019 and June 2020 to develop an evidence-based framework for action, propose global societal enabler targets, and identify indicators for monitoring progress. A re-envisioned framework called the '3 S's of the HIV response: Society, Systems and Services' was defined. In the framework, societal enablers enhance the effectiveness of HIV programmes by removing impediments to service availability, access and uptake at the societal level, while service and system enablers improve efficiencies in and expand the reach of HIV services and systems. Investments in societal enabling approaches that remove legal barriers, shift harmful social and gender norms, reduce inequalities and improve institutional and community structures are needed to progressively realize four overarching societal enablers, the first three of which fall within the purview of the HIV sector: (i) societies with supportive legal environments and access to justice, (ii) gender equal societies, (iii) societies free from stigma and discrimination, and (iv) co-action across development sectors to reduce exclusion and poverty. Three top-line and 15 detailed targets were recommended for monitoring progress towards their achievement. The clear articulation of societal enablers in the re-envisioned framework should have a substantial impact on improving the effectiveness of core HIV programmes if implemented. Together with the new global targets, the framework will also galvanize advocacy to scale up societal enabling approaches with proven impact on HIV outcomes.	[Stangl, Anne L.] Hera Solut, Baltimore, MD 21209 USA; [Stangl, Anne L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Pliakas, Triantafyllos; Beattie, Tara S.] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England; [Pliakas, Triantafyllos] Impact Epilysis, Thessaloniki, Greece; [Izazola-Licea, Jose Antonio; Bendaud, Victoria] Joint United Nations Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Ayala, George] Alameda Cty Publ Hlth Dept, Oakland, CA USA; [Ayala, George] MPact Global Act Gay Mens Hlth & Rights, Oakland, CA USA; [Ferguson, Laura] Univ Southern Calif, Inst Inequal Global Hlth, Los Angeles, CA USA; [Orza, Luisa] Frontline AIDS, Brighton, E Sussex, England; [Mathur, Sanyukta; Pulerwitz, Julie] Populat Council, Washington, DC USA; [Iovita, Alexandrina] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; UNAIDS; University of Southern California; Population Council	Stangl, AL (corresponding author), Hera Solut, Baltimore, MD 21209 USA.; Stangl, AL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	alstangl@gmail.com		Mathur, Sanyukta/0000-0003-1645-6734; Izazola-Licea, Jose Antonio/0000-0002-3658-2570	Joint United Nations Programme on HIV/AIDS (UNAIDS)	Joint United Nations Programme on HIV/AIDS (UNAIDS)	ALS and TP received funding from the Joint United Nations Programme on HIV/AIDS (UNAIDS) for the preparation of this article. JAI-L and VB are salaried employees of UNAIDS. The funders commissioned the study. JAI-L participated in the conceptualization of the study, the preparation of the manuscript and the decision to publish.	[Anonymous], 2018, DREAMING AIDS FREE F, DOI [10.1136/bmjopen-2018-021835 30173159, DOI 10.1136/BMJOPEN-2018-02183530173159]; Aristegui I., 2014, 20 INT AIDS C MELBOU; Arreola S, 2015, AIDS BEHAV, V19, P227, DOI 10.1007/s10461-014-0869-x; Ayala G, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21098; Ayala George, 2013, J Sex Transm Dis, V2013, P953123, DOI 10.1155/2013/953123; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Beattie TS, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20079; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Borquez A, 2018, LANCET PUBLIC HEALTH, V3, pE429, DOI 10.1016/S2468-2667(18)30097-5; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Brown S, 1995, BEST INTENTIONS UNIN; Bygrave H, 2020, CURR OPIN HIV AIDS, V15, P256, DOI 10.1097/COH.0000000000000629; Chimoyi L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26950; Christopoulos KA, 2020, AIDS, V34, P1665, DOI 10.1097/QAD.0000000000002595; Dalrymple J, 2019, SEX TRANSM INFECT, V95, P351, DOI 10.1136/sextrans-2018-053935; Gesesew HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173928; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Goodwin L., 2014, MAPPING EVIDENCE; Gruskin S, 2010, J PUBLIC HEALTH POL, V31, P129, DOI 10.1057/jphp.2010.7; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hargreaves JR, 2020, JAIDS-J ACQ IMM DEF, V85, P561, DOI 10.1097/QAI.0000000000002504; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Joint United Nations Programme on HIV/AIDS, 2020, COMMUNITY INNOVATION; Joint United Nations Programme on HIV/AIDS, 2020, EV EL HIV REL STIGM; Joint United Nations Programme on HIV/AIDS, 2019, GLOB AIDS UPD 2019 C; Joint United Nations Programme on HIV/AIDS, 2019, COMB HIV PREV TAIL C, DOI DOI 10.2307/J.CTT1T898KC.12; Joint United Nations Programme on HIV/AIDS, 2012, KEY PROGR RED STIGM; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kemp CG, 2019, AIDS, V33, P1511, DOI 10.1097/QAD.0000000000002212; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lango D., 2014, DIGITAL LITERACY CAM; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Lipira L, 2019, AIDS BEHAV, V23, P2025, DOI 10.1007/s10461-018-2301-4; McKinnon B, 2019, B WORLD HEALTH ORGAN, V97, P42, DOI 10.2471/BLT.18.212993; Mohlala BKF, 2011, AIDS, V25, P1535, DOI 10.1097/QAD.0b013e328348fb85; Munn Z, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0611-x; ONU, 2015, TRANSF OUR WORLD 203; Peitzmeier SM, 2015, JAIDS-J ACQ IMM DEF, V68, pS146, DOI 10.1097/QAI.0000000000000453; Platt L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002680; Pulerwitz J, 2019, AIDS BEHAV, V23, pS162, DOI 10.1007/s10461-019-02603-8; Quinn K, 2017, AIDS BEHAV, V21, P207, DOI 10.1007/s10461-016-1439-1; Remme M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19228; Sabapathy K, 2017, J INT AIDS SOC, V20, DOI 10.1002/jia2.25037; Sareen J, 2009, GEN HOSP PSYCHIAT, V31, P274, DOI 10.1016/j.genhosppsych.2009.02.004; Scheim AI, 2016, J INT AIDS SOC, V19, P52, DOI 10.7448/IAS.19.3.20779; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Schwartz SR, 2015, LANCET HIV, V2, pE299, DOI 10.1016/S2352-3018(15)00078-8; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Stangl AL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3692-1; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stannah J, 2019, LANCET HIV, V6, pE769, DOI 10.1016/S2352-3018(19)30239-5; The Global Fund, 2020, EXT WAMB ORG PIL INC; Thomas-Slayter BP, 2011, GLOB PUBLIC HEALTH, V6, pS323, DOI 10.1080/17441692.2011.617380; Turan JM, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1246-9; UNAIDS, 2020, IMPACT RESOURCE NEED; UNAIDS, 2018, GLOB PARTN ACT EL AL; UNAIDS, 2016, GLOB AIDS UPD; UNAIDS, 2015, UND FAST TRACK ACC A; UNAIDS, 2018, UNAIDS GEND ASS TOOL; UNDP, 2018, GLOB COMM HIV LAW RI; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; Wirtz AL, 2020, TRAUMA VIOLENCE ABUS, V21, P227, DOI 10.1177/1524838018757749; Wirya A, 2020, BMC INT HEALTH HUM R, V20, DOI 10.1186/s12914-020-00226-y; Zulliger R, 2015, JAIDS-J ACQ IMM DEF, V69, P216, DOI 10.1097/QAI.0000000000000590	69	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264249	10.1371/journal.pone.0264249	http://dx.doi.org/10.1371/journal.pone.0264249			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192663	Green Accepted, Green Published, gold			2022-12-26	WOS:000812552500045
J	Zhang, YJ; Dho, SE; Othman, K; Simpson, CD; Lapierre, J; Bondoc, A; McGlade, CJ				Zhang, Yangjing; Dho, Sascha E.; Othman, Kamal; Simpson, Craig D.; Lapierre, Jessica; Bondoc, Andrew; McGlade, C. Jane			Numb exon 9 inclusion regulates Integrin beta 5 surface expression and promotes breast cancer metastasis	ONCOGENE			English	Article							FATE DETERMINANT NUMB; CELL FATE; ISOFORMS; DIFFERENTIATION; IDENTIFICATION; INVOLVEMENT; ENDOCYTOSIS; PROGRESSION; ATTACHMENT; SUPPRESSOR	The endocytic adaptor protein Numb acts as a tumor suppressor through downregulation of oncogenic pathways in multiple cancer types. The identification of splicing alterations giving rise to changes in Numb protein isoform expression indicate that Numb also has tumor promoting activity, though the underlying mechanisms are unknown. Here we report that NUMB exon 9 inclusion, which results in production of a protein isoform with an additional 49 amino acids, is a feature of multiple cancer types including all subtypes of breast cancer and correlates with worse progression-free survival. Specific deletion of exon 9-included Numb isoforms (Exon9in) from breast cancer cells reduced cell growth and prevents spontaneous lung metastasis in a mouse model. Quantitative proteome profiling showed that loss of Exon9in causes downregulation of membrane receptors and adhesion molecules, as well as proteins involved in extracellular matrix organization and the epithelial-mesenchymal transition (EMT) state. In addition, exon 9 deletion caused remodeling of the endocytic network, decreased ITG beta 5 surface localization, cell spreading on vitronectin and downstream signaling to ERK and SRC. Together these observations suggest that Exon9in isoform expression disrupts the endocytic trafficking functions of Numb, resulting in increased surface expression of ITG beta 5 as well as other plasma membrane proteins to promote cell adhesion, EMT, and tumor metastasis.	[Zhang, Yangjing; Othman, Kamal; McGlade, C. Jane] Univ Toronto, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada; [Zhang, Yangjing; Dho, Sascha E.; Othman, Kamal; Lapierre, Jessica; Bondoc, Andrew; McGlade, C. Jane] Arthur & Sonia Labatt Brain Tumour Res Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Dho, Sascha E.; Lapierre, Jessica; Bondoc, Andrew; McGlade, C. Jane] Program Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Simpson, Craig D.] Hosp Sick Children, SPARC BioCtr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McGlade, CJ (corresponding author), Univ Toronto, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.; McGlade, CJ (corresponding author), Arthur & Sonia Labatt Brain Tumour Res Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; McGlade, CJ (corresponding author), Program Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jmcglade@sickkids.ca		Zhang, Yangjing/0000-0003-3762-0767	Canadian Institutes of Health Research [FRN 106507]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank the following: Michael Reedijk and Qiang Shen for assistance with mouse xenograft experiments, SPARC Molecular Analysis for TMT mass spectrometry, Amanda Luck for mouse colony maintenance and caliper measurements, Nesrin Sabha for help with IHC staining, and Kim Lau and Paul Paroutis (The Imaging Facility, The Hospital for Sick Children) for their assistance with TIRF microscopy and imaging analysis. This work was supported with funds from the Canadian Institutes of Health Research to CJM (FRN 106507).	Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Baschieri F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06367-y; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Chen HZ, 2009, PATHOBIOLOGY, V76, P149, DOI 10.1159/000209393; Cheng C, 2020, AM J PHYSIOL-GASTR L, V318, pG841, DOI 10.1152/ajpgi.00178.2019; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Colaluca IN, 2018, J CELL BIOL, V217, P745, DOI 10.1083/jcb.201709092; Cullen PJ, 2018, NAT REV MOL CELL BIO, V19, P679, DOI 10.1038/s41580-018-0053-7; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Dooley CM, 2003, J NEUROBIOL, V54, P313, DOI 10.1002/neu.10176; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Ke H, 2018, P NATL ACAD SCI USA, V115, pE3426, DOI 10.1073/pnas.1714573115; Khan I, 2021, BRIT J CANCER, V124, P66, DOI 10.1038/s41416-020-01179-8; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Koike S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09617-9; Krieger JR, 2019, J PROTEOME RES, V18, P2346, DOI 10.1021/acs.jproteome.9b00082; Krieger JR, 2015, PROTEOMICS, V15, P434, DOI 10.1002/pmic.201400232; Krieger JR, 2013, MOL CELL PROTEOMICS, V12, P499, DOI 10.1074/mcp.M112.020768; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lamaze C, 2015, BIOMED J, V38, P367, DOI 10.4103/2319-4170.164229; Lau KM, 2011, EXP CELL RES, V317, P539, DOI 10.1016/j.yexcr.2010.12.005; Leyton-Puig D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16068; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lock JG, 2018, NAT CELL BIOL, V20, P1290, DOI 10.1038/s41556-018-0220-2; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Lu YY, 2015, HEPATOLOGY, V62, P1122, DOI 10.1002/hep.27923; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Moran TB, 2011, MOL ENDOCRINOL, V25, P117, DOI 10.1210/me.2010-0248; Moreno-Layseca P, 2019, NAT CELL BIOL, V21, P122, DOI 10.1038/s41556-018-0223-z; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Rajendran D, 2016, ONCOGENE, V35, P5202, DOI 10.1038/onc.2016.69; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sanchez E, 2019, J BIOL CHEM, V294, P3012, DOI 10.1074/jbc.RA118.005532; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Song W, 2017, ONCOGENE, V36, P5620, DOI 10.1038/onc.2017.170; Sun LX, 2018, ONCOGENE, V37, P3698, DOI 10.1038/s41388-018-0202-7; TAFTAF R, NAT COMMUN, V2021, P12; Toriya M, 2006, DEV NEUROSCI-BASEL, V28, P142, DOI 10.1159/000090760; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wei R, 2019, J MOL CELL BIOL, V11, P994, DOI 10.1093/jmcb/mjz003; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152; Zhang SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094974; Zhang Y, 2016, FASEB J, V30, P3474, DOI 10.1096/fj.201600387R; Zheng KL, 2015, INT J CLIN EXP PATHO, V8, P6181; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289; Zuidema A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221317	68	2	2	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2079	2094		10.1038/s41388-022-02225-w	http://dx.doi.org/10.1038/s41388-022-02225-w		FEB 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35181737				2022-12-26	WOS:000757709600001
J	Gutral, J; Cypryanska, M; Nezlek, JB				Gutral, Joanna; Cypryanska, Marzena; Nezlek, John B.			Normative based beliefs as a basis for perceived changes in personality traits across the lifespan	PLOS ONE			English	Article							SELF; AGE; ADULTHOOD; BIG-5; EXPECTATIONS; PEOPLE	This article presents a new framework for understanding how people think personality changes across the life span. In two studies we examined the correspondence among how people thought their personalities would change, how people in general change, and changes found in a meta-analysis of changes in personality. We conceptualized and measured personality in terms of the Big Five model (FFM). In Study 1 participants rated either how they had changed from the past to the present or how they would change from the present to the future. We found that for openness to experience and social vitality participants thought these traits had increased from the past to the present, whereas participants did not think they would change from the present to the future. In contrast, participants thought that conscientiousness, agreeableness, and emotional stability would increase from the present to the future, although they did not report changes in most of these traits from the past to the present. The changes that occurred in Study 1 correspond to changes of personality found in previous research. In Study 2 participants rated themselves and other people on the FFM traits for each of nine intervals representing the lifespan. We found that people perceived changes in themselves to be similar to the changes found in meta-analyses, and perceptions of change in the self-corresponded to perception of changes for others. We believe these results can be explained by recognizing that people share normative based beliefs about how people change at certain age. Nevertheless, we also found that people perceived themselves as better than others, i.e., relatively greater increases in some positive traits and relatively smaller decreases in some negative traits, being first among equals. We discuss possible explanations for this phenomenon, which according to our knowledge, has not been discussed in this context previously.	[Gutral, Joanna] SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Gutral, Joanna; Cypryanska, Marzena; Nezlek, John B.] SWPS Univ Social Sci & Humanities, Ctr Climate Act & Social Transformat, Inst Psychol, Warsaw, Poland; [Nezlek, John B.] Coll William & Mary, Dept Psychol Sci, Williamsburg, VA USA	SWPS University of Social Sciences & Humanities; SWPS University of Social Sciences & Humanities; William & Mary	Gutral, J (corresponding author), SWPS Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland.; Gutral, J (corresponding author), SWPS Univ Social Sci & Humanities, Ctr Climate Act & Social Transformat, Inst Psychol, Warsaw, Poland.	jgutral@swps.edu.pl			National Science Center in Poland [2018/31/N/HS6/02665]	National Science Center in Poland(National Science Centre, Poland)	These studies were supported by a grant Preludium 16 from the National Science Center in Poland to JG (Grant 2018/31/N/HS6/02665: The relationship between social expectations, basic psychological needs, self-enhancement, and perceived changes in personality over the life span). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele AE, 2013, SOC PSYCHOL-GERMANY, V44, P61, DOI 10.1027/1864-9335/a000137; ALBERT S, 1977, PSYCHOL REV, V84, P485, DOI 10.1037/0033-295X.84.6.485; ALICKE MD, 1985, J PERS SOC PSYCHOL, V49, P1621, DOI 10.1037/0022-3514.49.6.1621; CODOL JP, 1975, EUR J SOC PSYCHOL, V5, P457, DOI 10.1002/ejsp.2420050404; Damian RI, 2019, J PERS SOC PSYCHOL, V117, P674, DOI 10.1037/pspp0000210; Digman JM, 1997, J PERS SOC PSYCHOL, V73, P1246, DOI 10.1037/0022-3514.73.6.1246; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Fleeson W, 1997, PSYCHOL AGING, V12, P125, DOI 10.1037/0882-7974.12.1.125; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Haddock G, 2006, EUR J SOC PSYCHOL, V36, P761, DOI 10.1002/ejsp.317; Haslam N, 2007, PERS INDIV DIFFER, V42, P1621, DOI 10.1016/j.paid.2006.11.001; HECKHAUSEN J, 1993, DEV PSYCHOL, V29, P539, DOI 10.1037/0012-1649.29.3.539; Helson R, 2002, J PERS SOC PSYCHOL, V83, P752, DOI 10.1037//0022-3514.83.3.752; Helson R, 2014, ADV PERSONALITY PSYC, V1, P77; Hogan R, 2004, J CAREER ASSESSMENT, V12, P207, DOI 10.1177/1069072703255882; Hornsey MJ, 2004, PERS SOC PSYCHOL REV, V8, P248, DOI 10.1207/s15327957pspr0803_2; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kanten AB, 2008, EUR J SOC PSYCHOL, V38, P343, DOI 10.1002/ejsp.457; Kwan VSY, 2004, PSYCHOL REV, V111, P94, DOI 10.1037/0033-295X.111.1.94; Lynn M, 2002, HDB POSITIVE PSYCHOL, P295; Nezlek J. B., 2011, MULTILEVEL MODELING; Orth U, 2018, PSYCHOL BULL, V144, P1045, DOI 10.1037/bul0000161; Quoidbach J, 2013, SCIENCE, V339, P96, DOI 10.1126/science.1229294; Raudenbush S.W., 2011, HLM 7 LINEAR NONLINE; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Robins RW, 2005, J PERS, V73, P489, DOI 10.1111/j.1467-6494.2005.00317.x; RYFF CD, 1991, PSYCHOL AGING, V6, P286, DOI 10.1037/0882-7974.6.2.286; Sedikides C., 2012, OXFORD HDB HUMAN MOT, P303, DOI DOI 10.1093/OXFORDHB/9780195399820.013.0017; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Trzesniewski KH, 2004, ADV CELL AGING GERON, V15, P163; Turner J.C., 1991, SOC INFLUENCE; Vignoles VL, 2006, J PERS SOC PSYCHOL, V90, P308, DOI 10.1037/0022-3514.90.2.308; Wilson AE, 2001, J PERS SOC PSYCHOL, V80, P572, DOI 10.1037//0022-3514.80.4.572; Wood D, 2006, PERS SOC PSYCHOL B, V32, P1482, DOI 10.1177/0146167206291008	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264036	10.1371/journal.pone.0264036	http://dx.doi.org/10.1371/journal.pone.0264036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176060	Green Published, gold			2022-12-26	WOS:000777505200066
J	Miura, K				Miura, Katsutoshi			Stiffness reduction and collagenase resistance of aging lungs measured using scanning acoustic microscopy	PLOS ONE			English	Article							NEWLY SYNTHESIZED COLLAGEN; TISSUE; DEGRADATION	Lung tissue stiffness is altered with aging. Quantitatively evaluating lung function is difficult using a light microscope (LM) alone. Scanning acoustic microscope (SAM) calculates the speed-of-sound (SOS) using sections to obtain histological images by plotting SOS values on the screen. As SOS is positively correlated with stiffness, SAM has a superior characteristic of simultaneously evaluating tissue stiffness and structure. SOS images of healthy bronchioles, arterioles, and alveoli were compared among young, middle-aged, and old lung sections. Formalin-fixed, paraffin-embedded (FFPE) sections consistently exhibited relatively higher SOS values than fresh-frozen sections, indicating that FFPE became stiffer but retained the relative stiffness reflecting fresh samples. All lung components exhibited gradually declining SOS values with aging and were associated with structural alterations such as loss of smooth muscles, collagen, and elastic fibers. Moreover, reaction to collagenase digestion resulted in decreased SOS values. SOS values of all components were significantly reduced in young and middle-aged groups, whereas no significant reduction was observed in the old group. Protease damage in the absence of regeneration or loss of elastic components was present in old lungs, which exbited dilated bronchioles and alveoli. Aging lungs gradually lose stiffness with decreasing structural components without exposure to specific insults such as inflammation.	[Miura, Katsutoshi] Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine	Miura, K (corresponding author), Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Hamamatsu, Shizuoka, Japan.	kmiura.hama.med@gmail.com	Miura, katsutoshi/K-1454-2017	Miura, katsutoshi/0000-0002-9262-7702				BATEMAN E, 1981, THORAX, V36, P645, DOI 10.1136/thx.36.9.645; Berg K, 2016, ARCH PATHOL LAB MED, V140, P1423, DOI 10.5858/arpa.2015-0455-RS; BIENKOWSKI RS, 1978, NATURE, V276, P413, DOI 10.1038/276413a0; Bowdish DME, 2019, CHEST, V155, P391, DOI 10.1016/j.chest.2018.09.003; Brandenberger C, 2017, CELL TISSUE RES, V367, P469, DOI 10.1007/s00441-016-2511-x; Clay R, 2019, J THORAC IMAG, V34, P313, DOI 10.1097/RTI.0000000000000334; CRENSHAW GL, 1954, DIS CHEST, V25, P427, DOI 10.1378/chest.25.4.427; DERRICO A, 1989, VIRCHOWS ARCH A, V415, P137, DOI 10.1007/BF00784351; Hozumi N, 2004, ULTRASONICS, V42, P717, DOI 10.1016/j.ultras.2003.11.005; LAURENT GJ, 1986, THORAX, V41, P418, DOI 10.1136/thx.41.6.418; MAYS PK, 1991, BIOCHEM J, V276, P307, DOI 10.1042/bj2760307; MCANULTY RJ, 1987, COLLAGEN REL RES, V7, P93; MITCHELL HH, 1945, J BIOL CHEM, V158, P625; Miura K., 2016, MICROSCOPY ANAL, P381; Miura K., 2013, PROTOC EXCH, DOI [10.1038/protex.2013.040, DOI 10.1038/PROTEX.2013.040]; Miura K, 2019, ULTRASOUND MED BIOL, V45, P3102, DOI 10.1016/j.ultrasmedbio.2019.08.012; Miura K, 2018, PATHOBIOL AGING AGE, V8, DOI 10.1080/20010001.2018.1516072; Miura K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6125204; Miura K, 2012, LAB INVEST, V92, P1760, DOI 10.1038/labinvest.2012.135; Polio SR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204765; Saijo Y, 2001, ANN BIOMED ENG, V29, P1048, DOI 10.1114/1.1424912; Sicard D, 2018, AM J PHYSIOL-LUNG C, V314, pL946, DOI 10.1152/ajplung.00415.2017; Skloot GS, 2017, CLIN GERIATR MED, V33, P447, DOI 10.1016/j.cger.2017.06.001; Verleden SE, 2021, LANCET RESP MED, V9, P167, DOI 10.1016/S2213-2600(20)30324-6; Zhou BR, 2019, RADIOLOGY, V291, P478, DOI 10.1148/radiol.2019181729	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263926	10.1371/journal.pone.0263926	http://dx.doi.org/10.1371/journal.pone.0263926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176066	gold, Green Published			2022-12-26	WOS:000777505200046
J	Siddique, MI; Lee, JH; Ahn, JH; Kusumawardhani, MK; Safitri, R; Harpenas, A; Kwon, JK; Kang, BC				Siddique, Muhammad Irfan; Lee, Joung-Ho; Ahn, Jung-Hwan; Kusumawardhani, Meirina Kartika; Safitri, Ramadhani; Harpenas, Asep; Kwon, Jin-Kyung; Kang, Byoung-Cheorl			Genotyping-by-sequencing-based QTL mapping reveals novel loci for Pepper yellow leaf curl virus (PepYLCV) resistance in Capsicum annuum	PLOS ONE			English	Article							TOMATO; DISEASE; GENE; BEGOMOVIRUS; AGROINOCULATION; EXPRESSION; DEFENSE; LINES; L.	Disease caused by Pepper yellow leaf curl virus (PepYLCV) is one of the greatest threats to pepper (Capsicum spp.) cultivation in the tropics and subtropics. Resistance to PepYLCV was previously identified in a few Capsicum accessions, but no resistance QTLs have been mapped. This study aimed to elucidate the genetics of PepYLCV resistance in C. annuum L. Augmented inoculation by the viruliferous whitefly Bemisia tabaci was used to evaluate parental lines and an F-2 segregating population derived from a cross between resistant C. annuum line LP97 and susceptible C. annuum line ECW30R. Final evaluation was performed six weeks after inoculation using a standardized 5-point scale (0 = no symptoms to 4 = very severe symptoms). A high-density linkage map was constructed using genotyping-by-sequencing (GBS) to identify single-nucleotide polymorphism (SNP) markers associated with PepYLCV resistance in the F-2 population. QTL analysis revealed three QTLs, peplcv-1, peplcv-7, and peplcv-12, on chromosomes P1, P7, and P12, respectively. Candidate genes associated with PepYLCV resistance in the QTL regions were inferred. In addition, single markers Chr7-LCV-7 and Chr12-LCV-12 derived from the QTLs were developed and validated in another F2 population and in commercial varieties. This work thus provides not only information for mapping PepYLCV resistance loci in pepper but also forms the basis for future molecular analysis of genes involved in PepYLCV resistance.	[Siddique, Muhammad Irfan; Lee, Joung-Ho; Kwon, Jin-Kyung; Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Agr Forestry & Bioresources, Res Inst Agr & Life Sci, Plant Genom & Breeding Inst,Coll Agr & Life Sci, Seoul, South Korea; [Ahn, Jung-Hwan] ECOSEED, Gimje Si, South Korea; [Kusumawardhani, Meirina Kartika; Safitri, Ramadhani; Harpenas, Asep] East West Seed Indonesia, Dept Plant Pathol, Java, Indonesia	Seoul National University (SNU)	Kang, BC (corresponding author), Seoul Natl Univ, Dept Agr Forestry & Bioresources, Res Inst Agr & Life Sci, Plant Genom & Breeding Inst,Coll Agr & Life Sci, Seoul, South Korea.	bk54@snu.ac.kr		Kang, Byoung-Cheorl/0000-0002-7606-7258	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) through the Agriculture, Food, and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center) - Ministry of Agriculture, Food, and R [710011-03]; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ01327801]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) through the Agriculture, Food, and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center) - Ministry of Agriculture, Food, and R; Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) through the Agriculture, Food, and Rural Affairs Research Center Support Program (Vegetable Breeding Research Center, 710011-03), funded by the Ministry of Agriculture, Food, and Rural Affairs (MAFRA). This work was carried out with the support of the Cooperative Research Program for Agriculture Science & Technology Development (Project No.PJ01327801), Rural Development Administration, Republic of Korea.	An JW, 2021, VIRUS RES, V291, DOI 10.1016/j.virusres.2020.198192; Anandhi K., 2011, Journal of Tropical Agriculture, V49, P107; Anaya-Lopez JL, 2003, HORTSCIENCE, V38, P251, DOI 10.21273/HORTSCI.38.2.251; Anbinder I, 2009, THEOR APPL GENET, V119, P519, DOI 10.1007/s00122-009-1060-z; Bal S. S., 1995, Indian Journal of Virology, V11, P77; Barchenger DW, 2019, HORTSCIENCE, V54, P2146, DOI 10.21273/HORTSCI14484-19; Chattopadhyay B, 2008, ARCH VIROL, V153, P533, DOI 10.1007/s00705-007-0017-2; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dong PanPan, 2016, Plant Breeding and Biotechnology, V4, P79, DOI 10.9787/PBB.2016.4.1.79; Gill U, 2019, THEOR APPL GENET, V132, P1543, DOI 10.1007/s00122-019-03298-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Han K, 2016, DNA RES, V23, P81, DOI 10.1093/dnares/dsv038; Hanson P, 2006, REP TOMATO GENET COO, V56, P17; Ji Y, 2007, MOL BREEDING, V20, P271, DOI 10.1007/s11032-007-9089-7; Ji YF, 2009, J AM SOC HORTIC SCI, V134, P281, DOI 10.21273/JASHS.134.2.281; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kenyon L, 2014, VIRUS RES, V186, P104, DOI 10.1016/j.virusres.2013.12.026; Kim N, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1093186; Koeda S, 2021, THEOR APPL GENET, V134, P2947, DOI 10.1007/s00122-021-03870-7; Koeda S, 2018, HORTICULT J, V87, P364, DOI 10.2503/hortj.OKD-137; Koeda S, 2017, HORTICULT J, V86, P479, DOI 10.2503/hortj.OKD-049; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S., 2009, VEG SCI, V36, P230; Kumar S, 2006, SCI HORTIC-AMSTERDAM, V110, P359, DOI 10.1016/j.scienta.2006.07.030; Kumar S, 2011, INDIAN J AGR SCI, V81, P187; Kushwaha N, 2015, APPL MICROBIOL BIOT, V99, P4757, DOI 10.1007/s00253-015-6415-6; Lapidot M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005538; Lee JH, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010009; Lee JH, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0717-6; Mangiola M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00004; Maurya PK, 2019, INDIAN J GENET PL BR, V79, P741, DOI 10.31742/IJGPB.79.4.13; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Naresh P, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0720-y; Nevame AYM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8120281; Pernezny K., 2003, COMPENDIUM PEPPER DI, P63; Rai VP, 2014, SCI HORTIC-AMSTERDAM, V172, P34, DOI 10.1016/j.scienta.2014.03.039; Rai VP, 2010, VEG SCI, V37, P124; Scott JW, 2015, HORTSCIENCE, V50, P1405, DOI 10.21273/HORTSCI.50.9.1405; Shafiq M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-367; Siddiqui MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38575-x; Singh AK, 2016, APPL MICROBIOL BIOT, V100, P4035, DOI 10.1007/s00253-015-7279-5; Srivastava A, 2017, CROP PROT, V100, P177, DOI 10.1016/j.cropro.2017.06.015; Thakur H, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02168-7; Thakur H, 2019, CROP PROT, V116, P115, DOI 10.1016/j.cropro.2018.10.007; Thakur H, 2018, J PLANT DIS PROTECT, V125, P239, DOI 10.1007/s41348-018-0146-8; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; Vijeth S, 2020, PLANT PATHOLOGY J, V19, P121; Wang S., 2011, WINDOWS QTL CARTOGRA; Yamaguchi H, 2018, THEOR APPL GENET, V131, P1345, DOI 10.1007/s00122-018-3082-x; Yang HB, 2012, MOL BREEDING, V30, P819, DOI 10.1007/s11032-011-9666-7; Yang XH, 2014, MOL BREEDING, V34, P749, DOI 10.1007/s11032-014-0072-9; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889	52	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264026	10.1371/journal.pone.0264026	http://dx.doi.org/10.1371/journal.pone.0264026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176091	Green Published, gold			2022-12-26	WOS:000777505200063
J	Biswas, MAA; Kafi, MA; Hemel, MMM; Ahmed, MMM; Khan, SI				Biswas, Md Abdullah Al Jubayer; Kafi, Mohammad Abdullah; Hemel, Muhammad Manwar Morshed; Ahmed, Mondar Maruf Moin; Khan, Sharful Islam			Women empowerment and sexually transmitted infections: Evidence from Bangladesh demographic and health survey 2014	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SAFER-SEX; CARE UTILIZATION; DECISION-MAKING; PREGNANT-WOMEN; MARRIED-WOMEN; AUTONOMY; KNOWLEDGE; PERSPECTIVES; NEGOTIATION	Background Sexually transmitted infections (STIs) among women have led to substantial public health and economic burdens in several low-middle-income countries. However, there is a paucity of scientific knowledge about the relationship between empowerment and symptoms of STIs among married Bangladeshi women. This article aimed to examine the association between women empowerment and symptoms of STIs among currently married Bangladeshi women of reproductive age. Materials and methods We extracted data from the Bangladesh Demographic and Health Survey (BDHS), conducted from June 28, 2014, to November 9, 2014. We utilised cross-tabulation, the conceptual framework and multivariable multilevel mixed-effect logistics regression to explore the association between women's empowerment indicators and women's self-reported symptoms of genital sore and abnormal genital discharge. All of the analysis was adjusted using cluster weight. Results We found that among 16,858 currently married women, 5.59% and 10.84% experienced genital sores and abnormal genital discharge during the past 12 months, respectively. Women who depended on husbands to make decisions regarding their health care (AOR = 0.75, 95% CI = 0.67-0.84), significant household purchases (AOR = 0.79, 95% CI = 0.71-0.88), and visiting family or relatives (AOR = 0.72, 95% CI = 0.64-0.80) were less likely to report signs of abnormal genital discharge. Women who could make joint healthcare decisions with their husbands were also less likely to report genital sores (AOR = 0.78, 95% CI = 0.67-0.90). Conclusion Genital sores and abnormal genital discharge were prevalent across all parameters of women empowerment among currently married women in Bangladesh. Our estimates show that the husband plays a significant role in decision-making about sexual and reproductive health. Efforts need to be invested in establishing culturally relevant gender policies which facilitate the involvement of women in joint decision-making.	[Biswas, Md Abdullah Al Jubayer; Hemel, Muhammad Manwar Morshed; Khan, Sharful Islam] Icddr B, Infect Dis Div, Program HIV & AIDS, Dhaka, Bangladesh; [Kafi, Mohammad Abdullah] Icddr B, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh; [Ahmed, Mondar Maruf Moin] Icddr B, Nutr & Clin Serv Div, Maternal & Child Nutr, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Khan, SI (corresponding author), Icddr B, Infect Dis Div, Program HIV & AIDS, Dhaka, Bangladesh.	sharful@icddrb.org	Biswas, Md. Jubayer/AFK-8120-2022	Biswas, Md. Jubayer/0000-0002-7879-8011; Khan, MBBS, MHSS, PhD, Sharful Islam/0000-0002-7319-1333; Morshed Hemel, Muhammad Manwar/0000-0002-6564-9172				Afroja S., WOMENS AUTONOMY REPR; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Alam N, 2010, SOC SCI MED, V71, P1921, DOI 10.1016/j.socscimed.2010.09.009; Alomair N, 2020, SEX REPROD HLTH MATT, V28, DOI 10.1080/26410397.2020.1731296; Becker S, 2006, SOC SCI MED, V62, P2313, DOI 10.1016/j.socscimed.2005.10.006; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Boroumandfar Zahra, 2017, Iran J Nurs Midwifery Res, V22, P303, DOI 10.4103/ijnmr.IJNMR_117_16; Chesson HW., 2017, SEXUALLY TRANSMITTED; Costa Eleonora C.V., 2018, Port J Public Health, V36, P1, DOI 10.1159/000486466; Darteh EKM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209985; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; FLEISHER JM, 1994, J COMMUN HEALTH, V19, P395, DOI 10.1007/BF02260322; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Gautam S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050709; GSMA, 2021, CONN WOM MOB GEND GA; Haque SE, 2012, WOMEN HEALTH ISS, V22, pE171, DOI 10.1016/j.whi.2011.08.004; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Heath R, 2015, J DEV ECON, V115, P1, DOI 10.1016/j.jdeveco.2015.01.006; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Jahangir YT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176195; James-Hawkins L, 2018, GLOB PUBLIC HEALTH, V13, P843, DOI 10.1080/17441692.2016.1239270; Jejeebhoy SJ, 2002, STUD FAMILY PLANN, V33, P299, DOI 10.1111/j.1728-4465.2002.00299.x; Jennings L, 2017, AIDS BEHAV, V21, P665, DOI 10.1007/s10461-016-1435-5; Jesmin SS, 2015, VIOLENCE VICTIMS, V30, P984, DOI 10.1891/0886-6708.VV-D-14-00066; Jesmin SS, 2014, CULT HEALTH SEX, V16, P666, DOI 10.1080/13691058.2014.901561; Kabir A, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00952-4; Kishor S., 1997, SEM FEM EMP DEM PROC; Korenromp EL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211720; Mainuddin Akm, 2015, J Family Reprod Health, V9, P65; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; McMorris BJ, 2000, J HEALTH SOC BEHAV, V41, P276, DOI 10.2307/2676321; Muchomba FM, 2015, J URBAN HEALTH, V92, P559, DOI 10.1007/s11524-014-9935-y; Mumtaz Z., 2009, MEDICINE, V68, P1349, DOI [10.1016/j.socscimed.2009.01.025, DOI 10.1016/J.SOCSCIMED.2009.01.025]; NIPORT NIoPR Training-NIPORT/Bangladesh Mitra Associates ICF International., 2016, BANGL DEM HLTH SURV; Organisation WH, 2019, SEXUALLY TRANSMITTED; Organization IL, LAB FORC PART RAT FE; Osborn D., 2015, UNIVERSAL SUSTAINABL; Parvin GA., 2004, J GEO ENV, V4, P47; Payton E, 2019, VIOLENCE GEND, V6, P219, DOI 10.1089/vio.2019.0003; Pitt MM, 2006, ECON DEV CULT CHANGE, V54, P791, DOI 10.1086/503580; Prevention CfDCa, SYPH CDC FACT SHEET; Rahman M, 2012, MATERN CHILD HLTH J, V16, P1206, DOI 10.1007/s10995-011-0897-3; Rich LM, 2002, PERSPECT SEX REPRO H, V34, P127, DOI 10.2307/3097711; Rizvi Narjis, 2004, JPMA Journal of the Pakistan Medical Association, V54, P620; Robinson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180699; Sanawar SB, 2019, J BIOSOC SCI, V51, P188, DOI [10.1017/S0021932018000068, 10.1017/s0021932018000068]; Schuler SR, 2017, VIOLENCE AGAINST WOM, V23, P1100, DOI 10.1177/1077801216654576; Silverman JG., 2007, GYNAECOLOGY, V114, P1246; Spence D, 2007, BMJ-BRIT MED J, V335, P1147, DOI 10.1136/bmj.39378.633287.80; STEINBERG L, 1991, DEV PSYCHOL, V27, P304, DOI 10.1037/0012-1649.27.2.304; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; Tchokossa AM, 2018, INT J CARING SCI, P267; Uddin J., 2017, COUPLES CONCORDANCE, V17, P107, DOI [10.1186/s12905-017-0462-3, DOI 10.1186/S12905-017-0462-3]; Ung M, 2014, J BIOSOC SCI, V46, P90, DOI 10.1017/S0021932013000151; Verma Anjana, 2015, Int J Reprod Med, V2015, P563031, DOI 10.1155/2015/563031; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wand H, 2012, AIDS CARE, V24, P1155, DOI 10.1080/09540121.2012.687820; Women KabeerN., 1997, DEV CHANGE, V28, P261; Yaya S, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0658-5	59	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263958	10.1371/journal.pone.0263958	http://dx.doi.org/10.1371/journal.pone.0263958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171939	Green Published, gold			2022-12-26	WOS:000795889700049
J	Shi, XY; Zhou, Q; Huang, BQ; Xia, SL; Jiang, YK; Fang, SF; Lin, JR				Shi, Xueying; Zhou, Qi; Huang, Bingqian; Xia, Shilin; Jiang, Yuankuan; Fang, Shifeng; Lin, Jingrong			Prognostic and immune-related value of STK17B in skin cutaneous melanoma	PLOS ONE			English	Article							CANCER; CELLS; METASTASIS; INFECTIONS; RADIATION; FAMILY	Skin cutaneous melanoma (SKCM) is a common cancer of which mortality is increasing continuously. Our study conducted a series of analyses on the clinical significance of Serine/threonine kinase 17B (STK17B) in SKCM to provide a new biomarker for diagnosis and treatment. The RNA-sequence data were obtained from The Cancer Genome Atlas and Genotype-Tissue Expression databases. The data of 468 SKCM patients were divided into STK17B high- and low-expression groups and analyzed by Bioconductor package to identify the differential expressed genes. The R package of "clusterProfiler" was used for Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and Gene-Set Enrichment Analysis analyses. A protein-protein interaction network and immune infiltration landscape were respectively constructed via STRING database and ssGSEA. STK17B had lower expression in SKCM than normal tissues. Besides, STK17B expression was significantly related to some clinicopathological characteristics in SKCM patients including T stage, Breslow depth, radiation therapy, melanoma Clark level, and pathologic stage. The Kaplan-Meier curve analyses revealed that the low expression of STK17B was correlated with poor overall survival and disease-specific survival. We constructed nomograms to predict the 1-, 3-, and 5-year survival of SKCM patients. The function enrichment analyses showed STK17B-related differential expressed genes were enriched in cellular differentiation and immune-related progress. STK17B expression level were positively correlated with infiltrating level of immune cells. In this study, we found that STK17B, which played an important role in immune infiltration, could be a new biomarker for diagnosis and prognosis in SKCM patients.	[Shi, Xueying; Zhou, Qi; Huang, Bingqian; Xia, Shilin] Dalian Med Univ, Clin Lab Integrat Med, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Shi, Xueying; Zhou, Qi; Huang, Bingqian] Dalian Med Univ, Inst Coll Integrat Med, Dalian, Liaoning, Peoples R China; [Jiang, Yuankuan; Lin, Jingrong] Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China; [Fang, Shifeng] Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Lin, JR (corresponding author), Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.; Fang, SF (corresponding author), Dalian Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Dalian, Liaoning, Peoples R China.	stonecrest@sina.com; amy4963@163.com			National Natural Science Foundation of China [81973603]; Natural Science Foundation of Liaoning Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This research was funded by the National Natural Science Foundation of China (81973603), Natural Science Foundation of Liaoning Province (No.2019-MS-094), Authors declared that the funding source did not participate in the study design; collection, analyses and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Angkasekwinai P, 2021, NAT REV IMMUNOL, V21, P37, DOI 10.1038/s41577-020-0396-0; [Anonymous], 2018, BMJ CLIN RES ED, V362, pk4131, DOI [10.1136/bmj.k4131, DOI 10.1136/BMJ.K4131]; Barker CA, 2014, INT J RADIAT ONCOL, V88, P986, DOI 10.1016/j.ijrobp.2013.08.035; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Cao Y, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.761350; Capra M, 2006, CANCER RES, V66, P8147, DOI 10.1158/0008-5472.CAN-05-3489; Crichton N, 2000, J CLIN NURS, V9, P584; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Kogel D, 2001, BIOESSAYS, V23, P352, DOI 10.1002/bies.1050; Kolmel KF, 1999, MELANOMA RES, V9, P511; Lan YL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0262-1; Li J, 2021, CHANNELS, V15, P528, DOI 10.1080/19336950.2021.1965422; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; McGargill MA, 2008, J IMMUNOL, V181, P7593, DOI 10.4049/jimmunol.181.11.7593; Netscher DT, 2011, PLAST RECONSTR SURG, V127, p37E, DOI 10.1097/PRS.0b013e318206352b; Pelster MS, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919830826; Rebecca VW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15546-9; Ru BB, 2019, BIOINFORMATICS, V35, P4200, DOI 10.1093/bioinformatics/btz210; Schadendorf D, 2018, LANCET, V392, P971, DOI 10.1016/S0140-6736(18)31559-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sierra J, 2020, MEDICINA-BUENOS AIRE, V80, P329; Situm M, 2014, ACTA DERMATOVENER CR, V22, P1; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szoltysek K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207663; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Vivian J, 2017, NAT BIOTECHNOL, V35, P314, DOI 10.1038/nbt.3772; Yang KM, 2012, CELL REP, V2, P1286, DOI 10.1016/j.celrep.2012.09.028; Ye P, 2013, LEUKEMIA RES, V37, P595, DOI 10.1016/j.leukres.2013.01.012; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang XB, 2017, ONCOL RES, V25, P1529, DOI 10.3727/096504017X14888987683152	34	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263311	10.1371/journal.pone.0263311	http://dx.doi.org/10.1371/journal.pone.0263311			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171924	Green Published, gold			2022-12-26	WOS:000795889700021
J	Sultan, AR; Tavakol, M; Lemmens-den Toom, NA; Croughs, PD; Verkaik, NJ; Verbon, A; Van Wamel, WJB				Sultan, Andi Rofian; Tavakol, Mehri; Lemmens-den Toom, Nicole A.; Croughs, Peter D.; Verkaik, Nelianne J.; Verbon, Annelies; van Wamel, Willem J. B.			Real time monitoring of Staphylococcus aureus biofilm sensitivity towards antibiotics with isothermal microcalorimetry	PLOS ONE			English	Article							RIFAMPIN COMBINATION THERAPY; SMALL-COLONY VARIANTS; SERUM CONCENTRATIONS; EXTRACELLULAR DNA; EPIDERMIDIS; RESISTANCE; EFFICACY; INFECTIONS; VANCOMYCIN; BIOAVAILABILITY	Biofilm-associated infections with Staphylococcus aureus are difficult to treat even after administration of antibiotics that according to the standard susceptibility assays are effective. Currently, the assays used in the clinical laboratories to determine the sensitivity of S. aureus towards antibiotics are not representing the behaviour of biofilm-associated S. aureus, since these assays are performed on planktonic bacteria. In research settings, microcalorimetry has been used for antibiotic susceptibility studies. Therefore, in this study we investigated if we can use isothermal microcalorimetry to monitor the response of biofilm towards antibiotic treatment in real-time. We developed a reproducible method to generate biofilm in an isothermal microcalorimeter setup. Using this system, the sensitivity of 5 methicillin-sensitive S. aureus (MSSA) and 5 methicillin-resistant S. aureus (MRSA) strains from different genetic lineages were determined towards: flucloxacillin, cefuroxime, cefotaxime, gentamicin, rifampicin, vancomycin, levofloxacin, clindamycin, erythromycin, linezolid, fusidic acid, co-trimoxazole, and doxycycline. In contrast to conventional assays, our calorimetry-based biofilm susceptibility assay showed that S. aureus biofilms, regardless MSSA or MRSA, can survive the exposure to the maximum serum concentration of all tested antibiotics. The only treatment with a single antibiotic showing a significant reduction in biofilm survival was rifampicin, yet in 20% of the strains, emerging antibiotic resistance was observed. Furthermore, the combination of rifampicin with flucloxacillin, vancomycin or levofloxacin was able to prevent S. aureus biofilm from becoming resistant to rifampicin. Isothermal microcalorimetry allows real-time monitoring of the sensitivity of S. aureus biofilms towards antibiotics in a fast and reliable way.	[Sultan, Andi Rofian; Tavakol, Mehri; Lemmens-den Toom, Nicole A.; Croughs, Peter D.; Verkaik, Nelianne J.; Verbon, Annelies; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Sultan, Andi Rofian] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia	Erasmus University Rotterdam; Erasmus MC; Universitas Hasanuddin	Van Wamel, WJB (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	w.vanwamel@erasmusmc.nl		van Wamel, Willem/0000-0001-9145-9121; Verkaik, Nelianne/0000-0003-2351-2669	DIKTI scholarship [3340/E4.4/K/2014]	DIKTI scholarship	This study was partly funded by a DIKTI scholarship, grant no. 3340/E4.4/K/2014 of the Republic of Indonesia which cover the first author (Andi R. Sultan) monthly allowance and bench fee during his stay in Rotterdam, the Netherland.	Ameen SM, 2014, J ANTIMICROB CHEMOTH, V69, P757, DOI 10.1093/jac/dkt400; Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Ashong CN, 2017, SURG INFECT, V18, P143, DOI 10.1089/sur.2016.165; Azeredo J, 2017, CRIT REV MICROBIOL, V43, P313, DOI 10.1080/1040841X.2016.1208146; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BARZA M, 1978, CLIN PHARMACOKINET, V3, P202, DOI 10.2165/00003088-197803030-00002; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Buchholz F, 2010, ANTIMICROB AGENTS CH, V54, P312, DOI 10.1128/AAC.00583-09; Bull JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094690; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cimmino MA, 1997, DRUGS, V54, P50, DOI 10.2165/00003495-199754010-00004; Coenye T, 2018, CLIN MICROBIOL INFEC, V24, P570, DOI 10.1016/j.cmi.2018.01.003; Corona F, 2013, ANTIBIOTICS-BASEL, V2, P237, DOI 10.3390/antibiotics2020237; Croes S, 2010, ANTIMICROB AGENTS CH, V54, P3907, DOI 10.1128/AAC.01811-09; den Reijer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145722; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522; Dusane DH, 2018, J ORTHOP RES, V36, P1086, DOI 10.1002/jor.23723; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072; GARNHAM JC, 1976, BRIT J CLIN PHARMACO, V3, P897, DOI 10.1111/j.1365-2125.1976.tb00644.x; Greimel F, 2017, DRUG DES DEV THER, V11, P1729, DOI 10.2147/DDDT.S138888; Haney EF, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020029; Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Iliadis AD, 2017, EFORT OPEN REV, V2, P7, DOI 10.1302/2058-5241.2.160027; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Joo HS, 2015, BBA-BIOMEMBRANES, V1848, P3055, DOI 10.1016/j.bbamem.2015.02.009; Jorgensen NP, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw019; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Leder K, 1999, J ANTIMICROB CHEMOTH, V43, P113, DOI 10.1093/jac/43.1.113; Lefebvre M, 2010, INT J ANTIMICROB AG, V36, P542, DOI 10.1016/j.ijantimicag.2010.07.008; Lerchner J, 2008, THERMOCHIM ACTA, V477, P48, DOI 10.1016/j.tca.2008.08.007; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lother SA, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0599-0; Macia MD, 2014, CLIN MICROBIOL INFEC, V20, P981, DOI 10.1111/1469-0691.12651; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Mariana F, 2013, INT J MED MICROBIOL, V303, P158, DOI 10.1016/j.ijmm.2012.12.009; Martin Jennifer H, 2010, Clin Biochem Rev, V31, P21; Maudsdotter L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00988; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; McConoughey SJ, 2014, FUTURE MICROBIOL, V9, P987, DOI [10.2217/fmb.14.64, 10.2217/FMB.14.64]; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; Morais FM, 2014, METHODS MOL BIOL, V1147, P267, DOI 10.1007/978-1-4939-0467-9_19; MYLOTTE JM, 1987, REV INFECT DIS, V9, P891; NICHOLAS P, 1975, ANTIMICROB AGENTS CH, V8, P220, DOI 10.1128/AAC.8.2.220; Niska JA, 2013, ANTIMICROB AGENTS CH, V57, P5080, DOI 10.1128/AAC.00702-13; Pancholi P, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01329-17, 10.1128/JCM.01329-17]; PARSONS RL, 1978, POSTGRAD MED J, V54, P68, DOI 10.1136/pgmj.54.628.68; Pea F, 2010, ANTIMICROB AGENTS CH, V54, P4605, DOI 10.1128/AAC.00177-10; Planet PJ, 2017, TRENDS MICROBIOL, V25, P153, DOI 10.1016/j.tim.2016.09.009; Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; ROSS A C, 1991, Current Opinion in Rheumatology, V3, P628, DOI 10.1097/00002281-199108000-00013; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sandoe JAT, 2006, J ANTIMICROB CHEMOTH, V57, P767, DOI 10.1093/jac/dkl013; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Singh R, 2009, J MED MICROBIOL, V58, P1067, DOI 10.1099/jmm.0.009720-0; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sultan AR, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00605-19; Sultan AR, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00352-18; Swoboda S, 2003, J ANTIMICROB CHEMOTH, V51, P459, DOI 10.1093/jac/dgk056; Tasse J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31437-y; Thoroddsen E, 1997, PEDIATR INFECT DIS J, V16, P959, DOI 10.1097/00006454-199710000-00011; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; UBUKATA K, 1989, J BACTERIOL, V171, P2882, DOI 10.1128/jb.171.5.2882-2885.1989; UEDA T, 1985, INFECTION, V13, pS43, DOI 10.1007/BF01644217; VAILLANT L, 1992, BRIT J DERMATOL, V126, P591; van Trijp MJCA, 2010, DIAGN MICR INFEC DIS, V66, P222, DOI 10.1016/j.diagmicrobio.2009.08.021; Waters V, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009528.pub4; WELLING PG, 1977, ANTIMICROB AGENTS CH, V11, P462, DOI 10.1128/AAC.11.3.462; Wertheim HFL, 2005, J INFECT DIS, V192, P1196, DOI 10.1086/444427; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wilson Christina, 2017, Res Rev J Eng Technol, V6; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F; Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002	80	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0260272	10.1371/journal.pone.0260272	http://dx.doi.org/10.1371/journal.pone.0260272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171906	gold, Green Published			2022-12-26	WOS:000795889700002
J	Yamkate, P; Gold, RM; Twedt, DC; Suchodolski, JS; Steiner, JM; Lidbury, JA				Yamkate, Punyamanee; Gold, Randi M.; Twedt, David C.; Suchodolski, Jan S.; Steiner, Joerg M.; Lidbury, Jonathan A.			Assessment of the intracellular distribution of copper in liver specimens from cats	PLOS ONE			English	Article							HEPATIC COPPER; TISSUE; PROTEIN; NUCLEAR; ZINC	The intracellular distribution of copper in the liver has been investigated in dogs and humans. However, this has not been reported in cats. This study aimed to assess the intracellular copper distribution in liver specimens from cats with a range of hepatic copper concentrations. Twenty-nine frozen liver specimens from cats were included. Each liver specimen was divided into two pieces for overall copper quantification and tissue fractionation. The copper concentrations in liver specimens and liver fractions were measured by flame atomic absorption spectroscopy. Five specimens had copper concentrations < 100 mu g/g dry weight, eight had copper concentrations between 100 and 180 mu g/g, 14 had copper concentrations between 181 and 700 mu g/g, and two had copper concentrations >700 mu g/g. Only one specimen had positive copper staining. Regardless of the overall concentrations, copper was mostly found in the cytosolic fraction followed by the nuclear, large granule, and microsomal fractions. Our findings indicate that similarly to other species, intracellular copper is predominantly found in the cytosolic and nuclear fractions in cats. The distribution in cats with copper-loaded conditions, such as primary copper hepatopathy, was not assessed but warrants evaluation.	[Yamkate, Punyamanee; Gold, Randi M.; Suchodolski, Jan S.; Steiner, Joerg M.; Lidbury, Jonathan A.] Texas A&M Univ, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Twedt, David C.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Yamkate, Punyamanee] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Med, Bangkok, Thailand; [Gold, Randi M.] Texas A&M Vet Med Diagnost Lab, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Colorado State University; Chulalongkorn University; Texas A&M University System; Texas A&M University College Station	Yamkate, P (corresponding author), Texas A&M Univ, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.; Yamkate, P (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Vet Med, Bangkok, Thailand.	punyamanee72@gmail.com						Andreani G, 2010, BIOL TRACE ELEM RES, V137, P177, DOI 10.1007/s12011-009-8569-5; BAUDHUIN P, 1964, BIOCHEM J, V92, P179, DOI 10.1042/bj0920179; BEAUFAY H, 1976, METHODS MEMBRANE BIO, V6, P1; Beaufray H, 1959, BIOCHEM J, V73, P263; Bolann BJ, 2007, SCAND J CLIN LAB INV, V67, P353, DOI 10.1080/00365510601095281; Center SA, 2013, AM J VET RES, V74, P1474, DOI 10.2460/ajvr.74.12.1474; DIPRISCO G, 1968, BIOCHEM BIOPH RES CO, V33, P606, DOI 10.1016/0006-291X(68)90339-2; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Graham John M, 2002, ScientificWorldJournal, V2, P1638; GREGORIA.G, 1967, CAN J BIOCHEM CELL B, V45, P1841, DOI 10.1139/o67-217; Harper AE, 1965, METHODS ENZYMATIC AN, P788; HAYNES JS, 1995, VET PATHOL, V32, P427, DOI 10.1177/030098589503200414; Hoffmann WE, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P351, DOI 10.1016/B978-0-12-370491-7.00012-X; Hurwitz BM, 2014, JAVMA-J AM VET MED A, V244, P68, DOI 10.2460/javma.244.1.68; JOHNSON GF, 1981, HEPATOLOGY, V1, P243, DOI 10.1002/hep.1840010309; Kawamura M, 2002, VET PATHOL, V39, P747, DOI 10.1354/vp.39-6-747; KETTELHUT IC, 1980, AM J PHYSIOL, V239, pR437, DOI 10.1152/ajpregu.1980.239.5.R437; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Lim J, 2011, ANAL BIOCHEM, V418, P78, DOI 10.1016/j.ab.2011.06.045; Lopez-Alonso M, 2005, VET J, V170, P332, DOI 10.1016/j.tvjl.2004.07.007; LYNCH WE, 1975, J BIOL CHEM, V250, P8179; Meertens NM, 2005, VET PATHOL, V42, P97, DOI 10.1354/vp.42-1-97; MIGLIORINI RH, 1973, AM J PHYSIOL, V225, P1389, DOI 10.1152/ajplegacy.1973.225.6.1389; NORDLIE RC, 1979, LIFE SCI, V24, P2397, DOI 10.1016/0024-3205(79)90447-8; Passlack N, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-163; PORTER H, 1964, ARCH NEUROL-CHICAGO, V11, P341, DOI 10.1001/archneur.1964.00460220003001; Puls R., 1988, Mineral levels in animal health. Diagnostic data.; Schultheiss PC, 2002, J VET DIAGN INVEST, V14, P396, DOI 10.1177/104063870201400506; SMEYERSVERBEKE J, 1977, ANAL BIOCHEM, V83, P746, DOI 10.1016/0003-2697(77)90080-X; Uauy R, 1998, AM J CLIN NUTR, V67, p952S, DOI 10.1093/ajcn/67.5.952S; Wu XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020196; Yamkate P, 2021, J FELINE MED SURG, V23, P526, DOI 10.1177/1098612X20961350	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0264003	10.1371/journal.pone.0264003	http://dx.doi.org/10.1371/journal.pone.0264003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157741	gold, Green Published			2022-12-26	WOS:000788004500032
J	Yousuf, M; Shamsi, A; Anjum, F; Shafie, A; Islam, A; Haque, QMR; Elasbali, AM; Yadav, DK; Hassan, MI				Yousuf, Mohd; Shamsi, Anas; Anjum, Farah; Shafie, Alaa; Islam, Asimul; Haque, Qazi Mohd Rizwanul; Elasbali, Abdelbaset Mohamed; Yadav, Dharmendra Kumar; Hassan, Md Imtaiyaz			Effect of pH on the structure and function of cyclin-dependent kinase 6	PLOS ONE			English	Article							CELL-CYCLE; CRYSTAL-STRUCTURE; THIOFLAVIN T; CDK6; PROLIFERATION; FLUORESCENCE; PATHWAY; DIFFERENTIATION; INHIBITION; ACTIVATION	Cyclin-dependent kinase 6 (CDK6) is an important protein kinase that regulates cell growth, development, cell metabolism, inflammation, and apoptosis. Its overexpression is associated with reprogramming glucose metabolism through alternative pathways and apoptosis, which ultimately plays a significant role in cancer development. In the present study, we have investigated the structural and conformational changes in CDK6 at varying pH employing a multi-spectroscopic approach. Circular dichroism (CD) spectroscopy revealed at extremely acidic conditions (pH 2.0-4.0), the secondary structure of CDK6 got significantly disrupted, leading to aggregates formation. These aggregates were further characterized by employing Thioflavin T (ThT) fluorescence. No significant secondary structural changes were observed over the alkaline pH range (pH 7.0-11.0). Further, fluorescence and UV spectroscopy revealed that the tertiary structure of CDK6 was disrupted under extremely acidic conditions, with slight alteration occurring in mild acidic conditions. The tertiary structure remains intact over the entire alkaline range. Additionally, enzyme assay provided an insight into the functional aspect of CDK at varying pH; CDK6 activity was optimal in the pH range of 7.0-8.0. This study will provide a platform that provides newer insights into the pH-dependent dynamics and functional behavior of CDK6 in different CDK6 directed diseased conditions, viz. different types of cancers where changes in pH contribute to cancer development.	[Yousuf, Mohd; Haque, Qazi Mohd Rizwanul] Jamia Millia Islamia, Dept Biosci, New Delhi, India; [Shamsi, Anas; Islam, Asimul; Hassan, Md Imtaiyaz] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Anjum, Farah; Shafie, Alaa] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Taif, Saudi Arabia; [Elasbali, Abdelbaset Mohamed] Jouf Univ, Coll Appl Med Sci Qurayyat, Clin Lab Sci, Sakaka, Saudi Arabia; [Yadav, Dharmendra Kumar] Gachon Univ Med & Sci, Coll Pharm, Incheon, South Korea	Jamia Millia Islamia; Jamia Millia Islamia; Taif University; Al Jouf University; Gachon University	Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.; Yadav, DK (corresponding author), Gachon Univ Med & Sci, Coll Pharm, Incheon, South Korea.	dharmendra30oct@gmail.com; mihassan@jmi.ac.in	Hassan, Mohammad/GZA-7507-2022; Elasbali, abdelbaset/AEY-0035-2022; Hassan, Md Imtaiyaz/G-7072-2017; Yadav, Dharmendra Kumar/L-1846-2015	Hassan, Mohammad/0000-0002-1712-0004; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Yadav, Dharmendra Kumar/0000-0003-1102-1993; Elasbali, Abdelbaset Mohamed/0000-0002-7003-9846; shamsi, anas/0000-0001-7055-7056	Taif University [TURSP-2020/131]; Indian Council of Medical Research [ISRM/12(22)/2020, 45/54/2018-PHA/BMS/OL]	Taif University; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	Taif University, TURSP-2020/131, Dr. Farah Anjum Indian Council of Medical Research, ISRM/12(22)/2020, Dr. Md. Imtaiyaz Hassan Indian Council of Medical Research, 45/54/2018-PHA/BMS/OL, Mohd Yousuf The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquezar C, 2015, J NEUROCHEM, V133, P886, DOI 10.1111/jnc.13070; Anwar S, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8050119; Anwar S, 2020, INT J BIOL MACROMOL, V147, P768, DOI 10.1016/j.ijbiomac.2020.01.218; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Buss H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051847; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Cho ES, 2018, BIOMOL THER, V26, P29, DOI 10.4062/biomolther.2017.179; Choe KS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077727; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Esteras N, 2015, MOL NEUROBIOL, V52, P386, DOI 10.1007/s12035-014-8870-y; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Galluzzi L, 2012, CELL CYCLE, V11, P1059, DOI 10.4161/cc.11.6.19746; Gasymov OK, 2010, BIOCHEMISTRY-US, V49, P582, DOI 10.1021/bi901435q; Grossel MJ, 2006, CELL CYCLE, V5, P266, DOI 10.4161/cc.5.3.2385; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Gupta P, 2020, SPECTROCHIM ACTA A, V225, DOI 10.1016/j.saa.2019.117453; Icard P, 2019, TRENDS BIOCHEM SCI, V44, P490, DOI 10.1016/j.tibs.2018.12.007; Idrees D, 2016, J BIOMOL STRUCT DYN, V34, P1987, DOI 10.1080/07391102.2015.1100552; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khan P, 2017, J BIOMOL STRUCT DYN, V35, P1582, DOI 10.1080/07391102.2016.1189359; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim HG, 2010, BASIC CLIN PHARMACOL, V107, P958, DOI 10.1111/j.1742-7843.2010.00612.x; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Lu XX, 2013, CELL TISSUE RES, V354, P891, DOI 10.1007/s00441-013-1711-x; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; McManus ML., 2020, CELLULAR MOL PHYSL C, P63; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Naz F, 2016, J BIOMOL STRUCT DYN, V34, P1241, DOI 10.1080/07391102.2015.1074942; Naz H, 2016, BIOCHEM CELL BIOL, V94, P221, DOI 10.1139/bcb-2015-0132; Nebenfuehr S, 2020, INT J CANCER, V147, P2988, DOI 10.1002/ijc.33054; Prasad S, 2017, CHEM SCI, V8, P5416, DOI 10.1039/c7sc00880e; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Shamsi A, 2019, CURR PHARM BIOTECHNO, V20, P1028, DOI 10.2174/1389201020666190731122806; Shamsi A, 2019, INT J BIOL MACROMOL, V138, P718, DOI 10.1016/j.ijbiomac.2019.07.140; Shamsi A, 2020, J BIOMOL STRUCT DYN, V38, P1094, DOI 10.1080/07391102.2019.1595728; Shamsi A, 2016, EUR BIOPHYS J BIOPHY, V45, P523, DOI 10.1007/s00249-016-1119-0; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Sun LC, 2018, BBA-REV CANCER, V1870, P51, DOI 10.1016/j.bbcan.2018.06.005; Syed SB, 2019, J BIOMOL STRUCT DYN, V37, P156, DOI 10.1080/07391102.2017.1420492; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Waseem R, 2022, J MOL STRUCT, V1252, DOI 10.1016/j.molstruc.2021.132141; Weber RA, 2020, MOL CELL, V77, P645, DOI 10.1016/j.molcel.2020.01.003; White KA, 2017, J CELL SCI, V130, P663, DOI 10.1242/jcs.195297; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Yang HC, 2021, BIOMED J, V44, P285, DOI 10.1016/j.bj.2020.08.001; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yousuf M, 2021, J CELL BIOCHEM, V122, P897, DOI 10.1002/jcb.29921; Yousuf M, 2020, ACS OMEGA, V5, P27480, DOI 10.1021/acsomega.0c03975; Yousuf M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103526; Zhang LC, 2021, NEUROTOX RES, V39, P2007, DOI 10.1007/s12640-021-00427-w	60	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263693	10.1371/journal.pone.0263693	http://dx.doi.org/10.1371/journal.pone.0263693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148332	Green Published, gold			2022-12-26	WOS:000800108800024
J	Alhendyani, F; Jolly, K; Jones, LL				Alhendyani, Fatemah; Jolly, Kate; Jones, Laura L.			Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis	PLOS ONE			English	Review							VIRUS-INFECTION; WOMEN; IMMUNIZATION; IMPACT; ATTITUDES; INCREASE; ACCEPTANCE; KNOWLEDGE; PERTUSSIS; VISITS	Background The World Health Organization (WHO) recommends that pregnant women receive influenza vaccination; however, uptake of the vaccine remains low. Maternity health care professionals (MHCPs) play an important role in motivating pregnant women to receive the influenza vaccine. However, factors such as MHCPs' views and knowledge about the vaccine, and time constraints due to workload may influence MHCPs' practices and opinions about women receiving the influenza vaccine during pregnancy. To date, the qualitative evidence exploring MHCPs' views and experiences around influenza vaccine uptake in pregnant women has not been synthesised. Aim To systematically review and thematically synthesise qualitative evidence that explores the views and experiences of MHCPs involved in the provision of the maternal influenza vaccine worldwide. Methods Five databases (MEDLINE, EMBASE, PsycINFO, CINAHL, Web of Science) were searched, supplemented with searches of included paper reference lists and grey literature. Study selection was conducted by up to three researchers applying pre-specified inclusion/exclusion criteria. Quality assessment was undertaken, data were extracted, coded and synthesised to develop descriptive and analytical themes. Results Eight studies involving 277 participants were included. Seventeen descriptive themes were interpreted, embedded within six analytical themes. MHCPs perceived that maternal influenza vaccination delivery can be facilitated by trusting relationships, good communication, knowledge about the vaccine leading to confidence in recommending vaccine, electronic vaccination prompts, and presence of national guidelines. However, workload, time constraints, MHCP's perception of pregnant women's concerns, and social/cultural/environmental influences could prevent the likelihood of delivery of influenza vaccine. Knowledgeable MHCPs who were regularly updated about vaccination based on scientific evidence were more confident when discussing and recommending the influenza vaccine to pregnant women. In addition, the presence of national policies and guidelines and electronic prompts for maternal influenza vaccination would enhance the delivery of the vaccine. Conclusion Our findings suggest that approaches to enhance the vaccination uptake rate in pregnant women include addressing MHCPs barriers to discussing influenza vaccination through education, sufficient time for discussions, and electronic prompts about vaccination, as well as evidence based local and national guidelines.	[Alhendyani, Fatemah; Jolly, Kate; Jones, Laura L.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Alhendyani, Fatemah] Minist Hlth, Dept Publ Hlth, Kuwait, Kuwait	University of Birmingham	Alhendyani, F (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.; Alhendyani, F (corresponding author), Minist Hlth, Dept Publ Hlth, Kuwait, Kuwait.	f.alhendyani@gmail.com	alhendyani, Fatemah/GON-8116-2022	alhendyani, Fatemah/0000-0002-0610-4850; Jones, Laura/0000-0002-4018-3855; Jolly, Kate/0000-0002-6224-2115	National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands	National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands	The author(s) received no specific funding for this work. KJ is supported by the National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands. However, the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Al-Husban N, 2019, MEDITERR J HEMATOL I, V11, DOI 10.4084/MJHID.2019.020; [Anonymous], 2020, INFLUENZA TDAP VACCI; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Baselga-Moreno V, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6713-5; Bergenfeld Irina, 2018, Gates Open Res, V2, P34, DOI 10.12688/gatesopenres.12833.1; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Buchy P, 2020, INT J INFECT DIS, V92, P1, DOI 10.1016/j.ijid.2019.12.019; Caskey RN, 2013, J PEDIATR INFECT DIS, V2, P198, DOI 10.1093/jpids/pit001; CASP ChecklistsCASPCritical Appraisal Skills Programme, 2018, CASPCRITICAL APPR SK; Changolkar S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232895; Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Dabrera G, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.45.20959; Dawood FS, 2021, LANCET INFECT DIS, V21, P97, DOI 10.1016/S1473-3099(20)30592-2; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fleming JA, 2018, VACCINE, V36, P4054, DOI 10.1016/j.vaccine.2018.05.096; Frew PM, 2018, HUM VACC IMMUNOTHER, V14, P1548, DOI 10.1080/21645515.2018.1425116; Garside R, 2014, INNOVATION-ABINGDON, V27, P67, DOI 10.1080/13511610.2013.777270; Gerede R, 2017, J RELIG HEALTH, V56, P1692, DOI 10.1007/s10943-017-0435-8; Grabenstein JD, 2013, VACCINE, V31, P2011, DOI 10.1016/j.vaccine.2013.02.026; He J, 2017, KIDNEY BLOOD PRESS R, V42, P232, DOI 10.1159/000477221; Hirve S, 2016, INFLUENZA OTHER RESP, V10, P254, DOI 10.1111/irv.12374; Kaufman J, 2019, HUM VACC IMMUNOTHER, V15, P2534, DOI 10.1080/21645515.2019.1607131; Kilich E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234827; Li RC, 2018, VACCINE, V36, P3315, DOI 10.1016/j.vaccine.2018.04.060; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MacDonald NE, 2014, PAED CHILD HEALT-CAN, V19, pE121, DOI [10.1093/pch/19.10.e121, 10.1093/pch/19.9.456]; Maertens K, 2016, VACCINE, V34, P5785, DOI 10.1016/j.vaccine.2016.09.055; Maher L, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-102; Marcus JA., 2008, PHILOS MED, V99; Murtough KL, 2015, J WOMENS HEALTH, V24, P849, DOI 10.1089/jwh.2014.5178; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; O'Leary ST, 2018, AM J PREV MED, V54, P205, DOI 10.1016/j.amepre.2017.10.016; O'Shea Aisling, 2018, BJGP Open, V2, pbjgpopen18X101457, DOI 10.3399/bjgpopen18X101457; Offeddu V, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7172-8; Omer SB, 2017, NEW ENGL J MED, V376, P1256, DOI 10.1056/NEJMra1509044; Opel DJ, 2012, VACCINE, V30, P1269, DOI 10.1016/j.vaccine.2011.12.129; Ozawa S, 2019, VACCINE, V37, P5525, DOI 10.1016/j.vaccine.2019.06.081; Paterson P, 2016, VACCINE, V34, P6700, DOI 10.1016/j.vaccine.2016.10.042; Pelcic G, 2016, CROAT MED J, V57, P516, DOI 10.3325/cmj.2016.57.516; Principi N, 2018, HUM VACC IMMUNOTHER, V14, P684, DOI 10.1080/21645515.2017.1405188; Regan AK, 2017, EPIDEMIOL INFECT, V145, P2930, DOI [10.1017/s0950268817001972, 10.1017/S0950268817001972]; Rohleder P., 2015, QUALITATIVE RES CLIN; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; Vishram B, 2018, HUM VACC IMMUNOTHER, V14, P179, DOI 10.1080/21645515.2017.1382789; Webb H, 2014, HUM VACC IMMUNOTHER, V10, P1114, DOI 10.4161/hv.27893; Wilcox CR, 2019, PEDIATR INFECT DIS J, V38, P625, DOI 10.1097/INF.0000000000002242; Wilcox CR, 2018, VACCINE, V36, P7625, DOI 10.1016/j.vaccine.2018.10.092; Wilson R, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6655-y; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Wong VWY, 2016, VACCINE, V34, P20, DOI 10.1016/j.vaccine.2015.11.020; World Health Organization, 2019, IMPR VACC DEM ADDR H; World Health Organization, 2018, INFL SEAS INT; Yuen CYS, 2016, VACCINE, V34, P33, DOI 10.1016/j.vaccine.2015.11.032; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Zimmerman RK, 2014, VACCINE, V32, P3656, DOI 10.1016/j.vaccine.2014.04.057	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263234	10.1371/journal.pone.0263234	http://dx.doi.org/10.1371/journal.pone.0263234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143531	gold, Green Published			2022-12-26	WOS:000797657800030
J	Angione, C; Silverman, E; Yaneske, E				Angione, Claudio; Silverman, Eric; Yaneske, Elisabeth			Using machine learning as a surrogate model for agent-based simulations	PLOS ONE			English	Article							ABSOLUTE ERROR MAE; RMSE	In this proof-of-concept work, we evaluate the performance of multiple machine-learning methods as surrogate models for use in the analysis of agent-based models (ABMs). Analysing agent-based modelling outputs can be challenging, as the relationships between input parameters can be non-linear or even chaotic even in relatively simple models, and each model run can require significant CPU time. Surrogate modelling, in which a statistical model of the ABM is constructed to facilitate detailed model analyses, has been proposed as an alternative to computationally costly Monte Carlo methods. Here we compare multiple machine-learning methods for ABM surrogate modelling in order to determine the approaches best suited as a surrogate for modelling the complex behaviour of ABMs. Our results suggest that, in most scenarios, artificial neural networks (ANNs) and gradient-boosted trees outperform Gaussian process surrogates, currently the most commonly used method for the surrogate modelling of complex computational models. ANNs produced the most accurate model replications in scenarios with high numbers of model runs, although training times were longer than the other methods. We propose that agent-based modelling would benefit from using machine-learning methods for surrogate modelling, as this can facilitate more robust sensitivity analyses for the models while also reducing CPU time consumption when calibrating and analysing the simulation.	[Angione, Claudio; Yaneske, Elisabeth] Teesside Univ, Sch Comp Engn & Digital Technol, Middlesbrough, Cleveland, England; [Silverman, Eric] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Angione, Claudio] Teesside Univ, Healthcare Innovat Ctr, Middlesbrough, Cleveland, England; [Angione, Claudio] Teesside Univ, Natl Horizons Ctr, Darlington, Durham, England; [Angione, Claudio] Teesside Univ, Ctr Digital Innovat, Middlesbrough, Cleveland, England	University of Teesside; University of Glasgow; University of Teesside; University of Teesside; University of Teesside	Angione, C (corresponding author), Teesside Univ, Sch Comp Engn & Digital Technol, Middlesbrough, Cleveland, England.; Angione, C (corresponding author), Teesside Univ, Healthcare Innovat Ctr, Middlesbrough, Cleveland, England.; Angione, C (corresponding author), Teesside Univ, Natl Horizons Ctr, Darlington, Durham, England.; Angione, C (corresponding author), Teesside Univ, Ctr Digital Innovat, Middlesbrough, Cleveland, England.	c.angione@tees.ac.uk		Angione, Claudio/0000-0002-3140-7909; Silverman, Eric/0000-0003-0147-6118	Medical Research Council [MC_UU_00022/1]; Chief Scientist Office [SPHSU16]; UKRI EPSRC through a Turing Network Development Award; UKRI Research England's THYME project; Children's Liver Disease Foundation; UK Prevention Research Partnership [MR/S037594/1]; British Heart Foundation; Cancer Research UK; Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Health and Social Care Research and Development Division (Welsh Government); Medical Research Council; National Institute for Health Research; Natural Environment Research Council; Public Health Agency (Northern Ireland); Health Foundation; Wellcome	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; UKRI EPSRC through a Turing Network Development Award; UKRI Research England's THYME project(UK Research & Innovation (UKRI)); Children's Liver Disease Foundation; UK Prevention Research Partnership; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Health and Social Care Research and Development Division (Welsh Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Public Health Agency (Northern Ireland); Health Foundation; Wellcome	ES is part of the Complexity in Health Improvement Programme supported by the Medical Research Council (MC_UU_00022/1) and the Chief Scientist Office (SPHSU16). CA would like to acknowledge the support from UKRI EPSRC through a Turing Network Development Award, UKRI Research England's THYME project, and the Children's Liver Disease Foundation. This work was supported by UK Prevention Research Partnership MR/S037594/1, which is funded by the British Heart Foundation, Cancer Research UK, Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Health and Social Care Research and Development Division (Welsh Government), Medical Research Council, National Institute for Health Research, Natural Environment Research Council, Public Health Agency (Northern Ireland), The Health Foundation and Wellcome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Carers UK, 2015, FACTAND FIG; Carter Shan, 2019, DISTILL, V1, P2, DOI [10.23915/distill.00015, DOI 10.23915/DISTILL.00015]; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cristianini N, 2000, INTRO SUPPORT VECTOR; Culley C, 2020, P NATL ACAD SCI USA, V117, P18869, DOI 10.1073/pnas.2002959117; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Dahlke J, 2020, ARXIV PREPRINT ARXIV; de Marchi S, 2014, ANNU REV POLIT SCI, V17, P1, DOI 10.1146/annurev-polisci-080812-191558; Du MN, 2020, COMMUN ACM, V63, P68, DOI 10.1145/3359786; Fricker TE, 2013, TECHNOMETRICS, V55, P47, DOI 10.1080/00401706.2012.715835; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gilpin LH, 2018, PR INT CONF DATA SC, P80, DOI 10.1109/DSAA.2018.00018; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Janssen MA, 2006, ECOL SOC, V11; JOLLIFFE I., 2005, PRINCIPAL COMPONENT; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kasim M, 2020, ARXIV PREPRINT ARXIV; Ke GL, 2017, ADV NEUR IN, V30; Kennedy MC, 2017, SENSITIVITY ANALYSIS IN EARTH OBSERVATION MODELLING, P341, DOI 10.1016/B978-0-12-803011-0.00017-3; Kennedy MC, 2001, J R STAT SOC B, V63, P425, DOI 10.1111/1467-9868.00294; Lambert C., 2017, UNMET NEED CARE; Lamperti F, 2018, J ECON DYN CONTROL, V90, P366, DOI 10.1016/j.jedc.2018.03.011; Lipton ZC, 2018, COMMUN ACM, V61, P36, DOI 10.1145/3233231; Lorenc T, 2014, J EPIDEMIOL COMMUN H, V68, P288, DOI 10.1136/jech-2013-203118; Lundberg SM, 2017, ADV NEUR IN, V30; Magazzo G., 2021, BIOINFORMATICS; Molnar C, 2020, LULU COM; MORRIS MD, 1995, J STAT PLAN INFER, V43, P381, DOI 10.1016/0378-3758(94)00035-T; Noble J, 2012, WINT SIMUL C PROC; O'Hagan A, 2006, RELIAB ENG SYST SAFE, V91, P1290, DOI 10.1016/j.ress.2005.11.025; Oliver K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-34; Pereda M, 2017, LECT NOTE MANAGE IND, P179, DOI 10.1007/978-3-319-55889-9_11; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Raghu M., 2020, ARXIV200311755; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Sawyer R. K., 2005, SOCIAL EMERGENCE SOC, DOI DOI 10.1017/CBO9780511734892; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Silverman E, 2018, METHODS SER, V13, P1, DOI 10.1007/978-3-319-72408-9; Silverman E, 2020, SITUATING AGENT BASE; Silverman E, 2013, PROCEEDINGS 27TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2013, P689, DOI 10.7148/2013-0689; Silverman E, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2327; Smith JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10827-4; Sobol I. M., 1976, COMP MATH MATH PHYS+, V16, P236, DOI DOI 10.1016/0041-5553(76)90154-3; Sobol IM, 1998, MATH COMPUT SIMULAT, V47, P103, DOI 10.1016/S0378-4754(98)00096-2; TENNSTEDT SL, 1989, GERONTOLOGIST, V29, P677, DOI 10.1093/geront/29.5.677; Torrens P, 2011, T GIS, V15, P67, DOI 10.1111/j.1467-9671.2011.01261.x; van der Hoog S, 2017, ARXIV PREPRINT ARXIV; Vijayakumar S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101818; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wittenberg R, 2011, PROJECTIONS DEMAND C; Wolfram Research Inc, 2019, MATH 12 0; Zampieri G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007084	59	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263150	10.1371/journal.pone.0263150	http://dx.doi.org/10.1371/journal.pone.0263150			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143521	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000797657800025
J	Chang, CJ; Chi, H; Jim, WT; Chiu, NC; Chang, L				Chang, Chia-Jung; Chi, Hsin; Jim, Wai-Tim; Chiu, Nan-Chang; Chang, Lung			Risk of infection in neonates born in accidental out-of-hospital deliveries	PLOS ONE			English	Article							BIRTH-WEIGHT; GASTRIC ASPIRATE; MORTALITY; SEPSIS; MORBIDITY; SPECTRUM	Accidental out-of-hospital deliveries (OHDs) are known to have a higher incidence of maternal and neonatal complications. However, neonatal infection related to OHDs has not been studied. The aim of this study was to determine the infection risk of OHDs. This retrospective cohort study enrolled neonates admitted at a children's hospital in an urban setting from January 2004 to December 2017. Accidental OHDs were compared with in-hospital births, and neonatal infection was assessed. This study also investigated both maternal and neonatal risk factors associated with OHDs. A cohort of 158 OHD neonates was enrolled, of whom 29 (23.2%) were preterm. Prematurity and low birth weight were significantly associated with OHD. Eight neonates in the OHD cohort had a documented infection within the first 72 hours of life, which was 11-fold higher than infections documented for the in-hospital births. Multivariate analysis identified low birth weight as the only factor independently associated with increased risk of infection in OHD neonates. Several specific characteristics of mothers with OHDs were identified. Forty-nine (31%) OHD mothers lacked antenatal care, and 10 (6.3%) were unaware of their pregnancies. The OHD group comprised of more teenage mothers compared to the in-hospital deliveries category. Neonatal infection was more prevalent among OHDs than for in-hospital deliveries, and the infection rate was associated with low birth weight. Hospitalization for further care and observation is suggested for the OHD neonates. Social support should be provided for populations with an increased risk of OHD, such as teenage mothers.	[Chang, Chia-Jung; Chi, Hsin; Jim, Wai-Tim; Chiu, Nan-Chang; Chang, Lung] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan; [Chang, Chia-Jung; Chi, Hsin; Jim, Wai-Tim; Chiu, Nan-Chang; Chang, Lung] MacKay Mem Hosp, Taipei, Taiwan; [Chi, Hsin; Jim, Wai-Tim; Chiu, Nan-Chang; Chang, Lung] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chi, Hsin; Jim, Wai-Tim; Chiu, Nan-Chang; Chang, Lung] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management	Chang, L (corresponding author), MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan.; Chang, L (corresponding author), MacKay Mem Hosp, Taipei, Taiwan.; Chang, L (corresponding author), MacKay Med Coll, Dept Med, New Taipei, Taiwan.; Chang, L (corresponding author), MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan.	covis77@yahoo.com.tw						Alemayehu A, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/3709672; Chan GJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0813-3; Chang JY, 2011, J PEDIATR GASTR NUTR, V53, P512, DOI 10.1097/MPG.0b013e318227e518; Cunningam FG GN., 2014, WILLIAMS OBSTET, V24, P455; Edwards MS, 2013, VACCINE, V31, pD66, DOI 10.1016/j.vaccine.2012.11.046; ELRADHI AS, 1983, J PEDIATR-US, V103, P300, DOI 10.1016/S0022-3476(83)80371-0; Flanagan B, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0267-9; Fowlie PW, 1998, ARCH DIS CHILD-FETAL, V78, pF92, DOI 10.1136/fn.78.2.F92; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Hornik CP, 2012, EARLY HUM DEV, V88, pS69, DOI 10.1016/S0378-3782(12)70019-1; Hughes MM, 2017, MATERN CHILD HLTH J, V21, P283, DOI 10.1007/s10995-016-2131-9; Javaudin F, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0600-z; Jost C, 2014, J CLIN MICROBIOL, V52, P657, DOI 10.1128/JCM.02532-13; Khupakonke S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1580-5; Lazic Z, 2011, WIEN KLIN WOCHENSCHR, V123, P11, DOI 10.1007/s00508-010-1505-z; McLelland G, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-017-1638-4; Millar M, 2003, ARCH DIS CHILD-FETAL, V88, pF354, DOI 10.1136/fn.88.5.F354; MIMS LC, 1972, AM J OBSTET GYNECOL, V114, P232, DOI 10.1016/0002-9378(72)90064-6; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; Ocviyanti D, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/4823404; Organization WH., 1998, CAR UMB CORD REV EV; Ovaskainen K, 2015, ACTA PAEDIATR, V104, P1248, DOI 10.1111/apa.13117; Patel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114664; RAMOS A, 1969, AM J OBSTET GYNECOL, V105, P1247, DOI 10.1016/0002-9378(69)90298-1; Ramsewak S., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P242; Renesme L, 2013, ACTA PAEDIATR, V102, pe174, DOI 10.1111/apa.12156; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rodie VA, 2002, ACTA OBSTET GYN SCAN, V81, P50, DOI 10.1046/j.0001-6349.2001.00420.x; Sawardekar KP, 2004, PEDIATR INFECT DIS J, V23, P22, DOI 10.1097/01.inf.0000105200.18110.1e; Schuchat A, 2000, NEW ENGL J MED, V343, P209, DOI 10.1056/NEJM200007203430310; Sheiner E, 2004, EUR J OBSTET GYN R B, V116, P43, DOI 10.1016/j.ejogrb.2004.02.006; Stewart D, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2149; Suzuki Shunji, 2015, J Clin Med Res, V7, P150, DOI 10.14740/jocmr2058w; Unterscheider J, 2011, J OBSTET GYNAECOL, V31, P721, DOI 10.3109/01443615.2011.605484; Yadav M., 2018, INT J CONT PEDIAT, V5, P2309, DOI [10.18203/2349-3291.ijcp20184302, DOI 10.18203/2349-3291.IJCP20184302]	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263825	10.1371/journal.pone.0263825	http://dx.doi.org/10.1371/journal.pone.0263825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143570	Green Published, gold			2022-12-26	WOS:000797657800083
J	Tschodu, D; Ulm, B; Bendrat, K; Lippoldt, J; Gottheil, P; Kas, JA; Niendorf, A				Tschodu, Dimitrij; Ulm, Bernhard; Bendrat, Klaus; Lippoldt, Jurgen; Gottheil, Pablo; Kaes, Josef A.; Niendorf, Axel			Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature	PLOS ONE			English	Article							DISTANT RECURRENCE; WORKING GROUP; ONCOTYPE DX; PREDICTION; MODELS; PERFORMANCE; PACKAGE; RISK	The diagnosis of breast cancer-including determination of prognosis and prediction-has been traditionally based on clinical and pathological characteristics such as tumor size, nodal status, and tumor grade. The decision-making process has been expanded by the recent introduction of molecular signatures. These signatures, however, have not reached the highest levels of evidence thus far. Yet they have been brought to clinical practice based on statistical significance in prospective as well as retrospective studies. Intriguingly, it has also been reported that most random sets of genes are significantly associated with disease outcome. These facts raise two highly relevant questions: What information gain do these signatures procure? How can one find a signature that is substantially better than a random set of genes? Our study addresses these questions. To address the latter question, we present a hybrid signature that joins the traditional approach with the molecular one by combining the Nottingham Prognostic Index with gene expressions in a data-driven fashion. To address the issue of information gain, we perform careful statistical analysis and comparison of the hybrid signature, gene expression lists of two commercially available tests as well as signatures selected at random, and introduce the Signature Skill Score-a simple measure to assess improvement on random signatures. Despite being based on in silico data, our research is designed to be useful for the decision-making process of oncologists and strongly supports association of random signatures with outcome. Although our study shows that none of these signatures can be considered as the main candidate for providing prognostic information, it also demonstrates that both the hybrid signature and the gene expression list of the OncotypeDx signature identify patients who may not require adjuvant chemotherapy. More importantly, we show that combining signatures substantially improves the identification of patients who do not need adjuvant chemotherapy.	[Tschodu, Dimitrij; Lippoldt, Jurgen; Gottheil, Pablo; Kaes, Josef A.] Univ Leipzig, Peter Debye Inst, Leipzig, Germany; [Ulm, Bernhard] Independent Stat Consulting Bernhard Ulm, Munich, Germany; [Bendrat, Klaus; Niendorf, Axel] MVZ Prof Dr Med A Niendorf Pathol Hamburg West Gm, Inst Histol Cytol & Mol Diagnost, Hamburg, Germany	Leipzig University	Kas, JA (corresponding author), Univ Leipzig, Peter Debye Inst, Leipzig, Germany.; Niendorf, A (corresponding author), MVZ Prof Dr Med A Niendorf Pathol Hamburg West Gm, Inst Histol Cytol & Mol Diagnost, Hamburg, Germany.	jkaes@uni-leipzig.de; a.niendorf@pathologie-hh-west.de		Lippoldt, Jurgen/0000-0002-2146-2162; Tschodu, Dimitrij/0000-0002-8862-0735	European Research Council [ERC 741350/HoldCancerBack]; Deutsche Forschungsgemeinschaft [DFG KA 1116/17-1, INST 268/296-1 FUGG]; National Science Foundation [NSF-PHY1607416]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	Dimitrij Tschodu, Jurgen Lippold, Pablo Gottheil and Josef. A. Kas have received funding from the European Research Council (ERC 741350/HoldCancerBack, https://cordis.europa.eu/project/id/741350/de), the Deutsche Forschungsgemeinschaft (DFG KA 1116/17-1 and INST 268/296-1 FUGG, https://www.dfg.de/), and the National Science Foundation (NSF-PHY1607416, https://www.nsf.gov/awardsearch/showAward?AWD_ID=1607416).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bernhard Ulm, Klaus Bendrat and Axel Niendorf received no specific funding for this work.	Azim HA, 2013, ANN ONCOL, V24, P647, DOI 10.1093/annonc/mds645; BALSLEV I, 1994, BREAST CANCER RES TR, V32, P281, DOI 10.1007/BF00666005; Bartlett JMS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw050; Boehm JS, 2021, CANC RES NEEDS BETTE; Bosl A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183458; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Brueffer C, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00135; Calonge N, 2016, GENET MED, V18, P770, DOI 10.1038/gim.2015.173; Cardoso F, 2020, MINDACT LONG TERM RE; Cox D.R., 1989, OR, V32; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Eredita G, 2001, EUR J CANCER, V37, P591, DOI 10.1016/S0959-8049(00)00435-4; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dunning M, 2015, ILLUMINAHUMANV3 DB I; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2009, J MACH LEARN RES, V10, P2013; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gnant M, 2009, LANCET, V374, P2029, DOI 10.1016/S0140-6736(09)62097-3; Graf E, 1999, STAT MED, V18, P2529; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2017, PACKAGE RMS, V229; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn Torsten, 2015, PACKAGE REFERENCE MA, V16, P37; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peters A, 2009, R PACKAGE; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; R Core Team, 2021, R LANGUAGE ENV STAT; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Saldana DF, 2018, J STAT SOFTW, V83, P1, DOI 10.18637/jss.v083.i02; Schneider D, 2015, PUBLIC HEALTH GENOM, V18, P349, DOI 10.1159/000441556; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Scott D, 2006, INT J MOD PHYS D, V15, P2229, DOI 10.1142/S0218271806009662; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sparano JA, 2018, NEW ENGL J MED, V379, P111, DOI 10.1056/NEJMoa1804710; Spiegelhalter D., 2020, HARVARD DATA SCI REV, V2; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Therneau T.M., 2014, SURVIVAL ANAL PUBLIS, V2, P3, DOI DOI 10.1038/S41525-021-00179-8; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Weigel AP, 2007, MON WEATHER REV, V135, P118, DOI 10.1175/MWR3280.1; Wilcoxon F., 1992, SPRINGER SERIES STAT, V1, P196, DOI DOI 10.2307/3001968; Wolf P, 2011, STAT PROBABIL LETT, V81, P783, DOI 10.1016/j.spl.2011.02.021; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	55	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0261035	10.1371/journal.pone.026103	http://dx.doi.org/10.1371/journal.pone.026103			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143511				2022-12-26	WOS:000797657800007
J	Trejo, I; Hengartner, NW				Trejo, Imelda; Hengartner, Nicolas W.			A modified Susceptible-Infected-Recovered model for observed under-reported incidence data	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; REPRODUCTIVE NUMBER; EPIDEMIC; OUTBREAK; IMPACT; EBOLA	Fitting Susceptible-Infected-Recovered (SIR) models to incidence data is problematic when not all infected individuals are reported. Assuming an underlying SIR model with general but known distribution for the time to recovery, this paper derives the implied differential-integral equations for observed incidence data when a fixed fraction of newly infected individuals are not observed. The parameters of the resulting system of differential equations are identifiable. Using these differential equations, we develop a stochastic model for the conditional distribution of current disease incidence given the entire past history of reported cases. We estimate the model parameters using Bayesian Markov Chain Monte-Carlo sampling of the posterior distribution. We use our model to estimate the transmission rate and fraction of asymptomatic individuals for the current Coronavirus 2019 outbreak in eight American Countries: the United States of America, Brazil, Mexico, Argentina, Chile, Colombia, Peru, and Panama, from January 2020 to May 2021. Our analysis reveals that the fraction of reported cases varies across all countries. For example, the reported incidence fraction for the United States of America varies from 0.3 to 0.6, while for Brazil it varies from 0.2 to 0.4.	[Trejo, Imelda; Hengartner, Nicolas W.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA; [Hengartner, Nicolas W.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Trejo, I (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.	imelda@lanl.gov		Trejo, Imelda/0000-0002-5582-5523	Laboratory Directed Research and Development program of Los Alamos National Laboratory [20210709ER, 20210043DR]; National Nuclear Security Administration of U.S. Department of Energy [89233218CNA000001]	Laboratory Directed Research and Development program of Los Alamos National Laboratory; National Nuclear Security Administration of U.S. Department of Energy	Research presented in this article was supported by the Laboratory Directed Research and Development program of Los Alamos National Laboratory, projects 20210709ER and 20210043DR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Los Alamos National Laboratory is operated by Triad National Security, LLC, for the National Nuclear Security Administration of U.S. Department of Energy (Contract No. 89233218CNA000001).	Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bar-On YM, 2021, PREPRINT; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Brauer F., 2012, MATH MODELS POPULATI, V2; Capistran MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245669; CDC. Centers for Disease Control and Prevention, 2020, COVID 19 VACC CHILDR; Chowell G, 2006, PREV VET MED, V73, P297, DOI 10.1016/j.prevetmed.2005.10.002; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Chowell G, 2007, MATH BIOSCI ENG, V4, P457, DOI 10.3934/mbe.2007.4.457; Cuellar L, 2022, INT J EPIDEMIOL, V51, P54, DOI [10.1101/2021.02.25.21252481, 10.1093/ije/dyab163]; Dahal S, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06122-7; Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Doll ME, 2020, INFECT CONT HOSP EP, V41, P859, DOI 10.1017/ice.2020.224; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; E. O.Romero-Severson, 2020, medRxiv, DOI 10.1101/2020.04.18.20070771; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Furuya-Kanamori L, 2016, EMERG INFECT DIS, V22, P1052, DOI 10.3201/eid2206.151080; Hasell J, COVID 19 DAILY TESTS; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Heesterbeek JAP, 1996, STAT NEERL, V50, P89, DOI [10.1111/j.1467-9574.1996.tb01482.x, DOI 10.1111/J.1467-9574.1996.TB01482.X]; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; HETHCOTE HW, 1980, J MATH BIOL, V9, P37, DOI 10.1007/BF00276034; Hyman JM, 1999, MATH BIOSCI, V155, P77, DOI 10.1016/S0025-5564(98)10057-3; Johns Hopkins University, 2020, COVID 19 DASHB CTR S; Kalajdzievska D, 2011, MATH BIOSCI ENG, V8, P711, DOI 10.3934/mbe.2011.8.711; Ke R., 2020, MEDRXIV, DOI [10.1101/2020.04.04.20050427, DOI 10.1101/2020.04.04.20050427]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kirkeby C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09209-x; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Lee K, 2009, GLOB INST, P1; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Makowski D, 2002, AGRONOMIE, V22, P191, DOI 10.1051/agro:2002007; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Pan American Health Organization and Inter-American Development Bank, 2020, TOOL ASS MAT LEV HLT; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Saldana F, 2020, MATH BIOSCI ENG, V17, P4165, DOI 10.3934/mbe.2020231; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sharpe FR, 1911, PHILOS MAG, V21, P435, DOI 10.1080/14786440408637050; Shmueli G, 2005, J ROY STAT SOC C-APP, V54, P127, DOI 10.1111/j.1467-9876.2005.00474.x; Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Wang ZL, 2011, J STAT PLAN INFER, V141, P1153, DOI 10.1016/j.jspi.2010.09.020; Weiss H., 2013, MAT MATEMATICS, DOI DOI 10.1016/J.CHAOS.2020.110057; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481; Wikipedia, 2020, COVID 19 PAND LOCKD; WILSON EB, 1945, P NATL ACAD SCI USA, V31, P24, DOI 10.1073/pnas.31.1.24; World Health Organization, 2020, COVID 19 EXPL; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4	56	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263047	10.1371/journal.pone.0263047	http://dx.doi.org/10.1371/journal.pone.0263047			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139110	Green Published, Green Submitted, gold			2022-12-26	WOS:000821499100022
J	Chen, Y; Cao, BL; Zheng, WW; Sun, YN; Xu, TJ				Chen, Ya; Cao, Baolan; Zheng, Weiwei; Sun, Yuena; Xu, Tianjun			eIF3k inhibits NF-kappa B signaling by targeting MyD88 for ATG5-mediated autophagic degradation in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; UBIQUITIN; RECOGNITION; TRANSLATION; APOPTOSIS; PROTEINS; CELLS; GENE; TRIF; RNA	Optimal activation of NF-kappa B signaling is crucial for the initiation of inflammatory responses and eliminating invading bacteria. Bacteria have likewise evolved the ability to evade immunity; however, mechanisms by which bacteria dysregulate host NF-kappa B signaling are unclear. In this study, we identify eukaryotic translation initiation factor eIF3k, a nonessential member of the eIF3 translation initiation complex, as a suppressor of the NF-kappa B pathway. Mechanistically, we show that eIF3k expression induced by Vibrio harveyi enhances E3 ligase Nrdp1-mediated K27-linked ubiquitination of MyD88, an upstream regulator of NF-kappa B pathway activation. Furthermore, we show that eIF3k acts as a bridge linking ubiquitin-tagged MyD88 and ATG5, an important mediator of autophagy. We demonstrate that the MyD88-eIF3k-ATG5 complex is transported to the autophagosome for degradation, and that innate immune signaling is subsequently terminated and does not attack invading V. harveyi. Therefore, our study identifies eIF3k as a specific inhibitor of the MyD88-dependent NF-kappa B pathway and suggests that eIF3k may act as a selective autophagic receptor that synergizes with ATG5 to promote the autophagic degradation of MyD88, which helps V. harveyi to evade innate immunity. We conclude that V. harveyi can manipulate a host's autophagy process to evade immunity in fish and also provide a new perspective on mammalian resistance to bacterial invasion.	[Chen, Ya; Cao, Baolan; Zheng, Weiwei; Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Sun, Yuena; Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Sun, Yuena; Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31822057) .	Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Case ED, 2014, CELL MICROBIOL, V16, P862, DOI 10.1111/cmi.12246; Cattie DJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006326; Choi JH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001981; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Di Padova F, 2018, EXPERT OPIN THER TAR, V22, P401, DOI 10.1080/14728222.2018.1464139; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gunther SD, 2020, NAT MICROBIOL, V5, P354, DOI 10.1038/s41564-019-0620-5; He X, 2019, EMBO J, V38, DOI 10.15252/embj.2018100978; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Jeong SJ, 2019, ANTIOXID REDOX SIGN, V31, P458, DOI 10.1089/ars.2018.7649; Jin SH, 2017, MOL CELL, V68, P308, DOI 10.1016/j.molcel.2017.09.005; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li P, 2020, AUTOPHAGY, V16, P1186, DOI 10.1080/15548627.2019.1659614; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mendoza-Barbera E, 2009, BIOCHEM BIOPH RES CO, V380, P183, DOI 10.1016/j.bbrc.2009.01.069; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Shen XY, 2004, FEBS LETT, V573, P139, DOI 10.1016/j.febslet.2004.07.071; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Suzuki J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32431-0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang WW, 2021, J IMMUNOL, V206, P2692, DOI 10.4049/jimmunol.2001404; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wierzbicki IH, 2019, CELL REP, V29, P2979, DOI 10.1016/j.celrep.2019.11.001; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; Wu YX, 2021, AUTOPHAGY, V17, P1379, DOI 10.1080/15548627.2020.1761653; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yan XL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00606; Yang Q, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006600; Yao L, 2020, MICROB PATHOGENESIS, V142, DOI 10.1016/j.micpath.2020.104051; Zeng Y, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009300; Zhang R, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007329; Zhao D, 2020, MOL CELL, V79, P963, DOI 10.1016/j.molcel.2020.07.019; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100414; Zheng WW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009438; Zinngrebe J, 2014, EMBO REP, V15, P28, DOI 10.1002/embr.201338025	63	1	1	7	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101730	10.1016/j.jbc.2022.101730	http://dx.doi.org/10.1016/j.jbc.2022.101730			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35176284	Green Published, gold			2022-12-26	WOS:000789398100005
J	Hayashima, K; Katoh, H				Hayashima, Kazuki; Katoh, Hironori			Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; DRUG-RESISTANCE; TRANSPEPTIDASE; INHIBITION; DEATH; GLUTATHIONE	Ferroptosis is an iron-dependent mode of cell death caused by excessive oxidative damage to lipids. Lipid peroxidation is normally suppressed by glutathione peroxidase 4, which requires reduced glutathione. Cystine is a major resource for glutathione synthesis, especially in cancer cells. Therefore, cystine deprivation or inhibition of cystine uptake promotes ferroptosis in cancer cells. However, the roles of other molecules involved in cysteine deprivation-induced ferroptosis are unexplored. We report here that the expression of gamma-glutamyltransferase 1 (GGT1), an enzyme that cleaves extracellular glutathione, determines the sensitivity of glioblastoma cells to cystine deprivation-induced ferroptosis at high cell density (HD). In glioblastoma cells expressing GGT1, pharmacological inhibition or deletion of GGT1 suppressed the cell density-induced increase in intracellular glutathione levels and cell viability under cystine deprivation, which were restored by the addition of cysteinylglycine, the GGT product of glutathione cleavage. On the other hand, cystine deprivation induced glutathione depletion and ferroptosis in GGT1deficient glioblastoma cells even at an HD. Exogenous expression of GGT1 in GGT1-deficient glioblastoma cells inhibited cystine deprivation-induced glutathione depletion and ferroptosis at an HD. This suggests that GGT1 plays an important role in glioblastoma cell survival under cystine-limited and HD conditions. We conclude that combining GGT inhibitors with ferroptosis inducers may provide an effective therapeutic approach for treating glioblastoma.	[Hayashima, Kazuki; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Kyoto, Japan	Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol Neurobiol, Kyoto, Japan.	hirokato@pharm.kyoto-u.ac.jp			Japan Society for the Promotion of Science [18K06215, 21K06065]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Prof Junichi Miyazaki (Osaka University, Osaka, Japan) for the CAG promoter-containing vector. We also thank Dr Yohei Katoh and Prof Kazuhisa Nakayama (Kyoto University) for providing peSpCAS9(1.1)-2xsgRNA and pDonortBFP-NLS-Neo. This study was supported in part by Grants-inaid for Scientific Research from the Japan Society for the Promotion of Science (grant nos.: 18K06215 and 21K06065).	Bansal A, 2019, MOL CANCER RES, V17, P1881, DOI 10.1158/1541-7786.MCR-18-1204; Bansal A, 2018, J CELL BIOL, V217, P2291, DOI 10.1083/jcb.201804161; Batsios G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63160-y; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Corti A, 2010, ANTICANCER RES, V30, P1169; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Goji T, 2017, J BIOL CHEM, V292, P19721, DOI 10.1074/jbc.M117.814392; GRIFFITH OW, 1978, P NATL ACAD SCI USA, V75, P5405, DOI 10.1073/pnas.75.11.5405; Gujral TS, 2017, P NATL ACAD SCI USA, V114, pE3729, DOI 10.1073/pnas.1703096114; HANES CS, 1950, NATURE, V166, P288, DOI 10.1038/166288a0; HANIGAN MH, 1995, CARCINOGENESIS, V16, P181, DOI 10.1093/carcin/16.2.181; Hayashima K, 2021, BIOCHEM BIOPH RES CO, V539, P56, DOI 10.1016/j.bbrc.2020.12.075; Heisterkamp N, 2008, HUM GENET, V123, P321, DOI 10.1007/s00439-008-0487-7; Horie K, 2020, ONCOLOGY-BASEL, V98, P734, DOI 10.1159/000508688; Hughes CE, 2020, CELL, V180, P296, DOI 10.1016/j.cell.2019.12.035; Ji Y, 2016, AMINO ACIDS, V48, P149, DOI 10.1007/s00726-015-2071-5; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Kawakami K, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3301-x; KOBAYASHI H, 1992, CANCER CHEMOTH PHARM, V31, P6, DOI 10.1007/BF00695987; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu XG, 2021, GENES DIS, V8, P731, DOI 10.1016/j.gendis.2020.11.010; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEYTS ERD, 1992, TOXICOL APPL PHARM, V114, P56, DOI 10.1016/0041-008X(92)90096-B; Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x; Poltorack CD, 2022, FEBS J, V289, P374, DOI 10.1111/febs.15842; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Shimomura T, 2021, ACS SENSORS, V6, P2125, DOI 10.1021/acssensors.1c00496; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; Tan SK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00218; West MB, 2011, J BIOL CHEM, V286, P28876, DOI 10.1074/jbc.M111.248823; Westhoff MA, 2008, ONCOGENE, V27, P5169, DOI 10.1038/onc.2008.148; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Yamaguchi I, 2020, J BIOL CHEM, V295, P6936, DOI 10.1074/jbc.RA119.012213; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang WH, 2020, MOL CANCER RES, V18, P79, DOI 10.1158/1541-7786.MCR-19-0691; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	41	3	3	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101703	10.1016/j.jbc.2022.101703	http://dx.doi.org/10.1016/j.jbc.2022.101703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148992	Green Published, gold			2022-12-26	WOS:000821054100004
J	Yang, J; Song, AS; Wiseman, RLC; Lander, G				Yang, Jie; Song, Albert S.; Wiseman, R. Luke C.; Lander, Gabriel			Cryo-EM structure of hexameric yeast Lon protease (PIM1) highlights the importance of conserved structural elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL LON; DNA; STRESS	Lon protease is a conserved ATP-dependent serine protease composed of an AAA+ domain that mechanically unfolds substrates and a serine protease domain that degrades these unfolded substrates. In yeast, dysregulation of Lon protease (PIM1) attenuates lifespan and leads to gross mitochondrial morphological perturbations. Although structures of the bacterial and human Lon protease reveal a hexameric assembly, yeast PIM1 was speculated to form a heptameric assembly and is uniquely characterized by a similar to 50-residue insertion between the ATPase and protease domains. To further understand the yeast-specific properties of PIM1, we determined a high resolution cryo-electron microscopy structure of PIM1 in a substrate-translocating state. Here, we reveal that PIM1 forms a hexamer, conserved with that of bacterial and human Lon proteases, wherein the ATPase domains form a canonical closed spiral that enables pore loop residues to translocate substrates to the protease chamber. In the substrate-translocating state, PIM1 protease domains form a planar protease chamber in an active conformation and are uniquely characterized by a similar to 15-residue C-terminal extension. These additional C-terminal residues form an alpha-helix located along the base of the protease domain. Finally, we did not observe density for the yeast-specific insertion between the ATPase and protease domains, likely due to high conformational flexibility. Biochemical studies to investigate the insertion using constructs that truncated or replaced the insertion with a glycineserine linker suggest that the yeast-specific insertion is dispensable for PIM1's enzymatic function. Altogether, our structural and biochemical studies highlight unique components of PIM1 machinery and demonstrate evolutionary conservation of Lon protease function.	[Yang, Jie; Song, Albert S.; Lander, Gabriel] Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Song, Albert S.; Wiseman, R. Luke C.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Lander, G (corresponding author), Scripps Res, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wiseman, RLC (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	glander@scripps.edu; wiseman@scripps.edu		Song, Albert/0000-0003-3176-6829; YANG, JIE/0000-0001-6662-4236	National Institutes of Health (NIH) [NS095892]; NIH [F31AG071162, S10OD021634]; Olson-King Endowed Skaggs Fellowship from Scripps Research	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Olson-King Endowed Skaggs Fellowship from Scripps Research	This work is supported by the National Institutes of Health (NIH) (NS095892 to R. L. W. and G. C. L). A. S. S. is supported by the NIH F31AG071162 and the Olson-King Endowed Skaggs Fellowship from Scripps Research. Computational analyses of EM data were performed using shared instrumentation funded by NIH S10OD021634 to G. C. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Coscia F, 2021, FEBS LETT, V595, P2691, DOI 10.1002/1873-3468.14199; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; Goke A, 2020, MOL BIOL CELL, V31, P527, DOI 10.1091/mbc.E19-08-0470; Haynes, 2018, LEGACY ROLE DNA BIND, DOI [10.1101/317677., DOI 10.1101/317677]; Herzik MA, 2021, METHODS MOL BIOL, V2215, P125, DOI 10.1007/978-1-0716-0966-8_6; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee AYL, 2014, ACTA CRYSTALLOGR D, V70, P218, DOI 10.1107/S139900471302631X; Li SS, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101239; Li SS, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj7835; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; Moehle EA, 2019, J BIOL CHEM, V294, P5396, DOI 10.1074/jbc.TM117.000893; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Santra M, 2019, P NATL ACAD SCI USA, V116, P22173, DOI 10.1073/pnas.1906592116; Shin M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23495-0; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Teichmann U, 1996, J BIOL CHEM, V271, P10137, DOI 10.1074/jbc.271.17.10137; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Voos W, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020253; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	36	2	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101694	10.1016/j.jbc.2022.101694	http://dx.doi.org/10.1016/j.jbc.2022.101694			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143841	Green Published, gold			2022-12-26	WOS:000789400700017
J	Bibi, F; Abbas, Z; Harun, N; Perveen, B; Bussmann, RW				Bibi, Fozia; Abbas, Zaheer; Harun, Nidaa; Perveen, Bushra; Bussmann, Rainer W.			Indigenous knowledge and quantitative ethnobotany of the Tanawal area, Lesser Western Himalayas, Pakistan	PLOS ONE			English	Article							MEDICINAL-PLANTS; TRADITIONAL KNOWLEDGE; ETHNOMEDICINAL PLANTS; TRIBAL COMMUNITIES; KAGHAN VALLEY; DISTRICT; WOMEN	Ethnobotanical field surveys were carried out in the Tanawal area of the Lesser Himalayan Region, Khyber Pakhtunkhawa, Province from April 2016 to October 2017. The area is located between 34.36 (34 degrees 21' 30 N) latitude and 73.07 (73 degrees 4' 0 E) longitude with an average elevation of 1374 meters above sea level. Ethnomedicinal data were collected through Participatory Rural Appraisal (PRA), and participants were selected through the snow-boll technique. Semi-structured, in-depth and open-ended interviews were conducted. The data were quantitatively evaluated using ethnomedicinal indices i.e. Relative frequency of citation (RFCs), Fidelity level (FL), and Use Value (UV). The ethnobotanical data were also comparatively analyzed through the Jaccard Index (JI). The study yielded 66 medicinal plants in 62 genera and 43 families. Asteraceae and Solanaceae were the most important families with five medicinal taxa each. Regarding medicinal plant part utilization, leaves (43.28%) were used predominantly, followed by whole plant (14.92%) and fruits (14.92%). Decoction was the main drug formulation applied to 21 species (31.15%) and the oral route was most common (56.1%) while 31.2% of medicinal plants were used for both oral and topical applications. Fifty health disorders were recorded and grouped in 15 categories. Maximum species were used to treat gastrointestinal disorders i.e. 13 species, dermal problems (12 species), and respiratory tract ailments (9). The calculated RFCs ranged between 81 to 31. The most important medicinal plants were Acacia modesta, Citrullus vulgaris, Tamarindus indica, and Momordica charantia with an RGFC of 81 each. The UV ranged between 0.58 and 3.6. Medicinal taxa with the highest UV were Dioscorea deltoidea (3.6), Withania coagulans (3.3), Momordica charantia (3.5), Silybum marianum and Pyrus pashia (3.2). FL values showed that 28 (41.79%) species had a FL value below 50 (74.62%) while 39 (58.20%) had higher FL values. Momordica charantia, Tamarindus indica, Acacia modesta and Citrullus vulgaris were 95.2 each. The Jaccard Index (JI) values ranged from16.77 to 0.98. The current study also reported 16 medicinal plants, commonly used around the globe, have been rarely documented for their medicinal values in the local ethnomedicinal literature i.e. Althaea officinalis, Plantanus orientalis, Jasminum sombac, Maytenus royleana, Cucurbita maxima, Phyllanthus emblica, Citrullus vulgaris. Polygonatum verticilliatum, Caseria tomentosa, Cistanche tubulosa, Bambusa arundinacea, Schinus molle, Tamarindus indica, Pongamia pinnata, Citrus limon and Catharanthus roseus. However, 48 medicinal plants had been reported in the literature but the current study reported their novel medicinal uses. Important taxa should be established in botanical gardens for in-situ conservation, chemical investigation and sustainable utilization. It would also be effective to improve the livelihoods of the local population.	[Bibi, Fozia; Perveen, Bushra] Rawalpindi Women Univ, Dept Bot, Rawalpindi, Pakistan; [Abbas, Zaheer] Univ Educ, Dept Bot, Div Sci & Technol, Lahore, Pakistan; [Harun, Nidaa] Univ Okara, Fac Life Sci, Dept Bot, Okara, Pakistan; [Bussmann, Rainer W.] Ilia State Univ, Inst Bot, Dept Ethnobot, Tbilisi, Georgia	Ilia State University	Harun, N (corresponding author), Univ Okara, Fac Life Sci, Dept Bot, Okara, Pakistan.	nidaadr@uo.edu.pk		nidaa, Dr./0000-0002-5387-0785				Abbas Z, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0172-9; Abbas Z, 2016, J ETHNOBIOL ETHNOMED, V12, DOI 10.1186/s13002-016-0114-y; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Abbasi AM, 2013, J ETHNOPHARMACOL, V148, P528, DOI 10.1016/j.jep.2013.04.050; Abbasi AM, 2010, INDIAN J TRADIT KNOW, V9, P175; Abidullah S., 2019, INT J BIOORG CHEM, V4, P70, DOI [10.11648/j.ijbc.20190401.20, DOI 10.11648/J.IJBC.20190401.20]; Adnan M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-16; Ahmad I, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-75; Ahmad KS, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0196-1; Ahmed E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-13; Alexiades MN., 1996, SELECTED GUIDELINES; Ali S.I, 1972, FLORA W PAKISTAN ANN; Anwar Ali, 2020, Sarhad Journal of Agriculture, V36, P236, DOI 10.17582/journal.sja/2020/36.1.236.244; Aziz MA, 2017, J ETHNOPHARMACOL, V198, P268, DOI 10.1016/j.jep.2017.01.024; Bano A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-43; CHAMBERS R, 1994, WORLD DEV, V22, P953, DOI 10.1016/0305-750X(94)90141-4; Ehlers E., 2000, HIGH MOUNTAIN PASTOR; Farooq A, 2019, J ETHNOBIOL ETHNOMED, V15, DOI 10.1186/s13002-019-0323-2; Farooq M., 2019, ACTA ECOL SIN, V39, P267, DOI [10.1016/j.chnaes.2018.09.014, DOI 10.1016/J.CHNAES.2018.09.014]; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Gonzalez-Tejero MR, 2008, J ETHNOPHARMACOL, V116, P341, DOI 10.1016/j.jep.2007.11.045; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; JAIN S K, 1977, P157; KAINER KA, 1992, ECON BOT, V46, P408, DOI 10.1007/BF02866513; Kayani S, 2015, J ETHNOPHARMACOL, V164, P186, DOI 10.1016/j.jep.2015.02.004; Kent M., 1992, VEGETATION DESCRIPTI; Khalid M, 2017, J RADIAT RES APPL SC, V10, P152, DOI 10.1016/j.jrras.2017.03.005; Khan N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-122; Khan SM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-4; Korner C, 2004, AMBIO, P11; Korner C, 2021, ALPINE BOT, V131, P213, DOI 10.1007/s00035-021-00265-8; Korner C, 2017, ALPINE BOT, V127, P1, DOI 10.1007/s00035-016-0182-6; Ladio A, 2007, J ARID ENVIRON, V69, P695, DOI 10.1016/j.jaridenv.2006.11.008; Leonti M, 2003, J ETHNOPHARMACOL, V88, P119, DOI 10.1016/S0378-8741(03)00188-0; Maden K, 2004, OUR NAT, V2, P53, DOI [DOI 10.3126/on.v2i1.327, 10.3126/on.v2i1.327, DOI 10.3126/ON.V2I1.327]; Majid A, 2019, REV BRAS FARMACOGN, V29, P785, DOI 10.1016/j.bjp.2019.03.005; Martin G.J., 2004, ETHNOBOTANY METHODS; Moerman Daniel, 1998, NATIVE AM ETHNOBOTAN; Murad W, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-77; Nasir E, 1970, FLORA W PAKISTAN; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Rahman IU, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120581; Reyes-Garcia V, 2013, EVOL HUM BEHAV, V34, P249, DOI 10.1016/j.evolhumbehav.2013.03.002; Shah G.M., 2006, ETHNOBOTANICAL LEAFL, V2006, P63; Shah GM, 2014, J ETHNOPHARMACOL, V155, P450, DOI 10.1016/j.jep.2014.05.047; Shah GM, 2013, PAK J BOT, V45, P253; Shoaib G., 2017, J APPL ENVIRON BIOL, V7, P21; Shoaib G, 2021, REV BIOL TROP, V69, P1; Sulaiman, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9081001; Tardio J, 2008, ECON BOT, V62, P24, DOI 10.1007/s12231-007-9004-5; Tariq F., 2019, J MED PLANT ST, V7, P24; Tounekti T, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3190670; ul Haq N, 2022, GEOJOURNAL, V87, P3307, DOI 10.1007/s10708-021-10437-y; Ullah S, 2020, PLANT SCI TODAY, V7, P17, DOI 10.14719/pst.2020.7.1.625; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Voeks RA, 2007, SINGAPORE J TROP GEO, V28, P7, DOI 10.1111/j.1467-9493.2006.00273.x; Yabesh JEM, 2014, J ETHNOPHARMACOL, V154, P774, DOI 10.1016/j.jep.2014.05.004; Zenderland J, 2019, ECON BOT, V73, P293, DOI 10.1007/s12231-019-09480-1	58	3	3	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263604	10.1371/journal.pone.026360	http://dx.doi.org/10.1371/journal.pone.026360			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192648				2022-12-26	WOS:000812552500025
J	Gebremariam, GT; Biratu, S; Alemayehu, M; Welie, AG; Beyene, K; Sander, B; Gebretekle, GB				Gebremariam, Girma Tekle; Biratu, Selam; Alemayehu, Metasebia; Welie, Abraham Gebregziabiher; Beyene, Kebede; Sander, Beate; Gebretekle, Gebremedhin Beedemariam			Health-related quality of life of patients with type 2 diabetes mellitus at a tertiary care hospital in Ethiopia	PLOS ONE			English	Article								Background Type 2 diabetes mellitus (T2DM) and its treatment impact patients' physical health as well as emotional and social wellbeing. This study aimed to assess health-related quality of life (HRQoL) and associated factors among patients with T2DM at a tertiary care hospital in Ethiopia. Methods A face-to-face cross-sectional survey was conducted among patients with T2DM at Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia. We collected data using a validated Amharic version of the 5-level EuroQoL-5 dimensions (EQ-5D-5L) questionnaire. Descriptive statistics were used to present patient characteristics. Kruskal-Wallis and Mann-Whitney U tests were performed to explore differences in the median scores of EQ-5D-5L utility and visual analog scale (EQ-VAS). Multivariable Tobit regression models were used to identify predictors of HRQoL. Utility scores were calculated using disutility weights of the Ethiopian general population. Statistical significance was determined at p < 0.05. Results A total of 360 patients with T2DM participated. Mean (SD) age was 64.43(10.61) years. Reported health problems were mostly in the pain/discomfort (67.3%) dimension followed by mobility (60.5%), whereas the usual activities domain (34.1%) was the least health problem being reported. The median (IQR) EQ-5D-5L utility and EQ-VAS scores were 0.95 (0.88-0.96) and 80 (75.0-85.0), respectively. In multivariable Tobit regression models older age, having poor glycemic control, longer duration of diabetes, insulin usage, obesity, and having diabetes-related complications were significant negative predictors of HRQoL. Conclusions Overall, patients with T2DM had lower HRQoL than the general population, which was attributed to being older age, longer duration of diabetes, insulin use, obesity, inadequate glycemic control, and diabetes-related complications. The utility index we generated can be used in future economic evaluations to inform decisions about alternative interventions and resource allocation.	[Gebremariam, Girma Tekle; Biratu, Selam; Alemayehu, Metasebia] Addis Ababa Univ, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Welie, Abraham Gebregziabiher] Mekelle Univ, Sch Pharm, Coll Hlth Sci, Mekelle, Ethiopia; [Beyene, Kebede] Univ Auckland, Sch Pharm, Auckland, New Zealand; [Sander, Beate; Gebretekle, Gebremedhin Beedemariam] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate; Gebretekle, Gebremedhin Beedemariam] Toronto Hlth Econ & Technol Assessment THETA Coll, Univ Hlth Network, Toronto, ON, Canada; [Sander, Beate] ICES, Toronto, ON, Canada; [Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada; [Gebretekle, Gebremedhin Beedemariam] Univ Toronto, Dalla Lana Sch Publ Hlth, Ctr Vaccine Preventable Dis, Toronto, ON, Canada	Addis Ababa University; Mekelle University; University of Auckland; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Gebremariam, GT (corresponding author), Addis Ababa Univ, Sch Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	girma.tekle@aau.edu.et	Beyene, Kebede Abera/I-5208-2019	Beyene, Kebede Abera/0000-0002-1057-2593; Gebremariam, Girma Tekle/0000-0002-2747-7955	Canada Research Chair in Economics of Infectious Diseases [CRC950-232429]	Canada Research Chair in Economics of Infectious Diseases	This research was supported, in part, by a Canada Research Chair in Economics of Infectious Diseases held by Beate Sander (CRC950-232429).	Abedini MR, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-1277-8; Al Hayek AA, 2014, DIABETES METAB J, V38, P220, DOI 10.4093/dmj.2014.38.3.220; AL-Aboudi IS, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115610129; Arifin B, 2019, QUAL LIFE RES, V28, P1179, DOI 10.1007/s11136-019-02105-z; Aschalew AY, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01311-5; Butt M., 2018, ASIAN J PHARM CLIN R, V11, P93, DOI DOI 10.22159/AJPCR.2018.V11I1.19120; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Ekwunife Obinna Ikechukwu, 2016, BMC Res Notes, V9, P24, DOI 10.1186/s13104-015-1832-2; Feyisa BR, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036106; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Girma M, 2020, DIABET METAB SYND OB, V13, P4529, DOI 10.2147/DMSO.S279306; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Herdman M, 2011, QUAL LIFE RES; Huang W, 2018, ASSESSING HLTH RELAT, P1; Imayama I, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-115; Isreal GD, US PUBL TABL US FORM; Jalkanen K, 2019, EQ 5D 5 L INDEX SCOR, V17, P1; Javanbakht M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044526; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Lins Liliane, 2016, SAGE Open Med, V4, p2050312116671725; Nguyen LH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0771-0; Muze M, 2017, J DIABETES METAB, V8, DOI 10.4172/2155-6156.1000751; Pennington B, 2019, PHARMACOECONOMICS, V37, P75, DOI 10.1007/s40273-018-0701-y; Power MJ, 2010, QUAL LIFE RES, V19, P571, DOI 10.1007/s11136-010-9616-6; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Rencz F, 2016, QUAL LIFE RES, V25, P2693, DOI 10.1007/s11136-016-1375-6; Rowen D, 2017, PHARMACOECONOMICS, V35, pS11, DOI 10.1007/s40273-017-0544-y; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Saleh Farzana, 2015, BMC Res Notes, V8, P497, DOI 10.1186/s13104-015-1453-9; Shim YT., 2012, DIABETIC MED, V29; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Takahara M, 2019, ACTA DIABETOL, V56, P309, DOI 10.1007/s00592-018-1244-6; Tan ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065958; Trikkalinou A, 2017, WORLD J DIABETES, V8, P120, DOI 10.4239/wjd.v8.i4.120; Pham TB, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/4360804; Varghese RT, 2007, DIABETES METAB SYND, V1, P173, DOI 10.1016/j.dsx.2007.05.005; Welie AG, 2020, VALUE HEALTH REG ISS, V22, P7, DOI 10.1016/j.vhri.2019.08.475; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong ELY, 2020, QUAL LIFE RES, V29, P1913, DOI 10.1007/s11136-020-02462-0; Yang N, 2019, ICMLC 2019: 2019 11TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND COMPUTING, P1, DOI 10.1145/3318299.3318367; Yuying Zhang AOL., 2014, J DIABETES METAB, V5; Zare F, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120965314; Zurita-Cruz JN, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0906-y	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264199	10.1371/journal.pone.0264199	http://dx.doi.org/10.1371/journal.pone.0264199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180266	Green Published, gold			2022-12-26	WOS:000796435800049
J	Kim, AR; Lee, S; Park, JH				Kim, Ah-Ram; Lee, Seohyun; Park, Ji-Hyuk			An analysis of the factors affecting children and adolescent lifestyle in South Korea: A cross-sectional study with KCYPS 2018	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; GENDER-DIFFERENCES; SLEEP DURATION; HEALTH; PREDICTORS; DEPRESSION; CHILDHOOD; OUTCOMES; SUPPORT	Objective The purpose of this study is to identify lifestyle factors that affect the subjective health conditions of adolescents in South Korea by utilizing data from the Korean Children's and Youth Panel Survey 2018 conducted in Korea. Methods This cross-sectional study used data from 4,490 students (2,399 students in the fourth grade of elementary school and 2,541 students in the first grade of middle school). The data obtained were evaluated using living time (sleep time, study time, leisure time), emotions (happiness, self-esteem, emotional problems), capabilities (cooperative attitude, grit), health (life satisfaction, exercise time, number of breakfasts, quality of sleep), media (smart-phone use and dependence), school (school life satisfaction, relationship with friends and teachers), and home (time spent with parents, parenting attitude). Results We confirmed that regardless of grade, living time (leisure time), emotion (happiness, self-esteem, emotional problems), capabilities (grit), health (life satisfaction, exercise time, quality of sleep), media (smartphone dependence), and school (school life satisfaction, friendly, and teacher relations) are related to subjective health conditions. These results confirmed that evaluation parameters are related to subjective health conditions regardless of grade. Conclusion This investigation revealed that the higher the quality of sleep enhanced positive emotions while increased exercise	[Kim, Ah-Ram] Yonsei Univ, Grad Sch, Dept Occupat Therapy, Wonju, South Korea; [Lee, Seohyun] Yonsei Univ, Coll Humanities & Social Sci Convergence, Dept Global Publ Adm, Wonju, South Korea; [Park, Ji-Hyuk] Yonsei Univ, Coll Software & Digital Healthcare Convergence, Dept Occupat Therapy, Wonju, South Korea; [Park, Ji-Hyuk] Yonsei Univ, Super Aged Soc New Normal Lifestyle Res Inst, Wonju, South Korea; [Kim, Ah-Ram] Yonsei Univ, Dept Occupat Therapy, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University	Park, JH (corresponding author), Yonsei Univ, Coll Software & Digital Healthcare Convergence, Dept Occupat Therapy, Wonju, South Korea.; Park, JH (corresponding author), Yonsei Univ, Super Aged Soc New Normal Lifestyle Res Inst, Wonju, South Korea.	otscientist@yonsei.ac.kr		Kim, Ah-Ram/0000-0003-2726-5239	Ministry of Education of Korea; National Research Foundation of Korea [NRF-2021S1A3A2A02096338]	Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of Korea and the National Research Foundation of Korea in the form of funding to JHP [NRF-2021S1A3A2A02096338].	Abel T, 2002, RES HLTH PROMOTION, P70; Aebi M, 2014, EUR CHILD ADOLES PSY, V23, P283, DOI 10.1007/s00787-013-0458-y; Aguilar-Farias N, 2018, INT J EPIDEMIOL, V47, P976, DOI 10.1093/ije/dyy033; Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Bae JY, 2015, KO J C STUD, V36, DOI [10.5723/KJCS.2015.36.6.59, DOI 10.5723/KJCS.2015.36.6.59]; Bae SY, 2013, SURVEY UTILIZATION Y; Bertoletti J, 2014, ARQ BRAS CARDIOL, V102, P192, DOI 10.5935/abc.20130244; Bisegger C, 2005, SOZ PRAVENTIV MED, V50, P281, DOI 10.1007/s00038-005-4094-2; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carson V, 2017, PREV MED, V95, P7, DOI 10.1016/j.ypmed.2016.12.005; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Choi MH, 2008, THESIS GYEONGIN NATL; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Cohen B, 2003, CAN J PUBLIC HEALTH, V94, P41, DOI 10.1007/BF03405051; Darfour-Oduro SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19956-0; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dong-il Kim, 2012, [Korea Journal of Counseling, 상담학연구], V13, P629; Duncan Susan C, 2012, Ment Health Phys Act, V5, P57; Edwardson CL, 2013, J PHYS ACT HEALTH, V10, P1153, DOI 10.1123/jpah.10.8.1153; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; 김태명, 2017, [Korean Journal of Youth Studies, 청소년학연구], V24, P313, DOI 10.21509/KJYS.2017.03.24.3.313; Fraillon J, 2009, ASIAN REPORT CIVIC K; FYLKESNES K, 1991, SOC SCI MED, V32, P141, DOI 10.1016/0277-9536(91)90053-F; Gillison F, 2008, QUAL LIFE RES, V17, P997, DOI 10.1007/s11136-008-9373-y; Giordano PC, 2003, ANNU REV SOCIOL, V29, P257, DOI 10.1146/annurev.soc.29.010202.100047; Gregory AM, 2017, J CLIN CHILD ADOLESC, V46, P284, DOI 10.1080/15374416.2016.1183499; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Hamilton K, 2017, HEALTH EDUC BEHAV, V44, P175, DOI 10.1177/1090198116648266; 김희명, 2015, [The Journal of Education, 경인교육대학교 교육연구원 교육논총], V35, P63, DOI 10.25020/je.2015.35.3.63; Ja-eun Choi, 2018, [The Korean Journal of Human Development, 인간발달연구], V25, P147, DOI 10.15284/kjhd.2018.25.1.147; Karaman S, 2014, EUR REV MED PHARMACO, V18, P2475; Kim KI, 1984, SYMPTOM CHECKLIST 90; Knab AM, 2010, INT J BIOL SCI, V6, P133; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Lee JL, 2015, PANEL STUDY KOREAN C; Leung CY, 2021, SLEEP MED, V81, P227, DOI 10.1016/j.sleep.2021.02.031; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Madrid-Valero JJ, 2017, J SLEEP RES, V26, P461, DOI 10.1111/jsr.12493; Man Bae Sung, 2015, [Korean Journal of Youth Studies, 청소년학연구], V22, P325; Meade T, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0415-9; Michel G, 2009, QUAL LIFE RES, V18, P1147, DOI 10.1007/s11136-009-9538-3; Moreno C., 2013, ESTUDIO HLTH BEHAV S; Naicker K, 2013, J ADOLESCENT HEALTH, V52, P533, DOI 10.1016/j.jadohealth.2012.12.016; National Youth Policy Institure, 2020, OV KOR CHILDR YOUTH; Palacio-Vieira JA, 2008, QUAL LIFE RES, V17, P1207, DOI 10.1007/s11136-008-9405-7; PATTERSON RE, 1994, PREV MED, V23, P453, DOI 10.1006/pmed.1994.1062; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Soon-Hwa Yoo, 2007, [The Journal of Elementary Education, 초등교육연구], V20, P355; Sterdt E, 2014, HEALTH EDUC J, V73, P72, DOI 10.1177/0017896912469578; Torsheim T, 2006, SOC SCI MED, V62, P815, DOI 10.1016/j.socscimed.2005.06.047; Trotta A, 2020, SCHIZOPHRENIA BULL, V46, P261, DOI 10.1093/schbul/sbz069; World Health Organization, HLTH PROM GLOSS	55	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263923	10.1371/journal.pone.0263923	http://dx.doi.org/10.1371/journal.pone.0263923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176077	gold, Green Published			2022-12-26	WOS:000777505200045
J	Rafique, MA; Khaskheli, F; Hassan, MT; Naseer, S; Jeon, M				Rafique, Muhammad Aasim; Khaskheli, Faheem; Hassan, Malik Tahir; Naseer, Sheraz; Jeon, Moongu			Employing automatic content recognition for teaching methodology analysis in classroom videos	PLOS ONE			English	Article								A teacher plays a pivotal role in grooming a society and paves way for its social and economic developments. Teaching is a dynamic role and demands continuous adaptation. A teacher adopts teaching techniques suitable for a certain discipline and a situation. A thorough, detailed, and impartial observation of a teacher is a desideratum for adaptation of an effective teaching methodology and it is a laborious exercise. An automatic strategy for analyzing a teacher's teaching methodology in a classroom environment is suggested in this work. The proposed strategy recognizes a teacher's actions in videos while he is delivering lectures. In this study, 3D CNN and Conv2DLSTM with time-distributed layers are used for experimentation. A range of actions are recognized for a complete classroom session during experimentation and the reported results are considered effective for analysis of a teacher's teaching technique.	[Rafique, Muhammad Aasim; Jeon, Moongu] Gwangju Inst Sci & Technol GIST, Sch Elect Engn & Comp Sci, Gwangju, South Korea; [Khaskheli, Faheem; Naseer, Sheraz] Univ Management & Technol, Sch Syst & Technol, Dept Comp Sci, Lahore, Pakistan; [Hassan, Malik Tahir] Univ Management & Technol, Sch Syst & Technol, Dept Software Engn, Lahore, Pakistan	Gwangju Institute of Science & Technology (GIST); University of Management & Technology (UMT); University of Management & Technology (UMT)	Jeon, M (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Elect Engn & Comp Sci, Gwangju, South Korea.	mgjeon@gist.ac.kr		Hassan, Malik Tahir/0000-0002-0651-5297	Institute of Information & communications Technology Planning & Evaluation (IITP) - Korea government(MSIT); AI National Strategy Project	Institute of Information & communications Technology Planning & Evaluation (IITP) - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); AI National Strategy Project	This work was supported by Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government(MSIT) (No.2014-3-00077, AI National Strategy Project).	Bhat Anmol, 2018, 2018 3rd International Conference on Computational Systems and Information Technology for Sustainable Solutions (CSITSS), P271, DOI 10.1109/CSITSS.2018.8768740; Brown S, 2002, LECT PRACTICAL GUIDE; Chen EQ, 2019, IEEE ACCESS, V7, P57267, DOI 10.1109/ACCESS.2019.2910604; Cho K., 2014, EMNLP, DOI 10.3115/v1/w14-4012; Donahue J, 2015, PROC CVPR IEEE, P2625, DOI 10.1109/CVPR.2015.7298878; Donaj G, 2019, IEEE ACCESS, V7, P130650, DOI 10.1109/ACCESS.2019.2937350; Tran D, 2015, IEEE I CONF COMP VIS, P4489, DOI 10.1109/ICCV.2015.510; Feichtenhofer C, 2017, PROC CVPR IEEE, P7445, DOI 10.1109/CVPR.2017.787; Feichtenhofer C, 2016, PROC CVPR IEEE, P1933, DOI 10.1109/CVPR.2016.213; Ferrari A, 2020, IEEE ACCESS, V8, P32066, DOI 10.1109/ACCESS.2020.2973425; Flammini F., 2011, Proceedings of the 2011 8th IEEE International Conference on Advanced Video and Signal Based Surveillance (AVSS 2011), P414, DOI 10.1109/AVSS.2011.6027364; Fu BY, 2020, IEEE ACCESS, V8, P83791, DOI 10.1109/ACCESS.2020.2991891; Gang Z, 2021, APPL INTELL, V51, P8828, DOI 10.1007/s10489-021-02329-y; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P163; Goyal A., 2021, INDUCTIVE BIASES DEE; Harrington C., 2017, DYNAMIC LECT RES BAS; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hoyos AAC, 2020, IEEE REV IBEROAM TEC, V15, P1, DOI 10.1109/RITA.2020.2979245; Hsu YL, 2018, IEEE ACCESS, V6, P31715, DOI 10.1109/ACCESS.2018.2839766; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; King DB, 2015, ACS SYM SER, V1214, P1; Ku YT, 2019, 2019 1ST INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE IN INFORMATION AND COMMUNICATION (ICAIIC 2019), P224, DOI 10.1109/ICAIIC.2019.8669072; Kuehne H, 2011, IEEE I CONF COMP VIS, P2556, DOI 10.1109/ICCV.2011.6126543; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li JH, 2019, IEEE ACCESS, V7, P42565, DOI 10.1109/ACCESS.2019.2905575; Li S, 2019, INT C INTEL HUM MACH, P154, DOI 10.1109/IHMSC.2019.10132; Liu JC, 2019, IEEE ACCESS, V7, P104308, DOI 10.1109/ACCESS.2019.2929684; Mohamad Ali N., 2017, INT VISUAL INFORMATI, P319; Murtaza F, 2016, IET COMPUT VIS, V10, P758, DOI 10.1049/iet-cvi.2015.0416; Naseer S, 2018, IEEE ACCESS, V6, P48231, DOI 10.1109/ACCESS.2018.2863036; Ngxande M, 2017, 2017 PATTERN RECOGNITION ASSOCIATION OF SOUTH AFRICA AND ROBOTICS AND MECHATRONICS (PRASA-ROBMECH), P156; Nida N, 2019, MATH PROBL ENG, V2019, DOI 10.1155/2019/2474865; Prieto LP, 2016, LAK '16 CONFERENCE PROCEEDINGS: THE SIXTH INTERNATIONAL LEARNING ANALYTICS & KNOWLEDGE CONFERENCE,, P148, DOI 10.1145/2883851.2883927; Qi C, 2018, IEEE ACCESS, V6, P18795, DOI 10.1109/ACCESS.2018.2816044; Ragheb H, 2008, 2 ACM IEEE INT C DIS, P1, DOI DOI 10.1109/ICDSC.2008.4635730; Sharma V, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21175699; Shi XJ, 2015, ADV NEUR IN, V28; Shyu ML, 2005, INTERNATIONAL WORKSHOP ON CHALLENGES IN WEB INFORMATION RETRIEVAL AND INTEGRATION, PROCEEDINGS, P128; Soomro K., 2012, ARXIV12120402; Sun B, 2021, NEURAL COMPUT APPL, V33, P8335, DOI 10.1007/s00521-020-05587-y; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Tan MX, 2019, PR MACH LEARN RES, V97; Tompson J, 2015, PROC CVPR IEEE, P648, DOI 10.1109/CVPR.2015.7298664; Ullah A, 2018, IEEE ACCESS, V6, P1155, DOI 10.1109/ACCESS.2017.2778011; Vaswani A, 2017, ADV NEUR IN, V30; Verner IM, 2016, IEEE ROBOT AUTOM MAG, V23, P74, DOI 10.1109/MRA.2016.2515018; Wang Y, 2017, IEEE INT CONF COMP V, P2129, DOI 10.1109/ICCVW.2017.249; Zhao CL, 2017, 2017 INTERNATIONAL SYMPOSIUM ON EDUCATIONAL TECHNOLOGY (ISET 2017), P44, DOI 10.1109/ISET.2017.18	52	0	0	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263448	10.1371/journal.pone.0263448	http://dx.doi.org/10.1371/journal.pone.0263448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176072	gold, Green Published			2022-12-26	WOS:000777505200021
J	Ghimire, A; Mahendradhata, Y; Paudel, S; Yonzon, CL; Bhuvan, KC; Sharma, S; Utarini, A				Ghimire, Ashmita; Mahendradhata, Yodi; Paudel, Sagun; Yonzon, Chhoden Lama; Bhuvan, K. C.; Sharma, Sushmita; Utarini, Adi			Implementation fidelity of tuberculosis preventive therapy for under five children exposed to sputum smear positive pulmonary tuberculosis in Kaski district, Nepal: An implementation research	PLOS ONE			English	Article							ADHERENCE; CONTACTS	Introduction In line with the WHO recommendation, Nepal has started implementing Tuberculosis prevention therapy (TBPT) for under five children exposed to Sputum Smear Positive Pulmonary Tuberculosis, as one of the strategies for prevention, care and control of TB. Implementation fidelity study is important to assess on what extent preventive program is being implemented. The objective of the study measured the implementation fidelity of TBPT program Kaski district, Nepal. Methods We used a mixed-method explanatory sequential design study. Quantitative data were collected through retrospective review of records from April 2018 to May 2019 and level of adherence was established. Moderating factors influencing the implementation of TBPT were TBPT were assessed qualitatively. Sixteen in-depth interviews and a focus group discussion was conducted purposively with responsible stakeholders. The study was guided by the Conceptual Framework for Implementation Fidelity (CFIR) developed by Carroll. Results The majority of the components of the TBPT program were found to be implemented with a moderate level of fidelity. The proportion of under five years children initiate and complete the full course of TBPT was 72.5% and 75.86% respectively. The proportion of index cases traced for household contact, contact tracing within two months and timely initiation of therapy within two months were 54.19%, 82.73% and 86.20%. Moderating factors identified in the implementation of the program were contact tracing and enrollment, partnership and ownership, training resources, medication, awareness and information dissemination. Conclusion The TBPT program is being moderately implemented in Kaski districts. Addressing the key challenges identified in contact tracing, partnership/ownership, incentives, training and knowledge of health workers results in more identification of children eligible for TBPT.	[Ghimire, Ashmita; Paudel, Sagun; Yonzon, Chhoden Lama] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Int Master Program Publ Hlth, Yogyakarta, Indonesia; [Mahendradhata, Yodi; Utarini, Adi] Univ Gadjah Mada, Fac Med, Dept Hlth Policy & Management, Yogyakarta, Indonesia; [Bhuvan, K. C.] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia; [Sharma, Sushmita] Prov Hlth Logist Management Ctr, Pokhara, Gandaki Provinc, Nepal	Gadjah Mada University; Gadjah Mada University; Monash University; Monash University Sunway	Ghimire, A (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Int Master Program Publ Hlth, Yogyakarta, Indonesia.	ashmi.gr8@gmail.com	Mahendradhata, Yodi/AAQ-9044-2020; Utarini, Adi/GQI-1980-2022	Mahendradhata, Yodi/0000-0002-4522-1785; K C, Bhuvan/0000-0002-9135-962X; Ghimire, Ashmita/0000-0003-3015-7917	Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR)	Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR)	This research was a part of postgraduate thesis. The scholarship for this degree was funded by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and Universitas Gadjah Mada, Indonesia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Belgaumkar V, 2018, INT J TUBERC LUNG D, V22, P1179, DOI 10.5588/ijtld.17.0848; Birungi FM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211934; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Compaore R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187460; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Egere U, 2016, PUBLIC HEALTH ACTION, V6, P226, DOI 10.5588/pha.16.0073; Fox GJ, 2015, EUR RESPIR J, V46, P578, DOI 10.1183/13993003.50708-2012; Gomes VF, 2011, INT J TUBERC LUNG D, V15, P1637, DOI 10.5588/ijtld.10.0558; Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7; Hall C, 2015, TROP MED INT HEALTH, V20, P730, DOI 10.1111/tmi.12479; Hasson H, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-67; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; National Tuberculosis Centre (NTC), 2018, NAT TUB PROGR NEP AN; NTC, 2018, TB SUB REC SR IMPL G; Nurjono M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3980-x; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Radhakrishna S, 2007, INT J TUBERC LUNG D, V11, P282; Rutherford Merrin E, 2012, BMC Res Notes, V5, P7, DOI 10.1186/1756-0500-5-7; Singh AR, 2017, J TROP PEDIATRICS, V63, P274, DOI 10.1093/tropej/fmw086; Tadesse Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155525; Triasih R, 2016, INT J TUBERC LUNG D, V20, P1078, DOI 10.5588/ijtld.15.0952; WHO, TUBERCULOSIS; WHO, 2014, GUIDANCE NATL TUBERC; World Health Organization, 2018, BEST PRACT CHILD AD; World Health Organization, GLOBAL TUBERCULOSIS; World Health Organization, 2018, LAT TUB INF UPD CONS	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263967	10.1371/journal.pone.0263967	http://dx.doi.org/10.1371/journal.pone.0263967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171959	gold, Green Published			2022-12-26	WOS:000795889700051
J	Carney, T; Rooney, JA; Niemand, N; Myers, B; Theron, D; Wood, R; White, LF; Meade, CS; Chegou, NN; Ragan, E; Walzl, G; Horsburgh, R; Warren, RM; Jacobson, KR				Carney, Tara; Rooney, Jennifer A.; Niemand, Nandi; Myers, Bronwyn; Theron, Danie; Wood, Robin; White, Laura F.; Meade, Christina S.; Chegou, Novel N.; Ragan, Elizabeth; Walzl, Gerhard; Horsburgh, Robert; Warren, Robin M.; Jacobson, Karen R.			Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK; METHAMPHETAMINE; COMPLICATIONS; INTERVENTION; RELIABILITY; DEPENDENCE; OUTBREAK; ALCOHOL; SIZE	People who use illicit drugs (PWUDs) have been identified as a key at-risk group for tuberculosis (TB). Examination of illicit drug use networks has potential to assess the risk of TB exposure and disease progression. Research also is needed to assess mechanisms for accelerated TB transmission in this population. This study aims to 1) assess the rate of TB exposure, risk of disease progression, and disease burden among PWUD; 2) estimate the proportion of active TB cases resulting from recent transmission within this network; and 3) evaluate whether PWUD with TB disease have physiologic characteristics associated with more efficient TB transmission. Our cross-sectional, observational study aims to assess TB transmission through illicit drug use networks, focusing on methamphetamine and Mandrax (methaqualone) use, in a high TB burden setting and identify mechanisms underlying accelerated transmission. We will recruit and enroll 750 PWUD (living with and without HIV) through respondent driven sampling in Worcester, South Africa. Drug use will be measured through self-report and biological measures, with sputum specimens collected to identify TB disease by Xpert Ultra (Cepheid) and mycobacterial culture. We will co-enroll those with microbiologic evidence of TB disease in Aim 2 for molecular and social network study. Whole genome sequencing of Mycobacteria tuberculosis (Mtb) specimens and social contact surveys will be done for those diagnosed with TB. For Aim 3, aerosolized Mtb will be compared in individuals with newly diagnosed TB who do and do not smoke illicit drug. Knowledge from this study will provide the basis for a strategy to interrupt TB transmission in PWUD and provide insight into how this fuels overall community transmission. Results have potential for informing interventions to reduce TB spread applicable to high TB and HIV burden settings.	[Carney, Tara; Myers, Bronwyn] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Tygerberg, South Africa; [Carney, Tara; Myers, Bronwyn] Univ Cape Town, Groote Schuur Hosp, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Rooney, Jennifer A.; Ragan, Elizabeth; Horsburgh, Robert; Jacobson, Karen R.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Niemand, Nandi; Chegou, Novel N.; Walzl, Gerhard; Warren, Robin M.] Stellenbosch Univ, DSI NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa; [Niemand, Nandi; Chegou, Novel N.; Walzl, Gerhard; Warren, Robin M.] Stellenbosch Univ, South African Med Res Council, Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Myers, Bronwyn] Curtin Univ, Fac Hlth Sci, Curtin EnAble Inst, Perth, WA, Australia; [Theron, Danie] Brewelskloof Hosp, Worcester, South Africa; [Wood, Robin] Desmond Tutu Hlth Fdn, UCT Fac Hlth Sci, Cape Town, South Africa; [White, Laura F.] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA; [Meade, Christina S.] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC USA; [Horsburgh, Robert] Boston Univ, Dept Epidemiol Biostat & Global Hlth, Sch Publ Hlth, Boston, MA USA; [Rooney, Jennifer A.] Massachusetts Gen Hosp, Div Pediat Global Hlth, Boston, MA 02114 USA	South African Medical Research Council; University of Cape Town; Boston University; Stellenbosch University; South African Medical Research Council; Stellenbosch University; Curtin University; University of Cape Town; Boston University; Duke University; Boston University; Harvard University; Massachusetts General Hospital	Carney, T (corresponding author), South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Tygerberg, South Africa.; Carney, T (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Psychiat & Mental Hlth, Cape Town, South Africa.	tara.carney@mrc.ac.za		Carney, Tara/0000-0001-5400-0565; White, Laura F/0000-0002-0588-8235; Myers, Bronwyn/0000-0003-0235-6716; Meade, Christina/0000-0002-0864-1123	United States National Institute of Allergy and Infectious Diseases (NIAID) [1R01A1147316]	United States National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary funder (K Jacobson) of this study is the United States National Institute of Allergy and Infectious Diseases (NIAID) (1R01A1147316); the study protocol underwent peer-review by the funding body. The content is solely the work of the authors and does not necessarily reflect the views of NIAID, who did not have a role in the study design, data collection and analysis plans, decision to publish, or preparation of the manuscript.	Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; Aho J, 2017, Can Commun Dis Rep, V43, P72; Ali R, 2002, ADDICTION, V97, P1183; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruchfeld J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017871; Burnhams NH, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0074-1; Carney T, 2019, AIDS CARE, V31, P77, DOI 10.1080/09540121.2018.1500008; Darboe F, 2018, TUBERCULOSIS, V108, P124, DOI 10.1016/j.tube.2017.11.001; DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Des Jarlais D, 2018, DRUG ALCOHOL DEPEN, V185, P106, DOI 10.1016/j.drugalcdep.2017.11.033; Duffy FJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00661; Erasmus J, 2019, MONITORING ALCOHOL T; FAO, 2022, GLOB STRAT DIG HLTH; Fiore-Gartland A, 2018, TUBERCULOSIS, V109, P61, DOI [10.1016/j.tube.2017.11.009, 10]; Getahun H, 2013, B WORLD HEALTH ORGAN, V91, P154, DOI 10.2471/BLT.13.117267; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Gotway MB, 2002, RADIOGRAPHICS, V22, pS119, DOI 10.1148/radiographics.22.suppl_1.g02oc01s119; Hannan MM, 2001, J HOSP INFECT, V47, P91, DOI 10.1053/jhin.2000.0884; Harker N, 2020, INT J DRUG POLICY, V83, DOI 10.1016/j.drugpo.2020.102839; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Herman AA, 2009, SAMJ S AFR MED J, V99, P339; Jacobs BKM, 2017, ANAL CHEM, V89, P4461, DOI 10.1021/acs.analchem.6b04208; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kimani SM, 2014, DRUG ALCOHOL DEPEN, V143, P134, DOI 10.1016/j.drugalcdep.2014.07.018; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Leavitt SV, 2020, INT J EPIDEMIOL, V49, P764, DOI 10.1093/ije/dyaa031; Longabaugh R., 1999, MANUAL ADM IMPORTANT; Lorvick J, 2012, INT J DRUG POLICY, V23, P385, DOI 10.1016/j.drugpo.2012.07.005; Mathema B, 2017, J INFECT DIS, V216, pS644, DOI 10.1093/infdis/jix354; McCreesh N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23797-2; Mitruka K, 2014, PUBLIC HEALTH REP, V129, P78, DOI 10.1177/003335491412900112; Myers B, 2020, 51 UNION WORLD C LUN; Myers B, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111403; Myers B, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3396-y; Myers B, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2568-9; Nimmo C, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5782-2; Oeltmann JE, 2009, ARCH INTERN MED, V169, P189, DOI 10.1001/archinternmed.2008.535; Olivier L, 2013, SAMJ S AFR MED J, V103, P402, DOI [10.7196/SAMJ.6249, 10.7196/samj.6249]; Palmero D, 2006, MEDICINA-BUENOS AIRE, V66, P399; Parry CDH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-500; Patterson B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238193; Patterson Benjamin, 2017, Gates Open Res, V1, P11, DOI 10.12688/gatesopenres.12758.2; Peltzer K, 2018, SAJP-S AFR J PSYCHI, V24, DOI 10.4102/sajpsychiatry.v24i0.1139; Pengpid S, 2021, AFR J PRIM HEALTH CA, V13, DOI 10.4102/phcfm.v13i1.2847; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rawson RA, 2008, J SUBST ABUSE TREAT, V35, P279, DOI 10.1016/j.jsat.2007.11.003; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; Riekstina V, 2003, INT J TUBERC LUNG D, V7, P903; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; Sabin K, 2010, METHODOL INNOV ONLIN, V5, P38, DOI [10.4256/mio.2010.0017, DOI 10.4256/MIO.2010.0017]; Scriba TJ, 2021, LANCET INFECT DIS, V21, P354, DOI 10.1016/S1473-3099(20)30914-2; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sobell LC, 1996, 30 ANN M ASS ADV BEH; Stamatakis A., 2015, CURRENT PROTOCOLS BI, V51, p6.14.1, DOI 10.1002/0471250953.bi0614s51; The Stop TB Partnership, 2016, KEY POP BRIEF PEOPL; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wejnert C, 2012, AIDS BEHAV, V16, P797, DOI 10.1007/s10461-012-0147-8; Wood R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146658; World Health Organization, 2013, SYST SCREEN ACT TUB; Wurcel AG, 2015, CLIN INFECT DIS, V61, P1840, DOI 10.1093/cid/civ689; Yuen CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153728; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	66	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0262440	10.1371/journal.pone.0262440	http://dx.doi.org/10.1371/journal.pone.0262440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167586	gold, Green Published			2022-12-26	WOS:000802227200001
J	Rebelo, AR; Ibfelt, T; Bortolaia, V; Leekitcharoenphon, P; Hansen, DS; Nielsen, HL; Ellermann-Eriksen, S; Kemp, M; Roder, BL; Frimodt-Moller, N; Sondergaard, TS; Coia, JE; Ostergaard, C; Pedersen, M; Westh, H; Aarestrup, FM				Rebelo, Ana Rita; Ibfelt, Tobias; Bortolaia, Valeria; Leekitcharoenphon, Pimlapas; Hansen, Dennis Schroder; Nielsen, Hans Linde; Ellermann-Eriksen, Svend; Kemp, Michael; Roder, Bent Lowe; Frimodt-Moller, Niels; Sondergaard, Turid Snekloth; Coia, John Eugenio; Ostergaard, Claus; Pedersen, Michael; Westh, Henrik; Aarestrup, Frank Moller			One Day in Denmark: Nationwide point-prevalence survey of human bacterial isolates and comparison of classical and whole-genome sequence-based species identification methods	PLOS ONE			English	Article							PATHOGENS	Objectives Implementing whole-genome sequencing (WGS) technologies in clinical microbiology laboratories can increase the amount and quality of information available for healthcare practitioners. In this study, we analysed the applicability of this method and determined the distribution of bacterial species processed in clinical settings in Denmark. Methods We performed a point-prevalence study of all bacterial isolates (n = 2,009) processed and reported in the Clinical Microbiology Laboratories in Denmark in one day in January 2018. We compared species identification as performed by classical methods (MALDI-TOF) and by bioinformatics analysis (KmerFinder and rMLST) of WGS (Illumina NextSeq) data. We compared the national point-prevalence of bacterial isolates observed in clinical settings with the research attention given to those same genera in scientific literature. Results The most prevalent bacterium was Escherichia coli isolated from urine (n = 646), followed by Staphylococcus spp. from skin or soft tissues (n = 197). The distribution of bacterial species throughout the country was not homogeneous. We observed concordance of species identification for all methods in 95.7% (n = 1,919) of isolates, furthermore obtaining concordance for 99.7% (n = 1,999) at genus level. The number of scientific publications in the country did not correlate with the number of bacterial isolates of each genera analysed in this study. Conclusions WGS technologies have the potential to be applied in clinical settings for routine diagnostics purposes. This study also showed that bioinformatics databases should be continuously improved and results from local point-prevalence surveys should not be applied at national levels without previously determining possible regional variations.	[Rebelo, Ana Rita; Bortolaia, Valeria; Leekitcharoenphon, Pimlapas; Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Ibfelt, Tobias; Pedersen, Michael; Westh, Henrik] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Hansen, Dennis Schroder] Herlev Hosp, Dept Clin Microbiol, Herlev, Denmark; [Nielsen, Hans Linde] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Ellermann-Eriksen, Svend] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark; [Kemp, Michael] Odense Univ Hosp, Dept Clin Microbiol, Odense, Denmark; [Roder, Bent Lowe] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Frimodt-Moller, Niels] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark; [Sondergaard, Turid Snekloth] Hosp Southern Jutland, Dept Clin Microbiol, Sonderborg, Denmark; [Coia, John Eugenio] Sydvestjysk Hosp, Dept Clin Microbiol, Esbjerg, Denmark; [Ostergaard, Claus] Vejle Hosp, Dept Clin Microbiol, Vejle, Denmark; [Westh, Henrik] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen	Rebelo, AR (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	anrire@food.dtu.dk	Kemp, Michael/HGU-4170-2022	Kemp, Michael/0000-0001-5989-0421; Rebelo, Ana Rita/0000-0002-9338-9697; Coia, John/0000-0002-4966-8453; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723	Novo Nordisk Foundation - Global Surveillance of Antimicrobial Resistance [NNF16OC0021856]; H2020 project VEO grant [874735]	Novo Nordisk Foundation - Global Surveillance of Antimicrobial Resistance; H2020 project VEO grant	This project was supported by The Novo Nordisk Foundation - Global Surveillance of Antimicrobial Resistance (NNF16OC0021856) attributed to FMA (https://novonordiskfonden.dk/en/), and the H2020 project VEO grant (874735) attributed to FMA (https://www.veo-europe.eu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4604-6; [Anonymous], 2004, INS MALPR FIN REP HO; Baker MG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-332; Bortolaia V, 2020, J ANTIMICROB CHEMOTH, V75, P3491, DOI 10.1093/jac/dkaa345; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cassini A, 2018, EUROSURVEILLANCE, V23, P15, DOI 10.2807/1560-7917.ES.2018.23.16.17-00454; Clausen PTLC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2336-6; DANMAP, 2018, US ANT AG OCC ANT RE; Diekema DJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00355-19, 10.1128/aac.00355-19]; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; Furuse Y, 2019, P NATL ACAD SCI USA, V116, P478, DOI 10.1073/pnas.1814484116; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Long SW, 2013, J CLIN MICROBIOL, V51, P1272, DOI 10.1128/JCM.03237-12; Mogensen CB, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0178-1; Mogensen CB, 2015, DAN MED J, V62; Perry MR., 2018, BIORXIV, P498329, DOI [10.1101/498329, DOI 10.1101/498329]; Quainoo S, 2017, CLIN MICROBIOL REV, V30, P1015, DOI 10.1128/CMR.00016-17; Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413; Rossen JWA, 2018, CLIN MICROBIOL INFEC, V24, P355, DOI 10.1016/j.cmi.2017.11.001; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; Skjot-Arkil H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029000; Suetens C, 2018, EUROSURVEILLANCE, V23, P41, DOI 10.2807/1560-7917.ES.2018.23.46.1800516; Tindall BJ, 2017, INT J SYST EVOL MICR, V67, P502, DOI 10.1099/ijsem.0.001572; WHO, 2018, GLOB HLTH EST 2016 D; World Health Organization, 2017, PRIOR PATH GUID DISC; World Health Organization, 2011, REP BURD END HLTH CA; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0261999	10.1371/journal.pone.0261999	http://dx.doi.org/10.1371/journal.pone.0261999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148318	gold, Green Published			2022-12-26	WOS:000800108800007
J	Santos, MD; de Resende, MLV; Ciscon, BAD; Freitas, NC; Pereira, MHD; Reichel, T; Mathioni, SM				Santos, Mariana de Lima; Vilela de Resende, Mario Lucio; dos Santos Ciscon, Barbara Alves; Freitas, Natalia Chagas; de Brito Pereira, Matheus Henrique; Reichel, Tharyn; Mathioni, Sandra Marisa			LysM receptors in Coffea arabica: Identification, characterization, and gene expression in response to Hemileia vastatrix	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; PLANT-PATHOGEN INTERACTIONS; DEFENSE RESPONSES; FUNCTIONAL-CHARACTERIZATION; DISEASE RESISTANCE; DUAL ROLES; CELL-DEATH; LEAF RUST; ARABIDOPSIS; KINASE	Pathogen-associated molecular patterns (PAMPs) are recognized by pattern recognition receptors (PRRs) localized on the host plasma membrane. These receptors activate a broad-spectrum and durable defense, which are desired characteristics for disease resistance in plant breeding programs. In this study, candidate sequences for PRRs with lysin motifs (LysM) were investigated in the Coffea arabica genome. For this, approaches based on the principle of sequence similarity, conservation of motifs and domains, phylogenetic analysis, and modulation of gene expression in response to Hemileia vastatrix were used. The candidate sequences for PRRs in C. arabica (Ca1-LYP, Ca2-LYP, Ca1-CERK1, Ca2-CERK1, Ca-LYK4, Ca1-LYK5 and Ca2-LYK5) showed high similarity with the reference PRRs used: Os-CEBiP, At-CERK1, At-LYK4 and At-LYK5. Moreover, the ectodomains of these sequences showed high identity or similarity with the reference sequences, indicating structural and functional conservation. The studied sequences are also phylogenetically related to the reference PRRs described in Arabidopsis, rice, and other plant species. All candidates for receptors had their expression induced after the inoculation with H. vastatrix, since the first time of sampling at 6 hours post-inoculation (hpi). At 24 hpi, there was a significant increase in expression, for most of the receptors evaluated, and at 48 hpi, a suppression. The results showed that the candidate sequences for PRRs in the C. arabica genome display high homology with fungal PRRs already described in the literature. Besides, they respond to pathogen inoculation and seem to be involved in the perception or signaling of fungal chitin, acting as receptors or co-receptors of this molecule. These findings represent an advance in the understanding of the basal immunity of this species.	[Santos, Mariana de Lima] Univ Fed Lavras, Programa Posgrad Biotecnol Vegetal, Lavras, MG, Brazil; [Vilela de Resende, Mario Lucio; dos Santos Ciscon, Barbara Alves; Freitas, Natalia Chagas; de Brito Pereira, Matheus Henrique; Reichel, Tharyn; Mathioni, Sandra Marisa] Univ Fed Lavras, Dept Fitopatol, Lavras, MG, Brazil; [dos Santos Ciscon, Barbara Alves; de Brito Pereira, Matheus Henrique] BASF Corp, Ludwigshafen, Brazil; [Mathioni, Sandra Marisa] Syngenta Crop Protect, Uberlandia, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras; BASF; Syngenta	Santos, MD (corresponding author), Univ Fed Lavras, Programa Posgrad Biotecnol Vegetal, Lavras, MG, Brazil.; de Resende, MLV (corresponding author), Univ Fed Lavras, Dept Fitopatol, Lavras, MG, Brazil.	santos-ml@outlook.com; mluico@dfp.ufla.br	de Lima Santos, Mariana/GQB-5100-2022	de Lima Santos, Mariana/0000-0003-0642-2696; Reichel, Tharyn/0000-0003-2754-0245	Minas Gerais Research Funding Foundation (FAPEMIG); National Council of Scientific and Technological Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); National Institutes of Science and Technology of Coffee INCT/Cafe; Federal University of Lavras (UFLA)	Minas Gerais Research Funding Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Science and Technology of Coffee INCT/Cafe; Federal University of Lavras (UFLA)	This work has been funded by the Minas Gerais Research Funding Foundation (FAPEMIG https://fapemig.br/pt/), National Council of Scientific and Technological Development (CNPq https://www.gov.br/cnpq/pt-br), Coordination for the Improvement of Higher Education Personnel (CAPES -https://www.gov.br/capes/pt-br).National Institutes of Science and Technology of Coffee INCT/Cafe -http://www.inctcafe.ufla.br/pt/) and Federal University of Lavras (UFLA -https://ufla.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2013, J EXP BOT, V64, P5269, DOI 10.1093/jxb/ert275; Monteiro ACA, 2016, J PHYTOPATHOL, V164, P1043, DOI 10.1111/jph.12525; Ao Y, 2014, PLANT J, V80, P1072, DOI 10.1111/tpj.12710; Avelino J, 2015, FOOD SECUR, V7, P303, DOI 10.1007/s12571-015-0446-9; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bohm H, 2014, CURR OPIN PLANT BIOL, V20, P47, DOI 10.1016/j.pbi.2014.04.007; Boutrot F, 2017, ANNU REV PHYTOPATHOL, V55, P257, DOI 10.1146/annurev-phyto-080614-120106; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brule D, 2019, PLANT BIOTECHNOL J, V17, P812, DOI 10.1111/pbi.13017; Buendia L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01531; Cabral PGC, 2016, PLANT PATHOL, V65, P196, DOI 10.1111/ppa.12411; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Chen Q, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-04976-x; de Almeida DP, 2021, SCI AGR, V78, DOI [10.1590/1678-992x-2020-0023, 10.1590/1678-992X-2020-0023]; de Carvalho K, 2013, MOL BIOTECHNOL, V53, P315, DOI 10.1007/s12033-012-9529-4; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Desaki Y, 2019, J GEN PLANT PATHOL, V85, P1, DOI 10.1007/s10327-018-0828-x; Dickman MB, 2013, ANNU REV PHYTOPATHOL, V51, P543, DOI 10.1146/annurev-phyto-081211-173027; Fernandes-Brum CN, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1213-1; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Ganesh D, 2006, PLANT SCI, V170, P1045, DOI 10.1016/j.plantsci.2005.12.009; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hegenauer V, 2016, SCIENCE, V353, P478, DOI 10.1126/science.aaf3919; ICO, 2020, CROP YEAR PROD COUNT CROP YEAR PROD COUNT; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kaku H, 2016, PHYSIOL MOL PLANT P, V95, P60, DOI 10.1016/j.pmpp.2016.02.003; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Klemptner RL, 2014, MOL PLANT PATHOL, V15, P747, DOI 10.1111/mpp.12127; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lee HA, 2017, MOL PLANT MICROBE IN, V30, P5, DOI [10.1094/mpmi-10-16-0213-cr, 10.1094/MPMI-10-16-0213-CR]; Lee STM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00371; Leppyanen IV, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010008; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; Liu SM, 2016, STRUCTURE, V24, P1192, DOI 10.1016/j.str.2016.04.014; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Lv ZY, 2018, PLANT CELL REP, V37, P1101, DOI 10.1007/s00299-018-2295-4; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; McCook S, 2015, PHYTOPATHOLOGY, V105, P1164, DOI 10.1094/PHYTO-04-15-0085-RVW; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Nazarian-Firouzabadi F, 2019, MOL BIOL REP, V46, P5005, DOI 10.1007/s11033-019-04951-z; Nomura H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1926; Periyannan S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006380; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porto BN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215598; R Core Team, 2021, R LANGUAGE ENV STAT; Ramiro DA, 2009, PLANT PATHOL, V58, P944, DOI 10.1111/j.1365-3059.2009.02122.x; Ranf S, 2017, CURR OPIN PLANT BIOL, V38, P68, DOI [10.1016/j.pbi.2017.04.011, 10.1016/j.p]; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Reichel T, 2022, MOL BIOTECHNOL, V64, P263, DOI 10.1007/s12033-021-00405-9; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shinya T, 2012, PLANT CELL PHYSIOL, V53, P1696, DOI 10.1093/pcp/pcs113; Silva MC, 2008, PHYSIOL MOL PLANT P, V72, P29, DOI 10.1016/j.pmpp.2008.04.004; Silva MC, 2002, PHYSIOL MOL PLANT P, V60, P169, DOI 10.1006/pmpp.2002.0389; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; Talhinhas P, 2017, MOL PLANT PATHOL, V18, P1039, DOI 10.1111/mpp.12512; Tanaka S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-288; Tang DZ, 2017, PLANT CELL, V29, P618, DOI 10.1105/tpc.16.00891; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tombuloglu G, 2019, PHYSIOL MOL PLANT P, V106, P217, DOI 10.1016/j.pmpp.2019.03.002; Tran HTM, 2018, PLANT BIOTECHNOL J, V16, P1756, DOI 10.1111/pbi.12912; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Xue DX, 2019, J EXP BOT, V70, P5507, DOI 10.1093/jxb/erz313; Zambolim L, 2016, TROP PLANT PATHOL, V41, P1, DOI 10.1007/s40858-016-0065-9; Zeng LR, 2012, PLANT J, V69, P92, DOI 10.1111/j.1365-313X.2011.04773.x; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zhou Z, 2018, PLANT SCI, V269, P56, DOI 10.1016/j.plantsci.2018.01.006; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	86	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0258838	10.1371/journal.pone.0258838	http://dx.doi.org/10.1371/journal.pone.0258838			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143519	gold, Green Published, Green Submitted			2022-12-26	WOS:000797657800002
J	Schmidt, V; Navarro, CM; Ottosson, M; Tagil, M; Christersson, A; Engquist, M; Sayed-Noor, A; Mukka, S; Wadsten, M				Schmidt, Viktor; Navarro, Cecilia Mellstrand; Ottosson, Marcus; Tagil, Magnus; Christersson, Albert; Engquist, Markus; Sayed-Noor, Arkan; Mukka, Sebastian; Wadsten, Mats			Forecasting effects of "fast-tracks" for surgery in the Swedish national guidelines for distal radius fractures	PLOS ONE			English	Article							LOCKING-PLATE FIXATION; CORTICAL COMMINUTION; EPIDEMIOLOGY; RISK; COMPLICATIONS; PARAMETERS	Background and purpose National guidelines for treatment of distal radius fractures (DRFs) were presented in Sweden in 2021. In the guidelines, a fast-track is recommended for 4 subgroups of highly unstable DRFs. Regardless of the results of the closed reduction these are recommended for surgery within 1 week of injury. This study aims to evaluate the potential consequences of the newly presented national guidelines on incidence of surgical interventions. Patients and methods In all, 1,609 patients (1,635 DRFs) with primary radiographs after a DRF between 2014 and 2017 at two Swedish hospitals were included in a retrospective cohort study. An estimation was made of the percentage of patients in the historical pre-guidelines cohort, that would have been recommended early primary surgery according to the new national guidelines compared to treatment implemented without the support of these guidelines. Results On a strict radiological basis, 32% (516 out of 1635) of DRFs were classified into one of the 4 defined subgroups. At 9-13 days follow-up, cast treatment was converted into delayed primary surgery in 201 cases. Out of these, 56% (112 out of 201) fulfilled the fast-track criteria and would with the new guidelines have been subject to early primary surgery. Interpretation The fast-track regimen in the new guidelines, has a high likelihood of identifying the unstable fractures benefitting from early primary surgery. If the proposed Swedish national guidelines for DRF treatment are implemented, a greater proportion of fractures would be treated with early primary surgery, and a delayed surgery avoided in the majority of cases. The potential benefits in relation to possible costs when using the fast-track criteria in every day practice are still unknown.	[Schmidt, Viktor; Ottosson, Marcus; Mukka, Sebastian; Wadsten, Mats] Umea Univ, Dept Surg & Perioperat Sci Orthoped, Umea, Sweden; [Navarro, Cecilia Mellstrand; Sayed-Noor, Arkan] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Navarro, Cecilia Mellstrand] Soder Sjukhuset, Dept Hand Surg, Stockholm, Sweden; [Tagil, Magnus] Lund Univ, Dept Clin Sci Lund, Orthoped, Lund, Sweden; [Christersson, Albert] Uppsala Univ, Inst Surg Sci, Dept Orthoped, Uppsala, Sweden; [Engquist, Markus] Ryhov Hosp, Dept Orthoped, Jonkoping, Sweden	Umea University; Karolinska Institutet; Sodersjukhuset Hospital; Sodersjukhuset Hospital; Lund University; Uppsala University	Schmidt, V (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Orthoped, Umea, Sweden.	viktor.schmidt@umu.se		Schmidt, Viktor/0000-0002-8727-9555	Landstinget Vasternorrland [LVNFOU921951]	Landstinget Vasternorrland	Financial support was provided by Landstinget Vasternorrland (grant number LVNFOU921951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo A, 2008, ACTA ORTHOP, V79, P376, DOI 10.1080/17453670710015283; [Anonymous], 2017, HANDLEDSFRAKTUR BENB; Astrand J, 2006, ACTA ORTHOP, V77, P3, DOI 10.1080/17453670610045623; Boersma EZ, 2021, ACTA ORTHOP, V92, P131, DOI 10.1080/17453674.2020.1846853; Caldwell RA, 2019, J HAND SURG-AM, V44, P331, DOI 10.1016/j.jhsa.2018.07.012; Chung KC, 2011, J BONE JOINT SURG AM, V93A, P2154, DOI 10.2106/JBJS.J.012802; Costa ML, 2019, BONE JOINT J, V101B, P978, DOI 10.1302/0301-620X.101B8.BJJ-2018-1285.R1; Cowie J, 2015, J ORTHOP SURG-HONG K, V23, P24, DOI 10.1177/230949901502300106; Fanuele J, 2009, J BONE JOINT SURG AM, V91A, P1313, DOI 10.2106/JBJS.H.00448; Finsen V, 2013, J HAND SURG-EUR VOL, V38E, P116, DOI 10.1177/1753193412445144; Graafmans WC, 1996, OSTEOPOROSIS INT, V6, P427, DOI 10.1007/BF01629573; ICD-10, 2011, ICD 10 INT STAT CLAS; Johnson NA, 2019, J HAND SURG-EUR VOL, V44, P450, DOI 10.1177/1753193419843201; Karantana A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006080.pub3; Kodama N, 2014, J ORTHOP SCI, V19, P292, DOI 10.1007/s00776-013-0514-y; Kvernmo HD., 2015, NORSK ORTOPEDISK F R; Kvernmo Hebe Desiree, 2017, Tidsskr Nor Laegeforen, V137, DOI 10.4045/tidsskr.17.0065; Lichtman DM, 2011, J BONE JOINT SURG AM, V93A, P775, DOI 10.2106/JBJS.938ebo; Lutz K, 2014, J HAND SURG-AM, V39, P1280, DOI 10.1016/j.jhsa.2014.04.018; MacIntyre NJ, 2016, J HAND THER, V29, P136, DOI 10.1016/j.jht.2016.03.003; Mackenney PJ, 2006, J BONE JOINT SURG AM, V88A, P1944, DOI 10.2106/JBJS.D.02520; Mellstrand Navarro C., 2021, NATIONELLT VARDPROGR; Mellstrand-Navarro C, 2014, BONE JOINT J, V96B, P963, DOI 10.1302/0301-620X.96B7.33149; Mosenthal William P, 2019, Hand (N Y), V14, P534, DOI 10.1177/1558944717751194; Mulders MAM, 2019, J BONE JOINT SURG AM, V101, P787, DOI 10.2106/JBJS.18.00693; Navarro CM, 2015, J ORTHOP TRAUMA, V29, pE36, DOI 10.1097/BOT.0000000000000199; Nederlandse Vereniging voor Heelkunde, 2016, RICHTLIJN OPEN ONDER, P136; Nellans KW, 2012, HAND CLIN, V28, P113, DOI 10.1016/j.hcl.2012.02.001; Ochen Y, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3497; Roos H., 2018, ORTOPEDI PATOFYSIOLO; Saving J, 2019, J BONE JOINT SURG AM, V101, P961, DOI 10.2106/JBJS.18.00768; Saving J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207702; Saving J, 2019, J HAND SURG-AM, V44, P18, DOI 10.1016/j.jhsa.2018.09.015; Sirnio K, 2019, ACTA ORTHOP, V90, P123, DOI 10.1080/17453674.2018.1561614; Sundhedsstyrelsen D., 2014, SUNDHEDSSTYRELSEN DK; Swedish National Quality Registry for Fractures, SVENSK FRAKT; The National Board of Health and Welfare (NBHW), 2020, STAT DAT; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Wadsten MA, 2014, BONE JOINT J, V96B, P978, DOI 10.1302/0301-620X.96B7.32728; Wadsten MA, 2017, J WRIST SURG, V6, P285, DOI 10.1055/s-0037-1601577; Walenkamp MMJ, 2017, J HAND SURG-EUR VOL, V42, P39, DOI 10.1177/1753193416651577; Walenkamp MMJ, 2016, J HAND SURG-EUR VOL, V41, P501, DOI 10.1177/1753193415604795; Wilcke MKT, 2007, J HAND THER, V20, P290, DOI 10.1197/j.jht.2007.06.001	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0260296	10.1371/journal.pone.0260296	http://dx.doi.org/10.1371/journal.pone.0260296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143508	Green Published, gold			2022-12-26	WOS:000797657800004
J	Kamstra, K; Rizwan, MZ; Grattan, DR; Horsfield, JA; Tups, A				Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Horsfield, Julia A.; Tups, Alexander			Leptin regulates glucose homeostasis via the canonical Wnt pathway in the zebrafish	FASEB JOURNAL			English	Article						CRISPR Cas9; glucose tolerance test; leptin receptor; leptin-a; leptin-b; lithium chloride	SYNTHASE KINASE 3-BETA; BODY-WEIGHT; INSULIN-RESISTANCE; GENETICALLY-OBESE; CATENIN PATHWAY; DANIO-RERIO; FOOD-INTAKE; INHIBITION; THERAPY; MICE	Leptin is best known for its role in adipostasis, but it also regulates blood glucose levels. The molecular mechanism by which leptin controls glucose homeostasis remains largely unknown. Here, we use a zebrafish model to show that Wnt signaling mediates the glucoregulatory effects of leptin. Under normal feeding conditions, leptin regulates glucose homeostasis but not adipostasis in zebrafish. In times of nutrient excess, however, we found that leptin also regulates body weight and size. Using a Wnt signaling reporter fish, we show that leptin activates the canonical Wnt pathway in vivo. Utilizing two paradigms for hyperglycemia, it is revealed that leptin regulates glucose homeostasis via the Wnt pathway, as pharmacological inhibition of this pathway impairs the glucoregulatory actions of leptin. Our results may shed new light on the evolution of the physiological function of leptin.	[Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Tups, Alexander] Univ Otago, Ctr Neuroendocrinol, Dunedin, New Zealand; [Kamstra, Kaj; Rizwan, Mohammed Z.; Grattan, David R.; Tups, Alexander] Univ Otago, Brain Hlth Res Ctr, Dunedin, New Zealand; [Kamstra, Kaj; Tups, Alexander] Univ Otago, Dunedin Sch Med, Dept Physiol, Dunedin, New Zealand; [Rizwan, Mohammed Z.; Grattan, David R.] Univ Otago, Dunedin Sch Med, Dept Anat, Dunedin, New Zealand; [Horsfield, Julia A.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Horsfield, Julia A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago; University of Otago; University of Auckland	Tups, A (corresponding author), Univ Otago, Ctr Neumendocrinol, Otago Sch Biomed Sci, POB 913, Dunedin 9054, New Zealand.	alexander.tups@otago.ac.nz	Horsfield, Julia/B-5091-2012	Horsfield, Julia/0000-0002-9536-7790; Grattan, Dave/0000-0001-5606-2559	Department of Physiology, University of Otago; Maurice Wilkins Centre, University of Otago	Department of Physiology, University of Otago; Maurice Wilkins Centre, University of Otago	K.K. was supported by a PhD scholarship from the Department of Physiology and by the Maurice Wilkins Centre, University of Otago	Aguilar AJ, 2010, PEPTIDES, V31, P1044, DOI 10.1016/j.peptides.2010.02.026; Anagnostou SH, 2008, BIOCHEM J, V416, P211, DOI 10.1042/BJ20081426; Audira G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124038; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Boucsein A, 2016, ENDOCRINOLOGY, V157, P799, DOI 10.1210/en.2015-1708; Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005; Chisada S, 2014, GEN COMP ENDOCR, V195, P9, DOI 10.1016/j.ygcen.2013.10.008; de Pedro N, 2006, J ENDOCRINOL, V188, P513, DOI 10.1677/joe.1.06349; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Facchinello N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09867-x; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; GENUTH SM, 1971, ENDOCRINOLOGY, V88, P1230, DOI 10.1210/endo-88-5-1230; Gleeson M, 2007, ACTA DIABETOL, V44, P157, DOI 10.1007/s00592-007-0257-3; Gorissen M, 2009, J ENDOCRINOL, V201, P329, DOI 10.1677/JOE-09-0034; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Helfer G, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12368; Hubschle T, 2001, J NEUROSCI, V21, P2413, DOI 10.1523/JNEUROSCI.21-07-02413.2001; Jansson JO, 2018, P NATL ACAD SCI USA, V115, P427, DOI 10.1073/pnas.1715687114; Kang JS, 2016, NATURE, V532, P201, DOI 10.1038/nature17644; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Krutzfeldt J, 2010, DIABETOLOGIA, V53, P123, DOI 10.1007/s00125-009-1578-2; Leibold S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120776; Liu Q, 2010, GEN COMP ENDOCR, V166, P346, DOI 10.1016/j.ygcen.2009.11.015; Lohr H, 2018, CELL REP, V23, P1728, DOI 10.1016/j.celrep.2018.04.018; Londraville RL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00058; Michel M, 2016, P NATL ACAD SCI USA, V113, P3084, DOI 10.1073/pnas.1513212113; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Nikoulina SE, 2002, DIABETES, V51, P2190, DOI 10.2337/diabetes.51.7.2190; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ohlsson C, 2018, ENDOCRINOLOGY, V159, P2676, DOI 10.1210/en.2018-00307; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prokop JW, 2012, PEPTIDES, V38, P326, DOI 10.1016/j.peptides.2012.10.002; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105	50	1	1	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22207	10.1096/fj.202101764R	http://dx.doi.org/10.1096/fj.202101764R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35188286				2022-12-26	WOS:000761250800048
J	Sofer, S; Lamkiewicz, K; Eilat, SA; Partouche, S; Marz, M; Moskovits, N; Stemmer, SM; Shlomai, A; Sklan, EH				Sofer, Summer; Lamkiewicz, Kevin; Eilat, Shir Armoza; Partouche, Shirly; Marz, Manja; Moskovits, Neta; Stemmer, Salomon M.; Shlomai, Amir; Sklan, Ella H.			A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells	FASEB JOURNAL			English	Article						CRISPR activation; hepatocellular carcinoma; tyrosine-kinase inhibitors	TRANSCRIPTIONAL ACTIVATION; VIRAL-HEPATITIS; SORAFENIB; METABOLISM; GENE	Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage and is, therefore, treated with systemic drugs, such as tyrosine-kinase inhibitors (TKIs). These drugs, however, offer only modest survival benefits due to the rapid development of drug resistance. To identify genes implicated in TKI resistance, a cluster of regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 activation screen was performed in hepatoma cells treated with regorafenib, a TKI used as second-line therapy for advanced HCC. The screen results show that Hexokinase 1 (HK1), catalyzing the first step in glucose metabolism, is a top candidate for conferring TKI resistance. Compatible with this, HK1 was upregulated in regorafenib-resistant cells. Using several experimental approaches, both in vitro and in vivo, we show that TKI resistance correlates with HK1 expression. Furthermore, an HK inhibitor resensitized resistant cells to TKI treatment. Together, our data indicate that HK1 may function as a critical factor modulating TKI resistance in hepatoma cells and, therefore, may serve as a biomarker for treatment success.	[Sofer, Summer; Eilat, Shir Armoza; Sklan, Ella H.] Tel Aviv Univ, Sadder Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel; [Lamkiewicz, Kevin; Marz, Manja] Friedrich Schiller Univ, RNA Bioinformat & High Throughput Anal, Jena, Germany; [Lamkiewicz, Kevin; Marz, Manja] European Virus Bioinformat Ctr, Jena, Germany; [Partouche, Shirly; Shlomai, Amir] Beilinson Med Ctr, Felsenstein Med Res Ctr, Rabin Med Ctr, Petah Tiqwa, Israel; [Marz, Manja] Leibniz Inst Age Res Fritz Lipmann Inst, Jena, Germany; [Moskovits, Neta; Stemmer, Salomon M.] Tel Aviv Univ, PDX Lab, Felsenstein Med Res Ctr, Tel Aviv, Israel; [Moskovits, Neta; Stemmer, Salomon M.; Shlomai, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Stemmer, Salomon M.] Davidoff Ctr, Rabin Med Ctr, Inst Oncol, Petah Tiqwa, Israel; [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Dept Med, Petah Tiqwa, Israel	Tel Aviv University; Friedrich Schiller University of Jena; Rabin Medical Center; Tel Aviv University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Sklan, EH (corresponding author), Tel Aviv Univ, Sadder Sch Med, Dept Clin Microbiol & Immunol, IL-6997801 Tel Aviv, Israel.	sklan@taucx.tau.ac.il		Sofer, Summer/0000-0001-6741-2526				[Anonymous], 2013, STIV EPAR PROD INF A; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Caruso S, 2019, GASTROENTEROLOGY, V157, P760, DOI 10.1053/j.gastro.2019.05.001; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; DOI I, 1975, GANN, V66, P385; Dukhovny A, 2019, J VIROL, V93, DOI 10.1128/JVI.00211-19; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Escudier B, 2019, EXPERT REV ANTICANC, V19, P177, DOI 10.1080/14737140.2019.1559058; Feng J, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-1528-x; FLORIDI A, 1981, CANCER RES, V41, P4661; FUJISE K, 1990, HEPATO-GASTROENTEROL, V37, P457; Gao RZ, 2021, ONCOGENESIS, V10, DOI 10.1038/s41389-021-00338-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irwin DM, 2008, COMP BIOCHEM PHYS D, V3, P96, DOI 10.1016/j.cbd.2007.11.002; Jackson KD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082367; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kelley RK, 2017, ANN ONCOL, V28, P528, DOI 10.1093/annonc/mdw651; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Laizure SC, 2013, PHARMACOTHERAPY, V33, P210, DOI 10.1002/phar.1194; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu JP, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.165; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nwosu ZC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0872-6; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pusec CM, 2019, ENDOCRINOLOGY, V160, P313, DOI 10.1210/en.2018-00887; Schindler A, 2013, CELL SIGNAL, V25, P2685, DOI 10.1016/j.cellsig.2013.08.035; Shlomai A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207132; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Tesori V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09149; Tong M, 2018, J HEPATOL, V69, P826, DOI 10.1016/j.jhep.2018.05.034; Tovoli F, 2020, CURR PHARM DESIGN, V26, P3909, DOI 10.2174/1381612826666200429093648; Wang SJ, 2016, AM J CANCER RES, V6, P1108; Wilhelm SM., REGORAFENIB BAY 73 4; Xu SL, 2019, CANCER RES, V79, P5907, DOI 10.1158/0008-5472.CAN-19-1789; Xu SL, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0181-8; Xu SL, 2019, J NUCL MED, V60, P212, DOI 10.2967/jnumed.118.212365; Yoo JJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061292; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	43	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22191	10.1096/fj.202101507RR	http://dx.doi.org/10.1096/fj.202101507RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147243				2022-12-26	WOS:000761250800006
J	Suzuki, K; Marin, MD; Konno, M; Bagherzadeh, R; Murata, T; Inoue, K				Suzuki, Kano; Marin, Maria del Carmen; Konno, Masae; Bagherzadeh, Reza; Murata, Takeshi; Inoue, Keiichi			Structural characterization of proton-pumping rhodopsin lacking a cytoplasmic proton donor residue by X-ray crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE; PURPLE MEMBRANE; BACTERIORHODOPSIN; TRANSLOCATION; INTERMEDIATE; PHOTOCYCLE; XANTHORHODOPSIN; REPLACEMENT; TRANSPORT	DTG/DTS rhodopsin, which was named based on a three residue motif (DTG or DTS) that is important for its function, is a light-driven proton-pumping microbial rhodopsin using a retinal chromophore. In contrast to other light-driven ion-pumping rhodopsins, DTG/DTS rhodopsin does not have a cytoplasmic proton donor residue, such as Asp, Glu, or Lys. Because of the lack of cytoplasmic proton donor residue, proton directly binds to the retinal chromophore from the cytoplasmic solvent. However, mutational experiments that showed the complicated effects of mutations were not able to clarify the roles played by each residue, and the detail of proton uptake pathway is unclear because of the lack of structural information. To understand the proton transport mechanism of DTG/ DTS rhodopsin, here we report the three-dimensional structure of one of the DTG/DTS rhodopsins, PspR from Pseudomonas putida, by X-ray crystallography. We show that the structure of the cytoplasmic side of the protein is significantly different from that of bacteriorhodopsin, the best characterized proton-pumping rhodopsin, and large cytoplasmic cavities were observed. We propose that these hydrophilic cytoplasmic cavities enable direct proton uptake from the cytoplasmic solvent without the need for a specialized cytoplasmic donor residue. The introduction of carboxylic residues homologous to the cytoplasmic donors in other proton-pumping rhodopsins resulted in higher pumping activity with less pH dependence, suggesting that DTG/DTS rhodopsins are advantageous for producing energy and avoiding intracellular alkalization in soil and plant-associated bacteria.	[Suzuki, Kano; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Marin, Maria del Carmen; Konno, Masae; Bagherzadeh, Reza; Inoue, Keiichi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan; [Konno, Masae] PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Kawaguchi, Saitama, Japan; [Murata, Takeshi] Chiba Univ, Membrane Prot Res & Mol Chiral Res Ctr, Chiba, Japan	Chiba University; University of Tokyo; Japan Science & Technology Agency (JST); Chiba University	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.; Inoue, K (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba, Japan.; Murata, T (corresponding author), Chiba Univ, Membrane Prot Res & Mol Chiral Res Ctr, Chiba, Japan.	t.murata@faculty.chiba-u.jp; inoue@issp.u-tokyo.ac.jp	Marin, Maria del Carmen/CAF-3433-2022; Konno, Masae/C-1066-2009	Marin, Maria del Carmen/0000-0001-6603-1692; Konno, Masae/0000-0002-0605-1816	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [JP20H05758]; Japan Society for the Promotion of Science KAKENHI [JP20F20081, JP18H05425, JP21H01875, JP20K21383]; Japan Agency for Medical Research and Development (AMED) [21fk0108092]	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology KAKENHI, Grant-in-aid for Transformative Research Areas (B) "Low-energy manipulation" (grant number: JP20H05758; to K. I.), Japan Society for the Promotion of Science KAKENHI, Grants-inaid (grant numbers: JP20F20081 [to M. d. C. M.], JP18H05425 [to T. M.], as well as JP21H01875 and JP20K21383 [to K. I.]), International Research Fellow of the Japan Society for the Promotion of Science (Postdoctoral Fellowships for Research in Japan; to M. d. C. M.), and the Japan Agency for Medical Research and Development (AMED) under grant no. 21fk0108092 to T. M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balashov SP, 2013, J BIOL CHEM, V288, P21254, DOI 10.1074/jbc.M113.465138; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Besaw JE, 2020, J BIOL CHEM, V295, P14793, DOI 10.1074/jbc.RA120.014118; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Dioumaev AK, 2003, BIOCHEMISTRY-US, V42, P6582, DOI 10.1021/bi034253r; Dioumaev AK, 1999, BIOCHEMISTRY-US, V38, P10070, DOI 10.1021/bi990873+; Donahue CET, 2021, J AM CHEM SOC, V143, P18877, DOI 10.1021/jacs.1c02156; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fudim R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav4203; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Govorunova EG, 2016, BIOCHEMISTRY-MOSCOW+, V81, P928, DOI 10.1134/S0006297916090029; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Harris A, 2015, BBA-BIOENERGETICS, V1847, P1518, DOI 10.1016/j.bbabio.2015.08.003; Higuchi A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016328118; Inoue K, 2021, ADV EXP MED BIOL, V1293, P89, DOI 10.1007/978-981-15-8763-4_6; Inoue K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz2441; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Irieda H, 2012, J BIOL CHEM, V287, P32485, DOI 10.1074/jbc.M112.390864; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kandori H, 2020, B CHEM SOC JPN, V93, P904, DOI 10.1246/bcsj.20200109; Kato HE, 2021, ADV EXP MED BIOL, V1293, P35, DOI 10.1007/978-981-15-8763-4_3; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lorenz-Fonfria VA, 2009, J AM CHEM SOC, V131, P5891, DOI 10.1021/ja900334c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Maliar N, 2020, DOKL BIOCHEM BIOPHYS, V495, P342, DOI 10.1134/S1607672920060162; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Mukherjee S, 2019, CURR OPIN STRUC BIOL, V57, P118, DOI 10.1016/j.sbi.2019.02.003; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Needham DM, 2019, P NATL ACAD SCI USA, V116, P20574, DOI 10.1073/pnas.1907517116; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Philosof A, 2017, CURR BIOL, V27, P1362, DOI 10.1016/j.cub.2017.03.052; Pushkarev A, 2018, NATURE, V558, P595, DOI 10.1038/s41586-018-0225-9; RACKER E, 1974, J BIOL CHEM, V249, P662; Rink T, 2000, BIOPHYS J, V78, P1519, DOI 10.1016/S0006-3495(00)76704-X; Rozenberg A, 2021, ANNU REV MICROBIOL, V75, P427, DOI 10.1146/annurev-micro-031721-020452; Rozenberg A, 2020, CURR BIOL, V30, P4910, DOI 10.1016/j.cub.2020.09.056; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; Shibata M, 2003, J AM CHEM SOC, V125, P13312, DOI 10.1021/ja037343s; Shibata M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26606-y; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/nnano.2010.7, 10.1038/NNANO.2010.7]; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P6873, DOI 10.1073/pnas.88.15.6873; Sudo Y, 2016, PHOTOCHEM PHOTOBIOL, V92, P420, DOI 10.1111/php.12585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vogt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16450; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zabelskii D, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02326-4; Zscherp C, 2001, BIOCHEM BIOPH RES CO, V283, P57, DOI 10.1006/bbrc.2001.4730; ZUCKERKANDL EMILE, 1965, P97	63	3	3	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101722	10.1016/j.jbc.2022.101722	http://dx.doi.org/10.1016/j.jbc.2022.101722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151692	Green Published, gold			2022-12-26	WOS:000789394500007
J	Takaura, K; Kurosaki, M; Inada, K; Kirino, S; Yamashita, K; Muto, T; Osawa, L; Sekiguchi, S; Hayakawa, Y; Higuchi, M; Kaneko, S; Maeyashiki, C; Tamaki, N; Yasui, Y; Itakura, J; Tsuchiya, K; Nakanishi, H; Takahashi, Y; Izumi, N				Takaura, Kenta; Kurosaki, Masayuki; Inada, Kento; Kirino, Sakura; Yamashita, Kouji; Muto, Tomohiro; Osawa, Leona; Sekiguchi, Shuhei; Hayakawa, Yuka; Higuchi, Mayu; Kaneko, Shun; Maeyashiki, Chiaki; Tamaki, Nobuharu; Yasui, Yutaka; Itakura, Jun; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Takahashi, Yuka; Izumi, Namiki			The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; B-VIRUS INFECTION; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; HEPATITIS-B; DOUBLE-BLIND; TRIAL; ALAFENAMIDE; INTERFERON	Background and aim The long-term prognosis of hepatocellular carcinoma (HCC) treated at a very-early-stage (the Barcelona Clinical Liver Cancer (BCLC) classification stage 0) was unclear, especially in terms of background liver disease. Methods This single-center, retrospective study included 302 patients with BCLC stage 0 HCC treated with radiofrequency ablation (RFA) and followed for at least six months. We examined the impact of background liver disease on overall survival and recurrence. Results The median age was 72 (range; 36-91) years; the median tumor diameter was 15 (range; 8-20) mm. The etiologies of background liver disease were hepatitis B virus infection (HBV) in 24 cases, hepatitis C virus infection (HCV) in 195 cases, and non-viral (NBNC) in 83 cases. Among the patients with HCV, 63 had achieved sustained virological response (SVR) by antiviral therapy (HCV SVR) before developing HCC (n = 37) or after HCC treatment (n = 26), and 132 had active HCV infection (HCV non-SVR). The median overall survival was 85 (95% CI; 72-98) months, and the median recurrence-free survival was 26 (95% CI; 20-30) months. Active infection with hepatitis C virus negatively contributed to overall survival (HR 2.91, 95% CI 1.31-3.60, p = 0.003) and recurrence-free survival (HR 1.47, 95% CI 1.06-2.05, p = 0.011). Conclusions The prognosis of RFA treatment for very early-stage HCC was favorable. Achieving SVR in hepatitis C was important for further prognosis improvement.	[Takaura, Kenta; Kurosaki, Masayuki; Inada, Kento; Kirino, Sakura; Yamashita, Kouji; Muto, Tomohiro; Osawa, Leona; Sekiguchi, Shuhei; Hayakawa, Yuka; Higuchi, Mayu; Kaneko, Shun; Maeyashiki, Chiaki; Tamaki, Nobuharu; Yasui, Yutaka; Itakura, Jun; Tsuchiya, Kaoru; Nakanishi, Hiroyuki; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Tamaki, Nobuharu] Univ Calif San Diego, NAFLD Res Ctr, Div Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp			Japan Agency for Medical Research and Development [JP20fk0210067h0001]; Japanese Ministry of Health, Welfare and Labor [H3-KanseiShitei-003]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	Masayuki Kurosaki (MK) received funding support from the Japan Agency for Medical Research and Development (grant number: JP20fk0210067h0001), and Namiki Izumi (NI) received funding support from Japanese Ministry of Health, Welfare and Labor (H3-KanseiShitei-003).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Buti M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30020-6, 10.1016/S2468-1253(16)30107-8]; Cabibbo G, 2019, J HEPATOL, V71, P265, DOI 10.1016/j.jhep.2019.03.027; Carrat F, 2019, LANCET, V393, P1453, DOI 10.1016/S0140-6736(18)32111-1; Chan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Himoto T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/871401; Hiraoka A, 2019, LIVER CANCER, V8, P121, DOI 10.1159/000488778; Hocquelet A, 2017, J HEPATOL, V66, P67, DOI 10.1016/j.jhep.2016.07.010; Hsiao CY, 2020, AM J SURG, V220, P958, DOI 10.1016/j.amjsurg.2020.03.017; Huang G, 2015, ANN SURG, V261, P56, DOI 10.1097/SLA.0000000000000858; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Ikeda K, 2017, DIGEST DIS SCI, V62, P2932, DOI 10.1007/s10620-017-4739-z; Izumi N, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4002; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kariyama K, 2020, LIVER CANCER, V9, P41, DOI 10.1159/000502479; Kawamura Y, 2019, HEPATOL RES, V49, P164, DOI 10.1111/hepr.13254; Kokudo N, 2019, HEPATOL RES, V49, P1109, DOI 10.1111/hepr.13411; Kwo PY, 2017, J HEPATOL, V67, P263, DOI 10.1016/j.jhep.2017.03.039; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Liu PH, 2016, ANN SURG, V263, P538, DOI 10.1097/SLA.0000000000001178; Maeda M, 2020, LIVER CANCER, V9, P50, DOI 10.1159/000502744; Mashiba T, 2019, HEPATOL RES, V49, P1114, DOI 10.1111/hepr.13362; Mashiba T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194704; Minami Y, 2020, HEPATOL RES, V50, P67, DOI 10.1111/hepr.13407; Ng KKC, 2017, BRIT J SURG, V104, P1775, DOI 10.1002/bjs.10677; Ochi H, 2021, J GASTROENTEROL, V56, P90, DOI 10.1007/s00535-020-01747-y; Okamura Y, 2019, ANN SURG ONCOL, V26, P4566, DOI 10.1245/s10434-019-07911-w; Ono A, 2012, J HEPATOL, V57, P508, DOI 10.1016/j.jhep.2012.04.037; Pompili M, 2013, J HEPATOL, V59, P89, DOI 10.1016/j.jhep.2013.03.009; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Sarin SK, 2020, LANCET GASTROENTEROL, V5, P167, DOI 10.1016/S2468-1253(19)30342-5; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Singal AG, 2019, GASTROENTEROLOGY, V156, P1215, DOI [10.1053/j.gastro.2018.08.066, 10.1053/j.gastro.2019.01.027]; Tahata Y, 2020, HEPATOL RES, V50, P1118, DOI 10.1111/hepr.13547; Tojima H, 2020, HEPATOL RES, V50, P303, DOI 10.1111/hepr.13462; Tsuji K, 2018, J GASTROENTEROL, V53, P1142, DOI 10.1007/s00535-018-1455-1; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Waziry R, 2017, J HEPATOL, V67, P1204, DOI 10.1016/j.jhep.2017.07.025; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264075	10.1371/journal.pone.0264075	http://dx.doi.org/10.1371/journal.pone.0264075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196341	gold, Green Published			2022-12-26	WOS:000835161600024
J	Vallarta-Robledo, JR; Joost, S; Ruas, MAV; Gubelmann, C; Vollenweider, P; Marques-Vidal, P; Guessous, I				Vallarta-Robledo, Juan R.; Joost, Stephane; Ruas, Marco Andre Vieira; Gubelmann, Cedric; Vollenweider, Peter; Marques-Vidal, Pedro; Guessous, Idris			Geographic clusters of objectively measured physical activity and the characteristics of their built environment in a Swiss urban area	PLOS ONE			English	Article							REGRESSION-MODELS; OBESITY; WALKING; ATTRIBUTES; INACTIVITY; OUTCOMES; IMPACT	Introduction Evidence suggests that the built environment can influence the intensity of physical activity. However, despite the importance of the geographic context, most of the studies do not consider the spatial framework of this association. We aimed to assess individual spatial dependence of objectively measured moderate and vigorous physical activity (MVPA) and describe the characteristics of the built environment among spatial clusters of MVPA. Methods Cross-sectional data from the second follow-up (2014-2017) of CoLaus vertical bar PsyCoLaus, a longitudinal population-based study of the Lausanne area (Switzerland), was used to objectively measure MVPA using accelerometers. Local Moran's I was used to assess the spatial dependence of MVPA and detect geographic clusters of low and high MVPA. Additionally, the characteristics of the built environment observed in the clusters based on raw MVPA and MVPA adjusted for socioeconomic and demographic factors were compared. Results Data from 1,889 participants (median age 63, 55% women) were used. The geographic distribution of MVPA and the characteristics of the built environment among clusters were similar for raw and adjusted MVPA. In the adjusted model, we found a low concentration of individuals within spatial clusters of high MVPA (median: 38.5mins; 3% of the studied population) and low MVPA (median: 10.9 mins; 2% of the studied population). Yet, clear differences were found in both models between clusters regarding the built environment; high MVPA clusters were located in areas where specific compositions of the built environment favor physical activity. Conclusions Our results suggest the built environment may influence local spatial patterns of MVPA independently of socioeconomic and demographic factors. Interventions in the built environment should be considered to promote physically active behaviors in urban areas.	[Vallarta-Robledo, Juan R.; Joost, Stephane; Guessous, Idris] Geneva Univ Hosp, Div Primary Care Med, Geneva, Switzerland; [Vallarta-Robledo, Juan R.; Joost, Stephane; Guessous, Idris] Geneva Univ Hosp, Dept Primary Care Med, Geneva, Switzerland; [Vallarta-Robledo, Juan R.; Guessous, Idris] Univ Geneva, Fac Med, Geneva, Switzerland; [Vallarta-Robledo, Juan R.; Joost, Stephane; Marques-Vidal, Pedro; Guessous, Idris] Grp Geog Informat Res & Anal Populat Hlth GIRAPH, Geneva, Switzerland; [Joost, Stephane; Ruas, Marco Andre Vieira] Ecole Polytech Fed Lausanne EPFL, Sch Architecture Civil & Environm Engn ENAC, Lab Geog Informat Syst LASIG, Lausanne, Switzerland; [Joost, Stephane] Univ Appl Sci & Arts Western Switzerland HES SO, Sch Nursing, La Source, Lausanne, Switzerland; [Gubelmann, Cedric; Vollenweider, Peter; Marques-Vidal, Pedro] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland; [Gubelmann, Cedric; Vollenweider, Peter; Marques-Vidal, Pedro] Univ Lausanne, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Guessous, I (corresponding author), Geneva Univ Hosp, Div Primary Care Med, Geneva, Switzerland.; Guessous, I (corresponding author), Geneva Univ Hosp, Dept Primary Care Med, Geneva, Switzerland.; Guessous, I (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.; Guessous, I (corresponding author), Grp Geog Informat Res & Anal Populat Hlth GIRAPH, Geneva, Switzerland.	idris.guessous@hcuge.ch	Colaus, PsyColaus/K-6607-2013; Marques-Vidal, Pedro/C-9449-2009; Gubelmann, Cedric/J-1513-2016	Marques-Vidal, Pedro/0000-0002-4548-8500; Gubelmann, Cedric/0000-0002-4358-4769; Joost, Stephane/0000-0002-1184-7501	GlaxoSmithKline; Faculty of Biology and Medicine of University of Lausanne; Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468, 33CS30-148401]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The CoLaus vertical bar PsyCoLaus study was and is supported by research grants from GlaxoSmithKline (https://www.gsk.com), the Faculty of Biology and Medicine of University of Lausanne (http://unil.ch/fbm/home.html), and the Swiss National Science Foundation (www.snf.ch, grants 3200B0-105993, 3200B0-118308, 33CSCO-122661, 33CS30-139468 and 33CS30-148401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RP, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111326; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Carlson JA, 2018, AM J HEALTH PROMOT, V32, P1723, DOI 10.1177/0890117118768767; Cerin E, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0493-z; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Charreire H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-59; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; Clary C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237323; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Franco Manuel, 2018, Gac Sanit, V32 Suppl 1, P69, DOI 10.1016/j.gaceta.2018.07.002; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Garden FL, 2009, J URBAN HEALTH, V86, P19, DOI 10.1007/s11524-008-9332-5; Greenough PG, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0234-9; Gubelmann C, 2017, PREV MED, V105, P350, DOI 10.1016/j.ypmed.2017.10.016; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Holliday KM, 2017, J URBAN HEALTH, V94, P459, DOI 10.1007/s11524-017-0164-z; Houston D, 2014, APPL GEOGR, V50, P40, DOI 10.1016/j.apgeog.2014.02.008; Huang L, 2009, AM J PREV MED, V37, P157, DOI 10.1016/j.amepre.2009.04.021; Joost S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010145; Karmeniemi M, 2018, ANN BEHAV MED, V52, P239, DOI 10.1093/abm/kax043; Koohsari MJ, 2017, J URBAN HEALTH, V94, P847, DOI 10.1007/s11524-017-0199-1; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee KH, 2017, LANDSCAPE URBAN PLAN, V168, P61, DOI 10.1016/j.landurbplan.2017.09.020; Li X., 2019, RGEODA R LIB SPATIAL; Limb ES, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-018-0762-5; Maki-Opas TE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3264-x; Mayne DJ, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0149-x; Mayne SL, 2015, OBES REV, V16, P362, DOI 10.1111/obr.12269; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mena C., 2017, SPORT SCI HLTH, V13, P9, DOI [10.1007/s11332-017-0349-6, DOI 10.1007/S11332-017-0349-6]; Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008; Migueles J.H., 2019, J MEAS PHYS BEHAV, V2, P188, DOI [10.1123/jmpb.2018-0063, DOI 10.1123/JMPB.2018-0063]; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Pebesma E, 2018, R J, V10, P439; Quick A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2016-7; R Core Team, 2020, R LANG ENV STAT COMP; Rahnama MR, 2019, J URBAN HEALTH, V96, P653, DOI 10.1007/s11524-019-00373-1; Rodrigues AM, 2015, HEALTH PSYCHOL, V34, P61, DOI 10.1037/hea0000104; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Schule SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123456; Schuurman N, 2009, OBESITY, V17, P2202, DOI 10.1038/oby.2009.119; Smith M, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0613-9; Sugiyama T, 2015, J URBAN HEALTH, V92, P253, DOI 10.1007/s11524-014-9932-1; Tamura K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1322; Tobler W, 1993, 931 NCGIA; Tom White, 2018, **DATA OBJECT**, DOI 10.5281/zenodo.1187043; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Valson JS, 2019, ASIA-PAC J PUBLIC HE, V31, P612, DOI 10.1177/1010539519879322; Wang J, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7040143; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; Weiss CC, 2011, J URBAN HEALTH, V88, P297, DOI 10.1007/s11524-011-9551-z; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkie Stephanie, 2018, Cities Health, V2, P198, DOI 10.1080/23748834.2019.1574954; World Health Organization Regional Office for Europe., 2018, MOR PHYS ACT CIT TRA; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH; Xu HW, 2014, SOCIOL METHODOL, V44, P229, DOI 10.1177/0081175013490188; Zhang M, 2020, J PLAN EDUC RES, V40, P304, DOI 10.1177/0739456X18755495	66	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0252255	10.1371/journal.pone.0252255	http://dx.doi.org/10.1371/journal.pone.0252255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196322	Green Published, gold, Green Submitted			2022-12-26	WOS:000835161600001
J	Ivanova, E; Abakumov, E; Vasilyeva, N; Zverev, A; Vladimirov, A; Ksenofontova, N; Andronov, E; Kostenko, I				Ivanova, Ekaterina; Abakumov, Evgeny; Vasilyeva, Nadezda; Zverev, Alexei; Vladimirov, Artem; Ksenofontova, Natalia; Andronov, Evgeny; Kostenko, Igor			The shifts in the structure of the prokaryotic community of mountain-grassland soil under the influence of artificial larch plantations	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; SPECIES RICHNESS; BACTERIAL; PH	Creation of artificial forest plantations on a global scale is one of the ways to mitigate the negative effects of climate change on ecosystems, at the same time providing soil protection from erosion, regulation of the hydrological regime and carbon sequestration in soils of different natural and climatic zones. However, the change of the dominant plant community cause significant ecosystem changes, reflecting at the structure and functioning of the soil microbial complex as well. The shifts in prokaryotic community of the meadow soil resulting from the conversion of the native meadow (further grassland) phytocenosis to the artificial forest plantations was investigated with the use of NGS sequencing technology and metabarcoding approach-amplicon sequencing of V4 region of 16 S rRNA (performed on Illumina Miseq platform). The identified shifts in taxonomic structure and diversity may be the result of changes in the physic-chemical conditions of soils and, on the other hand, may serve as indicators of such changes. Cultivation of larch led to an increase in the diversity of the prokaryotic community and its stratification by depth. The acidifying effect of larch manifested itself in an increase in the proportion and diversity of acidobacteria, in the abundance of oligotrophic microorganisms of phyla Chloroflexi, Firmicutes, and a simultaneous comparative decrease in the bacteria of Verrucomicrobia phylum, alphaproteobacteria of or. Rhizobiales and Burkholderiales. The absence of clearly expressed dominants in the prokaryotic community, as well as a significant increase in alpha-diversity indices, compared with the control plot of native mountain-meadow soil under grassland vegetation, suggests a transitional nature of the soil ecosystem of artificial forest plantations.	[Ivanova, Ekaterina; Vasilyeva, Nadezda; Vladimirov, Artem; Ksenofontova, Natalia] Dokuchaev Soil Sci Inst, Moscow, Russia; [Ivanova, Ekaterina] Agrophys Res Inst, St Petersburg, Russia; [Abakumov, Evgeny] St Petersburg State Univ, St Petersburg, Russia; [Zverev, Alexei; Andronov, Evgeny] All Russian Res Inst Agr Biol, St Petersburg, Russia; [Kostenko, Igor] RAS, Nikitsky Bot Garden Natl Sci Ctr, Jalta, Crimea, Russia; [Abakumov, Evgeny] St Peterburg State Univ, Dept Appl Soil Ecol, St Petersburg, Russia; [Zverev, Alexei] Russian Federat, Lab Microbiol Monitoring & Bioremediat Soils, St Petersburg, Russia	Dokuchaev Soil Science Institute; Agrophysics Research Institute; Saint Petersburg State University; Russian Academy of Sciences; Saint Petersburg State University	Ivanova, E (corresponding author), Dokuchaev Soil Sci Inst, Dept Soil Biol & Biochem, Moscow, Russia.	ektrnivanova@gmail.com	Zverev, Aleksei/GQZ-2682-2022; Vasilyeva, Nadezda/S-1219-2018; Ivanova, Ekaterina/F-9279-2017	Zverev, Aleksei/0000-0002-5315-8632; Vasilyeva, Nadezda/0000-0002-1942-3738; Ivanova, Ekaterina/0000-0003-1589-9875; Vladimirov, Artem/0000-0001-8223-393X	Russian Science Foundation [17-16-01030]	Russian Science Foundation(Russian Science Foundation (RSF))	Russian Science Foundation, grant number 17-16-01030. The grant holder(AE2) participated in the study design, data collection and decision to publish.	Bagrova LA., 2009, ECOSYS OPT PROT, V20, P134; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Cai P, 2006, SOIL BIOL BIOCHEM, V38, P471, DOI 10.1016/j.soilbio.2005.05.019; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cho Sun-Ja, 2016, Journal of Ecology and Environment, V40, P10, DOI 10.1186/s41610-016-0004-1; Clements FE, 1935, ECOLOGY, V16, P342, DOI 10.2307/1930074; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Huber KJ, 2017, INT J SYST EVOL MICR, V67, P4487, DOI 10.1099/ijsem.0.002318; IUSS WORKING GROUP WRB, 2015, WORLD REFERENCE BASE, V106; Ivanova AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230157; Ivanova EA, 2020, PEDOBIOLOGIA, V81-82, DOI 10.1016/j.pedobi.2020.150650; Janssen S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00021-18; Jin QS, 2018, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00101; Khakimov FI., 2005, EURASIAN SOIL SCI+, V6, P653; Kostenko IV., 2020, FOREST SCI, V3, P1, DOI [10.31509/2658-607x-2020-3-2-1-16, DOI 10.31509/2658-607X-2020-3-2-1-16]; Kostenko IV., 2018, EURASIAN SOIL SCI+, V5, P515, DOI [10.7868/S0032180X18050015, DOI 10.7868/S0032180X18050015]; Lange M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096182; Lei SN, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.762; Li SZ, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123255; Li XQ, 2017, ENVIRON POLLUT, V231, P908, DOI 10.1016/j.envpol.2017.08.057; Lynch J. M., 1995, Plant-soil interactions at low pH: principles and management. Proceedings of the Third International Symposium, Brisbane, Queensland, Australia, 12-16 September 1993., P167; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mineev VG., 2001, REV ADDITIONAL, V2nd ed; Neina D, 2019, APPL ENVIRON SOIL SC, V2019, DOI 10.1155/2019/5794869; Nikiforov AR., 2019, CRIMEA EKOSIS, V19, P60; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Pascual J, 2015, SYST APPL MICROBIOL, V38, P534, DOI 10.1016/j.syapm.2015.08.001; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schlatter DC, 2015, ECOLOGY, V96, P134, DOI 10.1890/13-1648.1; Semenov MV, 2018, APPL SOIL ECOL, V127, P8, DOI 10.1016/j.apsoil.2018.03.002; Tan WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62919-7; Tkachenko M.E., 1908, SPB, V18, P85; Vadyunina AF., 1986, METHODS INVESTIGATIO; van Dijl JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-3; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wu YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40093; Yagodin VA., 1987, TRAINING BOOK AGROCH; Yang K, 2013, PLANT SOIL, V368, P535, DOI 10.1007/s11104-012-1535-6; Zhang WW, 2017, APPL SOIL ECOL, V111, P73, DOI 10.1016/j.apsoil.2016.11.019	45	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263135	10.1371/journal.pone.0263135	http://dx.doi.org/10.1371/journal.pone.0263135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180237	Green Published, gold			2022-12-26	WOS:000796435800011
J	Akazawa, N; Kishi, M; Hino, T; Tsuji, R; Tamura, K; Hioka, A; Moriyama, H				Akazawa, Naoki; Kishi, Masaki; Hino, Toshikazu; Tsuji, Ryota; Tamura, Kimiyuki; Hioka, Akemi; Moriyama, Hideki			Relationship between muscle mass and fraction of intramuscular adipose tissue of the quadriceps in older inpatients	PLOS ONE			English	Article							ECHO INTENSITY; SKELETAL-MUSCLE; FAT; ULTRASONOGRAPHY; INDEPENDENCE; RELIABILITY; SARCOPENIA; STRENGTH; HEALTH; INDEX	Background In 2021, the International Society of Physical and Rehabilitation Medicine (ISPRM) special interest group on sarcopenia included the quadriceps thickness assessed with ultrasound image as an indicator of muscle mass in the diagnosis criteria of sarcopenia. If quadriceps echo intensity of older inpatients is to be a strong predictor of quadriceps thickness, muscle quality of the quadriceps may be estimated by the muscle mass when diagnosing sarcopenia using the criteria of ISPRM. Objective This study aimed to examine the association between muscle mass and fraction of intramuscular adipose tissue of the quadriceps in older inpatients. Methods This cross-sectional study included 399 inpatients aged. 65 years. Primary outcomes were muscle mass and fraction of intramuscular adipose tissue of the quadriceps. Images were acquired using a B-mode ultrasound. Muscle mass and fraction of intramuscular adipose tissue of the quadriceps were assessed based on the muscle thickness and echo intensity, respectively. A multiple regression analysis (forced entry method) was performed to confirm whether quadriceps echo intensity was related to quadriceps thickness even after adjusting for other factors. Results In the multiple regression analyses for both male and female models, quadriceps echo intensity (male: beta = - 0.537, p < 0.001; female: beta = - 0.438, p < 0.001), Geriatric Nutritional Risk Index (male: beta = 0.236, p < 0.001; female: beta = 0.213, p < 0.001), and subcutaneous fat thickness of the thigh (male: beta = 0.197, p < 0.001; female: beta = 0.248, p < 0.001) were independently and significantly associated with quadriceps thickness. Conclusions Our results show that there is a negative and significant association between muscle mass and fraction of intramuscular adipose tissue in older inpatients. Muscle quality of the quadriceps in older inpatients may be estimated to some extent by the muscle mass.	[Akazawa, Naoki; Hioka, Akemi] Tokushima Bunri Univ, Fac Hlth & Welf, Dept Phys Therapy, Tokushima, Japan; [Kishi, Masaki; Hino, Toshikazu; Tsuji, Ryota; Tamura, Kimiyuki] Kasei Tamura Hosp, Dept Rehabil, Wakayama, Wakayama, Japan; [Moriyama, Hideki] Kobe Univ, Hlth Sci Discipline, Life & Med Sci Area, Kobe, Hyogo, Japan	Tokushima Bunri University; Kobe University	Akazawa, N (corresponding author), Tokushima Bunri Univ, Fac Hlth & Welf, Dept Phys Therapy, Tokushima, Japan.	akazawa@tks.bunri-u.ac.jp			JSPS KAKENHI [JP17K18294]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP17K18294 (Grant-in-Aid for Young Scientists B).	Addison O, 2014, J NUTR HEALTH AGING, V18, P532, DOI 10.1007/s12603-014-0019-1; Akazawa N, 2021, NUTRITION, V91-92, DOI 10.1016/j.nut.2021.111364; Akazawa N, 2021, J AM MED DIR ASSOC, V22, P1287, DOI 10.1016/j.jamda.2020.09.017; Akazawa N, 2021, J CACHEXIA SARCOPENI, V12, P891, DOI 10.1002/jcsm.12713; Akazawa N, 2021, NUTRITION, V81, DOI 10.1016/j.nut.2020.110928; Akazawa N, 2021, CLIN NUTR, V40, P1381, DOI 10.1016/j.clnu.2020.08.029; Akazawa N, 2020, NUTRITION, V71, DOI 10.1016/j.nut.2019.110600; Akazawa N, 2020, CLIN NUTR, V39, P2586, DOI 10.1016/j.clnu.2019.11.028; Akazawa N, 2019, NUTR RES, V65, P71, DOI 10.1016/j.nutres.2019.02.006; Akazawa N, 2018, PHYSIOTHERAPY, V104, P438, DOI 10.1016/j.physio.2017.08.009; Akazawa N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201789; Akazawa N, 2017, GERIATR GERONTOL INT, V17, P1683, DOI 10.1111/ggi.12869; Akima H, 2017, ARCH GERONTOL GERIAT, V70, P105, DOI 10.1016/j.archger.2017.01.014; Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Hamaguchi Y, 2015, J HEPATO-BIL-PAN SCI, V22, P475, DOI 10.1002/jhbp.236; Hirani V, 2015, J AM MED DIR ASSOC, V16, P607, DOI 10.1016/j.jamda.2015.02.006; Kara M, 2021, J REHABIL MED, V53, DOI 10.2340/16501977-2851; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Ligthart-Melis GC, 2020, J AM MED DIR ASSOC, V21, P1216, DOI 10.1016/j.jamda.2020.03.006; Lopez P, 2017, MUSCLE NERVE, V55, P9, DOI 10.1002/mus.25168; Miyatani M, 2004, EUR J APPL PHYSIOL, V91, P264, DOI 10.1007/s00421-003-0974-4; Nishihara K, 2014, CLIN INTERV AGING, V9, P1471, DOI 10.2147/CIA.S67820; Osawa Y, 2017, J AGING PHYS ACTIV, V25, P189, DOI 10.1123/japa.2015-0203; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Perkisas S, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2010011; Pillen S, 2006, ULTRASOUND MED BIOL, V32, P1315, DOI 10.1016/j.ultrasmedbio.2006.05.028; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; REIMERS K, 1993, J ULTRAS MED, V12, P73; Ryan ED, 2016, APPL PHYSIOL NUTR ME, V41, P1104, DOI 10.1139/apnm-2016-0238; Verstraeten LMG, 2021, CLIN NUTR, V40, P4090, DOI 10.1016/j.clnu.2021.02.007; Watanabe Y, 2013, CLIN INTERV AGING, V8, P993, DOI 10.2147/CIA.S47263; Wilhelm EN, 2014, AGE, V36, P1113, DOI 10.1007/s11357-014-9625-4; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106; Young HJ, 2015, MUSCLE NERVE, V52, P963, DOI 10.1002/mus.24656; Zhang XM, 2020, CLIN NUTR, V39, P33, DOI 10.1016/j.clnu.2019.01.002	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263973	10.1371/journal.pone.0263973	http://dx.doi.org/10.1371/journal.pone.0263973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176070	Green Published, gold			2022-12-26	WOS:000777505200054
J	Fastner, C; Szabo, K; Samartzi, M; Kruska, M; Akin, I; Platten, M; Baumann, S; Alonso, A				Fastner, Christian; Szabo, Kristina; Samartzi, Melina; Kruska, Mathieu; Akin, Ibrahim; Platten, Michael; Baumann, Stefan; Alonso, Angelika			Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units	PLOS ONE			English	Article							SECONDARY PREVENTION; WARFARIN; RISK; RIVAROXABAN; THERAPY; DISEASE; EVENTS; SAFETY; DEATH	Background Acute ischemic stroke (AIS) in patients with non-valvular atrial fibrillation (AF) despite oral anticoagulation (OAC) is a complex and insufficiently investigated setting. Potential strategies range from maintaining the current OAC to changing the substance class. We have queried the specific treatment standards on German stroke units (SUs). Methods By means of a standardized online questionnaire via SurveyMonkey (TM) (San Mateo, CA, USA), all clinical heads of German SUs were asked about their treatment standards in the following clinical situations: first AIS of an OAC-naive AF patient, AF patient with AIS despite administration of a vitamin K antagonist (VKA), AF patient with AIS despite administration of direct OAC (DOAC). In addition, the performance of specific coagulation tests in AF patients with AIS despite OAC was queried. Results 160 (48%) clinical heads of German SU responded. Data from pivotal trials (84%), own experience with substances (71%), and side-effect profiles (66%) determine the initial DOAC prescription. In case of an AIS despite OAC, 83 and 18% would switch from VKA to DOAC under certain conditions and always, respectively. Half of respondents would switch from DOAC to VKA under certain conditions, while the other half would decline. 96% would switch to an alternative DOAC. The vast majority of those who made preconditions considered concomitant diseases (92, 90, and 81%, respectively). Few would consider infarct pattern (< 35%). 61% perform initial coagulation tests (only one-third substance-specific assessments); however, the majority do not use these to make further decisions. Conclusions In the setting of an OAC-naive AF patient with AIS, established pivotal data are most respected. In the unclear setting of an AIS despite OAC, most respondents consider concomitant diseases and give preference to switching to a (different) DOAC.	[Fastner, Christian; Kruska, Mathieu; Akin, Ibrahim; Baumann, Stefan] Heidelberg Univ, Dept Cardiol Angiol Haemostaseol & Med Intens Car, Univ Med Ctr Mannheim, Med Fac Mannheim,European Ctr AngioSci ECAS, Mannheim, Germany; [Fastner, Christian; Kruska, Mathieu; Akin, Ibrahim; Baumann, Stefan] German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Mannheim, Germany; [Szabo, Kristina; Samartzi, Melina; Platten, Michael; Alonso, Angelika] Heidelberg Univ, Dept Neurol, Univ Med Ctr Mannheim, Mannheim Ctr Translat Neurosci,Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg	Alonso, A (corresponding author), Heidelberg Univ, Dept Neurol, Univ Med Ctr Mannheim, Mannheim Ctr Translat Neurosci,Med Fac Mannheim, Mannheim, Germany.	angelika.alonso@umm.de	Platten, Michael/F-2902-2013	Platten, Michael/0000-0002-4746-887X				Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Bhatia HS, 2018, CLIN CARDIOL, V41, P1395, DOI 10.1002/clc.23085; Coleman CI, 2017, STROKE, V48, P2142, DOI 10.1161/STROKEAHA.117.017474; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Connors JM, 2018, BLOOD, V132, P2009, DOI 10.1182/blood-2018-04-791541; Foerster KI, 2020, CLIN PHARMACOKINET, V59, P967, DOI 10.1007/s40262-020-00879-x; Freedman B, 2016, JAMA CARDIOL, V1, P366, DOI 10.1001/jamacardio.2016.0393; Gabet A, 2021, CLIN EPIDEMIOL, V13, P131, DOI 10.2147/CLEP.S290707; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hillmann S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0819-0; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; Hohnloser SH, 2019, THROMB HAEMOSTASIS, V119, P882, DOI 10.1055/s-0039-1683428; Hohnloser SH, 2018, THROMB HAEMOSTASIS, V118, P526, DOI 10.1160/TH17-10-0733; Kanai Y, 2018, J STROKE CEREBROVASC, V27, P338, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.007; Klijn CJM, 2019, EUR STROKE J, V4, P198, DOI 10.1177/2396987319841187; Luger S, 2015, PATIENT PREFER ADHER, V9, P1695, DOI 10.2147/PPA.S88994; Mainbourg S, 2021, THROMB RES, V197, P24, DOI 10.1016/j.thromres.2020.10.011; Meinel TR, 2021, ANN NEUROL, V89, P42, DOI 10.1002/ana.25917; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Purrucker JC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092938; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schlieper G, 2017, INTERNIST, V58, P512, DOI 10.1007/s00108-017-0220-5; Seiffge DJ, 2020, ANN NEUROL, DOI 10.1002/ana.25700; Tanaka K, 2020, STROKE, V51, P1150, DOI 10.1161/STROKEAHA.119.027275; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Wang KL, 2019, EUR HEART J, V40, P1492, DOI 10.1093/eurheartj/ehy802; Wiggins BS, 2020, J AM COLL CARDIOL, V75, P1341, DOI 10.1016/j.jacc.2019.12.068; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaghi S, 2021, J NEUROL NEUROSUR PS, V92, P1062, DOI 10.1136/jnnp-2021-326166	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264122	10.1371/journal.pone.0264122	http://dx.doi.org/10.1371/journal.pone.0264122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176109	Green Published, gold			2022-12-26	WOS:000777505200081
J	Zaeske, C; Brueggemann, GP; Willwacher, S; Maehlich, D; Maintz, D; Bratke, G				Zaeske, Charlotte; Brueggemann, Gert-Peter; Willwacher, Steffen; Maehlich, Daniela; Maintz, David; Bratke, Grischa			The behaviour of T2*and T2 relaxation time in extrinsic foot muscles under continuous exercise: A prospective analysis during extended running	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; SKELETAL-MUSCLE; LACTATE KINETICS; FAST-TWITCH; INTENSITY; MRI; T-2-ASTERISK; HYPEREMIA; PERFUSION; CONTRAST	Objectives Previous studies on T2* and T2 relaxation time of the muscles have shown that exercise leads to an initial increase, presumably representing different intramuscular physiological processes such as increase in intracellular volume or blood oxygenation level dependent effects with a subsequent decrease after cessation of exercise. Their behaviour during prolonged exercise is still unknown but could provide important information for example about the pathophysiology of overuse injuries. The aim of this study was to evaluate the temporal course of T2* and T2 relaxation time in extrinsic foot muscles during prolonged exercise and determine the optimal mapping technique. Methods Ten participants had to run a total of 75 minutes at their individual highest possible running speed, with interleaved MR scans at baseline and after 2.5, 5, 10, 15, 45 and 75 minutes. The examined extrinsic foot muscles were manually segmented, and relaxation time were analysed regarding its respective time course. Results T2* and T2 relaxation time showed an initial increase, followed by a plateau phase between 2.5 and 15 minutes and a subsequent decrease. For the T2* relaxation time, this pattern was also apparent, but less pronounced, with more muscles not reaching significance (p<0.05) when comparing different time points. Conclusions T2* and T2 relaxation time showed a similar course with an initial rapid increase, a plateau phase and a subsequent decrease under prolonged exercise. Moderate but long-term muscular activity appears to have a weaker effect on T2* relaxation time than on T2 relaxation time.	[Zaeske, Charlotte; Maintz, David; Bratke, Grischa] Inst Diagnost & Intervent Radiol, Fac Med, Cologne, Germany; [Zaeske, Charlotte; Maintz, David; Bratke, Grischa] Univ Hosp Cologne, Cologne, Germany; [Brueggemann, Gert-Peter; Willwacher, Steffen; Maehlich, Daniela] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany	University of Cologne; University of Cologne; German Sport University Cologne	Zaeske, C (corresponding author), Inst Diagnost & Intervent Radiol, Fac Med, Cologne, Germany.; Zaeske, C (corresponding author), Univ Hosp Cologne, Cologne, Germany.	charlotte.zaeske@rwth-aachen.de		Bratke, Grischa/0000-0002-5696-9828; Zaeske, Charlotte/0000-0003-3746-8523				Bijker KE, 2002, EUR J APPL PHYSIOL, V87, P556, DOI 10.1007/s00421-002-0663-8; Bratke G, SCI REP-UK, V11, P7331, DOI 10.1038/; CATCHESIDE PG, 1993, J APPL PHYSIOL, V74, P435, DOI 10.1152/jappl.1993.74.1.435; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Cohen-Adad J, 2014, NEUROIMAGE, V93, P189, DOI 10.1016/j.neuroimage.2013.01.023; Damon BM, 2002, MAGN RESON MED, V47, P14, DOI 10.1002/mrm.10043; Duteil S, 2006, MAGN RESON MED, V55, P450, DOI 10.1002/mrm.20760; EDGERTON VR, 1975, HISTOCHEM J, V7, P259, DOI 10.1007/BF01003594; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; FLECKENSTEIN JL, 1988, AM J ROENTGENOL, V151, P231, DOI 10.2214/ajr.151.2.231; Francis P, 2019, J SPORT SCI MED, V18, P21; Hatakenaka M, 2001, INVEST RADIOL, V36, P692, DOI 10.1097/00004424-200112000-00003; Hooijmans MT, 2020, J MAGN RESON IMAGING, V52, P407, DOI 10.1002/jmri.27106; JENNER G, 1994, J APPL PHYSIOL, V76, P2119, DOI 10.1152/jappl.1994.76.5.2119; Joyner MJ, 2015, PHYSIOL REV, V95, P549, DOI 10.1152/physrev.00035.2013; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Kinugasa R, 2005, MED SCI SPORT EXER, V37, P593, DOI 10.1249/01.MSS.0000159026.99792.76; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; Menacho K, 2019, MAGN RESON IMAGING C, V27, P439, DOI 10.1016/j.mric.2019.04.008; Meyer R A, 2000, Exerc Sport Sci Rev, V28, P89; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Naruse S, 1995, Rinsho Shinkeigaku, V35, P1345; Noseworthy Michael D, 2003, Semin Musculoskelet Radiol, V7, P307; O'Connor KM, 2004, CLIN BIOMECH, V19, P71, DOI 10.1016/j.clinbiomech.2003.09.001; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ohno N, 2020, MAGN RESON IMAGING, V72, P42, DOI 10.1016/j.mri.2020.06.003; Patten Carolynn, 2003, Semin Musculoskelet Radiol, V7, P297; Pierpaoli Carlo, 2010, Top Magn Reson Imaging, V21, P63, DOI 10.1097/RMR.0b013e31821e56f8; PLOUTZSNYDER LL, 1995, AM J PHYSIOL-REG I, V269, pR536, DOI 10.1152/ajpregu.1995.269.3.R536; Pooley RA, 2005, RADIOGRAPHICS, V25, P1087, DOI 10.1148/rg.254055027; Poso AR, 2002, ACTA VET SCAND, V43, P63, DOI 10.1186/1751-0147-43-63; Price TB, 2003, MAGN RESON IMAGING, V21, P853, DOI 10.1016/S0730-725X(03)00183-8; REBER L, 1993, AM J SPORT MED, V21, P805, DOI 10.1177/036354659302100608; Saab G, 2000, J APPL PHYSIOL, V88, P226, DOI 10.1152/jappl.2000.88.1.226; Sanno M, 2018, MED SCI SPORT EXER, V50, P2507, DOI 10.1249/MSS.0000000000001707; Schoenfeld BJ, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14427; Schuermans J, 2014, BRIT J SPORT MED, V48, P1599, DOI 10.1136/bjsports-2014-094017; SHELLOCK FG, 1991, AM J ROENTGENOL, V156, P765, DOI 10.2214/ajr.156.4.2003443; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; TAKAHASHI H, 1994, EUR J APPL PHYSIOL, V69, P408, DOI 10.1007/BF00865404; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Varghese J, 2015, NMR BIOMED, V28, P998, DOI 10.1002/nbm.3332; Willwacher S, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14414; Yanagisawa O, 2011, J MAGN RESON IMAGING, V34, P887, DOI 10.1002/jmri.22668; Zuo CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049337	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264066	10.1371/journal.pone.0264066	http://dx.doi.org/10.1371/journal.pone.0264066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176114	Green Published, gold			2022-12-26	WOS:000777505200073
J	de Grave, RB; Hasselman, F; Bijleveld, E				de Grave, Remco Benthem; Hasselman, Fred; Bijleveld, Erik			From work stress to disease: A computational model	PLOS ONE			English	Article							PRESSURE-RADIUS RELATIONSHIPS; CIRCADIAN VARIATION; CORTISOL RESPONSES; ALLOSTATIC LOAD; ELASTIC TUBES; GLUCOCORTICOIDS; RESISTANCE; PATHOPHYSIOLOGY; HYPOCORTISOLISM; PERFORMANCE	In modern society, work stress is highly prevalent. Problematically, work stress can cause disease. To help understand the causal relationship between work stress and disease, we present a computational model of this relationship. That is, drawing from allostatic load theory, we captured the link between work stress and disease in a set of mathematical formulas. With simulation studies, we then examined our model's ability to reproduce key findings from previous empirical research. Specifically, results from Study 1 suggested that our model could accurately reproduce established findings on daily fluctuations in cortisol levels (both on the group level and the individual level). Results from Study 2 suggested that our model could accurately reproduce established findings on the relationship between work stress and cardiovascular disease. Finally, results from Study 3 yielded new predictions about the relationship between workweek configurations (i.e., how working hours are distributed over days) and the subsequent development of disease. Together, our studies suggest a new, computational approach to studying the causal link between work stress and disease. We suggest that this approach is fruitful, as it aids the development of falsifiable theory, and as it opens up new ways of generating predictions about why and when work stress is (un)healthy.	[de Grave, Remco Benthem; Hasselman, Fred; Bijleveld, Erik] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [de Grave, Remco Benthem] Newcastle Univ, Sch Comp, Open Lab, Newcastle Upon Tyne, Tyne & Wear, England	Radboud University Nijmegen; Newcastle University - UK	de Grave, RB (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.; de Grave, RB (corresponding author), Newcastle Univ, Sch Comp, Open Lab, Newcastle Upon Tyne, Tyne & Wear, England.	r.benthemdegrave2@newcastle.ac.uk		Benthem de Grave, Remco/0000-0002-7043-1119	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [016-165-100]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	EB was supported by grant 016-165-100 from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (https://www.nwo.nl/en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2017, PSYCHONEUROENDOCRINO, V83, P25, DOI 10.1016/j.psyneuen.2017.05.018; Alderman Liz., 2016, NEW YORK TIMES; Allport FH., 1924, SOC PSYCHOL-GERMANY; [Anonymous], 2011, ENCY MATH; Araiza AM, 2018, SOC PERSONAL PSYCHOL, V12, DOI 10.1111/spc3.12378; Baltes BB, 1999, J APPL PSYCHOL, V84, P496, DOI 10.1037/0021-9010.84.4.496; Bambra C, 2008, J EPIDEMIOL COMMUN H, V62, P764, DOI 10.1136/jech.2007.067249; Beckers DGJ, 2012, SCAND J WORK ENV HEA, V38, P291, DOI 10.5271/sjweh.3308; Bick A, 2018, AM ECON REV, V108, P170, DOI 10.1257/aer.20151720; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Born J, 1999, NATURE, V397, P29, DOI 10.1038/16166; Brosschot JF, 2005, PSYCHONEUROENDOCRINO, V30, P1043, DOI 10.1016/j.psyneuen.2005.04.008; Carroll BJ, 2007, ACTA PSYCHIAT SCAND, V115, P90, DOI 10.1111/j.1600-0447.2007.00967.x; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Dall'Ora C, 2016, INT J NURS STUD, V57, P12, DOI 10.1016/j.ijnurstu.2016.01.007; Dekker MJHJ, 2008, J CLIN ENDOCR METAB, V93, P3741, DOI 10.1210/jc.2008-0496; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Edwards JR, 2010, ORGAN RES METHODS, V13, P668, DOI 10.1177/1094428110380467; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fantidis P, 2010, CURR VASC PHARMACOL, V8, P517, DOI 10.2174/157016110791330889; Farber BA, 2000, J CLIN PSYCHOL, V56, P675, DOI 10.1002/(SICI)1097-4679(200005)56:5<675::AID-JCLP8>3.0.CO;2-D; Farrell S, 2010, CURR DIR PSYCHOL SCI, V19, P329, DOI 10.1177/0963721410386677; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Frankenhuis WE, 2018, CHILD DEV, V89, P2303, DOI 10.1111/cdev.13021; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Frone MR, 2016, WORK STRESS, V30, P374, DOI 10.1080/02678373.2016.1252971; Gartland N, 2014, PSYCHONEUROENDOCRINO, V50, P130, DOI 10.1016/j.psyneuen.2014.08.006; Geurts S, 2014, INTRO CONT WORK PSYC; Goodman WK, 2017, PSYCHONEUROENDOCRINO, V80, P26, DOI 10.1016/j.psyneuen.2017.02.030; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; GRUNFELD JP, 1987, HYPERTENSION, V10, P608, DOI 10.1161/01.HYP.10.6.608; Hassard J, 2018, J OCCUP HEALTH PSYCH, V23, P1, DOI 10.1037/ocp0000069; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hosseinichimeh N, 2015, MATH BIOSCI, V268, P52, DOI 10.1016/j.mbs.2015.08.004; Joseph JJ, 2017, ANN NY ACAD SCI, V1391, P20, DOI 10.1111/nyas.13217; Kagan J, 2016, PERSPECT PSYCHOL SCI, V11, P442, DOI 10.1177/1745691616635593; Kivimaki M, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0630-8; Kokko H, 2007, MODELLING FOR FIELD BIOLOGISTS AND OTHER INTERESTING PEOPLE, P1, DOI 10.1017/CBO9780511811388; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Kovacs W, 2011, TXB ENDOCRINE PHYSL; Lennartsson AK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00008; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; Manfredini R, 2005, CHRONOBIOL INT, V22, P417, DOI 10.1081/CBI-200062927; Mayo ClinicStaff., 2021, ERYTHROMYCIN TOPICAL; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MEEHL PE, 1978, J CONSULT CLIN PSYCH, V46, P806, DOI 10.1037/0022-006X.46.4.806; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller R, 2016, PSYCHONEUROENDOCRINO, V73, P16, DOI 10.1016/j.psyneuen.2016.07.201; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Oltermann P., 2017, GUARDIAN 0104; Papadatou A, 2018, HRREVIEW 1212; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131, DOI 10.1210/jcem-54-1-131; Robinaugh DJ, 2021, PERSPECT PSYCHOL SCI, V16, P725, DOI 10.1177/1745691620974697; Rohleder N, 2004, BIOL PSYCHIAT, V55, P745, DOI 10.1016/j.biopsych.2003.11.018; Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; SAMBHI MP, 1965, CIRCULATION, V31, P523, DOI 10.1161/01.CIR.31.4.523; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56; Schonfeld IS, 2016, J CLIN PSYCHOL, V72, P22, DOI 10.1002/jclp.22229; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Singh Raja B, 2002, Exp Clin Cardiol, V7, P40; Sluiter JK, 1998, OCCUP ENVIRON MED, V55, P407, DOI 10.1136/oem.55.6.407; Smaldino PE, 2017, FRONT SOC PSYCHOL, P311; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Strauss B, 2002, PSYCHOL SPORT EXERC, V3, P237, DOI 10.1016/S1469-0292(01)00019-X; TAYLOR LA, 1977, MED BIOL ENG COMPUT, V15, P11, DOI 10.1007/BF02441569; TAYLOR LA, 1977, MED BIOL ENG COMPUT, V15, P18, DOI 10.1007/BF02441570; Theorell T, 2016, EUR J PUBLIC HEALTH, V26, P470, DOI 10.1093/eurpub/ckw025; Thorn L, 2006, PSYCHONEUROENDOCRINO, V31, P1009, DOI 10.1016/j.psyneuen.2006.05.012; van der Leeuw SE, 2004, CYBERNET SYST, V35, P117, DOI 10.1080/01969720490426803; Vancouver JB, 2017, J APPL PSYCHOL, V102, P599, DOI 10.1037/apl0000177; Vancouver JB, 2016, PERS PSYCHOL, V69, P931, DOI 10.1111/peps.12141; Vancouver JB, 2010, J MANAGE, V36, P764, DOI 10.1177/0149206308321550; Weinhardt JM, 2012, ORGAN PSYCHOL REV, V2, P267, DOI 10.1177/2041386612450455; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	92	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263966	10.1371/journal.pone.0263966	http://dx.doi.org/10.1371/journal.pone.0263966			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171964	Green Submitted, gold, Green Published			2022-12-26	WOS:000795889700050
J	Hobbs, C; Jelbert, S; Santos, LR; Hood, B				Hobbs, Catherine; Jelbert, Sarah; Santos, Laurie R.; Hood, Bruce			Evaluation of a credit-bearing online administered happiness course on undergraduates' mental well-being during the COVID-19 pandemic	PLOS ONE			English	Article							POSITIVE PSYCHOLOGY COURSE; UNIVERSITY-STUDENTS; HEALTH SURVEY; METAANALYSIS	Psychoeducational courses focused on positive psychology interventions have been shown to benefit student well-being. However, since the onset of the COVID-19 pandemic and accompanying social restrictions, many educators have had to deliver their courses online. Given that online teaching presents a very different university experience for students, do psychoeducational courses provide similar well-being benefits in an online format? In this pre-registered study (https://osf.io/3f89m), we demonstrate that despite the challenges of remote learning, first year university students (N = 166) taking an online "Science of Happiness" course during the first term experienced positive benefits to mental well-being in comparison to a wait-list control group (N = 198) registered to take the course in the second term. Specifically, university students currently taking the course maintained their mental well-being over the semester relative to the wait-list control who showed a significant decline in well-being and increase in anxiety during the same period. Our findings suggest that the online-administered "Science of Happiness" course delivered during the COVID-19 pandemic was associated with a protective effect on mental well-being. We also observed that engagement with the course was high, though there was no evidence that this factor mediated the positive effects we observed. However, we did find evidence that prior interest in increasing well-being influenced the effects of the course; participants with lower well-being interest showed less of a benefit. Our results suggest that online psychoeducational courses might provide a relatively cheap, flexible, and efficient means of providing support as part of an integrated approach to student mental well-being.	[Hobbs, Catherine; Jelbert, Sarah; Hood, Bruce] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Santos, Laurie R.] Yale Univ, Dept Psychol, New Haven, CT USA	University of Bristol; Yale University	Hood, B (corresponding author), Univ Bristol, Sch Psychol Sci, Bristol, Avon, England.	bruce.hood@bristol.ac.uk		hood, bruce/0000-0001-7258-981X; Hobbs, Catherine/0000-0002-2324-5882	Elizabeth Blackwell Institute, University of Bristol; Rosetrees Trust [R105121-248]	Elizabeth Blackwell Institute, University of Bristol; Rosetrees Trust(Rosetrees Trust)	This work was supported by a grant awarded jointly by the Elizabeth Blackwell Institute, University of Bristol and the Rosetrees Trust (grant code: R105121-248). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College Health Association, 2009, J Am Coll Health, V57, P477, DOI 10.3200/JACH.57.5.477-488; [Anonymous], 2011, ROYAL COLL PSYCHIAT, DOI [10.1111/j.1751-7893.2011.00314.x, DOI 10.1111/J.1751-7893.2011.00314.X]; Anvari F., 2019, PREPRINT, DOI 10.31234/osf.io/syp5a; Arasil ABS, 2020, J EDUC FUTUR, P15, DOI 10.30786/jef.591777; Arday J., 2018, SOCIAL SCI, V7, P196, DOI [10.3390/socsci7100196, DOI 10.3390/SOCSCI7100196]; Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Auerbach RP, 2018, J ABNORM PSYCHOL, V127, P623, DOI 10.1037/abn0000362; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Bucker S, 2018, J RES PERS, V74, P83, DOI 10.1016/j.jrp.2018.02.007; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Conley CS, 2013, J AM COLL HEALTH, V61, P75, DOI 10.1080/07448481.2012.754757; De Neve JE, 2012, P NATL ACAD SCI USA, V109, P19953, DOI 10.1073/pnas.1211437109; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Fat LN, 2017, QUAL LIFE RES, V26, P1129, DOI 10.1007/s11136-016-1454-8; Goodmon LB, 2016, TEACH PSYCHOL, V43, P232, DOI 10.1177/0098628316649482; Greenberg MT, 2017, J RES EDUC EFF, V10, P40, DOI 10.1080/19345747.2016.1246632; Harzer C, 2012, J POSIT PSYCHOL, V7, P362, DOI 10.1080/17439760.2012.702784; Holanda R.F.L., 2019, ARXIV PREPRINT ARXIV; Hood B, 2021, HEALTH PSYCHOL OPEN, V8, DOI 10.1177/2055102921999291; Howell R., 2007, HEALTH PSYCHOL REV, V1, P83, DOI [DOI 10.1080/17437190701492486, 10.1080/17437190701492486]; Husky MM, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152191; Institute for Government Analysis, 2021, TIM UK COR LOCKD MA; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kaparounaki CK, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113111; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Krakauer Hubner von C, 2020, PREPRINT, DOI [10.1101/2020.06.19.20135251, DOI 10.1101/2020.06.19.20135251]; Kulkarni S., 2021, PREPRINT, DOI [10.20944/preprints202102.0192.v1, DOI 10.20944/PREPRINTS202102.0192.V1]; Lambert L, 2019, J HAPPINESS STUD, V20, P1141, DOI 10.1007/s10902-018-9993-z; Lefevor GT., 2018, PSYARXIV, DOI [10.31234/osf.io/r52wg, DOI 10.31234/OSF.IO/R52WG]; Linton MJA, 2021, J MED INTERNET RES, V23, DOI 10.2196/25279; Lipson SK, 2018, J MENT HEALTH, V27, P205, DOI 10.1080/09638237.2017.1417567; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Macaskill A, 2013, BRIT J GUID COUNS, V41, P426, DOI 10.1080/03069885.2012.743110; Maybury KK, 2013, TEACH PSYCHOL, V40, P62, DOI 10.1177/0098628312465868; Morton DP, 2020, AM J LIFESTYLE MED, V14, P216, DOI 10.1177/1559827617733941; NHS Health Scotland, 2007, SHORT WARW ED MENT W; Oettingen G, 2001, J PERS SOC PSYCHOL, V80, P736, DOI 10.1037//0022-3514.80.5.736; Office for National Statistics, 2021, REPORTED ROAD ACCIDE; Office for Students, 2019, MENT HLTH AR ALL STU; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Randstad, 2020, STUD WELLB HIGH ED; Raosoft, 2004, SAMPL SIZ CALC; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Seligman M, 2018, J POSIT PSYCHOL, V13, P333, DOI 10.1080/17439760.2018.1437466; Seligman MEP, 2009, OXFORD REV EDUC, V35, P293, DOI 10.1080/03054980902934563; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Seligman MEP., 1990, LEARNED OPTIMISM CHA; Smith BW, 2021, J HAPPINESS STUD, V22, P343, DOI 10.1007/s10902-020-00233-9; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Tejada-Gallardo C, 2020, J YOUTH ADOLESCENCE, V49, P1943, DOI 10.1007/s10964-020-01289-9; Thorley, 2017, NOT DEGREES IMPROVIN; Tinkler L., 2015, STAT TRANSITION, V16, P373, DOI [DOI 10.21307/STATTRANS-2015-021, 10.21307/stattrans-2015-021]; Toepfer SM, 2009, J WRIT RES, V1, P181, DOI 10.17239/jowr-2009.01.03.1; Wang CY, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01168; Warwick Medical School, COLL SCOR AN INT WEM; Waters L, 2011, EDUC DEV PSYCHOL, V28, P75, DOI 10.1375/aedp.28.2.75; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001; Yaden DB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249193; Young T, 2022, STUD HIGH EDUC, V47, P751, DOI 10.1080/03075079.2020.1793932; YouthSight, 2017, UPP ANN STUD EXP STU; Zimmermann M., 2020, PREPRINT, DOI [10.31234/osf.io/2y7hu, DOI 10.31234/OSF.IO/2Y7HU]	66	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263514	10.1371/journal.pone.0263514	http://dx.doi.org/10.1371/journal.pone.0263514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171917	gold, Green Submitted, Green Published			2022-12-26	WOS:000795889700025
J	Korn, AK; Muzingwani, L; O'Bryan, G; Ensminger, A; Boylan, AD; Kafidi, EL; Kashali, M; Ashipala, L; Nitschke, AM; Dziuban, EJ; Forster, N; Eckert, LO; O'Malley, G				Korn, Abigail K.; Muzingwani, Laura; O'Bryan, Gillian; Ensminger, Alison; Boylan, Ashley D.; Kafidi, Eva-Liisa; Kashali, Matheus; Ashipala, Laimi; Nitschke, Anne-Marie; Dziuban, Eric J.; Forster, Norbert; Eckert, Linda O.; O'Malley, Gabrielle			Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia	PLOS ONE			English	Article							PREVENTION; WOMEN	The aim of this study was to assess differences in cervical cancer screening and treatment outcomes by HIV status in a routine programmatic setting with a high generalized HIV prevalence. Women living with HIV (WLHIV) are at heightened risk of developing cervical cancer and the World Health Organization recommends all WLHIV who are sexually active be screened, regardless of age. In 2018, Namibia's Ministry of Health and Social Services introduced a screen-and-treat approach using visual inspection with acetic acid (VIA) and ablative treatment with cryotherapy or thermocoagulation with a focus on screening HIV-positive women due to Namibia's 11.5% prevalence of HIV in women aged 15-49. Using program data from October 2018 to March 2020 from seven of the country's 14 regions, we calculated descriptive statistics and chi-square tests to test the statistical significance of differences in VIA-positivity, ineligibility for ablative treatment, treatment completion, and same day treatment completion by HIV status. Between October 2018 and March 2020, the program conducted 14,786 cervical cancer screenings. Among 8,150 women who received their first VIA screening, more WLHIV screened VIA-positive (17%) than HIV-negative women (15%). This difference was statistically significant (p = 0.02). Among 2,272 women who screened VIA-positive at any screening, 1,159 (82%) completed ablative treatment. This suggests ablative treatment is feasible and acceptable in resource-limited settings. WLHIV were also more likely to complete treatment than HIV-negative women (p<0.01). Differences in health seeking behavior of sub-populations as well as resource availability between service delivery points should be considered for further investigation. Going forward in order to strengthen program implementation and expand screening access and uptake further investigation is needed to determine cancer incidence by HIV status, age, and time since last screening to assess cases that are averted as well as potential rates of overtreatment.	[Korn, Abigail K.; O'Bryan, Gillian; Ensminger, Alison; Eckert, Linda O.; O'Malley, Gabrielle] Univ Washington, Int Training & Educ Ctr Hlth TECH, Dept Global Hlth, Seattle, WA 98195 USA; [Muzingwani, Laura; Kafidi, Eva-Liisa; Forster, Norbert] Univ Washington, Int Training & Educ Ctr Hlth I TECH, Dept Global Hlth, Windhoek, Namibia; [Boylan, Ashley D.; Dziuban, Eric J.] US Ctr Dis Control & Prevent CDC, Windhoek, Namibia; [Kashali, Matheus; Ashipala, Laimi; Nitschke, Anne-Marie] Minist Hlth & Social Serv Namibia MoHSS, Windhoek, Namibia; [Eckert, Linda O.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Korn, AK (corresponding author), Univ Washington, Int Training & Educ Ctr Hlth TECH, Dept Global Hlth, Seattle, WA 98195 USA.	akorn@uw.edu		Ensminger, Alison/0000-0002-2627-6764; O&apos;Malley, Gabrielle/0000-0002-7514-8240	President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) [GH001430]	President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC)	This publication has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (https://www.state.gov/pepfar/) through the US Centers for Disease Control and Prevention (CDC) (https://www.cdc.gov) under the terms of cooperative agreement GH001430 to the International Training and Education Center for Health at the University of Washington, Principal Investigator: Gabrielle O'Malley. The findings and conclusions in this manuscript are those of the author(s) and do not necessarily represent the official position of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amukogo HJ., 2018, INT J HEALTHCARE, V4, DOI [10.5430/ijh.v42p51, DOI 10.5430/IJH.V42P51]; Anderson LA, 2016, J MED VIROL, V88, P1262, DOI 10.1002/jmv.24447; [Anonymous], 2018, IMPR DAT DEC MAK TOO; Bedell SL, 2020, SEX MED REV, V8, P28, DOI 10.1016/j.sxmr.2019.09.005; Belhadj H, 2013, INT J GYNECOL OBSTET, V121, pS29, DOI 10.1016/j.ijgo.2013.02.002; Bloch B., 1988, S AFRICAN MEDICAL J, V74; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campbell C, 2016, INT J CANCER, V139, P908, DOI 10.1002/ijc.30101; Chigbu C., 2020, J OBSTET GYNAECOL RE, V46, DOI [10.1111/jog/14139, DOI 10.1111/JOG/14139]; Dartell MA, 2014, INT J CANCER, V135, P896, DOI 10.1002/ijc.28712; de Fouw M, 2019, INT J GYNECOL OBSTET, V147, P4, DOI 10.1002/ijgo.12904; Horo A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-237; Hu S., 2021, WHO GUID SCREEN TREA, V101, P1; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Mabeya H, 2012, J LOW GENIT TRACT DI, V16, P92, DOI 10.1097/LGT.0b013e3182320f0c; Menon S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015123; Ministry of Health and Social Services (MoHSS) Namibia, 2019, NAM POP BAS HIV IMP; Ministry of Health and Social Services Namibia, 2016, REP JOINT REV MAT NE; Ministry of Health and Social Services Namibia, 2018, NAT CERV CANC PREV G; MoHSS and ICF International, 2014, NAM DEM HLTH SURV 20; Moon TD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17406; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; Stelzle D, 2021, LANCET GLOB HEALTH, V9, pE161, DOI 10.1016/S2214-109X(20)30459-9; WHO, 2020, WORLD HLTH ASS AD GL; World Health Organization, 2013, GUID SCREEN TREATM P	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263920	10.1371/journal.pone.0263920	http://dx.doi.org/10.1371/journal.pone.0263920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171941	gold, Green Published			2022-12-26	WOS:000795889700046
J	Schiavo, CL; Borges, RB; Castro, SMJ; Wolmeister, AS; de Souza, A; Martins, ORS; Galvao, GS; Nazario, KCK; Nickel, FJ; Caumo, W; Stefani, LC				Schiavo, Carolina L.; Borges, Rogerio B.; Castro, Stela M. J.; Wolmeister, Anelise S.; de Souza, Andressa; Martins, Otavio R. S.; Galvao, Gabriela S.; Nazario, Kahio C. K.; Nickel, Fabian J.; Caumo, Wolnei; Stefani, Luciana C.			Measuring emotional preoperative stress by an app approach and its applicability to predict postoperative pain	PLOS ONE			English	Article							CENTRAL SENSITIZATION; ANXIETY; QUALITY; HIP	Background The Brief Measure of Emotional Preoperative Stress (B-MEPS) was developed to evaluate the preoperative individual vulnerability to emotional stress. To obtain a refined version of B-MEPS suitable for an app approach, this study aimed: (i) to identify items with more discriminant properties; (ii) to classify the level of preoperative emotional stress based on cut-off points; (iii) to assess concurrent validity through correlation with the Central Sensitization Inventory (CSI) score; (iv) to confirm whether the refined version of BMEPS is an adequate predictive measure for identification of patients prone to intense postoperative pain. Methods We include 1016 patients who had undergone surgical procedures in a teaching hospital. The generalized partial credit model of item response theory and latent class model were employed, respectively, to reduce the number of items and to create cut-off points. We applied the CSI and assessed pain by Visual Analog Scale (0-10) and by the amount of postoperative morphine consumption. Results The refined B-MEPS shows satisfactory reliability (Cronbach's alpha 0.79). Preoperative emotional stress, according to the cut-off points, is classified into categories: low, intermediate or high stress. The refined B-MEPS exhibited a linear association with the CSI scores (r2 = 0.53, p < 0.01). Patients with higher levels of emotional stress displayed a positive association with moderate to severe pain and greater morphine consumption. Conclusion The refined version of B-MEPS, along with an interface of easy applicability, assess emotional vulnerability at the bedside before surgery. This app may support studies focused on intervening with perioperative stress levels.	[Schiavo, Carolina L.; Wolmeister, Anelise S.] Univ Fed Rio Grande do Sul UFRGS, Sch Med, Grad Program Med Sci, Porto Alegre, RS, Brazil; [Schiavo, Carolina L.; Wolmeister, Anelise S.; de Souza, Andressa; Caumo, Wolnei; Stefani, Luciana C.] Hosp Clin Porto Alegre HCPA, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil; [Schiavo, Carolina L.; Wolmeister, Anelise S.; Martins, Otavio R. S.; Nazario, Kahio C. K.; Nickel, Fabian J.; Stefani, Luciana C.] HCPA, Anaesthesia & Perioperat Med Serv, Porto Alegre, RS, Brazil; [Borges, Rogerio B.] Univ Fed Rio Grande do Sul, Sch Med, Grad Program Epidemiol, Porto Alegre, RS, Brazil; [Castro, Stela M. J.] Univ Fed Rio Grande do Sul, Dept Stat, Porto Alegre, RS, Brazil; [Galvao, Gabriela S.] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Caumo, Wolnei; Stefani, Luciana C.] Univ Fed Rio Grande do Sul, Dept Surg, Sch Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Stefani, LC (corresponding author), Hosp Clin Porto Alegre HCPA, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), HCPA, Anaesthesia & Perioperat Med Serv, Porto Alegre, RS, Brazil.; Stefani, LC (corresponding author), Univ Fed Rio Grande do Sul, Dept Surg, Sch Med, Porto Alegre, RS, Brazil.	lpstefani@hcpa.edu.br	Boff Borges, Rogério/AFJ-8172-2022	Boff Borges, Rogério/0000-0002-2548-1889; Galvao, Gabriela/0000-0001-9597-8658; Caumo, Wolnei/0000-0002-5083-4658	Research and Events Incentive Fund Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [1700900]; Graduate Program in Medical Sciences at the School of Medicine of the Universidade Federal do Rio Grande do Sul; Postgraduate Research Group at the Hospital de Clinicas de Porto Alegre	Research and Events Incentive Fund Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Graduate Program in Medical Sciences at the School of Medicine of the Universidade Federal do Rio Grande do Sul; Postgraduate Research Group at the Hospital de Clinicas de Porto Alegre	This study was supported with funding from the Research and Events Incentive Fund Hospital de Cli ' nicas de Porto Alegre (FIPE-HCPA) 1700900, Graduate Program in Medical Sciences at the School of Medicine of the Universidade Federal do Rio Grande do Sul and Postgraduate Research Group at the Hospital de Clinicas de Porto Alegre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowyer A, 2016, CURR OPIN ANESTHESIO, V29, P683, DOI 10.1097/ACO.0000000000000399; Caumo W, 2017, BRIT J ANAESTH, V118, P638, DOI 10.1093/bja/aex064; Caumo W, 2016, BRIT J ANAESTH, V117, P642, DOI 10.1093/bja/aew310; Caumo W, 2017, J PAIN RES, V10, P2109, DOI 10.2147/JPR.S131479; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Collins L.M, LATENT CLASS LATENT; COPELAND GP, 1991, BRIT J SURG, V78, P356; Cousley A, 2014, J Perioper Pract, V24, P164; de Andrade Dalton Francisco, 2000, TEORIA RESPOSTA AO I; EGBERT LD, 1963, JAMA-J AM MED ASSOC, V185, P553, DOI 10.1001/jama.1963.03060070021016; Garcia-Llana H, 2014, NEFROLOGIA, V34, P637, DOI 10.3265/Nefrologia.pre2014.Jun.11959; Jiang SY, 2016, FRONT PSYCHOL, V7, DOI [10.3359/fpsyg.2016.00109, 10.3389/fpsyg.2016.00109]; Katz J, 2015, J PAIN RES, V8, P695, DOI 10.2147/JPR.S91924; Kaunisto MA, 2013, ANESTHESIOLOGY, V119, P1410, DOI 10.1097/ALN.0000000000000012; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lee A, 2005, CURR OPIN ANESTHESIO, V18, P205, DOI 10.1097/01.aco.0000162842.09710.d5; Lewis GN, 2015, BRIT J ANAESTH, V114, P551, DOI 10.1093/bja/aeu441; Lingard EA, 2007, J BONE JOINT SURG AM, V89A, P1161, DOI 10.2106/JBJS.F.00914; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Luo JQ, 2012, J STAT SOFTW, V51; Luo JQ, 2013, COMMUN STAT-SIMUL C, V42, P1213, DOI 10.1080/03610918.2012.661906; Matsota P, 2013, J ALTERN COMPLEM MED, V19, P298, DOI 10.1089/acm.2010.0235; Moonesinghe SR, 2013, ANESTHESIOLOGY, V119, P959, DOI 10.1097/ALN.0b013e3182a4e94d; MURAKI E, 1992, APPL PSYCH MEAS, V16, P159, DOI 10.1177/014662169201600206; Navarro-Flores E, 2020, PAIN PHYSICIAN, V23, pE1; Paula Roberts HP, RELIABILITY VALIDITY, DOI [10.7748/ns2006.07.20.44.41.c6560, DOI 10.7748/NS2006.07.20.44.41.C6560]; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Radinovic K, 2014, INJURY, V45, P1246, DOI 10.1016/j.injury.2014.05.024; Shipton EA, 2011, ANAESTH INTENS CARE, V39, P824, DOI 10.1177/0310057X1103900506; Stefani LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187122; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Vandyk AD, 2011, JOGNN-J OBST GYN NEO, V40, P566, DOI 10.1111/j.1552-6909.2011.01278.x; Wang J., 2020, STRUCTURAL EQUATION, DOI [DOI 10.1002/, DOI 10.1002/9781118356258]; Yang Frances M, 2014, Shanghai Arch Psychiatry, V26, P171, DOI 10.3969/j.issn.1002-0829.2014.03.010	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263275	10.1371/journal.pone.0263275	http://dx.doi.org/10.1371/journal.pone.0263275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171934	gold, Green Published			2022-12-26	WOS:000795889700018
J	Montakhab-Yeganeh, H; Shafiei, R; Najm, M; Masoori, L; Aspatwar, A; Badirzadeh, A				Montakhab-Yeganeh, Hossein; Shafiei, Reza; Najm, Mehdi; Masoori, Leila; Aspatwar, Ashok; Badirzadeh, Alireza			Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice	PLOS ONE			English	Article							IMMUNE-RESPONSES; DNA; INFECTION; VACCINATION; PROTEIN; CELLS; GENE; OLIGONUCLEOTIDE; INTERLEUKIN-12; IMMUNIZATION	Background Leishmania (L) parasite, the causative agent of zoonotic cutaneous leishmaniasis (ZCL), effectively stimulates the mammalian cells to mount strong humoral responses by enhancing T-helper-2 (Th2)-associated cytokines for its survival. The best strategy to decrease the intensity of infection in the host is induction of cellular immunity. Methods We evaluated the effects of the empty bacterial pcDNA3 plasmid on mice infected with L. major and quantified the immune mediators including IFN-gamma, IL-4, IL-10, IgG2a, IgG1, arginase activity and nitric oxide (NO) in the mice. Moreover, the footpad lesion size and parasite load were assessed. Result We observed that pcDNA3 could modulate the immune responses in favor of host cells and decrease the disease severity. Th2- associated mediators, including arginase, IL-4, and IL-10 are downregulated, while cellular responses are upregulated in line with an increase in the levels of nitric oxide (NO) and interfero-gamma (IFN-gamma). Interestingly, pcDNA3 induced specific Th1-associated antibodies, IgG2a isotype; however, it suppressed the production of humoral IgG1. The stimulation of the immune response by the empty pcDNA3 is able to shift the immune function to predominant cellular responses caused by Th1, and it had a positive effect on the treatment of zoonotic cutaneous leishmaniasis (ZCL). Conclusions Altogether, we introduced the pcDNA3 as a potential interfering factor in the modulation of the immune system against ZCL. Since this vector has been widely used as a control group in different studies, we suggest that the potential function of the empty vector should be deeply assessed, as it exerts anti-parasitic effects on mice infected with L. major.	[Montakhab-Yeganeh, Hossein] Hormozgan Univ Med Sci, Mol Med Res Ctr, Hormozgan Hlth Inst, Bandar Abbas, Iran; [Montakhab-Yeganeh, Hossein] Hormozgan Univ Med Sci, Fac Med, Dept Biochem, Bandar Abbas, Iran; [Shafiei, Reza] North Khorasan Univ Med Sci, Vector Borne Dis Res Ctr, Bojnurd, Iran; [Najm, Mehdi; Badirzadeh, Alireza] Iran Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Tehran, Iran; [Masoori, Leila] Lorestan Univ Med Sci, Sch Allied Med Sci, Dept Lab Sci, Khorramabad, Iran; [Aspatwar, Ashok] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland	North Khorasan University of Medical Sciences; Iran University of Medical Sciences; Lorestan University of Medical Sciences; Tampere University	Badirzadeh, A (corresponding author), Iran Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Tehran, Iran.	badirzadeh.ar@iums.ac.ir	Shafiei, Reza/GLT-7702-2022	Shafiei, Reza/0000-0002-5925-4756	Iran University of Medical Sciences, Tehran, Iran [98-1-4-14329]	Iran University of Medical Sciences, Tehran, Iran	The Iran University of Medical Sciences, Tehran, Iran (grant number 98-1-4-14329 to Dr. Alireza Badirzadeh), financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the current manuscript.	Abdossamadi Z, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006123; Abebe T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001684; Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Ahmadabad HN, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04243-7; Alves DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196796; Amini SM, 2019, MAT SCI ENG C-MATER, V103, DOI 10.1016/j.msec.2019.109809; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P557; Antwi CA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007206; Babiuk S, 2006, INT REV IMMUNOL, V25, P51, DOI 10.1080/08830180600743008; Barani S, 2020, IRAN J PARASITOL, V15, P214, DOI 10.18502/ijpa.v15i2.3303; Boccaccio GL, 1999, INT IMMUNOL, V11, P289, DOI 10.1093/intimm/11.2.289; Boitz JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00554-16; Conceicao-Silva F, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00330; Cuna WR, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/96410; De Luca PM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00151; Dey S, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00222-19; Eastcott JW, 2001, VACCINE, V19, P1636, DOI 10.1016/S0264-410X(00)00422-9; Elikaee S, 2019, VACCINE, V37, P3221, DOI 10.1016/j.vaccine.2019.04.068; Ferreira JFL, 2008, VACCINE, V26, P677, DOI 10.1016/j.vaccine.2007.11.044; Firmino-Cruz L, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2019.10.006; Firooz A, 2021, J DERMATOL TREAT, V32, P673, DOI 10.1080/09546634.2019.1704214; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Ghosh S, 2021, CYTOKINE, V147, DOI 10.1016/j.cyto.2020.155266; Gilkeson GS, 1996, J EXP MED, V183, P1389, DOI 10.1084/jem.183.4.1389; Goyal DK, 2021, INFECT GENET EVOL, V93, DOI 10.1016/j.meegid.2021.104947; Gupta G, 2011, MED MICROBIOL IMMUN, V200, P241, DOI 10.1007/s00430-011-0197-y; Habibi Roudkenar M, 2009, IRANIAN J BLOOD CANC, V1, P69; Heidari-Kharaji M, 2019, PARASITE IMMUNOL, V41, DOI 10.1111/pim.12605; Jenkins MC, 2001, VET PARASITOL, V101, P291, DOI 10.1016/S0304-4017(01)00557-X; Jeon YH, 2010, NUCL MED MOLEC IMAG, V44, P199, DOI 10.1007/s13139-010-0039-7; Johansson E, 2002, VET IMMUNOL IMMUNOP, V87, P29, DOI 10.1016/S0165-2427(02)00024-7; Johansson E, 2001, VET MICROBIOL, V79, P171, DOI 10.1016/S0378-1135(00)00353-9; Kaluarachchi TDJ, 2019, PATHOG GLOB HEALTH, V113, P180, DOI 10.1080/20477724.2019.1650228; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Li Y, 2004, GENE THER, V11, P941, DOI 10.1038/sj.gt.3302240; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Liu YL, 2019, PLASMID, V106, DOI 10.1016/j.plasmid.2019.102441; Lopes A, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1154-7; Majumder S, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00261; Masoori L, 2018, J ARTHROPOD-BORNE DI, V12, P67; Mirzapour A, 2019, IRAN J PUBLIC HEALTH, V48, P2285; Murray HW, 2000, J INFECT DIS, V182, P1497, DOI 10.1086/315890; Murray HW, 2003, ANTIMICROB AGENTS CH, V47, P2513, DOI 10.1128/AAC.47.8.2513-2517.2003; Muxel SM, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02682; O'Keeffe A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219985; Okwor I, 2009, IMMUNOTHERAPY-UK, V1, P765, DOI 10.2217/IMT.09.40; Quintana FJ, 2000, J IMMUNOL, V165, P6148, DOI 10.4049/jimmunol.165.11.6148; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rathore SS., 2016, RECENT TRENDS ANTIFU, P149; Reza S, 2019, EXP PARASITOL, V203, P1, DOI 10.1016/j.exppara.2019.05.004; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Rostami B, 2019, IUBMB LIFE, V71, P1619, DOI 10.1002/iub.2107; Rostamian M, 2017, J MICROBIOL IMMUNOL, V50, P160, DOI 10.1016/j.jmii.2015.05.007; Saha B, 2021, CYTOKINE, V145, DOI 10.1016/j.cyto.2020.155320; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos TTO, 2021, MICROB PATHOGENESIS, V151, DOI 10.1016/j.micpath.2021.104745; Sosa N, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007253; Steinman L, 2014, GOOGLE PATENTS; Verma G., 2016, WJPPS, V5, P1334, DOI DOI 10.20959/ORG/10.3390/DISEASES6020042; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Zabala-Penafiel A, 2020, EXP PARASITOL, V210, DOI 10.1016/j.exppara.2020.107849; Zimmermann S, 1998, J IMMUNOL, V160, P3627	62	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263993	10.1371/journal.pone.0263993	http://dx.doi.org/10.1371/journal.pone.0263993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167596	Green Published, gold			2022-12-26	WOS:000802227200029
J	Bhatt, DP; Mills, CA; Anderson, KA; Henriques, BJ; Lucas, TG; Francisco, S; Liu, J; Ilkayeva, OR; Adams, AE; Kulkarni, SR; Backos, DS; Major, MB; Grimsrud, PA; Gomes, CM; Hirschey, MD				Bhatt, Dhaval P.; Mills, C. Allie; Anderson, Kristin A.; Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Liu, Juan; Ilkayeva, Olga R.; Adams, Alexander E.; Kulkarni, Shreyas R.; Backos, Donald S.; Major, Michael B.; Grimsrud, Paul A.; Gomes, Claudio M.; Hirschey, Matthew D.			Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-RESOLUTION METABOLOMICS; PROTEIN ACETYLATION; METABOLISM; SIRTUINS; REVEALS	A wide range of protein acyl modifications has been identified on enzymes across various metabolic processes; however, the impact of these modifications remains poorly understood. Protein glutarylation is a recently identified modification that can be nonenzymatically driven by glutaryl-CoA. In mammalian systems, this unique metabolite is only produced in the lysine and tryptophan oxidative pathways. To better understand the biology of protein glutarylation, we studied the relationship between enzymes within the lysine/tryptophan catabolic pathways, protein glutarylation, and regulation by the deglutarylating enzyme sirtuin 5 (SIRT5). Here, we identify glutarylation on the lysine oxidation pathway enzyme glutaryl-CoA dehydrogenase (GCDH) and show increased GCDH glutarylation when glutaryl-CoA production is stimulated by lysine catabolism. Our data reveal that glutarylation of GCDH impacts its function, ultimately decreasing lysine oxidation. We also demonstrate the ability of SIRT5 to deglutarylate GCDH, restoring its enzymatic activity. Finally, metabolomic and bioinformatic analyses indicate an expanded role for SIRT5 in regulating amino acid metabolism. Together, these data support a feedback loop model within the lysine/tryptophan oxidation pathway in which glutaryl-CoA is produced, in turn inhibiting and can be relieved by SIRT5 deacylation activity.	[Bhatt, Dhaval P.; Mills, C. Allie; Anderson, Kristin A.; Ilkayeva, Olga R.; Adams, Alexander E.; Kulkarni, Shreyas R.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27706 USA; [Bhatt, Dhaval P.; Major, Michael B.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Anderson, Kristin A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Pharmacol, Durham, NC 27706 USA; [Anderson, Kristin A.; Liu, Juan; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Canc Biol, Durham, NC 27706 USA; [Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Gomes, Claudio M.] Univ Lisbon, Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal; [Henriques, Barbara J.; Lucas, Tania G.; Francisco, Sara; Gomes, Claudio M.] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Lisbon, Portugal; [Ilkayeva, Olga R.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Sch Med, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27706 USA; [Backos, Donald S.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Computat Chem & Biol Core Facil, Anschutz Med Campus, Aurora, CO USA	Duke University; Washington University (WUSTL); Duke University; Duke University; Duke University; Duke University; BIOISI; Universidade de Lisboa; Universidade de Lisboa; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus	Hirschey, MD (corresponding author), Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Pharmacol, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Canc Biol, Durham, NC 27706 USA.; Hirschey, MD (corresponding author), Duke Univ, Sch Med, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27706 USA.	matthew.hirschey@duke.edu	Grimsrud, Paul A./GWZ-9287-2022; Gomes, Cláudio M./A-8152-2008; Henriques, Barbara/A-1814-2016	Grimsrud, Paul A./0000-0002-4706-914X; Gomes, Cláudio M./0000-0003-4662-6933; Henriques, Barbara/0000-0002-1724-9545	Ci?ncia e Tecnologia (FCT/MCTES, Portugal) [PTDC/BBB-BQB/5366/2014, SFRH/BPD/74475/2010, SFRH/BD/89690/2012]	Ci?ncia e Tecnologia (FCT/MCTES, Portugal)	Funding and additional information-This work was partly sup-ported by the Funda??o para a Ci?ncia e Tecnologia (FCT/MCTES, Portugal) through research grant PTDC/BBB-BQB/5366/2014 (to B. J. H.) and fellowship SFRH/BPD/74475/2010 (to B. J. H.) and SFRH/BD/89690/2012 (to T. G. L.) .	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Elkhwanky MS, 2018, ANTIOXID REDOX SIGN, V28, P662, DOI 10.1089/ars.2017.7270; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; Henriques BJ, 2011, FEBS LETT, V585, P505, DOI 10.1016/j.febslet.2011.01.002; Henriques BJ, 2009, J BIOL CHEM, V284, P4222, DOI 10.1074/jbc.M805719200; James AM, 2017, CELL REP, V18, P2105, DOI 10.1016/j.celrep.2017.02.018; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Kulkarni RA, 2017, CELL CHEM BIOL, V24, P231, DOI 10.1016/j.chembiol.2017.01.002; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Lucas TG, 2011, BBA-MOL BASIS DIS, V1812, P1658, DOI 10.1016/j.bbadis.2011.09.009; Madsen AS, 2016, J BIOL CHEM, V291, P7128, DOI 10.1074/jbc.M115.668699; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; NODA C, 1976, J BIOCHEM, V80, P1159, DOI 10.1093/oxfordjournals.jbchem.a131371; Osborne B, 2016, FREE RADICAL BIO MED, V100, P164, DOI 10.1016/j.freeradbiomed.2016.04.197; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Ribeiro JV, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2019.140269; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; The M, 2016, J AM SOC MASS SPECTR, V27, P1719, DOI 10.1007/s13361-016-1460-7; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089	32	2	3	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101723	10.1016/j.jbc.2022.101723	http://dx.doi.org/10.1016/j.jbc.2022.101723			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35157847	gold, Green Published			2022-12-26	WOS:000797895000012
J	Lin, CH; Sun, Y; Chan, CSY; Wu, MR; Gu, L; Davis, AE; Gu, BK; Zhang, WL; Tanasa, B; Zhong, LR; Emerson, MM; Chen, L; Ding, JB; Wang, S				Lin, Cheng-Hui; Sun, Yue; Chan, Candace S. Y.; Wu, Man-Ru; Gu, Lei; Davis, Alexander E.; Gu, Baokun; Zhang, Wenlin; Tanasa, Bogdan; Zhong, Lei R.; Emerson, Mark M.; Chen, Lu; Ding, Jun B.; Wang, Sui			<p>Identification of cis-regulatory modules for adeno-associated virus-based cell-type-specific targeting in the retina and brain</p>	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; GENE-THERAPY; GANGLION-CELLS; UP-REGULATION; IN-VIVO; GLIA; GFAP; EXPRESSION	Adeno-associated viruses (AAVs) targeting specific cell types are powerful tools for studying distinct cell types in the central nervous system (CNS). Cis-regulatory modules (CRMs), e.g., enhancers, are highly cell-type-specific and can be integrated into AAVs to render cell type specificity. Chromatin accessibility has been commonly used to nominate CRMs, which have then been incorporated into AAVs and tested for cell type specificity in the CNS. However, chromatin accessibility data alone cannot accurately annotate active CRMs, as many chromatin-accessible CRMs are not active and fail to drive gene expression in vivo. Using available large-scale datasets on chromatin accessibility, such as those published by the ENCODE project, here we explored strategies to increase efficiency in identifying active CRMs for AAV-based cell-type specific labeling and manipulation. We found that prescreening of chromatin-accessible putative CRMs based on the density of cell-type-specific transcription factor binding sites (TFBSs) can significantly increase efficiency in identifying active CRMs. In addition, generation of synthetic CRMs by stitching chromatin-accessible regions flanking cell-type specific genes can render cell type specificity in many cases. Using these straightforward strategies, we generated AAVs that can target the extensively studied interneuron and glial cell types in the retina and brain. Both strategies utilize available genomic datasets and can be employed to generate AAVs targeting specific cell types in CNS without conducting comprehensive screening and sequencing experiments, making a step forward in cell-type-specific research.	[Lin, Cheng-Hui; Sun, Yue; Chan, Candace S. Y.; Wu, Man-Ru; Davis, Alexander E.; Gu, Baokun; Tanasa, Bogdan; Wang, Sui] Stanford Univ, Byers Eye Inst, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol, Stanford, CA 94305 USA; [Sun, Yue; Zhong, Lei R.; Chen, Lu; Ding, Jun B.] Stanford Univ, Dept Neurosurg, Stanford, CA USA; [Gu, Lei] Max Planck Inst Heart & Lung Res, Epigenet Lab, Bad Nauheim, Germany; [Zhang, Wenlin] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China; [Emerson, Mark M.] CUNY City Coll, Dept Biol, New York, NY USA; [Ding, Jun B.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA USA	Stanford University; Stanford University; Max Planck Society; Zhejiang University; City University of New York (CUNY) System; City College of New York (CUNY); Stanford University	Wang, S (corresponding author), Stanford Univ, Byers Eye Inst, Mary M & Sash A Spencer Ctr Vis Res, Dept Ophthalmol, Stanford, CA 94305 USA.	suiwang@stanford.edu	Lin, Cheng-Hui/AAV-7085-2021; Ding, Jun/B-2513-2009	Lin, Cheng-Hui/0000-0002-1479-9533; Wang, Sui/0000-0003-1563-9117; /0000-0001-9667-7996; Chen, Lu/0000-0002-8097-2699; Ding, Jun/0000-0003-0690-1312; Sun, Yue/0000-0002-5681-130X	American Diabetes Association [1-16-INI-16]; NIH [5F32EY018287, MH086403, NS11566001]	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by American Diabetes Association (1-16-INI-16 to S. W.) , NIH 1R01EY03258501 (to S. W.) , NIH MH086403 (to L. C.) , NS11566001 (to L. C.) , NIH 5F32EY018287 (to M. M. E.) , and P30 to Stanford Ophthalmology (to S. W., C.-H. L., Y. S., C. S. Y. C, and A. E. D.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae JA, 2018, CELL, V173, P1293, DOI 10.1016/j.cell.2018.04.040; Balasubramanian Revathi, 2014, Curr Ophthalmol Rep, V2, P100; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Billings NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013739; Brenner M, 2014, NEUROSCI LETT, V565, P7, DOI 10.1016/j.neulet.2014.01.055; Chan CSY, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.187922; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Consortium E.P., 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; de Leeuw CN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0232-4; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Graybuck LT, 2020, BIORXIV, DOI [10.1101/525014, DOI 10.1101/525014]; Graybuck LT, 2021, NEURON, V109, P1449, DOI 10.1016/j.neuron.2021.03.011; Haery L, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00093; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Hocquemiller M, 2016, HUM GENE THER, V27, P478, DOI 10.1089/hum.2016.087; Hrvatin S, 2019, ELIFE, V8, DOI 10.7554/eLife.48089; Jorstad NL, 2017, NATURE, V548, P103, DOI 10.1038/nature23283; Juttner J, 2019, NAT NEUROSCI, V22, P1345, DOI 10.1038/s41593-019-0431-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Lykken EA, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9234-0; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masland RH, 2012, VISUAL NEUROSCI, V29, P3, DOI 10.1017/S0952523811000344; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mich JK, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108754; Ockuly JC, 2014, INVEST OPHTH VIS SCI, V55; Rheaume BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05134-3; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Vormstein-Schneider D, 2020, NAT NEUROSCI, V23, P1629, DOI 10.1038/s41593-020-0692-9; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yan WJ, 2020, J NEUROSCI, V40, P5177, DOI 10.1523/JNEUROSCI.0471-20.2020; Yao K, 2018, NATURE, V560, P484, DOI 10.1038/s41586-018-0425-3; Zhou HB, 2020, CELL, V181, P590, DOI 10.1016/j.cell.2020.03.024	45	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101674	10.1016/j.jbc.2022.101674	http://dx.doi.org/10.1016/j.jbc.2022.101674			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35148987	gold, Green Published			2022-12-26	WOS:000797895000011
J	Sanchez-Navarro, A; Murillo-de-Ozores, AR; Perez-Villalva, R; Linares, N; Carbajal-Contreras, H; Flores, ME; Gamba, G; Castaneda-Bueno, M; Bobadilla, NA				Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Linares, Nadyeli; Carbajal-Contreras, Hector; Flores, Maria Elena; Gamba, Gerardo; Castaneda-Bueno, Maria; Bobadilla, Norma A.			Transient response of serpinA3 during cellular stress	FASEB JOURNAL			English	Article						acute kidney injury; cellular stress; oxidative stress; starvation	SERINE-PROTEASE INHIBITOR; ALPHA-1-PROTEINASE INHIBITOR; ALPHA-1-ANTICHYMOTRYPSIN; ALPHA(1)-ANTICHYMOTRYPSIN; GLYCOSYLATION; DISEASE; DISRUPTION; STABILITY; BIOMARKER; PROTECTS	We demonstrated that serpinA3c/k relocates from the cytoplasm to the apical tubular membrane (ATM) in chronic kidney disease (CKD), suggesting its secretion in luminal space in pathophysiological contexts. Here, we studied serpinA3c/k expression and secretion under different stressful conditions in vitro and in vivo. HEK-293 cells were transfected with a FLAG-tagged serpinA3c/k clone and exposed to H2O2 or starvation. Both stressors induced serpinA3c/k secretion but with a higher molecular weight. Glycanase treatment established that serpinA3c/k is glycosylated. Site-directed mutagenesis for each of the four glycosylation sites was performed. During cellular stress, serpinA3c/k secretion increased with each mutant except in the quadruple mutant. In rats and patients suffering acute kidney injury (AKI), an atypical urinary serpinA3c/k excretion (uSerpinA3c/k) was observed. In rats with AKI, the greater the induced kidney damage, the greater the uSerpinA3 c/k, together with relocation toward ATM. Our findings show that: (1) serpinA3c/k is glycosylated and secreted, (2) serpinA3c/k secretion increases during cellular stress, (3) its appearance in urine reveals a pathophysiological state, and (4) urinary serpinA3 excretion could become a potential biomarker for AKI.	[Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Gamba, Gerardo; Bobadilla, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Mexico City, DF, Mexico; [Sanchez-Navarro, Andrea; Rafael Murillo-de-Ozores, Adrian; Perez-Villalva, Rosalba; Linares, Nadyeli; Carbajal-Contreras, Hector; Gamba, Gerardo; Castaneda-Bueno, Maria; Bobadilla, Norma A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, DF, Mexico; [Carbajal-Contreras, Hector] Univ Nacl Autonoma Mexico, Combined Studies Program Med MD PhD PECEM, Fac Med, Mexico City, DF, Mexico; [Flores, Maria Elena] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Bobadilla, NA (corresponding author), Unidad Fisiol Mol, Vasco Quiruga 15, Mexico City 14000, DF, Mexico.	nab@biomedicas.unam.mx	CASTANEDA-BUENO, MARIA/GYR-1202-2022	Sanchez-Navarro, Andrea/0000-0002-5625-323X; Bobadilla, Norma A/0000-0002-3153-9151	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [235855, 235964, 272390]; Universidad Nacional Autonoma de Mexico (UNAM) [IN201619, IN201022]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: 235855, 235964 and 272390; Universidad Nacional Autonoma de Mexico (UNAM), Grant/Award Number: IN201619 and IN201022	Ortega-Trejo JA, 2015, BIOMARKERS, V20, P453, DOI 10.3109/1354750X.2015.1096305; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Barrera-Chimal J, 2011, EMBO MOL MED, V3, P5, DOI 10.1002/emmm.201000105; Benchabane M, 2009, PLANT BIOTECHNOL J, V7, P146, DOI 10.1111/j.1467-7652.2008.00382.x; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Caval T, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.608466; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; CONZ P, 1990, NEPHRON, V56, P387, DOI 10.1159/000186180; DeCoux A, 2015, CRIT CARE MED, V43, P2049, DOI 10.1097/CCM.0000000000001134; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; Morales-Buenrostro LE, 2019, AM J PHYSIOL-RENAL, V317, pF519, DOI 10.1152/ajprenal.00606.2018; Garcia-Ortuno LE, 2019, AM J PHYSIOL-RENAL, V317, pF1637, DOI 10.1152/ajprenal.00356.2019; Garcia-Ortuno LE, 2018, REV INVEST CLIN, V70, P261, DOI 10.24875/RIC.18002546; Flintegaard TV, 2010, ENDOCRINOLOGY, V151, P5326, DOI 10.1210/en.2010-0574; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; GROSS V, 1990, BIOL CHEM H-S, V371, P231, DOI 10.1515/bchm3.1990.371.1.231; Hu JY, 2013, INVEST OPHTH VIS SCI, V54, P5400, DOI 10.1167/iovs.12-10145; JEPPSSON JO, 1975, NEW ENGL J MED, V293, P576, DOI 10.1056/NEJM197509182931203; Jing Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01215; Kamboh MI, 2006, NEUROBIOL AGING, V27, P1435, DOI 10.1016/j.neurobiolaging.2005.07.015; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; LECAM A, 1987, EMBO J, V6, P1225, DOI 10.1002/j.1460-2075.1987.tb02358.x; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Luo DY, 2017, ONCOTARGETS THER, V10, P2173, DOI 10.2147/OTT.S133022; Mahadeva R, 2001, THORAX, V56, P53, DOI 10.1136/thorax.56.1.53; McCarthy C, 2014, J PROTEOME RES, V13, P596, DOI 10.1021/pr400752t; Morales-Buenrostro LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109407; MUROHARA T, 1995, J PHARMACOL EXP THER, V274, P1246; Pere-Brissaud A, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150071; Perez-Villalva R, 2017, BIOMARKERS, V22, P548, DOI 10.1080/1354750X.2017.1315616; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Sanchez-Navarro A, 2020, AM J PHYSIOL-CELL PH, V320, pC106, DOI 10.1152/ajpcell.00366.2020; Sanchez-Navarro A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46601-1; Sandford AJ, 1998, DIS MARKERS, V13, P257, DOI 10.1155/1998/867620; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sun HO, 2008, LUPUS, V17, P56, DOI 10.1177/0961203307083443; TAKADA S, 1988, BIOCHEM INT, V16, P949; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zheng XL, 2017, INVEST OPHTH VIS SCI, V58, P2874, DOI 10.1167/iovs.17-21544; Zhou T, 2014, INVEST OPHTH VIS SCI, V55, P4863, DOI 10.1167/iovs.14-14023; Zhou T, 2012, INVEST OPHTH VIS SCI, V53, P5033, DOI 10.1167/iovs.12-9729; Zhu HZ, 2017, CELL PHYSIOL BIOCHEM, V41, P2289, DOI 10.1159/000475648	50	3	3	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22190	10.1096/fj.202101912R	http://dx.doi.org/10.1096/fj.202101912R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147994				2022-12-26	WOS:000761250800005
J	Tsuboyama, N; Wang, R; Szczepanski, AP; Chen, HH; Zhao, ZB; Shi, L; Wang, L				Tsuboyama, Natsumi; Wang, Ru; Szczepanski, Aileen Patricia; Chen, Huanhuan; Zhao, Zibo; Shi, Lei; Wang, Lu			Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer	ONCOGENE			English	Article							BRCA1-ASSOCIATED PROTEIN-1; UVEAL MELANOMA; BAP1; MUTATIONS; ASSOCIATION; GAIN	Small cell lung cancer (SCLC) is an aggressive disease, with patients diagnosed with either early-stage, limited stage, or extensive stage of SCLC tumor progression. Discovering and targeting the functional biomarkers for SCLC will be crucial in understanding the molecular basis underlying SCLC tumorigenesis to better assist in improving clinical treatment. Emerging studies have demonstrated that dysregulations in BAP1 histone H2A deubiquitinase complex are collectively associated with pathogenesis in human SCLC. Here, we investigated the function of the oncogenic BAP1/ASXL3/BRD4 epigenetic axis in SCLC by developing a next-generation BAP1 inhibitor, iBAP-II, and focusing on the epigenetic balance established between BAP1 and non-canonical PRC1 complexes in regulating SCLC-specific transcriptional programming. We further demonstrated that pharmacologic inhibition of BAP1's catalytic activity disrupted BAP1/ASXL3/BRD4 epigenetic axis by inducing protein degradation of the ASXL3 scaffold protein, which bridges BRD4 and BAP1 at active enhancers. Furthermore, treatment of iBAP-II represses neuroendocrine lineage-specific ASCL1/MYCL/E2F signaling in SCLC cell lines, and dramatically inhibits SCLC cell viability and tumor growth in vivo. In summary, this study has provided mechanistic insight into the oncogenic function of BAP1 in SCLC and highlighted the potential of targeting BAP1's activity as a novel SCLC therapy.	[Tsuboyama, Natsumi; Szczepanski, Aileen Patricia; Zhao, Zibo; Wang, Lu] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Tsuboyama, Natsumi; Szczepanski, Aileen Patricia; Zhao, Zibo; Wang, Lu] Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA; [Wang, Ru; Chen, Huanhuan; Shi, Lei] China Pharmaceut Univ, Dept Med Chem, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; China Pharmaceutical University	Wang, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.; Wang, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA.; Shi, L (corresponding author), China Pharmaceut Univ, Dept Med Chem, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 210009, Peoples R China.	shilei@cpu.edu.cn; lu.wang1@northwestern.edu	Zhao, Zibo/GWQ-3444-2022	, Aileen/0000-0002-4133-0634; Tsuboyama, Natsumi/0000-0002-8620-3479; Wang, Lu/0000-0003-0441-0747				Asada S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05085-9; Balasubramani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8307; Baymaz HI, 2014, PROTEOMICS, V14, P2179, DOI 10.1002/pmic.201400013; Bononi A, 2017, NATURE, V546, P549, DOI 10.1038/nature22798; Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campagne A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08255-x; Carbone M, 2020, CANCER DISCOV, V10, P1103, DOI 10.1158/2159-8290.CD-19-1220; Carbone M, 2020, NAT REV CANCER, V20, P533, DOI 10.1038/s41568-020-0265-y; Conway E, 2021, MOL CELL, V81, P3526, DOI 10.1016/j.molcel.2021.06.020; De I, 2019, STRUCTURE, V27, P528, DOI 10.1016/j.str.2018.11.013; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dobrinic P, 2021, NAT STRUCT MOL BIOL, V28, P811, DOI 10.1038/s41594-021-00661-y; Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006; Gazdar AF, 2017, NAT REV CANCER, V17, P725, DOI 10.1038/nrc.2017.87; Guo Y, 2018, LEUKEMIA, V32, P1834, DOI 10.1038/s41375-018-0126-9; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; He M, 2019, SCIENCE, V364, P283, DOI 10.1126/science.aav4902; Jiang LY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005895; Kalirai H, 2014, BRIT J CANCER, V111, P1373, DOI 10.1038/bjc.2014.417; Khan P, 2022, SEMIN CANCER BIOL, V83, P57, DOI 10.1016/j.semcancer.2020.11.006; Kim DW, 2016, GENE DEV, V30, P1289, DOI 10.1101/gad.279307.116; Krushkal J, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00876-8; Lee HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6128; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Novelli F, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2111946118; Okino Y, 2015, J BIOL CHEM, V290, P1580, DOI 10.1074/jbc.M114.609834; Piunti A, 2021, NAT REV MOL CELL BIO, V22, P326, DOI 10.1038/s41580-021-00341-1; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Rotinen M, 2018, NAT MED, V24, P1887, DOI 10.1038/s41591-018-0241-1; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Rudin CM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00235-0; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Srivastava A, 2016, HUM MOL GENET, V25, P597, DOI 10.1093/hmg/ddv499; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Szczepanski AP, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00760-3; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; van Essen TH, 2014, BRIT J OPHTHALMOL, V98, P1738, DOI 10.1136/bjophthalmol-2014-305047; Wang L, 2021, NAT CANCER, V2, P515, DOI 10.1038/s43018-021-00199-4; Yang H, 2018, BLOOD, V131, P328, DOI 10.1182/blood-2017-06-789669; Yu L, 2018, GENE DEV, V32, P1537, DOI 10.1101/gad.318436.118; Zhao ZB, 2021, CANCER RES, V81, P4696, DOI 10.1158/0008-5472.CAN-21-1114	46	3	3	3	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2152	2162		10.1038/s41388-022-02240-x	http://dx.doi.org/10.1038/s41388-022-02240-x		FEB 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35194152	hybrid, Green Published			2022-12-26	WOS:000759404700003
J	Islam, MR; Beni, MS; Ng, CY; Miyake, M; Rahman, M; Ito, S; Gotoh, S; Yamaya, T; Watabe, H				Islam, M. Rafiqul; Beni, Mehrdad Shahmohammadi; Ng, Chor-Yi; Miyake, Masayasu; Rahman, Mahabubur; Ito, Shigeki; Gotoh, Shinichi; Yamaya, Taiga; Watabe, Hiroshi			Proton range monitoring using N-13 peak for proton therapy applications	PLOS ONE			English	Article							QUALITY-ASSURANCE; PET; TOMOGRAPHY; PARTICLE; PATIENT	The Monte Carlo method is employed in this study to simulate the proton irradiation of a water-gel phantom. Positron-emitting radionuclides such as C-11, O-15, and N-13 are scored using the Particle and Heavy Ion Transport Code System Monte Carlo code package. Previously, it was reported that as a result of O-16(p,2p2n)N-13 nuclear reaction, whose threshold energy is relatively low (5.660 MeV), a N-13 peak is formed near the actual Bragg peak. Considering the generated N-13 peak, we obtain offset distance values between the N-13 peak and the actual Bragg peak for various incident proton energies ranging from 45 to 250 MeV, with an energy interval of 5 MeV. The offset distances fluctuate between 1.0 and 2.0 mm. For example, the offset distances between the N-13 peak and the Bragg peak are 2.0, 2.0, and 1.0 mm for incident proton energies of 80, 160, and 240 MeV, respectively. These slight fluctuations for different incident proton energies are due to the relatively stable energy-dependent cross-section data for the (160)(p,2p2n)N-13 nuclear reaction. Hence, we develop an open-source computer program that performs linear and non-linear interpolations of offset distance data against the incident proton energy, which further reduces the energy interval from 5 to 0.1 MeV. In addition, we perform spectral analysis to reconstruct the N-13 Bragg peak, and the results are consistent with those predicted from Monte Carlo computations. Hence, the results are used to generate three-dimensional scatter plots of the N-13 radionuclide distribution in the modeled phantom. The obtained results and the developed methodologies will facilitate future investigations into proton range monitoring for therapeutic applications.	[Islam, M. Rafiqul; Watabe, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan; [Islam, M. Rafiqul] Bangladesh Atom Energy Commiss, Inst Nucl Med Phys, AERE, Dhaka, Bangladesh; [Beni, Mehrdad Shahmohammadi; Miyake, Masayasu; Watabe, Hiroshi] Tohoku Univ, Div Radiat Protect & Safety Control, CYRIC, Sendai, Miyagi, Japan; [Beni, Mehrdad Shahmohammadi] City Univ Hong Kong, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Ng, Chor-Yi] Queen Mary Hosp, Pok Fu Lam, Hong Kong, Peoples R China; [Rahman, Mahabubur] Bangladesh Atom Energy Regular Author, Nucl Safety Secur Safeguard Div, Dhaka, Bangladesh; [Ito, Shigeki] Mirai Imaging Inc, Iwaki, Fukushima, Japan; [Gotoh, Shinichi] GO Proton Japan Inc, Tokyo, Japan; [Yamaya, Taiga] Natl Inst Quantum & Radiol Sci & Technol, Chiba, Japan	Tohoku University; Tohoku University; City University of Hong Kong; University of Hong Kong; National Institutes for Quantum Science & Technology	Watabe, H (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan.; Watabe, H (corresponding author), Tohoku Univ, Div Radiat Protect & Safety Control, CYRIC, Sendai, Miyagi, Japan.	watabe@cyric.tohoku.ac.jp	miyake, masayasu/GQR-5788-2022	Watabe, Hiroshi/0000-0001-6257-7735; ISLAM, MD Rafiqul/0000-0003-4230-665X	Agency for Medical Research and Development (AMED) [20he2202004h0402]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21F21103]	Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research work was funded by Agency for Medical Research and Development (AMED) under Grant Number 20he2202004h0402 and Ministry of Education, Culture, Sports, Science and Technology (MEXT) under Grant Number 21F21103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared	Beebe-Wang J, 2004, IEEE NUCL SCI CONF R, P2496, DOI 10.1109/NSSMIC.2003.1352399; Beni M.S., 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/S41598-018-37186-2; Beni MS, 2021, OPEN PHYS, V19, P454, DOI 10.1515/phys-2021-0055; Beni MS, 2021, OPEN PHYS, V19, P277, DOI 10.1515/phys-2021-0026; Beni MS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248300; Beni MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193575; Beni MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181281; Carson R. E., 1981, Proceedings of the Fifth Annual Symposium on Computer Applications in Medical Care, P562; Cherry SR, 2018, J NUCL MED, V59, P3, DOI 10.2967/jnumed.116.184028; Cho JM, 2017, MED PHYS, V44, P1734, DOI 10.1002/mp.12191; CUNNINGHAM VJ, 1993, J CEREBR BLOOD F MET, V13, P15, DOI 10.1038/jcbfm.1993.5; Del Guerra A., 9310TRA9 TERA; Draeger E, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaa203; Enghardt W, 1999, NUCL PHYS A, V654, p1047C, DOI 10.1016/S0375-9474(00)88597-8; Espana S, 2011, PHYS MED BIOL, V56, P2687, DOI 10.1088/0031-9155/56/9/003; Geissel H, 1998, NUCL INSTRUM METH B, V136, P114, DOI 10.1016/S0168-583X(97)00660-5; Guo SY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260374; Hayakawa Y., 1995, RADIAT ONCOL INVEST, V3, P42, DOI DOI 10.1002/roi.2970030107; Held KD, 2020, BRIT J RADIOL, V93, DOI 10.1259/bjr.20209004; ICRU, 2000, 63 ICRU; Jones KC, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa9d16; Knopf AC, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/R131; Litzenberg D., 1997, THESIS U MICHIGAN; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Min CH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378561; NIITA K, 1995, PHYS REV C, V52, P2620, DOI 10.1103/PhysRevC.52.2620; Niita K, 2001, NUCL INSTRUM METH B, V184, P406, DOI 10.1016/S0168-583X(01)00784-4; Nikezic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157627; Oelfke U, 1996, PHYS MED BIOL, V41, P177, DOI 10.1088/0031-9155/41/1/013; PAANS AMJ, 1993, IEEE T NUCL SCI, V40, P1041, DOI 10.1109/23.256709; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; Parodi K, 2000, PHYS MED BIOL, V45, pN151, DOI 10.1088/0031-9155/45/11/403; Parodi K, 2002, PHYS MED BIOL, V47, P21, DOI 10.1088/0031-9155/47/1/302; Poludniowski G, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150134; Sato T, 2018, J NUCL SCI TECHNOL, V55, P684, DOI 10.1080/00223131.2017.1419890; Schneider U, 2012, MED PHYS, V39, P798, DOI 10.1118/1.3676739; Testa M, 2013, PHYS MED BIOL, V58, P8215, DOI 10.1088/0031-9155/58/22/8215; Watabe H, 2006, ANN NUCL MED, V20, P583, DOI 10.1007/BF02984655; Yamaguchi M, 2016, NUCL INSTRUM METH A, V833, P199, DOI 10.1016/j.nima.2016.07.034; Yamaguchi M, 2012, PHYS MED BIOL, V57, P2843, DOI 10.1088/0031-9155/57/10/2843; Zhu XP, 2011, PHYS MED BIOL, V56, P4041, DOI 10.1088/0031-9155/56/13/019; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263521	10.1371/journal.pone.0263521	http://dx.doi.org/10.1371/journal.pone.0263521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167589	Green Published, gold			2022-12-26	WOS:000802227200009
J	Liao, YD; Huang, JM; Liu, P; Zhang, CY; Liu, JX; Xia, M; Shang, CL; Ooi, SY; Chen, YL; Qin, SH; Du, QQ; Liu, TY; Xu, MM; Zou, QJ; Zhou, YJ; Huang, H; Pan, YW; Wang, W; Yao, SZ				Liao, Yuandong; Huang, Jiaming; Liu, Pan; Zhang, Chunyu; Liu, Junxiu; Xia, Meng; Shang, Chunliang; Ooi, Shiyin; Chen, Yili; Qin, Shuhang; Du, Qiqiao; Liu, Tianyu; Xu, Manman; Zou, Qiaojian; Zhou, Yijia; Huang, Hua; Pan, Yuwen; Wang, Wei; Yao, Shuzhong			Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH; MECHANISMS; EXPRESSION; RATIO	Epithelial-mesenchymal transition (EMT) is an essential step to drive the metastatic cascade to lymph nodes (LNs) in cervical cancer cells. However, few of them metastasize successfully partially due to increased susceptibility to immunosurveillance conferred by EMT. The precise mechanisms of cancer cells orchestrate EMT and immune evasion remain largely unexplored. In this study, we identified a lncRNA termed lymph node metastasis associated suppressor (LNMAS), which was downregulated in LN-positive cervical cancer patients and correlated with LN metastasis and prognosis. Functionally, LNMAS suppressed cervical cancer cells metastasis in vitro and in vivo. Mechanistically, LNMAS exerts its metastasis suppressive activity by competitively interacting with HMGB1 and abrogating the chromatin accessibility of TWIST1 and STC1, inhibiting TWIST1-mediated partial EMT and STC1-dependent immune escape from macrophage phagocytosis. We further demonstrated that the CpG sites in the promoter region of LNMAS was hypermethylated and contributed to the downregulation of LNMAS. Taken together, our results reveal the essential role of LNMAS in the LN metastasis of cervical cancer and provide mechanistic insights into the regulation of LNMAS in EMT and immune evasion.	[Liao, Yuandong; Huang, Jiaming; Liu, Pan; Zhang, Chunyu; Liu, Junxiu; Xia, Meng; Ooi, Shiyin; Chen, Yili; Qin, Shuhang; Du, Qiqiao; Liu, Tianyu; Xu, Manman; Zou, Qiaojian; Zhou, Yijia; Huang, Hua; Pan, Yuwen; Wang, Wei; Yao, Shuzhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510080, Guangdong, Peoples R China; [Shang, Chunliang] Peking Univ Third Hosp, Dept Obstet & Gynecol, Beijing 100191, Peoples R China	Sun Yat Sen University; Peking University	Wang, W; Yao, SZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510080, Guangdong, Peoples R China.	wangw245@mail.sysu.edu.cn; yaoshuzh@mail.sysu.edu.cn	Zhang, Chun-yu/HDP-5776-2022	Yao, Shuzhong/0000-0002-5145-5705	National Natural Science Foundation of China [81874102, 82072874, 81902627]; Guangzhou Science and Technology Programme [202002020043]; Sun Yat-sen University Clinical Research Foundation of 5010 Project [2017006]; Natural Science Foundation of Guangdong Province [2017A030313509]; Guangdong Basic and Applied Basic Research Foundation [2021A1515011776]; First Affiliated Hospital of Sun Yat-sen University Undergraduate Teaching Reform Research Project [31911130-200437]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Programme; Sun Yat-sen University Clinical Research Foundation of 5010 Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Basic and Applied Basic Research Foundation; First Affiliated Hospital of Sun Yat-sen University Undergraduate Teaching Reform Research Project	This work was supported by the National Natural Science Foundation of China (No. 81874102, 82072874 to SZY; 81902627 to JMH), Guangzhou Science and Technology Programme (No. 202002020043 to SZY), Sun Yat-sen University Clinical Research Foundation of 5010 Project (No. 2017006 to SZY), Natural Science Foundation of Guangdong Province (No. 2017A030313509 to WW), Guangdong Basic and Applied Basic Research Foundation (No. 2021A1515011776 to WW) and the First Affiliated Hospital of Sun Yat-sen University Undergraduate Teaching Reform Research Project (No. 31911130-200437 to WW).	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Aiello NM, 2019, J EXP MED, V216, P1016, DOI 10.1084/jem.20181827; Athie A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201908078; Barkal AA, 2019, NATURE, V572, P392, DOI 10.1038/s41586-019-1456-0; Battistelli C, 2021, CANCER RES, V81, P103, DOI 10.1158/0008-5472.CAN-20-1764; Bejarano L, 2021, CANCER DISCOV, V11, P933, DOI 10.1158/2159-8290.CD-20-1808; Berger AC, 2018, CANCER CELL, V33, P690, DOI 10.1016/j.ccell.2018.03.014; Bhatla N, 2018, INT J GYNECOL OBSTET, V143, P22, DOI 10.1002/ijgo.12611; Blair RH, 2016, J MOL BIOL, V428, P4060, DOI 10.1016/j.jmb.2016.08.018; Brabletz S, 2021, EMBO J, V40, DOI 10.15252/embj.2021108647; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen Y, 2013, INT J GYNECOL CANCER, V23, P157, DOI 10.1097/IGC.0b013e3182778bcf; Chockley PJ, 2018, J CLIN INVEST, V128, P1384, DOI 10.1172/JCI97611; Chu Ci, 2012, J Vis Exp, DOI 10.3791/3912; Dong WH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00340; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fan JY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0705-2; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Fleming ND, 2015, GYNECOL ONCOL, V136, P48, DOI 10.1016/j.ygyno.2014.11.010; Garner H, 2020, NAT REV IMMUNOL, V20, P483, DOI 10.1038/s41577-019-0271-z; Guo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053989; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Huang JM, 2018, ONCOL LETT, V15, P5584, DOI 10.3892/ol.2018.8037; Iurlaro M, 2021, NAT GENET, V53, P279, DOI 10.1038/s41588-020-00768-w; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Klein M, 1999, J ENDOCRINOL, V161, P41, DOI 10.1677/joe.0.1610041; Kong DG, 2021, ONCOGENE, V40, P964, DOI 10.1038/s41388-020-01539-x; Kozlova AL, 2018, MOL BIOL+, V52, P637, DOI 10.1134/S0026893318050096; Lee CK, 2019, SCIENCE, V363, P644, DOI 10.1126/science.aav0173; Lepique AP, 2009, CLIN CANCER RES, V15, P4391, DOI 10.1158/1078-0432.CCR-09-0489; LIN H, CANCER CELL, V2021; Liu F, 2018, ONCOGENE, V37, P2394, DOI 10.1038/s41388-017-0119-6; Liu JQ, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117134; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Lv DJ, 2019, THERANOSTICS, V9, P5166, DOI 10.7150/thno.33972; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Mittal V, 2018, ANNU REV PATHOL-MECH, V13, P395, DOI 10.1146/annurev-pathol-020117-043854; Mohme M, 2017, NAT REV CLIN ONCOL, V14, P155, DOI 10.1038/nrclinonc.2016.144; Noman MZ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1345415; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pan X, 2021, CANCER BIOTHER RADIO, V36, P501, DOI 10.1089/cbr.2019.3344; Quan YS, 2018, BIOCHEM BIOPH RES CO, V497, P527, DOI 10.1016/j.bbrc.2018.02.072; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shang CL, 2018, CANCER RES, V78, P877, DOI 10.1158/0008-5472.CAN-17-2356; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Sikic BI, 2019, J CLIN ONCOL, V37, P946, DOI 10.1200/JCO.18.02018; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang JB, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00444; Winkle M, 2021, NAT REV DRUG DISCOV, V20, P629, DOI 10.1038/s41573-021-00219-z; Wu N, 2021, CELL DEATH DIFFER, V28, P219, DOI 10.1038/s41418-020-0596-y; Wu YM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1014-2; Xia M., 2020, CELL DEATH DIS, V11; Xu LL, 2021, ONCOGENE, V40, P3578, DOI 10.1038/s41388-021-01760-2; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yu BY, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01575; Zeng YT, 2019, ONCOGENE, V38, P6940, DOI 10.1038/s41388-019-0906-3; Zhang CY, 2020, THERANOSTICS, V10, P6561, DOI 10.7150/thno.44868; Zhu CY, 2020, EUR REV MED PHARMACO, V24, P2321, DOI 10.26355/eurrev_202003_20498	63	3	3	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1931	1943		10.1038/s41388-022-02202-3	http://dx.doi.org/10.1038/s41388-022-02202-3		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35152264	hybrid, Green Published			2022-12-26	WOS:000754368500001
J	Hossian, M; Khan, MAS; Nazir, A; Habi, MH; Hasan, M; Maliha, R; Hossain, MA; Rashid, MU; Itrat, N; Hawlader, MDH				Hossian, Mosharop; Khan, Md Abdullah Saeed; Nazir, Anum; Habi, Mohammad Hayatun; Hasan, Mehedi; Maliha, Ramisha; Hossain, Mohammad Ali; Rashid, Md Utba; Itrat, Nizwa; Hawlader, Mohammad Delwer Hossain			Factors affecting intention to take COVID-19 vaccine among Pakistani University Students	PLOS ONE			English	Article							EMERGENCY	Background Widespread vaccination coverage is essential for reducing the COVID-19 havoc and regarded as a crucial tool in restoring normal life on university campuses. Therefore, our research aimed to understand the intention to be vaccinated for COVID-19 among Pakistani university students. Methods This cross-sectional study was conducted in five administrative units of Pakistan, i.e., Punjab, Sindh, Balochistan, Azad Jammu and Kashmir, and Khyber Pakhtunkhwa. We obtained data from 2,865 university students between 17th January and 2nd February, 2021, using a semi-structured and self-administered questionnaire. We used Stata (version 16.1, StataCorp LLC) for data management and analysis. Results The majority (72.5%) of our respondents were willing to take COVID-19 vaccine. The current level of education had a statistically significant relationship with the intention to be vaccinated (p < 0.05). Respondents answered 11 questions encompassing five different domains of the Health Belief Model (HBM). All the items of HBM were significantly associated with the positive intention towards receiving the vaccine (p < 0.05). We conducted a multivariable logistic regression analysis to assess the relative contribution of different factors towards the intention to receive COVID-19 vaccine. Multiple factors such as belief that vaccination should be mandatory for everyone (AOR: 3.99, 95% CI: 3.20-4.98) and willingness to take vaccine even if it is not free (AOR: 3.91, 95% CI: 3.18-4.81) were observed to be associated with high odds of showing willingness to be vaccinated against COVID-19. Conclusion Most of our study participants intended to take vaccines based on their belief regarding the high effectiveness of COVID-19 vaccine. But as rumor-mongers are generating and spreading conspiracy theories daily, the health department and policymakers need to undertake evidence-based campaigns through electronic and social media to ensure expected countrywide vaccination coverage. In this case, our study findings can serve as a foundation for them to ensure mass vaccination coverage among university students, which is crucial now to reopen the dormitories and restore everyday life on campuses.	[Hossian, Mosharop; Khan, Md Abdullah Saeed; Habi, Mohammad Hayatun; Hasan, Mehedi; Maliha, Ramisha; Hossain, Mohammad Ali; Rashid, Md Utba; Hawlader, Mohammad Delwer Hossain] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Hossian, Mosharop] Publ Hlth Profess Dev Soc PPDS, Dhaka, Bangladesh; [Khan, Md Abdullah Saeed] Pi Res Consultancy Ctr, Dhaka, Bangladesh; [Nazir, Anum; Itrat, Nizwa] Univ Faisalabad, Dept Nutr & Dietet, Faisalabad, Punjab, Pakistan; [Hossain, Mohammad Ali] Ibn Sina Med Coll Hosp, Dhaka, Bangladesh; [Rashid, Md Utba] Int Ctr Diarrhoea Dis Res, Nutr & Clin Serv Div NCSD, Bangladesh Icddr B, Dhaka, Bangladesh	North South University (NSU); International Centre for Diarrhoeal Disease Research (ICDDR)	Hossian, M (corresponding author), North South Univ, Dept Publ Hlth, Dhaka, Bangladesh.; Hossian, M (corresponding author), Publ Hlth Profess Dev Soc PPDS, Dhaka, Bangladesh.	mosharop.hossian@northsouth.edu	Khan, Abdullah Saeed/ABD-3574-2020; Hossian, Mosharop/AAU-8960-2021	Khan, Abdullah Saeed/0000-0002-0707-0437; Hossian, Mosharop/0000-0001-9584-7076; Rashid, Md. Utba Bin/0000-0002-2530-9982; Hasan, Mehedi/0000-0001-6842-4449				Abedin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250495; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], HLTH BEHAV HLTH ED P; Biasio LR, 2021, HUM VACC IMMUNOTHER, V17, P1304, DOI 10.1080/21645515.2020.1829315; Borriello A, 2021, VACCINE, V39, P473, DOI 10.1016/j.vaccine.2020.12.032; BR Web Desk, 2021, SCH U REM OP SHAFQ M; Chakraborty I, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138882; Chen MS, 2021, HUM VACC IMMUNOTHER, V17, P2279, DOI 10.1080/21645515.2020.1853449; Cheney MK, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013484732; Conner M, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P19, DOI 10.1007/978-0-387-09488-5_2; Cordina M, 2021, PHARM PRACT-GRANADA, V19, DOI [10.18549/PharmPract.2021.1.2317, 10.18549/pharmpract.2021.1.2317]; De Coninck D, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.646394; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Dutta AK, 2020, INDIAN J PEDIATR, V87, P810, DOI 10.1007/s12098-020-03475-w; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Glanz K, 2008, HLTH BEHAV HLTH ED T, DOI 10.1007/s12160-008-9042-y; Guidry JPD, 2021, AM J INFECT CONTROL, V49, P137, DOI 10.1016/j.ajic.2020.11.018; Harapan H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00381; Head KJ, 2020, SCI COMMUN, V42, P698, DOI 10.1177/1075547020960463; Hogan V, 2019, OCCUP MED-OXFORD, V69, P494, DOI 10.1093/occmed/kqz124; Hu Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121551; ILO FAO IFAD WHO., 2020, IMP COVID 19 PEOPL L; JONES PK, 1987, J ASTHMA, V24, P199, DOI 10.3109/02770908709070940; Kabir R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050416; Kanyike AM, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00331-1; Khattak FA, 2021, INT J INFECT DIS, V104, P117, DOI 10.1016/j.ijid.2020.12.029; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lee K, 2009, GLOB INST, P1; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Lin YL, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008961; McCloskey B, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000254; Mercadante AR, 2021, RES SOC ADMIN PHARM, V17, P1596, DOI 10.1016/j.sapharm.2020.12.012; Ministry of National Health Services Regulations and Coordination, 2021, COVID 19 HLTH ADV PL; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Sarasty O, 2020, VACCINE, V38, P8090, DOI 10.1016/j.vaccine.2020.11.013; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472; Shahrabani S, 2009, EUR J HEALTH ECON, V10, P227, DOI 10.1007/s10198-008-0124-3; Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Soares P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030300; Szilagyi PG, 2021, JAMA-J AM MED ASSOC, V325, P396, DOI 10.1001/jama.2020.26419; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482; Ward JK, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113414; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; Yoda T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010048	54	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0262305	10.1371/journal.pone.0262305	http://dx.doi.org/10.1371/journal.pone.0262305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148317	gold, Green Published			2022-12-26	WOS:000800108800009
J	Singh, K; Lima, G; Cha, M; Cha, C; Kulshrestha, J; Ahn, YY; Varol, O				Singh, Karandeep; Lima, Gabriel; Cha, Meeyoung; Cha, Chiyoung; Kulshrestha, Juhi; Ahn, Yong-Yeol; Varol, Onur			Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic	PLOS ONE			English	Article							HEALTH	The COVID-19 pandemic has been damaging to the lives of people all around the world. Accompanied by the pandemic is an infodemic, an abundant and uncontrolled spread of potentially harmful misinformation. The infodemic may severely change the pandemic's course by interfering with public health interventions such as wearing masks, social distancing, and vaccination. In particular, the impact of the infodemic on vaccination is critical because it holds the key to reverting to pre-pandemic normalcy. This paper presents findings from a global survey on the extent of worldwide exposure to the COVID-19 infodemic, assesses different populations' susceptibility to false claims, and analyzes its association with vaccine acceptance. Based on responses gathered from over 18,400 individuals from 40 countries, we find a strong association between perceived believability of COVID-19 misinformation and vaccination hesitancy. Our study shows that only half of the online users exposed to rumors might have seen corresponding fact-checked information. Moreover, depending on the country, between 6% and 37% of individuals considered these rumors believable. A key finding of this research is that poorer regions were more susceptible to encountering and believing COVID-19 misinformation; countries with lower gross domestic product (GDP) per capita showed a substantially higher prevalence of misinformation. We discuss implications of our findings to public campaigns that proactively spread accurate information to countries that are more susceptible to the infodemic. We also defend that fact-checking platforms should prioritize claims that not only have wide exposure but are also perceived to be believable. Our findings give insights into how to successfully handle risk communication during the initial phase of a future pandemic.	[Singh, Karandeep; Lima, Gabriel; Cha, Meeyoung] Inst for Basic Sci Korea, Daejeon, South Korea; [Lima, Gabriel; Cha, Meeyoung] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Cha, Chiyoung] Ewha Womans Univ, Coll Nursing, Grad Program Syst Hlth Sci & Engn, Seoul, South Korea; [Kulshrestha, Juhi] Univ Konstanz, Dept Polit & Publ Adm, Constance, Germany; [Ahn, Yong-Yeol] Indiana Univ, Ctr Complex Networks & Syst Res, Luddy Sch Informat Comp & Engn, Bloomington, IN USA; [Ahn, Yong-Yeol] Indiana Univ, Indiana Univ Network Sci Inst, Bloomington, IN USA; [Ahn, Yong-Yeol] MIT, Connect Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Varol, Onur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University; University of Konstanz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Massachusetts Institute of Technology (MIT); Sabanci University	Cha, M (corresponding author), Inst for Basic Sci Korea, Daejeon, South Korea.; Cha, M (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea.; Cha, C (corresponding author), Ewha Womans Univ, Coll Nursing, Grad Program Syst Hlth Sci & Engn, Seoul, South Korea.	mcha@ibs.re.kr; chiyoung@ewha.ac.kr	Varol, Onur/L-7749-2014; Varol, Onur/T-6764-2019	Varol, Onur/0000-0002-3994-6106; Varol, Onur/0000-0002-3994-6106; Cha, Meeyoung/0000-0003-4085-9648	Institute for Basic Science in South Korea [IBS-R029-C2]; Basic Science Research Program through the National Research Foundation of Korea [NRF-2017R1E1A1A01076400]; Ministry of Science and ICT through the National Research Foundation of Korea [NRF-2021R1A2C2008166]; Defense Advanced Research Projects Agency (DARPA) [W911NF-17-C-0094, HR001121C0168]	Institute for Basic Science in South Korea; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and ICT through the National Research Foundation of Korea(National Research Foundation of Korea); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	K.S., G.L., and M.C. are supported by the Institute for Basic Science in South Korea [IBS-R029-C2]. M.C is also supported by the Basic Science Research Program through the National Research Foundation of Korea [NRF-2017R1E1A1A01076400]. C.C. is supported by the Ministry of Science and ICT through the National Research Foundation of Korea [NRF-2021R1A2C2008166]. Y.Y.A. was funded in part by the Defense Advanced Research Projects Agency (DARPA) under contracts [W911NF-17-C-0094; HR001121C0168].	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P242; [Anonymous], 2020, TANGLE; [Anonymous], 2020, NEW YORK TIMES; [Anonymous], 2020, KOREA HERALD; [Anonymous], 2020, QUITE FRANKLY TERRIF; [Anonymous], 2020, VERGE; [Anonymous], 2020, VOX; [Anonymous], 2020, THE CNN; Battaglia M.P., 2009, SURV PRACT, V2, P2953, DOI [10.29115/SP-2009-0019, DOI 10.29115/SP-2009-0019]; Benecke Olivia, 2019, Glob Pediatr Health, V6, p2333794X19862949, DOI 10.1177/2333794X19862949; Carr-Hill R, 2013, J ADV NURS, V69, P2525, DOI 10.1111/jan.12138; Cha M, P 18 INT C WORLD WID, P721, DOI DOI 10.1145/1526709.1526806; Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5; Corscadden L, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0740-1; Draulans D., 2020, SCI MAG 0508; Facebook, 2020, FAC REP 1 QUARTER 20; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Grosskurth H., 2019, REVOLUTIONIZING TROP, P37; Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926; Hudspeth J, 2017, J GEN INTERN MED, V32, P572, DOI 10.1007/s11606-016-3909-6; IRELAND CT, 1968, BIOMETRIKA, V55, P179; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Kachanoff FJ, 2021, SOC PSYCHOL PERS SCI, V12, P603, DOI 10.1177/1948550620931634; Kalimeri K, 2019, ARXIV PREPRINT ARXIV; Kalton G., 2003, J OFF STAT, V19, P81; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kwon S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168344; Kwon S, 2013, IEEE DATA MINING, P1103, DOI 10.1109/ICDM.2013.61; Larsen M., 2020, J BEHAV PUBL ADM, V3, P1, DOI [10.30636/jbpa.32.164, DOI 10.30636/JBPA.32.164]; Londono E., 2020, NEW YORK TIMES; Lorini C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040798; Ma J., 2018, RUMOR DETECTION TWIT; Ma J, 2016, P INT JOINT C ART IN; Mackenbach JP, 2013, INT J EPIDEMIOL, V42, P1100, DOI 10.1093/ije/dyt122; Meyer SB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-238; Palan S, 2018, J BEHAV EXP FINANC, V17, P22, DOI 10.1016/j.jbef.2017.12.004; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pham KH, 2019, ARXIV PREPRINT ARXIV; PlasticsEurope, 2020, PLAST THE FACTS 2020; Poushter J., 2018, PEW RES CTR, V22, P2; Poynter, 2020, COVID 19 POYNT RES; Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846; Rahman M, 2013, RELATIONSHIP GDP CAP; Ribeiro FN, 2020, 12 ACM C WEB SCI WEB, P325, DOI [DOI 10.1145/3394231.3397923, 10.1145/3394231.3397923]; Ross Joel, 2010, P ACM C HUM FACT COM, P2863; Schneider D, 2022, SOCIOL METHOD RES, V51, P108, DOI 10.1177/0049124119882477; Shahi Gautam Kishore, 2021, Online Soc Netw Media, V22, P100104, DOI 10.1016/j.osnem.2020.100104; Shao CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06930-7; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; World Health Organization, 2020, COR DIS COVID 19 ADV; World Health Organization, 2020, 1 WHO; Xaudiera S., 2020, HARVARD KENNEDY SCH, V1; Zar HJ, 2020, PAEDIATR RESPIR REV, V35, P70, DOI 10.1016/j.prrv.2020.06.016; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	57	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263381	10.1371/journal.pone.0263381	http://dx.doi.org/10.1371/journal.pone.0263381			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139117	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000821499100029
J	Mohamed-Raseek, N; Miller, AF				Mohamed-Raseek, Nishya; Miller, Anne-Frances			Contrasting roles for two conserved arginines: Stabilizing flavin semiquinone or quaternary structure, in bifurcating electron transfer flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; HYDROGEN-BONDING INTERACTIONS; MEGASPHAERA-ELSDENII; REDOX PROPERTIES; DEHYDROGENASE; FAD; BINDING; PURIFICATION; MECHANISM; COFACTOR	d Bifurcating electron transfer flavoproteins (Bf ETFs) are important redox enzymes that contain two flavin adenine dinucleotide (FAD) cofactors, with contrasting reactivities and complementary roles in electron bifurcation. However, for both the "electron transfer" (ET) and the "bifurcating" (Bf) FADs, the only charged amino acid within 5 angstrom of the flavin is a conserved arginine (Arg) residue. To understand how the two sites produce different reactivities utilizing the same residue, we investigated the consequences of replacing each of the Arg residues with lysine, glutamine, histidine, or alanine. We show that absence of a positive charge in the ET site diminishes accumulation of the anionic semiquinone (ASQ) that enables the ET flavin to act as a single electron carrier, due to depression of the oxidized versus. ASQ reduction midpoint potential, E degrees(OX/ASQ). Perturbation of the ET site also affected the remote Bf site, whereas abrogation of Bf FAD binding accelerated chemical modification of the ET flavin. In the Bf site, removal of the positive charge impaired binding of FAD or AMP, resulting in unstable protein. Based on pH dependence, we propose that the Bf site Arg interacts with the phosphate(s) of Bf FAD or AMP, bridging the domain interface via a conserved peptide loop ("zipper") and favoring nucleotide binding. We further propose a model that rationalizes conservation of the Bf site Arg even in non-Bf ETFs, as well as AMP's stabilizing role in the latter, and provides a mechanism for coupling Bf flavin redox changes to domain-scale motion.	[Mohamed-Raseek, Nishya; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afmill3r2@gmail.com		Mohamed Raseek, Nishya/0000-0002-5086-1410	National Science Foundation [CLP-1808433, CLP-2108134]	National Science Foundation(National Science Foundation (NSF))	The authors are grateful to the National Science Foundation for support under awards numbers CLP-1808433 and CLP-2108134. The authors thank H. D. Duan for providing R165K-and R165H-RpaETF constructs, T. Creamer for access to the CD spectrapolarimeter, A. Sebesta and B. Gess for maintenance of vital research infrastructure, S. Wang and A. Iyer for access to mass spectrometry, K. Ranguelova for guidance with EPR, and M. Ilham.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Augustin P, 2018, J BIOL CHEM, V293, P2829, DOI 10.1074/jbc.RA117.000846; Bradley LH, 2001, BIOCHEMISTRY-US, V40, P8686, DOI 10.1021/bi010571j; Burgess S. G, 2008, PROBING DYNAMIC INTE; Cerda JF, 2008, ORG BIOMOL CHEM, V6, P2204, DOI 10.1039/b801952e; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Clark W. M., 1960, OXIDATION REDUCTION; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Demmer JK, 2018, FEBS LETT, V592, P332, DOI 10.1002/1873-3468.12971; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Duan HD, 2020, J BIOL CHEM, V295, P12618, DOI 10.1074/jbc.RA120.013174; Duan HD, 2018, J BIOL CHEM, V293, P4688, DOI 10.1074/jbc.RA117.000707; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; Feng X, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016978118; Ghisla S., 1976, FLAVINS FLAVOPROTEIN, P334; Griffin KJ, 1997, BIOCHEMISTRY-US, V36, P4194, DOI 10.1021/bi962572v; He TF, 2013, BIOCHEMISTRY-US, V52, P9120, DOI 10.1021/bi401137u; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; HUSAIN M, 1984, BIOCHEM J, V219, P1043, DOI 10.1042/bj2191043; Jang MH, 2000, J BIOL CHEM, V275, P12546, DOI 10.1074/jbc.275.17.12546; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; Kar RK, 2021, J PHYS CHEM B, V125, P12654, DOI 10.1021/acs.jpcb.1c07306; Kayastha K, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108796; Ku HK, 2013, ANAL BIOCHEM, V434, P178, DOI 10.1016/j.ab.2012.10.045; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; LEHMAN TC, 1992, ARCH BIOCHEM BIOPHYS, V292, P594, DOI 10.1016/0003-9861(92)90036-V; Lei CH, 1996, ANAL CHIM ACTA, V332, P73, DOI 10.1016/0003-2670(96)82792-9; Lostao A, 1997, BIOCHEMISTRY-US, V36, P14334, DOI 10.1021/bi971384h; MACHEROUX P, 1991, BIOCHEMISTRY-US, V30, P4612, DOI 10.1021/bi00232a036; MASSEY V, 1962, J BIOL CHEM, V237, P2347; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; MAYHEW SG, 1974, EUR J BIOCHEM, V44, P579, DOI 10.1111/j.1432-1033.1974.tb03515.x; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Miller AF, 2019, METHOD ENZYMOL, V620, P365, DOI 10.1016/bs.mie.2019.03.017; Mohamed-Raseek N, 2019, CHEM SCI, V10, P7762, DOI 10.1039/c9sc00942f; Nitschke W, 2012, BIOESSAYS, V34, P106, DOI 10.1002/bies.201100134; O'Neill H, 1998, J BIOL CHEM, V273, P21015, DOI 10.1074/jbc.273.33.21015; Oja SM, 2014, ANAL CHEM, V86, P6040, DOI 10.1021/ac501194j; Peters JW, 2016, CURR OPIN CHEM BIOL, V31, P146, DOI 10.1016/j.cbpa.2016.03.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robbins JM, 2018, BIOCHEMISTRY-US, V57, P5818, DOI 10.1021/acs.biochem.8b00571; Robbins JM, 2017, BIOCHEMISTRY-US, V56, P3800, DOI 10.1021/acs.biochem.7b00335; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 1997, J BIOCHEM, V121, P477; SATO K, 1993, J BIOCHEM, V114, P215, DOI 10.1093/oxfordjournals.jbchem.a124157; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; SCHUMAN M, 1971, BIOCHIM BIOPHYS ACTA, V227, P500, DOI 10.1016/0005-2744(71)90003-9; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Stanley RJ, 2001, ANTIOXID REDOX SIGN, V3, P847, DOI 10.1089/15230860152665028; Sucharitakul J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016017; Sucharitakul J, 2021, FEBS J, V288, P1008, DOI 10.1111/febs.15343; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; Thorpe C, 1991, CHEM BIOCH FLAVOENZY, P471; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; TWIGG RS, 1945, NATURE, V155, P401, DOI 10.1038/155401a0; Vdovin A, 2013, CHEM PHYS, V422, P195, DOI 10.1016/j.chemphys.2012.11.001; Vigil W, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108793; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312; YAGI K, 1980, BIOCHEMISTRY-US, V19, P1553, DOI 10.1021/bi00549a003; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yousafzai FK, 2002, J BIOL CHEM, V277, P34067, DOI 10.1074/jbc.M204305200	72	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101733	10.1016/j.jbc.2022.101733	http://dx.doi.org/10.1016/j.jbc.2022.101733			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35176283	gold, Green Published			2022-12-26	WOS:000823106100002
J	Byts, N; Sharma, S; Malm, T; Kaakinen, M; Korhonen, P; Jaakkonen, L; Keuters, M; Huuskonen, M; Pietilae, I; Koistinaho, J; Koivunen, P; Myllyharju, J				Byts, Nadiya; Sharma, Subodh; Malm, Tarja; Kaakinen, Mika; Korhonen, Paula; Jaakkonen, Laura; Keuters, Meike; Huuskonen, Mikko; Pietilae, Ilkka; Koistinaho, Jari; Koivunen, Peppi; Myllyharju, Johanna			Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERY OCCLUSION; AGED MICE; HYPOXIA; STROKE; MECHANISMS; TRANSIENT	Hypoxia-inducible factor prolyl 4-hydroxylases (HIF-P4Hs) regulate the hypoxic induction of > 300 genes required for survival and adaptation under oxygen deprivation. Inhibition of HIF-P4H-2 has been shown to be protective in focal cerebral ischemia rodent models, while that of HIF-P4H-1 has no effects and inactivation of HIF-P4H-3 has adverse effects. A trans membrane prolyl 4-hydroxylase (P4H-TM) is highly expressed in the brain and contributes to the regulation of HIF, but the outcome of its inhibition on stroke is yet unknown. To study this, we subjected WT and P4htm(-/- )mice to permanent middle cerebral artery occlusion (pMCAO). Lack of P4H-TM had no effect on lesion size following pMCAO, but increased inflam-matory microgliosis and neutrophil infiltration was observed in the P4htm-/- cortex. Furthermore, both the permeability of blood brain barrier and ultrastructure of cerebral tight junctions were compromised in P4htm(-/-) mice. At the molecular level, P4H-TM deficiency led to increased expression of proinflammatory genes and robust activation of protein kinases in the cortex, while expression of tight junction proteins and the neuroprotective growth factors erythropoietin and vascular endothelial growth factor was reduced. Our data provide the first evidence that P4H-TM inactivation has no protective effect on infarct size and increases inflammatory microgliosis and neutrophil infiltration in the cortex at early stage after pMCAO. When considering HIF-P4H inhibitors as potential therapeutics in stroke, the current data support that isoenzyme-selective inhibitors that do not target P4H-TM or HIF-P4H-3 would be preferred.	[Byts, Nadiya; Sharma, Subodh; Kaakinen, Mika; Jaakkonen, Laura; Pietilae, Ilkka; Koivunen, Peppi; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland; [Malm, Tarja; Korhonen, Paula; Keuters, Meike; Huuskonen, Mikko; Koistinaho, Jari] Univ Eastern Finland, A I Virtanen Inst Mol Sci, Kuopio, Finland; [Keuters, Meike; Koistinaho, Jari] Univ Helsinki, Helsinki Inst Life Sci, Neurosci Ctr, Helsinki, Finland	University of Oulu; University of Eastern Finland; University of Helsinki	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Oulu, Finland.	johanna.myllyharju@oulu.fi		Koistinaho, Jari/0000-0001-6559-1153; Keuters, Meike Hedwig/0000-0003-4216-1024; Sharma, Subodh/0000-0001-7033-0927; Korhonen, Paula/0000-0001-5856-1474	Academy of Finland [133075, 218129, 278343, 296498]; Academy of Finland Center of Excellence 2012 to 2017 Grant [251314]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; European Union [607962]	Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence 2012 to 2017 Grant(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; FibroGen, Inc; European Union(European Commission)	This study was supported by the Academy of Finland through Grants 133075 (T. M.), 218129 (P. K.), 278343 (J. K.), 296498 (J. M.) and Academy of Finland Center of Excellence 2012 to 2017 Grant 251314 (J. M.), the S. Juselius Foundation (P. K. and J. M.), the Jane and Aatos Erkko Foundation (P. K. and J. M.), FibroGen, Inc (J. M.), and the European Union Seventh Framework Program FP7 Grant 607962 (nEUROinflammation) (J. K.).	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Bauer HC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00392; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Byts N, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0253-20.2020; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Chan MC, 2016, MOL ASPECTS MED, V47-48, P54, DOI 10.1016/j.mam.2016.01.001; Chen RL, 2012, J PHYSIOL-LONDON, V590, P4079, DOI 10.1113/jphysiol.2012.232884; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; Dhungana H, 2013, AGING CELL, V12, P842, DOI 10.1111/acel.12106; Dhungana H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-102; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Endres M., 2008, Cerebrovasc. Dis., V25; Gehringer M, 2015, EXPERT OPIN THER PAT, V25, P849, DOI 10.1517/13543776.2015.1039984; Greenberg DA, 2015, STROKE, V46, pE101, DOI 10.1161/STROKEAHA.114.007641; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Haronen H, 2017, HUM MOL GENET, V26, P2076, DOI 10.1093/hmg/ddx101; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Huuskonen MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33176; Hyvarinen J, 2010, J BIOL CHEM, V285, P42023, DOI 10.1074/jbc.M110.145904; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jurga AM, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00198; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kang YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0403-6; Kietzmann T, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00011; Kiriakidis S, 2017, KIDNEY INT, V92, P900, DOI 10.1016/j.kint.2017.03.008; Klotzsche-von Ameln A., 2013, Mol. Cancer Res., V11; Koepsell H., 2020, Pflugers Arch., V472; Koistinaho M., 2002, Proc. Natl. Acad.; Koivunen P., 2007, J. Biol. Chem., V282; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Kunze R, 2012, STROKE, V43, P2748, DOI 10.1161/STROKEAHA.112.669598; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Lange C, 2016, NAT REV NEUROL, V12, P439, DOI 10.1038/nrneurol.2016.88; Leinonen H., 2016, Lack of P4H-TM in mice results; Leinonen H, 2019, NEUROPHARMACOLOGY, V153, P63, DOI 10.1016/j.neuropharm.2019.04.023; Li L., 2016, Neurobiol. Dis., V91; Maurer MH, 2008, CURR MED CHEM, V15, P1407, DOI 10.2174/092986708784567671; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Mocco J., 2006, Circ. Res.; Mukandala G, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6010006; Myllyharju J, 2013, ACTA PHYSIOL, V208, P148, DOI 10.1111/apha.12096; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Payabvash S., 2011, Stroke, V42; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sanghani NS, 2019, ADV CHRONIC KIDNEY D, V26, P253, DOI 10.1053/j.ackd.2019.04.004; Santillan A, 2014, J NEUROSCI METH, V222, P106, DOI 10.1016/j.jneumeth.2013.11.008; Schdel J., 2013, Biol. Chem., V394; Selvaraju V, 2014, ANTIOXID REDOX SIGN, V20, P2631, DOI 10.1089/ars.2013.5186; Shah D, 2015, J BIOL CHEM, V290, P29642, DOI 10.1074/jbc.M115.690784; Shah FA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01178; Short KM, 2010, KIDNEY INT, V77, P1132, DOI 10.1038/ki.2010.42; Shuaib A., 2002, Stroke, V33; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Son M, 2015, IMMUNOL RES, V63, P101, DOI 10.1007/s12026-015-8705-6; Speer R, 2016, ADV EXP MED BIOL, V903, P221, DOI 10.1007/978-1-4899-7678-9_16; Taylor CT, 2016, J CLIN INVEST, V126, P3716, DOI 10.1172/JCI84433; Wei KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058995; Wendelboe AM, 2016, CIRC RES, V118, P1340, DOI 10.1161/CIRCRESAHA.115.306841; Zhou J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184049	74	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101721	10.1016/j.jbc.2022.101721	http://dx.doi.org/10.1016/j.jbc.2022.101721			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151685	Green Published, gold			2022-12-26	WOS:000789394500008
J	Johnson, OT; Nadel, CM; Carroll, EC; Arhar, T; Gestwicki, JE				Johnson, Oleta T.; Nadel, Cory M.; Carroll, Emma C.; Arhar, Taylor; Gestwicki, Jason E.			Two distinct classes of cochaperones compete for the EEVD motif in heat shock protein 70 to tune its chaperone activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							J-PROTEINS; J-DOMAIN; HSP70; MECHANISM; DISAGGREGATION; IDENTIFICATION; HYDROLYSIS; COMPLEXES; BINDING; BAG-1	Chaperones of the heat shock protein 70 (Hsp70) family engage in protein-protein interactions with many cochaper-ones. One "hotspot " for cochaperone binding is the EEVD motif, found at the extreme C terminus of cytoplasmic Hsp70s. This motif is known to bind tetratricopeptide repeat domain cochaperones, such as the E3 ubiquitin ligase CHIP. In addi-tion, the EEVD motif also interacts with a structurally distinct domain that is present in class B J-domain proteins, such as DnaJB4. These observations suggest that CHIP and DnaJB4 might compete for binding to Hsp70's EEVD motif; however, the molecular determinants of such competition are not clear. Using a collection of EEVD-derived peptides, including muta-tions and truncations, we explored which residues are critical for binding to both CHIP and DnaJB4. These results revealed that some features, such as the C-terminal carboxylate, are important for both interactions. However, CHIP and DnaJB4 also had unique preferences, especially at the isoleucine posi-tion immediately adjacent to the EEVD. Finally, we show that competition between these cochaperones is important in vitro, as DnaJB4 limits the ubiquitination activity of the Hsp70- CHIP complex, whereas CHIP suppresses the client refolding activity of the Hsp70-DnaJB4 complex. Together, these data suggest that the EEVD motif has evolved to support diverse protein-protein interactions, such that competition between cochaperones may help guide whether Hsp70-bound proteins are folded or degraded.	[Johnson, Oleta T.; Nadel, Cory M.; Carroll, Emma C.; Arhar, Taylor; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA USA; [Arhar, Taylor] Beloit Coll, Dept Chem, Beloit, WI USA; [Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of California System; University of California San Francisco; Beloit College; University of California System; University of California San Francisco	Arhar, T; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA USA.; Arhar, T (corresponding author), Beloit Coll, Dept Chem, Beloit, WI USA.; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA.	arhart@beloit.edu; jason.gestwicki@ucsf.edu		Carroll, Emma/0000-0002-6766-4245; Nadel, Cory/0000-0001-6827-3302	NIH [K12GM081266, NS059690, AG068125]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge support from the NIH (O. T. J. K12GM081266; J. E. G. NS059690 and AG068125). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arhar T, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101282; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Assimon V. A., 2015, Biochemistry, V54; Backe SJ, 2020, J BIOL CHEM, V295, P11099, DOI 10.1074/jbc.REV120.011833; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bernadotte A, 2018, FEBS OPEN BIO, V8, P1830, DOI 10.1002/2211-5463.12521; Bhattacharya K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19783-w; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brinker A., 2002, J. Biol. Chem., V277; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chand K., 2021, Cell Stress Chaperones, V26; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Connarn JN, 2014, J BIOL CHEM, V289, P2908, DOI 10.1074/jbc.M113.519421; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Costanzo M., 2010, Thegenetic; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Faust O, 2020, NATURE, V587, P489, DOI 10.1038/s41586-020-2906-4; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freilich R, 2018, ACCOUNTS CHEM RES, V51, P940, DOI 10.1021/acs.accounts.8b00036; Gestwicki JE, 2019, J BIOL CHEM, V294, P2151, DOI 10.1074/jbc.TM118.002813; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hennessy F, 2000, CELL STRESS CHAPERON, V5, P347, DOI 10.1379/1466-1268(2000)005<0347:AOTLOC>2.0.CO;2; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang Y., 2019, Science, V365; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Kundrat L., 2010, Biochemistry, V49; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li J., 2006, Biochem.J., V398; Li J., 2005, Biochem. J., V386; Li J., 2003, Structure, V11; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lizama BN, 2018, J NEUROSCI, V38, P6825, DOI 10.1523/JNEUROSCI.0699-18.2018; Lott A, 2020, PROTEIN SCI, V29, P2422, DOI 10.1002/pro.3969; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Miao WL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11552-8; Mok S. A., 2018, Mappinginteractions with the chaperone; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Otero JH, 2014, J BIOL CHEM, V289, P27504, DOI 10.1074/jbc.M114.587147; Petrucelli L., 2004, CHIP and Hsp70 regulatetau ubiquitination, degradation and aggregation; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Qian XG, 2002, BIOCHEM J, V361, P27, DOI 10.1042/0264-6021:3610027; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Ravalin M, 2019, NAT CHEM BIOL, V15, P786, DOI 10.1038/s41589-019-0322-6; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Rosser M. F., 2007, J. Biol.Chem., V282; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shimamoto S, 2013, J BIOL CHEM, V288, P7158, DOI 10.1074/jbc.M112.436758; Slepenkov SV, 1998, BIOCHEMISTRY-US, V37, P1015, DOI 10.1021/bi9720484; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Suzuki H, 2010, BIOCHEMISTRY-US, V49, P8577, DOI 10.1021/bi100876n; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tunyasuvunakool K, 2021, NATURE, V596, P590, DOI 10.1038/s41586-021-03828-1; WALL D, 1994, J BIOL CHEM, V269, P5446; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Weber B, 2020, J PEPT SCI, V26, DOI 10.1002/psc.3235; Wentink AS, 2020, NATURE, V587, P483, DOI 10.1038/s41586-020-2904-6; Xu Z., 2006, Biochemistry, V45; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Yu HY, 2015, FEBS LETT, V589, P2825, DOI 10.1016/j.febslet.2015.07.040; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang H., 2015, Structure, V23; Zhang M., 2005, Mol. Cell, V20; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	83	2	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101697	10.1016/j.jbc.2022.101697	http://dx.doi.org/10.1016/j.jbc.2022.101697			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148989	gold, Green Published			2022-12-26	WOS:000789400700012
J	Kimura, T; Hayama, Y; Okuzaki, D; Nada, S; Okada, M				Kimura, Tetsuya; Hayama, Yoshitomo; Okuzaki, Daisuke; Nada, Shigeyuki; Okada, Masato			The Ragulator complex serves as a substrate-specific mTORC1 scaffold in regulating the nuclear translocation of transcription factor EB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAG GTPASES; AMINO; TFEB	The mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is activated by intracellular nutritional sufficiency and extracellular growth signals. It has been reported that mTORC1 acts as a hub that integrates these inputs to orchestrate a number of cellular responses, including translation, nucleotide synthesis, lipid synthesis, and lysosome biogenesis. However, little is known about specific control of mTORC1 signaling downstream of this complex. Here, we demonstrate that Ragulator, a heteropentameric protein complex required for mTORC1 activation in response to amino acids, is critical for inhibiting the nuclear translocation of transcription factor EB (TFEB). We established a unique RAW264.7 clone that lacked Ragulator but retained total mTORC1 activity. In a nutrition-sufficient state, the nuclear translocation of TFEB was markedly enhanced in the clone despite total mTORC1 kinase activity. In addition, as a cellular phenotype, the number of lysosomes was increased by tenfold in the Ragulator-deficient clone compared with that of control cells. These findings indicate that mTORC1 essentially requires the Ragulator complex for regulating the subcellular distribution of TFEB. Our findings also suggest that other scaffold proteins may be associated with mTORC1 for the specific regulation of downstream signaling.	[Kimura, Tetsuya; Nada, Shigeyuki; Okada, Masato] WPI Immunol Frontier Res Ctr, Dept Oncogene Res, Suita, Osaka, Japan; [Hayama, Yoshitomo] Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka, Japan; [Okuzaki, Daisuke] WPI Immunol Frontier Res Ctr, Single Cell Genom, Human Immunol, Suita, Osaka, Japan; [Okuzaki, Daisuke] Res Inst Microbial Dis, Genome Informat Res Ctr, Suita, Osaka, Japan; [Okuzaki, Daisuke] Inst Open & Transdisciplinary Res Initiat, Suita, Osaka, Japan; [Nada, Shigeyuki; Okada, Masato] Osaka Univ, Res Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka, Japan	Osaka University	Kimura, T (corresponding author), WPI Immunol Frontier Res Ctr, Dept Oncogene Res, Suita, Osaka, Japan.	tetsuyakimura@biken.osaka-u.ac.jp		Nada, Shigeyuki/0000-0002-1103-6119	JSPS KAKENHI [18K16200]; Takeda Science Foundation; Mitsubishi Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	The authors acknowledge Ms Hiroko Ohmori of the Central Laboratory of WPI Immunology Frontier Research Center, Osaka University, for assisting in the studies on electron microscopy. This study was supported by the JSPS KAKENHI Grant-in-aid for Young Scientists (grant number: 18K16200) , Visionary Research Grant from Takeda Science Foundation, Research Grant in the Natural Sciences (young scientist grant) from the Mitsubishi Foundation, and a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Di Malta C, 2017, SCIENCE, V356, P1188, DOI 10.1126/science.aag2553; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Hayama Y, 2018, J IMMUNOL, V200, P3790, DOI 10.4049/jimmunol.1701283; Jung S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00966; Kimura T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13130; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Lotfi P, 2018, AUTOPHAGY, V14, P1419, DOI 10.1080/15548627.2018.1474313; Marques ARA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221739; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Rusmini P, 2019, AUTOPHAGY, V15, P631, DOI 10.1080/15548627.2018.1535292; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176	20	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101744	10.1016/j.jbc.2022.101744	http://dx.doi.org/10.1016/j.jbc.2022.101744			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35183507	Green Published, gold			2022-12-26	WOS:000789398100007
J	Nonnecke, EB; Castillo, PA; Johansson, MEV; Hollox, EJ; Shen, B; Lonnerdal, B; Bevins, CL				Nonnecke, Eric B.; Castillo, Patricia A.; Johansson, Malin E., V; Hollox, Edward J.; Shen, Bo; Lonnerdal, Bo; Bevins, Charles L.			Human intelectin-2 (ITLN2) is selectively expressed by secretory Paneth cells	FASEB JOURNAL			English	Article						alpha-defensin; Crohn's disease; innate immunity; intelectin; lectin; metaplasia; omentin; Paneth cell; small intestine; ulcerative colitis	GENOME-WIDE ASSOCIATION; ANTIMICROBIAL PEPTIDES; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; MICROBIAL GLYCANS; HUMAN DEFENSIN-5; LECTIN; LACTOFERRIN; INTERNALIZATION; IDENTIFICATION	Intelectins (intestinal lectins) are highly conserved across chordate evolution and have been implicated in various human diseases, including Crohn's disease (CD). The human genome encodes two intelectin genes, intelectin-1 (ITLN1) and intelectin-2 (ITLN2). Other than its high sequence similarity with ITLN1, little is known about ITLN2. To address this void in knowledge, we report that ITLN2 exhibits discrete, yet notable differences from ITLN1 in primary structure, including a unique amino terminus, as well as changes in amino acid residues associated with the glycan-binding activity of ITLN1. We identified that ITLN2 is a highly abundant Paneth cell-specific product, which localizes to secretory granules, and is expressed as a multimeric protein in the small intestine. In surgical specimens of ileal CD, ITLN2 mRNA levels were reduced approximately five-fold compared to control specimens. The ileal expression of ITLN2 was unaffected by previously reported disease-associated variants in ITLN2 and CD-associated variants in neighboring ITLN1 as well as NOD2 and ATG16L1. ITLN2 mRNA expression was undetectable in control colon tissue; however, in both ulcerative colitis (UC) and colonic CD, metaplastic Paneth cells were found to express ITLN2. Together, the data reported establish the groundwork for understanding ITLN2 function(s) in the intestine, including its possible role in CD.	[Nonnecke, Eric B.; Castillo, Patricia A.; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Johansson, Malin E., V] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Hollox, Edward J.] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Shen, Bo] Cleveland Clin, Dept Gastroenterol Hepatol & Nutr, Digest Dis & Surg Inst, Cleveland, OH 44106 USA; [Lonnerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of Gothenburg; University of Leicester; Cleveland Clinic Foundation; University of California System; University of California Davis	Nonnecke, EB; Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	ebnonnecke@ucdavis.edu; clbevins@ucdavis.edu	Johansson, Malin E. V./HCH-7451-2022	Nonnecke, Eric/0000-0001-5345-2009	National Institutes of Health [U01AI125926, R37AI32738]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: U01AI125926 and R37AI32738	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Allot A, 2018, NUCLEIC ACIDS RES, V46, pW530, DOI 10.1093/nar/gky355; Almalki F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94679-3; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Artis D, 2006, INT J PARASITOL, V36, P723, DOI 10.1016/j.ijpara.2006.02.011; Au-Yeung CL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17383-2; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Castillo PA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49471-9; Chairatana P, 2016, CHEM SCI, V7, P1738, DOI [10.1039/C5SC04194E, 10.1039/c5sc04194e]; Chen L, 2020, SCAND J IMMUNOL, V92, DOI 10.1111/sji.12882; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cunliffe RN, 2001, GUT, V48, P176, DOI 10.1136/gut.48.2.176; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kerr SC, 2014, AM J RESP CRIT CARE, V189, P1005, DOI 10.1164/rccm.201312-2220LE; Khaloian S, 2020, GUT, V69, P1939, DOI 10.1136/gutjnl-2019-319514; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lee JK, 2001, GLYCOBIOLOGY, V11, P65, DOI 10.1093/glycob/11.1.65; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu TC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86907; Lopez V, 2008, BIOCHEM J, V411, P271, DOI 10.1042/BJ20070393; Lu ZH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-110; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Nonnecke EB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92198-9; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senapati S, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0211-8; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Sherry ST, 1999, GENOME RES, V9, P677; Stappenbeck TS, 2017, GASTROENTEROLOGY, V152, P322, DOI 10.1053/j.gastro.2016.10.003; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Suzuki YA, 2008, BIOCHEMISTRY-US, V47, P10915, DOI 10.1021/bi8012164; Tanaka M, 2001, J GASTROEN HEPATOL, V16, P1353, DOI 10.1046/j.1440-1746.2001.02629.x; Tsuji S, 2010, BRIT J CANCER, V103, P517, DOI 10.1038/sj.bjc.6605786; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2007, GLYCOBIOLOGY, V17, P1045, DOI 10.1093/glycob/cwm075; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang YL, 2020, J EXP MED, V217, DOI 10.1084/jem.20191130; Wangkanont K, 2016, J BIOL CHEM, V291, P5596, DOI 10.1074/jbc.M115.709212; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Wehkamp J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00646; Wesener DA, 2017, CURR OPIN STRUC BIOL, V44, P168, DOI 10.1016/j.sbi.2017.04.002; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966	67	2	2	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22200	10.1096/fj.202101870R	http://dx.doi.org/10.1096/fj.202101870R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35182405	hybrid, Green Published			2022-12-26	WOS:000761250800056
J	Hernandez-Yanez, H; Kim, SY; Che-Castaldo, JP				Hernandez-Yanez, Haydee; Kim, Su Yeon; Che-Castaldo, Judy P.			Demographic and life history traits explain patterns in species vulnerability to extinction	PLOS ONE			English	Article							PLANT; RISK; PREDICT; POPULATION; DIVERSITY; VIABILITY; DRIVERS; RARITY; BIRDS; SPAN	As ecosystems face disruption of community dynamics and habitat loss, the idea of determining ahead of time which species can become extinct is an important subject in conservation biology. A species' vulnerability to extinction is dependent upon both intrinsic (life-history strategies, genetics) and extrinsic factors (environment, anthropogenic threats). Studies linking intrinsic traits to extinction risk have shown variable results, and to our knowledge, there has not been a systematic analysis looking at how demographic patterns in stage-specific survival and reproductive rates correlate to extinction risk. We used matrix projection models from the COMPADRE and COMADRE matrix databases and IUCN Red List status as our proxy of extinction risk to investigate if some demographic patterns are more vulnerable to extinction than others. We obtained data on demographic rates, phylogeny, and IUCN status for 159 species of herbaceous plants, trees, mammals, and birds. We calculated 14 demographic metrics related to different aspects of life history and elasticity values and analyzed whether they differ based on IUCN categories using conditional random forest analysis and phylogenetic generalized least square regressions. We mapped all species within the database, both with IUCN assessment and without, and overlaid them with biodiversity hotspots to investigate if there is bias within the assessed species and how many of the non-assessed species could use the demographic information recorded in COMPADRE and COMADRE for future IUCN assessments. We found that herbaceous perennials are more vulnerable when they mature early and have high juvenile survival rates; birds are more vulnerable with high progressive growth and reproduction; mammals are more vulnerable when they have longer generation times. These patterns may be used to assess relative vulnerability across species when lacking abundance or trend data.	[Hernandez-Yanez, Haydee; Kim, Su Yeon; Che-Castaldo, Judy P.] Lincoln Pk Zoo, Conservat & Sci Dept, Alexander Ctr Appl Populat Biol, Chicago, IL 60614 USA; [Hernandez-Yanez, Haydee] Woodwell Climate Res Ctr, Falmouth, MA USA; [Kim, Su Yeon] Univ Calif Riverside, Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Che-Castaldo, Judy P.] US Fish & Wildlife Serv, Branch SSA Sci Support, Baileys Crossroads, VA 80524 USA	University of California System; University of California Riverside; United States Department of the Interior; US Fish & Wildlife Service	Che-Castaldo, JP (corresponding author), Lincoln Pk Zoo, Conservat & Sci Dept, Alexander Ctr Appl Populat Biol, Chicago, IL 60614 USA.; Che-Castaldo, JP (corresponding author), US Fish & Wildlife Serv, Branch SSA Sci Support, Baileys Crossroads, VA 80524 USA.	jchecastaldo@gmail.com			NSF Advances in Bioinformatics Development Award [DBI-1661342]	NSF Advances in Bioinformatics Development Award	JCC, HHY, and SYK were supported by an NSF Advances in Bioinformatics Development Award (#DBI-1661342), https://www.nsf.gov/dir/index.jsp?org=BIO.	[Anonymous], 2011, BIODIVERSITY HOTSPOT; Barks P., 2021, RAGE R PACKAGE MANIP; Bekker RM, 2005, FOLIA GEOBOT, V40, P231, DOI 10.1007/BF02803237; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bossuyt B, 2006, LANDSCAPE ECOL, V21, P1195, DOI 10.1007/s10980-006-0016-9; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Brondizio E, 2019, SUMMARY POLICYMAKERS; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Che-Castaldo J, 2020, ECOL MODEL, V416, DOI 10.1016/j.ecolmodel.2019.108913; Davidson AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186934; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Freville H, 2007, ECOLOGY, V88, P2662, DOI 10.1890/06-1453.1; Gaillard J.-M., 2016, ENCY EVOLUTIONARY BI, P312, DOI DOI 10.1016/B978-0-12-800049-6.00085-8; Garcia MB, 2008, AM J BOT, V95, P258, DOI 10.3732/ajb.95.2.258; Garcia MB, 2003, CONSERV BIOL, V17, P1672, DOI 10.1111/j.1523-1739.2003.00030.x; Higgins SI, 2001, TRENDS ECOL EVOL, V16, P177, DOI 10.1016/S0169-5347(01)02112-7; Isaac JL, 2009, DIVERS DISTRIB, V15, P280, DOI 10.1111/j.1472-4642.2008.00531.x; IUCN, 2022, IUCN RED LIST THREAT; Jeppsson T, 2012, AM NAT, V179, P706, DOI 10.1086/665696; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Jones MJ, 2006, BIODIVERS CONSERV, V15, P1993, DOI 10.1007/s10531-005-4316-1; Jonsson A, 2001, J THEOR BIOL, V209, P455, DOI 10.1006/jtbi.2001.2280; Kendall BE, 2019, ECOL MODEL, V406, P33, DOI 10.1016/j.ecolmodel.2019.03.011; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Paniw M, 2021, J ANIM ECOL, V90, P1398, DOI 10.1111/1365-2656.13467; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Pinheiro J, R PACKAGE VERSION; Pocock MJO, 2011, P ROY SOC B-BIOL SCI, V278, P1532, DOI 10.1098/rspb.2010.1971; Puttker T, 2015, OIKOS, V124, P206, DOI 10.1111/oik.01018; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Core Team, 2020, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Saar L, 2012, DIVERS DISTRIB, V18, P808, DOI 10.1111/j.1472-4642.2012.00885.x; Salguero-Gomez R, 2016, J ANIM ECOL, V85, P371, DOI 10.1111/1365-2656.12482; Salguero-Gomez R, 2016, P NATL ACAD SCI USA, V113, P230, DOI 10.1073/pnas.1506215112; Salguero-Gomez R, 2015, J ECOL, V103, P202, DOI 10.1111/1365-2745.12334; Salguero-Gomez R, 2010, J ECOL, V98, P312, DOI 10.1111/j.1365-2745.2009.01616.x; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sullivan MS, 2006, BIODIVERS CONSERV, V15, P1977, DOI 10.1007/s10531-005-4315-2; Symonds M. R. E., 2014, MODERN PHYLOGENETIC, P105, DOI DOI 10.1007/978-3-662-43550-2_5; Upham NS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000494	55	3	3	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263504	10.1371/journal.pone.0263504	http://dx.doi.org/10.1371/journal.pone.0263504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196342	gold, Green Published			2022-12-26	WOS:000835161600013
J	Wang, H; Sun, MH; Zhang, H; Dong, LY				Wang, Hao; Sun, Ming-hui; Zhang, Hao; Dong, Li-yan			LHPE-nets: A lightweight 2D and 3D human pose estimation model with well-structural deep networks and multi-view pose sample simplification method	PLOS ONE			English	Article								The cross-view 3D human pose estimation model has made significant progress, it better completed the task of human joint positioning and skeleton modeling in 3D through multiview fusion method. The multi-view 2D pose estimation part of this model is very important, but its training cost is also very high. It uses some deep learning networks to generate heat-maps for each view. Therefore, in this article, we tested some new deep learning networks for pose estimation tasks. These deep networks include Mobilenetv2, Mobilenetv3, Efficientnetv2 and Resnet. Then, based on the performance and drawbacks of these networks, we built multiple deep learning networks with better performance. We call our network in this article LHPE-nets, which mainly includes Low-Span network and RDNS network. LHPE-nets uses a network structure with evenly distributed channels, inverted residuals, external residual blocks and a framework for processing small-resolution samples to achieve training saturation faster. And we also designed a static pose sample simplification method for 3D pose data. It implemented low-cost sample storage, and it was also convenient for models to read these samples. In the experiment, we used several recent models and two public estimation indicators. The experimental results show the superiority of this work in fast start-up and network lightweight, it is about 1-5 epochs faster than the Resnet-34 during training. And they also show the accuracy improvement of this work in estimating different joints, the estimated performance of approximately 60% of the joints is improved. Its performance in the overall human pose estimation exceeds other networks by more than 7mm. The experiment analyzes the network size, fast start-up and the performance in 2D and 3D pose estimation of the model in this paper in detail. Compared with other pose estimation models, its performance has also reached a higher level of application.	[Wang, Hao; Sun, Ming-hui; Zhang, Hao; Dong, Li-yan] Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China; [Wang, Hao; Sun, Ming-hui; Dong, Li-yan] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China	Jilin University; Jilin University	Dong, LY (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun, Peoples R China.; Dong, LY (corresponding author), Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun, Peoples R China.	dongly@jlu.edu.cn	Zhang, Hao/AAR-8325-2020	Zhang, Hao/0000-0002-2058-7123; dong, liyan/0000-0001-7491-5893; hao, wang/0000-0002-9613-6169	National Natural Science Foundation of China [61272209, 61872164]; Program of Science and Technology Development Plan of Jilin Province of China [20190302032GX]; Fundamental Research Funds for the Central Universities (Jilin University)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Science and Technology Development Plan of Jilin Province of China; Fundamental Research Funds for the Central Universities (Jilin University)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61272209, 61872164), in part by the Program of Science and Technology Development Plan of Jilin Province of China under Grant 20190302032GX, and in part by the Fundamental Research Funds for the Central Universities (Jilin University). Grant Recipient:Ming-hui Sun.	Alan Yuille, 2014, Arxiv, DOI arXiv:1407.3399; Amin S, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.45; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Andriluka M, 2014, PROC CVPR IEEE, P3686, DOI 10.1109/CVPR.2014.471; Belagiannis V, 2014, PROC CVPR IEEE, P1669, DOI 10.1109/CVPR.2014.216; Biswas Shubhadeep, 2019, 2019 Conference on Lasers and Electro-Optics Europe & European Quantum Electronics Conference (CLEO/Europe-EQEC), DOI 10.1109/CLEOE-EQEC.2019.8871819; Burenius M, 2013, PROC CVPR IEEE, P3618, DOI 10.1109/CVPR.2013.464; Cao Z, 2021, IEEE T PATTERN ANAL, V43, P172, DOI 10.1109/TPAMI.2019.2929257; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Pham H, 2021, PROC CVPR IEEE, P11552, DOI 10.1109/CVPR46437.2021.01139; Hirose Akira, 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P1237, DOI 10.1109/IJCNN.2009.5178754; Hor N, 2019, P IEEE C COMP VIS PA; Howard A, 2019, IEEE I CONF COMP VIS, P1314, DOI 10.1109/ICCV.2019.00140; Kanazawa A, 2018, PROC CVPR IEEE, P7122, DOI 10.1109/CVPR.2018.00744; Khan A.H., 2017, COMPUTING RES REPOSI; Li Z, 2021, P IEEECVF WINTER C A, P1888, DOI 10.1109/WACV48630.2021.00193; Martinez J, 2017, IEEE I CONF COMP VIS, P2659, DOI 10.1109/ICCV.2017.288; McMahan H. B., 2016, ARXIV160205629; Mehta D, 2017, ACM T GRAPHIC, V36, DOI 10.1145/3072959.3073596; Moskvyalc O, 2021, INT C LEARNING REPRE; Newell A, 2016, LECT NOTES COMPUT SC, V9912, P483, DOI 10.1007/978-3-319-46484-8_29; Pavlakos G, 2017, PROC CVPR IEEE, P1263, DOI 10.1109/CVPR.2017.139; Pavlakos G, 2017, PROC CVPR IEEE, P1253, DOI 10.1109/CVPR.2017.138; Feng Q, 2021, Arxiv, DOI arXiv:2112.13709; Qiu HB, 2019, IEEE I CONF COMP VIS, P4341, DOI 10.1109/ICCV.2019.00444; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Sapp B, 2013, PROC CVPR IEEE, P3674, DOI 10.1109/CVPR.2013.471; Simon T, 2017, PROC CVPR IEEE, P4645, DOI 10.1109/CVPR.2017.494; Sun K, 2019, PROC CVPR IEEE, P5686, DOI 10.1109/CVPR.2019.00584; Tan M., 2021, ARXIV; Tome D, 2018, INT CONF 3D VISION, P474, DOI 10.1109/3DV.2018.00061; Toshev A, 2014, PROC CVPR IEEE, P1653, DOI 10.1109/CVPR.2014.214; Trumble M., 2017, P BRIT MACH VIS C, V2, P1, DOI 10.5244/C.31.14; Trumble M, 2018, LECT NOTES COMPUT SC, V11214, P800, DOI 10.1007/978-3-030-01249-6_48; Wang CY, 2019, IEEE T PATTERN ANAL, V41, P1227, DOI 10.1109/TPAMI.2018.2828427; Wang H, 2022, KNOWL-BASED SYST, V239, DOI 10.1016/j.knosys.2021.107992; Wei GQ, 2020, IEEE T CIRC SYST VID, V30, P4601, DOI 10.1109/TCSVT.2019.2928813; Wei SE, 2016, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2016.511; Yang Y, 2011, PROC CVPR IEEE, P1385, DOI 10.1109/CVPR.2011.5995741; Zheng XT, 2020, IEEE T IMAGE PROCESS, V29, P4747, DOI 10.1109/TIP.2020.2972104; Zhou XY, 2017, IEEE I CONF COMP VIS, P398, DOI 10.1109/ICCV.2017.51	45	2	2	15	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264302	10.1371/journal.pone.0264302	http://dx.doi.org/10.1371/journal.pone.0264302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196346	Green Published, gold			2022-12-26	WOS:000835161600036
J	Oates, M; Crichton, K; Cranor, L; Budwig, S; Weston, EJL; Bernagozzi, BM; Pagaduan, J				Oates, Maggie; Crichton, Kyle; Cranor, Lorrie; Budwig, Storm; Weston, Erica J. L.; Bernagozzi, Brigette M.; Pagaduan, Julie			Audio, video, chat, email, or survey: How much does online interview mode matter?	PLOS ONE			English	Article							FACE-TO-FACE; SELF-DISCLOSURE; QUALITATIVE RESEARCH; SENSITIVE QUESTIONS; DATA-COLLECTION; RAPPORT; COMMUNICATION; TELEPHONE; AGE	In the design of qualitative interview studies, researchers are faced with the challenge of choosing between many different methods of interviewing participants. This decision is particularly important when sensitive topics are involved. Even prior to the Covid-19 pandemic, considerations of cost, logistics, and participant anonymity have increasingly pushed more interviews online. While previous work has anecdotally compared the advantages of different online interview methods, no empirical evaluation has been undertaken. To fill this gap, we conducted 154 interviews with sensitive questions across seven randomly assigned conditions, exploring differences arising from the mode (video, audio, email, instant chat, survey), anonymity level, and scheduling requirements. We surveyed interviewers and interviewees after their interview for perceptions on rapport, anonymity, and honesty. In addition, we completed a mock qualitative analysis, using the resulting codes as a measure of data equivalence. We note several qualitative differences across mode related to rapport, disclosure, and anonymity. However, we found little evidence to suggest that interview data was impacted by mode for outcomes related to interview experience or data equivalence. The most substantial differences were related logistics where we found substantially lower eligibility and completion rates, and higher time and monetary costs for audio and video modes.	[Oates, Maggie; Crichton, Kyle; Cranor, Lorrie; Budwig, Storm; Weston, Erica J. L.; Bernagozzi, Brigette M.; Pagaduan, Julie] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Oates, M (corresponding author), Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.	moates@cmu.edu		Crichton, Kyle/0000-0003-2746-0130; Cranor, Lorrie/0000-0003-2125-0124	Carnegie Corporation of New York	Carnegie Corporation of New York	L.C. was named an Andrew Carnegie Fellow in 2019. The associated award, provided by the Carnegie Corporation of New York (https://www.carnegie.org/), helped to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe A, 2013, J INVEST PSYCHOL OFF, V10, P237, DOI 10.1002/jip.1386; Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Altman I, 1973, SOCIAL PENETRATION D; [Anonymous], 1980, Med Teach, V2, P248, DOI 10.3109/01421598009081200; BENNEY M, 1956, AM J SOCIOL, V62, P143, DOI 10.1086/221954; Bordia P., 1997, J BUSINESS COMMUNICA, V34, P99, DOI [10.1177/002194369703400106, DOI 10.1177/002194369703400106]; Caine K, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P981, DOI 10.1145/2858036.2858498; COZBY PC, 1973, PSYCHOL BULL, V79, P73, DOI 10.1037/h0033950; Deegan A., 2012, CASES ONLINE INTERVI, P69, DOI [10.4135/9781506335155.n3, DOI 10.4135/9781506335155.N3]; Dennis AR, 2008, MIS QUART, V32, P575; Dowling S., 2012, CASES ONLINE INTERVI, P277, DOI [10.4135/9781506335155.n11, DOI 10.4135/9781506335155.N11]; Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001; GOUDY WJ, 1976, PUBLIC OPIN QUART, V39, P529; Halevy R, 2014, HUM COMMUN RES, V40, P54, DOI 10.1111/hcre.12019; Hart CM, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015621113; HILL RJ, 1963, SOUTHWEST SOC SCI Q, V44, P247; Hite D.M., 2014, J METHODS MEAS SOC S, V5, P22; Holbrook AL, 2003, PUBLIC OPIN QUART, V67, P79, DOI 10.1086/346010; Holbrook AL, 2019, WILEY SER SURV METH, P197; Hollenbaugh EE, 2013, J COMPUT-MEDIAT COMM, V18, P283, DOI 10.1111/jcc4.12008; Humes KR, 2011, OVERVIEW RACE HISPAN; Jenner BM, 2019, INT J SOC RES METHOD, V22, P165, DOI 10.1080/13645579.2018.1512694; Joinson AN, 2001, EUR J SOC PSYCHOL, V31, P177, DOI 10.1002/ejsp.36; King N., 2018, INTERVIEWS QUALITATI; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Lazar J, 2017, RESEARCH METHODS IN HUMAN-COMPUTER INTERACTION, 2ND EDITION, P299, DOI 10.1016/B978-0-12-805390-4.00011-X; Madill A, 2000, BRIT J PSYCHOL, V91, P1, DOI 10.1348/000712600161646; Mann C., 2002, HDB INTERVIEW RES CO, V29, P603; Meho LI, 2006, J AM SOC INF SCI TEC, V57, P1284, DOI 10.1002/asi.20416; Nguyen M, 2012, CYBERPSYCH BEH SOC N, V15, P103, DOI 10.1089/cyber.2011.0277; Moon Y, 2000, J CONSUM RES, V26, P323, DOI 10.1086/209566; Nandi A, 2017, INT J SOC RES METHOD, V20, P151, DOI 10.1080/13645579.2016.1165495; Pickard MD, 2018, BEHAV RES METHODS, V50, P1734, DOI 10.3758/s13428-017-0953-z; Prior MT, 2018, APPL LINGUIST REV, V9, P487, DOI 10.1515/applirev-2017-0029; Roulston K., 2014, SAGE HDB QUALITATIVE, P297, DOI 10.4135/9781446282243.n20; RUBIN Z, 1975, J EXP SOC PSYCHOL, V11, P233, DOI 10.1016/S0022-1031(75)80025-4; Salmons J., 2011, CASES ONLINE INTERVI; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Siegel DM, 1998, J ADOLESCENT HEALTH, V23, P20, DOI 10.1016/S1054-139X(97)00274-7; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Stanko T., 2011, CASES ONLINE INTERVI; Stieger S, 2006, CYBERPSYCHOL BEHAV, V9, P552, DOI 10.1089/cpb.2006.9.552; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Thurnell-Read T, 2016, STUD QUAL METHODOL, V14, P23, DOI 10.1108/S1042-319220160000014014; Tomprou M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247655; Torngren SO, 2018, QUAL RES, V18, P3, DOI 10.1177/1468794116683991; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7; WEISS CH, 1968, PUBLIC OPIN QUART, V32, P622, DOI 10.1086/267650; Weller S, 2017, INT J SOC RES METHOD, V20, P613, DOI 10.1080/13645579.2016.1269505; Wertz F., 2011, 5 WAYS DOING QUALITA; Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P437, DOI 10.1089/cyber.2020.29188.bkw; Xiao ZA, 2020, ACM T COMPUT-HUM INT, V27, DOI 10.1145/3381804; ZIMMERMAN RS, 1995, J SEX RES, V32, P107, DOI 10.1080/00224499509551781	55	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263876	10.1371/journal.pone.0263876	http://dx.doi.org/10.1371/journal.pone.0263876			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192659	gold, Green Published			2022-12-26	WOS:000812552500031
J	Shyr, ZA; Yan, Z; Ustione, A; Egan, EM; Remedi, MS				Shyr, Zeenat A.; Yan, Zihan; Ustione, Alessandro; Egan, Erin M.; Remedi, Maria S.			SGLT2 inhibitors therapy protects glucotoxicity-induced beta-cell failure in a mouse model of human K-ATP-induced diabetes through mitigation of oxidative and ER stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; DB/DB MICE; MASS; EMPAGLIFLOZIN; SENSITIVITY; MECHANISMS; DEDIFFERENTIATION; LUSEOGLIFLOZIN; PRESERVATION	Progressive loss of pancreatic beta-cell functional mass and anti-diabetic drug responsivity are classic findings in diabetes, frequently attributed to compensatory insulin hypersecretion and beta-cell exhaustion. However, loss of beta-cell mass and identity still occurs in mouse models of human K-ATP-gain-of-function induced Neonatal Diabetes Mellitus (NDM), in the absence of insulin secretion. Here we studied the temporal progression and mechanisms underlying glucotoxicity-induced loss of functional beta-cell mass in NDM mice, and the effects of sodium-glucose transporter 2 inhibitors (SGLT2i) therapy. Upon tamoxifen induction of transgene expression, NDM mice rapidly developed severe diabetes followed by an unexpected loss of insulin content, decreased proinsulin processing and increased proinsulin at 2-weeks of diabetes. These early events were accompanied by a marked increase in beta-cell oxidative and ER stress, without changes in islet cell identity. Strikingly, treatment with the SGLT2 inhibitor dapagliflozin restored insulin content, decreased proinsulin:insulin ratio and reduced oxidative and ER stress. However, despite reduction of blood glucose, dapagliflozin therapy was ineffective in restoring beta-cell function in NDM mice when it was initiated at >40 days of diabetes, when loss of beta-cell mass and identity had already occurred. Our data from mouse models demonstrate that: i) hyperglycemia per se, and not insulin hypersecretion, drives beta-cell failure in diabetes, ii) recovery of beta-cell function by SGLT2 inhibitors is potentially through reduction of oxidative and ER stress, iii) SGLT2 inhibitors revert/prevent beta-cell failure when used in early stages of diabetes, but not when loss of beta-cell mass/identity already occurred, iv) common execution pathways may underlie loss and recovery of beta-cell function in different forms of diabetes. These results may have important clinical implications for optimal therapeutic interventions in individuals with diabetes, particularly for those with long-standing diabetes.	[Shyr, Zeenat A.; Yan, Zihan; Egan, Erin M.; Remedi, Maria S.] Washington Univ St Louis, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63130 USA; [Shyr, Zeenat A.; Yan, Zihan; Remedi, Maria S.] Washington Univ St Louis, Ctr Investigat Membrane Excitabil Dis, St Louis, MO 63110 USA; [Ustione, Alessandro; Remedi, Maria S.] Washington Univ St Louis, Dept Cell Biol & Physiol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Remedi, MS (corresponding author), Washington Univ St Louis, Div Endocrinol Metab & Lipid Res, Dept Med, St Louis, MO 63130 USA.; Remedi, MS (corresponding author), Washington Univ St Louis, Ctr Investigat Membrane Excitabil Dis, St Louis, MO 63110 USA.; Remedi, MS (corresponding author), Washington Univ St Louis, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	mremedi@wustl.edu		Asghar Shyr, Zeenat/0000-0001-8710-9938	National Institute of health [NIHR01DK098584, NIHR56DK098584, NIHR01DK123163, T32 DK108742]; Metabolic Tissue Function Core, Diabetes Research Center, Washington University in St Louis, MO National Institute of health [NIH-P30 DK020579]	National Institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolic Tissue Function Core, Diabetes Research Center, Washington University in St Louis, MO National Institute of health	This work was supported by the National Institute of health [NIHR01DK098584, NIHR56DK098584, NIHR01DK123163] to M.S.R, and National Institute of health [T32 DK108742] to Z.A.S. We also acknowledge the Metabolic Tissue Function Core, Diabetes Research Center, Washington University in St Louis, MO National Institute of health [NIH-P30 DK020579]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2018, DIABETES OBES METAB, V20, P370, DOI 10.1111/dom.13081; Al Jobori H, 2018, J CLIN ENDOCR METAB, V103, P1402, DOI 10.1210/jc.2017-01838; Alarcon C, 2016, DIABETES, V65, P438, DOI 10.2337/db15-0792; [Anonymous], 1995, Diabetes, V44, P1249; Benninger RKP, 2011, DIABETOLOGIA, V54, P1087, DOI 10.1007/s00125-010-2039-7; Bensellam M, 2018, J ENDOCRINOL, V236, pR109, DOI 10.1530/JOE-17-0516; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Chae H, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101071; Chan JY, 2015, MOL CELL ENDOCRINOL, V413, P189, DOI 10.1016/j.mce.2015.06.025; Chen CG, 2017, MOL METAB, V6, P943, DOI 10.1016/j.molmet.2017.06.019; Cheng STW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147391; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cohrs CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.033; Cowie MR, 2020, NAT REV CARDIOL, V17, P761, DOI 10.1038/s41569-020-0406-8; Dai CH, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa080; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Eizirik DL, 2020, NAT REV ENDOCRINOL, V16, P349, DOI 10.1038/s41574-020-0355-7; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Fushimi Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94896-w; Ghosh R, 2019, MOL METAB, V27, pS60, DOI 10.1016/j.molmet.2019.06.012; Hansen HH, 2014, J PHARMACOL EXP THER, V350, P657, DOI 10.1124/jpet.114.213454; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Jurczak MJ, 2018, ISLETS, V10, P181, DOI 10.1080/19382014.2018.1503027; Kaneto H, 2017, J DIABETES, V9, P219, DOI 10.1111/1753-0407.12494; Kanno A, 2019, J DIABETES INVEST, V10, P577, DOI 10.1111/jdi.12945; Kern M, 2016, METABOLISM, V65, P114, DOI 10.1016/j.metabol.2015.10.010; Kim MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/509437; Kimura T, 2018, DIABETES OBES METAB, V20, P2442, DOI 10.1111/dom.13400; Kuhre RE, 2019, DIABETOLOGIA, V62, P1011, DOI 10.1007/s00125-019-4849-6; Kusakabe T, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001303; Latva-Rasku A, 2019, DIABETES CARE, V42, P931, DOI 10.2337/dc18-1569; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lopaschuk GD, 2020, JACC-BASIC TRANSL SC, V5, P632, DOI 10.1016/j.jacbts.2020.02.004; Matsuda Tomokazu, 2008, Kobe J Med Sci, V54, pE114; Merovci A, 2015, J CLIN ENDOCR METAB, V100, P1927, DOI 10.1210/jc.2014-3472; Mudaliar S, 2014, DIABETES TECHNOL THE, V16, P137, DOI 10.1089/dia.2013.0167; Okauchi S, 2016, BIOCHEM BIOPH RES CO, V470, P772, DOI 10.1016/j.bbrc.2015.10.109; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Packer M, 2020, DIABETES CARE, V43, P508, DOI 10.2337/dci19-0074; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Remedi MS, 2016, DIABETES OBES METAB, V18, P110, DOI 10.1111/dom.12727; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017; Shyr ZA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43452-8; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Swisa A, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00021; Syeda K, 2013, BIOCHEM PHARMACOL, V86, P1338, DOI 10.1016/j.bcp.2013.08.023; Takahashi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25126-z; Takasu T, 2018, BIOL PHARM BULL, V41, P761, DOI 10.1248/bpb.b17-01007; Tsai KF, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081166; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Walters SN, 2013, J MOL ENDOCRINOL, V51, P225, DOI 10.1530/JME-13-0016; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Wei R, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154324; Weir GC, 2020, DIABETES, V69, P273, DOI 10.2337/db19-0138; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Yanai H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094416; Zhang L, 2010, DIABETES OBES METAB, V12, P510, DOI 10.1111/j.1463-1326.2010.01216.x	60	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0258054	10.1371/journal.pone.0258054	http://dx.doi.org/10.1371/journal.pone.0258054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180212	Green Published, gold			2022-12-26	WOS:000796435800002
J	Axelsson, EL; Buddhadasa, T; Manca, L; Robbins, RA				Axelsson, Emma L.; Buddhadasa, Tharindi; Manca, Laura; Robbins, Rachel A.			Making heads or tails of body inversion effects: Do heads matter?	PLOS ONE			English	Article							BIOLOGICAL MOTION; COMBINING SPEED; FACE; PERCEPTION; ACCURACY	Observers are better at discriminating upright bodies than inverted bodies, and this body inversion effect (BIE) is reliable with whole figures (bodies with heads), but not with bodies presented without heads or the heads occluded suggesting that heads may be key to BIEs. Some studies present whole figures and bodies without heads between groups, and BIEs are not found for bodies without heads [1]. Other studies present whole figures and bodies without heads in the same blocks and BIEs are found with bodies without heads [2]. Does seeing the heads of whole figures induce BIEs in bodies without heads? Here, participants discriminated bodies with either whole figures and bodies without heads presented within blocks, or in separate blocks with bodies without heads presented first. We tested body identity and posture discrimination and measured participants' gaze. BIEs were found with whole figures and bodies without heads in both identity and posture discrimination, and in both study designs. However, efficiency scores were better for the whole figures than the bodies without heads, but only when whole figures appeared in separate blocks. The magnitude of the BIE was overall stronger for whole figures compared to bodies without heads, but only in identity discrimination. BIE magnitudes were similar in the identity and posture tasks. Participants were better at identity discrimination, yet, there was greater looking at heads and less at bodies. During posture discrimination, greater looking at bodies and less at heads was associated with better performance. Faces might influence BIEs but are not essential. Configural representations of bodies without heads are sufficient for BIEs in posture and identity discrimination.	[Axelsson, Emma L.] Univ Newcastle, Sch Psychol Sci, Callaghan, NSW, Australia; [Axelsson, Emma L.; Buddhadasa, Tharindi; Manca, Laura; Robbins, Rachel A.] Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia	University of Newcastle; Australian National University	Axelsson, EL (corresponding author), Univ Newcastle, Sch Psychol Sci, Callaghan, NSW, Australia.; Axelsson, EL (corresponding author), Australian Natl Univ, Res Sch Psychol, Canberra, ACT, Australia.	emma.axelsson@newcastle.edu.au		Axelsson, Emma/0000-0002-6038-6254				Arizpe JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169148; Atkinson AP, 2012, NEUROIMAGE, V59, P1700, DOI 10.1016/j.neuroimage.2011.08.073; Axelsson EL, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02686; Bidet-Ildei C, 2015, ATHENS J SOCIAL SCI, V2; Brandman T, 2012, COGNITION, V125, P365, DOI 10.1016/j.cognition.2012.08.001; Brandman T, 2010, J NEUROSCI, V30, P10534, DOI 10.1523/JNEUROSCI.0911-10.2010; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Cazzato V, 2021, PSYCHOL RES-PSYCH FO, V85, P3026, DOI 10.1007/s00426-020-01471-5; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Knudsen CO, 2021, VIS COGN, V29, P379, DOI 10.1080/13506285.2021.1930312; Liesefeld HR, 2019, BEHAV RES METHODS, V51, P40, DOI 10.3758/s13428-018-1076-x; Minnebusch DA, 2009, J COGNITIVE NEUROSCI, V21, P865, DOI 10.1162/jocn.2009.21074; Pavlova M, 2003, PERCEPTION, V32, P937, DOI 10.1068/p3428; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Piepers DW, 2021, Q J EXP PSYCHOL, V74, P2046, DOI 10.1177/17470218211019673; Quigan H, PREP; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Robbins RA, 2015, J EXP CHILD PSYCHOL, V138, P1, DOI 10.1016/j.jecp.2015.04.006; Robbins RA, 2012, J EXP PSYCHOL HUMAN, V38, P1098, DOI 10.1037/a0028584; Simhi N, 2020, VISION RES, V176, P91, DOI 10.1016/j.visres.2020.07.012; Stafford T, 2020, BEHAV RES METHODS, V52, P2142, DOI 10.3758/s13428-020-01372-w; Susilo T, 2013, COGNITION, V129, P88, DOI 10.1016/j.cognition.2013.06.004; Tarr MJ, 2013, PSYCHOL SCI, V24, P1069, DOI 10.1177/0956797612474669; Thompson JC, 2012, NEUROIMAGE, V59, P625, DOI 10.1016/j.neuroimage.2011.07.051; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Vandierendonck A, J COGNITION, V4; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2010, J EXP PSYCHOL HUMAN, V36, P759, DOI 10.1037/a0017451; Zogmaister C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229161	36	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263902	10.1371/journal.pone.0263902	http://dx.doi.org/10.1371/journal.pone.0263902			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176071	gold, Green Published			2022-12-26	WOS:000777505200043
J	Dotaniya, CK; Lakaria, BL; Sharma, Y; Meena, BP; Aher, SB; Shirale, AO; Pandurang, PG; Dotaniya, ML; Biswas, AK; Patra, AK; Yadav, SR; Reager, ML; Sanwal, RC; Doutaniya, RK; Lata, M				Dotaniya, Chetan Kumar; Lakaria, Brij Lal; Sharma, Yogesh; Meena, Bharat Prakash; Aher, Satish Bhagwatrao; Shirale, Abhay Omprakash; Pandurang, Priya Gurav; Dotaniya, Mohan Lal; Biswas, Ashis Kumar; Patra, Ashok Kumar; Yadav, Shish Ram; Reager, Madan Lal; Sanwal, Ramesh Chandra; Doutaniya, Rajesh Kumar; Lata, Manju			Performance of chickpea (Cicer arietinum L.) in maize-chickpea sequence under various integrated nutrient modules in a Vertisol of Central India	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; INORGANIC FERTILIZERS; CROPPING SEQUENCE; MANAGEMENT; PRODUCTIVITY; MECHANISMS; RESIDUES; NITROGEN; SYSTEM; MATTER	Present investigation was conducted at the Research Farm of Indian Institute of Soil Science, Bhopal during 2017-18 and 2018-19 to study the performance of chickpea crop under various nutrient management modules in a Vertisol. The field experiment was set up in a randomized block design with three replications of twelve different INM modules. During the rabi seasons of 2017-18 and 2018-19, the chickpea (cv. JG-315) was grown with a set of treatments. The crop's performance was evaluated in terms of growth, yield (grain and straw), nutritional content, and nutrient uptake under different treatments. At crop harvest, the physic-chemical characteristics of the soil were also evaluated. Finally, the relationship between the numerous examined parameters was determined. The results showed that integrated nutrient management modules had a positive impact on chickpea crop performance and productivity when compared to using only inorganic fertilizer. The INM modules dramatically increased soil organic carbon and improved soil health in terms of physical and chemical qualities, in addition to higher crop performance. Among the various modules, (1) application of 75% STCR dose + FYM@ 5t ha(-1) to maize followed by 100% P only to chickpea and (2) application of FYM@ 20t ha(-1) to maize followed by FYM@ 5t ha-1 to chickpea increased the productivity and nutrient uptake in chickpea, improved soil physico-chemical properties and reflected as viable technique in improving soil nutrient availability on sustainable basis.	[Dotaniya, Chetan Kumar; Sharma, Yogesh; Yadav, Shish Ram; Sanwal, Ramesh Chandra] Swami Keshwanand Rajasthan Agr Univ, Dept Soil Sci & Agr Chem, Bikaner, India; [Lakaria, Brij Lal; Meena, Bharat Prakash; Shirale, Abhay Omprakash; Pandurang, Priya Gurav; Biswas, Ashis Kumar; Patra, Ashok Kumar] ICAR Indian Inst Soil Sci, Divison Soil Chem & Fertil, Bhopal, India; [Aher, Satish Bhagwatrao] ICMR Natl Inst Res Environm Hlth, Bhopal, India; [Dotaniya, Mohan Lal] ICAR Directorate Rapeseed Mustard Res, Crop Prod Unit, Sewar, Bharatpur, India; [Reager, Madan Lal; Doutaniya, Rajesh Kumar] Sri Karan Narendra Agr Univ, Dept Agron, Jaipur, Rajasthan, India; [Lata, Manju] Rajasthan Univ, Jaipur, Rajasthan, India	Swami Keshwanand Rajasthan Agricultural University (SKRAU); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Soil Sciences; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH); Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Rapeseed & Mustard Research; University of Rajasthan	Lakaria, BL (corresponding author), ICAR Indian Inst Soil Sci, Divison Soil Chem & Fertil, Bhopal, India.; Dotaniya, ML (corresponding author), ICAR Directorate Rapeseed Mustard Res, Crop Prod Unit, Sewar, Bharatpur, India.; Doutaniya, RK (corresponding author), Sri Karan Narendra Agr Univ, Dept Agron, Jaipur, Rajasthan, India.	lakaria2001@gmail.com; mohan30682@gmail.com; rajeshkumardoutaniya@gmail.com	AHER, SATISH B/H-2082-2013	AHER, SATISH B/0000-0002-5535-7862	University Grants Commission [RGNF-2017-18-Raj-44310]	University Grants Commission(University Grants Commission, India)	The study was financially supported by University Grants Commission during the Ph.D degree (grant no. RGNF-2017-18-Raj-44310), awarded to CKD.	Alam MK, 2014, SCI WORLD J, DOI 10.1155/2014/437283; [Anonymous], 2012, ASIAN J PLANT SCI RE; Asangi AM, 2018, J PHARMACOGNOSY PHYT, V7, P1745; Aziz T, 2010, INT J AGRIC BIOL, V12, P621; Balai K., 2017, J PHARMACOGNOSY PHYT, V6, P392; Chapman H D, 1961, METHOD ANAL SOIL PLA; Choudhary M, 2018, AGR ECOSYST ENVIRON, V257, P38, DOI 10.1016/j.agee.2018.01.029; Dharwe DS, 2018, J PHARMACOGNOSY PHYT, V7, P147; Dharwe DS, 2019, INT J CURRENT RES, V11, P8225; Dotaniya C.K., 2020, INT J CURRENT MICROB, V9, P1055; Dotaniya CK, 2019, INT J PLANT SOIL SCI, V29, P1; Dotaniya CK, 2020, AGR FOOD E NEWSLETTE, P89; Dotaniya CK, 2020, INT J CURRENT MICROB, V9, P2745; Dotaniya M. L., 2016, International Journal of Recycling of Organic Waste in Agriculture, V5, P185, DOI 10.1007/s40093-016-0132-8; Dotaniya ML, 2013, P NATL A SCI INDIA B, V83, P305, DOI 10.1007/s40011-012-0153-7; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Elayarajan M., 2015, Karnataka Journal of Agricultural Sciences, V28, P29; Gomez KA, 1983, STAT PROCEDURES AGR, V2nd, P1; Hanway J.J., 1952, IOWA AGR, V57, P1, DOI DOI 10.12691/AJWR-7-1-5; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; Iyamuremye F, 1996, ADV AGRON, V56, P139, DOI 10.1016/S0065-2113(08)60181-9; Jackson M.L., 1973, SOIL CHEM ANAL, P69; Jat RL, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6785-1; Kong XB, 2014, AGR RES, V3, P246, DOI 10.1007/s40003-014-0118-6; Kushwa V, 2016, AGR RES, V5, P353, DOI 10.1007/s40003-016-0223-9; Lakaria B. L., 2012, Journal of the Indian Society of Soil Science, V60, P125; Lakaria BL, 2011, RECYCLING ORGANIC WA, P83; Lakaria BL, 2012, NATL ACAD SCI LETT, V35, P131, DOI 10.1007/s40009-012-0040-z; Lynch MJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2651-1; Meena B. P., 2015, African Journal of Microbiology Research, V9, P1402; Meena BP, 2022, J PLANT NUTR, V45, P828, DOI 10.1080/01904167.2021.1998529; Meena BP, 2019, FIELD CROP RES, V232, P62, DOI 10.1016/j.fcr.2018.12.012; Meena BP, 2017, ADV NUTRIENT DYNAMIC, P61; Muneshwar Singh, 2012, Indian Journal of Fertilisers, V8, P26; Purakayastha TJ, 2008, SOIL SCI SOC AM J, V72, P534, DOI 10.2136/sssaj2005.0369; Rasool R, 2008, SOIL TILL RES, V101, P31, DOI 10.1016/j.still.2008.05.015; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sawarkar S.D., 2013, J INDIAN SOC SOIL SC, V61, P94; Sharma AR, 2009, NUTR CYCL AGROECOSYS, V83, P197, DOI 10.1007/s10705-008-9212-0; Shivran RK, 2017, J PHARMACOGNOSY PHYT, V1, P115; Singh AK, 2018, INT J CURRENT MICROB, V7, P254; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Smith J.L., 1996, METHODS ASSESSING SO, P49; Srinivasa DK, 2019, INT J CHEM STUDIES, V7, P3435; SUBBIAH B. V., 1956, CURRENT SCI, V25, P259; Thakur N. S., 2003, Research on Crops, V4, P305; Tilahun T.F., 2013, AM J RES COMM, V1, P275; Veena Malvi, 2021, Journal of Soils and Crops, V31, P25; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WATANABE F. S., 1965, SOIL SCI SOC AMER PROC, V29, P677; Yadav K. K., 2007, Journal of the Indian Society of Soil Science, V55, P324; Yang J, 2015, SOIL TILL RES, V151, P67, DOI 10.1016/j.still.2015.03.008	54	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0262652	10.1371/journal.pone.0262652	http://dx.doi.org/10.1371/journal.pone.0262652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176054	Green Published, gold			2022-12-26	WOS:000777505200010
J	Pernat, N; Zscheischler, J; Kampen, H; Ostermann-Miyashita, EF; Jeschke, JM; Werner, D				Pernat, Nadja; Zscheischler, Jana; Kampen, Helge; Ostermann-Miyashita, Emu-Felicitas; Jeschke, Jonathan M.; Werner, Doreen			How media presence triggers participation in citizen science-The case of the mosquito monitoring project 'Muckenatlas'	PLOS ONE			English	Article							WEST-NILE-VIRUS; MASS-MEDIA; SURVEILLANCE; MOTIVATIONS; ENGAGEMENT; MANAGEMENT; BARRIERS; SYSTEM	Since 2012, the citizen science project 'Muckenatlas' has been supplementing the German mosquito monitoring programme with over 28,000 submissions of physical insect samples. As the factors triggering people to catch mosquitoes for science are still unknown, we analysed the influence of mass media reports on mosquito submission numbers. Based on a theoretical framework of how mass media affect citizen responsiveness, we identified five possible influencing factors related to citizen science: (i) project awareness and knowledge, (ii) attention (economy), (iii) individual characteristics of citizen scientists and targeted communication, (iv) spatial differences and varying affectedness, and (v) media landscape. Hypotheses based on these influencing factors were quantitatively and qualitatively tested with two datasets: clipping data of mass media reports (online, television, radio and print) referring to or focussing on the 'Muckenatlas', and corresponding data of 'Muckenatlas' submissions between 2014 and 2017. In general, the number of media reports positively affected the number of mosquito submissions on a temporal and spatial scale, i.e. many media reports provoke many mosquito submissions. We found that an already heightened public and media awareness of mosquito-relevant topics combined with a direct call-to-action in a media report title led to a maximum participation. Differences on federal state level, however, suggest that factors additional to quantitative media coverage trigger participation in the 'Muckenatlas', in particular the mosquito affectedness of the resident population. Lastly, media types appear to differ in their effects on the number of submissions. Our results show under which circumstances the media presence of the 'Muckenatlas' is most effective in activating people to submit mosquito samples, and thus provide advice for designing communication strategies for citizen science projects.	[Pernat, Nadja; Zscheischler, Jana; Ostermann-Miyashita, Emu-Felicitas; Werner, Doreen] Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany; [Pernat, Nadja; Jeschke, Jonathan M.] Freie Univ, Inst Biol, Dept Biol Chem Pharm, Berlin, Germany; [Pernat, Nadja; Jeschke, Jonathan M.; Werner, Doreen] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Kampen, Helge] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Ostermann-Miyashita, Emu-Felicitas] Humboldt Univ, Thaer Inst Agr & Hort Sci, Berlin, Germany; [Jeschke, Jonathan M.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Free University of Berlin; Friedrich Loeffler Institute; Humboldt University of Berlin; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Pernat, N (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Muncheberg, Germany.; Pernat, N (corresponding author), Freie Univ, Inst Biol, Dept Biol Chem Pharm, Berlin, Germany.; Pernat, N (corresponding author), Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany.	nadjapernat@gmail.com	Pernat, Nadja/AGW-8389-2022	Pernat, Nadja/0000-0003-2244-1002; Zscheischler, Jana/0000-0002-9062-820X	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE) [2810HS022, 2819104615, 2818SE001]	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE)	Our research was supported by grants to HK and DW from the German Federal Ministry of Food and Agriculture (BMEL, www.bmel.de/) through the Federal Office for Agriculture and Food (BLE, www.ble.de), grant numbers 2810HS022, 2819104615 and 2818SE001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin, 1989, PUBLIC COMMUNICATION, P43; Auerbach J, 2019, P NATL ACAD SCI USA, V116, P15336, DOI 10.1073/pnas.1909278116; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Bautista-Puig N, 2019, PUBLICATIONS, V7, DOI 10.3390/publications7010012; Bazin M, 2018, J VECTOR ECOL, V43, P98, DOI 10.1111/jvec.12288; Beaulieu MRS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215485; Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X; Bivand R., 2019, MAPTOOLS TOOLS HANDL; Bivand R, 2019, R PACKAGE VERSION 1; Bonney R., 2016, CITIZ SCI THEORY PRA, V1, P1, DOI [10.5334/cstp.65, DOI 10.5334/CSTP.65]; Bonney R, 2016, PUBLIC UNDERST SCI, V25, P2, DOI 10.1177/0963662515607406; Bryant J, 2004, J COMMUN, V54, P662, DOI 10.1093/joc/54.4.662; Bryant J, 2009, COMMUN SER, pXI; Burgess HK, 2017, BIOL CONSERV, V208, P113, DOI 10.1016/j.biocon.2016.05.014; Caputo B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217872; CATLINGROVES CL, 2012, INT J ZOOL, V2012, DOI DOI 10.1155/2012/349630; Chu M., 2012, CITIZEN SCI, DOI [10.7591/cornell/9780801449116.003.0005, DOI 10.7591/CORNELL/9780801449116.003.0005]; Cooper CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106508; Crall A, 2017, JCOM-J SCI COMMUN, V16; Curtis-Robles R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004235; Davies L, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0066-z; Davis A, 2019, HUM DIMENS WILDL, V24, P501, DOI 10.1080/10871209.2019.1641857; Dickinson JL, 2013, J ENVIRON EDUC, V44, P145, DOI 10.1080/00958964.2012.742032; Domroese MC, 2017, BIOL CONSERV, V208, P40, DOI 10.1016/j.biocon.2016.08.020; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Engelen M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-51; Eritja R, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3317-y; Eveleigh A, 2014, P 32 ANN ACM CHI C H; Follett R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143687; Ganier S., 2018, R PACKAGE VERSION 0; Geoghegan H., 2016, UNDERSTANDING MOTIVA; Hart PS, 2011, SOC NATUR RESOUR, V24, P276, DOI 10.1080/08941920802676464; Hecker S, 2014, MITT DEUT GES ALLGEM, V19, P131; Heigl F, 2019, P NATL ACAD SCI USA, V116, P8089, DOI 10.1073/pnas.1903393116; Hijmans Robert., 2019, R PACKAGE VERSION 2; Hobbs SJ, 2012, J NAT CONSERV, V20, P364, DOI 10.1016/j.jnc.2012.08.002; Jennett C, 2016, JCOM-J SCI COMMUN, V15, DOI 10.22323/2.15030205; Johnson BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34161-9; Jordan RC, 2017, J AM MOSQUITO CONTR, V33, P241, DOI 10.2987/17-6644R.1; kabsev.de, KOMM AKT BEK SCHNAK; Kampen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167948; Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5; Kassambara A, 2019, PIPE FRIENDLY FRAMEW; Kobori H, 2016, ECOL RES, V31, P1, DOI 10.1007/s11284-015-1314-y; Koivisto J, 2007, RES REPORT; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; Lie MP, 2018, NORD REV, V39, P49, DOI 10.2478/nor-2018-0011; Maki EC, 2015, CAN ENTOMOL, V147, P118, DOI 10.4039/tce.2014.27; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; Murindahabi MM, 2018, NJAS-WAGEN J LIFE SC, V86-87, P101, DOI 10.1016/j.njas.2018.07.005; Newman G, 2017, BIOL CONSERV, V208, P55, DOI 10.1016/j.biocon.2016.07.019; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Oltra A., 2016, EUROPEAN HDB CROWDSO, P295, DOI DOI 10.5334/BAX.V; Palmer JRB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00914-9; Pasek J, 2006, COMMUN RES, V33, P115, DOI 10.1177/0093650206287073; Pelacho M, 2021, SCIENTOMETRICS, V126, P225, DOI 10.1007/s11192-020-03724-x; Pernat N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80365-3; Perse Elizabeth M, 2001, MEDIA EFFECTS SOC; Pfitzner WP, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3199-4; Pietsch C, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.46.2001786; Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1; Potter WJ, 2011, J COMMUN, V61, P896, DOI 10.1111/j.1460-2466.2011.01586.x; Prudic KL, 2017, INSECTS, V8, DOI 10.3390/insects8020053; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; R Core Team, 2020, R LANG ENV STAT COMP; Robson C, 2013, P 2013 C COMP SUPP C; Ruafenacht S., 2021, SCI CITIZEN SCI, P475, DOI [10.1007/978-3-030-58278-4, DOI 10.1007/978-3-030-58278-4]; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Shoemaker Pamela J., 2009, GATEKEEPING THEORY; Skogerbo E, 2011, EUR J COMMUN, V26, P214, DOI 10.1177/0267323111413112; Sousa LB, 2020, SCI TOTAL ENVIRON, V704, DOI 10.1016/j.scitotenv.2019.135349; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006; Trapletti A., 2020, TSERIES TIME SERIES; Unell J, 2012, NATURAL ENGLAND COMM; van Vliet AJH, 2014, INT J BIOMETEOROL, V58, P565, DOI 10.1007/s00484-014-0821-9; Vohland K, 2021, SCI CITIZEN SCI, DOI [10.1098/rsos.202108, DOI 10.1098/RSOS.202108]; Walther D, 2017, J MED ENTOMOL, V54, P1790, DOI 10.1093/jme/tjx166; Werner D, 2020, PARASITOL RES, V119, P2765, DOI 10.1007/s00436-020-06775-4; West S., 2021, CITIZ SCI THEORY PRA, V6, P14, DOI [DOI 10.5334/CSTP.370, 10.5334/CSTP.370]; West S., 2016, CITIZEN SCI THEORY P, V1, P1, DOI [10.5334/cstp.8, DOI 10.5334/CSTP.8]; WHO, 2016, SIT REP ZIK VIR MICR; Wickham H., SCALES SCALE FUNCTIO; Wickham H., 2020, DPLYR GRAMMAR DATA M; Wickham H, 2014, J STAT SOFTW, V59, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams CR, 2017, T ROY SOC SOUTH AUST, V141, P57, DOI 10.1080/03721426.2016.1268564; Wurschum T, 2019, THEOR APPL GENET, V132, P617, DOI 10.1007/s00122-018-3134-2; Zeileis A, 2005, J STAT SOFTW, V14; Ziegler U, 2019, ANTIVIR RES, V162, P39, DOI 10.1016/j.antiviral.2018.12.005	91	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0262850	10.1371/journal.pone.0262850	http://dx.doi.org/10.1371/journal.pone.0262850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176044	Green Published, gold			2022-12-26	WOS:000777505200012
J	Alonso, S; Catala, M; Lopez, D; Alvarez-Lacalle, E; Jordan, I; Garcia-Garcia, JJ; Fumado, V; Munoz-Almagro, C; Gratacos, E; Balanza, N; Varo, R; Millat, P; Baro, B; Ajanovic, S; Arias, S; Claverol, J; de Sevilla, MF; Bonet-Carne, E; Garcia-Miquel, A; Coma, E; Medina-Peralta, M; Fina, F; Prats, C; Bassat, Q				Alonso, Sergio; Catala, Marti; Lopez, Daniel; Alvarez-Lacalle, Enric; Jordan, Iolanda; Jose Garcia-Garcia, Juan; Fumado, Victoria; Munoz-Almagro, Carmen; Gratacos, Eduard; Balanza, Nuria; Varo, Rosauro; Millat, Pere; Baro, Barbara; Ajanovic, Sara; Arias, Sara; Claverol, Joana; Fernandez de Sevilla, Mariona; Bonet-Carne, Elisenda; Garcia-Miquel, Aleix; Coma, Ermengol; Medina-Peralta, Manuel; Fina, Francesc; Prats, Clara; Bassat, Quique			Individual prevention and containment measures in schools in Catalonia, Spain, and community transmission of SARS-CoV-2 after school re-opening	PLOS ONE			English	Article							SYNDROME CORONAVIRUS 2; CHILDREN; COVID-19	Background Despite their clear lesser vulnerability to COVID-19, the extent by which children are susceptible to getting infected by SARS-CoV-2 and their capacity to transmit the infection to other people remains inadequately characterized. We aimed to evaluate the role of school reopening and the preventive strategies in place at schools in terms of overall risk for children and community transmission, by comparing transmission rates in children as detected by a COVID-19 surveillance platform in place in Catalonian Schools to the incidence at the community level. Methods and findings Infections detected in Catalan schools during the entire first trimester of classes (September-December 2020) were analysed and compared with the ongoing community transmission and with the modelled predicted number of infections. There were 30.486 infections (2.12%) documented among the circa 1.5M pupils, with cases detected in 54.0% and 97.5% of the primary and secondary centres, respectively. During the entire first term, the proportion of "bubble groups" (stable groups of children doing activities together) that were forced to undergo confinement ranged between 1 and 5%, with scarce evidence of substantial intraschool transmission in the form of chains of infections, and with similar to 75% of all detected infections not leading to secondary cases. Mathematical models were also used to evaluate the effect of different parameters related to the defined preventive strategies (size of the bubble group, number of days of confinement required by contacts of an index case). The effective reproduction number inside the bubble groups in schools (R*), defined as the average number of schoolmates infected by each primary case within the bubble, was calculated, yielding a value of 0.35 for primary schools and 0.55 for secondary schools, and compared with the outcomes of the mathematical model, implying decreased transmissibility for children in the context of the applied measures. Relative homogenized monthly cumulative incidence (r(CIhom; j)) was assessed to compare the epidemiological dynamics among different age groups and this analysis suggested the limited impact of infections in school-aged children in the context of the overall community incidence. Conclusions During the fall of 2020, SARS-CoV-2 infections and COVID-19 cases detected in Catalan schools closely mirrored the underlying community transmission from the neighbourhoods where they were set and maintaining schools open appeared to be safe irrespective of underlying community transmission. Preventive measures in place in those schools appeared to be working for the early detection and rapid containment of transmission and should be maintained for the adequate and safe functioning of normal academic and face-to-face school activities.	[Alonso, Sergio; Catala, Marti; Lopez, Daniel; Alvarez-Lacalle, Enric; Prats, Clara] Univ Politecn Cataluna, Dept Phys, Barcelona, Spain; [Catala, Marti] Fundacio Inst Invest Ciencies Salut Germans Trias, Comparat Med & Bioimage Ctr Catalonia CMCiB, Badalona, Catalonia, Spain; [Jordan, Iolanda] Univ Barcelona, Paediat Intens Care Unit, Hosp St Joan Deu, Barcelona, Spain; [Jordan, Iolanda; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen; Claverol, Joana; Fernandez de Sevilla, Mariona] Univ Barcelona, Inst Recerca St Joan Deu, Barcelona, Spain; [Jordan, Iolanda; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen; Fernandez de Sevilla, Mariona; Bassat, Quique] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain; [Jose Garcia-Garcia, Juan; Fernandez de Sevilla, Mariona; Bassat, Quique] Univ Barcelona, Hosp St Joan Deu, Pediat Dept, Barcelona, Spain; [Fumado, Victoria] Hosp St Joan Deu, Infect Dis Dept, Barcelona, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Dept Med, Barcelona, Spain; [Gratacos, Eduard; Bonet-Carne, Elisenda; Garcia-Miquel, Aleix] Univ Barcelona, Hosp Clin, BCNatal Fetal Med Res Ctr, Barcelona, Spain; [Gratacos, Eduard; Bonet-Carne, Elisenda; Garcia-Miquel, Aleix] Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain; [Gratacos, Eduard; Bonet-Carne, Elisenda] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain; [Balanza, Nuria; Varo, Rosauro; Millat, Pere; Baro, Barbara; Ajanovic, Sara; Arias, Sara; Bassat, Quique] Univ Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain; [Varo, Rosauro; Ajanovic, Sara; Bassat, Quique] Ctr Invest Saude Manhica, Maputo, Mozambique; [Claverol, Joana] Fundacio St Joan Deu, Barcelona, Spain; [Bonet-Carne, Elisenda] Univ Politecn Catalunya BarcelonaTech, Barcelona, Spain; [Coma, Ermengol; Medina-Peralta, Manuel; Fina, Francesc] Inst Catala Salut, Sistema Informacio Serv Atencio Primaria SISAP, Barcelona, Spain; [Bassat, Quique] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain	Universitat Politecnica de Catalunya; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Universitat Politecnica de Catalunya; ICREA	Bassat, Q (corresponding author), Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain.; Bassat, Q (corresponding author), Univ Barcelona, Hosp St Joan Deu, Pediat Dept, Barcelona, Spain.; Bassat, Q (corresponding author), Univ Barcelona, ISGlobal, Hosp Clin, Barcelona, Spain.; Bassat, Q (corresponding author), Ctr Invest Saude Manhica, Maputo, Mozambique.; Bassat, Q (corresponding author), Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain.	quique.bassat@isglobal.org	Alonso, Sergio/GVR-8346-2022; Redon, Ermengol Coma/AAZ-7655-2020; Varo, Rosauro/ACJ-5258-2022; Alvarez-Lacalle, Enrique/ADA-6394-2022; Prats, Clara/L-4797-2014; Bonet-Carne, Elisenda/ACF-2366-2022; Jordan, Iolanda/U-5791-2017; Bassat, Quique/P-2341-2016; Alonso, Sergio/L-6177-2014	Redon, Ermengol Coma/0000-0001-8000-3321; Varo, Rosauro/0000-0003-4282-5572; Alvarez-Lacalle, Enrique/0000-0001-6824-6857; Prats, Clara/0000-0002-1398-7559; Bonet-Carne, Elisenda/0000-0003-0567-6141; Jordan, Iolanda/0000-0002-2041-4425; Bassat, Quique/0000-0003-0875-7596; Baro Sastre, Barbara/0000-0001-7780-1744; Balanza, Nuria/0000-0002-3581-0383; Fina, Francesc/0000-0001-7106-5635; Arias, Sara/0000-0002-4873-8472; Catala, Marti/0000-0003-3308-9905; Alonso, Sergio/0000-0002-3989-8757; Gratacos, Eduard/0000-0002-7405-7224; de Sevilla, Mariona F/0000-0003-3104-675X; Garcia Miquel, Aleix/0000-0002-6348-3391	Stavros Niarchos Foundation (SNF); Banco Santander; La Caixa Foundation [100010434, LCF/PR/GN17/50300003]; Ministerio de Ciencia, Innovacion y Universidades; FEDER [PGC2018-095456-B-I00]; European Commission - DG Communications Networks, Content and Technology [LC-01485746]; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa" Program [CEX2018-000806-S]; Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development (AECID); FPU predoctoral fellowship from the Spanish Ministry of Universities [FPU18/04260]; Government of Catalonia's Secretariat for Universities and Research; Marie Sklodowska-Curie Actions COFUND Programme [801370]	Stavros Niarchos Foundation (SNF); Banco Santander; La Caixa Foundation(La Caixa Foundation); Ministerio de Ciencia, Innovacion y Universidades(Spanish Government); FEDER(European Commission); European Commission - DG Communications Networks, Content and Technology; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa" Program; Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development (AECID)(Spanish Government); FPU predoctoral fellowship from the Spanish Ministry of Universities; Government of Catalonia's Secretariat for Universities and Research; Marie Sklodowska-Curie Actions COFUND Programme	Funding The components of the analysis drawn from the different KIDS Corona platform have been funded by Stavros Niarchos Foundation (SNF), Banco Santander and other private donors of Kidscorona. We also acknowledge funding from La Caixa Foundation (ID 100010434), under agreement LCF/PR/GN17/50300003; and funding from Ministerio de Ciencia, Innovacio ' n y Universidades and FEDER, with the project PGC2018-095456-B-I00. This work has been also partially funded by the European Commission -DG Communications Networks, Content and Technology through the contract LC-01485746. ISGlobal receives support from the Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID). NB is supported by an FPU predoctoral fellowship from the Spanish Ministry of Universities (FPU18/04260). BB is a Beatriu de Pino ' s postdoctoral fellow granted by the Government of Catalonia's Secretariat for Universities and Research, and by Marie Sklodowska-Curie Actions COFUND Programme (BP3, 801370). Role of the funding source The funders had no role in the interpretation of the data or in the writing up of the manuscript.	Alonso S, 2021, PEDIATR INFECT DIS J, V40, P955, DOI 10.1097/INF.0000000000003279; Atherstone C, 2021, MMWR-MORBID MORTAL W, V70, P141, DOI [10.15585/mmwr.mm7004e4, 10.15585/mmwr.mm7004e4externalicon]; Baggio S., 2020, CLIN INFECT DIS OFFI; Brookman S, 2021, LANCET CHILD ADOLESC, V5, pE9, DOI 10.1016/S2352-4642(21)00030-4; Bullard J, 2021, CAN MED ASSOC J, V193, pE601, DOI 10.1503/cmaj.210263; Day M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n383; Ertem Z, 2021, NAT MED, V27, P2120, DOI 10.1038/s41591-021-01563-8; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fukumoto K, 2021, NAT MED, V27, P2111, DOI 10.1038/s41591-021-01571-8; Grech Victor, 2020, Early Hum Dev, P105206, DOI 10.1016/j.earlhumdev.2020.105206; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Ismail SA, 2021, LANCET INFECT DIS, V21, P344, DOI 10.1016/S1473-3099(20)30882-3; Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013; Jordan I., 2021, CLIN INFECT DIS OFFI; Kawasuji H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243597; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Kim S, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e143; Lee B, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-004879; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Levinson M, 2020, NEW ENGL J MED, V383, P981, DOI 10.1056/NEJMms2024920; Li F, 2021, LANCET INFECT DIS, V21, P617, DOI [10.1016/S1473-3099(20)30981-6, 10.1016/S1473-3099(20)30981-6Hubei430030]; Llupia A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251593; Ludvigsson JF, 2021, NEW ENGL J MED, V384, P669, DOI 10.1056/NEJMc2026670; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1525, DOI 10.1111/apa.15371; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Maltezou HC, 2020, PEDIATR INFECT DIS J, V39, pE388, DOI 10.1097/INF.0000000000002899; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; Merckx J, 2020, DTSCH ARZTEBL INT, V117, P553, DOI 10.3238/arztebl.2020.0553; Perramon A, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.754744; Sah P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109229118; Snape MD, 2020, SCIENCE, V370, P286, DOI 10.1126/science.abd6165; Soriano-Arandes A, 2021, CLIN INFECT DIS, V73, pE1261, DOI 10.1093/cid/ciab228; Stein-Zamir C, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.29.2001352; Szablewski CM, 2020, MMWR-MORBID MORTAL W, V69, P1023, DOI 10.15585/mmwr.mm6931e1; Tonshoff B, 2021, JAMA PEDIATR, V175, P586, DOI 10.1001/jamapediatrics.2021.0001; Vanhems Philippe, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.15.2000617; Varma JK, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2021-050605; Viner RM, 2021, ARCH DIS CHILD, V106, P111, DOI 10.1136/archdischild-2020-319963; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Vogel G, 2020, SCIENCE, V368, P562, DOI 10.1126/science.368.6491.562; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1735	45	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263741	10.1371/journal.pone.0263741	http://dx.doi.org/10.1371/journal.pone.0263741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171936	gold, Green Published			2022-12-26	WOS:000795889700035
J	Deacon-Crouch, M; Skinner, I; Tucci, J; Begg, S; Wallace, R; Skinner, T				Deacon-Crouch, Melissa; Skinner, Isabelle; Tucci, Joseph; Begg, Steve; Wallace, Ruth; Skinner, Timothy			Association between indigenous status and Body Mass Index (BMI) in Australian adults: Does sleep duration affect the relationship?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBESITY; HEALTH; SMOKING; METAANALYSIS; CONSUMPTION; US	Background Overweight/obesity is a well-defined risk factor for a variety of chronic cardiovascular and metabolic diseases. Sleep duration has been associated with overweight/obesity and other cardio metabolic and neurocognitive problems. Notably, overweight/obesity and many of the associated comorbidities are prevalent in Indigenous Australians. Generally, sleep duration has been associated with BMI for Australian adults but information about Australian Indigenous adults' sleep is scant. A recent report established that sleep is a weak predictor of obesity for Indigenous Australian adults. Aim To determine whether sleep remains a predictor of obesity when physical activity, diet and smoking status are accounted for; and to determine whether sleep duration plays a mediating role in the relationship between Indigenous status and BMI. Methods Statistical analyses of 5,886 Australian adults: 5236 non-Indigenous and 650 Indigenous people aged over 18 years who participated in the Australian Health Survey 2011-2013. Demographic and lifestyle characteristics were described by chi(2) and t-tests. ANOVA was used to determine the variables that significantly predicted BMI and sleep duration. Stepwise regression analyses were performed to determine the strongest significant predictors of BMI. Sleep duration was self-reported; BMI was calculated from measurement. Results The study revealed two main findings: (i) short sleep duration was an independent predictor of obesity (adjusted-R-2 = 0.056, p < 0.0001); and (ii) controlling for sleep duration and other possible confounders, Indigenous status was a significant predictor of BMI overweight/ obesity. Sleep duration played a weak, partial mediator role in this relationship. Increased BMI was associated with lower socioeconomic status and level of disadvantage of household locality for non-remote Indigenous and non-Indigenous people. Conclusion Indigenous status strongly predicted increased BMI. The effect was not mediated by the socioeconomic indicators but was partially mediated by sleep duration.	[Deacon-Crouch, Melissa; Skinner, Isabelle] La Trobe Univ, La Trobe Rural Hlth Sch, Rural Dept Nursing & Midwifery, Bendigo, Vic, Australia; [Tucci, Joseph] La Trobe Univ, La Trobe Inst Mol Sci, Dept Pharm & Biomed Sci, Bundoora, Vic, Australia; [Begg, Steve] La Trobe Univ, La Trobe Rural Hlth Sch, Rural Dept Community Hlth, Bendigo, Vic, Australia; [Wallace, Ruth] Charles Darwin Univ, Coll Indigenous Futures Educ & Arts, Darwin, NT, Australia; [Skinner, Timothy] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Skinner, Timothy] La Trobe Univ, La Trobe Rural Hlth Sch, Univ Dept Rural Hlth, Bendigo, Vic, Australia	La Trobe University; La Trobe University; La Trobe University; Charles Darwin University; University of Copenhagen; La Trobe University	Deacon-Crouch, M (corresponding author), La Trobe Univ, La Trobe Rural Hlth Sch, Rural Dept Nursing & Midwifery, Bendigo, Vic, Australia.	m.deacon-crouch@latrobe.edu.au	; Skinner, Timothy/N-2221-2013; Begg, Stephen/B-5971-2014	Deacon-Crouch, Melissa/0000-0002-0258-5933; Skinner, Timothy/0000-0002-0018-6963; Skinner, Isabelle/0000-0002-1719-2518; Begg, Stephen/0000-0001-7482-3278				Adams RJ, 2017, SLEEP HEALTH, V3, P35, DOI 10.1016/j.sleh.2016.11.005; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Anderson I, 2016, LANCET, V388, P131, DOI 10.1016/S0140-6736(16)00345-7; [Anonymous], AUSTR HLTH SURV US G; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV; Australian Bureau of Statistics, 2011, AUSTR HLTH SURV PRIV; Australian Bureau of Statistics, 2011, REM STRUCT; Australian Bureau of Statistics, 2018, LAB STAT CONC SOURC; Australian Bureau of Statistics, 2016, AUSTR ABORIGINAL TOR; Australian Bureau of Statistics, 2013, AUSTR AB TORR STRAIT; Australian Bureau of Statistics, 2014, WEEKL PAYR JOBS WAG; Australian Government Department of Health, 2009, CLOS GAP IND DIS CHA; Australian Government Department of Health, 2003, AUSTR PHYS ACT SED B; Australian Institute of Health and Welfare, 2018, NATL KEY PERFORMANCE, V5; Australian Institute of Health and Welfare, 2018, AUSTR HLTH SER, DOI 10.25816/5ec1e56f25480; Australian Institute of Health and Welfare, 2021, ALC TOB OTH DRUGS AU; Bartlett JG, 2007, SOC SCI MED, V65, P2371, DOI 10.1016/j.socscimed.2007.06.011; Baum F, 2022, INT J HEALTH POLICY, V11, P947, DOI 10.34172/ijhpm.2020.233; Came-Friar H, 2019, PUBLIC HEALTH, V176, P2, DOI 10.1016/j.puhe.2019.09.011; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006; Chattu VK, 2019, J RACIAL ETHN HEALTH, V6, P1053, DOI 10.1007/s40615-019-00607-7; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Deacon-Crouch M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09287-z; Deacon-Crouch M, 2019, J PAEDIATR CHILD H, V55, P915, DOI 10.1111/jpc.14308; Deacon-Crouch M, 2018, J PAEDIATR CHILD H, V54, P49, DOI 10.1111/jpc.13658; Deacon-Crouch Melissa, 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.03.798; Durey A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-151; First Nations National Constitutional Convention, 2017, UL STAT HEART; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Grandner MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00112; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Hale L, 2007, SLEEP, V30, P1096, DOI 10.1093/sleep/30.9.1096; IBM Corporation, 2016, SPSS STAT WIND VERS; Janochova K, 2019, BIOMED PAP, V163, P19, DOI 10.5507/bp.2018.062; Jansen EC, 2021, INT J BEHAV MED, V28, P177, DOI 10.1007/s12529-020-09853-0; Jean-Louis G, 2016, SLEEP MED, V18, P1, DOI 10.1016/j.sleep.2015.08.001; Keast K., 2015, INDIGENOUS HLTH STEP, V22, P18; Kingsbury JH, 2013, CURR CARDIOVASC RISK, V7, DOI 10.1007/s12170-013-0330-0; Kondalsamy-Chennakesavan S, 2008, AM J HUM BIOL, V20, P317, DOI 10.1002/ajhb.20729; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; La Trobe university Research Office, 2015, HUM RES ETH GUID; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Li M, 2010, DIABETES RES CLIN PR, V87, P401, DOI 10.1016/j.diabres.2009.12.004; Macniven Rona, 2016, Prev Med Rep, V3, P203, DOI 10.1016/j.pmedr.2016.01.006; Magee CA, 2010, J AGING HEALTH, V22, P1235, DOI 10.1177/0898264310372780; Magee CA, 2009, PREV MED, V49, P461, DOI 10.1016/j.ypmed.2009.10.006; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; McCarthy SN, 2002, P NUTR SOC, V61, P3, DOI 10.1079/PNS2001121; Miller TM, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-18; National Health and Medical Research Council, 2003, AUSTR DIET GUID; National Health and Medical Research Council, 2003, VAL ETH GUID ETH CON; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; ODEA K, 1991, MED J AUSTRALIA, V155, P258, DOI 10.5694/j.1326-5377.1991.tb142236.x; Paradies Y, 2016, J POPUL RES, V33, P83, DOI 10.1007/s12546-016-9159-y; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Patterson F, 2018, ADDICT BEHAV, V77, P47, DOI 10.1016/j.addbeh.2017.09.011; PHILLIPS BA, 1995, ARCH INTERN MED, V155, P734, DOI 10.1001/archinte.155.7.734; Piers LS, 2003, EUR J CLIN NUTR, V57, P956, DOI 10.1038/sj.ejcn.1601630; Ranganathan Priya, 2015, Perspect Clin Res, V6, P169, DOI 10.4103/2229-3485.159943; Rasmussen F, 2003, PREV MED, V37, P1, DOI 10.1016/S0091-7435(03)00043-4; Referendum Council, 2017, UL STAT HEART; Rosenman Robert, 2011, Int J Behav Healthc Res, V2, P320; Steene-Johannessen J, 2016, MED SCI SPORT EXER, V48, P235, DOI 10.1249/MSS.0000000000000760; Thurber KA, 2018, J EPIDEMIOL COMMUN H, V72, P491, DOI 10.1136/jech-2017-210064; Tomiyama AJ, 2019, ANNU REV PSYCHOL, V70, P703, DOI 10.1146/annurev-psych-010418-102936; Tuovinen Eeva-Liisa, 2016, Prev Med Rep, V4, P324, DOI 10.1016/j.pmedr.2016.07.003; Welfare AIoHa, 2017, AUSTR BURDEN DIS STU; Wilkinson RG, 2017, EUR J SOC PSYCHOL, V47, P11, DOI 10.1002/ejsp.2275; Wu YL, 2014, SLEEP MED, V15, P1456, DOI 10.1016/j.sleep.2014.07.018; Yiallourou SR, 2019, SLEEP MED, V59, P78, DOI 10.1016/j.sleep.2018.10.011	72	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263233	10.1371/journal.pone.0263233	http://dx.doi.org/10.1371/journal.pone.0263233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171935	Green Published, Green Accepted, gold			2022-12-26	WOS:000795889700016
J	Forys, U; Nahshony, A; Elishmereni, M				Forys, Urszula; Nahshony, Alon; Elishmereni, Moran			Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization	PLOS ONE			English	Article							ANDROGEN DEPRIVATION; TUMOR-GROWTH; DYNAMICS; PITUITARY	In this paper we present a new version of a mathematical model of Elishmereni et al. describing androgen deprivation therapy (ADT) for hormone sensitive prostate cancer patients (HSPC). We first focus on the detail description of the model, and then we present mathematical analysis of the proposed model, starting from the simplified model without resistance and ending on the full model with two resistance mechanisms present. We make a step towards personalization proposing an underlying tumor growth law base on a cohort of patients from Mayo hospital. We conclude that the model is able to reflect reality, that is in clinical scenarios the level of testosterone in HSPC patients inevitably rises leading to the failure of ADT.	[Forys, Urszula] Univ Warsaw, Fac Math Informat & Mech, Warsaw, Poland; [Forys, Urszula; Nahshony, Alon; Elishmereni, Moran] Inst Med Biomath, Bene Ataroth, Israel	University of Warsaw	Forys, U (corresponding author), Univ Warsaw, Fac Math Informat & Mech, Warsaw, Poland.; Forys, U (corresponding author), Inst Med Biomath, Bene Ataroth, Israel.	urszula@mimuw.edu.pl		Forys, Urszula/0000-0002-6198-3667	Polish National Agency for Academic Exchange (NAWA) [PPN/BEK/2018/1/00380/U/00001]	Polish National Agency for Academic Exchange (NAWA)(Polish National Agency for Academic Exchange (NAWA))	UF grant No. PPN/BEK/2018/1/00380/U/00001 Polish National Agency for Academic Exchange (NAWA) https://nawa.gov.pl/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSUKAS ID, 1994, CANCER RES, V54, P4385; Bodnar M, 2007, J BIOL SYST, V15, P453, DOI 10.1142/S0218339007002313; Bruce Justine Yang, 2012, Clin Adv Hematol Oncol, V10, P716; CARTWRIGHT M, 1986, J THEOR BIOL, V123, P239, DOI 10.1016/S0022-5193(86)80158-8; Crawford ED, 2019, PROSTATE CANCER P D, V22, P24, DOI 10.1038/s41391-018-0079-0; Elishmereni M, 2016, PROSTATE, V76, P48, DOI 10.1002/pros.23099; Fakhrejahani F, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0462-4; Fang D, 2019, ASIA-PAC J CLIN ONCO, V15, P108, DOI 10.1111/ajco.13108; FDA, HIGHL PRESCR INF LUP; Forys U, 2016, J MATH BIOL, V73, P867, DOI 10.1007/s00285-016-0978-4; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Greenhalgh D, 2009, NONLINEAR ANAL-THEOR, V71, pE925, DOI 10.1016/j.na.2009.01.031; GREENSPAN HP, 1976, J THEOR BIOL, V56, P229, DOI 10.1016/S0022-5193(76)80054-9; GREENSPAN HP, 1972, STUD APPL MATH, V51, P317; GREENSPAN HP, 1974, GROWTH, V38, P81; Higano CS, 2020, UROL ONCOL-SEMIN ORI, V38, P912, DOI 10.1016/j.urolonc.2020.07.004; Hoda MR, 2017, EXPERT OPIN PHARMACO, V18, P105, DOI 10.1080/14656566.2016.1258058; Katzenwadel A, 2015, CANCER LETT, V367, P12, DOI 10.1016/j.canlet.2015.06.021; LAIRD AK, 1965, BRIT J CANCER, V19, P278, DOI 10.1038/bjc.1965.32; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lim CN, 2015, CLIN PHARMACOKINET, V54, P963, DOI 10.1007/s40262-015-0251-9; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Murray JD., 2002, MATH BIOL, V1; Nakazawa M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0568-7; Phan T, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082721; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rawla P, 2019, WORLD J ONCOL, V10, P63, DOI 10.14740/wjon1191; Shore ND, 2020, PROSTATE, V80, P527, DOI 10.1002/pros.23967; SMITH WR, 1983, AM J PHYSIOL, V245, pR473, DOI 10.1152/ajpregu.1983.245.4.R473; SMITH WR, 1980, B MATH BIOL, V42, P57, DOI 10.1016/S0092-8240(80)80077-2; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wadosky KM, 2016, ONCOTARGET, V7, P64447, DOI 10.18632/oncotarget.10901	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263648	10.1371/journal.pone.0263648	http://dx.doi.org/10.1371/journal.pone.0263648			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167616	Green Published, gold			2022-12-26	WOS:000802227200012
J	Mushi, V; Zacharia, A; Shao, M; Mubi, M; Tarimo, D				Mushi, Vivian; Zacharia, Abdallah; Shao, Magdalena; Mubi, Marycelina; Tarimo, Donath			Persistence of Schistosoma haematobium transmission among school children and its implication for the control of urogenital schistosomiasis in Lindi, Tanzania	PLOS ONE			English	Article							RISK-FACTORS; SNAILS; AREA; IDENTIFICATION; PREVALENCE	Background Despite twelve rounds of school-based preventive chemotherapy for schistosomiasis in endemic areas of Tanzania such as Mtama district, Lindi: the burden of Schistosoma haematobium infection has remained highly conceivable due to re-infections. The factors associated with continuity of S.haematobium transmission in Mtama district, Lindi have not been fully established. This study investigated the burden and factors contributing to the ongoing transmission of S.haematobium infection in the endemic district of Mtama, Lindi. Methods A quantitative cross-sectional survey was carried out among 649 school-age children in the Mtama district to determine the burden and factors associated with continuity of S.haematobium infection transmission. A single urine specimen was obtained from each pupil and tested for macro- and microhaematuria, presence of S.haemato-bium ova, as well intensity of infection; this was complemented with a survey of Bulinus spp snail intermediate hosts and their infectivity. A structured questionnaire was employed to gather information on individual and environmental risk factors for S.haematobium transmission. Summary statistics were computed for individual variables; while a univariate and multivariate logistic regression analysis was performed to assess the association between risk factors with S.haemato-bium infection. Results Prevalence of S.haematobium infection by macro- and microhaematuria was 13.1% and 46.2% respectively. The prevalence of S.haematobium ova was 52.7%; intensity of infection was light in 53.1%, and heavy in 46.9%. Snail intermediate hosts were Bulinus globosus and B. nasutus, whose infectivity was 2.2% and 1.3%, respectively. Among the assessed risk factors, long residency (10-13 years) in the area was a significant risk factor for the con- tinuity of S.haematobium transmission (AOR: 21.79, 95% CI: 1.37-346.4). Conclusions The observed 52.7% prevalence of S.haematobium infection represents unacceptably high prevalence after 12 rounds of preventive chemotherapy. Therefore, an urgent need for the implementation of integrated multiple control interventions in the Mtama district; is considered to be imperative.	[Mushi, Vivian; Zacharia, Abdallah; Mubi, Marycelina; Tarimo, Donath] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Parasitol & Med Entomol, Dar Es Salaam, Tanzania; [Shao, Magdalena] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Environm & Occupat Hlth, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Mushi, V (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth & Social Sci, Dept Parasitol & Med Entomol, Dar Es Salaam, Tanzania.	vmushi31@gmail.com	Zacharia, Abdallah/AIB-8190-2022	Zacharia, Abdallah/0000-0001-9380-6158; Mushi, Vivian/0000-0001-9732-3057	Royal Society of Tropical Medicine & Hygiene Small Grants Program for early career researchers	Royal Society of Tropical Medicine & Hygiene Small Grants Program for early career researchers	VM received a small grant from the Royal Society of Tropical Medicine & Hygiene Small Grants Program for early career researchers (https://rstmh.org/grants/grant-awardees-2020).The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abbasi I, 2010, AM J TROP MED HYG, V83, P427, DOI 10.4269/ajtmh.2010.09-0764; Afiukwa FN., 2019, S E NIGERIA J PARASI, P7596069, DOI [10.1155/2019/7596069, DOI 10.1155/2019/7596069]; Ajibola O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36709-1; Allan F, 2013, ACTA TROP, V128, P234, DOI 10.1016/j.actatropica.2013.01.003; Amuta EU, 2014, ASIAN PAC J TROP MED, V7, P34, DOI 10.1016/S1995-7645(13)60188-1; Angelo T, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7041-5; Angelo T, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3064-5; [Anonymous], 2013, UN REP TANZ 2012 POP; Atalabi TE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006636; Bakuza Jared, 2018, East Afr Health Res J, V2, P156, DOI 10.24248/EAHRJ-D-18-00008; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Brown D., 1989, DANISH BILHARZ LAB; Brown DS, 1994, FRESHWATER SNAILS AF, DOI 10.1201/9781482295184; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd, DOI [10.1017/CBO9780511543470, DOI 10.1017/CBO9780511543470]; Creswell J.W., 2007, RES DESIGN QUALITATI; CSIR (Council for Scientific and Industrial Research), 2010, CSIRNREPWIR20110012A; Dabo A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-4; Dabo A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-21; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Ekpo UF, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-58; FRANDSEN F, 1984, ACTA TROP, V41, P181; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Grimes JET, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0766-9; Hajissa Khalid, 2018, BMC Res Notes, V11, P779, DOI 10.1186/s13104-018-3871-y; Kariuki HC, 2004, AM J TROP MED HYG, V70, P449; Kosinski KC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001709; M'Bra RK, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0431-6; Mazigo HD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-274; Mazigo HD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80317-x; Ministry of Health Community Development Gender E and C, 2018, NAT SAN CAMP; Musuva RM, 2014, AM J TROP MED HYG, V90, P646, DOI 10.4269/ajtmh.13-0488; Odhiambo GO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002784; Osakunor DNM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006144; Person B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004814; Sacolo H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2923-6; Secor WE, 2014, PATHOG GLOB HEALTH, V108, P246, DOI 10.1179/2047773214Y.0000000149; Senghor B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004557; Van GY, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050328; WHO, 2006, COORD US ANTH DRUGS; World Health Organization, 2002, PREV CONTR SCHIST SO; World Health Organization,, 1987, OSM DISTR SCHIST SO; World Health Organization, KEY FACTS SCHIST 201; World Health Organization, 2016, REP 2016 SCHIST CONT; Yangaza Y., 2021, MICROBES INFECT DIS	44	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263929	10.1371/journal.pone.0263929	http://dx.doi.org/10.1371/journal.pone.0263929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167622	Green Published, gold			2022-12-26	WOS:000802227200023
J	Zhao, D; Zheng, SL; Wang, XW; Liu, H; Zhao, KM; Li, L; Hu, Y				Zhao, Dong; Zheng, Shanliang; Wang, Xingwen; Liu, Hao; Zhao, Kunming; Li, Li; Hu, Ying			iASPP is essential for HIF-1 alpha stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HYPOXIA-INDUCIBLE FACTORS; UP-REGULATION; EXPRESSION; RESISTANCE; CELLS; HIF-1; P53; REPRESSION; HIF1-ALPHA	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays central roles in the hypoxia response. It is highly expressed in multiple cancers, but not always correlated with hypoxia. Mutation of the von Hippel-Lindau (VHL) gene, which encodes an E3 ligase, contributes to the constructive activation of HIF-1 alpha in specific tumor types, as exemplified by renal cell carcinoma; but how VHL wild-type tumors acquire this ability is not completely understood. Here, we found that the oncogene iASPP (inhibitor of apoptosis-simulating protein of p53) plays essential roles in such a context. Genetic inhibition of iASPP reduced tumor growth, accompanied by impaired angiogenesis, increased areas of tumor necrosis, and reduced glycolysis that was HIF-1 alpha-dependent. These abilities of iASPP were validated by in vitro assays. Mechanistically, iASPP directly binds VHL at its beta domain, a region also involved in HIF-1 alpha binding, therefore blocking VHL's binding and the subsequent degradation of HIF-1 alpha protein under normoxia. iASPP levels correlate with HIF-1 alpha protein and vascular endothelial growth factor (VEGF) and the glucose transporter protein type 1(GLUT1), representative HIF-1 alpha target genes, in human colon cancer tissues. Furthermore, inhibition of iASPP expression synergizes with low toxic dose of the HIF-1 alpha inhibitor YC-1 to inhibit HIF-1 alpha expression and tumor growth. Our findings suggest that iASPP contributes to HIF-1 alpha activation in cancers, and that iASPP-mediated HIF-1 alpha stabilization has potential as a therapeutic approach against cancer.	[Zhao, Dong; Zheng, Shanliang; Wang, Xingwen; Liu, Hao; Zhao, Kunming; Hu, Ying] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China; [Li, Li] Harbin Med Univ, Affiliated Hosp 3, Harbin 150040, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Medical University	Hu, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.	huying@hit.edu.cn		Zhao, Dong/0000-0001-7214-6947	National Natural Science Foundation of China [82025027, 31871389, 31741084, 32000517]; China Postdoctoral Science Foundation [2020M680045, 2021T140161]; Nature Science Foundation of Heilongjiang Province [YQ2021C024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nature Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was funded by the National Natural Science Foundation of China (No. 82025027, 31871389, 31741084, 32000517), China Postdoctoral Science Foundation (No. 2020M680045 and 2021T140161), and the Nature Science Foundation of Heilongjiang Province (No. YQ2021C024).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Buckley DL, 2012, J AM CHEM SOC, V134, P4465, DOI 10.1021/ja209924v; Cai Y, 2012, APOPTOSIS, V17, P777, DOI 10.1007/s10495-012-0728-z; de Heer EC, 2020, J CLIN INVEST, V130, P5074, DOI 10.1172/JCI137552; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Domene C, 2012, PROTEINS, V80, P733, DOI 10.1002/prot.23230; Du SC., 2019, CANCER CELL INT, V19; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Gao K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0561-6; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Ghosh AK, 2009, BLOOD, V113, P5568, DOI 10.1182/blood-2008-10-185686; Hoefflin R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17873-3; Hu Y, 2015, ONCOTARGET, V6, P42478, DOI 10.18632/oncotarget.6478; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jia YJ, 2014, FASEB J, V28, P2816, DOI 10.1096/fj.13-244632; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim JW, 2015, ANN SURG ONCOL, V22, P662, DOI 10.1245/s10434-014-4003-0; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Krzywinska E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01599-w; Kuczynski EA, 2019, NAT REV CLIN ONCOL, V16, P469, DOI 10.1038/s41571-019-0181-9; Kwon SJ, 2005, CLIN CANCER RES, V11, P7607, DOI 10.1158/1078-0432.CCR-05-0981; LaGory EL, 2016, NAT CELL BIOL, V18, P356, DOI 10.1038/ncb3330; Lang JY, 2019, ACS NANO, V13, P2176, DOI 10.1021/acsnano.8b08823; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; Lee YH, 2015, CLIN CANCER RES, V21, P1438, DOI 10.1158/1078-0432.CCR-14-1979; Li HY, 2020, J BIOL CHEM, V295, P4049, DOI 10.1074/jbc.RA119.011411; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Lu B, 2010, GASTROENTEROLOGY, V139, P2183, DOI 10.1053/j.gastro.2010.06.049; Lu M, 2016, CANCER CELL, V30, P822, DOI 10.1016/j.ccell.2016.09.019; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; Luu VD, 2009, CLIN CANCER RES, V15, P3297, DOI 10.1158/1078-0432.CCR-08-2779; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Martinez-Reyes I, 2021, NAT REV CANCER, V21, P669, DOI 10.1038/s41568-021-00378-6; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Merlo A, 2017, ONCOTARGET, V8, P1, DOI 10.18632/oncotarget.14265; Pandolfi S, 2015, CELL DEATH DIFFER, V22, P2006, DOI 10.1038/cdd.2015.56; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tosetti F, 2002, FASEB J, V16, P2, DOI 10.1096/fj.01-0300rev; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Triner D, 2016, J CLIN INVEST, V126, P3689, DOI 10.1172/JCI84430; Xiong Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0520-6; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhao WH, 2013, INT J MOL MED, V32, P101, DOI 10.3892/ijmm.2013.1365; Zhong H, 1999, CANCER RES, V59, P5830	55	2	2	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1944	1958		10.1038/s41388-022-02234-9	http://dx.doi.org/10.1038/s41388-022-02234-9		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35169254				2022-12-26	WOS:000755405100001
J	Tchakoute, CT; Rhee, SY; Hare, CB; Shaferid, RW; Sainani, K				Tchakoute, Christophe T.; Rhee, Soo-Yon; Hare, C. Bradley; Shaferid, Robert W.; Sainani, Kristin			Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system	PLOS ONE			English	Article							MEDICATION ADHERENCE; UNITED-STATES; DRUG-USERS; THERAPY; MORTALITY; SURVIVAL; SUPPRESSION; PROGRESSION; EFAVIRENZ; COUNT	Background Only a few recent reports have examined longitudinal adherence patterns in US clinics and its impact on immunological and virological outcomes among large cohorts initiating contemporary antiretroviral therapy (ART) in US clinics. Methods We followed all persons with HIV (PLWH) in a California clinic population initiating ART between 2010 and 2017. We estimated longitudinal adherence for each PLWH by calculating the medication possession ratio within multiple 6-month intervals using pharmacy refill records. Results During the study, 2315 PWLH were followed for a median time of 210.8 weeks and only 179 (7.7%) were lost-to-follow-up. The mean adherence was 84.9%. Age (Hazard Ratio (HR): (95% confidence interval): 1.25 (1.20-1.31) per 10-year increase) and Black race (HR: 0.62 (0.53-0.73) vs. White) were associated with adherence in the cohort. A 10% percent increase in adherence increased the odds of being virally suppressed by 37% (OR and 95% CI: 1.37 [1.33-1.41]) and was associated with an increase in mean CD4 count by 8.54 cells/ul in the next 6-month interval (p-value <0.0001). Conclusions Our study shows that despite large improvements in retention in care, demographic disparities in adherence to ART persist. Adherence was lower among younger patients and black patients. Our study confirmed the strong association between adherence to ART and viral suppression but could only establish a weak association between adherence and CD4 count. These findings reaffirm the importance of adherence and retention in care and further highlight the need for tailored patient-centered HIV Care Models as a strategy to improve PLWH's outcomes.	[Tchakoute, Christophe T.; Sainani, Kristin] Stanford Univ, Dept Med, Div Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Rhee, Soo-Yon; Shaferid, Robert W.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Hare, C. Bradley] Kaiser Permanente Northern Calif, Dept Infect Dis, San Francisco, CA USA	Stanford University; Stanford University; Kaiser Permanente	Sainani, K (corresponding author), Stanford Univ, Dept Med, Div Epidemiol & Populat Hlth, Stanford, CA 94305 USA.; Shaferid, RW (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.	rwshafer@stanford.edu; kcobb@stanford.edu		Sainani, Kristin/0000-0003-0614-303X	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH) [AI136618]	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH)	This study received support in part from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH) (award number AI136618, awarded to SYR and RWS). No additional external funding was received for this study.	Altice FL, 2007, CLIN INFECT DIS, V45, P770, DOI 10.1086/521166; Andrade ASA, 2013, JAIDS-J ACQ IMM DEF, V62, P282, DOI 10.1097/QAI.0b013e31827ed678; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Binquet C, 2001, AM J EPIDEMIOL, V153, P386, DOI 10.1093/aje/153.4.386; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Centers for Disease Control and Prevention, 2016, HIV SURVEILLANCE REP, V27; Chakraborty A, 2020, AIDS, V34, P127, DOI 10.1097/QAD.0000000000002384; Ciccarelli N, 2011, NEUROLOGY, V76, P1403, DOI 10.1212/WNL.0b013e31821670fb; Crepaz N, 2018, MMWR-MORBID MORTAL W, V67, P113, DOI 10.15585/mmwr.mm6704a2; DEGRUTTOLA V, 1994, BIOMETRICS, V50, P1003, DOI 10.2307/2533439; DeGruttola V, 1995, J ACQUIR IMMUNE DEFI, V6, P359; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Gordan N., 2015, SIMILARITY ADULT KAI; Haas DW, 2004, AIDS, V18, P2391; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Lima VD, 2007, AIDS, V21, P1175, DOI 10.1097/QAD.0b013e32811ebf57; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nance RM, 2018, ANN INTERN MED, V169, P376, DOI 10.7326/M17-2242; Oh DL, 2009, JAIDS-J ACQ IMM DEF, V52, P290, DOI 10.1097/QAI.0b013e3181ab6d48; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Press N, 2002, JAIDS-J ACQ IMM DEF, V31, pS112, DOI 10.1097/00126334-200212153-00005; Rhee SY, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa316; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Simoni JM, 2012, JAIDS-J ACQ IMM DEF, V60, P466, DOI 10.1097/QAI.0b013e31825db0bd; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	33	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263742	10.1371/journal.pone.0263742	http://dx.doi.org/10.1371/journal.pone.0263742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157724	Green Published, gold			2022-12-26	WOS:000788004500017
J	Chen, B; Xu, F; Gao, Y; Hu, GS; Zhu, KL; Lu, HY; Xu, A; Chen, SP; Wu, LJ; Zhao, GP				Chen, Bin; Xu, Feng; Gao, Yang; Hu, Guanshuo; Zhu, Kaili; Lu, Huayi; Xu, An; Chen, Shaopeng; Wu, Lijun; Zhao, Guoping			DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity	ONCOGENE			English	Article							STRAND BREAK REPAIR; PROTEIN-A RPA; REPLICATION; RAD51; IDENTIFICATION; INHIBITORS; DYNAMICS; SITES; SSDNA	HIGD1A is an important mitochondrial protein recently shown to have a novel nuclear localization under severe stress. However, whether this protein is also associated with the DNA damage response has rarely been studied. Here, we reported that DSBs-induced the translocation of mitochondrial HIGD1A to the nucleus is dependent on nuclear pore complex (NPCs), which finally promotes HR and radio/chemo-resistance. Importantly, NUP93 and HIGD1A physically interact and the interaction domain with NUP93 is located at residues 46-60 of HIGD1A. Chromatin-enriched HIGD1A can then directly interact with RPA. During the early stages of HR, HIGD1A promotes the loading of RPA to DSBs and activates the DNA damage-dependent chromatin association of RAD9-RAD1-HUS1 complex (9-1-1), which stimulates the ATR-Chk1-dependent G2/M DNA damage checkpoint. After facilitating RPA-ssDNA binding, HIGD1A in turn inhibits abnormal persistence of RPA1 foci by promoting ubiquitination of RPA1 and inducing its eventual proteasomal degradation. In addition, we have identified clinical drug Preveon associated with the HIGD1A-NUP93 interaction domain using a virtual screening approach. This compound directly interacted with HIGD1A, which was verified by NMR, and then inhibited HIGD1A translocation. Collectively, we demonstrate a novel role for HIGD1A in DSBs and provide rationale for using HIGD1A inhibitors as cancer therapeutics.	[Chen, Bin; Xu, Feng; Gao, Yang; Hu, Guanshuo; Zhu, Kaili; Xu, An; Chen, Shaopeng; Wu, Lijun; Zhao, Guoping] Chinese Acad Sci, High Magnet Field Lab, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Anhui, Peoples R China; [Chen, Bin; Xu, Feng; Gao, Yang; Hu, Guanshuo; Zhu, Kaili; Xu, An; Chen, Shaopeng; Wu, Lijun; Zhao, Guoping] Chinese Acad Sci, Hefei Inst Phys Sci, Anhui Prov Key Lab Environm Toxicol & Pollut Cont, Hefei 230031, Anhui, Peoples R China; [Chen, Bin; Xu, Feng; Gao, Yang; Hu, Guanshuo; Zhu, Kaili] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Lu, Huayi] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, USTC, Hefei 230001, Anhui, Peoples R China; [Wu, Lijun] Anhui Univ, Inst Phys Sci, Informat Mat & Intelligent Sensing Lab Anhui Prov, Hefei 230601, Anhui, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhao, GP (corresponding author), Chinese Acad Sci, High Magnet Field Lab, Key Lab High Magnet Field & Ion Beam Phys Biol, Hefei 230031, Anhui, Peoples R China.	gpz@ipp.ac.cn		Zhao, Guoping/0000-0002-4691-3257	National Science Fund for Excellent Young Scholars [12122510]; National Natural Science Foundation of China [32171240, 11835014, 31870845]; HFIPS Director's Fund [YZJJZX202014]; CAS Pioneer Hundred Talents Program	National Science Fund for Excellent Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HFIPS Director's Fund; CAS Pioneer Hundred Talents Program	This work was supported by the National Science Fund for Excellent Young Scholars (12122510), the National Natural Science Foundation of China (32171240, 11835014, and 31870845), the HFIPS Director's Fund (Grant No. YZJJZX202014) and the CAS Pioneer Hundred Talents Program (GZ).	Ameri K, 2015, CELL REP, V10, P891, DOI 10.1016/j.celrep.2015.01.020; Ameri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062758; An HJ, 2013, P NATL ACAD SCI USA, V110, P13014, DOI 10.1073/pnas.1307170110; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Cheng ZH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02823-0; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Ci SS, 2020, FASEB J, V34, P10443, DOI 10.1096/fj.201902904RR; Damasceno JD, 2016, MOL MICROBIOL, V101, P1054, DOI 10.1111/mmi.13441; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Dueva Rositsa, 2020, NAR Cancer, V2, pzcaa022, DOI 10.1093/narcan/zcaa022; Hayashi H, 2012, FASEB J, V26, P2306, DOI 10.1096/fj.11-196063; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Hsu DW, 2011, J CELL SCI, V124, P1655, DOI 10.1242/jcs.081471; Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Klammt C, 2012, NAT METHODS, V9, P834, DOI [10.1038/NMETH.2033, 10.1038/nmeth.2033]; Kosova AA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P643, DOI 10.1134/S0006297917060013; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Li T, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6051262; Liu C, 2013, INT J MOL SCI, V14, P14225, DOI 10.3390/ijms140714225; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Nagao T, 2020, FASEB J, V34, P1859, DOI 10.1096/fj.201800389R; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Pokhrel N, 2017, NUCLEIC ACIDS RES, V45, P9413, DOI 10.1093/nar/gkx598; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P783, DOI 10.1038/nrm.2017.116; Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tang JB, 2010, MOL CANCER RES, V8, P67, DOI 10.1158/1541-7786.MCR-09-0411; Timon-Gomez A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107607; Wassing IE, 2021, SEMIN CELL DEV BIOL, V113, P38, DOI 10.1016/j.semcdb.2020.08.010; WOZNIAK AJ, 1984, CANCER RES, V44, P626; Xu LM, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101604; Yang QY, 2017, P NATL ACAD SCI USA, V114, pE6054, DOI 10.1073/pnas.1700694114; Ying WH, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/691251; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	45	2	2	45	93	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1918	1930		10.1038/s41388-022-02226-9	http://dx.doi.org/10.1038/s41388-022-02226-9		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35152263				2022-12-26	WOS:000754368500002
J	Agyemang, EA; Kim, AA; Dobbs, T; Zungu, I; Payne, D; Maher, AD; Curran, K; Kim, E; Kwalira, H; Limula, H; Adhikari, A; Welty, S; Kandulu, J; Nyirenda, R; Auld, AF; Rutherford, GW; Parekh, BS				Agyemang, Elfriede A.; Kim, Andrea A.; Dobbs, Trudy; Zungu, Innocent; Payne, Danielle; Maher, Andrew D.; Curran, Kathryn; Kim, Evelyn; Kwalira, Hastings; Limula, Henry; Adhikari, Amitabh; Welty, Susie; Kandulu, James; Nyirenda, Rose; Auld, Andrew F.; Rutherford, George W.; Parekh, Bharat S.			Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018	PLOS ONE			English	Article							APPROPRIATE USE; COEFFICIENT; SPECIMENS; ASSAYS	Tests for recent HIV infection (TRI) distinguish recent from long-term HIV infections using markers of antibody maturation. The limiting antigen avidity enzyme immunoassay (LAg EIA) is widely used with HIV viral load (VL) in a recent infection testing algorithm (RITA) to improve classification of recent infection status, estimate population-level HIV incidence, and monitor trends in HIV transmission. A novel rapid test for recent HIV infection (RTRI), Asante (TM), can determine HIV serostatus and HIV recency within minutes on a lateral flow device through visual assessment of test strip or reader device. We conducted a field-based laboratory evaluation of the RTRI among pregnant adolescent girls and young women (AGYW) attending antenatal clinics (ANC) in Malawi. We enrolled pregnant AGYW aged <25 years testing HIV-positive for the first time at their first ANC visit from 121 ANCs in four high-HIV burden districts. Consenting participants provided blood for recency testing using LAg EIA and RTRI, which were tested in central laboratories. Specimens with LAg EIA normalized optical density values <= 2.0 were classified as probable recent infections. RTRI results were based on: (1) visual assessment: presence of a long-term line (LT) indicating non-recent infection and absence of the line indicating recent infection; or (2) a reader; specimens with LT line intensity units <3.0 were classified as probable recent infections. VL was measured for specimens classified as a probable recent infections by either assay; those with HIV-1 RNA >= 1,000 copies/mL were classified as confirmed recent infections. We evaluated the performance of the RTRI by calculating correlation between RTRI and LAg EIA results, and percent agreement and kappa between RTRI and LAg EIA RITA results.Between November 2017 to June 2018, 380 specimens were available for RTRI evaluation; 376 (98.9%) were confirmed HIV-positive on RTRI. Spearman's rho between RTRI and LAg EIA was 0.72 indicating strong correlation. Percent agreement and kappa between RTRI- and LAg EIA-based RITAs were >90% and >0.65 respectively indicating substantial agreement between the RITAs.This was the first field evaluation of an RTRI in sub-Saharan Africa, which demonstrated good performance of the assay and feasibility of integrating RTRI into routine HIV testing services for real-time surveillance of recent HIV infection.	[Agyemang, Elfriede A.; Kim, Andrea A.; Dobbs, Trudy; Curran, Kathryn; Adhikari, Amitabh; Parekh, Bharat S.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Zungu, Innocent; Payne, Danielle; Kim, Evelyn; Auld, Andrew F.] US Ctr Dis Control & Prevent, Div Global HIV & TB, Lilongwe, Malawi; [Maher, Andrew D.; Welty, Susie; Rutherford, George W.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Kwalira, Hastings; Limula, Henry; Kandulu, James; Nyirenda, Rose] Minist Hlth & Populat, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Agyemang, EA; Parekh, BS (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.	eagyemang@cdc.gov; bsp1@cdc.gov		Zungu, Lindiwe/0000-0001-5820-0281; Kim, Evelyn/0000-0002-9650-2093; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH000977]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement U2GGH000977. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	Aghaizu A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.2.20673; [Anonymous], 2014, KEN HIV PREV REV ROA; [Anonymous], 2011, US ASS REC INF EST H; [Anonymous], 2017, TECHNICAL SPECIFICAT; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Duong YT, 2019, AIDS RES HUM RETROV, V35, P896, DOI [10.1089/aid.2018.0284, 10.1089/AID.2018.0284]; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Garrett NJ, 2012, HIV MED, V13, P444, DOI 10.1111/j.1468-1293.2012.00990.x; Granade TC, 2013, AIDS RES HUM RETROV, V29, P61, DOI 10.1089/aid.2012.0121; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, AMB TREATM TARG HELP; Kassanjee R, 2016, AIDS, V30, P2361, DOI 10.1097/QAD.0000000000001209; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kim AA, 2019, AIDS, V33, P1527, DOI [10.1097/QAD.0000000000002239, 10.1097/qad.0000000000002239]; Maher AK AA, 2017, ASSESSMENT POINT OF, P18; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; McGillen JB, 2016, LANCET HIV, V3, pE441, DOI 10.1016/S2352-3018(16)30051-0; Measurement and Surveillance of HIV Epidemics (MeSH) Consortium, 2019, FEAS UT HIV REC INF; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Ministry of Health Malawi, 2019, EST HIV INC DE UNPUB; Ministry of Health Malawi, 2017, MAL POP BAS HIV IMP; Ministry of Health of Malawi, 2016, MAL HIV TEST SERV GU; Mukaka MM, 2012, MALAWI MED J, V24, P69; National AIDS Commission Malawi., 2015, NAT STRAT PLAN HIV A; Parekh B., 2017, IAS 2017 9 IAS C HIV; PEPFAR Solutions Platform, SURV REC HIV INF US; Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864; Sedia Biosciences Corporation, AS HIV 1 RAP REC ASS; Smith PR, 2014, 2014 AIDS C 2014 AID; SWRCB, 2015, EAR REP YEAR 2014; UNAIDS, 2020, GLOB HIV AIDS STAT F; UNAIDS, 2018, DAT 2018 REF; UNAIDS, 2014, FAST TRACK END AIDS; UNAIDS, GLOB HIV AIDS STAT 2; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0262071	10.1371/journal.pone.0262071	http://dx.doi.org/10.1371/journal.pone.0262071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148312	Green Published, gold			2022-12-26	WOS:000800108800008
J	Cole, LK; Sparagna, GC; Dolinsky, VW; Hatch, GM				Cole, Laura K.; Sparagna, Genevieve C.; Dolinsky, Vernon W.; Hatch, Grant M.			Altered cardiolipin metabolism is associated with cardiac mitochondrial dysfunction in pulmonary vascular remodeled perinatal rat pups	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEART-FAILURE; TETRALINOLEOYL-CARDIOLIPIN; FETAL CIRCULATION; RIGHT VENTRICLE; HYPERTENSION; BIOSYNTHESIS; INDOMETHACIN; HYPERTROPHY; NEWBORN	Pulmonary vascular remodeling (PVR) in utero results in the development of heart failure. The alterations that occur in cardiac lipid and mitochondrial bioenergetics during the development of in utero PVR was unknown. In this study, PVR was induced in pups in utero by exposure of pregnant dams to indomethacin and hypoxia and cardiac lipids, echocardiographic function and cardiomyocyte mitochondrial function were subsequently examined. Perinatal rat pups with PVR exhibited elevated left and right cardiac ventricular internal dimensions and reduced ejection fraction and fractional shortening compared to controls. Cardiac myocytes from these pups exhibited increased glycolytic capacity and glycolytic reserve compared to controls. However, respiration with glucose as substrate was unaltered. Fatty acid oxidation and ATP-insensitive respiration were increased in isolated cardiac myocytes from these pups compared to controls indicating a mitochondrial dysfunction. Although abundance of mitochondrial respiratory chain complexes was unaltered, increased trilinoleoyl-lysocardiolipin levels in these pups was observed. A compensatory increase in both cardiolipin and phosphatidylethanolamine content were observed due to increased synthesis of these phospholipids. These data indicate that alterations in cardiac cardiolipin and phospholipid metabolism in PVR rat pups is associated with the mitochondrial bioenergetic and cardiac functional defects observed in their hearts.	[Cole, Laura K.; Dolinsky, Vernon W.; Hatch, Grant M.] Univ Manitoba, Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada; [Cole, Laura K.; Dolinsky, Vernon W.; Hatch, Grant M.] Childrens Hosp Res Inst Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada; [Sparagna, Genevieve C.] Univ Colorado, Dept Med, Div Cardiol, Anschutz Med Ctr, Aurora, CO USA	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Colorado System; University of Colorado Anschutz Medical Campus	Hatch, GM (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, Winnipeg, MB, Canada.; Hatch, GM (corresponding author), Childrens Hosp Res Inst Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada.	ghatch@chrim.ca			Environments, Genes and Chronic Disease Canadian Institutes for Health Research (CIHR) [144626]; Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council (NSERC); Children's Hospital Research Institute of Manitoba (CHRIM); University of Manitoba Research Grants Program (URGP)	Environments, Genes and Chronic Disease Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Children's Hospital Research Institute of Manitoba (CHRIM); University of Manitoba Research Grants Program (URGP)	This research was supported by an Environments, Genes and Chronic Disease Canadian Institutes for Health Research (CIHR) Team Grant #144626, the Heart and Stroke Foundation of Canada, the Natural Sciences and Engineering Research Council (NSERC), Children's Hospital Research Institute of Manitoba (CHRIM) and the University of Manitoba Research Grants Program (URGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chatfield KC, 2014, J MOL CELL CARDIOL, V74, P251, DOI 10.1016/j.yjmcc.2014.06.002; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cole LK, 2020, J MOL CELL CARDIOL, V144, P24, DOI 10.1016/j.yjmcc.2020.05.001; Cole LK, 2016, DIABETES, V65, P3289, DOI 10.2337/db16-0114; Dakshinamurti S, 2005, PEDIATR PULM, V39, P492, DOI 10.1002/ppul.20201; Dolinsky VW, 2016, BBA-MOL CELL BIOL L, V1861, P1544, DOI 10.1016/j.bbalip.2016.03.008; Du YN, 2017, MOL MED REP, V16, P1117, DOI 10.3892/mmr.2017.6744; Duncan AL, 2020, BIOCHEM SOC T, V48, P993, DOI 10.1042/BST20190932; Fabris VE, 2001, PEDIATR PULM, V31, P344, DOI 10.1002/ppul.1057; Falabella M, 2021, TRENDS ENDOCRIN MET, V32, P224, DOI 10.1016/j.tem.2021.01.006; Fillmore N, 2014, J MOL CELL CARDIOL, V76, P71, DOI 10.1016/j.yjmcc.2014.08.002; Garcia AM, 2020, AM J PHYSIOL-HEART C, V318, pH787, DOI 10.1152/ajpheart.00494.2019; HARKER LC, 1981, PEDIATR RES, V15, P147, DOI 10.1203/00006450-198102000-00013; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; HERGET J, 1995, EUR RESPIR J, V8, P209, DOI 10.1183/09031936.95.08020209; Ikon N, 2017, LIPIDS, V52, P99, DOI 10.1007/s11745-016-4229-7; Koop AMC, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012086; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lozano Gonzalez C H, 1980, Ginecol Obstet Mex, V48, P103; Mejia Edgard M., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P98; MOISE KJ, 1988, NEW ENGL J MED, V319, P327, DOI 10.1056/NEJM198808113190602; Murashige D, 2020, SCIENCE, V370, P364, DOI 10.1126/science.abc8861; Perreault T, 2006, PAEDIATR RESPIR REV, V7, pS175, DOI 10.1016/j.prrv.2006.04.211; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; Rees ML, 2014, J ANIM PHYSIOL AN N, V98, P56, DOI 10.1111/jpn.12031; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Rohani L, 2020, CAN J CARDIOL, V36, P554, DOI 10.1016/j.cjca.2019.09.021; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; RUDOLPH AM, 1981, OBSTET GYNECOL, V58, pS63; Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979; Saini-Chohan HK, 2011, AM J PHYSIOL-HEART C, V301, pH1415, DOI 10.1152/ajpheart.00247.2011; Salatzki J, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007171; Shen ZN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891707; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Tarcan A, 2004, J PERINAT MED, V32, P98, DOI 10.1515/JPM.2004.019; Vosatka RJ, 2002, NEW ENGL J MED, V346, P864, DOI 10.1056/NEJM200203143461117; Wasmus C, 2020, LIFE-BASEL, V10, DOI 10.3390/life10110277; Xu XF, 2011, J MATERN-FETAL NEO M, V24, P172, DOI 10.3109/14767058.2010.482608; Xu XF, 2010, J HYPERTENS, V28, P2227, DOI 10.1097/HJH.0b013e32833e08f1; Yoshizawa T, 2013, HYPERTENSION, V61, P341, DOI 10.1161/HYPERTENSIONAHA.111.00647; Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263520	10.1371/journal.pone.0263520	http://dx.doi.org/10.1371/journal.pone.0263520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143544	gold, Green Published, Green Submitted			2022-12-26	WOS:000797657800052
J	Futerman, AH; Kim, JL; Mestre, B; Malitsky, S; Itkin, M; Kupervaser, M				Futerman, Anthony H.; Kim, Jiyoon L.; Mestre, Beatriz; Malitsky, Sergey; Itkin, Maxim; Kupervaser, Meital			Fatty acid transport protein 2 interacts with ceramide synthase 2 to promote ceramide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; FAMILY-MEMBERS; INHIBITION; GENES; IDENTIFICATION; METABOLISM; PHOSPHORYLATION; SPHINGOLIPIDS; NEUTROPHILS; CLONING	Dihydroceramide is a lipid molecule generated via the action of (dihydro)ceramide synthases (CerSs), which use two substrates, namely sphinganine and fatty acyl-CoAs. Sphinganine is generated via the sequential activity of two integral membrane proteins located in the endoplasmic reticulum. Less is known about the source of the fatty acyl-CoAs, although a number of cytosolic proteins in the pathways of acyl-CoA generation modulate ceramide synthesis via direct or indirect interaction with the CerSs. In this study, we demonstrate, by proteomic analysis of immunoprecipitated known as very long-chain acyl-CoA synthetase) directly interacts with CerS2 in mouse liver. Studies in cultured cells demonstrated that other members of the FATP family can also interact with CerS2, with the interaction dependent on both proteins being catalytically active. In addition, transfection of cells with FATP1, FATP2, or FATP4 increased ceramide levels although only FATP2 and 4 increased dihydroceramide levels, consistent with their known intracellular locations. Finally, we show that lipofermata, an FATP2 inhibitor which is believed to directly impact tumor cell growth via modulation of FATP2, decreased de novo dihydroceramide synthesis, suggesting that some of the proposed therapeutic effects of lipofermata may be mediated via (dihydro)ceramide rather than directly via acyl-CoA generation. In summary, our study reinforces the idea that manipulating the pathway of fatty acyl-CoA generation will impact a wide variety of down-stream lipids, not least the sphingolipids, which utilize two acyl-CoA moieties in the initial steps of their synthesis.	[Futerman, Anthony H.; Kim, Jiyoon L.; Kupervaser, Meital] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Mestre, Beatriz; Malitsky, Sergey] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel; [Itkin, Maxim] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.	tony.futerman@weizmann.ac.il	Itkin, Maxim/AFU-5181-2022	Itkin, Maxim/0000-0003-1348-2814; Kupervaser, Meital/0000-0002-1068-937X	Israel Science Foundation [1466/19]; Minerva Foundation; Walt and Rowena Shaw Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Walt and Rowena Shaw Foundation	We thank Dr Yael Pewzner-Yung for help with design of the coimmunoprecipitation experiments using CerS2 mouse null liver and Dr Tamir Dingjan for help with Figure 6. This work was supported by the Israel Science Foundation (grant number 1466/19) , the Minerva Foundation, and the Walt and Rowena Shaw Foundation. A. H. F. is the Joseph Meyerhoff Professor of Biochemistry at the Weizmann Institute of Science, Rehovot, Israel.	Ahowesso C, 2015, BIOCHEM PHARMACOL, V98, P167, DOI 10.1016/j.bcp.2015.09.004; Alicea GM, 2020, CANCER DISCOV, V10, P1282, DOI 10.1158/2159-8290.CD-20-0329; Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bickert A, 2018, BBA-MOL CELL BIOL L, V1863, P734, DOI 10.1016/j.bbalip.2018.04.006; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brachtendorf S, 2019, PROG LIPID RES, V74, P160, DOI 10.1016/j.plipres.2019.04.002; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Choi JY, 1999, J BIOL CHEM, V274, P4671, DOI 10.1074/jbc.274.8.4671; Dingjan T, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202100021; Elinger D, 2019, J PROTEOME RES, V18, P1441, DOI 10.1021/acs.jproteome.8b00891; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Ferreira NS, 2017, J BIOL CHEM, V292, P7588, DOI 10.1074/jbc.M117.785345; Fresques T, 2015, J BIOL CHEM, V290, P1395, DOI 10.1074/jbc.M114.621086; Futerman A. H., 2021, SPHINGOLIPIDS, V9, P281; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Kim JL, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101517; Kim JL, 2021, CELL SIGNAL, V82, DOI 10.1016/j.cellsig.2021.109958; Krammer J, 2011, INT J MED SCI, V8, P599, DOI 10.7150/ijms.8.599; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lin MH, 2014, BBA-MOL CELL BIOL L, V1841, P362, DOI 10.1016/j.bbalip.2013.09.016; Magaye RR, 2019, CELL MOL LIFE SCI, V76, P1107, DOI 10.1007/s00018-018-2984-8; Melton EM, 2011, J BIOL CHEM, V286, P30670, DOI 10.1074/jbc.M111.226316; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sandoval A, 2008, ARCH BIOCHEM BIOPHYS, V477, P363, DOI 10.1016/j.abb.2008.06.010; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tomasello DL, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103551; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; WANG E, 1991, J BIOL CHEM, V266, P14486; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Wellenstein MD, 2019, CANCER CELL, V35, P827, DOI 10.1016/j.ccell.2019.05.007; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang MM, 2018, CANCER DISCOV, V8, P1006, DOI 10.1158/2159-8290.CD-17-1371	53	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101735	10.1016/j.jbc.2022.101735	http://dx.doi.org/10.1016/j.jbc.2022.101735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35181339	Green Published, gold			2022-12-26	WOS:000797895000006
J	Bresque, M; Cal, K; Perez-Torrado, V; Colman, L; Rodriguez-Duarte, J; Vilaseca, C; Santos, L; Garat, MP; Ruiz, S; Evans, F; Dapueto, R; Contreras, P; Calliari, A; Escande, C				Bresque, Mariana; Cal, Karina; Perez-Torrado, Valentina; Colman, Laura; Rodriguez-Duarte, Jorge; Vilaseca, Cecilia; Santos, Leonardo; Garat, Maria Pia; Ruiz, Santiago; Evans, Frances; Dapueto, Rosina; Contreras, Paola; Calliari, Aldo; Escande, Carlos			SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; DEACETYLASE SIRT6; FATTY-ACIDS; ALPHA; OBESITY; DEGRADATION; ACTIVATION; EXPRESSION	Acute and chronic inflammations are key homeostatic events in health and disease. Sirtuins (SIRTs), a family of NAD-dependent protein deacylases, play a pivotal role in the regulation of these inflammatory responses. Indeed, SIRTs have anti-inflammatory effects through a myriad of signaling cascades, including histone deacetylation and gene silencing, p65/RelA deacetylation and inactivation, and nucleotide-binding oligomerization domain, leucine rich repeat, and pyrin domain-containing protein 3 inflammasome inhibition. Nevertheless, recent findings show that SIRTs, specifically SIRT6, are also necessary for mounting an active inflammatory response in macrophages. SIRT6 has been shown to positively regulate tumor necrosis factor alpha (TNF alpha) secretion by demyristoylating pro-TNF alpha in the cytoplasm. However, how SIRT6, a nuclear chromatin-binding protein, fulfills this function in the cytoplasm is currently unknown. Herein, we show by Western blot and immunofluorescence that in macrophages and fibroblasts there is a subpopulation of SIRT6 that is highly unstable and quickly degraded via the proteasome. Upon lipopolysaccharide stimulation in Raw 264.7, bone marrow, and peritoneal macrophages, this population of SIRT6 is rapidly stabilized and localizes in the cytoplasm, specifically in the vicinity of the endoplasmic reticulum, promoting TNF alpha secretion. Furthermore, we also found that acute SIRT6 inhibition dampens TNF alpha secretion both in vitro and in vivo, decreasing lipopolysaccharide-induced septic shock. Finally, we tested SIRT6 relevance in systemic inflammation using an obesity-induced chronic inflammatory in vivo model, where TNF alpha plays a key role, and we show that short-term genetic deletion of SIRT6 in macrophages of obese mice ameliorated systemic inflammation and hyperglycemia, suggesting that SIRT6 plays an active role in inflammation-mediated glucose intolerance during obesity.	[Bresque, Mariana; Cal, Karina; Perez-Torrado, Valentina; Colman, Laura; Santos, Leonardo; Garat, Maria Pia; Ruiz, Santiago; Dapueto, Rosina; Contreras, Paola; Calliari, Aldo; Escande, Carlos] Inst Pasteur Montevideo, INDICYO Program, Lab Metab Dis & Aging, Montevideo, Uruguay; [Bresque, Mariana; Rodriguez-Duarte, Jorge; Dapueto, Rosina] Inst Pasteur Montevideo, INDICYO Program, Lab Vasc Biol & Drug Dev, Montevideo, Uruguay; [Cal, Karina; Calliari, Aldo] Univ Republ UdelaR, Dept Biociencias, Fac Vet, Montevideo, Uruguay; [Perez-Torrado, Valentina] Univ Republ UdelaR, Dept Inmunobiol, Fac Med, Montevideo, Uruguay; [Perez-Torrado, Valentina] Univ Republ UdelaR, Area Inmunol, Dept Biociencias, Fac Quim, Montevideo, Uruguay; [Colman, Laura] Univ Republ UdelaR, Dept Quim Organ, Fac Quim, Montevideo, Uruguay; [Vilaseca, Cecilia; Contreras, Paola] Univ Republ UdelaR, Dept Fisiol, Fac Med, Montevideo, Uruguay; [Evans, Frances] Univ Republ UdelaR, Dept Histol & Embriol, Fac Med, Montevideo, Uruguay; [Evans, Frances] Inst Pasteur Montevideo, Lab Neuroinflammat & Gene Therapy, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Escande, C (corresponding author), Inst Pasteur Montevideo, INDICYO Program, Lab Metab Dis & Aging, Montevideo, Uruguay.	escande@pasteur.edu.uy	Ruíz, Santiago/HGU-6016-2022	Evans, Frances/0000-0002-7243-5295; Ruiz, Santiago/0000-0002-2626-6160	ANII [FCE_1_2014_1_104002, POS_NAC_2015_1_109950]; INNOVA II; FOCEM-Fondo para la Convergencia Estructural del Mercosur [COF 03/11]; CAP (UdelaR)	ANII; INNOVA II; FOCEM-Fondo para la Convergencia Estructural del Mercosur; CAP (UdelaR)	This work was supported by grants by ANII (grant nos.: FCE_1_2014_1_104002 and INNOVA II; to C. E.) and FOCEM-Fondo para la Convergencia Estructural del Mercosur (grant no.:COF 03/11). M. B. was supported by scholarships from ANII (grant no.: POS_NAC_2015_1_109950) and CAP (UdelaR).	Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837; Carreno M, 2020, J BIOL CHEM, V295, P18355, DOI 10.1074/jbc.RA120.014883; Chang AR, 2020, PHYSIOL REV, V100, P145, DOI 10.1152/physrev.00030.2018; Choi JE, 2014, CURR OPIN GENET DEV, V26, P24, DOI 10.1016/j.gde.2014.05.005; Dapueto R, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101833; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Enam C, 2018, ANNU REV BIOCHEM, V87, P725, DOI 10.1146/annurev-biochem-062917-012730; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Ferrara G, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01906-1; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iwahara T, 2012, MOL CELL BIOL, V32, P5022, DOI 10.1128/MCB.00822-12; Jiang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24371; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kitade M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00187; Kito Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62697-2; Lasiglie D, 2016, AGING-US, V8, P34, DOI 10.18632/aging.100870; Lee Y, 2017, DIABETES, V66, P2659, DOI 10.2337/db16-1446; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Pepin G, 2016, NUCLEIC ACIDS RES, V44, P5356, DOI 10.1093/nar/gkw405; Ronnebaum SM, 2013, MOL CELL BIOL, V33, P4461, DOI 10.1128/MCB.00480-13; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825; So KY, 2021, CELL BIOL TOXICOL, V37, P193, DOI 10.1007/s10565-020-09528-2; Sociali G, 2017, FASEB J, V31, P3138, DOI 10.1096/fj.201601294R; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667	33	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101711	10.1016/j.jbc.2022.101711	http://dx.doi.org/10.1016/j.jbc.2022.101711			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150745	Green Published, gold			2022-12-26	WOS:000821054100011
J	Fusi, L; Paudel, R; Meder, K; Schlosser, A; Schrama, D; Goebeler, M; Schmidt, M				Fusi, Lorenza; Paudel, Rupesh; Meder, Katharina; Schlosser, Andreas; Schrama, David; Goebeler, Matthias; Schmidt, Marc			Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER; FORKHEAD; DAF-16; IDENTIFICATION; ANGIOGENESIS; ACTIVATION; CHROMATIN; COFACTOR; TRIGGERS; BIM	Forkhead box O (FoxO) transcription factors are conserved proteins involved in the regulation of life span and age-related diseases, such as diabetes and cancer. Stress stimuli or growth factor deprivation promotes nuclear localization and activation of FoxO proteins, which-depending on the cellular context- can lead to cell cycle arrest or apoptosis. In endothelial cells (ECs), they further regulate angiogenesis and may promote inflammation and vessel destabilization implicating a role of FoxOs in vascular diseases. In several cancers, FoxOs exert a tumor-suppressive function by regulating proliferation and survival. We and others have previously shown that FoxOs can regulate these processes via two different mechanisms: by direct binding to forkhead-responsive elements at the promoter of target genes or by a poorly understood alternative process that does not require direct DNA binding and regulates key targets in primary human ECs. Here, we performed an interaction study in ECs to identify new nuclear FoxO3 interaction partners that might contribute to FoxO-dependent gene regulation. Mass spectrometry analysis of FoxO3-interacting proteins revealed transformation/transcription domain- associated protein (TRRAP), a member of multiple histone acetyltransferase complexes, as a novel binding partner of FoxO family proteins. We demonstrate that TRRAP is required to support FoxO3 transactivation and FoxO3-dependent G1 arrest and apoptosis in ECs via transcriptional activation of the cyclin-dependent kinase inhibitor p27kip1 and the proapoptotic TRRAP interaction could explain FoxO-induced alternative	[Fusi, Lorenza; Paudel, Rupesh; Meder, Katharina; Schrama, David; Goebeler, Matthias; Schmidt, Marc] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Schlosser, Andreas] Univ Wurzburg, Rudolf Virchow Ctr, Ctr Integrat & Translat Bioimaging, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Schmidt, M (corresponding author), Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany.	schmidt_M11@ukw.de	Schmidt, Marc/E-8821-2010	Schmidt, Marc/0000-0002-8643-1615; Fusi, Lorenza/0000-0003-3488-5137; Paudel, Rupesh/0000-0001-6361-0162; Schrama, David/0000-0002-6931-8194	Deutsche Forschungsgemeinschaft (DFG) [DFG SCHM2460/3-1, DFG SCHM2460/2-1]; Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg [Z4/153]; Open Access Publication Fund of the University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg; Open Access Publication Fund of the University of Wuerzburg	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG) (grant nos.: DFG SCHM2460/3-1 and DFG SCHM2460/2-1; to M. S.) and the Interdisciplinary Centre for Clinical Research (IZKF), Wuerzburg (grant no.: Z4/153; to M. S.) In addition, this publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calissi G, 2021, NAT REV DRUG DISCOV, V20, P21, DOI 10.1038/s41573-020-0088-2; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Elias-Villalobos A, 2019, BIOCHEM SOC T, V47, P1597, DOI 10.1042/BST20180496; Finkbeiner MG, 2008, CELL CYCLE, V7, P3908, DOI 10.4161/cc.7.24.7354; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Hornsveld M, 2018, SEMIN CANCER BIOL, V50, P90, DOI 10.1016/j.semcancer.2017.11.017; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Muller V, 2007, J IMMUNOL, V179, P8435, DOI 10.4049/jimmunol.179.12.8435; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Voss AK, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800078; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498	42	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101714	10.1016/j.jbc.2022.101714	http://dx.doi.org/10.1016/j.jbc.2022.101714			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151693	Green Published, gold			2022-12-26	WOS:000789394500001
J	Wang, HQ; Zhang, JB; Zheng, Y; Zhang, WD; Guo, HX; Cong, S; Ding, Y; Yuan, B				Wang, Hao-Qi; Zhang, Jia-Bao; Zheng, Yi; Zhang, Wei-Di; Guo, Hai-Xiang; Cong, Shuai; Ding, Yu; Yuan, Bao			Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in the rat adenohypophysis after GnRH treatment	FASEB JOURNAL			English	Article						animal reproduction; follicle-stimulating hormone; m(6)A modification; m(6)A-seq; Pituitary	MESSENGER-RNA; GENE-EXPRESSION; SUBUNIT; TRANSCRIPTION; TRANSLATION; TURNOVER; ACTIVIN; NUCLEAR	N6-methyladenosine is considered to be the most common and abundant internal chemical modification among the more than 150 identified chemical RNA modifications. It is involved in most biological processes and actively participates in the regulation of animal reproduction. However, the potential function of m(6)A in the pituitaries of mammals is not yet clear. It is also unknown whether m(6)A is involved in the secretion and regulation of FSH by GnRH, which in turn affects mammalian reproduction. In this study, rats were treated with gonadorelin to simulate physiological GnRH-mediated regulation of FSH synthesis and secretion, and m(6)A-seq was used to analyze the differential m(6)A modification of the rat pituitary after gonadorelin treatment. A whole-transcriptome map of m(6)A in the rat pituitary gland before and after gonadorelin treatment was successfully created. A total of 6413 differential peaks were identified, of which 3764 m(6)A peaks were upregulated and 2649 m(6)A peaks were downregulated. Among the 709 differentially expressed genes, 250 genes were discovered with differential methylation modifications. Intriguingly, the altered m(6)A peaks within mRNAs were enriched in steroid biosynthetic processes and responses to cAMP. The results of the study will lay a foundation for further exploration of the potential role of m(6)A modification in the regulation of reproductive hormone secretion and provide a theoretical basis for the application of GnRH analogs in mammalian artificial reproduction.	[Wang, Hao-Qi; Zhang, Jia-Bao; Zheng, Yi; Zhang, Wei-Di; Guo, Hai-Xiang; Cong, Shuai; Ding, Yu; Yuan, Bao] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun 130062, Jilin, Peoples R China	Jilin University	Ding, Y; Yuan, B (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun 130062, Jilin, Peoples R China.	ding_yu@jlu.edu.cn; yuan_bao@jlu.edu.cn			National Natural Science Foundation of China (NSFC) [32172729]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 32172729	Bi XH, 2021, CANCER GENE THER, V28, P335, DOI 10.1038/s41417-020-00222-3; BOURNE GA, 1987, AM J PHYSIOL, V253, pE296, DOI 10.1152/ajpendo.1987.253.3.E296; Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Chen De-Quan, 2015, Sheng Li Ke Xue Jin Zhan, V46, P408; Chen YJ, 2007, J ENDOCRINOL, V192, P405, DOI 10.1677/JOE-06-0076; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Cui XC, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12768; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Gan Haili, 2019, Sheng Wu Gong Cheng Xue Bao, V35, P775, DOI 10.13345/j.cjb.180416; Hong GK, 2016, OTOLARYNG CLIN N AM, V49, P21, DOI 10.1016/j.otc.2015.09.002; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kaprara A, 2018, METABOLISM, V86, P3, DOI 10.1016/j.metabol.2017.11.018; Kwon J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44714-1; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1; Lesbirel S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32310-8; Li D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051660; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Liu SP, 2020, AM J CANCER RES, V10, P1631; Livneh I, 2020, NAT REV NEUROSCI, V21, P36, DOI 10.1038/s41583-019-0244-z; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Minegishi T, 1999, MOL CELL ENDOCRINOL, V149, P71, DOI 10.1016/S0303-7207(98)00259-7; PERRY RP, 1973, J MOL BIOL, V79, P681, DOI 10.1016/0022-2836(73)90071-5; PERRY RP, 1974, J MOL BIOL, V82, P315, DOI 10.1016/0022-2836(74)90593-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schang G, 2019, J MOL ENDOCRINOL, V62, P67, DOI 10.1530/JME-18-0145; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Stamatiades GA, 2018, MOL CELL ENDOCRINOL, V463, P131, DOI 10.1016/j.mce.2017.10.015; Thompson IR, 2016, MOL ENDOCRINOL, V30, P348, DOI 10.1210/me.2015-1222; Thompson IR, 2013, MOL ENDOCRINOL, V27, P606, DOI 10.1210/me.2012-1281; Wang CX, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004880; Wang HQ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11113262; Wang HQ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11041134; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang YR, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01318; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Wu ZM, 2020, NUCLEIC ACIDS RES, V48, P11083, DOI 10.1093/nar/gkaa816; Xie HM, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0304-z; Xie HM, 2015, MOL ENDOCRINOL, V29, P842, DOI 10.1210/me.2014-1279; Yang Ying, 2018, Yichuan, V40, P964, DOI 10.16288/j.yczz.18-175; Yao YX, 2019, FASEB J, V33, P7529, DOI 10.1096/fj.201802644R; Yuan B, 2015, INT J CLIN EXP MED, V8, P13289; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	51	2	2	6	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22204	10.1096/fj.202101608R	http://dx.doi.org/10.1096/fj.202101608R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147984				2022-12-26	WOS:000761250800054
J	Zhang, J; Zhang, ZJ; Holst, S; Bloechl, C; Madunic, K; Wuhrer, M; Ten Dijke, P; Zhang, T				Zhang, Jing; Zhang, Zejian; Holst, Stephanie; Bloechl, Constantin; Madunic, Katarina; Wuhrer, Manfred; Ten Dijke, Peter; Zhang, Tao			Transforming growth factor-beta challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NON-SMAD; GENE-EXPRESSION; CANCER; GLYCOSYLATION; RECEPTOR; MIGRATION; PROTEINS; KINASE; METASTASIS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor prognosis and high mortality. Transforming growth factor-beta (TGF-beta) plays a key role in PDAC tumor progression, which is often associated with aberrant glycosylation. However, how PDAC cells respond to TGF-beta and the role of glycosylation therein is not well known. Here, we investigated the TGF-beta-mediated response and glycosylation changes in the PaTu-8955S (PaTu-S) cell line deficient in SMA-related and MAD-related protein 4 (SMAD4), a signal transducer of the TGF-beta signaling. PaTu-S cells responded to TGF-beta by upregulating SMAD2 phosphorylation and target gene expression. We found that TGF-beta induced expression of the mesenchymal marker N-cadherin but did not significantly affect epithelial marker E-cadherin expression. We also examined differences in N-glycans, O-glycans, and glycosphingolipid-linked glycans in PaTu-S cells upon TGF-beta stimulation. TGF-beta treatment primarily induced N-glycome aberrations involving elevated levels of branching, core fucosylation, and sialylation in PaTu-S cells, in agreement with TGF-beta-induced changes in the expression of glycosylation-associated genes. In addition, we observed differences in O glycosylation and glycosphingolipid glycosylation profiles after TGF-beta treatment, including lower levels of sialylated Tn antigen and neoexpression of globosides. Furthermore, the expression of transcription factor sex-determining region Y-related high-mobility group box 4 was upregulated upon TGF-beta stimulation, and its depletion blocked TGF-beta-induced N-glycomic changes. Thus, TGF-beta-induced N-glycosylation changes can occur in a sex-determining region Y-related high-mobility group box 4-dependent and SMAD4-independent manner in the pancreatic PaTu-S cancer cell line. Our results open up avenues to study the relevance of glycosylation in TGF-beta signaling in SMAD4-inactivated PDAC.	[Zhang, Jing; Ten Dijke, Peter] Oncode Inst, Leiden, Netherlands; [Zhang, Jing; Ten Dijke, Peter] Dept Cell Chem Biol, Leiden, Netherlands; [Zhang, Zejian; Holst, Stephanie; Bloechl, Constantin; Madunic, Katarina; Wuhrer, Manfred; Zhang, Tao] Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands; [Bloechl, Constantin] Salzburg Univ, Dept Biosci, Salzburg, Austria; [Zhang, Zejian] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med Res Ctr, Beijing, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Salzburg University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Ten Dijke, P (corresponding author), Oncode Inst, Leiden, Netherlands.; Ten Dijke, P (corresponding author), Dept Cell Chem Biol, Leiden, Netherlands.; Zhang, T (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metab, Leiden, Netherlands.	P.ten_Dijke@lumc.nl; T.Zhang@lumc.nl	Zhang, Zejian/GQG-9538-2022; Dijke, Peter ten/AAG-4660-2021; Zhang, Zejian/GQG-9492-2022	Dijke, Peter ten/0000-0002-7234-342X; Blochl, Constantin/0000-0003-3406-4232; Madunic, Katarina/0000-0002-9310-4110; Wuhrer, Manfred/0000-0002-0814-4995	Chinese Scholarship Council; Cancer Genomics Centre Netherlands; Austrian Science Fund (FWF) [W1213]	Chinese Scholarship Council(China Scholarship Council); Cancer Genomics Centre Netherlands; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Chinese Scholarship Council to J. Z., Cancer Genomics Centre Netherlands to P. t. D., and Austrian Science Fund (FWF, grant number: W1213) to C. B.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Anugraham M, 2015, RAPID COMMUN MASS SP, V29, P545, DOI 10.1002/rcm.7130; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Bagati A, 2021, CANCER CELL, V39, P54, DOI 10.1016/j.ccell.2020.12.001; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; Budi EH, 2017, TRENDS CELL BIOL, V27, P658, DOI 10.1016/j.tcb.2017.04.005; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Dardare J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103534; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2019, DEV CELL, V49, P313, DOI 10.1016/j.devcel.2019.04.026; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Distler M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/474905; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Engle DD, 2019, SCIENCE, V364, P1156, DOI 10.1126/science.aaw3145; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Fink SP, 2003, ONCOGENE, V22, P1317, DOI 10.1038/sj.onc.1206128; Fischer CG, 2018, J PATHOL, V246, P395, DOI 10.1002/path.5154; Geyer PE, 2016, MOL CANCER THER, V15, P1008, DOI 10.1158/1535-7163.MCT-15-0633; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Holst S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16811-6; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Huang CY, 2015, FEBS J, V282, P4295, DOI 10.1111/febs.13419; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; INOKUCHI J, 1990, CANCER RES, V50, P6731; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Itakura J, 1997, CLIN CANCER RES, V3, P1309; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kabacaoglu D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01878; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim SJ, 2013, BIOCHEM J, V449, P241, DOI 10.1042/BJ20120189; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Leeming DJ, 2011, BIOMARKERS, V16, P193, DOI 10.3109/1354750X.2011.557440; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Madunic K, 2021, CELL MOL LIFE SCI, V78, P337, DOI 10.1007/s00018-020-03504-z; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malik R, 2015, TRENDS BIOTECHNOL, V33, P230, DOI 10.1016/j.tibtech.2015.01.004; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070063; Munkley J, 2019, ONCOL LETT, V17, P2569, DOI 10.3892/ol.2019.9885; Munkley J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030275; Murphy SJ, 2013, GASTROENTEROLOGY, V145, P1098, DOI 10.1053/j.gastro.2013.07.049; Nie S, 2014, J PROTEOME RES, V13, P1873, DOI 10.1021/pr400967x; Niedergethmann M, 2002, PANCREAS, V25, P122, DOI 10.1097/00006676-200208000-00002; Nigjeh EN, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700064; Pan S, 2020, CANCER LETT, V469, P429, DOI 10.1016/j.canlet.2019.11.020; Pan S, 2014, J PROTEOME RES, V13, P1293, DOI 10.1021/pr4010184; Perkhofer L, 2021, GUT, V70, P606, DOI 10.1136/gutjnl-2019-319984; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Qian YZ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00958-3; Reitz D, 2015, J CLIN PATHOL, V68, P427, DOI 10.1136/jclinpath-2014-202451; Ren J, 2017, JOVE-J VIS EXP, DOI 10.3791/55459; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Saxena K, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100845; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stimmer L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-916; Storck W, 2012, BIOL CHEM, V393, P785, DOI 10.1515/hsz-2012-0165; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Varadaraj A, 2017, MOL BIOL CELL, V28, P1195, DOI 10.1091/mbc.E16-08-0601; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang MM, 2019, CLIN CHEM LAB MED, V57, P407, DOI 10.1515/cclm-2018-0379; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Yang YB, 1997, BIOCHEMISTRY-US, V36, P11923, DOI 10.1021/bi9710479; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang J, 2021, PROTEIN CELL, V12, P89, DOI 10.1007/s13238-020-00741-7; Zhang L, 2013, MOL CELL, V51, P559, DOI 10.1016/j.molcel.2013.07.014; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang T, 2020, MOL OMICS, V16, P355, DOI 10.1039/c9mo00180h; Zhang T, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00732; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhang YM, 2015, INT J CLIN EXP MED, V8, P11683; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhao J, 2007, J PROTEOME RES, V6, P1126, DOI 10.1021/pr0604458	109	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101717	10.1016/j.jbc.2022.101717	http://dx.doi.org/10.1016/j.jbc.2022.101717			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151689	gold, Green Published			2022-12-26	WOS:000789394500010
J	Bedi, S; Richardson, TM; Jia, BF; Saab, H; Brinkman, FSL; Westley, M				Bedi, Suhana; Richardson, Tiffany M.; Jia, Baofeng; Saab, Hadeel; Brinkman, Fiona S. L.; Westley, Monica			Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes	PLOS ONE			English	Article							BETA-CELLS; MICROBIOTA; ONSET; GABA	A variety of islet autoantibodies (AAbs) can predict and possibly dictate eventual type 1 diabetes (T1D) diagnosis. Upwards of 75% of those with T1D are positive for AAbs against glutamic acid decarboxylase (GAD65 or GAD), a producer of gamma-aminobutyric acid (GABA) in human pancreatic beta cells. Interestingly, bacterial populations within the human gut also express GAD and produce GABA. Evidence suggests that dysbiosis of the microbiome may correlate with T1D pathogenesis and physiology. Therefore, autoimmune linkages between the gut microbiome and islets susceptible to autoimmune attack need to be further elucidated. Utilizing in silico analyses, we show that 25 GAD sequences from human gut bacterial sources show sequence and motif similarities to human beta cell GAD65. Our motif analyses determined that most gut GAD sequences contain the pyroxical dependent decarboxylase (PDD) domain of human GAD65, which is important for its enzymatic activity. Additionally, we showed overlap with known human GAD65 T cell receptor epitopes, which may implicate the immune destruction of beta cells. Thus, we propose a physiological hypothesis in which changes in the gut microbiome in those with T1D result in a release of bacterial GAD, thus causing miseducation of the host immune system. Due to the notable similarities we found between human and bacterial GAD, these deputized immune cells may then target human beta cells leading to the development of T1D.	[Bedi, Suhana] Univ Texas Dallas, Dept Nat Sci & Math, Richardson, TX 75083 USA; [Richardson, Tiffany M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA; [Jia, Baofeng; Brinkman, Fiona S. L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, CA USA; [Saab, Hadeel; Westley, Monica] Sugar sci, Los Angeles, CA 90001 USA	University of Texas System; University of Texas Dallas; Vanderbilt University	Westley, M (corresponding author), Sugar sci, Los Angeles, CA 90001 USA.	monica@thesugarscience.org		Richardson, Tiffany/0000-0002-0272-6804; Bedi, Suhana/0000-0002-4502-4191	Canadian Institutes of Health Research (CIHR) doctoral scholarship; National Science Foundation Graduate Research Fellowship; Simon Fraser University distinguished professorship; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR) doctoral scholarship(Canadian Institutes of Health Research (CIHR)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Simon Fraser University distinguished professorship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The(sugar)science is an all-volunteer 501c3 non-profit organization. B.J. was supported by a Canadian Institutes of Health Research (CIHR) doctoral scholarship. T.M.R. was supported by a National Science Foundation Graduate Research Fellowship, and F.S.L.B. has a Simon Fraser University distinguished professorship and support from the Natural Sciences and Engineering Research Council of Canada (NSERC).	Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Cianciaruso C, 2017, DIABETES, V66, P460, DOI 10.2337/db16-0671; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Duranti S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70986-z; EMBL-EBI, SIMPL PHYL; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Harbison JE, 2019, PEDIATR DIABETES, V20, P574, DOI 10.1111/pedi.12865; James EA, 2020, DIABETES, V69, P1311, DOI 10.2337/dbi19-0022; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Leiva-Gea I, 2018, DIABETES CARE, V41, P2385, DOI 10.2337/dc18-0253; Li Y, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.690783; Mishra S, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030067; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Pereira MS, 2022, J INVEST DERMATOL, V142, P834, DOI 10.1016/j.jid.2021.12.005; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; Pokusaeva K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12904; Prause M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910427; Rubi B, 2012, MED HYPOTHESES, V78, P179, DOI 10.1016/j.mehy.2011.10.021; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243; Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Towns R, 2011, DRUG FUTURE, V36, P847, DOI 10.1358/dof.2011.036.11.1710754; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Zhou H, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00125	28	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0261103	10.1371/journal.pone.0261103	http://dx.doi.org/10.1371/journal.pone.0261103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196314	Green Submitted, gold, Green Published			2022-12-26	WOS:000835161600002
J	Inoue, M; Nagai-Yoshioka, Y; Yamasaki, R; Kawamoto, T; Nishihara, T; Ariyoshi, W				Inoue, Momoko; Nagai-Yoshioka, Yoshie; Yamasaki, Ryota; Kawamoto, Tatsuo; Nishihara, Tatsuji; Ariyoshi, Wataru			Mechanisms involved in suppression of osteoclast supportive activity by transforming growth factor-beta 1 via the ubiquitin-proteasome system	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; TGF-BETA; BONE; EXPRESSION; DIFFERENTIATION; CELLS; RANKL	Orthodontic treatment requires the regulation of bone remodeling in both compression and tension sides. Transforming growth factor-beta 1 (TGF-beta 1) is an important coupling factor for bone remodeling. However, the mechanism underlying the TGF-beta 1-mediated regulation of the osteoclast-supporting activity of osteoblasts and stromal cells remain unclear. The current study investigated the effect of TGF-beta 1 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in stromal cells induced by 1 alpha,25(OH)(2)D-3 (D-3) and dexamethasone (Dex). TGF-beta 1 downregulated the expression of RANKL induced by D-3 and Dex in mouse bone marrow stromal lineage, ST2 cells. Co-culture system revealed that TGF-beta 1 suppressed osteoclast differentiation from bone marrow cell induced by D-3 and Dex-activated ST2 cells. The inhibitory effect of TGF-beta 1 on RANKL expression was recovered by inhibiting the interaction between TGF-beta 1 and the TGF-beta type I/activin receptor or by down-regulating of smad2/3 expression. Interestingly, TGF-beta 1 degraded the retinoid X receptor (RXR)-alpha protein which forms a complex with vitamin D receptor (VDR) and regulates transcriptional activity of RANKL without affecting nuclear translocation of VDR and phosphorylation of signal transducer and activator of transcription3 (STAT3). The degradation of RXR-alpha protein by TGF-beta 1 was recovered by a ubiquitin-proteasome inhibitor. We also observed that poly-ubiquitination of RXR-alpha protein was induced by TGF-beta 1 treatment. These results indicated that TGF-beta 1 downregulates RANKL expression and the osteoclast-supporting activity of osteoblasts/stromal cells induced by D-3 and Dex through the degradation of the RXR-alpha protein mediated by ubiquitin-proteasome system.	[Inoue, Momoko; Nagai-Yoshioka, Yoshie; Yamasaki, Ryota; Nishihara, Tatsuji; Ariyoshi, Wataru] Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan; [Inoue, Momoko; Kawamoto, Tatsuo] Kyushu Dent Univ, Div Orofacial Funct & Orthodont, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan	Kyushu Dental University; Kyushu Dental University	Ariyoshi, W (corresponding author), Kyushu Dent Univ, Div Infect & Mol Biol, Dept Hlth Promot, Kitakyushu, Fukuoka, Japan.	arikichi@kyu-dent.ac.jp			Japan Society for the Promotion of Science [18K09797, 21H03145]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by the Japan Society for the Promotion of Science Grantin-Aid for Scientific Research awarded to WA (grant number: 18K09797 and 21H03145).	Alotaibi MK, 2016, ARCH ORAL BIOL, V71, P38, DOI 10.1016/j.archoralbio.2016.06.023; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Castroflorio T, 2017, ANGLE ORTHOD, V87, P74, DOI 10.2319/022416-159.1; Chaweewannakorn W, 2019, J CELL PHYSIOL, V234, P1745, DOI 10.1002/jcp.27045; Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085; Chen Y, 1996, J BIOL CHEM, V271, P31602, DOI 10.1074/jbc.271.49.31602; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Galvin RJS, 1999, BIOCHEM BIOPH RES CO, V265, P233, DOI 10.1006/bbrc.1999.1632; Garlet TP, 2007, EUR J ORAL SCI, V115, P355, DOI 10.1111/j.1600-0722.2007.00469.x; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Henneman S, 2008, EUR J ORTHODONT, V30, P299, DOI 10.1093/ejo/cjn020; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Kajita T, 2018, J CELL BIOCHEM, V119, P6974, DOI 10.1002/jcb.26906; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kasagi S, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-4; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Onal M, 2016, J BONE MINER RES, V31, P416, DOI 10.1002/jbmr.2698; Pike JW, 2017, ENDOCRIN METAB CLIN, V46, P815, DOI 10.1016/j.ecl.2017.07.001; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Shoji-Matsunaga A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09326-7; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tokunaga T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030800; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Uematsu S, 1996, ARCH ORAL BIOL, V41, P1091, DOI 10.1016/S0003-9969(96)00063-5; Wrana JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011197; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yu Z, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190350; Zhao HY, 2017, MOL CELLS, V40, P211, DOI 10.14348/molcells.2017.2303	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0262612	10.1371/journal.pone.0262612	http://dx.doi.org/10.1371/journal.pone.0262612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196318	gold, Green Published			2022-12-26	WOS:000835161600004
J	Bugalhao, JN; Luis, MP; Pereira, IS; da Cunha, M; Pais, SV; Mota, LJ				Bugalhao, Joana N.; Luis, Maria P.; Pereira, Ines S.; da Cunha, Maria; Pais, Sara, V; Mota, Luis Jaime			The Chlamydia trachomatis inclusion membrane protein CT006 associates with lipid droplets in eukaryotic cells	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; SECRETED PROTEINS; EXPRESSION; IDENTIFICATION; LOCALIZATION; SEQUENCE; PLATFORM; BIOLOGY	Chlamydia trachomatis causes genital and ocular infections in humans. This bacterial pathogen multiplies exclusively within host cells in a characteristic vacuole (inclusion) and delivers proteins such as inclusion membrane proteins (Ins) into the host cell. Here, we identified CT006 as a novel C. trachomatis protein that when expressed ectopically eukaryotic cells can associate with lipid droplets (LDs). A screen using Saccharomyces cerevisiae identified two Ins causing vacuolar protein sorting defects and seven Ins showing tropism for eukaryotic organelles. Ectopic expression in yeast and mammalian cells of genes encoding different fragments of CT006 revealed tropism for the endoplasmic reticulum and LDs. We identified a LD-targeting region within the first 88 amino acid residues of CT006, and positively charged residues important for this targeting. Comparing with the parental wild-type strain, cells infected by a newly generated C. trachomatis strain overproducing CT006 with a double hemagglutinin tag showed a slight increase in the area occupied by LDs within the inclusion region. However, we could not correlate this effect with the LD-targeting regions within CT006. We further showed that both the amino and carboxy-terminal regions of CT006, flanking the Inc-characteristic bibbed hydrophobic domain, are exposed to the host cell cytosol during C. trachomatis infection, supporting their availability to interact with host cell targets. Altogether, our data suggest that CT006 might participate in the interaction of LDs with C. trachomatis inclusions.	[Bugalhao, Joana N.; Luis, Maria P.; Pereira, Ines S.; da Cunha, Maria; Mota, Luis Jaime] NOVA Univ Lisbon, Associate Lab i4HB, Inst Hlth & Bioecon, NOVA Sch Sci & Technol, Caparica, Portugal; [Bugalhao, Joana N.; Luis, Maria P.; Pereira, Ines S.; da Cunha, Maria; Pais, Sara, V; Mota, Luis Jaime] NOVA Univ Lisbon, NOVA Sch Sci & Technol, Dept Life Sci, UCIBIO Appl Mol Biosci Unit, Caparica, Portugal; [Pais, Sara, V] Univ Tubingen, Interfac Inst Microbiol & Infect Med IMIT, Fac Med, Tubingen, Germany	Universidade Nova de Lisboa; Universidade Nova de Lisboa; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Mota, LJ (corresponding author), NOVA Univ Lisbon, Associate Lab i4HB, Inst Hlth & Bioecon, NOVA Sch Sci & Technol, Caparica, Portugal.; Mota, LJ (corresponding author), NOVA Univ Lisbon, NOVA Sch Sci & Technol, Dept Life Sci, UCIBIO Appl Mol Biosci Unit, Caparica, Portugal.	ljmota@fct.unl.pt	Mota, Luis/B-9497-2008; Serrano Pereira, Ines/T-3655-2017	Mota, Luis/0000-0002-5592-8397; Paiva Raposo Da Cunha, Maria/0000-0002-6453-7785; Serrano Pereira, Ines/0000-0001-6650-7371	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/28503/2017, PTDC/IMI-MIC/1300/2014, UIDP/04378/2020, UIDB/04378/2020]; Associate Laboratory Institute for Health and Bioeconomy - i4HB [LA/P/0140/2020]; FCT [PD/BD/128214/2016, PD/BD/52210/2013, PD/00133/2012, SFRH/BD/129756/2017, SFRH/BD/144284/2019]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Associate Laboratory Institute for Health and Bioeconomy - i4HB; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT) through grants PTDC/BIA-MIC/28503/2017 and PTDC/IMI-MIC/1300/2014 attributed to LJM, and in the scope of the projects UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIO, and LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB. JNB and SVP were supported by PhD fellowships PD/BD/128214/2016 and PD/BD/52210/2013, respectively, within the scope of the PhD program Molecular Biosciences (PD/00133/2012) funded by FCT. ISP and MPL were supported by PhD fellowships SFRH/BD/129756/2017 and SFRH/BD/144284/2019, also funded by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Alzhanov Damir T, 2009, BMC Microbiol, V9, P2, DOI 10.1186/1471-2180-9-2; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Bond SR, 2012, NUCLEIC ACIDS RES, V40, pW209, DOI 10.1093/nar/gks396; Bugalhao JN, 2019, MICROB CELL, V6, P414, DOI 10.15698/mic2019.09.691; Bui DC, 2021, INFECT IMMUN, V89, DOI 10.1128/IAI.00409-20; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; da Cunha M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178856; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Dumoux M, 2015, J CELL SCI, V128, P3420, DOI 10.1242/jcs.169318; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Faris R, 2019, CELL REP, V26, P3380, DOI 10.1016/j.celrep.2019.02.079; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; Franco IS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002546; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; Gehre L, 2016, ELIFE, V5, DOI 10.7554/eLife.12552; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Khaddaj R, 2022, J CELL SCI, V135, DOI 10.1242/jcs.256206; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kunze M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00259; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Monteiro-Bras T, 2020, MICROB CELL, V7, P46, DOI 10.15698/mic2020.02.707; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mueller KE, 2016, MBIO, V7, DOI 10.1128/mBio.01817-15; Nguyen BD, 2013, JOVE-J VIS EXP, DOI 10.3791/50636; O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Ouellette SP, 2021, INFECT IMMUN, V89, DOI 10.1128/IAI.00108-21; Pais SV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42647-3; Rank RG, 2011, INFECT IMMUN, V79, P3291, DOI 10.1128/IAI.00200-11; Recuero-Checa MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23148; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Roingeard P, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12688; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Saka HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124630; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Sharma M, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12801; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Sixt BS, 2017, CELL HOST MICROBE, V21, P113, DOI 10.1016/j.chom.2016.12.002; Stanhope R, 2017, P NATL ACAD SCI USA, V114, P12039, DOI 10.1073/pnas.1709060114; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Vallochi AL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01022; Weber MM, 2017, CELL REP, V19, P1406, DOI 10.1016/j.celrep.2017.04.058; Weber MM, 2015, INFECT IMMUN, V83, P4710, DOI 10.1128/IAI.01075-15; Wesolowski J, 2017, MBIO, V8, DOI 10.1128/mBio.02280-16; Yanatori Izumi, 2021, J Bacteriol, DOI 10.1128/JB.00511-20; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264292	10.1371/journal.pone.0264292	http://dx.doi.org/10.1371/journal.pone.0264292			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192658	Green Published, gold			2022-12-26	WOS:000812552500047
J	Kalina, M; Kwangulero, J; Ali, F; Tilley, E				Kalina, Marc; Kwangulero, Jonathan; Ali, Fathima; Tilley, Elizabeth			"You need to dispose of them somewhere safe": Covid-19 masks, and the pit latrine in Malawi and South Africa	PLOS ONE			English	Article							RESOURCE RECOVERY	The ongoing Covid-19 pandemic has generated an immense amount of potentially infectious waste, primarily face masks, which require rapid and sanitary disposal in order to mitigate the spread of the disease. Yet, within Africa, large segments of the population lack access to reliable municipal solid waste management (SWM) services, both complicating the disposal of hazardous waste, and public health efforts. Drawing on extensive qualitative fieldwork, including 96 semi-structured interviews, across four different low-income communities in Blantyre, Malawi and Durban, South Africa, the purpose of this article is to respond to a qualitative gap on mask disposal behaviours, particularly from within low-income and African contexts. Specifically, our purpose was to understand what behaviours have arisen over the past year, across the two disparate national contexts, and how they have been influenced by individual risk perceptions, established traditional practice, state communication, and other media sources. Findings suggest that the wearing of cloth masks simplifies disposal, as cloth masks can (with washing) be reused continuously. However, in communities where disposable masks are more prevalent, primarily within Blantyre, the pit latrine had been adopted as the most common space for 'safe' disposal for a used mask. We argue that this is not a new behaviour, however, and that the pit latrine was already an essential part of many low-income households SWM systems, and that within the Global South, the pit latrine fulfils a valuable and uncounted solid waste management function, in addition to its sanitation role.	[Kalina, Marc; Tilley, Elizabeth] Swiss Fed Inst Technol, Dept Mech & Proc Engn MAVT, Zurich, Switzerland; [Kalina, Marc; Ali, Fathima] Univ KwaZulu Natal, Sch Engn, Durban, South Africa; [Kwangulero, Jonathan] Univ Malawi, Dept Environm Hlth, Polytech, Blantyre, Malawi	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kwazulu Natal; University of Malawi	Kalina, M (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn MAVT, Zurich, Switzerland.; Kalina, M (corresponding author), Univ KwaZulu Natal, Sch Engn, Durban, South Africa.	mkalina@ethz.ch	Kalina, Marc/AAP-1884-2020; Tilley, Elizabeth/N-1675-2013	Kalina, Marc/0000-0002-6335-3845; Tilley, Elizabeth/0000-0002-2095-9724				Ammendolia J, 2021, ENVIRON POLLUT, V269, DOI 10.1016/j.envpol.2020.116160; Andriessen N, 2019, J WATER SANIT HYG DE, V9, P210, DOI 10.2166/washdev.2019.184; Aragaw Tadele Assefa, 2021, Environ Syst Res (Heidelb), V10, P8, DOI 10.1186/s40068-020-00217-x; Aragaw TA, 2020, MAR POLLUT BULL, V159, DOI 10.1016/j.marpolbul.2020.111517; Benson NU, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2021.105222; Brouckaert CJ, 2013, WATER SA, V39, P555, DOI 10.4314/wsa.v39i4.15; CDC, 2021, DIET INT AD AG 20 OV; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Chowdhry S., 2012, BUSINESS ANAL FECAL; de Albuquerque F.P., 2021, CASE STUD CHEM ENV E, V3, DOI DOI 10.1016/J.CSCEE.2021.100082; De-la-Torre GE, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145774; De-la-Torre GE, 2021, MAR POLLUT BULL, V163, DOI 10.1016/j.marpolbul.2020.111879; Didar-Ul-Islam SM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.592345; Diener S, 2014, RESOUR CONSERV RECY, V88, P32, DOI 10.1016/j.resconrec.2014.04.005; Fadare OO, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140279; Farling S, 2019, SCI TOTAL ENVIRON, V648, P1082, DOI 10.1016/j.scitotenv.2018.08.147; FOUCAULT M, 1986, DIACRITICS, V16, P22, DOI 10.2307/464648; Hantoko D, 2021, J ENVIRON MANAGE, V286, DOI 10.1016/j.jenvman.2021.112140; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Didar-Ul Islam SM, 2021, ENVIRON DEV SUSTAIN, V23, P11953, DOI 10.1007/s10668-020-01151-9; Jimenez Gomez Tagle M., 2021, RES SQUARE, DOI [10.21203/rs.3.rs-323037/v1, DOI 10.21203/RS.3.RS-323037/V1]; Jung S, 2021, CHEM ENG J, V405, DOI 10.1016/j.cej.2020.126658; Kalina M, 2021, WASTE MANAGE, V120, P277, DOI 10.1016/j.wasman.2020.11.051; Kalina M, 2020, WASTE MANAGE, V108, P202, DOI 10.1016/j.wasman.2020.05.006; Kayode AJ, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10091108; Khan Z., 2020, ASIA PACIFIC J MED T, V9, P82; Kumar H, 2021, ENVIRON DEV SUSTAIN, V23, P9418, DOI 10.1007/s10668-020-01033-0; Manga M, 2021, INT J HYG ENVIR HEAL, V232, DOI 10.1016/j.ijheh.2020.113670; Mangal V., 2020, CHRISMED J HEALTH RE, V7, P261; Neelakandan SN., 2020, T INDIAN NATL ACAD E, V5, P305; Nowakowski P, 2020, RESOURCES-BASEL, V9, DOI 10.3390/resources9100116; Ogoina D, 2020, AM J TROP MED HYG, V103, P33, DOI 10.4269/ajtmh.20-0433; Ortelan N., 2021, 101 NCIA SA DE COLET, V26, P669; Rahman M.H., 2020, POPULATION MED, V2, P1, DOI 10.18332/popmed/128325; Roxburgh H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235339; Sangkham S., 2020, CASE STUD CHEM ENV E, V2, P100052, DOI [10.1016/j.cscee.2020.100052, DOI 10.1016/J.CSCEE.2020.100052]; Scalvenzi M, 2021, J COMMUN HEALTH, V46, P786, DOI 10.1007/s10900-020-00952-3; Shammi M, 2021, GLOB SOC WELFARE, V8, P133, DOI 10.1007/s40609-020-00195-z; Sisco T, 2017, J WATER SANIT HYG DE, V7, P85, DOI 10.2166/washdev.2017.106; Sun JH, 2020, DES AUT CON; Tilley E., 2020, WORLDW WASTE J INTER, V3, P3, DOI 10.5334/wwwj.54; Huynh TLD, 2020, REV BEHAV ECON, V7, P145, DOI 10.1561/105.00000121; United Nations Children's Fund (UNICEF), 2019, PROGR HOUS DRINK WAT	43	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0262741	10.1371/journal.pone.0262741	http://dx.doi.org/10.1371/journal.pone.0262741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192618	gold, Green Published			2022-12-26	WOS:000812552500011
J	Huang, ZH; Tanaka, F				Huang, Zhenhan; Tanaka, Fumihide			MSPM: A modularized and scalable multi-agent reinforcement learning-based system for financial portfolio management	PLOS ONE			English	Article								Financial portfolio management (PM) is one of the most applicable problems in reinforcement learning (RL) owing to its sequential decision-making nature. However, existing RL-based approaches rarely focus on scalability or reusability to adapt to the ever-changing markets. These approaches are rigid and unscalable to accommodate the varying number of assets of portfolios and increasing need for heterogeneous data input. Also, RL agents in the existing systems are ad-hoc trained and hardly reusable for different portfolios. To confront the above problems, a modular design is desired for the systems to be compatible with reusable asset-dedicated agents. In this paper, we propose a multi-agent RL-based system for PM (MSPM). MSPM involves two types of asynchronously-updated modules: Evolving Agent Module (EAM) and Strategic Agent Module (SAM). An EAM is an information-generating module with a Deep Q-network (DQN) agent, and it receives heterogeneous data and generates signal-comprised information for a particular asset. An SAM is a decision-making module with a Proximal Policy Optimization (PPO) agent for portfolio optimization, and it connects to multiple EAMs to reallocate the corresponding assets in a financial portfolio. Once been trained, EAMs can be connected to any SAM at will, like assembling LEGO blocks. With its modularized architecture, the multi-step condensation of volatile market information, and the reusable design of EAM, MSPM simultaneously addresses the two challenges in RL-based PM: scalability and reusability. Experiments on 8-year U.S. stock market data prove the effectiveness of MSPM in profit accumulation by its outperformance over five different baselines in terms of accumulated rate of return (ARR), daily rate of return (DRR), and Sortino ratio (SR). MSPM improves ARR by at least 186.5% compared to constant rebalanced portfolio (CRP), a widely-used PM strategy. To validate the indispensability of EAM, we back-test and compare MSPMs on four different portfolios. EAM-enabled MSPMs improve ARR by at least 1341.8% compared to EAM-disabled MSPMs.	[Huang, Zhenhan] Univ Tsukuba, Grad Sch Sci & Technol, Tsukuba, Ibaraki, Japan; [Tanaka, Fumihide] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Huang, ZH (corresponding author), Univ Tsukuba, Grad Sch Sci & Technol, Tsukuba, Ibaraki, Japan.	huang@ftl.iit.tsukuba.ac.jp		Tanaka, Fumihide/0000-0002-8443-5591				Araci D., 2019, FINBERT FINANCIAL SE; DeMiguel V, 2009, REV FINANC STUD, V22, P1915, DOI 10.1093/rfs/hhm075; Devlin J., 2018, ARXIV181004805; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Hasselt Hv, 2016, P 30 AAAI C ARTIFICI; Hong SD, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.178-245; Hudson and Thames Quantitative Research, 2021, MACHINE LEARNING FIN; InfoTrie, 2021, FINSENTS WEB NEWS SE; Jiang Z., 2017, ARXIV170610059; Lapan M., 2018, DEEP REINFORCEMENT L; Law J, 2008, DICT FINANCE BANKING, DOI [10.1093/acref/9780199229741.001.0001/acref-9780199229741, DOI 10.1093/ACREF/9780199229741.001.0001/ACREF-9780199229741]; Lee J, 2020, PROCEEDINGS OF THE TWENTY-NINTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4520; Li B, 2014, ACM COMPUT SURV, V46, DOI 10.1145/2512962; Liang Z., 2018, ADVERSARIAL DEEP REI; Lillicrap T. P., 2016, 4 INT C LEARN REPR I; Liu Y, 2020, AAAI CONF ARTIF INTE, V34, P2128; Lopez VF, 2010, ADV INTEL SOFT COMPU, V71, P53; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mnih V., 2013, ARXIV13125602, DOI DOI 10.1038/NATURE14236; Murphy J. J., 1999, TECHNICAL ANAL FINAN; Nair Vinod, 2010, P 27 INT C INT C MAC, P807; Olkin I, 1960, CONTRIBUTIONS PROBAB; Ormos M, 2013, QUANT FINANC, V13, P1587, DOI 10.1080/14697688.2011.570368; QuoteMedia, 2020, END OF DAY DATA; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Schulman J., 2017, PROXIMAL POLICY OPTI, DOI 10.48550/arXiv.1707.06347; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Silver D., 2014, JMLR P, P387; Sortino F.A., 1994, J INVEST, V3, P59, DOI [10.3905/joi.3.3.59, DOI 10.3905/JOI.3.3.59]; Sycara K, 1995, P AAAI WORKSHOP INTE; Wang Z., 2016, DUELING NETWORK ARCH; Ye YN, 2020, AAAI CONF ARTIF INTE, V34, P1112	33	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263689	10.1371/journal.pone.0263689	http://dx.doi.org/10.1371/journal.pone.0263689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180235	gold, Green Submitted, Green Published			2022-12-26	WOS:000796435800025
J	Miao, L; Yang, S; Yi, Y; Tian, P; He, L				Miao, Lvqing; Yang, Suyu; Yi, Yuye; Tian, Peipei; He, Lichun			Research on the prediction of longevity from both individual and family perspectives	PLOS ONE			English	Article							SOCIAL SUPPORT; NEAR-CENTENARIANS; MENTAL-HEALTH; LIFE-STYLE; PERSONALITY; PEOPLE; MORTALITY	Increasing human longevity is of global interest. The present study explored the prediction of longevity from both individual perspective and family perspective based on demographic and psychosocial factors. A total of 186 longevous family members and 237 ordinary elderly family members participated in a cross-sectional study, and a sample of 62 longevous elderly and 57 ordinary elderly were selected for comparative research. The results showed that it was three times more female than male in longevous elderly group. Up to 71.2% of longevous elderly had no experience in education, which was significantly lower than that of ordinary elderly. Due to such extreme age, more widowed (81.4%) elderly than those in married (18.6%). Less than one-seventh of the longevous elderly maintained the habit of smoking, and about one-third of them liked drinking, both were significantly lower than that of ordinary elderly. In terms of psychosocial factors, longevous elderly showed lower neuroticism and social support, while higher extraversion, compared with the ordinary elderly. However, there were no significant differences between the two family groups in demographic and psychosocial variables, except longevous families showing lower scores in neuroticism. Regression analysis found that neuroticism, social support and smoking habit had significant impact on individuals' life span, then, neuroticism and psychoticism were the key factor to predict families' longevity. We conclude that good emotional management, benign interpersonal support, and moderation of habits are important factors for individual longevity, and the intergenerational influence of personality is closely related to family longevity.	[Miao, Lvqing; He, Lichun] Nantong Univ, Inst Special Environm Med, Dept Psychol, Nantong, Jiangsu, Peoples R China; [Yang, Suyu] Shandong Normal Univ, Sch Psychol, Jinan, Shandong, Peoples R China; [Yi, Yuye; Tian, Peipei] Nantong Univ, Sch Educ Sci, Nantong, Jiangsu, Peoples R China	Nantong University; Shandong Normal University; Nantong University	He, L (corresponding author), Nantong Univ, Inst Special Environm Med, Dept Psychol, Nantong, Jiangsu, Peoples R China.	hlc1019@ntu.edu.cn		He, Lichun/0000-0002-4351-1543	Nantong University Introduced Talent Research Startup Fund [03081154]; Suyu Yang: Nantong University College Student Innovation Training Program [2019056]	Nantong University Introduced Talent Research Startup Fund; Suyu Yang: Nantong University College Student Innovation Training Program	Lichun He: Nantong University Introduced Talent Research Startup Fund (No. 03081154); Suyu Yang: Nantong University College Student Innovation Training Program (2019056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of themanuscript.	Ahrenfeldt LJ, 2018, PUBLIC HEALTH, V165, P74, DOI 10.1016/j.puhe.2018.09.009; Ailshire JA, 2011, GERONTOLOGIST, V51, P621, DOI 10.4061/2011/530534; [Anonymous], 2014, Harv Health Lett, V39, P5; Boerner K, 2016, J AGING SOC POLICY, V28, P165, DOI 10.1080/08959420.2016.1160708; Brown SL, 2003, PSYCHOL SCI, V14, P320, DOI 10.1111/1467-9280.14461; Cai D, 2015, BIOL TRACE ELEM RES, V165, P18, DOI 10.1007/s12011-015-0233-7; Cheung KSL, 2016, AGING MENT HEALTH, V20, P1314, DOI 10.1080/13607863.2015.1078281; Cohen Gene., 1992, HDB MENTAL HLTH AGIN, V2nd ed., P893, DOI [10.1300/J021v01n04_04, DOI 10.1300/J021V01N04_04]; Cornman JC, 2003, J AGING HEALTH, V15, P616, DOI 10.1177/0898264303256215; Deng YL., 2008, CHINESE J GERONTOLOG, V28, P2256; Feng ZX, 2015, SOC SCI MED, V130, P181, DOI 10.1016/j.socscimed.2015.02.020; Friedman HS, 2010, J PERS, V78, P179, DOI 10.1111/j.1467-6494.2009.00613.x; Gana K, 2016, J PSYCHOSOM RES, V85, P28, DOI 10.1016/j.jpsychores.2016.04.004; Gao D., 2008, J JILIN U ED, V24, P86; Gao S, 2018, PUBLIC HEALTH, V160, P159, DOI 10.1016/j.puhe.2018.01.026; Giacosa A, 2016, CRIT REV FOOD SCI, V56, P635, DOI 10.1080/10408398.2012.747484; Gremeaux V, 2012, MATURITAS, V73, P312, DOI 10.1016/j.maturitas.2012.09.012; Han BX., 2013, RES REPORT MENTAL HL, V1st; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; [胡峻梅 HU Junmei], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P580; Jeune B, 2002, AGING CLIN EXP RES, V14, P72; Jiang JM, 2010, TOB CONTROL, V19, P7, DOI 10.1136/tc.2009.031245; Jokela M, 2020, J PERS, V88, P596, DOI 10.1111/jopy.12513; Jopp DS, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-015-0167-0; Kern ML, 2014, J PERS, V82, P472, DOI 10.1111/jopy.12062; Li J., 2007, POP RES, V31, P50, DOI [10.3969/j.issn.1000-6087.2007.03.00, DOI 10.3969/J.ISSN.1000-6087.2007.03.00]; Li JX., 2004, CHINA POPULATION SCI, VS1, P45; Li X., 2017, THESIS SHANDONG U; Liu Y, 2013, BIOL TRACE ELEM RES, V153, P119, DOI 10.1007/s12011-013-9673-0; Lv JM, 2011, BIOL TRACE ELEM RES, V143, P702, DOI 10.1007/s12011-010-8914-8; Lv Y., 2016, CHINESE J GERONTOLOG, V36, P4326, DOI [10.3969/j.issn.1005-9202.2016.17.096, DOI 10.3969/J.ISSN.1005-9202.2016.17.096]; Macdonald M., 2007, ANN REV GERONTOLOGY, V27, P107; Makita R, 2009, ACTA MED OKAYAMA, V63, P331; Martin P, 2006, AGE, V28, P343, DOI 10.1007/s11357-006-9022-8; Masui Y, 2006, AGE, V28, P353, DOI 10.1007/s11357-006-9024-6; Okamoto K, 2007, ARCH GERONTOL GERIAT, V45, P335, DOI 10.1016/j.archger.2007.02.002; Park J, 2020, AGING MENT HEALTH, V24, P2063, DOI 10.1080/13607863.2019.1660849; Peng KP., 1990, PSYCHOL TESTING PRIN; Perls T, 2002, CURR OPIN GENET DEV, V12, P362, DOI 10.1016/S0959-437X(02)00310-6; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Rajpathak SN, 2011, J AM GERIATR SOC, V59, P1509, DOI 10.1111/j.1532-5415.2011.03498.x; Randall GK, 2010, GERONTOLOGY, V56, P106, DOI 10.1159/000272026; Robine JM, 2012, EXP GERONTOL, V47, P660, DOI 10.1016/j.exger.2012.05.009; Shadyab AH, 2015, AGEING RES REV, V19, P1, DOI 10.1016/j.arr.2014.10.005; Shavelle R, 2012, J AM GERIATR SOC, V60, P1185, DOI 10.1111/j.1532-5415.2012.03988.x; Sun YP., 2005, J XINJIANG MED U, V28, P33; Sun YY, 2009, J CHANGCHUN U, V19, P74, DOI [10.3969/j.issn.1009-3907-B.2009.02.027, DOI 10.3969/J.ISSN.1009-3907-B.2009.02.027]; Taylor DH, 2002, AM J PUBLIC HEALTH, V92, P990, DOI 10.2105/AJPH.92.6.990; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Terry DF, 2003, J GERONTOL A-BIOL, V58, P425; Ti C., 2009, THESIS BEIJING SPORT; Wang JF, 2014, AGING MENT HEALTH, V18, P232, DOI 10.1080/13607863.2013.837143; Wong ST, 2014, J AGING HEALTH, V26, P663, DOI 10.1177/0898264314527478; [伍业光 WU Yegnang], 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P441; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Yang F, 2020, AGING MENT HEALTH, V24, P879, DOI 10.1080/13607863.2018.1558174; Yang Q., 2020, LONGEVITY, V2, P154; Yao Y., 2005, DEMOGRAPHIC J, V4, P12, DOI [10.3969/j.issn.1004-129X.2005.04.003, DOI 10.3969/J.ISSN.1004-129X.2005.04.003]; Ye L, 2020, PUBLIC HEALTH, V178, P15, DOI 10.1016/j.puhe.2019.08.023; Zeng Y, 2013, J GERONTOL A-BIOL, V68, P473, DOI 10.1093/gerona/gls203; Zhang XH., 2019, POPULATION EC, V4, P94; [张玉静 Zhang Yujing], 2016, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V24, P741; 李松桃, 2016, [中国老年学杂志, Chinese Journal of Gerontology], V36, P2260; 钱铭怡, 2000, [心理学报, Acta Psychologica Sinica], V32, P317; 王林, 2010, [中国老年学杂志, Chinese Journal of Gerontology], V30, P420	66	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263992	10.1371/journal.pone.0263992	http://dx.doi.org/10.1371/journal.pone.0263992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180255	Green Published, gold			2022-12-26	WOS:000796435800039
J	Wang, X; Ma, H; Qi, X; Gao, K; Li, S; Yang, X				Wang, Xiaoqi; Ma, Heng; Qi, Xiaohan; Gao, Ke; Li, Shengnan; Yang, Xuesong			Experimental study on the effect of high-temperature oxidation coal mechanical characteristics	PLOS ONE			English	Article							FRACTURE	After long-term oxidation and energy storage, broken coal body borehole walls and drainage shaft walls may cause spontaneous combustion during gas extraction. The high-temperature thermal shock caused by the spontaneous combustion of coal incurs thermal damage on adjacent coal, which, in turn, causes changes in the mechanical properties of the coal. However, only a few studies have been conducted in this context, which has limited our understanding of the thermal damage characteristics of coal bodies in such situations. This study aimed to experimentally investigate the correlation between the crack evolution law and the mechanical properties of coal bodies at different temperatures (50-300 degrees C) using heat-force loading considering Ping Mei No. 10 coal mine as the research object. The results suggest that the coal body experiences a large amount of visible damage, and becomes increasingly complex. At 50-300 degrees C, some indexes (such as longitudinal wave velocity, Poisson's ratio, compressive strength, elastic modulus, impact energy index, and pre-peak strain) are positively correlated with temperature. In addition, the dynamic failure time and temperature show a negative correlation, and the overall change slope is small. The relationship between each index and temperature at 200-300 degrees C is opposite to that at 50-200 degrees C, and the overall change slope is larger. Moreover, when the oxidation temperature exceeds 200 degrees C, the destruction of the coal body changes from elastic brittleness to ductility-plasticity. High-temperature oxidation incurs irreversible thermal damage of coal. Hence, it is necessary to focus on the changes in mechanical properties of coal after a spontaneous combustion process is extinguished.	[Wang, Xiaoqi; Ma, Heng; Qi, Xiaohan; Gao, Ke; Li, Shengnan; Yang, Xuesong] Liaoning Tech Univ, Coll Safety Sci & Engn, Huludao, Liaoning, Peoples R China; [Wang, Xiaoqi; Ma, Heng; Qi, Xiaohan; Gao, Ke; Li, Shengnan; Yang, Xuesong] Liaoning Tech Univ, Key Lab Mine Thermodynam Disasters & Control Mini, Huludao, Liaoning, Peoples R China	Liaoning Technical University; Liaoning Technical University	Qi, X (corresponding author), Liaoning Tech Univ, Coll Safety Sci & Engn, Huludao, Liaoning, Peoples R China.; Qi, X (corresponding author), Liaoning Tech Univ, Key Lab Mine Thermodynam Disasters & Control Mini, Huludao, Liaoning, Peoples R China.	qxh550799007@163.com	Qi, Xiaohan/GXV-0968-2022		Natural Science Foundation of China [52074148]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the Natural Science Foundation of China (No. 52074148).	Cha WH., 2014, ROCK SOIL MECH, V35, P1334; Deng JX, 2009, J GEOPHYS ENG, V6, P269, DOI 10.1088/1742-2132/6/3/006; Feng XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145757; Gan QQ, 2021, ENERGY, V237, DOI 10.1016/j.energy.2021.121548; Guo Y., 2019, PLOS ONE, V14; Hassani F, 2016, J ROCK MECH GEOTECH, V8, P1, DOI 10.1016/j.jrmge.2015.10.004; Hong YD, 2020, INT J ROCK MECH MIN, V127, DOI 10.1016/j.ijrmms.2020.104232; Huang XL, 2014, ROCK MECH ROCK ENG, V47, P549, DOI 10.1007/s00603-013-0399-2; Jiang Y, 2021, ENERGY, V223, DOI 10.1016/j.energy.2021.119977; Kong B, 2016, INT J ROCK MECH MIN, V90, P43, DOI 10.1016/j.ijrmms.2016.10.004; Lan WJ, 2020, ENERGY, V206, DOI 10.1016/j.energy.2020.118211; Liu S., 2013, J MINING SAFETY ENG, V30, P583; Liu WZ, 2020, J MATER RES TECHNOL, V9, P9537, DOI 10.1016/j.jmrt.2020.06.071; Liu XF, 2017, SHOCK VIB, V2017, DOI 10.1155/2017/7643451; [卢志国 Lu Zhiguo], 2021, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V40, P1559; Ma Z., 2005, MINE PRESSURE ROOF M, V03, P46; Morcote A, 2010, GEOPHYSICS, V75, pE227, DOI 10.1190/1.3508874; Pan RK M., 2020, J CHINA COAL SOC, P1045; [齐消寒 Qi Xiaohan], 2020, [中国安全科学学报, China Safety Science Journal（CSSJ）], V30, P85; Qin L, 2022, FUEL, V309, DOI 10.1016/j.fuel.2021.122124; Qin L, 2021, FUEL, V292, DOI 10.1016/j.fuel.2021.120404; Song JJ, 2021, ENERGY, V214, DOI 10.1016/j.energy.2020.118995; Tang SC., 2021, CHINESE J UNDERGROUN, V17; Tao M, 2020, ENERGY, V203, DOI 10.1016/j.energy.2020.117838; Wang P, 2015, NONDESTRUCT TEST EVA, V30, P74, DOI 10.1080/10589759.2014.1002838; Wu G, 2013, GEOTECH GEOL ENG, V31, P809, DOI 10.1007/s10706-013-9614-x; [吴鑫 Wu Xin], 2013, [地下空间与工程学报, Chinese Journal of Underground Space and Engineering], V9, P1045; Yang YL, 2019, INT J ROCK MECH MIN, V116, P13, DOI 10.1016/j.ijrmms.2019.03.004; Yavuz H, 2010, INT J ROCK MECH MIN, V47, P94, DOI 10.1016/j.ijrmms.2009.09.014; Yin DW, 2021, J MATER RES TECHNOL, V10, P322, DOI 10.1016/j.jmrt.2020.12.010; Yu X., 2019, SCI TECHNOLOGY ENG, V019, P133; Zhang HT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232182; [张洪伟 Zhang Hongwei], 2021, [采矿与安全工程学报, Journal of Mining & Safety Engineering], V38, P138; Zhang HW., 2021, J MINING SAFETY ENG, V38, P8; Zhang L., 2019, GEOLOGICAL HAZARDS E, V04, P583	35	3	3	10	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264039	10.1371/journal.pone.0264039	http://dx.doi.org/10.1371/journal.pone.0264039			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180275	gold, Green Published			2022-12-26	WOS:000796435800044
J	Plesa, J; Kozinc, Z; Smajla, D; Sarabon, N				Plesa, Jernej; Kozinc, Ziga; Smajla, Darjan; Sarabon, Nejc			The association between reactive strength index and reactive strength index modified with approach jump performance	PLOS ONE			English	Article							PART I; VOLLEYBALL; RELIABILITY; HEIGHT; TIME	Jumping performance is one of the key components of volleyball game, thus evaluating jumping ability through different biomechanical variables offers opportunity for performance optimization. The aim of this study was to assess the associations between reactive strength index (RSI), reactive strength index modified (RSImod) and approach jump performance in male volleyball players. Forty volleyball players performed drop jump (DJ) form 40 cm high box, bilateral and unilateral countermovement jumps (CMJ) and approach jump. RSI in DJ was calculated as the ratio between jump height and ground contact time, while the RSI in CMJ tasks (RSImod) was calculated as ratio between jump height and jump time. Our results indicate that the relationships among different RSI variants and approach jump in volleyball players are moderate to strong (r = 0.42-0.73), with the highest correlations being observed for RSImod from bilateral CMJ (r = 0.676-0.727). Those observations are in line with the principle of movement specificity, which suggests that the best performance indicator should be the task that best resembles the demands of the sport-specific movements. Further research is needed to reveal more about the potential of implementing these findings for training optimization through monitoring RSI and RSImod values.	[Plesa, Jernej; Kozinc, Ziga; Smajla, Darjan; Sarabon, Nejc] Univ Primorska, Fac Hlth Sci, Izola, Slovenia; [Kozinc, Ziga] Univ Primorska, Andrej Marusi Inst, Koper, Slovenia; [Smajla, Darjan; Sarabon, Nejc] Human Hlth Dept, InnoRenew CoE, Izola, Slovenia; [Sarabon, Nejc] Sci Practice Ltd, S2P, Lab Motor Control & Motor Behav, Ljubljana, Slovenia	University of Primorska; University of Primorska	Sarabon, N (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.; Sarabon, N (corresponding author), Human Hlth Dept, InnoRenew CoE, Izola, Slovenia.; Sarabon, N (corresponding author), Sci Practice Ltd, S2P, Lab Motor Control & Motor Behav, Ljubljana, Slovenia.	nejc.sarabon@fvz.upri.si		Smajla, Darjan/0000-0001-5441-8988; Sarabon, Nejc/0000-0003-0747-3735	Slovenian Research Agency [P5-0147 (B), L5-1845]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors received part of the salary through the Slovenian Research Agency through the programme `Kinesiology of monostructural, polystructural and conventional sports' [P5-0147 (B)] and the project TELASI-PREVENT [L5-1845] (Body asymmetries as a risk factor in musculoskeletal injury development: studying aetiological mechanisms and designing corrective interventions for primary and tertiary preventive care). The Agency had no role in conceptualization of the study, analysis of the data, manuscript preparation or any other activities leading to the creation of this article. There was no additional external funding received for this study.	Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; BOBBERT MF, 1990, SPORTS MED, V9, P7, DOI 10.2165/00007256-199009010-00002; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Bosco C, 1999, STRENGTH ASSESSMENT, P5; Byrne DJ, 2017, J STRENGTH COND RES, V31, P721, DOI 10.1519/JSC.0000000000001534; COUTTS KD, 1982, MED SCI SPORT EXER, V14, P57, DOI 10.1249/00005768-198201000-00011; Ebben WP, 2010, J STRENGTH COND RES, V24, P1983, DOI 10.1519/JSC.0b013e3181e72466; Flanagan EP, 2008, STRENGTH COND J, V30, P32, DOI 10.1519/SSC.0b013e318187e25b; Flanagan EP, 2008, J STRENGTH COND RES, V22, P1677, DOI 10.1519/JSC.0b013e318182034b; Forthomme B, 2005, AM J SPORT MED, V33, P1513, DOI 10.1177/0363546505274935; Fuchs PX, 2019, J SCI MED SPORT, V22, P833, DOI 10.1016/j.jsams.2019.01.002; GIATSIS G, 2001, EXERC SOC J SPORTS S, P95; Hedrick A, 2007, STRENGTH COND J, V29, P50, DOI 10.1519/00126548-200712000-00009; HOF AL, 1986, HUM MOVEMENT SCI, V5, P107, DOI 10.1016/0167-9457(86)90018-7; Honish A, 2005, BIOMEHANICAL COMP IN; Ikeda Y, 2018, J STRENGTH COND RES, V32, P267, DOI 10.1519/JSC.0000000000002191; Jarvis P, SPORTS MED, V2021, DOI [10.1016/j.medj.2020.12.010, DOI 10.1016/J.MEDJ.2020.12.010]; Kipp K, 2018, INT J SPORT PHYSIOL, V13, P44, DOI 10.1123/ijspp.2017-0021; Kipp K, 2016, J STRENGTH COND RES, V30, P1341, DOI 10.1519/JSC.0000000000001226; KUNSTLINGER U, 1987, INT J SPORTS MED, V8, P315, DOI 10.1055/s-2008-1025676; Liu GS, 2001, 2001 CIE INTERNATIONAL CONFERENCE ON RADAR PROCEEDINGS, P120, DOI 10.1109/ICR.2001.984636; Maloney SJ, 2017, SCAND J MED SCI SPOR, V27, P661, DOI 10.1111/sms.12682; Markwick WJ, 2015, INT J SPORT PHYSIOL, V10, P482, DOI 10.1123/ijspp.2014-0265; McGuigan MR, 2015, STRENGTH COND J, P1; Mroczek D, 2019, J STRENGTH COND RES, V33, P910, DOI 10.1519/JSC.0000000000003074; Perez-Castilla A, 2021, MEAS PHYS EDUC EXERC, V25, P227, DOI 10.1080/1091367X.2021.1872578; Perez-Castilla A, 2021, EUR J SPORT SCI, V21, P1606, DOI 10.1080/17461391.2020.1845815; Potach DH, 2000, ESSENTIALS STRENGTH, P427; Prsala J., 1982, VOLLEYB TECH J, V7, P57; Ramirez-Campillo R, 2018, J STRENGTH COND RES, V32, P885, DOI 10.1519/JSC.0000000000002467; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Sattler T, 2012, J STRENGTH COND RES, V26, P1532, DOI 10.1519/JSC.0b013e318234e838; Schmidtbleicher D., 1992, ENCY SPORTS MED STRE, VVolume 3, P169; Sorenson SC, 2010, J ORTHOP SPORT PHYS, V40, P568, DOI 10.2519/jospt.2010.3313; Suchomel TJ, 2016, SPORTS MED, V46, P1419, DOI 10.1007/s40279-016-0486-0; Suchomel TJ, 2015, J STRENGTH COND RES, V29, P1310, DOI 10.1519/JSC.0000000000000761; Suchomel TJ, 2015, J STRENGTH COND RES, V29, P899, DOI 10.1519/JSC.0000000000000743; Tilp M, 2008, SPORT BIOMECH, V7, P386, DOI 10.1080/14763140802233231; Tsiokanos A, 2002, ISOKINET EXERC SCI, V10, P107, DOI 10.3233/IES-2002-0092; Wagner H, 2009, INT J SPORTS MED, V30, P760, DOI 10.1055/s-0029-1224177; Young W., 1995, NEW STUD ATHL, V10, P88; Zatsiorsky VM, 2007, SCI PRACTICE STRENGT	42	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264144	10.1371/journal.pone.0264144	http://dx.doi.org/10.1371/journal.pone.0264144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176119	Green Published, gold			2022-12-26	WOS:000777505200087
J	Suchowilska, E; Wiwart, M; Wachowska, U; Radawiec, W; Combrzynski, M; Gontarz, D				Suchowilska, Elzbieta; Wiwart, Marian; Wachowska, Urszula; Radawiec, Wioleta; Combrzynski, Maciej; Gontarz, Dariusz			A comparison of phenotypic variation in Triticum durum Desf. genotypes deposited in gene banks based on the shape and color descriptors of kernels in a digital image analysis	PLOS ONE			English	Article							WHEAT; DISCRIMINATION; YIELD; VARIETIES; GRAINS; SIZE	Durum wheat is the tenth most valuable crop on a global scale. The aim of this study was to compare the phenotypic variation of T. durum accessions of different origin with contemporary spring cultivars of this cereal species. One hundred and two accessions and 12 contemporary cultivars of Triticum durum Desf. as well as Kamut (R) wheat (T. turanicum), a Triticum species closely related to T. durum, were analyzed. The aim of this study was to describe the degree of variation in the phenotypic traits of grain and selected traits associated with technological quality. The examined genotypes were characterized by considerable phenotypic variation, and they can be a valuable source of material for genetic recombination in durum wheat breeding. The analyzed accessions were characterized by a higher average content of protein (16.48 vs. 14.56%) and wet gluten (38.04 vs. 32.07%), higher Zeleny sedimentation values (69.7 vs. 60.4ml), and higher flour strength (W index values of 404.64 vs. 353.47) than the reference cultivars. The kernels of the evaluated accessions and cultivars did not differ significantly in average crease depth, but significant differences were observed in the values of descriptors directly linked with kernel size, especially kernel image area and minimal Feret diameter. The traits responsible for the processing suitability of grain were more strongly correlated with color descriptors than shape descriptors, which suggests that color parameters can be used to select high-quality breeding material. The analyzed accessions have two major weaknesses, namely relatively low yields (22.6 dt ha(-1) on average) and undesirable grain color, indicative of low carotenoid concentration. The accessions deposited in gene banks do not meet the relevant agronomic requirements. However, both grain yield and carotenoid concentration are polygenic traits which can be improved if desirable combinations of QTLs are assembled in breeding lines and cultivars.	[Suchowilska, Elzbieta; Wiwart, Marian; Radawiec, Wioleta] Univ Warmia & Mazury, Dept Genet Plant Breeding & Bioresource Engn, Olsztyn, Poland; [Wachowska, Urszula] Univ Warmia & Mazury, Dept Entomol Phytopathol & Mol Diagnost, Olsztyn, Poland; [Combrzynski, Maciej] Univ Life Sci Lublin, Dept Thermal Technol & Food Proc Engn, Lublin, Poland; [Combrzynski, Maciej; Gontarz, Dariusz] Polskie Zaklady Zbozowe Lubella GMW Ltd LP, Lublin, Poland	University of Warmia & Mazury; University of Warmia & Mazury; University of Life Sciences in Lublin	Wiwart, M (corresponding author), Univ Warmia & Mazury, Dept Genet Plant Breeding & Bioresource Engn, Olsztyn, Poland.	marian.wiwart@uwm.edu.pl	; Radawiec, Wioleta/P-4070-2018	Suchowilska, Elzbieta/0000-0002-8999-6742; Radawiec, Wioleta/0000-0002-8167-8141; Wiwart, Marian/0000-0003-2693-7021				Abbaspour-Gilandeh Y, 2020, J INTELL SYST, V29, P1576, DOI 10.1515/jisys-2018-0430; Alemu A, 2020, CROP J, V8, P757, DOI 10.1016/j.cj.2020.01.001; [Anonymous], 2019, AGRONOMY, V9, P399; Bordoni A, 2017, INT J FOOD SCI NUTR, V68, P278, DOI 10.1080/09637486.2016.1247434; Branlard G., 2020, Wheat Quality For Improving Processing And Human Health, P39, DOI 10.1007/978-3-030-34163-3_4; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brester GW, 2009, REV AGR ECON, V31, P359, DOI 10.1111/j.1467-9353.2009.01442.x; Catterall Paul, 2007, TECHNOLOGY BREADMAKI, P333; Chen FN, 2018, INTELL AUTOM SOFT CO, V24, P351, DOI 10.1080/10798587.2017.1293927; Ciudad-Mulero M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020504; De Vita P, 2019, ADVANCES IN PLANT BREEDING STRATEGIES: CEREALS, VOL 5, P471, DOI 10.1007/978-3-030-23108-8_13; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Fortner B, 1997, NUMBER COLORS GUIDE, P349; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Goriewa-Duba K, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8120296; Grausgruber H, 2005, FIELD CROP RES, V91, P319, DOI 10.1016/j.fcr.2004.08.001; Heslop-Harrison JS, 2001, ENCYLOPEDIA GENETICS, P1509; Lin P, 2018, FOOD BIOPROCESS TECH, V11, P765, DOI 10.1007/s11947-017-2050-9; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mefleh M, 2019, J SCI FOOD AGR, V99, P2059, DOI 10.1002/jsfa.9388; NEUMAN M, 1987, J CEREAL SCI, V6, P125, DOI 10.1016/S0733-5210(87)80049-8; Pham N, 2019, J PUBLIC POLICY MARK, V38, P263, DOI 10.1177/0743915618818168; Novaro P, 2001, CEREAL CHEM, V78, P217, DOI 10.1094/CCHEM.2001.78.3.217; Quinn RM, 1999, PERSPECTIVES NEW CRO, P182; Rasband W., 2006, IMAGEJ; Ropelewska E, 2018, EUR FOOD RES TECHNOL, V244, P1453, DOI 10.1007/s00217-018-3059-7; Shouche SP, 2001, COMPUT ELECTRON AGR, V33, P55, DOI 10.1016/S0168-1699(01)00174-0; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Symons SJ, 1996, CEREAL CHEM, V73, P561; Szczypinski PM, 2015, COMPUT ELECTRON AGR, V110, P1, DOI 10.1016/j.compag.2014.09.016; Le TDQ, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0468-y; TIBCO Software Inc, 2020, STATISTICA DATA ANAL; Tosi P, 2011, ANN BOT-LONDON, V108, P23, DOI 10.1093/aob/mcr098; Vermeulen P, 2018, J CEREAL SCI, V84, P74, DOI 10.1016/j.jcs.2018.10.001; Wang N, 2003, T ASAE, V46, P1143; Witzenberger A., 1989, Gesunde Pflanzen, V41, P384; Wiwart M, 2012, COMPUT ELECTRON AGR, V83, P68, DOI 10.1016/j.compag.2012.01.015; Wiwart M, 2009, COMPUT ELECTRON AGR, V65, P125, DOI 10.1016/j.compag.2008.08.003; Zapotoczny P, 2011, J CEREAL SCI, V54, P60, DOI 10.1016/j.jcs.2011.02.012; ZAYAS I, 1989, CEREAL CHEM, V66, P233	40	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0259413	10.1371/journal.pone.0259413	http://dx.doi.org/10.1371/journal.pone.0259413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176021	gold, Green Published			2022-12-26	WOS:000777505200003
J	Kwon, J; Choi, H; Ware, AD; Morillo, BC; Wang, HY; Bouker, KB; Lu, XB; Waldman, T; Han, C				Kwon, Juntae; Choi, Hyeongjwa; Ware, Anna D.; Morillo, Bernadette Cecilia; Wang, Haiyang; Bouker, Kerrie B.; Lu, Xiongbin; Waldman, Todd; Han, Cecil			USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model	ONCOGENE			English	Article							SURFACE EPITHELIUM; CANCER; AUTOPHAGY; ORIGIN; PTEN; P53; PACLITAXEL; PATHWAY; BIOLOGY; CELLS	Epithelial ovarian cancer is the most lethal gynecologic malignancy and one of the most common causes of cancer mortality among women worldwide. Ubiquitin-Specific Peptidase 13 (USP13) gene copy is strongly amplified in human epithelial ovarian cancer, and high USP13 expression is correlated with poor survival outcomes. Yet, its pathological contribution to ovarian tumorigenesis remains unknown. We crossed a conditional Usp13 overexpressing knock-in mouse with a conditional knockout of Trp53 and Pten mouse and generated a novel ovarian cancer genetically engineered mouse model (GEMM), which closely recapitulates the genetic changes driving ovarian cancer in humans. Overexpression of USP13 with deletion of Trp53 and Pten in murine ovarian surface epithelium accelerated ovarian tumorigenesis and led to decreased survival in mice. Notably, USP13 greatly enhanced peritoneal metastasis of ovarian tumors with frequent development of hemorrhagic ascites. The primary and metastatic tumors exhibited morphology and clinical behavior similar to human high-grade serous ovarian cancer. Co-inhibition of USP13 and AKT significantly decreased the viability of the primary murine ovarian cancer cells isolated from the GEMM. USP13 also increased the tumorigenic and metastatic abilities of primary murine ovarian cancer cells in a syngeneic mouse study. These findings suggest a critical role of USP13 in ovarian cancer development and reveal USP13 as a potential therapeutic target for ovarian cancer.	[Kwon, Juntae; Choi, Hyeongjwa; Ware, Anna D.; Wang, Haiyang; Waldman, Todd; Han, Cecil] Georgetown Univ, Dept Oncol, Sch Med, Washington, DC 20007 USA; [Morillo, Bernadette Cecilia; Waldman, Todd] Georgetown Univ, Biochem & Mol Biol, Sch Med, Washington, DC 20007 USA; [Bouker, Kerrie B.; Waldman, Todd; Han, Cecil] Georgetown Univ, Lombardi Comprehens Canc Ctr, Sch Med, Washington, DC 20007 USA; [Lu, Xiongbin] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Georgetown University; Georgetown University; Georgetown University; Indiana University System; Indiana University Bloomington	Han, C (corresponding author), Georgetown Univ, Dept Oncol, Sch Med, Washington, DC 20007 USA.; Han, C (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Sch Med, Washington, DC 20007 USA.	ch1182@georgetown.edu		Kwon, Juntae/0000-0002-5439-3239	Rivkin Center Foundation [616749]; Mary Kay Foundation [05-19]; American Cancer Society [RSG-21120-01-TBE]; National Institutes of Health [R01CA222251]	Rivkin Center Foundation; Mary Kay Foundation; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants to C.H. from the Rivkin Center Foundation (#616749), the Mary Kay Foundation (#05-19), the American Cancer Society (RSG-21120-01-TBE, Grant DOI #: doi.org/10.53354/pc.gr.151096), and to X.L. from the National Institutes of Health (R01CA222251).	Al Habyan S, 2018, ONCOGENE, V37, P5127, DOI 10.1038/s41388-018-0317-x; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Auersperg N, 2008, GYNECOL ONCOL, V110, P452, DOI 10.1016/j.ygyno.2008.05.031; Auersperg N, 2013, GYNECOL ONCOL, V130, P246, DOI 10.1016/j.ygyno.2013.03.021; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bobbs AS, 2015, CANCER GROWTH METAST, P29, DOI 10.4137/CGM.S21221; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Coscia F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12645; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dobbin ZC, 2013, INT J MOL SCI, V14, P8213, DOI 10.3390/ijms14048213; Flesken-Nikitin A, 2003, CANCER RES, V63, P3459; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Han C., 2016, NAT COMMUN, V7; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; Hao DP, 2017, CLIN CANCER RES, V23, P7400, DOI 10.1158/1078-0432.CCR-17-0638; Karnezis AN, 2017, NAT REV CANCER, V17, P65, DOI 10.1038/nrc.2016.113; Kim J, 2018, CANCERS, V10; Kim O, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008808; Klotz DM, 2017, ARCH GYNECOL OBSTET, V296, P1055, DOI 10.1007/s00404-017-4529-z; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kroeger PT, 2017, CURR OPIN OBSTET GYN, V29, P26, DOI 10.1097/GCO.0000000000000340; Labidi-Galy SI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00962-1; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lawrenson K, 2019, CELL REP, V29, P3726, DOI 10.1016/j.celrep.2019.10.122; Lheureux S, 2019, CA-CANCER J CLIN, V69, P280, DOI 10.3322/caac.21559; Li Y., 2017, NAT COMMUN, V8; Lisio MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040952; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lo Riso P, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00786-7; Macintyre G, 2018, NAT GENET, V50, P1262, DOI 10.1038/s41588-018-0179-8; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mehra Karishma, 2011, Front Biosci (Elite Ed), V3, P625, DOI 10.2741/e275; Meidhof S, 2015, EMBO MOL MED, V7, P831, DOI 10.15252/emmm.201404396; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Motohara T, 2019, ONCOGENE, V38, P2885, DOI 10.1038/s41388-018-0637-x; Nagy A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84787-5; Otsuka I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094409; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Perets R, 2016, CANCER RES, V76, P10, DOI 10.1158/0008-5472.CAN-15-1382; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sandercock J, 2002, BRIT J CANCER, V87, P815, DOI 10.1038/sj.bjc.6600567; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stuckelberger S, 2018, J PATHOL, V245, P129, DOI 10.1002/path.5065; Sun H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15534; Szabova L, 2012, CANCER RES, V72, P4141, DOI 10.1158/0008-5472.CAN-11-3834; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wu R, 2016, J PATHOL, V240, P341, DOI 10.1002/path.4783; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Zhai YL, 2017, J PATHOL, V243, P16, DOI 10.1002/path.4927; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang L, 2016, ONCOGENE, V35, P5010, DOI 10.1038/onc.2016.53; Zhang SZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02693-9; Zhang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13116-2; Zhao XS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1421	67	3	3	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1974	1985		10.1038/s41388-022-02224-x	http://dx.doi.org/10.1038/s41388-022-02224-x		FEB 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35173307	Green Published, hybrid			2022-12-26	WOS:000756457400002
J	Miller, AP; Mugamba, S; Bulamba, RM; Kyasanku, E; Nkale, J; Nalugoda, F; Nakigozi, G; Kigozi, G; Nalwoga, GK; Kagaayi, J; Watya, S; Wagman, JA				Miller, Amanda P.; Mugamba, Stephen; Bulamba, Robert M.; Kyasanku, Emmanuel; Nkale, James; Nalugoda, Fred; Nakigozi, Gertrude; Kigozi, Godfrey; Nalwoga, Grace K.; Kagaayi, Joseph; Watya, Stephen; Wagman, Jennifer A.			Exploring the impact of COVID-19 on women's alcohol use, mental health, and experiences of intimate partner violence in Wakiso, Uganda	PLOS ONE			English	Article							SELF-EFFICACY; DEPRESSIVE SYMPTOMS; MOOD DISORDERS; SUBSTANCE USE; RURAL UGANDA; VICTIMIZATION; CONSUMPTION; PREVALENCE; SEVERITY; MEDICATION	Introduction Uganda confirmed its first COVID-19 case in March 2020, leading to country-wide closures and a stay-at-home order. Infectious disease pandemics can overwhelm adaptive coping capacity (e.g., general self-efficacy and resilience) and increase the risk for mental distress. For individuals experiencing intimate partner violence (IPV) and cohabitating with a perpetrator, stay-at-home orders can also increase risk of violence, which can further exacerbate mental distress. The present study explores women's perceived self-efficacy and resilient coping, mental health outcomes (depression and COVID-19 related anxiety), hazardous alcohol use and IPV in the context of Uganda's national 2020 lockdown. Methods A phone-based survey was undertaken from June-August of 2020 in Wakiso District, Uganda. The study sample consisted of Africa Medical and Behavioral Sciences Organization (AMBSO) Population Health Surveillance (APHS) study participants who agreed to be contacted for future research. The analytic sample was restricted to women aged 13-80 years. Bivariate analysis and multivariable models explored associations between experiences of IPV and measures of adaptive coping, mental health and alcohol use. Results A total of 556 women aged 13-79 years (mean age of 33.4 years) participated. Over half (55%) were currently married. The majority (60%) reported a decrease in alcohol use during the lockdown. Nearly half of the sample were experiencing physical or verbal IPV and reported an increase in violence during the lockdown. In adjusted analysis, alcohol use was associated with four times greater odds of recent physical IPV (aOR 4.06, 95% CI = 1.65-10.02, p = 0.0024), while participants had lower odds of experiencing any form of IPV as general self-efficacy increased (aOR 0.95, 95% CI = 0.91-0.99, p = 0.0308). Conclusion Lockdown measures in Uganda may have mitigated increased alcohol consumption. IPV was exacerbated during lockdown; more than 2 in 5 IPV victims experienced increased physical or verbal violence. Development of programming and policies aimed at mitigating women's risk of IPV during future lockdowns are needed.	[Miller, Amanda P.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA; [Mugamba, Stephen] Makerere Univ Walter Reed Project MUWRP, Kampala, Uganda; [Mugamba, Stephen; Bulamba, Robert M.; Kyasanku, Emmanuel; Nkale, James; Nalugoda, Fred; Nakigozi, Gertrude; Kigozi, Godfrey; Nalwoga, Grace K.; Kagaayi, Joseph; Watya, Stephen] Uro Care Ltd, Africa Med & Behav Sci Org AMBSO, Wakiso Dist, Hoima, Uganda; [Wagman, Jennifer A.] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Miller, Amanda P.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Miller, AP (corresponding author), Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, La Jolla, CA 92093 USA.; Miller, AP (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.	apmiller@g.ucla.edu	Miller, Amanda P/AAR-9714-2020	Miller, Amanda P/0000-0002-2252-6973; Bulamba, Robert/0000-0001-7870-5041	EMERGE project (Bill and Melinda Gates Foundation) [OPP1163682, INV018007]; National Institute of Alcohol Abuse and Alcoholism [F31AA028198-01]	EMERGE project (Bill and Melinda Gates Foundation); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this work has come from the EMERGE project (Bill and Melinda Gates Foundation Grants: OPP1163682 and INV018007; PI Anita Raj) and National Institute of Alcohol Abuse and Alcoholism (grant F31AA028198-01 PI Amanda P Miller) which provided protected time to develop this manuscript.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero JM, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105217; Akina Mama wa Afrika, 2020, GEND IMPL COVID 19 U; Alupo B., 2020, GENDER COVID 19 CONT; [Anonymous], 1966, PSYCHOL DISTRESS COP; [Anonymous], 2020, GENDER BASED VIOLENC; [Anonymous], 2020, EMERGE COVID 19 GEND; [Anonymous], 2020, GEND IMPL COVID 19 A; Awungafac G, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045427; Babor T., 1994, LEXICON ALCOHOL DRUG; Babor T.F., 1992, GUIDELINES USE PRIMA; Barbosa C, 2021, J ADDICT MED, V15, P341, DOI 10.1097/ADM.0000000000000767; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Britton PC, 2004, ADDICT RES THEORY, V12, P103, DOI 10.1080/16066350310001613062; Buonsenso D, 2020, INT J INFECT DIS, V97, P23, DOI 10.1016/j.ijid.2020.05.104; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Center on Gender Equity and Health (GEH), 2020, EMERGE COVID 19 GEND; Centers for Disease Control and Prevention, 2020, STRONG PARTN CDC INV; Cepeda Z, 2017, DOMINICAN REPUBLIC G; Chiwona-Karltun L, 2021, AMBIO, V50, P794, DOI 10.1007/s13280-020-01481-y; Cornwall Andrea., 2017, MASCULINITIES NEOLIB; Costa C., 2020, CNBC; Devereux S, 2021, GLOB SOC POLICY, V21, P421, DOI 10.1177/14680181211021260; Devries KM, 2014, ADDICTION, V109, P379, DOI 10.1111/add.12393; Eckhardt CI, 2007, J CONSULT CLIN PSYCH, V75, P61, DOI 10.1037/0022-006X.75.1.61; Ettman CK, 2021, J EPIDEMIOL COMMUN H, V75, P501, DOI 10.1136/jech-2020-215213; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Fusar-Poli P, 2020, J AFFECT DISORDERS, V275, P78, DOI 10.1016/j.jad.2020.06.028; Gender E.S., 2020, GENDER POLICE BRUTAL; Gezinski LB, 2021, VIOLENCE AGAINST WOM, V27, P108, DOI 10.1177/1077801219882496; Graham K, 2011, J INTERPERS VIOLENCE, V26, P1503, DOI 10.1177/0886260510370596; Greene MC, 2017, GLOB MENT HEALTH, V4, DOI 10.1017/gmh.2017.9; Grossman ER, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249189; Guloba MM., 2021, IMPACT COVID 19 IND; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hasking P, 2011, ADDICT BEHAV, V36, P479, DOI 10.1016/j.addbeh.2011.01.014; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Holmila M, 2014, DRUG-EDUC PREV POLIC, V21, P398, DOI 10.3109/09687637.2014.911245; Human Rights Watch, 2020, UG RESP RIGHTS COVID; Iob E, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26064; Jalloh MF, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000471; Jetelina KK, 2021, INJURY PREV, V27, P93, DOI 10.1136/injuryprev-2020-043831; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Kgaugelo M., 2020, TIMES LIVE 0403, V3, P2020; Khan KS, 2022, INT J MENT HEALTH AD, V20, P380, DOI 10.1007/s11469-020-00367-0; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; Koenig MA, 2003, B WORLD HEALTH ORGAN, V81, P53; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai HMX, 2015, DRUG ALCOHOL DEPEN, V154, P1, DOI 10.1016/j.drugalcdep.2015.05.031; Lee SA, 2020, DEATH STUD, DOI [10.1080/07481187.2020.1748481, 10.1080/07481187.2020.1853885]; Leonard KE, 1998, J ABNORM PSYCHOL, V107, P602, DOI 10.1037/0021-843X.107.4.602; Leonard KE, 1999, J STUD ALCOHOL, V60, P537, DOI 10.15288/jsa.1999.60.537; Lord F.M., 1952, PSYCHOMETRIKA MONOGR, V7, DOI DOI 10.1039/TF9524800166; Lord F. M., 1968, STAT THEORIES MENTAL; Luo Y, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.565098; Lyons M, 2022, J FAM VIOLENCE, V37, P969, DOI 10.1007/s10896-021-00260-x; Maciejewski PK, 2000, BRIT J PSYCHIAT, V176, P373, DOI 10.1192/bjp.176.4.373; Matheson FI, 2015, WOMEN HEALTH ISS, V25, P561, DOI 10.1016/j.whi.2015.04.006; McKinney CM, 2010, ALCOHOL CLIN EXP RES, V34, P655, DOI 10.1111/j.1530-0277.2009.01134.x; Miller AP, 2022, VIOLENCE AGAINST WOM, V28, P1483, DOI 10.1177/10778012211019054; Miller AP, 2021, QUAL HEALTH RES, V31, P967, DOI 10.1177/1049732320986164; Miller AP., 2021, PSYCHIAT RES COMMUN, V1; Ministry of Health Uganda, 2020, COR PAND COVID 19 KA; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Mumtaz A, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9040424; O'Brien M, 2016, INT J HUM RIGHTS HEA, V9, P151, DOI 10.1108/IJHRH-09-2015-0027; Peng LP, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-8125-y; Pengpid S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09064-y; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pollard MS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22942; Posel D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249352; Pozhidaev D., 2020, IMPACT COVID 19 UGAN; Ramalho R, 2020, AUSTRALAS PSYCHIATRY, V28, P524, DOI 10.1177/1039856220943024; Reed E, 2014, JAMA PEDIATR, V168, P581, DOI 10.1001/jamapediatrics.2013.5408; Rieper M., 2020, STATES RELAX ALCOHOL, DOI [10.3390/ijms21186564 32911706, DOI 10.3390/IJMS2118656432911706]; Sallie SN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044276; SAS Institute Inc, SAS U; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Semakula E., 2020, GENDER POLICE BRUTAL; Sharma A, 2022, J FAM VIOLENCE, V37, P759, DOI 10.1007/s10896-020-00188-8; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Sommerlad A, 2021, PSYCHOL MED, DOI 10.1017/S0033291721000039; Spencer C, 2019, PSYCHOL VIOLENCE, V9, P1, DOI 10.1037/vio0000156; Ssebunnya J, 2019, GLOB MENT HEALTH, V6, DOI 10.1017/gmh.2019.25; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Sweetland AC, 2014, DEPRESS ANXIETY, V31, P223, DOI 10.1002/da.22142; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-399; Uganda Bureau of Statistics-UBOS and ICF, 2018, UG DEM HLTH SURV 201; Union African, 2020, FRAM DOC IMP COVID 1; Weerakoon SM, 2021, AM J DRUG ALCOHOL AB, V47, P98, DOI 10.1080/00952990.2020.1832508; WHO, 2001, AUDIT ALCOHOL USE DI; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; World Health Organization and Pan American Health Organization, 2012, INTIMATE PARTNER VIO; Wu P, 2008, ALCOHOL ALCOHOLISM, V43, P706, DOI 10.1093/alcalc/agn073; Wu TC, 2021, J AFFECT DISORDERS, V281, P91, DOI 10.1016/j.jad.2020.11.117; Ye Z, 2020, APPL PSYCHOL-HLTH WE, V12, P1074, DOI 10.1111/aphw.12211; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	101	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263827	10.1371/journal.pone.0263827	http://dx.doi.org/10.1371/journal.pone.0263827			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171949	Green Published, gold			2022-12-26	WOS:000795889700039
J	Gangisetty, O; Chaudhary, S; Palagani, A; Sarkar, DK				Gangisetty, Omkaram; Chaudhary, Shaista; Palagani, Ajay; Sarkar, Dipak K.			Transgenerational inheritance of fetal alcohol effects on proopiomelanocortin gene expression and methylation, cortisol response to stress, and anxiety-like behaviors in offspring for three generations in rats: Evidence for male germline transmission	PLOS ONE			English	Article							EXPOSURE; DRINKING; TRAUMA; SONS	Previously it has been shown that fetal alcohol exposure increases the stress response partly due to lowering stress regulatory proopiomelanocortin (Pomc) gene expression in the hypothalamus via epigenetic mechanisms for multiple generations in mixed-breed rats. In this study we assess the induction of heritable epigenetic changes of Pomc-related variants by fetal alcohol exposure in isogenic Fischer 344 rats. Using transgenerational breeding models and fetal alcohol exposure procedures, we determined changes in hypothalamic Pomc gene expression and its methylation levels, plasma corticosterone hormone response to restraint stress, and anxiety-like behaviors using elevated plus maze tests in fetal alcoholexposed offspring for multiple generations in isogenic Fischer rats. Fetal alcohol-exposed male and female rat offspring showed significant deficits in POMC neuronal functions with increased Pomc gene methylation and reduced expression. These changes in POMC neuronal functions were associated with increased plasma corticosterone response to restraint stress and increased anxiety-like behavior. These effects of fetal alcohol exposure persisted in the F1, F2, and F3 progeny of the male germline but not of the female germline. These data suggest that fetal alcohol exposure induces heritable changes in Pomc-related variants involving stress hyperresponsiveness and anxiety-like behaviors which perpetuate into subsequent generations through the male germline via epigenetic modifications.	[Gangisetty, Omkaram; Chaudhary, Shaista; Palagani, Ajay; Sarkar, Dipak K.] Rutgers State Univ, Dept Anim Sci, Rutgers Endocrine Res Program, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Rutgers Endocrine Res Program, New Brunswick, NJ 08901 USA.	Dipak.sarkar@rutgers.edu	Chaudhary, Shaista/GNW-6856-2022; Sarkar, Dipak/O-7942-2017	Gangisetty, Omkaram/0000-0001-6280-0642; Sarkar, Dipak/0000-0003-3237-9871	National Institutes of Health [R01 AA025359]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health Grant R01 AA025359 to DKS.	Abel EL, 2004, ADDICT BIOL, V9, P127, DOI 10.1080/13556210410001716980; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Babenko O, 2015, NEUROSCI BIOBEHAV R, V48, P70, DOI 10.1016/j.neubiorev.2014.11.013; Boyadjieva NI, 2009, ALCOHOL CLIN EXP RES, V33, P931, DOI 10.1111/j.1530-0277.2009.00911.x; Bruner-Tran KL, 2017, REPROD TOXICOL, V68, P59, DOI 10.1016/j.reprotox.2016.07.007; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Ehrlich S, 2010, J PSYCHIATR RES, V44, P827, DOI 10.1016/j.jpsychires.2010.01.011; Finegersh A, 2015, ALCOHOL, V49, P461, DOI 10.1016/j.alcohol.2015.02.008; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gangisetty O, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00859-9; Gangisetty O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113228; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; HEGEDUS AM, 1984, ALCOHOL CLIN EXP RES, V8, P330, DOI 10.1111/j.1530-0277.1984.tb05522.x; Jabbar S, 2016, NEUROPSYCHOPHARMACOL, V41, P2782, DOI 10.1038/npp.2016.92; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kellermann NPF, 2013, ISR J PSYCHIATR REL, V50, P33; Lemire M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S159; LITTLE RE, 1987, TERATOLOGY, V36, P59, DOI 10.1002/tera.1420360109; Liu XQ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S160; Logan RW, 2015, ALCOHOL CLIN EXP RES, V39, P146, DOI 10.1111/acer.12611; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Manzardo AM, 2012, ALCOHOL CLIN EXP RES, V36, P1325, DOI 10.1111/j.1530-0277.2012.01740.x; Miller LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086781; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; Minguez L, 2015, ENVIRON SCI TECHNOL, V49, P1148, DOI 10.1021/es504808g; Nizhnikov ME, 2016, ALCOHOL CLIN EXP RES, V40, P497, DOI 10.1111/acer.12978; Olino TM, 2008, J AM ACAD CHILD PSY, V47, P53, DOI 10.1097/chi.0b013e31815a6ae6; Ouko LA, 2009, ALCOHOL CLIN EXP RES, V33, P1615, DOI 10.1111/j.1530-0277.2009.00993.x; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Sarkar DK, 2019, ALCOHOL CLIN EXP RES, V43, P1887, DOI 10.1111/acer.14148; Sotnikov SV, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.127; TARTER RE, 1984, ALCOHOL CLIN EXP RES, V8, P216, DOI 10.1111/j.1530-0277.1984.tb05842.x; Vaage Aina B, 2011, Child Adolesc Psychiatry Ment Health, V5, P2, DOI 10.1186/1753-2000-5-2; VandeVoort CA, 2015, FERTIL STERIL, V103, P560, DOI 10.1016/j.fertnstert.2014.10.051; Vassoler FM, 2014, NEUROPHARMACOLOGY, V76, P269, DOI 10.1016/j.neuropharm.2013.06.016; Yohn NL, 2015, PROG BIOPHYS MOL BIO, V118, P21, DOI 10.1016/j.pbiomolbio.2015.03.002; Zuo LJ, 2013, PSYCHIAT GENET, V23, P233, DOI 10.1097/YPG.0b013e328364b8c7	40	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263340	10.1371/journal.pone.0263340	http://dx.doi.org/10.1371/journal.pone.0263340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143549	Green Published, gold			2022-12-26	WOS:000797657800037
J	White, MGE; Bezodis, NE; Neville, J; Summers, H; Rees, P				White, Mark G. E.; Bezodis, Neil E.; Neville, Jonathon; Summers, Huw; Rees, Paul			Determining jumping performance from a single body-worn accelerometer using machine learning	PLOS ONE			English	Article							AUSTRALIAN RULES FOOTBALL; FUNCTIONAL DATA-ANALYSIS; POWER PREDICTION EQUATIONS; VERTICAL JUMP; COUNTERMOVEMENT-JUMP; CROSS-VALIDATION; MODEL SELECTION; CONCURRENT VALIDITY; STRENGTH; RELIABILITY	External peak power in the countermovement jump is frequently used to monitor athlete training. The gold standard method uses force platforms, but they are unsuitable for field-based testing. However, alternatives based on jump flight time or Newtonian methods applied to inertial sensor data have not been sufficiently accurate for athlete monitoring. Instead, we developed a machine learning model based on characteristic features (functional principal components) extracted from a single body-worn accelerometer. Data were collected from 69 male and female athletes at recreational, club or national levels, who performed 696 jumps in total. We considered vertical countermovement jumps (with and without arm swing), sensor anatomical locations, machine learning models and whether to use resultant or triaxial signals. Using a novel surrogate model optimisation procedure, we obtained the lowest errors with a support vector machine when using the resultant signal from a lower back sensor in jumps without arm swing. This model had a peak power RMSE of 2.3 W.kg(-1) (5.1% of the mean), estimated using nested cross validation and supported by an independent holdout test (2.0 W.kg(-1)). This error is lower than in previous studies, although it is not yet sufficiently accurate for a field-based method. Our results demonstrate that functional data representations work well in machine learning by reducing model complexity in applications where signals are aligned in time. Our optimisation procedure also was shown to be robust can be used in wider applications with low-cost, noisy objective functions.	[White, Mark G. E.; Bezodis, Neil E.] Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales; [White, Mark G. E.; Summers, Huw; Rees, Paul] Swansea Univ, Dept Biomed Engn, Swansea, W Glam, Wales; [Neville, Jonathon] Auckland Univ Technol, Sport Performance Res Inst New Zealand, Auckland, New Zealand	Swansea University; Swansea University; Auckland University of Technology	White, MGE (corresponding author), Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales.; White, MGE (corresponding author), Swansea Univ, Dept Biomed Engn, Swansea, W Glam, Wales.	markgewhite@gmail.com		Rees, Paul/0000-0002-7715-6914; White, Mark/0000-0001-5404-9289				Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Amonette WE, 2012, J STRENGTH COND RES, V26, P1749, DOI 10.1519/JSC.0b013e3182576f1e; [Anonymous], 2014, SWISS SPORTS EXERC M, DOI [10.34045/SSEM/2014/6, DOI 10.34045/SSEM/2014/6]; Aouadi R, 2012, J SPORT MED PHYS FIT, V52, P11; Aragon-Vargas L. F., 2000, Measurement in Physical Education and Exercise Science, V4, P215, DOI 10.1207/S15327841MPEE0404_2; Baker D, 1999, J STRENGTH COND RES, V13, P230; Baker D, 2002, J STRENGTH COND RES, V16, P581; Baker D, 1999, J STRENGTH COND RES, V13, P224, DOI 10.1519/00124278-199908000-00008; Balandat Maximilian, 2020, ADV NIPS; Baumann D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0047-1; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Braga-Neto Ulisses, 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5916, p59160V, DOI 10.1117/12.619331; BURMAN P, 1989, BIOMETRIKA, V76, P503, DOI 10.2307/2336116; Camomilla V, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030873; Canavan PK, 2004, MED SCI SPORT EXER, V36, P1589, DOI 10.1249/01.MSS.0000139802.96395.AC; Castagna C, 2013, J STRENGTH COND RES, V27, P761, DOI 10.1519/JSC.0b013e31825dbcc5; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Claudino JG, 2017, J SCI MED SPORT, V20, P397, DOI 10.1016/j.jsams.2016.08.011; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P359, DOI 10.1123/ijspp.3.3.359; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Cormie P., 2011, SPORTS MED, V22; Cronin J, 2005, SPORTS MED, V35, P213, DOI 10.2165/00007256-200535030-00003; Derie R, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00033; Dona G, 2009, SPORT BIOMECH, V8, P284, DOI 10.1080/14763140903414425; Donoghue OA, 2008, MED SCI SPORT EXER, V40, P1323, DOI 10.1249/MSS.0b013e31816c4807; DOWLING JJ, 1993, J APPL BIOMECH, V9, P95, DOI 10.1123/jab.9.2.95; Eggensperger K, 2018, MACH LEARN, V107, P15, DOI 10.1007/s10994-017-5683-z; Eric Brochu, 2010, TUTORIAL BAYESIAN OP; Field A.P., 2020, DISCOVERING STAT USI, V4th; Filzmoser P, 2009, J CHEMOMETR, V23, P160, DOI 10.1002/cem.1225; Floria P, 2019, J SPORT SCI, V37, P370, DOI 10.1080/02640414.2018.1504602; Forner-Cordero A, 2008, PHYSIOL MEAS, V29, pN21, DOI 10.1088/0967-3334/29/4/N01; French DN, 2004, J STRENGTH COND RES, V18, P101; Gathercole R, 2015, INT J SPORT PHYSIOL, V10, P84, DOI 10.1123/ijspp.2013-0413; Giroux C, 2015, INT J SPORTS MED, V36, P143, DOI 10.1055/s-0034-1385886; Godwin A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000109; Guo YZ, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102181; Gurchiek RD, 2019, J APPL BIOMECH, V35, P164, DOI 10.1123/jab.2018-0107; Harrison AJ, 2007, SPORT BIOMECH, V6, P199, DOI 10.1080/14763140701323042; Hatze H, 1998, J APPL BIOMECH, V14, P127, DOI 10.1123/jab.14.2.127; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hojka V, 2018, ACTA GYMNICA, V48, P95, DOI 10.5507/ag.2018.013; Hori N, 2007, J STRENGTH COND RES, V21, P314; Jones TW, 2016, J STRENGTH COND RES, V30, P3354, DOI 10.1519/JSC.0000000000001445; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Kipp K, 2012, J STRENGTH COND RES, V26, P1838, DOI 10.1519/JSC.0b013e318239c1d2; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Krstajic D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-10; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; Lara-Sanchez AJ, 2011, J STRENGTH COND RES, V25, P1957, DOI 10.1519/JSC.0b013e3181e06ef8; Letham B, 2019, BAYESIAN ANAL, V14, P495, DOI 10.1214/18-BA1110; Li C, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2096; LUHTANEN P, 1978, EUR J APPL PHYSIOL O, V38, P181, DOI 10.1007/BF00430076; Madgwick Sebastian O H, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975346, DOI 10.1109/ICORR.2011.5975346; Makaruk H, 2011, J STRENGTH COND RES, V25, P3311, DOI 10.1519/JSC.0b013e318215fa33; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; McGuigan MR, 2009, J STRENGTH COND RES, V23, P26, DOI 10.1519/JSC.0b013e31818753ca; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; McMahon J., 2019, PERFORMANCE ASSESSME; McMahon JJ, 2017, INT J SPORT PHYSIOL, V12, P803, DOI 10.1123/ijspp.2016-0467; Methenitis SK, 2016, J STRENGTH COND RES, V30, P807, DOI 10.1519/JSC.0000000000001147; Miller DI., 1976, KINEMATIC KINETIC CO, P65; Monnet T, 2014, SPORTS ENG, V17, P249, DOI 10.1007/s12283-014-0155-1; Neugebauer JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099023; Newton RU, 2006, J STRENGTH COND RES, V20, P955; Nuzzo JL, 2008, J STRENGTH COND RES, V22, P699, DOI 10.1519/JSC.0b013e31816d5eda; Owen NJ, 2014, J STRENGTH COND RES, V28, P1552, DOI 10.1519/JSC.0000000000000311; PANDY MG, 1990, J BIOMECH, V23, P1185, DOI 10.1016/0021-9290(90)90376-E; Picerno P, 2011, J SPORT SCI, V29, P139, DOI 10.1080/02640414.2010.523089; Pogson M, 2020, MED ENG PHYS, V78, P82, DOI 10.1016/j.medengphy.2020.02.002; Quagliarella L, 2010, J STRENGTH COND RES, V24, P1229, DOI 10.1519/JSC.0b013e3181cb281a; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Richter C, 2014, J BIOMECH, V47, P3012, DOI 10.1016/j.jbiomech.2014.07.001; Rodacki ALF, 2002, MED SCI SPORT EXER, V34, P105, DOI 10.1097/00005768-200201000-00017; Rodriguez JD, 2013, PATTERN RECOGN, V46, P855, DOI 10.1016/j.patcog.2012.09.007; Ryan W, 2006, SPORT BIOMECH, V5, P121, DOI 10.1080/14763141.2006.9628228; Sacilotto GBD, 2015, 33 INT C BIOMECHANIC; Sayers SP, 1999, MED SCI SPORT EXER, V31, P572, DOI 10.1097/00005768-199904000-00013; Shao J, 1997, STAT SINICA, V7, P221; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shull PB, 2017, IEEE SENS J, V17, P480, DOI 10.1109/JSEN.2016.2630938; Snoek J., 2015, ARXIV150205700 STAT; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Street G, 2001, J APPL BIOMECH, V17, P43, DOI 10.1123/jab.17.1.43; Tan T, 2019, J BIOMECH, V97, DOI 10.1016/j.jbiomech.2019.109416; Taylor K., 2012, J AUST STRENGTH COND, V20, P12; Tessier JF, 2013, J HUM KINET, V38, P5, DOI 10.2478/hukin-2013-0040; Twist C, 2013, INT J SPORT PHYSIOL, V8, P467, DOI 10.1123/ijspp.8.5.467; Unler A, 2010, EUR J OPER RES, V206, P528, DOI 10.1016/j.ejor.2010.02.032; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Warmenhoven J, 2018, SCAND J MED SCI SPOR, V28, P1379, DOI 10.1111/sms.13031; Warmenhoven J, 2019, SPORT BIOMECH, V18, P10, DOI 10.1080/14763141.2017.1384050; Wouda FJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00218; Young WB, 2005, J SCI MED SPORT, V8, P333, DOI 10.1016/S1440-2440(05)80044-1; ZHANG P, 1993, ANN STAT, V21, P299, DOI 10.1214/aos/1176349027; Zhang YL, 2015, J ECONOMETRICS, V187, P95, DOI 10.1016/j.jeconom.2015.02.006; ZIEGERT JC, 1979, J BIOMECH ENG-T ASME, V101, P218, DOI 10.1115/1.3426248; Zucchini W, 2000, J MATH PSYCHOL, V44, P41, DOI 10.1006/jmps.1999.1276	101	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263846	10.1371/journal.pone.0263846	http://dx.doi.org/10.1371/journal.pone.0263846			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143555	Green Submitted, Green Published, gold			2022-12-26	WOS:000797657800087
J	Robles, JP; Zamora, M; Adan-Castro, E; Siqueiros-Marquez, L; de la Escalera, GM; Clapp, C				Robles, Juan Pablo; Zamora, Magdalena; Adan-Castro, Elva; Siqueiros-Marquez, Lourdes; de la Escalera, Gonzalo Martinez; Clapp, Carmen			The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin alpha 5 beta 1 and NF-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CELLS; MECHANISMS; MICE	Vascular endothelial cells (ECs) form a critical interface between blood and tissues that maintains whole-body homeostasis. In COVID-19, disruption of the EC barrier results in edema, vascular inflammation, and coagulation, hallmarks of this severe disease. However, the mechanisms by which ECs are dysregulated in COVID-19 are unclear. Here, we show that the spike protein of SARS-CoV-2 alone activates the EC inflammatory phenotype in a manner dependent on integrin alpha 5 beta 1 signaling. Incubation of human umbilical vein ECs with whole spike protein, its receptor-binding domain, or the integrin-binding tripeptide RGD induced the nuclear translocation of NF-kappa B and subsequent expression of leukocyte adhesion molecules (VCAM1 and ICAM1), coagulation factors (TF and FVIII), proinflammatory cytokines (TNF alpha, IL-1 beta, and IL-6), and ACE2, as well as the adhesion of peripheral blood leukocytes and hyperpermeability of the EC monolayer. In addition, inhibitors of integrin alpha 5 beta 1 activation prevented these effects. Furthermore, these vascular effects occur in vivo, as revealed by the intravenous administration of spike, which increased expression of ICAM1, VCAM1, CD45, TNF alpha, IL-1 beta, and IL-6 in the lung, liver, kidney, and eye, and the intravitreal injection of spike, which disrupted the barrier function of retinal capillaries. We suggest that the spike protein, through its RGD motif in the receptor-binding domain, binds to integrin alpha 5 beta 1 in ECs to activate the NF-kappa B target gene expression programs responsible for vascular leakage and leukocyte adhesion. These findings uncover a new direct action of SARS-CoV-2 on EC dysfunction and introduce integrin alpha 5 beta 1 as a promising target for treating vascular inflammation in COVID-19.	[Robles, Juan Pablo; Zamora, Magdalena; Adan-Castro, Elva; Siqueiros-Marquez, Lourdes; de la Escalera, Gonzalo Martinez; Clapp, Carmen] Univ Nacl Autonoma Mex UNAM, Inst Neurobiol, Queretaro, Mexico		Robles, JP (corresponding author), Univ Nacl Autonoma Mex UNAM, Inst Neurobiol, Queretaro, Mexico.	juanpabloroblesa@gmail.com	Clapp, Carmen/P-5128-2014	Clapp, Carmen/0000-0002-7670-6718; Zamora, Magdalena/0000-0001-5579-1004; Robles, Juan Pablo/0000-0001-8429-1914; Martinez de la Escalera, Gonzalo/0000-0002-4309-3476; Siqueiros-Marquez, Lourdes/0000-0001-9528-8489	"Consejo Nacional de Ciencia y Tecnologia" (CONACYT) [A1-S-9620B, 289568]; CONACYT [768182]	"Consejo Nacional de Ciencia y Tecnologia" (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported from "Consejo Nacional de Ciencia y Tecnologia" (CONACYT) grants A1-S-9620B and 289568 to C. C. M. Z. is a doctoral student from "Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM)" and received fellowship 768182 from CONACYT.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Al-Yafeai Z, 2018, ARTERIOSCL THROM VAS, V38, P2601, DOI 10.1161/ATVBAHA.118.311705; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Amruta N, 2021, LIFE SCI, V284, DOI 10.1016/j.lfs.2021.119881; Avolio E, 2021, CLIN SCI, V135, P2668, DOI 10.1042/CS20210735; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Bermejo-Martin JF, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110400; Besse B, 2013, ANN ONCOL, V24, P90, DOI 10.1093/annonc/mds281; Biancatelli RMLC, 2021, AM J PHYSIOL-LUNG C, V321, pL477, DOI 10.1152/ajplung.00223.2021; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Elezkurtaj S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82862-5; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Gianni T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004477; Godo S, 2017, ARTERIOSCL THROM VAS, V37, pE108, DOI 10.1161/ATVBAHA.117.309813; Hakanpaa L, 2018, P NATL ACAD SCI USA, V115, pE6467, DOI 10.1073/pnas.1722317115; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jin YF, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00454-7; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kawanami D, 2004, BIOCHEM BIOPH RES CO, V314, P415, DOI 10.1016/j.bbrc.2003.12.104; Khan S, 2021, ELIFE, V10, DOI [10.7554/eLife.68563, 10.1101/2021.03.16.435700]; Klein S, 2002, MOL CELL BIOL, V22, P5912, DOI 10.1128/MCB.22.16.5912-5922.2002; Lei YY, 2021, CIRC RES, V128, P1323, DOI 10.1161/CIRCRESAHA.121.318902; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li F, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166260; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Lv XL, 2019, VET MICROBIOL, V233, P147, DOI 10.1016/j.vetmic.2019.04.029; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Meyer K, 2021, J VIROL, V95, DOI 10.1128/JVI.00794-21; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Ogata AF, 2022, CLIN INFECT DIS, V74, P715, DOI 10.1093/cid/ciab465; Ou ZW, 2021, AM J PHYSIOL-HEART C, V320, pH734, DOI 10.1152/ajpheart.00518.2020; Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Raghavan S, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.687783; Ramirez M, 2011, INVEST OPHTH VIS SCI, V52, P8944, DOI 10.1167/iovs.11-8190; Rojas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084357; Rossi AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88944-8; Semeraro F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/582060; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shirato K, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06187; Siddiqi HK, 2021, TRENDS CARDIOVAS MED, V31, P1, DOI 10.1016/j.tcm.2020.10.005; Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759; TEIXEIRA MM, 1993, BRIT J PHARMACOL, V110, P1515, DOI 10.1111/j.1476-5381.1993.tb13994.x; Teuwen LA, 2020, NAT REV IMMUNOL, V20, P389, DOI 10.1038/s41577-020-0343-0; Tresoldi I, 2020, J MED VIROL, V92, P1741, DOI 10.1002/jmv.25831; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vrints CJM, 2021, ACTA CARDIOL, V76, P109, DOI 10.1080/00015385.2020.1846921; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yamamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7429; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	59	20	20	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101695	10.1016/j.jbc.2022.101695	http://dx.doi.org/10.1016/j.jbc.2022.101695			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143839	Green Published, gold			2022-12-26	WOS:000789400700011
J	Ulatowski, L; Ghelfi, M; West, R; Atkinson, J; Finno, CJ; Manor, D				Ulatowski, L.; Ghelfi, Mikel; West, Ryan; Atkinson, J.; Finno, C. J.; Manor, D.			The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LOW-DENSITY-LIPOPROTEIN; ALPHA-TOCOPHEROL; E-DEFICIENCY; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; CHOLESTEROL-METABOLISM	Alpha-tocopherol (vitamin E) is an essential nutrient that functions as a major lipid-soluble antioxidant in humans. The alpha-tocopherol transfer protein (TTP) binds alpha-tocopherol with high affinity and selectivity and regulates whole-body distribution of the vitamin. Heritable mutations in the TTPA gene result in familial vitamin E deficiency, elevated indices of oxidative stress, and progressive neurodegeneration that manifest primarily in spinocerebellar ataxia. Although the essential role of vitamin E in neurological health has been recognized for over 50 years, the mechanisms by which this essential nutrient is transported in the central nervous system are poorly understood. Here we found that, in the murine cerebellum, TTP is selectively expressed in glial fibrillary acidic protein-positive astrocytes, where it facilitates efflux of vitamin E to neighboring neurons. We also show that induction of oxidative stress enhances the transcription of the TtpA gene in cultured cerebellar astrocytes. Furthermore, secretion of vitamin E from astrocytes is mediated by an ABC-type transporter, and uptake of the vitamin into neurons involves the low-density lipoprotein receptor-related protein 1. Taken together, our data indicate that TTP-expressing astrocytes control the delivery of vitamin E from astrocytes to neurons, and that this process is homeostatically responsive to oxidative stress. These are the first observations that address the detailed molecular mechanisms of vitamin E transport in the central nervous system, and these results have important implications for understanding the molecular underpinnings of oxidative stress-related neurodegenerative diseases.	[Ulatowski, L.] Ursuline Coll, Dept Biol, Pepper Pike, OH USA; [Ghelfi, Mikel; West, Ryan; Atkinson, J.] Brock Univ, Dept Chem, St Catharines, ON, Canada; [Finno, C. J.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA USA; [Manor, D.] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Manor, D.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Manor, D.] Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Ursuline College; Brock University; University of California System; University of California Davis; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Manor, D (corresponding author), Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	dxm178@case.edu		Atkinson, Jeffrey/0000-0003-3710-4893; ulatowski, lynn/0000-0002-1495-293X	National Institutes of Health [DK067494, DK125115, T32DK007319]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health awards DK067494 and DK125115 (to D. M.) and T32DK007319 (to L. U.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Asmis R, 1997, EUR J BIOCHEM, V250, P600, DOI 10.1111/j.1432-1033.1997.0600a.x; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; BJORNEBOE A, 1991, J NUTR, V121, P1208, DOI 10.1093/jn/121.8.1208; Bourdel-Marchasson I, 2001, AGE AGEING, V30, P235, DOI 10.1093/ageing/30.3.235; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; BURTON GW, 1983, CIBA F SYMP, V101, P4; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; BUTTRISS JL, 1988, BIOCHIM BIOPHYS ACTA, V962, P81, DOI 10.1016/0005-2760(88)90098-7; CACCAMO DV, 1989, ACTA NEUROPATHOL, V79, P248, DOI 10.1007/BF00294658; CACCAMO DV, 1989, AM J PATHOL, V135, P801; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Chung S, 2016, J BIOL CHEM, V291, P17028, DOI 10.1074/jbc.M116.734210; COHN W, 1992, BIOCHEM J, V287, P247, DOI 10.1042/bj2870247; Copp RP, 1999, BRAIN RES, V822, P80, DOI 10.1016/S0006-8993(99)01090-2; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Etminan M, 2005, LANCET NEUROL, V4, P362, DOI 10.1016/S1474-4422(05)70097-1; Etzl RP, 2012, J PERINAT MED, V40, P373, DOI 10.1515/jpm-2011-0307; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fariss MW, 2003, TOXICOLOGY, V189, P129, DOI 10.1016/S0300-483X(03)00158-6; Ferris HA, 2017, P NATL ACAD SCI USA, V114, P1189, DOI 10.1073/pnas.1620506114; Finno CJ, 2018, FREE RADICAL BIO MED, V120, P289, DOI 10.1016/j.freeradbiomed.2018.02.037; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Glaso M, 2004, J Nutr Health Aging, V8, P407; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Gohil K, 2003, FREE RADICAL BIO MED, V35, P1343, DOI 10.1016/S0891-5849(03)00509-4; Gosselet F, 2009, BRAIN RES, V1249, P34, DOI 10.1016/j.brainres.2008.10.036; Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x; GOTODA T, 1995, NEW ENGL J MED, V333, P1313, DOI 10.1056/NEJM199511163332003; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Guerineau NC, 1997, J NEUROSCI METH, V73, P169, DOI 10.1016/S0165-0270(97)02224-3; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Huebbe P, 2010, MOL NUTR FOOD RES, V54, P623, DOI 10.1002/mnfr.200900398; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7; JEANDEL C, 1989, GERONTOLOGY, V35, P275, DOI 10.1159/000213037; JimenezJimenez FJ, 1997, J NEURAL TRANSM, V104, P703, DOI 10.1007/BF01291887; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kolleck I, 1999, FREE RADICAL BIO MED, V27, P882, DOI 10.1016/S0891-5849(99)00139-2; Larnaout A, 1997, ACTA NEUROPATHOL, V93, P633, DOI 10.1007/s004010050662; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Marras C, 2009, MOVEMENT DISORD, V24, P2370, DOI 10.1002/mds.22828; Martin KR, 1997, P SOC EXP BIOL MED, V214, P367, DOI 10.3181/00379727-214-44105; Miller GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047402; Montine TJ, 1998, ANN NEUROL, V44, P410, DOI 10.1002/ana.410440322; Morley S, 2006, BIOCHEMISTRY-US, V45, P1075, DOI 10.1021/bi052271y; Morley S, 2008, J BIOL CHEM, V283, P17797, DOI 10.1074/jbc.M800121200; Morley S, 2010, J BIOL CHEM, V285, P35578, DOI 10.1074/jbc.M110.169664; MULLER DPR, 1982, ANN NY ACAD SCI, V393, P133, DOI 10.1111/j.1749-6632.1982.tb31239.x; NALECZ KA, 1992, EUR J BIOCHEM, V209, P37, DOI 10.1111/j.1432-1033.1992.tb17258.x; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Pham DQ, 2005, ANN PHARMACOTHER, V39, P2065, DOI 10.1345/aph.1G271; Qian JH, 2005, J LIPID RES, V46, P2072, DOI 10.1194/jlr.M500143-JLR200; Qian JH, 2006, BIOCHEMISTRY-US, V45, P8236, DOI 10.1021/bi060522c; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Roghani M, 2001, BRAIN RES, V892, P211, DOI 10.1016/S0006-8993(00)03296-0; RUNGE P, 1986, BRIT J OPHTHALMOL, V70, P166, DOI 10.1136/bjo.70.3.166; RUPAR CA, 1992, BIOCHEM CELL BIOL, V70, P486, DOI 10.1139/o92-075; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schuelke M, 1999, J PEDIATR-US, V134, P240, DOI 10.1016/S0022-3476(99)70424-5; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Sokol R J, 1990, Adv Pediatr, V37, P119; SOKOL RJ, 1993, GASTROENTEROLOGY, V104, P1727, DOI 10.1016/0016-5085(93)90652-S; SOKOL RJ, 1985, NEW ENGL J MED, V313, P1580, DOI 10.1056/NEJM198512193132505; SOKOL RJ, 1987, GASTROENTEROLOGY, V93, P975, DOI 10.1016/0016-5085(87)90559-2; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sutherland L, 2008, CELL MOL NEUROBIOL, V28, P949, DOI 10.1007/s10571-008-9269-y; Tachibana M, 2019, J CLIN INVEST, V129, P1272, DOI 10.1172/JCI124853; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; THELLMAN CA, 1985, J NUTR, V115, P1673, DOI 10.1093/jn/115.12.1673; TOHGI H, 1994, NEUROSCI LETT, V174, P73, DOI 10.1016/0304-3940(94)90122-8; TRABER MG, 1994, AM J CLIN NUTR, V59, P1270, DOI 10.1093/ajcn/59.6.1270; TRABER MG, 1984, AM J CLIN NUTR, V40, P747, DOI 10.1093/ajcn/40.4.747; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; TRABER MG, 1988, LIPIDS, V23, P791, DOI 10.1007/BF02536223; Ulatowski L, 2014, NEUROSCIENCE, V260, P120, DOI 10.1016/j.neuroscience.2013.12.001; Ulatowski L, 2013, ANNU REV NUTR, V33, P87, DOI 10.1146/annurev-nutr-071812-161252; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Usenko CY, 2008, TOXICOL APPL PHARM, V229, P44, DOI 10.1016/j.taap.2007.12.030; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vatassery GT, 2007, BBA-MOL BASIS DIS, V1772, P797, DOI 10.1016/j.bbadis.2007.04.006; Vatassery GT, 2006, J NEUROSCI RES, V84, P1335, DOI 10.1002/jnr.21037; Vatassery GT, 2009, J NEUROL SCI, V283, P195, DOI 10.1016/j.jns.2009.02.350; VATASSERY GT, 1992, ANN NY ACAD SCI, V669, P97; VATASSERY GT, 1984, BIOCHIM BIOPHYS ACTA, V792, P118, DOI 10.1016/0005-2760(84)90211-X; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang H, 2011, AM J EPIDEMIOL, V173, P595, DOI 10.1093/aje/kwq416; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; West R, 2010, J ORG CHEM, V75, P2883, DOI 10.1021/jo100095n; Yokota T, 1996, NEW ENGL J MED, V335, P1770, DOI 10.1056/NEJM199612053352315; Yokota T, 2000, J NEUROL NEUROSUR PS, V68, P521, DOI 10.1136/jnnp.68.4.521; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Yu CJ, 2010, BBA-MOL CELL BIOL L, V1801, P819, DOI 10.1016/j.bbalip.2010.05.001; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhang WX, 2009, LIPIDS, V44, P631, DOI 10.1007/s11745-009-3310-x	114	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101712	10.1016/j.jbc.2022.101712	http://dx.doi.org/10.1016/j.jbc.2022.101712			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150738	Green Published, gold			2022-12-26	WOS:000821054100012
J	Bakshi, A; Van Doren, A; Maser, C; Aubin, K; Stewart, C; Soileau, S; Friedman, K; Williams, A				Bakshi, Arundhati; Van Doren, Alicia; Maser, Colette; Aubin, Kathleen; Stewart, Collette; Soileau, Shannon; Friedman, Kate; Williams, Alexis			Identifying Louisiana communities at the crossroads of environmental and social vulnerability, COVID-19, and asthma	PLOS ONE			English	Article							HOME VISITS; CHILDREN	The COVID-19 pandemic has disproportionately affected the socially and environmentally vulnerable, including through indirect effects on other health conditions. Asthma is one such condition, which may be exacerbated by both prolonged adverse in-home exposures if quarantining in unhealthy homes and prolonged outdoor exposures if the ambient air quality is unhealthy or hazardous. As both are often the case in Environmental Justice (EJ) communities, here we have analyzed data at the census tract (CT) level for Louisiana to assess any correlation between social and environmental vulnerability, and health issues like COVID-19 and asthma. Higher Social Vulnerability Index (SVI), Particulate Matter less than 2.5 mu m in diameter (PM2.5) and Ozone levels were associated with higher rates of cumulative COVID-19 incidence at various time points during the pandemic, as well as higher average annual asthma hospitalization rates and estimated asthma prevalence. Further, cumulative COVID-19 incidence during the first three months of the pandemic was moderately correlated with both asthma hospitalizations and estimated prevalence, suggesting similar underlying factors may be affecting both conditions. Additionally, 137 CTs were identified where social and environmental vulnerabilities co-existed, of which 75 (55%) had high estimated prevalence of asthma. These areas are likely to benefit from asthma outreach that considers both social and environmental risk factors. Fifteen out of the 137 CTs (11%) not only had higher estimated prevalence of asthma but also a high burden of COVID-19. Further research in these areas may help to elucidate any common social determinants of health that underlie both asthma and COVID-19 burdens, as well as better clarify the possible role of the environment as related to the COVID-19 burden in Louisiana.	[Bakshi, Arundhati; Van Doren, Alicia; Maser, Colette; Aubin, Kathleen; Stewart, Collette; Soileau, Shannon; Friedman, Kate; Williams, Alexis] Off Publ Hlth, Louisiana Dept Hlth, Sect Environm Epidemiol & Toxicol, Baton Rouge, LA 70806 USA		Bakshi, A (corresponding author), Off Publ Hlth, Louisiana Dept Hlth, Sect Environm Epidemiol & Toxicol, Baton Rouge, LA 70806 USA.	Arundhati.Bakshi@LA.gov		Bakshi, Arundhati/0000-0001-8483-1597	CDC Environmental Public Health Tracking Cooperative Agreement; EPA State Environmental Justice Cooperative Agreement; State General Fund	CDC Environmental Public Health Tracking Cooperative Agreement; EPA State Environmental Justice Cooperative Agreement; State General Fund	Authors in this study have been supported through the CDC Environmental Public Health Tracking Cooperative Agreement (AB, KF, AW); the EPA State Environmental Justice Cooperative Agreement (AB); and the State General Fund (CM, CS, SS, KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Al-Hegelan M, 2011, IMMUNOL RES, V49, P173, DOI 10.1007/s12026-010-8180-z; Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442; Anenberg SC, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/ehp3766, 10.1289/EHP3766]; [Anonymous], CAS STUD BEN HOM VIS; Bryant-Stephens T, 2016, J ALLERGY CLIN IMMUN, V138, P1526, DOI 10.1016/j.jaci.2016.10.006; Bullard RD., 1993, YALE J INT L, V18, P319; Campbell JD, 2015, AM J PUBLIC HEALTH, V105, P2366, DOI 10.2105/AJPH.2015.302685; Centers for Disease Control and Prevention, 2018, NATL HLTH INTERVIEW; Centers for Disease Control and Prevention/ Agency for Toxic Substances and Disease Registry/ Geospatial Research Analysis and Services Program, CDC SOC VULN IND 201; Chakraborty J, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110586; Chatkin J, 2022, CLIN REV ALLERG IMMU, V62, P72, DOI 10.1007/s12016-020-08830-5; Chibwana M.G., 2020, PREPRINT, DOI [10.1101/2020.07.30.20164970, DOI 10.1101/2020.07.30.20164970]; Cyrus E, 2020, HEALTH EQUITY, V4, P476, DOI [10.1089/heq.2020.0030, 10.1101/2020.05.15.20096552]; Fitzpatrick AM, 2019, J ALLERGY CLIN IMMUN, V143, P2052, DOI 10.1016/j.jaci.2018.11.022; Hendryx M, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.115126; Hernandez ML, 2018, J ALLERGY CLIN IMMUN, V142, P1974, DOI 10.1016/j.jaci.2018.08.003; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Madhav KC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243028; Marshall ET, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.190288; Moore JT, 2020, J CELL MOL MED, V24, P11038, DOI 10.1111/jcmm.15599; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Office of Air Quality Planning and Standards Environmental Protection Agency, TECHN SUPP DOC EPAS; Pacheco CM, 2014, ALLERGY ASTHMA PROC, V35, P467, DOI 10.2500/aap.2014.35.3792; Reff A., 2015, EPA454S15001 OFF AIR; Strosnider H, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6613a1; Terrell KA, 2022, ENVIRON JUSTICE, V15, P286, DOI 10.1089/env.2020.0021; Tiotiu AI, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176212; To T, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00913-2019; Wu X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4049; Zhang ZH, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0667-9	32	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264336	10.1371/journal.pone.0264336	http://dx.doi.org/10.1371/journal.pone.0264336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196332	Green Submitted, Green Published, gold			2022-12-26	WOS:000835161600039
J	Zhao, DR; Zhang, HW; Cao, Q; Wang, ZY; He, SZ; Zhou, MH; Zhang, RH				Zhao, Daren; Zhang, Huiwu; Cao, Qing; Wang, Zhiyi; He, Sizhang; Zhou, Minghua; Zhang, Ruihua			The research of ARIMA, GM(1,1), and LSTM models for prediction of TB cases in China	PLOS ONE			English	Article							TUBERCULOSIS; OPTIMIZATION; PROVINCE; DISEASE	Background and objective Tuberculosis (Tuberculosis, TB) is a public health problem in China, which not only endangers the population's health but also affects economic and social development. It requires an accurate prediction analysis to help to make policymakers with early warning and provide effective precautionary measures. In this study, ARIMA, GM(1,1), and LSTM models were constructed and compared, respectively. The results showed that the LSTM was the optimal model, which can be achieved satisfactory performance for TB cases predictions in mainland China. Methods The data of tuberculosis cases in mainland China were extracted from the National Health Commission of the People's Republic of China website. According to the TB data characteristics and the sample requirements, we created the ARIMA, GM(1,1), and LSTM models, which can make predictions for the prevalence trend of TB. The mean absolute error (MAE), root mean square error (RMSE), and mean absolute percentage error (MAPE) were applied to evaluate the effects of model fitting predicting accuracy. Results There were 3,021,995 tuberculosis cases in mainland China from January 2018 to December 2020. And the overall TB cases in mainland China take on a downtrend trend. We established ARIMA, GM(1,1), and LSTM models, respectively. The optimal ARIMA model is the ARIMA (0,1,0) x (0,1,0)12. The equation for GM(1,1) model was X(k+1) = -10057053.55e((-0.01k)) + 10153178.55 the Mean square deviation ratio C value was 0.49, and the Small probability of error P was 0.94. LSTM model consists of an input layer, a hidden layer and an output layer, the parameters of epochs, learning rating are 60, 0.01, respectively. The MAE, RMSE, and MAPE values of LSTM model were smaller than that of GM(1,1) and ARIMA models. Conclusions Our findings showed that the LSTM model was the optimal model, which has a higher accuracy performance than that of ARIMA and GM (1,1) models. Its prediction results can act as a predictive tool for TB prevention measures in mainland China.	[Zhao, Daren; Zhang, Huiwu] Sichuan Prov Orthoped Hosp, Dept Med Adm, Chengdu, Sichuan, Peoples R China; [Cao, Qing] Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Dept Med Adm, Chengdu, Sichuan, Peoples R China; [Wang, Zhiyi] Sichuan Canc Hosp & Inst, Dept Med Adm, Chengdu, Sichuan, Peoples R China; [He, Sizhang] Southwest Med Univ, Dept Informat & Stat, Affiliated Hosp, Luzhou, Sichuan, Peoples R China; [Zhou, Minghua] Luzhou Peoples Hosp, Dept Med Adm, Luzhou, Sichuan, Peoples R China; [Zhang, Ruihua] Chengdu Univ Tradit Chinese Med, Sch Management, Chengdu, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Southwest Medical University; Chengdu University of Traditional Chinese Medicine	Zhang, RH (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Management, Chengdu, Sichuan, Peoples R China.	cdzhangrh@126.com		Zhang, Ruihua/0000-0003-1471-009X	Hospital Management Institute; National Health Commission of the People's Republic of China [YLZLXZ-2021-005]	Hospital Management Institute; National Health Commission of the People's Republic of China	We state that the study and the paper were financially supported by the Hospital Management Institute, the National Health Commission of the People's Republic of China grant no. YLZLXZ-2021-005].	Alim M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039676; Alzahrani SI, 2020, J INFECT PUBLIC HEAL, V13, P914, DOI 10.1016/j.jiph.2020.06.001; ArunKumar KE, 2021, APPL SOFT COMPUT, V103, DOI 10.1016/j.asoc.2021.107161; Benvenuto D, 2020, DATA BRIEF, V29, DOI 10.1016/j.dib.2020.105340; Ceylan Z, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138817; Cheon SA, 2016, J MICROBIOL METH, V123, P51, DOI 10.1016/j.mimet.2016.02.007; Dansana D, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.580327; Esmaeilzadeh N, 2020, ASIAN PAC J TROP MED, V13, P521, DOI 10.4103/1995-7645.291407; Feng W., 2011, ENERGY PROCEDIA, V11, P3714; Gao JQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241217; Ge Wendong, 2018, AMIA Annu Symp Proc, V2018, P460; Guo XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115664; Guo YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237750; Hu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185478; Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063; Ilie OD, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56110566; Kaya K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60102-6; Li ZM, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01157-3; Li ZQ, 2019, INFECT DRUG RESIST, V12, P1011, DOI 10.2147/IDR.S190418; Lin YW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218942; Liu FL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238280; Liu L, 2016, EPIDEMIOL INFECT, V144, P144, DOI [10.1017/S0950268815001144, 10.1017/S0950268815001582]; Liu Q, 2019, INFECT DRUG RESIST, V12, P2311, DOI 10.2147/IDR.S207809; Lu CM, 2007, PROCEEDINGS OF 2007 IEEE INTERNATIONAL CONFERENCE ON GREY SYSTEMS AND INTELLIGENT SERVICES, VOLS 1 AND 2, P453; Lu R, 2021, ANN PALLIAT MED, V10, P1296, DOI 10.21037/apm-19-406; Luo XL, 2020, ENERGY, V205, DOI 10.1016/j.energy.2020.118085; Ma RF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97037-5; Mousquer GT, 2021, TUBERCULOSIS, V126, DOI 10.1016/j.tube.2020.102020; Munir HS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247444; Ramezanian Maryam, 2019, Med J Islam Repub Iran, V33, P25, DOI 10.34171/mjiri.33.25; Rath S, 2020, DIABETES METAB SYND, V14, P1467, DOI 10.1016/j.dsx.2020.07.045; Singh S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110086; Singh S, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109866; Togun T, 2020, ANN CLIN MICROB ANTI, V19, DOI 10.1186/s12941-020-00363-1; Valencia VN, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182212108; Wang BB, 2021, IOP C SER EARTH ENV, V634, DOI 10.1088/1755-1315/634/1/012013; Wang G, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881900075X, 10.1017/s095026881900075x]; Wang JZ, 2012, INT J ELEC POWER, V43, P109, DOI 10.1016/j.ijepes.2012.04.027; Wang LL, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/1429462; Wang YW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201987; Wang YN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6837052; Wang YW, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014384; Wei WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156768; World Health Organization, 2019, GLOB TUB REP; Wu HA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111386; Wu W, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4028-x; Yang XB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011787; Zhai MM, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05973-4; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang LP, 2014, COMPUT BIOL MED, V49, P67, DOI 10.1016/j.compbiomed.2014.02.008; Zhang P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225362; Zhang R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116174; Zhang XK, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15051032; Zhang XL, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/1720134; Zhang YQ, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00742-y; Zheng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116832; Zheng YL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91176-5	57	0	0	9	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0262734	10.1371/journal.pone.0262734	http://dx.doi.org/10.1371/journal.pone.0262734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196309	gold, Green Published			2022-12-26	WOS:000835161600005
J	Lin, MC; Dai, CY; Huang, CF; Yeh, ML; Liu, YC; Hsu, PY; Wei, YJ; Lee, PL; Huang, CI; Liang, PC; Hsieh, MY; Hsieh, MH; Jang, TY; Lin, ZY; Huang, JF; Yu, ML; Chuang, WL				Lin, Ming-Chieh; Dai, Chia-Yen; Huang, Chung-Feng; Yeh, Ming-Lun; Liu, Yi-Chan; Hsu, Po-Yao; Wei, Yu-Ju; Lee, Pei-Lun; Huang, Ching-, I; Liang, Po-Cheng; Hsieh, Ming-Yen; Hsieh, Meng-Hsuan; Jang, Tyng-Yuan; Lin, Zu-Yau; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long			Itemization difference of patient-reported outcome in patients with chronic liver disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONIC HEPATITIS-C; EXTRAHEPATIC MANIFESTATIONS; VIRUS-INFECTION; MULTICENTER	Background and aims The itemization difference of patient-reported outcome (PRO) in hepatitis patients with different etiologies remains elusive in Asia. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients. Methods We conducted the study in an outpatient setting. The 36-Item Short Form Health Survey (SF-36) was completed by the patients upon the initial diagnosis and recruitment for a long-term follow-up purpose. The PRO results were also assessed by disease severity. Results There were 244 patients (198 males) of CHB, 54 patients (29 males) of CHC, and 129 patients (85 males) of NAFLD, respectively. CHC patient had the mean score of 67.1 +/- 23.3 in physical component summary (PCS) of the SF-36 health survey, which was significantly lower than CHB patients (76.4 +/- 19.5), and NAFLD patients (77.5 +/- 13.7), respectively (p = 0.001). The significantly lower performance of PCS in CHC patients was mainly attributed to the lower performance in physical functioning and bodily pain components. Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups. There was no significant difference of mean mental component summary (MCS) between groups. However, NAFLD patients had significantly lower mental health scores than other groups (p = 0.02). Conclusions The significant difference of HRQoL exists in hepatitis patients with different etiologies. Disease severity leads to a lower PCS performance.	[Lin, Ming-Chieh; Dai, Chia-Yen; Huang, Chung-Feng; Yeh, Ming-Lun; Liu, Yi-Chan; Hsu, Po-Yao; Wei, Yu-Ju; Huang, Ching-, I; Liang, Po-Cheng; Hsieh, Ming-Yen; Hsieh, Meng-Hsuan; Jang, Tyng-Yuan; Lin, Zu-Yau; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Chung-Feng; Yeh, Ming-Lun; Hsu, Po-Yao; Huang, Ching-, I; Hsieh, Meng-Hsuan; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Wei, Yu-Ju; Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Pei-Lun] Chi Mei Med Ctr Liou Ying, Dept Internal Med, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Huang, JF (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Internal Med, Kaohsiung, Taiwan.; Lee, PL (corresponding author), Chi Mei Med Ctr Liou Ying, Dept Internal Med, Tainan, Taiwan.	peilun57@yahoo.com.tw; jf71218@gmail.com	Hsu, Po-Yao/GZL-8778-2022	Hsu, Po-Yao/0000-0002-5443-7203; Lin, Ming-Chieh/0000-0001-7770-2607	Kaohsiung Medical University [97CM-KMU]; Kaohsiung Medical University Hospital [SA10907]	Kaohsiung Medical University; Kaohsiung Medical University Hospital	This study was supported partly by grant from Kaohsiung Medical University (grant number 97CM-KMU for the author Jee-Fu Huang) and Kaohsiung Medical University Hospital (grant number SA10907 for the author Jee-Fu Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang Ki Bae, 2015, J Lifestyle Med, V5, P7, DOI 10.15280/jlm.2015.5.1.7; Barreira DP, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02666; Cacoub P, 2000, MEDICINE, V79, P47, DOI 10.1097/00005792-200001000-00005; Castellanos-Fernandez MI, 2021, ANN HEPATOL, V22, DOI 10.1016/j.aohep.2020.10.005; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; Dan AA, 2007, ALIMENT PHARM THER, V26, P815, DOI 10.1111/j.1365-2036.2007.03426.x; David K, 2009, HEPATOLOGY, V49, P1904, DOI 10.1002/hep.22868; Estes C, 2020, ALIMENT PHARM THER, V51, P801, DOI 10.1111/apt.15673; Glass Lisa M, 2019, Fed Pract, V36, P64; Golabi P, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0420-z; Hsiao PJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-54; Huang CF, 2020, AM J GASTROENTEROL, V115, P1226, DOI 10.14309/ajg.0000000000000606; Huang JF, 2007, AM J GASTROENTEROL, V102, P1237, DOI 10.1111/j.1572-0241.2007.01181.x; Huang JF, 2017, KAOHSIUNG J MED SCI, V33, P567, DOI 10.1016/j.kjms.2017.07.003; Kennedy-Martin T, 2018, J PATIENT-REP OUTCOM, V2, DOI 10.1186/s41687-018-0052-7; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Newton JL, 2009, CLIN AUTON RES, V19, P319, DOI 10.1007/s10286-009-0031-4; Petta S, 2020, GASTROENTEROL CLIN N, V49, P347, DOI 10.1016/j.gtc.2020.01.012; Sapena V, 2022, GUT, V71, P593, DOI 10.1136/gutjnl-2020-323663; Strauss E, 2006, LIVER INT, V26, P755, DOI 10.1111/j.1478-3231.2006.01331.x; Tsai PC, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042861; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi Z, 2016, GASTROENTEROLOGY, V150, P1599, DOI 10.1053/j.gastro.2016.02.039; Zignego AL, 1995, CLIN EXP RHEUMATOL, V13, pS33	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264348	10.1371/journal.pone.0264348	http://dx.doi.org/10.1371/journal.pone.0264348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192675	Green Published, gold			2022-12-26	WOS:000812552500051
J	Morishita, A; Tadokoro, T; Fujihara, S; Iwama, H; Oura, K; Fujita, K; Tani, J; Takuma, K; Nakahara, M; Shi, TT; Haba, R; Okano, K; Nishiyama, A; Ono, M; Himoto, T; Masaki, T				Morishita, Asahiro; Tadokoro, Tomoko; Fujihara, Shintaro; Iwama, Hisakazu; Oura, Kyoko; Fujita, Koji; Tani, Joji; Takuma, Kei; Nakahara, Mai; Shi, Tingting; Haba, Reiji; Okano, Keiichi; Nishiyama, Akira; Ono, Masafumi; Himoto, Takashi; Masaki, Tsutomu			Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SELECTIVE INHIBITOR IPRAGLIFLOZIN; PLACEBO-CONTROLLED TRIAL; OXIDATIVE STRESS; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; JAPANESE PATIENTS; PIOGLITAZONE; OBESITY; HYPERGLYCEMIA	Non-alcoholic steatohepatitis (NASH) is a common chronic liver disease with no decisive treatment. The sodium glucose cotransporter 2 (SGLT2) inhibitor ipragliflozin was developed as a new oral hypoglycemic drug, which can improve NASH via an insulin-independent glucose-lowering effect by inhibiting glucose reabsorption in the renal proximal tubules. However, ipragliflozin appears to modulate steatosis or inflammation via different pathways. To elucidate the new mechanism of ipragliflozin for the treatment of NASH, we evaluated its effects in a NASH mouse model (STAM mice) with beta cell depletion, and compared the expression of microRNAs (miRNAs) in STAM mice treated with or without ipragliflozin (16.7 mu g/day for 5 weeks). Ipragliflozin reduced aspartate transaminase and alanine aminotransferase levels, along with reduced hepatic steatosis, hepatocyte ballooning, lobular inflammation, and liver fibrosis. In addition, ipragliflozin upregulated mitochondrial transport-related and antioxidant defensive system-related genes in the liver. Among 2555 mouse miRNA probes, miR-19b-3p was commonly differentially expressed with ipragliflozin treatment for 5 weeks in both the liver and serum but in different directions, with a decrease in the liver and increase in the serum. Therefore, ipragliflozin can improve NASH development likely through the antioxidative stress pathway and by regulating miR-19b-3p.	[Morishita, Asahiro; Tadokoro, Tomoko; Fujihara, Shintaro; Oura, Kyoko; Fujita, Koji; Tani, Joji; Takuma, Kei; Nakahara, Mai; Shi, Tingting; Ono, Masafumi; Masaki, Tsutomu] Dept Gastroenterol & Neurol, Kita, Kagawa, Japan; [Iwama, Hisakazu] Life Sci Res Ctr, Miki, Kagawa, Japan; [Haba, Reiji] Dept Pathol, Miki, Kagawa, Japan; [Okano, Keiichi] Dept Gastroenterol Surg, Takamatsu, Kagawa, Japan; [Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Fac Med, Takamatsu, Kagawa, Japan; [Himoto, Takashi] Kagawa Prefectual Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan	Kagawa University	Morishita, A (corresponding author), Dept Gastroenterol & Neurol, Kita, Kagawa, Japan.	asahiro@med.kagawa-u.ac.jp	Shi, Tingting/GXG-8492-2022					Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Armstrong MJ, 2016, LANCET, V387, P679, DOI 10.1016/S0140-6736(15)00803-X; Bandyopadhyay S, 2011, J INFECT DIS, V203, P1753, DOI 10.1093/infdis/jir186; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Corey KE, 2014, CLIN LIVER DIS, V18, P1, DOI 10.1016/j.cld.2013.09.019; Duan L, 2019, MOL CELL BIOCHEM, V459, P205, DOI 10.1007/s11010-019-03563-2; Eguchi Y, 2015, HEPATOL RES, V45, P269, DOI 10.1111/hepr.12351; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Hayashizaki-Someya Y, 2015, EUR J PHARMACOL, V754, P19, DOI 10.1016/j.ejphar.2015.02.009; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Katsiki N, 2017, LANCET DIABETES ENDO, V5, P329, DOI 10.1016/S2213-8587(17)30109-2; Kleiner DE, 2016, CLIN LIVER DIS, V20, P293, DOI 10.1016/j.cld.2015.10.011; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lan T, 2018, HEPATOLOGY, V68, P1070, DOI 10.1002/hep.29885; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Loomba R, 2015, HEPATOLOGY, V61, P1239, DOI 10.1002/hep.27647; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mitsuyoshi H, 1999, BIOCHEM BIOPH RES CO, V263, P537, DOI 10.1006/bbrc.1999.1403; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Nakamura J, 2017, J DIABETES INVEST, V8, P397, DOI 10.1111/jdi.12645; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Park H, 2011, J GASTROENTEROL, V46, P101, DOI 10.1007/s00535-010-0291-8; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Ramachandran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070744; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sumida Y, 2013, FREE RADICAL RES, V47, P869, DOI 10.3109/10715762.2013.837577; Sumida Y, 2003, J HEPATOL, V38, P32, DOI 10.1016/S0168-8278(02)00331-8; Sumida Y, 2017, HEPATOL RES, V47, P266, DOI 10.1111/hepr.12856; Tahara A, 2014, J PHARM PHARMACOL, V66, P975, DOI 10.1111/jphp.12223; Tahara A, 2013, EUR J PHARMACOL, V715, P246, DOI 10.1016/j.ejphar.2013.05.014; Tahara A, 2012, J PHARMACOL SCI, V120, P36, DOI 10.1254/jphs.12089FP; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xu HM, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00408-3; Yilmaz Y, 2014, CLIN LIVER DIS, V18, P19, DOI 10.1016/j.cld.2013.09.018; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	51	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0261310	10.1371/journal.pone.0261310	http://dx.doi.org/10.1371/journal.pone.0261310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192632	gold, Green Published			2022-12-26	WOS:000812552500006
J	Govender, P; Fashoto, SG; Maharaj, L; Adeleke, MA; Mbunge, E; Olamijuwon, J; Akinnuwesi, B; Okpeku, M				Govender, Priyanka; Fashoto, Stephen Gbenga; Maharaj, Leah; Adeleke, Matthew A.; Mbunge, Elliot; Olamijuwon, Jeremiah; Akinnuwesi, Boluwaji; Okpeku, Moses			The application of machine learning to predict genetic relatedness using human mtDNA hypervariable region I sequences	PLOS ONE			English	Article							POPULATION-GENETICS; CLASSIFICATION	Human identification of unknown samples following disaster and mass casualty events is essential, especially to bring closure to family and friends of the deceased. Unfortunately, victim identification is often challenging for forensic investigators as analysis becomes complicated when biological samples are degraded or of poor quality as a result of exposure to harsh environmental factors. Mitochondrial DNA becomes the ideal option for analysis, particularly for determining the origin of the samples. In such events, the estimation of genetic parameters plays an important role in modelling and predicting genetic relatedness and is useful in assigning unknown individuals to an ethnic group. Various techniques exist for the estimation of genetic relatedness, but the use of Machine learning (ML) algorithms are novel and presently the least used in forensic genetic studies. In this study, we investigated the ability of ML algorithms to predict genetic relatedness using hypervariable region I sequences; that were retrieved from the GenBank database for three race groups, namely African, Asian and Caucasian. Four ML classification algorithms; Support vector machines (SVM), Linear discriminant analysis (LDA), Quadratic discriminant analysis (QDA) and Random Forest (RF) were hybridised with one-hot encoding, Principal component analysis (PCA) and Bags of Words (BoW), and were compared for inferring genetic relatedness. The findings from this study on WEKA showed that genetic inferences based on PCA-SVM achieved an overall accuracy of 80-90% and consistently outperformed PCA-LDA, PCA-RF and PCA-QDA, while in Python BoW-PCA-RF achieved 94.4% accuracy which outperformed BoW-PCA-SVM, BoW-PCA-LDA and BoW-PCA-QDA respectively. ML results from the use of WEKA and Python software tools displayed higher accuracies as compared to the Analysis of molecular variance results. Given the results, SVM and RF algorithms are likely to also be useful in other sequence classification applications, making it a promising tool in genetics and forensic science. The study provides evidence that ML can be utilized as a supplementary tool for forensic genetics casework analysis.	[Govender, Priyanka; Maharaj, Leah; Adeleke, Matthew A.; Okpeku, Moses] Univ KwaZulu Natal, Sch Life Sci, Discipline Genet, Westville, South Africa; [Fashoto, Stephen Gbenga; Mbunge, Elliot; Olamijuwon, Jeremiah; Akinnuwesi, Boluwaji] Univ Eswatini, Dept Comp Sci, Computat Intelligence & Hlth Informat Res Grp, Fac Sci & Engn, Kwaluseni, Eswatini	University of Kwazulu Natal	Okpeku, M (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Discipline Genet, Westville, South Africa.	okpekum@ukzn.ac.za	Maharaj, Leah/GVS-2771-2022	Mbunge, Elliot/0000-0003-4504-6697; Okpeku, Moses/0000-0002-8337-6294; Govender, Priyanka/0000-0003-0166-9569; Akinnuwesi, Boluwaji Ade/0000-0002-7755-6061	National Research Foundation [120368]	National Research Foundation	This study was supported by the National Research Foundation (Grant Number: 120368 which was awarded to PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnuwesi Boluwaji A., 2020, Responsible Design, Implementation and Use of Information and Communication Technology. 19th IFIP WG 6.11 Conference on e-Business, e-Services, and e-Society, I3E 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12067), P414, DOI 10.1007/978-3-030-45002-1_36; Amorim A, 2019, PEERJ, V7, DOI 10.7717/peerj.7314; Behravan H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31573-5; Berrar D., 2018, CROSS VALIDATION ENC, P542, DOI [10.1016/B978-0-12-809633-8.20349-X, DOI 10.1016/B978-0-12-809633-8.20349-X]; Borges VRP., 2018, BRAZILIAN S COMPUTER; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Carriquiry A., 2019, SIGNIFICANCE, V16, P29, DOI DOI 10.1111/J.1740-9713.2019.01252.X; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Chierchia G, 2016, IEEE INT WORKS MACH; Chou V, SCI RACE ARE SHAPING; Chuang LC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39943; Bui DT, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/974638; Dimov R., 2007, TOOLS SEMINARUNIVERS, V6, P1; Egeland T, 2004, ANN HUM GENET, V68, P461, DOI 10.1046/j.1529-8817.2004.00109.x; Elujide I., 2021, INFORM MED UNLOCKED, V23, DOI [10.1016/J.IMU.2021.100545, DOI 10.1016/J.IMU.2021.100545, 10.1016/j.imu.2021.100545]; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gomez F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a008524; HaCohen-Kerner Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232525; Hong HY, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4866-9; Karpatne A, 2019, IEEE T KNOWL DATA EN, V31, P1544, DOI 10.1109/TKDE.2018.2861006; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee Chih, 2011, BMC Proc, V5 Suppl 2, pS11, DOI 10.1186/1753-6561-5-S2-S11; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Mersha TB, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-014-0023-x; NCBI, 2018, NAT CTR BIOT INF; Okser S, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-5; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Provost F, 2017, GEOPHYS RES LETT, V44, P113, DOI 10.1002/2016GL070709; Schrider DR, 2018, TRENDS GENET, V34, P301, DOI 10.1016/j.tig.2017.12.005; Shokolenko IN, 2016, MITOCHONDRIAL DNA A, V27, P490, DOI 10.3109/19401736.2014.905829; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Templeton Jennifer E L, 2013, Investig Genet, V4, P26, DOI 10.1186/2041-2223-4-26; Tharwat A, 2017, AI COMMUN, V30, P169, DOI 10.3233/AIC-170729; Witten IH, 2011, MOR KAUF D, P1; Wong C, 2011, BRIEF BIOINFORM, V12, P1, DOI 10.1093/bib/bbq008; Yang AM, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.01032	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263790	10.1371/journal.pone.0263790	http://dx.doi.org/10.1371/journal.pone.0263790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180257	Green Published, gold			2022-12-26	WOS:000796435800031
J	Munir, MB; Hlavacek, P; Keshishian, A; Guo, JD; Mallampati, R; Ferri, M; Russ, C; Emir, B; Cato, M; Yuce, H; Hsu, JC				Munir, Muhammad Bilal; Hlavacek, Patrick; Keshishian, Allison; Guo, Jennifer D.; Mallampati, Rajesh; Ferri, Mauricio; Russ, Cristina; Emir, Birol; Cato, Matthew; Yuce, Huseyin; Hsu, Jonathan C.			Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database	PLOS ONE			English	Article							HEALTH-CARE COSTS; ISCHEMIC-STROKE; RISK-FACTOR; HOSPITALIZATION; POPULATION; HEMORRHAGE; WARFARIN; UNDERUSE; BURDEN; IMPACT	Background Oral anticoagulants (OACs) mitigate the risk of stroke in atrial fibrillation (AF) patients. Objective Elderly AF patients who were treated with OACs (apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin) were compared against AF patients who were not treated with OACs with respect to their clinical and economic outcomes. Methods Newly diagnosed AF patients were identified between January 2013 and December 2017 in the Medicare database. Evidence of an OAC treatment claim on or after the first AF diagnosis was used to classify patients into treatment-defined cohorts, and these cohorts were further stratified based on the initial OAC prescribed. The risks of stroke/systemic embolism (SE), major bleeding (MB), and death were analyzed using inverse probability treatment weighted time-dependent Cox regression models, and costs were compared with marginal structural models. Results The two treatment groups were composed of 1,421,187 AF patients: OAC treated (N = 583,350, 41.0% [36.4% apixaban, 4.9% dabigatran, 0.1% edoxaban, 26.7% rivaroxaban, and 31.9% warfarin patients]) and untreated (N = 837,837, 59.0%). OAC-treated patients had a lower adjusted risk of stroke/SE compared to untreated patients (hazard ratio [HR]: 0.70; 95% confidence interval [CI]: 0.68-0.72). Additionally patients receiving OACs had a lower adjusted risk of death (HR: 0.56; 95% CI: 0.55-0.56) and a higher risk of MB (HR: 1.57; 95% CI: 1.54-1.59) and this trend was consistent across each OAC sub-group. The OAC-treated cohort had lower adjusted total healthcare costs per patient per month ($4,381 vs $7,172; p < .0001). Conclusion For the OAC-treated cohort in this elderly US population, stroke/SE and all-cause death were lower, while risk of MB was higher. Among OAC treated patients, total healthcare costs were lower than those of the untreated cohort.	[Munir, Muhammad Bilal; Hsu, Jonathan C.] Univ Calif San Diego, Div Cardiol, Sect Electrophysiol, Sch Med, La Jolla, CA 92093 USA; [Hlavacek, Patrick; Russ, Cristina; Emir, Birol; Cato, Matthew] Pfizer, New York, NY USA; [Keshishian, Allison; Mallampati, Rajesh] STATinMED Res LLC, Ann Arbor, MI USA; [Guo, Jennifer D.; Ferri, Mauricio] Bristol Myers Squibb, Lawrenceville, NJ USA; [Yuce, Huseyin] CUNY, New York City Coll Technol, New York, NY USA	University of California System; University of California San Diego; Pfizer; Bristol-Myers Squibb; City University of New York (CUNY) System	Hsu, JC (corresponding author), Univ Calif San Diego, Div Cardiol, Sect Electrophysiol, Sch Med, La Jolla, CA 92093 USA.	Jonathan.Hsu@ucsd.edu	Munir, Muhammad Bilal/G-3640-2011	Munir, Muhammad Bilal/0000-0002-9804-898X	Pfizer; Bristol Myers Squibb; Janssen Pharmaceuticals	Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was funded by Pfizer and Bristol Myers Squibb. MBM and HY have no financial relationships or other potential conflicts of interest to declare. AK and RM are paid employees of STATinMED Research, which is a paid consultant to Bristol Myers Squibb and Pfizer. in connection with the development of this manuscript. PH, CR, BE, and MC are paid employees of Pfizer. JDG and MF are paid employees of Bristol Myers Squibb. JCH has received research support from Janssen Pharmaceuticals, Pfizer, and Bristol Myers Squibb. MBM, HY, AK, RM, PH, CR, BE, MC, JDG, MF, and JCH contributed to conceptualize or design the work. AK and HY contributed to acquire the data for the work. AK and RM contributed to analyze the data for the work. All authors contributed to interpret the data for the work. MBM, JCH, RM, and AK drafted the work. All authors critically revised for important intellectual content. All authors finally approved the version to be published. All authors agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development, or marketed products associated with this research to declare.	Abraham NS, 2017, GASTROENTEROLOGY, V152, P1014, DOI 10.1053/j.gastro.2016.12.018; Al-Khatib SM, 2020, AM HEART J, V229, P110, DOI 10.1016/j.ahj.2020.07.012; Amin A, 2018, J MANAG CARE SPEC PH, V24, P911, DOI 10.18553/jmcp.2018.24.9.911; Amin A, 2018, J MED ECON, V21, P244, DOI 10.1080/13696998.2017.1394866; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boccuzzi SJ, 2009, CURR MED RES OPIN, V25, P2853, DOI 10.1185/03007990903196422; Borne RT, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0671-6; Chan YH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008150; Chen NM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21357; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Faries DE., 2010, ANAL OBSERVATIONAL H, V1, P211; Fitch K, 2014, AM HEALTH DRUG BENEF, V7, P200; Friberg L, 2018, EUR HEART J, V39, P453, DOI 10.1093/eurheartj/ehx579; Gupta K, 2018, J MANAG CARE SPEC PH, V24, P1116, DOI 10.18553/jmcp.2018.17488; Hannon N, 2014, STROKE, V45, P3670, DOI 10.1161/STROKEAHA.114.005960; Hernandez I, 2020, AM J CARDIOVASC DRUG, V20, P199, DOI 10.1007/s40256-019-00371-3; January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665; Jarosek S., DEATH INFORM RES IDE; Kim MH, 2011, CIRC-CARDIOVASC QUAL, V4, P313, DOI 10.1161/CIRCOUTCOMES.110.958165; Lip GYH, 2017, JAMA CARDIOL, V2, P872, DOI 10.1001/jamacardio.2017.1883; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1280, DOI 10.1016/j.jacc.2009.04.091; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ray WA, 2018, JAMA-J AM MED ASSOC, V320, P2221, DOI 10.1001/jama.2018.17242; Saposnik G, 2013, STROKE, V44, P99, DOI 10.1161/STROKEAHA.112.676551; Seet RCS, 2011, ARCH NEUROL-CHICAGO, V68, P1454, DOI 10.1001/archneurol.2011.248; Suarez J, 2012, AM HEART J, V163, P804, DOI 10.1016/j.ahj.2012.02.008; Thigpen JL, 2015, CIRC-CARDIOVASC QUAL, V8, P8, DOI 10.1161/CIRCOUTCOMES.113.000371; Xie L, 2016, J MED ECON, V19, P769, DOI 10.3111/13696998.2016.1171774; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003074	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263903	10.1371/journal.pone.0263903	http://dx.doi.org/10.1371/journal.pone.0263903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176074	gold, Green Published			2022-12-26	WOS:000777505200044
J	Ochola, D; Boekelo, B; van de Ven, GWJ; Taulya, G; Kubiriba, J; van Asten, PJA; Giller, KE				Ochola, Dennis; Boekelo, Bastiaen; van de Ven, Gerrie W. J.; Taulya, Godfrey; Kubiriba, Jerome; van Asten, Piet J. A.; Giller, Ken E.			Mapping spatial distribution and geographic shifts of East African highland banana (Musa spp.) in Uganda	PLOS ONE			English	Article							AAA-EA; COSMOPOLITES-SORDIDUS; PREDICTION; WEEVIL; YIELD; PERFORMANCE; GRADIENT; DENSITY; GROWTH; PLANTS	East African highland banana (Musa acuminata genome group AAA-EA; hereafter referred to as banana) is critical for Uganda's food supply, hence our aim to map current distribution and to understand changes in banana production areas over the past five decades. We collected banana presence/absence data through an online survey based on high-resolution satellite images and coupled this data with independent covariates as inputs for ensemble machine learning prediction of current banana distribution. We assessed geographic shifts of production areas using spatially explicit differences between the 1958 and 2016 banana distribution maps. The biophysical factors associated with banana spatial distribution and geographic shift were determined using a logistic regression model and classification and regression tree, respectively. Ensemble models were superior (AUC = 0.895; 0.907) compared to their constituent algorithms trained with 12 and 17 covariates, respectively: random forests (AUC = 0.883; 0.901), gradient boosting machines (AUC = 0.878; 0.903), and neural networks (AUC = 0.870; 0.890). The logistic regression model (AUC = 0.879) performance was similar to that for the ensemble model and its constituent algorithms. In 2016, banana cultivation was concentrated in the western (44%) and central (36%) regions, while only a small proportion was in the eastern (18%) and northern (2%) regions. About 60% of increased cultivation since 1958 was in the western region; 50% of decreased cultivation in the eastern region; and 44% of continued cultivation in the central region. Soil organic carbon, soil pH, annual precipitation, slope gradient, bulk density and blue reflectance were associated with increased banana cultivation while precipitation seasonality and mean annual temperature were associated with decreased banana cultivation over the past 50 years. The maps of spatial distribution and geographic shift of banana can support targeting of context-specific intensification options and policy advocacy to avert agriculture driven environmental degradation.	[Ochola, Dennis; Taulya, Godfrey; van Asten, Piet J. A.] Int Inst Trop Agr IITA, Kampala, Uganda; [Ochola, Dennis; Boekelo, Bastiaen; van de Ven, Gerrie W. J.; Giller, Ken E.] Wageningen Univ & Res WUR, Wageningen, Netherlands; [Kubiriba, Jerome] Natl Agr Res Labs NARL, Kawanda, Uganda; [Taulya, Godfrey] Makerere Univ, Dept Agr Prod, Kampala, Uganda; [van Asten, Piet J. A.] Olam Int Ltd, Singapore, Singapore	Wageningen University & Research; Makerere University	Ochola, D (corresponding author), Int Inst Trop Agr IITA, Kampala, Uganda.	dennis.ochola@wur.nl	Ochola, Dennis/F-2948-2015	Ochola, Dennis/0000-0003-0179-3607	Bill & Melinda Gates Foundation (BMGF) [OPP1134098]	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	The study was conducted within the framework of the project "Improving Scalable Banana Agronomy for Small Scale Farmers in Highland Banana Cropping Systems in East Africa" led by the National Banana Research Program (NBRP) of the National Agricultural Research Organization (NARO) with financial support from the Bill & Melinda Gates Foundation (BMGF), Grant ID: OPP1134098. The funding agency had no role in study design, data collection, preparation of the manuscript or decision to publish. https://www.gatesfoundation.org/about/committed-grants.	Aguilar EA, 2008, PHILIPP J CROP SCI, V33, P14; [Anonymous], FAOSTAT STAT DAT; Atkinson B., 2015, RPART RECURSIVE PART; BHATTACHARYYA RK, 1985, SCI HORTIC-AMSTERDAM, V25, P263, DOI 10.1016/0304-4238(85)90124-4; Blomme G, 2002, ADV AGRON, V38, P95; Breiman L., 2001, MACH LEARN, V45, P5; Bryant BP, 2018, ECOSYST SERV, V33, P103, DOI 10.1016/j.ecoser.2018.09.001; Bunnik N., 1981, ADV SPACE RES, V1, P21, DOI [10.1016/0273-1177(81)90379-3, DOI 10.1016/0273-1177(81)90379-3]; Chaurasia AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06118-x; Costea M., 2012, CASE STUDY SECASUL M, P313; Drummond C., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P198, DOI 10.1145/347090.347126; Duan SB, 2019, INT J REMOTE SENS, V40, P1763, DOI 10.1080/01431161.2018.1460513; Eledu C. A., 2004, African Crop Science Journal, V12, P33; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESRI, 2018, ARCGIS DESKT REL 10; Fausett LV, 2006, FUNDAMENTALS NEURAL; Fermont AM, 2008, AGR ECOSYST ENVIRON, V128, P239, DOI 10.1016/j.agee.2008.06.009; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; GIMP, 2019, GNU IM MAN PROGR; Gold CS, 2004, ANN APPL BIOL, V145, P263, DOI 10.1111/j.1744-7348.2004.tb00382.x; Gold CS, 1999, INT J SUST DEV WORLD, V6, P45, DOI 10.1080/13504509.1999.9728471; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Grabs T, 2009, J HYDROL, V373, P15, DOI 10.1016/j.jhydrol.2009.03.031; Gurung RB, 2009, REMOTE SENS ENVIRON, V113, P2186, DOI 10.1016/j.rse.2009.05.015; HarvestChoice: International Food Policy Research Institute (IFPRI), 2018, TRAV TIM MARK AFR S; Hassan QK, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2740040; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hijmans R.J., 2015, PACKAGE RASTERR PACK, P734; Hodgkins GA, 2002, INT J CLIMATOL, V22, P1819, DOI 10.1002/joc.857; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jameson J. D., 1970, AGR UGANDA; Jarvis A., 2008, HOLE FILLED SRTM GLO; Katrutsa A, 2017, EXPERT SYST APPL, V76, P1, DOI 10.1016/j.eswa.2017.01.048; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kuhle S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1971-2; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Lal R, 1988, IAHS PUBL, V174, P79; Liu QQ, 2001, APPL MATH MECH-ENGL, V22, P510, DOI 10.1023/A:1016303213326; Lufafa A, 2003, AGR SYST, V76, P883, DOI 10.1016/S0308-521X(02)00012-4; McMaster D., 1962, SUBSISTENCE CROP GEO; Meyer H, 2019, ECOL MODEL, V411, DOI 10.1016/j.ecolmodel.2019.108815; Milborrow S, 2019, R PACKAGE VERSION 3; Minten B, 1999, J DEV ECON, V60, P467, DOI 10.1016/S0304-3878(99)00049-8; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moore D. S, 2007, BASIC PRACTICE STAT; Ndabamenye T, 2013, SCI HORTIC-AMSTERDAM, V150, P299, DOI 10.1016/j.scienta.2012.11.037; Nyombi K, 2010, FIELD CROP RES, V117, P38, DOI 10.1016/j.fcr.2010.01.011; Nyombi K., 2010, THESIS WAGENINGEN U; Pingali PL, 1984, 22 ARU AGR RUR DEV D; QGIS, QUANT GEOGR INF SYST; Ricker-Gilbert J, 2014, FOOD POLICY, V48, P114, DOI 10.1016/j.foodpol.2014.02.006; Robinson OJ, 2018, DIVERS DISTRIB, V24, P460, DOI 10.1111/ddi.12698; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Rukazambuga NDTM, 1998, CROP PROT, V17, P581, DOI 10.1016/S0261-2194(98)00056-8; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sabiiti G., 2016, J ENV AGR SCI, V7, P3; Sassen M., 2014, THESIS WAGENINGEN U; Smithson PC, 2001, NUTR CYCL AGROECOSYS, V59, P239, DOI 10.1023/A:1014462923539; Soriano-Disla JM, 2014, APPL SPECTROSC REV, V49, P139, DOI 10.1080/05704928.2013.811081; Speijer P, 1996, 1 INT S BAN 1 INT C, P540; Stover RH, 1987, BANANAS LONGMAN SCI, DOI [10.1016/ S0140-6736(19)32039-2, DOI 10.1016/S0140-6736(19)32039-2]; Tadesse T., 2012, THESIS WAGENINGEN U; Taulya G, 2013, FIELD CROP RES, V151, P45, DOI 10.1016/j.fcr.2013.07.010; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; TURNER DW, 1986, SCI HORTIC-AMSTERDAM, V28, P47, DOI 10.1016/0304-4238(86)90123-8; TURNER DW, 1983, AUST J PLANT PHYSIOL, V10, P43, DOI 10.1071/PP9830043; Tushemereirwe W, 2004, PLANT PATHOL, V53, P802, DOI 10.1111/j.1365-3059.2004.01090.x; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; van Asten PJA, 2011, AGR WATER MANAGE, V98, P541, DOI 10.1016/j.agwat.2010.10.005; Vanlauwe B, 2013, AGRO ECOLOGICAL INTE; Vaquero M, 2003, P INT S 3 5 NOV 2003; Venables W., 2002, MODERN APPL STAT S, V4, P435, DOI DOI 10.1007/978-0-387-21706-2; Wairegi L, 2015, BANANA COFFEE SYSTEM; Wairegi LWI, 2010, FIELD CROP RES, V117, P146, DOI 10.1016/j.fcr.2010.02.010; Walsh M, 2018, GEOSURVEY DATA PREDI; Webster R., 2007, STAT PRACTICE; Wilson AM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002415; Wortmann C.S., 1999, UGANDAS AGROECOLOGIC; Wu CY, 2011, REMOTE SENS ENVIRON, V115, P3424, DOI 10.1016/j.rse.2011.08.006; Zhao YL, 2013, MATH COMPUT MODEL, V57, P1395, DOI 10.1016/j.mcm.2012.11.028; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	84	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263439	10.1371/journal.pone.0263439	http://dx.doi.org/10.1371/journal.pone.0263439			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176065	gold, Green Published			2022-12-26	WOS:000777505200020
J	Yang, KQ				Yang, Kaiqin			An enhanced pairing-free certificateless directed signature scheme	PLOS ONE			English	Article							AGGREGATE SIGNATURE; AUTHENTICATION; SECURITY	Directed signature is a special cryptographic technique in which only the verifier designated by the signer can verify the validity of the signature. Directed signature can effectively protect the privacy of the signer's identity, so it is very suitable for medical records, taxation, and other fields. To improve the security and performance of the directed signature scheme, Gayathri et al. proposed the first certificateless directed signature (CLDS) scheme without bilinear pairing and claimed that their CLDS scheme could withstand Type I and Type II attacks. In this article, we provide two attack methods to assess the security of their CLDS scheme. Unfortunately, our results indicate that their CLDS scheme is insecure against Type I and Type II attacks. That is, their CLDS scheme does not meet the unforgeability and cannot achieve the expected security goals. To resist these attacks, we present an improved CLDS scheme and give the security proof. Compared with similar schemes, our scheme has better performance and higher security.	[Yang, Kaiqin] Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China	Shandong University	Yang, KQ (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China.	yangkaiqin2021@163.com						Ahamed ABS, 2018, PROCEEDINGS OF THE 2018 SECOND INTERNATIONAL CONFERENCE ON INVENTIVE COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICICCT), P1320; Azees M, 2021, WIREL NETW, V27, P2119, DOI 10.1007/s11276-021-02560-y; Azees M, 2017, IEEE T INTELL TRANSP, V18, P2467, DOI 10.1109/TITS.2016.2634623; Bhagya GN, 2021, J KING SAUD UNIV-COM, V33, P225, DOI 10.1016/j.jksuci.2018.02.016; Chang JY, 2020, IEEE ACM T NETWORK, V28, P2615, DOI 10.1109/TNET.2020.3013902; Gayathri N B, 2017, P ISNN 2017, P28; Huang XY, 2007, LECT NOTES COMPUT SC, V4586, P308; Hwang JY, 2014, INFORM SCIENCES, V275, P284, DOI 10.1016/j.ins.2014.02.038; Ismail ES, 2006, J TEKNOL, V2, P37; Jegadeesan S, 2019, SUSTAIN CITIES SOC, V49, DOI 10.1016/j.scs.2019.101522; Kong W, 2020, J PARALLEL DISTR COM, V136, P29, DOI 10.1016/j.jpdc.2019.09.016; Ku JH, 2012, COMM COM INF SC, V316, P440; Kumar P, 2018, SUSTAIN COMPUT-INFOR, V18, P80, DOI 10.1016/j.suscom.2017.09.002; Lim C H, 1992, P 2017 IEEE COMP COM, P308; Liu JH, 2020, IEEE INTERNET THINGS, V7, P5256, DOI 10.1109/JIOT.2020.2979613; Lu R., 2006, INT J NETWORK SECURI, V2, P182; Lu RX, 2008, INFORM SCIENCES, V178, P756, DOI 10.1016/j.ins.2007.07.025; Maria A, 2021, SECUR COMMUN NETW, V2021, DOI 10.1155/2021/6679882; Mohammed MEA, 2020, AGING MALE, V23, P1409, DOI 10.1080/13685538.2020.1773424; Mundhe P, 2020, WIRELESS PERS COMMUN, V114, P853, DOI 10.1007/s11277-020-07396-x; Pointcheval D, 2000, J CRYPTOL, V13, P361, DOI 10.1007/s001450010003; Ramlee NN, 2013, APPL MATH-CZECH, V125, P6217; Rao RK, 2019, INT J AP MAT COM-POL, V10, P1091; Thorncharoensri P, 2020, IEEE ACCESS, V8, P95019, DOI 10.1109/ACCESS.2020.2987336; Vijayakumar P, 2020, IEEE T IND INFORM, V16, P2603, DOI 10.1109/TII.2019.2925071; Vijayakumar P, 2016, IEEE T INTELL TRANSP, V17, P1015, DOI 10.1109/TITS.2015.2492981; Wan Z. M., 2011, P ICEPT HDP SHANGH C, P1; Xin XJ, 2020, INT J THEOR PHYS, V59, P918, DOI 10.1007/s10773-019-04377-0; Xu ZY, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-1527-7; Zhan Y, 2021, IEEE INTERNET THINGS, V8, P5973, DOI 10.1109/JIOT.2020.3033337; Zhang JH, 2009, LECT NOTES COMPUT SC, V5553, P318, DOI 10.1007/978-3-642-01513-7_34; Zheng MC, 2021, QUANTUM INF PROCESS, V20, DOI 10.1007/s11128-021-03162-5	32	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263943	10.1371/journal.pone.0263943	http://dx.doi.org/10.1371/journal.pone.0263943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176087	Green Published, gold			2022-12-26	WOS:000777505200051
J	Warnasekara, J; Srimantha, S; Senavirathna, I; Kappagoda, C; Farika, N; Nawinna, A; Agampodi, S				Warnasekara, Janith; Srimantha, Shalka; Senavirathna, Indika; Kappagoda, Chamila; Farika, Nirmani; Nawinna, Achala; Agampodi, Suneth			The variable presence of Leptospira in the environment; an epidemiological explanation based on serial analysis of water samples	PLOS ONE			English	Article							RISK-FACTORS; OUTBREAK	Human leptospirosis involves the classic epidemiological triad (agent, host and environment); hence the investigations should include the knowledge on Leptospira within the animals and the environment. The objectives of this study are to explore the abundance of Leptospira in different climate zones of Sri Lanka and to describe the presence of Leptospira in the same water source at serial time points. First, water and soil samples were collected from different parts of Sri Lanka (Component-1); second, water sampling continued only in the dry zone (Component-2). Finally, serial water sampling from ten open wells was performed at five different time points (Component-3). Quantitative PCR of water and metagenomic sequencing of soil were performed to detect Leptospira. Three replicates for each sample were used for PCR testing, and positive result of two or more replicates was defined as 'strongly positive,' and one positive replicate was defined as positive. In the water and soil sample analysis in the whole country (Component-1), two out of 12 water sites were positive, and both were situated in the wet zone. Very small quantities of the genus Leptospira were detected by 16 amplicon analysis of soil in all 11 sites. In the dry zone water sample analysis (Component-2), only samples from 6 out of 26 sites were positive, of which one site was strongly positive. In the serial sample analysis (Component-3), Six, five, four, five, and six wells were positive in serial measurements. All wells were positive for at least one time point, while only one well was positive for all five time points. Proximity to the tank and greater distances from the main road were associated with strong positive results for Leptospira (P<0.05). The presence of Leptospira was not consistent, indicating the variable abundance of Leptospira in the natural environment. This intermittent nature of positivity could be explained by the repetitive contamination by animal urine.	[Warnasekara, Janith; Srimantha, Shalka; Senavirathna, Indika; Kappagoda, Chamila; Farika, Nirmani; Agampodi, Suneth] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka; [Senavirathna, Indika] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka; [Nawinna, Achala] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Saliyapura, Sri Lanka; [Agampodi, Suneth] Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA	Rajarata University of Sri Lanka; Rajarata University of Sri Lanka; Rajarata University of Sri Lanka; Yale University	Agampodi, S (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Saliyapura, Sri Lanka.; Agampodi, S (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.	sunethagampodi@yahoo.com	Agampodi, Suneth/G-3320-2012	Agampodi, Suneth/0000-0001-7810-1774; Warnasekara, Janith/0000-0002-6554-6851; Lanka Acharige, Shalka/0000-0003-1678-5140	US Public Service [U19AI115658]; Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka	US Public Service; Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka	SA: JW and IS are partially supported by US Public Service Grant U19AI115658. The sample analysis was funded through the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka annual publication award received by the first and last authors. All the other costs are self-funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2014, EPIDEMIOL INFECT, V142, P843, DOI 10.1017/S0950268813001465; Agampodi SB, 2012, EPIDEMIOL INFECT, V140, P1530, DOI 10.1017/S0950268811002512; Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Agampodi SB, 2010, INT J PREVENTIVE MED, V1, P158; Ambekar A N, 2004, Indian J Public Health, V48, P27; [Anonymous], 2013, EMERG INFECT DIS, DOI [10.3201/eid1912.130265, DOI 10.3201/EID1912.130265]; Backstedt BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128913; Bandara M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0061-0; Barragan VA, 2011, CURR MICROBIOL, V62, P1802, DOI 10.1007/s00284-011-9931-3; Bierque E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227055; Brett-Major DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007342.pub2; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; credencegenomics, CRED GEN DNA TEST GE; Deutz A, 2003, BERL MUNCH TIERARZTL, V116, P306; Epidemiology Unit, US; Esmaeili S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144953; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S., 1994, Leptospira and leptospirosis.; Lucchesi Paula M.A., 2004, Rev. Soc. Bras. Med. Trop., V37, P131, DOI 10.1590/S0037-86822004000200003; Meteorology department, SEVERAL SPELLS SHOWE; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Parveen SMA, 2016, AM J TROP MED HYG, V95, P38, DOI 10.4269/ajtmh.16-0095; Riediger IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160523; Ristow P, 2008, MICROBIOL-SGM, V154, P1309, DOI 10.1099/mic.0.2007/014746-0; Sahneh E, 2019, J RES HEALTH SCI, V19; Sanhueza JM, 2015, EPIDEMIOL INFECT, V143, P2116, DOI 10.1017/S0950268815000515; Schneider AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006415; Thibeaux R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005414; Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122; Vein J, 2012, CAN J MICROBIOL, V58, P828, DOI [10.1139/W2012-060, 10.1139/w2012-060]; Vincent AT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007270; Warnasekara J, 2021, LEPTOSPIROSIS SOIL M; Warnasekara Janith, 2020, F1000Res, V9, P1129, DOI 10.12688/f1000research.26202.1; Warnasekara J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3655-y; Warnasekara JN, 2017, SRI LANKAN J INFECT, V7, DOI [10.4038/sljid.v7i2.8155, DOI 10.4038/SLJID.V7I2.8155]; Yupiana Y, 2019, PREV VET MED, V170, DOI 10.1016/j.prevetmed.2019.104727	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263719	10.1371/journal.pone.0263719	http://dx.doi.org/10.1371/journal.pone.0263719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167605	Green Published, gold			2022-12-26	WOS:000802227200015
J	Miyano, K; Ikehata, M; Ohshima, K; Yoshida, Y; Nose, Y; Yoshihara, S; Oki, K; Shiraishi, S; Uzu, M; Nonaka, M; Higami, Y; Uezono, Y				Miyano, Kanako; Ikehata, Minori; Ohshima, Kaori; Yoshida, Yuki; Nose, Yasuhiro; Yoshihara, Sei-ichi; Oki, Katsuyuki; Shiraishi, Seiji; Uzu, Miaki; Nonaka, Miki; Higami, Yoshikazu; Uezono, Yasuhito			Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; STROMAL CELLS; HYPERALGESIA; INTERLEUKIN-1-BETA; REGENERATION; MACROPHAGE; EXPRESSION; CYTOKINES; THERAPY; MICE	Mesenchymal stem cells (MSCs), which are isolated from adipose tissue (AD-MSCs), umbilical cord (UC-MSCs), or bone marrow, have therapeutic potential including anti-inflammatory and immunomodulatory activities. It was recently reported that MSCs are also effective as a therapeutic treatment for neuropathic pain, although the underlying mechanisms have yet to be resolved. Therefore, in this study, we investigated the effects of human AD-and UC-MSCs on neuropathic pain and its mechanisms using rat models of partial sciatic nerve ligation (PSNL). AD- or UC-MSCs were intravenously administered 4 days after PSNL. Antinociceptive effects were then evaluated using the von Frey and weight-bearing tests. We found that, 3-9 days after the administration of AD- or UC-MSCs to PSNL-exposed rats, both the mechanical threshold and differences in weight-bearing of the right and left hind paws were significantly improved. To reveal the potential underlying antinociceptive mechanisms of MSCs, the levels of activation transcription factor 3- and ionized calcium-binding adapter molecule 1-positive cells were measured by immunohistochemical analysis. AD- and UC-MSCs significantly decreased the levels of these proteins that were induced by PSNL in the dorsal root ganglia. Additionally, UC-MSC significantly improved the PSNL-induced decrease in the myelin basic protein level in the sciatic nerve, indicating that UC-MSC reversed demyelination of the sciatic nerve produced by PSNL. These data suggest that AD- and UC-MSCs may help in the recovery of neuropathic pain via the different regulation; AD-MSCs exhibited their effects via suppressed neuronal damage and anti-inflammatory actions, while UC-MSCs exhibited their effects via suppressed neuronal damage, anti-inflammatory actions and remyelination.	[Miyano, Kanako; Ohshima, Kaori; Nonaka, Miki; Uezono, Yasuhito] Jikei Univ, Dept Pain Control Res, Sch Med, Minato Ku, Tokyo, Japan; [Ikehata, Minori; Nose, Yasuhiro; Yoshihara, Sei-ichi; Oki, Katsuyuki] Biomimet Sympathies Inc, R&D Dept, Koto Ku, Tokyo, Japan; [Ohshima, Kaori] Univ Tokyo, Grad Sch Med, Pathol Immunol & Microbiol, Bunkyo Ku, Tokyo, Japan; [Yoshida, Yuki; Higami, Yoshikazu] Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Mol Pathol & Metab Dis, Noda, Chiba, Japan; [Shiraishi, Seiji] Natl Hosp Org Kure Med, Div Canc Pathophysiol, Kure, Hiroshima, Japan; [Uzu, Miaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Vitrigel Project, Tsukuba, Ibaraki, Japan	Jikei University; University of Tokyo; Tokyo University of Science; National Agriculture & Food Research Organization - Japan	Miyano, K (corresponding author), Jikei Univ, Dept Pain Control Res, Sch Med, Minato Ku, Tokyo, Japan.	k.miyano@jikei.ac.jp	Shiraishi, Seiji/GPX-5566-2022	Miyano, Kanako/0000-0003-1673-6074	Biomimetics Sympathies Inc. [C2017-128, C2019197]; Japan Society for the Promotion of Science [20K07750]	Biomimetics Sympathies Inc.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by Biomimetics Sympathies Inc. (https://www.bm-s.biz/) under grant C2017-128 to Yasuhito Uezono and C2019197 to Kanako Miyano. The funder provided support in the form of salaries for authors [M.I., Y. N., S.Y., and K.O.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All authors reviewed the manuscript. It was also funded by a Grant-in-Aid 20K07750 for Scientific Research (C) from the Japan Society for the Promotion of Science.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Asgharzade S, 2020, CURR STEM CELL RES T, V15, P349, DOI 10.2174/1574888X15666200214112908; Aso K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148185; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Berebichez-Fridman R, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2638305; Brini AT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09487-5; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen CX, 2016, NEUROCHEM RES, V41, P3250, DOI 10.1007/s11064-016-2051-5; Chu LW, 2020, PHYTOMEDICINE, V67, DOI 10.1016/j.phymed.2019.153166; Connick P, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-62; Copray JCVM, 2001, J NEUROIMMUNOL, V118, P203, DOI 10.1016/S0165-5728(01)00324-1; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fischer G, 2017, EXP BRAIN RES, V235, P2627, DOI 10.1007/s00221-017-5000-x; Gama KB, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8179013; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Jafarzadeh Bejargafshe Mohammadmahdi, 2019, Stem Cell Investig, V6, P44, DOI 10.21037/sci.2019.10.06; Jung N, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111867; Li D, 2016, TOXINS, V8, DOI 10.3390/toxins8010027; Liu LP, 2017, MIL MED, V182, P175, DOI 10.7205/MILMED-D-16-00096; Liu ZH, 2016, ANESTHESIOLOGY, V124, P934, DOI 10.1097/ALN.0000000000001010; Majka M, 2017, STEM CELL TRANSL MED, V6, P1859, DOI 10.1002/sctm.16-0484; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Miyano K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133271; Monfrini M, 2017, EXP NEUROL, V288, P75, DOI 10.1016/j.expneurol.2016.11.006; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Myers RR, 1996, EXP NEUROL, V141, P94, DOI 10.1006/exnr.1996.0142; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; PERKINS MN, 1994, NEUROPHARMACOLOGY, V33, P657, DOI 10.1016/0028-3908(94)90171-6; Quadros AU, 2015, SCI REP-UK, V5, DOI 10.1038/srep14648; Riordan NH, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1433-7; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shindou H, 2017, FASEB J, V31, P2973, DOI 10.1096/fj.201601183R; Shiue SJ, 2019, PAIN, V160, P210, DOI 10.1097/j.pain.0000000000001395; Silva RV, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00723; Siniscalco D, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00079; Wang L, 2018, CELL PHYSIOL BIOCHEM, V50, P1535, DOI 10.1159/000494652; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0262892	10.1371/journal.pone.0262892	http://dx.doi.org/10.1371/journal.pone.0262892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157707	gold, Green Published			2022-12-26	WOS:000788004500008
J	Laxmeshwar, C; Das, M; Mathur, T; Israni, T; Jha, S; Iyer, A; Morales, M; Decroo, T; Gils, T; Ferlazzo, G; Iakovidi, K; Garcia, M; Isaakidis, P				Laxmeshwar, Chinmay; Das, Mrinalini; Mathur, Taanya; Israni, Tarun; Jha, Santosh; Iyer, Aparna; Morales, Mabel; Decroo, Tom; Gils, Tinne; Ferlazzo, Gabriella; Iakovidi, Kleio; Garcia, Mariana; Isaakidis, Petros			Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India	PLOS ONE			English	Article							DEPRESSION	Background People with drug-resistant tuberculosis (DR-TB) are known to suffer from many mental-health disorders. This study aims to describe the proportion of patients diagnosed with psychiatric comorbidities, the different psychiatric diagnoses made, and treatment outcomes among DR-TB patients with or without psychiatric comorbidity and initiated on DR-TB treatment between January 2012 and March 2019 at Medecins Sans Frontieres independent clinic in Mumbai, India. Methods This is a retrospective study using routinely collected clinical data. DR-TB care included individualised treatment, psychosocial support, and integrated psychiatric care. Results During the study period, 341 DR-TB patients were enrolled, with a median age of 25 years (IQR:20.0-36.5 years), 185 (54.2%) females, 143 (41.9%) with PreXDR-TB, and 140 (41.0%) with XDR-TB. All 341 patients were screened by a counsellor, 119 (34.9%) were referred for psychiatric evaluation, and 102 (29.9% of 341) were diagnosed with a psychiatric comorbidity. Among 102 diagnosed with a psychiatric comorbidity, 48 (47.0%) were diagnosed at baseline, and 86 (84.3%), or 25.2% of all 341 patients enrolled, were treated with psychotropic drugs. Depressive disorders were diagnosed in 49 (48.0%), mixed anxiety and depression in 24 (23.5%), neurocognitive disorders and anxiety in five (4.9%), and medication induced psychosis in two (2.0%). No anti-TB drugs were significantly associated with psychiatric comorbidities developed during treatment. Of 102 DR-TB patients with a psychiatric comorbidity, 75.5% (77) had successful DR-TB treatment outcomes, compared to 61.1% (146/239) not diagnosed with a psychiatric comorbidity (p = 0.014). Conclusion In our setting, among people started on DR-TB treatment, and with a complex TB resistance profile, about one in three patients experienced a psychiatric comorbidity, of which half developed this comorbidity during treatment. With comprehensive psychiatric care integrated into DR-TB care delivery, treatment outcomes were at least as good among those with psychiatric comorbidities compared to those without such comorbidities.	[Laxmeshwar, Chinmay; Das, Mrinalini; Mathur, Taanya; Israni, Tarun; Jha, Santosh; Iyer, Aparna; Morales, Mabel] Medecins Sans Frontieres, Mumbai, Maharashtra, India; [Decroo, Tom; Gils, Tinne] Inst Trop Med, Antwerp, Belgium; [Ferlazzo, Gabriella; Iakovidi, Kleio; Garcia, Mariana; Isaakidis, Petros] Medecins Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa	Institute of Tropical Medicine (ITM)	Laxmeshwar, C (corresponding author), Medecins Sans Frontieres, Mumbai, Maharashtra, India.	chinmay2210@gmail.com	Gils, Tinne/GYU-8606-2022; Decroo, Tom/AAV-7208-2020	Gils, Tinne/0000-0002-5518-9600; Decroo, Tom/0000-0002-1205-1484; Isaakidis, Petros/0000-0002-7881-1554; Laxmeshwar, Chinmay/0000-0003-1561-3857				Alene KA, 2018, J INFECTION, V77, P357, DOI 10.1016/j.jinf.2018.07.007; Ambaw F, 2018, B WORLD HEALTH ORGAN, V96, P243, DOI 10.2471/BLT.17.192658; Ambaw F, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1231-4; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Census, MUMB GREAT MUMB CIT; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Das M., 2020, CLIN INFECT DIS, P1; Das M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24912; de Araujo GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099551; Deribew A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-201; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Fullilove M T, 1993, J Law Med Ethics, V21, P324, DOI 10.1111/j.1748-720X.1993.tb01257.x; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Lawford BR, 2012, J PSYCHOPHARMACOL, V26, P324, DOI 10.1177/0269881110393051; Mistry N, 2012, OPER RES HEALTH CARE, V1, P45, DOI 10.1016/j.orhc.2012.06.001; Pavlenko E, 2018, INT J TUBERC LUNG D, V22, P197, DOI 10.5588/ijtld.17.0254; Scuffell J, 2017, PUBLIC HEALTH ACTION, V7, P237, DOI 10.5588/pha.17.0044; Singh Lalit, 2015, Ind Psychiatry J, V24, P168, DOI 10.4103/0972-6748.181722; Sweetland AC, 2019, INT J TUBERC LUNG D, V23, P600, DOI 10.5588/ijtld.18.0530; Sweetland AC, 2017, INT J TUBERC LUNG D, V21, P852, DOI 10.5588/ijtld.16.0584; Sweetland AC, 2018, LANCET PSYCHIAT, V5, P952, DOI 10.1016/S2215-0366(18)30347-X; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; Walker IF, 2017, INT J TUBERC LUNG D, V21, P603, DOI 10.5588/ijtld.17.0135; WHO, 2015, IMPLEMENTING END TB; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2013, DEFINITIONS REPORTIN	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263759	10.1371/journal.pone.0263759	http://dx.doi.org/10.1371/journal.pone.0263759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148328	gold, Green Published			2022-12-26	WOS:000800108800026
J	Nguyen, DT; Voko, B; Nyaradi, BB; Munkacsi, T; Berczi, A; Voko, Z; Dosa, E				Nguyen, Dat Tin; Voko, Boldizsar; Nyaradi, Balazs Bence; Munkacsi, Tamas; Berczi, Akos; Voko, Zoltan; Dosa, Edit			Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting	PLOS ONE			English	Article							VASCULAR-SURGERY; STENOSIS; ANGIOPLASTY; SOCIETY; STROKE; INTERVENTIONS; GUIDELINES; STANDARDS; COMMITTEE; DEATH	Purpose We aimed to evaluate the long-term outcome of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in patients who underwent both procedures on different sides. Methods In this single-center retrospective study (2001-2019), 117 patients (men, N = 78; median age at CEA, 64.4 [interquartile range {IQR}, 57.8-72.2] years; median age at CAS, 68.8 [IQR, 61.0-76.0] years) with >= 50% internal carotid artery stenosis who had CEA on one side and CAS on the other side were included. The risk of restenosis was estimated by treatment adjusted for patient and lesion characteristics. Results Neurological symptoms were significantly more common (41.9% vs 16.2%, P<0.001) and patients had a significantly shorter mean duration of smoking (30.2 [standard deviation {SD}, 22.2] years vs 31.8 [SD, 23.4] years, P<0.001), hypertension (10.1 [SD, 9.8] years vs 13.4 [SD, 9.1] years, P<0.001), hyperlipidemia (3.6 [SD, 6.6] years vs 5.0 [SD, 7.3] years, P = 0.001), and diabetes mellitus (3.9 [SD, 6.9] years vs 5.7 [SD, 8.9] years, P<0.001) before CEA compared to those before CAS. While the prevalence of heavily calcified stenoses on the operated side (25.6% vs 6.8%, P<0.001), the incidence of predominantly echogenic/echogenic plaques (53.0% vs 70.1%, P = 0.011) and suprabulbar lesions (1.7% vs 22.2%, P<0.001) on the stented side was significantly higher. Restenosis rates were 10.4% at 1 year, 22.3% at 5 years, and 33.7% at the end of the follow-up (at 11 years) for CEA, while these were 11.4%, 14.7%, and 17.2%, respectively, for CAS. Cox regression analysis revealed a significantly higher risk of restenosis (hazard ratio [HR], 1.80; 95% confidence interval [CI], 1.05-3.10; P = 0.030) for CEA compared to that for CAS. After adjusting for relevant confounding factors (smoking, hypertension, diabetes mellitus, calcification severity, plaque echogenicity, and lesion location), the estimate effect size materially did not change, although it did not remain statistically significant (HR, 1.85; 95% CI, 0.95-3.60; P = 0.070). Conclusion Intra-patient comparison of CEA and CAS in terms of restenosis tilts the balance toward CAS.	[Nguyen, Dat Tin; Voko, Boldizsar; Nyaradi, Balazs Bence; Munkacsi, Tamas; Berczi, Akos; Dosa, Edit] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Nguyen, Dat Tin; Berczi, Akos; Dosa, Edit] Hungarian Vasc Radiol Res Grp, Budapest, Hungary; [Voko, Zoltan] Semmelweis Univ, Ctr Hlth Technol Assessment, Budapest, Hungary	Semmelweis University; Semmelweis University	Dosa, E (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary.; Dosa, E (corresponding author), Hungarian Vasc Radiol Res Grp, Budapest, Hungary.	dosa.edit@med.semmelweis-univ.hu		Berczi, Akos/0000-0002-1278-3677; Munkacsi, Tamas/0000-0002-6463-7073; Voko, Boldizsar/0000-0001-6323-892X	HRDOP (Human Resource Development Operational Programme) [EFOP-3.6.3-VEKOP-16-2017-00009]	HRDOP (Human Resource Development Operational Programme)	This article was funded by the EFOP-3.6.3-VEKOP-16-2017-00009 project (Akos Berczi and Balazs Bence Nyaradi). Name of the funder: HRDOP (Human Resource Development Operational Programme) Website: https://www.palyazat.gov.hu/human_resource_development_ operational_programme.	AbuRahma AF, 2009, J VASC SURG, V50, P286, DOI 10.1016/j.jvs.2009.01.065; Ariyoshi K, 2015, J DIABETES INVEST, V6, P91, DOI 10.1111/jdi.12242; Bonati LH, 2014, INT J STROKE, V9, P297, DOI 10.1111/ijs.12084; Bonati LH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub4; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Ciccone MM, 2017, VASCULAR, V25, P290, DOI 10.1177/1708538116674375; CLAGETT G P, 1989, Journal of Vascular Surgery, V10, P577; de Borst GJ, 2007, J VASC SURG, V45, P118, DOI 10.1016/j.jvs.2006.09.013; De Borst GJ, 2006, J CARDIOVASC SURG, V47, P49; Eckstein HH, 2018, EUR J VASC ENDOVASC, V55, P1, DOI 10.1016/j.ejvs.2017.06.026; Eckstein HH, 2016, EUR J VASC ENDOVASC, V51, P761, DOI 10.1016/j.ejvs.2016.02.005; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Hirschberg K, 2009, J CARDIOVASC SURG, V50, P655; Kumar R, 2017, EUR J VASC ENDOVASC, V53, P766, DOI 10.1016/j.ejvs.2017.02.016; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Macdonald S, 2009, STROKE, V40, P1698, DOI 10.1161/STROKEAHA.109.547117; Manheim D, 2017, J CARDIOVASC SURG, V58, P814, DOI 10.23736/S0021-9509.16.09513-6; Markovic DM, 2008, J CARDIOVASC SURG, V49, P619; Martelli E, 2016, J CARDIOVASC SURG, V57, P503; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Moore WS, 2016, J VASC SURG, V63, P851, DOI 10.1016/j.jvs.2015.08.119; MOORE WS, 1995, STROKE, V26, P188, DOI 10.1161/01.STR.26.1.188; Muller MD, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000515.pub5, 10.1161/STROKEAHA.120.030521]; Naylor AR, 2018, EUR J VASC ENDOVASC, V55, P3, DOI 10.1016/j.ejvs.2017.06.021; Ouriel K, 2004, J VASC SURG, V39, P916, DOI 10.1016/j.jvs.2004.01.028; Rizwan M, 2019, VASC ENDOVASC SURG, V53, P216, DOI 10.1177/1538574418823379; Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI 10.1056/NEJMoa1515706; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Stanley JC, 1996, J VASC SURG, V23, P172, DOI 10.1016/S0741-5214(05)80050-3; Stanziale SF, 2005, J ENDOVASC THER, V12, P346, DOI 10.1583/04-1527.1; Stenudd I, 2020, INT J CARDIOVAS IMAG, V36, P1061, DOI 10.1007/s10554-020-01801-z; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Timaran CH, 2011, J VASC SURG, V53, P1679, DOI 10.1016/j.jvs.2010.11.122; Vertes M, 2020, CARDIOVASC INTER RAD, V43, P1134, DOI 10.1007/s00270-020-02522-5; Woodcock RJ, 1999, AM J NEURORADIOL, V20, P495; Xu RW, 2016, ANN VASC SURG, V33, P138, DOI 10.1016/j.avsg.2015.11.017; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yan D, 2019, ANN VASC SURG, V59, P21, DOI 10.1016/j.avsg.2019.01.019	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0262735	10.1371/journal.pone.0262735	http://dx.doi.org/10.1371/journal.pone.0262735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148323	Green Published, gold			2022-12-26	WOS:000800108800012
J	Lin, RM; Yang, MQ; Yao, BW				Lin, Rongmei; Yang, Mengquan; Yao, Bowen			The phylogenetic and evolutionary analyses of detoxification gene families in Aphidinae species	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GLYCOSYLTRANSFERASE UGT SUPERFAMILY; ACYRTHOSIPHON-PISUM; CARBOXYLESTERASE GENE; SITOBION-AVENAE; RESISTANCE; IDENTIFICATION; ENZYMES; ADAPTATION; INSECTS	Detoxification enzymes play significant roles in the interactions between insects and host plants, wherein detoxification-related genes make great contributions. As herbivorous pests, aphids reproduce rapidly due to parthenogenesis. They are good biological materials for studying the mechanisms that allow insect adaptation to host plants. Insect detoxification gene families are associated with insect adaptation to host plants. The Aphidinae is the largest subfamily in the Aphididae with at least 2483 species in 256 genera in 2 tribes: the Macrosiphini (with 3/4 of the species) and the Aphidini. Most aphid pests on crops and ornamental plants are Aphidinae. Members of the Aphidinae occur in nearly every region of the world. The body shape and colour vary significantly. To research the role that detoxification gene families played in the process of aphid adaptation to host evolution, we analyzed the phylogeny and evolution of these detoxification gene families in Aphidinae. In general, the P450/GST/CCE gene families contract, whereas the ABC/UGT families are conserved in Aphidinae species compared to these families in other herbivorous insects. Genus-specific expansions of P450 CYP4, and GST Delta have occurred in the genus Acyrthosiphon. In addition, the evolutionary rates of five detoxification gene families in the evolution process of Aphidinae are different. The comparison of five detoxification gene families among nine Aphidinae species and the estimated relative evolutionary rates provided herein support an understanding of the interaction between and the co-evolution of Aphidinae and plants.	[Lin, Rongmei] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Lin, Rongmei] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, CAS Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Yang, Mengquan] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan; [Yao, Bowen] Beijing Univ Chem Technol, Sch Sci, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; University of Tokyo; Beijing University of Chemical Technology	Lin, RM (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.; Lin, RM (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, CAS Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China.; Yao, BW (corresponding author), Beijing Univ Chem Technol, Sch Sci, Beijing, Peoples R China.	rmlin@mail.hzau.edu.cn; byao@pku.edu.cn	Yang, Mengquan/GXA-2728-2022		Fundamental Research Funds for the Central Universities [buctrc202145]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Fundamental Research Funds for the Central Universities (buctrc202145, awarded to BY).	Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Arockiaraj J, 2014, GENE, V546, P437, DOI 10.1016/j.gene.2014.05.063; Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113; Behura SK, 2015, INSECT MOL BIOL, V24, P403, DOI 10.1111/imb.12174; Bock KW, 2016, BIOCHEM PHARMACOL, V99, P11, DOI 10.1016/j.bcp.2015.10.001; Chen CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20981-2; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cheng TC, 2017, NAT ECOL EVOL, V1, P1747, DOI 10.1038/s41559-017-0314-4; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Duan XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172513; Eakteiman G, 2018, INSECT BIOCHEM MOLEC, V100, P10, DOI 10.1016/j.ibmb.2018.05.008; Feng XC, 2018, INSECT BIOCHEM MOLEC, V92, P30, DOI 10.1016/j.ibmb.2017.11.007; Francis F, 2001, COMP BIOCHEM PHYS B, V129, P165, DOI 10.1016/S1096-4959(01)00329-3; Gaddelapati SC, 2018, INSECT BIOCHEM MOLEC, V99, P54, DOI 10.1016/j.ibmb.2018.05.006; Godfray HCJ, 2010, INSECT MOL BIOL, V19, P1, DOI 10.1111/j.1365-2583.2009.00980.x; Gong YH, 2017, INSECT MOL BIOL, V26, P702, DOI 10.1111/imb.12331; Guo SM, 2012, J EXP BOT, V63, P3913, DOI 10.1093/jxb/ers084; Huang FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-563; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Lee SY, 2015, GENE, V568, P203, DOI 10.1016/j.gene.2015.05.058; Li S, 2019, ANNU REV ENTOMOL, V64, P315, DOI 10.1146/annurev-ento-011118-112007; Li S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03281-1; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Liu XD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02248-4; Mathers TC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1145-3; Meech R, 2019, PHYSIOL REV, V99, P1153, DOI 10.1152/physrev.00058.2017; Nicholson SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1525-1; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pan YO, 2009, COMP BIOCHEM PHYS B, V152, P266, DOI 10.1016/j.cbpb.2008.12.002; Pan YO, 2018, PESTIC BIOCHEM PHYS, V148, P182, DOI 10.1016/j.pestbp.2018.04.015; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Qi WP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3096-1; Quan QM, 2019, INSECT BIOCHEM MOLEC, V105, P25, DOI 10.1016/j.ibmb.2018.12.007; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Rane RV, 2016, CURR OPIN INSECT SCI, V13, P70, DOI 10.1016/j.cois.2015.12.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rispe C, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00820-5; Schoville SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20154-1; Schuler MA, 2013, J CHEM ECOL, V39, P1232, DOI 10.1007/s10886-013-0335-7; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Tian LX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3706-6; Urlacher VB, 2019, TRENDS BIOTECHNOL, V37, P882, DOI 10.1016/j.tibtech.2019.01.001; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Wang HD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07226-6; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Ward CM, 2021, INSECT BIOCHEM MOLEC, V138, DOI 10.1016/j.ibmb.2021.103622; Wenger JA, 2020, INSECT BIOCHEM MOLEC, V123, DOI 10.1016/j.ibmb.2017.01.005; Xie W, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix018; Xu LJ, 2014, TRANSGENIC RES, V23, P389, DOI 10.1007/s11248-013-9765-9; Yan HR, 2012, J INSECT PHYSIOL, V58, P782, DOI 10.1016/j.jinsphys.2012.02.003; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yan SG, 2009, PROTEIN PEPTIDE LETT, V16, P1181; Yates AD, 2018, CURR OPIN INSECT SCI, V26, P41, DOI 10.1016/j.cois.2018.01.003; Ye YX, 2021, MOL ECOL RESOUR, V21, P1287, DOI 10.1111/1755-0998.13328; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhang LP, 2017, SCI CHINA LIFE SCI, V60, P927, DOI 10.1007/s11427-017-9105-x; Zhang Y, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6743-5; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930; Zhu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-174	60	3	3	10	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263462	10.1371/journal.pone.0263462	http://dx.doi.org/10.1371/journal.pone.0263462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143545	Green Published, gold			2022-12-26	WOS:000797657800047
J	Pock, T; Schulte, K; Schlatt, S; Boiani, M; Nordhoff, V				Pock, Tim; Schulte, Katharina; Schlatt, Stefan; Boiani, Michele; Nordhoff, Verena			GM-CSF perturbs cell identity in mouse pre-implantation embryos	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CULTURE-MEDIUM; FATE SPECIFICATION; MEDIA; TROPHECTODERM; WEIGHT; TRIAL; BIRTH; CDX2	Growth factors became attractive candidates for medium supplementation to further improve the quality of embryo culture and to mimic in vivo nutrition. Granulocyte macrophage colony-stimulating factor (GM-CSF) is a cytokine influencing the maternal-fetal interface and supporting placental development in mouse and human. It is expressed in epithelial cells of the endometrium under the regulation of estrogens. The factor is already in clinical use and a large clinical trial showed that, if supplemented to an embryo culture medium, it leads to increased survival of embryos, especially in women with previous miscarriages. Animal and cell culture studies on isolated trophectoderm cells support an effect mainly on cellular expansion. Aim of this study was to investigate, if the supplementation of GM-CSF either in a human ART medium or in a mouse optimized medium, leads to a change in cell number and cell lineages in the early pre-implantation mouse embryo. Our data shows that mouse GM-CSF increased total cell numbers with increasing concentrations. This increase of cell number has not been found in embryos cultured in ART media with or without human GM-CSF (hGM-CSF) or in a mouse medium supplemented with different concentrations of hGM-CSF. The changes were caused by a marked difference in TE and primitive endoderm cell numbers but not due to a change in epiblast cell numbers. Additionally, results show an ectopic expression of NANOG among trophectoderm cells in both, human ART media (with and without GM-CSF) and at increasing concentrations in the mouse and the human GM-CSF supplemented media. In conclusion, we could show that GM-CSF has an effect on cell identity in mice, which might probably also occur in the human. Therefore, we would like to rare awareness that the use of supplements without proper research could bare risks for the embryo itself and probably also in the post-implantation phase.	[Pock, Tim; Schlatt, Stefan; Nordhoff, Verena] Univ Munster, Ctr Reprod Med & Androl CeRA, Munster, Germany; [Schulte, Katharina] Univ Munster, Cent Anim Facil Fac Med, Munster, Germany; [Boiani, Michele] Max Planck Inst Mol Biomed, Munster, Germany	University of Munster; University of Munster; Max Planck Society	Nordhoff, V (corresponding author), Univ Munster, Ctr Reprod Med & Androl CeRA, Munster, Germany.	verena.nordhoff@ukmuenster.de		Nordhoff, Verena/0000-0001-5963-1366	German Research Foundation [413/3-3, BO2540/43]	German Research Foundation(German Research Foundation (DFG))	This work was funded by the German Research Foundation (NO 413/3-3 and BO2540/43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm I, 2010, REPROD BIOMED ONLINE, V20, P477, DOI 10.1016/j.rbmo.2009.12.026; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Behr B, 2005, J ASSIST REPROD GEN, V22, P25, DOI 10.1007/s10815-005-0817-9; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; BRINSTER RL, 1963, EXP CELL RES, V32, P205, DOI 10.1016/0014-4827(63)90093-4; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chin PY, 2009, HUM REPROD, V24, P2997, DOI 10.1093/humrep/dep307; Chronopoulou E, 2015, HUM REPROD UPDATE, V21, P39, DOI 10.1093/humupd/dmu040; Dumoulin JC, 2010, HUM REPROD, V25, P605, DOI 10.1093/humrep/dep456; Elaimi A, 2012, HUM REPROD, V27, P1590, DOI 10.1093/humrep/des108; Gurner KH, 2020, MOL HUM REPROD, V26, P953, DOI 10.1093/molehr/gaaa072; Hemkemeyer SA, 2014, HUM REPROD, V29, P220, DOI 10.1093/humrep/det411; Jeong W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088731; Karagenc L, 2005, REPROD BIOMED ONLINE, V10, P511, DOI 10.1016/S1472-6483(10)60829-2; Kaye Peter L., 1995, Progress in Growth Factor Research, V6, P1, DOI 10.1016/0955-2235(95)00001-1; Kleijkers SHM, 2014, HUM REPROD, V29, P661, DOI 10.1093/humrep/deu025; Kwak SS, 2012, J VET MED SCI, V74, P1095, DOI 10.1292/jvms.12-0050; Laskowski D, 2016, THERIOGENOLOGY, V86, P457, DOI 10.1016/j.theriogenology.2016.04.062; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Ozawa Manabu, 2016, BMC Res Notes, V9, P250, DOI 10.1186/s13104-016-2038-y; Rahmati M, 2015, J REPROD IMMUNOL, V109, P1, DOI 10.1016/j.jri.2015.01.005; Robertson SA, 1996, BIOL REPROD, V54, P183, DOI 10.1095/biolreprod54.1.183; Rose RD, 2020, REPROD BIOMED ONLINE, V40, P645, DOI 10.1016/j.rbmo.2020.01.011; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulte K, 2015, THERIOGENOLOGY, V84, P1620, DOI 10.1016/j.theriogenology.2015.08.009; Schwarzer C, 2012, HUM REPROD, V27, P2627, DOI 10.1093/humrep/des223; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Sjoblom C, 2002, BIOL REPROD, V67, P1817, DOI 10.1095/biolreprod.101.001503; STEPTOE PC, 1978, LANCET, V2, P366; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Wamaitha SE, 2018, CURR TOP DEV BIOL, V128, P295, DOI 10.1016/bs.ctdb.2017.11.004; WHITTEN WK, 1956, NATURE, V177, P96, DOI 10.1038/177096a0; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Zandstra H, 2018, HUM REPROD, V33, P1645, DOI 10.1093/humrep/dey246; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhou WH, 2016, J ASSIST REPROD GEN, V33, P39, DOI 10.1007/s10815-015-0627-7; Ziebe S, 2013, FERTIL STERIL, V99, P1600, DOI 10.1016/j.fertnstert.2012.12.043	39	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263793	10.1371/journal.pone.026379	http://dx.doi.org/10.1371/journal.pone.026379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143564				2022-12-26	WOS:000797657800080
J	Teshale, AB				Teshale, Achamyeleh Birhanu			Factors associated with unmet need for family planning in sub-Saharan Africa: A multilevel multinomial logistic regression analysis	PLOS ONE			English	Article								Background More than one out of every ten married women in the world, and one out of every five women in Africa, have unmet family planning needs. Despite this, studies concerning sub-Saharan Africa as well as the community-level factors that may influence the unmet need for family planning are scarce. Objective To assess factors associated with unmet need for family planning in sub-Saharan Africa. Methods This study used the nineteen demographic and health surveys (DHS) conducted between 2015 and 2020 in sub-Saharan Africa. A total weighted sample of 175, 820 women of reproductive age who were married during the survey was used for this study. To assess the factors associated with unmet need for family planning, I have employed a multilevel multinomial logistic regression model. After selecting variables using the bivariable analysis, a multivariable model was fitted. Finally, an adjusted relative risk ratio with its 95% Confidence Interval was reported and variables with a p-value less than 0.05 were declared to be significant predictors of unmet need for family planning. Result The overall prevalence of unmet need for family planning in sub-Saharan Africa was 23.70%, of which unmet need for spacing and limiting was 15.81% and 7.90% respectively. In the multivariable multilevel multinomial model, women's age, women's education, age at cohabitation, heard about family planning through media, parity, number of under-five children, and knowledge about modern contraceptive methods were among the individual-level factors that were associated with both the unmet need for spacing and limiting. Place of residence, community level of women illiteracy, and region were among the community-level factors that were associated with both unmet needs for spacing and limiting. Household size and visiting the health facility in the last 12 months were associated with unmet need for spacing only and husband education was associated with unmet need for limiting only. Conclusion Unmet need for family planning in sub-Saharan Africa was high. Both individual and community level factors were associated with both unmet need for spacing and limiting. Therefore, it is better to consider interventions at both individual and community levels.	[Teshale, Achamyeleh Birhanu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Teshale, Achamyeleh/0000-0002-7572-9993				Adebowale S. A., 2014, African Population Studies, V28, P499, DOI 10.11564/28-1-503; Affairs S, 2017, WORLD FAM PLANN 2017; Ajmal S., 2018, DHS Working Papers; Ali AAA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-102; Anita Pal JY., 2018, INT J REPROD CONTRAC, V7, P3638, DOI [10.18203/2320-1770.ijrcog20183768, DOI 10.18203/2320-1770.IJRCOG20183768]; Asif MF., 2019, BMC PUBLIC HEALTH, V19, P1, DOI [10.1186/s12889-018-6343-3, DOI 10.1186/S12889-018-6343-3]; Ayele W, 2013, TRENDS DETERMINANTS; Bahk J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0505-4; Bhusal Chet Kant, 2018, Int J Reprod Med, V2018, P9312687, DOI 10.1155/2018/9312687; Bishwajit G, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1379-4; Bradley S.E.K., 2012, DHS ANAL STUDIES; Bradley SarahE.K., 2012, DHS ANAL STUDIES; Brown S.S., 1995, BEST INTENTIONS UNIN; Dejene H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250297; Fagbamigbe AF, 2018, SAGE OPEN, V8, DOI 10.1177/2158244017754023; Gebre G, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.195.8386; Gebreselassie T, 2013, LEVELS TRENDS UNMET; Guure C, 2019, ARCH PUBLIC HEALTH, V77, DOI 10.1186/s13690-019-0340-6; Hailemariam A, 2011, ETHIOP J HEALTH SCI, V21, P77; Khan SM., 2008, UNMET NEED DEMAND FA; Klima CS, 1998, J NURSE-MIDWIFERY, V43, P483, DOI 10.1016/S0091-2182(98)00063-9; Korra A., 2002, ATTITUDES FAMILY PLA; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Nkoka O, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08885-1; Nzokirishaka A, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-018-0062-0; Pradhan J., 2015, J WOMENS HLTH CARE, V4, P1; Solanke BL, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0093-1; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Teshale AB, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09550-3; The Alan Guttmacher Institute, 1999, SHARING RESPONSIBILI; The DHS Program, DHS METH; United Nations Department of Economic and Social Affairs Population Division, 2014, POPDBCPREV2014; Wafula SW, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0240-z; Waqas Hameed, 2011, Pakistan Journal of Public Health, V1, P21; Westoff CF., 2006, DHS COMP REPORTS; Worku SA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4180-9; Wulifan JK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1614-z; Yalew M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08653-1; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209801	40	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263885	10.1371/journal.pone.0263885	http://dx.doi.org/10.1371/journal.pone.0263885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143584	Green Published, gold			2022-12-26	WOS:000797657800089
J	Thiam, MM; Pontais, I; Forgeot, C; Pedrono, G; Paget, LM; Fouillet, A; Caserio-Schonemann, C				Thiam, Marie-Michele; Pontais, Isabelle; Forgeot, Cecile; Pedrono, Gaelle; Paget, Louis-Marie; Fouillet, Anne; Caserio-Schonemann, Celine		SurSaUD Regional Focal Point; SOS Med; Grp Emergency Med Doctors	Syndromic surveillance: A key component of population health monitoring during the first wave of the COVID-19 outbreak in France, February-June 2020	PLOS ONE			English	Article								Background The French syndromic surveillance (SyS) system, SurSaUD (R) , was one of the systems used to monitor the COVID-19 outbreak. Aim This study described the epidemiological characteristics of COVID-19-related visits to both emergency departments (EDs) and the network of emergency general practitioners known as SOS Medecins (SOSMed) in France from 17 February to 28 June 2020. Methods Data on all visits to 634 EDs and 60 SOSMed associations were collected daily. COVID-19-related visits were identified using ICD-10 codes after coding recommendations were sent to all ED and SOSMed doctors. The time course of COVID-19-related visits was described by age group and region. During the lockdown period, the characteristics of ED and SOSMed visits and hospitalisations after visits were described by age group and gender. The most frequent diagnoses associated with COVID-19-related visits were analysed. Results COVID-19 SyS was implemented on 29 February and 4 March for EDs and SOSMed, respectively. A total of 170,113 ED and 59,087 SOSMed visits relating to COVID-19 were recorded, representing 4.0% and 5.6% of the overall coded activity with a peak in late March representing 22.5% and 25% of all ED and SOSMed visits, respectively. COVID-19-related visits were most frequently reported for women and those aged 15-64 years, although patients who were subsequently hospitalised were more often men and persons aged 65 years and older. Conclusion SyS allowed for population health monitoring of the COVID-19 epidemic in France. As SyS has more than 15 years of historical data with high quality and reliability, it was considered sufficiently robust to contribute to defining the post-lockdown strategy.	[Thiam, Marie-Michele; Pontais, Isabelle; Forgeot, Cecile; Pedrono, Gaelle; Fouillet, Anne; Caserio-Schonemann, Celine] Sante Publ France, Data Sci Div, St Maurice, France; [SurSaUD Regional Focal Point] Sante Publ France, Reg Div, St Maurice, France; [SOS Med] SOS Med France Natl Board, Paris, France; [Grp Emergency Med Doctors] OSCOUR Network, Marseille, France; [Paget, Louis-Marie] Sante Publ France, Noncommunicable & Traumat Dis Div, St Maurice, France	Institute of Public Health Surveillance; Institute of Public Health Surveillance; Institute of Public Health Surveillance	Thiam, MM (corresponding author), Sante Publ France, Data Sci Div, St Maurice, France.	marie-michele.thiam@santepubliquefrance.fr			Federation of the Regional Observatories of Emergencies; Scientific Society of Emergency Medicine; Federation of Emergency General Practitioners' (SOS Medecins) associations	Federation of the Regional Observatories of Emergencies; Scientific Society of Emergency Medicine; Federation of Emergency General Practitioners' (SOS Medecins) associations	The authors acknowledge the contribution made by the emergency departments and clinicians involved in the OSCOUR and SOS Medecins networks in France; the ongoing support of the Federation of the Regional Observatories of Emergencies; the Scientific Society of Emergency Medicine; and the Federation of Emergency General Practitioners' (SOS Medecins) associations. We also thank Nicolas Vincent (Sante publique France Centre-Val-de-Loire, Orleans, France), Erica Fougere (Sante publique France Auvergne-Rhone-Alpes, Lyon, France), Laure Meurice (Sante publique France Nouvelle-Aquitaine, Bordeaux, France), Noemie Fortin (Sante publique France Pays-de-la-Loire, Nantes, France), Pierre-Henry Juan (SOS Medecins, Lyon, France), Agnes Barondeau-Leuret (Federation des Observatoires regionaux des urgences (FEDORU), Bourgogne-Franche-Comte, France), and Karim Tazarourte (Hospices civils de Lyon, Lyon, France) for reviewing the manuscript.	Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Caserio Schonemann CB V., 2014, B EPID MIOLOGIQUE HE, P38; Caserio-Schonemann C, 2015, EUROSURVEILLANCE, V20, P35, DOI 10.2807/1560-7917.ES2015.20.19.21126; Clifford CT, 2021, AM J EMERG MED, V46, P520, DOI 10.1016/j.ajem.2020.11.006; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; COVID 19 APHP Univ INRIA INSERM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241406; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.5.200131e; Falahi S, 2021, J MED VIROL, V93, P151, DOI 10.1002/jmv.26243; Fouillet A, 2020, EUROSURVEILLANCE, V25, P5, DOI 10.2807/1560-7917.ES.2020.25.34.2001485; Fouillet A, 2020, EUROSURVEILLANCE, V25, P9, DOI 10.2807/1560-7917.ES.2020.25.7.2000060; France Sp, 2021, COR COVID 19 SANT PU; France Sp, COVID 19 POINT PIDM; Government F, INF COR COVID 19 LES; Hartnett KP, 2020, MMWR-MORBID MORTAL W, V69, P699, DOI 10.15585/mmwr.mm6923e1; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kaeuffer C, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.48.2000895; Dana PM, 2020, PREHOSP DISASTER MED, V35, P438, DOI 10.1017/S1049023X20000837; Pascal V., 2019, ONLINE J PUBLIC HLTH, V11; Prevention CfDCa, COVID DAT TRACK 2021; Redondo-Bravo L, 2020, EUROSURVEILLANCE, V25, P15, DOI 10.2807/1560-7917.ES.2020.25.50.2001431; Spaccaferri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.50.2001974; Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Vandentorren S, 2016, LANCET, V387, P846, DOI 10.1016/S0140-6736(16)00507-9; World Health Organization, COVID 19 COD ICD 10; World Health Organization, 2020, MENT HLTH PSYCH CONS	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0260150	10.1371/journal.pone.0260150	http://dx.doi.org/10.1371/journal.pone.0260150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143501	Green Published, gold			2022-12-26	WOS:000797657800003
J	Tiper, I; Kourout, M; Fisher, C; Konduru, K; Purkayastha, A; Kaplan, G; Duncan, R				Tiper, Irina; Kourout, Moussa; Fisher, Carolyn; Konduru, Krishnamurthy; Purkayastha, Anjan; Kaplan, Gerardo; Duncan, Robert			Tracking ebolavirus genomic drift with a resequencing microarray	PLOS ONE			English	Article							VIRUS DISEASE; MOLECULAR EVOLUTION; SEQUENCE ALIGNMENT; IDENTIFICATION; GLYCOPROTEIN; OUTBREAK	Filoviruses are emerging pathogens that cause acute fever with high fatality rate and present a global public health threat. During the 2013-2016 Ebola virus outbreak, genome sequencing allowed the study of virus evolution, mutations affecting pathogenicity and infectivity, and tracing the viral spread. In 2018, early sequence identification of the Ebolavirus as EBOV in the Democratic Republic of the Congo supported the use of an Ebola virus vaccine. However, field-deployable sequencing methods are needed to enable a rapid public health response. Resequencing microarrays (RMA) are a targeted method to obtain genomic sequence on clinical specimens rapidly, and sensitively, overcoming the need for extensive bioinformatic analysis. This study presents the design and initial evaluation of an ebolavirus resequencing microarray (Ebolavirus-RMA) system for sequencing the major genomic regions of four Ebolaviruses that cause disease in humans. The design of the Ebolavirus-RMA system is described and evaluated by sequencing repository samples of three Ebolaviruses and two EBOV variants. The ability of the system to identify genetic drift in a replicating virus was achieved by sequencing the ebolavirus glycoprotein gene in a recombinant virus cultured under pressure from a neutralizing antibody. Comparison of the Ebolavirus-RMA results to the Genbank database sequence file with the accession number given for the source RNA and Ebolavirus-RMA results compared to Next Generation Sequence results of the same RNA samples showed up to 99% agreement.	[Tiper, Irina; Kourout, Moussa; Fisher, Carolyn; Konduru, Krishnamurthy; Kaplan, Gerardo; Duncan, Robert] US FDA, Div Emerging & Transfus Transmitted Dis, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Purkayastha, Anjan] OpenBox Bio, Vienna, VA USA; [Tiper, Irina] US FDA, Ctr Biol Evaluat & Res, Off Tissues & Adv Therapies, Div Cell & Gene Therapies, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Duncan, R (corresponding author), US FDA, Div Emerging & Transfus Transmitted Dis, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	robert.duncan@fda.hhs.gov	Duncan, Robert/I-8168-2015	Duncan, Robert/0000-0001-8409-2501	FDA Medical Countermeasures Initiative (MCMi)	FDA Medical Countermeasures Initiative (MCMi)	Irina Tiper and Moussa Kourout were supported in part by an appointment to the Oak Ridge Institute for Science and Education (ORISE) Research Fellowship Program at the Center for Biologics Evaluation and Research administered by the ORISE through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. Funding for this research was partially provided by the FDA Medical Countermeasures Initiative (MCMi). Received by RD There is no grant number. https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/medicalcountermeasures-initiative-mcmi.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881; Berthet N, 2013, J CLIN VIROL, V56, P238, DOI 10.1016/j.jcv.2012.10.022; Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Dietzel E, 2017, J VIROL, V91, DOI [10.1128/JVI.01913-16, 10.1128/jvi.01913-16]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faye M., 2021, GUINEA 2021 EBOV OUT; Fox Edward J, 2014, Next Gener Seq Appl, V1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardick J, 2016, J MED VIROL, V88, P1303, DOI 10.1002/jmv.24487; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Jacob ST, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0147-3; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Keita A., 2021, RESURGENCE EBOLA VIR; Konduru K, 2018, J VIROL METHODS, V254, P1, DOI 10.1016/j.jviromet.2018.01.003; Konduru K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162446; Konduru K, 2011, VACCINE, V29, P2968, DOI 10.1016/j.vaccine.2011.01.113; Kourout M, 2016, TRANSFUSION, V56, P1537, DOI 10.1111/trf.13524; Kuhn JH, 2019, NAT REV MICROBIOL, V17, P261, DOI 10.1038/s41579-019-0187-4; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Liu SQ, 2015, INFECT GENET EVOL, V32, P51, DOI 10.1016/j.meegid.2015.02.024; Marzi A, 2018, CELL REP, V23, P1806, DOI 10.1016/j.celrep.2018.04.027; Mbala-Kingebeni P, 2019, CLIN INFECT DIS, V68, P330, DOI 10.1093/cid/ciy527; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Metzgar D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008995; Meyer M, 2019, TRENDS MICROBIOL, V27, P8, DOI 10.1016/j.tim.2018.08.008; Miler CR, 2016, PEERJ, V4, DOI 10.7717/peerj.1674; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Quinlan DS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45886; Raftery P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006135; Santana-Quintero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099033; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Sulaiman IM, 2007, J CLIN MICROBIOL, V45, P358, DOI 10.1128/JCM.01848-06; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874; Wang HY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r5; WHO, 2020, HER EB RESP WHO; WHO, 2021, EB VIR DIS GUIN; WHO, 11 EB OUTBR DEM REP; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2021, 107 STUD FOUND EB OR; Wu WW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4677-y	51	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263732	10.1371/journal.pone.0263732	http://dx.doi.org/10.1371/journal.pone.0263732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143574	gold, Green Published			2022-12-26	WOS:000797657800074
J	Kunitsu, Y; Hira, D; Morikochi, A; Ueda, T; Isono, T; Morita, S; Terada, T				Kunitsu, Yuki; Hira, Daiki; Morikochi, Aya; Ueda, Tomohiro; Isono, Tetsuichiro; Morita, Shin-ya; Terada, Tomohiro			Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM INHIBITORS; RENAL-FUNCTION; HEART-FAILURE; DIURETICS; RISK; METAANALYSIS; PATHWAYS; DISEASE; NSAIDS; KEGG	Acute kidney injury (AKI) associated with "Triple Whammy" drug therapy consisting of renin-angiotensin system inhibitors, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) has been reported. There have been no reports investigating "Triple Whammy" drug therapy and the time to AKI onset using adverse drug events report databases. The aim of this study was to determine the relationship between the time to AKI onset and treatment with "Triple Whammy" drug therapy. We analyzed AKI cases registered in the Japanese Adverse Drug Event Report database. The data were analyzed using the Kaplan-Meier approach, generalized Wilcoxon tests, and Weibull distribution. AKI was reported in 18,415 cases, of which 7,466 cases used Triple Whammy drugs. All combinations of Triple Whammy drugs were associated with significantly higher odds ratios for reporting AKI. In Weibull analysis, AKI onset was early for most combination patterns of Triple Whammy drugs. The Kaplan-Meier approach showed that the treatment duration to AKI onset was much shorter in cases using NSAIDs; median onsets, 8 days for triple combination, 7 days for NSAIDs added to renin-angiotensin system inhibitors, 9 days for NSAIDs added to diuretics, 6 days for diuretics added to NSAIDs, and 9 days for NSAIDs alone. AKI associated with Triple Whammy drugs is likely to occur in the early stages of treatment, especially with concomitant NSAIDs. Patients should be monitored for the occurrence of AKI within the first 2 weeks.	[Kunitsu, Yuki; Hira, Daiki; Morikochi, Aya; Ueda, Tomohiro; Isono, Tetsuichiro; Morita, Shin-ya; Terada, Tomohiro] Shiga Univ, Dept Pharm, Med Sci Hosp, Otsu, Shiga, Japan; [Hira, Daiki; Terada, Tomohiro] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto, Kyoto, Japan; [Hira, Daiki] Ritsumeikan Univ, Coll Pharmaceut Sci, Shiga, Japan	Shiga University; Kyoto University; Ritsumeikan University	Morita, S; Terada, T (corresponding author), Shiga Univ, Dept Pharm, Med Sci Hosp, Otsu, Shiga, Japan.; Terada, T (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto, Kyoto, Japan.	smorita@belle.shiga-med.ac.jp; teradat@kuhp.kyoto-u.ac.jp		Isono, Tetsuichiro/0000-0001-5771-3819	JSPS KAKENHI [21H04191]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 21H04191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0048-5; Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Boddu R, 2017, AM J PHYSIOL-RENAL, V313, pF740, DOI 10.1152/ajprenal.00049.2017; Boyd IW, 2000, MED J AUSTRALIA, V173, P274, DOI 10.5694/j.1326-5377.2000.tb125642.x; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Dreischulte T, 2015, KIDNEY INT, V88, P396, DOI 10.1038/ki.2015.101; Fournier JP, 2014, RENAL FAILURE, V36, P1166, DOI 10.3109/0886022X.2014.917943; Camin RMG, 2015, NEFROLOGIA, V35, P197, DOI 10.1016/j.nefro.2015.05.021; Heerdink ER, 1998, ARCH INTERN MED, V158, P1108, DOI 10.1001/archinte.158.10.1108; Hosohata K, 2019, J CLIN PHARM THER, V44, P49, DOI 10.1111/jcpt.12748; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Ikuta K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041543; Inaba I, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00874; Japanese Society of Nephrology, 2019, CLIN EXP NEPHROL, V23, P1, DOI 10.1007/s10157-018-1648-1; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Markowitz GS, 2015, CLIN J AM SOC NEPHRO, V10, P1291, DOI 10.2215/CJN.00860115; Matsuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126413; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; Nakamura M, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0035-2; Pharmaceuticals and Medical Devices Agency, PHARM MEDICAL DEVICE; Sasaoka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164309; Sharma N, 2019, BIOMED PHARMACOTHER, V110, P764, DOI 10.1016/j.biopha.2018.12.018; Swan SK, 2000, ANN INTERN MED, V133, P1, DOI 10.7326/0003-4819-133-1-200007040-00002; Tamura MK, 2009, CURR OPIN NEPHROL HY, V18, P252, DOI 10.1097/MNH.0b013e328326f3ac; Thomas MC, 2000, MED J AUSTRALIA, V172, P184, DOI 10.5694/j.1326-5377.2000.tb125548.x; Whelton A, 2000, ARCH INTERN MED, V160, P1465, DOI 10.1001/archinte.160.10.1465; World Health Organization Collaborating Centre for Drug Statistics Methodology; Norwegian Institute of Public Health, ATC DDD IND; Yang Y, 2017, DRUG DES DEV THER, V11, P1291, DOI 10.2147/DDDT.S130568; Yue ZH, 2014, PHARMACOEPIDEM DR S, V23, P1154, DOI 10.1002/pds.3626; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263682	10.1371/journal.pone.0263682	http://dx.doi.org/10.1371/journal.pone.0263682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139129	Green Published, gold			2022-12-26	WOS:000821499100044
J	Rao, TC; Beggs, RR; Ankenbauer, KE; Hwang, J; Ma, VPY; Salaita, K; Bellis, SL; Mattheyses, AL				Rao, Tejeshwar C.; Beggs, Reena R.; Ankenbauer, Katherine E.; Hwang, Jihye; Ma, Victor Pui-Yan; Salaita, Khalid; Bellis, Susan L.; Mattheyses, Alexa L.			ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; PROTECTS TUMOR-CELLS; OVARIAN-CANCER; SIALIC-ACID; SIGNAL-TRANSDUCTION; TYROSINE KINASES; EGFR LIGANDS; CROSS-TALK; N-GLYCANS; INTEGRIN	Heterogeneity within the glycocalyx influences cell adhesion mechanics and signaling. However, the role of specific glycosylation subtypes in influencing cell mechanics via alterations of receptor function remains unexplored. It has been shown that the addition of sialic acid to terminal glycans impacts growth, development, and cancer progression. In addition, the sialyltransferase ST6Gal-I promotes epidermal growth factor receptor (EGFR) activity, and we have shown EGFR is an 'allosteric mechano-organizer' of integrin tension. Here, we investigated the impact of ST6Gal-I on cell mechanics. Using DNA-based tension gauge tether probes of variable thresholds, we found that high ST6Gal-I activity promotes increased integrin forces and spreading in Cos-7 and OVCAR3, OVCAR5, and OV4 cancer cells. Further, employing inhibitors and function-blocking antibodies against beta 1, beta 3, and beta 5 integrins and ST6Gal-I targets EGFR, tumor necrosis factor receptor, and Fas cell surface death receptor, we validated that the observed phenotypes are EGFR-specific. We found that while tension, contractility, and adhesion are extracellularsignal-regulated kinase pathway-dependent, spreading, proliferation, and invasion are phosphoinositide 3-kinase-Akt serine/threonine kinase dependent. Using total internal reflection fluorescence microscopy and flow cytometry, we also show that high ST6Gal-I activity leads to sustained EGFR membrane retention, making it a key regulator of cell mechanics. Our findings suggest a novel sialylation-dependent mechanism orchestrating cellular mechanics and enhancing cell motility via EGFR signaling.	[Rao, Tejeshwar C.; Beggs, Reena R.; Ankenbauer, Katherine E.; Hwang, Jihye; Bellis, Susan L.; Mattheyses, Alexa L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Ma, Victor Pui-Yan; Salaita, Khalid] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; Emory University	Mattheyses, AL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	mattheyses@uab.edu	Rao, Tejeshwar/AAI-9877-2020	Rao, Tejeshwar/0000-0002-3285-1630; Hwang, Jihye/0000-0001-8224-0240; Mattheyses, Alexa L/0000-0002-5119-7750; Salaita, Khalid/0000-0003-4138-3477	National Science Foundation (NSF) CAREER [1832100]; National Institutes of Health (NIH) [R01GM131099]; NIH [U01CA233581, R01CA225177]; National Cancer Institute (NCI) [K00CA223074]	National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding to A. L. M. from the National Science Foundation (NSF) CAREER (1832100), to A. L. M. and K. S. from the National Institutes of Health (NIH) (R01GM131099), to S. L. B. from the NIH (U01CA233581 and R01CA225177), and to V. P.-Y. M. from the National Cancer Institute (NCI) (K00CA223074). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Arkhipov A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003742; Blayney J. K., 2016, NUCLEIC; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Britain CM, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.014126; Britain CM, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0385-0; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Broders-Bondon F, 2018, J CELL BIOL, V217, P1571, DOI 10.1083/jcb.201701039; Buffone A, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910070; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Butler PJ, 2019, BIORHEOLOGY, V56, P101, DOI 10.3233/BIR-190212; Caldieri G, 2018, PROG MOL SUBCELL BIO, V57, P235, DOI 10.1007/978-3-319-96704-2_9; Carey SP, 2012, CRIT REV ONCOL HEMAT, V83, P170, DOI 10.1016/j.critrevonc.2011.11.005; Chen YF, 2017, MATRIX BIOL, V60-61, P70, DOI 10.1016/j.matbio.2016.07.002; Chiasson-MacKenzie C, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9473; Cooper J, 2019, CANCER CELL, V35, P347, DOI 10.1016/j.ccell.2019.01.007; Cornelison R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102171; Cosgun ZC, 2020, AM J PATHOL, V190, P732, DOI 10.1016/j.ajpath.2019.07.021; D'Addio M, 2020, GLYCOBIOLOGY, V30, P490, DOI 10.1093/glycob/cwaa008; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; Dorsett KA, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0574-5; Eberwein P, 2015, BBA-MOL CELL RES, V1853, P2183, DOI 10.1016/j.bbamcr.2015.06.004; Francavilla C, 2016, NAT STRUCT MOL BIOL, V23, P608, DOI 10.1038/nsmb.3218; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gargalionis AN, 2018, J CELL MOL MED, V22, P704, DOI 10.1111/jcmm.13452; Garnham R, 2019, ONCOL LETT, V18, P983, DOI 10.3892/ol.2019.10458; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Granovsky M, 2000, NAT MED, V6, P306; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphries JD, 2019, CURR OPIN CELL BIOL, V56, P14, DOI 10.1016/j.ceb.2018.08.004; Irani MA, 2017, PROTEINS, V85, P1529, DOI 10.1002/prot.25314; Jalal S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.220780; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jones RB, 2018, J BIOL CHEM, V293, P5659, DOI 10.1074/jbc.RA117.001194; Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.0.CO;2-4; Kanyo N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-80033-6; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kechagia JZ, 2019, NAT REV MOL CELL BIO, V20, P457, DOI 10.1038/s41580-019-0134-2; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Kuo JCH, 2018, NAT PHYS, V14, P658, DOI 10.1038/s41567-018-0186-9; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li D, 2012, ONCOTARGETS THER, V5, P271, DOI 10.2147/OTT.S35322; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Liu QQ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1208-x; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Ma VPY, 2016, ANGEW CHEM INT EDIT, V55, P5488, DOI 10.1002/anie.201600351; Makale Milan, 2007, Birth Defects Research, V81, P329, DOI 10.1002/bdrc.20110; Malinouski M, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4301, 10.1038/ncomms6167]; Monne HMS, 2013, BIOPHYS J, V104, p251A; Monteiro AI, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5045231; Mosayebi M, 2015, ACS NANO, V9, P11993, DOI 10.1021/acsnano.5b04726; Murugaesu N, 2014, CANCER DISCOV, V4, P304, DOI 10.1158/2159-8290.CD-13-0287; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Panciera T, 2020, NAT MATER, V19, P797, DOI 10.1038/s41563-020-0615-x; Park JJ, 2013, GUT LIVER, V7, P629, DOI 10.5009/gnl.2013.7.6.629; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Pavelka M., 2010, FUNCTIONAL ULTRASTRU, P164, DOI [10.1007/978-3-211-99390-3_86, DOI 10.1007/978-3-211-99390-3_86]; Pietrobono S, 2021, CANCERS, V13, DOI 10.3390/cancers13092014; Randles MJ, 2020, MATRIX BIOL, V90, P61, DOI 10.1016/j.matbio.2020.02.005; Rao TC, 2020, J CELL SCI, V133, DOI 10.1242/jcs.238840; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Salomon-Perzynski A, 2017, ARCH GYNECOL OBSTET, V295, P569, DOI 10.1007/s00404-017-4292-1; Samarzija I, 2020, CANCERS, V12, DOI 10.3390/cancers12071910; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Stuart AD, 2007, J GEN VIROL, V88, P177, DOI 10.1099/vir.0.82158-0; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Suzuki O, 2015, INT J ONCOL, V46, P973, DOI 10.3892/ijo.2015.2818; Swain PS, 2002, BIOPHYS J, V82, P2928, DOI 10.1016/S0006-3495(02)75633-6; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Tao Y, 2019, CYTOTECHNOLOGY, V71, P1155, DOI 10.1007/s10616-019-00352-z; Tee YH, 2015, NAT CELL BIOL, V17, P445, DOI 10.1038/ncb3137; Thomas JR, 2019, ESSAYS BIOCHEM, V63, P553, DOI 10.1042/EBC20190025; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vasudevan HN, 2016, CURR TOP DEV BIOL, V117, P393, DOI 10.1016/bs.ctdb.2015.10.016; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vlahovic G, 2003, ONCOLOGIST, V8, P531, DOI 10.1634/theoncologist.8-6-531; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Wang XF, 2015, BIOPHYS J, V109, P2259, DOI 10.1016/j.bpj.2015.10.029; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wei AW, 2016, ONCOTARGET, V7, P65374, DOI 10.18632/oncotarget.11699; Wichert B, 2018, GLYCOBIOLOGY, V28, P898, DOI 10.1093/glycob/cwy065; Wu YS, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.540332; Xie H., 1998, J CELL SCI; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang ZJ, 2018, GLYCOCONJUGATE J, V35, P139, DOI 10.1007/s10719-018-9820-0; Zhou XM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020273	113	4	4	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101726	10.1016/j.jbc.2022.101726	http://dx.doi.org/10.1016/j.jbc.2022.101726			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35157848	gold, Green Published			2022-12-26	WOS:000793694800006
J	Verma, G; Bowen, A; Gheibi, S; Hamilton, A; Muthukumar, S; Cataldo, LR; Asplund, O; Esguerra, J; Karagiannopoulos, A; Lyons, C; Cowan, E; Bellodi, C; Prasad, R; Fex, M; Mulder, H				Verma, Gaurav; Bowen, Alexander; Gheibi, Sevda; Hamilton, Alexander; Muthukumar, Sowndarya; Cataldo, Luis Rodrigo; Asplund, Olof; Esguerra, Jonathan; Karagiannopoulos, Alexandros; Lyons, Claire; Cowan, Elaine; Bellodi, Cristian; Prasad, Rashmi; Fex, Malin; Mulder, Hindrik			Ribosomal biogenesis regulator DIMT1 controls beta-cell protein synthesis, mitochondrial function, and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								We previously reported that loss of mitochondrial transcription factor B1 (TFB1M) leads to mitochondrial dysfunction and is involved in the pathogenesis of type 2 diabetes (T2D). Whether defects in ribosomal processing impact mitochondrial function and could play a pathogenetic role in beta-cells and T2D is not known. To this end, we explored expression and the functional role of dimethyladenosine transferase 1 homolog (DIMT1), a homolog of TFB1M and a ribosomal RNA (rRNA) methyltransferase implicated in the control of rRNA. Expression of DIMT1 was increased in human islets from T2D donors and correlated positively with expression of insulin mRNA, but negatively with insulin secretion. We show that silencing of DIMT1 in insulin-secreting cells impacted mitochondrial function, leading to lower expression of mitochondrial OXPHOS proteins, reduced oxygen consumption rate, dissipated mitochondrial membrane potential, and a slower rate of ATP production. In addition, the rate of protein synthesis was retarded upon DIMT1 deficiency. Consequently, we found that DIMT1 deficiency led to perturbed insulin secretion in rodent cell lines and islets, as well as in a human beta-cell line. We observed defects in rRNA processing and reduced interactions between NIN1 (RPN12) binding protein 1 homolog (NOB-1) and pescadillo ribosomal biogenesis factor 1 (PES-1), critical ribosomal subunit RNA proteins, the dysfunction of which may play a part in disturbing protein synthesis in beta-cells. In conclusion, DIMT1 deficiency perturbs protein synthesis, resulting in mitochondrial dysfunction and disrupted insulin secretion, both potential pathogenetic processes in T2D.	[Verma, Gaurav; Bowen, Alexander; Gheibi, Sevda; Hamilton, Alexander; Cataldo, Luis Rodrigo; Karagiannopoulos, Alexandros; Lyons, Claire; Cowan, Elaine; Prasad, Rashmi; Fex, Malin; Mulder, Hindrik] Lund Univ, Lund Univ Diabet Ctr, Malmo, Sweden; [Muthukumar, Sowndarya; Cowan, Elaine] Lund Univ, Fac Med, Lund Stem Cell Ctr, Dept Lab Med, Lund, Sweden; [Esguerra, Jonathan; Karagiannopoulos, Alexandros] Lund Univ Diabet Ctr, Unit Islet Cell Exocytosis, Malmo, Sweden; [Bellodi, Cristian; Prasad, Rashmi] Lund Univ Diabet Ctr, Unit Genom Diabet & Endocrinol, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University	Mulder, H (corresponding author), Lund Univ, Lund Univ Diabet Ctr, Malmo, Sweden.	hindrik.mulder@med.lu.se	Verma, Gaurav/F-5696-2015; Prasad, Rashmi B/GRJ-5491-2022; Bellodi, Cristian/N-2341-2015	Prasad, Rashmi B/0000-0002-4400-6741; Bellodi, Cristian/0000-0001-8047-5329; Muthukumar, Sowndarya/0000-0002-9110-722X; Cowan, Elaine/0000-0003-3939-8864; Mulder, Hindrik/0000-0002-6593-8417	European Unions Horizons 2020 Research and Innovation Program [667191]; Swedish Research Council [2009-1039]; LUDC-IRC [IRC15-0067]; LUDC [349-2006-237]	European Unions Horizons 2020 Research and Innovation Program; Swedish Research Council(Swedish Research CouncilEuropean Commission); LUDC-IRC; LUDC	The authors thank Lund University of Diabetes Centre, Lund University, Malmo, Sweden. The work is supported by European Unions Horizons 2020 Research and Innovation Program under grant agreement No. 667191. It was also funded by Swedish Research Council (Dnr 2009-1039) , LUDC-IRC (Dnr IRC15-0067) , and LUDC (349-2006-237) . Laila Jacobsson is acknowledged for providing all the laboratory facilities. The authors thank Peter Spegel for his input on the study.	Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Shanik M. H., 2008, PLOS BIOL, V8	3	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101692	10.1016/j.jbc.2022.101692	http://dx.doi.org/10.1016/j.jbc.2022.101692			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148993	Green Published, gold			2022-12-26	WOS:000789400700008
J	Lambraki, IA; Cousins, M; Graells, T; Leger, A; Henriksson, P; Harbarth, S; Troell, M; Wernli, D; Jorgensen, PS; Desbois, AP; Carson, CA; Parmley, EJ; Majowicz, SE				Lambraki, Irene Anna; Cousins, Melanie; Graells, Tiscar; Leger, Anais; Henriksson, Patrik; Harbarth, Stephan; Troell, Max; Wernli, Didier; Jorgensen, Peter Sogaard; Desbois, Andrew P.; Carson, Carolee A.; Parmley, Elizabeth Jane; Majowicz, Shannon Elizabeth			Factors influencing antimicrobial resistance in the European food system and potential leverage points for intervention: A participatory, One Health study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANIMALS; BACTERIA	Introduction Antimicrobial resistance (AMR) is a global crisis that evolves from a complex system of factors. Understanding what factors interact is key to finding solutions. Our objective was to identify the factors influencing AMR in the European food system and places to intervene. Materials and methods We conducted two workshops involving participants with diverse perspectives to identify the factors influencing AMR and leverage points (places) to target interventions. Transcripts were open coded for factors and connections, then transcribed into Vensim 8.0.4 to develop a causal loop diagram (CLD) and compute the number of feedback loops. Thematic analysis followed to describe AMR dynamics in Europe's food system and places for intervention. The CLD and themes were confirmed via participant feedback. Results Seventeen participants representing human, animal and agricultural sectors identified 91 CLD factors and 331 connections. Seven themes (e.g., social and economic conditions) describing AMR dynamics in Europe's food system, five 'overarching factors' that impact the entire CLD system (e.g., leadership) and fourteen places for intervention (e.g., consumer demand) emerged from workshop discussions. Most leverage points fell on highly networked feedback loops suggesting that intervening at these places may create unpredictable consequences. Conclusions Our study produced a CLD of factors influencing AMR in Europe's food system that implicates sectors across the One Health spectrum. The high connectivity between the CLD factors described by participants and our finding that factors are connected with many feedback mechanisms underscores the complexity of the AMR problem and the challenge with finding long-term solutions. Identifying factors and feedbacks helped identify relevant leverage points in the system. Some actions, such as government's setting AMU standards may be easier to implement. These actions in turn can support multi-pronged actions that can help redefine the vision, values and goals of the system to sustainably tackle AMR.	[Lambraki, Irene Anna; Cousins, Melanie; Majowicz, Shannon Elizabeth] Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada; [Graells, Tiscar; Jorgensen, Peter Sogaard] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden; [Graells, Tiscar; Henriksson, Patrik; Troell, Max; Jorgensen, Peter Sogaard] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Leger, Anais; Wernli, Didier] Univ Geneva, Global Studies Inst, Geneva, Switzerland; [Henriksson, Patrik; Troell, Max] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, Stockholm, Sweden; [Henriksson, Patrik] WorldFish, Jalan Batu Maung, Batu Maung, Penang, Malaysia; [Harbarth, Stephan] Geneva Univ Hosp, Infect Control Programme, Geneva, Switzerland; [Harbarth, Stephan] Geneva Univ Hosp, WHO Collaborating Ctr Patient Safety, Geneva, Switzerland; [Harbarth, Stephan] Fac Med, Geneva, Switzerland; [Desbois, Andrew P.] Univ Stirling, Inst Aquaculture, Stirling, Scotland; [Carson, Carolee A.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Parmley, Elizabeth Jane] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada	University of Waterloo; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Stockholm University; University of Geneva; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; CGIAR; Worldfish; University of Geneva; University of Geneva; World Health Organization; University of Geneva; University of Stirling; Public Health Agency of Canada; University of Guelph	Lambraki, IA (corresponding author), Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada.	ilambrak@uwaterloo.ca	; Graells, Tiscar/U-6347-2018	Lambraki, Irene/0000-0003-3011-2954; Majowicz, Shannon/0000-0002-0006-8369; Desbois, Andrew/0000-0001-6052-8761; Graells, Tiscar/0000-0002-2376-3559	Canadian Institutes for Health Research(Institute of Infection and Immunity, Institute of Population and Public Health) [155210]; Swedish Research Council [2017-05981]; Swiss National Science Foundation [40AR40_180189]	Canadian Institutes for Health Research(Institute of Infection and Immunity, Institute of Population and Public Health); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.This study is funded through an operating grant of the 5th Joint Programming Initiative on Antimicrobial Resistance (JPIAMR 2017). Funding was provided by an operating grant from the Canadian Institutes for Health Research(Institute of Infection and Immunity, Institute of Population and Public Health: https://cihr-irsc.gc.ca/e/193.html) (PI: SEM, grant number 155210); a Swedish Research Council grant (https://www.vr.se/english.html) (PI and project consortium coordinator: PSJ, grant number 2017-05981); and an operating grant from the Swiss National Science Foundation (https://www.snf.ch/en) (PI: DW, grant number 40AR40_180189).	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Abson DJ, 2017, AMBIO, V46, P30, DOI 10.1007/s13280-016-0800-y; Alividza V, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0459-7; Arif M, 2021, VET ANIM SCI, V14, DOI 10.1016/j.vas.2021.100216; Aziz Mousavi SMA, 2018, J APPL BIOTECHNOLOGY, V5, P48, DOI [DOI 10.29252/JABR.05.02.02, 10.29252/JABR.05.02.02]; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Collignon P, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030086; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Collignon P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116746; Council of Canadian Academies, 2019, ANT FAIL EXP PAN POT; da Costa PM, 2013, INT J ENV RES PUB HE, V10, P278, DOI 10.3390/ijerph10010278; Davis GS, 2015, CLIN INFECT DIS, V61, P892, DOI 10.1093/cid/civ428; FAO, 2018, FRONT SUSTAIN FOOD S; Finegood DT, 2021, INT J HEALTH POLICY, V10, P351, DOI 10.34172/ijhpm.2020.194; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Frost I, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz036; Henriksson PJG, 2018, SUSTAIN SCI, V13, P1105, DOI 10.1007/s11625-017-0511-8; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; IACG, 2019, NO TIM WAIT SEC FUT; Khani Soghra, 2012, Inflammation & Allergy Drug Targets, V11, P79; Kim D, 1994, SYSTEMS THINKING TOO; Littlejohns LB, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0394-x; MacFadden DR, 2018, NAT CLIM CHANGE, V8, P510, DOI 10.1038/s41558-018-0161-6; Machowska A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010027; Maedows D, 1999, LEVERAGE POINTS PLAC; Majowicz Shannon E, 2018, BMC Res Notes, V11, P170, DOI 10.1186/s13104-018-3279-8; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Robinson TP, 2016, T ROY SOC TROP MED H, V110, P377, DOI 10.1093/trstmh/trw048; Rossolini GM, 2021, DIAGN MICR INFEC DIS, V101, DOI 10.1016/j.diagmicrobio.2021.115512; Schmiege D, 2020, INT J HYG ENVIR HEAL, V226, DOI 10.1016/j.ijheh.2020.113497; Shallcross LJ, 2014, BRIT J GEN PRACT, V64, P604, DOI 10.3399/bjgp14X682561; Singer AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01728; Tang KL, 2017, LANCET PLANET HEALTH, V1, pE316, DOI 10.1016/S2542-5196(17)30141-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Towse A, 2017, HEALTH POLICY, V121, P1025, DOI 10.1016/j.healthpol.2017.07.011; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vandenbroeck P, 2007, FORESIGHT TACKLING O; Weese JS, 2015, J VET INTERN MED, V29, P487, DOI 10.1111/jvim.12562; Wernli D, 2020, LANCET INFECT DIS, V20, pE307, DOI 10.1016/S1473-3099(20)30392-3; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Zanichelli V, 2019, CLIN MICROBIOL INFEC, V25, P48, DOI 10.1016/j.cmi.2018.04.031	41	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263914	10.1371/journal.pone.0263914	http://dx.doi.org/10.1371/journal.pone.0263914			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192666	Green Published, gold			2022-12-26	WOS:000812552500032
J	Taniguchi, H; Nirengi, S; Ishihara, K; Sakane, N				Taniguchi, Hirokazu; Nirengi, Shinsuke; Ishihara, Kengo; Sakane, Naoki			Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus	PLOS ONE			English	Article							HEPATIC FAT-CONTENT; FGF21 LEVELS; METABOLIC SYNDROME; EXERCISE; OBESITY; MICE; BASAL	Introduction Fibroblast growth factor (FGF) 21 is an important regulator of glycemic control, but the association between circulating FGF21 and diabetic complications is poorly understood. Moreover, basal FGF21 secretion, especially in response to insulin dose, in patients with type 1 diabetes mellitus (T1DM), has not been well examined. Therefore, this study aimed to determine the association of circulating FGF21 levels with diabetic complications and insulin dosage in middle-aged and elderly patients with T1DM. Materials and methods A total of 127 middle-aged and elderly patients with T1DM, including 68 patients with diabetic complications, and 106 non-diabetic individuals were analyzed in this cross-sectional study. Information on demographic characteristics and T1DM was extracted from their electronic medical records. Serum FGF21 levels were determined using ELISA. Results Serum FGF21 levels were significantly lower in T1DM patients (75.2 [37.4-135.1] pg/mL) than in non-diabetic participants (151.6 [92.0-224.6] pg/mL; P < 0.001). No diabetic complications were associated with serum FGF21 concentrations. Both basal and bolus insulin doses were significantly and positively correlated with serum FGF21 levels (P < 0.05). Stepwise multiple regression analysis showed that FGF21 level was associated with age and body mass index (P < 0.05), while the basal insulin dose was an independent positive predictor of serum FGF21 levels (beta = 0.197, P = 0.032). Conclusions Circulating FGF21 levels are reduced in patients with T1DM; however, they are not associ- ated with diabetic complications. In addition, aging, obesity, and insulin dosage are positive determinants of circulating FGF21.	[Taniguchi, Hirokazu] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto, Japan; [Taniguchi, Hirokazu; Ishihara, Kengo] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nirengi, Shinsuke; Sakane, Naoki] Natl Hosp Org, Clin Res Inst, Div Prevent Med, Kyoto Med Ctr, Kyoto, Japan; [Nirengi, Shinsuke] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Kyoto Prefectural University; Ryukoku University; University System of Ohio; Ohio State University	Sakane, N (corresponding author), Natl Hosp Org, Clin Res Inst, Div Prevent Med, Kyoto Med Ctr, Kyoto, Japan.	nsakane@gf6.so-net.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K18244]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-inAid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17K18244, 2017-2019) to Hirokazu Taniguchi. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TREATMENT GUIDE DIAB; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294; Coate KC, 2017, CELL METAB, V25, P472, DOI 10.1016/j.cmet.2016.12.004; Domouzoglou EM, 2015, AM J PHYSIOL-HEART C, V309, pH1029, DOI 10.1152/ajpheart.00527.2015; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Eriksson O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235827; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Hanks LJ, 2015, J CLIN TRANSL ENDOCR, V2, P77, DOI 10.1016/j.jcte.2015.02.001; Hashidume T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28183; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lin ZF, 2012, J CLIN ENDOCR METAB, V97, pE1224, DOI 10.1210/jc.2012-1132; Malik FS, 2014, PEDIATR DRUGS, V16, P141, DOI 10.1007/s40272-014-0064-6; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Rask SR, 2019, ENDOCRINE, V65, P550, DOI 10.1007/s12020-019-02027-3; Samms RJ, 2017, J CLIN ENDOCR METAB, V102, P3806, DOI 10.1210/jc.2017-01257; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Staiger H, 2017, ENDOCR REV, V38, P468, DOI 10.1210/er.2017-00016; Strich D, 2017, J PEDIATR-US, V182, P133, DOI 10.1016/j.jpeds.2016.11.029; Taniguchi H, 2019, J NUTR SCI VITAMINOL, V65, P515, DOI 10.3177/jnsv.65.515; Taniguchi H, 2016, CLIN ENDOCRINOL, V85, P861, DOI 10.1111/cen.13162; Taniguchi H, 2016, J CLIN ENDOCR METAB, V101, P190, DOI 10.1210/jc.2015-3308; Taniguchi H, 2014, J CLIN ENDOCR METAB, V99, pE1877, DOI 10.1210/jc.2014-1877; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; Xiao Y, 2012, J CLIN ENDOCR METAB, V97, pE54, DOI 10.1210/jc.2011-1930; Xu PF, 2015, J DIABETES COMPLICAT, V29, P5, DOI 10.1016/j.jdiacomp.2014.10.001; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184; Zhang J, 2018, INT J BIOL SCI, V14, P1000, DOI 10.7150/ijbs.25026; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zibar K, 2015, ENDOCRINE, V48, P848, DOI 10.1007/s12020-014-0413-9	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263774	10.1371/journal.pone.0263774	http://dx.doi.org/10.1371/journal.pone.0263774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192641	gold, Green Published			2022-12-26	WOS:000812552500029
J	Lee, DC; Lee, SY; Jun, JH				Lee, Dong Cheol; Lee, Se Youp; Jun, Jong Hwa			Alterations of lower- and higher-order aberrations after unilateral horizontal rectus muscle surgery in children with intermittent exotropia: A retrospective cross-sectional study	PLOS ONE			English	Article							CORNEAL TOPOGRAPHIC CHANGES; STRABISMUS SURGERY; REFRACTIVE CHANGES; THICKNESS; ASTIGMATISM; PREVALENCE; RECESSION; MYOPIA	Background This retrospective, cross-sectional study investigated changes in corneal lower- and higher-order aberrations that cause visual disturbance after lateral rectus recession and medial rectus resection in children. Methods Eighty-five eyes of 85 patients ( 44 boys; 8.64 +/- 2.88 years) who underwent lateral rectus recession and medial rectus resection to correct intermittent exotropia were assessed. The Galilei G4 Dual Scheimpflug Analyzer was used for wavefront analysis. Risk factors (age, sex, amount of surgery, preoperative axial length, preoperative intraocular pressure) were determined. Outcome measures included simulated and ray-tracing mode keratometry with secondary defocus, oblique, and vertical astigmatism (for lower-order aberrations) and the root mean square, 3rd-order vertical and horizontal coma, oblique and horizontal trefoil, 4th-order spherical aberration, oblique and vertical secondary astigmatism, and oblique and vertical quadrafoil (2nd - 8th sums) (for higher-order aberrations). Results Myopic with-the-rule changes in low-order aberrations and increases in simulated and ray-tracing mode keratometry during the 3 months following lateral rectus recession and medial rectus resection were attributed to muscle healing and stability changes. High-order aberrations altered in the week following surgery almost returned to normal within 3 months. Axial length, the amount of surgery, age, and sex affected astigmatism due to differences in patients' scleral states. Conclusions Clinicians should consider changes in high-order aberrations of young individuals who underwent lateral rectus recession and medial rectus resection and may not be able to verbalize changes in vision.	[Lee, Dong Cheol; Lee, Se Youp; Jun, Jong Hwa] Keimyung Univ, Sch Med, Dept Ophthalmol, Daegu, South Korea	Keimyung University	Jun, JH (corresponding author), Keimyung Univ, Sch Med, Dept Ophthalmol, Daegu, South Korea.	junjonghwa@gmail.com			Keimyung University	Keimyung University	This study was supported by the Bisa Research Grant of Keimyung University in 2020 (no URL; no grant number, recipient: DCL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri A, 2003, J AAPOS, V7, P42, DOI 10.1016/S1091-8531(02)42007-1; Brum GS, 2011, ARQ BRAS OFTALMOL, V74, P24, DOI 10.1590/S0004-27492011000100006; Buckhurst HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132902; Chougule P, 2019, BMJ OPEN OPHTHALMOL, V4, DOI 10.1136/bmjophth-2018-000243; DENIS D, 1995, OPHTHALMOLOGICA, V209, P136, DOI 10.1159/000310599; Fix A, 1985, AM ORTHOPT J, V35, P59; Guirao A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1143; Hainsworth DP, 1999, J AAPOS, V3, P80, DOI 10.1016/S1091-8531(99)70074-1; Hong Seung Woo, 2012, Korean J Ophthalmol, V26, P438, DOI 10.3341/kjo.2012.26.6.438; Killer HE, 1999, OPHTHALMOLOGICA, V213, P209, DOI 10.1159/000027422; KWITKO S, 1992, CORNEA, V11, P36, DOI 10.1097/00003226-199201000-00005; Loman J, 2002, OPHTHALMOLOGY, V109, P1032, DOI 10.1016/S0161-6420(02)01012-6; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Miller JM, 2015, J AAPOS, V19, P352, DOI 10.1016/j.jaapos.2015.05.004; Mohamed-Noor J, 2009, J GLAUCOMA, V18, P32, DOI 10.1097/IJG.0b013e31816b2fd1; Nardi M, 1997, J PEDIAT OPHTH STRAB, V34, P244; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Oshika T, 2005, AM J OPHTHALMOL, V140, P744, DOI 10.1016/j.ajo.2005.04.026; Prakash G, 2011, ACTA OPHTHALMOL, V89, pe257, DOI 10.1111/j.1755-3768.2009.01804.x; PRESLAN MW, 1992, J PEDIATR OPHTHALMOL, V29, P300; Rajavi Zhale, 2008, International Ophthalmology, V28, P83, DOI 10.1007/s10792-007-9116-z; Read SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33796; Schlatter B, 2015, J CATARACT REFR SURG, V41, P1073, DOI 10.1016/j.jcrs.2014.08.035; SIRETEANU R, 1982, VISION RES, V22, P889, DOI 10.1016/0042-6989(82)90025-6; Siso-Fuertes I, 2015, J CATARACT REFR SURG, V41, P981, DOI 10.1016/j.jcrs.2014.08.038; SNIR M, 1989, OPHTHALMIC SURG LAS, V20, P57; Vincent SJ, 2012, VISION RES, V66, P39, DOI 10.1016/j.visres.2012.06.016; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692	28	0	0	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264037	10.1371/journal.pone.0264037	http://dx.doi.org/10.1371/journal.pone.0264037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176076	gold, Green Published			2022-12-26	WOS:000777505200067
J	Silva, EPE; Moraes, EP; Anaya, K; Silva, YMO; Lopes, HAP; Neto, JCA; Oliveira, JPF; Oliveira, JB; Rangel, AHN				Silva, Emmanuelle P. E.; Moraes, Edgar P.; Anaya, Katya; Silva, Yhelda M. O.; Lopes, Heloysa A. P.; Neto, Julio C. Andrade; Oliveira, Juliana P. F.; Oliveira, Josenalde B.; Rangel, Adriano H. N.			Lactoperoxidase potential in diagnosing subclinical mastitis in cows via image processing	PLOS ONE			English	Article							SOMATIC-CELL COUNT; MICROFLUIDIC DEVICES; REAL-TIME; MILK; QUALITY; CHEESE; SYSTEM; CAMERA; ASSAY	This report describes how image processing harnessed to multivariate analysis techniques can be used as a bio-analytical tool for mastitis screening in cows using milk samples collected from 48 animals (32 from Jersey, 7 from Gir, and 9 from Guzerat cow breeds), totalizing a dataset of 144 sequential images was collected and analyzed. In this context, this methodology was developed based on the lactoperoxidase activity to assess mastitis using recorded images of a cuvette during a simple experiment and subsequent image treatments with an R statistics platform. The color of the sample changed from white to brown upon its exposure to reagents, which is a consequence of lactoperoxidase enzymatic reaction. Data analysis was performed to extract the channels from the RGB (Red-Green-Blue) color system, where the resulting dataset was evaluated with Principal Component Analysis (PCA), Multiple Linear Regression (MLR), and Second-Order Regression (SO). Interesting results in terms of enzymatic activity correlation (R-2 = 0.96 and R-2 = 0.98 by MLR and SO, respectively) and of somatic cell count (R-2 = 0.97 and R-2 = 0.99 by MLR and SO, respectively), important mastitis indicators, were obtained using this simple method. Additionally, potential advantages can be accessed such as quality control of the dairy chain, easier bovine mastitis prognosis, lower cost, analytical frequency, and could serve as an evaluative parameter to verify the health of the mammary gland.	[Silva, Emmanuelle P. E.; Silva, Yhelda M. O.; Lopes, Heloysa A. P.; Rangel, Adriano H. N.] Univ Fed Rio Grande do Norte, Postgrad Program Anim Prod, Macaiba, RN, Brazil; [Moraes, Edgar P.] Univ Fed Rio Grande do Norte, Inst Chem, Natal, RN, Brazil; [Anaya, Katya] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, RN, Brazil; [Neto, Julio C. Andrade; Oliveira, Josenalde B.] Fed Univ Rio Grande Norte UFRN, Acad Unit Specialized Agr Sci, Macaiba, RN, Brazil; [Oliveira, Juliana P. F.] Fed Rural Univ Campina Grande, Rural Hlth & Technol Ctr, Patos de Minas, Paraiba, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Oliveira, JPF (corresponding author), Fed Rural Univ Campina Grande, Rural Hlth & Technol Ctr, Patos de Minas, Paraiba, Brazil.	jupaula.oliv@yahoo.com.br	Moraes, Edgar P/E-2539-2014; OLIVEIRA, JOSENALDE/D-4092-2011	Anaya, Katya/0000-0002-4394-7777; Paula Felipe de Oliveira, Juliana/0000-0001-9005-5272; OLIVEIRA, JOSENALDE/0000-0001-8297-9678; PERIN MORAES, EDGAR/0000-0002-1998-8042	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett NE, 1999, J DAIRY RES, V66, P73, DOI 10.1017/S0022029998003252; Bergmeyer H. U., METHODS ENZYMATIC AN, V1083, P286; Blel M, 2001, INT DAIRY J, V11, P795, DOI 10.1016/S0958-6946(01)00106-6; Bobbo T, 2017, J DAIRY SCI, V100, P4868, DOI 10.3168/jds.2016-12353; Che HX, 2015, J ZHEJIANG UNIV-SC B, V16, P672, DOI 10.1631/jzus.B1400359; Chinnappan R, 2017, ANAL BIOCHEM, V523, P58, DOI 10.1016/j.ab.2017.02.009; de Souza FR, 2014, QUIM NOVA, V37, P1171, DOI 10.5935/0100-4042.20140189; De Vliegher S, 2018, J INTEGR AGR, V17, P1214, DOI 10.1016/S2095-3119(17)61893-8; Ferrero FJ, 2014, MEASUREMENT, V47, P855, DOI 10.1016/j.measurement.2013.10.015; Figueredo F, 2016, ACS APPL MATER INTER, V8, P11, DOI 10.1021/acsami.5b10027; Garcia PT, 2017, ANAL CHIM ACTA, V974, P69, DOI 10.1016/j.aca.2017.04.040; Hibbert DB, 2016, PURE APPL CHEM, V88, P407, DOI 10.1515/pac-2015-0605; Huang YM, 2016, J TAIWAN INST CHEM E, V62, P39, DOI 10.1016/j.jtice.2016.01.030; Isobe N, 2011, J DAIRY SCI, V94, P3868, DOI 10.3168/jds.2010-4133; Kim B, 2017, TALANTA, V170, P238, DOI 10.1016/j.talanta.2017.04.014; Kim H, 2019, COMPUT ELECTRON AGR, V162, P119, DOI 10.1016/j.compag.2019.04.004; Korhonen H, 1995, BOVINE UDDER MASTITI, P76; Kumar R, 1999, LAIT, V79, P269, DOI 10.1051/lait:1999222; Kussendrager KD, 2000, BRIT J NUTR, V84, pS19, DOI 10.1155/2014/517164; Langoni H, 2015, PESQUI VET BRASIL, V35, P518, DOI 10.1590/S0100-736X2015000600005; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Magro G, 2017, RES VET SCI, V114, P44, DOI 10.1016/j.rvsc.2017.03.002; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; de Morais CDM, 2014, TALANTA, V126, P145, DOI 10.1016/j.talanta.2014.03.066; Moraes EP, 2014, J CHEM EDUC, V91, P1958, DOI 10.1021/ed400797k; Nogueira SA, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8050139; Oliveira KA, 2016, ANAL METHODS-UK, V8, P6506, DOI 10.1039/c6ay01262k; Panchuk V, 2018, ANAL CHIM ACTA, V1040, P19, DOI 10.1016/j.aca.2018.05.023; Petrou M, 2010, IMAGE PROCESSING FUN; Resmini P., 1985, RIV SOC ITAL SCI ALI, V14, P187; Ubaldo JCSR, 2015, FOOD CHEM, V178, P229, DOI 10.1016/j.foodchem.2015.01.084; Seifu E, 2005, TRENDS FOOD SCI TECH, V16, P137, DOI 10.1016/j.tifs.2004.11.002; Shamila-Syuhada AK, 2016, INT DAIRY J, V61, P120, DOI 10.1016/j.idairyj.2016.05.002; Smallman L, 2018, PATTERN RECOGN, V83, P443, DOI 10.1016/j.patcog.2018.06.014; Taffarel LE, 2015, SEMIN-CIENC AGRAR, V36, P2287, DOI 10.5433/1679-0359.2015v36n3Supl1p2287; Takahashi Fabio Henrique, 2012, Ciencia Animal Brasileira, V13, P99, DOI 10.5216/cab.v13i1.14870; Trujillo AJ, 2007, SMALL RUMINANT RES, V67, P243, DOI 10.1016/j.smallrumres.2005.10.013; Urtasun N, 2017, FOOD BIOPROD PROCESS, V103, P58, DOI 10.1016/j.fbp.2017.02.011; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h; Zhang XD, 2020, COMPUT ELECTRON AGR, V178, DOI 10.1016/j.compag.2020.105754; Zhuang XL, 2019, BIOSYST ENG, V179, P106, DOI 10.1016/j.biosystemseng.2019.01.003	41	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263714	10.1371/journal.pone.0263714	http://dx.doi.org/10.1371/journal.pone.0263714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176036	Green Published, gold			2022-12-26	WOS:000777505200029
J	Chowdhury, HA; Paromita, P; Mayaboti, CA; Rakhshanda, S; Rahman, FN; Abedin, M; Rahman, AKMF; Mashreky, SR				Chowdhury, Hasina Akhter; Paromita, Progga; Mayaboti, Cinderella Akbar; Rakhshanda, Shagoofa; Rahman, Farah Naz; Abedin, Minhazul; Rahman, A. K. M. Fazlur; Mashreky, Saidur Rahman			Assessing service availability and readiness of healthcare facilities to manage diabetes mellitus in Bangladesh: Findings from a nationwide survey	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; COMPLICATIONS; HYPERTENSION	Introduction Diabetes Mellitus (DM) is one of the most prevalent non-communicable diseases (NCDs)as well as a major cause of morbidity and mortality worldwide. Around 80% diabetic patients live in low- and middle-income countries. In Bangladesh, there is a scarcity of data on the quality of DM management within health facilities. This study aims to describe service availability and readiness for DM at all tiers of health facilities using the World Health Organization's (WHO) Service Availability and Readiness Assessment (SARA) standard tool. Methods This cross-sectional survey was conducted in 266 health facilities all across Bangladesh using the WHO SARA standard tool. Descriptive analyses for the availability of DM services was carried out. Composite scores for facility readiness index (RI) were calculated in four domains: staff and guideline, basic equipment, diagnostic capacity, and essential medicines. Indices were stratified by facility level and a cut off value of 70% was considered as `ready' to manage diabetes at each facility level. Results The mean RI score of tertiary and specialized hospitals was above the cutoff value of 70% (RI: 79%), whereas for District Hospitals (DHs), Upazila Health Complexes (UHCs) and NGO and Private hospitals the RI scores were other levels of 65%, 51% and 62% respectively. This indicating that only the tertiary level of health facilities was ready to manage DM. However, it has been observed that the RI scores of the essential medicine domain was low at all levels of health facilities including tertiary-level. Conclusions The study revealed only tertiary level facilities were ready to manage DM. However, like other facilities, they require an adequate supply of essential medicines. Alongside the inadequate supply of medicines, shortage of trained staff and unavailability of guidelines on the diagnosis and treatment of DM also contributed to the low RI score for rest of the facilities.	[Chowdhury, Hasina Akhter; Mayaboti, Cinderella Akbar; Rakhshanda, Shagoofa; Rahman, Farah Naz; Abedin, Minhazul; Rahman, A. K. M. Fazlur; Mashreky, Saidur Rahman] Ctr Injury Prevent & Res Bangladesh CIPRB, Dhaka, Bangladesh; [Chowdhury, Hasina Akhter] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Paromita, Progga] Kirtipasha Hlth & Family Welf Ctr, Jhalokathi Sadar Upazila, Barishal, Bangladesh; [Mashreky, Saidur Rahman] Bangladesh Univ Hlth Sci BUNS, Dept Noncommunicable Dis, Dhaka, Bangladesh	Monash University	Chowdhury, HA (corresponding author), Ctr Injury Prevent & Res Bangladesh CIPRB, Dhaka, Bangladesh.; Chowdhury, HA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	hachowdhury01@gmail.com	; Mashreky, Saidur/N-9113-2017	Rahman, Farah Naz/0000-0002-2265-2742; Mashreky, Saidur/0000-0001-7892-798X; Abedin, Minhazul/0000-0002-7667-9270	Directorate General of Health Services (DGHS) of Bangladesh [DGHS/LD/NCDC/Procurement Plan/GOB (Service)/2017-18/539 Sp-02]	Directorate General of Health Services (DGHS) of Bangladesh	The study was funded by Directorate General of Health Services (DGHS) of Bangladesh. Reference Number: DGHS/LD/NCDC/Procurement Plan/GOB (Service)/2017-18/539 Sp-02. Prof AKM Fazlur Rahman as the Principal Investigator received the fund. DGHS provided technical support during the implementation of the study.	Afroz A, 2019, DIABETES METAB SYND, V13, P2939, DOI 10.1016/j.dsx.2019.07.046; Ahmed S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-1987-8; Ahmed SM, 2015, BANGLADESH HLTH SYST; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Alam D., 2013, HLTH SYSTEMS PREPARE, P1; [Anonymous], 2016, BANGL ESS HLTH SERV; [Anonymous], HLTH NUTR POPULATION; [Anonymous], HLTH SERVICES DEV; Simao CCAL, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/1709807; Bekele A, 2017, ETHIOP J HEALTH DEV, V31, P110; Biswas T, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022817; Biswas T, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4494-2; Elias Maya Annie, 2017, BMJ Glob Health, V2, pe000519, DOI 10.1136/bmjgh-2017-000519; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gabert R, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2796-9; International Diabetes Foundation (IDF), IDF ATL 2019, V9 th; Joarder Taufique, 2019, Psyche (Camb Mass), V2019, P4954095, DOI 10.1155/2019/4954095; Kabir A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-051961; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Latif ZA., 2017, BIRDEM MEDICAL JOURN, V7; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Mutale W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200994; O'Neill K, 2013, B WORLD HEALTH ORGAN, V91, P923, DOI 10.2471/BLT.12.116798; Paromita P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247700; Radwan M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021195; Rakhshanda S, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08387-2; Rawal LB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029562; Rogers HE, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3426-x; Shah A, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0476-5; Spiegel DA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014496; Stringer JSA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S7; Suwattee P, 2003, DIABETES CARE, V26, P563, DOI 10.2337/diacare.26.3.563; The TOF, 2011, HIN STRAT PLAN HLTH; Wood R, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.838; Zaman M., 2016, CHRONIC DIS INT, V3, P1021	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263259	10.1371/journal.pone.0263259	http://dx.doi.org/10.1371/journal.pone.0263259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171912	Green Published, gold			2022-12-26	WOS:000795889700017
J	Kunaseth, J; Waiyaput, W; Chanchaem, P; Sawaswong, V; Permpech, R; Payungporn, S; Sophonsritsuk, A				Kunaseth, Jitsupa; Waiyaput, Wanwisa; Chanchaem, Prangwalai; Sawaswong, Vorthon; Permpech, Rattana; Payungporn, Sunchai; Sophonsritsuk, Areepan			Vaginal microbiome of women with adenomyosis: A case-control study	PLOS ONE			English	Article							ENDOMETRIOSIS; PATHOGENESIS; DIVERSITY; INFECTION; UPDATE; HEALTH; TRACT	Immune dysregulation can involve invasion and survival of endometrial glands inside the myometrium of the adenomyosis. There is limited available data concerning alterations of the bacterial microbiome in the reproductive tract of adenomyosis women. The present cross-sectional age-matched study aims to compare vaginal microbiota between women with and without adenomyosis. We recruited women with adenomyosis (N = 40) and age-matched women without adenomyosis (N = 40) from the Departments of Obstetrics and Gynaecology, Ramathibodi Hospital Mahidol University, from August 2020 to January 2021. Vaginal swab samples were collected from the participants. DNA isolation and bacterial 16s rDNA gene sequencing and data analyses were then performed. Comparison of the diversity of vaginal microbiota, microbiota composition, and the operational taxonomic unit (OTU) between adenomyosis and non-adenomyosis (control) groups were undertaken. Data from 40 and 38 women with and without adenomyosis, respectively, were analyzed. Alpha-diversity analysis (Chao1 index) at the species level showed higher vaginal microbial richness in the adenomyosis group when compared with the control group (p = 0.006). The linear discriminant analysis effect size technique (LeFSe) indicated an elevated abundance of several vaginal microbial taxa in the adenomyosis group, including Alloscardovia, Oscillospirales, Ruminoccoccaceae, UCG_002, Oscillospiraceae, Enhydrobacter, Megamonas, Moraxellaceae, Subdoligranulum, Selenomonadaceae, and Faecalibacterium. On the other hand, an increase in the abundance of Megaspehera, Fastidiosipila, Hungateiclostridiaceae, and Clostridia was identified in the control group. Vaginal community state type (CST)-III and -IV were dominated in adenomyosis, while only CST-IV was dominated in the non-adenomyosis group. Lactobacillus was the most abundant vaginal microbial in both groups. In this study, the differences in vaginal microbiome profile were noted between adenomyosis and non-adenomyosis group. The increasing of microbial richness was associated with adenomyosis. Nevertheless, further investigations were required to elucidate the mechanisms and apply them for clinical implications.	[Kunaseth, Jitsupa; Sophonsritsuk, Areepan] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Obstet & Gynaecol,Reprod Endocrinol & Infert, Bangkok, Thailand; [Waiyaput, Wanwisa] Mahidol Univ, Fac Med, Off Res Acad & Innovat, Ramathibodi Hosp, Bangkok, Thailand; [Chanchaem, Prangwalai; Sawaswong, Vorthon; Payungporn, Sunchai] Chulalongkorn Univ, Res Unit Syst Microbiol, Bangkok, Thailand; [Sawaswong, Vorthon] Chulalongkorn Univ, Grad Sch, Program Bioinformat & Computat Biol, Bangkok, Thailand; [Permpech, Rattana] Mahidol Univ, Fac Med, Dept Ramathibodi Nursing Serv, Perioperat Nursing Div,Ramathibodi Hosp, Bangkok, Thailand; [Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok, Thailand	Mahidol University; Mahidol University; Chulalongkorn University; Chulalongkorn University; Mahidol University; Chulalongkorn University	Sophonsritsuk, A (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Obstet & Gynaecol,Reprod Endocrinol & Infert, Bangkok, Thailand.; Payungporn, S (corresponding author), Chulalongkorn Univ, Res Unit Syst Microbiol, Bangkok, Thailand.; Payungporn, S (corresponding author), Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok, Thailand.	sp.medbiochemcu@gmail.com; areepan.sop@mahidol.ac.th			Faculty of Medicine, Ramathibodi Hospital, Mahidol University [RF_63085]	Faculty of Medicine, Ramathibodi Hospital, Mahidol University	The study was financially supported by the Faculty of Medicine, Ramathibodi Hospital, Mahidol University (project number RF_63085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 2011, ADV EXP MED BIOL, V697, P107, DOI 10.1007/978-1-4419-7185-2_9; Al-Memar M, 2020, BJOG-INT J OBSTET GY, V127, P264, DOI 10.1111/1471-0528.15972; Aleshkin Vladimir A., 2006, Microbial Ecology in Health and Disease, V18, P71, DOI 10.1080/17482960600891473; Allaband C, 2019, CLIN GASTROENTEROL H, V17, P218, DOI 10.1016/j.cgh.2018.09.017; Ata B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39700-6; Barrientos-Duran A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020419; Bayigga L, 2019, AM J OBSTET GYNECOL, V220, P155, DOI 10.1016/j.ajog.2018.10.014; Bernabeu A, 2019, J ASSIST REPROD GEN, V36, P2111, DOI 10.1007/s10815-019-01564-0; Bharti R, 2021, BRIEF BIOINFORM, V22, P178, DOI 10.1093/bib/bbz155; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brown RG, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0999-x; Ceccarani C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50410-x; Chao XP, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-4586; Chapron C, 2020, HUM REPROD UPDATE, V26, P392, DOI 10.1093/humupd/dmz049; Chee WJY, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01464-4; Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00901-0; Chen SK, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-1309; Cobo T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55611-y; Diop K., 2019, HUM MICROB J, V11, P100051, DOI [10.1016/j.humic.2018.11.002, DOI 10.1016/J.HUMIC.2018.11.002]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Freitas AC, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0502-8; Fu M, 2020, MBIO, V11, DOI 10.1128/mBio.03242-19; Garcia EM, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00646-18; Garcia-Solares J, 2018, FERTIL STERIL, V109, P371, DOI 10.1016/j.fertnstert.2017.12.030; Habiba M., 2016, UTERINE ADENOMYOSIS, P45; Hernandes C, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030163; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Huang B, 2014, CLIN LAB MED, V34, P747, DOI 10.1016/j.cll.2014.08.006; Huang P, 2020, GYNECOL ENDOCRINOL, V36, P605, DOI 10.1080/09513590.2020.1754788; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Jefferson KK, 2019, J PERINATOL, V39, P824, DOI 10.1038/s41372-019-0343-8; Jiang CX, 2016, GYNECOL MINIM INVASI, V5, P137, DOI 10.1016/j.gmit.2016.06.002; Li YY, 2020, INFECT DRUG RESIST, V13, P1213, DOI 10.2147/IDR.S210615; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Ma DW, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz025; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Mendling W, 2016, LABORATORIUMSMEDIZIN, V40, P239, DOI 10.1515/labmed-2016-0011; Mitra A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0203-0; Moore RJ, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0033-2018; Muhleisen AL, 2016, MATURITAS, V91, P42, DOI 10.1016/j.maturitas.2016.05.015; Orazov MR, 2017, GYNECOL ENDOCRINOL, V33, P44, DOI 10.1080/09513590.2017.1399696; Ota H, 1998, HUM REPROD UPDATE, V4, P360, DOI 10.1093/humupd/4.4.360; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrova MI, 2017, TRENDS MICROBIOL, V25, P182, DOI 10.1016/j.tim.2016.11.007; Qu H, 2020, REPROD SCI, V27, P1276, DOI 10.1007/s43032-019-00127-z; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sirichoat A, 2018, PEERJ, V6, DOI 10.7717/peerj.5977; Sirivongrangson P, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00362-8; Stapleton AE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0025-2016; Tremellen KP, 2012, J REPROD IMMUNOL, V93, P58, DOI 10.1016/j.jri.2011.12.001; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; Vannuccini S, 2017, REPROD BIOMED ONLINE, V35, P592, DOI 10.1016/j.rbmo.2017.06.016; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zevin AS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005889; Zhai JY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00716; Zhang F, 2019, EXP THER MED, V17, P3307, DOI 10.3892/etm.2019.7337; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; Ziklo N, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00001	63	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263283	10.1371/journal.pone.0263283	http://dx.doi.org/10.1371/journal.pone.0263283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171931	Green Published, gold			2022-12-26	WOS:000795889700019
J	Giese-Kraft, K; Jung, K; Schlueter, N; Vach, K; Ganss, C				Giese-Kraft, Katja; Jung, Katja; Schlueter, Nadine; Vach, Kirstin; Ganss, Carolina			Detecting and monitoring dental plaque levels with digital 2D and 3D imaging techniques	PLOS ONE			English	Article							QUANTIFICATION	Detecting and monitoring dental plaque is an important issue in research and clinical practice. In this context, new digital imaging methods that permit permanent documentation of the clinical findings could be promising tools. The aim of the study was therefore to investigate whether disclosed plaque can be reliably visualised on 2D and 3D images captured with digital intraoral imaging devices. Clinical examination was the reference method. Twenty subjects (27.5 +/- 1.2 years) were included and plaque was measured at three different stages: habitual plaque (T1), after 72 h without oral hygiene (T2) and after a subsequent habitual brushing exercise (T3). At each time point, plaque was disclosed followed by the clinical examination and capturing the 2D and 3D images (intraoral-camera CS 1500 and intraoral-scanner CS 3600; Carestream Dental, Germany). Plaque amounts were recorded on oral and vestibular surfaces of the Ramfjord-teeth (16, 21, 24, 36, 41, 44) using the Rustogi-modified-Navy-Plaque-Index (RMNPI) and expressed as percentage of plaque-containing RMNPI areas of all RMNPI areas. At T1, percentages (mean +/- SD) obtained from the clinical examination, 2D and 3D images were 62.2 +/- 10.6, 65.1 +/- 10.0 and 64.4 +/- 10.6 resp. increasing to 76.9 +/- 8.0, 77.9 +/- 8.6 and 77.5 +/- 9.4 resp. at T2. After toothbrushing (T3), values decreased to 56.3 +/- 11.1, 58.2 +/- 12.1 and 61.2 +/- 10.8 resp. All methods were able to show statistically significant changes in plaque amounts at the different time points with in part statistically significant but minor differences between them. The Bland-Altmann analysis revealed a good agreement between values from both 2D and 3D images with the clinical examination. The agreement of the scores obtained with the both image-based methods for the single RMNPI areas with the clinical examination was mainly classified as substantial to almost perfect. Amounts of plaque can be reliably detected and monitored on 2D images from an intraoral camera and on 3D images from an intraoral scanner.	[Giese-Kraft, Katja; Jung, Katja; Ganss, Carolina] Justus Liebig Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, Giessen, Germany; [Schlueter, Nadine] Univ Freiburg, Div Cariol, Fac Med, Ctr Dent Med,Dept Operat Dent & Periodontol,Med C, Freiburg, Germany; [Vach, Kirstin] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Freiburg, Germany; [Vach, Kirstin] Univ Freiburg, Med Ctr, Freiburg, Germany	Justus Liebig University Giessen; University of Freiburg; University of Freiburg; University of Freiburg	Giese-Kraft, K (corresponding author), Justus Liebig Univ Giessen, Dept Conservat & Prevent Dent, Dent Clin, Giessen, Germany.	katja.giese-kraft@dentist.uni-giessen.de	Vach, Kirstin/GQP-0449-2022; Vach, Kirstin/AAI-4643-2020	Vach, Kirstin/0000-0001-9278-2203; Vach, Kirstin/0000-0001-9278-2203				Bernabe E, 2020, J DENT RES, V99, P362, DOI 10.1177/0022034520908533; C G, 2020, PHOTODIAGN PHOTODYN, V32, DOI 10.1016/j.pdpdt.2020.102063; Carter K, 2004, J DENT, V32, P623, DOI 10.1016/j.jdent.2004.06.006; Doi K, 2021, J ORAL SCI, V63, P292, DOI 10.2334/josnusd.21-0048; FISCHMAN SL, 1986, J CLIN PERIODONTOL, V13, P371, DOI 10.1111/j.1600-051X.1986.tb01475.x; GOLDBERG P, 1985, COMMUNITY DENT ORAL, V13, P44, DOI 10.1111/j.1600-0528.1985.tb00419.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marro F, 2020, J DENT, V93, DOI 10.1016/j.jdent.2020.103282; Michou S, 2020, J DENT, V100, DOI 10.1016/j.jdent.2020.103445; Pretty IA, 2005, J DENT, V33, P193, DOI 10.1016/j.jdent.2004.10.017; Ramfjord S, 1959, J PERIODONTOL, V30, P51, DOI [10.1902/jop.1959.30.1.51, DOI 10.1902/JOP.1959.30.1.51]; Rustogi Kedar N., 1992, Journal of Clinical Dentistry, V3, pC9; Smith RN, 2006, J PERIODONTAL RES, V41, P55, DOI 10.1111/j.1600-0765.2005.00841.x; Tran DT, 2013, J CLIN PERIODONTOL, V40, P1064, DOI 10.1111/jcpe.12165; Volgenant CMC, 2016, CLIN ORAL INVEST, V20, P2551, DOI 10.1007/s00784-016-1761-z; You WZ, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01114-6	16	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263722	10.1371/journal.pone.0263722	http://dx.doi.org/10.1371/journal.pone.0263722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167618	Green Published, gold			2022-12-26	WOS:000802227200016
J	Limenie, AA; Dugul, TT; Eshetu, EM				Limenie, Abebaye Aragaw; Dugul, Tesfaye Tolessa; Eshetu, Eyasu Mekonnen			Effects of Catha Edulis Forsk on spatial learning, memory and correlation with serum electrolytes in wild-type male white albino rats	PLOS ONE			English	Article							KHAT; HYPONATREMIA; AMPHETAMINE; STRESS; IMPAIRMENT; DEPRESSION; POTASSIUM; ANXIETY; WOMEN	Background The burdens of psychostimulant use disorders are becoming a worldwide problem. One of the psychostimulants widely consumed in Ethiopia and East African countries is Catha adults Forsk (khat). However, no studies have been conducted on the cognitive effects of khat and its correlation with serum electrolytes. The present study was aimed to evaluate the effects of khat on spatial learning and memory and their correlation with serum electrolytes. Materials and methods Diethyl ether and chloroform (3:1v/v ratio) were solvents used to obtain the crude khat extract in this study. T80W was used to prepare the khat juice, fresh khat leave extract. The rats were received crude khat extract subchronically (KESC) (100 mg/kg, 200 mg/kg and 300 mg/kg b.w), khat juice (KHJ 2.5 mUkg), 2% tween 80 in distilled water (T80W- v/v, vehicle) and khat extract subacutely (KESA) (300 mg/kg). For subchronic treatment, each rat was administered for twelve weeks before Morris water maze experiment has been started, while it was administered for a week for acute treatment. Spatial learning and memory were measured using the Morris water maze model and serum sodium, calcium, potassium, and chloride were evaluated using Cobas 6000. Results Spatial learning was improved with trials across the groups, while average escape latency (s) of rats received KESC 200 mg/kg (p<0.001), KESC 300 mg/kg (p<0.01) and KHJ 2.5 mUkg (p<0.05) was significantly greater than rats that received vehicle. There was no significant difference in the latency between rats that received KESA 300mg/kg and vehicle (p>0.05). Thigmotaxis was significantly higher in rats that received all doses of khat extract (p<0.001). The time spent in the target quadrant in rats that received KESC 300 mg/kg was significantly reduced (p<0.05). Serum calcium level was inversely correlated with the escape latency (R = -0.417, p<0.05) in rats that received khat. Conclusions Khat extract and juice administered subchronically, but not subacutely, impaired learning and memory and was associated with serum calcium reduction. The neuronal basis for such alteration should be investigated.	[Limenie, Abebaye Aragaw; Dugul, Tesfaye Tolessa] Addis Ababa Univ, Dept Physiol, Coll Hlth Sci, Addis Ababa, Ethiopia; [Eshetu, Eyasu Mekonnen] Addis Ababa Univ, Coll Hlth Sci, Dept Pharmacol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Limenie, AA (corresponding author), Addis Ababa Univ, Dept Physiol, Coll Hlth Sci, Addis Ababa, Ethiopia.	abebaye.aragaw@aau.edu.et		Makonnen, Eyasu/0000-0002-9259-5288				Abidin I, 2004, INT J NEUROSCI, V114, P683, DOI 10.1080/00207450490430543; Ageely HMA, 2008, J FAM COMMUNITY MED, V15, P3; Al-Habori Molham, 2005, Expert Opin Drug Saf, V4, P1145, DOI 10.1517/14740338.4.6.1145; Alfaifi H, 2017, PHCOG MAG, V13, P354; Alsalahi A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/829401; Atlabachew M, 2013, B CHEM SOC ETHIOPIA, V27, P347, DOI 10.4314/bcse.v27i3.3; Bae YJ, 2012, NUTR RES PRACT, V6, P527, DOI 10.4162/nrp.2012.6.6.527; Bolton S, 2017, LEARN MEMORY, V24, P532, DOI 10.1101/lm.045187.117; Bora F, 2016, IRAN J BASIC MED SCI, V19, P1151; Colzato LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020602; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Echoru I., 2018, ANAT J AFR, V7, P1121, DOI [10.4314/aja.v7i1.169485, DOI 10.4314/AJA.V7I1.169485]; El-Sayed M. I. K., 2012, American Journal of Biochemistry and Biotechnology, V8, P157; Engidawork, 2014, ETHIOP PHARM J, V30, P77, DOI [10.4314/epj.v30i2, DOI 10.4314/EPJ.V30I2.2]; Fitri FI, 2018, EARTH ENV SCI, V25, P1; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Fujisawa H, 2016, J AM SOC NEPHROL, V27, P766, DOI 10.1681/ASN.2014121196; Gebrehanna E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1198; Hassan NA, 2002, SAUDI MED J, V23, P850; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; KALIX P, 1990, PHARMACOL THERAPEUT, V48, P397, DOI 10.1016/0163-7258(90)90057-9; Kassa A, 2017, AFR HEALTH SCI, V17, P175, DOI 10.4314/ahs.v17i1.22; Kimani ST, 2016, METAB BRAIN DIS, V31, P45, DOI 10.1007/s11011-015-9738-1; Kimani ST, 2008, BEHAV BRAIN RES, V195, P192, DOI 10.1016/j.bbr.2008.05.022; Kiunga J, 2016, INT J ETHNOBIOLOGY E, V3, P1; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Lee S, 2012, BMC MED INFORM DECIS, V12, DOI [10.1186/1472-6947-12-S1-S1, 10.1186/1472-6947-12-S1]; LEONARD BE, 1971, BRIT J PHARMACOL, V41, P198, DOI 10.1111/j.1476-5381.1971.tb08022.x; Ljomone Omamuyovwi M, 2011, J NEUROSCIENCE BEHAV, V3, P107; Lourida I, 2015, PARATHYROID HORMONE, V10, P1; Luethi M, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.005.2008; Macuchova E, 2013, PHYSIOL RES, V62, pS89, DOI 10.33549/physiolres.932598; Manzar MD, 2017, ANN THORAC MED, V12, P247, DOI [10.4103/atm.ATM_24_17, 10.4103/atm.atm_24_17]; Mendez IA, 2008, NEUROBIOL LEARN MEM, V89, P185, DOI 10.1016/j.nlm.2007.08.005; Miller M, 2006, J AM GERIATR SOC, V54, P345, DOI 10.1111/j.1532-5415.2005.00609.x; Mirzaei F, 2013, ANATOMICAL SCI, V10, P24; Moritz ML, 2013, NEPHROL DIAL TRANSPL, V28, P2206, DOI 10.1093/ndt/gft192; Muela HCS, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004579; Mwaniki DM, 2014, E AFR MED J, V9, P1; National academies press, 2010, GUIDE CARE USE LAB A, V8th; Perez V, 2014, ADV NUTR, V5, P712, DOI 10.3945/an.114.006783; Sathi MM, 2014, J ETHNOPHARMACOL, V156, P102, DOI 10.1016/j.jep.2014.08.004; Shewamene Z, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-66; Siedlecka-Kroplewska K, 2014, J PHYSIOL PHARMACOL, V65, P241; Sivaraman S, 2016, J PSYCHOL PSYCHOTHER, V6, P1; Thanos PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155457; Thouri A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1751-y; Veetil PK., 2014, INDIAN J PHYSIOL PH, V58, P239; Vintimilla RM, 2018, DEMENT GER COGN D EX, V8, P151, DOI 10.1159/000488483; Wabe Nasir Tajure, 2011, Addict Health, V3, P137; Whiteford H, 2016, HEALTH AFFAIR, V35, P1114, DOI 10.1377/hlthaff.2016.0082; Wood S, 2009, PSYCHOPHARMACOLOGY, V202, P197, DOI 10.1007/s00213-008-1185-9; Yamaguchi Kiyoshi, 2015, Clin Calcium, V25, P189, DOI CliCa1502189194; Yates JW, 2007, NEUROSCI LETT, V427, P66, DOI 10.1016/j.neulet.2007.09.011	54	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0257932	10.1371/journal.pone.0257932	http://dx.doi.org/10.1371/journal.pone.0257932			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157725	gold, Green Published			2022-12-26	WOS:000788004500001
J	Tenaw, LA				Tenaw, Lebeza Alemu			Practice and determinants of emergency contraceptive utilization among women seeking termination of pregnancy in Northwest Ethiopia-A mixed quantitative and qualitative study	PLOS ONE			English	Article							ABORTION	Background Emergency contraceptives are used within 72 hours after unprotected sexual intercourse to prevent unwanted pregnancy. Although emergency contraceptives are widely available in Ethiopia, termination of pregnancy remains a public health problem indicating low uptake of emergency contraceptives after unprotected sexual intercourse. This study aimed to assess utilization and determinants of emergency contraceptives among women seeking termination of pregnancy in Northwest Ethiopia. Methods An institutional-based cross-sectional study was carried out, supplemented by phenomenologically approached in-depth interviews. Systematic random sampling was used to select study participants. A structured questionnaire and an in-depth interview guide were used to collect data. Data were entered by EPI-info and analyzed through SPSS version 23 to conduct logistic regressions. Thematic analysis was used to conduct qualitative interpretation. Results Almost one-fifth (78; 19.2%) of the study participants used emergency contraceptives to prevent their index pregnancy. Women who had secondary education (aOR 3.28; 95% CI 1.59, 6.79) and women who had no living children (aOR 4.52; 95% CI 1.40, 14.57) had a positive significant association with emergency contraceptive utilization. On the other hand, women who did not discuss contraceptives with their sexual partner (aOR 0.49; 95% CI 0.27-0.91) and women without a history of abortion (aOR 0.45; 95% CI 0.24-0.97) had a negative significant association with emergency contraceptive utilization. Conclusion and recommendation There is relatively low utilization of emergency contraception among pregnancy terminating women. Reproductive health programs should encourage women discussion with their partners about emergency contraceptives to decrease occurrence of unwanted pregnancy and termination of pregnancy.	[Tenaw, Lebeza Alemu] Woldia Univ, Coll Hlth Sci, Dept Reprod Hlth, Woldia, Ethiopia		Tenaw, LA (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Reprod Hlth, Woldia, Ethiopia.	lebezaa@gmail.com		tenaw, Lebeza/0000-0003-0144-4968				Abate M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110008; Abraha D, 2019, KNOWLEDGE UTILIZATIO, V2019; Amalba A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-114; [Anonymous], 2012, EMERGENCY CONTRACEPT; Anteneh A., 2009, ETHIOP J REPROD HLTH, V3, P16; Baird DT, 2015, HUM REPROD, V30, P751, DOI 10.1093/humrep/dev019; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Bertrand J., 1994, HDB INDICATORS FAMIL; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Demographic E., 2012, HLTH SURVEY 2011 CEN; Eyal N, 2011, SCALING CHANGES DOCT; Feleke AE, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4707-0; Hatcher R, 1997, CHINESE VERSION; IPAS, 2017, IND AB POST CAR ETH; Kathpalia S K, 2016, Med J Armed Forces India, V72, P116, DOI 10.1016/j.mjafi.2015.09.012; Keesbury J, 2007, POPULATION COUNCIL E; Meng CX, 2009, HUM REPROD, V24, P1612, DOI 10.1093/humrep/dep064; Mohammed A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-13; Oluwole EO, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1094; Prata N., 2013, AFR J REPROD HEALTH, V17; Raymond E, 2004, EMERGENCY CONTRACEPT, VSecond; Sahu Monalisha, 2019, Niger Med J, V60, P117, DOI 10.4103/nmj.NMJ_121_17; Singh S, 2010, INT PERSPECT SEX R H, V36, P16, DOI 10.1363/ipsrh.36.016.10; Smit J, 2001, CONTRACEPTION, V64, P333, DOI 10.1016/S0010-7824(01)00272-4; Tafesse L., 2014, J BIOL AGR HEALTHCAR, V4; Tesfa Endalamaw, 2018, BMC Res Notes, V11, P926, DOI 10.1186/s13104-018-4031-0; Tesfaye T, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-3; Tolossa K, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-32; Workie N.W, 2013, HLTH EXTENSION PROGR; Zareba K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183413	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263776	10.1371/journal.pone.0263776	http://dx.doi.org/10.1371/journal.pone.0263776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148342	gold, Green Published			2022-12-26	WOS:000800108800028
J	Chang, YJ; Chen, LJ; Chang, YJ				Chang, Yao-Jen; Chen, Li-Ju; Chang, Yun-Jau			Did the severity of appendicitis increase during the COVID-19 pandemic?	PLOS ONE			English	Article								Background This study aimed to assess the severity of appendicitis during the coronavirus disease 2019 (COVID-19) pandemic, as patients with appendicitis may procrastinate seeking medical attention during the pandemic. Methods Information on patients with appendicitis who were treated at the Taipei City Hospital during the COVID-19 pandemic (January 1, 2020 to June 30, 2020) was retrieved. Patients who were diagnosed with appendicitis and treated at the same hospital from January 1, 2019 to July 1, 2019 were designated as the control group. Multivariate logistic regression analysis was conducted to assess changes in the severity of appendicitis (at a 2-week interval) between the two groups. Results We identified 307 (study group: 149; control group: 158) consecutive patients with appendicitis. The mean age was 46.2 +- 19.8 years. Between the two groups, there were no significant differences in age, sex, comorbidity, surgery type (laparoscopic or open appendectomy) or surgery time. The number of patients in the study group decreased between January 29, 2020 and April 21, 2020, which paralleled the period of spikes in the confirmed COVID-19 cases and restricted daily activities. The percentage of uncomplicated and complicated appendicitis (excluding mild appendicitis or normal appendix) in the study group increased between February 26 and March 10, as well as between April 8 and April 21. In the multivariate regression analysis, the odds of uncomplicated and complicated appendicitis increased in three bi-weeks for the study group but not in the control group. Conclusion The severity of acute appendicitis might increase during the COVID-19 pandemic, because patients with mild appendicitis (or abdominal pain) may hesitate to seek help.	[Chang, Yao-Jen] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Surg, New Taipei, Taiwan; [Chang, Yao-Jen] Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Li-Ju] Univ Taipei, Taipei, Taiwan; [Chen, Li-Ju] Taipei City Hosp, Dept Ophthalmol, HepingFuyou Branch, Taipei, Taiwan; [Chang, Yun-Jau] Natl Taiwan Univ Hosp, Dept Gen Surg, Taipei, Taiwan; [Chang, Yun-Jau] Taipei City Hosp, Dept Gen Surg, Zhong Xing Branch, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University; University of Taipei; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital	Chang, YJ (corresponding author), Natl Taiwan Univ Hosp, Dept Gen Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei City Hosp, Dept Gen Surg, Zhong Xing Branch, Taipei, Taiwan.	yunjauchang2003@yahoo.com.tw		Chang, Yun-Jau/0000-0002-2433-0544				Basamh M, 2020, BRIT J SURG, V107, pE450, DOI 10.1002/bjs.11910; Bhangu A, 2013, BRIT J SURG, V100, P1240, DOI 10.1002/bjs.9201; Collard M, 2020, J VISC SURG, V157, pS33, DOI 10.1016/j.jviscsurg.2020.04.014; COVIDSurg Collaborative, 2020, BRIT J SURG, V107, P1097, DOI 10.1002/bjs.11646; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dick L, 2020, WORLD J SURG, V44, P3590, DOI 10.1007/s00268-020-05760-3; Dreifuss NH, 2020, BRIT J SURG, V107, pE368, DOI 10.1002/bjs.11806; Englehardt RK, 2014, JSLS-J SOC LAPAROEND, V18, DOI 10.4293/JSLS.2014.00361; English W, 2021, LANGENBECK ARCH SURG, V406, P357, DOI 10.1007/s00423-020-02023-6; Fares A, 2014, ANN MED HEALTH SCI R, V4, P18, DOI 10.4103/2141-9248.126603; Findlay JM, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13650; Finkelstein P, 2021, J LAPAROENDOSC ADV S, V31, P243, DOI 10.1089/lap.2020.0749; Global Change Data Lab, DAIL CONF COVID 19 C; Ielpo B, 2021, BRIT J SURG, V108, P717, DOI 10.1002/bjs.11999; Javanmard-Emamghissi H, 2021, TECH COLOPROCTOL, V25, P401, DOI 10.1007/s10151-020-02297-4; Kelly ME, 2020, COLORECTAL DIS, V22, P648, DOI 10.1111/codi.15141; Kim C, 2020, WORLD J CLIN CASES, V8, P1944, DOI 10.12998/wjcc.v8.i10.1944; Kim HC, 2011, BRIT J RADIOL, V84, P1115, DOI 10.1259/bjr/47699219; Lee-Archer P, 2020, J PAEDIATR CHILD H, V56, P1313, DOI 10.1111/jpc.15058; Leite NP, 2005, AM J ROENTGENOL, V185, P406, DOI 10.2214/ajr.185.2.01850406; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1036; Ngaserin SHN, 2020, LANGENBECK ARCH SURG, V405, P353, DOI 10.1007/s00423-020-01891-2; Orthopoulos G, 2021, AM J SURG, V221, P1056, DOI 10.1016/j.amjsurg.2020.09.026; Patel VK, 2021, J GASTROINTEST SURG, V25, P1327, DOI 10.1007/s11605-020-04844-8; Teixeira FJR, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0122-9; Romero J, 2020, J AM COLL RADIOL, V17, P1011, DOI 10.1016/j.jacr.2020.06.002; Scott C, 2020, BRIT J SURG, V107, pE271, DOI 10.1002/bjs.11752; Soreide K, 2020, BRIT J SURG, V107, P1250, DOI 10.1002/bjs.11670; Swischuk LE, 2015, EMERG RADIOL, V22, P643, DOI 10.1007/s10140-015-1338-1; Tankel J, 2020, WORLD J SURG, V44, P2458, DOI 10.1007/s00268-020-05599-8; Tuech JJ, 2020, J VISC SURG, V157, pS7, DOI 10.1016/j.jviscsurg.2020.03.008; Turanli S, 2021, WORLD J SURG, V45, P18, DOI 10.1007/s00268-020-05825-3; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang ZY, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0578-5; Zhou Y, 2020, WORLD J CLIN CASES, V8, P4349, DOI 10.12998/wjcc.v8.i19.4349	35	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263814	10.1371/journal.pone.0263814	http://dx.doi.org/10.1371/journal.pone.0263814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143582	Green Published, gold			2022-12-26	WOS:000797657800082
J	Jayes, LT; Fitzsimmons, G; Weal, MJ; Kaakinen, JK; Drieghe, D				Jayes, Lewis T.; Fitzsimmons, Gemma; Weal, Mark J.; Kaakinen, Johanna K.; Drieghe, Denis			The impact of hyperlinks, skim reading and perceived importance when reading on the Web	PLOS ONE			English	Article							EYE-MOVEMENTS; WRAP-UP; TEXT; INFORMATION; ATTENTION; RECALL; COMPREHENSION; FIXATIONS; HEADINGS; TIME	It has previously been shown that readers spend a great deal of time skim reading on the Web and that this type of reading can affect comprehension of text. Across two experiments, we examine how hyperlinks influence perceived importance of sentences and how perceived importance in turn affects reading behaviour. In Experiment 1, participants rated the importance of sentences across passages of Wikipedia text. In Experiment 2, a different set of participants read these passages while their eye movements were tracked, with the task being either reading for comprehension or skim reading. Reading times of sentences were analysed in relation to the type of task and the importance ratings from Experiment 1. Results from Experiment 1 show readers rated sentences without hyperlinks as being of less importance than sentences that did feature hyperlinks, and this effect is larger when sentences are lower on the page. It was also found that short sentences with more links were rated as more important, but only when they were presented at the top of the page. Long sentences with more links were rated as more important regardless of their position on the page. In Experiment 2, higher importance scores resulted in longer sentence reading times, measured as fixation durations. When skim reading, however, importance ratings had a lesser impact on online reading behaviour than when reading for comprehension. We suggest readers are less able to establish the importance of a sentence when skim reading, even though importance could have been assessed by information that would be fairly easy to extract (i.e. presence of hyperlinks, length of sentences, and position on the screen).	[Jayes, Lewis T.] Univ Surrey, Sch Psychol, Guildford, Surrey, England; [Fitzsimmons, Gemma; Drieghe, Denis] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Weal, Mark J.] Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England; [Kaakinen, Johanna K.] Univ Turku, Finland INVEST Res, Dept Psychol, Turku, Finland; [Kaakinen, Johanna K.] Univ Turku, Flagship, Turku, Finland	University of Surrey; University of Southampton; University of Southampton; University of Turku; University of Turku	Fitzsimmons, G (corresponding author), Univ Southampton, Sch Psychol, Southampton, Hants, England.	gemma.fitzsimmons@soton.ac.uk	; Fitzsimmons, Gemma/J-2509-2016	Drieghe, Denis/0000-0001-9630-8410; Fitzsimmons, Gemma/0000-0002-4519-0499	EPSRC [EP/G036926/1]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	GF was funded by an EPSRC grant for the Doctoral Training Centre in Web Science: EP/G036926/1. This work formed a part of a PhD completed in the Web Science DTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, STAT POWER SOCIAL SC; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Carr N., 2010, THE SHALLOWS; CARVER RP, 1984, READ RES QUART, V19, P205, DOI 10.2307/747363; Cashen V. M., 1970, J EDUC PSYCHOL, V61, P484, DOI [10.1037/h0030286, DOI 10.1037/H0030286]; Cauchard F, 2010, DISCOURSE PROCESS, V47, P617, DOI 10.1080/01638531003628791; CROUSE JH, 1972, J EDUC PSYCHOL, V63, P309, DOI 10.1037/h0033574; Duggan GB, 2009, J EXP PSYCHOL-APPL, V15, P228, DOI 10.1037/a0016995; Fitzsimmons G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239134; Fitzsimmons G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210900; FOWLER RL, 1974, J APPL PSYCHOL, V59, P358, DOI 10.1037/h0036750; Gagl B, 2016, PEERJ, V4, DOI 10.7717/peerj.2467; Green P, 2016, METHODS ECOL EVOL, V7, P493, DOI 10.1111/2041-210X.12504; HABERLANDT KF, 1985, J EXP PSYCHOL GEN, V114, P357, DOI 10.1037/0096-3445.114.3.357; Haselgrove, 2000, J RES READ, V23, P210, DOI [DOI 10.1111/1467-9817.00115, 10.1111/1467-9817.00115]; HENDERSON JM, 1990, J EXP PSYCHOL LEARN, V16, P417, DOI 10.1037/0278-7393.16.3.417; Hyona J, 2004, LEARN INSTR, V14, P131, DOI 10.1016/j.learninstruc.2004.01.001; Hyona J, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P313, DOI 10.1016/B978-044451020-4/50018-9; INHOFF AW, 1986, PERCEPT PSYCHOPHYS, V40, P431, DOI 10.3758/BF03208203; Josephson S, 2002, BEHAV RES METH INS C, V34, P539, DOI 10.3758/BF03195483; Just M.A., 1987, PSYCHOL READING LANG; Just M. A., 1982, WHAT EYE FIXATIONS T; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kaakinen JK, 2010, J EXP PSYCHOL LEARN, V36, P1561, DOI 10.1037/a0020693; Lemarie J, 2008, EDUC PSYCHOL-US, V43, P27, DOI 10.1080/00461520701756321; Lenhard W, 2017, DISCOURSE PROCESS, V54, P427, DOI 10.1080/0163853X.2017.1319653; Lim D.J., 2021, J INTERACTIVE ADVERT, V21, P1, DOI [10.1080/15252019.2021.1921084, DOI 10.1080/15252019.2021.1921084]; Liu ZM, 2005, J DOC, V61, P700, DOI 10.1108/00220410510632040; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; LORCH RF, 1995, CONTEMP EDUC PSYCHOL, V20, P51; Lorch RF, 2012, J EXP PSYCHOL-APPL, V18, P265, DOI 10.1037/a0029547; Lorch RF, 2011, DISCOURSE PROCESS, V48, P139, DOI 10.1080/0163853X.2010.503526; Lorch RF, 1989, EDUC PSYCHOL REV, V1, P209, DOI 10.1007/BF01320135; Macmillan NA, 2005, DETECTION THEORY USE; MASSON MEJ, 1982, J EXP PSYCHOL LEARN, V8, P400, DOI 10.1037/0278-7393.8.5.400; Morkes J., 1997, CONCISE SCANNABLE OB; Nikolova OR, 2004, APPRENTISSAGE LANGUE, V07, P29, DOI [10.4000/alsic.2279, DOI 10.4000/ALSIC.2279]; Nuzzolese AG, 2011, LECT NOTES COMPUT SC, V7031, P520, DOI 10.1007/978-3-642-25073-6_33; R Core Development Team, 2009, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2000, Q J EXP PSYCHOL-A, V53, P1061, DOI 10.1080/02724980050156290; Rayner K, 1996, PERCEPT PSYCHOPHYS, V58, P734, DOI 10.3758/BF03213106; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reader WR, 2007, HUM-COMPUT INTERACT, V22, P263; SADOSKI M, 1990, READ RES QUART, V25, P256, DOI 10.2307/747691; Salmeron L, 2017, J COMPUT ASSIST LEAR, V33, P222, DOI 10.1111/jcal.12152; Salmeron L, 2013, COMPUT HUM BEHAV, V29, P2161, DOI 10.1016/j.chb.2013.04.034; Salmeron L, 2011, COMPUT HUM BEHAV, V27, P1143, DOI 10.1016/j.chb.2010.12.008; Scanlan C., 2003, WRITING TOP PROS CON; Schotter ER, 2019, TRENDS COGN SCI, V23, P811, DOI 10.1016/j.tics.2019.06.005; Singer LM, 2017, REV EDUC RES, V87, P1007, DOI 10.3102/0034654317722961; Stine-Morrow EAL, 2010, PSYCHOL AGING, V25, P168, DOI 10.1037/a0018127; Tiffin-Richards SP, 2018, J EXP PSYCHOL LEARN, V44, P1051, DOI 10.1037/xlm0000506; WADE SE, 1990, J READING BEHAV, V22, P331, DOI 10.1080/10862969009547717; Warren T, 2009, COGNITION, V111, P132, DOI 10.1016/j.cognition.2008.12.011; Wu YY, 2021, J COGN PSYCHOL, V33, P146, DOI 10.1080/20445911.2021.1879817	57	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263669	10.1371/journal.pone.0263669	http://dx.doi.org/10.1371/journal.pone.0263669			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139122	Green Published, Green Accepted, gold			2022-12-26	WOS:000821499100042
J	Li, Q; Zhong, XF; Yao, WC; Yu, JL; Wang, C; Li, ZY; Lai, SQ; Qu, FL; Fu, XY; Huang, XJ; Zhang, DW; Liu, YJ; Li, HY				Li, Qian; Zhong, Xiaofang; Yao, Weicheng; Yu, Junli; Wang, Chao; Li, Zongyan; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Zhang, Dawei; Liu, Yujie; Li, Haiyan			Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; BREAST-CANCER; CELLS; B7-H3; EXPRESSION; PROLIFERATION; ACTIVATION; TARGETS; GROWTH	Despite the enormous successes of anti-PD-1/PD-L1 immunotherapy in multiple other cancer types, the overall response rates of breast cancer remain suboptimal. Therefore, exploring additional immune checkpoint molecules for potential cancer treatment is crucial. B7H3, a T-cell coinhibitory molecule, is specifically overexpressed in breast cancer compared with normal breast tissue and benign lesions, making it an attractive therapeutic target. However, the mechanism by which B7H3 contributes to the cancer phenotype is unclear. Here we show that the expression of B7H3 is negatively related to the number of CD8+ T cells in breast tumor sites. In addition, analysis of the differentially expressed B7H3 reveals that it is inversely correlated to autophagic flux both in breast cancer cell lines and clinical tumor tissues. Furthermore, block of autophagy by bafilomycin A1 (Baf A1) increases B7H3 levels and attenuates CD8(+) T cell activation, while promotion of autophagy by V9302, a small-molecule inhibitor of glutamine metabolism, decreases B7H3 expression and enhances granzyme B (GzB) production of CD8(+) T cells via regulation of reactive oxygen species (ROS) accumulation. We demonstrate that combined treatment with V9302 and anti-PD-1 monoclonal antibody (mAb) enhances antitumor immunity in syngeneic mouse models. Collectively, our findings unveil the beneficial effect of V9302 in boosting antitumor immune response in breast cancer and illustrate that anti-PD-1 together with V9302 treatment may provide synergistic effects in the treatment of patients insensitive to anti-PD-1 therapy.	[Li, Qian; Zhong, Xiaofang; Yu, Junli; Wang, Chao; Li, Zongyan; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Zhang, Dawei; Li, Haiyan] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Peoples R China; [Li, Qian; Zhong, Xiaofang; Yu, Junli; Lai, Shengqing; Qu, Fanli; Fu, Xiaoyan; Huang, Xiaojia; Li, Haiyan] Sun Yat Sen Univ, Dept Breast Surg, Affiliated Hosp 6, Guangzhou, Peoples R China; [Yao, Weicheng; Liu, Yujie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China; [Wang, Chao] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China; [Li, Zongyan; Zhang, Dawei] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Hepatobiliary Surg, Guangzhou, Peoples R China; [Liu, Yujie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, DW; Li, HY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou, Peoples R China.; Li, HY (corresponding author), Sun Yat Sen Univ, Dept Breast Surg, Affiliated Hosp 6, Guangzhou, Peoples R China.; Liu, YJ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China.	zhangdaweiwinner@163.com; liuyujie554@163.com; lihy27@mail.sysu.edu.cn		li, zong yan/0000-0002-8196-7269	Guangdong Science and Technology Department [2020A1515010425, 2019A1515010146]; Guangzhou Science and Technology Project [805275295029]; National Natural Science Foundation of China [81672622]; Dongguan Science and Technology of Social Development Program [20211800904582]	Guangdong Science and Technology Department; Guangzhou Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dongguan Science and Technology of Social Development Program	We thank Dr Jianjian Wu for assistance with sample staining. We thank all the patients who agreed to participate in the trial. This work was supported by grants from Guangdong Science and Technology Department (2020A1515010425, 2019A1515010146), Guangzhou Science and Technology Project (805275295029), and National Natural Science Foundation of China (81672622), Dongguan Science and Technology of Social Development Program (20211800904582).	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Andrews LP, 2019, NAT IMMUNOL, V20, P1425, DOI 10.1038/s41590-019-0512-0; Bachawal SV, 2015, CANCER RES, V75, P2501, DOI 10.1158/0008-5472.CAN-14-3361; Bernhardt S, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0905-7; Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Byun JK, 2020, MOL CELL, V80, P592, DOI 10.1016/j.molcel.2020.10.015; Cai D., 2020, CELL MOL IMMUNOL, V17; Chen G, 2020, BIOCHEM BIOPH RES CO, V531, P282, DOI 10.1016/j.bbrc.2020.06.154; Clarke R, 2021, CANCER DRUG RESIST, V4, P762, DOI 10.20517/cdr.2021.33; Denkert C., 2015, TUMOR; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; Edwards DN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140100; El-Ansari R, 2019, BREAST CANCER RES TR, V175, P27, DOI 10.1007/s10549-018-05111-w; Emens LA, 2021, JNCI-J NATL CANCER I, V113, P1005, DOI 10.1093/jnci/djab004; Emens LA, 2019, JAMA ONCOL, V5, P74, DOI 10.1001/jamaoncol.2018.4224; Ewens A, 2005, ANTICANCER RES, V25, P3905; Flem-Karlsen K, 2018, TRENDS CANCER, V4, P401, DOI 10.1016/j.trecan.2018.03.010; Ganesan B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67101-7; Hegde S, 2021, IMMUNITY, V54, P875, DOI 10.1016/j.immuni.2021.04.004; Huang D, 2018, NAT IMMUNOL, V19, P1112, DOI 10.1038/s41590-018-0207-y; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Kim K., 2014, P NATL ACAD SCI USA; Le Naour A, 2020, CANCER MED-US, V9, P8074, DOI 10.1002/cam4.3295; Lee YH, 2017, CELL RES, V27, P1034, DOI 10.1038/cr.2017.90; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu J, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-020-01024-8; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Loi S., 2014, TUMOR INFILTRATING; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Ma GF, 2020, MOL CANCER RES, V18, P324, DOI 10.1158/1541-7786.MCR-19-0517; Mehazri L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073387; Munoz-Rojas AR, 2021, NAT REV IMMUNOL, V21, P597, DOI 10.1038/s41577-021-00519-w; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nanda R., 2016, J CLIN ONCOL, V34; Oh MH, 2020, J CLIN INVEST, V130, P3865, DOI 10.1172/JCI131859; Qin S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1091-2; Ren W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.222; Rugo HS, 2018, CLIN CANCER RES, V24, P2804, DOI 10.1158/1078-0432.CCR-17-3452; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schmid P, 2020, NEW ENGL J MED, V382, P810, DOI 10.1056/NEJMoa1910549; Schmid P, 2020, LANCET ONCOL, V21, P44, DOI 10.1016/S1470-2045(19)30689-8; Schulte M., 2018, NAT MED; Seaman S, 2017, CANCER CELL, V31, P501, DOI 10.1016/j.ccell.2017.03.005; Sharma NS, 2020, J CLIN INVEST, V130, P451, DOI 10.1172/JCI127515; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Signorelli S, 2019, TRENDS PLANT SCI, V24, P413, DOI 10.1016/j.tplants.2019.02.001; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Tan HWS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00369-y; Wang Cheng, 2021, Cell Stem Cell, V28, P1597, DOI 10.1016/j.stem.2021.04.011; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518; Yang S, 2020, INT J BIOL SCI, V16, P1767, DOI 10.7150/ijbs.41105; Yang WH, 2021, TRENDS CANCER, V7, P790, DOI 10.1016/j.trecan.2021.04.003; Yonesaka K., 2018, CLIN CANC RES 24; Zhang H, 2021, PATHOL RES PRACT, V224, DOI 10.1016/j.prp.2021.153525; Zhou FF, 2021, BIOMATERIALS, V265, DOI 10.1016/j.biomaterials.2020.120421; Zhou J, 2022, AUTOPHAGY, V18, P1240, DOI 10.1080/15548627.2021.1984656; Zhu XW, 2019, BIOCHEM BIOPH RES CO, V508, P1067, DOI 10.1016/j.bbrc.2018.12.055	62	7	8	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101753	10.1016/j.jbc.2022.101753	http://dx.doi.org/10.1016/j.jbc.2022.101753			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3GT	35189139	Green Published, gold			2022-12-26	WOS:000793692600005
J	Gatta, R; Wiese, A; Iwanicki, A; Obuchowski, M				Gatta, Roberta; Wiese, Andrzej; Iwanicki, Adam; Obuchowski, Michal			Influence of glucose on swarming and quorum sensing of Dickeya solani	PLOS ONE			English	Article							SP-NOV.; PSEUDOMONAS-AERUGINOSA; DADANTII 3937; VIRULENCE; MOTILITY; SYSTEM; PROTEIN; POTATO; LEAVES	Dickeya solani is a pathogen most frequently responsible for infecting potato plants in Europe. As in the case of most plant pathogens, its ability to colonize and invade the host depends on chemotaxis and motility. The coordinated movement of Dickeya over solid surfaces is governed by a quorum sensing mechanism. In D. solani motility is regulated by Expl-ExpR proteins, homologous to luxl-luxR system from Vibrio fisheri, in which N-acyl-homoserine lactones (AHLs) serve as signaling molecules. Moreover, in many Gram-negative bacteria motility is coupled with central metabolism via carbon catabolite repression. This enables them to reach more nutrient-efficient niches. The aim of this study was to analyze the swarming motility of D. solani depending on the volume of the medium in the cultivation plate and glucose content. We show that the ability of this bacterium to move is strictly dependent on both these factors. Moreover, we analyze the production of AHLs and show that the quorum sensing mechanism in D. solani is also influenced by the availability of glucose in the medium and that the distribution of these signaling molecules are different depending on the volume of the medium in the plate.	[Gatta, Roberta; Wiese, Andrzej] Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Div Med Biotechnol, Gdansk, Poland; [Iwanicki, Adam; Obuchowski, Michal] Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Div Med Biotechnol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Obuchowski, M (corresponding author), Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Div Med Biotechnol, Gdansk, Poland.	michal.obuchowski@ug.edu.pl	Obuchowski, Michal/F-5836-2011	Obuchowski, Michal/0000-0001-5410-2350	National Science Center OPUS project [2018/29/B/NZ9/02339]	National Science Center OPUS project	This work was supported by the National Science Center OPUS project no. 2018/29/B/NZ9/02339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; ARMITAGE JP, 1976, EXPERIENTIA, V32, P1266, DOI 10.1007/BF01953085; Brady CL, 2012, INT J SYST EVOL MICR, V62, P1592, DOI 10.1099/ijs.0.035055-0; Chakravarthy S, 2017, MOL PLANT MICROBE IN, V30, P283, DOI 10.1094/MPMI-09-16-0196-R; Crepin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035176; Czajkowski R, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.580330; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hugouvieux-Cotte-Pattat N, 2016, PROG MOL BIOL TRANSL, V142, P93, DOI 10.1016/bs.pmbts.2016.05.006; Ichinose Yuki, 2003, Journal of General Plant Pathology, V69, P244, DOI 10.1007/s10327-003-0045-z; Jafra S, 2004, J MICROBIOL METH, V57, P415, DOI 10.1016/j.mimet.2004.01.015; Jahid IK, 2013, J FOOD PROTECT, V76, P239, DOI 10.4315/0362-028X.JFP-12-321; Khayi S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1997-z; Lai HC, 1997, BIOCHEM BIOPH RES CO, V231, P692, DOI 10.1006/bbrc.1997.6169; Lee J, 2015, PROTEIN CELL, V6, P26, DOI 10.1007/s13238-014-0100-x; Mattingly AE, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02847-17; Nasser W, 2013, ENVIRON MICROBIOL, V15, P865, DOI 10.1111/1462-2920.12049; PANOPOULOS NJ, 1974, PHYTOPATHOLOGY, V64, P1389, DOI 10.1094/Phyto-64-1389; Parkinson N, 2014, INT J SYST EVOL MICR, V64, P2264, DOI 10.1099/ijs.0.058693-0; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Potrykus M, 2018, MOL PLANT PATHOL, V19, P1238, DOI 10.1111/mpp.12614; Reverchon S, 1997, J BACTERIOL, V179, P3500, DOI 10.1128/jb.179.11.3500-3508.1997; Reverchon S, 2016, PROG MOL BIOL TRANSL, V142, P51, DOI 10.1016/bs.pmbts.2016.05.005; Reverchon S, 1998, MOL MICROBIOL, V29, P1407, DOI 10.1046/j.1365-2958.1998.01023.x; Reverchon S, 2013, ENV MICROBIOL REP, V5, P622, DOI 10.1111/1758-2229.12073; Rio-Alvarez I, 2015, MOL PLANT PATHOL, V16, P685, DOI 10.1111/mpp.12227; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Swift S, 1996, TRENDS BIOCHEM SCI, V21, P214; Tian YL, 2016, INT J SYST EVOL MICR, V66, P2831, DOI 10.1099/ijsem.0.001060; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Yang NN, 2016, CURR GENET, V62, P1, DOI 10.1007/s00294-015-0499-5	39	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263124	10.1371/journal.pone.0263124	http://dx.doi.org/10.1371/journal.pone.0263124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192621	Green Published, gold			2022-12-26	WOS:000812552500017
J	Seward, CH; Saul, MC; Troy, JM; Dibaeinia, P; Zhang, HM; Sinha, S; Stubbs, LJ				Seward, Christopher H.; Saul, Michael C.; Troy, Joseph M.; Dibaeinia, Payam; Zhang, Huimin; Sinha, Saurabh; Stubbs, Lisa J.			An epigenomic shift in amygdala marks the transition to maternal behaviors in alloparenting virgin female mice	PLOS ONE			English	Article							RNA-POLYMERASE-II; NEUROENDOCRINE REGULATION; EXPERIENCE; RECEPTOR; GENE; TRANSCRIPTION; EXPRESSION; DOPAMINE; PUP; ENVIRONMENT	Adults of many species will care for young offspring that are not their own, a phenomenon called alloparenting. However, in many cases, nonparental adults must be sensitized by repeated or extended exposures to newborns before they will robustly display parental-like behaviors. To capture neurogenomic events underlying the transition to active parental caring behaviors, we analyzed brain gene expression and chromatin profiles of virgin female mice co-housed with pregnant dams during pregnancy and after birth. After an initial display of antagonistic behaviors and a surge of defense-related gene expression, we observed a dramatic shift in the chromatin landscape specifically in amygdala of the pup-exposed virgin females compared to females co-housed with mother before birth, accompanied by a dampening of anxiety-related gene expression. This epigenetic shift coincided with hypothalamic expression of the oxytocin gene and the emergence of behaviors and gene expression patterns classically associated with maternal care. The results outline a neurogenomic program associated with dramatic behavioral changes and suggest molecular networks relevant to human postpartum mental health.	[Seward, Christopher H.; Stubbs, Lisa J.] Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA; [Seward, Christopher H.; Saul, Michael C.; Troy, Joseph M.; Zhang, Huimin; Sinha, Saurabh; Stubbs, Lisa J.] Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Dibaeinia, Payam; Sinha, Saurabh] Univ Illinois, Dept Comp Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Stubbs, LJ (corresponding author), Pacific Northwest Res Inst, 720 Broadway, Seattle, WA 98122 USA.; Stubbs, LJ (corresponding author), Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	lstubbs@pnri.org	Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619; Seward, Christopher/0000-0002-0536-0190; Stubbs, Lisa/0000-0002-9556-1972	Simons Foundation [SfLife 291812]; University of Illinois; Pacific Northwest Research Institute	Simons Foundation; University of Illinois; Pacific Northwest Research Institute	This work was supported by the Simons Foundation (#SfLife 291812, awarded to LJS), with additional funding provided by the University of Illinois and the Pacific Northwest Research Institute.	Adachi M, 2016, BIOL PSYCHIAT, V80, P140, DOI 10.1016/j.biopsych.2015.09.018; Althammer F, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12549; Araujo DJ, 2015, GENE DEV, V29, P2081, DOI 10.1101/gad.267989.115; Atzil S, 2017, P NATL ACAD SCI USA, V114, P2361, DOI 10.1073/pnas.1612233114; Bridges RS, 2015, FRONT NEUROENDOCRIN, V36, P178, DOI 10.1016/j.yfrne.2014.11.007; Brunton PJ, 2019, CELL TISSUE RES, V375, P69, DOI 10.1007/s00441-018-2948-1; CALAMANDREI G, 1994, BEHAV NEUROSCI, V108, P113, DOI 10.1037/0735-7044.108.1.113; Carcea I, 2021, NATURE, V596, P553, DOI 10.1038/s41586-021-03814-7; Driessen TM, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-11; Dufford AJ, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12737; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Eisinger BE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00110; Eisinger BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063824; FLEMING AS, 1974, J COMP PHYSIOL PSYCH, V86, P957, DOI 10.1037/h0036414; Frederic F, 2006, J NEUROSCI RES, V83, P1525, DOI 10.1002/jnr.20843; Gammie SC, 2016, FRONT NEUROENDOCRIN, V42, P1, DOI 10.1016/j.yfrne.2016.05.002; GANDELMAN R, 1973, HORM BEHAV, V4, P191, DOI 10.1016/0018-506X(73)90003-2; GUASTAVINO JM, 1983, PHYSIOL BEHAV, V30, P771, DOI 10.1016/0031-9384(83)90176-2; Harding KM, 2016, DEV PSYCHOBIOL, V58, P492, DOI 10.1002/dev.21392; Harrington AJ, 2020, BIOL PSYCHIAT, V88, P488, DOI 10.1016/j.biopsych.2020.03.011; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; KINSLEY CH, 1990, DEV PSYCHOBIOL, V23, P331, DOI 10.1002/dev.420230405; Kinsley CH, 2015, NEUROSCI BIOBEHAV R, V58, P92, DOI 10.1016/j.neubiorev.2015.05.015; Kinsley CH, 2008, ARCH SEX BEHAV, V37, P43, DOI 10.1007/s10508-007-9277-x; Kitaoka K, 2011, BRAIN RES, V1423, P10, DOI 10.1016/j.brainres.2011.09.023; Kombian SB, 2005, J NEUROSCI RES, V79, P412, DOI 10.1002/jnr.20349; Kombian SB, 2004, J PHYSIOL-LONDON, V555, P71, DOI 10.1113/jphysiol.2003.056739; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lepagnol-Bestel AM, 2007, NEUROREPORT, V18, P441, DOI 10.1097/WNR.0b013e328011dc81; Lonstein JS, 1999, HORM BEHAV, V36, P242, DOI 10.1006/hbeh.1999.1544; MANN PE, 1995, HORM BEHAV, V29, P392, DOI 10.1006/hbeh.1995.1027; Mayer HS, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12734; Mayer HS, 2019, HORM BEHAV, V108, P94, DOI 10.1016/j.yhbeh.2018.02.011; Miller MW, 2013, J AFFECT DISORDERS, V151, P702, DOI 10.1016/j.jad.2013.07.022; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Ray S, 2016, G3-GENES GENOM GENET, V6, P221, DOI [10.1534/g3.115.020982/-/DC1, 10.1534/g3.115.020982]; ROSENBLATT JS, 1988, PSYCHONEUROENDOCRINO, V13, P29, DOI 10.1016/0306-4530(88)90005-4; Rotzinger S, 2003, J PSYCHIATR NEUROSCI, V28, P171; Russell JA, 2003, FRONT NEUROENDOCRIN, V24, P27, DOI 10.1016/S0091-3022(02)00104-8; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; Sarachana T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017116; Saul MC, 2017, GENOME RES, V27, P959, DOI 10.1101/gr.214221.116; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh-Taylor A, 2018, MOL PSYCHIATR, V23, P648, DOI 10.1038/mp.2016.240; Stohn JP, 2018, GENES BRAIN BEHAV, V17, P23, DOI 10.1111/gbb.12400; Stolzenberg DS, 2011, J NEUROENDOCRINOL, V23, P345, DOI 10.1111/j.1365-2826.2011.02112.x; Stolzenberg DS, 2016, HORM BEHAV, V77, P204, DOI 10.1016/j.yhbeh.2015.07.005; Stolzenberg DS, 2014, ENDOCRINOLOGY, V155, P3674, DOI 10.1210/en.2013-1946; Stolzenberg DS, 2012, HORM BEHAV, V62, P128, DOI 10.1016/j.yhbeh.2012.05.012; Stolzenberg DS, 2011, NEUROSCI BIOBEHAV R, V35, P826, DOI 10.1016/j.neubiorev.2010.10.003; VACCARINO FJ, 1994, NEUROSCI BIOBEHAV R, V18, P207, DOI 10.1016/0149-7634(94)90025-6; Wonch KE, 2016, SOC NEUROSCI-UK, V11, P600, DOI 10.1080/17470919.2015.1131193; Zhao CJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00388; Zhu XZ, 2008, BEHAV BRAIN RES, V193, P225, DOI 10.1016/j.bbr.2008.05.024	64	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263632	10.1371/journal.pone.0263632	http://dx.doi.org/10.1371/journal.pone.0263632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192674	Green Published, gold			2022-12-26	WOS:000812552500026
J	Ndejjo, R; Musinguzi, G; Nuwaha, F; Bastiaens, H; Wanyenze, RK				Ndejjo, Rawlance; Musinguzi, Geofrey; Nuwaha, Fred; Bastiaens, Hilde; Wanyenze, Rhoda K.			Understanding factors influencing uptake of healthy lifestyle practices among adults following a community cardiovascular disease prevention programme in Mukono and Buikwe districts in Uganda: A qualitative study	PLOS ONE			English	Article							INTERVENTION; CARE	Introduction Healthy lifestyle practices including physical activity, healthy diets, non-smoking, reduced alcohol consumption and stress reduction are important in the prevention of metabollic CVD risk factors such as hypertension, overweight and obesity, diabetes and hyperlipidaemia. Owing to current lifestyle changes, the increasing burden of CVD and importance of healthy behaviours, the need for strategies to increase uptake of healthy lifestyles among sub-Saharan African populations are apparent. This study explored the factors influencing uptake of healthy lifestyle practices among adults following implementation of a community CVD prevention programme. Methods This was a descriptive qualitative study conducted among purposively selected adults who had engaged in a community CVD prevention programme. Data were collected using in-depth interviews, which were audio recorded and transcribed verbatim. Study transcripts were read into NVIVO 12.6 software for coding and analysis guided by thematic analysis following the semantic approach. Results This study found variations in uptake of healthy lifestyle practices for CVD prevention with most changes reported for dietary behaviour especially in vegetable and fruit intake, reduction of salt intake and fats and oils consumption. Changes in physical activity were also notable. On the other hand, participants were slow in making changes in alcohol consumption, smoking behaviours and stress reduction. The barriers to uptake of healthy lifestyle practices were individual such as limited capability or skills, structural such as limited physical activity facilities, and social such as cultural and peer influence. Relatedly, the facilitators of practices uptake were individual including knowledge and personal determination to change, and social including social support from family and the community. Conclusions Insights from understanding the uptake of lifestyle practices should guide planning and design of community programmes with an emphasis on removing barriers and strengthening facilitators building on the intermediate motivating factors and considering individual needs and expectations.	[Ndejjo, Rawlance; Musinguzi, Geofrey; Nuwaha, Fred; Wanyenze, Rhoda K.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Ndejjo, Rawlance; Musinguzi, Geofrey; Bastiaens, Hilde] Univ Antwerp, Fac Med & Hlth Sci, Dept Family Med & Populat Hlth, Antwerp, Belgium	Makerere University; University of Antwerp	Ndejjo, R (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.; Ndejjo, R (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Family Med & Populat Hlth, Antwerp, Belgium.	rndeijo@musph.ac.ug		Bastiaens, Hilde/0000-0002-5509-3406; Ndejjo, Rawlance/0000-0001-9263-557X	SPICES project in Uganda from European Commission through the Horizon 2020 research and innovation action [733356]	SPICES project in Uganda from European Commission through the Horizon 2020 research and innovation action	This study was funded under the SPICES project in Uganda which received funding from the European Commission through the Horizon 2020 research and innovation action grant agreement No 733356 to implement and evaluate a comprehensive CVD prevention program in five settings: a rural & semi-urban community in a low-income country (Uganda), middle income (South Africa) and vulnerable groups in three high-income countries (Belgium, France and United Kingdom). The funder had no role in the design, decision to publish, or preparation of the manuscript. The contents of this article are the views of the authors alone and do not represent the views of the European Union.	[Anonymous], 2016, NAT POP HOUS CENS 20; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Baghaei A, 2010, ARCH MED SCI, V6, P24, DOI 10.5114/aoms.2010.13503; Bahendeka S, 2016, TROP MED INT HEALTH, V21, P405, DOI 10.1111/tmi.12663; Braun V, 2021, QUAL RES PSYCHOL, V18, P328, DOI 10.1080/14780887.2020.1769238; Chandraratne N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7142-1; Desa U, 2016, TRANSF OUR WORLD 203; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Everett -Murphy K, 2014, HELPING PEOPLE CHANG; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fottrell E, 2019, LANCET DIABETES ENDO, V7, P200, DOI 10.1016/S2213-8587(19)30001-4; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Kabwama Steven Ndugwa, 2018, BMC Obes, V5, P40, DOI 10.1186/s40608-018-0217-1; Kelly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145074; Lanier JB, 2016, AM FAM PHYSICIAN, V93, P919; Larsson SC., 2020, CIRC-GENOM PRECIS ME; Leblanc V, 2015, HEALTH PSYCHOL OPEN, V3, DOI 10.1177/2055102915622094; Ma CH, 2018, HEART LUNG, V47, P136, DOI 10.1016/j.hrtlng.2017.12.001; Markland D, 2005, J SOC CLIN PSYCHOL, V24, P811, DOI 10.1521/jscp.2005.24.6.811; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; MILLER KA, 1988, CONTEMP SOCIOL, V17, P253, DOI 10.2307/2070638; Mons U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1551; Musinguzi G, 2021, GLOB HEART, V16, DOI 10.5334/gh.917; Musinguzi G, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4095-0; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Musoke D., 2020, HLTH PEOPLE NATL COM, P405; Namey E, 2005, QUALITATIVE RES METH; Ndejjo R, 2021, PUBLIC HEALTH REV, V42, DOI 10.3389/phrs.2021.1604018; Ndejjo R, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09264-6; Ndejjo R, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8188-9; Neupane D, 2018, LANCET GLOB HEALTH, V6, pE66, DOI [10.1016/S2214-109X(17)30411-4, 10.1016/s2214-109x(17)30411-4]; Patrick H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-18; Nguyen QN, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-56; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Tian DY, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3756750; Toma A, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0647-0; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van de Vijver S, 2012, ETHNIC HEALTH, V17, P651, DOI 10.1080/13557858.2012.754409; Williams GC, 2006, HEALTH PSYCHOL, V25, P91, DOI 10.1037/0278-6133.25.1.91; World Health Organization, 2018, NONC DIS NCD COUNTR; World Health Organization, 2021, PHYS ACT GEN SWITZER; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2013, GLOB ACT PLAN PREV C	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263867	10.1371/journal.pone.0263867	http://dx.doi.org/10.1371/journal.pone.0263867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176069	gold, Green Published			2022-12-26	WOS:000777505200039
J	Suwimol, S; Pisit, T; Anchalee, A; Narisorn, K; Jureeporn, J; Wiroj, J				Suwimol, Sapwarobol; Pisit, Tangkijvanich; Anchalee, Avihingsanon; Narisorn, Kongruttanachok; Jureeporn, Jantarapakde; Wiroj, Jiamjarasrangsi			Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PREVALENCE; OVERWEIGHT; PREDICTOR; STIFFNESS	Neck circumference (NC) reflects the fat deposition in upper body and has potential to be used as a predictor of Non-Alcoholic Fatty Liver Disease (NAFLD). Our objectives were to examine the association of NC with NAFLD prevalence, and to determine the optimal cut-off of NC in identifying the presence of NAFLD among the employees of an academic institution in Bangkok, Thailand. In this cross-sectional study, 635 employees of an academic institution underwent anthropometric measurement and transient elastography following an overnight fast. NAFLD was defined as a CAP value >238 dB.m-1. The NAFLD prevalence in men and women were 66.17% and 46.22%, respectively. The mean NCs for men and women with NAFLD were higher (38.53 +/- 0.31 cm and 35.83 +/- 0.48 cm, respectively) than those without NAFLD (33.58 +/- 0.24 and 31.098 +/- 0.14 cm, respectively) (p< 0.001). Metabolic markers including age, weight, BMI, NC, WC, WHR, FBS, triglycerides were significantly higher, HDL was significantly lower among participants with NAFLD compared to those without NAFLD (p< 0.05). NC was independently associated with NAFLD among women with OR (95%CI) of 1.17 (1.05, 1.32). The optimal cut-offs of NC to predict NAFLD were 37.07 cm (sensitivity: 70.50%; specificity: 68.90%) and 32.07 cm (sensitivity: 70.70%; specificity: 62.10%), respectively for men and women. NC significantly correlated with NAFLD in women. The optimal cut-off points of 32 cm and 37 cm for men and women, which similar to Chinese populations. Therefore, it can be used as a cost-effective tool to predict NAFLD.	[Suwimol, Sapwarobol] Chulalongkorn Univ, Fac Allied Hlth Sci, Nutr & Dietet Dept, Med Food Res Grp, Bangkok, Thailand; [Pisit, Tangkijvanich; Jureeporn, Jantarapakde] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Bangkok, Thailand; [Anchalee, Avihingsanon] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Narisorn, Kongruttanachok] Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok, Thailand; [Wiroj, Jiamjarasrangsi] Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University	Suwimol, S (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Nutr & Dietet Dept, Med Food Res Grp, Bangkok, Thailand.	suwimol.sa@chula.ac.th			Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University [RA62/116]; Ratchadapisek Sompoch Endowment Fund under Telehealth Cluster, Chulalongkorn University; Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University; Medical Food Research group, Chulalongkorn University	Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University); Ratchadapisek Sompoch Endowment Fund under Telehealth Cluster, Chulalongkorn University; Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University; Medical Food Research group, Chulalongkorn University	This research was funded by Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, grant number RA62/116, the Ratchadapisek Sompoch Endowment Fund (2021) under Telehealth Cluster, Chulalongkorn University and Center of Excellence in Hepatitis and Liver Cancer, Chulalongkorn University. This research was also supported by the Medical Food Research group, Chulalongkorn University.	Aday LA, 1996, DESIGNING CONDUCTING; Asano J., 2013, JAPANESE J BIOMETRIC, V34, P21; Ataie-Jafari A, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0373-y; Augustin S, 2017, MED CLIN-BARCELONA, V149, P542, DOI 10.1016/j.medcli.2017.06.026; Ben-Noun L, 2003, OBES RES, V11, P226, DOI 10.1038/oby.2003.35; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Carazo A, 2011, OBES SURG, V21, P492, DOI 10.1007/s11695-010-0353-2; Donati G, 2004, GUT, V53, P1020, DOI 10.1136/gut.2003.027086; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Fantin F, 2017, EUR J PREV CARDIOL, V24, P1532, DOI 10.1177/2047487317721655; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Godoy-Matos AF, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00570-y; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hu XY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019974; Hu YY, 2014, J CLIN TRANSL ENDOCR, V1, P133, DOI 10.1016/j.jcte.2014.07.001; Huang BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118071; Jian CH, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/7982107; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kroll C, 2017, ANN HUM BIOL, V44, P667, DOI 10.1080/03014460.2017.1390153; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Li Q, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0060-z; Lin SL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010021; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Luo YQ, 2017, ENDOCRINE, V55, P822, DOI 10.1007/s12020-016-1151-y; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P7236, DOI 10.3748/wjg.v22.i32.7236; Mondal Samim Ali, 2018, Indian J Endocrinol Metab, V22, P347, DOI 10.4103/ijem.IJEM_31_18; Moura BAB, 2020, BRAZ J MED BIOL RES, V53, DOI [10.1590/1414-431x20209815, 10.1590/1414-431X20209815]; Patel P, 2013, J OBES, V2013, DOI 10.1155/2013/489187; Sakboonyarat B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09004-w; Salmanroghani H, 2019, TURK J GASTROENTEROL, V30, P163, DOI 10.5152/tjg.2018.18004; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; StataCorp, 2017, STATA STAT SOFTWARE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Summart Ueamporn, 2017, F1000Res, V6, P1630, DOI 10.12688/f1000research.12417.2; Tomah Shaheen, 2020, Clin Diabetes Endocrinol, V6, P9, DOI 10.1186/s40842-020-00097-1; Xia MF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00877; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	39	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263826	10.1371/journal.pone.0263826	http://dx.doi.org/10.1371/journal.pone.0263826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176047	Green Published, gold			2022-12-26	WOS:000777505200036
J	Zhuang, QF; Shao, H; Guan, DL				Zhuang, Qifeng; Shao, Hua; Guan, Dongliang			Operational daily evapotranspiration mapping at field scale based on SSEBop model and spatiotemporal fusion of multi-source remote sensing data	PLOS ONE			English	Article							ENERGY-BALANCE; RIVER-BASIN; FLUX; LANDSAT; MODIS; PARAMETERIZATION; RESOLUTION; SOIL	Accurate understanding of daily evapotranspiration (ET) at field scale is of great significance for agricultural water resources management. The operational simplified surface energy balance (SSEBop) model has been applied to estimate field scale ET with Landsat satellite imagery. However, there is still uncertainty in the ET time reconstruction for cloudy days based on limited clear days' Landsat ET fraction (ETf) computed by SSEBop. The Moderate Resolution Imaging Spectroradiometer (MODIS) remote sensing data can provide daily surface observation over clear-sky areas. This paper presented an enhanced gap-filling scheme for the SSEBop ET model, which improved the temporal resolution of Landsat ETf through the spatio-temporal fusion with SSEBop MODIS ETf on clear days and increased the time reconstruction accuracy of field-scale ET. The results were validated with the eddy covariance (EC) measurements over cropland in northwestern China. It indicated that the improved scheme performed better than the original SSEBop Landsat approach in daily ET estimation, with higher Nash-Sutcliffe efficiency (NSE, 0.75 vs. 0.70), lower root mean square error (RMSE, 0.95 mm.d(-1) vs. 1.05 mm.d(-1)), and percent bias (PBias, 16.5% vs. 25.0%). This fusion method reduced the proportion of deviation (13.3% vs. 25.5%) in the total errors and made the random error the main proportion, which can be reduced over time and space in regional ET estimation. It also evidently improved the underestimation of crop ET by the SSEBop Landsat scheme during irrigation before sowing and could more accurately describe the synergistic changes of soil moisture and cropland ET. The proposed MODIS and Landsat ETf fusion can significantly improve the accuracy of SSEBop in estimating field-scale ET.	[Zhuang, Qifeng; Shao, Hua; Guan, Dongliang] Nanjing Tech Univ, Coll Geomat Sci & Technol, Nanjing, Peoples R China	Nanjing Tech University	Zhuang, QF (corresponding author), Nanjing Tech Univ, Coll Geomat Sci & Technol, Nanjing, Peoples R China.	zhuangqf@njtech.edu.cn		Zhuang, Qifeng/0000-0002-4498-7922	Natural Science Foundation of the Jiangsu Higher Education Institutions of China [17KJB420002]; National Key Research and Development Project [2018YFC0704305-04]	Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This research was funded by the project of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 17KJB420002) and the National Key Research and Development Project (2018YFC0704305-04).	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2007, J IRRIG DRAIN ENG, V133, P395, DOI 10.1061/(ASCE)0733-9437(2007)133:4(395); Anderson MC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007506; Bastiaanssen WGM, 1998, J HYDROL, V212, P213, DOI [10.1016/S0022-1694(98)00254-6, 10.1016/S0022-1694(98)00253-4]; Bei XY, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102811; Boulet G, 2012, AGR FOREST METEOROL, V161, P148, DOI 10.1016/j.agrformet.2012.03.008; Cammalleri C, 2013, WATER RESOUR RES, V49, P4672, DOI 10.1002/wrcr.20349; Chen MS, 2016, J HYDROL, V536, P384, DOI 10.1016/j.jhydrol.2016.02.026; Fatolazadeh F, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138932; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Gao F, 2006, IEEE T GEOSCI REMOTE, V44, P2207, DOI 10.1109/TGRS.2006.872081; Gong P, 2019, SCI BULL, V64, P370, DOI 10.1016/j.scib.2019.03.002; Guzinski R, 2019, REMOTE SENS ENVIRON, V221, P157, DOI 10.1016/j.rse.2018.11.019; He MZ, 2019, REMOTE SENS ENVIRON, V230, DOI 10.1016/j.rse.2019.05.020; Kljun N, 2015, GEOSCI MODEL DEV, V8, P3695, DOI 10.5194/gmd-8-3695-2015; Li Y, 2017, AGR FOREST METEOROL, V244, P82, DOI 10.1016/j.agrformet.2017.05.023; Liu SM, 2011, HYDROL EARTH SYST SC, V15, P1291, DOI 10.5194/hess-15-1291-2011; Liu SM, 2018, VADOSE ZONE J, V17, DOI 10.2136/vzj2018.04.0072; Ma YF, 2018, REMOTE SENS ENVIRON, V216, P715, DOI 10.1016/j.rse.2018.07.019; Meng XY, 2017, WATER-SUI, V9, DOI 10.3390/w9100765; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; NORMAN JM, 1995, AGR FOREST METEOROL, V77, P263, DOI 10.1016/0168-1923(95)02265-Y; Paul G, 2014, J HYDROL, V509, P231, DOI 10.1016/j.jhydrol.2013.11.040; Purdy AJ, 2018, REMOTE SENS ENVIRON, V219, P1, DOI 10.1016/j.rse.2018.09.023; Santhi C, 2001, J AM WATER RESOUR AS, V37, P1169, DOI 10.1111/j.1752-1688.2001.tb03630.x; Senay GB, 2018, APPL ENG AGRIC, V34, P555, DOI 10.13031/aea.12614; Senay G.B., 2014, HYDROLOGY EARTH SYST, V11, P723, DOI [https://doi.org/10.5194/hessd-11-723-2014, DOI 10.5194/HESSD-11-723-2014]; Senay GB, 2017, REMOTE SENS ENVIRON, V202, P98, DOI 10.1016/j.rse.2017.05.005; Senay GB, 2016, REMOTE SENS ENVIRON, V185, P171, DOI 10.1016/j.rse.2015.12.043; Senay GB, 2013, J AM WATER RESOUR AS, V49, P577, DOI 10.1111/jawr.12057; Wang DK, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13020225; Yang K, 2008, J APPL METEOROL CLIM, V47, P276, DOI 10.1175/2007JAMC1547.1; Zhuang QF, 2021, AGRICULTURE-BASEL, V11, DOI [10.3390/agriculture11050424/, 10.3390/agriculture11050424]	34	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264133	10.1371/journal.pone.0264133	http://dx.doi.org/10.1371/journal.pone.0264133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176120	Green Published, gold			2022-12-26	WOS:000777505200084
J	Soares, ESD; Itavo, CCBF; Itavo, LCV; dos Santos, GT; Nazario, CED; Soares, ISS; Cavalheiro, LF				de Melo Soares, Evelyn Silva; Brandao Ferreira Itavo, Camila Celeste; Vinhas Itavo, Luis Carlos; dos Santos, Geraldo Tadeu; Domingues Nazario, Carlos Eduardo; Souza Soares, Israel Shekinah; Cavalheiro, Leandro Fontoura			Comparison of analytical methods for the fatty acid profile in ewes' milk	PLOS ONE			English	Article								Studies comparing methodologies for fatty acids are very important, since they can influence the quality and final quantification of the lipid fraction. Objective-to compare different extraction methods for total lipids and to evaluate the effect of these methodologies on the quantitative composition of fatty acids in milk of lactating ewes raised in tropical pastures. The methodologies used were simple direct transesterification, using the HPLC grade organic solvent n-hexane, Bligh; Dyer (cold extraction, extracting mixture proportions 5, 10, and 15 mL in a ratio of 2:1:1 (v/v/v) of chloroform-methanol-water). The fatty acid methyl esters were separated by gas chromatography coupled with a flame ionization detector (GC-FID). The results show that there was no significant difference (p < 0.05) in the total lipid content between the extraction methods. However, the Bligh's method; Dyer obtained the best yield of lipids to be extracted from ewe's milk, since the volume with 15 mL of the extraction solution was able to identify 87% of the chromatographic peaks. It was also observed that ewe's milk has a higher percentage of palmitic, stearic and oleic fatty acids, with percentages of 20.1%, 15.5% and 33.1%, respectively. Therefore, an extraction mixture with a volume of 15 mL used in this study may be an alternative to perform the extraction of milk fat from high lactating ewes in tropical pastures as a routine method, as it expresses the best lipid content of this food.	[de Melo Soares, Evelyn Silva; Brandao Ferreira Itavo, Camila Celeste; Vinhas Itavo, Luis Carlos; dos Santos, Geraldo Tadeu] Fac Vet Med & Anim Sci, Anim Sci Postgrad Program, Campo Grande, MS, Brazil; [Domingues Nazario, Carlos Eduardo; Souza Soares, Israel Shekinah; Cavalheiro, Leandro Fontoura] Inst Chem, Campo Grande, MS, Brazil; [Vinhas Itavo, Luis Carlos] Univ Fed Mato Grosso do Sul, Anim Sci Dept, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul	Itavo, LCV (corresponding author), Fac Vet Med & Anim Sci, Anim Sci Postgrad Program, Campo Grande, MS, Brazil.; Itavo, LCV (corresponding author), Univ Fed Mato Grosso do Sul, Anim Sci Dept, Campo Grande, MS, Brazil.	luis.itavo@ufms.br	ÍTAVO, CAMILA CELESTE BRANDÃO FERREIRA/GRX-9526-2022; Ítavo, Luís Carlos Vinhas/AEY-8425-2022	ÍTAVO, CAMILA CELESTE BRANDÃO FERREIRA/0000-0002-4790-8177; Ítavo, Luís Carlos Vinhas/0000-0001-6895-8483	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funding by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; the Fundacao de Apoio ao Desenvolvimento do Ensino. Ciencia e Tecnologia do Estado de Mato Grosso do Sul; and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. (Financing Code 001).	Aguilar C, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.0460141; Amores G, 2019, SEPARATIONS, V6, DOI 10.3390/separations6010014; Balthazar CF., 2017, FOOD SCI FOOD SAFETY, V16, P247, DOI [10.1111/1541-4337.12250, DOI 10.1111/1541-4337.12250]; Benson ME, 1999, J ANIM SCI, V77, P2330; Bligh EG DYER., 1959, CAN J BIOCHEM PHYS, V27, P911, DOI [10.1139/o59-099, DOI 10.1139/O59-099]; Zeola NMBL, 2015, REV BRAS ZOOTECN, V44, P146, DOI 10.1590/S1806-92902015000400003; Brum AAS., 2009, J BRAZILIAN CHEM SOC, V32, P849, DOI [10.1590/S0100-40422009000400005, DOI 10.1590/S0100-40422009000400005]; Djordjevic J, 2019, IOP C SER EARTH ENV, V333, DOI 10.1088/1755-1315/333/1/012057; Feng S, 2004, J DAIRY SCI, V87, P3785, DOI 10.3168/jds.S0022-0302(04)73517-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Inostroza K, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010092; Kasapidou E, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11092578; Maia Everaldo Lima, 1993, Revista do Instituto Adolfo Lutz, V53, P27; Moatsou G, 2019, SMALL RUMINANT RES, V180, P86, DOI 10.1016/j.smallrumres.2019.07.009; Rule DC, 1997, MEAT SCI, V46, P23, DOI 10.1016/S0309-1740(97)00008-9; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Rydlewski AA., 2020, VIRTUAL J CHEM, V12, P1; SAS Institute Inc, 2002, STAT AN SYST REL 9 0; Zacarchenco PB., 2013, J HLTH SCI, V15, P401, DOI [10.17921/2447-8938.2013v0n0p%25p, DOI 10.17921/2447-8938.2013V0N0P%25P]	19	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263071	10.1371/journal.pone.0263071	http://dx.doi.org/10.1371/journal.pone.0263071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171914	gold, Green Published			2022-12-26	WOS:000795889700012
J	Yu, XY; Zhang, KX; Zhang, YH				Yu, Xianyu; Zhang, Kaixiang; Zhang, Yanghui			Land use classification of open-pit mine based on multi-scale segmentation and random forest model	PLOS ONE			English	Article							LANDSLIDE SUSCEPTIBILITY; PREDICTION; ALGORITHM; SCALE; COVER; TREE	The mining industry production is an important pillar industry in China, while its extensive production activities have led to several ecological and environmental problems. Earth observation technology using high-resolution satellite imagery can help us efficiently obtain information on surface elements, surveying and monitoring various land occupation issues arising from open-pit mining production activities. Conventional pixel-based interpretation methods for high-resolution remote sensing images are restricted by "salt and pepper" noise caused by environmental factors, making it difficult to meet increasing requirements for monitoring accuracy. With the Jingxiang phosphorus mining area in Jingmen Hubei Province as the studied area, this paper uses a multi-scale segmentation algorithm to extract large-scale main characteristic information using a layered mask method based on the hierarchical structure of the image object. The remaining characteristic elements were classified and extracted in combination with the random forest model and characteristic factors to obtain land occupation information related mining industry production, which was compared with the results of the Classification and Regression Tree model. 23 characteristic factors in three aspects were selected, including spectral, geometric and texture characteristics. The methods employed in this study achieved 86% and 0.78 respectively in overall extraction accuracy analysis and the Kappa coefficient analysis, compared to 79% and 0.68 using the conventional method.	[Yu, Xianyu] Hubei Univ Technol, Sch Civil Engn Architecture & Environm, Wuhan, Peoples R China; [Zhang, Kaixiang] China Railway Siyuan Survey & Design Grp CO LTD, Wuhan, Peoples R China; [Zhang, Yanghui] CNIPA, Patent Off, Patent Examinat Cooperat Hubei Ctr, Wuhan, Peoples R China	Hubei University of Technology	Yu, XY (corresponding author), Hubei Univ Technol, Sch Civil Engn Architecture & Environm, Wuhan, Peoples R China.	yuxianyu@hbut.edu.cn			National Natural Science Foundation of China [41807297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Initials of the authors who received each award: X.Y. Grant numbers awarded to each author: 41807297. The full name of each funder: National Natural Science Foundation of China. URL of each funder website: http://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company China Railway Siyuan Survey and Design Group CO., LTD. provided support in the form of salaries for Zhang K.X., who is at the second rank. But this company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this authors are articulated in the author contributions' section.	Acharya TD, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071075; Althuwaynee OF, 2016, INT J REMOTE SENS, V37, P1190, DOI 10.1080/01431161.2016.1148282; Breiman L., 1984, CLASSIFICATION REGRE; Breiman L., 2001, MACH LEARN, V45, P5; Chen CH, 1997, INT J IMAG SYST TECH, V8, P491, DOI 10.1002/(SICI)1098-1098(1997)8:5<491::AID-IMA11>3.0.CO;2-Z; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen W, 2017, CATENA, V151, P147, DOI 10.1016/j.catena.2016.11.032; Chen Z, 2006, RES HIGH RESOLUTION; Dou J, 2019, SCI TOTAL ENVIRON, V662, P332, DOI 10.1016/j.scitotenv.2019.01.221; Du PJ, 2012, SENSORS-BASEL, V12, P4764, DOI 10.3390/s120404764; [李慧 Li Hui], 2015, [测绘学报, Acta Geodetica et Cartographica Sinica], V44, P791; Ling H, 2011, B SURVEYING MAPPING; Liu F, 2005, THEORY PRACTICE MINE; Liu Y, 2016, RES METHOD MULTISCAL; Ma G, 2017, YUNNAN GEOGRAPHIC EN, V29, P59; Ma X, 2017, REMOTE SENSING LAND, V29, P127; Mas JF, 1999, INT J REMOTE SENS, V20, P139, DOI 10.1080/014311699213659; Mezned N, 2014, INT GEOSCI REMOTE SE, DOI 10.1109/IGARSS.2014.6947568; Pelletier C, 2016, REMOTE SENS ENVIRON, V187, P156, DOI 10.1016/j.rse.2016.10.010; Peng Ying, 2009, Industry and Mine Automation, V35, P6; Pourghasemi HR, 2018, CATENA, V162, P177, DOI 10.1016/j.catena.2017.11.022; Segl K, 2001, IEEE T GEOSCI REMOTE, V39, P2080, DOI 10.1109/36.951105; Sui CH, 2015, IEEE GEOSCI REMOTE S, V12, P185, DOI 10.1109/LGRS.2014.2331674; Tang Z, 2005, J EARTH SCI ENV, V27, P1, DOI [10.3969/j.issn.1672-6561.2005.02. 001, DOI 10.3969/J.ISSN.1672-6561.2005.02.001]; Wang M, 2018, IEEE T GEOSCI REMOTE, V56, P228, DOI 10.1109/TGRS.2017.2745507; Weiss SM, 1994, MACHINE LEARNING P 1, P335; Witharana C, 2014, ISPRS J PHOTOGRAMM, V87, P108, DOI 10.1016/j.isprsjprs.2013.11.006; WOODCOCK CE, 1987, REMOTE SENS ENVIRON, V21, P311, DOI 10.1016/0034-4257(87)90015-0; [吴亚楠 Wu Yanan], 2017, [中国稀土学报, Journal of the Chinese Society of Rare Earths], V35, P262; Xue Q, 2017, REMOTE SENSING LAND, V29, P67; Yang H, 2015, LAND USE REMOTE SENS; Yong W, 2016, RES MULTISCALE SEGME; Youssef AM, 2016, LANDSLIDES, V13, P839, DOI 10.1007/s10346-015-0614-1; [于博文 Yu Bowen], 2017, [现代地质, Geoscience], V31, P843; Zhang KX, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6731-5	35	1	1	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263870	10.1371/journal.pone.0263870	http://dx.doi.org/10.1371/journal.pone.0263870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157729	Green Published, gold			2022-12-26	WOS:000788004500024
J	Hirata, T; Kobayashi, A; Furuse, T; Yamada, I; Tamura, M; Tomita, H; Tokoro, Y; Ninomiya, A; Fujihara, Y; Ikawa, M; Maeda, Y; Murakami, Y; Kizuka, Y; Kinoshita, T				Hirata, Tetsuya; Kobayashi, Atsushi; Furuse, Tamio; Yamada, Ikuko; Tamura, Masaru; Tomita, Hiroyuki; Tokoro, Yuko; Ninomiya, Akinori; Fujihara, Yoshitaka; Ikawa, Masahito; Maeda, Yusuke; Murakami, Yoshiko; Kizuka, Yasuhiko; Kinoshita, Taroh			Loss of the N-acetylgalactosamine side chain of the GPI-anchor impairs bone formation and brain functions and accelerates the prion disease pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT ANTIGEN; CENTRAL-NERVOUS-SYSTEM; ALKALINE-PHOSPHATASE; TOXOPLASMA-GONDII; KURU PLAQUES; LIPID RAFTS; SIALIC-ACID; PROTEIN; SCRAPIE; PRP	Glycosylphosphatidylinositol (GPI) is a posttranslational glycolipid modification of proteins that anchors proteins in lipid rafts on the cell surface. Although some GPI-anchored proteins (GPI-APs), including the prion protein PrPC, have a glycan side chain composed of N-acetylgalactosamine (GalNAc)-galactose-sialic acid on the core structure of GPI glycolipid, in vivo functions of this GPI-GalNAc side chain are largely unresolved. Here, we investigated the physiological and pathological roles of the GPI-GalNAc side chain in vivo by knocking out its initiation enzyme, PGAP4, in mice. We show that Pgap4 mRNA is highly expressed in the brain, particularly in neurons, and mass spectrometry analysis confirmed the loss of the GalNAc side chain in PrPC GPI in PGAP4-KO mouse brains. Furthermore, PGAP4-KO mice exhibited various phenotypes, including an elevated blood alkaline phosphatase level, impaired bone formation, decreased locomotor activity, and impaired memory, despite normal expression levels and lipid raft association of various GPI-APs. Thus, we conclude that the GPI-GalNAc side chain is required for in vivo functions of GPI-APs in mammals, especially in bone and the brain. Moreover, PGAP4-KO mice were more vulnerable to prion diseases and died earlier after intracerebral inoculation of the pathogenic prion strains than wildtype mice, highlighting the protective roles of the GalNAc side chain against prion diseases.	[Hirata, Tetsuya; Tokoro, Yuko; Kizuka, Yasuhiko] Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan; [Kobayashi, Atsushi] Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Furuse, Tamio; Yamada, Ikuko; Tamura, Masaru] RIKEN BioResource Res Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Tomita, Hiroyuki] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Ninomiya, Akinori] Core Instrumentat Facil, Suita, Osaka, Japan; [Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Dept Expt Genome Res, Suita, Osaka, Japan	Gifu University; Hokkaido University; RIKEN; Gifu University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Inst Glyco Core Res iGCORE, Gifu, Japan.; Kinoshita, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.; Kinoshita, T (corresponding author), Dept Expt Genome Res, Suita, Osaka, Japan.	kizuka@gifu-u.ac.jp; tkinoshi@biken.osaka-u.ac.jp	Furuse, Tamio/I-2163-2019; ikawa, masahito/A-5315-2009; Fujihara, Yoshitaka/G-2043-2011	Furuse, Tamio/0000-0002-9276-6040; ikawa, masahito/0000-0001-9859-6217; Fujihara, Yoshitaka/0000-0001-8332-3507; Kizuka, Yasuhiko/0000-0002-3181-9743	Japan Science and Technology (JST) [20K15746, JPMJAX201B]; Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science (JSPS) [20H03207]; CREST grant from JST [18070267]; Takeda Science Foundation; Tokyo Biochemical Research Foundation	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST grant from JST; Takeda Science Foundation(Takeda Science Foundation (TSF)); Tokyo Biochemical Research Foundation	This work was partially supported by a Grant-in-Aid for Early-Career Scientists to T. H. (20K15746) , an ACT-X grant (JPMJAX201B to T. H.) from Japan Science and Technology (JST) , Dr Yoshifumi Jigami Memorial Fund from The Society of Yeast Scientists to T. H. and a grant from Kato Memorial Bioscience Foundation to T. H., a Grant-in-Aid for Sci-entific Research (B) to Y. K. (20H03207) , a Leading Initiative forExcellent Young Researchers (LEADER) project (Y. K.) from the Japan Society for the Promotion of Science (JSPS) , a CREST grant (18070267 to Y. K.) from JST, a grant from the Takeda Science Foundation to Y. K., and a grant from the Tokyo Biochemical Research Foundation to Y. K.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CHANDLER RL, 1961, LANCET, V1, P1378; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Horn D, 2014, EUR J HUM GENET, V22, P762, DOI 10.1038/ejhg.2013.241; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Karp NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15475; Kasahara K, 2002, NEUROCHEM RES, V27, P823, DOI 10.1023/A:1020265225916; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; Knaus A, 2019, AM J HUM GENET, V105, P395, DOI 10.1016/j.ajhg.2019.06.009; Knaus A, 2018, GENOME MED, V10, DOI 10.1186/s13073-017-0510-5; Kobayashi A, 2020, J BIOL CHEM, V295, P7789, DOI 10.1074/jbc.RA120.013444; Liu YS, 2020, BIOCHEM SOC T, V48, P1129, DOI 10.1042/BST20191142; Lukacs M, 2020, HUM MOL GENET, V29, P1205, DOI 10.1093/hmg/ddaa046; Lukacs M, 2019, ELIFE, V8, DOI 10.7554/eLife.45248; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; Michalovicz LT, 2019, J NEUROCHEM, V150, P420, DOI 10.1111/jnc.14800; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; MUKASA R, 1995, ARCH BIOCHEM BIOPHYS, V318, P182, DOI 10.1006/abbi.1995.1219; Munesue Y, 2018, NEUROSCI LETT, V668, P43, DOI 10.1016/j.neulet.2018.01.014; Murakami H, 2012, BIOCHEM BIOPH RES CO, V417, P1235, DOI 10.1016/j.bbrc.2011.12.116; Murakami Y, 2019, AM J HUM GENET, V105, P384, DOI 10.1016/j.ajhg.2019.05.019; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Puig B, 2014, PRION, V8, P11, DOI 10.4161/pri.27892; Qiu SF, 2010, BIOL PSYCHIAT, V68, P197, DOI 10.1016/j.biopsych.2010.02.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangel A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-8; Rodriguez de Los Santos M., 2021, P NATL ACAD SCI USA, V118; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Smith HL, 2020, NEURON, V105, P855, DOI 10.1016/j.neuron.2019.12.014; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Tan RPA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00378; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Wang YT, 2013, J BIOL CHEM, V288, P25490, DOI 10.1074/jbc.M113.492611; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wang YC, 2019, J BIOL CHEM, V294, P5038, DOI 10.1074/jbc.RA119.007472; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	77	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101720	10.1016/j.jbc.2022.101720	http://dx.doi.org/10.1016/j.jbc.2022.101720			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151686	gold, Green Published			2022-12-26	WOS:000789394500005
J	Teoh, PJ; An, O; Chung, TH; Vaiyapuri, T; Raju, A; Hoppe, MM; Toh, SHM; Wang, W; Chan, MC; Fullwood, MJ; Jeyasekharan, AD; Tergaonkar, V; Chen, LL; Yang, H; Chng, WJ				Teoh, Phaik Ju; An, Omer; Chung, Tae-Hoon; Vaiyapuri, Thamil; Raju, Anandhkumar; Hoppe, Michal M.; Toh, Sabrina H. M.; Wang, Wilson; Chan, Ming Chun; Fullwood, Melissa J.; Jeyasekharan, Anand D.; Tergaonkar, Vinay; Chen, Leilei; Yang, Henry; Chng, Wee Joo			p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain)	ONCOGENE			English	Article							CHECKPOINT KINASE INHIBITOR; DNA-REPAIR; PLASMA-CELLS; DEXAMETHASONE; AZD7762; CANCER; DAMAGE; LENALIDOMIDE; CARFILZOMIB; MECHANISMS	Recurrent cytogenetic abnormalities are the main hallmark of multiple myeloma (MM) and patients having 2 or more high-risk prognostic events are associated with extremely poor outcome. 17p13(del) and 1q21(gain) are critical and independent high-risk cytogenetic markers, however, the biological significance underlying the poor outcome in MM patients having co-occurrence of both these chromosomal aberrations has never been interrogated. Herein, we identified that patients harbouring concomitant 17p13(del) with 1q21(gain) demonstrated the worst prognosis as compared to patients with single- (either 17p13(del) or 1q21(gain)) and with no chromosomal events (WT for both chromosomal loci); and they are highly enriched for genomic instability (GI) signature. We discovered that the GI feature in the patients with concomitant 17p13(del)-1q21(gain) was recapitulating the biological properties of myeloma cells with co-existing p53-deficiency and NEIL1 mRNA-hyper-editing (associated with chromosome 17p and 1q, respectively) that have inherent DNA damage response (DDR) and persistent activation of Chk1 pathway. Importantly, this became a vulnerable point for therapeutic targeting whereby the cells with this co-abnormalities demonstrated hyper-sensitivity to siRNA- and pharmacological-mediated-Chk1 inhibition, as observed at both the in vitro and in vivo levels. Mechanistically, this was attributable to the synthetic lethal relationship between p53-NEIL1-Chk1 abnormalities. The Chk1 inhibitor (AZD7762) tested showed good synergism with standard-of-care myeloma drugs, velcade and melphalan, thus further reinforcing the translational potential of this therapeutic approach. In summary, combination of NEIL1-p53 abnormalities with an ensuing Chk1 activation could serve as an Achilles heel and predispose MM cells with co-existing 1q21(gain) and 17p13(del) to therapeutic vulnerability for Chk1 inhibition.	[Teoh, Phaik Ju; Jeyasekharan, Anand D.; Chng, Wee Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Teoh, Phaik Ju; An, Omer; Chung, Tae-Hoon; Hoppe, Michal M.; Toh, Sabrina H. M.; Fullwood, Melissa J.; Jeyasekharan, Anand D.; Chen, Leilei; Yang, Henry; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Vaiyapuri, Thamil; Raju, Anandhkumar; Tergaonkar, Vinay] ASTAR, Inst Mol & Cell Biol IMCB, Singapore, Singapore; [Wang, Wilson; Chan, Ming Chun] Natl Univ Singapore Hosp, Dept Orthopaed Surg, Singapore, Singapore; [Wang, Wilson; Chan, Ming Chun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore, Singapore; [Jeyasekharan, Anand D.; Chng, Wee Joo] Natl Univ Canc Inst, Singapore, Singapore; [Jeyasekharan, Anand D.; Chng, Wee Joo] Natl Univ Hlth Syst, Dept Haematol Oncol, Natl Univ Canc Inst Singapore, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Teoh, PJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.; Teoh, PJ (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.	mdctpju@nus.edu.sg	wang, wilson/GYD-5657-2022	Teoh, Phaik Ju/0000-0001-8350-1641; Hoppe, Michal Marek/0000-0002-0364-6080	Ministry of Education of Singapore [MOE2019-T2-1-083]; NMRC OF-YIRG grant [NMRC/OFYIRG/032/201700]	Ministry of Education of Singapore(Ministry of Education, Singapore); NMRC OF-YIRG grant	This study was funded by Tier 2 grant provided by the Ministry of Education of Singapore (MOE2019-T2-1-083) and NMRC OF-YIRG grant (NMRC/OFYIRG/032/201700). We would like to thank Pamela Chng for helping out with tissue culture and functional assays, Y.F. Goh, J.Q. Thng and W.N. Fam for helping with the processing and isolation of normal CD138 + plasma cells from healthy volunteers' samples and M.Y. Koh for assisting in lentivirus work.	Agnelli L, 2013, EXPERT OPIN BIOL TH, V13, pS55, DOI 10.1517/14712598.2013.793305; Avet-Loiseau H, 2010, J CLIN ONCOL, V28, P4630, DOI 10.1200/JCO.2010.28.3945; Herrero AB, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00098; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bolli N, 2018, LEUKEMIA, V32, P2604, DOI 10.1038/s41375-018-0037-9; Boyd KD, 2012, LEUKEMIA, V26, P349, DOI 10.1038/leu.2011.204; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang H, 2011, LEUKEMIA RES, V35, P95, DOI 10.1016/j.leukres.2010.05.002; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Chung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066361; Cottini F, 2015, CANCER DISCOV, V5, P972, DOI 10.1158/2159-8290.CD-14-0943; Dimopoulos MA, 2010, LEUKEMIA, V24, P1769, DOI 10.1038/leu.2010.175; Eischen CM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026096; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gkotzamanidou M, 2016, BLOOD, V128, P1214, DOI 10.1182/blood-2016-01-691618; Gourzones-Dmitriev C, 2013, CELL CYCLE, V12, P2760, DOI 10.4161/cc.25951; Gu CY, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01380-0; Hao SY, 2021, MODERN PATHOL, V34, P327, DOI 10.1038/s41379-020-00669-7; Hayden PJ, 2007, HUM MOL GENET, V16, P3117, DOI 10.1093/hmg/ddm273; Herrero AB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122003; Herrero AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121581; Jakubowiak AJ, 2013, LEUKEMIA, V27, P2351, DOI 10.1038/leu.2013.152; Janz S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00424; Kawasumi M, 2014, CANCER RES, V74, P7534, DOI 10.1158/0008-5472.CAN-14-2650; Kumar SK, 2019, CANCER J, V25, P59, DOI 10.1097/PPO.0000000000000353; Landau HJ, 2012, MOL CANCER THER, V11, P1781, DOI 10.1158/1535-7163.MCT-11-0949; Lazzari E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01890-w; Ma ZK, 2012, MOL MED REP, V6, P897, DOI 10.3892/mmr.2012.999; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Neri P, 2013, EXPERT OPIN BIOL TH, V13, pS69, DOI 10.1517/14712598.2013.814637; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Qiu ZJ, 2018, RADIOTHER ONCOL, V126, P450, DOI 10.1016/j.radonc.2017.09.043; Ray A, 2016, BRIT J HAEMATOL, V174, P397, DOI 10.1111/bjh.14065; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Schmidt TM, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00474-8; Shah V, 2018, LEUKEMIA, V32, P102, DOI 10.1038/leu.2017.179; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Sonneveld P, 2016, HAEMATOLOGICA, V101, P396, DOI 10.3324/haematol.2015.129189; Sousa MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055493; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Tembhare P, 2012, LEUKEMIA LYMPHOMA, V53, P721, DOI 10.3109/10428194.2011.623257; Teoh PJ, 2021, LEUKEMIA, V35, P346, DOI 10.1038/s41375-020-01076-2; Teoh PJ, 2020, HAEMATOLOGICA, V105, P1391, DOI 10.3324/haematol.2019.221176; Teoh PJ, 2018, BLOOD, V132, P1304, DOI 10.1182/blood-2018-02-832576; Walker BA, 2019, LEUKEMIA, V33, P159, DOI 10.1038/s41375-018-0196-8; Yan, 2014, LEUKEMIA, V14, P102; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492	51	0	0	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2106	2121		10.1038/s41388-022-02227-8	http://dx.doi.org/10.1038/s41388-022-02227-8		FEB 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35190641				2022-12-26	WOS:000758960300001
J	Barnes, TC; Candy, SG; Morris, S; Johnson, DD				Barnes, Thomas C.; Candy, Steven G.; Morris, Stephen; Johnson, Daniel D.			Understanding discarding in trawl fisheries: A model based demersal case study with implications for mitigating and assessing impacts	PLOS ONE			English	Article							BYCATCH REDUCTION DEVICES; BY-CATCH; MEDITERRANEAN FISHERIES; LANDING OBLIGATION; PRAWN TRAWLERS; AUSTRALIA; QUEENSLAND; MORTALITY; ELASMOBRANCHS; INSIGHTS	Despite research and public scrutiny over recent decades, discarding continues to be an issue for trawl fisheries. Previous research demonstrates that environmental, biological, operational, legislative and socioeconomic drivers affect a fisher's decision to discard an organism. Therefore, the reduction of fishery discards requires a better understanding of fishery-specific drivers. Despite considerable research and mitigation, further work is required to reduce discarding to acceptable levels (currently similar to 50% in Australia). To better understand the drivers of discarding, this study used a modelling approach to determine environmental and operational factors that drive discarding in the New South Wales (NSW) ocean prawn trawl fishery (OPT). Further, the study investigated the relationship between the discarded number of individuals from all functional species groups (i.e. elasmobranchs, crustaceans and fish combined) and the retained catch weight. This model was also run on just fish partly due to their disproportionally high contribution to the discard assemblage (e.g. 76% of all species or higher taxon) and importance (e.g. to the ecosystem and fisheries). The results quantified relationships of environmental and operational drivers of discarding and the relationship of fish discarding and retained catch weight was found to be linear. However, the identified relationships appear complicated and, whilst an important first step, more work is required to identify all drivers influencing discarding practices. We, in combination with previous research, suggest implementation of effort quotas may be a suitable management initiative to reduce discarding and its impact; at least whilst more research is conducted to better understand this complex process. Furthering our understanding of discarding is urgent given its global impact and the rate of discarding in the OPT.	[Barnes, Thomas C.; Morris, Stephen; Johnson, Daniel D.] Port Stephens Fisheries Inst, New South Wales Dept Primary Ind, Nelson Bay, NSW, Australia; [Barnes, Thomas C.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Candy, Steven G.] Scandy Stat Modelling Pty Ltd, Blackmans Bay, Tas, Australia	NSW Department of Primary Industries; University of Tasmania	Barnes, TC (corresponding author), Port Stephens Fisheries Inst, New South Wales Dept Primary Ind, Nelson Bay, NSW, Australia.; Barnes, TC (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	tom.barnes@dpi.nsw.gov.au		Barnes, Thomas C./0000-0003-1493-1407	NSW Commercial Fishing Trust [581-1]; Marine Estate Management Strategy (Initiative 5.5)	NSW Commercial Fishing Trust; Marine Estate Management Strategy (Initiative 5.5)	Funding was provided by the NSW Commercial Fishing Trust (Trust Fund Project no. 581-1 to Daniel D. Johnson) and the Marine Estate Management Strategy (Initiative 5.5 to Daniel D. Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Steven G. Candy is the sole trader with SCANDY STATISTICAL MODELLING PTY LTD and provided some statistical advice for a fee. This company had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali SF., 2020, ENV DNA; [Anonymous], 2011, INT GUID BYC MAN RED; Attwood CG., POTENTIAL IMPA UNPUB, P84; Barnes TC, 2021, ENDANGER SPECIES RES, V44, P327, DOI 10.3354/esr01100; Bellido JM, 2011, HYDROBIOLOGIA, V670, P317, DOI 10.1007/s10750-011-0721-5; Booth DJ, 2007, ESTUAR COAST SHELF S, V72, P102, DOI 10.1016/j.ecss.2006.10.003; Borges L, 2021, ICES J MAR SCI, V78, P134, DOI 10.1093/icesjms/fsaa200; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2012, FISH RES, V113, P68, DOI 10.1016/j.fishres.2011.09.006; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Campbell MJ, 2020, FISH RES, V224, DOI 10.1016/j.fishres.2019.105456; Campbell MJ, 2018, MAR FRESHWATER RES, V69, P551, DOI 10.1071/MF17161; Catchpole TL, 2005, FISH RES, V72, P45, DOI 10.1016/j.fishres.2004.10.012; Courtney AJ, 2006, FISH RES, V80, P136, DOI 10.1016/j.fishres.2006.05.005; Courtney AJ, 2014, FISH RES, V157, P113, DOI 10.1016/j.fishres.2014.03.021; Criales-Hernandez MI, 2006, FISH RES, V77, P333, DOI 10.1016/j.fishres.2005.10.005; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Damalas D, 2018, MEDITERR MAR SCI, V19, P459, DOI 10.12681/mms.14195; Damalas D, 2015, ICES J MAR SCI, V72, P2600, DOI 10.1093/icesjms/fsv141; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Di Lorenzo M, 2020, FISH FISH, V21, P906, DOI 10.1111/faf.12469; Ellis JR, 2017, J FISH BIOL, V90, P653, DOI 10.1111/jfb.13197; EU, COMM DEL REG EU 2017, V14; Feekings J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036409; Flood M., 2014, STATUS KEY AUSTR FIS; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Gucu AC, 2012, TURK J FISH AQUAT SC, V12, P817, DOI 10.4194/1303-2712-v12_4_10; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hall S.J., 1999, EFFECTS FISHING MARI, P274, DOI [10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9, DOI 10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9]; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Heard M, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou040; Heather M., 2019, NO DALY LEADER; Helidoniotis F., 2020, STOCK ASSESSMENT E K; HILL BJ, 1990, AUST J MAR FRESH RES, V41, P53; Hill BJ, 2000, FISH RES, V48, P277, DOI 10.1016/S0165-7836(00)00185-5; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Industries NDoP, IND NDOP, P99; Itaya K, 2007, FISHERIES SCI, V73, P1007, DOI 10.1111/j.1444-2906.2007.01430.x; Johnson D, 2021, NSW STOCK STATUS SUM; Kelleher K., 2005, 470 FAO; Kennelly SJ, 1998, FISH RES, V36, P217, DOI 10.1016/S0165-7836(98)00091-5; Kennelly SJ, 2020, FISH FISH, V21, P1046, DOI 10.1111/faf.12494; Knotek R, 2020, ICES J MAR SCI, V77, P256, DOI 10.1093/icesjms/fsz177; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Little AS, 2015, FISH FISH, V16, P576, DOI 10.1111/faf.12080; Macbeth WG, 2012, FISH RES, V134, P29, DOI 10.1016/j.fishres.2012.07.012; Maina I, 2018, J SEA RES, V139, P10, DOI 10.1016/j.seares.2018.06.001; Murawski S, 1996, J NORTHWEST ATL FISH, P19; Noack T, 2020, MAR POLICY, V115, DOI 10.1016/j.marpol.2020.103852; NSW DPI, 2017, NEW S WAL MAR EST TH, P251; Perez Roda MA., 2019, FAO FISHERIES AQUACU; Plet-Hansen KS, 2017, MAR POLICY, V76, P98, DOI 10.1016/j.marpol.2016.11.028; Punt AE, 2006, FISH RES, V79, P239, DOI 10.1016/j.fishres.2006.04.007; R Core Team, 2020, R LANG ENV STAT COMP; Rochet MJ, 2002, ICES J MAR SCI, V59, P538, DOI 10.1006/jmsc.2002.1182; Rodrigues JL, 2020, FISH RES, V230, DOI 10.1016/j.fishres.2020.105587; Saila SB., 1983, IMPORTANCE ASSESSMEN; Silburn J, 2020, FISH RES, V224, DOI 10.1016/j.fishres.2019.105459; Stergiou K.I., 1998, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V35, P490; Sterling DJ., 2005, THESIS CURTIN U TECH; Stewart J, 2020, NSW STOCK STATUS SUM; Sumpton W, 2005, FISH RES, V71, P335, DOI 10.1016/j.fishres.2004.07.003; Taylor MD, 2021, REG STUD MAR SCI, V47, DOI 10.1016/j.rsma.2021.101924; Taylor MD, 2020, REG STUD MAR SCI, V35, DOI 10.1016/j.rsma.2020.101206; Tsagarakis K, 2014, ICES J MAR SCI, V71, P1219, DOI 10.1093/icesjms/fst074; Uhlmann SS, 2007, DIS AQUAT ORGAN, V76, P173, DOI 10.3354/dao076173; Uhlmann SS, 2019, EUROPEAN LANDING OBLIGATION: REDUCING DISCARDS IN COMPLEX, MULTI-SPECIES AND MULTI-JURISDICTIONAL FISHERIES, P1, DOI 10.1007/978-3-030-03308-8; van Putten I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233237; Wang N, 2020, ICES J MAR SCI, V77, P680, DOI 10.1093/icesjms/fsz205; WATSON R A, 1989, Memoirs of the Queensland Museum, V27, P611; Weinberg KL, 2008, FISH RES, V93, P265, DOI 10.1016/j.fishres.2008.05.011; White WT, 2004, MAR BIOL, V144, P439, DOI 10.1007/s00227-003-1218-1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood S., 2017, PACKAGE MGCV R PACKA, P1; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Ye YM, 2000, FISH RES, V45, P9, DOI 10.1016/S0165-7836(99)00105-8; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	77	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264055	10.1371/journal.pone.0264055	http://dx.doi.org/10.1371/journal.pone.0264055			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176093	Green Published, gold			2022-12-26	WOS:000777505200069
J	Chang, YL; Xing, YX; Dong, YA; Li, XW; Lin, SB; Chen, Y; Sun, XL				Chang, Yali; Xing, Yuxian; Dong, Yanan; Li, Xiwang; Lin, Songbo; Chen, Yi; Sun, Xiaoling			Biological evidences for successive oogenesis and egg-laying of Matsumurasca onukii	PLOS ONE			English	Article							NILAPARVATA-LUGENS STAL; BROWN PLANTHOPPER; OVIPOSITION; HEMIPTERA; CICADELLIDAE	Tea plant (Camellia sinensis) is one of the most important horticultural cash crops, and tea green leafhopper (Matsumurasca onukii) is an extremely harmful sap-sucking pest of tea plant. Serious generation overlapping, which is mainly caused by the long oviposition period, leads to poor control effect of pesticides on this pest in the tea plantation. But the intuitive evidences of continuous oogenesis and egg-laying of this pest are still lacking, which seriously hindered the development of genetic control methods. Here, we clarified the main structures of the inner reproductive system of tea green leafhopper female adult. Oviposition behaviors were monitored as well, and six oviposition steps were recorded. According to the maturity of oocytes, the maturity stages of the reproductive system under different copulation periods were classified into 4 stages. For female adults at stage IV, mature and immature oocytes were presented simultaneously, and the developmental levels of oocytes were asynchronous among different ovarioles. The proportion of gravid females with mature oocytes significantly increased when the continuous copulation time was prolonged. In sync with the development of the ovary maturity, female adults started to slightly deposit eggs at the 5th day, and then increased dramatically. In addition, we found that, whether mature or immature, oocytes in the ovarioles always emitted green fluorescence under blue light excitation, which in turn provide solid proof for the new egg detection method from the insect physiology point of view.	[Chang, Yali; Chen, Yi] Xinyang Agr & Forestry Univ, Henan Key Lab Tea Plants Comprehens Utilizat Sout, Henan Engn Res Ctr Tea Proc & Testing, Tea Sci Dept, Xinyang, Henan, Peoples R China; [Chang, Yali; Xing, Yuxian; Dong, Yanan; Li, Xiwang; Lin, Songbo; Sun, Xiaoling] Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China	Xinyang Agriculture & Forestry University; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Chen, Y (corresponding author), Xinyang Agr & Forestry Univ, Henan Key Lab Tea Plants Comprehens Utilizat Sout, Henan Engn Res Ctr Tea Proc & Testing, Tea Sci Dept, Xinyang, Henan, Peoples R China.; Sun, XL (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Key Lab Tea Biol & Resources Utilizat, Minist Agr, Hangzhou, Zhejiang, Peoples R China.	chenyitea@163.com; xlsun@mail.tricaas.com			National Natural Science Foundation of China [31772180]; Science and Technology Research Project of Henan Province [182102110181]; Postdoctoral Research Project of Zhejiang Province [ZJ2020134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Henan Province; Postdoctoral Research Project of Zhejiang Province	This work were financially supported by the National Natural Science Foundation of China (31772180), the Science and Technology Research Project of Henan Province (182102110181) and the Postdoctoral Research Project of Zhejiang Province (ZJ2020134). And the corresponding funders were Xiaoling Sun, Yichen and Yali Chang, respectively. Xiaoling Sun had a role in the conceptualization, methodology and reviewing of the manuscript. Yichen played a part in the reviewing of the manuscript. Yali Chang played a role in the investigation, methodology, data curation and original draft preparation of the manuscript.	Bao YY, 2019, J INTEGR AGR, V18, P716, DOI [10.1016/s2095-3119(17)61888-4, 10.1016/S2095-3119(17)61888-4]; CARLSON OV, 1970, ANN ENTOMOL SOC AM, V63, P516, DOI 10.1093/aesa/63.2.516; CHEN JC, 1979, ACTA ENTOMOL SINICA, V22, P280; Chen Lilin, 2019, Journal of Plant Protection, V46, P989, DOI 10.13802/j.cnki.zwbhxb.2019.2018196; DREW R A I, 1969, Journal of the Australian Entomological Society, V8, P21; Hattori M, 2002, J INSECT BEHAV, V15, P283, DOI 10.1023/A:1015445202906; Herrmann JV, 2004, J PLANT DIS PROTECT, V111, P193; Hix R. L., 2001, California Agriculture, V55, P19, DOI 10.3733/ca.v055n04p19; Hummel NA, 2006, ANN ENTOMOL SOC AM, V99, P920, DOI 10.1603/0013-8746(2006)99[920:AAHORO]2.0.CO;2; Hummel NA, 2006, ARTHROPOD STRUCT DEV, V35, P111, DOI 10.1016/j.asd.2006.05.001; Jin Shan, 2012, Scientia Agricultura Sinica, V45, P255; Kendra PE, 2006, FLA ENTOMOL, V89, P144, DOI 10.1653/0015-4040(2006)89[144:AOFRSI]2.0.CO;2; Klowden MJ., 2008, PHYSL SYSTEM INSECT, V2nd; Li H.L., 2008, THESIS FUJIAN AGR FO; Lu Fang, 2011, Chinese Journal of Applied Entomology, V48, P1394; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MOCHIDA O., 1964, JAP J APPL ENTOMOL ZOOL, V8, P141, DOI 10.1303/jjaez.8.141; Ouyang Q, 2014, J BIO, V23, P24; Qiao L, 2015, RESPONSE EMPOASCA ON; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Sanderson ED., 1905, USDA FARMERS B, V223, P18; Saxena RC, 1979, BROWN PLANTHOPPER TH; Shi LQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168439; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Su M., 2014, THESIS NW A F U; Tan JC., 2011, PEST CONTROL TEA PLA, V2nd; Tang Y, 2020, INSECT MOL BIOL, V29, P183, DOI 10.1111/imb.12617; Tian SZ, 1986, CHIN TEA, V1, P32; Vieira G, 2020, NEOTROP ENTOMOL, V49, P662, DOI 10.1007/s13744-020-00782-x; Wu ZX, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.593613; Xu L.Y., 2013, THESIS FUJIAN AGR FO; Xu Y, 2021, SYST ENTOMOL, V46, P266, DOI 10.1111/syen.12461; Xu Z.F., 2009, GEN ENTOMOLOGY; Yao Q, 2020, INSECTS, V11, DOI 10.3390/insects11100707; Yue Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00482; Zhang BB, 2012, THESIS NW A F U	36	0	0	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263933	10.1371/journal.pone.0263933	http://dx.doi.org/10.1371/journal.pone.0263933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176082	gold, Green Published			2022-12-26	WOS:000777505200049
J	Hajihashemi, M; Samani, KA				Hajihashemi, Mahdi; Samani, Keivan Aghababaei			Multi-strategy evolutionary games: A Markov chain approach	PLOS ONE			English	Article							FIXATION PROBABILITY; COOPERATION; PAPER; DYNAMICS; BIODIVERSITY; PROMOTES; MUTANT; GRAPHS	Interacting strategies in evolutionary games is studied analytically in a well-mixed population using a Markov chain method. By establishing a correspondence between an evolutionary game and Markov chain dynamics, we show that results obtained from the fundamental matrix method in Markov chain dynamics are equivalent to corresponding ones in the evolutionary game. In the conventional fundamental matrix method, quantities like fixation probability and fixation time are calculable. Using a theorem in the fundamental matrix method, conditional fixation time in the absorbing Markov chain is calculable. Also, in the ergodic Markov chain, the stationary probability distribution that describes the Markov chain's stationary state is calculable analytically. Finally, the Rock, scissor, paper evolutionary game are evaluated as an example, and the results of the analytical method and simulations are compared. Using this analytical method saves time and computational facility compared to prevalent simulation methods.	[Hajihashemi, Mahdi; Samani, Keivan Aghababaei] Isfahan Univ Technol, Dept Phys, Esfahan, Iran	Isfahan University of Technology	Hajihashemi, M (corresponding author), Isfahan Univ Technol, Dept Phys, Esfahan, Iran.	mehdi.hajihashemi@alumni.iut.ac.ir			Iran National Science Foundation (INSF) [99007738]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This research is financially supported by Iran National Science Foundation (INSF) under Postdoctoral Research Grant number 99007738.	Altrock PM, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.022407; Altrock PM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011925; Amaral MA, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042304; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Askari M, 2017, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aa79b2; Askari M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042707; Black AJ, 2012, TRENDS ECOL EVOL, V27, P337, DOI 10.1016/j.tree.2012.01.014; Broom M, 2008, P ROY SOC A-MATH PHY, V464, P2609, DOI 10.1098/rspa.2008.0058; Broom M, 2011, J STAT THEORY PRACT, V5, P369, DOI 10.1080/15598608.2011.10412035; Brush E, 2018, J THEOR BIOL, V443, P56, DOI 10.1016/j.jtbi.2018.01.005; Cheng HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07486; Debarre F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4409; Dehghani MA, 2021, PLOS COMPUT BIOL, P17; Duh M, 2021, CHAOS SOLITON FRACT, V144, DOI 10.1016/j.chaos.2021.110720; Ewens W.J., 2004, MATH POPULATION GENE; Frean M, 2001, P ROY SOC B-BIOL SCI, V268, P1323, DOI 10.1098/rspb.2001.1670; Frean M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0211; Grinstead C. M., 1997, INTRO PROBABILITY; Hajihashemi M, 2021, EUR PHYS J B, V94, DOI 10.1140/epjb/s10051-021-00061-7; Hajihashemi M, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.042304; Hilbe C, 2014, P NATL ACAD SCI USA, V111, P16425, DOI 10.1073/pnas.1407887111; Hilbe C, 2011, B MATH BIOL, V73, P2068, DOI 10.1007/s11538-010-9608-2; Hindersin L, 2016, BIOSYSTEMS, V150, P87, DOI 10.1016/j.biosystems.2016.08.010; Hindersin L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004437; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J., 1988, THEORY EVOLUTION DYN; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Il Park J, 2021, PHYS REV E, V104, DOI 10.1103/PhysRevE.104.024133; Jiang LL, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021912; Kabir KMA, 2021, APPL MATH COMPUT, V394, DOI 10.1016/j.amc.2020.125767; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Li XP, 2021, J STAT MECH-THEORY E, V2021, DOI 10.1088/1742-5468/abd4cf; Li YM, 2019, PHYSICA A, V521, P248, DOI 10.1016/j.physa.2019.01.088; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Mobilia M, 2010, J THEOR BIOL, V264, P1, DOI 10.1016/j.jtbi.2010.01.008; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Park HJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57857; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Rock Fisher L., 2008, ROCK PAPER SCISSORS; Shakarian P, 2012, BIOSYSTEMS, V107, P66, DOI 10.1016/j.biosystems.2011.09.006; Shen C, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180199; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38608; Szolnoki A, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.062307; Szolnoki A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0735; Tanimoto J., 2019, EVOLUTIONARY EC; TANIMOTO J., 2021, SOCIOPHYSICS APPROAC; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vasconcelos VV, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.058301; Verma T, 2021, CHAOS SOLITON FRACT, V153, DOI 10.1016/j.chaos.2021.111538; Wang XF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227902; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wu B, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.042303; Xu B, 2013, PHYSICA A, V392, P4997, DOI 10.1016/j.physa.2013.06.039; Yoshida T, 2021, PHYS REV E, V104, DOI 10.1103/PhysRevE.104.025003; Yu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep28585; Zeeman E C, GLOBAL THEORY DYNAMI, P471	72	1	1	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263979	10.1371/journal.pone.0263979	http://dx.doi.org/10.1371/journal.pone.0263979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176094	Green Published, gold			2022-12-26	WOS:000777505200055
J	Golinelli, D; Sanmarchi, F; Capodici, A; Gribaudo, G; Altini, M; Rosa, S; Esposito, F; Fantini, MP; Lenzi, J				Golinelli, Davide; Sanmarchi, Francesco; Capodici, Angelo; Gribaudo, Giorgia; Altini, Mattia; Rosa, Simona; Esposito, Francesco; Fantini, Maria Pia; Lenzi, Jacopo			Variations of the quality of care during the COVID-19 pandemic affected the mortality rate of non-COVID-19 patients with hip fracture	PLOS ONE			English	Article								Introduction As COVID-19 roared through the world, governments worldwide enforced containment measures that affected various treatment pathways, including those for hip fractures (HFs). This study aimed to measure process and outcome indicators related to the quality of care provided to non-COVID-19 elderly patients affected by HF in Emilia-Romagna, a region of Italy severely hit by the pandemic. Methods We collected the hospital discharge records of all patients admitted to the hospitals of Emilia-Romagna with a diagnosis of HF from January to May in the years 2019 (pre-pandemic period) and 2020 (pandemic period). We analyzed surgery rate, surgery delays, length of hospital stay, timely rehabilitation, and 30-day mortality for each HF patient. We evaluated monthly data (2020 vs. 2019) with the chi-square and t-test, where appropriate. Logistic regression was used to investigate the differences in 30-day mortality. Results Our study included 5379 patients with HF. In April and May 2020, there was a significant increase in the proportion of HF patients that did not undergo timely surgery. In March 2020, we found a significant increase in mortality (OR = 2.22). Male sex (OR = 1.92), age >= 90 years (OR = 4.33), surgery after 48 hours (OR = 3.08) and not receiving surgery (OR = 6.19) were significantly associated with increased mortality. After adjusting for the aforementioned factors, patients hospitalized in March 2020 still suffered higher mortality (OR = 2.21). Conclusions There was a reduction in the overall quality of care provided to non-COVID-19 elderly patients affected by HF, whose mortality increased in March 2020. Patients' characteristics and variations in processes of care partially explained this increase. Policymakers and professionals involved in the management of COVID-19 patients should be aware of the needs of patients with other health needs, which should be carefully investigated and included in future emergency preparedness and response plans.	[Golinelli, Davide; Sanmarchi, Francesco; Capodici, Angelo; Gribaudo, Giorgia; Rosa, Simona; Esposito, Francesco; Fantini, Maria Pia; Lenzi, Jacopo] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy; [Altini, Mattia] AUSL Romagna, Healthcare Adm, Ravenna, Italy	University of Bologna; AUSL della Romagna	Sanmarchi, F (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy.	francesco.sanmarchi@gmail.com	Sanmarchi, Francesco/AAX-2311-2021; Golinelli, Davide/Q-8059-2016; Lenzi, Jacopo/W-4835-2017	Sanmarchi, Francesco/0000-0001-8288-0563; Golinelli, Davide/0000-0001-7331-9520; Lenzi, Jacopo/0000-0003-2882-4223; Capodici, Angelo/0000-0002-7505-0702; Esposito, Francesco/0000-0001-7775-1695				Amer Geriatrics Soc, 2020, J AM GERIATR SOC, V68, P908, DOI 10.1111/jgs.16477; Baldi E, 2021, DISASTER MED PUBLIC, V15, pE8, DOI 10.1017/dmp.2020.338; Beaupre LA, 2019, INJURY, V50, P950, DOI 10.1016/j.injury.2019.03.031; Brugel M, 2021, ONCOLOGIST, V26, pE338, DOI 10.1002/onco.13578; Caminiti C, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040880; Campo G, 2021, LANCET REG HEALTH-EU, V3, DOI 10.1016/j.lanepe.2021.100055; Clement Nicholas D, 2021, J Clin Orthop Trauma, V12, P43, DOI 10.1016/j.jcot.2020.11.007; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Gibertoni D, 2021, METHODSX, V8, DOI 10.1016/j.mex.2021.101257; Golinelli D, 2021, PEERJ, V9, DOI 10.7717/peerj.12046; Golinelli D, 2021, AM J EMERG MED, V50, P22, DOI 10.1016/j.ajem.2021.07.010; Golinelli D, 2021, HEALTH SERV INSIGHTS, V14, DOI 10.1177/1178632921991122; Golinelli D, 2020, APPL HEALTH ECON HEA, V18, P739, DOI 10.1007/s40258-020-00608-2; Hadfield JN, 2020, INJURY, V51, P1411, DOI 10.1016/j.injury.2020.06.006; Iommi M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240899; Lavikainen P, 2020, J GERONTOL A-BIOL, V75, P2184, DOI 10.1093/gerona/glaa199; Liebensteiner MC, 2020, KNEE SURG SPORT TR A, V28, P1705, DOI 10.1007/s00167-020-06032-2; Liem IS, 2013, INJURY, V44, P1403, DOI 10.1016/j.injury.2013.06.018; Lo Noce C, 2021, ISS; Di Martino A, 2020, INJURY, V51, P1684, DOI 10.1016/j.injury.2020.04.033; Moyet J, 2019, INT ORTHOP, V43, P1449, DOI 10.1007/s00264-018-3928-5; Napoli N, 2020, NAT REV ENDOCRINOL, V16, P467, DOI 10.1038/s41574-020-0379-z; Persiani P, 2021, J PAIN RES, V14, P575, DOI 10.2147/JPR.S285814; Randelli PS, 2020, KNEE SURG SPORT TR A, V28, P1683, DOI 10.1007/s00167-020-06023-3; Rasidovic D, 2020, BONE JOINT OPEN, V1, P696, DOI 10.1302/2633-1462.111.BJO-2020-0132.R1; Richards M, 2020, NAT CANCER, V1, P565, DOI 10.1038/s43018-020-0074-y; Roberts KC, 2015, J AM ACAD ORTHOP SUR, V23, P138, DOI 10.5435/JAAOS-D-14-00433; Sanmarchi F, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.17359; Santi L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248995; Slullitel PA, 2020, INT ORTHOP, V44, P1887, DOI 10.1007/s00264-020-04769-6; Tedesco D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3523-x; Veronese N, 2018, INJURY, V49, P1458, DOI 10.1016/j.injury.2018.04.015; Wheaton MG, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.567379	33	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263944	10.1371/journal.pone.0263944	http://dx.doi.org/10.1371/journal.pone.0263944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171967	gold, Green Published, Green Submitted			2022-12-26	WOS:000795889700048
J	Wu, HZ; Ding, XY; Hu, XY; Zhao, Q; Chen, QC; Sun, T; Li, YL; Guo, H; Li, M; Gao, ZM; Yao, WF; Zhao, L; Li, K; Wei, MJ				Wu, Huizhe; Ding, Xiangyu; Hu, Xiaoyun; Zhao, Qing; Chen, Qiuchen; Sun, Tong; Li, Yalun; Guo, Hao; Li, Meng; Gao, Ziming; Yao, Weifan; Zhao, Lin; Li, Kai; Wei, Minjie			LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer	ONCOGENE			English	Article							RNA-BINDING PROTEINS; M(6)A MODIFICATION; MESSENGER-RNA; NONCODING RNAS; METHYLATION; CROSSTALK; ROLES	Insulin-like growth factor-2 mRNA-binding protein 2 (IGF2BP2, also known as IMP2), a novel class III N6-methyladenosine (m(6)A) reader, has recently gained attention due to its critical functions in recognizing and stabilizing m(6)A modified oncogenic transcripts. However, whether and how long non-coding RNAs (lncRNAs) facilitate IMP2's role as m(6)A "reader" remains elusive, particularly in colorectal cancer (CRC). Here, we demonstrated that oncogenic LINC021 specifically bound with the m(6)A "reader" IMP2 protein and enhanced the mRNA stability of MSX1 and JARID2 in an m(6)A regulatory manner during CRC tumorigenesis and pathogenesis. Specifically, a remarkable upregulation of LINC021 was confirmed in CRC cell lines and clinical tissues (n = 130). High level of LINC021acted as an independent prognostic predictor for CRC clinical outcomes. Functional assays demonstrated that LINC021 exerted its functions as an oncogene to aggravate CRC malignant phenotypes including enhanced cell proliferation, colony formation, migration capabilities, and reduced cell apoptosis. Mechanistically, LINC021 directly recognized IMP2 protein, the latter enhanced the mRNA stability of transcripts such as MSX1 and JARID2 by recognizing their m(6)A-modified element RGGAC. Thus, these findings uncovered an essential LINC021/IMP2/MSX1 and JARID2 signaling axis in CRC tumorigenesis, which provided profound insights into our understanding of m(6)A modification regulated by lncRNA in CRC initiation and progression and shed light on the targeting of this axis for CRC treatment.	[Wu, Huizhe; Ding, Xiangyu; Hu, Xiaoyun; Zhao, Qing; Chen, Qiuchen; Sun, Tong; Guo, Hao; Li, Meng; Yao, Weifan; Zhao, Lin; Wei, Minjie] China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang 110122, Peoples R China; [Wu, Huizhe; Ding, Xiangyu; Hu, Xiaoyun; Zhao, Qing; Chen, Qiuchen; Sun, Tong; Guo, Hao; Li, Meng; Yao, Weifan; Zhao, Lin; Wei, Minjie] China Med Univ, Liaoning Key Lab Mol Targeted Antitumor Drug Dev, Shenyang 110122, Peoples R China; [Wu, Huizhe; Ding, Xiangyu; Hu, Xiaoyun; Zhao, Qing; Chen, Qiuchen; Sun, Tong; Guo, Hao; Li, Meng; Yao, Weifan; Zhao, Lin; Wei, Minjie] China Med Univ, Liaoning Canc Immune Peptide Drug Engn Technol Re, Shenyang 110122, Peoples R China; [Wu, Huizhe; Ding, Xiangyu; Hu, Xiaoyun; Zhao, Qing; Chen, Qiuchen; Sun, Tong; Guo, Hao; Li, Meng; Yao, Weifan; Zhao, Lin; Wei, Minjie] China Med Univ, Ctr Key Lab Precis Diag & Treatment Gastrointesti, Minist Educ, Shenyang 110122, Peoples R China; [Li, Yalun] China Med Univ, Affiliated Hosp 1, Dept Anorectal Surg, Shenyang 110001, Peoples R China; [Gao, Ziming; Li, Kai] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, Minist Educ,Key Lab Precis Diag & Treatment Gastr, Shenyang 110001, Peoples R China; [Wei, Minjie] Liaoning Med Diag & Treatment Ctr, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Wei, MJ (corresponding author), China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang 110122, Peoples R China.; Wei, MJ (corresponding author), China Med Univ, Liaoning Key Lab Mol Targeted Antitumor Drug Dev, Shenyang 110122, Peoples R China.; Wei, MJ (corresponding author), China Med Univ, Liaoning Canc Immune Peptide Drug Engn Technol Re, Shenyang 110122, Peoples R China.; Wei, MJ (corresponding author), China Med Univ, Ctr Key Lab Precis Diag & Treatment Gastrointesti, Minist Educ, Shenyang 110122, Peoples R China.; Li, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Surg Oncol & Gen Surg, Minist Educ,Key Lab Precis Diag & Treatment Gastr, Shenyang 110001, Peoples R China.; Wei, MJ (corresponding author), Liaoning Med Diag & Treatment Ctr, Shenyang, Peoples R China.	cmu_likai@163.com; mjwei@cmu.edu.cn	Hu, Xiao/GQI-0007-2022	Hu, Xiao/0000-0003-1128-4099	National Natural Science Foundation of China [81872905, 82073884]; Science and Technology Innovative Foundation for Young and Middle-aged Scientists of Shenyang City [RC200382]; Shenyang High Level Talent Innovation and Entrepreneurship Team [2019-SYRCCY-B-01]; Major Special S&T Projects in Liaoning Province [2019JH1/10300005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovative Foundation for Young and Middle-aged Scientists of Shenyang City; Shenyang High Level Talent Innovation and Entrepreneurship Team; Major Special S&T Projects in Liaoning Province	This work was supported by grants from the National Natural Science Foundation of China (81872905, 82073884), Science and Technology Innovative Foundation for Young and Middle-aged Scientists of Shenyang City (RC200382), Shenyang High Level Talent Innovation and Entrepreneurship Team (2019-SYRCCY-B-01), and Major Special S&T Projects in Liaoning Province [2019JH1/10300005].	Adhikari A, 2019, J BIOL CHEM, V294, P19451, DOI 10.1074/jbc.RA119.010060; Ban YY, 2020, MOL ONCOL, V14, P1282, DOI 10.1002/1878-0261.12676; Chatterji P, 2018, TRENDS MOL MED, V24, P490, DOI 10.1016/j.molmed.2018.03.008; Dai FS, 2020, MOL THER-NUCL ACIDS, V22, P62, DOI 10.1016/j.omtn.2020.08.004; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Ferre F, 2016, BRIEF BIOINFORM, V17, P106, DOI 10.1093/bib/bbv031; Francescangeli F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122936; He LE, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1109-9; Heppt MV, 2018, J INVEST DERMATOL, V138, P141, DOI 10.1016/j.jid.2017.05.038; Hou PF, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01857-2; Hu XG, 2020, CELL DEATH DIFFER, V27, P1782, DOI 10.1038/s41418-019-0461-z; Huang HL, 2020, CANCER CELL, V37, P270, DOI 10.1016/j.ccell.2020.02.004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hunten S, 2015, MOL CELL PROTEOMICS, V14, P2609, DOI 10.1074/mcp.M115.050237; Khan RIN, 2021, GENOMICS, V113, P2860, DOI 10.1016/j.ygeno.2021.06.013; Li T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1038-7; Liu HM, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02833-y; Lu SX, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01204-0; Ma S, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0805-7; Marmol I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010197; Meyer J, 2019, CLIN GASTROENTEROL H, V17, P1448, DOI 10.1016/j.cgh.2018.07.031; Muller S, 2019, NUCLEIC ACIDS RES, V47, P375, DOI 10.1093/nar/gky1012; Ni W, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1079-y; Qu F, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.645823; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Shen CQ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01190-w; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Wang LY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225758; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang TY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01204-7; Wang YL, 2020, THERANOSTICS, V10, P9407, DOI 10.7150/thno.48520; Wang Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1105-0; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yi YC, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01233-2; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zhang J., 2020, CELL DEATH DIS, V11; Zhang YH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01706-8; Zhao W, 2020, MOL THER-NUCL ACIDS, V19, P405, DOI 10.1016/j.omtn.2019.11.022; Zhao YC, 2021, THERANOSTICS, V11, P4549, DOI 10.7150/thno.54967; Zhou B, 2021, CANCER LETT, V497, P89, DOI 10.1016/j.canlet.2020.10.002; Zhou DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16777-6; Zhou ZJ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01216-3; Zhu PP, 2021, ONCOGENE, V40, P1609, DOI 10.1038/s41388-020-01638-9	46	3	3	5	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1959	1973		10.1038/s41388-022-02189-x	http://dx.doi.org/10.1038/s41388-022-02189-x		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35173309				2022-12-26	WOS:000756457400001
J	Hong, SY; Lu, YC; Hsiao, SH; Kao, YR; Lee, MH; Lin, YP; Wang, CY; Wu, CW				Hong, Shiao-Ya; Lu, Yi-Chun; Hsiao, Shih-Hsin; Kao, Yu-Rung; Lee, Meng-Hsuan; Lin, Yi-Ping; Wang, Cheng-Yi; Wu, Cheng-Wen			Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma	ONCOGENE			English	Article							AURORA-A KINASE; FAMILY; GROWTH	CBL family proteins (CBL, CBLB and CBLC in mammals) are E3 ubiquitin ligases of protein tyrosine kinases. CBL mediates the lysosomal degradation of activated EGFR through K63-linked ubiquitination, while CBLC has an oncogenic function by positively regulating EGFR activation through K6 and K11-linked ubiquitination in EGFR mutant lung adenocarcinoma (LAD). Here, we used immunoprecipitation and mass spectrometry to study the CBLC interactome, and found that CBLC is also involved in cell cycle regulation by stabilizing Aurora kinase A (AURKA). CBLC interacted with the kinase domain of AURKA and positively regulated the stability of AURKA by conjugating monoubiquitination and K11/K63-linked polyubiquitination, which are protective from degrading K11/K48 polyubiquitination. CBLC depletion markedly decreased the half-life of AURKA in cycloheximide-treated LAD cells. When LAD cells were synchronized with double thymidine block at the G1/S boundary and then released into mitotic arrest, CBLC depletion delayed the accumulation and activation of AURKA and prevented cancer cells from entering mitosis. CBLC deficiency significantly delayed cell cycle progression, reduced the mitotic population, and increased apoptosis of LAD cells. Targeting CBLC inhibited tumor growth of LAD cells and enhanced their sensitivity to paclitaxel in xenograft models. Immunohistochemical staining of the tissue microarray also revealed a positive correlation between the expression of CBLC and AURKA in normal and LAD tissues, further supporting the positive regulation of AURKA expression by CBLC. In summary, these findings indicate that the oncogenic E3 ligase CBLC plays a role in mitotic entry by stabilizing AURKA via ubiquitination in LAD. This work demonstrates that targeting CBLC combined with paclitaxel might be a potential option for the treatment of LAD patients who have no available targeted therapies.	[Hong, Shiao-Ya; Lu, Yi-Chun] Cardinal Tien Hosp, Med Res Ctr, New Taipei, Taiwan; [Hong, Shiao-Ya; Kao, Yu-Rung; Wu, Cheng-Wen] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsiao, Shih-Hsin] Taipei Med Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lee, Meng-Hsuan; Lin, Yi-Ping] Natl Yang Ming Chiao Tung Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Wang, Cheng-Yi] Cardinal Tien Hosp, Dept Internal Med, New Taipei, Taiwan; [Wang, Cheng-Yi] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Wu, Cheng-Wen] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University	Wu, CW (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Wang, CY (corresponding author), Cardinal Tien Hosp, Dept Internal Med, New Taipei, Taiwan.; Wang, CY (corresponding author), Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan.; Wu, CW (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan.	cywang@mospital.com; chengwenwu@nycu.edu.tw		Hong, Shiao-Ya/0000-0003-4302-1509; Wang, Cheng-Yi/0000-0001-7426-0743	Ministry of Science and Technology of Taiwan [MOST 109-2314-B-567-001-MY2, MOST 110-2314-B-567-004, MOST 109-2320-B-A49-001]; Cardinal Tien Hospital [CTH 110A-2207, CTH 110A-NDMC-2227]; Academia Sinica [AS-CFII-108-115, AS-CFII-108-113]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Cardinal Tien Hospital; Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST 109-2314-B-567-001-MY2 and MOST 110-2314-B-567-004 to SYH, MOST 109-2320-B-A49-001 to CWW) and Cardinal Tien Hospital (CTH 110A-2207 to SYH and CTH 110A-NDMC-2227 to CYW). We also thank the core facilities of IBMS, funded by Academia Sinica Core Facility and Innovative Instrument Projects (AS-CFII-108-115, AS-CFII-108-113).	Abdelbaki A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.243071; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Bertolin G, 2020, CELL MOL LIFE SCI, V77, P1031, DOI 10.1007/s00018-019-03310-2; Caracciolo D, 2020, INT J CANCER, V147, P2658, DOI 10.1002/ijc.33038; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; Du RJ, 2021, MOL CANCER, V20, DOI 10.1186/s12943-020-01305-3; Frankum J, 2015, ONCOTARGET, V6, P10746, DOI 10.18632/oncotarget.3628; Galetta D, 2020, CANCERS, P12; Genova C, 2020, EXPERT REV RESP MED, V14, P367, DOI 10.1080/17476348.2020.1714441; Gilberto S, 2017, J CELL BIOL, V216, P2259, DOI 10.1083/jcb.201703170; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hirst J, 2017, AGING-US, V9, P1945, DOI 10.18632/aging.101291; Hong SY, 2018, CANCER RES, V78, P4984, DOI 10.1158/0008-5472.CAN-17-3858; Hsu FF, 2017, ONCOGENE, V36, P6805, DOI 10.1038/onc.2017.294; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; Kim B, 2007, CANCER RES, V67, P7431, DOI 10.1158/0008-5472.CAN-07-0003; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Lee WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138789; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lin XR, 2020, AM J CANCER RES, V10, P2705; Lindon C, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00307; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Moghe S, 2012, BIOL OPEN, V1, P82, DOI 10.1242/bio.2011018; Mou PK, 2021, EXP MOL MED, V53, P835, DOI 10.1038/s12276-021-00635-6; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Do TV, 2017, ONCOTARGET, V8, P50376, DOI 10.18632/oncotarget.18970; Willems E, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0040-6; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358	42	2	2	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1907	1917		10.1038/s41388-022-02180-6	http://dx.doi.org/10.1038/s41388-022-02180-6		FEB 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35149839				2022-12-26	WOS:000754149000001
J	Cookson, R; Winichayakul, S; Xue, H; Richardson, K; Moraga, R; Laugraud, A; Biswas, A; Bryan, G; Roberts, N				Cookson, Ruth; Winichayakul, Somrutai; Xue, Hong; Richardson, Kim; Moraga, Roger; Laugraud, Aurelie; Biswas, Ambarish; Bryan, Greg; Roberts, Nick			Evolution and conserved functionality of organ size and shape regulator PEAPOD	PLOS ONE			English	Article							SEQUENCES; PLANTS; TRANSCRIPTION; MORPHOLOGY; PHYLOGENY; CURVATURE; ALIGNMENT; PATTERNS; MUTATION; HISTORY	Transcriptional regulator PEAPOD (PPD) and its binding partners comprise a complex that is conserved throughout many core eudicot plants with regard to protein domain sequence and the function of controlling organ size and shape. Orthologues of PPD also exist in the basal angiosperm Amborella trichopoda, various gymnosperm species, the lycophyte Selaginella moellendorffii and several monocot genera, although until now it was not known if these are functional sequences. Here we report constitutive expression of orthologues from species representing diverse taxa of plant phylogeny in the Arabidopsis Delta ppd mutant. PPD orthologues from S. moellendorffii, gymnosperm Picea abies, A. trichopoda, monocot Musa acuminata, and dicot Trifolium repens were able to complement the mutant and return it to the wild-type phenotype, demonstrating the conserved functionality of PPD throughout vascular plants. In addition, analysis of bryophyte genomes revealed potential PPD orthologues in model liverwort and moss species, suggesting a more primitive lineage for this conserved regulator. The Poaceae (grasses) lack the genes for the PPD module and the reason for loss of the complex from this economically significant family is unclear, given that grasses were the last of the flowering plants to evolve. Bioinformatic analyses identified putative PPD orthologues in close relatives of the Poaceae, indicating that the explanation for absence of PPD in the grasses may be more complex than previously considered. Understanding the mechanisms which led to loss of PPD from the grasses will provide insight into evolution of the Poaceae.	[Cookson, Ruth; Winichayakul, Somrutai; Xue, Hong; Richardson, Kim; Bryan, Greg; Roberts, Nick] AgResearch Ltd, Grasslands Res Ctr, Plant Biotechnol, Palmerston North, New Zealand; [Moraga, Roger; Laugraud, Aurelie; Biswas, Ambarish] AgResearch Ltd, Grasslands Res Ctr, Bioinformat & Stat, Palmerston North, New Zealand; [Moraga, Roger] Tea Break Bioinformat Ltd, Palmerston North, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand	Cookson, R; Roberts, N (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Plant Biotechnol, Palmerston North, New Zealand.	ruth.cookson@agresearch.co.nz; nick.roberts@agresearch.co.nz		Moraga, Roger/0000-0001-7806-1135; Cookson, Ruth/0000-0001-6567-7256	Ministry of Business, Innovation and Employment [C10X0815]; AgResearch Strategic Science Investment Fund [PRJ0110170]	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); AgResearch Strategic Science Investment Fund	Funding for this work was provided by the Ministry of Business, Innovation and Employment Contract #C10X0815 (Exploiting Opportunities from Forage Plant Genomics) and the AgResearch Strategic Science Investment Fund Contract #PRJ0110170. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auliya I, 2019, ANN C ENV SCI SOC IT; Baekelandt A, 2018, PLANT PHYSIOL, V178, P217, DOI 10.1104/pp.18.00327; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Ballester P, 2021, PLANT CELL, V33, P3645, DOI 10.1093/plcell/koab236; Bolser D, 2016, METHODS MOL BIOL, V1374, P115, DOI 10.1007/978-1-4939-3167-5_6; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Can MY, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0518-3; Chater CCC, 2017, PLANT PHYSIOL, V174, P624, DOI 10.1104/pp.17.00183; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DJGaRKS LigroneR., 2020, PHILOS T BIOL SCI, V355, P795; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; Kanazashi Y, 2018, PLANT CELL REP, V37, P553, DOI 10.1007/s00299-018-2251-3; Karidas P, 2015, J EXP BOT, V66, P2107, DOI 10.1093/jxb/erv015; Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Li N, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007218; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; LINDER HP, 1985, GRANA, V24, P65, DOI 10.1080/00173138509429917; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Menges M, 2007, PLANT PHYSIOL, V145, P1558, DOI 10.1104/pp.107.104901; Naito K, 2017, BREEDING SCI, V67, P151, DOI 10.1270/jsbbs.16184; Nunes TDG, 2020, PLANT J, V101, P780, DOI 10.1111/tpj.14552; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Perez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084891; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; Raissig MT, 2017, SCIENCE, V355, P1215, DOI 10.1126/science.aal3254; Roberts N., 2016, International Patent, Patent No. [WO2016071830A2, 2016071830]; SACK FD, 1994, AM J BOT, V81, P339, DOI 10.2307/2445461; Schneider M, 2021, TRENDS PLANT SCI, V26, P220, DOI 10.1016/j.tplants.2020.10.012; Scott RW, 2010, PLANT BIOTECHNOL J, V8, P912, DOI 10.1111/j.1467-7652.2010.00522.x; Shimamura M, 2016, PLANT CELL PHYSIOL, V57, P230, DOI 10.1093/pcp/pcv192; Shtein I, 2017, ANN BOT-LONDON, V119, P1021, DOI 10.1093/aob/mcw275; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Sun Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42418; Swinnen G., 2020, PREPRINT; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vaten A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-11; Wang ZB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11192; Watson L, 1992, FAMILIES FLOWERING P; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; White DWR., 2017, BIORXIV; Wu ZL, 2019, NEW PHYTOL, V223, P220, DOI 10.1111/nph.15766; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhu Y, 2020, J INTEGR PLANT BIOL, V62, P812, DOI 10.1111/jipb.12841	52	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263928	10.1371/journal.pone.0263928	http://dx.doi.org/10.1371/journal.pone.0263928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148336	gold, Green Published			2022-12-26	WOS:000800108800042
J	Cline, C; Bell, TM; Facemire, P; Zeng, XK; Briese, T; Lipkin, WI; Shamblin, JD; Esham, HL; Donnelly, GC; Johnson, JC; Hensley, LE; Honko, AN; Johnston, SC				Cline, Curtis; Bell, Todd M.; Facemire, Paul; Zeng, Xiankun; Briese, Thomas; Lipkin, W. Ian; Shamblin, Joshua D.; Esham, Heather L.; Donnelly, Ginger C.; Johnson, Joshua C.; Hensley, Lisa E.; Honko, Anna N.; Johnston, Sara C.			Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route	PLOS ONE			English	Article							HENIPAVIRUS INFECTION; AEROSOL EXPOSURE; MODEL; MANIFESTATIONS; EPIDEMIOLOGY; ENCEPHALITIS; PATHOGENESIS; BANGLADESH; FEATURES	Disease associated with Nipah virus infection causes a devastating and often fatal spectrum of syndromes predominated by both respiratory and neurologic conditions. Additionally, neurologic sequelae may manifest months to years later after virus exposure or apparent recovery. In the two decades since this disease emerged, much work has been completed in an attempt to understand the pathogenesis and facilitate development of medical countermeasures. Here we provide detailed organ system-specific pathologic findings following exposure of four African green monkeys to 2.41 x 10(5) pfu of the Malaysian strain of Nipah virus. Our results further substantiate the African green monkey as a model of human Nipah virus disease, by demonstrating both the respiratory and neurologic components of disease. Additionally, we demonstrate that a chronic phase of disease exists in this model, that may provide an important opportunity to study the enigmatic late onset and relapse encephalitis as it is described in human disease.	[Cline, Curtis; Bell, Todd M.; Facemire, Paul; Zeng, Xiankun] US Army Med Res Inst Infect Dis, Pathol Div, Ft Detrick, MD 21702 USA; [Briese, Thomas; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA; [Shamblin, Joshua D.; Esham, Heather L.] US Army Med Res Inst Infect Dis, Vet Med Div, Ft Detrick, MD USA; [Donnelly, Ginger C.; Johnston, Sara C.] US Army Med Res Inst Infect Dis, Virol Div, Ft Detrick, MD USA; [Johnson, Joshua C.] Moderna, Infect Dis Res Portfolio Strategy & Operat, Boston, MA USA; [Hensley, Lisa E.] NIAID, Off Chief Scientist, Integrated Res Facil, Ft Detrick, MD USA; [Honko, Anna N.] Boston Univ, Nonclin Studies Unit, Natl Emerging Infect Dis Labs, Sch Med, Boston, MA USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; Columbia University; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Boston University	Cline, C; Bell, TM (corresponding author), US Army Med Res Inst Infect Dis, Pathol Div, Ft Detrick, MD 21702 USA.	curtis.r.cline.mil@mail.mil; todd.m.bell.mil@mail.mil		Zeng, Xiankun (Kevin)/0000-0003-3526-8755; Hensley, Lisa/0000-0003-1188-4342	 [AI57158];  [1882367]	; 	This work was supported by AI57158 (Northeast Biodefense Center) and performed under USAMRIID project number 1882367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2014, HAND CLINIC, V123, P663, DOI 10.1016/B978-0-444-53488-0.00032-8; Chakraborty A, 2016, EPIDEMIOL INFECT, V144, P371, DOI 10.1017/S0950268815001314; Clayton BA, 2013, ZOONOSES PUBLIC HLTH, V60, P69, DOI 10.1111/j.1863-2378.2012.01501.x; Cole EC, 1998, AM J INFECT CONTROL, V26, P453, DOI 10.1016/S0196-6553(98)70046-X; Cong Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005532; Dawes BE, 2019, PATHOG DIS, V77, DOI 10.1093/femspd/ftz023; Epstein JH, 2020, P NATL ACAD SCI USA, V117, P29190, DOI 10.1073/pnas.2000429117; Escaffre O, 2016, J GEN VIROL, V97, P1077, DOI 10.1099/jgv.0.000441; Escaffre O, 2013, J INFECT DEV COUNTR, V7, P308, DOI 10.3855/jidc.3648; Geisbert JB, 2020, J INFECT DIS, V221, pS414, DOI 10.1093/infdis/jiz391; Geisbert TW, 2012, CURR TOP MICROBIOL, V359, P153, DOI 10.1007/82_2012_208; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Hammoud DA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006978; Johnston SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117817; Kenmoe S, 2019, J CLIN VIROL, V117, P19, DOI 10.1016/j.jcv.2019.05.009; Lara A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007454; Lee JH, 2020, J INFECT DIS, V221, pS419, DOI 10.1093/infdis/jiz502; Liu J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129629; Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011; Maisner A, 2009, THROMB HAEMOSTASIS, V102, P1014, DOI 10.1160/TH09-05-0310; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Mire CE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30916; Munster VJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00736; Pelissier Rodolphe, 2019, F1000Res, V8, DOI 10.12688/f1000research.19975.1; Prasad AN, 2020, J INFECT DIS, V221, pS431, DOI 10.1093/infdis/jiz469; Rockx B, 2011, J VIROL, V85, P7658, DOI 10.1128/JVI.00473-11; Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178; Singh RK, 2019, VET QUART, V39, P26, DOI 10.1080/01652176.2019.1580827; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tiong V, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02747; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Wong KT, 2012, CURR TOP MICROBIOL, V359, P95, DOI 10.1007/82_2012_205; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263834	10.1371/journal.pone.0263834	http://dx.doi.org/10.1371/journal.pone.0263834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143571	Green Published, gold			2022-12-26	WOS:000797657800085
J	Cuco, RM; Loquiha, O; Juga, A; Couto, A; Meggi, B; Vubil, A; Sevene, E; Osman, N; Temermam, M; Degomme, O; Sidat, M; Bhatt, N				Cuco, Rosa Marlene; Loquiha, Osvaldo; Juga, Adelino; Couto, Aleny; Meggi, Bindiya; Vubil, Adolfo; Sevene, Esperanca; Osman, Nafissa; Temermam, Marleen; Degomme, Olivier; Sidat, Mohsin; Bhatt, Nilesh			Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY; VIROLOGICAL RESPONSE; ADHERENCE; TRANSMISSION; EFAVIRENZ; OUTCOMES; DRUGS	Introduction Prevention of mother to child transmission of HIV (PMTCT) is frequently challenged by irregular access to more effective anti-retroviral therapy. Nevirapine single dose (sdNVP), sdNVP+AZT+3TC for MTCT prophylaxis and NVP+ AZT+3TC for treatment and PMTCT were withdrawn due to low genetic resistance barrier and low efficacy. However current PMTCT lines in Mozambique include DTG+3TC+TDF, TDF+3TC+EFV, DTG +ABC+3TC, and AZT + NVP syrup prophylaxis for exposed babies. We assessed NVP hair and plasma concentrations and association with HIV-1RNA suppression among HIV+ ante-partum and post-partum women under PMTCT in Maputo, Mozambique. Methods From December 2013 to November 2014, prospectively were enrolled 200 HIV+ ante-partum women on 200mg nevirapine and zidovudine 300 plus lamivudine 150mg twice daily at least with 3 months treatment and seen again at 24 weeks post-partum. Self-reported pill-taking adherence, NVP concentrations in hair, plasma, hemoglobin, CD4 cell count, HIV-1 RNA load was evaluated. NVP concentration in hair and plasma was analyzed as categorical quartile variable based on better data fit. NVP concentration was set between <= 3.77 ng/ml in plasma and <= 17,20 ng/mg in hair in quartile one to >= 5.36 ng/ml in plasma and >= 53.21 ng/mg in hair in quartile four. Logistic regression models for repeated measures were calculated. Following the World Health Organization (WHO) guidelines we set viral suppression at HIV-1RNA < 1000 c/mL. Outcome was HIV-1 RNA<1000 copies/ml. Predictor was NVP concentration in hair categorized in quartiles. Results In total 369 person-visits (median of 1.85) were recorded. Self-reported adherence was 98% (IQR 97-100%) at ante-partum. In 25% person visits, NVP concentrations were within therapeutic levels (3.77 ng/ml to 5.35 ng/ml) in plasma and (17.20 ng/mg to 53.20 ng/mg) in hair. In 50% person visits NVP concentrations were above 5.36 ng/ml in plasm and 53.21 ng/mg in hair. HIV-1 RNA suppression was found in 34.7% of women with two viral loads, one at enrollment and another in post-partum. Odds of HIV-1 RNA suppression in quartile 4, was about 6 times higher than in quartile 1 (p-value = 0.006) for NVP hair concentration and 7 times for NVP plasma concentration (p-value = 0.012). Conclusions The study results alert for potential low efficacy of current PMTCT drug regimens in use in Mozambique. Affordable means for individual monitoring adherence, ART plasma and hair levels, drug resistant and HIV-1 RNA levels monitoring are recommended for prompt identification of inadequate drug regimens exposure patterns and adjust accordingly.	[Cuco, Rosa Marlene; Sevene, Esperanca; Osman, Nafissa; Sidat, Mohsin] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Cuco, Rosa Marlene; Couto, Aleny] Minist Hlth, Natl Directorate Publ Hlth, Maputo, Mozambique; [Cuco, Rosa Marlene; Temermam, Marleen; Degomme, Olivier] Univ Ghent, Int Ctr Reprod Hlth ICRH, Ghent, Belgium; [Loquiha, Osvaldo; Juga, Adelino] Eduardo Mondlane Univ, Dept Math & Informat, Fac Sci, Maputo, Mozambique; [Meggi, Bindiya; Vubil, Adolfo; Bhatt, Nilesh] Inst Nacl Saude INS, Marracuene, Mozambique; [Osman, Nafissa] Maputo Cent Hosp, Dept Gynecol & Obstet, Maputo, Mozambique; [Temermam, Marleen] Aga Khan Univ Hosp, Dept Gynecol & Obstet, Nairobi, Kenya	Eduardo Mondlane University; Ghent University; Eduardo Mondlane University	Cuco, RM (corresponding author), Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique.; Cuco, RM (corresponding author), Minist Hlth, Natl Directorate Publ Hlth, Maputo, Mozambique.; Cuco, RM (corresponding author), Univ Ghent, Int Ctr Reprod Hlth ICRH, Ghent, Belgium.	marlene.cuco@gmail.com		Sidat, Mohsin/0000-0002-8378-2014	VRIL-UOS Flemish Interuniversity Council Development Cooperation, Belgium; Eduardo Mondlane University, Mozambique	VRIL-UOS Flemish Interuniversity Council Development Cooperation, Belgium; Eduardo Mondlane University, Mozambique	RMC was the only author who benefitted of an award for doctoral degree at Gent University. This work was funded by VRIL-UOS Flemish Interuniversity Council Development Cooperation, Belgium and by Eduardo Mondlane University, Mozambique. The funders had no role in the study, data collection, analysis, decision to publish or preparation of the manuscript.	Arvold ND, 2007, AIDS PATIENT CARE ST, V21, P638, DOI 10.1089/apc.2006.0169; Baxi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129100; Beumer JH, 2001, INT J CLIN PRACT, V55, P353; Calcagno A, 2012, BRIT J CLIN PHARMACO, V74, P134, DOI 10.1111/j.1365-2125.2012.04163.x; Carnimeo V, 2021, JAC-ANTIMICROB RESIS, V3, DOI 10.1093/jacamr/dlab050; Chetty T, 2018, TROP MED INT HEALTH, V23, P79, DOI 10.1111/tmi.13001; Ciccacci C DFD., 2013, INT J MOL SCI, V69, P7, DOI [10.1007/s00228-013-1549-x, DOI 10.1007/S00228-013-1549-X]; Duval X, 2007, AIDS, V21, P106, DOI 10.1097/QAD.0b013e3280118486; Eshleman Susan H., 2002, AIDS Reviews, V4, P59; Fletcher CV, 2005, JAIDS-J ACQ IMM DEF, V40, P301, DOI 10.1097/01.qai.0000180078.53321.6a; Gandhi M, 2019, JAIDS-J ACQ IMM DEF, V81, P202, DOI 10.1097/QAI.0000000000001993; Gandhi M, 2012, J INFECT DIS, V206, P1453, DOI 10.1093/infdis/jis508; Gandhi M, 2011, CLIN INFECT DIS, V52, P1267, DOI 10.1093/cid/cir131; Gandhi M, 2009, AIDS, V23, P471, DOI 10.1097/QAD.0b013e328325a4a9; Giaquinto C, 2006, CLIN DRUG INVEST, V26, P611, DOI 10.2165/00044011-200626110-00001; Haberer JE, 2013, AIDS, V27, P2166, DOI 10.1097/QAD.0b013e328363b53f; Hickey MD, 2014, JAIDS-J ACQ IMM DEF, V66, P311, DOI 10.1097/QAI.0000000000000154; Huang Y, 2008, RAPID COMMUN MASS SP, V22, P3401, DOI 10.1002/rcm.3750; INS INdS INE INdE GTM GTMdCaHS, 2011, ROND VIG EP HIV SFIL; Joint United Nations Program on HIV/AIDS (UNAIDS), 2019, UNAIDS SPECTR NATL H; Joint United Nations Programme on HIV/AIDS, 2018, MIL GO CLOS GAPS BRE; Koss CA, 2015, AIDS, V29, P825, DOI 10.1097/QAD.0000000000000619; Kusumaningrum A, 2019, ACTA MED INDONES, V51, P253; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Maseng MJ, 2021, PHARMACOGEN PERS MED, V14, P335, DOI 10.2147/PGPM.S289471; Mhandire D, 2015, OMICS, V19, P553, DOI 10.1089/omi.2015.0104; Micek MA, 2014, J INFECT DIS, V210, P641, DOI 10.1093/infdis/jiu130; Miln RS SL., 2020, HLTH ED RES THEORY P; Ministerio da Saude, 2015, INQ IND IM MAL HIV S; Ministrio da Sade, 2019, NORM CLN AT SEG PAC; Ministrio da Sade, MOZ NORM PREV TRANSM; Ministrio da Sade, REL AN AT PREV TRANS; Ministrio da Sade, 2012, PLAN NACL EL TRANSM; Ministry H. Mozambique, 2011, REL PREL AV NACL PRO; misau, MINISTRY HLTH MOZAMB; Mock PA, 1999, AIDS, V13, P407, DOI 10.1097/00002030-199902250-00014; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Nettles RE, 2006, CLIN INFECT DIS, V42, P1189, DOI 10.1086/501458; Nwogu JN, 2021, AIDS, V35, P1919, DOI 10.1097/QAD.0000000000002984; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Punyawudho B, 2016, EXPERT REV CLIN PHAR, V9, P1583, DOI 10.1080/17512433.2016.1235972; Ruperez M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196451; Sebunya R, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-25; Srivastava P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063305; UNAIDS, GLOB AIDS UPD 2018; UNAIDS PEPFAR UNICEF WHO, 2016, GLOB PLAN 2016N FAST; WHO, 2007, GUIDANCE GLOBAL SCAL; WHO Ua U, 2010, UNIVERSAL ACCESS SCA; WHO. World Health Organization, MOTH TO CHILD TRANSM; WHO. World Health Organization, 2018, PREV MOTH TO CHILD T; WHO World Health Organization, 2018, WHOCDSHIV1819	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0261522	10.1371/journal.pone.0261522	http://dx.doi.org/10.1371/journal.pone.0261522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143515	gold, Green Published			2022-12-26	WOS:000797657800009
J	Kim, J; Lee, J; Lee, D; Jeong, J; Kim, P; Shin, CS				Kim, Jiyoun; Lee, Jinkyu; Lee, Donghwan; Jeong, Jiyoung; Kim, Pankwon; Shin, Choongsoo S.			Design and investigation of the effectiveness of a metatarsophalangeal assistive device on the muscle activities of the lower extremity	PLOS ONE			English	Article							GROUND REACTION FORCES; WALKING; GAIT; TREADMILL; KNEE	The metatarsophalangeal (MTP) joint is not considered in most current walking assistive devices even though it plays an important role during walking. The purpose of this study was to develop a new MTP assistive device and investigate its effectiveness on the muscle activities of the lower extremities during walking while wearing the device. The MTP assistive device is designed to support MTP flexion by transmitting force through a cable that runs parallel with the plantar fascia. Eight participants were instructed to walk at a constant speed on a treadmill while wearing the device. The muscle activities of their lower extremities and MTP joint kinematics were obtained during walking under both actuated and nonactuated conditions. Paired t-tests were performed to compare the differences in each dependent variable between the two conditions. The muscle activity of the MTP flexor was significantly reduced during walking under actuated conditions (p = 0.013), whereas no differences were found in the muscle activities of other muscles or in the MTP joint angle between actuated and non-actuated conditions (p> 0.05 for all comparisons). In conclusion, the cable-driven MTP assistive device is able to properly assist the MTP flexor without interfering with the action of other muscles in the lower extremities; as such, this MTP assistive device, when integrated into existing exoskeleton designs, has the potential to offer improved walking assistance by reducing the amount of muscle activity needed from the MTP flexor.	[Kim, Jiyoun; Lee, Jinkyu; Lee, Donghwan; Jeong, Jiyoung; Kim, Pankwon; Shin, Choongsoo S.] Sogang Univ, Dept Mech Engn, Seoul, South Korea	Sogang University	Shin, CS (corresponding author), Sogang Univ, Dept Mech Engn, Seoul, South Korea.	cshin@sogang.ac.kr		SHIN, CHOONGSOO/0000-0003-4674-6222; Lee, Jinkyu/0000-0003-4698-4538	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF2019R1A2C1089522]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF2019R1A2C1089522). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari A, 2016, J MECH ROBOT, V8, DOI 10.1115/1.4032274; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Bruening DA, 2018, GAIT POSTURE, V62, P111, DOI 10.1016/j.gaitpost.2018.03.001; Bruening DA, 2010, J BIOMECH, V43, P3222, DOI 10.1016/j.jbiomech.2010.08.003; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Donahue SW, 1999, J BONE JOINT SURG AM, V81A, P1236, DOI 10.2106/00004623-199909000-00005; GERSTEN J W, 1956, Am J Phys Med, V35, P223; Gray H., 1918, ANATOMY HUMAN BODY, V20th; Green BA., 2017, 41 ANN MEET AM SOCIE, P2; Hayafune N, 1999, FOOT, V9, P88, DOI DOI 10.1054/F00T.1999; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HINTERMANN B, 1994, FOOT ANKLE INT, V15, P386, DOI 10.1177/107110079401500708; Hong YNG, 2015, CLIN BIOMECH, V30, P1210, DOI 10.1016/j.clinbiomech.2015.08.002; Johnson L, 2014, J REHABIL RES DEV, V51, P429, DOI 10.1682/JRRD.2013.05.0126; Kalita B, 2021, INT J SOC ROBOT, V13, P775, DOI 10.1007/s12369-020-00662-9; Kuni B, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-13; Laroche D, 2006, RHEUMATOLOGY, V45, P435, DOI 10.1093/rheumatology/kei168; Lee HJ, 2017, IEEE T NEUR SYS REH, V25, P1549, DOI 10.1109/TNSRE.2017.2664801; Liu YX, 2018, APPL BIONICS BIOMECH, V2018, DOI 10.1155/2018/9289505; Malcolm P, 2009, GAIT POSTURE, V30, P322, DOI 10.1016/j.gaitpost.2009.06.002; Malcolm P, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00069; McDonald KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152602; Miyazaki S, 1993, GAIT POSTURE, V1, P133, DOI 10.1016/0966-6362(93)90054-5; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Raychoudhury S., 2014, FRONT BIOENG BIOTECH, V2, P1, DOI [10.3389/fbioe.2014.00001, DOI 10.3389/FBIOE.2014.00001]; Reynard F, 2009, Foot (Edinb), V19, P69, DOI 10.1016/j.foot.2008.11.012; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; Shamaei K, 2014, IEEE T BIO-MED ENG, V61, P1809, DOI 10.1109/TBME.2014.2307698; Sharkey N. A., 1995, Journal of Bone and Joint Surgery American Volume, V77, P1050; Van de Putte M, 2006, BIO-MED MATER ENG, V16, P43; Wang W, 2020, IEEE T IND INFORM, V16, P7168, DOI 10.1109/TII.2020.2974232; Witte KA, 2015, IEEE INT CONF ROBOT, P1223, DOI 10.1109/ICRA.2015.7139347; Yan TF, 2015, ROBOT AUTON SYST, V64, P120, DOI 10.1016/j.robot.2014.09.032; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	37	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263176	10.1371/journal.pone.0263176	http://dx.doi.org/10.1371/journal.pone.0263176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143528	gold, Green Published			2022-12-26	WOS:000797657800028
J	Prieto, K; Chavez-Hernandez, MV; Romero-Leiton, JP				Prieto, Kernel; Victoria Chavez-Hernandez, M.; Romero-Leiton, Jhoana P.			On mobility trends analysis of COVID-19 dissemination in Mexico City	PLOS ONE			English	Article							MODEL; EPIDEMIC; DISTRIBUTIONS; COMPUTATION; SYSTEMS	This work presents a tool for forecasting the spread of the new coronavirus in Mexico City, which is based on a mathematical model with a metapopulation structure that uses Bayesian statistics and is inspired by a data-driven approach. The daily mobility of people in Mexico City is mathematically represented by an origin-destination matrix using the open mobility data from Google and the Transportation Mexican Survey. This matrix is incorporated in a compartmental model. We calibrate the model against borough-level incidence data collected between 27 February 2020 and 27 October 2020, while using Bayesian inference to estimate critical epidemiological characteristics associated with the coronavirus spread. Given that working with metapopulation models leads to rather high computational time consumption, and parameter estimation of these models may lead to high memory RAM consumption, we do a clustering analysis that is based on mobility trends to work on these clusters of borough separately instead of taken all of the boroughs together at once. This clustering analysis can be implemented in smaller or larger scales in different parts of the world. In addition, this clustering analysis is divided into the phases that the government of Mexico City has set up to restrict individual movement in the city. We also calculate the reproductive number in Mexico City using the next generation operator method and the inferred model parameters obtaining that this threshold is in the interval (1.2713, 1.3054). Our analysis of mobility trends can be helpful when making public health decisions.	[Prieto, Kernel] Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico; [Victoria Chavez-Hernandez, M.] Univ Autonoma Nuevo Leon, Fac Ingn Mecan & Elect, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Romero-Leiton, Jhoana P.] Univ Cesmag, Fac Ingn, Pasto, Colombia	Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Nuevo Leon	Prieto, K (corresponding author), Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico.	kernel@ciencias.unam.mx						Acuna Zegarra M., 2020, MEDRXIV; Acuna-Zegarra MA, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108370; Alavez-Ramirez J., 2007, REV ELECT NICA CONTE, V21; Christen JA, 2010, BAYESIAN ANAL, V5, P263, DOI 10.1214/10-BA60; Arguedas YN, 2019, MATH BIOSCI ENG, V16, P7477, DOI 10.3934/mbe.2019375; Bagal DK, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110154; Batistela CM, ARXIV PREPRINT ARXIV; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Bliznashki S., 2020, BAYESIAN LOGISTIC GR, V14; Boersch-Supan PH, 2017, METHODS ECOL EVOL, V8, P511, DOI 10.1111/2041-210X.12679; Brown GD, 2018, SPAT SPATIO-TEMPORAL, V24, P27, DOI 10.1016/j.sste.2017.11.001; Calvetti D, 2020, ARXIV PREPRINT ARXIV; Capistran MA, 2009, B MATH BIOL, V71, P1890, DOI 10.1007/s11538-009-9429-3; Capistrn M, 2020, ARXIV E PRINTS; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chatzilena A, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100367; Chavez Hernandez M.V., 2014, MODELOS MATEMATICOS; Hernandez MVC, 2019, TRANSPORTMETRICA A, V15, P915, DOI 10.1080/23249935.2018.1546780; Chen TM, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00640-3; Choi S., 2020, EPIDEMIOL HEALTH, P123; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Coletti P., 2020, MEDRXIV; Coly S, 2016, J SFDS, V157, P39; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dbouk T, 2021, PHYS FLUIDS, V33, DOI 10.1063/5.0037640; de Anda-Juregui G., 2020, ARXIV E PRINTS; de la Ciudad de Mxico G, 2020, AFL PREL TRANSP PBLI; de Mexico G., 2020, TOD COVID 19; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Google, 2020, INF MOV LOC COVID 19; Grinsztajn L, 2020, ARXIV E PRINTS; House T, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0279; INEGI, 2018, ENC NAC DIN DEM ENAD; INEGI. Instituto Nacional de Estadstica y Geografa, 2020, TEMAS; Izquierdo LD, 2020, INFORME TCNICO NUEVO; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Liu F, 2020, SCI BULL, V65, P1297, DOI 10.1016/j.scib.2020.04.043; Piccolomini EL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237417; Ma Z, ARXIV PREPRINT ARXIV; Magal P, 2018, J MATH BIOL, V77, P1629, DOI 10.1007/s00285-017-1203-9; McBryde ES, 2006, B MATH BIOL, V68, P889, DOI 10.1007/s11538-005-9005-4; Miller A., 2020, MEDRXIV, DOI 10.1101/2020.03.24.20042937; Nesteruk I, 2020, MEDRXIV, V4, P1988, DOI DOI 10.1101/2020.02.12.20021931; Neyens T, 2012, SPAT SPATIO-TEMPORAL, V3, P185, DOI 10.1016/j.sste.2011.10.004; Nour M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106580; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Pei S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd6370; Pei S, 2018, P NATL ACAD SCI USA, V115, P2752, DOI 10.1073/pnas.1708856115; Prieto K., 2019, Journal of Physics: Conference Series, V1408, DOI 10.1088/1742-6596/1408/1/012020; Prieto K., 2020, MEDRXIV; Prieto K, 2017, INVERSE PROBL, V33, DOI 10.1088/0266-5611/33/1/014001; Roosa K, 2019, THEOR BIOL MED MODEL, V16, DOI 10.1186/s12976-018-0097-6; Saldana F., 2020, MEDRXIV; Savi PV, 2020, ARXIV PREPRINT ARXIV; Senel K., 2020, Turkiye Klinikleri tip Bilimleri Dergisi, V40, P127, DOI 10.5336/medsci.2020-76462; Shaikh AS, 2020, ADV DIFFER EQU-NY; Smirnova A., 2016, INVERSE PROBLEMS EBO, P103; SPIESS H, 1987, TRANSPORT RES B-METH, V21, P395, DOI 10.1016/0191-2615(87)90037-3; Stojanovic O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225838; [Лузянина Т. Tatyana Luzyanina], 2018, [Математическая биология и биоинформатика, Matematicheskaya biologiya i bioinformatika], V13, P376, DOI 10.17537/2018.13.376; Wells K., 2020, MEDRXIV; World Health Organization, 2021, NOV COR 2019 NCOV SI; Worldometer, 2020, WORLD COR UPD; Yang CY, 2020, MATH BIOSCI ENG, V17, P2708, DOI 10.3934/mbe.2020148; Yang W, ARXIV PREPRINT ARXIV; Zhao Z, 2020, MEDRXIV; Zhong LH, 2020, IEEE ACCESS, V8, P51761, DOI 10.1109/ACCESS.2020.2979599; Zhou C., 2020, MEDRXIV	70	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263367	10.1371/journal.pone.026336	http://dx.doi.org/10.1371/journal.pone.026336			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143548				2022-12-26	WOS:000797657800041
J	Amaya, JA; Lamb, DC; Kelly, SL; Caffrey, P; Murarka, VC; Poulos, TL				Amaya, Jose A.; Lamb, David C.; Kelly, Steven L.; Caffrey, Patrick; Murarka, Vidhi C.; Poulos, Thomas L.			Structural analysis of P450 AmphL from Streptomyces nodosus provides insights into substrate selectivity of polyene macrolide antibiotic biosynthetic P450s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEERED MOLECULAR-DYNAMICS; CYTOCHROME P450CAM; BINDING; FORCE; SITE	AmphL is a cytochrome P450 enzyme that catalyzes the C8 oxidation of 8-deoxyamphotericin B to the polyene macrolide antibiotic, amphotericin B. To understand this substrate selectivity, we solved the crystal structure of AmphL to a resolution of 2.0 angstrom in complex with amphotericin B and performed molecular dynamics (MD) simulations. A detailed comparison with the closely related P450, PimD, which catalyzes the epoxidation of 4,5-desepoxypimaricin to the macrolide antibiotic, pimaricin, reveals key catalytic structural features responsible for stereo- and regio-selective oxidation. Both P450s have a similar access channel that runs parallel to the active site I helix over the surface of the heme. Molecular dynamics simulations of substrate binding reveal PimD can "pull" substrates further into the P450 access channel owing to additional electrostatic interactions between the protein and the carboxyl group attached to the hemiketal ring of 4,5-desepoxypimaricin. This substrate interaction is absent in AmphL although the additional substrate -OH groups in 8-deoxyamphotericin B help to correctly position the substrate for C8 oxidation. Simulations of the oxy-complex indicates that these -OH groups may also participate in a proton relay network required for O-2 activation as has been suggested for two other macrolide P450s, PimD and P450eryF. These findings provide experimentally testable models that can potentially contribute to a new generation of novel macrolide antibiotics with enhanced antifungal and/or antiprotozoal efficacy.	[Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA; [Amaya, Jose A.; Murarka, Vidhi C.; Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Lamb, David C.; Kelly, Steven L.] Swansea Univ, Fac Hlth Med & Life Sci, Swansea, W Glam, Wales; [Caffrey, Patrick] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Swansea University; University College Dublin	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.; Poulos, TL (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92717 USA.; Poulos, TL (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.	poulos@uci.edu		Amaya, Jose A./0000-0001-7826-0185; Murarka, Vidhi/0000-0002-3471-9211; Caffrey, Patrick/0000-0002-0132-2410	NIH [GM131920]; European Regional Development Fund/Welsh European Funding Office via the BEACON project	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Regional Development Fund/Welsh European Funding Office via the BEACON project	Funding and additional information-Work at UCI was supported by NIH grant GM131920 (T. L. P.). Funding at Swansea University was supported by the European Regional Development Fund/Welsh European Funding Office via the BEACON project (S. L. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Caffrey P, 2016, APPL MICROBIOL BIOT, V100, P3893, DOI 10.1007/s00253-016-7474-z; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; GERBER NC, 1994, J BIOL CHEM, V269, P4260; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Ho K, 2020, J PHYS CHEM B, V124, P5338, DOI 10.1021/acs.jpcb.0c02009; Lee YT, 2010, BIOCHEMISTRY-US, V49, P3412, DOI 10.1021/bi100183g; Ludemann SK, 2000, J MOL BIOL, V303, P813, DOI 10.1006/jmbi.2000.4155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mermelstein DJ, 2018, J COMPUT CHEM, V39, P1354, DOI 10.1002/jcc.25187; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Santos-Aberturas J, 2015, CHEMCATCHEM, V7, P490, DOI 10.1002/cctc.201402773; Shahrokh K, 2012, J COMPUT CHEM, V33, P119, DOI 10.1002/jcc.21922; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhang ZS, 2016, BIOPHYS CHEM, V211, P28, DOI 10.1016/j.bpc.2016.01.003	26	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101746	10.1016/j.jbc.2022.101746	http://dx.doi.org/10.1016/j.jbc.2022.101746			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35189143	Green Published, gold			2022-12-26	WOS:000793502000015
J	Tehlan, A; Bhowmick, K; Kumar, A; Subbarao, N; Dhar, SK				Tehlan, Ankita; Bhowmick, Krishanu; Kumar, Amarjeet; Subbarao, Naidu; Dhar, Suman Kumar			The tetrameric structure of Plasmodium falciparum phosphoglycerate mutase is critical for optimal enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLYTIC-ENZYMES; HOST-CELL; EXPRESSION; OLIGOMERIZATION; METABOLISM; GROWTH; TRANSFORMATION; LOCALIZATION; DISSOCIATION; DIMERIZATION	The glycolytic enzyme phosphoglycerate mutase (PGM) is of utmost importance for overall cellular metabolism and has emerged as a novel therapeutic target in cancer cells. This enzyme is also conserved in the rapidly proliferating malarial parasite Plasmodium falciparum, which have a similar metabolic framework as cancer cells and rely on glycolysis as the sole energy-yielding process during intraerythrocytic development. There is no redundancy among the annotated PGM enzymes in Plasmodium, and PfPGM1 is absolutely required for the parasite survival as evidenced by conditional knockdown in our study. A detailed comparison of PfPGM1 with its counterparts followed by in-depth structure-function analysis revealed unique attributes of this parasitic protein. Here, we report for the first time the importance of oligomerization for the optimal functioning of the enzyme in vivo, as earlier studies in eukaryotes only focused on the effects in vitro. We show that single point mutation of the amino acid residue W68 led to complete loss of tetramerization and diminished catalytic activity in vitro. Additionally, ectopic expression of the WT PfPGM1 protein enhanced parasite growth, whereas the monomeric form of PfPGM1 failed to provide growth advantage. Furthermore, mutation of the evolutionarily conserved residue K100 led to a drastic reduction in enzymatic activity. The indispensable nature of this parasite enzyme highlights the potential of PfPGM1 as a therapeutic target against malaria, and targeting the interfacial residues critical for oligomerization can serve as a focal point for promising drug development strategies that may not be restricted to malaria only.	[Tehlan, Ankita; Bhowmick, Krishanu; Dhar, Suman Kumar] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India; [Kumar, Amarjeet; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Dhar, SK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi, India.	skdhar@mail.jnu.ac.in	Bhowmick, Krishanu/CEH-1458-2022; Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165; Bhowmick, Krishanu/0000-0001-6213-8230; Kumar, Amarjeet/0000-0001-7740-9881	Department of Biotechnology [BT/PR15639/Med/29/1145/2016]; Department of Science and Technology, SERB; CSIR, India	Department of Biotechnology; Department of Science and Technology, SERB(Department of Science & Technology (DOST), PhilippinesDepartment of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	S. K. D. acknowledges the Department of Biotechnology (BT/PR15639/Med/29/1145/2016) and Department of Science and Technology, SERB, Govt. of India (DPRP) for financial assistance. A. T. acknowledges CSIR, India for fellowship.	Alam Asrar, 2014, Malar Res Treat, V2014, P451065, DOI 10.1155/2014/451065; Bachman J, 2013, METHOD ENZYMOL, V529, P241, DOI 10.1016/B978-0-12-418687-3.00019-7; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Banu K, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny182; Batugedara G, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000327; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhowmick K, 2020, J CELL SCI, V133, DOI 10.1242/jcs.236489; Bhowmick K, 2014, FEMS MICROBIOL LETT, V351, P78, DOI 10.1111/1574-6968.12343; Blackburn EA, 2014, BIOCHEM BIOPH RES CO, V450, P936, DOI 10.1016/j.bbrc.2014.06.113; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; BRITTON HG, 1972, BIOCHEM J, V130, P397, DOI 10.1042/bj1300397; Burda PC, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107817; Burley SK, 2021, NUCLEIC ACIDS RES, V49, pD437, DOI 10.1093/nar/gkaa1038; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Caruthers J. M., 2004, Structural Genomics of Pathogenic Protozoa Consortium (SGPP), DOI 10.2210/pdb1XQ9/pdb; Chander M, 1999, J STRUCT BIOL, V126, P156, DOI 10.1006/jsbi.1999.4112; Chaneton B, 2012, CANCER CELL, V22, P565, DOI 10.1016/j.ccr.2012.10.014; Dar A, 2009, EUKARYOT CELL, V8, P1759, DOI 10.1128/EC.00149-09; de Atauri P, 2005, BBA-MOL BASIS DIS, V1740, P403, DOI 10.1016/j.bbadis.2004.11.023; Delto CF, 2015, STRUCTURE, V23, P364, DOI 10.1016/j.str.2014.11.016; Deshmukh AS, 2012, NUCLEIC ACIDS RES, V40, P5313, DOI 10.1093/nar/gks202; Evans MJ, 2007, MOL BIOSYST, V3, P495, DOI 10.1039/b705113a; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Florentin A, 2017, CELL REP, V21, P1746, DOI 10.1016/j.celrep.2017.10.081; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; Ghashghaeinia M, 2019, CELL CYCLE, V18, P1316, DOI 10.1080/15384101.2019.1618125; Gizak A, 2015, ONCOTARGET, V6, P17237, DOI 10.18632/oncotarget.4044; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gruring C, 2012, METHOD ENZYMOL, V506, P81, DOI 10.1016/B978-0-12-391856-7.00029-9; Hallows WC, 2012, J BIOL CHEM, V287, P3850, DOI 10.1074/jbc.M111.317404; Harlow E., 1988, ANTIBODIES LAB MANUA; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Huang K, 2019, CELL METAB, V30, P1107, DOI 10.1016/j.cmet.2019.09.014; Huang K, 2019, EUR J MED CHEM, V168, P45, DOI 10.1016/j.ejmech.2019.01.085; Jankowska-Dollken M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54854-z; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jiang XL, 2014, INT J CANCER, V135, P1991, DOI 10.1002/ijc.28637; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Koike R, 2009, PROTEIN SCI, V18, P2060, DOI 10.1002/pro.218; Kondoh H, 2005, CANCER RES, V65, P177; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Liang Q, 2021, ACTA PHARMACOL SIN, V42, P115, DOI 10.1038/s41401-020-0399-1; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Liu XL, 2018, ONCOL RES, V26, P1123, DOI 10.3727/096504018X15166223632406; Liu ZG, 2018, ONCOL LETT, V15, P8935, DOI 10.3892/ol.2018.8477; Lopez CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090796; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maier AG, 2019, TRENDS PARASITOL, V35, P481, DOI 10.1016/j.pt.2018.11.010; Mehra P, 2005, BIOCHEM BIOPH RES CO, V337, P955, DOI 10.1016/j.bbrc.2005.09.131; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Miao J, 2010, MOL MICROBIOL, V78, P883, DOI 10.1111/j.1365-2958.2010.07371.x; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Mikawa T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101306; Miranda E, 2013, J AM CHEM SOC, V135, P10418, DOI 10.1021/ja402993u; Moll K., 2013, METHODS MALARIA RES, V6th, DOI DOI 10.1007/S00436-008-0981-9; Nagar S, 2014, METHODS MOL BIOL, V1113, P1, DOI 10.1007/978-1-62703-758-7_1; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Oslund RC, 2017, NAT CHEM BIOL, V13, P1081, DOI [10.1038/NCHEMBIO.2453, 10.1038/nchembio.2453]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Rigden DJ, 1998, J MOL BIOL, V276, P449, DOI 10.1006/jmbi.1997.1554; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; ROTH E, 1990, BLOOD CELLS, V16, P453; SAKODA S, 1988, J BIOL CHEM, V263, P16899; Salcedo-Sora JE, 2014, TRENDS PARASITOL, V30, P170, DOI 10.1016/j.pt.2014.02.001; Schneider MP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006659; Sharif F, 2019, IUBMB LIFE, V71, P1418, DOI 10.1002/iub.2100; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Takahashi Y, 1998, EUR J BIOCHEM, V254, P497, DOI 10.1046/j.1432-1327.1998.2540497.x; Thezenas ML, 2013, J PROTEOME RES, V12, P1211, DOI 10.1021/pr300858g; TSUJINO S, 1993, AM J HUM GENET, V52, P472; Verma V, 2016, NUCLEIC ACIDS RES, V44, P3288, DOI 10.1093/nar/gkw148; Wang HL, 2016, PARASITE, V23, DOI 10.1051/parasite/2016012; WHITE MF, 1993, BIOCHEM J, V295, P743, DOI 10.1042/bj2950743; WHITE MF, 1993, BIOCHEM J, V291, P479, DOI 10.1042/bj2910479; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wisniewski JR, 2015, J PROTEOME RES, V14, P3263, DOI 10.1021/acs.jproteome.5b00276; Xu HY, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100572; Zhang D, 2017, ONCOGENE, V36, P2900, DOI 10.1038/onc.2016.446; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	89	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101713	10.1016/j.jbc.2022.101713	http://dx.doi.org/10.1016/j.jbc.2022.101713			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150741	gold, Green Published			2022-12-26	WOS:000821054100013
J	Honarmand, K; Yarnell, CJ; Young-Ritchie, C; Maunder, R; Priestap, F; Abdalla, M; Ball, IM; Basmaji, J; Bell, CM; Jeffs, L; Shah, S; Chen, J; LeBlanc, D; Kayitesi, J; Eta-Ndu, C; Mehta, S				Honarmand, Kimia; Yarnell, Christopher J.; Young-Ritchie, Carol; Maunder, Robert; Priestap, Fran; Abdalla, Mohamed; Ball, Ian M.; Basmaji, John; Bell, Chaim M.; Jeffs, Lianne; Shah, Sumesh; Chen, Jennifer; LeBlanc, Danielle; Kayitesi, Jessica; Eta-Ndu, Catherine; Mehta, Sangeeta			Personal, professional, and psychological impact of the COVID-19 pandemic on hospital workers: A cross-sectional survey	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; HEALTH-CARE WORKERS; SCREENING SCALES; STRESS; SARS; DEPRESSION; OUTBREAK; NURSES	Objectives We aimed to evaluate the personal, professional, and psychological impact of the COVID-19 pandemic on hospital workers and their perceptions about mitigating strategies. Design Cross-sectional web-based survey consisting of (1) a survey of the personal and professional impact of the COVID-19 pandemic and potential mitigation strategies, and (2) two validated psychological instruments (Kessler Psychological Distress Scale [K10] and Impact of Events Scale Revised [IES-R]). Regression analyses were conducted to identify the predictors of workplace stress, psychological distress, and post-traumatic stress. Setting and participants Hospital workers employed at 4 teaching and 8 non-teaching hospitals in Ontario, Canada during the COVID-19 pandemic. Results Among 1875 respondents (84% female, 49% frontline workers), 72% feared falling ill, 64% felt their job placed them at great risk of COVID-19 exposure, and 48% felt little control over the risk of infection. Respondents perceived that others avoided them (61%), reported increased workplace stress (80%), workload (66%) and responsibilities (59%), and 44% considered leaving their job. The psychological questionnaires revealed that 25% had at least some psychological distress on the K10, 50% had IES-R scores suggesting clinical concern for post-traumatic stress, and 38% fulfilled criteria for at least one psychological diagnosis. Female gender and feeling at increased risk due to PPE predicted all adverse psychological outcomes. Respondents favoured clear hospital communication (59%), knowing their voice is heard (55%), expressions of appreciation from leadership (55%), having COVID-19 protocols (52%), and food and beverages provided by the hospital (50%). Conclusions Hospital work during the COVID-19 pandemic has had important personal, professional, and psychological impacts. Respondents identified opportunities to better address information, training, and support needs.	[Honarmand, Kimia; Ball, Ian M.; Basmaji, John; LeBlanc, Danielle] Western Univ, Dept Med, Div Crit Care, London, ON, Canada; [Yarnell, Christopher J.; Bell, Chaim M.; Shah, Sumesh; Mehta, Sangeeta] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Yarnell, Christopher J.; Shah, Sumesh; Mehta, Sangeeta] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Young-Ritchie, Carol] London Hlth Sci Ctr, London, ON, Canada; [Maunder, Robert] Sinai Hlth Syst, Dept Psychiat, Toronto, ON, Canada; [Maunder, Robert] Univ Toronto, Toronto, ON, Canada; [Priestap, Fran] London Hlth Sci Ctr, Dept Surg, Trauma Program, London, ON, Canada; [Abdalla, Mohamed] Tillsonburg Dist Mem Hosp, Dept Med, Tillsonburg, ON, Canada; [Ball, Ian M.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jeffs, Lianne] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Jeffs, Lianne] Univ Toronto, Bloomberg Fac Nursing, Toronto, ON, Canada; [Jeffs, Lianne] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Chen, Jennifer] Western Univ, Dept Med Biophys, London, ON, Canada; [Kayitesi, Jessica; Eta-Ndu, Catherine] Sinai Hlth Syst, Dept Nursing, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; London Health Sciences Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Honarmand, K (corresponding author), Western Univ, Dept Med, Div Crit Care, London, ON, Canada.	kimia.honarmand@medportal.ca	Honarmand, Kimia/AAS-6878-2021; Ball, Ian/GRR-4073-2022	Honarmand, Kimia/0000-0002-7583-1445; Yarnell, Christopher/0000-0001-5657-9398; Chen, Jennifer/0000-0001-6815-0820	 [IRF-5-20]		KH, SM, IB, JB Lawson Health Research Institute's Internal Research Fund (IRF-5-20). https://www.lawsonresearch.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2020, J AFFECT DISORDERS, V276, P312, DOI 10.1016/j.jad.2020.06.047; Azoulay E, 2020, AM J RESP CRIT CARE, V202, P1388, DOI 10.1164/rccm.202006-2568OC; Azoulay E, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00722-3; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Du J, 2020, GEN HOSP PSYCHIAT, V67, P144, DOI 10.1016/j.genhosppsych.2020.03.011; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Giusti EM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01684; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Kawamura N, 2001, AM J PSYCHIAT, V158, P484, DOI 10.1176/appi.ajp.158.3.484; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Mahmoud AB, 2020, J STRATEG MARK, DOI 10.1080/0965254X.2020.1844785; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; Mehta S, 2021, LANCET RESP MED, V9, P226, DOI 10.1016/S2213-2600(21)00068-0; Mohr J, 2006, WORLD HLTH REP, P117; NEAL LA, 1994, J TRAUMA STRESS, V7, P447, DOI 10.1002/jts.2490070310; Shahrour G, 2020, J NURS MANAGE, V28, P1686, DOI 10.1111/jonm.13124; Weiss Daniel S., 1997, P399; WHO, FACTS HLTH CAR WORK	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263438	10.1371/journal.pone.0263438	http://dx.doi.org/10.1371/journal.pone.0263438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167590	gold, Green Published			2022-12-26	WOS:000802227200006
J	Malek, M; Wawrzyniak, AM; Ebner, M; Puchkov, D; Haucke, V				Malek, Mouhannad; Wawrzyniak, Anna M.; Ebner, Michael; Puchkov, Dmytro; Haucke, Volker			Inositol triphosphate-triggered calcium release from the endoplasmic reticulum induces lysosome biogenesis via TFEB/TFE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE 5-PHOSPHATASE; TFEB; CALCINEURIN; AUTOPHAGY; INHIBITOR; MTOR	Lysosomes serve as dynamic regulators of cell and organismal physiology by integrating the degradation of macromolecules with receptor and nutrient signaling. Previous studies have established that activation of the transcription factor EB (TFEB) and transcription factor E3 (TFE3) induces the expression of lysosomal genes and proteins in signaling inactive starved cells, that is, under conditions when activity of the master regulator of nutrient-sensing signaling mechanistic target of rapamycin complex 1 is repressed. How lysosome biogenesis is triggered in signaling-active cells is incompletely understood. Here, we identify a role for calcium release from the lumen of the endoplasmic reticulum in the control of lysosome biogenesis that is independent of mechanistic target of rapamycin complex 1. We show using functional imaging that calcium efflux from endoplasmic reticulum stores induced by inositol triphosphate accumulation upon depletion of inositol polyphosphate-5phosphatase A, an inositol 5-phosphatase downregulated in cancer and defective in spinocerebellar ataxia, or receptor mediated phospholipase C activation leads to the induction of lysosome biogenesis. This mechanism involves calcineurin and the nuclear translocation and elevated transcriptional activity of TFEB/TFE3. Our findings reveal a crucial function for inositol polyphosphate-5-phosphatase A-mediated triphosphate hydrolysis in the control of lysosome biogenesis via TFEB/TFE3, thereby contributing to our understanding how cells are able to maintain their lysosome content under conditions of active receptor and nutrient signaling.	[Malek, Mouhannad; Wawrzyniak, Anna M.; Ebner, Michael; Puchkov, Dmytro; Haucke, Volker] Leibniz Forschungsinst Mol Pharmakol FMP, Dept Mol Pharmacol & Cell Biol, Berlin, Germany; [Haucke, Volker] Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin	Haucke, V (corresponding author), Leibniz Forschungsinst Mol Pharmakol FMP, Dept Mol Pharmacol & Cell Biol, Berlin, Germany.; Haucke, V (corresponding author), Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany.	haucke@fmp-berlin.de		malek, mouhannad/0000-0002-7523-7593	Leibniz SAW Program; Deutsche Forschungsgemeinschaft [HA2686/21-1]	Leibniz SAW Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by grants from the Leibniz SAW Program and the Deutsche Forschungsgemeinschaft (FOR 2625-Mechanisms of Lysosomal Homeostasis; grant no.: HA2686/21-1) (to V. H.) .	Ballabio A, 2020, NAT REV MOL CELL BIO, V21, P101, DOI 10.1038/s41580-019-0185-4; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Erdmann F, 2010, J BIOL CHEM, V285, P1888, DOI 10.1074/jbc.M109.024844; Erneux Christophe, 2015, Advances in Biological Regulation, V60, P135, DOI 10.1016/j.jbior.2015.09.004; Garrity AG, 2016, ELIFE, V5, DOI 10.7554/eLife.15887; Golyan FF, 2021, ADV MED SCI-POLAND, V66, P231, DOI 10.1016/j.advms.2021.03.004; Kohn EA, 2003, CANCER RES, V63, P31; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu Q, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14931-8; Lopez-Hernandez T, 2020, NAT CELL BIOL, V22, P815, DOI 10.1038/s41556-020-0535-7; Malek Mouhannad, 2021, Metabolights, DOI 10.1038/s41467-021-22882-x; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Martina JA, 2016, EMBO J, V35, P479, DOI 10.15252/embj.201593428; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Parenti G, 2015, ANNU REV MED, V66, P471, DOI 10.1146/annurev-med-122313-085916; Perera RM, 2019, ANNU REV CANC BIOL, V3, P203, DOI 10.1146/annurev-cancerbio-030518-055835; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Peretti D, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00371; Puertollano R, 2018, EMBO J, V37, DOI 10.15252/embj.201798804; Raben N, 2016, ANNU REV CELL DEV BI, V32, P255, DOI 10.1146/annurev-cellbio-111315-125407; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sekulic A, 2010, CANCER PREV RES, V3, P1277, DOI 10.1158/1940-6207.CAPR-10-0058; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shao Rong, 2021, Biochem J, V478, P1159, DOI 10.1042/BCJ20200676; Speed CJ, 1996, EMBO J, V15, P4852, DOI 10.1002/j.1460-2075.1996.tb00866.x; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Wu HX, 2018, SCIENCE, V361, pCP15, DOI 10.1126/science.aan5835; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yao WT, 2019, NATURE, V568, P410, DOI 10.1038/s41586-019-1062-1	33	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101740	10.1016/j.jbc.2022.101740	http://dx.doi.org/10.1016/j.jbc.2022.101740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35182526	Green Published, gold			2022-12-26	WOS:000789398100003
J	Raun, SH; Knudsen, JR; Han, XQ; Jensen, TE; Sylow, L				Raun, Steffen H.; Knudsen, Jonas Roland; Han, Xiuqing; Jensen, Thomas E.; Sylow, Lykke			Cancer causes dysfunctional insulin signaling and glucose transport in a muscle-type-specific manner	FASEB JOURNAL			English	Article						Akt; AMPK; cachexia; cancer; glucose metabolism; insulin resistance; Lewis lung carcinoma; muscle; mTORC1	GLYCOGEN-SYNTHASE KINASE-3; ACTIVATED PROTEIN-KINASE; BODY-WEIGHT LOSS; SKELETAL-MUSCLE; 14-3-3 BINDING; MASS INDEX; PHOSPHORYLATION; RESISTANCE; AMPK; CONTRACTION	Metabolic dysfunction and insulin resistance are emerging as hallmarks of cancer and cachexia, and impair cancer prognosis. Yet, the molecular mechanisms underlying impaired metabolic regulation are not fully understood. To elucidate the mechanisms behind cancer-induced insulin resistance in muscle, we isolated extensor digitorum longus (EDL) and soleus muscles from Lewis Lung Carcinoma tumor-bearing mice. Three weeks after tumor inoculation, muscles were isolated and stimulated with or without a submaximal dose of insulin (1.5 nM). Glucose transport was measured using 2-[H-3]Deoxy-Glucose and intramyocellular signaling was investigated using immunoblotting. In soleus muscles from tumor-bearing mice, insulin-stimulated glucose transport was abrogated concomitantly with abolished insulin-induced TBC1D4 and GSK3 phosphorylation. In EDL, glucose transport and TBC1D4 phosphorylation were not impaired in muscles from tumor-bearing mice, while AMPK signaling was elevated. Anabolic insulin signaling via phosphorylation of the mTORC1 targets, p70S6K thr389, and ribosomal-S6 ser235, were decreased by cancer in soleus muscle while increased or unaffected in EDL. In contrast, the mTOR substrate, pULK1 ser757, was reduced in both soleus and EDL by cancer. Hence, cancer causes considerable changes in skeletal muscle insulin signaling that is dependent on muscle-type, which could contribute to metabolic dysregulation in cancer. Thus, the skeletal muscle could be a target for managing metabolic dysfunction in cancer.	[Raun, Steffen H.; Knudsen, Jonas Roland; Han, Xiuqing; Jensen, Thomas E.; Sylow, Lykke] Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Mol Physiol, Panum Bldg,Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Sylow, Lykke] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Sylow, L (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Sect Mol Physiol, Panum Bldg,Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	Lykkesylow@sund.ku.dk	Jensen, Thomas/E-1215-2015; Sylow, Lykke/C-8997-2015	Jensen, Thomas/0000-0001-6139-8268; Sylow, Lykke/0000-0003-0905-5932	Novo Nordisk Foundation [NNF16OC0023418, NNF20OC0063577, NNF18OC0032082]; Independent Research Fund Denmark [9039-00170B]; Independent Research Fund Denmark	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Independent Research Fund Denmark; Independent Research Fund Denmark	Steffen H. Raun is supported via a grant to Lykke Sylow from the Novo Nordisk Foundation (NNF18OC0032082). Lykke Sylow is further supported by grants from Novo Nordisk Foundation (NNF16OC0023418 and NNF20OC0063577) and Independent Research Fund Denmark (9039--00170B). Jonas Roland Knudsen is supported by an international Postdoc grant from the Independent Research Fund Denmark	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Alves CRR, 2021, FASEB J, V35, DOI 10.1096/fj.202100263R; Alves CRR, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101012; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Ballaro R, 2016, CURR OPIN SUPPORT PA, V10, P281, DOI 10.1097/SPC.0000000000000233; Baracos VE, 2010, AM J CLIN NUTR, V91, p1133S, DOI 10.3945/ajcn.2010.28608C; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Calip GS, 2014, BREAST CANCER RES TR, V148, P363, DOI 10.1007/s10549-014-3157-6; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2012, DIABETES CARE, V35, P1835, DOI 10.2337/dc12-0002; Chadt A, 2020, PFLUG ARCH EUR J PHY, V472, P1273, DOI 10.1007/s00424-020-02417-x; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; COPELAND GP, 1987, BRIT J SURG, V74, P1031, DOI 10.1002/bjs.1800741124; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; den Kamp CMO, 2013, AM J CLIN NUTR, V98, P738, DOI 10.3945/ajcn.113.058388; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Ebhardt HA, 2017, J CACHEXIA SARCOPENI, V8, P567, DOI 10.1002/jcsm.12188; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Fazakerley DJ, 2019, J LIPID RES, V60, P1720, DOI 10.1194/jlr.R087510; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gallot YS, 2014, CANCER RES, V74, P7344, DOI 10.1158/0008-5472.CAN-14-0057; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Han XQ, 2020, METABOLISM, V105, DOI 10.1016/j.metabol.2020.154169; Hanson ED, 2017, J CLIN ENDOCR METAB, V102, P1076, DOI 10.1210/jc.2016-3383; Hardee JP, 2018, J CACHEXIA SARCOPENI, V9, P369, DOI 10.1002/jcsm.12271; Hardee JP, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8018197; Harding JL, 2020, DIABETOLOGIA, V63, P75, DOI 10.1007/s00125-019-04991-x; Huot JR, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136687; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kjobsted R, 2019, DIABETES, V68, P1427, DOI 10.2337/db19-0050; Kjobsted R, 2019, DIABETES, V68, P1756, DOI 10.2337/db18-0769; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Larsen MR, 2020, J PHYSIOL-LONDON, V598, P5687, DOI 10.1113/JP280475; Martin A, 2021, J CACHEXIA SARCOPENI, V12, P252, DOI 10.1002/jcsm.12678; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Penna F, 2016, SEMIN CELL DEV BIOL, V54, P20, DOI 10.1016/j.semcdb.2015.09.002; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; PERMERT J, 1993, AM J SURG, V165, P61, DOI 10.1016/S0002-9610(05)80405-2; PISTERS PWT, 1992, SURGERY, V111, P301; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Puppa MJ, 2014, J APPL PHYSIOL, V116, P1078, DOI 10.1152/japplphysiol.01270.2013; Raun SH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073469; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shum Angie M Y, 2018, Oncotarget, V9, P22001, DOI 10.18632/oncotarget.25146; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Sylow L, 2017, DIABETES, V66, P1548, DOI 10.2337/db16-1138; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Wallengren O, 2015, SUPPORT CARE CANCER, V23, P79, DOI 10.1007/s00520-014-2332-y; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708; Winter A, 2012, CLIN NUTR, V31, P765, DOI 10.1016/j.clnu.2012.05.003; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416; Yamada T, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00445; YOSHIKAWA T, 1994, SURGERY, V116, P62; Yoskikawa T, 2001, NUTRITION, V17, P590, DOI 10.1016/S0899-9007(01)00561-5	81	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22211	10.1096/fj.202101759R	http://dx.doi.org/10.1096/fj.202101759R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195922	hybrid, Green Submitted			2022-12-26	WOS:000761250800042
J	Shandell, MA; Capatina, AL; Lawrence, SM; Brackenbury, WJ; Lagos, D				Shandell, Mia A.; Capatina, Alina L.; Lawrence, Samantha M.; Brackenbury, William J.; Lagos, Dimitris			Inhibition of the Na+/K+-ATPase by cardiac glycosides suppresses expression of the IDO1 immune checkpoint in cancer cells by reducing STAT1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE JAK1; INTERFERON-GAMMA; ION CHANNELS; INDOLEAMINE 2,3-DIOXYGENASE; K+-ATPASE; CRYSTAL-STRUCTURE; SODIUM-PUMP; OUABAIN	Despite extensive basic and clinical research on immune checkpoint regulatory pathways, little is known about the effects of the ionic tumor microenvironment on immune check-point expression and function. Here we describe a mechanistic link between Na+/K+-ATPase (NKA) inhibition and activity of the immune checkpoint protein indoleamine-pyrrole 2',3'-dioxygenase 1 (IDO1). We found that IDO1 was necessary and sufficient for production of kynurenine, a downstream tryptophan metabolite, in cancer cells. We developed a spectrophotometric assay to screen a library of 31 model ion transport-targeting compounds for potential effects on IDO1 function in A549 lung and MDA-MB-231 breast cancer cells. This revealed that the cardiac glycosides ouabain and digoxin inhibited kynurenine production at concentrations that did not affect cell survival. NKA inhibition by ouabain and digoxin resulted in increased intracellular Na+ levels and down-regulation of IDO1 mRNA and protein levels, which was consistent with the reduction in kynurenine levels. Knockdown of ATP1A1, the alpha 1 subunit of the NKA and target of cardiac glycosides, increased Na+ levels to a lesser extent than cardiac glycoside treatment and did not affect IDO1 expression. However, ATP1A1 knockdown significantly enhanced the effect of cardiac glycosides on IDO1 expression and kynurenine production. Mechanistically, we show that cardiac glycoside treatment resulted in curtailing the length of phosphorylation-mediated stabilization of STAT1, a transcriptional regulator of IDO1 expression, an effect enhanced by ATP1A1 knockdown. Our findings reveal cross talk between ionic modulation via cardiac glycosides and immune checkpoint protein expression in cancer cells with broad mechanistic and clinical implications.	[Shandell, Mia A.; Capatina, Alina L.; Lawrence, Samantha M.; Brackenbury, William J.] Univ York, Dept Biol, York, N Yorkshire, England; [Shandell, Mia A.; Lagos, Dimitris] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Shandell, Mia A.; Capatina, Alina L.; Brackenbury, William J.; Lagos, Dimitris] Univ York, York Biomed Res Inst, York, N Yorkshire, England; [Lawrence, Samantha M.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Lawrence, Samantha M.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England	University of York - UK; University of Hull; University of York - UK; University of York - UK; University of Leeds; University of Leeds	Lagos, D (corresponding author), Univ York, Hull York Med Sch, York, N Yorkshire, England.; Lagos, D (corresponding author), Univ York, York Biomed Res Inst, York, N Yorkshire, England.	dimitris.lagos@york.ac.uk	; Brackenbury, William/D-8029-2014	Shandell, Mia/0000-0002-7864-758X; Brackenbury, William/0000-0001-6882-3351	MRC Confidence in Concept Award [MC/PC/16064]; BBSRC [BB/J014443/1]; Wellcome Trust Institutional Strategic Support Fund through the Centre for Future Health at the University of York [WT204829]	MRC Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust Institutional Strategic Support Fund through the Centre for Future Health at the University of York(Wellcome Trust)	This work was supported by an MRC Confidence in Concept Award (MC/PC/16064; managed by the University of York) to D. L. and W. J. B. M. A. S. was funded by an MRC Confidence in Concept Award (MC/PC/16064; managed by University of York). A. L. C. is funded by the BBSRC White Rose doctoral training partnership (BB/J014443/1). S. M. L. was supported by a Wellcome Trust Institutional Strategic Support Fund Grant (WT204829) through the Centre for Future Health at the University of York.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; AlberatiGiani D, 1996, J NEUROCHEM, V66, P996; Aperia A, 2016, AM J PHYSIOL-CELL PH, V310, pC491, DOI 10.1152/ajpcell.00359.2015; Askari A, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.505; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Balzan S, 2000, LIFE SCI, V67, P1921, DOI 10.1016/S0024-3205(00)00779-7; Banerjee M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29995-2; Banzola I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01051; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Blair AB, 2019, J CLIN INVEST, V129, P1742, DOI 10.1172/JCI124077; Brackenbury WJ, 2016, PERSP TRANS CELL BIO, P131, DOI 10.1016/B978-0-12-802002-9.00006-6; Campbell TM, 2013, J CELL SCI, V126, P4939, DOI 10.1242/jcs.130013; Capatina Alina L, 2022, Rev Physiol Biochem Pharmacol, V183, P1, DOI 10.1007/112_2020_46; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; Clausen MV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00371; Clifford RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084306; D Basu G, 2006, J IMMUNOL, V177, P2391, DOI 10.4049/jimmunol.177.4.2391; Djamgoz MBA, 2019, CANCERS, V11, DOI 10.3390/cancers11111675; DORNAND J, 1986, IMMUNOBIOLOGY, V171, P436, DOI 10.1016/S0171-2985(86)80075-4; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Gable ME, 2014, BIOCHEM BIOPH RES CO, V446, P1151, DOI 10.1016/j.bbrc.2014.03.071; Galindo CA, 2004, NEUROCHEM RES, V29, P659, DOI 10.1023/B:NERE.0000018836.82122.23; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Haux J, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-11; Havel JJ, 2019, NAT REV CANCER, V19, P133, DOI 10.1038/s41568-019-0116-x; Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p; Humeau J, 2018, CELL CALCIUM, V70, P3, DOI 10.1016/j.ceca.2017.07.006; Iamshanova O, 2016, EUR BIOPHYS J BIOPHY, V45, P765, DOI 10.1007/s00249-016-1173-7; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Karitskaya I, 2010, PFLUG ARCH EUR J PHY, V460, P777, DOI 10.1007/s00424-010-0843-z; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee SY, 2009, J IMMUNOTHER, V32, P22, DOI 10.1097/CJI.0b013e31818ac2f7; Leslie TK, 2019, BBA-REV CANCER, V1872, DOI 10.1016/j.bbcan.2019.07.001; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu J, 2000, J BIOL CHEM, V275, P27838; Mailankot M, 2010, INT J BIOCHEM CELL B, V42, P1446, DOI 10.1016/j.biocel.2010.04.014; Melero CP, 2000, MOLECULES, V5, P51, DOI 10.3390/50100051; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mohammed FH, 2016, INT J ONCOL, V48, P73, DOI 10.3892/ijo.2015.3239; Moretti S, 2017, J BIOL CHEM, V292, P1785, DOI 10.1074/jbc.M116.745448; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Mycielska ME, 2005, J PHYSIOL-LONDON, V563, P393, DOI 10.1113/jphysiol.2004.079491; NICHOLSON SE, 1994, P NATL ACAD SCI USA, V91, P2985, DOI 10.1073/pnas.91.8.2985; Nie Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61920-4; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Ouwerkerk R, 2007, BREAST CANCER RES TR, V106, P151, DOI 10.1007/s10549-006-9485-4; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Peng M, 1996, J BIOL CHEM, V271, P10372, DOI 10.1074/jbc.271.17.10372; Popov S, 2012, AM J PHYSIOL-HEART C, V303, pH57, DOI 10.1152/ajpheart.00512.2011; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Prevarskaya N, 2018, PHYSIOL REV, V98, P559, DOI 10.1152/physrev.00044.2016; REDONDO JM, 1986, FEBS LETT, V206, P199, DOI 10.1016/0014-5793(86)80980-2; Repke K R, 1993, Prog Med Chem, V30, P135, DOI 10.1016/S0079-6468(08)70377-1; Riess C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00055; Robinson CM, 2003, J INTERF CYTOK RES, V23, P413, DOI 10.1089/107999003322277829; Roger S, 2007, INT J BIOCHEM CELL B, V39, P774, DOI 10.1016/j.biocel.2006.12.007; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Sekine A, 2016, NEUROCHEM RES, V41, P2256, DOI 10.1007/s11064-016-1940-y; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Shen JJ, 2020, ACTA PHARMACOL SIN, V41, P110, DOI 10.1038/s41401-019-0290-0; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; SKRIVER E, 1981, FEBS LETT, V131, P219, DOI 10.1016/0014-5793(81)80371-7; SPECIALE C, 1989, J NEUROSCI, V9, P2066; Sugi K, 2001, GASTROENTEROLOGY, V120, P1393, DOI 10.1053/gast.2001.24045; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Venkateswaran N, 2019, GENE DEV, V33, P1236, DOI 10.1101/gad.327056.119; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Weigand KM, 2012, BBA-BIOMEMBRANES, V1818, P1269, DOI 10.1016/j.bbamem.2012.01.015; Wu J, 2013, BIOCHEMISTRY-US, V52, P9059, DOI 10.1021/bi4011804; Wu Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705750; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yang M, 2020, J CELL PHYSIOL, V235, P3950, DOI 10.1002/jcp.29290; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Yosef E, 2016, J BIOL CHEM, V291, P11736, DOI 10.1074/jbc.M116.721084; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00320; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; ZSNAGY I, 1981, J CELL BIOL, V90, P769, DOI 10.1083/jcb.90.3.769; Zuo YB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14948-z	96	4	4	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101707	10.1016/j.jbc.2022.101707	http://dx.doi.org/10.1016/j.jbc.2022.101707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150740	gold, Green Published, Green Accepted			2022-12-26	WOS:000821054100007
J	Teng, XY; Hu, P; Chen, YY; Zang, YY; Ye, XL; Ou, JM; Chen, GQ; Shi, YS				Teng, Xiao-Yu; Hu, Ping; Chen, Yangyang; Zang, Yanyu; Ye, Xiaolian; Ou, Jingmin; Chen, Guiquan; Shi, Yun Stone			A novel Lgi1 mutation causes white matter abnormalities and impairs motor coordination in mice	FASEB JOURNAL			English	Article						LGI1; myelination; oligodendrocyte differentiation; Sox10; white matter	DOMINANT PARTIAL EPILEPSY; AUTOSOMAL-DOMINANT; MAMMALIAN TARGET; OLIGODENDROCYTE DIFFERENTIATION; MOUSE MODEL; GENE; DISRUPTION; INTEGRITY; AKT; TRANSCRIPTION	Leucine-rich glioma-inactivated protein 1 (LGI1) is known to play a key role in autosomal dominant lateral temporal lobe epilepsy (ADLTE). The ADLTE is an inherited disease characterized by focal seizures with distinctive auditory or aphasic symptoms. A large number of mutations on the Lgi1 gene have been reported and are believed to be the genetic cause for ADLTE. We identified a novel missense mutation, c.152A>G (p.Asp51Gly), on Lgi1 from a Chinese ADLTE patient who manifests locomotor imbalance and white matter reduction. However, it remains unknown how mutant LGI1 causes white matter abnormalities at molecular and cellular levels. Here, we generated a knock-in mouse bearing this Lgi1 mutation. We found that Lgi1(D51G)(/)(D51G) mice exhibited impaired defective white matter and motor coordination. We observed that Lgi1(D51G)(/)(D51G) mice displayed a reduced number of mature oligodendrocytes (OLs) and deficient OL differentiation in the white matter. However, the population of oligodendrocyte precursor cells was not affected in Lgi1(D51G)(/)(D51G) mice. Mechanistically, we showed that the Lgi1(D51G) mutation resulted in altered mTOR signaling and led to decreased levels of Sox10. Given that Sox10 is a key transcriptional factor to control OL differentiation, our results strongly suggest that the Lgi1(D51G) mutation may cause white matter abnormalities via inhibiting Sox10-dependent OL differentiation and myelination in the central nervous system.	[Teng, Xiao-Yu; Chen, Yangyang; Zang, Yanyu; Ye, Xiaolian; Chen, Guiquan; Shi, Yun Stone] Nanjing Univ, Med Sch, Model Anim Res Ctr, Minister Educ,Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Hu, Ping] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Womens Hosp, State Key Lab Reprod Med,Dept Prenatal Diag, Nanjing, Peoples R China; [Ou, Jingmin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Shi, Yun Stone] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Neurol, Affiliated Drum Tower Hosp,Med Sch, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Inst Brain Sci, Nanjing, Peoples R China; [Shi, Yun Stone] Nanjing Univ, Chem & Biomed Innovat Ctr, Nanjing, Peoples R China	Nanjing University; Nanjing Medical University; Shanghai Jiao Tong University; Nanjing University; Nanjing University; Nanjing University	Chen, GQ; Shi, YS (corresponding author), Nanjing Univ, Model Anim Res Ctr, Minister Educ, Key Lab Model Anim Dis Study, 12 Xuefu Ave, Nanjing 210023, Peoples R China.	chenguiquan@nju.edu.cn; yunshi@nju.edu.cn	Shi, Yun S/T-8845-2018; Teng, Xiao-Yu/GQH-5261-2022; Shi, Yun/B-5623-2009	Teng, Xiao-Yu/0000-0003-4631-6716; Shi, Yun/0000-0002-8842-9818	National Natural Science Foundation of China [91849112, 31571060]; Natural Science Foundation of Jiangsu Province [BE2019707, BK20201255]; Fundamental Research Funds for the Central Universities [0903-14380029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China, Grant/Award Number: 91849112 and 31571060; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BE2019707 and BK20201255; Fundamental Research Funds for the Central Universities, Grant/Award Number: 0903-14380029	Assareh A, 2011, CNS NEUROSCI THER, V17, P525, DOI 10.1111/j.1755-5949.2010.00181.x; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Bujalka H, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001625; Cheng SS, 2014, INT J BIOCHEM CELL B, V57, P186, DOI 10.1016/j.biocel.2014.10.029; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Cordon-Barris L, 2016, MOL CELL BIOL, V36, P2967, DOI 10.1128/MCB.00230-16; Elbaz B, 2019, TRENDS NEUROSCI, V42, P263, DOI 10.1016/j.tins.2019.01.002; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Figlia G, 2017, ELIFE, V6, DOI 10.7554/eLife.29241; Fleischman DA, 2015, NEUROLOGY, V84, P1294, DOI 10.1212/WNL.0000000000001417; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; He DY, 2016, NAT NEUROSCI, V19, P678, DOI 10.1038/nn.4258; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P1005, DOI 10.1038/jcbfm.2015.12; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Horsburgh K, 2011, BIOCHEM SOC T, V39, P881, DOI 10.1042/BST0390881; Hoshi Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj8080; Hou JX, 2021, J NEUROSCI, V41, P4976, DOI 10.1523/JNEUROSCI.2455-19.2021; Jiang MQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12185; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lee MK, 2014, SEIZURE-EUR J EPILEP, V23, P69, DOI 10.1016/j.seizure.2013.10.001; Li HL, 2007, J NEUROSCI, V27, P14375, DOI 10.1523/JNEUROSCI.4456-07.2007; Liu F, 2019, BRAIN RES, V1721, DOI 10.1016/j.brainres.2019.146332; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Nobile C, 2009, HUM MUTAT, V30, P530, DOI 10.1002/humu.20925; Ohkawa T, 2013, J NEUROSCI, V33, P18161, DOI 10.1523/JNEUROSCI.3506-13.2013; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; Reimer MM, 2011, J NEUROSCI, V31, P18185, DOI 10.1523/JNEUROSCI.4936-11.2011; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rosanoff MJ, 2008, NEUROLOGY, V71, P567, DOI 10.1212/01.wnl.0000323926.77565.ee; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Senechal KR, 2005, HUM MOL GENET, V14, P1613, DOI 10.1093/hmg/ddi169; Shi Y, 2021, NEURON, V109, P2413, DOI 10.1016/j.neuron.2021.05.034; Silva J, 2015, BRAIN PATHOL, V25, P587, DOI 10.1111/bpa.12225; Silva J, 2010, J NEUROSCI RES, V88, P3328, DOI 10.1002/jnr.22496; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Striano P, 2011, NEUROLOGY, V76, P1173, DOI 10.1212/WNL.0b013e318212ab2e; Su LD, 2015, CEREBELLUM, V14, P12, DOI 10.1007/s12311-014-0628-6; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas R, 2010, J NEUROSCI, V30, P6607, DOI 10.1523/JNEUROSCI.5147-09.2010; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Wang F, 2018, NEURON, V99, P689, DOI 10.1016/j.neuron.2018.07.017; Wang H, 2021, J NEUROSCI, V41, P8163, DOI 10.1523/JNEUROSCI.2432-20.2021; Wang H, 2021, NEUROBIOL DIS, V148, DOI 10.1016/j.nbd.2020.105212; Wang H, 2017, CNS NEUROSCI THER, V23, P99, DOI 10.1111/cns.12647; Xie YJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00231; Xie YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07827; Xu CY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00330; Yamagata A, 2020, CELL MOL LIFE SCI, V77, P267, DOI 10.1007/s00018-019-03269-0; Yamagata A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03947-w; Yokoi N, 2015, NAT MED, V21, P19, DOI 10.1038/nm.3759; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873	61	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22212	10.1096/fj.202101652R	http://dx.doi.org/10.1096/fj.202101652R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35167164				2022-12-26	WOS:000761250800036
J	Bsharat-Maalouf, D; Karawani, H				Bsharat-Maalouf, Dana; Karawani, Hanin			Bilinguals' speech perception in noise: Perceptual and neural associations	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; FREQUENCY-FOLLOWING RESPONSE; ATTENTIONAL CONTROL EVIDENCE; BACKGROUND-NOISE; SELECTIVE ATTENTION; ADVERSE CONDITIONS; PROCESSING SPEECH; EXPERIENCE; LANGUAGE; PLASTICITY	The current study characterized subcortical speech sound processing among monolinguals and bilinguals in quiet and challenging listening conditions and examined the relation between subcortical neural processing and perceptual performance. A total of 59 normal-hearing adults, ages 19-35 years, participated in the study: 29 native Hebrew-speaking monolinguals and 30 Arabic-Hebrew-speaking bilinguals. Auditory brainstem responses to speech sounds were collected in a quiet condition and with background noise. The perception of words and sentences in quiet and background noise conditions was also examined to assess perceptual performance and to evaluate the perceptual-physiological relationship. Perceptual performance was tested among bilinguals in both languages (first language (L1-Arabic) and second language (L2-Hebrew)). The outcomes were similar between monolingual and bilingual groups in quiet. Noise, as expected, resulted in deterioration in perceptual and neural responses, which was reflected in lower accuracy in perceptual tasks compared to quiet, and in more prolonged latencies and diminished neural responses. However, a mixed picture was observed among bilinguals in perceptual and physiological outcomes in noise. In the perceptual measures, bilinguals were significantly less accurate than their monolingual counterparts. However, in neural responses, bilinguals demonstrated earlier peak latencies compared to monolinguals. Our results also showed that perceptual performance in noise was related to subcortical resilience to the disruption caused by background noise. Specifically, in noise, increased brainstem resistance (i.e., fewer changes in the fundamental frequency (FO) representations or fewer shifts in the neural timing) was related to better speech perception among bilinguals. Better perception in L1 in noise was correlated with fewer changes in FO representations, and more accurate perception in L2 was related to minor shifts in auditory neural timing. This study delves into the importance of using neural brainstem responses to speech sounds to differentiate individuals with different language histories and to explain inter-subject variability in bilinguals' perceptual abilities in daily life situations.	[Bsharat-Maalouf, Dana; Karawani, Hanin] Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel	University of Haifa	Karawani, H (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel.	hkarawani@staff.haifa.ac.il		Bsharat-Maalouf, Dana/0000-0002-6561-3364; Karawani, Hanin/0000-0003-1346-8502	University of Haifa; Planning and Budgeting Committee	University of Haifa; Planning and Budgeting Committee	The current study was supported by the University of Haifa and by the Planning and Budgeting Committee (grant awarded to HK). A student fellowship was awarded from the University of Haifa to DBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Abutalebi J, 2015, NEUROPSYCHOLOGIA, V69, P201, DOI 10.1016/j.neuropsychologia.2015.01.040; Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Akker E., 2003, BILING-LANG COGN, V6, P81, DOI [10.1017/s1366728903001056, DOI 10.1017/S1366728903001056, 10.1017/S1366728903001056]; Anderson S., 2013, AUDITORY BRAINSTEM R; Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Anderson S, 2010, J AM ACAD AUDIOL, V21, P575, DOI 10.3766/jaaa.21.9.3; Anderson S, 2010, HEARING RES, V270, P151, DOI 10.1016/j.heares.2010.08.001; Anderson S, 2010, J NEUROSCI, V30, P4922, DOI 10.1523/JNEUROSCI.0107-10.2010; ANSI, 1989, S361989 ANSI; Assmann P.F., 2004, SPEECH PROCESSING AU, P231; Bakhshi E., 2019, AUDITORY VESTIBULAR, V28, P36, DOI 10.18502/avr.v28i1.414; BAUER LO, 1990, BIOL PSYCHOL, V30, P21, DOI 10.1016/0301-0511(90)90088-E; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 2011, CAN J EXP PSYCHOL, V65, P229, DOI 10.1037/a0025406; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bidelman GM, 2018, HEARING RES, V367, P149, DOI 10.1016/j.heares.2018.05.018; Bidelman GM, 2017, SPRINGER HANDB AUDIT, V61, P193, DOI 10.1007/978-3-319-47944-6_8; Bidelman GM, 2018, J AM ACAD AUDIOL, V29, P164, DOI 10.3766/jaaa.16167; Bidelman GM, 2015, BRAIN LANG, V143, P32, DOI 10.1016/j.bandl.2015.02.002; Bidelman GM, 2015, NEUROPSYCHOLOGIA, V68, P38, DOI 10.1016/j.neuropsychologia.2014.12.020; BinKhamis G, 2019, EAR HEARING, V40, P659, DOI 10.1097/AUD.0000000000000648; Bird J., 1998, PSYCHOPHYSICAL PHYSL, P263; Bishop CW, 2009, J COGNITIVE NEUROSCI, V21, P1790, DOI 10.1162/jocn.2009.21118; Blumenfeld HK, 2011, COGNITION, V118, P245, DOI 10.1016/j.cognition.2010.10.012; Borghini G, 2020, J ACOUST SOC AM, V147, P3783, DOI 10.1121/10.0001126; Borghini G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00152; Bradlow AR, 2007, J ACOUST SOC AM, V121, P2339, DOI 10.1121/1.2642103; Bradlow AR, 2018, LAB PHONOL, V9, DOI 10.5334/labphon.137; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Bsharat-Maalouf D, 2022, COGNITION, V222, DOI 10.1016/j.cognition.2022.105018; Burkard Robert F, 2002, Am J Audiol, V11, P13, DOI 10.1044/1059-0889(2002/004); Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Chandrasekaran B, 2009, BRAIN LANG, V108, P1, DOI 10.1016/j.bandl.2008.02.001; Coffey EBJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00479; Darwin CJ, 2003, J ACOUST SOC AM, V114, P2913, DOI 10.1121/1.1616924; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; Degani T, 2011, J COGN PSYCHOL, V23, P18, DOI 10.1080/20445911.2011.445986; Desjardins JL, 2019, J SPEECH LANG HEAR R, V62, P2553, DOI 10.1044/2019_JSLHR-H-18-0435; Du Y, 2011, NEUROSCI BIOBEHAV R, V35, P2046, DOI 10.1016/j.neubiorev.2011.05.008; Ezzatian P, 2010, SPEECH COMMUN, V52, P919, DOI 10.1016/j.specom.2010.04.001; Filippini R, 2012, FOLIA PHONIATR LOGO, V64, P217, DOI 10.1159/000342139; Florentine M., 1984, J ACOUST SOC AM, V75, pS84; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 1997, ELECTROEN CLIN NEURO, V102, P46, DOI 10.1016/S0013-4694(96)96006-X; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; Lecumberri MLG, 2010, SPEECH COMMUN, V52, P864, DOI 10.1016/j.specom.2010.08.014; Giroud N, 2020, BRAIN LANG, V207, DOI 10.1016/j.bandl.2020.104815; Gollan TH, 2008, J MEM LANG, V58, P787, DOI 10.1016/j.jml.2007.07.001; Gollan TH, 2011, J EXP PSYCHOL GEN, V140, P186, DOI 10.1037/a0022256; Gorga M., 1985, AUDITORY BRAINSTEM R, P49; Grote KS, 2021, FIRST LANG, V41, P677, DOI 10.1177/01427237211024220; Gruter T, 2012, SECOND LANG RES, V28, P191, DOI 10.1177/0267658312437990; Grundy JG, 2017, ANN NY ACAD SCI, V1396, P183, DOI 10.1111/nyas.13333; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Hairston WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055215; Hall JW, 1992, HDB AUDITORY EVOKED; Hayakawa S, 2019, BEHAV BRAIN FUNCT, V15, DOI 10.1186/s12993-019-0157-z; Hermans D., 1998, BILING-LANG COGN, V1, P213, DOI [10.1017/S1366728998000364, DOI 10.1017/S1366728998000364]; Hervais-Adelman A, 2018, BRAIN STRUCT FUNCT, V223, P3495, DOI 10.1007/s00429-018-1695-0; Hopp H, 2013, SECOND LANG RES, V29, P33, DOI 10.1177/0267658312461803; HOUTGAST T, 1981, APPL ACOUST, V14, P15, DOI 10.1016/0003-682X(81)90040-2; Hurtig A, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02029; Hygge S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01390; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Johnson KL, 2008, J NEUROSCI, V28, P4000, DOI 10.1523/JNEUROSCI.0012-08.2008; Kaan E, 2014, LINGUIST APPROACH BI, V4, P257, DOI 10.1075/lab.4.2.05kaa; Karawani H, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02066; Karawani H, 2010, INT J AUDIOL, V49, P844, DOI 10.3109/14992027.2010.495083; Kilman L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00651; Klatte M, 2010, NOISE HEALTH, V12, P270, DOI 10.4103/1463-1741.70506; Koravand A, 2019, CAN ACOUST, V47, P23; Kraus N, 2017, HEARING J, V70, P40; Kraus N, 2021, HEARING RES, V407, DOI 10.1016/j.heares.2021.108291; Krishnamurti S, 2013, INT J PEDIATR OTORHI, V77, P594, DOI 10.1016/j.ijporl.2012.12.032; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Krizman J, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.717572; Krizman J, 2019, HEARING RES, V382, DOI 10.1016/j.heares.2019.107779; Krizman J, 2017, BILING-LANG COGN, V20, P834, DOI 10.1017/S1366728916000444; Krizman J, 2016, DEVELOPMENTAL SCI, V19, P881, DOI 10.1111/desc.12347; Krizman J, 2015, NEUROSCI LETT, V585, P48, DOI 10.1016/j.neulet.2014.11.011; Krizman J, 2014, BRAIN LANG, V128, P34, DOI 10.1016/j.bandl.2013.11.006; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Krizman J, 2010, AUDIOL NEURO-OTOL, V15, P332, DOI 10.1159/000289572; Liu LF, 2006, J NEUROPHYSIOL, V95, P1926, DOI 10.1152/jn.00497.2005; Lotfi Y, 2019, MED HYPOTHESES, V132, DOI 10.1016/j.mehy.2019.109355; LUKAS JH, 1981, INT J NEUROSCI, V12, P137, DOI 10.3109/00207458108985796; Maddieson Ian, 1984, PATTERNS SOUNDS; Maggu AR., 2018, INTERSPEECH, DOI [10.1016/j.mri.2017.09.011, DOI 10.1016/J.MRI.2017.09.011]; Malmierca MS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00019; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI DOI 10.1017/S1366728903001068; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Martin CD, 2013, J MEM LANG, V69, P574, DOI 10.1016/j.jml.2013.08.001; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Mayo LH, 1997, J SPEECH LANG HEAR R, V40, P686, DOI 10.1044/jslhr.4003.686; Meador D., 2000, BILING-LANG COGN, V3, P55, DOI DOI 10.1017/S1366728900000134; Mendel LL, 2016, INT J AUDIOL, V55, P126, DOI 10.3109/14992027.2015.1061710; Morini G, 2020, LANG SPEECH, V63, P381, DOI 10.1177/0023830919846158; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nahum M, 2008, PLOS BIOL, V6, P978, DOI 10.1371/journal.pbio.0060126; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Olulade OA, 2016, CEREB CORTEX, V26, P3196, DOI 10.1093/cercor/bhv152; Omote A, 2017, CORTEX, V93, P146, DOI 10.1016/j.cortex.2017.05.005; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peng ZE, 2019, J SPEECH LANG HEAR R, V62, P1068, DOI 10.1044/2018_JSLHR-H-17-0423; Perrone-Bertolotti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180084; Raizada RDS, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.003.2007; Ratcliff ER, 2006, PSYCHOMETRICALLY EQU; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Rogers CL, 2006, APPL PSYCHOLINGUIST, V27, P465, DOI 10.1017/S014271640606036X; Ronnberg J, 2019, INT J AUDIOL, V58, P247, DOI 10.1080/14992027.2018.1551631; Ronnberg J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00031; Rosenhouse J., 2006, INT J BILINGUAL, V10, P119; Rudner M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00148; Ruggles D, 2011, P NATL ACAD SCI USA, V108, P15516, DOI 10.1073/pnas.1108912108; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Sanju Himanshu Kumar, 2016, J Otol, V11, P63, DOI 10.1016/j.joto.2016.04.002; Scharenborg O, 2019, SPEECH COMMUN, V108, P53, DOI 10.1016/j.specom.2019.03.001; Scharenborg O, 2018, J EXP PSYCHOL LEARN, V44, P233, DOI 10.1037/xlm0000441; Schmidtke J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00678; Scott SK, 2004, J ACOUST SOC AM, V115, P813, DOI 10.1121/1.1639336; Scott SK, 2009, J ACOUST SOC AM, V125, P1737, DOI 10.1121/1.3050255; Shook A, 2013, BILING-LANG COGN, V16, P304, DOI 10.1017/S1366728912000466; Skoe E, 2019, J AM ACAD AUDIOL, V30, P115, DOI 10.3766/jaaa.17082; Skoe E, 2017, NEUROSCIENCE, V349, P278, DOI 10.1016/j.neuroscience.2017.02.049; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Song JH, 2008, AUDIOL NEURO-OTOL, V13, P335, DOI 10.1159/000132689; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; Song JH, 2011, CLIN NEUROPHYSIOL, V122, P346, DOI 10.1016/j.clinph.2010.07.009; Sorace Antonella., 1993, SECOND LANG RES, V9, P22, DOI DOI 10.1177/026765839300900102; Soveri A, 2011, BILING-LANG COGN, V14, P371, DOI 10.1017/S1366728910000118; Strait DL, 2013, DEV COGN NEUROS-NETH, V6, P51, DOI 10.1016/j.dcn.2013.06.003; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Tabri D, 2015, INT J LANGUAGE COMMU, P1; Tierney A, 2011, HEARING RES, V282, P145, DOI 10.1016/j.heares.2011.08.014; Tremblay A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181709; Warzybok A, 2015, INT J AUDIOL, V54, P88, DOI 10.3109/14992027.2015.1063715; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Weiss D, 2008, J AM ACAD AUDIOL, V19, P5, DOI 10.3766/jaaa.19.1.2; Weiss MW, 2015, J NEUROSCI, V35, P1687, DOI 10.1523/JNEUROSCI.3680-14.2015; White-Schwoch T, 2013, J NEUROSCI, V33, P17667, DOI 10.1523/JNEUROSCI.2560-13.2013; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Yellamsetty A, 2019, BRAIN RES, V1714, P182, DOI 10.1016/j.brainres.2019.02.025; Zekveld AA, 2006, NEUROIMAGE, V32, P1826, DOI 10.1016/j.neuroimage.2006.04.199; Zhang YK, 2005, J NEUROPHYSIOL, V94, P2676, DOI 10.1152/jn.00549.2005; Zou LJ, 2012, CORTEX, V48, P1197, DOI 10.1016/j.cortex.2011.05.022	158	4	4	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264282	10.1371/journal.pone.0264282	http://dx.doi.org/10.1371/journal.pone.0264282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196339	gold, Green Published			2022-12-26	WOS:000835161600034
J	Jamal, R; LaCombe, J; Patel, R; Blackwell, M; Thomas, JR; Sloan, K; Wallace, JM; Roper, RJ				Jamal, Raza; LaCombe, Jonathan; Patel, Roshni; Blackwell, Matthew; Thomas, Jared R.; Sloan, Kourtney; Wallace, Joseph M.; Roper, Randall J.			Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GREEN TEA EXTRACT; DOUBLE-BLIND; DYRK1A; OSTEOPOROSIS; HEALTH; WOMEN; DRINKING; ADULTS; BRAIN	Bone abnormalities affect all individuals with Down syndrome (DS) and are linked to abnormal expression of DYRK1A, a gene found in three copies in people with DS and Ts65Dn DS model mice. Previous work in Ts65Dn male mice demonstrated that both genetic normalization of Dyrk1a and treatment with similar to 9 mg/kg/day Epigallocatechin-3-gallate (EGCG), the main polyphenol found in green tea and putative DYRK1A inhibitor, improved some skeletal deficits. Because EGCG treatment improved mostly trabecular skeletal deficits, we hypothesized that increasing EGCG treatment dosage and length of administration would positively affect both trabecular and cortical bone in Ts65Dn mice. Treatment of individuals with DS with green tea extract (GTE) containing EGCG also showed some weight loss in individuals with DS, and we hypothesized that weights would be affected in Ts65Dn mice after EGCG treatment. Treatment with similar to 20 mg/kg/day EGCG for seven weeks showed no improvements in male Ts65Dn trabecular bone and only limited improvements in cortical measures. Comparing skeletal analyses after similar to 20mg/kg/day EGCG treatment with previously published treatments with similar to 9, 50, and 200 mg/kg/day EGCG showed that increased dosage and treatment time increased cortical structural deficits leading to weaker appendicular bones in male mice. Weight was not affected by treatment in mice, except for those given a high dose of EGCG by oral gavage. These data indicate that high doses of EGCG, similar to those reported in some treatment studies of DS and other disorders, may impair long bone structure and strength. Skeletal phenotypes should be monitored when high doses of EGCG are administered therapeutically.	[Jamal, Raza; LaCombe, Jonathan; Patel, Roshni; Blackwell, Matthew; Thomas, Jared R.; Sloan, Kourtney; Roper, Randall J.] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46205 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Roper, RJ (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA.	rjroper@iupui.edu		Roper, Randall/0000-0002-9860-5037	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R15HD090603]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R15HD090603 (RJR).	Abeysekera I, 2016, MOL NUTR FOOD RES, V60, P717, DOI 10.1002/mnfr.201500781; Angelopoulou N, 1999, EUR RADIOL, V9, P648, DOI 10.1007/s003300050726; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Becker W, 2014, CNS NEUROL DISORD-DR, V13, P26, DOI 10.2174/18715273113126660186; Berman AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130504; Blazek JD, 2015, HUM MOL GENET, V24, P5687, DOI 10.1093/hmg/ddv284; Blazek JD, 2015, MECH DEVELOP, V136, P133, DOI 10.1016/j.mod.2014.12.004; Blazek JD, 2011, BONE, V48, P275, DOI 10.1016/j.bone.2010.09.028; Blazek JD, 2010, DEV DYNAM, V239, P1645, DOI 10.1002/dvdy.22295; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Carfi A, 2017, OSTEOPOROSIS INT, V28, P2929, DOI 10.1007/s00198-017-4133-x; Carr J, 2018, J APPL RES INTELLECT, V31, P743, DOI 10.1111/jar.12438; Catuara-Solarz S, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0103-16.2016; Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003; Chen Z, 2003, AM J EPIDEMIOL, V158, P772, DOI 10.1093/aje/kwg214; Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353; Costa R, 2018, J CLIN DENSITOM, V21, P493, DOI 10.1016/j.jocd.2018.03.001; de la Torre R, 2016, LANCET NEUROL, V15, P801, DOI 10.1016/S1474-4422(16)30034-5; De la Torre R, 2014, MOL NUTR FOOD RES, V58, P278, DOI 10.1002/mnfr.201300325; Devine A, 2007, AM J CLIN NUTR, V86, P1243, DOI 10.1093/ajcn/86.4.1243; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Dostal AM, 2016, J NUTR, V146, P256, DOI 10.3945/jn.115.219238; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Fowler TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042967; Goodlett CR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67133-z; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; Hegarty VM, 2000, AM J CLIN NUTR, V71, P1003; Hoover PA, 1996, CAN J PHYSIOL PHARM, V74, P911, DOI 10.1139/cjpp-74-8-911; Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007; Huang HT, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111136; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002; Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044; Kara IH, 2007, INT J VITAM NUTR RES, V77, P389, DOI 10.1024/0300-9831.77.6.389; LaCombe JM, 2020, BONE, V133, DOI 10.1016/j.bone.2019.115215; Lee Y, 2009, J BIOL CHEM, V284, P33343, DOI 10.1074/jbc.M109.042234; de Moraes MEL, 2008, SPEC CARE DENT, V28, P101, DOI 10.1111/j.1754-4505.2008.00020.x; Levy Y, 2017, CLIN NUTR, V36, P315, DOI 10.1016/j.clnu.2016.11.001; Lewanda AF, 2018, J PEDIATR-US, V201, P100, DOI 10.1016/j.jpeds.2018.05.022; Li X, 2019, OSTEOPOROSIS INT, V30, P333, DOI 10.1007/s00198-018-4767-3; Long R, 2019, COMPLEMENT THER MED, V45, P234, DOI 10.1016/j.ctim.2019.07.002; McElyea SD, 2016, HUM MOL GENET, V25, P4856, DOI 10.1093/hmg/ddw309; Muraki S, 2007, J ORTHOP SCI, V12, P317, DOI 10.1007/s00776-007-1143-0; Myrelid A, 2002, ARCH DIS CHILD, V87, P97, DOI 10.1136/adc.87.2.97; Nash LA, 2017, CRIT REV FOOD SCI, V57, P1603, DOI 10.1080/10408398.2014.1001019; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016; Pons-Espinal M, 2013, NEUROBIOL DIS, V60, P18, DOI 10.1016/j.nbd.2013.08.008; Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Roper RJ, 2009, MECH DEVELOP, V126, P212, DOI 10.1016/j.mod.2008.11.002; Roper RJ, 2006, GENETICS, V172, P437, DOI 10.1534/genetics.105.050898; Shaw PR, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.046243; Shen CL, 2012, OSTEOPOROSIS INT, V23, P1541, DOI 10.1007/s00198-011-1731-x; Shen CL, 2016, J INVEST MED, V64, P1151, DOI 10.1136/jim-2016-000190; Shen CL, 2011, CALCIFIED TISSUE INT, V88, P455, DOI 10.1007/s00223-011-9477-1; Shen CL, 2009, BONE, V44, P684, DOI 10.1016/j.bone.2008.11.018; Shen Q, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111633; Soucher B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00267; Stagni F, 2016, NEUROSCIENCE, V333, P277, DOI 10.1016/j.neuroscience.2016.07.031; Stringer M, 2017, PHYSIOL BEHAV, V177, P230, DOI 10.1016/j.physbeh.2017.05.003; Stringer M, 2015, PHARMACOL BIOCHEM BE, V138, P70, DOI 10.1016/j.pbb.2015.09.002; Suzuki T, 1997, BONE, V21, P461, DOI 10.1016/S8756-3282(97)00179-8; Tang JYM, 2019, J INTELL DISABIL RES, V63, P936, DOI 10.1111/jir.12608; Thomas JR, 2021, GENES-BASEL, V12, DOI 10.3390/genes12111729; Thomas JR, 2021, CURR OSTEOPOROS REP, V19, P338, DOI 10.1007/s11914-021-00674-y; Thomas JR, 2020, BONE, V136, DOI 10.1016/j.bone.2020.115367; Weijerman ME, 2010, EUR J PEDIATR, V169, P1445, DOI 10.1007/s00431-010-1253-0; Wu CH, 2002, ARCH INTERN MED, V162, P1001, DOI 10.1001/archinte.162.9.1001; Xicota L, 2020, CLIN NUTR, V39, P1292, DOI 10.1016/j.clnu.2019.05.028	74	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264254	10.1371/journal.pone.0264254	http://dx.doi.org/10.1371/journal.pone.0264254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196359	gold, Green Published			2022-12-26	WOS:000835161600031
J	Jung, C; Excoffier, JB; Raphael-Rousseau, M; Salaun-Penquer, N; Ortala, M; Chouaid, C				Jung, Camille; Excoffier, Jean-Baptiste; Raphael-Rousseau, Mathilde; Salaun-Penquer, Noemie; Ortala, Matthieu; Chouaid, Christos			Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysis	PLOS ONE			English	Article							AGE	Characteristics of patients at risk of developing severe forms of COVID-19 disease have been widely described, but very few studies describe their evolution through the following waves. Data was collected retrospectively from a prospectively maintained database from a University Hospital in Paris area, over a year corresponding to the first three waves of COVID-19 in France. Evolution of patient characteristics between non- severe and severe cases through the waves was analyzed with a classical multivariate logistic regression along with a complementary Machine-Learning-based analysis using explainability methods. On 1076 hospitalized patients, severe forms concerned 29% (123/429), 31% (66/214) and 18% (79/433) of each wave. Risk factors of the first wave included old age (>= 70 years), male gender, diabetes and obesity while cardiovascular issues appeared to be a protective factor. Influence of age, gender and comorbidities on the occurrence of severe COVID-19 was less marked in the 3rd wave compared to the first 2, and the interactions between age and comorbidities less important. Typology of hospitalized patients with severe forms evolved rapidly through the waves. This evolution may be due to the changes of hospital practices and the early vaccination campaign targeting the people at high risk such as elderly and patients with comorbidities.	[Jung, Camille] CHI Creteil, Clin Res Ctr, Creteil, France; [Excoffier, Jean-Baptiste; Salaun-Penquer, Noemie; Ortala, Matthieu] Kaduceo, Toulouse, France; [Raphael-Rousseau, Mathilde] CHI Creteil, Dept Med Informat, Creteil, France; [Chouaid, Christos] CHI Creteil, Dept Pneumol, Creteil, France; [Chouaid, Christos] IMRB, UPEC, INSERM, U955, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Excoffier, JB (corresponding author), Kaduceo, Toulouse, France.	jeanbaptiste.excoffier@kaduceo.com		JUNG, Camille/0000-0001-8486-8939				Bae S, 2021, HEART, V107, P373, DOI 10.1136/heartjnl-2020-317901; Bottino F, 2021, J PERS MED, V11, DOI 10.3390/jpm11090893; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; Caruana R., 2006, PROC 23 INT C MACH L, P161, DOI DOI 10.1145/1143844.1143865; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Couronne R, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2264-5; Domingo P, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.04.005; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Institut Pasteur, SHORT TERM PROJECTIO; Jassat W, 2021, LANCET GLOB HEALTH, V9, pE1216, DOI 10.1016/S2214-109X(21)00289-8; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Lampart M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10122672; Lee K, 2009, GLOB INST, P1; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liang WH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00562-2020; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Lu S, 2021, ARXIV PREPRINT ARXIV; Lundberg S.M, 2018, CONSISTENT INDIVIDUA; Lundberg SM, 2017, ADV NEUR IN, V30; Markus AF, 2021, J BIOMED INFORM, V113, DOI 10.1016/j.jbi.2020.103655; Meintrup D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126680; Moncada-Torres A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86327-7; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Smilowitz Nathaniel R, 2021, Eur Heart J, V42, P2270, DOI 10.1093/eurheartj/ehaa1103; Sohrabi Y, 2021, MED-CAMBRIDGE, V2, P378, DOI 10.1016/j.medj.2021.02.004; Vaid A, 2020, J MED INTERNET RES, V22, DOI 10.2196/24018; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yan BD, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2021.100521	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263266	10.1371/journal.pone.0263266	http://dx.doi.org/10.1371/journal.pone.0263266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192649	gold, Green Published			2022-12-26	WOS:000812552500019
J	Davis, RB; Ounap, E; Tammaru, T				Davis, Robert B.; Ounap, Erki; Tammaru, Toomas			A supertree of Northern European macromoths	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; MATRIX REPRESENTATION; MOTHS LEPIDOPTERA; LEVEL CLASSIFICATION; NOCTUOIDEA; EVOLUTION; EREBIDAE; NOCTUIDAE; GEOMETRIDAE	Ecological and life-history data on the Northern European macromoth (Lepidoptera: Macroheterocera) fauna is widely available and ideal for use in answering phylogeny-based research questions: for example, in comparative biology. However, phylogenetic information for such studies lags behind. Here, as a synthesis of all currently available phylogenetic information on the group, we produce a supertree of 114 Northern European macromoth genera (in four superfamilies, with Geometroidea considered separately), providing the most complete phylogenetic picture of this fauna available to date. In doing so, we assess those parts of the phylogeny that are well resolved and those that are uncertain. Furthermore, we identify those genera for which phylogenetic information is currently too poor to include in such a supertree, or entirely absent, as targets for future work. As an aid to studies involving these genera, we provide information on their likely positions within the macromoth tree. With phylogenies playing an ever more important role in the field, this supertree should be useful in informing future ecological and evolutionary studies.	[Davis, Robert B.; Ounap, Erki; Tammaru, Toomas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Ounap, Erki] Estonian Univ Life Sci, Inst Agr & Environm Sci, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Estonian University of Life Sciences	Davis, RB (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	davis@ut.ee		Davis, Robert/0000-0002-0104-0747	Estonian Research Council [PRG741]	Estonian Research Council(Estonian Research Council)	RBD, EO~ and TT were supported by Estonian Research Council grant PRG741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Estonian Research Council URL: https://www.etag.ee/en/estonian-research-council/.	AARVIK L, 2017, J ENTOMOL SUPPLEMENT, V3, P1; Baker J, 2015, P NATL ACAD SCI USA, V112, P5093, DOI 10.1073/pnas.1419823112; Bininda-Emonds O.R., 2004, COMPU BIOL, P267; Bininda-Emonds O.R.P., 2014, MODERN PHYLOGENETIC, P49; Bininda-Emonds ORP, 2004, TRENDS ECOL EVOL, V19, P315, DOI 10.1016/j.tree.2004.03.015; Bininda-Emonds ORP, 2003, SYST BIOL, V52, P839, DOI 10.1080/10635150390252242; Bininda-Emonds ORP, 2001, SYST BIOL, V50, P565, DOI 10.1080/106351501750435112; Breinholt JW, 2018, SYST BIOL, V67, P78, DOI 10.1093/sysbio/syx048; Chazot N, 2019, SYST BIOL, V68, P797, DOI 10.1093/sysbio/syz002; Chen ZS, 2018, MITOCHONDRIAL DNA B, V3, P78, DOI 10.1080/23802359.2017.1422406; Chialvo CHS, 2018, MOL PHYLOGENET EVOL, V121, P23, DOI 10.1016/j.ympev.2017.12.015; Coates BS, 2016, MITOCHONDRIAL DNA B, V1, P487, DOI 10.1080/23802359.2016.1192499; Davis RB, 2009, J EVOLUTION BIOL, V22, P1750, DOI 10.1111/j.1420-9101.2009.01789.x; Davis RB, 2016, ECOLOGY, V97, P2112, DOI 10.1002/ecy.1435; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Davis RB, 2010, P ROY SOC B-BIOL SCI, V277, P1597, DOI 10.1098/rspb.2009.2299; Dong WW, 2016, GENE, V577, P37, DOI 10.1016/j.gene.2015.11.020; Dowdy NJ, 2020, SYST ENTOMOL, V45, P874, DOI 10.1111/syen.12433; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Garamszegi L. Z., 2014, MODERN PHYLOGENETIC; Gatesy J, 2002, SYST BIOL, V51, P652, DOI 10.1080/10635150290102311; Gatesy J., 2004, COMPU BIOL, P369; GITTLEMAN JL, 2004, COMPU BIOL, V4, P439; Guinot G, 2018, FISH FISH, V19, P577, DOI 10.1111/faf.12275; Hamilton CA, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1505-1; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Homziak NT, 2019, MOL PHYLOGENET EVOL, V131, P99, DOI 10.1016/j.ympev.2018.10.038; Huang Y, 2019, INT J BIOL MACROMOL, V125, P1257, DOI 10.1016/j.ijbiomac.2018.09.104; Kawahara AY, 2019, P NATL ACAD SCI USA, V116, P22657, DOI 10.1073/pnas.1907847116; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Keegan KL, 2021, INSECT SYST DIVER, V5, DOI 10.1093/isd/ixab005; Keegan KL, 2019, SYST ENTOMOL, V44, P451, DOI 10.1111/syen.12336; Kergoat GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07537-8; Kim MJ, 2020, SYST ENTOMOL, V45, P857, DOI 10.1111/syen.12431; Kitching IJ, 1998, HDB ZOOLOGY ARTHROPO, VIV, P355, DOI DOI 10.1515/9783110804744.355; Kivela SM, 2020, FUNCT ECOL, V34, P1391, DOI 10.1111/1365-2435.13556; Klug S, 2010, ZOOL SCR, V39, P331, DOI 10.1111/j.1463-6409.2010.00427.x; Li J, 2019, GENOMICS, V111, P1239, DOI 10.1016/j.ygeno.2018.08.003; Li ZQ, 2020, MITOCHONDRIAL DNA B, V5, P1346, DOI 10.1080/23802359.2020.1735278; Liu QN, 2016, GENES GENOM, V38, P205, DOI 10.1007/s13258-015-0346-6; Liu QN, 2015, EUR J ENTOMOL, V112, P399, DOI 10.14411/eje.2015.055; Liu TT, 2019, MITOCHONDRIAL DNA B, V4, P2759, DOI 10.1080/23802359.2019.1644546; Liu Y, 2017, INT J BIOL MACROMOL, V105, P219, DOI 10.1016/j.ijbiomac.2017.07.033; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Mayer C, 2021, SYST ENTOMOL, V46, P649, DOI 10.1111/syen.12481; MILLER JS, 1991, B AM MUS NAT HIST, P1; MILLER JS, 1992, J NEW YORK ENTOMOL S, V100, P228; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Murillo-Ramos L, 2021, MOL PHYLOGENET EVOL, V162, DOI 10.1016/j.ympev.2021.107198; Murillo-Ramos L, 2019, PEERJ, V7, DOI 10.7717/peerj.7386; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nicholson DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128554; Nomura M, 1998, APPL ENTOMOL ZOOL, V33, P513, DOI 10.1303/aez.33.513; Nyakatura K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-12; Ounap E, 2016, SYST ENTOMOL, V41, P824, DOI 10.1111/syen.12195; Page R.D., 2004, COMPU BIOL, P247; Peng XY, 2016, MITOCHONDRIAL DNA A, V27, P3749, DOI 10.3109/19401736.2015.1079888; Pisani D, 2002, SYST BIOL, V51, P151, DOI 10.1080/106351502753475925; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2017, SYST ENTOMOL, V42, P82, DOI 10.1111/syen.12199; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Ronka K, 2016, SYST ENTOMOL, V41, P844, DOI 10.1111/syen.12194; Rota J, 2016, SYST ENTOMOL, V41, P416, DOI 10.1111/syen.12162; Salamin N., 2004, COMPU BIOL, V4; Schintlmeister A., 2008, Palaearctic Macrolepidoptera, Volume 1: Notodontidae; Scott CH, 2014, SYST ENTOMOL, V39, P286, DOI 10.1111/syen.12047; Scott CH, 2012, INSECT SYST EVOL, V43, P321, DOI 10.1163/1876312X-04303006; Seo BY, 2019, MITOCHONDRIAL DNA B, V4, P3918, DOI 10.1080/23802359.2019.1688119; Sihvonen P, 2020, SYST ENTOMOL, V45, P606, DOI 10.1111/syen.12418; Sivasankaran K, 2017, GENOM DATA, V14, P66, DOI 10.1016/j.gdata.2017.09.004; Springer MS, 2001, SCIENCE, V291, P1709, DOI 10.1126/science.1059434; Sun YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39153; Sun YX, 2020, PEERJ, V8, DOI 10.7717/peerj.8780; SUREHKA C, 2019, ESSENTIALS BIOINFORM, P167; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Swofford D.L., 2013, PAUP PHYLOGENETIC AN; Tammaru T, 2018, J EVOLUTION BIOL, V31, P1400, DOI 10.1111/jeb.13306; Toussaint EFA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041377; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wang HS, 2015, CLADISTICS, V31, P579, DOI 10.1111/cla.12108; Waring P, 2003, FIELD GUIDE MOTHS GR; WELLER SJ, 1994, SYST BIOL, V43, P194, DOI 10.2307/2413461; Wiemers M, 2020, ZOOKEYS, P97, DOI 10.3897/zookeys.938.50878; Wilkinson M, 2005, SYST BIOL, V54, P823, DOI 10.1080/10635150590950362; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Wink M, 1997, J CHEM ECOL, V23, P1549, DOI 10.1023/B:JOEC.0000006421.49263.ae; Wu K, 2019, MITOCHONDRIAL DNA B, V4, P3654, DOI 10.1080/23802359.2019.1678422; Wu Y-P., 2020, MITOCHONDRIAL DNA B, V5, p1290 2; Wu YP, 2016, GENE, V591, P161, DOI 10.1016/j.gene.2016.07.003; Wu ZY, 2019, MITOCHONDRIAL DNA B, V4, P3128, DOI 10.1080/23802359.2019.1666673; XIAOHUI G, 2017, CONSERV GENET RESOUR, V9, P277; Xin ZZ, 2018, INT J BIOL MACROMOL, V107, P121, DOI 10.1016/j.ijbiomac.2017.08.153; Xue S, 2019, MITOCHONDRIAL DNA B, V4, P3509, DOI 10.1080/23802359.2019.1675551; Yang MS, 2019, INT J BIOL MACROMOL, V123, P485, DOI 10.1016/j.ijbiomac.2018.10.149; Yang ZH, 2019, INT J BIOL MACROMOL, V137, P317, DOI [10.1016/j.ijbiomac.2019.06238, 10.1016/j.ijbiomac.2019.06.238]; Yao S, 2018, MITOCHONDRIAL DNA B, V3, P474, DOI 10.1080/23802359.2018.1462114; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2013, ZOOL SCR, V42, P488, DOI 10.1111/zsc.12022; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; Zaspel JM, 2012, MOL PHYLOGENET EVOL, V65, P786, DOI 10.1016/j.ympev.2012.06.029; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975; Zenker MM, 2017, ZOOL SCR, V46, P348, DOI 10.1111/zsc.12202; Zhang Y, 2019, MOL ECOL RESOUR, V19, P1037, DOI 10.1111/1755-0998.13026; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhu XY, 2018, INT J BIOL MACROMOL, V118, P1574, DOI 10.1016/j.ijbiomac.2018.06.188; Zhu XY, 2017, GENOMICS, V109, P221, DOI 10.1016/j.ygeno.2017.04.002; Zolotukhin VV, 2012, ZOOL ZH, V91, P321; TAXON	110	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264211	10.1371/journal.pone.0264211	http://dx.doi.org/10.1371/journal.pone.0264211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180261	Green Published, gold			2022-12-26	WOS:000796435800050
J	Suri, GK; Braich, S; Noy, DM; Rosewarne, GM; Cogan, NOI; Kaur, S				Suri, Gurpreet Kaur; Braich, Shivraj; Noy, Dianne M.; Rosewarne, Garry M.; Cogan, Noel O. I.; Kaur, Sukhjiwan			Advances in lentil production through heterosis: Evaluating generations and breeding systems	PLOS ONE			English	Article							INBREEDING DEPRESSION; GENETIC DIVERSITY; HYBRID VIGOR; YIELD; TRAITS; FORMAT; L.	Heterosis is defined as increased performance of the F-1 hybrid relative to its parents. In the current study, a cohort of populations and parents were created to evaluate and understand heterosis across generations (i.e., F-1 to F-3) in lentil, a self-pollinated annual diploid (2n = 2x = 14) crop species. Lentil plants were evaluated for heterotic traits in terms of plant height, biomass fresh weight, seed number, yield per plant and 100 grain weight. A total of 47 selected lentil genotypes were cross hybridized to generate 72 F-1 hybrids. The F-1 hybrids from the top five crosses exhibited between 31%-62% heterosis for seed number with reference to the better parent. The five best performing heterotic crosses were selected with a negative control for evaluation at the subsequent F-2 generation and only the tails of the distribution taken forward to be assessed in the F-3 generation as a sub selection. Overall, heterosis decreases across the subsequent generations for all traits studied. However, some individual genotypes were identified at the F-2 and sub-selected F-3 generations with higher levels of heterosis than the best F-1 mean value (hybrid mimics). The phenotypic data for the selected F-2 and sub selected F-3 hybrids were analysed, and the study suggested that 100 grain weight was the biggest driver of yield followed by seed number. A genetic diversity analysis of all the F-1 parents failed to correlate genetic distance and divergence among parents with heterotic F-1's. Therefore, genetic distance was not a key factor to determine heterosis in lentil. The study highlights the challenges associated with different breeding systems for heterosis (i.e., F-1 hybrid-based breeding systems and/or via hybrid mimics) but demonstrates the potential significant gains that could be achieved in lentil productivity.	[Suri, Gurpreet Kaur; Braich, Shivraj; Cogan, Noel O. I.; Kaur, Sukhjiwan] Ctr AgriBiosci, Agr Victoria, AgriBio, Bundoora, Vic, Australia; [Suri, Gurpreet Kaur; Braich, Shivraj; Cogan, Noel O. I.] Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Noy, Dianne M.; Rosewarne, Garry M.] Agr Victoria, Grains Innovation Pk, Horsham, Vic, Australia	La Trobe University; La Trobe University	Kaur, S (corresponding author), Ctr AgriBiosci, Agr Victoria, AgriBio, Bundoora, Vic, Australia.	sukhjiwan.kaur@agriculture.vic.gov.au		Suri, Gurpreet Kaur/0000-0002-3075-8125; Kaur, Sukhjiwan/0000-0003-3972-7058	National Lentil Breeding Programme - GRDC (Grains Research and Development Corporation); Agriculture Victoria (Department of Jobs, Precincts and Regions, State Government of Victoria, Australia)	National Lentil Breeding Programme - GRDC (Grains Research and Development Corporation); Agriculture Victoria (Department of Jobs, Precincts and Regions, State Government of Victoria, Australia)	The authors are thankful to National Lentil Breeding Programme funded by GRDC (Grains Research and Development Corporation), and Agriculture Victoria (Department of Jobs, Precincts and Regions, State Government of Victoria, Australia) for providing the facilities and supporting germplasm to conduct this research.	Adsule R., 1989, HDB WORLD FOOD LEGUM, P215; Ahmar S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072590; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Bicer BT, 2008, J CENT EUR AGRIC, V9, P175; Birchler JA, 2006, P NATL ACAD SCI USA, V103, P12957, DOI 10.1073/pnas.0605627103; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Braich S., 2020, BIORXIV; BRIM CHARLES A., 1961, CROP SCI, V1, P187, DOI 10.2135/cropsci1961.0011183X000100030009x; Burton JW, 2006, CROP SCI, V46, P2643, DOI 10.2135/cropsci2006.03.0156; BUSCH RH, 1971, CROP SCI, V11, P357, DOI 10.2135/cropsci1971.0011183X001100030014x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Corporation GRD, 2021, STILL LOVING THOSE L; Corporation GRD, 2021, DAV00154PULSE BREEDI; Crow JF, 1998, GENETICS, V148, P923; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dinkins RD, 2002, J HERED, V93, P346, DOI 10.1093/jhered/93.5.346; Diondra W., 2008, REV BIOL BIOTECHNOL, V7, P70; Durazzo A, 2013, FOOD CHEM, V140, P666, DOI 10.1016/j.foodchem.2012.09.062; Fischer RA, 2018, CROP PASTURE SCI, V69, P439, DOI 10.1071/CP17409; Fisher RA., 1949, THEORY INBREEDING OL; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Food and Agriculture Organization [FAO], 2019, FAOSTAT FOOD AGR DAT; Foyer CH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.112, 10.1038/nplants.2016.112]; Fu DH, 2014, EUPHYTICA, V197, P161, DOI 10.1007/s10681-014-1103-7; Fujimoto R, 2018, BREEDING SCI, V68, P145, DOI 10.1270/jsbbs.17155; Gilmour AR, 2009, ASREML USER GUIDE RE; Girke A, 2012, THEOR APPL GENET, V124, P1017, DOI 10.1007/s00122-011-1765-7; Kawamura K, 2016, PLANT GENE, V5, P1, DOI DOI 10.1016/J.PLGENE.2015.10.003; Kearsey M.J., 2020, GENETICAL ANAL QUANT; Khazaei H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01093; Leilah AA, 2005, J ARID ENVIRON, V61, P483, DOI 10.1016/j.jaridenv.2004.10.011; Lewers KS, 1998, CROP SCI, V38, P1143, DOI 10.2135/cropsci1998.0011183X003800050006x; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lombardi M, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0150-3; Malmberg MM, 2018, PLANT BIOTECHNOL J, V16, P877, DOI 10.1111/pbi.12835; MOLL RH, 1965, GENETICS, V52, P139; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Perrier X., 2006, DARWIN SOFTWARE; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Saed-Moucheshi A, 2013, INT J AGRON, V2013, DOI 10.1155/2013/682781; Saeki N, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0734-3; SARAWAT P, 1994, EUPHYTICA, V80, P39, DOI 10.1007/BF00039296; SARAWAT P, 1994, EUPHYTICA, V73, P265, DOI 10.1007/BF00036705; Scheffler TA, 2008, MAYDICA, V53, P189; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Seymour DK, 2016, P NATL ACAD SCI USA, V113, pE7317, DOI 10.1073/pnas.1615268113; Shi JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021645; Singh M, 2018, PLANT BREEDING, V137, P470, DOI 10.1111/pbr.12615; SINGH SP, 1978, INDIAN J AGR SCI, V48, P705; Smith H., 1952, HETEROSIS; Sudheesh S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111887; Tambal HAA, 2000, EXP AGR, V36, P369, DOI 10.1017/S0014479700003082; Tang L., 2018, SCI REP-UK, V8, P1; Tewodros Mulualem, 2016, International Journal of Plant Breeding and Genetics, V10, P69; Toker C., 2007, P209, DOI 10.1007/978-1-4020-6313-8_13; Vacher M, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0101-8; van Hulten MHA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205564; Varshney RK, 2015, CRIT REV PLANT SCI, V34, P169, DOI 10.1080/07352689.2014.897909; Vasseur F, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000214; Wadan A., 2013, WORLD J AGR RES FOOD, V1, P46; Wang L, 2017, P NATL ACAD SCI USA, V114, pE3555, DOI 10.1073/pnas.1703179114; Wang L, 2015, P NATL ACAD SCI USA, V112, pE4959, DOI 10.1073/pnas.1514190112; WILLIAMS W., 1959, Journal of Agricultural Science, V53, P347, DOI 10.1017/S002185960002075X; Wolko J, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2482-6; Wright DM, 2021, PLANTS PEOPLE PLANET, V3, P171, DOI 10.1002/ppp3.10158	67	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0262857	10.1371/journal.pone.0262857	http://dx.doi.org/10.1371/journal.pone.0262857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180225	Green Published, gold			2022-12-26	WOS:000796435800007
J	Arita, S; Ishimoto, Y; Hashizume, H; Nagata, K; Muraki, S; Oka, H; Takami, M; Tsutsui, S; Iwasaki, H; Yukawa, Y; Akune, T; Kawaguchi, H; Tanaka, S; Nakamura, K; Yoshida, M; Yoshimura, N; Yamada, H				Arita, Satoshi; Ishimoto, Yuyu; Hashizume, Hiroshi; Nagata, Keiji; Muraki, Shigeyuki; Oka, Hiroyuki; Takami, Masanari; Tsutsui, Shunji; Iwasaki, Hiroshi; Yukawa, Yasutsugu; Akune, Toru; Kawaguchi, Hiroshi; Tanaka, Sakae; Nakamura, Kozo; Yoshida, Munehito; Yoshimura, Noriko; Yamada, Hiroshi		Consortium	Is radiographic lumbar spinal stenosis associated with the quality of life?: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; CLINICAL SYMPTOMS; POPULATION; DISABILITY; SURGERY; TRENDS; COMPLICATIONS; PREVALENCE; MANAGEMENT; COHORT	Objectives This prospective study aimed to determine the association between radiographic lumbar spinal stenosis (LSS) and the quality of life (QOL) in the general Japanese population. Methods The severity of radiographic LSS was qualitatively graded on axial magnetic resonance images as follows: no stenosis, mild stenosis with.1/3 narrowing, moderate stenosis with a narrowing between 1/3 and 2/3, and severe stenosis with > 2/3 narrowing. Patients less than 40 years of age and those who had undergone previous lumbar spine surgery were excluded from the study. The Oswestry Disability Index (ODI), which includes 10 sections, was used to assess the QOL. One-way analysis of variance was performed to determine the statistical relationship between radiographic LSS and ODI. Further, logistic regression analysis adjusted for gender, age, and body mass index was performed to detect the relationship. Results Complete data were available for 907 patients (300 men and 607 women; mean age, 67.3 +/- 12.4 years). The prevalence of severe, moderate, and non-mild/non-radiographic were 30%, 48%, and 22%, respectively. In addition, the mean values of ODI in each group were 12.9%, 13.1%, and 11.7%, respectively, and there was no statistically significant difference between the three groups in logistic analysis (P = 0.55). In addition, no significant differences in any section of the ODI were observed among the groups. However, severe radiographic LSS was associated with low back pain in the "severe" group as determined by logistic analysis adjusted for gender, age, and body mass index (odds ratio: 1.53, confidence interval: 1.13-2.07) compared with the non-severe group. Conclusion In this general population study, severe radiographic LSS was associated with low back pain (LBP), but did not affect ODI.	[Arita, Satoshi; Ishimoto, Yuyu; Hashizume, Hiroshi; Nagata, Keiji; Takami, Masanari; Tsutsui, Shunji; Iwasaki, Hiroshi; Yukawa, Yasutsugu; Yamada, Hiroshi] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Wakayama, Japan; [Muraki, Shigeyuki; Yoshimura, Noriko] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Prevent Med Locomot Organ Disorders,Bunkyo K, Tokyo, Japan; [Oka, Hiroyuki] Univ Tokyo Hosp, 22nd Century Med & Res Ctr, Dept Med Res & Management Musculoskeletal Pain, Bunkyo Ku, Tokyo, Japan; [Akune, Toru; Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, Tokorozawa, Saitama, Japan; [Kawaguchi, Hiroshi] Tokyo Neurol Ctr, Dept Orthopaed & Spine, Minato Ku, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo Hosp, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan; [Yoshida, Munehito] Sumiya Orthopaed Hosp, Dept Orthopaed Surg, Wakayama, Wakayama, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Ishimoto, Y (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Wakayama, Japan.	yuyu.ishimoto@gmail.com			Ministry of Health, Labour and Welfare [H-25-houjyu-007, H25-Nanchitou (Men)005, 201417014A]; JSPS KAKENHI grant [C 26861206]; Ministry of Education, Culture, Sports, Science and Technology in Japan [NSF 08033011-00262]; Japan Osteoporosis Society; JA Kyosai Research Institute; Japan Society for the Promotion of Science [17K10937, 20K09439]; Japanese Orthopaedics and Traumatology Foundation, Inc [287]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Osteoporosis Society(Japan Osteoporosis Society); JA Kyosai Research Institute; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Orthopaedics and Traumatology Foundation, Inc	This work was supported by H-25-houjyu-007 (Director, NY), H25-Nanchitou (Men)005 (Director, ST), and 201417014A (Director, NY) from the Ministry of Health, Labour and Welfare, a Grant-in-Aid for Scientific Research (C 26861206) of JSPS KAKENHI grant. And Collaborating Research with NSF 08033011-00262 (Director, NY) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. This study also was supported by grants from the Japan Osteoporosis Society (NY, HO, and TA), a grant from JA Kyosai Research Institute (HO), Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI) Research C (17K10937) (MT), (20K09439)(YI), a Grant from the Japanese Orthopaedics and Traumatology Foundation, Inc (No. 287) (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist.	AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Binder DK, 2002, SEMIN NEUROL, V22, P157, DOI 10.1055/s-2002-36539; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Chad DA, 2007, NEUROL CLIN, V25, P407, DOI 10.1016/j.ncl.2007.01.003; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Conway J, 2011, SPINE J, V11, P816, DOI 10.1016/j.spinee.2010.10.019; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Deyo RA, 2010, SPINE J, V10, P625, DOI 10.1016/j.spinee.2010.05.006; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Haig AJ, 2010, JAMA-J AM MED ASSOC, V303, P71, DOI 10.1001/jama.2009.1946; Hughes A, 2015, INT J SPINE SURG, V9, DOI 10.14444/2008; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Ishimoto Y, 2019, AM J IND MED, V62, P430, DOI 10.1002/ajim.22957; Iwahashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160002; Jensen RK, 2020, EUR SPINE J, V29, P2143, DOI 10.1007/s00586-020-06339-1; Jones KE, 2019, NEUROSURG CLIN N AM, V30, P365, DOI 10.1016/j.nec.2019.02.010; Kanno H, 2012, SPINE, V37, P207, DOI 10.1097/BRS.0b013e3182134e73; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Lohman CM, 2006, SPINE, V31, P1834, DOI 10.1097/01.brs.0000227370.65573.ac; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Minamide A, 2013, J ORTHOP SCI, V18, P693, DOI 10.1007/s00776-013-0435-9; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; Nakamura K, 2016, CLIN REV BONE MINER, V14, P56, DOI 10.1007/s12018-016-9208-2; Ogikubo O, 2007, SPINE, V32, P1423, DOI 10.1097/BRS.0b013e318060a5f5; Parker SL, 2014, J NEUROSURG-SPINE, V21, P143, DOI 10.3171/2014.3.SPINE1320; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; Schulte TL, 2010, EUR SPINE J, V19, P1855, DOI 10.1007/s00586-010-1324-y; Steurer J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-175; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Suzuki H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160454; Tonosu J, 2012, EUR SPINE J, V21, P1596, DOI 10.1007/s00586-012-2173-7; Winter CC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-233; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263930	10.1371/journal.pone.0263930	http://dx.doi.org/10.1371/journal.pone.0263930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176078	gold, Green Published			2022-12-26	WOS:000777505200047
J	Mahmoudi, J; Xiong, CF				Mahmoudi, Jina; Xiong, Chenfeng			How social distancing, mobility, and preventive policies affect COVID-19 outcomes: Big data-driven evidence from the District of Columbia-Maryland-Virginia (DMV) megaregion	PLOS ONE			English	Article							CORONAVIRUS	Many factors play a role in outcomes of an emerging highly contagious disease such as COVID-19. Identification and better understanding of these factors are critical in planning and implementation of effective response strategies during such public health crises. The objective of this study is to examine the impact of factors related to social distancing, human mobility, enforcement strategies, hospital capacity, and testing capacity on COVID-19 outcomes within counties located in District of Columbia as well as the states of Maryland and Virginia. Longitudinal data have been used in the analysis to model county-level COVID-19 infection and mortality rates. These data include big location-based service data, which were collected from anonymized mobile devices and characterize various social distancing and human mobility measures within the study area during the pandemic. The results provide empirical evidence that lower rates of COVID-19 infection and mortality are linked with increased levels of social distancing and reduced levels of travel-particularly by public transit modes. Other preventive strategies and polices also prove to be influential in COVID-19 outcomes. Most notably, lower COVID-19 infection and mortality rates are linked with stricter enforcement policies and more severe penalties for violating stay-at-home orders. Further, policies that allow gradual relaxation of social distancing measures and travel restrictions as well as those requiring usage of a face mask are related to lower rates of COVID-19 infections and deaths. Additionally, increased access to ventilators and Intensive Care Unit (ICU) beds, which represent hospital capacity, are linked with lower COVID-19 mortality rates. On the other hand, gaps in testing capacity are related to higher rates of COVID-19 infection. The results also provide empirical evidence for reports suggesting that certain minority groups such as African Americans and Hispanics are disproportionately affected by the COVID-19 pandemic.	[Mahmoudi, Jina; Xiong, Chenfeng] Univ Maryland, Maryland Transportat Inst, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Xiong, Chenfeng] Univ Maryland, Shock Trauma Anesthesiol Res Ctr, Sch Med, Baltimore, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Xiong, CF (corresponding author), Univ Maryland, Maryland Transportat Inst, Dept Civil & Environm Engn, College Pk, MD 20742 USA.; Xiong, CF (corresponding author), Univ Maryland, Shock Trauma Anesthesiol Res Ctr, Sch Med, Baltimore, MD 20742 USA.	cxiong@umd.edu						Andersen M., 2020, EARLY EVIDENCE SOCIA; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bick A., 2020, CEPR DISCUSSION PAPE, DOI DOI 10.24149/WP2017; CDC, 2021, GUID WEAR MASKS; CDC, 2021, SYMPT COR; CDC, 2020, 1 TRAV REL CAS 2019; Centers of Disease Control and Prevention (CDC), 2021, PROT YOURS OTH; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Colbourn T, 2020, LANCET PUBLIC HEALTH, V5, pE236, DOI 10.1016/S2468-2667(20)30072-4; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Flaxman S., 2020, REPORT 13 ESTIMATING, DOI 10.25561/77731; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Hamidi S, 2020, J AM PLANN ASSOC, V86, P495, DOI 10.1080/01944363.2020.1777891; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Johns Hopkins coronavirus resource centre, COVID 19 DASHB CTR S; Johns Hopkins University, 2020, COVID 19 DAT REP CTR; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Maryland Transportation Institute University of Maryland, 2020, U MAR COVID 19 IMP A; Mazziotta J, 2020, 25000 FINE WARNING H; OECD, 2020, TEST COVID 19 WAY LI; Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3; Pearl B., 2020, ENFORCEMENT COVID 19; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; StataCorp LP, 2013, STAT LONG DAT PAN DA; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; The Centers for Disease Control and Prevention (CDC), 2021, ACT GATH HOL; The Centers for Disease Control and Prevention (CDC), 2021, COVID 19 INF SPEC GR; The Centers for Disease Control and Prevention (CDC), 2021, QUAR IS; Thebault Reis, 2020, WASH POST; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Xiong C, 2020, ARXIV200500667; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	41	6	6	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263820	10.1371/journal.pone.0263820	http://dx.doi.org/10.1371/journal.pone.0263820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176031	Green Published, gold			2022-12-26	WOS:000777505200034
J	Abdulla, F; Hossain, MM; Karimuzzaman, M; Ali, M; Rahman, A				Abdulla, Faruq; Hossain, Md Moyazzem; Karimuzzaman, Md; Ali, Mohammad; Rahman, Azizur			Likelihood of infectious diseases due to lack of exclusive breastfeeding among infants in Bangladesh	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTION; 1ST 6 MONTHS; BIRTH COHORT; DIARRHEA; CHILDREN; ASSOCIATION; DISTRICT; MOTHERS; HEALTH; HOSPITALIZATION	Background Bangladesh is a South Asian developing country trying to achieve the Sustainable Development Goals (SDG)-3 and the objective of the Rural Electrification Board (REB) regarding child mortality. Infectious diseases are leading causes of child mortality, and lack of exclusive breastfeeding (EBF) among infants aged 0-6 months increases child morbidity and mortality from various infectious diseases in developing countries. However, as per existing literature, no study has been conducted yet to determine the lack of EBF practice effect on child mortality in Bangladesh. With this backdrop, the authors intend to measure the likelihood of infectious diseases due to the lack of EBF of infants aged 0-6 months in Bangladesh. Materials and methods This study used Bangladesh Demographic and Health Survey (BDHS) data over 1996-97 to 2017-18. The mothers of infants aged 0-6 months who were willingly participated in the BDHSs were considered to include in our analysis. Initially, there were 9,133 cases in the combined dataset. After filtering, there were 5,724 cases in the final dataset. We have considered diarrhea (D), acute respiratory infection (ARI) separately as well as the presence of either D or ARI or both and named as CoDARI as outcome variables. This study used both graphical and statistical techniques (Chi-square test, Wald test, and logistic regression) to analyze the data. The odds ratio (OR) and 95% confidence interval (CI) were used to quantify the likelihood of infectious diseases due to lack of EBF practice and its elasticity, respectively. Results The EBF practice got a conspicuous increasing trend, but the prevalence of infectious diseases was declined from 0 to 3 months of age of infants, whereas an inverse scenario is observed between 4-6 months. The significance of that inverse relationship was confirmed by p-value corresponding to the chi-square test and the Wald test of the adjusted regression coefficients after adjusting the associated factor's effect on infectious diseases. The adjusted ORs also concluded that the lack of EBF practice up to six months of age could enhance the risk of D, ARI, and CoDARI by 2.11 [95% CI: 1.56-2.85], 1.43 [95% CI: 1.28-1.60], and 1.48 [95% CI: 1.32-1.66] times higher, respectively. Conclusion Findings of this study emphasize the importance of EBF up to six months of age of infants against diarrhea and ARI specific morbidity and mortality. Our results also agreed to the recommendation of the World Health Organization (WHO), United Nations International Children's Emergency Fund (UNICEF), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP), and National Nutrition Programme of Ethiopia (NNPE) that the EBF practice for the first six months of age could be a best, cost-effective, long-lasting natural preventive way to reduce the child morbidity and mortality due to infectious diseases in developing countries. Therefore, findings would help policymakers ensuring the achievement target of REB and SDG-3 associated with the health sector in Bangladesh.	[Abdulla, Faruq] RTM Al Kabir Tech Univ, Dept Appl Hlth & Nutr, Sylhet, Bangladesh; [Hossain, Md Moyazzem] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne, Tyne & Wear, England; [Hossain, Md Moyazzem; Karimuzzaman, Md] Jahangirnagar Univ, Fac Math & Phys Sci, Dept Stat, Dhaka, Bangladesh; [Ali, Mohammad] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Rahman, Azizur] Charles Sturt Univ, Sch Comp Math & Engn, Wagga Wagga, NSW, Australia	Newcastle University - UK; Jahangirnagar University; University of Oxford; Charles Sturt University	Abdulla, F (corresponding author), RTM Al Kabir Tech Univ, Dept Appl Hlth & Nutr, Sylhet, Bangladesh.; Rahman, A (corresponding author), Charles Sturt Univ, Sch Comp Math & Engn, Wagga Wagga, NSW, Australia.	faruqiustat09mnil@gmail.com; azrahman@csu.edu.au	Hossain, Md. Moyazzem/I-6547-2018; Abdulla, Faruq/AAV-6666-2020	Hossain, Md. Moyazzem/0000-0003-3593-6936; Abdulla, Faruq/0000-0003-3952-5843; ALI, MOHAMMAD/0000-0003-0170-7182; Rahman, Associate Professor Azizur/0000-0002-7670-5192				Ajetunmobi OM, 2015, J PEDIATR-US, V166, P620, DOI 10.1016/j.jpeds.2014.11.013; Andrews K. M., 2008, ENCYCL INFANT EARLY, DOI [10.1016/B978-012370877-9.00084-0, DOI 10.1016/B978-012370877-9.00084-0]; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Arage G., 2016, ADV PUBLIC HLTH, V2016, P1, DOI DOI 10.1155/2016/3426249; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bhandari Nita, 2016, Proceedings of the Indian National Science Academy, V82, P1507, DOI 10.16943/ptinsa/2016/48883; Bhattacharjee NV, 2021, NAT HUM BEHAV, V5, P1027, DOI 10.1038/s41562-021-01108-6; Cattaneo A, 2006, ACTA PAEDIATR, V95, P540, DOI 10.1080/08035250500447936; CDC, REC BEN; Covian C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02806; Cramer J.S, 2002, 20021194 TINB I, DOI [10.2139/ssrn.360300, DOI 10.2139/SSRN.360300]; Dhakal S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050455; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Ezeh OK, 2014, INT J ENV RES PUB HE, V11, P9256, DOI 10.3390/ijerph110909256; Fayehun O., 2010, DHS WORKING PAPERS, V74, P1; Frank Nicole M, 2019, BMC Pediatr, V19, P339, DOI 10.1186/s12887-019-1693-2; Hamze L, 2019, MIDWIFERY, V74, P68, DOI 10.1016/j.midw.2019.03.009; Hossain MM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11576-0; Hossain MM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11607-w; Hossain MM, 2020, ASIA-PAC J PUBLIC HE, V32, P509, DOI 10.1177/1010539520957808; Hossain M, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1076-0; Hunegnaw MT, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0121-1; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jama A, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-0252-7; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan MN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4913-4; Ladomenou F, 2010, ARCH DIS CHILD, V95, P1004, DOI 10.1136/adc.2009.169912; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lawrence R., 2010, BREASTFEEDING GUIDE; Lin HL, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0645-6; Manun'ebo MF., 2020, AFRICAN J MED HEAL S, V19, P55, DOI [10.5897/AJMHS2020.0096, DOI 10.5897/AJMHS2020.0096]; Menon P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002159; Mgongo M, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-12; Mihrshahi S, 2007, J HEALTH POPUL NUTR, V25, P195; Mogre V, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0071-z; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Naficy AB, 1999, AM J EPIDEMIOL, V150, P770, DOI 10.1093/oxfordjournals.aje.a010080; NIPORT MaA ICF International, 2020, BANGLADESH DEMOGRAPH; Nussbaum M.C., 2011, CREATING CAPABILITIE; Oddy W H, 2001, Breastfeed Rev, V9, P11; Park HW, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e272; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rahman A., 2017, SMALL AREA ESTIMATIO, V1st; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Rahman MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236080; Sajjad S., 2018, MOJ CURR RES REV, V1, P212, DOI [10.15406/mojcrr.2018.01.00035, DOI 10.15406/MOJCRR.2018.01.00035]; Scariati PD, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.6.e5; Schwarz EB, 2015, AM FAM PHYSICIAN, V91, P602; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Ssemukasa E. L., 2014, African Journal of Food, Agriculture, Nutrition and Development, V14, P9071; Sumon MN., 2014, INT J SCI FOOTPR, V2, P52; Taye T., 2013, SCI J CLIN MED, V2, P153, DOI 10.11648/j.sjcm.20130206.12; Tewabe T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0103-3; Thet MM, 2016, APPETITE, V96, P62, DOI 10.1016/j.appet.2015.08.044; Turin Christie G, 2014, Curr Trop Med Rep, V1, P97; UNICEF WHO, 2017, UNICEF NURTURING HLT; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; Vijay J, 2020, CLIN EPIDEMIOL GLOB, V8, DOI 10.1016/j.cegh.2019.07.003; WHO, 2015, SUCC FACT WOM CHILDS; WHO, 2015, UN SUST DEV SUMM SUS; World Health Organization, HLTH 2015 MDGS SDGS; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization [WHO], 2004, PHYS SCH ENV ESS COM	64	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263890	10.1371/journal.pone.0263890	http://dx.doi.org/10.1371/journal.pone.0263890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171952	gold, Green Published			2022-12-26	WOS:000795889700042
J	Grover, G; Sharma, A; Mackay, I; Srivastava, P; Kaur, S; Kaur, J; Burridge, A; Allen, SP; Bentley, AR; Chhuneja, P; Bains, NS				Grover, Gomti; Sharma, Achla; Mackay, Ian; Srivastava, Puja; Kaur, Satinder; Kaur, Jaspal; Burridge, Amanda; Allen, Sacha Przewieslik; Bentley, Alison R.; Chhuneja, Parveen; Bains, N. S.			Identification of a novel stripe rust resistance gene from the European winter wheat cultivar 'Acienda': A step towards rust proofing wheat cultivation	PLOS ONE			English	Article							F-SP TRITICI	All stage resistance to stripe rust races prevalent in India was investigated in the European winter wheat cultivar 'Acienda'. In order to dissect the genetic basis of the resistance, a backcross population was developed between 'Acienda' and the stripe rust susceptible Indian spring wheat cultivar 'HD 2967'. Inheritance studies revealed segregation for a dominant resistant gene. High density SNP genotyping was used to map stripe rust resistance and marker regression analysis located stripe rust resistance to the distal end of wheat chromosome 1A. Interval mapping located this region between the SNP markers AX-95162217 and AX-94540853, at a LOD score of 15.83 with a phenotypic contribution of 60%. This major stripe rust resistance locus from 'Acienda' has been temporarily designated as Yraci. A candidate gene search in the 2.76 Mb region carrying Yraci on chromosome 1A identified 18 NBS-LRR genes based on wheat RefSeqv1.0 annotations. Our results indicate that as there is no major gene reported in the Yraci chromosome region, it is likely to be a novel stripe rust resistance locus and offers potential for deployment, using the identified markers, to confer all stage stripe rust resistance.	[Grover, Gomti; Sharma, Achla; Srivastava, Puja; Kaur, Satinder; Kaur, Jaspal; Chhuneja, Parveen; Bains, N. S.] Punjab Agr Univ, Ludhiana, Punjab, India; [Mackay, Ian] IMPlant Consultancy Ltd, Chelmsford, Essex, England; [Burridge, Amanda; Allen, Sacha Przewieslik] Univ Bristol, Life Sci, Bristol, Avon, England; [Bentley, Alison R.] NIAB, John Bingham Lab, Cambridge, England; [Bentley, Alison R.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico	Punjab Agricultural University; University of Bristol; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Grover, G (corresponding author), Punjab Agr Univ, Ludhiana, Punjab, India.	gomtigrover@pau.edu		Sharma, Achla/0000-0002-7932-3499; Burridge, Amanda/0000-0002-0140-5523; Mackay, Ian/0000-0002-1109-4730	Department of Science & Technology, Govt. of India under 'INSPIRE fellowship scheme	Department of Science & Technology, Govt. of India under 'INSPIRE fellowship scheme	The first author acknowledges the fellowship provide during her Ph.D program by Department of Science & Technology, Govt. of India under 'INSPIRE fellowship scheme. All authors from PAU duly acknowledge Dr Kuldeep Singh, Director, National Bureau of Plant Genetic Resources for procuring the European winter wheat set from NIAB, UK and sharing it with Department of Plant Breeding and Genetics, PAU, Ludhiana.	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; Allen AM, 2017, PLANT BIOTECHNOL J, V15, P390, DOI 10.1111/pbi.12635; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Basnet BR., 2016, MOL BREEDING, V33, P385; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Biffen RH, 1905, J AGR SCI, V1, P4, DOI 10.1017/S0021859600000137; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen JL, 2012, MOL BREEDING, V29, P791, DOI 10.1007/s11032-011-9590-x; Chen WQ, 2014, MOL PLANT PATHOL, V15, P433, DOI 10.1111/mpp.12116; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Goyeau H, 2011, EUPHYTICA, V178, P45, DOI 10.1007/s10681-010-0261-5; Grover G, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2380-y; Markell SG, 2008, PHYTOPATHOLOGY, V98, P632, DOI 10.1094/PHYTO-98-6-0632; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Milus EA, 2009, PHYTOPATHOLOGY, V99, P89, DOI 10.1094/PHYTO-99-1-0089; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Singh H, 2020, PHYTOPARASITICA, V48, P383, DOI 10.1007/s12600-020-00809-4; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Singh RP., 2004, P 4 INT CROP SCI C; Singh RP, 2017, INDIAN J GENET PL BR, V77, P10, DOI 10.5958/0975-6906.2017.00002.5; Tomar SMS, 2014, INDIAN J GENET PL BR, V74, P129, DOI 10.5958/0975-6906.2014.00150.3	23	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0264027	10.1371/journal.pone.0264027	http://dx.doi.org/10.1371/journal.pone.0264027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171951	gold, Green Published			2022-12-26	WOS:000795889700059
J	Wang, SW; Chan, LP; Wang, LF; Wu, CW; Lin, SH; Huang, TY; Lee, KW				Wang, Shih-Wei; Chan, Leong-Perng; Wang, Ling-Feng; Wu, Che-Wei; Lin, Sheng-Hsuan; Huang, Tzu-Yen; Lee, Ka-Wo			Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools	PLOS ONE			English	Article							2ND PRIMARY MALIGNANCIES; NASOPHARYNGEAL CARCINOMA; AERODIGESTIVE TRACT; FIELD CANCERIZATION; PRIMARY-CANCER; PRIMARY TUMORS; LUNG-CANCER; SURVIVAL; ESOPHAGEAL; RISK	Background The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. Methods This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992-2003; Group B: 20042014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. Results Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. Conclusion Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment.	[Wang, Shih-Wei; Chan, Leong-Perng; Wang, Ling-Feng; Wu, Che-Wei; Huang, Tzu-Yen; Lee, Ka-Wo] Kaohsiung Med Univ Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Chan, Leong-Perng; Wang, Ling-Feng; Wu, Che-Wei; Huang, Tzu-Yen; Lee, Ka-Wo] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Chan, Leong-Perng; Lee, Ka-Wo] Kaohsiung Municipal Tatung Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Wu, Che-Wei] Kaohsiung Municipal Siaogang Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Lin, Sheng-Hsuan] Natl Chiao Tung Univ, Inst Data Sci & Engn, Hsinchu, Taiwan; [Huang, Tzu-Yen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, TY; Lee, KW (corresponding author), Kaohsiung Med Univ Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Huang, TY; Lee, KW (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Lee, KW (corresponding author), Kaohsiung Municipal Tatung Hosp, Dept Otolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Huang, TY (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	tyhuang.ent@gmail.com; kawolee@kmu.edu.tw	Huang, Tzu-Yen/AAZ-1374-2020; Wu, Che-Wei/J-2015-2019	Huang, Tzu-Yen/0000-0002-5044-0325; Wu, Che-Wei/0000-0003-1052-5348	Kaohsiung Medical University Hospital [KMUH108-8M48, KMUH109-9M44, KMUH109-9M45]; Kaohsiung Municipal Hsiao-Kang Hospital [Kmhk-DK109004]; Kaohsiung Medical University, Taiwan; Ministry of Science and Technology, Taiwan; MOST [110-2314-B-037-120]	Kaohsiung Medical University Hospital; Kaohsiung Municipal Hsiao-Kang Hospital; Kaohsiung Medical University, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); MOST	This study was supported by grants from Kaohsiung Medical University Hospital, (KMUH108-8M48, KMUH109-9M44, KMUH109-9M45), Kaohsiung Municipal Hsiao-Kang Hospital (Kmhk-DK109004), Kaohsiung Medical University, Taiwan, and MOST 110-2314-B-037-120, funder as MD Tzu-Yen Huang, Ministry of Science and Technology, Taiwan.	Becker M, 2018, EUR RADIOL, V28, P651, DOI 10.1007/s00330-017-4999-1; Bogowicz M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51599-7; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen MC, 2008, ANN ONCOL, V19, P1180, DOI 10.1093/annonc/mdn003; Chen MC, 2010, ORAL ONCOL, V46, P249, DOI 10.1016/j.oraloncology.2010.01.002; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Chuang SC, 2008, INT J CANCER, V123, P2390, DOI 10.1002/ijc.23798; Cui JL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81971-5; Di Martino E, 2002, J LARYNGOL OTOL, V116, P831, DOI 10.1258/00222150260293664; Fontaine P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76310-z; Goerres GW, 2004, J NUCL MED, V45, p66S; Griffioen GHMJ, 2015, LUNG CANCER, V88, P94, DOI 10.1016/j.lungcan.2015.01.011; Ha PK, 2003, CRIT REV ORAL BIOL M, V14, P363, DOI 10.1177/154411130301400506; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Jacobson FL, 2012, J THORAC CARDIOV SUR, V144, P25, DOI 10.1016/j.jtcvs.2012.05.059; Lee YC, 2009, GASTROINTEST ENDOSC, V69, P408, DOI 10.1016/j.gie.2008.05.033; Leon X, 2002, ACTA OTO-LARYNGOL, V122, P765, DOI 10.1080/003655402/000028048; LICCIARDELLO JTW, 1989, INT J RADIAT ONCOL, V17, P467, DOI 10.1016/0360-3016(89)90096-5; Lin K, 2005, HEAD NECK-J SCI SPEC, V27, P1042, DOI 10.1002/hed.20272; Lo Nigro C, 2017, CANCER MANAG RES, V9, P363, DOI 10.2147/CMAR.S115761; Priante AVM, 2011, CURR ONCOL REP, V13, P132, DOI 10.1007/s11912-010-0147-7; Morris LGT, 2011, CANCER CAUSE CONTROL, V22, P671, DOI 10.1007/s10552-011-9739-2; Nevens D, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160492; PANOSETTI E, 1989, LARYNGOSCOPE, V99, P1267; Park J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66506-8; Parry C, 2011, CANCER EPIDEM BIOMAR, V20, P1996, DOI 10.1158/1055-9965.EPI-11-0729; Le QC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78338-7; Rafferty MA, 2001, J LARYNGOL OTOL, V115, P988; Rohde M, 2017, J NUCL MED, V58, P1919, DOI 10.2967/jnumed.117.189704; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; STURGIS EM, 1995, ANN OTO RHINOL LARYN, V104, P946, DOI 10.1177/000348949510401206; Takenaka R, 2009, AM J GASTROENTEROL, V104, P2942, DOI 10.1038/ajg.2009.426; Tseng CM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57630-6; Tsou YA, 2007, ACTA OTO-LARYNGOL, V127, P651, DOI 10.1080/00016480600951517; VIKRAM B, 1984, ARCH OTOLARYNGOL, V110, P564; Warren S., 1932, AM J CANCER, V16, P1358	37	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263773	10.1371/journal.pone.0263773	http://dx.doi.org/10.1371/journal.pone.0263773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167611	Green Published, gold			2022-12-26	WOS:000802227200019
J	Diehl, C; Hunkler, C				Diehl, Claudia; Hunkler, Christian			Vaccination-related attitudes and behavior across birth cohorts: Evidence from Germany	PLOS ONE			English	Article							BARRIERS; CHILDREN; TRUST	We use German KiGGS data to add to existing knowledge about trends in vaccination-related attitudes and behavior. Looking at vaccinations against measles, we assess whether a low confidence in vaccination and vaccination complacency is particularly prevalent among parents whose children were born somewhat recently, as compared to parents whose children belong to earlier birth cohorts. We further analyze how these attitudes relate to vaccination rates in the corresponding birth cohorts, and which sociodemographic subgroups are more likely to have vaccination-hesitant attitudes and to act upon them. Results show that the share of parents who report "deliberate" reasons against vaccination has decreased across birth cohorts; at the same time, the children of these parents have become less likely to be vaccinated. This suggests that vaccination-hesitant parents became more willing to act upon their beliefs towards the turn of the millennium. Regarding efforts to convince parents and the public about the benefits of vaccination, the number of parents who think that vaccinations have serious side effects, or that it is better for a child to live through a disease, may have become smaller-but these parents are more determined to follow their convictions. Interestingly, the trend we describe started before the Internet became a widespread source of health-related information.	[Diehl, Claudia] Univ Konstanz, Cluster Excellence Polit Inequal, Constance, Germany; [Hunkler, Christian] Humboldt Univ, Berlin Inst Integrat & Migrat Res BIM, Berlin, Germany	University of Konstanz; Humboldt University of Berlin	Diehl, C (corresponding author), Univ Konstanz, Cluster Excellence Polit Inequal, Constance, Germany.	claudia.diehl@uni-konstanz.de	Hunkler, Christian/AAW-2367-2020	Hunkler, Christian/0000-0002-1632-9834; Diehl, Claudia/0000-0002-5309-2960				Arzteblatt, 2018, EINGEIMPFT ARZTE WIS; Bedford H, 2018, VACCINE, V36, P6556, DOI 10.1016/j.vaccine.2017.08.004; Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Born S, 2015, AUSWERTUNGSHINWEISE; Bronfman ZZ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0228; Carrieri V, 2019, HEALTH ECON, V28, P1377, DOI 10.1002/hec.3937; Chen XW, 2018, J HEALTH COMMUN, V23, P724, DOI 10.1080/10810730.2018.1511658; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Deer B., 2020, DOCTOR WHO FOOLED WO; DiMaggio P, 1996, AM J SOCIOL, V102, P690, DOI 10.1086/230995; European Union, 2019, SPECIAL EUROBAROMETE; Illich I., 1976, MED NEMESIS EXPROPRI; Illich I., 1977, DISABLING PROFESSION; Jensen M., 2003, COLUMBIA JOURNAL REV, V42, P22; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Kriwy P., 2007, GESUNDHEITSVORSORGE; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x; Larson H., 2018, REPORT EUROPEAN COMM, DOI DOI 10.2875/241099; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Miyachi T, 2020, LANCET, V395, P31, DOI 10.1016/S0140-6736(19)32686-8; Neufeind J, 2020, VACCINE, V38, P4252, DOI 10.1016/j.vaccine.2020.04.052; Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012; Poethko-Muller C, 2019, BUNDESGESUNDHEITSBLA, V62, P410, DOI 10.1007/s00103-019-02901-5; Reiter S., 2006, EPIDEMIOL B, V2006, P430; Rieck T., 2020, EPIDEMIOLOGISCHES B, V32/33, P9, DOI DOI 10.25646/7027.4; Rieck T, 2014, HUM VACC IMMUNOTHER, V10, P476, DOI 10.4161/hv.26986; Rubin DB, 2004, MULTIPLE IMPUTATION; Sanborn S., 1999, INFOWORLD, V21, P34; Schmelz K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016385118; Standige Impfkommission (STIKO), 2001, EPIDEMIOLOGISCHES B, V28, P203; STIKO-Standige Impfkommission [Standing Committee on Vacination] am Robert Koch-Institut, 2000, EPIDEMIOLOGISCHES B, V2, P9; Stolle LB, 2020, ADV THER, V37, P4481, DOI 10.1007/s12325-020-01502-y; von Lengerke T, 2021, DTSCH ARZTEBL INT, V118, P96, DOI 10.3238/arztebl.m2021.0134; Ward JK, 2016, HUM VACC IMMUNOTHER, V12, P1924, DOI 10.1080/21645515.2016.1146430; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263871	10.1371/journal.pone.0263871	http://dx.doi.org/10.1371/journal.pone.0263871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157742	Green Published, gold			2022-12-26	WOS:000788004500025
J	Torniainen, J; Ristaniemi, A; Sarin, JK; Prakash, M; Afara, IO; Finnila, MAJ; Stenroth, L; Korhonen, RK; Toyras, J				Torniainen, Jari; Ristaniemi, Aapo; Sarin, Jaakko K.; Prakash, Mithilesh; Afara, Isaac O.; Finnila, Mikko A. J.; Stenroth, Lauri; Korhonen, Rami K.; Toyras, Juha			Near infrared spectroscopic evaluation of biochemical and crimp properties of knee joint ligaments and patellar tendon	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; ELASTIN; PROTEOGLYCANS; DISEASE; SHEAR; WATER	Knee ligaments and tendons play an important role in stabilizing and controlling the motions of the knee. Injuries to the ligaments can lead to abnormal mechanical loading of the other supporting tissues (e.g., cartilage and meniscus) and even osteoarthritis. While the condition of knee ligaments can be examined during arthroscopic repair procedures, the arthroscopic evaluation suffers from subjectivity and poor repeatability. Near infrared spectroscopy (NIRS) is capable of non-destructively quantifying the composition and structure of collagen-rich connective tissues, such as articular cartilage and meniscus. Despite the similarities, NIRS-based evaluation of ligament composition has not been previously attempted. In this study, ligaments and patellar tendon of ten bovine stifle joints were measured with NIRS, followed by chemical and histological reference analysis. The relationship between the reference properties of the tissue and NIR spectra was investigated using partial least squares regression. NIRS was found to be sensitive towards the water (R2(CV) = .65) and collagen (R2(CV) = .57) contents, while elastin, proteoglycans, and the internal crimp structure remained undetectable. As collagen largely determines the mechanical response of ligaments, we conclude that NIRS demonstrates potential for quantitative evaluation of knee ligaments.	[Torniainen, Jari; Ristaniemi, Aapo; Sarin, Jaakko K.; Afara, Isaac O.; Stenroth, Lauri; Korhonen, Rami K.; Toyras, Juha] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Torniainen, Jari; Sarin, Jaakko K.] Kuopio Univ Hosp, Diagnost Imaging Ctr, Kuopio, Finland; [Sarin, Jaakko K.] Pirkanmaa Hosp Dist, Dept Med Phys, Med Imaging Ctr, Tampere, Finland; [Prakash, Mithilesh] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Finnila, Mikko A. J.] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Toyras, Juha] Kuopio Univ Hosp, Sci Serv Ctr, Kuopio, Finland; [Afara, Isaac O.; Toyras, Juha] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Pirkanmaa Hospital District; University of Eastern Finland; University of Oulu; Kuopio University Hospital; University of Eastern Finland; University of Queensland	Torniainen, J (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.; Torniainen, J (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Kuopio, Finland.	jari.torniainen@uef.fi	; Toyras, Juha/AAH-4448-2019	Korhonen, Rami/0000-0002-3486-7855; Toyras, Juha/0000-0002-8035-1606; Sarin, Jaakko/0000-0002-6237-9015; Torniainen, Jari/0000-0003-4953-4508	Kuopio University Hospital (Kuopion Yliopistollinen Sairaala) [5203111]; Academy of Finland [315820, 324529, 316258]; Sigrid Juselius Foundation (Sigrid Juseliuksen Saatio)	Kuopio University Hospital (Kuopion Yliopistollinen Sairaala); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation (Sigrid Juseliuksen Saatio)	Source: Valtion tutkimusrahoitus of Kuopio University Hospital (Kuopion Yliopistollinen Sairaala) Project: 5203111 URL: https://www.psshp.fi/tutkimus/tutkimusrahoitus/valtiontutkimusrahoitus} Statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recipient(s): Jari Torniainen Source: Academy of Finland Project: 315820 URL: https://www.aka.fi/en/Statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recipient(s): Isaac O. Afara Source: Sigrid Juselius Foundation (Sigrid Juseliuksen Saatio) URL: https://www.sigridjuselius.fi/en/Statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recipient(s): Rami K. Korhonen, Aapo Ristaniemi Source: Academy of Finland Project: 324529 URL: https://www.aka.fi/en/Statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recipient(s): Rami K. Korhonen, Aapo Ristaniemi Source: Academy of Finland Project: 316258 URL: https://www.aka.fi/en/Statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recipient(s): Mithilesh Prakash.	Ala-Myllymaki J, 2016, J ORTHOP RES, V34, P270, DOI 10.1002/jor.23025; Barry KP, 1996, SKELETAL RADIOL, V25, P365, DOI 10.1007/s002560050096; Benjamin M, 2000, INT REV CYTOL, V196, P85; Berenson MC, 1996, J ORTHOP RES, V14, P518, DOI 10.1002/jor.1100140404; CHIMICH D, 1992, J BIOMECH, V25, P831, DOI 10.1016/0021-9290(92)90223-N; Corry IS, 1999, AM J SPORT MED, V27, P444, DOI 10.1177/03635465990270040701; CURCIO JA, 1951, J OPT SOC AM, V41, P302, DOI 10.1364/JOSA.41.000302; Dare D, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0448-1; Fang F, 2016, J MECH BEHAV BIOMED, V63, P443, DOI 10.1016/j.jmbbm.2016.06.032; Frank C. B., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P199; GATHERCOLE LJ, 1991, MATRIX, V11, P214, DOI 10.1016/S0934-8832(11)80161-7; Henninger HB, 2015, ACTA BIOMATER, V25, P304, DOI 10.1016/j.actbio.2015.07.011; Henninger HB, 2013, J ORTHOP RES, V31, P1226, DOI 10.1002/jor.22352; Jones E., 2001, SCIPY OPEN SOURCE SC; Martin RB., 1998, SKELETAL TISSUE MECH, P190, DOI [DOI 10.1007/978-1-4757-2968-9, 10.1007/978-1-4757-2968-9]; MILLESI H, 1995, CLIN BIOMECH, V10, P29, DOI 10.1016/0268-0033(95)90434-B; Nelson F, 2006, OSTEOARTHR CARTILAGE, V14, P114, DOI 10.1016/j.joca.2005.08.005; Padalkar M, 2013, NORTHEAST BIOENGIN C, P66, DOI 10.1109/NEBEC.2013.121; Padalkar MV, 2013, ANN BIOMED ENG, V41, P2426, DOI 10.1007/s10439-013-0844-0; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; POOLE AR, 1986, BIOCHEM J, V236, P1; Prakash M, 2019, OSTEOARTHR CARTILAGE, V27, P1235, DOI 10.1016/j.joca.2019.04.008; Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; Riley G., 2004, SOFT TISSUE RHEUMATO, P2053; Ristaniemi A, 2020, J MECH BEHAV BIOMED, V104, DOI 10.1016/j.jmbbm.2020.103639; Ristaniemi A, 2018, J BIOMECH, V79, P31, DOI 10.1016/j.jbiomech.2018.07.031; Ristaniemi A, 2021, DATA BRIEF, V36, DOI 10.1016/j.dib.2021.106976; Ristaniemi A, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2020.0737; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Sarin JK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31670-5; Siesler H. W., 2008, NEAR INFRARED SPECTR; Smith KD, 2011, J ANAT, V218, P600, DOI 10.1111/j.1469-7580.2011.01374.x; Spahn G, 2010, AM J SPORT MED, V38, P2516, DOI 10.1177/0363546510376744; Spahn G, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-47; Spiesz EM, 2018, ACTA BIOMATER, V70, P281, DOI 10.1016/j.actbio.2018.01.034; Torniainen J, 2020, ANAL CHIM ACTA, V1108, P1, DOI 10.1016/j.aca.2020.02.030; Torniainen J, 2019, ANN BIOMED ENG, V47, P213, DOI 10.1007/s10439-018-02125-9; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; West RV, 2005, J AM ACAD ORTHOP SUR, V13, P197, DOI 10.5435/00124635-200505000-00006; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22	41	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263280	10.1371/journal.pone.0263280	http://dx.doi.org/10.1371/journal.pone.0263280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157708	gold, Green Published			2022-12-26	WOS:000788004500010
J	Cho, B; Song, S; Wan, JY; Axelrod, JD				Cho, Bomsoo; Song, Song; Wan, Joy Y.; Axelrod, Jeffrey D.			Prickle isoform participation in distinct polarization events in the Drosophila eye	PLOS ONE			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; ASYMMETRIC LOCALIZATION; OMMATIDIAL ROTATION; FAT; STRABISMUS; ESTABLISHMENT; MORPHOGENESIS; CADHERINS; FLAMINGO	Planar cell polarity (PCP) signaling regulates several polarization events during development of ommatidia in the Drosophila eye, including directing chirality by polarizing a cell fate choice and determining the direction and extent of ommatidial rotation. The pk(sple) isoform of the PCP protein Prickle is known to participate in the R3/R4 cell fate decision, but the control of other polarization events and the potential contributions of the three Pk isoforms have not been clarified. Here, by characterizing expression and subcellular localization of individual isoforms together with re-analyzing isoform specific phenotypes, we show that the R3/R4 fate decision, its coordination with rotation direction, and completion of rotation to a final +/- 90 degrees rotation angle are separable polarization decisions with distinct Pk isoform requirements and contributions. Both pk(sple) and pk(pk) can enforce robust R3/R4 fate decisions, but only pk(sple) can correctly orient them along the dorsal-ventral axis. In contrast, pk(sple) and pk(pk) can fully and interchangeably sustain coordination of rotation direction and rotation to completion. We propose that expression dynamics and competitive interactions determine isoform participation in these processes. We propose that the selective requirement for pk(sple) to orient the R3/R4 decision and their interchangeability for coordination and completion of rotation reflects their previously described differential interaction with the Fat/Dachsous system which is known to be required for orientation of R3/R4 decisions but not for coordination or completion of rotation.	[Cho, Bomsoo; Song, Song; Wan, Joy Y.; Axelrod, Jeffrey D.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	jaxelrod@stanford.edu	song, song/GWN-2626-2022		NIH [R01 GM097081, 5R35 GM13191402]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01 GM097081 and NIH 5R35 GM13191402 to JDA (https://www.nigms.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambegaonkar AA, 2015, ELIFE, V4, DOI 10.7554/eLife.09946; Ayukawa T, 2014, CELL REP, V8, P609, DOI 10.1016/j.celrep.2014.06.009; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Butler MT, 2017, NAT REV MOL CELL BIO, V18, P375, DOI 10.1038/nrm.2017.11; Caddy J, 2010, DEV CELL, V19, P138, DOI 10.1016/j.devcel.2010.06.008; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho B, 2020, ELIFE, V9, DOI 10.7554/eLife.51456; Choi KW, 1996, P NATL ACAD SCI USA, V93, P5737, DOI 10.1073/pnas.93.12.5737; Collu GM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007391; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Davey CF, 2017, DEVELOPMENT, V144, P187, DOI 10.1242/dev.122804; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Doyle K, 2008, DEV BIOL, V317, P354, DOI 10.1016/j.ydbio.2008.02.041; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Gaengel Konstantin, 2008, V420, P277, DOI 10.1007/978-1-59745-583-1_17; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; GUBB D, 1993, DEVELOPMENT, P269; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; Hogan J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001305; Jenny A, 2003, EMBO J, V22, P4409, DOI 10.1093/emboj/cdg424; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Koca Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55203-w; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Kunimoto K, 2017, CURR BIOL, V27, P3120, DOI 10.1016/j.cub.2017.09.011; Lee HY, 2004, MECH DEVELOP, V121, P37, DOI 10.1016/j.mod.2003.11.002; Li D, 2018, PEDIATR CARDIOL, V39, P1052, DOI 10.1007/s00246-018-1860-5; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Matis M, 2014, ELIFE, V3, DOI 10.7554/eLife.02893; Matis M, 2013, GENE DEV, V27, P2207, DOI 10.1101/gad.228098.113; Merkel M, 2014, CURR BIOL, V24, P2111, DOI 10.1016/j.cub.2014.08.005; Montcouquiol M, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a033266; Olofsson J, 2014, DEVELOPMENT, V141, P2866, DOI 10.1242/dev.105932; Peng Y, 2012, DEV CELL, V23, P507, DOI 10.1016/j.devcel.2012.07.016; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; Santos N, 2010, DEV CELL, V19, P5, DOI 10.1016/j.devcel.2010.07.001; Sharp KA, 2016, BIOL OPEN, V5, P229, DOI 10.1242/bio.016162; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Strutt D, 2002, CURR BIOL, V12, P813, DOI 10.1016/S0960-9822(02)00841-2; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; Strutt Helen, 2021, Open Biol, V11, P200356, DOI 10.1098/rsob.200356; Strutt H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003654; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Taylor J, 1998, GENETICS, V150, P199; VanderVorst K, 2019, CANCER RES, V79, P1719, DOI 10.1158/0008-5472.CAN-18-2757; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wolff T, 1998, DEVELOPMENT, V125, P1149; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zakaria S, 2014, CURR BIOL, V24, P1620, DOI 10.1016/j.cub.2014.05.067; ZHENG L, 1995, DEVELOPMENT, V121, P3045	57	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0262328	10.1371/journal.pone.0262328	http://dx.doi.org/10.1371/journal.pone.0262328			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148314	gold, Green Published			2022-12-26	WOS:000800108800010
J	Makunts, T; Burkhart, K; Abagyan, R; Lee, P				Makunts, Tigran; Burkhart, Keith; Abagyan, Ruben; Lee, Peter			Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events	PLOS ONE			English	Article							INDUCED AUTOIMMUNITY; CANCER; IMMUNOLOGY; ACTIVATION; MECHANISMS	Biologics targeting PD-1, PD-L1, and CTLA-4 immune checkpoint proteins have been used in a variety of tumor types including small and non-small cell lung cancers, melanoma, and renal cell carcinoma. Their anti-tumor activity is achieved through amplifying components of the patient's own immune system to target immune response evading cancer cells. However, this unique mechanism of action causes a range of immune related adverse events, irAEs, that affect multiple physiological systems in the body. These irAEs, depending on severity, often cause suspension or discontinuation of therapy and, in rare cases, may lead to fatal outcomes. In this study we focused on pembrolizumab, a PD-1 inhibitor currently approved for multiple types of cancer. We analyzed over ten thousand adverse event reports from Keynote clinical trials of pembrolizumab for various cancer indications with or without co-occurring infections, and observed a statistically significant 80% increase in the risk of developing an irAE in subjects with infections.	[Makunts, Tigran; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Burkhart, Keith; Lee, Peter] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA	University of California System; University of California San Diego; US Food & Drug Administration (FDA)	Makunts, T (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	tmakunts@health.ucsd.edu		Abagyan, Ruben/0000-0001-9309-2976; Makunts, Tigran/0000-0001-5536-1266				accessdata.fda, KEYTRUDA HIGHLIGHTS; Alexander Walter, 2016, P T, V41, P185; Anastasopoulou A, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0717-7; Angum F, 2020, CUREUS, V12, DOI 10.7759/cureus.8094; Araujo-Fernandez S, 2014, LUPUS, V23, P545, DOI 10.1177/0961203314523871; Arnson Y, 2007, ANN RHEUM DIS, V66, P1137, DOI 10.1136/ard.2007.069831; Bajwa Ravneet, 2019, J Clin Med Res, V11, P225, DOI 10.14740/jocmr3750; Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920; Basch E, 2021, CLIN TRIALS, V18, P104, DOI 10.1177/1740774520975120; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Burtness B, 2019, LANCET, V394, P1915, DOI 10.1016/S0140-6736(19)32591-7; Cappelli LC, 2020, BEST PRACT RES CL RH, V34, DOI 10.1016/j.berh.2019.101472; Center for Drug Evaluation and Research, CDER SYST REC FDA GO; Chang C, 2010, J AUTOIMMUN, V34, pJ266, DOI 10.1016/j.jaut.2009.11.012; Davar D, 2021, SCIENCE, V371, P595, DOI 10.1126/science.abf3363; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Freites-Martinez A, 2021, ACTAS DERMO-SIFILOGR, V112, P90, DOI 10.1016/j.ad.2019.05.009; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Karam JD, 2020, EUR J CANCER, V141, P137, DOI 10.1016/j.ejca.2020.09.025; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Lee AN, 2004, ARCH DERMATOL, V140, P723, DOI 10.1001/archderm.140.6.723; Lewis MJ, 2017, RHEUMATOLOGY, V56, P67, DOI 10.1093/rheumatology/kew399; Mok TSK, 2019, LANCET, V393, P1819, DOI 10.1016/S0140-6736(18)32409-7; Molina V, 2005, AUTOIMMUNITY, V38, P235, DOI 10.1080/08916930500050277; Olsen NJ, 2004, BEST PRACT RES CL RH, V18, P677, DOI 10.1016/j.berh.2004.05.006; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Roberts MH, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102423; Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928; Sinha P, 2005, CANCER IMMUNOL IMMUN, V54, P1137, DOI 10.1007/s00262-005-0703-4; Smith DA, 1999, ENVIRON HEALTH PERSP, V107, P661, DOI 10.2307/3434323; Spiers L, 2019, RHEUMATOLOGY, V58, P7, DOI 10.1093/rheumatology/kez418; Takemura M, 2021, RESPIR MED CASE REP, V32, DOI 10.1016/j.rmcr.2021.101361; Thompson JA, 2020, J NATL COMPR CANC NE, V18, P230, DOI 10.6004/jnccn.2020.0012; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; TOMER Y, 1995, BAILLIERE CLIN ENDOC, V9, P47, DOI 10.1016/S0950-351X(95)80819-1; Vadasz Z, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-94; Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235; Xiao X, 2014, J AUTOIMMUN, V48-49, P66, DOI 10.1016/j.jaut.2014.01.005; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263402	10.1371/journal.pone.0263402	http://dx.doi.org/10.1371/journal.pone.0263402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143542	Green Published, gold			2022-12-26	WOS:000797657800042
J	Wyka, S; Mondo, S; Liu, M; Nalam, V; Broders, K				Wyka, Stephen; Mondo, Stephen; Liu, Miao; Nalam, Vamsi; Broders, Kirk			A large accessory genome and high recombination rates may influence global distribution and broad host range of the fungal plant pathogen Claviceps purpurea	PLOS ONE			English	Article							INDUCED POINT MUTATION; EVOLUTION; ERGOT; CLASSIFICATION; PREDICTION; VIRULENCE; TOPOLOGY; SEQUENCE; SEARCH; TOOL	Pangenome analyses are increasingly being utilized to study the evolution of eukaryotic organisms. While pangenomes can provide insight into polymorphic gene content, inferences about the ecological and adaptive potential of such organisms also need to be accompanied by additional supportive genomic analyses. In this study we constructed a pangenome of Claviceps purpurea from 24 genomes and examined the positive selection and recombination landscape of an economically important fungal organism for pharmacology and agricultural research. Together, these analyses revealed that C. purpurea has a relatively large accessory genome (similar to 38%), high recombination rates (rho = 0.044), and transposon mediated gene duplication. However, due to observations of relatively low transposable element (TE) content (8.8%) and a lack of variability in genome sizes, prolific TE expansion may be controlled by frequent recombination. We additionally identified that within the ergoline biosynthetic cluster the IpsA1 and IpsA2 were the result of a recombination event. However, the high recombination rates observed in C. purpurea may be influencing an overall trend of purifying selection across the genome. These results showcase the use of selection and recombination landscapes to identify mechanisms contributing to pangenome structure and primary factors influencing the evolution of an organism.	[Wyka, Stephen; Mondo, Stephen; Nalam, Vamsi] Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA; [Mondo, Stephen] US DOE, Joint Genome Inst, Berkeley, CA USA; [Liu, Miao] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Broders, Kirk] ARS, USDA, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, Peoria, IL 61604 USA; [Broders, Kirk] Smithsonian Trop Res Inst, Panama City, Panama	Colorado State University; United States Department of Energy (DOE); Joint Genome Institute - JGI; Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian Tropical Research Institute	Broders, K (corresponding author), ARS, USDA, Natl Ctr Agr Utilizat Res, Mycotoxin Prevent & Appl Microbiol Res Unit, Peoria, IL 61604 USA.; Broders, K (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	kirk.broders@usda.gov		Broders, Kirk/0000-0002-8569-6005; Nalam, Vamsi/0000-0001-6472-118X	Agriculture and Food Research Initiative (AFRI) National Institute of Food and Agriculture (NIFA) [2019-67011-29502]; United States Department of Agriculture (USDA) [1019134]; American Malting Barley Association [17037621]; U.S. Department of Agriculture, Agricultural Research Service; Simon's Foundation [429440]	Agriculture and Food Research Initiative (AFRI) National Institute of Food and Agriculture (NIFA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); American Malting Barley Association; U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Simon's Foundation	This work was supported by the Agriculture and Food Research Initiative (AFRI) National Institute of Food and Agriculture (NIFA) Fellowships Grant Program: Predoctoral Fellowships grant no. 2019-67011-29502/project accession no. 1019134 from the United States Department of Agriculture (USDA), the American Malting Barley Association grant no. 17037621, and the U.S. Department of Agriculture, Agricultural Research Service. Dr. Broders was supported in part by the Simon's Foundation Grant number 429440 to the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI AM, 1967, APPL MICROBIOL, V15, P597, DOI 10.1128/AEM.15.3.597-602.1967; Araki H, 2006, P NATL ACAD SCI USA, V103, P5887, DOI 10.1073/pnas.0601431103; Auton A, 2014, ARXIV 14034264; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Avalos J, 2015, CURR GENET, V61, P309, DOI 10.1007/s00294-014-0454-x; Badet T, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0744-3; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Berriman M., 2018, PROTOCOL EXCHANGE, DOI 101038/protex2018054; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Brynildsrud O, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000055; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Croll D, 2015, GENETICS, V201, P1213, DOI 10.1534/genetics.115.180968; Dutheil JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-53; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; ESSER K, 1978, THEOR APPL GENET, V53, P145, DOI 10.1007/BF00273574; Fisher AJ, 2007, PLANT DIS, V91, P380, DOI 10.1094/PDIS-91-4-0380; Flieger M, 2019, TOXINS, V11, DOI 10.3390/toxins11080439; Fudal I, 2009, MOL PLANT MICROBE IN, V22, P932, DOI 10.1094/MPMI-22-8-0932; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gordon A, 2020, THEOR APPL GENET, V133, P1873, DOI 10.1007/s00122-020-03561-9; Grandaubert J, 2019, EVOL LETT, V3, P299, DOI 10.1002/evl3.117; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hane JK, 2015, FUNG BIOL-US, P55, DOI 10.1007/978-3-319-10503-1_4; Hartmann FE, 2018, GENOME BIOL EVOL, V10, P1298, DOI 10.1093/gbe/evy089; Hartmann FE, 2017, ISME J, V11, P1189, DOI 10.1038/ismej.2016.196; Hass B., 2010, TRANSPOSONPSI; Hinsch J, 2016, NEW PHYTOL, V211, P980, DOI 10.1111/nph.13960; Hinsch J, 2015, ENVIRON MICROBIOL, V17, P2935, DOI 10.1111/1462-2920.12838; Hubley R., 2013, REPEATMASKER OPEN 40; Jeffares DC, 2015, METHODS MOL BIOL, V1201, P65, DOI 10.1007/978-1-4939-1438-8_4; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kan FL, 2011, NUCLEIC ACIDS RES, V39, P1460, DOI 10.1093/nar/gkq993; Kind S, 2018, CURR GENET, V64, P1303, DOI 10.1007/s00294-018-0847-3; Kind S, 2018, MOL PLANT PATHOL, V19, P1005, DOI 10.1111/mpp.12563; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu M, 2021, ECOL EVOL, V11, P273, DOI 10.1002/ece3.7028; McCarthy CGP, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000243; McInerney JO, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.40; Menzies JG, 2015, CAN J PLANT PATHOL, V37, P40, DOI 10.1080/07060661.2014.986527; Menzies JG, 2017, CAN J PLANT PATHOL, V39, P307, DOI 10.1080/07060661.2017.1355334; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Neubauer Lisa, 2016, Fungal Biol Biotechnol, V3, P2, DOI 10.1186/s40694-016-0020-z; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Oeser B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3619-4; Peng Z, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008272; Pichova K, 2018, MOL PHYLOGENET EVOL, V123, P73, DOI 10.1016/j.ympev.2018.02.013; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Raybould AF, 1998, NEW PHYTOL, V138, P497, DOI 10.1046/j.1469-8137.1998.00123.x; Sanchez-Vallet A, 2018, ANNU REV PHYTOPATHOL, V56, P21, DOI 10.1146/annurev-phyto-080516-035303; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Song H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01399; Sperschneider J, 2018, MOL PLANT PATHOL, V19, P2094, DOI 10.1111/mpp.12682; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; Stukenbrock EH., 2018, DATA SCRIPTS FINE SC; Stukenbrock EH, 2018, GENETICS, V208, P1209, DOI 10.1534/genetics.117.300502; Testa A, 2015, FUNGAL GENET BIOL, V79, P13, DOI 10.1016/j.fgb.2015.04.011; Tiley GP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0473-3; Tudzynski P, 2014, FUNG BIOL-US, P303, DOI 10.1007/978-1-4939-1191-2_14; Urquhart AS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03058; Van de Wouw AP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001180; Wali PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069249; Wall JD, 2016, G3-GENES GENOM GENET, V6, P2265, DOI 10.1534/g3.116.029587; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wyka SA, 2020, THESIS; Wyka SA., 2020, V4 DRYAD DATASET, DOI [10.5061/dryad.6hdr7sqxp, DOI 10.5061/DRYAD.6HDR7SQXP]; Wyka SA, 2021, GENOME BIOL EVOL, V13, DOI 10.1093/gbe/evaa267; Xia C, 2018, PLANT SOIL, V424, P555, DOI 10.1007/s11104-018-3561-5; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	78	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263496	10.1371/journal.pone.0263496	http://dx.doi.org/10.1371/journal.pone.0263496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143550	Green Published, gold			2022-12-26	WOS:000797657800050
J	Arellano-Saab, A; McErlean, CSP; Lumba, S; Savchenko, A; Stogios, PJ; McCourt, P				Arellano-Saab, Amir; McErlean, Christopher S. P.; Lumba, Shelley; Savchenko, Alexei; Stogios, Peter J.; McCourt, Peter			A novel strigolactone receptor antagonist provides insights into the structural inhibition, conditioning, and germination of the crop parasite Striga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUICIDAL GERMINATION; SORGHUM; HERMONTHICA; SENSITIVITY; SELECTIVITY; HORMONE; MODEL; DAD2	Crop parasites of the Striga genera are a major biological deterrent to food security in Africa and are one of the largest obstacles to poverty alleviation on the continent. Striga seeds germinate by sensing small-molecule hormones, strigolactones (SLs), that emanate from host roots. Although SL receptors (Striga hermonthica HYPOSENSITIVE TO LIGHT [ShHTL]) have been identified, discerning their function has been diffi- cult because these parasites cannot be easily grown under laboratory conditions. Moreover, many Striga species are obligate outcrossers that are not transformable, hence not amenable to genetic analysis. By combining phenotypic screening with ShHTL structural information and hybrid drug discovery methods, we discovered a potent SL perception inhibitor for Striga, dormirazine (DOZ). Structural analysis of this piperazine-based antagonist reveals a novel binding mechanism, distinct from that of known SLs, blocking access of the hormone to its receptor. Furthermore, DOZ reduces the flexibility of protein-protein interaction domains important for receptor signaling to downstream partners. In planta, we show, via temporal additions of DOZ, that SL receptors are required at a specific time during seed conditioning. This conditioning is essential to prime seed germination at the right time; thus, this SL-sensitive stage appears to be critical for adequate receptor signaling. Aside from uncovering a function for ShHTL during seed conditioning, these results suggest that future Ag-Biotech Solutions to Striga infestations will need to carefully time the application of antagonists to exploit receptor availability and outcompete natural SLs, critical elements for successful parasitic plant invasions. favor turb Striga germination crops also that seeds tions, targets. drolases siveness which season called expression, seeds embryo	[Arellano-Saab, Amir; Lumba, Shelley; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Arellano-Saab, Amir; Savchenko, Alexei; Stogios, Peter J.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McErlean, Christopher S. P.] Univ Sydney, Sch Chem, Camperdown, NSW, Australia; [Savchenko, Alexei] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Toronto; University of Toronto; University of Sydney; University of Calgary	McCourt, P (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.; Stogios, PJ (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	p.stogios@utoronto.ca; peter.mccourt@utoronto.ca		McErlean, Chris/0000-0001-8930-7495; Arellano-Saab, Amir/0000-0002-3497-4538; McCourt, Peter/0000-0002-5905-7170	Mexican National Council of Science and Technology (CONACyT); Mitacs Globalink Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC) [06752]; NSERC Accelerator Supplement [507992]; NSERC Research Tools and Instruments grant [00356]; New Frontiers in Research Fund [NFRFE-2018-00118]; NSERC [04298]	Mexican National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Mitacs Globalink Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Accelerator Supplement; NSERC Research Tools and Instruments grant; New Frontiers in Research Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding and additional information-A. A.-S. was partially funded by the Mexican National Council of Science and Technology (CONACyT) and by a Mitacs Globalink Graduate Scholarship. This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (grant no.: 06752), an NSERC Accelerator Supplement (grant no.: 507992), an NSERC Research Tools and Instruments grant (grant no.: 00356), a New Frontiers in Research Fund (grant no.: NFRFE-2018-00118) awarded to S. L., as well as an NSERC Discovery grant (grant no.: 04298) awarded to P. M.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arellano-Saab A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103175118; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Bai N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37072-x; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; Bunsick M, 2020, NAT PLANTS, V6, P646, DOI 10.1038/s41477-020-0653-z; Burger M, 2020, PLANT DIRECT, V4, DOI 10.1002/pld3.263; Burger M, 2019, CELL REP, V26, P855, DOI 10.1016/j.celrep.2019.01.003; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; Dubach JM, 2017, NAT CHEM BIOL, V13, P168, DOI [10.1038/NCHEMBIO.2248, 10.1038/nchembio.2248]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Aparicio M, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9091184; Flematti GR, 2016, PLANTA, V243, P1361, DOI 10.1007/s00425-016-2523-5; Garcia-Contreras R, 2012, FEBS J, V279, P4145, DOI 10.1111/febs.12007; Gobena D, 2017, P NATL ACAD SCI USA, V114, P4471, DOI 10.1073/pnas.1618965114; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gurney AL, 1999, NEW PHYTOL, V143, P573, DOI 10.1046/j.1469-8137.1999.00467.x; Hameed US, 2018, EMBO REP, V19, DOI 10.15252/embr.201745619; Hamiaux C, 2018, J BIOL CHEM, V293, P6530, DOI 10.1074/jbc.RA117.001154; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hearne SJ, 2009, PEST MANAG SCI, V65, P603, DOI 10.1002/ps.1735; Holbrook-Smith D, 2016, NAT CHEM BIOL, V12, P724, DOI 10.1038/nchembio.2129; Hu LY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239013; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee HW, 2020, J BIOL CHEM, V295, P4181, DOI 10.1074/jbc.RA119.011509; Lumba S, 2017, TRENDS BIOCHEM SCI, V42, P556, DOI 10.1016/j.tibs.2017.04.006; Mashiguchi K, 2021, PLANT J, V105, P335, DOI 10.1111/tpj.15059; Matusova R, 2004, SEED SCI RES, V14, P335, DOI 10.1079/SSR2004187; McEneny-King A, 2015, BIOORG MED CHEM LETT, V25, P297, DOI 10.1016/j.bmcl.2014.11.046; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miyakawa T, 2020, CELL MOL LIFE SCI, V77, P1103, DOI 10.1007/s00018-019-03318-8; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Mohemed N, 2016, PEST MANAG SCI, V72, P2082, DOI 10.1002/ps.4426; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakamura H, 2019, MOL PLANT, V12, P44, DOI 10.1016/j.molp.2018.10.006; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Pinzi L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184331; Samejima H, 2016, PEST MANAG SCI, V72, P2035, DOI 10.1002/ps.4215; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Schrdinger, 2015, PYMOL MOL GRAPHICS S; Skarina T, 2014, METHODS MOL BIOL, V1140, P159, DOI 10.1007/978-1-4939-0354-2_12; Takahashi I, 2018, J EXP BOT, V69, P2241, DOI 10.1093/jxb/ery126; Takeuchi J, 2018, PLANT CELL PHYSIOL, V59, P1545, DOI 10.1093/pcp/pcy087; Tippe DE, 2017, FIELD CROP RES, V214, P14, DOI 10.1016/j.fcr.2017.08.013; Tippe DE, 2017, CROP PROT, V99, P93, DOI 10.1016/j.cropro.2017.05.007; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Toh S, 2012, PLANT CELL PHYSIOL, V53, P107, DOI 10.1093/pcp/pcr176; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Uraguchi D, 2018, SCIENCE, V362, P1301, DOI 10.1126/science.aau5445; Wang YP, 2021, PLANT PHYSIOL, V185, P1411, DOI 10.1093/plphys/kiaa048; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Xu YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06452-2; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Yoneyama K, 2010, PLANT CELL PHYSIOL, V51, P1095, DOI 10.1093/pcp/pcq055; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zwanenburg B, 2016, PEST MANAG SCI, V72, P2016, DOI 10.1002/ps.4222	61	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101734	10.1016/j.jbc.2022.101734	http://dx.doi.org/10.1016/j.jbc.2022.101734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0LO	35181340	gold, Green Published			2022-12-26	WOS:000793502000007
J	Gauberg, J; Elkhatib, W; Smith, CL; Singh, A; Senatore, A				Gauberg, Julia; Elkhatib, Wassim; Smith, Carolyn L.; Singh, Anhadvir; Senatore, Adriano			Divergent Ca2+/calmodulin feedback regulation of Ca(V)1 and Ca(V)2 voltage-gated calcium channels evolved in the common ancestor of Placozoa and Bilateria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NEGATIVELY CHARGED RESIDUES; CA2+ CHANNEL; BETA-SUBUNIT; DEPENDENT INACTIVATION; FUNCTIONAL EXPRESSION; CA2+-DEPENDENT INACTIVATION; DIHYDROPYRIDINE BINDING; CALMODULIN REGULATION; TRICHOPLAX-ADHAERENS	Ca(V)1 and Ca(V)2 voltage-gated calcium channels evolved from an ancestral Ca(V)1/2 channel via gene duplication somewhere near the stem animal lineage. The divergence of these channel types led to distinguishing functional properties that are conserved among vertebrates and bilaterian invertebrates and contribute to their unique cellular roles. One key difference pertains to their regulation by calmodulin (CaM), wherein bilaterian Ca(V)1 channels are uniquely subject to pronounced, buffer-resistant Ca2+/CaM-dependent inactivation, permitting negative feedback regulation of calcium influx in response to local cytoplasmic Ca2+ rises. Early diverging, nonbilaterian invertebrates also possess Ca(V)1 and Ca(V)2 channels, but it is unclear whether they share these conserved functional features. The most divergent animals to possess both Ca(V)1 and Ca(V)2 channels are placozoans such as Trichoplax adhaerens, which separated from other animals over 600 million years ago shortly after their emergence. Hence, placozoans can provide important insights into the early evolution of Ca(V)1 and Ca(V)2 channels. Here, we build upon previous characterization of Trichoplax Ca-V channels by determining the cellular expression and ion-conducting properties of the Ca(V)1 channel orthologue, TCa(V)1. We show that TCa(V)1 is expressed in neuroendocrine-like gland cells and contractile dorsal epithelial cells. In vitro, this channel conducts dihydropyridineinsensitive, high-voltage-activated Ca2+ currents with kinetics resembling those of rat Ca(V)1.2 but with left-shifted voltage sensitivity for activation and inactivation. Interestingly, TCa(V)1, inactivation, indicating that this functional divergence evolved prior to the emergence of bilaterian animals and may have signaling within various cellular contexts.	[Gauberg, Julia; Elkhatib, Wassim; Singh, Anhadvir; Senatore, Adriano] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Smith, Carolyn L.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	University of Toronto; University Toronto Mississauga; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Senatore, A (corresponding author), Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada.	adriano.senatore@utoronto.ca			NSERC Discovery Grant [RGPIN-2016-06023]; Canadian Foundation for Innovation Grant [35297]; Ontario Early Researcher Award [ER17-13-247]; NSERC Canadian Graduate Scholarship; Intramural Research Program of the NIH, NINDS	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Grant; Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Intramural Research Program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was funded by an NSERC Discovery Grant (RGPIN-2016-06023), a Canadian Foundation for Innovation Grant (35297), and an Ontario Early Researcher Award (ER17-13-247) to Adriano Senatore, an NSERC Canadian Graduate Scholarship to J. G., and the Intramural Research Program of the NIH, NINDS to C. L. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PJ, 2009, CHANNELS, V3, P110, DOI 10.4161/chan.3.2.7932; Armon S, 2018, P NATL ACAD SCI USA, V115, pE10333, DOI 10.1073/pnas.1802934115; Banerjee R, 2018, P NATL ACAD SCI USA, V115, pE3026, DOI 10.1073/pnas.1716381115; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Blesneac I, 2015, P NATL ACAD SCI USA, V112, P13705, DOI 10.1073/pnas.1511740112; Bourdin B, 2017, J BIOL CHEM, V292, P17236, DOI 10.1074/jbc.M117.806893; Byczkowicz N, 2019, ELIFE, V8, DOI 10.7554/eLife.42766; Canti C., 2005, P NATL ACAD SCI; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Catterall WA, 2019, IUPHARBPS GUIDE PHAR, V2019, DOI [10.2218/gtopdb/F80/2019.4, DOI 10.2218/GTOPDB/F80/2019.4]; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cens T, 2015, INSECT BIOCHEM MOLEC, V58, P12, DOI 10.1016/j.ibmb.2015.01.005; Chan JD, 2017, BBA-MOL CELL RES, V1864, P1036, DOI 10.1016/j.bbamcr.2016.10.010; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chi CH, 2017, IBRO REP, V2, P63, DOI 10.1016/j.ibror.2017.03.002; Cottrell GS, 2018, J NEUROSCI, V38, P9186, DOI 10.1523/JNEUROSCI.3572-15.2018; Dafi O, 2004, BIOPHYS J, V87, P3181, DOI 10.1529/biophysj.104.045559; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dawson TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092941; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; ECKERT R, 1981, J PHYSIOL-LONDON, V314, P265, DOI 10.1113/jphysiol.1981.sp013706; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eitel M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005359; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fernandez-Valverde SL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1588-z; Ferreira G, 2003, BIOPHYS J, V84, P3662, DOI 10.1016/S0006-3495(03)75096-6; Fuller MD, 2014, J GEN PHYSIOL, V143, P315, DOI 10.1085/jgp.201311075; Gauberg J, 2020, J BIOL CHEM, V295, P18553, DOI 10.1074/jbc.RA120.015725; Gauberg J, 2021, METHODS MOL BIOL, V2219, P277, DOI 10.1007/978-1-0716-0974-3_18; Gul IS, 2018, GENOME BIOL EVOL, V10, P909, DOI 10.1093/gbe/evy040; Guzman C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18774; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hering S, 2018, PFLUG ARCH EUR J PHY, V470, P1291, DOI 10.1007/s00424-018-2163-7; Hofer NT, 2021, CHANNELS, V15, P38, DOI 10.1080/19336950.2020.1859260; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Jeziorski MC, 1999, RECEPTOR CHANNEL, V6, P375; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kamm K., 2018, SCI REP-UK, V8, P1; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kapli P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5162; KASS RS, 1987, CIRC RES, V61, P1; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kohn AB, 2003, PARASITOLOGY, V127, P349, DOI 10.1017/S003118200300386X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lacinova L, 2005, ARCH BIOCHEM BIOPHYS, V437, P42, DOI 10.1016/j.abb.2005.02.025; Laine V, 2011, J BIOL CHEM, V286, P36180, DOI 10.1074/jbc.M111.256149; Leys SP, 2015, J EXP BIOL, V218, P581, DOI 10.1242/jeb.110817; Li X, 2015, P NATL ACAD SCI USA, V112, pE1010, DOI 10.1073/pnas.1422941112; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu Z, 2003, J PHYSIOL-LONDON, V553, P473, DOI 10.1113/jphysiol.2003.051110; LLINAS R, 1981, BIOPHYS J, V33, P289, DOI 10.1016/S0006-3495(81)84898-9; Mahapatra S, 2012, CELL CALCIUM, V51, P321, DOI 10.1016/j.ceca.2012.01.005; Mayorova TD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02735-9; Mayorova TD, 2019, BIOL OPEN, V8, DOI 10.1242/bio.045674; Mayorova TD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190905; Mehta A., 2016, CLONING CHARACTERIZA; Michailidis IE, 2014, NEURON, V82, P1045, DOI 10.1016/j.neuron.2014.04.017; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; Moran Y, 2014, GENOME BIOL EVOL, V6, P2210, DOI 10.1093/gbe/evu177; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Moroz LL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.669087; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pozdnyakov I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21897-7; RAVENS U, 1990, N-S ARCH PHARMACOL, V341, P232; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Romanova DY, 2020, BIOCHEM BIOPH RES CO, V532, P120, DOI 10.1016/j.bbrc.2020.08.020; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Salvador-Recatala Vicenta, 2008, BMC Physiology, V8, P6, DOI 10.1186/1472-6793-8-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebe-Pedros A, 2018, NAT ECOL EVOL, V2, P1176, DOI 10.1038/s41559-018-0575-6; Segura E, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183439; Senatore A., 2012, WIRES MEMBR TRANSP S, V1, P467, DOI DOI 10.1002/WMTS.41; Senatore A, 2017, J EXP BIOL, V220, P3381, DOI 10.1242/jeb.162396; Senatore A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00481; Senatore A, 2014, J BIOL CHEM, V289, P11952, DOI 10.1074/jbc.M114.551473; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Simion P, 2017, CURR BIOL, V27, P958, DOI 10.1016/j.cub.2017.02.031; Simms BA, 2014, PFLUG ARCH EUR J PHY, V466, P1793, DOI 10.1007/s00424-013-1423-9; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Smith CL, 2017, J GEN PHYSIOL, V149, P483, DOI 10.1085/jgp.201611683; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stephens GJ, 2019, CHANNELS, V13, P120, DOI 10.1080/19336950.2019.1600968; Stephens RF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00153; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; TAMM SL, 1981, J CELL BIOL, V89, P495, DOI 10.1083/jcb.89.3.495; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Thorington GU, 2020, BIOL BULL-US, V238, P180, DOI 10.1086/708947; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Tuluc P, 2009, BIOPHYS J, V96, P35, DOI 10.1016/j.bpj.2008.09.027; Tyson J.R, 2013, WILEY INTERDISCIP RE, V2, P181, DOI DOI 10.1002/wmts.91; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weir K, 2020, ELIFE, V9, DOI 10.7554/eLife.57578; Whelan NV, 2017, NAT ECOL EVOL, V1, P1737, DOI 10.1038/s41559-017-0331-3; Wong Y-Y, 2019, RES SQUARE, DOI [10.21203/ rs.2.14504/v1thorn, DOI 10.21203/RS.2.14504/V1, 10.21203/rs.2.14504/v1]; Yamaguchi H, 1999, P NATL ACAD SCI USA, V96, P1357, DOI 10.1073/pnas.96.4.1357; Yamaguchi S, 2003, MOL PHARMACOL, V64, P235, DOI 10.1124/mol.64.2.235; Zarin T, 2019, ELIFE, V8, DOI 10.7554/eLife.46883; Zhao YY, 2019, CELL, V177, P1495, DOI 10.1016/j.cell.2019.04.043	133	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101741	10.1016/j.jbc.2022.101741	http://dx.doi.org/10.1016/j.jbc.2022.101741			32	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35182524	gold, Green Published			2022-12-26	WOS:000793560400003
J	Rahim, M; Nakhe, AY; Banerjee, DR; Overway, EM; Bosma, KJ; Rosch, JC; Oeser, JK; Wang, B; Lippmann, ES; Jacobson, DA; Brien, RMO'; Young, JD				Rahim, Mohsin; Nakhe, Arya Y.; Banerjee, Deveena R.; Overway, Emily M.; Bosma, Karin J.; Rosch, Jonah C.; Oeser, James K.; Wang, Bo; Lippmann, Ethan S.; Jacobson, David A.; Brien, Richard M. O. '; Young, Jamey D.			Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G6PC2 GENE; ISOTOPOMER; PATHWAYS; ISLETS; NADPH; RATES; LINES	Elevated fasting blood glucose (FBG) is associated with increased risks of developing type 2 diabetes (T2D) and cardiovascular-associated mortality. G6PC2 is predominantly expressed in islets, encodes a glucose-6-phosphatase catalytic subunit that converts glucose-6-phosphate (G6P) to glucose, and has been linked with variations in FBG in genome-wide association studies. Deletion of G6pc2 in mice has been shown to lower FBG without affecting fasting plasma insulin levels in vivo. At 5 mM glucose, pancreatic islets from G6pc2 knockout (KO) mice exhibit no glucose cycling, increased glycolytic flux, and enhanced glucose-stimulated insulin secretion (GSIS). However, the broader effects of G6pc2 KO on beta-cell metabolism and redox regulation are unknown. Here we used CRISPR/Cas9 gene editing and metabolic flux analysis in beta TC3 cells, a murine pancreatic beta-cell line, to examine the role of G6pc2 in regulating glycolytic and mitochondrial fluxes. We found that deletion of G6pc2 led to X60% increases in glycolytic and citric acid cycle (CAC) fluxes at both 5 and 11 mM glucose concentrations. Furthermore, intracellular insulin content and GSIS were enhanced by approximately two-fold, along with increased cytosolic redox potential and reductive carboxylation flux. Normalization of fluxes relative to net glucose uptake revealed upregulation in two NADPHproducing pathways in the CAC. These results demonstrate but also, independently, citric acid cycle activity in beta-cells. Overall, our findings implicate G6PC2 as a potential therawhich could benefit individuals with prediabetes, T2D, and obesity.	[Rahim, Mohsin; Rosch, Jonah C.; Wang, Bo; Lippmann, Ethan S.; Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN USA; [Nakhe, Arya Y.; Banerjee, Deveena R.; Overway, Emily M.; Bosma, Karin J.; Oeser, James K.; Jacobson, David A.; Brien, Richard M. O. '; Young, Jamey D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA; [Lippmann, Ethan S.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA; [Lippmann, Ethan S.] Vanderbilt Univ, Dept Neurol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Young, JD (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN USA.; Young, JD (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN USA.	j.d.young@vanderbilt.edu		Hawes, Emily/0000-0002-3266-3824; Bosma, Karin/0000-0002-1221-1169; Jacobson, David A./0000-0003-1816-5375; Rahim, Mohsin/0000-0001-8407-5621	Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563]; Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant [T32 DK101003]	Vanderbilt Molecular Endocrinology Training Program; Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant	K. J. B. and E. M. O. were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. D. R. B. was supported by the Vanderbilt Integrated Training in Engineering and Diabetes pro-gram grant T32 DK101003.	Antoniewicz MR, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0060-y; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Berger C, 2020, PFLUG ARCH EUR J PHY, V472, P1249, DOI 10.1007/s00424-020-02383-4; Bock T, 1999, APMIS, V107, P791, DOI 10.1111/j.1699-0463.1999.tb01474.x; Boortz KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162439; Bosma KJ, 2020, MOL METAB, V41, DOI 10.1016/j.molmet.2020.101043; Bosma KJ, 2020, J MOL ENDOCRINOL, V64, P235, DOI 10.1530/JME-20-0031; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Campbell JE, 2021, NAT REV MOL CELL BIO, V22, P142, DOI 10.1038/s41580-020-00317-7; Chung RH, 2021, DIABETOLOGIA, V64, P1613, DOI 10.1007/s00125-021-05449-9; Cole JT, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00051; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Gooding JR, 2015, CELL REP, V13, P157, DOI 10.1016/j.celrep.2015.08.072; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jesinkey SR, 2019, CELL REP, V28, P759, DOI 10.1016/j.celrep.2019.06.058; Krebs H A, 1969, Adv Enzyme Regul, V7, P397, DOI 10.1016/0065-2571(69)90030-2; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Lee WNP, 1998, AM J PHYSIOL-ENDOC M, V274, pE843, DOI 10.1152/ajpendo.1998.274.5.E843; Lewandowski SL, 2020, CELL METAB, V32, P736, DOI 10.1016/j.cmet.2020.10.007; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li X, 2009, DIABETES, V58, P2946, DOI 10.2337/db09-0228; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Malinowski R. M., 2020, SCI REP-UK, V10, P1; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Morsi M, 2020, ENDOCR CONNECT, V9, P769, DOI 10.1530/EC-20-0289; Mugabo Y, 2017, J BIOL CHEM, V292, P7407, DOI 10.1074/jbc.M116.763060; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Murphy TA, 2013, BIOTECHNOL BIOENG, V110, P1748, DOI 10.1002/bit.24836; Noguchi Y, 2009, J BIOL CHEM, V284, P33425, DOI 10.1074/jbc.M109.049478; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Overway E. M., 2021, J BIOL CHEM, V298; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Rahim M, 2022, METAB ENG, V69, P275, DOI 10.1016/j.ymben.2021.12.009; Ren JQ, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-1; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Spegel P, 2013, BIOCHEM J, V450, P595, DOI 10.1042/BJ20121349; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Veiga-da-Cunha M, 2019, P NATL ACAD SCI USA, V116, P1241, DOI 10.1073/pnas.1816143116; Wall ML, 2015, DIABETES, V64, P2129, DOI 10.2337/db14-0745; Wheeler E, 2017, HUM MOL GENET, V26, pR172, DOI 10.1093/hmg/ddx293; WOLF BA, 1986, J BIOL CHEM, V261, P6284; Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087; Xu YQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10337-7; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Young Jamey D, 2014, Methods Mol Biol, V1083, P85, DOI 10.1007/978-1-62703-661-0_7; Zhang GF, 2021, CELL METAB, V33, P804, DOI 10.1016/j.cmet.2020.11.020	62	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101729	10.1016/j.jbc.2022.101729	http://dx.doi.org/10.1016/j.jbc.2022.101729			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J4NE	35176280	gold, Green Published			2022-12-26	WOS:000797895000010
J	Mathew, MP; Abramowitz, LK; Donaldson, JG; Hanover, JA				Mathew, Mohit P.; Abramowitz, Lara K.; Donaldson, Julie G.; Hanover, John A.			Nutrient-responsive O-GlcNAcylation dynamically modulates the secretion of glycan-binding protein galectin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Endomembrane glycosylation and cytoplasmic O-GlcNAcyla-tion each play essential roles in nutrient sensing, and character-istic changes in glycan patterns have been described in disease states such as diabetes and cancer. These changes in glycosylation have important functional roles and can drive disease progression. However, little is known about the molecular mechanisms un-derlying how these signals are integrated and transduced into biological effects. Galectins are proteins that bind glycans and that are secreted by a poorly characterized nonclassical secretory mechanism. Once outside the cell, galectins bind to the terminal galactose residues of cell surface glycans and modulate numerous extracellular functions, such as clathrin-independent endocytosis (CIE). Originating in the cytoplasm, galectins are predicted sub-strates for O-GlcNAc addition and removal; and as we have shown, galectin 3 isa substrate for O-GlcNAc transferase. In this study, we also show that galectin 3 secretion is sensitive to changes in O-GlcNAc levels. We determined using immunoprecipitation and Western blotting that there is a significant difference in O-GlcNAcylation status between cytoplasmic and secreted galectin 3. We observed dramatic alterations in galectin 3 secre-tion in response to nutrient conditions, which were dependent on dynamic O-GlcNAcylation. Importantly, we showed that these O-GlcNAc-driven alterations in galectin 3 secretion also facili-tated changes in CIE. These results indicate that dynamic O-GlcNAcylation of galectin 3 plays a role in modulating its secretion and can tune its function in transducing nutrient-sensing information coded in cell surface glycosylation into bio-logical effects.	[Mathew, Mohit P.; Abramowitz, Lara K.; Hanover, John A.] NIDDK, Lab Cell & Mol Biol, Bethesda, MD 20892 USA; [Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hanover, JA (corresponding author), NIDDK, Lab Cell & Mol Biol, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NHLBI, National Institutes of Health [Hl006130]; NIDDK, National Institutes of Health [ZIADK060103]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The mass spectrometry experiments were carried out by Yanling Yang and Marjan Gucek at the Proteomics Core Facility, NHLBI, NIH, Bethesda, Maryland, USA. Recombinant OGT was expressed and purified by Agata Steenackers. This work was supported by NHLBI, National Institutes of Health, intramural research program grant Hl006130 and 6by NIDDK, National In-stitutes of Health, intramural research program grant ZIADK060103. The content is solely the responsibility of the au-thors and does not necessarily represent the official views of the National Institutes of Health.	Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017	2	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101743	10.1016/j.jbc.2022.101743	http://dx.doi.org/10.1016/j.jbc.2022.101743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35183508	Green Published, gold			2022-12-26	WOS:000789398100002
J	Gerace, A; Rigney, G; Anderson, JR				Gerace, Adam; Rigney, Gabrielle; Anderson, Joel R.			Predicting attitudes towards easing COVID-19 restrictions in the United States of America: The role of health concerns, demographic, political, and individual difference factors	PLOS ONE			English	Article							PSYCHOLOGICAL REACTANCE; CULTURES-CONSEQUENCES; UNCERTAINTY AVOIDANCE; NEED; ORIENTATION; VALUES; IMPACT; RISK	Despite rising cases of COVID-19 in the United States of America, several states are easing restrictions (e.g., relaxing physical distancing requirements, reopening businesses) that were imposed to limit community transmission of the virus. Individuals hold differing opinions regarding whether restrictions should continue to be imposed or lifted, evidenced, for example, by debate and protests regarding reopening of businesses and venues. Health and social psychological research suggest that perceptions of COVID-19related risk, experiences of the virus, and individual difference factors can help explain individuals' attitudes towards health initiatives and their tendency to be persuaded towards a specific course of action. The purpose of this study was to investigate what factors influence support or opposition to easing COVID-19-related restrictions. A sample of 350 United States citizens, responding to an anonymous survey, were asked about the extent to which they support/ oppose easing of COVID-19-related restrictions, both generally and in relation to specific restrictions. Respondents completed measures of their experiences of COVID-19, individual difference factors, and demographic variables, including political affiliation and degree of social and economic conservatism. In a series of regression analyses, significant demographic predictors of support or opposition for easing restrictions were gender, age, ethnicity, and education, with political affiliation and degree of social and economic conservatism also predicting attitudes. Experiences related to COVID-19 that predicted attitudes were concerns for self and family, perceptions of threat posed by the virus, perceived ability to adhere to restrictions, willingness to take government direction, and belief in COVID-19-related conspiracy theories. At an individual differences level, uncertainty avoidance, collectivism, long-term orientation, masculinity, empathic concern, personal distress, reactance, and general conspiracy theory beliefs all significantly precited attitudes to easing restrictions. Understanding the factors that help explain attitudes towards COVID-19 restrictions can inform how best to position health messaging and initiatives going forward, particularly as states or countries open borders.	[Gerace, Adam; Rigney, Gabrielle] CQUniversity, Coll Psychol, Sch Hlth Med & Appl Sci, Adelaide, SA, Australia; [Anderson, Joel R.] Australian Catholic Univ, Sch Psychol, Fitzroy, Vic, Australia; [Anderson, Joel R.] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Bundoora, Vic, Australia	Central Queensland University; Australian Catholic University; La Trobe University	Gerace, A (corresponding author), CQUniversity, Coll Psychol, Sch Hlth Med & Appl Sci, Adelaide, SA, Australia.	a.gerace@cqu.edu.au	Gerace, Adam/K-4091-2015; Anderson, Joel, R/M-1066-2018	Gerace, Adam/0000-0001-8272-8799; Anderson, Joel, R/0000-0003-3649-2003	Central Queensland University	Central Queensland University	Funding to recruit respondents for the survey was provided to AG by Central Queensland University.	Alzueta E, 2021, J CLIN PSYCHOL, V77, P556, DOI 10.1002/jclp.23082; Anderson J, COVID 19 MULTIFACETE; [Anonymous], 2010, Am Psychol, V65, P493, DOI 10.1037/a0020168; Associated Press, 2021, NEW COVID 19 CAS HAV; Ball H, 2022, HEALTH COMMUN, V37, P1812, DOI 10.1080/10410236.2021.1920717; Batson C.D., 2011, ALTRUISM HUMANS; Bearden WO, 2006, J ACAD MARKET SCI, V34, P456, DOI 10.1177/0092070306286706; Bem S. L., 1981, J PERS SOC PSYCHOL; Berg SH, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11468-3; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brehm J.W., 1966, THEORY PSYCHOL REACT; Brehm S.S., 1981, PSYCHOL REACTANCE, DOI DOI 10.1016/B978-0-12-129840-1.50005-3; Brotherton R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00279; BURGER J M, 1979, Motivation and Emotion, V3, P381, DOI 10.1007/BF00994052; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Capodilupo ER, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256063; Carnegie Endowment for International Peace, 2021, GLOB PROT TRACK; Carver LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076356; Center for Disease Control, 2021, US COVID 19 CAS DEAT; Centers for Disease Control and Prevention (CDC), 2021, SCREEN TIME TRENDS A; Champion V.L., 2008, HLTH BEHAV HLTH ED, V4, P45; Coelho GLD, 2020, ASSESSMENT, V27, P1870, DOI 10.1177/1073191118793208; Conner M., 2005, PREDICTING HLTH BEHA, P1; Conway LG., 2021, PERS INDIV DIFFER, V183, P111124, DOI [10.1016/j.paid.2021.111124, DOI 10.1016/j.paid.2021.111124]; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Coninck D, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110220; De Meulenaer S, 2018, HEALTH COMMUN, V33, P291, DOI 10.1080/10410236.2016.1266573; Dhanani LY, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.560828; Dheer RJS, 2021, J INT BUS STUD, V52, P1871, DOI 10.1057/s41267-021-00455-w; Diaz R, 2022, COGNITION EMOTION, V36, P120, DOI 10.1080/02699931.2021.1941783; Dillard JP, 2005, COMMUN MONOGR, V72, P144, DOI 10.1080/03637750500111815; Douglas KM, 2019, POLIT PSYCHOL, V40, P3, DOI 10.1111/pops.12568; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Farrell L., 2021, SMITHSONIAN MAG 0924; Ferrer RA, 2018, PSYCHOL HEALTH, V33, P1, DOI 10.1080/08870446.2017.1385787; French J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165893; Fridman A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250123; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gerace Adam., 2017, J RELATIONSHIPS RES, V8, P1, DOI [10.1017/jrr.2017.8, DOI 10.1017/JRR.2017.8]; Germani A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103497; Han Q, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001306; Harsin J, 2020, EUR J CULT STUD, V23, P1060, DOI 10.1177/1367549420944934; Hattrup K, 2007, J OCCUP ORGAN PSYCH, V80, P499, DOI 10.1348/096317906X130843; Havey NF, 2020, J COMPUT SOC SCI, V3, P319, DOI 10.1007/s42001-020-00089-2; Heywood AE, 2020, LANCET INFECT DIS, V20, P1005, DOI 10.1016/S1473-3099(20)30633-2; Hofstede G., 1998, MASCULINITY FEMININI; Hofstede G, 2013, VALUES SURVEY MODULE; Hofstede G, 1984, CULTURES CONSEQUENCE; Hofstede G., 2011, ONLINE READINGS PSYC, V2, P2307, DOI DOI 10.9707/2307-0919.1014; Hong SM, 1996, EDUC PSYCHOL MEAS, V56, P173, DOI 10.1177/0013164496056001014; HONG SM, 1989, PSYCHOL REP, V64, P1323, DOI 10.2466/pr0.1989.64.3c.1323; Ingram KM, 2019, J SCHOOL PSYCHOL, V77, P139, DOI 10.1016/j.jsp.2019.10.007; Ipsen C, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2021.101062; Jay J, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00998-2; Jung JM, 2004, PSYCHOL MARKET, V21, P739, DOI 10.1002/mar.20027; Kirkman BL, 2006, J INT BUS STUD, V37, P285, DOI 10.1057/palgrave.jibs.8400202; Kiviniemi MT, 2018, PSYCHOL HEALTH, V33, P98, DOI 10.1080/08870446.2017.1324973; Lachlan KA, 2021, PROG DISASTER SCI, V9, DOI 10.1016/j.pdisas.2021.100145; Lee JC, 2021, NEW YORK TIMES; Leung TYM, 2020, EMERG MICROBES INFEC, V9, P2190, DOI 10.1080/22221751.2020.1825914; Lins S, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04746; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Maaravi Y, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.627559; Millstein SG, 2002, J ADOLESCENT HEALTH, V31, P10, DOI 10.1016/S1054-139X(02)00412-3; Miron AM, 2006, Z SOZIALPSYCHOL, V37, P9, DOI 10.1024/0044-3514.37.1.9; Mohring K, 2021, EUR SOC, V23, pS601, DOI 10.1080/14616696.2020.1833066; National Vector Borne Disease Control Program, 2021, MON US E CIG SAL STA; Nguyen TT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197032; Pancani L, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.663799; Panzeri M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565823; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Pieh C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238906; Politi E, 2021, EUR PSYCHOL, V26, P298, DOI 10.1027/1016-9040/a000460; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Pummerer L, 2022, SOC PSYCHOL PERS SCI, V13, P49, DOI 10.1177/19485506211000217; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Reynolds-Tylus T, 2019, FRONT COMMUN, V4, DOI 10.3389/fcomm.2019.00056; Romer D, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113356; Schneider CR, 2021, J RISK RES, V24, P294, DOI 10.1080/13669877.2021.1890637; Seyd B., 2016, PSA ANN C BRIGHT 21; Shen LJ, 2015, Z PSYCHOL, V223, P225, DOI 10.1027/2151-2604/a000224; Sprengholz P, 2021, APPL PSYCHOL-HLTH WE, V13, P986, DOI 10.1111/aphw.12285; Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065; Stecula DA, 2021, RES POLITICS, V8, DOI 10.1177/2053168021993979; Sturman D, 2021, HEALTH PROMOT J AUST, V32, P344, DOI 10.1002/hpja.443; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tan X, 2021, AUST J SOC ISSUES, V56, P464, DOI 10.1002/ajs4.176; Taras V, 2010, J APPL PSYCHOL, V95, P405, DOI 10.1037/a0018938; The National Health and Medical Research Council Australian Research Council and Universities Australia, 2018, NAT STAT ETH COND HU; Travis J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256178; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; Udow-Phillips M, 2020, J HOSP MED, V15, P431, DOI 10.12788/jhm.3474; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wang C, 2009, PREV MED, V48, P197, DOI 10.1016/j.ypmed.2008.11.008; Williamson HC, 2020, PSYCHOL SCI, V31, P1479, DOI 10.1177/0956797620972688; Worldometer, 2021, REP CAS DEATHS COUNR; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891; Yoo B, 2011, J INT CONSUM MARK, V23, P193, DOI 10.1080/08961530.2011.578059	102	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263128	10.1371/journal.pone.0263128	http://dx.doi.org/10.1371/journal.pone.0263128			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196316	Green Published, gold			2022-12-26	WOS:000835161600008
J	Doenyas-Barak, K; Catalogna, M; Kutz, I; Levi, G; Hadanny, A; Tal, S; Daphna-Tekoha, S; Sasson, E; Shechter, Y; Efrati, S				Doenyas-Barak, Keren; Catalogna, Merav; Kutz, Ilan; Levi, Gabriela; Hadanny, Amir; Tal, Sigal; Daphna-Tekoha, Shir; Sasson, Efrat; Shechter, Yarden; Efrati, Shai			Hyperbaric oxygen therapy improves symptoms, brain's microstructure and functionality in veterans with treatment resistant post-traumatic stress disorder: A prospective, randomized, controlled trial	PLOS ONE			English	Article							POST-CONCUSSION SYNDROME; VIETNAM VETERANS; SERVICE MEMBERS; PTSD; CONNECTIVITY; INTEGRITY	Introduction Post-traumatic stress disorder (PTSD) is characterized by changes in both brain activity and microstructural integrity. Cumulative evidence demonstrates that hyperbaric oxygen therapy (HBOT) induces neuroplasticity and case-series studies indicate its potentially positive effects on PTSD. The aim of the study was to evaluate HBOT's effect in veterans with treatment resistant PTSD. Methods Veterans with treatment resistant PTSD were 1:1 randomized to HBOT or control groups. All other brain pathologies served as exclusion criteria. Outcome measures included clinician-administered PTSD scale-V (CAPS-V) questionnaires, brief symptom inventory (BSI), BECK depression inventory (BDI), brain microstructural integrity evaluated by MRI diffuse tensor imaging sequence (DTI), and brain function was evaluated by an n-back task using functional MRI (fMRI). The treatment group underwent sixty daily hyperbaric sessions. No interventions were performed in the control group. Results Thirty-five veterans were randomized to HBOT (N = 18) or control (n = 17) and 29 completed the protocol. Following HBOT, there was a significant improvement in CAPS-V scores and no change in the control (F = 30.57, P<0.0001, Net effect size = 1.64). Significant improvements were also demonstrated in BSI and BDI scores (F = 5.72, P = 0.024 Net effect size = 0.89, and F = 7.65, P = 0.01, Net effect size = 1.03). Improved brain activity was seen in fMRI in the left dorsolateral prefrontal, middle temporal gyri, both thalami, left hippocampus and left insula. The DTI showed significant increases in fractional anisotropy in the frontolimbic white-matter, genu of the corpus callosum and fornix. Conclusions HBOT improved symptoms, brain microstructure and functionality in veterans with treatment resistant PTSD.	[Doenyas-Barak, Keren; Catalogna, Merav; Kutz, Ilan; Levi, Gabriela; Hadanny, Amir; Sasson, Efrat; Shechter, Yarden; Efrati, Shai] Shamir Med Ctr Zerifin, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Doenyas-Barak, Keren; Hadanny, Amir; Tal, Sigal; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Tal, Sigal] Shamir Med Ctr, Radiol Dept, Zerifin, Israel; [Daphna-Tekoha, Shir] Kaplan Med Ctr, Rehovot, Israel; [Daphna-Tekoha, Shir] Ashkelon Acad Coll, Fac Social Work, Ashqelon, Israel; [Daphna-Tekoha, Shir] Emili Sagol Creat Arts Therapies Res Ctr, Haifa, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University	Doenyas-Barak, K (corresponding author), Shamir Med Ctr Zerifin, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Doenyas-Barak, K (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	Kerendoenyas@gmail.com		Hadanny, Amir/0000-0001-9028-7268; Doenyas-Barak, Keren/0000-0002-9212-5075	Research Fund of Shamir Medical Center, Israel	Research Fund of Shamir Medical Center, Israel	The study was funded by the Research Fund of Shamir Medical Center, Israel.	American-Psychiatric-Association, 2013, DIAGN STAT MAN MENT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Doniger GM., 2013, CONSTRUCT VALIDITY M; Efrati S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00848; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; Hadanny A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02495; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Khacho M, 2019, NAT REV NEUROSCI, V20, P34, DOI 10.1038/s41583-018-0091-3; Kida S, 2019, PSYCHOPHARMACOLOGY, V236, P49, DOI 10.1007/s00213-018-5086-2; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mozayeni BR, 2019, MED GAS RES, V9, P1, DOI 10.4103/2045-9912.254636; Olson EA, 2017, DEPRESS ANXIETY, V34, P437, DOI 10.1002/da.22615; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; van Rooij SJH, 2016, NEUROPSYCHOPHARMACOL, V41, P1156, DOI 10.1038/npp.2015.257; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	33	3	3	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264161	10.1371/journal.pone.0264161	http://dx.doi.org/10.1371/journal.pone.0264161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192645	Green Published, gold			2022-12-26	WOS:000812552500039
J	Harjen, HJ; Hellum, M; Rortveit, R; Oscarson, M; Anfinsen, KP; Moldal, ER; Solbak, S; Kanse, SM; Henriksson, CE				Harjen, Hannah J.; Hellum, Marit; Rortveit, Runa; Oscarson, Malin; Anfinsen, Kristin P.; Moldal, Elena R.; Solbak, Susanna; Kanse, Sandip M.; Henriksson, Carola E.			Persistent hypercoagulability in dogs envenomated by the European adder (Vipera berus berus)	PLOS ONE			English	Article							THROMBIN-GENERATION; BITES; VENOM; STANDARDIZATION; MICROPARTICLES; ANTIVENOM	Background Envenomation by the European adder, Vipera berus berus (Vbb), is a medical emergency. The overall in vivo haemostatic effects of pro- and anticoagulant components in Vbb venom, and the downstream effects of cellular injury and systemic inflammation, are unclear. Objectives To longitudinally describe the global coagulation status of dogs after Vbb envenomation and compare to healthy controls. A secondary aim was to investigate differences between dogs treated with and without antivenom. Methods Citrated plasma was collected at presentation, 12 hours (h), 24 h, 36 h and 15 days after bite from 28 dogs envenomated by Vbb, and from 28 healthy controls at a single timepoint. Thrombin generation (initiated with and without exogenous phospholipids and tissue factor), thrombin-antithrombin (TAT)-complexes and the procoagulant activity of phosphatidylserine (PS)-expressing extracellular vesicles (EVs), expressed as PS-equivalents, were measured. Results At presentation the envenomated dogs were hypercoagulable compared to controls, measured as increased thrombin generation, TAT-complexes and PS-equivalents. The hypercoagulability decreased gradually but compared to controls thrombin generation and PS-equivalents were still increased at day 15. The discrepancy in peak thrombin between envenomated dogs and controls was greater when the measurement was phospholipid-dependent, indicating that PS-positive EVs contribute to hypercoagulability. Lag time was shorter in non-antivenom treated dogs, compared to antivenom treated dogs <24 h after envenomation. Conclusions Hypercoagulability was measured in dogs up to 15 days after Vbb envenomation. Dogs treated with antivenom may be less hypercoagulable than their non-antivenom treated counterparts. Thrombin generation is a promising diagnostic and monitoring tool for Vbb envenomation.	[Harjen, Hannah J.; Anfinsen, Kristin P.; Moldal, Elena R.] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway; [Hellum, Marit; Henriksson, Carola E.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hellum, Marit; Henriksson, Carola E.] Oslo Univ Hosp, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway; [Rortveit, Runa] Norwegian Univ Life Sci, Dept Preclin Sci & Pathol, Fac Vet Med, Oslo, Norway; [Oscarson, Malin] Norwegian Food Safety Author, Brumunddal, Norway; [Solbak, Susanna] Anicura Dyresykehus Oslo, Oslo, Norway; [Solbak, Susanna] Anicura Jeloy Dyresykehus, Moss, Norway; [Kanse, Sandip M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Oslo	Harjen, HJ (corresponding author), Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, Fac Vet Med, Oslo, Norway.	Hannah.harjen@nmbu.no		Harjen, Hannah/0000-0001-6636-4868; Kanse, Sandip/0000-0003-0782-9957	Agria; SKK Research Fund for Pets [N2018-0014]; Raagholt Foundation	Agria; SKK Research Fund for Pets; Raagholt Foundation	HH received funding for this study from: the Agria and SKK Research Fund for Pets, Grant number N2018-0014,www.skk.se/sv/Agria-SKKForskningsfond.-The Raagholt Foundation, www.raagholtstiftelsen.no -Dyrlege Smiths Legat The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroch I, 2010, VET J, V185, P180, DOI 10.1016/j.tvjl.2009.05.024; AUDEBERT F, 1994, HUM EXP TOXICOL, V13, P683, DOI 10.1177/096032719401301006; Berntorp E, 2008, SEMIN THROMB HEMOST, V34, P670, DOI 10.1055/s-0028-1104546; Bocian A, 2016, MOLECULES, V21, DOI 10.3390/molecules21101398; Bolton FMS, 2014, VET REC, V174, P406, DOI 10.1136/vr.102286; Brandeker E, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0352-6; Christensen MB, 2014, CAN VET J, V55, P161; Duarte Rita Carolina Figueiredo, 2017, Rev. Bras. Hematol. Hemoter., V39, P259, DOI 10.1016/j.bjhh.2017.03.009; Dylag-Trojanowska KE, 2018, ANN AGR ENV MED, V25, P630, DOI 10.26444/aaem/75941; Duarte RCF, 2019, TOXICON, V163, P36, DOI 10.1016/j.toxicon.2019.03.012; Gary T, 2010, VASA, V39, P199, DOI 10.1024/0301-1526/a000029; Gordin E, 2021, RES VET SCI, V134, P12, DOI 10.1016/j.rvsc.2020.11.019; Harjen HJ, 2020, J VET INTERN MED, V34, P1369, DOI 10.1111/jvim.15817; Helmond SE, 2013, AM J VET RES, V74, P207, DOI 10.2460/ajvr.74.2.207; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hermansen MN., 2018, EUROPEAN J EMERGENCY; Hodgson L., 2017, VET EVIDENCE, V2; Isbister GK, 2007, TOXICON, V49, P57, DOI 10.1016/j.toxicon.2006.09.007; Isbister GK, 2010, TOXICON, V56, P75, DOI 10.1016/j.toxicon.2010.03.013; Jorgensen MR., 2014, UGESKR LAEGER, V176; Judge P, 2013, AUST VET PRACT, V43, P483; Karlson-Stiber C, 2006, CLIN TOXICOL, V44, P25, DOI 10.1080/15563650500394597; Kolbjornsen O., 2014, NORSK VETERIN RTIDSS, V3, P126; Krogh AKH, 2021, RES VET SCI, V135, P504, DOI 10.1016/j.rvsc.2020.11.012; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Langhorn R, 2014, J VET EMERG CRIT CAR, V24, P174, DOI 10.1111/vec.12127; Latinovic Z, 2016, J PROTEOMICS, V146, P34, DOI 10.1016/j.jprot.2016.06.020; Mallow D., 2003, TRUE VIPERS NATURAL, V14, P359; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; McMichael MA, 2015, J VET INTERN MED, V29, P499, DOI 10.1111/jvim.12538; MOORE RS, 1988, ARCH EMERG MED, V5, P116; Nivy R, 2020, J VET EMERG CRIT CAR, V30, P396, DOI 10.1111/vec.12978; Otto CM, 2000, J AM VET MED ASSOC, V217, P1500, DOI 10.2460/javma.2000.217.1500; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Paolino G, 2020, J EUR ACAD DERMATOL, V34, P2247, DOI 10.1111/jdv.16722; PERSSON H, 1981, ACTA MED SCAND, V210, P433; Riviere G, 1998, J PHARMACOL EXP THER, V285, P490; Salvagno GL, 2019, CLIN CHEM LAB MED, V57, P1784, DOI 10.1515/cclm-2019-0135; Samel M, 2003, COMP BIOCHEM PHYS B, V135, P575, DOI 10.1016/S1096-4959(03)00171-4; SAMEL M, 1995, TOXICON, V33, P41, DOI 10.1016/0041-0101(94)00143-V; Samel M, 2006, BBA-PROTEINS PROTEOM, V1764, P707, DOI 10.1016/j.bbapap.2006.01.021; Segev G, 2004, TOXICON, V43, P691, DOI 10.1016/j.toxicon.2004.03.001; Seifert SA, 1997, ANN EMERG MED, V30, P49, DOI 10.1016/S0196-0644(97)70110-0; Tarnow I, 2007, J VET INTERN MED, V21, P451, DOI 10.1892/0891-6640(2007)21[451:HBIDWC]2.0.CO;2; TIBBALLS J, 1992, MED J AUSTRALIA, V156, P270, DOI 10.5694/j.1326-5377.1992.tb139749.x; Turkovic V, 2015, TIERAERZTL PRAX K H, V43, P221, DOI 10.15654/TPK-140364; Wagg CR, 2009, VET CLIN PATH, V38, P453, DOI 10.1111/j.1939-165X.2009.00161.x; World Health Organization, 2017, GUID PROD CONTR REG, P197; Yuana Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29260; Zanetti G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28135-0; Zdenek CN, 2020, COMP BIOCHEM PHYS C, V236, DOI 10.1016/j.cbpc.2020.108769	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263238	10.1371/journal.pone.0263238	http://dx.doi.org/10.1371/journal.pone.0263238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180240	Green Published, gold			2022-12-26	WOS:000796435800013
J	Schatteburg, J; Langenbucher, A				Schatteburg, Jan; Langenbucher, Achim			Protocol for the diagnosis of keratoconus using convolutional neural networks	PLOS ONE			English	Article							CORNEAL TOPOGRAPHY; RECOGNITION	Keratoconus is the corneal disease with the highest reported incidence of 1:2000. The treatment's level of success highly depends on how early it was started. Subsequently, a fast and highly capable diagnostic tool is crucial. While there are many computer-based systems that are capable of the analysis of medical image data, they only provide parameters. These have advanced quite far, though full diagnosis does not exist. Machine learning has provided the capabilities for the parameters, and numerous similar scientific fields have developed full image diagnosis based on neural networks. The Homburg Keratoconus Center has been gathering almost 2000 patient datasets, over 1000 of them over the course of their disease. Backed by this databank, this work aims to develop a convolutional neural network to tackle diagnosis of keratoconus as the major corneal disease.	[Schatteburg, Jan; Langenbucher, Achim] Saarland Univ, Dept Expt Ophthalmol, Homburg, Germany	Universitatsklinikum des Saarlandes	Schatteburg, J (corresponding author), Saarland Univ, Dept Expt Ophthalmol, Homburg, Germany.	jan.schatteburg@uks.eu		Schatteburg, Jan/0000-0001-5544-5507	Rolf M. Schwiete Stiftung [2020-024]	Rolf M. Schwiete Stiftung	J.S. was supported in part by the Rolf M. Schwiete Stiftung under project nr. 2020-024 (https://schwiete-stiftung.com/).The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 12 USENIX S OPERATIN; AMSLER M, 1946, OPHTHALMOLOGICA, V111, P96, DOI 10.1159/000300309; Amsler M., 1938, OPHTHALMOLOGICA, V96, P77; [Anonymous], 2015, BBC; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; Burnham KP., 2010, PRACTICAL INFORM THE, V2nd ed; Chollet F., 2018, PRAXIS HDB ENTWICKLE, V1st; Claesen M., 2015, ARXIV150202127, P1; Deng L, 2013, ICASSP 20132013 IEEE; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Elsawy A., 2020, OPTHALMIC TECHNOLOGI, P80; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gentsch P., 2017, TECHNOLOGIEN BEST PR; Glorot X., P 14 INT C ARTIFICIA, P31523; Godefrooij DA, 2017, AM J OPHTHALMOL, V175, P169, DOI 10.1016/j.ajo.2016.12.015; Goebels S, 2015, AM J OPHTHALMOL, V159, P733, DOI 10.1016/j.ajo.2015.01.014; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hazelwood K, 2018, INT S HIGH PERF COMP, P620, DOI 10.1109/HPCA.2018.00059; Huval B., 2015, EMPIRICAL EVALUATION, DOI [10.1039/c4lc01513d, DOI 10.1039/C4LC01513D]; Jain AK, 1996, COMPUTER, V29, P31, DOI 10.1109/2.485891; Kingma D., 2014, ADAM METHOD STOCHAST; Kohavi R., 2001, INT JOINT C ART INT; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuo BI, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.53; Labiris G, 2013, ACTA OPHTHALMOL, V91, pE258, DOI 10.1111/aos.12056; Lang GK., 2015, AUGENHEILKUNDE ESSEN; MAEDA N, 1995, INVEST OPHTH VIS SCI, V36, P1327; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; Mark J. L., 1996, INTRO RADIAL BASIS F; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Rabinowitz Y S, 1989, Refract Corneal Surg, V5, P400; Rabinowitz YS, 1999, J CATARACT REFR SURG, V25, P1327, DOI 10.1016/S0886-3350(99)00195-9; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; Ruder S., 2016, ARXIV; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Scherer D, 2010, LECT NOTES COMPUT SC, V6354, P92, DOI 10.1007/978-3-642-15825-4_10; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Simonyan K., 2015, PROC 3 INT C LEARN R; Tay HuntE., 2016, MICROSOFTS AI CHATBO; Tomey Corporation, CASIA2 APPL MAN; Tomey Corporation, FOUR DOM OCT CASIA2; Uniklinikum Saarland, 2020, AUG UKS FEIERT 10 JA; Vinyals O, 2019, NATURE, V575, P350, DOI 10.1038/s41586-019-1724-z; WERBOS PJ, 1990, P IEEE, V78, P1550, DOI 10.1109/5.58337; WILSON SE, 1991, CORNEA, V10, P2; Winston PH., 1993, ARTIF INTELL, V3rd; Yao Y, 2007, CONSTR APPROX, V26, P289, DOI 10.1007/s00365-006-0663-2; YERUSHALMY J, 1947, PUBLIC HEALTH REP, V62, P1432, DOI 10.2307/4586294; Zeboulon P, 2020, AM J OPHTHALMOL, V219, P33, DOI 10.1016/j.ajo.2020.06.005	55	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264219	10.1371/journal.pone.0264219	http://dx.doi.org/10.1371/journal.pone.0264219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180279	Green Published, gold			2022-12-26	WOS:000796435800053
J	Agarwal, S; Sarkar, S				Agarwal, Swati; Sarkar, Sayantani			Topical analysis of migration coverage during lockdown in India by mainstream print media	PLOS ONE			English	Article								Implementing countrywide lockdown measures in India, from March 2020 to May 2020 was a major step to deal with the COVID-19 pandemic crisis. The decision of country lockdown adversely affected the urban migrant population, and a large section of them was compelled to move out of the urban areas to their native places. The reverse migration garnered widespread media attention and coverage in electronic as well as print media. The present study focuses on the coverage of the issue by print media using descriptive natural language text mining. The study uses topic modelling, clustering, and sentiment analysis to examine the articles on migration issues during the lockdown period published in two leading English newspapers in India-The Times of India and The Hindu. The sentiment analysis results indicate that the majority of articles have neutral sentiment while very few articles show high negative or positive polarity. Descriptive topic modelling results show that transport, food security, special services, and employment with migration and migrants are the majorly covered topics after employing Bag of Words and TF-IDF models. Clustering is performed to group the article titles based on similar traits using agglomerative hierarchical clustering.	[Agarwal, Swati] BITS Pilani, Dept Comp Sci & Informat Syst, Goa Campus, Pilani, Goa, India; [Sarkar, Sayantani] BITS Pilani, Dept Humanities & Social Sci, Goa Campus, Pilani, Goa, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Birla Institute of Technology & Science Pilani (BITS Pilani)	Agarwal, S (corresponding author), BITS Pilani, Dept Comp Sci & Informat Syst, Goa Campus, Pilani, Goa, India.; Sarkar, S (corresponding author), BITS Pilani, Dept Humanities & Social Sci, Goa Campus, Pilani, Goa, India.	swatia@goa.bits-pilani.ac.in; sayantanis@goa.bits-pilani.ac.in						Allen W, 2013, MIGRATION NEWS PORTR; Backfried G., 2016, INT C INF SYST CRIS, P234; Bajracharya Shraddha, 2018, SOCIAL RESPONSIBILIT; Balasubramanyan R, 2012, P 6 INT AAAI C WEB S, P18; Bibi M, 2020, IEEE ACCESS, V8, P68580, DOI 10.1109/ACCESS.2020.2983859; Breman J, 2020, INDIAN J LABOUR ECON, V63, P901, DOI 10.1007/s41027-020-00285-8; Chen M, 2020, HUNGER VIRUS ALL TOO; Chen Y, 2021, SIGIR '21 - PROCEEDINGS OF THE 44TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P1328, DOI 10.1145/3404835.3462888; Choudhari R, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102254; Dahal B, 2019, SOC NETW ANAL MIN, V9, DOI 10.1007/s13278-019-0568-8; Debnath R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238972; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; ILO, 2021, COV 19 WORLD WORK, V7th ed.; Kang E, 2020, HEALTH INFORM J, V26, P2237, DOI 10.1177/1460458220901360; Keller TR, 2020, ENVIRON COMMUN, V14, P219, DOI 10.1080/17524032.2019.1643383; Klochikhin E, 2020, BIG DATA SOCIAL SCI, P193; Liu Q, 2020, J MED INTERNET RES, V22, DOI 10.2196/19118; Mihalcea R., 2004, P EMNLP, P404, DOI DOI 10.3115/1219044.1219064; Panchamukhi V., 2013, INDIAN EC J, V61, P129, DOI [/10.1177/0019466220130107, DOI 10.1177/0019466220130107]; Raj A., 2021, MEDIA ASIA, V48, P5, DOI [10.1080/01296612.2021, DOI 10.1080/01296612.2021, 10.1080/01296612.2021.1881283, DOI 10.1080/01296612.2021.1881283]; Rani U., 2021, J SCI RES, V65, P304, DOI [10.37398/JSR.2021.650140, DOI 10.37398/JSR.2021.650140]; Roder M, 2015, WSDM'15: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P399, DOI 10.1145/2684822.2685324; Sahas J, 2020, VOICES INVISIBLE CIT; Scott AJ, 2009, J ECON GEOGR, V9, P583, DOI 10.1093/jeg/lbp019; Sengupta S., 2020, INT J COMMUNITY SOCI, V2, P152, DOI [10.1177/2516602620933715, DOI 10.1177/2516602620933715]; Shirley K., 2014, P WORKSHOP INTERACTI, P63, DOI 10.3115/v1/W14-3110; Shome R, 2021, CULT STUD, V35, P319, DOI 10.1080/09502386.2021.1898033; Srivastava R., 2011, HUMAN DEV INDIA; Srivastava R, 2020, CTR EMPLOYMENT STUDI, P4; Tiwary Guddi, 2012, Indian J Occup Environ Med, V16, P66, DOI 10.4103/0019-5278.107072; Tokuda EK, PHYS STAT MECH ITS A, V585, DOI [10.1016/j.physa.2021.126433, DOI 10.1016/J.PHYSA.2021.126433]; Vazquez P, 2020, INT CONF EDEMOC EGOV, P106, DOI 10.1109/ICEDEG48599.2020.9096804; Zamani Mohammadzaman, 2020, Proc Conf Empir Methods Nat Lang Process, V2020, P193, DOI 10.18653/v1/2020.nlpcss-1.21	33	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263787	10.1371/journal.pone.0263787	http://dx.doi.org/10.1371/journal.pone.0263787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176059	Green Published, gold			2022-12-26	WOS:000777505200031
J	Hehir, MK; Conaway, M; Clark, EM; Aronzon, DB; Kolb, N; Kolb, A; Ruzhansky, K; Sadjadi, R; De Sousa, EA; Burns, TM				Hehir, Michael K.; Conaway, Mark; Clark, Eric M.; Aronzon, Denise B.; Kolb, Noah; Kolb, Amanda; Ruzhansky, Katherine; Sadjadi, Reza; De Sousa, Eduardo A.; Burns, Ted M.			The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events	PLOS ONE			English	Article							SIDE-EFFECT PROFILE; MYASTHENIA-GRAVIS; MECHANICAL TURK; DRUG EVENTS; QUALITY; TOLERABILITY; PATIENT; COSTS	Objective To design a physician and patient derived tool, the Adverse Event Unit (AEU), akin to currency (e.g. U.S. Dollar), to improve AE burden measurement independent of any particular disease or medication class. Patients/Methods A Research Electronic Data Capture (REDCap) online survey was administered to United States physicians with board certification or board eligibility in general neurology, subspecialty neurology, primary care internal medicine or family medicine, subspecialty internal medicine, general pediatrics, and subspecialty pediatrics. Physicians assigned value to 73 AE categories chosen from the Common Terminology Criteria of Adverse Events (CTCAE) relevant to neurologic disorder treatments. An online forced choice survey was administered to non-physician, potential patients, through Amazon Mechanical Turk (MTurK) to weight the severity of the same AE categories. Physician and non-physician data was combined to assign value to the AEU. Surveys completed between 1/2017 and 3/2019. Results 363 physicians rated the 73 AE categories derived from CTCAE. 660 non-physicians completed forced choice experiments comparing AEs. The AEU provides 0-10, weighted values for the AE categories studied that differ from the ordinal 1-4 CTCAE scale. For example, CTCAE severe diabetes (category 4) is assigned an AEU score of 9. Although non-physician input changed physician assigned AEU values, there was general agreement among physicians and non-physicians about severity of AEs. Conclusion The AEU has promise to be a useful, practical tool to add precision to AE burden measurement in the clinic and in comparative efficacy research with neurology patients. AEU utility will be assessed in planned comparative efficacy clinical trials.	[Hehir, Michael K.; Kolb, Noah] Univ Vermont, Larner Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Conaway, Mark; Burns, Ted M.] Univ Virginia, Charlottesville, VA USA; [Clark, Eric M.] Univ Vermont, Complex Syst Ctr, Burlington, VT USA; [Aronzon, Denise B.] Timberlane Pediat, S Burlington, VT USA; [Kolb, Amanda] Univ Vermont, Larner Coll Med, Dept Family Med, Burlington, VT USA; [Ruzhansky, Katherine] Med Univ South Carolina, Charleston, SC 29425 USA; [Sadjadi, Reza] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [De Sousa, Eduardo A.] Neurosci Inst Oklahoma City, Mercy Clin Neurol, Oklahoma City, OK USA	University of Vermont; University of Virginia; University of Vermont; University of Vermont; Medical University of South Carolina; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hehir, MK (corresponding author), Univ Vermont, Larner Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	Michael.hehir@uvmhealth.org		Hehir, Michael/0000-0002-5034-6988; Sadjadi, Reza/0000-0003-3829-6030; De Sousa, Eduardo/0000-0002-7431-6169	American Academy of Neurology; American Brain Foundation; Myasthenia Gravis Foundation of America 2016-2019 [2016-0231]	American Academy of Neurology; American Brain Foundation; Myasthenia Gravis Foundation of America 2016-2019	This study was supported by American Academy of Neurology, American Brain Foundation, Myasthenia Gravis Foundation of America 2016-2019 (Grant No. 2016-0231) awarded to MH. The funder did not play role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 2013, NEURODEVELOPMENTAL D, V5th; Basch E, 2006, LANCET ONCOL, V7, P903, DOI 10.1016/S1470-2045(06)70910-X; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bernstein J, 2018, PM&R, V10, P45, DOI 10.1016/j.pmrj.2017.06.010; Bravo Vergel Yolanda, 2008, Pract Neurol, V8, P175, DOI 10.1136/pn.2007.140186; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bureau USC, RAC HISP OR 2010; Burns TM, 2016, MUSCLE NERVE, V53, P3, DOI 10.1002/mus.24953; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354; Guptill JT, 2011, MUSCLE NERVE, V44, P907, DOI 10.1002/mus.22212; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Hunsinger M, 2014, PAIN, V155, P2253, DOI 10.1016/j.pain.2014.08.004; Hunter DR, 2004, ANN STAT, V32, P384; Institute NC, 2009, NIH PUBLICATION; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Katz NP, 2015, PAIN, V156, P1357, DOI 10.1097/j.pain.0000000000000186; Louviere JJ, 2010, J CHOICE MODEL, V3, P57; Martinez-Ramirez D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124356; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Mohr DC, 1998, MULT SCLER, V4, P487, DOI 10.1191/135245898678845160; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Quality AfHRa, 2001, RED PREV ADV DRUG EV; Sanders DB, 2016, NEUROLOGY, V87, P419, DOI 10.1212/WNL.0000000000002790; Sassi F, 2006, HEALTH POLICY PLANN, V21, P402, DOI 10.1093/heapol/czl018; Schepelmann K, 2010, J NEUROL, V257, P15, DOI 10.1007/s00415-009-5256-6; Schmidt GB, 2016, BUS HORIZONS, V59, P391, DOI 10.1016/j.bushor.2016.02.004; Smith AG, 2017, HARVARD BUS REV; Smith SM, 2013, PAIN, V154, P997, DOI 10.1016/j.pain.2013.03.003; TESTA MA, 1993, NEW ENGL J MED, V328, P907, DOI 10.1056/NEJM199304013281302; Voruganti L, 2000, SCHIZOPHR RES, V43, P135, DOI 10.1016/S0920-9964(99)00154-1	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0262109	10.1371/journal.pone.0262109	http://dx.doi.org/10.1371/journal.pone.0262109			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176061	Green Published, gold			2022-12-26	WOS:000777505200006
J	Temesgen, MY; Assen, AA; Gizaw, TT; Minalu, BA; Mersha, AY				Temesgen, Migbnesh Yekoye; Assen, Alula Alemayehu; Gizaw, Tarekegn Tintagu; Minalu, Bethelehem Alemu; Mersha, Anteneh Yenehun			Factors affecting calving to conception interval (days open) in dairy cows located at Dessie and Kombolcha towns, Ethiopia	PLOS ONE			English	Article							BODY-CONDITION SCORE; REPRODUCTIVE-PERFORMANCE; MILK-YIELD; SURVIVAL ANALYSIS; RISK-FACTORS; 1ST SERVICE; FERTILITY; TIME; INSEMINATION; CATTLE	This study was aimed at determining the median days of calving to conception interval (days open) and identifying the major risk factors determining the days open in dairy cows. Both retrospective and longitudinal studies were conducted on dairy cows located in the Dessie and Kombolcha towns of South Wollo Zone, northeast Ethiopia from August 2019 to August 2020. The Kaplan-Meier model of survival analysis was used to determine the median days open and compare the survival distribution of each level of explanatory variables likely to influence the days open of dairy cows. Accordingly, the overall conception rate of dairy cows was 44.7%. The median days open in the study was 154 days. There is a 16% probability of surviving (i.e, the probability that the conception event has not yet occurred) at the end of 210 days postpartum period. The Cox proportional hazard model was used to quantify the effect of each of the explanatory variables on the days open in the first 210 days postpartum. Factors that had a significant effect (p<0.05) on the calving to conception interval were the season of insemination, breeding system, calving to insemination interval, and herd milk yield level. However, the peripartum, postpartum disorders, and the town of the farm are not significant (p>0.05). Accordingly, cows inseminated in the autumn season (HR = 4.45), cows less than or equal to 85 days calving to insemination interval (HR = 2.41), artificially inseminated cows (HR = 1.45), and high herd milk yield cow had a higher probability of becoming pregnant. In conclusion, the management practices and breeding decisions seem to be important determinants to improve the conception rate or decrease the days open in dairy cows.	[Temesgen, Migbnesh Yekoye; Assen, Alula Alemayehu; Gizaw, Tarekegn Tintagu; Minalu, Bethelehem Alemu] Wollo Univ, Sch Vet Med, Dessie, Ethiopia; [Mersha, Anteneh Yenehun] Pinnacle Private Ltd, Addis Ababa, Ethiopia		Assen, AA (corresponding author), Wollo Univ, Sch Vet Med, Dessie, Ethiopia.	alulaalemayehu@gmail.com	Assen, Alula Alemayehu/GQA-6273-2022	Assen, Alula Alemayehu/0000-0002-4316-0173				Abegaz WB., 2020, INT J ENV SCI NAT RE, V25, P97; Alemneh T., 2019, BIOMEDICAL J SCI TEC, V16, P12304, DOI [10.26717/BJSTR.2019.16.002903, DOI 10.26717/BJSTR.2019.16.002903]; Ali T, 2017, VALUE CHAIN ANAL MIL, P136; Allison PD., 2010, SURVIVAL ANAL USING, V36; Allore HG, 2001, PREV VET MED, V49, P223, DOI 10.1016/S0167-5877(01)00190-8; Berry DP, 2007, J DAIRY SCI, V90, P637, DOI 10.3168/jds.S0022-0302(07)71546-1; Cabrera VE, 2014, ANIMAL, V8, P211, DOI 10.1017/S1751731114000512; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; COX DR, 1972, J R STAT SOC B, V34, P187; Dahl GE, 2000, J DAIRY SCI, V83, P885, DOI 10.3168/jds.S0022-0302(00)74952-6; EALY AD, 1993, J DAIRY SCI, V76, P2899, DOI 10.3168/jds.S0022-0302(93)77629-8; Eicker SW, 1996, J DAIRY SCI, V79, P235, DOI 10.3168/jds.S0022-0302(96)76356-7; FRANCOS G, 1983, THERIOGENOLOGY, V19, P625, DOI 10.1016/0093-691X(83)90103-6; Garcia SC, 2001, LIVEST PROD SCI, V68, P189, DOI 10.1016/S0301-6226(00)00237-2; Gonzalez-Recio O, 2004, J DAIRY SCI, V87, P3053, DOI 10.3168/jds.S0022-0302(04)73438-4; Grimard B, 2006, ANIM REPROD SCI, V91, P31, DOI 10.1016/j.anireprosci.2005.03.003; GWAZDAUSKAS FC, 1973, J DAIRY SCI, V56, P873, DOI 10.3168/jds.S0022-0302(73)85270-1; Hansen PJ, 1999, J ANIM SCI, V77, P36; Harman JL, 1996, PREV VET MED, V26, P263, DOI 10.1016/0167-5877(95)00553-6; HOWELL JL, 1994, J DAIRY SCI, V77, P735, DOI 10.3168/jds.S0022-0302(94)77007-7; Inchaisri C, 2010, THERIOGENOLOGY, V74, P835, DOI 10.1016/j.theriogenology.2010.04.008; Kim IH, 2019, ASIAN AUSTRAL J ANIM, V32, P519, DOI 10.5713/ajas.18.0296; Kim KD, 2005, J REPROD DEVELOP, V51, P491, DOI 10.1262/jrd.17001; Loeffler SH, 1999, J DAIRY SCI, V82, P2589, DOI 10.3168/jds.S0022-0302(99)75514-1; Lombard JE, 2007, J DAIRY SCI, V90, P1751, DOI 10.3168/jds.2006-295; LOUCA A, 1968, J DAIRY SCI, V51, P573, DOI 10.3168/jds.S0022-0302(68)87031-6; Lumley T., 2021, PACKAGE SURVIVAL; Martin AD, 2015, J DAIRY SCI, V98, P8655, DOI 10.3168/jds.2015-9464; Overton MW, 2005, THERIOGENOLOGY, V64, P603, DOI 10.1016/j.theriogenology.2005.05.030; Package T.., 2021, PACK GGALLY; Portas V., 2004, RISK FACTORS LOW PRE; Pryce JE, 1997, ANIM SCI, V65, P353, DOI 10.1017/S1357729800008559; Punyapornwithaya V.., 2004, REPROD EFFICIENCY DA; R Core Team, 2019, R R PROJ STAT COMP; Radostitis O, 2001, TXB DIS CATTLE HORSE; ROMANPONCE H, 1977, J DAIRY SCI, V60, P424, DOI 10.3168/jds.S0022-0302(77)83882-4; ROSENBERG M, 1977, J REPROD FERTIL, V51, P363, DOI 10.1530/jrf.0.0510363; Santos JEP, 2009, ANIM REPROD SCI, V110, P207, DOI 10.1016/j.anireprosci.2008.01.014; Siddiqui MAR, 2013, REPROD DOMEST ANIM, V48, P500, DOI 10.1111/rda.12114; Suriyasathaporn W, 1998, PREV VET MED, V37, P159, DOI 10.1016/S0167-5877(98)00100-7; Thatcher WW, 2018, THERMAL STRESS EFFEC, V46; Thompson JA, 1996, THERIOGENOLOGY, V46, P547, DOI 10.1016/0093-691X(96)00176-8; Tillard E, 2008, THERIOGENOLOGY, V69, P443, DOI 10.1016/j.theriogenology.2007.10.014; Vargas B, 1998, J DAIRY SCI, V81, P2881, DOI 10.3168/jds.S0022-0302(98)75848-5; Yusuf M, 2011, J REPROD DEVELOP, V57, P643, DOI 10.1262/jrd.10-097T	45	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264029	10.1371/journal.pone.0264029	http://dx.doi.org/10.1371/journal.pone.0264029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176089	Green Published, gold			2022-12-26	WOS:000777505200064
J	Lopez, D; Roberts, J; Bourgeois, M; Kootstra, J; Minnick, S; Black, A; Mauss, J; Flores, N				Lopez, Denise; Roberts, Jill; Bourgeois, Marie; Kootstra, Joshua; Minnick, Sharon; Black, Allison; Mauss, Joshua; Flores, Nick			Infection clusters can elevate risk of diagnostic target failure for detection of SARS-CoV-2	PLOS ONE			English	Article							PCR; QUANTIFICATION	The C29197T mutation is one of 4 point mutations known to cause N-gene target failure (NGTF) in the Xpert Xpress SARS-CoV-2 and Xpert Omni SARS-CoV-2 assays from Cepheid (Sunnyvale, CA). We describe a high local prevalence in January of 8.5% (CI 4.914.2%) for the C29197T mutation, which was over 3-fold higher than the prevalence estimated statewide in California during the same time frame, 2.5% (CI 2.1-2.8%). Using phylogenetic analysis, we discovered that this increase in prevalence was due, at least in part, to a disproportionately large infection cluster of unknown origin. This study emphasizes the importance of sequencing at the local jurisdictional level and demonstrates the impact that regional variation can have when assessing risk due to point mutations that impact clinical test performance. It also reinforces the need for diligent reporting of abnormal test results by clinical laboratories, especially during Emergency Use Authorization (EUA) periods, as additional information is gathered about the target organism and the performance of EUA-authorized tests over time.	[Lopez, Denise; Roberts, Jill; Bourgeois, Marie] Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA; [Lopez, Denise; Kootstra, Joshua; Minnick, Sharon; Mauss, Joshua; Flores, Nick] Cty Tulare, Publ Hlth Branch, Tulare, CA 93274 USA; [Black, Allison] CZBiohub, San Francisco, CA USA	State University System of Florida; University of South Florida	Lopez, D (corresponding author), Univ S Florida, Coll Publ Hlth, Tampa, FL 33620 USA.; Lopez, D (corresponding author), Cty Tulare, Publ Hlth Branch, Tulare, CA 93274 USA.	DeLopez@tularecounty.ca.gov		Bourgeois, Marie/0000-0001-8610-1109; Roberts, Jill/0000-0001-6204-623X				Alvarez-Diaz DA, 2020, INFECT GENET EVOL, V84, DOI 10.1016/j.meegid.2020.104390; Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Bahreini Fatemeh, 2020, Int J MCH AIDS, V9, P408, DOI 10.21106/ijma.421; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; CDC, 2021, COVID DAT TRACK VAR; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; FDA, 2021, COR COVID 19 TEST DE; Fox-Lewis S, 2021, IDCASES, V25, DOI 10.1016/j.idcr.2021.e01233; Gand M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155585; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hasan MR, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03278-20; Khan KA, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200636; Liu Q, 1997, BIOTECHNIQUES, V22, P292, DOI 10.2144/97222st01; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Mwakibete L., 2021, ARTIC NEB SARS COV 2, DOI [10.3390/v13081475, DOI 10.3390/V13081475]; Navarathna DH, 2021, DIAGN MICR INFEC DIS, V100, DOI 10.1016/j.diagmicrobio.2021.115334; Oranger A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02748-0; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rhoads DD., 2021, J CLIN MICROBIOL; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Simsek M, 2000, J Sci Res Med Sci, V2, P11; Staheli JR, 2011, METHODS MOL BIOL, V687, P57, DOI 10.1007/978-1-60761-944-4_5; Tahan S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00075-21; Vanaerschot M, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02369-20; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Ziegler K, 2020, EUROSURVEILLANCE, V25, P5, DOI 10.2807/1560-7917.ES.2020.25.39.2001650	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0264008	10.1371/journal.pone.0264008	http://dx.doi.org/10.1371/journal.pone.0264008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171960	gold, Green Published			2022-12-26	WOS:000795889700056
J	Mateus, O; Estraviz-Lopez, D				Mateus, Octavio; Estraviz-Lopez, Dario			A new theropod dinosaur from the early cretaceous (Barremian) of Cabo Espichel, Portugal: Implications for spinosaurid evolution	PLOS ONE			English	Article							IBERIAN PENINSULA; TEETH; MEGALOSAUROIDEA; VERTEBRATES; MORPHOLOGY; BARYONYX; ARCILLAS; MORELLA; HABITS; SKULL	Spinosaurids are some of the most enigmatic Mesozoic theropod dinosaurs due to their unique adaptations to aquatic environments and their relative scarcity. Their taxonomy has proven to be especially problematic. Recent discoveries from Western Europe in general, specifically Iberia, provide some of the best specimens for the understanding of their phylogeny, leading to the description of the spinosaurid Vallibonavenatrix cani and the recognition of the Iberian dinosaur Camarillasaurus cirugedae as one of them. Portuguese associated spinosaurid remains (ML1190) from the Papo Seco Formation (early Barremian) were previously assigned to Baryonyx walkeri but new material recovered in 2020 along with new phylogenetic analyses suggests a different phylogenetic placement, making their revision necessary. Here we show that these remains are not attributable to Baryonyx walkeri, but to a new genus and species, Iberospinus natarioi, gen. et sp. nov. The new taxon is characterized by the presence of a single Meckelian foramen in the Meckelian sulcus, a straight profile of the ventral surface of the dentary and a distal thickening of the acromion process of the pubis between other characters. Iberospinus natarioi is recovered as a sister taxon of the clade formed by Baryonyx and Suchomimus, and outside Spinosaurinae when Vallibonaventrix cani is excluded from the analysis. The description of this taxon reinforces Iberia as a hotspot for spinosaur biodiversity, with several endemic taxa for the region. As expected for the clade, the dentary displays a highly vascularized neurovascular network. The morphometric analysis of parts of the skeleton (pedal phalanx and caudal vertebrae, among others) shows an intermediate condition between basal tetanurans and spinosaurines.	[Mateus, Octavio; Estraviz-Lopez, Dario] NOVA Sch Sci & Technol, Dept Earth Sci, GEOBIOTEC, Caparica, Portugal; [Mateus, Octavio; Estraviz-Lopez, Dario] Museu Lourinha, Lourinha, Portugal		Estraviz-Lopez, D (corresponding author), NOVA Sch Sci & Technol, Dept Earth Sci, GEOBIOTEC, Caparica, Portugal.; Estraviz-Lopez, D (corresponding author), Museu Lourinha, Lourinha, Portugal.	estravizlopez.dario@gmail.com	Mateus, Octávio/F-2910-2010	Mateus, Octávio/0000-0003-1253-3616; Estraviz Lopez, Dario/0000-0002-4532-2738	PDLParque dos dinossauros da Lourinha through the "BARY-PT" grant - Program "Bolsas Super Animais 3"; Fundacao para a Ciencia e Tecnologia [UIDB/04035/2020]; Pingo Doce supermarkets	PDLParque dos dinossauros da Lourinha through the "BARY-PT" grant - Program "Bolsas Super Animais 3"; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Pingo Doce supermarkets	This research was supported by PDLParque dos dinossauros da Lourinha (https://www.dinoparque.pt/pt/), through the "BARY-PT" grant financed by the Program "Bolsas Super Animais 3" in collaboration with Pingo Doce supermarkets. This research is also under the GeoBioTecGeoBioSciences, GeoTechnologies and GeoEngineering NOVA [GeoBioCiencias, GeoTecnologias e GeoEngenharias], grant UIDB/04035/2020 by the Fundacao para a Ciencia e Tecnologia (https://www.fct.pt/).Both O.M and D. E.L received funding from those sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aillud GS., 2001, PALAEOECOLOGY PALAEO; Allain R., 2014, J VERTEBRATE PALEONT, P78; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Alonso A, 2018, J IBER GEOL, V44, P7, DOI 10.1007/s41513-018-0051-9; Alonso A, 2016, HIST BIOL, V28, P823, DOI 10.1080/08912963.2015.1036751; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Rolando AA, 2022, HIST BIOL, V34, P226, DOI 10.1080/08912963.2021.1910816; Arden TMS, 2019, CRETACEOUS RES, V93, P275, DOI 10.1016/j.cretres.2018.06.013; Barker CT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97870-8; Barker CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03671-3; Bell PR, 2020, CURR BIOL, V30, pR1068, DOI 10.1016/j.cub.2020.08.066; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Bertin Tor, 2010, PalArch's Journal of Vertebrate Palaeontology, V7, P1; Brink KS, 2020, INTEGR COMP BIOL, V60, P581, DOI 10.1093/icb/icaa099; Brownstein CD, 2018, VERTEBRATE ANATOMY M, V6, P68; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; Buffetaut E, 2007, GEOL MAG, V144, P1021, DOI 10.1017/S0016756807003883; Buffetaut Eric, 2012, Oryctos, V10, P1; Canudo JI, 2008, AMEGHINIANA, V45, P649; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Cau Andrea, 2021, Atti della Societa dei Naturalisti e Matematici di Modena, V152, P81; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Choffat P., 1904, COMUNICA ES SERVI OS, VVI, P1; Cuesta E, 2019, CRETACEOUS RES, V95, P106, DOI 10.1016/j.cretres.2018.10.026; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; David W.E., 2021, Palaeontologia Electronica, V24, P1; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; de Franca TC., 2021, HIST BIOL, P1; Dinis JL, 2008, CRETACEOUS RES, V29, P772, DOI 10.1016/j.cretres.2008.05.027; Evers S, 2015, PEERJ, V3, DOI 10.7717/peerj.1323; Figueiredo S, 2015, J IBER GEOL, V41, P301, DOI 10.5209/rev_JIGE.2015.v41.n3.47828; Figueiredo S., 2018, REV GEIST RIA PR HIS, V2, P66; Figueiredo S.D., 2021, J GEOSCIENCE ENV PRO, V9, P84, DOI DOI 10.4236/GEP.2021.91007; Figueiredo SD., 2020, B CTR PORTUGUES GEO, V2, P59; Figueiredo SD., 2016, J ENV SCI ENG A, V5, P463, DOI DOI 10.17265/2162-5298/2016.09.004; Figueiredo SD., 2020, J ENV SCI ENG A, V9, P66, DOI [10.17265/2162-5298/2020.02.003, DOI 10.17265/2162-5298/2020.02.003]; Figueiredo S, 2017, B SOC PALEONTOL ITAL, V56, P217, DOI 10.4435/BSPI.2017.20; Fitzinger L., 1843, AMBLYGLOSSAE APUD BR; Foffa D, 2014, NATURWISSENSCHAFTEN, V101, P453, DOI 10.1007/s00114-014-1173-3; Galton Peter M., 1994, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V194, P253; Gasca JM, 2018, CRETACEOUS RES, V84, P141, DOI 10.1016/j.cretres.2017.11.011; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Heckeberg Nicola S., 2020, Palaeontologia Electronica, V23, P1; Hendrickx C, 2020, CAN J EARTH SCI, V57, P1127, DOI 10.1139/cjes-2019-0231; Hendrickx C, 2019, PALAEONTOL ELECTRON, V22, DOI 10.26879/820; Hendrickx C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144695; Hendrickx C, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.982797; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Hone DWE, 2021, PEERJ, V9, DOI 10.7717/peerj.10721; Hone DWE, 2017, ACTA GEOL SIN-ENGL, V91, P1120, DOI 10.1111/1755-6724.13328; Ibrahim N, 2020, NATURE, V581, P67, DOI 10.1038/s41586-020-2190-3; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Isasmendi E, 2020, CRETACEOUS RES, V116, DOI 10.1016/j.cretres.2020.104600; Kawabe S, 2022, HIST BIOL, V34, P1137, DOI 10.1080/08912963.2021.1965137; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P99, DOI 10.1590/S0001-37652011000100006; Lacerda MBS, 2022, HIST BIOL, V34, P2089, DOI 10.1080/08912963.2021.2000974; Lapparent AFde., 1957, MEMORIAS SERVICOS GE; Maganuco S, 2018, PEERJ, V6, DOI 10.7717/peerj.4785; Malafaia E, 2020, J IBER GEOL, V46, P431, DOI 10.1007/s41513-020-00138-9; Malafaia E., 2013, 6 JORNADAS INTERNACI, P82; Malafaia E, 2020, CRETACEOUS RES, V106, DOI 10.1016/j.cretres.2019.104221; Malafaia E, 2018, CRETACEOUS RES, V92, P174, DOI 10.1016/j.cretres.2018.08.006; Manuppella G., 1999, CARTA GEOLGICA PORTU; Marsh AD, 2020, J PALEONTOL, V94, P1, DOI 10.1017/jpa.2020.14; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mateus O, 2011, ZOOTAXA, P54, DOI 10.11646/zootaxa.2827.1.3; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Rauhut O. W., 2019, 17 ANN M EUR ASS VER, P96; Rauhut OWM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53672-7; Rauhut OWM, 2016, PALAEONTOL ELECTRON, V19; Rey J., 1972, MEMORIAS SERVICOS GE; Rey J., 2003, COMUNICA ES INSTITUT, V90, P15; Rey Jacques, 1992, Comunicacoes dos Servicos Geologicos de Portugal, V78, P103; Richter U, 2013, PALAEONTOL Z, V87, P291, DOI 10.1007/s12542-012-0153-1; Sales MAF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187070; Samathi A, 2021, HIST BIOL, V33, P3480, DOI 10.1080/08912963.2021.1874372; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Sanchez-Hernandez B, 2014, ACTA PALAEONTOL POL, V59, P581, DOI 10.4202/app.2011.0144; Sanguino F, 2020, J IBER GEOL, V46, P223, DOI 10.1007/s41513-020-00126-z; Sattler F, 2021, HIST BIOL, V33, P949, DOI 10.1080/08912963.2019.1675052; Sauvage HE, 1898, MMOIRES DIRECTION TR; Schade M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66261-w; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Serrano-Martinez A, 2016, ACTA PALAEONTOL POL, V61, P403, DOI 10.4202/app.00101.2014; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smyth RSH, 2020, CRETACEOUS RES, V114, DOI 10.1016/j.cretres.2020.104520; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Torres JA., 1995, MUNIBE CIENCIAS NATU, P57; Vidarte CF., 1999, COLECTIVO ARQUEOLOGI, P349; Waskow K, 2017, CR PALEVOL, V16, P425, DOI 10.1016/j.crpv.2017.01.003; White MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1512; Wu P, 2013, P NATL ACAD SCI USA, V110, pE2009, DOI 10.1073/pnas.1213202110	96	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0262614	10.1371/journal.pone.0262614	http://dx.doi.org/10.1371/journal.pone.0262614			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171930	Green Published, gold			2022-12-26	WOS:000795889700006
J	Ma, ZX; Holland, AA; Szlamkowicz, I; Anagnostopoulos, V; Nogueira, MLCD; Caranto, JDL; Davidson, V				Ma, Zhongxin; Holland, Ashley A.; Szlamkowicz, Ilana; Anagnostopoulos, Vasileios; Nogueira, Maria Luiza Caldas D.; Caranto, Jonathan D. L.; Davidson, Victor			The hemerythrin-like diiron protein from Mycobacterium kansasii is a nitric oxide peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; REDUCTIVE NITROSYLATION; CRYSTAL-STRUCTURE; REACTIVE OXYGEN; DIOXYGENASE; IRON; FLAVOHEMOGLOBIN; TUBERCULOSIS; MACROPHAGES; SUBSTRATE	The hemerythrin-like protein from Mycobacterium kansasii (Mka HLP) is a member of a distinct class of oxo-bridged diiron proteins that are found only in mycobacterial species that cause respiratory disorders in humans. Because it had been shown to exhibit weak catalase activity and a change in absorbance on exposure to nitric oxide (NO), the reactivity of Mka HLP toward NO was examined under a variety of conditions. Under anaerobic conditions, we found that NO was converted to nitrite (NO2-) via an intermediate, which absorbed light at 520 nm. Under aerobic conditions NO was converted to nitrate (NO3-). In each of these two cases, the maximum amount of nitrite or nitrate formed was at best stoichiometric with the concentration of Mka HLP. When incubated with NO and H2O2, we observed NO peroxidase activity yielding nitrite and water as reaction products. Steady-state kinetic analysis of NO consumption during this reaction yielded a K-m for NO of 0.44 mu M and a k(cat)/K-m of 2.3 x 10(5) M(-1)s(-1). This high affinity for NO is consistent with a physiological role for Mka HLP in deterring nitrosative stress. This is the first example of a peroxidase that uses an oxo-bridged diiron center and a rare example of a peroxidase utilizing NO as an electron donor and cosubstrate. This activity provides a mechanism by which the infectious Mycobacterium may combat against the cocktail of NO and superoxide (O-2(center dot-)) generated by macrophages to defend against bacteria, as well as to produce NO2- to adapt to hypoxic conditions.	[Ma, Zhongxin; Nogueira, Maria Luiza Caldas D.; Davidson, Victor] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA; [Holland, Ashley A.; Szlamkowicz, Ilana; Anagnostopoulos, Vasileios; Nogueira, Maria Luiza Caldas D.; Caranto, Jonathan D. L.] Univ Cent Florida, Dept Chem, Orlando, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Davidson, V (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA.; Caranto, JDL (corresponding author), Univ Cent Florida, Dept Chem, Orlando, FL USA.	jonathan.caranto@ucf.edu; victor.davidson@ucf.edu	NOGUEIRA, MARIA LUIZA CALDAS/ABD-4713-2020	NOGUEIRA, MARIA LUIZA CALDAS/0000-0003-2548-6564; Caranto, Jonathan/0000-0002-9196-5275; Szlamkowicz, Ilana/0000-0002-6308-0226	National Institute of General Medical Sciences of the National Institutes of Health [R35GM130173]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R35GM130173 (V. L. D.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Alvarez-Carreno C, 2018, PROTEIN SCI, V27, P848, DOI 10.1002/pro.3374; Alvarez-Carreno C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157904; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Cunningham-Bussel A, 2013, P NATL ACAD SCI USA, V110, pE4256, DOI 10.1073/pnas.1316894110; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; FORD PC, 1993, FEBS LETT, V326, P1, DOI 10.1016/0014-5793(93)81748-O; Ford PC, 2005, CHEM REV, V105, P2439, DOI 10.1021/cr0307289; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; Kao WC, 2008, J INORG BIOCHEM, V102, P1607, DOI 10.1016/j.jinorgbio.2008.02.008; Khan A, 2012, MICROBIOL-SGM, V158, P301, DOI 10.1099/mic.0.054759-0; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lehnert N, 2019, ACS CATAL, V9, P10499, DOI 10.1021/acscatal.9b03219; Lo FC, 2016, CHEM-EUR J, V22, P9768, DOI 10.1002/chem.201600990; Ma ZX, 2020, ACS OMEGA, V5, P23385, DOI 10.1021/acsomega.0c03338; Ma ZX, 2020, BIOCHEM J, V477, P567, DOI 10.1042/BCJ20190827; Ma ZX, 2018, J BIOL CHEM, V293, P1590, DOI 10.1074/jbc.RA117.000421; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nogueira MLC, 2021, ARCH BIOCHEM BIOPHYS, V705, DOI 10.1016/j.abb.2021.108917; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Romao CV, 2016, J BIOL INORG CHEM, V21, P39, DOI 10.1007/s00775-015-1329-4; Ruiz JC, 2014, J INORG BIOCHEM, V133, P73, DOI 10.1016/j.jinorgbio.2014.01.015; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Wang J, 2016, MOL MICROBIOL, V100, P877, DOI 10.1111/mmi.13356	37	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101696	10.1016/j.jbc.2022.101696	http://dx.doi.org/10.1016/j.jbc.2022.101696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35150744	gold, Green Published			2022-12-26	WOS:000789400700007
J	Shi, S; Ma, B; Sun, FD; Qu, C; Li, G; Shi, DH; Liu, WX; Zhang, HL; An, HL				Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; Li, Gen; Shi, Donghong; Liu, Wenxin; Zhang, Hailin; An, Hailong			Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE; ICI-204,219; ANTAGONIST; EXPRESSION; MODEL	Lung cancer has the highest mortality among cancers worldwide due to its high incidence and lack of the effective cures. We have previously demonstrated that the membrane ion channel TMEM16A is a potential drug target for the treatment of lung adenocarcinoma and have identified a pocket of inhibitor binding that provides the basis for screening covery strategies are lengthy and costly, and the unpredictable side effects lead to a high failure rate in drug development. Therefore, finding new therapeutic directions for already marketed drugs may be a feasible strategy to obtain safe and effective therapeutic drugs. Here, we screened a library of over 1400 Food and Drug Administration-approved drugs through virtual screening and activity testing. We identified a drug candidate, Zafirlukast (ZAF), clinically approved for the treatment of asthma, that could inhibit the TMEM16A channel in a lations and site-directed mutagenesis experiments showed that ZAF can bind to S387/N533/R535 in the nonselective inhibitor binding pocket, thereby blocking the channel pore. Furthermore, we demonstrate ZAF can target TMEM16A channel to inhibit the proliferation and migration of lung adenocarcinoma LA795 cells. In vivo experiments showed that ZAF can significantly inhibit lung adenocarcinoma tumor growth in mice. Taken together, we identified ZAF as a novel TMEM16A channel inhibitor with excellent anticancer activity, and as such, it represents a promising candidate for future preclinical and clinical studies.	[Shi, Sai; Ma, Biao; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; Li, Gen; Shi, Donghong; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys Hebei Prov, Tianjin, Peoples R China; [Liu, Wenxin] Tianjin Med Univ Canc Inst & Hosp, Dept Gynecol Oncol, Tianjin, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China	Hebei University of Technology; Hebei University of Technology; Hebei University of Technology; Tianjin Medical University; Hebei Medical University	An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys Hebei Prov, Tianjin, Peoples R China.	hailong_an@hebut.edu.cn			National Natural Science Foundation of China [81830061]; Natural Science Foundation of Tianjin of China [19JCYBJC28300]; Natural Science Foundation of Hebei Province of China [H2020202005]; Tianjin Municipal Education Commission of China [2019ZD033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin of China(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Tianjin Municipal Education Commission of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81830061 to H. A.) , the Natural Science Foundation of Tianjin of China (Grant No. 19JCYBJC28300 to H. A.) , the Natural Science Foundation of Hebei Province of China (Grant No. H2020202005 to H. A.) , and the Tianjin Municipal Education Commission of China (Grant No. 2019ZD033 to W. L.)	Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Case D. A., 2016, AMBER 2016; CP Wild, 2014, WORLD CANC REPORT 20; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Ferlay J, 2021, INT J CANCER, V149, P778, DOI 10.1002/ijc.33588; Figueroa EE, 2019, AM J PHYSIOL-CELL PH, V317, pC857, DOI 10.1152/ajpcell.00281.2019; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gobel T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00263; Guo S, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.643489; Guo S, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104721; Guo S, 2019, J CELL PHYSIOL, V234, P8698, DOI 10.1002/jcp.27529; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Holbrook LM, 2021, BRIT J PHARMACOL, V178, P550, DOI 10.1111/bph.15291; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jia LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136584; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; KRELL RD, 1990, AM REV RESPIR DIS, V141, P978, DOI 10.1164/ajrccm/141.4_Pt_1.978; Li PF, 2014, J CHEM THEORY COMPUT, V10, P289, DOI 10.1021/ct400751u; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Luginina A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2518; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Nguyen TM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00583; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.442; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi S, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101016; Shi S, 2020, ARCH BIOCHEM BIOPHYS, V695, DOI 10.1016/j.abb.2020.108650; Shi S, 2020, COMPUT STRUCT BIOTEC, V18, P714, DOI 10.1016/j.csbj.2020.03.015; Silverman RA, 2004, CHEST, V126, P1480, DOI 10.1378/chest.126.5.1480; Sleire L, 2017, PHARMACOL RES, V124, P74, DOI 10.1016/j.phrs.2017.07.013; SPECTOR SL, 1994, AM J RESP CRIT CARE, V150, P618, DOI 10.1164/ajrccm.150.3.8087328; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0720-x; Wang TY, 2021, BRIT J PHARMACOL, V178, P4137, DOI 10.1111/bph.15606; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang X, 2017, BRIT J PHARMACOL, V174, P2334, DOI 10.1111/bph.13841	49	3	3	9	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101731	10.1016/j.jbc.2022.101731	http://dx.doi.org/10.1016/j.jbc.2022.101731			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35176281	gold, Green Published			2022-12-26	WOS:000789398100009
J	Hughes, B; Bowman, J; Stock, NL; Burness, G				Hughes, Bryan; Bowman, Jeff; Stock, Naomi L.; Burness, Gary			Using mass spectrometry to investigate fluorescent compounds in squirrel fur	PLOS ONE			English	Article							ULTRAVIOLET FLUORESCENCE; VISIBLE-FLUORESCENCE; PIGMENTS; PHOTOLUMINESCENCE; PARROT; YIELDS; LIGHT	While an array of taxa are capable of producing fluorescent pigments, fluorescence in mammals is a novel and poorly understood phenomenon. A first step towards understanding the potential adaptive functions of fluorescence in mammals is to develop an understanding of fluorescent compounds, or fluorophores, that are present in fluorescent tissue. Here we use Fourier transform-ion cyclotron resonance mass spectrometry (FT-ICR MS) of flying squirrel fur known to fluoresce under ultraviolet (UV) light to identify potentially fluorescent compounds in squirrel fur. All of the potentially fluorescent compounds we identified were either present in non-fluorescent fur or were not present in all species of fluorescent flying squirrel. Therefore, we suggest that the compounds responsible for fluorescence in flying squirrels may also be present in non-fluorescent mammal fur. Some currently unexplained factor likely leads to excitation of fluorophores in flying squirrel fur. A recently suggested hypothesis that fluorescence in mammals is widely caused by porphyrins is consistent with our findings.	[Hughes, Bryan; Burness, Gary] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Bowman, Jeff] Trent Univ, Ontario Minist Northern Dev Mines Nat Resources &, DNA Bldg, Peterborough, ON, Canada; [Stock, Naomi L.] Trent Univ, Water Qual Ctr, Peterborough, ON, Canada; [Hughes, Bryan] Laurentian Univ, Dept Biol, Sudbury, ON, Canada	Trent University; Trent University; Trent University; Laurentian University	Hughes, B (corresponding author), Trent Univ, Dept Biol, Peterborough, ON, Canada.; Hughes, B (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.	Bhughes1@laurentian.ca			natural sciences and engineering research council discovery grant	natural sciences and engineering research council discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research is funded by the natural sciences and engineering research council discovery grant held by JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J MICROSC-OXFORD, V232, P197, DOI 10.1111/j.1365-2818.2008.02089.x; Anich PS, 2021, MAMMALIA, V85, P179, DOI 10.1515/mammalia-2020-0027; Anthes N, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00126; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; Barreira AS, 2012, J ZOOL, V288, P135, DOI 10.1111/j.1469-7998.2012.00931.x; Camacho C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55522-y; Cerovic ZG, 1999, AGRONOMIE, V19, P543, DOI 10.1051/agro:19990701; Croce A.C., 2021, PHOTOCHEM, V1, P67, DOI [10.3390/photochem1020007, DOI 10.3390/PHOTOCHEM1020007]; DAWSON WR, 1968, J PHYS CHEM-US, V72, P3251, DOI 10.1021/j100855a027; Du JL, 2016, J MATER CHEM C, V4, P2235, DOI 10.1039/c6tc00548a; Duchatelet L, 2019, ZOOL LETT, V5, DOI 10.1186/s40851-019-0126-2; Dunning J, 2018, BIRD STUDY, V65, P570, DOI 10.1080/00063657.2018.1563771; Eshelman E, 2018, PLANET SPACE SCI, V151, P1, DOI 10.1016/j.pss.2017.09.003; Fedorov VI, 2004, P SOC PHOTO-OPT INS, V5474, P80, DOI 10.1117/12.578355; Gruber DF, 2015, AM MUS NOVIT, P1; Guijas C, 2018, ANAL CHEM, V90, P3156, DOI 10.1021/acs.analchem.7b04424; Haddock SHD, 2015, BIOL OPEN, V4, P1094, DOI 10.1242/bio.012138; Hamchand R, 2021, J CHEM ECOL, V47, P588, DOI 10.1007/s10886-021-01279-6; Hausmann F, 2003, P ROY SOC B-BIOL SCI, V270, P61, DOI 10.1098/rspb.2002.2200; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; Jeng M.L., 2019, BIOLUMINESCENCE ANAL, P87, DOI [DOI 10.5772/INTECHOPEN.86029, 10.5772/intechopen.86029]; Kloock CT, 2010, J ARACHNOL, V38, P441, DOI 10.1636/B09-111.1; Kohler AM, 2019, J MAMMAL, V100, P21, DOI 10.1093/jmammal/gyy177; LATHAM RM, 1953, J MAMMAL, V34, P385, DOI 10.1093/jmammal/34.3.385a; LEVIN EY, 1973, J CLIN INVEST, V52, P96, DOI 10.1172/JCI107178; Li QQ, 2018, SMALL, V14, DOI 10.1002/smll.201801560; Marshall J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0335; McDonald B, 2020, J MAMMAL, V101, P1257, DOI 10.1093/jmammal/gyaa083; MEISNER DH, 1983, OHIO J SCI, V83, P4; NICHOLLS EM, 1971, INT J BIOCHEM, V2, P593, DOI 10.1016/0020-711X(71)90031-0; NIJEGORODOV NI, 1994, J PHYS CHEM-US, V98, P5639, DOI 10.1021/j100073a011; O'Brien PP, 2021, CAN J ZOOL, V99, P859, DOI 10.1139/cjz-2021-0086; Olson ER, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83588-0; Park HB, 2019, ISCIENCE, V19, P1277, DOI 10.1016/j.isci.2019.07.019; Pearlstein E, 2015, J AM INST CONSERV, V54, P149, DOI 10.1179/1945233015Y.0000000010; Pearn SM, 2001, P ROY SOC B-BIOL SCI, V268, P2273, DOI 10.1098/rspb.2001.1813; PINE RH, 1985, MAMMALIA, V49, P249, DOI 10.1515/mamm.1985.49.2.249; Protzel D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19070-7; Shimizu M, 2010, CHEM-ASIAN J, V5, P1516, DOI 10.1002/asia.200900727; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; SPIKES JD, 1992, PHOTOCHEM PHOTOBIOL, V55, P797, DOI 10.1111/j.1751-1097.1992.tb08527.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X; STRAKA JG, 1990, ANNU REV MED, V41, P457; Taboada C, 2017, P NATL ACAD SCI USA, V114, P3672, DOI 10.1073/pnas.1701053114; TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476; Tinbergen J, 2013, J EXP BIOL, V216, P4358, DOI 10.1242/jeb.091561; Toussaint S., 2021, RES SQUARE, DOI [10.21203/rs.3.rs-499384/v2, DOI 10.21203/RS.3.RS-499384/V2]; Uchiyama S, 1999, J CHEM SOC PERK T 2, P2525, DOI 10.1039/a904989d; Wankhede RA., 2004, EXTRACTION ISOLATION; Weidensaul CS, 2011, WILSON J ORNITHOL, V123, P373, DOI 10.1676/09-125.1; YOLTON RL, 1974, J MAMMAL, V55, P14, DOI 10.2307/1379253	52	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0257156	10.1371/journal.pone.0257156	http://dx.doi.org/10.1371/journal.pone.0257156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192622	gold, Green Submitted, Green Published			2022-12-26	WOS:000812552500003
J	Brim, A; Flann, NS				Brim, Andrew; Flann, Nicholas S.			Deep reinforcement learning stock market trading, utilizing a CNN with candlestick images	PLOS ONE			English	Article							COEFFICIENTS	Billions of dollars are traded automatically in the stock market every day, including algorithms that use neural networks, but there are still questions regarding how neural networks trade. The black box nature of a neural network gives pause to entrusting it with valuable trading funds. A more recent technique for the study of neural networks, feature map visualizations, yields insight into how a neural network generates an output. Utilizing a Convolutional Neural Network (CNN) with candlestick images as input and feature map visualizations gives a unique opportunity to determine what in the input images is causing the neural network to output a certain action. In this study, a CNN is utilized within a Double Deep Q-Network (DDQN) to outperform the S&P 500 Index returns, and also analyze how the system trades. The DDQN is trained and tested on the 30 largest stocks in the S&P 500. Following training the CNN is used to generate feature map visualizations to determine where the neural network is placing its attention on the candlestick images. Results show that the DDQN is able to yield higher returns than the S&P 500 Index between January 2, 2020 and June 30, 2020. Results also show that the CNN is able to switch its attention from all the candles in a candlestick image to the more recent candles in the image, based on an event such as the coronavirus stock market crash of 2020.	[Brim, Andrew; Flann, Nicholas S.] Utah State Univ, Dept Comp Sci, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Brim, A (corresponding author), Utah State Univ, Dept Comp Sci, Logan, UT 84322 USA.	andrew.brim@usu.edu		Brim, Andrew/0000-0003-0341-4797				Abadi M., 2015, TENSORFLOW LARGE SCA; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 1981, RANDOM WALK WALL STR; Brim Andrew, 2020, 2020 10 ANN COMPUTIN; BROCK W, 1992, J FINANC, V47, P1731, DOI 10.2307/2328994; Brockman Greg, 2016, arXiv; Bui VH, 2020, IEEE T SMART GRID, V11, P457, DOI 10.1109/TSG.2019.2924025; Carta S, 2021, EXPERT SYST APPL, V164, DOI 10.1016/j.eswa.2020.113820; Donahue J, 2014, PR MACH LEARN RES, V32; Dosovitskiy Alexey, 2016, P IEEE C COMPUTER VI; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Grn Felix, 2016, ARXIV PREPRINT ARXIV; Han XF, 2019, APPL ENERG, V254, DOI 10.1016/j.apenergy.2019.113708; Hirschberg J, 2001, APPL ECON LETT, V8, P701, DOI 10.1080/13504850110042187; Kim T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212320; Li K, 2019, IEEE T VEH TECHNOL, V68, P12215, DOI 10.1109/TVT.2019.2945037; Li YM, 2020, COMPUTING, V102, P1305, DOI 10.1007/s00607-019-00773-w; Marshall BR, 2006, J BANK FINANC, V30, P2303, DOI 10.1016/j.jbankfin.2005.08.001; Nguyen Anh, 2016, ADV NEURAL INFORM PR; Nguyen Anh., 2019, UNDERSTANDING NEURAL, P55; Okuyama Takafumi, 2018, 2018 INT C INTELLIGE; Olah C., 2017, DISTILL, V2, P7, DOI DOI 10.23915/DISTILL.00007; Sasaki Hikaru, 2017, 2017 56 ANN C SOC IN; Selvin S, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1643; Shi Y, 2021, APPL SOFT COMPUT, V107, DOI 10.1016/j.asoc.2021.107320; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Skouras S, 2001, J ECON DYN CONTROL, V25, P213, DOI 10.1016/S0165-1889(99)00074-3; Springenberg JT, 2014, ARXIV; Sutton R. S., 1998, INTRO REINFORCEMENT, V2; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tsai YHH, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P4344, DOI 10.18653/v1/p19-1656; VANHASSELT H, 2016, 30 AAAI C ARTIFICIAL; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yang CL, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20010168; Yu Wei, 2014, ARXIV PREPRINT ARXIV; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang QC, 2019, IEEE T SERV COMPUT, V12, P739, DOI 10.1109/TSC.2018.2867482; Zhang Yi, 2018, 2018 IEEE INTELLIGEN	40	0	0	20	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263181	10.1371/journal.pone.0263181	http://dx.doi.org/10.1371/journal.pone.0263181			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180250	Green Published, gold			2022-12-26	WOS:000796435800012
J	Cho, I; Kang, U				Cho, Ikhyun; Kang, U.			Pea-KD: Parameter-efficient and accurate Knowledge Distillation on BERT	PLOS ONE			English	Article								Knowledge Distillation (KD) is one of the widely known methods for model compression. In essence, KD trains a smaller student model based on a larger teacher model and tries to retain the teacher model's level of performance as much as possible. However, existing KD methods suffer from the following limitations. First, since the student model is smaller in absolute size, it inherently lacks model capacity. Second, the absence of an initial guide for the student model makes it difficult for the student to imitate the teacher model to its fullest. Conventional KD methods yield low performance due to these limitations. In this paper, we propose Pea-KD (Parameter-efficient and accurate Knowledge Distillation), a novel approach to KD. Pea-KD consists of two main parts: Shuffled Parameter Sharing (SPS) and Pretraining with Teacher's Predictions (PTP). Using this combination, we are capable of alleviating the KD's limitations. SPS is a new parameter sharing method that increases the student model capacity. PTP is a KD-specialized initialization method, which can act as a good initial guide for the student. When combined, this method yields a significant increase in student model's performance. Experiments conducted on BERT with different datasets and tasks show that the proposed approach improves the student model's performance by 4.4% on average in four GLUE tasks, outperforming existing KD baselines by significant margins.	[Cho, Ikhyun; Kang, U.] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea	Seoul National University (SNU)	Kang, U (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	ukang@snu.ac.kr			Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT) [2020-0-00894, 2021-0-0268]	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No.2020-0-00894, Flexible and Efficient Model Compression Method for Various Applications and Environments) and (NO.2021-0-0268, Artificial Intelligence Innovation Hub (Artificial Intelligence Institute, Seoul National University)). The Institute of Engineering Research and ICT at Seoul National University provided research facilities for this work.	Devlin J., 2018, ARXIV181004805; Dolan WB, 2005, P 3 INT WORKSHOP PAR; Gong Y., 2014, COMPRESSING DEEP CON; Han S, 2015, ADV NEUR IN, V28; Hinton G., 2015, DISTILLING KNOWLEDGE; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Jiao X. Q., 2020, PROC FINDINGS ASS CO, P4163; Kim J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256187; Liu Yinhan, 2019, ROBERTA ROBUSTLY OPT; Peters M., 2018, PROC NAACL, P2227, DOI DOI 10.18653/V1/N18-1202; Rajpurkar Pranav, 2016, ARXIV160605250, DOI DOI 10.18653/V1/D16-1264; Socher R, 2013, P 2013 C EMPIRICAL M; Sun SQ, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P4323; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Wang A., 2018, INT C LEARN REPR, DOI DOI 10.18653/V1/W18-5446; Xu C., ARXIV PREPRINT ARXIV; Yang ZW, 2021, ANIM BIOTECHNOL, V32, P67, DOI 10.1080/10495398.2019.1653901; Yoo J, 2019, ADV NEUR IN, V32	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263592	10.1371/journal.pone.0263592	http://dx.doi.org/10.1371/journal.pone.0263592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180258	Green Published, Green Submitted, gold			2022-12-26	WOS:000796435800021
J	Jaskulak, M; Rorat, A; Vandenbulcke, F; Pauwels, M; Grzmil, P; Plytycz, B				Jaskulak, Marta; Rorat, Agnieszka; Vandenbulcke, Franck; Pauwels, Maxime; Grzmil, Pawel; Plytycz, Barbara			Polymorphic microsatellite markers demonstrate hybridization and interspecific gene flow between lumbricid earthworm species, Eisenia andrei and E. fetida	PLOS ONE			English	Article							MITOCHONDRIAL; FOETIDA; URBAN; INCOMPATIBILITY; IDENTIFICATION; REPRODUCTION; POPULATIONS; SAVIGNY; NUCLEAR; GENOMES	The lumbricid earthworms Eisenia andrei (Ea) and E. fetida (Ef) have been used as model organisms for studies on hybridization. Previously they have been identified by species specific sequences of the mitochondrial COI gene of maternal origin ('a' or 'f') and the nuclear 28S gene of maternal/paternal origin ('A' or 'F'). In experimental crosses, these hermaphroditic species produce progeny of genotypes Ea (aAA), Ef (fFF) and hybrids (aAF and fFA) originating by self-fertilization or cross-fertilization. To facilitate studies on new aspects of the breeding biology and hybridization of earthworms, polymorphic microsatellite markers were developed based on 12 Ea and 12 Ef specimens and validated on DNA samples extracted from 24 genotyped specimens (aAA, fFF, aAF and fFA) from three laboratory-raised families and 10 of them were applied in the present study. The results indicate that microsatellite markers are valuable tools for tracking interspecific gene flow between these species.	[Jaskulak, Marta; Rorat, Agnieszka; Vandenbulcke, Franck; Pauwels, Maxime] Univ Lille, Univ Artois, Laboratoire Genie Civil & Geoenviron, IMT Lille Douai,ULR4515 LGCgE, Yncrea Hauts France, Lille, France; [Pauwels, Maxime] Univ Lille, CNRS, UMR 8198, Lab Evolut Ecol Paleontol,EEP, F-59000 Lille, France; [Jaskulak, Marta] Med Univ Gdansk, Fac Hlth Sci, Dept Immunobiol & Environm Microbiol, Inst Maritime & Trop Med, Gdansk, Poland; [Grzmil, Pawel] Jagiellonian Univ, Inst Zool & Biomed Res, Lab Genet & Evolutionism, Krakow, Poland; [Plytycz, Barbara] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland	IMT - Institut Mines-Telecom; IMT Nord Europe; Universite d'Artois; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille; Fahrenheit Universities; Medical University Gdansk; Jagiellonian University; Jagiellonian University	Plytycz, B (corresponding author), Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland.	Barbara.plytycz@uj.edu.pl	Jaskulak, Marta/Z-2922-2019	Jaskulak, Marta/0000-0001-7611-7617; Plytycz, Barbara/0000-0002-3869-500X	National Centre of Science (Poland) [2016/23/B/NZ8/00748]; Jagiellonian University (Poland) [K/ZDS/005405]	National Centre of Science (Poland)(National Science Centre, Poland); Jagiellonian University (Poland)	National Centre of Science (Poland) (2016/23/B/NZ8/00748) to BP Jagiellonian University (Poland) (K/ZDS/005405) to BP] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani JR, 2003, PHOTOCHEM PHOTOBIOL, V78, P599, DOI 10.1562/0031-8655(2003)078<0599:FFOEFA>2.0.CO;2; Anderson C, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0557-8; Audusseau H, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2020.137259; Blackmon H., 2012, ELS, DOI [10.1002/9780470015902.a0001751.pub3, DOI 10.1002/9780470015902.A0001751.PUB3]; Cunha L, 2017, APPL SOIL ECOL, V119, P152, DOI 10.1016/j.apsoil.2017.05.029; Ding WL, 2021, SCI TOTAL ENVIRON, V781, DOI 10.1016/j.scitotenv.2021.146884; Dominguez J, 2003, PEDOBIOLOGIA, V47, P530, DOI 10.1078/0031-4056-00224; Dupont L, 2016, MOL ECOL RESOUR, V16, P883, DOI 10.1111/1755-0998.12517; Dupont L, 2011, PEDOBIOLOGIA, V54, P217, DOI 10.1016/j.pedobi.2011.03.004; Dupont L, 2019, APPL SOIL ECOL, V135, P33, DOI 10.1016/j.apsoil.2018.11.004; Harper GL, 2006, MOL ECOL NOTES, V6, P325, DOI 10.1111/j.1471-8286.2005.01219.x; Hill GE, 2019, OX ECOL EV, P1, DOI 10.1093/oso/9780198818250.001.0001; Jaskulak M., DATA GENOME ID UNPUB; Jaskulak M, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111425; Klein A, 2017, APPL SOIL ECOL, V120, P265, DOI 10.1016/j.apsoil.2017.08.009; Kruk J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214757; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu HY, 2020, MOL BIOL REP, V47, P8265, DOI 10.1007/s11033-020-05799-4; Lounsberry ZT, 2013, PEDOBIOLOGIA, V56, P191, DOI 10.1016/j.pedobi.2013.07.002; Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Martinsson S, 2018, EUR J SOIL BIOL, V88, P41, DOI 10.1016/j.ejsobi.2018.06.003; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Mustonen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174960; Novo M, 2013, PEDOBIOLOGIA, V56, P97, DOI 10.1016/j.pedobi.2013.01.002; OIEN N, 1984, COMP BIOCHEM PHYS C, V78, P277, DOI 10.1016/0742-8413(84)90083-5; Payseur BA, 2016, MOL ECOL, V25, P2337, DOI 10.1111/mec.13557; Pennisi E, 2016, SCIENCE, V354, P817, DOI 10.1126/science.354.6314.817; Plytycz B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235789; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204469; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191711; Podolak A, 2020, FOLIA BIOL-KRAKOW, V68, P1, DOI 10.3409/fb_68-1.01; Rorat A, 2014, J EXP ZOOL PART A, V321, P28, DOI 10.1002/jez.1834; Roubalova R., 2018, ADV COMP IMMUNOLOGY, P933, DOI [10.1007/978-3-319-76768-0_27, DOI 10.1007/978-3-319-76768-0_27]; Rozen S, 2000, Methods Mol Biol, V132, P365; Runemark A, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008404; Rybak AV, 2020, SCI TOTAL ENVIRON, V723, DOI 10.1016/j.scitotenv.2020.137920; Somers CM, 2011, PEDOBIOLOGIA, V54, P111, DOI 10.1016/j.pedobi.2010.11.002; Souleman D, 2016, EUR J SOIL BIOL, V74, P76, DOI 10.1016/j.ejsobi.2016.03.009; Strunk H, 2012, EUR J SOIL BIOL, V48, P56, DOI 10.1016/j.ejsobi.2011.11.004; Torres-Leguizamon M, 2012, SOIL BIOL BIOCHEM, V51, P16, DOI 10.1016/j.soilbio.2012.03.020; Torres-Leguizamon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101597; Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951	43	0	0	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0262493	10.1371/journal.pone.0262493	http://dx.doi.org/10.1371/journal.pone.0262493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180227	Green Published, gold			2022-12-26	WOS:000796435800005
J	Wang, KW; Iizuka, Y; Jackson, C				Wang, Kuan-Wen; Iizuka, Yoshiyuki; Jackson, Caroline			The production technology of mineral soda alumina glass: A perspective from microstructural analysis of glass beads in Iron Age Taiwan	PLOS ONE			English	Article							EXCHANGE; BEADMAKING; POLITIES; INDIA; OXIDE; BCE; CE	Mineral soda alumina (m-Na-Al) glass is a common glass production group found around the Indo-Pacific region. In Iron Age Taiwan, its presence dates back to the early 1st millennium AD. This research discusses m-Na-Al glass beads excavated from Iron Age sites in Taiwan. No production sites for m-Na-Al have been found, but microstructural analysis suggests m-Na-Al glass appears to originate around South Asia and is exchanged widely. SEM-EDS and EPMA were used to analyse red, orange, yellow, green and blue m-Na-Al glass. The microstructure of the glass shows the presence of plagioclase and alkali feldspar relics in the glass, suggesting a low manufacturing temperature. Copper-based colourants are identified in red, orange, blue and green glass, while lead tin oxide is used in yellow and green glass. It appears that various types of copper-containing raw materials were procured by craftspeople, and a self-reduction process for producing red and orange glass is tentatively proposed. Additionally, the microstructure of yellow glass reveals different colouring paths were used. These results increase our understanding of the selection of raw materials, and provide an impetus for further research on the cross craft interaction between glass and copper production.	[Wang, Kuan-Wen] Acad Sinica, Inst Hist & Philol, Taipei, Taiwan; [Iizuka, Yoshiyuki] Acad Sinica, Inst Earth Sci, Taipei, Taiwan; [Jackson, Caroline] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England	Academia Sinica - Taiwan; Academia Sinica - Taiwan; University of Sheffield	Wang, KW (corresponding author), Acad Sinica, Inst Hist & Philol, Taipei, Taiwan.	kmnwang@mail.ihp.sinica.edu.tw		Wang, Kuan-Wen/0000-0003-4115-1174; Jackson, Caroline/0000-0002-7379-7466				Abraham SA, 2016, ARCHAEOL RES ASIA, V6, P4, DOI 10.1016/j.ara.2016.02.003; AHMED AA, 1981, GLASS TECHNOL, V22, P24; [Anonymous], 1987, CHEM ANAL SOME EARLY, P1; Barber D.J., 2009, MINE MICROSCOPE ADV, P115; Bellina B, 2019, J ANTHROPOL ARCHAEOL, V54, P102, DOI 10.1016/j.jaa.2019.02.005; BENNETT A, 1989, WORLD ARCHAEOL, V20, P329, DOI 10.1080/00438243.1989.9980077; Bhardwaj H. C., 1979, ASPECTS ANCIENT INDI; Bring T, 2007, GLASS TECHNOL-PART A, V48, P101; Cadet M, 2021, J ARCHAEOL SCI-REP, V37, DOI 10.1016/j.jasrep.2021.102932; Capatina C, 2005, CERAM-SILIKATY, V49, P283; Carter AK, 2016, ARCHAEOL RES ASIA, V6, P16, DOI 10.1016/j.ara.2016.02.004; Carter AK, 2015, CAMB ARCHAEOL J, V25, P733, DOI 10.1017/S0959774315000207; Corning Museum of Glass, 2012, GLASSM HER; Dumanska-Slowik M, 2015, SPECTROCHIM ACTA A, V150, P837, DOI 10.1016/j.saa.2015.06.039; DURAN A, 1984, J MATER SCI, V19, P1468, DOI 10.1007/BF00563041; Dussubieux L., 2001, APPORT ABLATION LASE; Dussubieux L., 2010, 50 YEARS ARCHAEOLOGY, P246; Dussubieux L, 2018, ARCHAEOL RES ASIA, V13, P25, DOI 10.1016/j.ara.2017.08.001; Dussubieux L, 2010, J ARCHAEOL SCI, V37, P1646, DOI 10.1016/j.jas.2010.01.025; FRANCIS P, 1991, WORLD ARCHAEOL, V23, P28, DOI 10.1080/00438243.1991.9980157; Francis P., 1990, ASIAN PERSPECT, V29, P1; Fredrickx P, 2004, X-RAY SPECTROM, V33, P326, DOI 10.1002/xrs.734; Freestone I.C., 2003, GLASS BRIGHTLY STUDI, P142; Freestone I.C., 1987, EARLY VITREOUS MAT, P173; Hamilton EG, 2018, BAN CHIANG NE THAILA, V2A; Hauptmann A., 2003, MAN MINING MENSCH BE, P197; Heck M, 2003, ARCHAEOMETRY, V45, P33, DOI 10.1111/1475-4754.00095; Hung HC, 2016, ANTIQUITY, V90, P1537, DOI 10.15184/aqy.2016.184; ISHIDA S, 1987, J NON-CRYST SOLIDS, V95-6, P793, DOI 10.1016/S0022-3093(87)80683-X; Kanungo AK, 2010, ARCHAEOMETRY, V52, P899, DOI 10.1111/j.1475-4754.2009.00497.x; Kanungo AK., 2016, MAPPING INDOPACIFIC; Kuhn H, 1968, STUDIES CONSERVATION, V13, P7, DOI [10.2307/1505386, DOI 10.2307/1505386]; Levin E. M., 1964, PHASE DIAGRAMS CERAM; Peake JRN, 2012, PROC SPIE, V8422, DOI 10.1117/12.973765; Peltenburg E., 1987, EARLY VITREOUS MAT, P5; Rehren T, 1998, CERAM CIVIL, P227; SAHA P, 1961, AM MINERAL, V46, P859; Sode T, 2001, J GLASS STUD, V43, P155; Tite M, 2008, ARCHAEOMETRY, V50, P67, DOI 10.1111/j.1475-4754.2007.00339.x; Waida DN, 1926, GEOLOGY INDIA STUDEN; Wang K.-W., 2018, J SOC BEAD RES, V30, P16; Wang K-W, 2022, MARITIME EXCHANGE LO; Wang KW, 2021, J ARCHAEOL SCI-REP, V35, DOI 10.1016/j.jasrep.2020.102737; Wang KW, 2019, ARCHAEOL ANTHROP SCI, V11, P1391, DOI 10.1007/s12520-017-0593-3; Zellmer GF, 2021, NEW ZEAL J GEOL GEOP, V64, P443, DOI 10.1080/00288306.2020.1848883	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263986	10.1371/journal.pone.0263986	http://dx.doi.org/10.1371/journal.pone.0263986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167606	Green Published, Green Accepted, gold			2022-12-26	WOS:000802227200028
J	Janowski, AB; Polgreen, PM; Beekmann, SE; Newland, JG				Janowski, Andrew B.; Polgreen, Philip M.; Beekmann, Susan E.; Newland, Jason G.			Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey	PLOS ONE			English	Article							COVID-19	Background The perception of the transmission risks of SARS-CoV-2 in social and educational settings by US healthcare providers have not been previously quantified. Methods Respondents completed an online survey between September and October 2020 to estimate the risk of SARS-CoV-2 transmission on a scale of 0-10 for different social and educational activities prior to the availability of the SARS-CoV-2 vaccines. Demographic information and experiences during the pandemic were also collected. The risk assessment was emailed to three listservs of healthcare providers, including national listservs of pediatric (PID) and adult infectious diseases (AID) providers, and a listserv of general pediatric practitioners in the St Louis, USA metropolitan area. Results Respondents identified the highest risk of SARS-CoV-2 transmission in spending time in a bar, eating at a restaurant, and attending an indoor sporting event. In the school setting, lower risk was identified in elementary and daycare students compared to high school or university-level students. Comparatively, the risk of transmission to students and teachers was lower than the identified high-risk social activities. Factors increasing risk perception in social activities included the absence of children in the respondent's household and female gender. For the school setting, AID providers perceived greater risk compared to PID providers or pediatric practitioners. Conclusions Respondents identified high risk activities that were associated with a high density of participants in an indoor space where masks are removed for eating and drinking. Differences were apparent in the school setting where pediatric providers perceived lower risks when compared to adult providers.	[Janowski, Andrew B.; Newland, Jason G.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Polgreen, Philip M.; Beekmann, Susan E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	Washington University (WUSTL); University of Iowa	Janowski, AB (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	abjanowski@wustl.edu		Polgreen, Philip/0000-0002-0630-5898	National Institute of Allergy and Infectious Disease [K08 AI132745]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002345, 1 U50 CK00477]; Centers for Disease Control and Prevention	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the following: ABJ receives support from National Institute of Allergy and Infectious Disease [K08 AI132745] http://www.niaid.nih.gov/and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number [UL1 TR002345] http://ncats.nih.gov/.This work was supported by Cooperative Agreement Number 1 U50 CK00477, funded by the Centers for Disease Control and Prevention. Disclaimer http://www.cdc.gov/.The findings and conclusions presented in this manuscript are those of the authors and do not necessarily represent the views of the US Centers for Disease Control and Prevention or the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071; Allhands J, 2020, LIKELY ARE YOU GET C; American Academy of Pediatrics., 2020, COVID 19 PLANN CONS; Aubrey A, 2020, NATL PUBLIC RADIO; Barrett ES, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05587-2; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Centers for Disease Control, 2020, DAIL ACT GOING OUT; Centers for Disease Control., 2020, SCH CHILDC PROGR; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; de Zwart O, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-114; Deressa W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0242471; Ding YN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237626; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Emanuel EJ, 2020, COVID 19 ACTIVITY RI; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P1258, DOI 10.15585/mmwr.mm6936a5; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; He S, 2021, J COMMUN HEALTH, V46, P278, DOI 10.1007/s10900-020-00870-4; Hotle Susan, 2020, Transp Res Interdiscip Perspect, V5, P100127, DOI 10.1016/j.trip.2020.100127; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Malik AA., MEDRXIV 202020200820; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008; Olmos D, 2020, CHARTS RANK COVID 19; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Pillai SK, 2014, CLIN INFECT DIS, V58, P991, DOI 10.1093/cid/cit932; Shah ASV, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3582; Society. ISM, 2020, ISMS COVID 19 RISK S; Sridhar S., 2016, New Microbes and New Infections, V12, P61, DOI 10.1016/j.nmni.2016.04.010; Texas Medical Association., 2020, BE INF KNOW YOUR RIS; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; WHO, 2020, WHO COR COVID 19 DAS; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263767	10.1371/journal.pone.0263767	http://dx.doi.org/10.1371/journal.pone.0263767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148344	gold, Green Published			2022-12-26	WOS:000800108800027
J	Manzano-Lopez, J; Rodriguez-Gallardo, S; Sabido-Bozo, S; Cortes-Gomez, A; Perez-Linero, AM; Lucena, R; Cordones-Romero, A; Lopez, S; Aguilera-Romero, A; Muniz, M				Manzano-Lopez, Javier; Rodriguez-Gallardo, Sofia; Sabido-Bozo, Susana; Cortes-Gomez, Alejandro; Perez-Linero, Ana Maria; Lucena, Rafael; Cordones-Romero, Antonio; Lopez, Sergio; Aguilera-Romero, Auxiliadora; Muniz, Manuel			Crosslinking assay to study a specific cargo-coat interaction through a transmembrane receptor in the secretory pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; ANCHORED PROTEINS; P24 COMPLEX; YEAST; CAPTURE; FAMILY	Intracellular trafficking through the secretory organelles depends on transient interactions between cargo proteins and transport machinery. Cytosolic coat protein complexes capture specific luminal cargo proteins for incorporation into transport vesicles by interacting with them indirectly through a transmembrane adaptor or cargo receptor. Due to their transient nature, it is difficult to study these specific ternary protein interactions just using conventional native co-immunoprecipitation. To overcome this technical challenge, we have applied a crosslinking assay to stabilize the transient and/or weak protein interactions. Here, we describe a protocol of protein crosslinking and co-immunoprecipitation, which was employed to prove the indirect interaction in the endoplasmic reticulum of a luminal secretory protein with a selective subunit of the cytosolic COPII coat through a specific transmembrane cargo receptor. This method can be extended to address other transient ternary interactions between cytosolic proteins and luminal or extracellular proteins through a transmembrane receptor within the endomembrane system.	[Manzano-Lopez, Javier; Aguilera-Romero, Auxiliadora; Muniz, Manuel] Univ Seville, Dept Cell Biol, Seville, Spain; Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen Rocio, CSIC, Seville, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Manzano-Lopez, J; Aguilera-Romero, A; Muniz, M (corresponding author), Univ Seville, Dept Cell Biol, Seville, Spain.	jmanzano@us.es; Auxi@us.es; mmuniz@us.es	muñiz, manuel/Q-2890-2019	muñiz, manuel/0000-0001-8011-6991; Manzano-Lopez, Javier/0000-0002-7149-1690; Rodriguez-Gallardo, Sofia/0000-0002-5189-5671	Proyecto [PID2020-119505GBI00, MCIN/AEI/10.13039/501100011033]	Proyecto	MM, Proyecto PID2020-119505GBI00 financiado por MCIN/AEI/10.13039/501100011033 https://www.ciencia.gob.es/portal/site/MICINN/aei The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Lopez S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051295; Manzano-Lopez J, 2015, CURR BIOL, V25, P152, DOI 10.1016/j.cub.2014.11.039; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Muniz M, 2016, J LIPID RES, V57, P352, DOI 10.1194/jlr.R062760; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Rodriguez-Gallardo S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8237; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263617	10.1371/journal.pone.0263617	http://dx.doi.org/10.1371/journal.pone.0263617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143573	gold, Green Published			2022-12-26	WOS:000797657800064
J	Khan, AM; Mobli, A; Werth, JA; Chauhan, BS				Khan, Asad M.; Mobli, Ahmadreza; Werth, Jeff A.; Chauhan, Bhagirath S.			Germination and seed persistence of Amaranthus retroflexus and Amaranthus viridis: Two emerging weeds in Australian cotton and other summer crops	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; MANAGEMENT; DORMANCY; PALMERI; TEMPERATURE; ECOLOGY; GROWTH; FLORA; L.	Redroot pigweed (Amaranthus retroflexus L.) and slender amaranth (Amaranthus viridis L.) are becoming problematic weeds in summer crops, including cotton in Australia. A series of laboratory and field experiments were performed to examine the germination ecology, and seed persistence of two populations of A. retroflexus and A. viridis collected from the Goondiwindi and Gatton regions of Australia. Both populations of A. retroflexus and A. viridis behaved similarly to different environmental conditions. Initial dormancy was observed in fresh seeds of both species; however, germination reached maximum after an after-ripening period of two months at room temperature. Light was not a mandatory prerequisite for germination of both species as they could germinate under complete darkness. Although both species showed very low germination at the alternating day/night temperature of 15/5 C, these species germinated more than 40% between ranges of 25/15 C to 35/25 C. Maximum germination of A. retroflexus (93%) and A. viridis (86%) was observed at 35/25 C and 30/20, respectively. Germination of A. retroflexus and A. viridis was completely inhibited at osmotic potentials of -1.0 and -0.6 MPa, respectively. No germination was observed in both species at the sodium chloride concentration of 200 mM. A. retroflexus seedling emergence (87%) was maximum from the seeds buried at 1 cm while the maximum germination of A. viridis (72%) was observed at the soil surface. No seedling emergence was observed from a burial depth of 8 cm for both species. In both species, seed persistence increased with increasing burial depth. At 24 months after seed placement, seed depletion ranged from 75% (10 cm depth) to 94% (soil surface) for A. retroflexus, and ranged from 79% to 94% for A. viridis, respectively. Information gained from this study will contribute to an integrated control programs for A. retroflexus and A. viridis.	[Khan, Asad M.; Mobli, Ahmadreza; Chauhan, Bhagirath S.] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia; [Mobli, Ahmadreza] Ferdowsi Univ Mashhad, Fac Agr, Dept Agrotechnol, Mashhad, Razavi Khorasan, Iran; [Werth, Jeff A.] Queensland Dept Agr & Fisheries, Leslie Res Ctr, Toowoomba, Qld, Australia; [Chauhan, Bhagirath S.] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Qld, Australia; [Chauhan, Bhagirath S.] Chaudhary Charan Singh Haryana Agr Univ CCSHAU, Hisar, Haryana, India	University of Queensland; Ferdowsi University Mashhad; Queensland Department of Agriculture & Fisheries; University of Queensland; CCS Haryana Agricultural University	Mobli, A (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Qld, Australia.; Mobli, A (corresponding author), Ferdowsi Univ Mashhad, Fac Agr, Dept Agrotechnol, Mashhad, Razavi Khorasan, Iran.	mo.ahmadreza@gmail.com		Mobli, Ahmadreza/0000-0002-9332-1879	Cotton Research and Development Corporation (CRDC) [UQ1703]	Cotton Research and Development Corporation (CRDC)(Cotton R&D Corp)	This work was supported by a grant from Cotton Research and Development Corporation (CRDC) under Project UQ1703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguyoh JN, 2003, WEED SCI, V51, P202, DOI 10.1614/0043-1745(2003)051[0202:IORPAR]2.0.CO;2; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Borza JK, 2007, WEED TECHNOL, V21, P518, DOI 10.1614/WT-06-110; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P379, DOI 10.1614/WS-08-179.1; Costea M, 2004, CAN J PLANT SCI, V84, P631, DOI 10.4141/P02-183; Cristaudo A, 2007, WEED RES, V47, P327, DOI 10.1111/j.1365-3180.2007.00574.x; Ghorbani R, 1999, WEED SCI, V47, P505, DOI 10.1017/S0043174500092183; Guo PG, 2003, WEED SCI, V51, P869, DOI 10.1614/P2002-127; Hao JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170297; Heap I., 2022, INT SURVEY HERBICIDE; Holm L., 1997, WORLD WEEDS NATURAL; Holm LG, 1979, GEOGRAPHICAL ATLAW; Jha P., 2014, American Journal of Plant Sciences, V5, P1599, DOI 10.4236/ajps.2014.511173; Jha P, 2010, WEED SCI, V58, P426, DOI 10.1614/WS-D-09-00038.1; Karimmojeni H, 2014, PLANT SPEC BIOL, V29, pE1, DOI 10.1111/1442-1984.12022; Korres NE, 2018, WEED SCI, V66, P446, DOI 10.1017/wsc.2018.27; Long RL, 2015, BIOL REV, V90, P31, DOI 10.1111/brv.12095; Lutman PJW, 2002, WEED RES, V42, P231, DOI 10.1046/j.0043-1737.2002.00281.x; Manalil S, 2017, CROP PASTURE SCI, V68, P773, DOI 10.1071/CP17116; MCLACHLAN SM, 1995, J APPL ECOL, V32, P157, DOI 10.2307/2404425; Menon S., 2020, INT J PHARM MED BIOL, V9, P70, DOI [10.18178/ijpmbs.9.2.70-74, DOI 10.18178/IJPMBS.9.2.70-74]; MICHEL BE, 1995, AGRON J, V87, P126, DOI 10.2134/agronj1995.00021962008700010022x; Mobli A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229817; Mobli A, 2019, WEED SCI, V67, P642, DOI 10.1017/wsc.2019.47; Orzari I., 2018, African Journal of Agricultural Research, V13, P2460, DOI 10.5897/ajar2018.13332; Osten VA, 2007, AUST J EXP AGR, V47, P57, DOI 10.1071/EA05141; de Carvalho SJP, 2008, SCI AGR, V65, P239, DOI 10.1590/S0103-90162008000300003; POLJAKOFFMAYBER A, 1994, AM J BOT, V81, P54, DOI 10.2307/2445562; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rengasamy P, 2002, AUST J EXP AGR, V42, P351, DOI 10.1071/EA01111; Rezaie F, 2009, J FOOD AGRIC ENVIRON, V7, P516; Steckel LE, 2007, WEED SCI, V55, P235, DOI 10.1614/WS-06-198; Taylor IN, 2004, WEED RES, V44, P254, DOI 10.1111/j.1365-3180.2004.00397.x; Thomas WE, 2006, WEED SCI, V54, P316; Walker SR, 2005, AUST J EXP AGR, V45, P79, DOI 10.1071/EA03189	37	1	1	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263798	10.1371/journal.pone.0263798	http://dx.doi.org/10.1371/journal.pone.0263798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139125	gold, Green Accepted, Green Published			2022-12-26	WOS:000821499100055
J	Alferiev, IS; Guerrero, DT; Guan, P; Nguyen, F; Kolla, V; Soberman, D; Pressly, BB; Fishbein, I; Brodeur, GM; Chorny, M				Alferiev, Ivan S.; Guerrero, David T.; Guan, Peng; Nguyen, Ferro; Kolla, Venkatadri; Soberman, Danielle; Pressly, Benjamin B.; Fishbein, Ilia; Brodeur, Garrett M.; Chorny, Michael			Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance	FASEB JOURNAL			English	Article						ABCG2; drug resistance; neuroblastoma; SN22; topoisomerase I inhibitor	MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CELL-LINES; POLY(ETHYLENE GLYCOL); CAMPTOTHECIN ANALOGS; P53 MUTATIONS; CANCER	High-risk solid tumors continue to pose a tremendous therapeutic challenge due to multidrug resistance. Biological mechanisms driving chemoresistance in high-risk primary and recurrent disease are distinct: in newly diagnosed patients, non-response to therapy is often associated with a higher level of tumor "stemness" paralleled by overexpression of the ABCG2 drug efflux pump, whereas in tumors relapsing after non-curative therapy, poor drug sensitivity is most commonly linked to the dysfunction of the tumor suppressor protein, p53. In this study, we used preclinical models of aggressive neuroblastoma featuring these characteristic mechanisms of primary and acquired drug resistance to experimentally evaluate a macromolecular prodrug of a structurally enhanced camptothecin analog, SN22, resisting ABCG2-mediated export, and glucuronidation. Together with extended tumor exposure to therapeutically effective drug levels via reversible conjugation to Pluronic F-108 (PF108), these features translated into rapid tumor regression and long-term survival in models of both ABCG2-overexpressing and p53-mutant high-risk neuroblastomas, in contrast to a marginal effect of the clinically used camptothecin derivative, irinotecan. Our results demonstrate that pharmacophore enhancement, increased tumor uptake, and optimally stable carrier-drug association integrated into the design of the hydrolytically activatable PF108-[SN22](2) have the potential to effectively combat multiple mechanisms governing chemoresistance in newly diagnosed (chemo-naive) and recurrent forms of aggressive malignancies. As a macromolecular carrier-based delivery system exhibiting remarkable efficacy against two particularly challenging forms of high-risk neuroblastoma, PF108-[SN22](2) can pave the way to a robust and clinically viable therapeutic strategy urgently needed for patients with multidrug-resistant disease presently lacking effective treatment options.	[Alferiev, Ivan S.; Guerrero, David T.; Guan, Peng; Nguyen, Ferro; Kolla, Venkatadri; Soberman, Danielle; Pressly, Benjamin B.; Fishbein, Ilia; Brodeur, Garrett M.; Chorny, Michael] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Abramson Res Bldg,Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chorny, M (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Abramson Res Bldg,Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	chorny@chop.edu	Guan, Peng/GWM-9170-2022	Chorny, Michael/0000-0002-8243-9089	HHS \ NIH \ National Cancer Institute (NCI) [R01-CA251883]; Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD) [W81XWH2110536]	HHS \ NIH \ National Cancer Institute (NCI); Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD)(United States Department of Defense)	HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: R01-CA251883; Solving Kids' Cancer (SKC); Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF); CURE Childhood Cancer (CURE); Peel Therapeutics; Audrey E. Evans Endowed Chair; U.S. Department of Defense (DOD), Grant/Award Number: W81XWH2110536	Alakhova DY, 2014, MOL PHARMACEUT, V11, P2566, DOI 10.1021/mp500298q; Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615; Bates SE, 2004, J PHARMACOL EXP THER, V310, P836, DOI 10.1124/jpet.103.063149; BIEDLER JL, 1976, J NATL CANCER I, V57, P683, DOI 10.1093/jnci/57.3.683; Brangi M, 1999, CANCER RES, V59, P5938; Byrne FL, 2016, METHODS MOL BIOL, V1372, P61, DOI 10.1007/978-1-4939-3148-4_5; Chen L, 2018, INT J ONCOL, V52, P967, DOI 10.3892/ijo.2018.4261; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Cialfi S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.9524; Davis SS, 2002, DRUG DISCOV TODAY, V7, P1159, DOI 10.1016/S1359-6446(02)02517-5; Ekladious I, 2019, NAT REV DRUG DISCOV, V18, P273, DOI 10.1038/s41573-018-0005-0; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Gandhi YA, 2009, AAPS J, V11, P541, DOI 10.1208/s12248-009-9132-1; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Ivens IA, 2015, TOXICOL PATHOL, V43, P959, DOI 10.1177/0192623315591171; Keshelava N, 2001, CANCER RES, V61, P6185; Keshelava N, 1998, CANCER RES, V58, P5396; Keshelava N, 2000, CANCER CHEMOTH PHARM, V45, P1, DOI 10.1007/PL00006736; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; KUNIMOTO T, 1987, CANCER RES, V47, P5944; Kuosmanen T, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009418; Laetsch TW, 2021, CANCER DISCOV, V11, P545, DOI 10.1158/2159-8290.CD-20-0779; Lele BS, 1998, J APPL POLYM SCI, V70, P883, DOI 10.1002/(SICI)1097-4628(19981031)70:5<883::AID-APP7>3.0.CO;2-P; London WB, 2017, CANCER-AM CANCER SOC, V123, P4914, DOI 10.1002/cncr.30934; Maskarinec SA, 2003, LANGMUIR, V19, P1809, DOI 10.1021/la026175z; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013; Nakagawa H, 2006, CANCER LETT, V234, P81, DOI 10.1016/j.canlet.2005.05.052; Nema Sandeep, 2011, PDA J Pharm Sci Technol, V65, P287, DOI 10.5731/pdajpst.2011.00634; Nguyen F, 2020, CANCER RES, V80, P4258, DOI 10.1158/0008-5472.CAN-20-1344; Pastorino F, 2010, CLIN CANCER RES, V16, P4809, DOI 10.1158/1078-0432.CCR-10-1354; Patterson Danielle M, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1417s52; Pitto-Barry A, 2014, POLYM CHEM-UK, V5, P3291, DOI 10.1039/c4py00039k; Polunin Y, 2021, ACS PHARMACOL TRANSL, V4, P240, DOI 10.1021/acsptsci.0c00182; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rebucci M, 2013, BIOCHEM PHARMACOL, V85, P1219, DOI 10.1016/j.bcp.2013.02.017; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Sawada S., 1995, CURR PHARM DESIGN, V1, P113; Schellens JHM, 2000, ANN NY ACAD SCI, V922, P188; Serrano LA, 2018, CHEM COMMUN, V54, P1485, DOI 10.1039/c7cc07668a; Shah N., 2019, CANC DRUG RESIST, V2, P428; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; Singla P, 2022, ADV COLLOID INTERFAC, V299, DOI 10.1016/j.cis.2021.102563; Smith V, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5090114; Strickley RG, 2004, PHARM RES-DORDR, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23; Swift CC, 2018, RADIOGRAPHICS, V38, P566, DOI 10.1148/rg.2018170132; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Thomas A, 2019, CLIN CANCER RES, V25, P6581, DOI 10.1158/1078-0432.CCR-19-1089; Toyoda Y, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00208; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Tweddle DA, 2001, CANCER RES, V61, P8; Westover D, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0275-x; Wong M, 2020, NAT MED, V26, P1742, DOI 10.1038/s41591-020-1072-4; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Yamauchi T, 2011, ONCOL REP, V25, P347, DOI 10.3892/or.2010.1100; Yoshikawa M, 2004, INT J CANCER, V110, P921, DOI 10.1002/ijc.20216; Zage PE, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5110148; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s	59	0	0	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22213	10.1096/fj.202101830RR	http://dx.doi.org/10.1096/fj.202101830RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35192728	hybrid, Green Published			2022-12-26	WOS:000761250800037
J	Moughaizel, M; Dagher, E; Jablaoui, A; Thorin, C; Rhimi, M; Desfontis, JC; Mallem, Y				Moughaizel, Michelle; Dagher, Elie; Jablaoui, Amin; Thorin, Chantal; Rhimi, Moez; Desfontis, Jean-Claude; Mallem, Yassine			Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits	PLOS ONE			English	Article							METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; CARDIAC DYSFUNCTION; HEPATIC STEATOSIS; GLUCOSE-TOLERANCE; INDUCED OBESITY; WESTERN DIET; CONTRIBUTES; PATHOPHYSIOLOGY; CONSEQUENCES	The metabolic syndrome (MetS) has become a global public health burden due to its link to cardiovascular disease and diabetes mellitus. The present study was designed to characterize the metabolic and cardiovascular disturbances, as well as changes in gut microbiota associated with high-fructose high-fat diet (HFFD)-induced MetS in Watanabe heritable hyperlipidemic (WHHL) rabbits. Twenty-one Watanabe rabbits were assigned to a control (n = 9) and HFFD (n = 12) groups, receiving a chow diet and a HFFD, respectively. During a 12-weeks protocol, morphological parameters were monitored; plasma fasting levels of lipids, glucose and insulin were measured and a glucose tolerance test (GTT) was performed. HOMA-IR was calculated. Cardiac function and vascular reactivity were evaluated using the Langendorff isolated heart and isolated carotid arteries methods, respectively. 16S rRNA sequencing of stool samples was used to determine gut microbial composition and abundance. HFFD-fed Watanabe rabbits exhibited increased fasting insulin (p < 0.03, 12th week vs. Baseline), HOMA-IR (p < 0.03 vs. Control), area under the curve of the GTT (p < 0.02 vs. Control), triglycerides (p < 0.05, 12th week vs. Baseline), TC (p < 0.01 vs. Control), LDL-C (p < 0.001 vs. Control). The HFFD group also displayed a significant decrease in intestinal microbial richness, evenness and diversity (FDR < 0.001, FDR < 0.0001, FDR < 0.01, respectively vs. Control group) and an increase in its Firmicutes/Bacteroidetes ratio (R = 3.39 in control vs. R = 28.24 in the HFFD group) indicating a shift in intestinal microbial composition and diversity. Our results suggest that HFFD induces insulin resistance and gut microbiota dysbiosis and accentuates dyslipidemia; and that, when subjected to HFFD, Watanabe rabbits might become a potential diet-induced MetS animal models with two main features, dyslipidemia and insulin resistance.	[Moughaizel, Michelle; Thorin, Chantal; Desfontis, Jean-Claude; Mallem, Yassine] Nantes Atlant Coll Vet Med Food Sci & Engn, Oniris, Nutr PathoPhysiol & Pharmacol NP3 Unit, Nantes, France; [Dagher, Elie] Nantes Atlant Coll Vet Med Food Sci & Engn, Oniris, Laboniris, Nantes, France; [Jablaoui, Amin; Rhimi, Moez] Univ Paris Saclay, Inst Micalis, INRAE, AgroParisTech, Jouy En Josas, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Moughaizel, M; Mallem, Y (corresponding author), Nantes Atlant Coll Vet Med Food Sci & Engn, Oniris, Nutr PathoPhysiol & Pharmacol NP3 Unit, Nantes, France.	m_moughaizel@hotmail.com; yassine.mallem@oniris-nantes.fr		Moughaizel, Michelle/0000-0001-8394-272X				Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Baena M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26149; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bhatta A, 2017, CARDIOVASC RES, V113, P1664, DOI 10.1093/cvr/cvx164; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Carroll JF, 2002, INT J OBESITY, V26, P627, DOI 10.1038/sj.ijo.0801957; Chavez-Carbajal A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020438; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Ciubotaru I, 2015, TRANSL RES, V166, P401, DOI 10.1016/j.trsl.2015.06.015; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Di Pino A, 2019, ENDOCR REV, V40, P1447, DOI 10.1210/er.2018-00141; Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761; Drake I, 2018, BRIT J NUTR, V119, P1168, DOI 10.1017/S000711451800079X; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Egshatyan L, 2016, ENDOCR CONNECT, V5, P1, DOI 10.1530/EC-15-0094; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Ferreira Abel, 2015, 2015 17th European Conference on Power Electronics and Applications (EPE'15 ECCE-Europe), P1, DOI 10.1109/EPE.2015.7309386; Festi D, 2014, WORLD J GASTROENTERO, V20, P16079, DOI 10.3748/wjg.v20.i43.16079; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gildner TE, 2020, EVOL MED PUBLIC HLTH, P45, DOI 10.1093/emph/eoaa007; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hecker M, 2011, FASEB J, V25, DOI [10.1096/FASEBJ.25.1_SUPPLEMENT.116.11, DOI 10.1096/FASEBJ.25.1_SUPPLEMENT.116.11]; Helfenstein T, 2011, INT J EXP PATHOL, V92, P40, DOI 10.1111/j.1365-2613.2010.00753.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horne RG, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113557; Ibrahim M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0526-2; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kim JA, 2015, AM J PHYSIOL-ENDOC M, V309, pE767, DOI 10.1152/ajpendo.00369.2015; Kobayashi T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/406473; Kopp W, 2019, DIABET METAB SYND OB, V12, P2221, DOI 10.2147/DMSO.S216791; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lambert E, 2013, AM J HYPERTENS, V26, P250, DOI 10.1093/ajh/hps016; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li TT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103075; Lima-Leopoldo AP, 2014, J APPL PHYSIOL, V117, P669, DOI 10.1152/japplphysiol.00088.2014; Lima-Leopoldo AP, 2011, ARQ BRAS CARDIOL, V97, P232, DOI 10.1590/S0066-782X2011005000061; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Lopes-Vicente WRP, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0286-1; Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S; Lustig RH, 2015, PEDIATR ADOLESC MED, V19, P137, DOI 10.1159/000368125; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mazidi M, 2016, DIABETES METAB SYND, V10, pS150, DOI 10.1016/j.dsx.2016.01.024; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Namekawa J, 2017, J VET MED SCI, V79, P988, DOI 10.1292/jvms.17-0136; Ning B, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0024-3; Nunes PM, 2021, NATURE, V597, P180, DOI 10.1038/d41586-021-02195-1; Ottosson F, 2018, J CLIN ENDOCR METAB, V103, P1491, DOI 10.1210/jc.2017-02114; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Razani B, 2008, ENDOCRIN METAB CLIN, V37, P603, DOI 10.1016/j.ecl.2008.05.001; Roberts CK, 2005, J APPL PHYSIOL, V98, P203, DOI 10.1152/japplphysiol.00463.2004; Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Smith CJ, 2011, HYPERTENSION, V58, P935, DOI 10.1161/HYPERTENSIONAHA.111.178129; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stanhope KL, 2008, CURR OPIN LIPIDOL, V19, P16, DOI 10.1097/MOL.0b013e3282f2b24a; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Taylor SR, 2021, NATURE, V597, P263, DOI [10.1038/s41586-021-03827-2, https://doi.org/10.1038/d41586-021-02195-1]; Thorin C, 2010, J PHARM PHARMACOL, V62, P339, DOI 10.1211/jpp.62.03.0008; Thorp AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/341583; Tissier F, 2016, ATHEROSCLEROSIS, V251, P70, DOI 10.1016/j.atherosclerosis.2016.05.039; Toklu HZ, 2016, J PHYSIOL PHARMACOL, V67, P205; Trajkovska KT, 2017, ANATOL J CARDIOL, V18, P149, DOI 10.14744/AnatolJCardiol.2017.7608; Tran V, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00148; Tranchida F, 2012, J ZHEJIANG UNIV-SC B, V13, P307, DOI 10.1631/jzus.B1100090; Tune JD, 2017, TRANSL RES, V183, P57, DOI 10.1016/j.trsl.2017.01.001; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tysoe O, 2021, NAT REV ENDOCRINOL, V17, P639, DOI 10.1038/s41574-021-00561-7; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; Van Hul M, 2020, GUT MICROBES, V12, P1, DOI 10.1080/19490976.2020.1849998; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang PX, 2020, CHINESE MED J-PEKING, V133, P808, DOI 10.1097/CM9.0000000000000696; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Z, 2016, CURR OPIN LIPIDOL, V27, P216, DOI 10.1097/MOL.0000000000000308; Waqar AB, 2010, ATHEROSCLEROSIS, V213, P148, DOI 10.1016/j.atherosclerosis.2010.07.051; Welsh JA, 2010, JAMA-J AM MED ASSOC, V303, P1490, DOI 10.1001/jama.2010.449; Zeng Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49462-w; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhao T, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.647529; Zouiouich S, 2021, DIABETOLOGIA, V64, P1749, DOI 10.1007/s00125-021-05464-w	104	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264215	10.1371/journal.pone.0264215	http://dx.doi.org/10.1371/journal.pone.0264215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196347	gold, Green Published			2022-12-26	WOS:000835161600028
J	Abuhammad, S; Hatamleh, R; Alrawashdeh, M; Alrabadi, N; Mukattash, T; Abuhammad, M; Howard, K				Abuhammad, Sawsan; Hatamleh, Reem; Alrawashdeh, Mohammad; Alrabadi, Nasr; Mukattash, Tareq; Abuhammad, Mai; Howard, Kimberly			Personal attributes and attitudes to substance use disorder: A study among Jordanian undergraduate medical majors students	PLOS ONE			English	Article							HEALTH-CARE; ILLICIT DRUG; ADDICTION; STIGMA; NURSES; VIEWS	Background Emerging health professionals in undergraduate programs should be equipped to provide care to people with substance use disorder (SUD). The students' personal attributes may impact their attitude toward those with SUD. This study aims to evaluate the impact of personal attributes of Jordanian undergraduate health students on their attitudes toward SUD and examine the relationship between the personal attributes and their devaluation and discriminatory (stigmatory) behaviour toward those with SUD. Method A cross-sectional descriptive design was used to examine the attitudes and stigmatory behaviours. The data were collected between May to October 2017 with a structured questionnaire that consisted of three parts: 1) a data sheet to collect the socio-demographic characteristics of the participants, 2) the Acute Mental Health Scale (ATAMHS), and 3) the Devaluation-Discrimination Scale (DDS). Findings Younger and females demonstrated a positive attitude toward those with SUD compared to older or male students. Age, gender, and previous experience with SUD are significant factors that affect their attitude. Conclusion Identifying the attitude to people with SUD and personal attributes of emerging health professionals in Jordan will help identify the need to educate them prior to their entry into practice.	[Abuhammad, Sawsan; Hatamleh, Reem; Alrawashdeh, Mohammad] Jordan Univ Sci & Technol, Fac Nursing, Maternal & Child Hlth Dept, Irbid, Jordan; [Alrabadi, Nasr] Jordan Univ Sci & Technol, Fac Med, Dept Pharm, Irbid, Jordan; [Mukattash, Tareq] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan; [Abuhammad, Mai] Jordan Univ Sci & Technol, Hlth Ctr, Dept Emergency, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Abuhammad, S (corresponding author), Jordan Univ Sci & Technol, Fac Nursing, Maternal & Child Hlth Dept, Irbid, Jordan.	shabuhammad@just.edu.jo		AbuHammad, Ma'mon/0000-0003-1099-3600	Jordan University of Science and Technology	Jordan University of Science and Technology	Jordan University of Science and Technology, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhammad S, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07214; Abuhammad S, 2019, J PSYCHOSOC NURS MEN, V57, P43, DOI 10.3928/02793695-20180907-01; Ahmad M, 2016, CONCEPTUAL MODELS NU; Ahmad Muayyad M, 2018, Asian Pac J Cancer Prev, V19, P479; Al-Natour A, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06565; Baker JA, 2005, J ADV NURS, V49, P522, DOI 10.1111/j.1365-2648.2004.03325.x; Barry CL, 2014, PSYCHIAT SERV, V65, P1269, DOI 10.1176/appi.ps.201400140; Bogdanowicz KM, 2015, DRUG ALCOHOL DEPEN, V148, P85, DOI 10.1016/j.drugalcdep.2014.12.025; Boyle MJ, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-71; Chang YP, 2013, PERSPECT PSYCHIATR C, V49, P94, DOI 10.1111/ppc.12000; Chu Charlene, 2013, Can Nurse, V109, P29; Drug Policy Alliance, 2016, BRIEF HIST DRUG WAR; Gilchrist G, 2011, ADDICTION, V106, P1114, DOI 10.1111/j.1360-0443.2011.03407.x; LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; Monks R, 2013, J ADV NURS, V69, P935, DOI 10.1111/j.1365-2648.2012.06088.x; Munro S, 2007, J PSYCHIATR MENT HLT, V14, P196, DOI 10.1111/j.1365-2850.2007.01063.x; Tierney M, 2020, ARCH PSYCHIAT NURS, V34, P297, DOI 10.1016/j.apnu.2020.07.010; van Boekel LC, 2013, DRUG ALCOHOL DEPEN, V131, P23, DOI 10.1016/j.drugalcdep.2013.02.018	19	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263442	10.1371/journal.pone.0263442	http://dx.doi.org/10.1371/journal.pone.0263442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192667	Green Published, gold			2022-12-26	WOS:000812552500023
J	Hartmann, K; Seweryn, M; Sadee, W				Hartmann, Katherine; Seweryn, Michal; Sadee, Wolfgang			Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance	PLOS ONE			English	Article							WIDE ASSOCIATION; VARIANTS; EXPRESSION; COLOCALIZATION; HERITABILITY; COMMON; LOCI	Genome-wide association studies (GWAS) have implicated 58 loci in coronary artery disease (CAD). However, the biological basis for these associations, the relevant genes, and causative variants often remain uncertain. Since the vast majority of GWAS loci reside outside coding regions, most exert regulatory functions. Here we explore the complexity of each of these loci, using tissue specific RNA sequencing data from GTEx to identify genes that exhibit altered expression patterns in the context of GWAS-significant loci, expanding the list of candidate genes from the 75 currently annotated by GWAS to 245, with almost half of these transcripts being non-coding. Tissue specific allelic expression imbalance data, also from GTEx, allows us to uncover GWAS variants that mark functional variation in a locus, e.g., rs7528419 residing in the SORT1 locus, in liver specifically, and rs72689147 in the GUYC1A1 locus, across a variety of tissues. We consider the GWAS variant rs1412444 in the LIPA locus in more detail as an example, probing tissue and transcript specific effects of genetic variation in the region. By evaluating linkage disequilibrium (LD) between tissue specific eQTLs, we reveal evidence for multiple functional variants within loci. We identify 3 variants (rs1412444, rs1051338, rs2250781) that when considered together, each improve the ability to account for LIPA gene expression, suggesting multiple interacting factors. These results refine the assignment of 58 GWAS loci to likely causative variants in a handful of cases and for the remainder help to re-prioritize associated genes and RNA isoforms, suggesting that ncRNAs maybe a relevant transcript in almost half of CAD GWAS results. Our findings support a multi-factorial system where a single variant can influence multiple genes and each genes is regulated by multiple variants.	[Hartmann, Katherine; Sadee, Wolfgang] Ohio State Univ, Coll Med, Ctr Pharmacogen, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Seweryn, Michal] Univ Lodz, Dept Mol Biophys, Biobank Lab, Lodz, Poland; [Hartmann, Katherine] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University of Lodz; University of Pennsylvania	Hartmann, K (corresponding author), Ohio State Univ, Coll Med, Ctr Pharmacogen, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Hartmann, K (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	katherine.hartmann@pennmedicine.upenn.edu			National Institutes of Health National Institute of General Medical Science Pharmacogenetics Research Network [U01 GM092655]; National Center for Advancing Translational Sciences [TL1 TR001069]	National Institutes of Health National Institute of General Medical Science Pharmacogenetics Research Network; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Institutes of Health National Institute of General Medical Science Pharmacogenetics Research Network [Grant U01 GM092655 awarded to WS] https://www.nigms.nih.gov/and the National Center for Advancing Translational Sciences [TL1 TR001069 awarded to KH] https://ncats.nih.gov/.	[Anonymous], 2011, NAT GENET, V43; Barrie ES, 2017, HUM MUTAT, V38, P112, DOI 10.1002/humu.23135; Crouch DJM, 2020, P NATL ACAD SCI USA, V117, P18924, DOI 10.1073/pnas.2005634117; Drivas TG, 2021, BIODATA MIN, V14, DOI 10.1186/s13040-021-00267-6; Evangelou E, 2018, NAT GENET, V50, P1412, DOI 10.1038/s41588-018-0205-x; Giambartolomei C, 2018, BIOINFORMATICS, V34, P2538, DOI 10.1093/bioinformatics/bty147; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Hartmann K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3075-6; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Inouye M, 2018, J AM COLL CARDIOL, V72, P1883, DOI 10.1016/j.jacc.2018.07.079; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Jones PD, 2019, AGING-US, V11, P1611, DOI 10.18632/aging.101891; Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01099; Liu MH, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116459; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Lu R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1749-0; Mascarenhas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136798; Mongelli A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00369; Musunuru K, 2019, CELL, V177, P132, DOI 10.1016/j.cell.2019.02.015; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Ni GY, 2018, AM J HUM GENET, V102, P1185, DOI 10.1016/j.ajhg.2018.03.021; Nie SF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01775; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nurnberg ST, 2016, CIRC RES, V118, P586, DOI 10.1161/CIRCRESAHA.115.306464; Pericleous M, 2017, LANCET GASTROENTEROL, V2, P670, DOI 10.1016/S2468-1253(17)30052-3; Rio S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008241; Roberts Robert, 2014, Methodist Debakey Cardiovasc J, V10, P7; Sadee W, 2014, HUM GENET, V133, P1199, DOI 10.1007/s00439-014-1476-7; Skwark MJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006508; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Wang DX, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002082; Won HH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005622; Yu H, 2020, EXP MOL PATHOL, V116, DOI 10.1016/j.yexmp.2020.104493	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0244904	10.1371/journal.pone.0244904	http://dx.doi.org/10.1371/journal.pone.0244904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192625	Green Submitted, gold, Green Published			2022-12-26	WOS:000812552500001
J	Ahmad, T; Khan, FU; Ali, S; Rahman, AU; Khan, SA				Ahmad, Tawseef; Khan, Faiz Ullah; Ali, Sayyad; Rahman, Asad Ur; Khan, Shujaat Ali			Assessment of without prescription antibiotic dispensing at community pharmacies in Hazara Division, Pakistan: A simulated client's study	PLOS ONE			English	Article							SELF-MEDICATION; ANTIMICROBIAL RESISTANCE; ACUTE DIARRHEA; KNOWLEDGE; DETERMINANTS; PERCEPTIONS; EUROPE; SALES; CHINA	Antibiotics dispensing without a prescription is an irrational practice and can increase the risk of antibiotic resistance, which is a significant public health concern around the globe. This study was aimed to determine the extent to which antibiotics are supplied without prescription in the community pharmacies (CPs) at Hazara Division from November 2020 to February 2021. The simulated client method (SCM) was used, and the data were gathered, recorded, and analyzed through different statistical methods with descriptive and inferential techniques. The antibiotic dispensing was observed in CPs (90.5%), the most dispensed antibiotics were azithromycin (29.4%) and ciprofloxacin (46.5%) respectively. Furthermore, visited medical stores/ drug outlets, 9.5% of the visited stores denied dispensing of antibiotics because they preferred a referral to visit physicians (23. 9%) and (12.8%) did not had the antibiotics at the time of visits. Antibiotics were more obtainable in retail medical stores (AOR = 8.6, 95 percent Cl: 3.0-24.7; p = 0.001) than in pharmacies. In rural areas antibiotics dispensing was more (p = 0.004) as compared to urban areas. Staff members also had asked about patient's (17.7%) symptoms and drug allergies (12.3% and 3.9%), and (1.5%) they consoled them about their medications. The findings of this study indicate that nonprescription antibiotic sales are very common, despite national rules prohibiting this activity. When the simulated Client requested for any medication to relieve his or her discomfort, many antibiotics were given out without a prescription. Pharmacies/medical stores in Hazara Division selling antibiotics without a prescription are worrying and need immediate action by regulators.	[Ahmad, Tawseef; Ali, Sayyad; Rahman, Asad Ur; Khan, Shujaat Ali] COMSATS Univ Islamabad, Dept Pharm, Abbottabad Campus, Abbottabad, Pakistan; [Khan, Faiz Ullah] Xi An Jiao Tong Univ, Sch Pharm, Dept Pharm Adm & Clin Pharm, Xian, Peoples R China	COMSATS University Islamabad (CUI); Xi'an Jiaotong University	Khan, SA (corresponding author), COMSATS Univ Islamabad, Dept Pharm, Abbottabad Campus, Abbottabad, Pakistan.	drshujatalikhan@cuiatd.edu.pk	Khan, Faiz Ullah/N-9346-2017	Khan, Faiz Ullah/0000-0002-1022-8688; Rahman, Asad ur/0000-0001-6862-0554				Akinyandenu O, 2014, J SCI INNOV RES, V3, P251; Akkerman AE, 2005, J ANTIMICROB CHEMOTH, V56, P930, DOI 10.1093/jac/dki283; Alhomoud F, 2017, INT J INFECT DIS, V57, P3, DOI 10.1016/j.ijid.2017.01.014; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; Ayukekbong JA, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0208-x; Azkarate I, 2012, MED INTENSIVA, V36, P250, DOI 10.1016/j.medin.2011.10.006; Bahta M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228013; Chang J, 2017, J ANTIMICROB CHEMOTH, V72, P1235, DOI 10.1093/jac/dkw519; Damisie G, 2019, J PHARMACEUTICS, V2019, DOI 10.1155/2019/3510659; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Ekambi GAE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212875; Farah R, 2015, J INFECT PUBLIC HEAL, V8, P37, DOI 10.1016/j.jiph.2014.07.003; Gaash B, 2008, INDIAN J PRACTISING, V5, P2008; Gillani AH, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101152; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Haddadin RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216115; Holloway KA, 2017, BMJ-BRIT MED J, V358, P9, DOI 10.1136/bmj.j2291; Horumpende PG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207465; Hoxha I, 2015, INT J RES DEV PHARM, V4, P1545; Hussain A, 2019, EUR J CLIN MICROBIOL, V38, P2145, DOI 10.1007/s10096-019-03658-0; Kalungia A, 2019, LANCET INFECT DIS, V19, P1272, DOI 10.1016/S1473-3099(19)30408-6; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Karras DJ, 2003, ANN EMERG MED, V42, P835, DOI 10.1016/S0196-0644(03)00602-4; Khan FU, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031320; Khan FU, 2021, EURASIAN BUS REV, V11, P497, DOI 10.1007/s40821-020-00154-w; Khan SA, 2010, MANUAL DRUG LAWS CON; Kot B, 2019, POL J MICROBIOL, V68, P403, DOI 10.33073/pjm-2019-048; Laxminarayan R, 2016, SCIENCE, V353, P874, DOI 10.1126/science.aaf9286; Liu B, 2018, J HETEROCYCLIC CHEM, V55, P1863, DOI 10.1002/jhet.3241; Llor C, 2009, CLIN INFECT DIS, V48, P1345, DOI 10.1086/598183; Malik UR, 2021, INFECT DRUG RESIST, V14, P1129, DOI 10.2147/IDR.S301812; Markovic-Pekovic V, 2017, J RES PHARM PRACT, V6, P120, DOI 10.4103/jrpp.JRPP_17_12; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Ocan M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2109-3; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Rasheed H, 2019, ENCY PHARM PRACTICE, P317; Rezal RSM, 2015, EXPERT REV ANTI-INFE, V13, P665, DOI 10.1586/14787210.2015.1025057; Ronning M, 2003, EUR J CLIN PHARMACOL, V58, P843, DOI 10.1007/s00228-003-0572-8; Sakeena MHF, 2018, INT J ANTIMICROB AG, V52, P771, DOI 10.1016/j.ijantimicag.2018.09.022; Saleem Z, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00233-3; Saleem Z, 2018, LANCET INFECT DIS, V18, P1066, DOI 10.1016/S1473-3099(18)30516-4; Saleem Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149929; Sarwar MR, 2018, INFECT DRUG RESIST, V11, P133, DOI 10.2147/IDR.S148102; Servia-Dopazo M, 2018, J ANTIMICROB CHEMOTH, V73, P3244, DOI 10.1093/jac/dky319; Torres NF, 2019, PUBLIC HEALTH, V168, P92, DOI 10.1016/j.puhe.2018.11.018; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Ventola C Lee, 2015, P T, V40, P277; WHO, 2009, MED USE DEV TRANS CO; WHO, 2015, WORLD HLTH ASS ANT R; World Health Organization, 2002, WHO POL PERSP MED PR; Ye D, 2017, INT J CLIN PHARM-NET, V39, P927, DOI 10.1007/s11096-017-0472-0; Zapata-Cachafeiro M, 2019, J ANTIMICROB CHEMOTH, V74, P511, DOI 10.1093/jac/dky440; Zawahir S, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0510-x	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263756	10.1371/journal.pone.0263756	http://dx.doi.org/10.1371/journal.pone.0263756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176043	Green Published, gold			2022-12-26	WOS:000777505200030
J	Giraudier, M; Ventura-Bort, C; Wendt, J; Lischke, A; Weymar, M				Giraudier, Manon; Ventura-Bort, Carlos; Wendt, Julia; Lischke, Alexander; Weymar, Mathias			Memory advantage for untrustworthy faces: Replication across lab- and web-based studies	PLOS ONE			English	Article							SEX-DIFFERENCES; SOCIAL ANXIETY; RECOGNITION MEMORY; THREATENING FACES; DATA-COLLECTION; ONLINE; PSYTOOLKIT; EXPRESSION; JUDGMENTS; EMOTIONS	The Covid-19 pandemic imposed new constraints on empirical research and forced researchers to transfer from traditional laboratory research to the online environment. This study tested the validity of a web-based episodic memory paradigm by comparing participants' memory performance for trustworthy and untrustworthy facial stimuli in a supervised laboratory setting and an unsupervised web setting. Consistent with previous results, we observed enhanced episodic memory for untrustworthy compared to trustworthy faces. Most importantly, this memory bias was comparable in the online and the laboratory experiment, suggesting that web-based procedures are a promising tool for memory research.	[Giraudier, Manon; Ventura-Bort, Carlos; Wendt, Julia; Weymar, Mathias] Univ Potsdam, Fac Human Sci, Dept Biol Psychol & Affect Sci, Potsdam, Germany; [Lischke, Alexander] Med Sch Hamburg, Dept Psychol, Hamburg, Germany; [Lischke, Alexander] Med Sch Hamburg, Inst Clin Psychol & Psychotherapy, Hamburg, Germany; [Weymar, Mathias] Univ Potsdam, Fac Hlth Sci Brandenburg, Potsdam, Germany	University of Potsdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Potsdam	Giraudier, M (corresponding author), Univ Potsdam, Fac Human Sci, Dept Biol Psychol & Affect Sci, Potsdam, Germany.	manon.giraudier@uni-potsdam.de		Giraudier, Manon/0000-0003-0159-1925; Weymar, Mathias/0000-0002-3968-9656	Deutsche Forschungsgemeinschaft (DFG) [WE 4801/6-1, LI 2517/2-1]; Open Access Publication Fund of the University of Potsdam	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Potsdam	This research was supported by grants from the Deutsche Forschungsgemeinschaft (DFG; WE 4801/6-1 to MW and LI 2517/2-1 to AL) and by the Open Access Publication Fund of the University of Potsdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage J, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02883; Bartneck C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121595; Bentley SV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176611; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1111, DOI 10.1016/j.paid.2003.10.008; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Clifford Scott., 2014, J EXP POLITICAL SCI, V1, P120, DOI [10.1017/xps.2014.5, DOI 10.1017/XPS.2014.5]; Cooper R, 2014, ANXIETY STRESS COPIN, V27, P190, DOI 10.1080/10615806.2013.834049; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dandurand F, 2008, BEHAV RES METHODS, V40, P428, DOI 10.3758/BRM.40.2.428; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Dolcos F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01867; Dorociak KE, 2021, GERONTOLOGY, V67, P740, DOI 10.1159/000514871; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gould SJJ., 2015, HUMAN COMPUTATION, V2, P45, DOI [10.15346/hc.v2i1.4, DOI 10.15346/HC.V2I1.4]; Grimshaw GM, 2004, BRAIN COGNITION, V54, P248, DOI 10.1016/j.bandc.2004.02.029; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hawes MT, 2022, PSYCHOL MED, V52, P3222, DOI 10.1017/S0033291720005358; Hilbig BE, 2016, BEHAV RES METHODS, V48, P1718, DOI 10.3758/s13428-015-0678-9; Huh TJ, 2006, J INT NEUROPSYCH SOC, V12, P1, DOI 10.1017/S1355617706060024; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221802; Kleinberg B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118715; Krantz J. H., 2000, PSYCHOL EXPT INTERNE, P35, DOI DOI 10.1016/B978-012099980-4/50003-4; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Leding JK, 2019, J COGN PSYCHOL, V31, P4, DOI 10.1080/20445911.2018.1564756; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Linnman C, 2006, COMPUT HUM BEHAV, V22, P448, DOI 10.1016/j.chb.2004.09.010; Lischke A, 2018, EMOTION, V18, P181, DOI 10.1037/emo0000318; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mattarozzi K, 2015, PSYCHOL RES-PSYCH FO, V79, P308, DOI 10.1007/s00426-014-0554-8; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Peng RC, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/516826; Peyton K., 2020, GENERALIZABILITY ONL; Qin SZ, 2012, J NEUROSCI, V32, P4032, DOI 10.1523/JNEUROSCI.3101-11.2012; Reips U.-D., 2006, HDB MULTIMETHOD MEAS, P73, DOI [10.1037/11383-006, DOI 10.1037/11383-006]; Reips U.-D., 2007, OXFORD HDB INTERNET, P373; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; RStudio Team, 2021, RSTUDIO INTEGRATED D; Rule NO, 2012, COGNITION, V125, P207, DOI 10.1016/j.cognition.2012.06.017; Russell G, 2009, J MENT HEALTH, V18, P198, DOI 10.1080/09638230802522494; Saraswathi I, 2020, PEERJ, V8, DOI 10.7717/peerj.10164; Sauter M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040251; Saylik R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01072; Schmidt WC, 2007, OXFORD HDB INTERNET, P461; Semmelmann K, 2018, BEHAV RES METHODS, V50, P451, DOI 10.3758/s13428-017-0913-7; Singer M, 2006, MEM COGNITION, V34, P125, DOI 10.3758/BF03193392; Slepian ML, 2012, SOC COGNITION, V30, P232, DOI 10.1521/soco.2012.30.2.232; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stangier U., 2005, INT SKALEN F R PSYCH, P299; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Stoet G, 2017, TEACH PSYCHOL, V44, P24, DOI 10.1177/0098628316677643; Stoet G, 2010, BEHAV RES METHODS, V42, P1096, DOI 10.3758/BRM.42.4.1096; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Verschuere B, 2016, J FORENSIC SCI, V61, pS237, DOI 10.1111/1556-4029.12960; [王乾东 Wang Qiandong], 2015, [心理科学进展, Advances in Psychological Science], V23, P1508; Wendt J, 2019, EMOTION, V19, P178, DOI 10.1037/emo0000396; Weymar M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55705-7; Wieser MJ, 2012, EMOTION, V12, P1050, DOI 10.1037/a0027069; Zlomuzica A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00131	64	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264034	10.1371/journal.pone.0264034	http://dx.doi.org/10.1371/journal.pone.0264034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176058	Green Published, gold			2022-12-26	WOS:000777505200065
J	Ho, CC; Yang, YS; Huang, CN; Lo, SC; Wang, YH; Kornelius, E				Ho, Chao-Chung; Yang, Yi-Sun; Huang, Chien-Ning; Lo, Shih-Chang; Wang, Yu-Hsun; Kornelius, Edy			The efficacy of pioglitazone for renal protection in diabetic kidney disease	PLOS ONE			English	Article							TYPE-2; OUTCOMES; INSULIN; GLUCOSE; THIAZOLIDINEDIONES; ROSIGLITAZONE; METAANALYSIS; NEPHROPATHY; EVENTS; TRIAL	There is limited information on the efficacy of pioglitazone in diabetic kidney diseases (DKD). We evaluated whether pioglitazone exerts renal-protective effects in DKD patients. We designed a retrospective cohort study, which included 742 type 2 diabetes mellitus (T2DM) patients with DKD in Taiwan, with eGFR between 30 and 90 ml/min/1.73 m(2) and UACR level 300-5000 mg/g. Patients not meeting the target range for HbA1c (above 7%) were given additional medication with pioglitazone (n = 111) or received standard care (non-pioglitazone group, n = 631). The primary endpoint was the occurrence of composite renal endpoints, which was defined as sustained eGFR< 15 ml/min/1.73 m(2) (confirmed by two measurements within 90 days); doubling of serum creatinine (compared to baseline); and the presence of hemodialysis or renal transplantation. The median follow-up duration was two years. At baseline, the mean HbA1C levels in the pioglitazone and non-pioglitazone groups were 8.8% and 8.1%, respectively; mean ages were 64.4 and 66.2 years old, respectively; diabetes durations were 14.3 and 12.3 years, respectively. Baseline eGFR showed no significant difference between the pioglitazone and non-pioglitazone groups (55.8 and 58.8 mL/min/1.73 m(2), respectively). In terms of gender, 63% of patients were male in the pioglitazone group compared with 57% in the non-pioglitazone group. Pioglitazone use did not reduce the risk of composite renal endpoints in DKD patients (HR: 0.97, 95% CI = 0.53-1.77), including persistent eGFR< 15 ml/min/1.73 m2 (HR = 1.07, 95% CI = 0.46-2.52), doubling of serum creatinine (HR = 0.97, 95% CI = 0.53-1.77), or ESRD (HR = 2.58, 95% CI = 0.29-23.04). The results were not changed after various adjustments. A non-significant albuminuria reduction was also noted after pioglitazone prescription in DKD patients. Further randomized controlled studies are needed to establish the effects of pioglitazone definitively.	[Ho, Chao-Chung; Yang, Yi-Sun; Huang, Chien-Ning; Lo, Shih-Chang; Kornelius, Edy] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yang, Yi-Sun; Huang, Chien-Ning; Kornelius, Edy] Chung Shan Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan; [Yang, Yi-Sun; Huang, Chien-Ning; Lo, Shih-Chang; Kornelius, Edy] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Yu-Hsun] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Kornelius, E (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Kornelius, E (corresponding author), Chung Shan Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taichung, Taiwan.; Kornelius, E (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	korn3lius82@gmail.com		Ho, Chao-Chung/0000-0001-6169-4948; Kornelius, Edy/0000-0002-9342-5467	Chung Shan Medical University hospital [CSH-2022-A-002]	Chung Shan Medical University hospital	This research received a study grant from Chung Shan Medical University hospital (CSH-2022-A-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2011, DIABETES CARE, V34, P2090, DOI 10.2337/dc11-0175; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Bonner R, 2020, PRIMARY CARE, V47, P645, DOI 10.1016/j.pop.2020.08.004; Cefalu WT, 2019, DIABETES CARE, V42, pS61, DOI 10.2337/dc19-S006; Chang YH, 2017, ACTA DIABETOL, V54, P561, DOI 10.1007/s00592-017-0983-0; Chen YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129922; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Corrales P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072063; DeFronzo RA, 2016, DIABETES OBES METAB, V18, P454, DOI 10.1111/dom.12652; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heerspink HJL, 2020, NEW ENGL J MED, V383, P1436, DOI 10.1056/NEJMoa2024816; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Isshiki K, 2000, DIABETES, V49, P1022, DOI 10.2337/diabetes.49.6.1022; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Kiss-Toth E, 2008, PPAR RES, V2008, DOI 10.1155/2008/183108; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P2750, DOI 10.1093/ndt/gfn157; Kornelius E, 2020, ENDOCR PRACT, V26, P1486, DOI 10.4158/EP-2020-0143; Kornelius E, 2015, AM J MED, V128, P977, DOI 10.1016/j.amjmed.2015.03.025; Lu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079815; Mannucci E, 2008, DIABETES OBES METAB, V10, P1221, DOI 10.1111/j.1463-1326.2008.00892.x; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Nigro C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070749; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Oh YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170874; Okada T, 2006, DIABETES, V55, P1666, DOI 10.2337/db05-1285; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sarafidis PA, 2010, AM J KIDNEY DIS, V55, P835, DOI 10.1053/j.ajkd.2009.11.013; Tuttle KR, 2021, AM J KIDNEY DIS, V77, P94, DOI 10.1053/j.ajkd.2020.08.003; Wang W, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/62641; Wang ZJ, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109346; Yaghi S, 2018, CIRCULATION, V137, P455, DOI 10.1161/CIRCULATIONAHA.117.030458; Zhou Y, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgz252	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264129	10.1371/journal.pone.0264129	http://dx.doi.org/10.1371/journal.pone.0264129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176115	Green Published, gold			2022-12-26	WOS:000777505200083
J	Rauf, S; Austin, JJ; Higgins, D; Khan, MR				Rauf, Sobiah; Austin, Jeremy J.; Higgins, Denice; Khan, Muhammad Ramzan			Unveiling forensically relevant biogeographic, phenotype and Y-chromosome SNP variation in Pakistani ethnic groups using a customized hybridisation enrichment forensic intelligence panel	PLOS ONE			English	Article							DNA-BASED EYE; COLOR PREDICTION; PHYLOGENETIC RESOLUTION; HIRISPLEX SYSTEM; SNAPSHOT ASSAY; ANCESTRY; DIVERSITY; MULTIPLEX; HAIR; EAST	Massively parallel sequencing following hybridisation enrichment provides new opportunities to obtain genetic data for various types of forensic testing and has proven successful on modern as well as degraded and ancient DNA. A customisable forensic intelligence panel that targeted 124 SNP markers (67 ancestry informative markers, 23 phenotype markers from the HIrisplex panel, and 35 Y-chromosome SNPs) was used to examine biogeographic ancestry, phenotype and sex and Y-lineage in samples from different ethnic populations of Pakistan including Pothwari, Gilgit, Baloach, Pathan, Kashmiri and Siraiki. Targeted sequencing and computational data analysis pipeline allowed filtering of variants across the targeted loci. Study samples showed an admixture between East Asian and European ancestry. Eye colour was predicted accurately based on the highest p-value giving overall prediction accuracy of 92.8%. Predictions were consistent with reported hair colour for all samples, using the combined highest p-value approach and step-wise model incorporating probability thresholds for light or dark shade. Y-SNPs were successfully recovered only from male samples which indicates the ability of this method to identify biological sex and allow inference of Y-haplogroup. Our results demonstrate practicality of using hybridisation enrichment and MPS to aid in human intelligence gathering and will open many insights into forensic research in South Asia.	[Rauf, Sobiah; Khan, Muhammad Ramzan] Quaid I Azam Univ, Natl Ctr Bioinformat, Genome Editing & Sequencing Lab, Islamabad, Pakistan; [Austin, Jeremy J.; Higgins, Denice] Univ Adelaide, Australian Ctr Ancient DNA ACAD, Sch Biol Sci, Adelaide, SA, Australia; [Higgins, Denice] Univ Adelaide, Sch Dent Hlth & Med Sci, Adelaide, SA, Australia; [Khan, Muhammad Ramzan] Natl Agr Res Ctr NARC, Natl Inst Genom & Adv Biotechnol NIGAB, Islamabad, Pakistan	Quaid I Azam University; University of Adelaide; University of Adelaide	Khan, MR (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Genome Editing & Sequencing Lab, Islamabad, Pakistan.; Khan, MR (corresponding author), Natl Agr Res Ctr NARC, Natl Inst Genom & Adv Biotechnol NIGAB, Islamabad, Pakistan.	drmrkhan_nigab@yahoo.com		Khan, Muhammad Ramzan/0000-0001-9167-6556				Bardan F., 2019, THESIS U ADELAIDE; Bose N, 2018, FORENSIC SCI INT-GEN, V34, P186, DOI 10.1016/j.fsigen.2018.01.010; Breslin K, 2019, FORENSIC SCI INT-GEN, V43, DOI 10.1016/j.fsigen.2019.102152; Cann HM, 2002, SCIENCE, V296, P261; Chaitanya L, 2018, FORENSIC SCI INT-GEN, V35, P123, DOI 10.1016/j.fsigen.2018.04.004; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Daca-Roszak P, 2016, FORENSIC SCI INT-GEN, V20, P89, DOI 10.1016/j.fsigen.2015.10.004; Daya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082224; de la Puente M, 2017, FORENSIC SCI INT-GEN, V28, P35, DOI 10.1016/j.fsigen.2017.01.012; de la Puente M, 2016, FORENSIC SCI INT-GEN, V22, P81, DOI 10.1016/j.fsigen.2016.01.015; Dilliott AA, 2018, JOVE-J VIS EXP, DOI 10.3791/57266; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hallast P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003666; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Hussing C, 2015, FORENS SCI INT-GEN S, V5, pE449, DOI 10.1016/j.fsigss.2015.09.178; Jobling MA, 2019, HUMAN EVOLUTIONARY G, V1st; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2015, EUR J HUM GENET, V23, P369, DOI 10.1038/ejhg.2014.106; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kayser M., 2007, BIOTECHNIQUES, V43, pS16; Kayser M, 2015, FORENSIC SCI INT-GEN, V18, P33, DOI 10.1016/j.fsigen.2015.02.003; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Lao O, 2010, HUM MUTAT, V31, pE1875, DOI 10.1002/humu.21366; Larmuseau MHD, 2014, FORENSIC SCI INT-GEN, V9, P179, DOI 10.1016/j.fsigen.2013.04.002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Meiklejohn KA, 2017, FORENSIC SCI INT-GEN, V31, P48, DOI 10.1016/j.fsigen.2017.08.009; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Nagle N, 2016, AM J PHYS ANTHROPOL, V159, P367, DOI 10.1002/ajpa.22886; Park MJ, 2013, FORENSIC SCI INT-GEN, V7, P75, DOI 10.1016/j.fsigen.2012.06.014; Phillips C, 2014, FORENSIC SCI INT-GEN, V11, P13, DOI 10.1016/j.fsigen.2014.02.012; Rauf S, **DATA OBJECT**, V2021, DOI 10.25909/17469443.v1; Ruiz Y, 2013, FORENSIC SCI INT-GEN, V7, P28, DOI 10.1016/j.fsigen.2012.05.009; Santos C, 2016, METHODS MOL BIOL, V1420, P255, DOI 10.1007/978-1-4939-3597-0_19; Santos C, 2016, FORENSIC SCI INT-GEN, V20, P71, DOI 10.1016/j.fsigen.2015.10.003; Schneider PM, 2019, DTSCH ARZTEBL INT, V116, P873, DOI 10.3238/arztebl.2019.0873; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Sharma V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187932; Shih SY, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010049; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Soubrier J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13158; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Templeton Jennifer E L, 2013, Investig Genet, V4, P26, DOI 10.1186/2041-2223-4-26; Valverde L, 2013, ELECTROPHORESIS, V34, P605, DOI 10.1002/elps.201200433; Van Oven M, 2011, INVESTIG GENET, V2, P1, DOI [10.1186/ 2041-2223-2-1, DOI 10.1186/2041-2223-2-1]; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; van Oven M, 2012, J HUM GENET, V57, P65, DOI 10.1038/jhg.2011.120; Walsh S, 2014, FORENSIC SCI INT-GEN, V9, P150, DOI 10.1016/j.fsigen.2013.12.006; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Walsh S, 2012, FORENSIC SCI INT-GEN, V6, P330, DOI 10.1016/j.fsigen.2011.07.009; Xavier C, 2017, FORENSIC SCI INT-GEN, V28, P188, DOI 10.1016/j.fsigen.2017.02.018; Yang Yaran, 2014, Genomics Proteomics & Bioinformatics, V12, P190, DOI 10.1016/j.gpb.2014.09.001	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264125	10.1371/journal.pone.0264125	http://dx.doi.org/10.1371/journal.pone.0264125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176104	gold, Green Published			2022-12-26	WOS:000777505200082
J	Philp, CP; Pitchford, NW; Fell, JW; Kitic, CM; Buchheit, M; Petersen, AC; Minson, CT; Visentin, DC; Watson, G				Philp, Calvin P.; Pitchford, Nathan W.; Fell, James W.; Kitic, Cecilia M.; Buchheit, Martin; Petersen, Aaron C.; Minson, Christopher T.; Visentin, Denis C.; Watson, Greig			Hot water immersion; potential to improve intermittent running performance and perception of in-game running ability in semi-professional Australian Rules Footballers?	PLOS ONE			English	Article							HEAT ACCLIMATION PROTOCOL; TEAM SPORT; ADAPTATION; BENEFITS; PLASMA; CAMP	This study investigated whether hot water immersion (HWI) could heat acclimate athletes and improve intermittent running performance and perception of in-game running ability, during a competitive Australian Rules Football (ARF) season. Fifteen male semi-professional ARF athletes (Mean (SD); age: 22 (3) years, height: 182.3 (6.5) cm, mass: 80.5 (5.1) kg) completed either HWI (HEAT, N = 8, 13 (2) sessions, 322 (69) min exposure, 39.5 (0.3) degrees C) or acted as a control (CON, N = 7, no water immersion) over 6-weeks. Athletes completed a 30-15 Intermittent Fitness Test pre and post-intervention to assess intermittent running performance (V-IFT), with perception of in-game running ability measured. Heat acclimation was determined via change in resting plasma volume, as well as physiological and perceptual responses during HWI. HEAT elicited large PV expansion (mean +/- 90% CI: d = 1.03 +/- 0.73), large decreases in heart rate (d = -0.89 +/- 0.70), thermal sensation (d = -2.30 +/- 1.15) and tympanic temperature (d = -1.18 +/- 0.77). Large improvements in V-IFT were seen in HEAT (d = 1.67 +/- 0.93), with HEAT showing a greater improvement in V-IFT when compared to CON (d = 0.81 +/- 0.88). HEAT also showed greater belief that in-game running ability improved post-intervention (d = 2.15 +/- 1.09) compared to CON. A 6-week HWI intervention can elicit heat acclimation, improve perception of in-game running ability, and potentially improve V-IFT in semi-professional ARF athletes.	[Philp, Calvin P.; Pitchford, Nathan W.; Fell, James W.; Visentin, Denis C.; Watson, Greig] Univ Tasmania, Sch Hlth Sci, Sport Performance Optimisat Res Team, Launceston, Tas, Australia; [Philp, Calvin P.] Western Bulldogs Football Club, Footscray, Vic, Australia; [Kitic, Cecilia M.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Brisbane, Qld, Australia; [Buchheit, Martin] French Natl Inst Sport INSEP, Lab Sport Expertise & Performance EA 7370, Paris, France; [Buchheit, Martin; Petersen, Aaron C.] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Buchheit, Martin] HIITSci, Revelstoke, BC, Canada; [Buchheit, Martin] Performance Res Intelligence Initiat, Kitman Labs, Dublin, Ireland; [Minson, Christopher T.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA	University of Tasmania; Central Queensland University; Victoria University; University of Oregon	Philp, CP (corresponding author), Univ Tasmania, Sch Hlth Sci, Sport Performance Optimisat Res Team, Launceston, Tas, Australia.; Philp, CP (corresponding author), Western Bulldogs Football Club, Footscray, Vic, Australia.	cp.philp@gmail.com	Visentin, Denis/J-7467-2014	Visentin, Denis/0000-0001-9961-4384; Philp, Calvin/0000-0001-6938-2308; Pitchford, Nathan/0000-0003-3169-9347				American Society of Heating Refrigerating and Air Conditioning Engineers, 2009, AM SOC HEAT REFR AIR, P30329; [Anonymous], 2019, DAILY MAXIMUM TEMPER; Aughey RJ, 2014, J SCI MED SPORT, V17, P113, DOI 10.1016/j.jsams.2013.02.013; Beedie CJ, 2006, MED SCI SPORT EXER, V38, P2159, DOI 10.1249/01.mss.0000233805.56315.a9; Brazaitis M, 2010, EUR J APPL PHYSIOL, V109, P771, DOI 10.1007/s00421-010-1429-3; Broatch JR, 2014, MED SCI SPORT EXER, V46, P2139, DOI 10.1249/MSS.0000000000000348; Buchheit M, 2011, SCAND J MED SCI SPOR, V21, pE477, DOI 10.1111/j.1600-0838.2011.01378.x; Buchheit M, 2008, J STRENGTH COND RES, V22, P365, DOI 10.1519/JSC.0b013e3181635b2e; Cohen J.E., 1988, STAT POWER ANAL BEHA; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Feltz D L, 1988, Exerc Sport Sci Rev, V16, P423; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Garvican LA, 2011, EUR J APPL PHYSIOL, V111, P1089, DOI 10.1007/s00421-010-1732-z; Kelly M, 2016, J SPORT SCI MED, V15, P118; McCleave EL, 2017, MED SCI SPORT EXER, V49, P509, DOI 10.1249/MSS.0000000000001138; McClung M, 2007, J SPORT EXERCISE PSY, V29, P382, DOI 10.1123/jsep.29.3.382; Mooney M, 2011, J SCI MED SPORT, V14, P447, DOI 10.1016/j.jsams.2011.03.010; Moreira A, 2015, INT J SPORT PHYSIOL, V10, P566, DOI 10.1123/ijspp.2014-0326; Natera AOW, 2019, J STRENGTH COND RES, V33, P486, DOI 10.1519/JSC.0000000000001865; Petersen CJ, 2010, INT J SPORT PHYSIOL, V5, P535, DOI 10.1123/ijspp.5.4.535; Pethick WA, 2018, SCI MED FOOTBALL, V2, P16, DOI 10.1080/24733938.2017.1384559; Philp CP, 2016, INT J SPORTS PHYSL P, P1; Racinais S, 2014, INT J SPORT PHYSIOL, V9, P598, DOI [10.1123/IJSPP.2013-0284, 10.1123/ijspp.2013-0284]; Racinais S, 2012, BRIT J SPORT MED, V46, P810, DOI 10.1136/bjsports-2012-091227; Scoon GSM, 2007, J SCI MED SPORT, V10, P259, DOI 10.1016/j.jsams.2006.06.009; Shin YO, 2013, NEUROSCI LETT, V542, P17, DOI 10.1016/j.neulet.2013.03.017; Sunderland C, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.034207; Taylor N., 2000, J HUM ENV SYST, V4, P11, DOI DOI 10.1618/JHES.4.11; Taylor NAS, 2006, INT SPORTMED J, V7, P33; Tyler CJ, 2016, SPORTS MED, V46, P1699, DOI 10.1007/s40279-016-0538-5; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Zurawlew MJ, 2016, SCAND J MED SCI SPOR, V26, P745, DOI 10.1111/sms.12638; Zurawlew MJ, 2018, INT J SPORT PHYSIOL, V13, P1281, DOI 10.1123/ijspp.2017-0620	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263752	10.1371/journal.pone.0263752	http://dx.doi.org/10.1371/journal.pone.0263752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171968	gold, Green Accepted, Green Published			2022-12-26	WOS:000795889700036
J	Sapire, R; Ostrowski, J; Maier, M; Samari, G; Bencomo, C; McGovern, T				Sapire, Rachel; Ostrowski, Jennifer; Maier, Malia; Samari, Goleen; Bencomo, Clarisa; McGovern, Terry			COVID-19 and gender-based violence service provision in the United States	PLOS ONE			English	Article							BARRIERS; WOMEN	Introduction Gender-based violence (GBV) policies and services in the United States (U.S.) have historically been underfunded and siloed from other health services. Soon after the onset of the COVID-19 pandemic, reports emerged noting increases in GBV and disruption of health services but few studies have empirically investigated these impacts. This study examines how the existing GBV funding and policy landscape, COVID-19, and resulting state policies in the first six months of the pandemic affect GBV health service provision in the U.S. Methods This is a mixed method study consisting of 1) an analysis of state-by-state emergency response policies review; 2) a quantitative analysis of a survey of U.S.-based GBV service providers (N = 77); and 3) a qualitative analysis of in-depth interviews with U.S.-based GBV service providers (N = 11). Respondents spanned a range of organization types, populations served, and states. Results Twenty-one states enacted protections for GBV survivors and five states included explicit exemptions from non-essential business closures for GBV service providers. Through the surveys and interviews, GBV service providers note three major themes on COVID-19's impact on GBV services: reductions in GBV service provision and quality and increased workload, shifts in service utilization, and funding impacts. Findings also indicate GBV inequities were exacerbated for historically underserved groups. Discussion The noted disruptions on GBV services from the COVID-19 pandemic overlaid long-term policy and funding limitations that left service providers unprepared for the challenges posed by the pandemic. Future policies, in emergency and non-emergency contexts, should recognize GBV as essential care and ensure comprehensive services for clients, particularly members of historically underserved groups.	[Sapire, Rachel; Ostrowski, Jennifer; Maier, Malia; Samari, Goleen; Bencomo, Clarisa; McGovern, Terry] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Ostrowski, Jennifer; Maier, Malia; Samari, Goleen; Bencomo, Clarisa; McGovern, Terry] Columbia Univ, Program Global Hlth Justice & Governance, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Sapire, R (corresponding author), Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA.	rjs2175@columbia.edu		Ostrowski, Jennifer/0000-0002-8517-0409; Sapire, Rachel/0000-0002-1308-9062	Ford Foundation [133189]	Ford Foundation	Funder: Ford Foundation, https://www.fordfoundation.org, Grant #133189; TM, Principal Investigator. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhammad S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13824; [Anonymous], 2021, STAT COVID 19 DAT PO; Ashford L, 2017, CRUCIAL ROLE HLTH SE, P6; Bleiweis R, 2020, ENSURING DOMESTIC VI; Boserup B, 2020, AM J EMERG MED, V38, P2753, DOI 10.1016/j.ajem.2020.04.077; Bramucci G, 2015, ARE WE THERE YET PRO, P1; Calton JM, 2016, TRAUMA VIOLENCE ABUS, V17, P585, DOI 10.1177/1524838015585318; Carvajal AE, 2020, B LAT AM RES, V39, P7, DOI 10.1111/blar.13188; CDC, 2020, COVID DAT TRACK TREN; Donovan MK, 2019, IMPROVING ACCESS ABO; Evans DP, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01115-1; Fernandes-Alcantara AL, 2019, FAMILY VIOLENCE PREV, P37; Goodmark L, 2021, VIOLENCE AGAINST WOM, V27, P84, DOI 10.1177/1077801220949686; Gover AR, 2021, VIOLENCE AGAINST WOM, V27, P8, DOI 10.1177/1077801220949705; Haq W, 2020, PEERJ, V8, DOI 10.7717/peerj.10472; Inter-Agency Standing Committee, 2015, GUID INT GEND BAS VI; John N., 2021, Gender and Development, V29, P55, DOI 10.1080/13552074.2021.1885219; Johnson K, 2020, INT J GYNECOL OBSTET, V150, P285, DOI 10.1002/ijgo.13285; Kofman YB, 2020, PSYCHOL TRAUMA-US, V12, pS199, DOI 10.1037/tra0000866; Krebs C. K., 2020, SECURITY USDOH; Lee M, 2013, VIOLENCE AGAINST WOM, V19, P1350, DOI 10.1177/1077801213514486; Lima V, 2020, B LAT AM RES, V39, P84, DOI 10.1111/blar.13191; Lokuge K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156813; Mariscal TL, 2020, WOMEN HEALTH ISS, V30, P338, DOI 10.1016/j.whi.2020.05.002; Martins-Filho PR, 2020, J PAEDIATR CHILD H, V56, P1980, DOI 10.1111/jpc.15213; Miller E, 2019, NEW ENGL J MED, V380, P850, DOI 10.1056/NEJMra1807166; Mittal Shalini, 2020, Front Glob Womens Health, V1, P4, DOI 10.3389/fgwh.2020.00004; Moore A, 2021, VIOLENCE AGAINST WOM, V27, P3, DOI 10.1177/1077801220949693; Morgan A., 2020, TRENDS ISSUES CRIME, V609, P1, DOI [10.52922/ti04855, DOI 10.52922/TI04855]; Ms. Foundation for Women, EFF ADDR GEND BAS VI, P36; Murshid NS, 2018, VIOLENCE AGAINST WOM, V24, P1540, DOI 10.1177/1077801217741991; Nabukeera M, 2021, J ADULT PROT, V23, P116, DOI 10.1108/JAP-08-2020-0032; Noman AHM, 2021, J PSYCHIATR RES, V134, P111, DOI 10.1016/j.jpsychires.2020.12.057; O'Neal EN, 2017, VIOLENCE AGAINST WOM, V23, P643, DOI 10.1177/1077801216646223; Parry BR, 2021, GENDER WORK ORGAN, V28, P795, DOI 10.1111/gwao.12565; Pfitzner N, 2020, RESPONDING SHADOW PA; Roesch E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1712; Sacco LN, 2019, VIOLENCE WOMEN ACT V, P42; Sanchez OR, 2020, INT J GYNECOL OBSTET, V151, P180, DOI 10.1002/ijgo.13365; Segers G, 2021, CBS NEWS; Slakoff DC, 2020, ARCH SEX BEHAV, V49, P2779, DOI 10.1007/s10508-020-01820-w; State of Arkansas Executive Department, 2020, REG PUBL HLTH EM COV; State of Minnesota Executive Department, 2020, EM EX ORD 2020 DIR M; State of New Hampshire Office of the Governor, 2020, EM ORD 21 PURS EX OR; State of New Jersey Office of the Governor, 2020, 107 STAT NEW JERS OF; State of New York Executive Chamber, 2020, 20243 STAT NEW YORK; State of Washington: Office of the Governor, 2020, PROCL GOV AM PROCL 2; Vu Alexander, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.835f10778fd80ae031aac12d3b533ca7; Waechter R, 2015, AM J PUBLIC HEALTH, V105, P2430, DOI 10.2105/AJPH.2015.302860; World Health Organization, VIOLENCE AGAINST WOM	50	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263970	10.1371/journal.pone.0263970	http://dx.doi.org/10.1371/journal.pone.0263970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171963	Green Published, gold			2022-12-26	WOS:000795889700052
J	Tian, M; Mochizuki, K; Loidl, J				Tian, Miao; Mochizuki, Kazufumi; Loidl, Josef			Arrested crossover precursor structures form stable homologous bonds in a Tetrahymena meiotic mutant	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MEIOSIS; REORGANIZATION; E2FL1	Meiotic DNA double-strand breaks produce reciprocally exchanged DNA strands, which mature into chiasmata that hold homologous chromosomes together as bivalents. These bivalents are subsequently separated in the first meiotic division. In a mutant lacking the newly identified Tetrahymena gene APRO1 (Anaphase promoting 1), meiosis is arrested by the end of prophase. Mature chiasmata are not formed but bivalents are connected via a molecular precursor structure. In-depth analysis of this arrested intermediate structure may help to elucidate the noncanonical molecular recombination pathway in Tetrahymena.	[Tian, Miao; Loidl, Josef] Univ Vienna, Dept Chromosome Biol, Max Perutz Labs, Vienna, Austria; [Mochizuki, Kazufumi] IGH Inst Human Genet, Montpellier, France; [Tian, Miao] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Ocean University of China	Loidl, J (corresponding author), Univ Vienna, Dept Chromosome Biol, Max Perutz Labs, Vienna, Austria.	josef.loidl@univie.ac.at		Mochizuki, Kazufumi/0000-0001-7987-9852	Austrian Science Fund [P27313-B20]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by grant P27313-B20 from the Austrian Science Fund (www.fwf.ac.at/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Bruns PJ, 2000, METHOD CELL BIOL, V62, P501; Hayashi A, 2015, GENETICS, V201, P55, DOI 10.1534/genetics.115.178525; Howard-Till RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001359; Kataoka K, 2015, DEV CELL, V35, P775, DOI 10.1016/j.devcel.2015.11.017; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Loidl J, 2004, J CELL SCI, V117, P5791, DOI 10.1242/jcs.01504; Loidl J, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009627; Loidl J, 2016, SEMIN CELL DEV BIOL, V54, P126, DOI 10.1016/j.semcdb.2016.02.021; Loidl J, 2012, J CELL SCI, V125, P5873, DOI 10.1242/jcs.112664; Loidl J, 2009, MOL BIOL CELL, V20, P2428, DOI 10.1091/mbc.E08-10-1058; Lukaszewicz A, 2010, CHROMOSOMA, V119, P505, DOI 10.1007/s00412-010-0274-9; Mochizuki K, 2008, J CELL SCI, V121, P2148, DOI 10.1242/jcs.031799; Orias E, 2000, METHOD CELL BIOL, V62, P189; Shodhan A, 2014, GENETICS, V198, P983, DOI 10.1534/genetics.114.169698; Stover NA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas007; Tian M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.253724; Xiong J, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat008; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Zhang J, 2018, CELL CYCLE, V17, P634, DOI 10.1080/15384101.2018.1431595; Zhang J, 2017, CELL CYCLE, V16, P123, DOI 10.1080/15384101.2016.1259779	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263691	10.1371/journal.pone.0263691	http://dx.doi.org/10.1371/journal.pone.0263691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171923	gold, Green Published			2022-12-26	WOS:000795889700033
J	Yang, Y; Xiong, B; Peng, SX; Liu, SQ; Chen, HB; Zhang, TY				Yang, Yang; Xiong, Bin; Peng, Sanxi; Liu, Siqin; Chen, Hanbo; Zhang, Tianyu			Transient electromagnetic characteristics of coal seams intruded by magmatic rocks	PLOS ONE			English	Article							GEOCHEMISTRY; METAMORPHISM; INVERSION; BASIN	The intrusion of magmatic rocks into coal seams affects the coal quality and leads to unforeseen hazards in safety of the coal mines' production. This paper summarizes the mechanism of magmatic rocks intruding into coal seams, depicts the electromagnetic characteristics of the coal seams intruded by magmatic rocks, briefly describes the characteristics of transient electromagnetic method (TEM), and introduces the method of detection by TEM and the data processing steps. Then, the effectiveness of TEM in detecting the ranges of the coal seams intruded by magmatic rocks is theoretically analysed. It is observed that after the intrusion of magmatic rocks in the coal seams, the electromagnetic characteristics (secondary field potential and resistivity) will be dramatically affected, namely high secondary field potential and low resistivity. For experimental verification purposes, this study selects the test project of the Tongxin Minefield in the Datong Coalfield in Shanxi, China as an example, and the accuracy for the detection of the ranges of the coal seams intruded by magmatic rock using TEM is successfully verified.	[Yang, Yang; Xiong, Bin; Peng, Sanxi; Chen, Hanbo; Zhang, Tianyu] Guilin Univ Technol, Coll Earth Sci, Guilin, Guangxi, Peoples R China; [Liu, Siqin] Cent South Univ, Sch Geosci & Infophys, Changsha, Hunan, Peoples R China	Guilin University of Technology; Central South University	Xiong, B; Chen, HB (corresponding author), Guilin Univ Technol, Coll Earth Sci, Guilin, Guangxi, Peoples R China.	xiongbin@msn.com; chenhanbo@glut.edu.cn			National Natural Science Foundation of China [42174080, 41674075, 42062015]; Natural Science Foundation of Guangxi Province [2016GXNSFGA380004, 2018AD19204]; Research Start-up Foundation of Guilin University of Technology [RD2100002165]; China Postdoctoral Science Foundation [2021MD703820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Research Start-up Foundation of Guilin University of Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This Research is sponsored by the National Natural Science Foundation of China (Nos. 42174080, 41674075, and 42062015), co-funded by the Natural Science Foundation of Guangxi Province (Nos. 2016GXNSFGA380004 and 2018AD19204), Research Start-up Foundation of Guilin University of Technology (No. RD2100002165), and China Postdoctoral Science Foundation Funded Project (No. 2021MD703820).	Chen B, 2018, CHINESE J ENG GEOPHY, V15, P798; Chen YL, 2019, INT J COAL GEOL, V217; Cooper JR, 2007, INT J COAL GEOL, V71, P15, DOI 10.1016/j.coal.2006.05.007; [崔大尉 Cui Dawei], 2014, [煤田地质与勘探, Coal Geology & Exploration], V42, P76; [戴方尧 Dai Fangyao], 2013, [物探与化探, Geophysical and Geochemical Exploration], V37, P104; Deng RL, 2016, GEOPHYSICAL PROSPECT, V41, P222; [符德贵 Fu Degui], 2010, [地质与勘探, Geology and Prospecting], V46, P414; [郭娜欣 Guo Naxin], 2016, [中国地质, Geology of China], V43, P1645; Gurba LW, 2001, INT J COAL GEOL, V46, P113, DOI 10.1016/S0166-5162(01)00020-9; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Hu B, 2019, CHINESE J GEOPHYS-CH, V62, P1362, DOI 10.6038/cjg2019M0467; Jiang Mengmeng, 2012, Journal of University of Science and Technology of China, V42, P10, DOI 10.3969/j.issn.0253-2778.2012.01.002; [康天慧 Kang Tianhui], 2016, [地质与勘探, Geology and Exploration], V52, P918; [李冰 Li Bing], 2013, [中国地质, Geology of China], V40, P1644; Li H, 2017, PURE APPL GEOPHYS, V174, P3939, DOI 10.1007/s00024-017-1603-1; Li H, 2016, J APPL GEOPHYS, V128, P87, DOI 10.1016/j.jappgeo.2016.03.017; Li H, 2015, PURE APPL GEOPHYS, V172, P2917, DOI 10.1007/s00024-015-1075-0; Li HH, 2020, IEEE ACCESS, V8, P7758, DOI 10.1109/ACCESS.2020.2964050; LISTER JR, 1991, J GEOPHYS RES-SOLID, V96, P10049, DOI 10.1029/91JB00600; [刘东娜 Liu Dongna], 2015, [煤炭学报, Journal of China Coal Society], V40, P422; [刘娇 Liu Jiao], 2016, [中国地质, Geology of China], V43, P1977; Liu P., 2019, CHINESE J ENG GEOPHY, V16, P500; Menand T, 2002, J GEOPHYS RES-SOL EA, V107, P16; Menand T, 2008, EARTH PLANET SC LETT, V267, P93, DOI 10.1016/j.epsl.2007.11.043; Niu XL, 2017, ACTA PETROL SIN, V33, P3897; Rimmer SM, 2009, INT J COAL GEOL, V79, P74, DOI 10.1016/j.coal.2009.06.002; [孙学凯 Sun Xuekai], 2010, [煤田地质与勘探, Coal Geology & Exploration], V38, P58; [汪雷 Wang Lei], 2015, [煤炭学报, Journal of China Coal Society], V40, P1900; [王亮 Wang Liang], 2019, [煤炭科学技术, Coal Science and Technology], V47, P125; [王正科 Wang Zhengke], 2015, [煤田地质与勘探, Coal Geology & Exploration], V43, P91; Xin CH., 2013, COAL SCI TECHNOLOGY, V41, P166; [薛国强 Xue Guoqiang], 2017, [地球物理学进展, Progress in Geophysiscs], V32, P319; [于淼 Yu Miao], 2013, [地质与勘探, Geology and Exploration], V49, P723; [袁和 Yuan He], 2017, [地质与勘探, Geology and Exploration], V53, P300; Zhou NN, 2018, J ENVIRON ENG GEOPH, V23, P143, DOI 10.2113/JEEG23.1.143; Zhu WP, 2020, COAL GEOLOGY CHINA, V32, P22	36	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263293	10.1371/journal.pone.0263293	http://dx.doi.org/10.1371/journal.pone.0263293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171937	gold, Green Published			2022-12-26	WOS:000795889700020
J	Ramezanpour, MR; Farajpour, M				Ramezanpour, Mahmoud Reza; Farajpour, Mostafa			Application of artificial neural networks and genetic algorithm to predict and optimize greenhouse banana fruit yield through nitrogen, potassium and magnesium	PLOS ONE			English	Article								The excess of the chemical fertilizers not only causes the environmental pollution but also has many deteriorating effects including global warming and alteration of soil microbial diversity. In conventional researches, chemical fertilizers and their concentrations are selected based on the knowledge of experts involved in the projects, which this kind of models are usually subjective. Therefore, the present study aimed to introduce the optimal concentrations of three macro elements including nitrogen (0, 100, and 200 g), potassium (0, 100, 200, and 300 g), and magnesium (0, 50, and 100 g) on fruit yield (FY), fruit length (FL), and number of rows per spike (NRPS) of greenhouse banana using analysis of variance (ANOVA) followed by post hoc LSD test and two well-known artificial neural networks (ANNs) including multilayer perceptron (MLP) and generalized regression neural network (GRNN). According to the results of ANOVA, the highest mean value of the FY was obtained with 200 g of N, 300 g of K, and 50 g of Mg. Based on the results of the present study, the both ANNs models had high predictive accuracy (R-2 = 0.66-0.99) in the both training and testing data for the FY, FL, and NRPS. However, the GRNN model had better performance than MLP model for modeling and predicting the three characters of greenhouse banana. Therefore, genetic algorithm (GA) was subjected to the GRNN model in order to find the optimal amounts of N, K, and Mg for achieving the high amounts of the FY, FL, and NRPS. The GRNN-GA hybrid model confirmed that high yield of the plant could be achieved by reducing chemical fertilizers including nitrogen, potassium, and magnesium by 65, 44, and 62%, respectively, in compared to traditional method.	[Ramezanpour, Mahmoud Reza] AREEO, Soil & Water Res Dept, Mazandaran Agr & Nat Resources Res & Educ Ctr, Sari, Iran; [Farajpour, Mostafa] AREEO, Crop & Hort Sci Res Dept, Mazandaran Agr & Nat Resources Res & Educ Ctr, Sari, Iran		Farajpour, M (corresponding author), AREEO, Crop & Hort Sci Res Dept, Mazandaran Agr & Nat Resources Res & Educ Ctr, Sari, Iran.	Farajpour_m@ut.ac.ir						Buchelt AC, 2020, J SOIL SCI PLANT NUT, V20, P1532, DOI 10.1007/s42729-020-00245-7; FAO, 2019, CROP STAT; Fratoni MMJ, 2017, COMMUN SOIL SCI PLAN, V48, P1511, DOI 10.1080/00103624.2017.1373791; Gallardo M, 2021, SCI HORTIC-AMSTERDAM, V279, DOI 10.1016/j.scienta.2020.109862; Gouda FE-ZM, 2021, J PLANT PROD, V12, P613; Hartinee A, 2010, MALAY J SOIL SCI, V14, P15; He H, 2021, J SOIL SCI PLANT NUT, P1; Hesami M, 2021, IND CROP PROD, V170, DOI 10.1016/j.indcrop.2021.113753; Hesami M, 2021, APPL MICROBIOL BIOT, V105, P5201, DOI 10.1007/s00253-021-11375-y; Hesami M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10155370; Islam M.A., 2020, J BIOSCI AGR RES, V26, P2159, DOI 10.18801/jbar.260120.264; Jafari M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240427; Kakhki RM, 2020, RSC ADV, V10, P5951, DOI 10.1039/c9ra10349j; Keppel G., 2004, DESIGN ANAL RES HDB; Kraithong S, 2021, J SAUDI SOC AGR SCI; Kumar K.P.S., 2012, J PHARMACOGN PHYTOCH, V1, P51; Li M, 2009, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL : ICACC 2009 - PROCEEDINGS, P425, DOI 10.1109/ICACC.2009.153; Macabiog REN, 2020, 2020 16TH IEEE INTERNATIONAL COLLOQUIUM ON SIGNAL PROCESSING & ITS APPLICATIONS (CSPA 2020), P141, DOI 10.1109/CSPA48992.2020.9068717; Marie-Laure T. L. T. G., 2021, Agricultural Sciences, V12, P783, DOI 10.4236/as.2021.127051; Mengstu A., 2021, NONTIMBER FOREST PRO, P339, DOI [10.1186/s12884-021-03822-5, DOI 10.1186/S12884-021-03822-5]; Moreira A, 2009, J PLANT NUTR, V32, P443, DOI 10.1080/01904160802660750; Moriwaki T, 2019, PLANT SCI, V278, P1, DOI 10.1016/j.plantsci.2018.10.012; Nadarajan S., 2021, CONTROLLED RELEASE F, P195, DOI [10.1016/B978-0-12-819555-0.00012-1, DOI 10.1016/B978-0-12-819555-0.00012-1]; Naderi A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5821-x; Niazian M, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10100436; Nyombi K, 2020, FRUIT CROPS: DIAGNOSIS AND MANAGEMENT OF NUTRIENT CONSTRAINTS, P651, DOI 10.1016/B978-0-12-818732-6.00044-7; Pandey GK, 2020, ROLE POTASSIUM PLANT, P69; Peerzada JG, 2021, SILICON-NETH, V13, P2089, DOI 10.1007/s12633-020-00629-5; Ranjha MMAN, 2022, FOOD REV INT, V38, P199, DOI 10.1080/87559129.2020.1725890; Sabzi-Nojadeh M, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11121191; Salehi M, 2021, PLANT METHODS, V17, DOI 10.1186/s13007-021-00714-9; Scremin OB, 2020, J AGR STUD, V8, P610; Silva PHS, 2021, EMIR J FOOD AGR; Siva F, 2019, SMART FERTILIZER REC; Valiev AA, 2020, BIO WEB C; Vu HT, 2018, J FUNCT FOODS, V40, P238, DOI 10.1016/j.jff.2017.11.006; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Ye TH, 2021, FOOD ENERGY SECUR, V10, DOI 10.1002/fes3.295; Yoosefzadeh-Najafabadi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250665; Yousaf M, 2021, SAUDI J BIOL SCI, V28, P3021, DOI 10.1016/j.sjbs.2021.02.043	40	3	3	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0264040	10.1371/journal.pone.0264040	http://dx.doi.org/10.1371/journal.pone.0264040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157736	Green Published, gold			2022-12-26	WOS:000788004500034
J	Zhang, ZY; McGettigan, C; Belyk, M				Zhang, Ziyun; McGettigan, Carolyn; Belyk, Michel			Speech timing cues reveal deceptive speech in social deduction board games	PLOS ONE			English	Article							INDICATORS; MODELS; TRUST; VOICE; LIES	The faculty of language allows humans to state falsehoods in their choice of words. However, while what is said might easily uphold a lie, how it is said may reveal deception. Hence, some features of the voice that are difficult for liars to control may keep speech mostly, if not always, honest. Previous research has identified that speech timing and voice pitch cues can predict the truthfulness of speech, but this evidence has come primarily from laboratory experiments, which sacrifice ecological validity for experimental control. We obtained ecologically valid recordings of deceptive speech while observing natural utterances from players of a popular social deduction board game, in which players are assigned roles that either induce honest or dishonest interactions. When speakers chose to lie, they were prone to longer and more frequent pauses in their speech. This finding is in line with theoretical predictions that lying is more cognitively demanding. However, lying was not reliably associated with vocal pitch. This contradicts predictions that increased physiological arousal from lying might increase muscular tension in the larynx, but is consistent with human specialisations that grant Homo sapiens sapiens an unusual degree of control over the voice relative to other primates. The present study demonstrates the utility of social deduction board games as a means of making naturalistic observations of human behaviour from semi-structured social interactions.	[Zhang, Ziyun; McGettigan, Carolyn; Belyk, Michel] UCL, Dept Speech Hearing & Phonet Sci, London, England; [Belyk, Michel] Edge Hill Univ, Dept Psychol, Ormskirk, England	University of London; University College London; Edge Hill University	Belyk, M (corresponding author), UCL, Dept Speech Hearing & Phonet Sci, London, England.; Belyk, M (corresponding author), Edge Hill Univ, Dept Psychol, Ormskirk, England.	belykm@edgehill.ac.uk	McGettigan, Carolyn/A-3660-2010	McGettigan, Carolyn/0000-0001-6293-3795; Belyk, Michel/0000-0002-3270-8666	Leverhulme Trust [RL-2016-013]	Leverhulme Trust(Leverhulme Trust)	Research Leadership Award from The Leverhulme Trust awarded to CM (RL-2016-013; https://www.leverhulme.ac.uk/).	Anolli L, 1997, J NONVERBAL BEHAV, V21, P259, DOI 10.1023/A:1024916214403; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belyk M, 2017, NEUROSCI BIOBEHAV R, V77, P177, DOI 10.1016/j.neubiorev.2017.03.014; Benus S., 2006, P INT C SPEECH PROSO, P2; Boersma P., 2019, PRAAT DOING PHONETIC; Bona J, 2020, TARGET-NETH, V32, P482, DOI 10.1075/target.19041.bon; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Cattell JM., 1890, MIND, V15, P373, DOI [10.1093/mind/os-XV.59.373, DOI 10.1093/MIND/OS-XV.59.373]; Charlton BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12739; Chen X, 2020, T ASSOC COMPUT LING, V8, P199, DOI 10.1162/tacl_a_00311; Cohen D, 2010, SEMIOTICA, V182, P133, DOI 10.1515/semi.2010.055; DEPAULO BM, 1988, J NONVERBAL BEHAV, V12, P177, DOI 10.1007/BF00987487; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; Ekman P., 1976, SEMIOTICA, V16, P23, DOI [10.1515/semi.1976.16.1.23, DOI 10.1515/SEMI.1976.16.1.23]; Garcia M, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0081; Giddens CL, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2012.12.010; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hall K, 2017, INFANT BEHAV DEV, V48, P38, DOI 10.1016/j.infbeh.2016.11.007; Jensen A. R., 2006, CLOCKING MIND MENTAL; Kempster G.B., 1988, J VOICE, V2, P221, DOI [https://doi.org/10.1016/S0892-1997(88)80080-8, DOI 10.1016/S0892-1997(88)80080-8, 10.1016/S0892-1997(88)80080-8]; Levitan SI, 2018, INTERSPEECH, P416; Loy Jia E, 2018, J Cogn, V1, P42, DOI 10.5334/joc.46; Mann S, 2002, LAW HUMAN BEHAV, V26, P365, DOI 10.1023/A:1015332606792; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mazza C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61636-5; Mazza C, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00389; Mokkonen M, 2016, BIOL REV, V91, P1020, DOI 10.1111/brv.12208; Monaro M, 2021, PSYCHOL RES-PSYCH FO, V85, P3094, DOI 10.1007/s00426-020-01473-3; Patel S, 2011, BIOL PSYCHOL, V87, P93, DOI 10.1016/j.biopsycho.2011.02.010; R Core Team, 2021, R LANG ENV STAT; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; RIECHERT SE, 1984, ANIM BEHAV, V32, P1, DOI 10.1016/S0003-3472(84)80318-8; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Searcy WA., 2005, EVOLUTION ANIMAL COM; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Sporer SL, 2006, APPL COGNITIVE PSYCH, V20, P421, DOI 10.1002/acp.1190; Titze IR, 2002, J ACOUST SOC AM, V112, P1064, DOI 10.1121/1.1496080; Villar G, 2013, PSYCHIAT PSYCHOL LAW, V20, P123, DOI 10.1080/13218719.2011.633320; Villar G, 2012, APPL PSYCHOLINGUIST, V33, P83, DOI 10.1017/S0142716411000117; Vrij A, 1999, PSYCHOL CRIME LAW, V5, P203; Vrij A, 2001, APPL COGNITIVE PSYCH, V15, P187; Vrij A, 2019, APPL COGNITIVE PSYCH, V33, P160, DOI 10.1002/acp.3457; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, VVolume 14, P1, DOI [10.1002/aic.690020228, DOI 10.1016/S0065-2601(08)60369-X]	46	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263852	10.1371/journal.pone.0263852	http://dx.doi.org/10.1371/journal.pone.0263852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148352	Green Published, gold			2022-12-26	WOS:000800108800037
J	Davis, B; Krautmann, M; Leroueil, PR				Davis, Ben; Krautmann, Michael; Leroueil, Pascale R.			A method for estimating the impact of new vaccine technologies on vaccination coverage rates	PLOS ONE			English	Article							DELIVERY	Vaccines are one of the most cost-effective tools for improving human health and well-being. The impact of a vaccine on population health is partly determined by its coverage rate, the proportion of eligible individuals vaccinated. Coverage rate is a function of the vaccine presentation and the population in which that presentation is deployed. This population includes not only the individuals vaccinated, but also the logistics and healthcare systems responsible for vaccine delivery. Because vaccine coverage rates remain below targets in many settings, vaccine manufacturers and purchasers have a shared interest in better understanding the relationship between vaccine presentation, population characteristics, and coverage rate. While there have been some efforts to describe this relationship, existing research and tools are limited in their ability to quantify coverage rate changes across a broad set of antigens, vaccine presentations, and geographies. In this article, we present a method for estimating the impact of improved vaccine technologies on vaccination coverage rates. It is designed for use with low- and middle-income country vaccination programs. This method uses publicly available data and simple calculations based on probability theory to generate coverage rate values. We first present the conceptual framework and mathematical approach. Using a Microsoft Excel-based implementation, we then apply the method to a vaccine technology in early-stage development: micro-array patch for a measles-rubella vaccine (MR-MAP). Example outputs indicate that a complete switch from the current subcutaneous presentation to MR-MAP in the 73 countries ever eligible for Gavi support would increase overall vaccination coverage by 3.0-4.9 percentage points depending on the final characteristics of the MR-MAP. This change equates to an additional 2.6-4.2 million children vaccinated per year. Our method can be readily extended to other antigens and vaccine technologies to provide quick, low-cost estimates of coverage impact. As vaccine manufacturers and purchasers face increasingly complex decisions, such estimates could facilitate objective comparisons between options and help these decision makers obtain the most value for money.	[Davis, Ben; Krautmann, Michael; Leroueil, Pascale R.] Univ Michigan, William Davidson Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Leroueil, PR (corresponding author), Univ Michigan, William Davidson Inst, Ann Arbor, MI 48109 USA.	lerouepr@umich.edu			Bill & Melinda Gates Foundation [OPP1192983, OPP1119213, INV023696]; World Health Organization [2019/899282-0, 2019/921263-0]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Health Organization(World Health Organization)	This publication is based on research funded by the Bill & Melinda Gates Foundation (https://www.gatesfoundation.org/) under contract numbers OPP1192983, OPP1119213, and INV023696, and by the World Health Organization (https://www.who.int/) under contract numbers 2019/899282-0 and 2019/921263-0. All authors (BD, MK and PRL) received support from each of the contracts listed. Both the Bill & Melinda Gates Foundation and the World Health Organization were given the opportunity to comment on the study design. The Bill & Melinda Gates Foundation was given the opportunity to comment on the manuscript before submission. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or the World Health Organization.	[Anonymous], SERVICE DELIVERY IND; [Anonymous], ACC EL POP; [Anonymous], 2019, ISLAM COUNTRY; [Anonymous], BIRTHS ATTENDED SKIL; [Anonymous], 2019, MR MAP TARGET PRODUC; [Anonymous], BIRTH RATE CRUDE PER; [Anonymous], 2010, GLOBAL ERADICATION M; [Anonymous], POPULATION TOTAL DAT; [Anonymous], 2019, WIKIPEDIA; [Anonymous], ZAMBIA ACCESS BOTTLE; Bauch CT, 2008, VALUE HEALTH, V11, pA102, DOI 10.1016/S1098-3015(10)70331-4; Botwright S, 2020, VACCINE-X, V6, DOI 10.1016/j.jvacx.2020.100078; Burch A, 2020, PROGR CHALLENGES ACH, P22; Clements CJ, 2004, VACCINE, V22, P2054, DOI 10.1016/j.vaccine.2004.01.008; Drain PK, 2003, B WORLD HEALTH ORGAN, V81, P553; extranet, WHO PREQUALIFIED VAC; gavi.org, VACCINE INNOVATION P; Giersing BK, 2017, VACCINE, V35, P6793, DOI 10.1016/j.vaccine.2017.04.063; Hull TH, 2015, B INDONES ECON STUD, V51, P154, DOI 10.1080/00074918.2015.1023418; Kanagat N., 2017, DOSE CONTAINER PARTN; Krudwig K, 2020, VACCINE, V38, P5905, DOI 10.1016/j.vaccine.2020.07.012; Lemoine C, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020304; Levin CE, 2005, B WORLD HEALTH ORGAN, V83, P456; Phillips DE, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2626-0; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; STATcompiler, DHS PROGRAM STATCOMP; The, 2012, LIST HLTH FACILITIES; Walters AA, 2015, J PHARM PHARMACOL, V67, P400, DOI 10.1111/jphp.12367; WHO, IMM PRACT ADV COMM I; WHO-UNICEF Coverage Estimates WHO World Health Organization, IMMUNIZATION VACCINE; Zehrung D, 2017, VACCINE, V35, P2265, DOI 10.1016/j.vaccine.2016.11.095	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263612	10.1371/journal.pone.0263612	http://dx.doi.org/10.1371/journal.pone.0263612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143563	gold, Green Published			2022-12-26	WOS:000797657800062
J	Dong, XF; Wang, Y; Tang, CH; Huang, BF; Du, Z; Wang, Q; Shao, JK; Lu, HJ; Wang, CQ				Dong, Xiao-Fang; Wang, Yan; Tang, Chih-Hsin; Huang, Bi-Fei; Du, Zhang; Wang, Qian; Shao, Jun-Kang; Lu, Hua-Jun; Wang, Chao-Qun			Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation	PLOS ONE			English	Article							MORTALITY; MARKER	Few reports exist regarding the expression and function of Wilms' tumor 1-associated protein (WTAP) in colorectal cancer (CRC), and the evidence is controversial. Our analysis explored the expression of WTAP in CRC tissue, and analyzed its clinical and prognostic significance. WTAP expression was significantly higher in CRC tissue than in colorectal adenoma and normal colorectal tissue. WTAP was highest in left colon tumor samples and negatively associated with tumor differentiation, as well as depth of tumor invasion. In multiple logistic regression analysis, independent predictors of WTAP expression in CRC included tumor in the left colon (odds ratio = 2.634; 95% confidence interval: 1.129-6.142; P = 0.025) and poorly differentiated tissue (0.072; 0.014-0.367; P= 0.002). No clear relationship was observed between CRC patient prognosis and WTAP expression. We suggest that WTAP expression is upregulated in CRC, highly expressed in left colon cancer and negatively correlated with tumor differentiation.	[Dong, Xiao-Fang; Wang, Yan] Wenzhou Med Univ, Dept Med Oncol, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Huang, Bi-Fei; Wang, Qian; Shao, Jun-Kang; Wang, Chao-Qun] Wenzhou Med Univ, Affiliated Dongyang Hosp, Dept Pathol, Dongyang, Zhejiang, Peoples R China; [Du, Zhang] Wenzhou Med Univ, Affiliated Dongyang Hosp, Dept Anus & Intestine Surg, Dongyang, Zhejiang, Peoples R China; [Lu, Hua-Jun] Wenzhou Med Univ, Dept Oncol Radiotherapy, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China	Wenzhou Medical University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, CQ (corresponding author), Wenzhou Med Univ, Affiliated Dongyang Hosp, Dept Pathol, Dongyang, Zhejiang, Peoples R China.; Lu, HJ (corresponding author), Wenzhou Med Univ, Dept Oncol Radiotherapy, Affiliated Dongyang Hosp, Dongyang, Zhejiang, Peoples R China.	luhuajun1215@hotmail.com; chaoqun869@163.com			National Natural Science Foundation of China [81802660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	CQW. This work was supported by a grant from the National Natural Science Foundation of China (No. 81802660).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Bosman F. T., 2010, WHO classification of tumours of the digestive system; Chen LZ, 2018, ONCOL LETT, V16, P6966, DOI 10.3892/ol.2018.9554; Chen SJ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02847-6; Chen YH, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1053-8; Dong XF, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8823270; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Li HF, 2020, J CELL MOL MED, V24, P4452, DOI 10.1111/jcmm.15104; Li Q, 2021, CELL BIOL INT, V45, P1269, DOI 10.1002/cbin.11570; Liang HG, 2021, ACTA BIOCH BIOPH SIN, V53, P85, DOI 10.1093/abbs/gmaa151; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu X, 2019, AM J TRANSL RES, V11, P3972; Nagtegaal ID, 2020, HISTOPATHOLOGY, V76, P182, DOI 10.1111/his.13975; Powell AGMT, 2012, COLORECTAL DIS, V14, P1493, DOI 10.1111/j.1463-1318.2012.03048.x; Shen H, 2015, WORLD J GASTROENTERO, V21, P6470, DOI 10.3748/wjg.v21.i21.6470; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Shimada Y, 2017, ONCOTARGET, V8, P93567, DOI 10.18632/oncotarget.20510; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Takahashi Y, 2016, INT J CANCER, V139, P2493, DOI 10.1002/ijc.30377; Tokunaga R, 2019, CLIN CANCER RES, V25, P3096, DOI 10.1158/1078-0432.CCR-18-3388; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Wang CQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75783-2; Wang CQ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8753175; Wang CQ, 2020, J CANCER, V11, P2769, DOI 10.7150/jca.38088; Wang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15939-9; Wang CQ, 2016, CANCER MED-US, V5, P1983, DOI 10.1002/cam4.746; Wang S, 2021, BIOCHEM BIOPH RES CO, V546, P65, DOI 10.1016/j.bbrc.2021.02.001; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Wu LS, 2016, MOL MED REP, V14, P2823, DOI 10.3892/mmr.2016.5528; Yu HL, 2019, ONCOTARGETS THER, V12, P6191, DOI 10.2147/OTT.S205730; Zeng Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8835398; Zhang JW, 2016, GUT, V65, P1482, DOI 10.1136/gutjnl-2014-308614	32	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263749	10.1371/journal.pone.0263749	http://dx.doi.org/10.1371/journal.pone.0263749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143566	gold, Green Published			2022-12-26	WOS:000797657800076
J	Rydenfelt, K; Strand-Amundsen, R; Horneland, R; Hodneb, S; Kjosen, G; Pischke, SE; Tonnessen, TI; Haugaa, H				Rydenfelt, Kristina; Strand-Amundsen, Runar; Horneland, Rune; Hodneb, Stina; Kjosen, Gisle; Pischke, Soren Erik; Tonnessen, Tor Inge; Haugaa, Hakon			Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model	PLOS ONE			English	Article							SURFACE MICRODIALYSIS; THROMBOSIS; SYSTEM; TRANSPLANTS; MANAGEMENT	Background Pancreatic transplantation is associated with a high rate of early postoperative graft thrombosis. If a thrombosis is detected in time, a potentially graft-saving intervention can be initiated. Current postoperative monitoring lacks tools for early detection of ischemia. The aim of this study was to investigate if microdialysis and tissue pCO(2) sensors detect pancreatic ischemia and whether intraparenchymal and organ surface measurements are comparable. Methods In 8 anaesthetized pigs, pairs of lactate monitoring microdialysis catheters and tissue pCO(2) sensors were simultaneously inserted into the parenchyma and attached to the surface of the pancreas. lschemia was induced by sequential arterial and venous occlusions of 45minute duration, with two-hour reperfusion after each occlusion. Microdialysate was analyzed every 15 minutes. Tissue pCO(2) was measured continuously. We investigated how surface and parenchymal measurements correlated and the capability of lactate and pCO(2) to discriminate ischemic from non-ischemic periods. Results Ischemia was successfully induced by arterial occlusion in 8 animals and by venous occlusion in 5. During all ischemic episodes, lactate increased with a fold change of 3.2-9.5 (range) in the parenchyma and 1.7-7.6 on the surface. Tissue pCO(2) increased with a fold change of 1.6-3.5 in the parenchyma and 1.3-3.0 on the surface. Systemic lactate and pCO(2) remained unchanged. The area under curve (AUC) for lactate was 0.97 (95% confidence interval (CI) 0.931.00) for parenchymal and 0.90 (0.83-0.97) for surface (p<0.001 for both). For pCO(2) the AUC was 0.93 (0.89-0.96) for parenchymal and 0.85 (0.81-0.90) for surface (p<0.001 for both). The median correlation coefficients between parenchyma and surface were 0.90 (interquartile range (IQR) 0.77-0.95) for lactate and 0.93 (0.89-0.97) for pCO(2). Conclusions Local organ monitoring with microdialysis and tissue pCO(2) sensors detect pancreatic ischemia with adequate correlation between surface and parenchymal measurements. Both techniques and locations seem feasible for further development of clinical pancreas monitoring.	[Rydenfelt, Kristina; Hodneb, Stina; Pischke, Soren Erik; Tonnessen, Tor Inge; Haugaa, Hakon] Oslo Univ Hosp, Dept Anesthesiol, Div Emergencies & Crit Care, Oslo, Norway; [Rydenfelt, Kristina; Hodneb, Stina; Kjosen, Gisle; Pischke, Soren Erik; Tonnessen, Tor Inge] Univ Oslo, Inst Clin Med, Oslo, Norway; [Strand-Amundsen, Runar] Oslo Univ Hosp, Dept Clin & Biomed Engn, Oslo, Norway; [Horneland, Rune] Oslo Univ Hosp, Dept Transplantat Med, Sect Transplantat Surg, Oslo, Norway; [Kjosen, Gisle] Oslo Univ Hosp, Dept Res & Dev, Div Emergencies & Crit Care, Oslo, Norway; [Pischke, Soren Erik] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Haugaa, Hakon] Lovisenberg Diaconal Univ Coll, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Lovisenberg Diaconal University College	Rydenfelt, K (corresponding author), Oslo Univ Hosp, Dept Anesthesiol, Div Emergencies & Crit Care, Oslo, Norway.; Rydenfelt, K (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	kriryd@ous-hf.no		Rydenfelt, Kristina/0000-0001-6383-3585; Strand-Amundsen, Runar James/0000-0002-2224-9355	South-Eastern Norway Regional Health Authority (Helse Sor-Ost RHF) [2016028]; Norwegian Diabetes Association [36989]; Norwegian Association of Kidney Patients [36945]	South-Eastern Norway Regional Health Authority (Helse Sor-Ost RHF); Norwegian Diabetes Association; Norwegian Association of Kidney Patients	This work was supported by research grants from South-Eastern Norway Regional Health Authority (Helse Sor-Ost RHF, 2016028), The Norwegian Diabetes Association (36989) and The Norwegian Association of Kidney Patients and Organ Transplanted (36945).	Abrahamsson P, 2012, CLIN PHYSIOL FUNCT I, V32, P99, DOI 10.1111/j.1475-097X.2011.01061.x; Akesson O, 2020, J SURG RES, V245, P537, DOI 10.1016/j.jss.2019.07.060; Akesson O, 2016, J SURG RES, V204, P39, DOI 10.1016/j.jss.2016.04.001; Barrufet M, 2014, CARDIOVASC INTER RAD, V37, P1226, DOI 10.1007/s00270-013-0799-4; Blind PJ, 2012, EUR SURG RES, V49, P113, DOI 10.1159/000343806; Chandran SR, 2013, CLIN TRANSPLANT, V27, P410, DOI 10.1111/ctr.12105; Durlik M, 2018, TRANSPL P, V50, P2124, DOI 10.1016/j.transproceed.2018.02.097; Furbetta N, 2020, PROG TRANSPLANT, V30, P69, DOI 10.1177/1526924819893318; Gowers SAN, 2018, ANAL METHODS-UK, V10, P5273, DOI 10.1039/c8ay01807c; Hakeem A, 2018, AM J TRANSPLANT, V18, P163, DOI 10.1111/ajt.14433; Han K, 2016, J VASC INTERV RADIOL, V27, P882, DOI 10.1016/j.jvir.2016.02.022; Haugaa H, 2012, LIVER TRANSPLANT, V18, P839, DOI 10.1002/lt.23425; Khan F, 2015, SCAND J IMMUNOL, V82, P467, DOI 10.1111/sji.12332; Kim YH, 2012, TRANSPLANTATION, V94, P925, DOI 10.1097/TP.0b013e3182692b4d; Kjosen G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247615; Koga I, 2000, ACTA ANAESTH SCAND, V44, P985, DOI 10.1034/j.1399-6576.2000.440815.x; Mirtaheri P., 2005, NOVEL BIOMEDICAL SEN; Muthusamy ASR, 2010, TRANSPLANTATION, V90, P705, DOI 10.1097/TP.0b013e3181eb2ea0; O'Malley RB, 2016, RADIOL CLIN N AM, V54, P251, DOI 10.1016/j.rcl.2015.09.012; Pischke SE, 2012, LIVER TRANSPLANT, V18, P1485, DOI 10.1002/lt.23544; Prsic A, 2019, HAND CLIN, V35, P221, DOI 10.1016/j.hcl.2019.01.003; Sabroe JE, 2019, WORLD J SURG, V43, P944, DOI 10.1007/s00268-018-4860-y; Ungerstedt U, 1997, Acta Anaesthesiol Scand Suppl, V110, P123; Venkatesh B, 2002, Crit Care Resusc, V4, P291; von Platen A, 2019, TRANSPLANT DIRECT, V5, DOI 10.1097/TXD.0000000000000952; Yang WX, 2003, LIVER INT, V23, P163, DOI 10.1034/j.1600-0676.2003.00818.x	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0262848	10.1371/journal.pone.0262848	http://dx.doi.org/10.1371/journal.pone.0262848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143517	gold, Green Published			2022-12-26	WOS:000797657800018
J	Sarchet, JJ; Pollreisz, JP; Bechtol, DT; Blanding, MR; Saltman, RL; Taube, PC				Sarchet, Jeffrey J.; Pollreisz, John P.; Bechtol, David T.; Blanding, Mitchell R.; Saltman, Roger L.; Taube, Patrick C.			Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATIONS; ANTIMICROBIAL SUSCEPTIBILITY; MANNHEIMIA-HAEMOLYTICA; PASTEURELLA-MULTOCIDA; MASTITIS PATHOGENS; LEUKOTRIENE B-4; FEEDLOT CALVES; ASSOCIATIONS; RESISTANCE; CATTLE	A cross-sectional prospective cohort study including 1026 heifers administered tulathromycin due to high risk of clinical signs of bovine respiratory disease (BRD), measured poor association between BRD clinical outcomes and results of bacterial culture and tulathromycin susceptibility from BRD isolates of deep nasopharyngeal swabs (DNS) and adequate association with viral polymerase chain reaction (PCR) results from nasal swabs. Isolation rates from DNS collected on day-0 and at 1st BRD-treatment respectively were: Mannheimia haemolytica (10.9% & 34.1%); Pasteurella multocida (10.4% & 7.4%); Mycoplasma bovis (1.0% & 36.6%); and Histophilus somni (0.7% & 6.3%). Prevalence of BRD viral nucleic acid on nasal swabs collected exclusively at 1st BRD-treatment were: bovine parainfluenza virus type-3 (bPIV-3) 34.1%; bovine viral diarrhea virus (BVDV) 26.3%; bovine herpes virus type-1 (BHV-1) 10.8%; and bovine respiratory syncytial virus (BRSV) 54.1%. Increased relative risk, at 95% confidence intervals, of 1st BRD-treatment failure was associated with positive viral PCR results: BVDV 1.39 (1.17-1.66), bPIV-3 1.26 (1.06-1.51), BHV-1 1.52 (1.25-1.83), and BRSV 1.35 (1.11-1.63) from nasal swabs collected at 1st BRD-treatment and culture of M. haemolytica 1.23 (1.00-1.51) from DNS collected at day-0. However, in this population of high-risk feeder heifers, the predictive values of susceptible and resistant isolates had inadequate association with BRD clinical outcome. These results indicate, that using tulathromycin susceptibility testing of isolates of M. haemolytica or P. multocida from DNS collected on arrival or at 1st BRD-treatment to evaluate tulathromycin clinical efficacy, is unreliable.	[Sarchet, Jeffrey J.; Pollreisz, John P.; Blanding, Mitchell R.; Saltman, Roger L.; Taube, Patrick C.] Zoetis, Parsippany, NJ 07054 USA; [Bechtol, David T.] Agri Res Ctr, Canyon, TX USA	Zoetis	Sarchet, JJ (corresponding author), Zoetis, Parsippany, NJ 07054 USA.	jeffrey.sarchet@zoetis.com			Zoetis	Zoetis	David Bechtol was the principle investigator that conducted the research and was funded by Zoetis. All other authors were employees of Zoetis (www.Zoetis.com) and determined study design, data analysis, preparation of the manuscript and decided to publish.	Abell KM, 2017, J ANIM SCI, V95, P626, DOI 10.2527/jas.2016.1062; Alexander TW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00297; ALLEN JW, 1991, CAN J VET RES, V55, P341; ALLEN JW, 1992, CAN J VET RES, V56, P281; Angen O, 2009, VET MICROBIOL, V137, P165, DOI 10.1016/j.vetmic.2008.12.024; Apparao MD, 2009, J DAIRY SCI, V92, P2589, DOI 10.3168/jds.2008-1693; Beef Quality Assurance, US INTR BQA WHAT IS; Benedict KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143995; BLECHA F, 1984, J ANIM SCI, V59, P576, DOI 10.2527/jas1984.593576x; Broadway PR, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00413; Brogden KA, 2002, POLYMICROBIAL DISEASES, P3; Cernicchiaro N, 2012, J ANIM SCI, V90, P1328, DOI 10.2527/jas.2011-4657; Cox SR, 2010, INT J APPL RES VET M, V8, P129; DeRosa DC, 2000, J CLIN MICROBIOL, V38, P327; Diekema DJ, 2004, J CLIN MICROBIOL, V42, P2258, DOI 10.1128/JCM.42.5.2258-2260.2004; Doern GV, 2011, J CLIN MICROBIOL, V49, P3109, DOI 10.1128/JCM.00580-11; Doyle D, 2017, J VET INTERN MED, V31, P954, DOI 10.1111/jvim.14683; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Duquette SC, 2015, AM J VET RES, V76, P507, DOI 10.2460/ajvr.76.6.507; Er A, 2012, ACTA VET HUNG, V60, P465, DOI 10.1556/AVet.2012.041; Ersoy SC, 2017, EBIOMEDICINE, V20, P173, DOI 10.1016/j.ebiom.2017.05.026; Fernandez M, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101770; Fischer CD, 2014, ANTIMICROB AGENTS CH, V58, P4298, DOI 10.1128/AAC.02813-14; Fischer CD, 2013, ANTIMICROB AGENTS CH, V57, P1385, DOI 10.1128/AAC.01598-12; Fulton RW, 2012, CAN VET J, V53, P754; Godinho KS, 2007, VET REC, V160, P22, DOI 10.1136/vr.160.1.22; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004; Harhay GP, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.00976-18, 10.1128/mra.00976-18]; Hurley MN, 2012, J CYST FIBROS, V11, P288, DOI 10.1016/j.jcf.2012.02.006; Klement E, 2005, MICROB DRUG RESIST, V11, P342, DOI 10.1089/mdr.2005.11.342; Klima CL, 2014, J CLIN MICROBIOL, V52, P438, DOI 10.1128/JCM.02485-13; Kubicek-Sutherland JZ, 2015, EBIOMEDICINE, V2, P1169, DOI 10.1016/j.ebiom.2015.08.012; Leary S, 2013, AVMA GUIDELINES EUTH; Lubbers BV, 2015, VET J, V203, P149, DOI 10.1016/j.tvjl.2014.12.009; Magstadt DR, 2018, J VET DIAGN INVEST, V30, P99, DOI 10.1177/1040638717737589; McClary DG, 2011, JAVMA-J AM VET MED A, V239, P129, DOI 10.2460/javma.239.1.129; McGill JL, 2020, VET CLIN N AM-FOOD A, V36, P333, DOI 10.1016/j.cvfa.2020.03.002; Mosier D, 2014, ANIM HEALTH RES REV, V15, P166, DOI 10.1017/S1466252314000176; Nautrup B. P., 2017, Bovine Practitioner, V51, P1; Nowakowski MA, 2004, VET THER, V5, P60; O'Connor AM, 2016, PREV VET MED, V132, P130, DOI 10.1016/j.prevetmed.2016.07.003; Papich MG, 2013, VET CLIN N AM-SMALL, V43, P1079, DOI 10.1016/j.cvsm.2013.04.005; Rex JH, 2002, CLIN INFECT DIS, V35, P982, DOI 10.1086/342384; Smith RA, 2004, P 23 WORLD BUIATR C, V34; Srikumaran Subramaniam, 2007, Animal Health Research Reviews, V8, P215, DOI 10.1017/S1466252307001326; Tan SH, 2010, PROC SINGAP HEALTHC, V19, P276, DOI 10.1177/201010581001900316; Taylor JD, 2015, RES VET SCI, V99, P41, DOI 10.1016/j.rvsc.2014.12.015; Taylor JD, 2010, CAN VET J, V51, P1351; Thomas JK, 1998, ANTIMICROB AGENTS CH, V42, P521, DOI 10.1128/AAC.42.3.521; Timsit E, 2017, VET MICROBIOL, V208, P118, DOI 10.1016/j.vetmic.2017.07.013; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06; Walz PH, 2017, J VET DIAGN INVEST, V29, P628, DOI 10.1177/1040638717709039; Zeineldin MM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1042-2	55	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0247213	10.1371/journal.pone.0247213	http://dx.doi.org/10.1371/journal.pone.0247213			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143504	gold, Green Published			2022-12-26	WOS:000797657800001
J	Ripmeester, EGJ; Welting, TJM; van den Akker, GGH; Surtel, DAM; Steijns, JSJ; Cremers, A; van Rhijn, LW; Caron, MMJ				Ripmeester, Ellen G. J.; Welting, Tim J. M.; van den Akker, Guus G. H.; Surtel, Don A. M.; Steijns, Jessica S. J.; Cremers, Andy; van Rhijn, Lodewijk W.; Caron, Marjolein M. J.			BMP7 increases protein synthesis in SW1353 cells and determines rRNA levels in a NKX3-2-dependent manner	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; ARTICULAR CHONDROCYTES; GENE-TRANSCRIPTION; PHOSPHORYLATION; EXPRESSION; REPRESSION; RUNX2; ACTS; UBF; DNA	BMP7 is a morphogen capable of counteracting the OA chondrocyte hypertrophic phenotype via NKX3-2. NKX3-2 represses expression of RUNX2, an important transcription factor for chondrocyte hypertrophy. Since RUNX2 has previously been described as an inhibitor for 47S pre-rRNA transcription, we hypothesized that BMP7 positively influences 47S pre-rRNA transcription through NKX3-2, resulting in increased protein translational capacity. Therefor SW1353 cells and human primary chondrocytes were exposed to BMP7 and rRNA (18S, 5.8S, 28S) expression was determined by RT-qPCR. NKX3-2 knockdown was achieved via transfection of a NKX3-2-specific siRNA duplex. Translational capacity was assessed by the SUNsET assay, and 47S pre-rRNA transcription was determined by transfection of a 47S gene promoter-reporter plasmid. BMP7 treatment increased protein translational capacity. This was associated by increased 18S and 5.8S rRNA and NKX3-2 mRNA expression, as well as increased 47S gene promotor activity. Knockdown of NKX3-2 led to increased expression of RUNX2, accompanied by decreased 47S gene promotor activity and rRNA expression, an effect BMP7 was unable to restore. Our data demonstrate that BMP7 positively influences protein translation capacity of SW1353 cells and chondrocytes. This is likely caused by an NKX3-2-dependent activation of 47S gene promotor activity. This finding connects morphogen-mediated changes in cellular differentiation to an aspect of ribosome biogenesis via key transcription factors central to determining the chondrocyte phenotype.	[Ripmeester, Ellen G. J.; Welting, Tim J. M.; van den Akker, Guus G. H.; Surtel, Don A. M.; Steijns, Jessica S. J.; Cremers, Andy; van Rhijn, Lodewijk W.; Caron, Marjolein M. J.] Maastricht Univ, Dept Orthoped Surg, Lab Expt Orthoped, Maastricht, Netherlands; [Welting, Tim J. M.; van Rhijn, Lodewijk W.] Maastricht Univ Med Ctr, Dept Orthoped Surg, Lab Expt Orthoped, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Caron, MMJ (corresponding author), Maastricht Univ, Dept Orthoped Surg, Lab Expt Orthoped, Maastricht, Netherlands.	marjolein.caron@maastrichtuniversity.nl		Caron, Marjolein/0000-0001-5316-9211	Dutch Arthritis Association [LLP14, 13-02-201, 1503-403]; Stichting de Weijerhorst	Dutch Arthritis Association; Stichting de Weijerhorst	This work was financially supported by the Dutch Arthritis Association (https://reumanederland.nl; grants LLP14, 13-02-201, 1503-403) and Stichting de Weijerhorst (www.deweijerhorst.nl) granted to TW and LvR. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aarts MM, 2001, J BIOL CHEM, V276, P37934; Ali SA, 2012, J CELL SCI, V125, P2732, DOI 10.1242/jcs.100909; Ali SA, 2010, P NATL ACAD SCI USA, V107, P4165, DOI 10.1073/pnas.1000620107; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Badlani N, 2009, CLIN ORTHOP RELAT R, V467, P3221, DOI 10.1007/s11999-008-0569-9; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BRIMACOMBE R, 1985, BIOCHEM J, V229, P1; Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Caron MMJ, 2015, ARTHRITIS RHEUMATOL, V67, P2944, DOI 10.1002/art.39293; Chubinskaya S, 2008, GROWTH FACTORS, V26, P275, DOI 10.1080/08977190802291733; Chubinskaya S, 2007, INT ORTHOP, V31, P773, DOI 10.1007/s00264-007-0423-9; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Gebauer M, 2005, OSTEOARTHR CARTILAGE, V13, P697, DOI 10.1016/j.joca.2005.04.004; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Henrich CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165192; Henrotin Y, 1999, OSTEOARTHR CARTILAGE, V7, P310, DOI 10.1053/joca.1998.0175; Hunter DJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-232; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Khatter H, 2015, NATURE, V520, P640, DOI 10.1038/nature14427; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Pande S, 2009, J CELL PHYSIOL, V218, P473, DOI 10.1002/jcp.21630; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Prakash V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10100-8; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Ripmeester EGJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70453-9; Ripmeester EGJ, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00018; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sekiya I, 2009, J ORTHOP RES, V27, P1088, DOI 10.1002/jor.20840; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Tanaka Y, CONTROL RIBOSOMAL RN; Trainor PA, 2014, BBA-MOL BASIS DIS, V1842, P769, DOI 10.1016/j.bbadis.2013.11.010; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zhang W, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4025; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263430	10.1371/journal.pone.0263430	http://dx.doi.org/10.1371/journal.pone.0263430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139106	Green Published, gold			2022-12-26	WOS:000821499100030
J	Du, S; Wang, GP; Zhang, ZY; Ma, CY; Gao, N; Xiao, JY				Du, Shuo; Wang, Guopeng; Zhang, Zhiying; Ma, Chengying; Gao, Ning; Xiao, Junyu			Structural insights into how GlcNAc-1-phosphotransferase directs lysosomal protein transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; GAMMA-SUBUNITS; MUTATIONS; DOMAINS; IDENTIFICATION; RECOGNITION; ALPHA	GlcNAc-1-phosphotransferase catalyzes the initial step in the formation of the mannose-6-phosphate tag that labels similar to 60 lysosomal proteins for transport. Mutations in GlcNAc-1-phosphotransferase are known to cause lysosomal storage disorders such as mucolipidoses. However, the molecular mechanism of GlcNAc-1-phosphotransferase activity remains unclear. Mammalian GlcNAc-1-phosphotransferases are alpha 2 beta 2 gamma 2 hexamers in which the core catalytic alpha- and beta-subunits are derived from the GNPTAB (N-acetylglucosamine-1-phosphate transferase subunits alpha and beta) gene. Here, we present the cryo-electron microscopy structure of the Drosophila melanogaster GNPTAB homolog, DmGNPTAB. We identified four conserved regions located far apart in the sequence that fold into the catalytic domain, which exhibits structural similarity to that of the UDP-glucose glycoprotein glucosyltransferase. Comparison with UDP-glucose glycoprotein glucosyltransferase also revealed a putative donor substrate-binding site, and the functional requirements of critical residues in human GNPTAB were validated using GNPTAB-knockout cells. Finally, we show that DmGNPTAB forms a homodimer that is evolutionarily conserved and that perturbing the dimer interface undermines the maturation and activity of human GNPTAB. These results provide important insights into GlcNAc-l-phosphotransferase function and related diseases.	[Du, Shuo; Zhang, Zhiying; Xiao, Junyu] Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Du, Shuo; Wang, Guopeng; Zhang, Zhiying; Ma, Chengying; Gao, Ning; Xiao, Junyu] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Ma, Chengying; Gao, Ning] Peking Univ, State Key Lab Membrane Biol, Beijing, Peoples R China; [Ma, Chengying; Gao, Ning; Xiao, Junyu] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Xiao, Junyu] Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Xiao, JY (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China.; Gao, N; Xiao, JY (corresponding author), Peking Univ, Sch Life Sci, Beijing, Peoples R China.; Gao, N (corresponding author), Peking Univ, State Key Lab Membrane Biol, Beijing, Peoples R China.; Gao, N; Xiao, JY (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Xiao, JY (corresponding author), Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China.	gaon@pku.edu.cn; junyuxiao@pku.edu.cn		Zhang, zhiying/0000-0002-5690-9796	National Key Research and Development Program of China [2017YFA0505200, 2019YFA0508904]; National Science Foundation of China [31822014, 31725007, 31630087]; Qidong-SLS Innovation Fund	National Key Research and Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qidong-SLS Innovation Fund	The work was supported by the National Key Research and Development Program of China (2017YFA0505200 to J. X., 2019YFA0508904 to N. G.), the National Science Foundation of China (31822014 to J. X., 31725007 and 31630087 to N. G.), and the Qidong-SLS Innovation Fund to J. X. and N. G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Danyukova T, 2020, HUM MUTAT, V41, P133, DOI 10.1002/humu.23928; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Encarnacao M, 2011, J BIOL CHEM, V286, P5311, DOI 10.1074/jbc.M110.202382; Flint M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08135-4; Frigerio-Domingues C, 2017, MOL GENET GENOM MED, V5, P95, DOI 10.1002/mgg3.276; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Liu L, 2017, FEBS LETT, V591, P47, DOI 10.1002/1873-3468.12525; Ludwig NF, 2017, INT J BIOCHEM CELL B, V92, P90, DOI 10.1016/j.biocel.2017.09.006; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Roversi P, 2017, P NATL ACAD SCI USA, V114, P8544, DOI 10.1073/pnas.1703682114; Satoh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12283-w; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P99; Tagliabracci VS, 2016, METHODS MOL BIOL, V1496, P197, DOI 10.1007/978-1-4939-6463-5_16; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; Velho RV, 2019, HUM MUTAT, V40, P842, DOI 10.1002/humu.23748; Velho RV, 2016, FEBS LETT, V590, P4287, DOI 10.1002/1873-3468.12456; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	34	0	0	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101702	10.1016/j.jbc.2022.101702	http://dx.doi.org/10.1016/j.jbc.2022.101702			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148990	Green Published, gold			2022-12-26	WOS:000821054100003
J	Liu, JN; Lu, F; Chen, YH; Plow, E; Qin, J				Liu, Jiamnin; Lu, Fan; Chen, Yinghua; Plow, Edward; Qin, Jun			Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE; CORONAVIRUS	Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is broadly accepted that SARS-CoV-2 utilizes its spike protein to recognize the extracellular domain of angiotensin-converting enzyme 2 (ACE2) to enter cells for viral infection. However, other mechanisms of SARS-CoV-2 cell entry may occur. We show quantitatively that the SARS-CoV-2 spike protein also binds to the extracellular domain of broadly expressed integrin alpha 5 beta 1 with an affinity comparable to that of SARS-CoV-2 binding to ACE2. More importantly, we provide direct evidence that such binding promotes the internalization of SARS-CoV-2 into non-ACE2 cells in a manner critically dependent upon the activation of the integrin. Our data demonstrate an alternative pathway for the cell entry of SARS-CoV-2, suggesting that upon initial ACE2-mediated invasion of the virus in the respiratory system, which is known to trigger an immune response and secretion of cytokines to activate integrin, the integrin-mediated cell invasion of SARS-CoV-2 into the respiratory system and other organs becomes effective, thereby promoting further infection and progression of COVID-19.	[Liu, Jiamnin; Lu, Fan; Plow, Edward; Qin, Jun] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA; [Lu, Fan; Qin, Jun] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chen, Yinghua] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Qin, J (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA.; Qin, J (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	qinj@ccf.org		Liu, Jianmin/0000-0003-1883-9165; Chen, Yinghua/0000-0001-6295-7068	National Institutes of Health, United States [R01 HL58758, P01s HL73311, P01HL154811]; AHA, United States, Career Development [18CDA34110364]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA, United States, Career Development	The work was supported by the National Institutes of Health, United States, grants R01 HL58758 to J. Q., P01s HL73311 and P01HL154811 to E. P. and J. Q., and AHA, United States, Career Development grant #18CDA34110364 to J. L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, United States.	A. Riad, 2021, bioRxiv, DOI 10.1101/2021.03.14.435180; Andrews M. G., 2021, BIORXIV, DOI [10.1101/2021.01.17.427024v1, DOI 10.1101/2021.01.17.427024V1, 10.1101/2021.01.17.427024, DOI 10.1101/2021.01.17.427024]; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Beddingfield BJ, 2021, JACC-BASIC TRANSL SC, V6, P1, DOI 10.1016/j.jacbts.2020.10.003; Bojadzic D, 2021, ACS INFECT DIS, V7, P1519, DOI 10.1021/acsinfecdis.1c00070; Bojadzic D, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.600372; Buszko M, 2021, NAT IMMUNOL, V22, P404, DOI 10.1038/s41590-021-00901-9; Caccuri F, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9071438; Chertow D., 2022, RES SQ, DOI [10.21203/rs.3.rs-1139035/v1, DOI 10.21203/RS.3.RS-1139035/V1]; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Evans JP, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100847; Gaestel M, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMc2036236; Gao S, 2021, J INFECTION, V83, P511, DOI 10.1016/j.jinf.2021.07.007; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kotecha A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15408; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li J, 2017, EMBO J, V36, P629, DOI 10.15252/embj.201695803; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Luan JW, 2020, J INFECTION, V81, P337, DOI 10.1016/j.jinf.2020.03.046; Maginnis MS, 2018, J MOL BIOL, V430, P2590, DOI 10.1016/j.jmb.2018.06.024; Makowski L, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020146; Mezu-Ndubuisi OJ, 2021, PEDIATR RES, V89, P1619, DOI 10.1038/s41390-020-01177-9; Nader D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253347; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Nolte MA, 2021, TRENDS BIOCHEM SCI, V46, P124, DOI 10.1016/j.tibs.2020.09.001; Park EJ, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13040645; Puray-Chavez M, 2021, CELL REP, V36, DOI [10.1101/2021.03.01.433431, 10.1016/j.celrep.2021.109364]; Rucci N, 2005, J CELL SCI, V118, P3263, DOI 10.1242/jcs.02436; Schumacher S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe9716; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shayakhmetov DM, 2005, J VIROL, V79, P1053, DOI 10.1128/JVI.79.2.1053-1061.2005; Shen D, 2017, J BIOL CHEM, V292, P18848, DOI 10.1074/jbc.M116.773713; Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759; Simons P, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99893-7; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Winkler ES, 2022, J VIROL, V96, DOI 10.1128/JVI.01511-21; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yan SJ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00912; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	52	12	12	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101710	10.1016/j.jbc.2022.101710	http://dx.doi.org/10.1016/j.jbc.2022.101710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150743	gold, Green Published			2022-12-26	WOS:000821054100010
J	Protze, J; Naas, S; Krueger, R; Stoehr, C; Kraus, A; Grampp, S; Wiesener, M; Schiffer, M; Hartmann, A; Wullich, B; Schoedel, J				Protze, Johanna; Naas, Stephanie; Krueger, Rene; Stoehr, Christine; Kraus, Andre; Grampp, Steffen; Wiesener, Michael; Schiffer, Mario; Hartmann, Arndt; Wullich, Bernd; Schoedel, Johannes			The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; TARGET GENE; HIF; PBRM1; 2P21	Evolution of clear cell renal cell carcinoma is guided by dysregulation of hypoxia-inducible transcription factor (HIF) pathways following loss of the von Hippel-Lindau tumor suppressor protein. Renal cell carcinoma (RCC)-associated polymorphisms influence HIF-DNA interactions at enhancers of important oncogenes thereby modulating the risk of developing renal cancer. A strong signal of genome-wide association with RCC was determined for the single nucleotide polymorphism (SNP) rs4903064, located on chr14q.24.2 within an intron of DPF3, encoding for Double PHD Fingers 3, a member of chromatin remodeling complexes; however, it is unclear how the risk allele operates in renal cells. In this study, we used tissue specimens and primary renal cells from a large cohort of RCC patients to examine the function of this polymorphism. In clear cell renal cell carcinoma tissue, isolated tumor cells as well as in primary renal tubular cells, in which HIF was stabilized, we determined genotype-specific increases of DPF3 mRNA levels and identified that the risk SNP resides in an active enhancer region, creating a novel HIF-binding motif. We then confirmed allele-specific HIF binding to this locus using chromatin immunoprecipitation of HIF subunits. Consequentially, HIF-mediated DPF3 regulation was dependent on the presence of the risk allele. Finally, we show that DPF3 deletion in proximal tubular cells retarded cell growth, indicating potential roles for DPF3 in cell proliferation. Our analyses suggest that the HIF pathway differentially operates on a SNP-induced hypoxia-response element at 14q24.2, thereby affecting DPF3 expression, which increases the risk of developing renal cancer.	[Protze, Johanna; Naas, Stephanie; Krueger, Rene; Kraus, Andre; Grampp, Steffen; Wiesener, Michael; Schiffer, Mario; Schoedel, Johannes] Universitatsklinikum Erlangen & Friedrich Alexande, Dept Nephrol & Hypertens, Erlangen, Germany; [Hartmann, Arndt] Universitatsklinikum Erlangen & Friedrich Alexande, Inst Pathol, Erlangen, Germany; [Hartmann, Arndt; Wullich, Bernd] Comprehens Canc Ctr Erlangen EMN CCC ER EMN, Universitatsklinikum Erlangen, Erlangen, Germany; [Wullich, Bernd] Universitatsklinikum Erlangen & Friedrich Alexande, Dept Urol & Pediat Urol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schoedel, J (corresponding author), Universitatsklinikum Erlangen & Friedrich Alexande, Dept Nephrol & Hypertens, Erlangen, Germany.	johannes.schoedel@uk-erlangen.de		Schiffer, Mario/0000-0002-8414-1470; Stoehr, Christine/0000-0001-7501-4886	Interdisciplinary Centre for Clinical Research at the Universitatsklinikum Erlangen [D35]; German Research Foundation [387509280, SFB 1350]; Core Unit for Next Generation Sequencing at the Universitatsklinikum Erlangen; Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen	Interdisciplinary Centre for Clinical Research at the Universitatsklinikum Erlangen; German Research Foundation(German Research Foundation (DFG)); Core Unit for Next Generation Sequencing at the Universitatsklinikum Erlangen; Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen	We thank Stephanie Palffy, Astrid EbenauEggers, Barbara Teschemacher, Johanna Stockert, and Margot Rehm for excellent technical assistance. We thank the Core Unit for Next Generation Sequencing and the Comprehensive Cancer Center Erlangen-EMN at the Universitatsklinikum Erlangen for their support. J. P. performed parts of this work in fulfillment of the requirements for obtaining the degree "Dr. med." This study was funded by the Interdisciplinary Centre for Clinical Research (D35) at the Universitatsklinikum Erlangen and the German Research Foundation (Projektnummer 387509280; SFB 1350).	Castro-Giner F, 2015, NAT REV CANCER, V15, P680, DOI 10.1038/nrc3999; Colli LM, 2021, AM J HUM GENET, V108, P1590, DOI 10.1016/j.ajhg.2021.07.009; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Grampp S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006872; Grampp S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13183; Han SS, 2012, HUM MOL GENET, V21, P1190, DOI 10.1093/hmg/ddr551; Hoefflin R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17873-3; Jasinski-Bergner S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008805; Keller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043584; Laskar RS, 2019, EUR J HUM GENET, V27, P1589, DOI 10.1038/s41431-019-0455-9; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lauer V, 2020, J BIOL CHEM, V295, P4065, DOI 10.1074/jbc.RA119.009827; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Mitchell TJ, 2018, CELL, V173, P611, DOI 10.1016/j.cell.2018.02.020; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; REMMELE W, 1987, PATHOLOGE, V8, P138; Scelo G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15724; Schick S, 2019, NAT GENET, V51, P1399, DOI 10.1038/s41588-019-0477-9; Schmid V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55098-7; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Theodorou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076155; van den Heuvel CNAM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00117; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Yao XS, 2017, CANCER DISCOV, V7, P1284, DOI 10.1158/2159-8290.CD-17-0375; Young AP, 2008, CELL CYCLE, V7, P1709, DOI 10.4161/cc.7.12.6124; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	37	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101699	10.1016/j.jbc.2022.101699	http://dx.doi.org/10.1016/j.jbc.2022.101699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148991	Green Published, gold			2022-12-26	WOS:000789400700001
J	Kelemen, A; Halasz, L; Eross, L; Rudas, G; Muthuraman, M; Zadori, D; Laczo, B; Kis, D; Klivenyi, P; Fekete, G; Bognar, L; Bereczki, D; Tamas, G				Kelemen, Andrea; Halasz, Laszlo; Eross, Lorand; Rudas, Gabor; Muthuraman, Muthuraman; Zadori, Denes; Laczo, Bence; Kis, David; Klivenyi, Peter; Fekete, Gabor; Bognar, Laszlo; Bereczki, Daniel; Tamas, Gertrud			Factors affecting postural instability after more than one-year bilateral subthalamic stimulation in Parkinson's disease: A cross- sectional study	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; NUCLEUS STIMULATION; BALANCE; GAIT; MEDICATION; FALLS; REGRESSION; IMPROVES; MOTOR; SWAY	Background Balance impairment in Parkinson's disease is multifactorial and its changes due to subthalamic stimulation vary in different studies. Objective We aimed to analyze the combination of predictive clinical factors of balance impairment in patients with Parkinson's disease treated with bilateral subthalamic stimulation for at least one year. Methods We recruited 24 patients with Parkinson's disease treated with bilateral subthalamic stimulation and 24 healthy controls. They wore an Opal monitor (APDM Inc.) consisting of three-dimensional gyroscopes and accelerometers in the lumbar region. We investigated four stimulation conditions (bilateral stimulation OFF, bilateral stimulation ON, and unilateral right- and left-sided stimulation ON) with four tests: stance on a plain ground with eyes open and closed, stance on a foam platform with eyes open and closed. Age, disease duration, the time elapsed after implantation, levodopa, and stimulation responsiveness were analyzed. The distance of stimulation location from the subthalamic motor center was calculated individually in each plane of the three dimensions. We analyzed the sway values in the four stimulation conditions in the patient group and compared them with the control values. We explored factor combinations (with age as confounder) in the patient group predictive for imbalance with cluster analysis and a machine-learning-based multiple regression method. Results Sway combined from the four tasks did not differ in the patients and controls on a group level. The combination of the disease duration, the preoperative levodopa responsiveness, and the stimulation responsiveness predicted individual stimulation-induced static imbalance. The more affected patients had more severe motor symptoms; primarily, the proprioceptive followed by visual sensory feedback loss provoked imbalance in them when switching on the stimulation. Conclusions The duration of the disease, the severity of motor symptoms, the levodopa responsiveness, and additional sensory deficits should be carefully considered during preoperative evaluation to predict subthalamic stimulation-induced imbalance in Parkinson's disease.	[Kelemen, Andrea; Bereczki, Daniel; Tamas, Gertrud] Semmelwei Univ, Dept Neurol, Budapest, Hungary; [Halasz, Laszlo; Eross, Lorand] Natl Inst Clin Neurosci, Budapest, Hungary; [Rudas, Gabor] Semmelweis Univ, MR Res Ctr, Budapest, Hungary; [Muthuraman, Muthuraman] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Dept Neurol, Biomed Stat & Multimodal Signal Proc Unit, Mainz, Germany; [Zadori, Denes; Laczo, Bence] Univ Szeged, Dept Neurol, Szeged, Hungary; [Kis, David; Klivenyi, Peter] Univ Szeged, Dept Neurosurg, Szeged, Hungary; [Fekete, Gabor; Bognar, Laszlo] Univ Debrecen, Dept Neurosurg, Debrecen, Hungary	Semmelweis University; Johannes Gutenberg University of Mainz; Szeged University; Szeged University; University of Debrecen	Tamas, G (corresponding author), Semmelwei Univ, Dept Neurol, Budapest, Hungary.	tamas.gertrud@med.semmelweis-univ.hu		Tamas, Gertrud/0000-0001-8054-3678	Hungarian Brain Research Program [2017-1.2.1-NKP-201700002 VI/4]	Hungarian Brain Research Program	PK reports support from the Hungarian Brain Research Program [2017-1.2.1-NKP-201700002 VI/4].	Accolla EA, 2014, HUM BRAIN MAPP, V35, P5083, DOI 10.1002/hbm.22533; Artusi CA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123931; Aviles-Olmos I, 2014, J NEUROL NEUROSUR PS, V85, P1419, DOI 10.1136/jnnp-2013-306907; Barbosa Alessandra Ferreira, 2016, Dement. neuropsychol., V10, P280, DOI 10.1590/s1980-5764-2016dn1004005; Bloem BR, 1996, MOVEMENT DISORD, V11, P509, DOI 10.1002/mds.870110506; Bohnen NI, 2009, NEUROLOGY, V73, P1670, DOI 10.1212/WNL.0b013e3181c1ded6; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Camicioli R, 2010, GAIT POSTURE, V32, P87, DOI 10.1016/j.gaitpost.2010.03.013; Charles PD, 2002, NEUROLOGY, V59, P932, DOI 10.1212/WNL.59.6.932; Colnat-Coulbois S, 2005, J NEUROL NEUROSUR PS, V76, P780, DOI 10.1136/jnnp.2004.047829; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; De la Casa-Fages B, 2017, GAIT POSTURE, V52, P374, DOI 10.1016/j.gaitpost.2016.12.025; Defer GL, 1999, MOVEMENT DISORD, V14, P572, DOI 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C; Deuschl G, 2020, J NEUROSURG, V132, P1376, DOI 10.3171/2018.12.JNS182042; Drucker H, 1997, ADV NEUR IN, V9, P155; Frenklach A, 2009, MOVEMENT DISORD, V24, P377, DOI 10.1002/mds.22358; George RJS, 2010, NEUROLOGY, V75, P1292, DOI 10.1212/WNL.0b013e3181f61329; Halmi Z, 2019, BRAIN RES BULL, V152, P45, DOI 10.1016/j.brainresbull.2019.07.001; Hartmann CJ, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419838096; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Ickenstein GW, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00020; Johnsen EL, 2010, EUR J NEUROL, V17, P746, DOI 10.1111/j.1468-1331.2010.02962.x; Johnsen EL, 2011, DAN MED BULL, V58; Johnson L, 2013, MOVEMENT DISORD, V28, P1250, DOI 10.1002/mds.25449; JUDGE JO, 1995, J GERONTOL A-BIOL, V50, pM263, DOI 10.1093/gerona/50A.5.M263; Kammermeier S, 2018, CLIN NEUROPHYSIOL, V129, P1137, DOI 10.1016/j.clinph.2018.03.002; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kumar R, 1999, NEUROLOGY, V53, P561, DOI 10.1212/WNL.53.3.561; Levy G, 2005, ARCH NEUROL-CHICAGO, V62, P467, DOI 10.1001/archneur.62.3.467; Mancini Martina, 2011, J Bioeng Biomed Sci, VSuppl 1, P007; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; McNeely ME, 2011, J NEUROL NEUROSUR PS, V82, P1250, DOI 10.1136/jnnp.2010.232900; McNeely ME, 2013, PARKINSONISM RELAT D, V19, P86, DOI 10.1016/j.parkreldis.2012.07.013; Nantel J, 2012, PARKINSONISM RELAT D, V18, P285, DOI 10.1016/j.parkreldis.2011.11.005; Potter-Nerger M, 2013, MOVEMENT DISORD, V28, P1609, DOI 10.1002/mds.25677; Rinalduzzi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434683; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Saranza G, 2021, J NEUROL, V268, P3135, DOI 10.1007/s00415-020-09810-7; Schoneburg B, 2013, MOVEMENT DISORD, V28, P1474, DOI 10.1002/mds.25613; Schrag A, 2015, LANCET NEUROL, V14, P57, DOI 10.1016/S1474-4422(14)70287-X; Shivitz N, 2006, MOVEMENT DISORD, V21, P1088, DOI 10.1002/mds.20905; Shulman LM, 2008, MOVEMENT DISORD, V23, P790, DOI 10.1002/mds.21879; St George RJ, 2014, MOVEMENT DISORD, V29, P949, DOI 10.1002/mds.25831; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Szlufik S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00906; Tamas G, 2016, BRAIN RES, V1648, P438, DOI 10.1016/j.brainres.2016.08.019; Venhovens J, 2016, EUR J NEUROSCI, V43, P1636, DOI 10.1111/ejn.13253; Workman CD, 2019, GAIT POSTURE, V70, P98, DOI 10.1016/j.gaitpost.2019.02.015	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264114	10.1371/journal.pone.0264114	http://dx.doi.org/10.1371/journal.pone.0264114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196348	Green Published, gold, Green Accepted			2022-12-26	WOS:000835161600025
J	Cho, M; Kim, HM				Cho, Minkwang; Kim, Hyun Mee			Effect of assimilating CO2 observations in the Korean Peninsula on the inverse modeling to estimate surface CO2 flux over Asia	PLOS ONE			English	Article							ATMOSPHERIC CO2; GOSAT; ENSEMBLE; OCO-2; OPTIMIZATION; SATELLITE; EMISSIONS; CONTRAIL; EXCHANGE; SINKS	To investigate the impact of two CO2 observation datasets obtained from the Korean Peninsula on the surface CO2 flux estimation over Asia, the two datasets are assimilated into the CarbonTracker (CT) inverse modeling system and the estimated surface CO2 fluxes are analyzed. Anmyeon-do (AMY) and Gosan (GSN) sites in the Korean Peninsula have observed surface CO2 mole fraction since the late 1990s. To investigate the effect of assimilating the additional Korean observations on the surface CO2 flux estimation over Asia, two experiments are conducted. The reference experiment (CNTL) only assimilates observations provided by National Oceanic and Atmospheric Administration (NOAA), while the other experiment (EXP1) assimilates both NOAA observations and two Korean observation datasets. The results are analyzed for 9 years from 2003 to 2011 in Asia region because both AMY and GSN datasets exist almost completely for this period. The annual average of estimated biosphere CO2 flux of EXP1 shows more flux absorption in summer and less flux emission from fall to spring compared to CNTL, mainly on Eurasia Temperate and Eurasia Boreal regions. When comparing model results to independent CO2 concentration data from surface stations and aircraft, the root mean square error is smaller for EXP1 than CNTL. The EXP1 yields more reduction on uncertainty of estimated biosphere CO2 flux over Asia, and the observation impact of AMY, GSN sites on flux estimation is approximately 11%, which is greater than other observation sites around the world. Therefore, the two CO2 observation sets in the Korean Peninsula are useful in reducing uncertainties for regional as well as global scale CO2 flux estimation.	[Cho, Minkwang; Kim, Hyun Mee] Yonsei Univ, Dept Atmospher Sci, Atmospher Predictabil & Data Assimilat Lab, Seoul, South Korea	Yonsei University	Kim, HM (corresponding author), Yonsei Univ, Dept Atmospher Sci, Atmospher Predictabil & Data Assimilat Lab, Seoul, South Korea.	khm@yonsei.ac.kr			National Research Foundation of Korea (NRF) - South Korean government (Ministry of Science and ICT) [2021R1A2C1012572]; Yonsei Signature Research Cluster Program of 2021 [2021-22-0003]	National Research Foundation of Korea (NRF) - South Korean government (Ministry of Science and ICT); Yonsei Signature Research Cluster Program of 2021	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the South Korean government (Ministry of Science and ICT) (Grant 2021R1A2C1012572) and the Yonsei Signature Research Cluster Program of 2021 (2021-22-0003).	[Anonymous], 2019, VERSION 662 SOFTWARE, DOI [10.5065/D6WD3XH5, DOI 10.5065/D6WD3XH5]; [Anonymous], 2015, CARBONTRACKER DOC CT; Basu S, 2014, GEOPHYS RES LETT, V41, P1809, DOI 10.1002/2013GL059105; Boden TA., 2010, DOI 10.3334/CDIAC/00001_V2010; Bruhwiler LMP, 2005, ATMOS CHEM PHYS, V5, P2691, DOI 10.5194/acp-5-2691-2005; Byrne B, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2019JD032029; Cervarich M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/10/105006; Chevallier F, 2019, ATMOS CHEM PHYS, V19, P14233, DOI 10.5194/acp-19-14233-2019; Cho M., 2019, EUROPEAN GEOSCIENCES; Crisp D, 2004, ADV SPACE RES-SERIES, V34, P700, DOI 10.1016/j.asr.2003.08.062; Crowell S, 2019, ATMOS CHEM PHYS, V19, P9797, DOI 10.5194/acp-19-9797-2019; Deng F, 2016, J GEOPHYS RES-ATMOS, V121, P1896, DOI 10.1002/2015JD024157; Eldering A, 2017, ATMOS MEAS TECH, V10, P549, DOI 10.5194/amt-10-549-2017; ENTING IG, 1995, TELLUS B, V47, P35, DOI 10.1034/j.1600-0889.47.issue1.5.x; Feng L, 2016, ATMOS CHEM PHYS, V16, P1289, DOI 10.5194/acp-16-1289-2016; Gaubert B, 2019, BIOGEOSCIENCES, V16, P117, DOI 10.5194/bg-16-117-2019; Gerard JC, 1999, GEOPHYS RES LETT, V26, P243, DOI 10.1029/1998GL900269; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Houtekamer PL, 2001, MON WEATHER REV, V129, P123, DOI 10.1175/1520-0493(2001)129<0123:ASEKFF>2.0.CO;2; Houweling S, 2015, J GEOPHYS RES-ATMOS, V120, P5253, DOI 10.1002/2014JD022962; Intergovernmental Panel on Climate Change (IPCC), 2021, CLIM CHANG 2021 PHYS; Jacobson AR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002703; Jiang F, 2021, ATMOS CHEM PHYS, V21, P1963, DOI 10.5194/acp-21-1963-2021; Kim H, 2018, ATMOS-KOREA, V28, P113, DOI 10.14191/Atmos.2018.28.2.113; Kim H, 2018, ASIA-PAC J ATMOS SCI, V54, P1, DOI 10.1007/s13143-017-0049-9; Kim J, 2014, ATMOS CHEM PHYS, V14, P13515, DOI 10.5194/acp-14-13515-2014; Kim J, 2017, ATMOS CHEM PHYS, V17, P2881, DOI 10.5194/acp-17-2881-2017; Kim J, 2014, ASIA-PAC J ATMOS SCI, V50, P327, DOI 10.1007/s13143-014-0020-y; Kim J, 2012, ATMOS-KOREA, V22, P415, DOI 10.14191/Atmos.2012.22.4.415; Knorr W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029019; Krol M, 2005, ATMOS CHEM PHYS, V5, P417, DOI 10.5194/acp-5-417-2005; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Liu JJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam5690; Machida T, 2008, J ATMOS OCEAN TECH, V25, P1744, DOI 10.1175/2008JTECHA1082.1; Machida T., 2018, ATMOSPHERIC CO MOLE, DOI [10.17595/20180208.001, DOI 10.17595/20180208.001]; Maksyutov S, 2003, TELLUS B, V55, P522, DOI 10.1034/j.1600-0889.2003.00052.x; Masarie KA, 2014, EARTH SYST SCI DATA, V6, P375, DOI 10.5194/essd-6-375-2014; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Miller SM, 2018, ATMOS CHEM PHYS, V18, P6785, DOI 10.5194/acp-18-6785-2018; Park J, 2020, ATMOS CHEM PHYS, V20, P5175, DOI 10.5194/acp-20-5175-2020; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Peylin P, 2013, BIOGEOSCIENCES, V10, P6699, DOI 10.5194/bg-10-6699-2013; Saeki T, 2013, SOLA, V9, P45, DOI 10.2151/sola.2013-011; Steinkamp K, 2017, ATMOS CHEM PHYS, V17, P47, DOI 10.5194/acp-17-47-2017; Takagi H, 2011, SOLA, V7, P161, DOI 10.2151/sola.2011-041; UNFCCC Conference of the Parties (COP), 2015, PROPOSAL PRESIDENT P; van der Laan-Luijkx IT, 2017, GEOSCI MODEL DEV, V10, P2785, DOI 10.5194/gmd-10-2785-2017; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Wang HM, 2019, ATMOS CHEM PHYS, V19, P12067, DOI 10.5194/acp-19-12067-2019; Whitaker JS, 2002, MON WEATHER REV, V130, P1913, DOI 10.1175/1520-0493(2002)130<1913:EDAWPO>2.0.CO;2; Whites ED, 2019, ATMOS CHEM PHYS, V19, P4345, DOI 10.5194/acp-19-4345-2019; Yokota T, 2009, SOLA, V5, P160, DOI 10.2151/sola.2009-041; Zhang HF, 2014, ATMOS CHEM PHYS, V14, P5807, DOI 10.5194/acp-14-5807-2014	54	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263925	10.1371/journal.pone.0263925	http://dx.doi.org/10.1371/journal.pone.0263925			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180259	Green Published, gold			2022-12-26	WOS:000796435800037
J	Hong, MY; Yoon, JW				Hong, Mi Yeon; Yoon, Ji Won			The impact of COVID-19 on cryptocurrency markets: A network analysis based on mutual information	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; BITCOIN; EXCHANGE; NEXUS	The purpose of our study is to figure out the transitions of the cryptocurrency market due to the outbreak of COVID-19 through network analysis, and we studied the complexity of the market from different perspectives. To construct a cryptocurrency network, we first apply a mutual information method to the daily log return values of 102 digital currencies from January 1, 2019, to December 31, 2020, and also apply a correlation coefficient method for comparison. Based on these two methods, we construct networks by applying the minimum spanning tree and the planar maximally filtered graph. Furthermore, we study the statistical and topological properties of these networks. Numerical results demonstrate that the degree distribution follows the power-law and the graphs after the COVID-19 outbreak have noticeable differences in network measurements compared to before. Moreover, the results of graphs constructed by each method are different in topological and statistical properties and the network's behavior. In particular, during the post-COVID-19 period, it can be seen that Ethereum and Qtum are the most influential cryptocurrencies in both methods. Our results provide insight and expectations for investors in terms of sharing information about cryptocurrencies amid the uncertainty posed by the COVID-19 pandemic.	[Hong, Mi Yeon; Yoon, Ji Won] Korea Univ, Sch Cybersecur, Seoul, South Korea; [Hong, Mi Yeon; Yoon, Ji Won] Korea Univ, Inst Cybersecur & Privacy ICSP, Seoul, South Korea	Korea University; Korea University	Yoon, JW (corresponding author), Korea Univ, Sch Cybersecur, Seoul, South Korea.; Yoon, JW (corresponding author), Korea Univ, Inst Cybersecur & Privacy ICSP, Seoul, South Korea.	jiwon_yoon@korea.ac.kr			Institute of Information and communications Technology Planning and Evaluation(IITP) - Korea government(MSIT)	Institute of Information and communications Technology Planning and Evaluation(IITP) - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by Institute of Information and communications Technology Planning and Evaluation(IITP) grant funded by the Korea government(MSIT) (No.2021-0-00558).	Akbulaev N, 2020, J STRUCT FINANC, V26, P46, DOI 10.3905/jsf.2020.1.099; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], US; [Anonymous], MATLAB CENTRAL FILE; Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008; Bastian M., 2009, GEPHI OPEN SOURCE SO; Baur DG, 2018, J INT FINANC MARK I, V54, P177, DOI 10.1016/j.intfin.2017.12.004; Benesty J, 2009, SPRINGER TOP SIGN PR, V2, P1, DOI 10.1007/978-3-642-00296-0_1; Borvka O, 1926, JISTM PROBLMU MINIML; Bouri E, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101497; Bouri E, 2020, Q REV ECON FINANC, V76, P396, DOI 10.1016/j.qref.2019.09.003; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Caferra R, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101954; Caporale GM, 2019, FINANC RES LETT, V31, P258, DOI 10.1016/j.frl.2018.11.012; Carrick J, 2016, EMERG MARK FINANC TR, V52, P2321, DOI 10.1080/1540496X.2016.1193002; Chaim P, 2019, N AM J ECON FINANC, V48, P32, DOI 10.1016/j.najef.2019.01.015; Cheung A, 2015, APPL ECON, V47, P2348, DOI 10.1080/00036846.2015.1005827; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Coinmarketcap, US; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Conlon T, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101248; Corbet S, 2020, ECON LETT, V194, DOI 10.1016/j.econlet.2020.109377; Corbet S, 2018, ECON LETT, V165, P28, DOI 10.1016/j.econlet.2018.01.004; Daw CS, 2003, REV SCI INSTRUM, V74, P915, DOI 10.1063/1.1531823; Dionisio A, 2004, PHYSICA A, V344, P326, DOI 10.1016/j.physa.2004.06.144; Dyhrberg AH, 2016, FINANC RES LETT, V16, P85, DOI 10.1016/j.frl.2015.10.008; Eyvazian M, 2008, INT J ADV MANUF TECH, V39, P261, DOI 10.1007/s00170-007-1213-7; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gandal Neil., 2016, GAMES-BASEL, V7, P16, DOI [10.3390/g7030016, DOI 10.3390/G7030016]; Hartman D, 2018, CHAOS, V28, DOI 10.1063/1.5023309; Iori G, 2018, HANDB COMPUT ECON, V4, P637, DOI 10.1016/bs.hescom.2018.02.005; Iqbal N, 2021, INT REV FINANC ANAL, V73, DOI 10.1016/j.irfa.2020.101613; James N, 2021, PHYSICA A, V565, DOI 10.1016/j.physa.2020.125581; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kurihara Y., 2017, J APPL FINANCE BANK, V7, P57; Li M, 2001, BIOINFORMATICS, V17, P149, DOI 10.1093/bioinformatics/17.2.149; Liu JN, 2019, OPEN ECON REV, V30, P779, DOI 10.1007/s11079-019-09547-5; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Marin A., 2011, SAGE HDB SOCIAL NETW, P11, DOI DOI 10.4135/9781446294413.N2; Mazur M, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101690; Mnif E, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2020.101647; Nakamoto S., 2019, BITCOIN PEER TO PEER, P21260; Nesetril J, 2001, DISCRETE MATH, V233, P3, DOI 10.1016/S0012-365X(00)00224-7; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Przulj N, 2016, SCIENCE, V353, P123, DOI 10.1126/science.aah3449; Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sharif A, 2020, INT REV FINANC ANAL, V70, DOI 10.1016/j.irfa.2020.101496; Smith R, 2015, STAT-US, V4, P291, DOI 10.1002/sta4.96; Spearman Charles, 1961, GEN INTELLIGENCE OBJ; Tang Y, 2018, COMPLEXITY, DOI 10.1155/2018/4680140; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Vidal-Tomas D, 2021, FINANC RES LETT, V43, DOI 10.1016/j.frl.2021.101981; Yang X, 2019, MATHEMATICS-BASEL, V7, DOI 10.3390/math7090832; Zhang WP, 2019, PHYSICA A, V515, P748, DOI 10.1016/j.physa.2018.09.140	58	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0259869	10.1371/journal.pone.0259869	http://dx.doi.org/10.1371/journal.pone.0259869			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180208	Green Published, gold			2022-12-26	WOS:000796435800003
J	Kubas, EA; Fischer, JR; Hales, EN				Kubas, Elizabeth A.; Fischer, Julie R.; Hales, Erin N.			Endoparasitism of Golden Retrievers: Prevalence, risk factors, and associated clinicopathologic changes	PLOS ONE			English	Article								Endoparasitism is a common disease in dogs throughout their lifetime despite the widespread availability of inexpensive diagnostic tests and effective treatments. The consequences of host parasite interactions in otherwise apparently healthy dogs remains largely unknown. This cross-sectional study used complete blood count, serum biochemistry, and fecal flotation data collected from 3,018 young dogs (<3 years of age) enrolled within the Morris Animal Foundation Golden Retriever Lifetime Study (GRLS) to determine the prevalence of endoparasitism and compare bloodwork values of parasite positive and negative participants using logistic regression. Variables including age, gender, reproductive status, and geographic region at the time of evaluation were assessed to identify potential associations. To the authors' knowledge, a comprehensive assessment of clinicopathological changes associated with endoparasite infection in a large cohort has not been completed in the recent decade. The overall prevalence of endoparasitism was 6.99% (211/3018). Dogs who were parasite positive had statistically lower albumin (P = 0.004), lower RBC count (P = 0.01), higher neutrophil count (P = 0.002), and higher platelet count (P <0.001) as compared to parasite negative dogs. It was also concluded that dogs living in rural areas were more likely to have endoparasites than those living in suburban areas. Epidemiological data is crucial for the design and monitoring of prevention and control strategies. Identification of endoparasites by fecal testing is an essential tool to identify susceptible and resistant animals that can act as spreaders and reservoirs of intestinal parasites thereby enabling appropriate therapy and reducing the risk of new infection to animals and humans. Further epidemiological studies are needed to prevent, monitor, and develop new strategies to control endoparasites.	[Kubas, Elizabeth A.; Fischer, Julie R.] Vet Specialty Hosp, Dept Internal Med, San Diego, CA 92121 USA; [Hales, Erin N.] Morris Anim Fdn, Denver, CO USA		Kubas, EA (corresponding author), Vet Specialty Hosp, Dept Internal Med, San Diego, CA 92121 USA.	elizabethkubas@gmail.com		Hales, Erin/0000-0002-8007-6552; Kubas, Elizabeth/0000-0002-7712-690X	Morris Animal Foundation	Morris Animal Foundation	The Golden Retriever Lifetime Study is funded by the Morris Animal Foundation. We would like to thank the owners, breeders, and primary care veterinarians for their invaluable contribution to the Golden Retriever Lifetime Study.	Adolph C, 2017, VET PARASITOL, V247, P108, DOI 10.1016/j.vetpar.2017.10.002; Ballweber LR, 2014, VET PARASITOL, V204, P73, DOI 10.1016/j.vetpar.2014.05.009; Bonagura JD., 2014, KIRKS CURRENT VET TH, P528; BUTTERWORTH AE, 1984, ADV PARASIT, V23, P143, DOI 10.1016/S0065-308X(08)60287-0; Campos DR., 2017, REV BRAS MED VET, V39; Chikazawa S, 2016, J SMALL ANIM PRACT, V57, P348, DOI 10.1111/jsap.12498; Duncan KT., 2020, REGIONAL STUDIES REP, V19, P100362; Ettinger SJ., 2017, TXB VET INTERNAL MED, P1516; Foster N, 2012, PARASITOL RES, V110, P1587, DOI 10.1007/s00436-012-2832-y; Gates MC, 2009, J SMALL ANIM PRACT, V50, P636, DOI 10.1111/j.1748-5827.2009.00814.x; Gates MC, 2009, VET PARASITOL, V166, P153, DOI 10.1016/j.vetpar.2009.07.041; Huwer M., 1989, ZENTRALBLATT F R BAK, V270; Little SE, 2009, VET PARASITOL, V166, P144, DOI 10.1016/j.vetpar.2009.07.044; Mohamed AS., 2009, J AM VET MEDICAL ASS, V234; R Development Core Team, 2019, R LANG ENV STAT COMP; Savilla TM, 2011, VET PARASITOL, V178, P115, DOI 10.1016/j.vetpar.2010.12.034; Schmidt EMS, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0833-2; Shin Myeong Heon, 2009, Korean J Parasitol, V47 Suppl, pS125, DOI 10.3347/kjp.2009.47.S.S125; Simpson Melissa, 2017, Canine Genet Epidemiol, V4, P14, DOI 10.1186/s40575-017-0053-5; STADNYK AW, 1991, IMMUNOPARASITOL TOD, pA7, DOI 10.1016/S0167-5699(05)80004-0; Stafford K, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04147-6; Sweet S, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04678-6; Villeneuve A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0870-x; Woolcock AD., 2017, J VET INTERN MED, V31	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263517	10.1371/journal.pone.0263517	http://dx.doi.org/10.1371/journal.pone.0263517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180232	gold, Green Published			2022-12-26	WOS:000796435800020
J	Yazawa, A; Inoue, Y; Yamamoto, T; Watanabe, C; Tu, R; Kawachi, I				Yazawa, Aki; Inoue, Yosuke; Yamamoto, Taro; Watanabe, Chiho; Tu, Raoping; Kawachi, Ichiro			Can social support buffer the association between loneliness and hypertension? a cross-sectional study in rural China	PLOS ONE			English	Article							RISK-FACTORS; DARK SIDE; HEALTH; ADJUSTMENT; DRINKING; DISEASE; AGE	Objectives Hypertension has reached epidemic levels in rural China, where loneliness has been a major problem among community dwellers as a consequence of rural-to-urban migration among younger generations. The objective of the study is to investigate the association between loneliness and hypertension, and whether social support can buffer the association (i.e., stress buffering theory), using cross-sectional data from 765 adults (mean age: 59.1 years) in rural Fujian, China. Methods Social support was measured as the reciprocal instrumental social support from/to neighbors and the reciprocal emotional support (i.e., the number of close friends that the respondent could turn to for help immediately when they are in trouble). A mixed-effect Poisson regression model with a robust variance estimator was used to investigate the association between loneliness, social support, and hypertension. Results Analysis revealed that those who were lonely had a higher prevalence ratio for hypertension (prevalence ratio = 1.12, 95% confidence interval 0.99-1.26) compared to those who reported not being lonely. There was an interaction between social support and loneliness in relation to hypertension. Specifically, contrary to the stress buffering theory, the positive association between loneliness and hypertension was more pronounced among those who reported higher social support compared to those who reported lower support (p for interaction <0.001 for instrumental support). Conclusion The results suggest that being lonely despite high levels of social support poses the greatest risk for hypertension. This study did not confirm a buffering effect of social support on the association between loneliness and hypertension.	[Yazawa, Aki; Inoue, Yosuke; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan; [Yazawa, Aki; Kawachi, Ichiro] Harvard T H Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Inoue, Yosuke] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Taro; Tu, Raoping] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Int Hlth, Nagasaki Shi, Nagasaki, Japan; [Watanabe, Chiho] Natl Inst Environm Studies, Tsukuba Shi, Ibaraki, Japan; [Tu, Raoping] Yangzhou Univ, Sch Nursing, Yangzhou, Jiangsu, Peoples R China	University of Tokyo; Harvard University; Harvard T.H. Chan School of Public Health; National Center for Global Health & Medicine - Japan; Nagasaki University; Yangzhou University	Yazawa, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo, Japan.; Yazawa, A (corresponding author), Harvard T H Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.	aki.yazawa@gmail.com			JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS KAKENHI) [JP13J06172]; National Center for Global Health and Medicine [21A1020]; Japan Society for the Promotion of Science	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS KAKENHI); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number JP13J06172; recipient: AY), and National Center for Global Health and Medicine (Grant Number 21A1020; recipient: YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AY is financially supported by Japan Society for the Promotion of Science as a JSPS Overseas Research Fellow.	AKERLIND I, 1992, SOC SCI MED, V34, P405, DOI 10.1016/0277-9536(92)90300-F; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Berkman LF., SOCIAL EPIDEMIOLOGY, DOI [10.1093/med/9780195377903.001.0001/med-9780195377903-chapter-7, DOI 10.1093/MED/9780195377903.001.0001/MED-9780195377903-CHAPTER-7]; Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102104; Cornwell EY., 2012, SOCIAL NETWORK RESOU, V53, P215, DOI [10.1177/0022146512446832, DOI 10.1177/0022146512446832]; Coulon SM., 2015, AT RISK AFRICAN AM A, V38, P830, DOI [10.1007/s10865-015-9656-z, DOI 10.1007/S10865-015-9656-Z]; Global Burden of Disease (GBD 2019), I HLTH METR EV; Guanxi SmartA., 1998, ANTHROPOS, V93, P559; Hawkley LC, 2006, PSYCHOL AGING, V21, P152, DOI 10.1037/0882-7974.21.1.152; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2010, PSYCHOL AGING, V25, P132, DOI 10.1037/a0017805; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Holt-Lunstad J, 2016, HEART, V102, P987, DOI 10.1136/heartjnl-2015-309242; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kessler R. C., 1985, SOCIAL SUPPORT HLTH, P219; KESSLER RC, 1994, J HEALTH SOC BEHAV, V35, P13, DOI 10.2307/2137332; Lash TL., 2007, MODERN EPIDEMIOLOGY, V3rd; Li W, 2016, J HYPERTENS, V34, P39, DOI 10.1097/HJH.0000000000000745; Li YC, 2011, ADDICTION, V106, P1946, DOI 10.1111/j.1360-0443.2011.03514.x; Liabsuetrakul T, 2011, J HEALTH POPUL NUTR, V29, P218, DOI 10.3329/jhpn.v29i3.7869; Luo Y, 2014, J GERONTOL B-PSYCHOL, V69, P633, DOI 10.1093/geronb/gbu007; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Mitchell C. U., 2002, CITY COMMUNITY, V1, P199, DOI DOI 10.1111/1540-6040.00017; Momtaz YA, 2012, J AGING HEALTH, V24, P696, DOI 10.1177/0898264311431305; Myroniuk TW, 2015, J HEALTH SOC BEHAV, V56, P552, DOI 10.1177/0022146515613416; Nanping City Bureau of Statistics, 2015, NANP CIT BUR STAT; National Heart Lung and Blood Institute U.S. Department of Health and Human Services, 2004, HYPERTENSION; Nie X, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102249; Pearson JE., 1986, DEVELOPMENT, V64, P390, DOI [10.1002/j.1556-6676.1986.tb01144.x, DOI 10.1002/J.1556-6676.1986.TB01144.X]; PERLMAN D, 1978, ESSENCE, V2, P239; Pinquart M, 2003, ADV PSY RES, V19, P111; Stress SteptoeA., 2000, INT J PSYCHOPHYSIOL, V37, P299, DOI [10.1016/s0167-8760(00)00109-4, DOI 10.1016/S0167-8760(00)00109-4]; Tu RP, 2018, GERIATR GERONTOL INT, V18, P1093, DOI 10.1111/ggi.13317; Valtorta NK, 2016, HEART, V102, P1009, DOI 10.1136/heartjnl-2015-308790; van Deth JW, 2010, AM BEHAV SCI, V53, P631, DOI 10.1177/0002764209350827; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Villalonga-Olives E, 2017, SOC SCI MED, V194, P105, DOI 10.1016/j.socscimed.2017.10.020; Wang GY, 2011, INT J GERIATR PSYCH, V26, P1162, DOI 10.1002/gps.2656; Wang JN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195340; Warner LM, 2011, EUR J AGEING, V8, P3, DOI 10.1007/s10433-011-0176-6; WEEKS DG, 1980, J PERS SOC PSYCHOL, V39, P1238, DOI 10.1037/h0077709; WETHINGTON E, 1986, J HEALTH SOC BEHAV, V27, P78, DOI 10.2307/2136504; WHO, WHO; Yazawa A, 2018, AM J HUM BIOL, V30, DOI 10.1002/ajhb.23135; Zhang J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071468	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264086	10.1371/journal.pone.0264086	http://dx.doi.org/10.1371/journal.pone.0264086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180267	gold, Green Published			2022-12-26	WOS:000796435800045
J	Kubo, T; Takayama, T; Fujisaki, A; Nakamura, S; Teratani, T; Sata, N; Kitayama, J; Nakai, H; Iwami, D; Fujimura, T				Kubo, Taro; Takayama, Tatsuya; Fujisaki, Akira; Nakamura, Shigeru; Teratani, Takumi; Sata, Naohiro; Kitayama, Joji; Nakai, Hideo; Iwami, Daiki; Fujimura, Tetsuya			Novel high-quality and reality biomaterial as a kidney surgery simulation model	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; COMPLETE CADAVERS; RENAL TUMORS; PRESERVATION; SURVIVAL	Surgical training using live animals such as pigs is one of the best ways of achieving skilled techniques and fostering confidence in preclinical medical students and surgeon trainees. However, due to animal welfare ethics, laboratory animals' usage for training should be kept to a minimum. We have developed a novel kidney organ model utilizing a simple procedure in which the kidney is first refluxed with N-vinyl-2-pyrrolidone (NVP) solution for 1 hour in its bath, followed by permeation for 23 hours, with a subsequent freshwater refluxed for 48 hours in the washing step. Surgical simulation of the prepared kidney model (NVP-fixed kidney) was compared with three types of other basic known simulation models (fresh kidney, freeze-thaw kidney, and FA-fixed kidney) by various evaluations. We found the NVP-fixed kidney to mimicked fresh kidney function the most, pertaining to the hardness, and strength of the renal parenchyma. Moreover, the NVP-fixed kidney demonstrated successful bloodlike fluids perfusion and electrocautery. Further, we confirmed that surgical training could be performed under conditions closer to actual clinical practice. Our findings suggest that our model does not only contribute to improving surgical skills but also inspires the utilization of otherwise, discarded inedible livestock organs as models for surgical training.	[Kubo, Taro; Takayama, Tatsuya; Fujisaki, Akira; Fujimura, Tetsuya] Jichi Med Univ, Dept Urol, Shimotsuke, Tochigi, Japan; [Kubo, Taro; Iwami, Daiki] Jichi Med Univ, Div Renal Surg & Transplantat, Shimotsuke, Tochigi, Japan; [Nakamura, Shigeru; Nakai, Hideo] Jichi Med Univ, Childrens Med Ctr Tochigi, Dept Pediat Urol, Shimotsuke, Tochigi, Japan; [Teratani, Takumi; Sata, Naohiro; Kitayama, Joji] Jichi Med Univ, Dept Surg, Div Gastroenterol Gen & Transplant Surg, Shimotsuke, Tochigi, Japan; [Teratani, Takumi; Kitayama, Joji] Jichi Med Univ, Div Translat Res, Shimotsuke, Tochigi, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University; Jichi Medical University; Jichi Medical University	Teratani, T (corresponding author), Jichi Med Univ, Dept Surg, Div Gastroenterol Gen & Transplant Surg, Shimotsuke, Tochigi, Japan.; Teratani, T (corresponding author), Jichi Med Univ, Div Translat Res, Shimotsuke, Tochigi, Japan.	teratani@jichi.ac.jp		Nakamura, Shigeru/0000-0002-3607-5974				Chang KD, 2018, BJU INT, V122, P618, DOI 10.1111/bju.14250; CLERICI T, 1995, WIEN KLIN WOCHENSCHR, V107, P43; Dankelman J, 2003, MINIM INVASIV THER, V12, P129, DOI 10.1080/13645700310007689; HAAF F, 1985, POLYM J, V17, P143, DOI 10.1295/polymj.17.143; Haizuka Y, 2018, CLIN ANAT, V31, P90, DOI 10.1002/ca.23011; Hammer N, 2012, ANAT SCI EDUC, V5, P225, DOI 10.1002/ase.1270; Hofstad EF, 2013, SURG ENDOSC, V27, P854, DOI 10.1007/s00464-012-2524-9; Hopmans CJ, 2013, J SURG EDUC, V70, P647, DOI 10.1016/j.jsurg.2013.04.015; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Kobayashi E, 2018, EXP ANIM TOKYO, V67, P7, DOI 10.1538/expanim.17-0086; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Liu H, 2009, UROL INT, V82, P388, DOI 10.1159/000218525; Maruyama K, 2019, NEUROL MED-CHIR, V59, P379, DOI 10.2176/nmc.oa.2019-0069; McKiernan J, 2002, UROLOGY, V59, P816, DOI 10.1016/S0090-4295(02)01501-7; Monda SM, 2018, UROLOGY, V114, P114, DOI 10.1016/j.urology.2018.01.030; Nagase M, 2020, ANAT SCI INT, V95, P156, DOI 10.1007/s12565-019-00494-2; Rai BP, 2012, ANAT SCI EDUC, V5, P182, DOI 10.1002/ase.1267; Samia H, 2013, CLIN COLON RECT SURG, V26, P47, DOI 10.1055/s-0033-1333661; Sideris M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/463987; Szinicz G, 1997, Langenbecks Arch Chir Suppl Kongressbd, V114, P687; Szinicz Gerhard, 1994, ALTEX, V11, P40; Taylor GD, 2006, BJU INT, V97, P179, DOI 10.1111/j.1464-410X.2005.05877.x; Taylor GD, 2004, J UROLOGY, V172, P382, DOI 10.1097/01.ju.0000132358.82641.10; THIEL W, 1992, ANN ANAT, V174, P185, DOI 10.1016/S0940-9602(11)80346-8; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2; Thompson RH, 2008, J UROLOGY, V179, P468, DOI 10.1016/j.juro.2007.09.077; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Volpe A, 2011, EUR UROL, V60, P501, DOI 10.1016/j.eururo.2011.05.044; von Rundstedt FC, 2017, BJU INT, V119, P598, DOI 10.1111/bju.13712; Yantazaki M, 2020, TRANSL ANDROL UROL, V9, P494, DOI 10.21037/tau.2019.12.31; Zini L, 2009, CANCER-AM CANCER SOC, V115, P1465, DOI 10.1002/cncr.24035	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263179	10.1371/journal.pone.0263179	http://dx.doi.org/10.1371/journal.pone.0263179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176048	gold, Green Published			2022-12-26	WOS:000777505200015
J	Seid, A; Cherie, HA				Seid, Awel; Cherie, Hirut Assaye			Dietary diversity, nutritional status and associated factors among lactating mothers visiting government health facilities at Dessie town, Amhara region, Ethiopia	PLOS ONE			English	Article							HOUSEHOLD FOOD INSECURITY; ACCESS SCALE; WOMEN	Background Maternal undernutrition is one of the most common causes of maternal morbidity and mortality in developing countries. Severe undernutrition among mothers leads to reduced lactation performance which further contributes to an increased risk of infant mortality. However, data regarding nutritional status of lactating mothers at Dessie town and its surrounding areas is lacking. This study assessed dietary diversity, nutritional status and associated factors of lactating mothers visiting health facilities at Dessie town, Amhara region, Ethiopia. Methods Institutional based cross-sectional study was conducted from March to April, 2017 among 408 lactating mothers. Systematic random sampling technique was employed to select the study participants. Data on socio-demographic and economic characteristics, health related characteristics, dietary diversity and food security status of participants were collected using interviewer administered questionnaire. Data were entered into EPI-INFO and analyzed using SPSS Version 22. Bivariate and multivariate analyses were performed to identify factors associated with dietary diversity and nutritional status of lactating mothers. Results More than half (55.6%) of lactating mothers had inadequate dietary diversity (DDS<5.3) and about 21% were undernourished (BMI< 18.5 kg/m(2)). Household monthly income [AOR = 2.0, 95% CI (1.15, 3.65)], type of house [AOR = 1.8, 95% CI (1.15, 2.94)], nutrition information [AOR = 1.6, 95% CI (1.05, 2.61)] and household food insecurity [AOR = 1.8, 95% CI (1.05, 3.06)] were factors associated with dietary diversity of lactating mothers. Being young in age 15-19 years [AOR = 10.3, 95% CI (2.89, 36.39)] & 20-29 years [AOR = 3.4, 95% CI (1.57, 7.36)], being divorced/separated [AOR = 10.1, 95% CI (1.42, 72.06)], inadequate dietary diversity [AOR = 3.8, 95% CI (2.08, 7.03)] and household food insecurity [AOR = 3.1, 95% CI (1.81, 5.32)] were factors associated with maternal undernutrition. Conclusion The dietary diversity of lactating mothers in the study area was sub optimal and the prevalence of undernutrition was relatively high. Public health nutrition interventions such as improving accessibility of affordable and diversified nutrient rich foods are important to improve the nutritional status of mothers and their children in the study area.	[Seid, Awel; Cherie, Hirut Assaye] Bahir Dar Univ, Bahir Dar Inst Technol, Dept Appl Human Nutr, Bahir Dar, Ethiopia	Bahir Dar University	Cherie, HA (corresponding author), Bahir Dar Univ, Bahir Dar Inst Technol, Dept Appl Human Nutr, Bahir Dar, Ethiopia.	hirutas2000@gmail.com		Assaye Cherie, Hirut/0000-0003-3560-4552				Alemayehu M., 2015, DEV COUNTRY STUDIES, V5, P114; [Anonymous], 2016, CSA ETH DEM HLTH SUR; [Anonymous], 2012, CENTR STAT AG ETH IC; Arimond M., 2009, DIETARY DIVERSITY ME; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Becquey E, 2010, J NUTR, V140, P2233, DOI 10.3945/jn.110.125716; Berihun Sileshi, 2017, BMC Nutr, V3, P46, DOI 10.1186/s40795-017-0165-z; Boke Moges Muluneh, 2018, BMC Res Notes, V11, P892, DOI 10.1186/s13104-018-4001-6; Coates J, 2007, HOUSEHOLD FOOD INSEC, V3; Doran L, 1997, J AM DIET ASSOC, V97, P1283, DOI 10.1016/S0002-8223(97)00306-4; Gebreyesus S.H., 2015, BMC NUTR, V1, P2, DOI [DOI 10.1186/2055-0928-1-1, 10.1186/2055-0928-1-2]; Gewa CA, 2012, MATERN CHILD NUTR, V8, P275, DOI 10.1111/j.1740-8709.2011.00322.x; Haileslassie K, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-28; Hundera TD., 2015, INT J NUTR FOOD SCI, V4, P216, DOI [10.11648/j.ijnfs.20150402.23, DOI 10.11648/J.IJNFS.20150402.23]; Kennedy G., 2013, GUID MEAS HOUS IND D; Knueppel D, 2010, PUBLIC HEALTH NUTR, V13, P360, DOI 10.1017/S1368980009991121; Kominiarek MA, 2016, MED CLIN N AM, V100, P1199, DOI 10.1016/j.mcna.2016.06.004; Mohammadi F, 2012, PUBLIC HEALTH NUTR, V15, P149, DOI 10.1017/S1368980011001376; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Oldewage-Theron WH, 2006, PUBLIC HEALTH, V120, P795, DOI 10.1016/j.puhe.2006.02.009; Sanusi R, 2007, AFR J BIOMED RES, V12, P107; Savy M, 2006, J NUTR, V136, P2625, DOI 10.1093/jn/136.10.2625; Singh DR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227873; Sitotaw Ismael Kalayu, 2017, BMC Nutr, V3, P61, DOI 10.1186/s40795-017-0179-6; Teller C.H., 2000, ETHIOP J HEALTH DEV, V14, P57; Thorne-Lyman AL, 2010, J NUTR, V140, p182S, DOI 10.3945/jn.109.110809; Tsegaye Demissie, 2003, Ethiopian Journal of Health Development, V17, P189; Weldehaweria N.B., 2016, BMC NUTR, V2, P38; World Health Organization (WHO), 2009, WORLD HLTH STAT	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263957	10.1371/journal.pone.0263957	http://dx.doi.org/10.1371/journal.pone.0263957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176095	Green Published, gold			2022-12-26	WOS:000777505200052
J	Stacey, MJ; Hill, NE; Parsons, IT; Wallace, J; Taylor, N; Grimaldi, R; Shah, N; Marshall, A; House, C; O'Hara, JP; Brett, SJ; Woods, DR				Stacey, Michael J.; Hill, Neil E.; Parsons, Iain T.; Wallace, Jenny; Taylor, Natalie; Grimaldi, Rachael; Shah, Nishma; Marshall, Anna; House, Carol; O'Hara, John P.; Brett, Stephen J.; Woods, David R.			Relative changes in brain and kidney biomarkers with Exertional Heat Illness during a cool weather marathon	PLOS ONE			English	Article							INJURY; HEATSTROKE; COPEPTIN; ENOLASE; STROKE; DAMAGE; BLOOD; RISK	Background Medical personnel may find it challenging to distinguish severe Exertional Heat Illness (EHI), with attendant risks of organ-injury and longer-term sequalae, from lesser forms of incapacity associated with strenuous physical exertion. Early evidence for injury at point-ofincapacity could aid the development and application of targeted interventions to improve outcomes. We aimed to investigate whether biomarker surrogates for end-organ damage sampled at point-of-care (POC) could discriminate EHI versus successful marathon performance. Methods Eight runners diagnosed as EHI cases upon reception to medical treatment facilities and 30 successful finishers of the same cool weather marathon (ambient temperature 8 rising to 12 degrees C) were recruited. Emerging clinical markers associated with injury affecting the brain (neuron specific enolase, NSE; S100 calcium-binding protein B, S100) and renal system (cystatin C, cysC; kidney-injury molecule-1, KIM-1; neutrophil gelatinase-associated lipocalin, NGAL), plus copeptin as a surrogate for fluid-regulatory stress, were sampled in blood upon marathon collapse/completion, as well as beforehand at rest (successful finishers only). Results Versus successful finishers, EHI showed significantly higher NSE (10.33 [6.37, 20.00] vs. 3.17 [2.71, 3.92] ug.L-1, P<0.0001), cysC (1.48 [1.10, 1.67] vs. 1.10 [0.95, 1.21] mg.L-1, P = 0.0092) and copeptin (339.4 [77.0, 943] vs. 18.7 [7.1, 67.9] pmol.L-1, P = 0.0050). Discrimination of EHI by ROC (Area-Under-the- Curve) showed performance that was outstanding for NSE (0.97, P<0.0001) and excellent for copeptin (AUC = 0.83, P = 0.0066). Conclusions As novel biomarker candidates for EHI outcomes in cool-weather endurance exercise, early elevations in NSE and copeptin provided sufficient discrimination to suggest utility at point-of-incapacity. Further investigation is warranted in patients exposed to greater thermal insult, followed up over a more extended period.	[Stacey, Michael J.; Parsons, Iain T.; Woods, David R.] Royal Ctr Def Med, Acad Dept Mil Med, Birmingham, W Midlands, England; [Stacey, Michael J.; Brett, Stephen J.] Imperial Coll London, Dept Surg & Canc, London, England; [Stacey, Michael J.; Parsons, Iain T.; O'Hara, John P.; Woods, David R.] Leeds Beckett Univ, Carnegie Sch Sport, Leeds, W Yorkshire, England; [Hill, Neil E.] Imperial Coll London, Dept Metab Digest & Reprod, London, England; [Parsons, Iain T.] Kings Coll London, Sch Cardiovasc Med & Sci, London, England; [Wallace, Jenny; Taylor, Natalie] Natl Hlth Serv Wales, Cardiff, Wales; [Grimaldi, Rachael] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Shah, Nishma; Marshall, Anna] UCL, London, England; [House, Carol] Inst Naval Med, Environm Med Serv, Gosport, Hants, England; [Brett, Stephen J.] Hammersmith Hosp, Gen Intens Care Unit, London, England	Royal Centre for Defence Medicine; Imperial College London; Leeds Beckett University; Imperial College London; University of London; King's College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of London; University College London; Imperial College London	Stacey, MJ (corresponding author), Royal Ctr Def Med, Acad Dept Mil Med, Birmingham, W Midlands, England.; Stacey, MJ (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.; Stacey, MJ (corresponding author), Leeds Beckett Univ, Carnegie Sch Sport, Leeds, W Yorkshire, England.	m.stacey13@imperial.ac.uk		Parsons, Iain/0000-0002-8577-8289	Ministry of Defence	Ministry of Defence	The sources of funding for the study were (a) direct financial support from the Ministry of Defence to cover assay costs, salaries of involved military personnel, their temporary accommodation if required close to the study site and (b) material hosting by the Brighton marathon medical team, who provided medical tentage in which the study was performed and appropriate screens to protect volunteer dignity while being sampled etc. No formal numbered grant award was made, rather the MoD raised and settled purchase orders e.g. with Affinity Biomarkers, the commercial company that assayed the chemistry reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245210; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Breslow RG, 2021, CLIN J SPORT MED, V31, pE499, DOI 10.1097/JSM.0000000000000829; Carter R, 2005, MED SCI SPORT EXER, V37, P1338, DOI 10.1249/01.mss.0000174895.19639.ed; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Dickinson J G, 1989, J R Army Med Corps, V135, P27; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Epstein Y, 2019, NEW ENGL J MED, V380, P2449, DOI 10.1056/NEJMra1810762; Feng Q, 2017, Zhonghua Nei Ke Za Zhi, V56, P747, DOI 10.3760/cma.j.issn.0578-1426.2017.10.008; Horowitz M, 2021, J PHYSIOL-LONDON, V599, P7, DOI 10.1113/JP280928; Hosokawa Y, 2018, INT J BIOMETEOROL, V62, P1147, DOI 10.1007/s00484-018-1517-3; Jochberger S, 2006, J CLIN ENDOCR METAB, V91, P4381, DOI 10.1210/jc.2005-2830; Junglee NA, 2013, AM J PHYSIOL-RENAL, V305, pF813, DOI 10.1152/ajprenal.00091.2013; Korley FK, COMP GFAP UCH L1 MEA, V2021, DOI [10.1089/neur.2020.0037, DOI 10.1089/NEUR.2020.0037]; Leon LR, 2015, COMPR PHYSIOL, V5, P611, DOI 10.1002/cphy.c140017; Macaluso F, 2013, WILD ENVIRON MED, V24, P362, DOI 10.1016/j.wem.2013.04.008; MALAMUD N, 1946, Mil Surg, V99, P397; Mansour SG, 2019, CLIN J AM SOC NEPHRO, V14, P1297, DOI 10.2215/CJN.01400219; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Omassoli J, 2019, J SCI MED SPORT, V22, P1004, DOI 10.1016/j.jsams.2019.04.010; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1748, DOI 10.1681/ASN.2010121302; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Roberts WO, 2007, SPORTS MED, V37, P440, DOI 10.2165/00007256-200737040-00044; Sabbisetti VS, 2014, J AM SOC NEPHROL, V25, P2177, DOI 10.1681/ASN.2013070758; Scherman H, 2018, J ATHL TRAINING, V53, P423, DOI 10.4085/1062-6050-519-16; SHIBOLET S, 1967, Q J MED, V36, P525; STEFANINI M, 1971, AM J CLIN PATHOL, V55, P180; Walter E, 2021, EUR J APPL PHYSIOL, V121, P1179, DOI 10.1007/s00421-021-04603-w; Wang Q, 2012, FORENSIC SCI INT, V219, P259, DOI 10.1016/j.forsciint.2012.01.015; Wesseling C, 2016, ENVIRON RES, V147, P125, DOI 10.1016/j.envres.2016.02.002; Wu L, 2019, J CRIT CARE, V52, P172, DOI 10.1016/j.jcrc.2019.04.018; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	33	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263873	10.1371/journal.pone.0263873	http://dx.doi.org/10.1371/journal.pone.0263873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176088	Green Published, gold, Green Accepted			2022-12-26	WOS:000777505200041
J	Gu, XM; Hickey, R; Rath, A; Palmer, AF				Gu, Xiangming; Hickey, Richard; Rath, Antara; Palmer, Andre F.			Scalable manufacturing platform for the production of methemoglobin as a non-oxygen carrying control material in studies of cell-free hemoglobin solutions	PLOS ONE			English	Article							NITRIC-OXIDE; BINDING; BLOOD	Methemoglobin (metHb) arises from the oxidation of ferrous hemoglobin (HbFe(2+), Hb) to ferric hemoglobin (HbFe(3+), metHb), which is unable to bind gaseous ligands such as oxygen (O-2) and carbon monoxide (CO), and binds to nitric oxide (NO) significantly slower compared to Hb. Therefore, metHb does not elicit vasoconstriction and systemic hypertension in vivo due to its extremely slow NO scavenging rate in comparison to cell-free Hb, but will induce oxidative tissue injury, demonstrating the potential of using metHb as a control material when studying the toxicity of cell-free Hb. Hence, the goal of this work was to develop a novel manufacturing strategy for production of metHb that is amenable to scale-up. In this study, small scale (e.g. 1 mL reaction volume) screening experiments were initially conducted to determine the optimal molar ratio of Hb to the oxidization agents hydrogen peroxide (H2O2) or sodium nitrite (NaNO2) to achieve the highest conversion of Hb into metHb. A spectral deconvolution program was employed to determine the molar fraction of various species (hemichrome, metHb, oxyHb, metHb-NO2-, and NaNO2) in solution during the oxidation reaction. From this analysis, either a 1:1 or 1:5 molar ratio was identified as optimal molar ratios of Hb:NaNO2 (heme basis) that yielded the highest conversion of Hb into metHb with negligible amounts of side products. Hence in order to reduce the reaction time, a 1:5 molar ratio was chosen for large scale (i.e. 1.5 L reaction volume) synthesis of bovine metHb (metbHb) and human metHb (methHb). The biophysical properties of metHb were then characterized to elucidate the potential of using the synthesized metHb as a non-O-2 carrying control material. The haptoglobin binding kinetics of metHb were found to be similar to Hb. Additionally, the synthesized metHb was stable in phosphate buffered saline (PBS, 50 mM, pH 7.4) at 4 degrees C for approximately one week, indicating the high stability of the material.	[Gu, Xiangming; Hickey, Richard; Rath, Antara; Palmer, Andre F.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Palmer, AF (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu		Hickey, Richard/0000-0002-1675-5497; Gu, Xiangming/0000-0001-9096-5911	NIH [R01HL126945, R01HL138116, R01HL156526, R01HL159862, R01EB021926]; NSF	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	AFP was awarded by NIH grant (R01HL126945, R01HL138116, R01HL156526, R01HL159862, and R01EB021926.) RH was awarded with NSF fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAYASH AI, 1993, ARCH BIOCHEM BIOPHYS, V303, P332, DOI 10.1006/abbi.1993.1292; ATHA DH, 1976, J BIOL CHEM, V251, P5537; Belcher DA, 2020, BIOCONJUGATE CHEM, V31, P605, DOI 10.1021/acs.bioconjchem.9b00766; Buehler PW, 2020, TRENDS MOL MED, V26, P683, DOI 10.1016/j.molmed.2020.02.004; CORDONE L, 1990, BIOPHYS CHEM, V37, P171, DOI 10.1016/0301-4622(90)88017-M; Cruz-Landeira A, 2002, J ANAL TOXICOL, V26, P67, DOI 10.1093/jat/26.2.67; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; FORD WH, 1968, BIOCHIM BIOPHYS ACTA, V160, P1, DOI 10.1016/0005-2795(68)90058-5; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Gu XM, 2022, BIOTECHNOL BIOENG, V119, P176, DOI 10.1002/bit.27962; Gu XM, 2020, BIOTECHNOL BIOENG, V117, P2362, DOI 10.1002/bit.27382; Hahn RG, 2016, EUR J ANAESTH, V33, P475, DOI 10.1097/EJA.0000000000000436; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; KOSAKA H, 1979, BIOCHIM BIOPHYS ACTA, V581, P184, DOI 10.1016/0005-2795(79)90235-6; Lim SK, 2001, REDOX REP, V6, P219, DOI 10.1179/135100001101536364; Manning LR, 1996, PROTEIN SCI, V5, P775; MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104; Martini WZ, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-86; Meng FT, 2018, BIOCONJUGATE CHEM, V29, P1560, DOI 10.1021/acs.bioconjchem.8b00093; Meng FT, 2017, ANAL BIOCHEM, V521, P11, DOI 10.1016/j.ab.2017.01.002; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P189, DOI 10.1002/btpr.119; Pires IS, 2020, BIOTECHNOL PROGR, V36, DOI 10.1002/btpr.3010; Pires IS, 2020, BIOTECHNOL BIOENG, V117, P125, DOI 10.1002/bit.27193; SAWICKI CA, 1981, BIOPHYS J, V35, P265, DOI 10.1016/S0006-3495(81)84788-1; Schwab DE, 2010, INORG CHEM, V49, P6330, DOI 10.1021/ic902085s; SHARMA VS, 1983, BIOCHEMISTRY-US, V22, P3897, DOI 10.1021/bi00285a026; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Sugawara Y, 2003, ACTA PHYSIOL SCAND, V179, P49, DOI 10.1046/j.1365-201X.2003.01142.x; Suzuki Y, 2021, INT J PHARMACEUT, V610, DOI 10.1016/j.ijpharm.2021.121260; Suzuki Y, 2021, J CONTROL RELEASE, V337, P59, DOI 10.1016/j.jconrel.2021.07.015; Svistunenko DA, 2000, BIOCHEM J, V351, P595, DOI 10.1042/0264-6021:3510595; Taguchi K, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8010011; TOMODA A, 1979, BIOCHIM BIOPHYS ACTA, V581, P128, DOI 10.1016/0005-2795(79)90229-0; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; VANSLYKE DD, 1946, J BIOL CHEM, V166, P121; Wang D, 2013, TRANSFUSION, V53, P3149, DOI 10.1111/trf.12162; Welbourn EM, 2017, FREE RADICAL BIO MED, V103, P95, DOI 10.1016/j.freeradbiomed.2016.12.024	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263782	10.1371/journal.pone.0263782	http://dx.doi.org/10.1371/journal.pone.0263782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171971	gold, Green Published			2022-12-26	WOS:000795889700037
J	Sahoo, N; Bhuyan, K; Panda, B; Behura, NC; Biswal, S; Samal, L; Chaudhary, D; Bansal, N; Singh, R; Joshi, VG; Jindal, N; Mahajan, NK; Maan, S; Ravishankar, C; Rajasekhar, R; Radzio-Basu, J; Herzog, CM; Kapur, V; Mor, SK; Goyal, SM				Sahoo, Niranjana; Bhuyan, Kashyap; Panda, Biswaranjan; Behura, Nrushingha Charan; Biswal, Sangram; Samal, Lipismita; Chaudhary, Deepika; Bansal, Nitish; Singh, Renu; Joshi, Vinay G.; Jindal, Naresh; Mahajan, Nand K.; Maan, Sushila; Ravishankar, Chintu; Rajasekhar, Ravindran; Radzio-Basu, Jessica; Herzog, Catherine M.; Kapur, Vivek; Mor, Sunil K.; Goyal, Sagar M.			Prevalence of Newcastle disease and associated risk factors in domestic chickens in the Indian state of Odisha	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; VIRUS; WATERFOWL; GENOTYPES; POULTRY; WEST; PCR	Newcastle disease (ND), caused by Newcastle disease virus (NDV), is a contagious disease that affects a variety of domestic and wild avian species. Though ND is vaccine-preventable, it is a persistent threat to poultry industry across the globe. The disease represents a leading cause of morbidity and mortality in chickens. To better understand the epidemiology of NDV among commercial and backyard chickens of Odisha, where chicken farming is being prioritized to assist with poverty alleviation, a cross-sectional study was conducted in two distinct seasons during 2018. Choanal swabs (n = 1361) from live birds (commercial layers, broilers, and backyard chicken) and tracheal tissues from dead birds (n = 10) were collected and tested by real-time reverse transcription polymerase chain reaction (RT-PCR) for the presence of matrix (M) and fusion (F) genes of NDV. Risk factors at the flock and individual bird levels (health status, ND vaccination status, geographical zone, management system, and housing) were assessed using multivariable logistic regression analyses. Of the 1371 samples tested, 160 were positive for M gene amplification indicating an overall apparent prevalence of 11.7% (95% CI 10.1-13.5%). Circulation of virulent NDV strains was also evident with apparent prevalence of 8.1% (13/160; 95% CI: 4.8-13.4%). In addition, commercial birds had significantly higher odds (75%) of being infected with NDV as compared to backyard poultry (p = 0.01). This study helps fill a knowledge gap in the prevalence and distribution of NDV in apparently healthy birds in eastern India, and provides a framework for future longitudinal research of NDV risk and mitigation in targeted geographies-a step forward for effective control of ND in Odisha.	[Sahoo, Niranjana; Bhuyan, Kashyap; Panda, Biswaranjan; Behura, Nrushingha Charan; Biswal, Sangram; Samal, Lipismita] Odisha Univ Agr & Technol, Coll Vet Sci & Anim Husb, Dept Epidemiol & Prevent Med & Poultry Sci, Bhubaneswar, Odisha, India; [Chaudhary, Deepika; Bansal, Nitish; Singh, Renu; Joshi, Vinay G.; Jindal, Naresh; Mahajan, Nand K.; Maan, Sushila] LalaLajpat Rai Univ Vet & Anim Sci, Coll Vet Sci, Dept Vet Publ Hlth & Epidemiol, Hisar, Haryana, India; [Ravishankar, Chintu; Rajasekhar, Ravindran] Kerala Vet & Anim Sci Univ, Coll Vet & Anim Sci, Dept Vet Microbiol, Pookode, Kerala, India; [Radzio-Basu, Jessica; Herzog, Catherine M.; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Mor, Sunil K.; Goyal, Sagar M.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA	Orissa University of Agriculture & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Minnesota System; University of Minnesota Twin Cities	Sahoo, N (corresponding author), Odisha Univ Agr & Technol, Coll Vet Sci & Anim Husb, Dept Epidemiol & Prevent Med & Poultry Sci, Bhubaneswar, Odisha, India.	niranjanasahoo@hotmail.com	Sahoo, Niranjana/GSN-0995-2022; Herzog, Catherine M./AAS-8881-2020; Mor, Sunil Kumar/M-6325-2018	Herzog, Catherine M./0000-0003-3021-888X; Joshi, Vinay/0000-0001-8872-1838; Mor, Sunil Kumar/0000-0002-1112-088X	United States Department of Defence, Defence Threat Reduction Agency, Biological Threat Reduction Program, Broad Agency Announcement grant [HDTRA1-17-1-0045]	United States Department of Defence, Defence Threat Reduction Agency, Biological Threat Reduction Program, Broad Agency Announcement grant	This project was funded by a United States Department of Defence, Defence Threat Reduction Agency, Biological Threat Reduction Program, Broad Agency Announcement grant HDTRA1-17-1-0045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 2008, DIS POULTRY, V12th, P75; Alexander DJ, 2003, DIS POULTRY, P63; [Anonymous], EpiCollect: a mobile app for collecting data and a web app, enabling users to set up a project, design forms and visualize data. Funded by Welcome Trust; [Anonymous], 2013, 19 LIV CENS 2012 ALL; Census of India, 2011, GOVT INDIA, P2011; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; Dhaygude VS, 2017, VET WORLD, V10, P319, DOI 10.14202/vetworld.2017.319-323; Dimitrov KM, 2019, INFECT GENET EVOL, V74, DOI 10.1016/j.meegid.2019.103917; Dimitrov KM, 2016, ARCH VIROL, V161, P3345, DOI 10.1007/s00705-016-3033-2; ENVIS center of Odishas State of Environment, 2020, US; Farkas T, 2009, J CLIN MICROBIOL, V47, P2114, DOI 10.1128/JCM.01652-08; Fentie T, 2014, TROP ANIM HEALTH PRO, V46, P299, DOI 10.1007/s11250-013-0487-z; Ferreira HL, 2019, VIRUS GENES, V55, P479, DOI 10.1007/s11262-019-01663-1; Gowrakkal M., 2015, INTERNJ CURRENT MICR, V4, P578; Jindal N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-191; Joshi VG, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.725232; Kuhn JH, 2019, NATURE, V566, P318, DOI 10.1038/d41586-019-00599-8; Maan S, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00467-19, 10.1128/mra.00467-19]; Munir M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-46; Nagy A, 2020, TRANSBOUND EMERG DIS, V67, P2000, DOI 10.1111/tbed.13543; Nwanta JA, 2008, WORLD POULTRY SCI J, V64, P416, DOI 10.1017/S0043933908000147; Ogali IN, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/2368597; OIE Terrestrial Manual, 2012, NEWCASTLE DIS; R Core Team, 2021, R LANG ENV STAT; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Snoeck CJ, 2013, APPL ENVIRON MICROB, V79, P7867, DOI 10.1128/AEM.02716-13; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0264028	10.1371/journal.pone.0264028	http://dx.doi.org/10.1371/journal.pone.0264028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171961	gold, Green Published			2022-12-26	WOS:000795889700060
J	Ueki, Y; Zanchin, T; Losdat, S; Karagiannis, A; Otsuka, T; Siontis, GCM; Haner, J; Stortecky, S; Pilgrim, T; Valgimigli, M; Windecker, S; Raber, L				Ueki, Yasushi; Zanchin, Thomas; Losdat, Sylvain; Karagiannis, Alexios; Otsuka, Tatsuhiko; Siontis, George C. M.; Haener, Jonas; Stortecky, Stefan; Pilgrim, Thomas; Valgimigli, Marco; Windecker, Stephan; Raeber, Lorenz			Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium classification	PLOS ONE			English	Article							DUAL ANTIPLATELET THERAPY; CARDIOVASCULAR EVENTS; STENT TRIALS; ADHERENCE; DEFINITIONS; CLOPIDOGREL; MONOTHERAPY; TICAGRELOR; ESC	Aims The Non-adherence Academic Research Consortium (NARC) has recently developed a consensus-based standardized classification for medication non-adherence in cardiovascular clinical trials. We aimed to assess the prevalence of NARC-defined self-reported nonadherence to P2Y12 inhibitors and its impact on clinical outcomes in patients undergoing percutaneous coronary intervention (PCI). Methods and results Using a standardized questionnaire administered at 1 year after PCI, we assessed the 4 NARC-defined non-adherence levels including type, decision-maker, reasons, and timing within the Bern PCI registry. The primary endpoint was the patient-oriented composite endpoint (POCE) defined as a composite of death, myocardial infarction, stroke, and any revascularization at 1 year. The recommended P2Y12 inhibitor duration was 12 months. Among 3,896 patients, P2Y12 inhibitor non-adherence was observed in 647 (17%) patients. Discontinuation was permanent in the majority of patients (84%). The decision was mainly driven by a physician (94%), and rarely by patients (6%). The most frequent reason was risk profile change (43%), followed by unlisted reasons (25%), surgery (17%), and adverse events (14%). Non-adherence occurred early (< 30 days) in 21%, late (30-180 days) in 45%, and very late (> 180 days) in 33%. The majority of POCE events (n = 421/502, 84%) occurred during adherence to the prescribed P2Y12 inhibitor. Permanent discontinuation, doctordriven non-adherence, and risk profile change emerged as independent predictors for POCE. Conclusions In real-world PCI population treated with 1-year DAPT, non-adherence was observed in nearly one-fifth of patients. Non-adherence to P2Y12 inhibitors was associated with worse clinical outcomes, while the risk was related to underlying contexts.	[Ueki, Yasushi; Zanchin, Thomas; Otsuka, Tatsuhiko; Siontis, George C. M.; Haener, Jonas; Stortecky, Stefan; Pilgrim, Thomas; Windecker, Stephan; Raeber, Lorenz] Bern Univ Hosp, Dept Cardiol, Bern, Switzerland; [Losdat, Sylvain; Karagiannis, Alexios] Univ Bern, CTU Bern, Bern, Switzerland; [Valgimigli, Marco] Cardiocentro, Lugano, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Raber, L (corresponding author), Bern Univ Hosp, Dept Cardiol, Bern, Switzerland.	lorenz.raeber@insel.ch	Pilgrim, Thomas/AAS-9120-2021; Häner, Jonas Dominik/H-7662-2019	Pilgrim, Thomas/0000-0001-8721-4068; Häner, Jonas Dominik/0000-0002-1420-8967				Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Bonaca MP, 2016, JAMA CARDIOL, V1, P425, DOI 10.1001/jamacardio.2016.1017; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ferdinand KC, 2017, J AM COLL CARDIOL, V69, P437, DOI 10.1016/j.jacc.2016.11.034; Garcia-Garcia HM, 2018, EUR HEART J, V39, P2192, DOI 10.1093/eurheartj/ehy223; Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Valgimigli M, 2019, EUR HEART J, V40, P2070, DOI 10.1093/eurheartj/ehy377; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Vrijens B, 2008, BMJ-BRIT MED J, V336, P1114, DOI 10.1136/bmj.39553.670231.25; Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263180	10.1371/journal.pone.0263180	http://dx.doi.org/10.1371/journal.pone.0263180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171913	Green Published, gold			2022-12-26	WOS:000795889700014
J	Yamanaka, N; Kanazawa, S; Yamaguchi, MK				Yamanaka, Nanako; Kanazawa, So; Yamaguchi, Masami K.			Infants' brain activity to cartoon face using functional near-infrared spectroscopy	PLOS ONE			English	Article							NEURAL ACTIVATION; PERCEPTION; PREFERENCE; CORTEX	In this study, to investigate whether infants showed face-specific brain activity to a cartoon human face, we conducted a functional near-infrared spectroscopy (fNIRS) experiment and a behavioral experiment. In the fNIRS experiment, we measured the hemodynamic responses of 5- and 6-month-old infants to cartoon female and cartoon character faces using fNIRS. The results showed that the concentration of oxy-Hb increased for cartoon female faces but not for cartoon character faces. This indicates that face-specific brain activity occurred for cartoon female faces but not cartoon character faces, despite the fact that both are faces. In the behavioral experiment, we examined whether the 5- and 6-month-old infants preferred cartoon female faces to cartoon character faces in the upright and inverted conditions. The results showed a preference for cartoon female faces in the upright but not in the inverted condition. This indicates that 5- and 6-month-old infants can perceive cartoon female faces, but not cartoon character faces, as faces. The results of the two experiments indicated that face-specific brain activity occurred for cartoon female faces. This indicates that infants can perceive cartoon female faces as faces.	[Yamanaka, Nanako; Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Tokyo, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan	Chuo University; Japan Womens University	Yamanaka, N (corresponding author), Chuo Univ, Dept Psychol, Tokyo, Japan.	a17.cnay@g.chuo-u.ac.jp			 [17H06343]		This research was financially supported by "Construction of the Face-Body Studies Transcultural Conditions"(17H06343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartocci M, 2000, PEDIATR RES, V48, P18, DOI 10.1203/00006450-200007000-00006; Csibra G, 2004, J PEDIAT NEUROL, V2, P85, DOI DOI 10.1055/S-0035-15; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Gomez J, 2019, NAT HUM BEHAV, V3, P611, DOI 10.1038/s41562-019-0592-8; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Honda Y, 2010, BRAIN RES, V1308, P137, DOI 10.1016/j.brainres.2009.10.046; Ichikawa H, 2019, NEUROIMAGE, V186, P817, DOI 10.1016/j.neuroimage.2018.11.031; Ichikawa H, 2013, NEUROPSYCHOLOGIA, V51, P2556, DOI 10.1016/j.neuropsychologia.2013.08.020; Ichikawa H, 2010, NEUROSCI LETT, V482, P90, DOI 10.1016/j.neulet.2010.06.086; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kobayashi M, 2020, DEV PSYCHOBIOL, V62, P1011, DOI 10.1002/dev.21972; Kobayashi M, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12498; Kobayashi M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00153; Kobayashi M, 2012, J EXP CHILD PSYCHOL, V111, P22, DOI 10.1016/j.jecp.2011.07.008; Lloyd-Fox S, 2009, CHILD DEV, V80, P986, DOI 10.1111/j.1467-8624.2009.01312.x; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Nakato E, 2009, HUM BRAIN MAPP, V30, P462, DOI 10.1002/hbm.20516; Nakato E, 2018, INFANT BEHAV DEV, V50, P257, DOI 10.1016/j.infbeh.2018.01.007; Nakato E, 2011, NEUROIMAGE, V54, P1600, DOI 10.1016/j.neuroimage.2010.09.021; Otsuka Y, 2012, J EXP CHILD PSYCHOL, V111, P164, DOI 10.1016/j.jecp.2010.10.014; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551; Yamashita W, 2014, INFANT BEHAV DEV, V37, P16, DOI 10.1016/j.infbeh.2013.10.003	30	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0262679	10.1371/journal.pone.0262679	http://dx.doi.org/10.1371/journal.pone.0262679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171920	gold, Green Published			2022-12-26	WOS:000795889700007
J	Conte, F; Sibilio, P; Grimaldi, AM; Salvatore, M; Paci, P; Incoronato, M				Conte, Federica; Sibilio, Pasquale; Grimaldi, Anna Maria; Salvatore, Marco; Paci, Paola; Incoronato, Mariarosaria			In silico recognition of a prognostic signature in basal-like breast cancer patients	PLOS ONE			English	Article							SYNTHETASE-ACTIVITY; SURVIVAL ANALYSIS; DNA METHYLATION; GENES; EXPRESSION; MORPHOLOGY; DATABASE; THERAPY; COMPLEX; ATLAS	Background Triple-negative breast cancers (TNBCs) display poor prognosis, have a high risk of tumour recurrence, and exhibit high resistance to drug treatments. Based on their gene expression profiles, the majority of TNBCs are classified as basal-like breast cancers. Currently, there are not available widely-accepted prognostic markers to predict outcomes in basal-like subtype, so the selection of new prognostic indicators for this BC phenotype represents an unmet clinical challenge. Results Here, we attempted to address this challenging issue by exploiting a bioinformatics pipeline able to integrate transcriptomic, genomic, epigenomic, and clinical data freely accessible from public repositories. This pipeline starts from the application of the well-established net-work-based SWIM methodology on the transcriptomic data to unveil important (switch) genes in relation with a complex disease of interest. Then, survival and linear regression analyses are performed to associate the gene expression profiles of the switch genes with both the patients' clinical outcome and the disease aggressiveness. This allows us to identify a prognostic gene signature that in turn is fed to the last step of the pipeline consisting of an analysis at DNA level, to investigate whether variations in the expression of identified prognostic switch genes could be related to genetic (copy number variations) or epigenetic (DNA methylation differences) alterations in their gene loci, or to the activities of transcription factors binding to their promoter regions. Finally, changes in the protein expression levels corresponding to the so far identified prognostic switch genes are evaluated by immunohistochemical staining results taking advantage of the Human Protein Atlas. Conclusion The application of the proposed pipeline on the dataset of The Cancer Genome Atlas (TCGA)-Breast Invasive Carcinoma (BRCA) patients affected by basal-like subtype led to an in silico recognition of a basal-like specific gene signature composed of 11 potential prognostic biomarkers to be further investigated.	[Conte, Federica; Sibilio, Pasquale; Paci, Paola] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Sibilio, Pasquale] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy; [Grimaldi, Anna Maria; Salvatore, Marco; Incoronato, Mariarosaria] IRCCS Synlab SDN SpA, Naples, Italy; [Paci, Paola] Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Sapienza University Rome; Sapienza University Rome	Paci, P (corresponding author), CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy.; Paci, P (corresponding author), Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy.	paci@diag.uniroma1.it	Grimaldi, Anna Maria/K-2078-2019	Grimaldi, Anna Maria/0000-0002-3957-9780; Paci, Paola/0000-0002-9393-2047; Sibilio, Pasquale/0000-0001-8477-9020	PRIN 2017 Settore ERC LS2 - Codice Progetto [20178L3P38]; Ministry of Health [RRC-2020-523 23669967, 2015 5M-20152360353]	PRIN 2017 Settore ERC LS2 - Codice Progetto; Ministry of Health	This work was supported by PRIN 2017 Settore ERC LS2 - Codice Progetto 20178L3P38, the Ministry of Health under contract "Ricerca Corrente RRC-2020-523 23669967" and in part under contract "5 per mille 2015 5M-20152360353". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khadairi G, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1757-3; Albande MAH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00049; Andres SA, 2015, BREAST CANCER RES TR, V152, P545, DOI 10.1007/s10549-015-3507-z; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caldera M., 2017, CURR OPIN SYST BIOL, V3, P88, DOI [10.1016/j.coisb.2017.04.015, DOI 10.1016/J.COISB.2017.04.015]; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chen DQ, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/539721; Cheng FX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05116-5; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Falcone R, 2019, ENDOCRINE, V64, P406, DOI 10.1007/s12020-019-01890-4; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Fiscon G, 2021, FEBS LETT, V595, P1569, DOI 10.1002/1873-3468.14085; Fiscon G, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2421-x; Fiscon G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26081-5; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grimaldi AM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.668464; Grimaldi AM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186690; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2021, COMPUT STRUCT BIOTEC, V19, P4101, DOI 10.1016/j.csbj.2021.07.014; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Hao S, 2016, ONCOTARGET, V7, P24824, DOI 10.18632/oncotarget.8531; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Huang M, 2011, MOL PHARMACOL, V80, P40, DOI 10.1124/mol.110.070284; Jin GC, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00100-y; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31804; Kim JT, 2019, J CANCER, V10, P6142, DOI 10.7150/jca.32339; KIZAKI H, 1980, CANCER RES, V40, P3921; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Koppula P, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0288-x; Lin CC, 2018, CANCER LETT, V438, P165, DOI 10.1016/j.canlet.2018.09.022; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Maire V, 2019, CANCER MED-US, V8, P325, DOI 10.1002/cam4.1923; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166422; Milioli HH, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0250-9; Munzone E, 2012, BREAST CANCER RES TR, V134, P277, DOI 10.1007/s10549-012-2040-6; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Nami B, 2018, CANCERS, V10, DOI 10.3390/cancers10080274; Osthus RC, 2005, CANCER RES, V65, P5620, DOI 10.1158/0008-5472.CAN-05-0536; Paci P, 2021, NPJ SYST BIOL APPL, V7, DOI 10.1038/s41540-020-00168-0; Paci P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60228-7; Paci P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44797; Palumbo MC, 2014, PLANT CELL, V26, P4617, DOI 10.1105/tpc.114.133710; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Rakha EA, 2008, PATHOBIOLOGY, V75, P95, DOI 10.1159/000123847; Ramos J, 2020, J CANCER RES CLIN, V146, P2777, DOI 10.1007/s00432-020-03320-9; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Rong ZY, 2020, CANCER SCI, V111, P1203, DOI 10.1111/cas.14341; Shahbandi A, 2020, TRENDS CANCER, V6, P98, DOI 10.1016/j.trecan.2020.01.007; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Sun ZW, 2016, GENE, V594, P160, DOI 10.1016/j.gene.2016.09.016; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Wang CCN, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081160; Wang J, 2017, ONCOTARGET, V8, P96215, DOI 10.18632/oncotarget.21894; WEBER G, 1983, CANCER RES, V43, P1019; Wei J, 2020, MOL MED REP, V21, P360, DOI 10.3892/mmr.2019.10837; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WILLIAMS JC, 1978, NATURE, V271, P71, DOI 10.1038/271071a0; Yamane K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30941; Yang YZ, 2014, CANCER RES, V74, P2295, DOI 10.1158/0008-5472.CAN-13-1803; Ye LP, 2018, INT J CANCER, V143, P2602, DOI 10.1002/ijc.31766; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	73	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264024	10.1371/journal.pone.0264024	http://dx.doi.org/10.1371/journal.pone.0264024			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167614	gold, Green Published			2022-12-26	WOS:000802227200035
J	Takechi, H; Tsuzuki, A; Matsumoto, K; Fukui, A; Kawakita, H; Yoshino, H; Kanada, Y				Takechi, Hajime; Tsuzuki, Akira; Matsumoto, Komaki; Fukui, Akane; Kawakita, Hitomi; Yoshino, Hiroshi; Kanada, Yoshikiyo			Differences in the frequency of subjective geriatric complaints along with aging and their associations with physical function, multimorbidity, and mood: A cross-sectional study	PLOS ONE			English	Article							OLDER-ADULTS; SYMPTOM BURDEN; FRAILTY; HEALTH; CARE; CHALLENGES; PREVALENCE	Background In this study, we investigated subjective geriatric complaints (SGCs) as conditions regarding health concerns in community-dwelling older people and analyzed their frequencies with aging and relationships with other factors. Methods This cross-sectional study enrolled 10,434 older people living in a community with a representative aging population in Japan. A questionnaire was sent by mail to those who had not applied for formal care needs certification. The presence of and concern for symptoms common in old age were asked as SGCs, as were physical function levels, multimorbidity, and depression. Categorical principal component analysis (CATPCA) of the symptoms was performed, and the association between the obtained components and other factors was analyzed. Results The mean age of the participants was 73.7 6.1 years, and 52.5% were women. On average, they had 1.72 +/- 1.57 SGCs, which showed a gradual increase with age. The results of the CATPCA revealed four components: SGC1, excretory/circulatory/swallowing complaints; SGC2, audiovisual complaints; SGC3, neurological complaints; and SGC4, musculoskeletal complaints. All SGC components were independently associated with physical function, multimorbidity, and depression. Conclusions Each SGC showed various frequencies and differences along with aging, and SGCs were classified into four components that were thought to share a common background. These findings could contribute to the planning of better health management strategies for older people.	[Takechi, Hajime; Yoshino, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Geriatr & Cognit Disorders, Toyoake, Aichi, Japan; [Tsuzuki, Akira] Fujita Hlth Univ, Fac Rehabil, Sch Hlth Sci, Toyoake, Aichi, Japan; [Matsumoto, Komaki; Fukui, Akane; Kanada, Yoshikiyo] Toyoake City Municipal Off, Dept Community Care, Toyoake, Aichi, Japan; [Kawakita, Hitomi] Kyoto Univ, Fac Human Hlth Sci, Grad Sch Med, Kyoto, Japan	Fujita Health University; Fujita Health University; Kyoto University	Takechi, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Geriatr & Cognit Disorders, Toyoake, Aichi, Japan.	takechi@fujita-hu.ac.jp			Fujita Health University	Fujita Health University	This study was supported by a grant for promoting research from Fujita Health University (to H.T.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anpalahan M, 2008, INTERN MED J, V38, P16, DOI 10.1111/j.1445-5994.2007.01398.x; Aoki T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21917-6; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beauchet O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100636; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Dent E, 2019, LANCET, V394, P1376, DOI 10.1016/S0140-6736(19)31785-4; Flacker JM, 2003, J AM GERIATR SOC, V51, P574, DOI 10.1046/j.1532-5415.2003.51174.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; HALE WE, 1986, J AM GERIATR SOC, V34, P333, DOI 10.1111/j.1532-5415.1986.tb04315.x; Henchoz Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014485; Hirosaki M, 2017, INT PSYCHOGERIATR, V29, P1475, DOI 10.1017/S1041610217000692; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hubbard RE, 2017, AGE AGEING, V46, P801, DOI 10.1093/ageing/afx081; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Isaacs B, 1992, CHALLENGE GERIATRIC; JARRETT PG, 1995, ARCH INTERN MED, V155, P1060, DOI 10.1001/archinte.155.10.1060; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Kuzuya M, 2019, GERIATR GERONTOL INT, V19, P699, DOI 10.1111/ggi.13742; Lakhan P, 2011, J AM GERIATR SOC, V59, P2001, DOI 10.1111/j.1532-5415.2011.03663.x; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Murphy SL, 2002, J AM GERIATR SOC, V50, P516, DOI 10.1046/j.1532-5415.2002.50119.x; Olde Rikkert MG., 2017, OXFORD TXB GERIATRIC, V3rd ed, P355; Patel KV, 2019, J AM GERIATR SOC, V67, P223, DOI 10.1111/jgs.15673; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Rikkert MGMO, 2003, NETH J MED, V61, P83; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Salanitro AH, 2012, J AM GERIATR SOC, V60, P1632, DOI 10.1111/j.1532-5415.2012.04121.x; Sampaio PYS, 2016, GERIATR GERONTOL INT, V16, P893, DOI 10.1111/ggi.12833; Sanford AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233857; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Stevenson JM, 2020, AGE AGEING, V49, P7, DOI 10.1093/ageing/afz121; Syddall H, 2010, AGE AGEING, V39, P197, DOI 10.1093/ageing/afp204; Takechi H, 2020, GERIATR GERONTOL INT, V20, P867, DOI 10.1111/ggi.13992; Theou O, 2015, AGE AGEING, V44, P471, DOI 10.1093/ageing/afv010; Thillainadesan J, 2020, AGE AGEING, V49, P758, DOI 10.1093/ageing/afaa112; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Walston J, 2018, CLIN GERIATR MED, V34, P25, DOI 10.1016/j.cger.2017.09.004; Whitson HE, 2009, J AM GERIATR SOC, V57, P676, DOI 10.1111/j.1532-5415.2009.02178.x; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Won CW, 2013, EUR GERIATR MED, V4, P335, DOI 10.1016/j.eurger.2013.07.005; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Zamudio-Rodriguez A, 2020, AGE AGEING, V49, P764, DOI 10.1093/ageing/afaa031	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263889	10.1371/journal.pone.0263889	http://dx.doi.org/10.1371/journal.pone.0263889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148335	Green Published, gold			2022-12-26	WOS:000800108800040
J	de Almeida, JM; Matheus, HR; Alves, BES; Gusman, DJR; Nagata, MJH; Furquim, EMD; Ervolino, E				de Almeida, Juliano Milanezi; Matheus, Henrique Rinaldi; Sendao Alves, Breno Edson; Rodrigues Gusman, David Jonathan; Hitomi Nagata, Maria Jose; de Abreu Furquim, Elisa Mara; Ervolino, Edilson			Evaluation of antimicrobial photodynamic therapy with acidic methylene blue for the treatment of experimental periodontitis	PLOS ONE			English	Article							CITRIC-ACID; LISTERIA-MONOCYTOGENES; PERI-IMPLANTITIS; EXPRESSION; ADHESION; DENTIN; DEMINERALIZATION; INFLAMMATION; PRINCIPLES; BIOFILMS	Objective To investigate the security and effectiveness of antimicrobial photodynamic therapy (aPDT) with a citric acid-based methylene blue (MB) on the periodontal repair following the treatment of ligature-induced experimental periodontitis (EP) in rats. Material and methods Were used 120 male rats, randomly divided into 4 experimental groups (n = 30): no treatment (NT), SRP alone (SRP), SRP plus aPDT using conventional MB pH 7.0 (aPDT-pH7), SRP plus aPDT using acidic MB pH 1.0 (aPDT-pH1). EP was induced at day 0 by the placement of a ligature around the mandibular left first molars. Ten animals per group/period were euthanized at 14, 22 and 37 days. Histopathological, histometric (percentage of bone in the furcation [PBF]) and immunohistochemical (for tartrate-resistant acid phosphatase [TRAP] and osteocalcin [OCN]) analyses were performed. Data were statistically analyzed. Results aPDT-pH1 showed the highest PBF as compared with the other treatments. Collectively, tissues' reaction to both dyes were controlled and healthy for the periodontium. Both aPDT protocols reduced the extent and intensity of the local inflammatory response, reduced the alveolar bone resorption, and promoted a better structural arrangement of the connective tissue as compared with SRP. TRAP expression was downregulated while OCN expression was upregulated by aPDT as compared with SRP alone. Conclusion Our data implicate that the novel MB pH 1.0 is as safe as the conventional MB for use in aPDT and raises its additional benefit of increasing the amount of alveolar bone in the furcation.	[de Almeida, Juliano Milanezi; Matheus, Henrique Rinaldi; Sendao Alves, Breno Edson; Rodrigues Gusman, David Jonathan; Hitomi Nagata, Maria Jose; de Abreu Furquim, Elisa Mara] Sao Paulo State Univ Unesp, Sch Dent, Dept Diag & Surg, Periodont Div, Aracatuba, Brazil; [de Almeida, Juliano Milanezi; Matheus, Henrique Rinaldi; Sendao Alves, Breno Edson; Rodrigues Gusman, David Jonathan; Hitomi Nagata, Maria Jose; de Abreu Furquim, Elisa Mara; Ervolino, Edilson] Sao Paulo State Univ Unesp, Nucleus Study & Res Periodont & Implantol NEPPI, Sch Dent, Aracatuba, SP, Brazil; [Ervolino, Edilson] Sao Paulo State Univ Unesp, Sch Dent, Dept Basic Sci, Aracatuba, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	de Almeida, JM (corresponding author), Sao Paulo State Univ Unesp, Sch Dent, Dept Diag & Surg, Periodont Div, Aracatuba, Brazil.; de Almeida, JM (corresponding author), Sao Paulo State Univ Unesp, Nucleus Study & Res Periodont & Implantol NEPPI, Sch Dent, Aracatuba, SP, Brazil.	jumilanezi@hotmail.com	de Abreu Furquim, Elisa Mara/AAI-2683-2020; /F-7995-2012	de Abreu Furquim, Elisa Mara/0000-0002-0618-2787; /0000-0002-5995-5747; Rinaldi Matheus, Henrique/0000-0003-3318-5980				Adamopoulos IE, 2018, CURR OPIN RHEUMATOL, V30, P59, DOI 10.1097/BOR.0000000000000449; Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Arany PR, 2016, J DENT RES, V95, P977, DOI 10.1177/0022034516648939; Araujo NC, 2014, LASER MED SCI, V29, P629, DOI 10.1007/s10103-013-1369-3; Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; Bertero E, 2018, CIRC RES, V122, P1460, DOI 10.1161/CIRCRESAHA.118.310082; BEUCHAT LR, 1989, FOOD TECHNOL-CHICAGO, V43, P134; Braham P, 2009, J PERIODONTOL, V80, P1790, DOI 10.1902/jop.2009.090214; BUCHANAN RL, 1994, J FOOD PROTECT, V57, P567, DOI 10.4315/0362-028X-57.7.567; Burel C, 2021, LETT APPL MICROBIOL, V72, P332, DOI 10.1111/lam.13420; Cadore UB, 2019, J PERIODONTOL, V90, P339, DOI 10.1002/JPER.18-0373; Carrera ET, 2016, LASER PHYS, V26, DOI 10.1088/1054-660X/26/12/123001; Chambrone L, 2018, J PERIODONTOL, V89, P783, DOI 10.1902/jop.2017.170172; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Dascalu LM, 2020, MATERIALS, V13, DOI 10.3390/ma13133012; De Almeida J, 2015, J PERIODONTOL, V86, P1166, DOI 10.1902/jop.2015.150166; de Almeida JM, 2008, J PERIODONTOL, V79, P2156, DOI [10.1902/jop.2008.080103, 10.1902/jop.2008.080103 ]; de Freitas LM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050769; de Molon RS, 2014, J PERIODONTOL, V85, P465, DOI 10.1902/jop.2013.130225; de Oliveira RR, 2007, J PERIODONTOL, V78, P965, DOI 10.1902/jop.2007.060494; de Rezende MLR, 2015, J PERIODONTOL, V86, P146, DOI 10.1902/jop.2014.130657; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Eke PI, 2018, J AM DENT ASSOC, V149, P576, DOI 10.1016/j.adaj.2018.04.023; Ghorbani Jaber, 2018, Laser Ther, V27, P293, DOI 10.5978/islsm.27_18-RA-01; Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011; Horowitz M., 2006, BONE RESORPTION, P91; Htet M, 2016, J PERIODONTOL, V87, P953, DOI 10.1902/jop.2016.150615; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; JOHNSON IH, 1975, J PERIODONTAL RES, V10, P332, DOI 10.1111/j.1600-0765.1975.tb00042.x; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Klepac-Ceraj V, 2011, LASER SURG MED, V43, P600, DOI 10.1002/lsm.21069; Matheus HR, 2018, J CLIN PERIODONTOL, V45, P241, DOI 10.1111/jcpe.12824; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Misra DN, 1996, J DENT RES, V75, P1418, DOI 10.1177/00220345960750061401; Mizutani K, 2016, PERIODONTOL 2000, V71, P185, DOI 10.1111/prd.12123; MOUGHAL NA, 1992, J PERIODONTAL RES, V27, P623, DOI 10.1111/j.1600-0765.1992.tb01746.x; Nikinmaa S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232775; Pfitzner A, 2004, J PERIODONTOL, V75, P1343, DOI 10.1902/jop.2004.75.10.1343; Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x; Qi ML, 2019, INT J NANOMED, V14, P6937, DOI 10.2147/IJN.S212807; Qin YL, 2008, J PERIODONTAL RES, V43, P162, DOI 10.1111/j.1600-0765.2007.01007.x; Ren L, 2005, J PERIODONTOL, V76, P1950, DOI 10.1902/jop.2005.76.11.1950; Renvert S, 2002, J CLIN PERIODONTOL, V29, P82, DOI 10.1034/j.1600-051X.29.s-3.2.x; Gusman DJR, 2019, J CLIN PERIODONTOL, V46, P457, DOI 10.1111/jcpe.13101; Gusman DJR, 2018, CLIN ORAL INVEST, V22, P361, DOI 10.1007/s00784-017-2120-4; Romanova NA, 2003, APPL ENVIRON MICROB, V69, P6393, DOI 10.1128/AEM.69.11.6393-6398.2003; ROVIN SHELDON, 1966, J PERIODONTAL RES, V1, P193, DOI 10.1111/j.1600-0765.1966.tb01860.x; Ruggeri A, 2007, ARCH ORAL BIOL, V52, P1, DOI 10.1016/j.archoralbio.2006.07.001; Sharma M, 2008, ANTIMICROB AGENTS CH, V52, P299, DOI 10.1128/AAC.00988-07; Shih MH, 2013, PHOTODIAGN PHOTODYN, V10, P664, DOI 10.1016/j.pdpdt.2013.07.003; Souza JGS, 2019, J PERIODONTOL, V90, P149, DOI 10.1002/JPER.18-0178; STERRETT JD, 1993, J CLIN PERIODONTOL, V20, P366, DOI 10.1111/j.1600-051X.1993.tb00374.x; Subramanian S, 2017, J CLIN DIAGN RES, V11, pZC82, DOI 10.7860/JCDR/2017/27768.10443; Tonetti MS, 1997, J PERIODONTAL RES, V32, P104, DOI 10.1111/j.1600-0765.1997.tb01389.x; Zhang XM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4170	56	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263103	10.1371/journal.pone.026310	http://dx.doi.org/10.1371/journal.pone.026310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143492				2022-12-26	WOS:000797657800023
J	Gebrezgabiher, G; Yewhalaw, D; Ayana, M; Hailu, A; Mekonnen, Z				Gebrezgabiher, Gebremedhin; Yewhalaw, Delenasaw; Ayana, Mio; Hailu, Asrat; Mekonnen, Zeleke			Impact of ivermectin mass drug administration on burden of soil-transmitted helminths in onchocerciasis control and elimination programs, Yeki district, southwest Ethiopia	PLOS ONE			English	Article							INTESTINAL HELMINTHS; EFFICACY; ALBENDAZOLE; INFECTIONS; PREVALENCE; VOLVULUS; ASCARIS	Community-directed treatment with ivermectin (CDTi) is the primary strategy employed to control and eliminate human onchocerciasis in Ethiopia. After long-term mass distribution for onchocerciasis, ivermectin is expected to have additional benefits beyond the envisioned targets by reducing the burden of other co-endemic parasitic infections as to STHs. To date, studies focused on the collateral impact of CDTi on STH in Ethiopia are scanty. Two community-based cross-sectional surveys (baseline in 1997 and post-CDTi in 2017) were conducted to evaluate the impact of long-term CDTi employed to control and eliminate onchocerciasis on the burden of STH infections in Yeki district of southwest Ethiopia. Stool samples were collected and examined using Ritchie's concentration and Kato-Katz techniques in the baseline and current study, respectively. Overall, 188(38.3%, 95% Confidence interval (CI) 34.1-42.7%) individuals were positive at least for any of the STH species from 491 study participants in the post-CDTi. The prevalence of A. lumbricoides, hookworms, and T. trichiura was 11.2% (95% CI 8.7-14.3%), 16.3% (95% CI 13.3-19.8%), and 29.9% (95% CI 26.1-34.1%), respectively. Individuals aged 5-9 years had a significantly higher prevalence of A. lumbricoides (Adjusted odds ratio (AOR) 6.5, 95% CI 1.7-25.4), T. trichuria (AOR 8, 95% CI 2.6-25.1), and any STH infection (AOR 5, 95% CI 1.7-14.7) than those of >= 51 years. Also, significantly higher prevalences of T. trichuria infection were observed in individuals aged 10-14 years (AOR 4.1, 95% CI 1.7-9.9), 15-20 years (AOR 3.1, 95% CI 1.2-8.1), 21-30 years (AOR 2.4, 95% CI 1.1-5.5), and 31-40 years (AOR 3.2, 95% CI 1.3-7.5) compared with those of >= 51 years. The prevalence of A. lumbricoides was significantly higher in males (AOR 0.5, 95% CI 0.3-0.9). Of the 491 study participants, only data from 400 individuals who had not been involved in a mass drug administration (MDA) with other STH anthelmintics were considered in the comparative analysis. Before CDTi, the prevalence of A. lumbricoides, T. trichiura, hookworm, and any STH infection was 47.1% (95% CI 41.6-52.7%), 3.3% (95% CI 1.8-5.9%), 37.9% (95% CI 32.7-43.5%), and 58.8% (95% CI 53.2-64.1%), respectively. Long-term CDTi considerably reduced the prevalences of A. lumbricoides and hookworm by 76.2% and 56.9%, respectively (p < 0.001). Nonetheless, CDTi did not affect the prevalence of T. trichiura infection and, in contrast, it was significantly higher in the current study (P < 0.001). Overall post-CDTi prevalence of any STH infection was considerably lower than reported in the baseline (p < 0.001). It is evidenced that long-term CDTi for onchocerciasis control and elimination had additional benefits by reducing the prevalence of STH infections specifically of A. lumbricoides and hookworm, but had no impact on infections with T. trichuria. Our finding of additional health benefits of large-scale ivermectin administration taking it will aid to increase positive engagement and sustain participation of communities during MDA campaigns, and strengthen governmental and non-governmental organizations (NGOs) support for the undergoing national onchocerciasis elimination program.	[Gebrezgabiher, Gebremedhin; Yewhalaw, Delenasaw; Ayana, Mio; Mekonnen, Zeleke] Jimma Univ, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia; [Gebrezgabiher, Gebremedhin] Samara Univ, Coll Vet Med, Samara, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Hailu, Asrat] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia	Jimma University; Samara University; Jimma University; Addis Ababa University	Gebrezgabiher, G (corresponding author), Jimma Univ, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia.; Gebrezgabiher, G (corresponding author), Samara Univ, Coll Vet Med, Samara, Ethiopia.	gebruska2012@yahoo.com	Gebrezgabiher, Gebremedhin/GLV-3693-2022	Gebrezgabiher, Gebremedhin/0000-0002-0597-0407; Mekonnen, Zeleke/0000-0003-3418-7291	Institute of Health, Jimma University	Institute of Health, Jimma University	DY, ZM, GG. The research was funded by the Institute of Health, Jimma University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuar TS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04101; Awadzi K, 2003, ANN TROP MED PARASIT, V97, P165, DOI 10.1179/000349803235001697; BA B., 2016, NEGLECTED TROPICAL D, P87; Beach MJ, 1999, AM J TROP MED HYG, V60, P479, DOI 10.4269/ajtmh.1999.60.479; BEHNKE JM, 1994, J HELMINTHOL, V68, P187, DOI 10.1017/S0022149X00014334; Belizario VY, 2003, B WORLD HEALTH ORGAN, V81, P35; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Crump A, 2017, J ANTIBIOT, V70, P495, DOI 10.1038/ja.2017.11; Crump A, 2012, TRENDS PARASITOL, V28, P280, DOI 10.1016/j.pt.2012.04.005; Deribew A, 2017, Ethiop Med J, V55, P3; DUKE BOL, 1990, AM J TROP MED HYG, V43, P657, DOI 10.4269/ajtmh.1990.43.657; Etya'ale D, 2001, Community Eye Health, V14, P19; FDRE, 2015, HLTH SECT TRANSF PLA, P1; Federal Ministry of Health, 2019, TACKL NEGL TROP DIS, P21; Federal Ministry of Health, 2016, 2 ED ETH NAT MAST PL, Vsecond, P1; Federal Ministry of Health, 2015, GUID ONCH EL ETH ADD; FREEDMAN DO, 1989, J INFECT DIS, V159, P1151, DOI 10.1093/infdis/159.6.1151; Gebretsadik GG, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03151-z; Gutman J, 2010, AM J TROP MED HYG, V83, P534, DOI 10.4269/ajtmh.2010.10-0033; Heukelbach J, 2004, B WORLD HEALTH ORGAN, V82, P563; Hopkins Adrian, 2017, Community Eye Health, V30, P92; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Jejaw A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1952-6; Karagiannis-Voules DA, 2015, LANCET INFECT DIS, V15, P74, DOI 10.1016/S1473-3099(14)71004-7; Khurana S, 2021, RES REP TROP MED, V12, P181, DOI 10.2147/RRTM.S278140; Krotneva SP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004051; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Moncayo AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000293; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Maegga BTA., 2006, TANZAN J HLTH RES, V8, P70; Marti H, 1996, AM J TROP MED HYG, V55, P477, DOI 10.4269/ajtmh.1996.55.477; Mengistu G, 2002, ETHIOPIAN MED J, V40, P19; Meribo Kadu, 2017, Ethiop Med J, V55, P55; Moser W, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4307; NAQUIRA C, 1989, AM J TROP MED HYG, V40, P304, DOI 10.4269/ajtmh.1989.40.304; Negussu Nebiyu, 2017, Ethiop Med J, V55, P75; Oluwole Akinola Stephen, 2017, Parasite Epidemiol Control, V2, P21, DOI 10.1016/j.parepi.2017.01.002; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; QGIS Development Team, 2021, QGIS GEOGR INF SYST; Ranque S, 2001, ANN TROP MED PARASIT, V95, P389, DOI 10.1080/00034980120065822; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; TATICHEFF S, 1994, ETHIOPIAN MED J, V32, P7; Tchuente LAT, 2011, ACTA TROP, V120, pS4, DOI 10.1016/j.actatropica.2010.07.001; Tekalign E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3687873; Turner HC, 2017, TRENDS PARASITOL, V33, P435, DOI 10.1016/j.pt.2017.01.007; WHITWORTH JAG, 1991, T ROY SOC TROP MED H, V85, P232, DOI 10.1016/0035-9203(91)90037-Y; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; World Health Organization, 1991, BAS LAB METH MED PAR, P1; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, FRAM EST EXP SPEC PR, P1; Yemeli LD., 2020, PLOS NEGL TROP DIS, V14, P1	55	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263625	10.1371/journal.pone.0263625	http://dx.doi.org/10.1371/journal.pone.0263625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143567	gold, Green Published			2022-12-26	WOS:000797657800065
J	Zhang, T; Wang, Y; Li, Q; Lin, LY; Xu, CL; Xue, YQ; Hu, MY; Shi, YF; Wang, Y				Zhang, Tao; Wang, Yu; Li, Qing; Lin, Liangyu; Xu, Chunliang; Xue, Yueqing; Hu, Mingyuan; Shi, Yufang; Wang, Ying			Mesenchymal stromal cells equipped by IFN alpha empower T cells with potent anti-tumor immunity	ONCOGENE			English	Article							I INTERFERON; DENDRITIC CELLS; TUMOR-METASTASIS; PD-1 BLOCKADE; RESPONSES; MELANOMA; CXCR3; EXPRESSION; INSIGHTS; GENES	Cancer treatments have been revolutionized by the emergence of immune checkpoint blockade therapies. However, only a minority of patients with various tumor types have benefited from such treatments. New strategies focusing on the immune contexture of the tumor tissue microenvironment hold great promises. Here, we created IFN alpha-overexpressing mesenchymal stromal cells (IFN alpha-MSCs). Upon direct injection into tumors, we found that these cells are powerful in eliminating several types of tumors. Interestingly, the intra-tumoral injection of IFN alpha-MSCs could also induce specific anti-tumor effects on distant tumors. These IFN alpha-MSCs promoted tumor cells to produce CXCL10, which in turn potentiates the infiltration of CD8(+) T cells in the tumor site. Furthermore, IFN alpha-MSCs enhanced the expression of granzyme B (GZMB) in CD8(+) T cells and invigorated their cytotoxicity in a Stat3-dependent manner. Genetic ablation of Stat3 in CD8(+) T cells impaired the effect of IFN alpha-MSCs on GZMB expression. Importantly, the combination of IFN alpha-MSCs and PD-L1 blockade induced an even stronger anti-tumor immunity. Therefore, IFN alpha-MSCs represent a novel tumor immunotherapy strategy, especially when combined with PD-L1 blockade.	[Zhang, Tao; Wang, Yu; Li, Qing; Lin, Liangyu; Xu, Chunliang; Xue, Yueqing; Hu, Mingyuan; Shi, Yufang; Wang, Ying] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China; [Shi, Yufang] Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Soochow Univ Med Coll,Affiliated Hosp 3, Suzhou 215123, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Soochow University - China	Shi, YF; Wang, Y (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China.; Shi, YF (corresponding author), Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Soochow Univ Med Coll,Affiliated Hosp 3, Suzhou 215123, Jiangsu, Peoples R China.	yufangshi@sibs.ac.cn; yingwang@sibs.ac.cn	Shi, Yufang/AAE-4431-2020	Shi, Yufang/0000-0001-8964-319X; wang, ying/0000-0002-2571-9367; Wang, Yu/0000-0002-7309-7304; Xu, Chunliang/0000-0002-4514-8477; Liangyu, Lin/0000-0003-4312-8955; shi, yu fang/0000-0001-9716-2126	National Key R&D Program of China [2018YFA0107500]; Scientific Innovation Project of the Chinese Academy of Sciences [XDA16020403]; National Natural Science Foundation of China [32070872, 31961133024, 31771641, 81571612, 31771581, 81861138015]; Soochow University; Department of Science and Technology of Jiangsu Province research fund [BE2016671]	National Key R&D Program of China; Scientific Innovation Project of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Soochow University; Department of Science and Technology of Jiangsu Province research fund	The study was supported by grants from the National Key R&D Program of China (2018YFA0107500), the Scientific Innovation Project of the Chinese Academy of Sciences (XDA16020403), the National Natural Science Foundation of China (32070872, 31961133024, 31771641, 81571612, 31771581 and 81861138015), a start-up fund from Soochow University, and the Department of Science and Technology of Jiangsu Province research fund (BE2016671).	Aref S, 2020, MOL THER, V28, P1043, DOI 10.1016/j.ymthe.2020.01.027; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02129; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Cauwels A, 2018, CANCER RES, V78, P463, DOI 10.1158/0008-5472.CAN-17-1980; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chheda ZS, 2016, J IMMUNOL, V197, P2016, DOI 10.4049/jimmunol.1502376; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Delaunay T, 2020, J THORAC ONCOL, V15, P827, DOI 10.1016/j.jtho.2019.12.128; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Doron H, 2019, CELL REP, V28, P1785, DOI 10.1016/j.celrep.2019.07.033; Fend L, 2017, CANCER RES, V77, P4146, DOI 10.1158/0008-5472.CAN-16-2165; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guo J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219829; Hegde PS, 2020, IMMUNITY, V52, P17, DOI 10.1016/j.immuni.2019.12.011; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; Liang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06890-y; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Muller E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02520; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Paolini R, 2015, CYTOKINE GROWTH F R, V26, P113, DOI 10.1016/j.cytogfr.2014.11.003; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Robb RJ, 2011, BLOOD, V118, P3399, DOI 10.1182/blood-2010-12-325746; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Shou P, 2016, ONCOGENE, V35, P5953, DOI 10.1038/onc.2016.128; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Tsuchiya N, 2019, CELL REP, V29, P162, DOI 10.1016/j.celrep.2019.08.086; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wightman SC, 2015, BRIT J CANCER, V113, P327, DOI 10.1038/bjc.2015.193; Xu C, 2014, ONCOGENE, V33, P5047, DOI 10.1038/onc.2013.458; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	57	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1866	1881		10.1038/s41388-022-02201-4	http://dx.doi.org/10.1038/s41388-022-02201-4		FEB 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35145233	hybrid, Green Published			2022-12-26	WOS:000754012300002
J	Monsted, B; Lehmann, S				Monsted, Bjarke; Lehmann, Sune			Characterizing polarization in online vaccine discourse-A large-scale study	PLOS ONE			English	Article							HPV VACCINE; IMMUNIZATION; EXEMPTIONS; HESITANCY; PERTUSSIS; MISINFORMATION; ASSOCIATION; INFORMATION; REFUSAL; MEASLES	Vaccine hesitancy is currently recognized by the WHO as a major threat to global health. Recently, especially during the COVID-19 pandemic, there has been a growing interest in the role of social media in the propagation of false information and fringe narratives regarding vaccination. Using a sample of approximately 60 billion tweets, we conduct a large-scale analysis of the vaccine discourse on Twitter. We use methods from deep learning and transfer learning to estimate the vaccine sentiments expressed in tweets, then categorize individual-level user attitude towards vaccines. Drawing on an interaction graph representing mutual interactions between users, we analyze the interplay between vaccine stances, interaction network, and the information sources shared by users in vaccine-related contexts. We find that strongly anti-vaccine users frequently share content from sources of a commercial nature; typically sources which sell alternative health products for profit. An interesting aspect of this finding is that concerns regarding commercial conflicts of interests are often cited as one of the major factors in vaccine hesitancy. Further, we show that the debate is highly polarized, in the sense that users with similar stances on vaccination interact preferentially with one another. Extending this insight, we provide evidence of an epistemic echo chamber effect, where users are exposed to highly dissimilar sources of vaccine information, depending the vaccination stance of their contacts. Our findings highlight the importance of understanding and addressing vaccine mis- and dis-information in the context in which they are disseminated in social networks.	[Monsted, Bjarke; Lehmann, Sune] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Lehmann, Sune] Univ Copenhagen, Ctr Social Data Sci, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Lehmann, S (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark.; Lehmann, S (corresponding author), Univ Copenhagen, Ctr Social Data Sci, Copenhagen, Denmark.	sljo@dtu.dk		Lehmann, Sune/0000-0001-6099-2345	Danish Council for Independent Research [4184-00556a]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This study was funded entirely by the Danish Council for Independent Research (Project: Microdynamics of Social Interactions, grant number 4184-00556a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FE, 2003, VACCINE, V21, P593, DOI 10.1016/S0264-410X(02)00702-8; Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; Bail CA, 2018, P NATL ACAD SCI USA, V115, P9216, DOI 10.1073/pnas.1804840115; Baumann F, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.048301; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Bonnevie E., 2021, Journal of Communication in Healthcare, V14, P12, DOI 10.1080/17538068.2020.1858222; Bradford WD, 2015, HEALTH AFFAIR, V34, P1383, DOI 10.1377/hlthaff.2014.1428; Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; Burki T, 2019, LANCET DIGIT HEALTH, V1, pE258, DOI 10.1016/S2589-7500(19)30136-0; Cornwall W, 2020, SCIENCE, V369, P14, DOI 10.1126/science.369.6499.14; Crescitelli MED, 2020, PUBLIC HEALTH, V180, P38, DOI 10.1016/j.puhe.2019.10.027; DeStefano F, 2019, CLIN INFECT DIS, V69, P726, DOI 10.1093/cid/ciz135; Dube E, 2016, QUAL HEALTH RES, V26, P411, DOI 10.1177/1049732315573207; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Dyda A, 2019, HUM VACC IMMUNOTHER, V15, P1488, DOI 10.1080/21645515.2019.1596712; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Evans T, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.181122; Featherstone, 2020, ONLINE SOC NETW MEDI, V20, P100105, DOI 10.1016/j.osnem.2020.100105; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Felbo B., 2017, P 2017 C EMP METH NA, P1615; Forman G., 2010, ACM SIGKDD, V12, P49, DOI [10.1145/1882471.1882479, DOI 10.1145/1882471.1882479]; Frimer JA, 2017, J EXP SOC PSYCHOL, V72, P1, DOI 10.1016/j.jesp.2017.04.003; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Giese H, 2020, VACCINE, V38, P2070, DOI 10.1016/j.vaccine.2019.11.038; Gunaratne K, 2019, VACCINE, V37, P4867, DOI 10.1016/j.vaccine.2019.06.086; Hall V, 2017, MMWR-MORBID MORTAL W, V66, P713, DOI 10.15585/mmwr.mm6627a1; Helps C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026299; Hviid A, 2019, ANN INTERN MED, V170, P513, DOI 10.7326/M18-2101; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jamison A, 2020, AM J PUBLIC HEALTH, V110, pS331, DOI 10.2105/AJPH.2020.305940; Johnson NF, 2016, SCIENCE, V352, P1459, DOI 10.1126/science.aaf0675; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Joulin Armand, 2016, ARXIV160701759; Kahan DM, 2013, JUDGM DECIS MAK, V8, P407; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Larson HJ, 2020, NATURE, V580, P306, DOI 10.1038/d41586-020-00920-w; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Majid U, 2020, QUAL HEALTH RES, V30, P1762, DOI 10.1177/1049732320933863; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mitra T., 2016, 10 INT AAAI C WEB SO, V10, P269; Monsted B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184148; Motta M, 2021, POLIT GROUPS IDENTIT, DOI 10.1080/21565503.2021.1932528; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Ozawa S, 2013, SOC SCI MED, V91, P10, DOI 10.1016/j.socscimed.2013.05.005; Perkins RB, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-2737; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Puri N, 2020, HUM VACC IMMUNOTHER, V16, P2586, DOI 10.1080/21645515.2020.1780846; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Schmid P, 2018, VACCINE, V36, P196, DOI 10.1016/j.vaccine.2016.09.065; Schmidt AL, 2018, VACCINE, V36, P3606, DOI 10.1016/j.vaccine.2018.05.040; Smith PJ, 2006, PEDIATRICS, V118, pE1287, DOI 10.1542/peds.2006-0923; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Smith TC, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx146; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Thelwall M, 2021, PROF INFORM, V30, DOI 10.3145/epi.2021.mar.12; Nguyen CT, 2020, EPISTEME-J INDIV SOC, V17, P141, DOI 10.1017/epi.2018.32; Tomaszewski T, 2021, J MED INTERNET RES, V23, DOI 10.2196/30451; Truong J, 2022, HEALTH PROMOT INT, V37, DOI 10.1093/heapro/daab105; Vaz OM, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-0620; Wilson SL, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004206; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	71	5	6	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263746	10.1371/journal.pone.0263746	http://dx.doi.org/10.1371/journal.pone.0263746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139121	Green Published, gold			2022-12-26	WOS:000821499100050
J	Yu, XF; Gu, JA; Huang, ZD; Zhang, ZJ				Yu, Xuefei; Gu, Jinan; Huang, Zedong; Zhang, Zhijie			Parallax attention stereo matching network based on the improved group-wise correlation stereo network	PLOS ONE			English	Article								Recent stereo matching methods, especially end-to-end deep stereo matching networks, have achieved remarkable performance in the fields of autonomous driving and depth sensing. However, state-of-the-art stereo algorithms, even with the deep neural network framework, still have difficulties at finding correct correspondences in near-range regions and object edge cues. To reinforce the precision of disparity prediction, in the present study, we propose a parallax attention stereo matching algorithm based on the improved group-wise correlation stereo network to learn the disparity content from a stereo correspondence, and it supports end-to-end predictions of both disparity map and edge map. Particular, we advocate for a parallax attention module in three-dimensional (disparity, height and width) level, which structure ensures high-precision estimation by improving feature expression in near-range regions. This is critical for computer vision tasks and can be utilized in several existing models to enhance their performance. Moreover, in order to making full use of the edge information learned by two-dimensional feature extraction network, we propose a novel edge detection branch and multi-featured integration cost volume. It is demonstrated that based on our model, edge detection project is conducive to improve the accuracy of disparity estimation. Our method achieves better results than previous works on both Scene Flow and KITTI datasets.	[Yu, Xuefei; Gu, Jinan; Huang, Zedong; Zhang, Zhijie] Jiangsu Univ, Sch Mech Engn, Zhenjiang 212000, Jiangsu, Peoples R China	Jiangsu University	Gu, JA (corresponding author), Jiangsu Univ, Sch Mech Engn, Zhenjiang 212000, Jiangsu, Peoples R China.	gujinan@tsinghua.org.cn			National Natural Science Foundation of China [51875266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (No. 51875266). J.G. is the author who received the award, and whose role in our study is to provide experimental equipment and supervise the rationality of our research. you can find this funding at the link of https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	Chang JR, 2018, PROC CVPR IEEE, P5410, DOI 10.1109/CVPR.2018.00567; Chen C., 2021, CROSS PARALLAX ATTEN; Geiger A, 2012, PROC CVPR IEEE, P3354, DOI 10.1109/CVPR.2012.6248074; Gidaris S, 2017, PROC CVPR IEEE, P7187, DOI 10.1109/CVPR.2017.760; Guo XY, 2019, PROC CVPR IEEE, P3268, DOI 10.1109/CVPR.2019.00339; Hirschmuller H, 2008, IEEE T PATTERN ANAL, V30, P328, DOI 10.1109/TPAMl.2007.1166; Hirschmuller H, 2005, PROC CVPR IEEE, P807, DOI 10.1109/cvpr.2005.56; Hu J., 2020, P IEEE C COMP VIS PA; Kendall A, 2017, IEEE I CONF COMP VIS, P66, DOI 10.1109/ICCV.2017.17; Kerl C, 2013, IEEE INT CONF ROBOT, P3748, DOI 10.1109/ICRA.2013.6631104; Liang ZF, 2018, PROC CVPR IEEE, P2811, DOI 10.1109/CVPR.2018.00297; Liu Y, 2017, PROC CVPR IEEE, P5872, DOI 10.1109/CVPR.2017.622; Long J., 2015, P IEEE C COMP VIS PA, P3431, DOI DOI 10.1109/CVPR.2015.7298965; Luo WJ, 2016, PROC CVPR IEEE, P5695, DOI 10.1109/CVPR.2016.614; Mayer N, 2016, PROC CVPR IEEE, P4040, DOI 10.1109/CVPR.2016.438; Menze M, 2015, PROC CVPR IEEE, P3061, DOI 10.1109/CVPR.2015.7298925; Nair Vinod, 2010, P 27 INT C INT C MAC, P807; Oliver NM, 2000, IEEE T PATTERN ANAL, V22, P831, DOI 10.1109/34.868684; Pang JH, 2017, IEEE INT CONF COMP V, P878, DOI 10.1109/ICCVW.2017.108; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Shotton J, 2013, IEEE T PATTERN ANAL, V35, P2821, DOI 10.1109/TPAMI.2012.241; Song X., 2018, ASIAN C COMPUTER VIS; Song X., 2020, IJCV, V128, P910, DOI DOI 10.1007/s11263-019-01287-w; Wang LG, 2019, PROC CVPR IEEE, P12242, DOI 10.1109/CVPR.2019.01253; Wang YQ, 2021, IEEE COMPUT SOC CONF, P766, DOI 10.1109/CVPRW53098.2021.00086; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xie SN, 2015, IEEE I CONF COMP VIS, P1395, DOI 10.1109/ICCV.2015.164; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Ying XY, 2020, IEEE SIGNAL PROC LET, V27, P496, DOI 10.1109/LSP.2020.2973813; Zbontar J, 2016, J MACH LEARN RES, V17; Zbontar J, 2015, PROC CVPR IEEE, P1592, DOI 10.1109/CVPR.2015.7298767; Zhang FH, 2019, PROC CVPR IEEE, P185, DOI 10.1109/CVPR.2019.00027	33	0	0	12	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263735	10.1371/journal.pone.0263735	http://dx.doi.org/10.1371/journal.pone.0263735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139127	gold, Green Published			2022-12-26	WOS:000821499100048
J	Bansal, A; Mostafa, MM; Kooi, C; Sasse, SK; Michi, AN; Shah, SV; Leigh, R; Gerber, AN; Newton, R				Bansal, Akanksha; Mostafa, Mahmoud M.; Kooi, Cora; Sasse, Sarah K.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Gerber, Anthony N.; Newton, Robert			Interplay between nuclear factor-KB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY GENE-EXPRESSION; INNATE IMMUNE-SYSTEM; THERAPEUTIC TARGET; BINDING-SITES; KINASE; TRANSCRIPTION; REPRESSION; ROLES; MECHANISMS	While glucocorticoids act via the glucocorticoid receptor (GR; NR3C1) to reduce the expression of many inflammatory genes, repression is not an invariable outcome. Here, we explore synergy occurring between synthetic glucocorticoids (dexamethasone and budesonide) and proinflammatory cyto-kines (IL1B and TNF) on the expression of the toll-like re-ceptor 2 (TLR2). This effect is observed in epithelial cell lines and both undifferentiated and differentiated primary human bronchial epithelial cells (pHBECs). In A549 cells, IL1B-plus-glucocorticoid-induced TLR2 expression required nuclear factor (NF)-KB and GR. Likewise, in A549 cells, BEAS-2B cells, and pHBECs, chromatin immunoprecipitation identified GR-and NF-KB/p65-binding regions X32 kb (R1) and X7.3 kb (R2) upstream of the TLR2 gene. Treatment of BEAS-2B cells with TNF or/and dexamethasone followed by global run-on sequencing confirmed transcriptional activity at these re-gions. Furthermore, cloning R1 or R2 into luciferase reporters revealed transcriptional activation by budesonide or IL1B, respectively, while R1+R2 juxtaposition enabled synergistic activation by IL1B and budesonide. In addition, small-molecule inhibitors and siRNA knockdown showed p38a MAPK to negatively regulate both IL1B-induced TLR2 expression and R1+R2 reporter activity. Finally, agonism of IL1B-plus-dexamethasone-induced TLR2 in A549 cells and pHBECs stimulated NF-KB-and interferon regulatory factor-dependent reporter activity and chemokine release. We conclude that glucocorticoid-plus-cytokine-driven synergy at TLR2 involves GR and NF-KB acting via specific enhancer regions, which combined with the inhibition of p38a MAPK promotes TLR2 expression. Subsequent inflammatory effects that occur following TLR2 agonism may be pertinent in severe neutrophilic asthma or chronic obstructive pulmonary dis-ease, where glucocorticoid-based therapies are less efficacious.	[Bansal, Akanksha; Mostafa, Mahmoud M.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Bansal, Akanksha; Mostafa, Mahmoud M.; Michi, Aubrey N.; Shah, Suharsh, V; Leigh, Richard; Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Snyder Inst Chron Dis, Dept Med, Calgary, AB, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Gerber, Anthony N.] Univ Colorado, Dept Med, Aurora, CO USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada.	rnewton@ucalgary.ca			Canadian Institutes of Health Research (CIHR) [MOP 125918, PJT 156310]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04549]; Eyes High Doctoral Scholarship in Women's Health from University of Calgary; Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; NSERC; Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Eyes High Doctoral Scholarship in Women's Health from University of Calgary; Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards	This work was supported by the following: R. N. grants: Canadian Institutes of Health Research (CIHR) (MOP 125918, PJT 156310) and Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant (RGPIN-2016-04549); A. B. studentships: Eyes High Doctoral Scholarship and Eleanor Mackie Doctoral Scholarship in Women's Health from University of Calgary; M. M. M. studentships: NSERC Postgraduate Scholarship -Doctoral, Queen Elizabeth II Doctoral scholarship, and The Lung Association-Alberta & NWT studentship awards. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Ambrosini G, 2018, BIOINFORMATICS, V34, P2483, DOI 10.1093/bioinformatics/bty127; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chivers JE, 2004, EUR J BIOCHEM, V271, P4042, DOI 10.1111/j.1432-1033.2004.04342.x; Cruz-Topete D, 2015, NEUROIMMUNOMODULAT, V22, P20, DOI 10.1159/000362724; D'lppolito AM, 2018, CELL SYST, V7, P146, DOI 10.1016/j.cels.2018.06.007; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Hoppstadter J., 2019, FRONT IMMUNOL; Hsieh C. L., 2014, PROC NATL ACAD; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kis K, 2006, INT IMMUNOPHARMACOL, V6, P358, DOI 10.1016/j.intimp.2005.08.022; Klassen C, 2017, J IMMUNOL, V199, P48, DOI 10.4049/jimmunol.1601691; Kukushkin A. N., 2002, ONCOGENE 21; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Liu DR, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-30; Liu SY, 2019, BRIT J PHARMACOL, V176, P1793, DOI 10.1111/bph.14656; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Maruyama A, 2014, NUCLEIC ACIDS RES, V42, P13599, DOI 10.1093/nar/gku1169; McDowell IC, 2018, GENOME RES, V28, P1272, DOI 10.1101/gr.233346.117; Michi AN, 2021, AM J PHYSIOL-LUNG C, V321, pL263, DOI 10.1152/ajplung.00141.2021; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Mostafa MM, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015755; Mostafa MM, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0467-2; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Newton R, 1998, EUR J BIOCHEM, V254, P81, DOI 10.1046/j.1432-1327.1998.2540081.x; Newton R, 1996, BIOCHEM BIOPH RES CO, V218, P518, DOI 10.1006/bbrc.1996.0093; Newton Robert, 2006, Drug Discov Today Dis Mech, V3, P53, DOI 10.1016/j.ddmec.2006.02.007; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Newton R, 2017, J BIOL CHEM, V292, P7163, DOI 10.1074/jbc.R117.777318; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Proud PC, 2021, EBIOMEDICINE, V63, DOI 10.1016/j.ebiom.2020.103153; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rider CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116773; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sasse SK, 2019, GENOME RES, V29, P1753, DOI 10.1101/gr.248187.119; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shah S, 2016, J BIOL CHEM, V291, P21802, DOI 10.1074/jbc.M116.728964; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Shuto T, 2002, J BIOL CHEM, V277, P17263, DOI 10.1074/jbc.M112190200; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; Su Q, 2017, J STEROID BIOCHEM, V171, P201, DOI 10.1016/j.jsbmb.2017.03.023; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Warner SM, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1120-0; Winder AA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-96; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng M, 2021, NAT IMMUNOL, V22, P829, DOI 10.1038/s41590-021-00937-x; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	94	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101747	10.1016/j.jbc.2022.101747	http://dx.doi.org/10.1016/j.jbc.2022.101747			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35189144	gold, Green Published			2022-12-26	WOS:000793617400001
J	Ma, YH; Cai, FH; Huang, XH; Wang, HJ; Yu, BF; Wang, JN; Nie, WY; Cai, KD; Yang, Y; Chen, JH; Xiao, L; Han, F				Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei			Mannose-binding lectin activates the nuclear factor-kappa B and renal inflammation in the progression of diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic nephropathy; macrophage; mannose-binding lectin; nuclear factor-kappa B	RECEPTOR 4; ASSOCIATION	Increased serum mannose-binding lectin (MBL) level has been proven to correlate with the development of diabetic nephropathy (DN). Here, we aim to find the role and mechanism of MBL involved in the progression of DN. Patients with DN were recruited and divided into two groups according to different rs1800450 genotypes of the MBL2 gene, and inflammatory profiles in monocytes/macrophages were compared between the two groups. MBL was given to treat macrophages, HK2, and HMC, and a co-culture transwell system was then employed. Renal inflammation and fibrosis parameters were measured after knocking down or overexpressing MBL genes in mice. Proinflammatory profile, manifesting as enhanced IL-1 beta production and M1 polarization, was found in monocytes/macrophages from DN with a rs1800450 GG genotype of MBL2 gene who had higher MBL level, compared with those with a rs1800450 GA genotype. In mechanism, MBL directly induced inflammatory responses in macrophages, which promoted inflammatory and fibrotic markers in HK2 and HMCs during co-culture. Further experiments showed that MBL can promote macrophages transforming to the M1 subset mainly by activating the nuclear factor-kappa B pathway. After downregulation of MBL, the blood glucose, triglyceride, urine protein, injuries of glomerulus and tubules, and the degree of renal inflammation and fibrosis were ameliorated in db/db mice treated with AAV-MBL1/2-shRNA. Overexpression of MBL promoted macrophage infiltration in the kidney. In conclusion, MBL is a crucial mediator in the progression of DN via activating the nuclear factor-kappa B pathway in macrophages. This will serve as a genetic base for some patients with DN who have poor outcomes and provide a direction for the screening.	[Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Zhejiang Univ, Inst Nephrol, Hangzhou, Peoples R China; [Ma, Yanhong; Cai, Fanghao; Huang, Xiaohan; Wang, Huijing; Yu, Binfeng; Wang, Junni; Nie, Wanyun; Cai, Kedan; Yang, Yi; Chen, Jianghua; Xiao, Liang; Han, Fei] Key Lab Kidney Dis Prevent & Control Technol, Hangzhou, Peoples R China; [Cai, Kedan] Univ Chinese Acad Sci, HwaMei Hosp, Ningbo, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, L; Han, F (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Kidney Dis Ctr, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	xiaoliang@zju.edu.cn; hanf8876@zju.edu.cn	MA, YAN/HHN-2912-2022; Xiao, Liang/HCI-1002-2022	Xiao, Liang/0000-0003-0312-7149	National key R&D Program of China [2018YFC1314003]; National Natural Science Foundation of China (NSFC) [81770674]; Primary Research and Development Plan of Zhejiang Province [2020C03034]	National key R&D Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Primary Research and Development Plan of Zhejiang Province	National key R&D Program of China, Grant/Award Number: 2018YFC1314003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770674; Primary Research and Development Plan of Zhejiang Province, Grant/Award Number: 2020C03034	Aso Y, 2004, CLIN CHIM ACTA, V348, P139, DOI 10.1016/j.cccn.2004.05.006; Awad AS, 2015, KIDNEY INT, V88, P722, DOI 10.1038/ki.2015.162; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Cai KD, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-1073; Campbell MT, 2011, J SURG RES, V168, pE61, DOI 10.1016/j.jss.2009.09.053; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chen CA, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03362-4; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P687, DOI 10.1016/S2213-8587(15)00261-2; Fernandez-Fernandez B, 2014, NAT REV NEPHROL, V10, P325, DOI 10.1038/nrneph.2014.74; Fioretto P, 2016, DIABETES CARE, V39, pS165, DOI 10.2337/dcS15-3006; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Hansen TK, 2004, DIABETES, V53, P1570, DOI 10.2337/diabetes.53.6.1570; Hansen TK, 2006, ARCH INTERN MED, V166, P2007, DOI 10.1001/archinte.166.18.2007; Hovind P, 2005, DIABETES, V54, P1523, DOI 10.2337/diabetes.54.5.1523; Klessens CQF, 2017, NEPHROL DIAL TRANSPL, V32, P1322, DOI 10.1093/ndt/gfw260; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Li XQ, 2019, DIABETES METAB, V45, P248, DOI 10.1016/j.diabet.2018.04.001; Luan PP, 2018, FASEB J, V32, P1070, DOI 10.1096/fj.201700511RR; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Mogues T, 1996, GLYCOBIOLOGY, V6, P543, DOI 10.1093/glycob/6.5.543; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ostergaard J, 2007, DIABETOLOGIA, V50, P1541, DOI 10.1007/s00125-007-0686-0; Ostergaard JA, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1825738; Pan HZ, 2010, ACTA DIABETOL, V47, pS71, DOI 10.1007/s00592-009-0128-1; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tang SCW, 2020, NAT REV NEPHROL, V16, P206, DOI 10.1038/s41581-019-0234-4; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Turner M W, 2000, Rev Immunogenet, V2, P305; van der Pol P, 2012, AM J TRANSPLANT, V12, P877, DOI 10.1111/j.1600-6143.2011.03887.x; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; You HN, 2013, AM J PHYSIOL-RENAL, V305, pF1719, DOI 10.1152/ajprenal.00141.2013; Zhang NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083059	40	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22227	10.1096/fj.202101852R	http://dx.doi.org/10.1096/fj.202101852R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195918				2022-12-26	WOS:000761250800014
J	Niu, CY; Sun, XY; Hu, F; Tang, XW; Wang, KW				Niu, Canyang; Sun, Xiaoying; Hu, Fang; Tang, Xiaowen; Wang, KeWei			Molecular determinants for the chemical activation of the warmth-sensitive TRPV3 channel by the natural monoterpenoid carvacrol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-AMINOETHOXYDIPHENYL BORATE; OLMSTED SYNDROME; MISSENSE MUTATION; STRUCTURAL BASIS; ION CHANNELS; HAIR-GROWTH; HEAT; MECHANISM; INHIBITION; BOY	Transient receptor potential vanilloid 3 (TRPV3), robustly expressed in the skin, is a nonselective calcium-permeable cation channel activated by warm temperature, voltage, and certain chemicals. Natural monoterpenoid carvacrol from plant oregano is a known skin sensitizer or allergen that specifically activates TRPV3 channel. However, how carvacrol activates TRPV3 mechanistically remains to be understood. Here, we describe the molecular determinants for chemical activation of TRPV3 by the agonist carvacrol. Patch clamp recordings reveal that carvacrol activates TRPV3 in a concentration-dependent manner, with an EC50 of 0.2 mM, by increasing the probability of single-channel open conformation. Molecular docking of carvacrol into cryo-EM structure of TRPV3 combined with site-directed mutagenesis further identified a unique binding pocket formed by the channel S2-S3 linker important for mediating this interaction. Within the binding pocket consisting of four residues (11e505, Leu508, Arg509, and Asp512), we report that Leu508 is the most critical residue for the activation of TRPV3 by carvacrol, but not 2-APB, a widely used nonspecific agonist and TRP channel modulator. Our findings demonstrate a direct binding of carvacrol to TRPV3 by targeting the channel S2-S3 linker that serves as a critical domain for chemical-mediated activation of TRPV3. We also propose that carvacrol can function as a molecular tool in the design of novel specific TRPV3 modulators for the further understanding of TRPV3 channel pharmacology.	[Niu, Canyang; Sun, Xiaoying; Hu, Fang; Wang, KeWei] Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China; [Sun, Xiaoying; Hu, Fang; Tang, Xiaowen; Wang, KeWei] Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China; [Tang, Xiaowen] Qingdao Univ, Dept Med Chem, Sch Pharm, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wang, KW (corresponding author), Qingdao Univ, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China.; Tang, XW; Wang, KW (corresponding author), Qingdao Univ, Inst Innovat Drugs, Qingdao, Peoples R China.; Tang, XW (corresponding author), Qingdao Univ, Dept Med Chem, Sch Pharm, Qingdao, Peoples R China.	xwtang1219@qdu.edu.cn; wangkw@qdu.edu.cn			National Natural Science Foundation of China [81903734, 81973299]; Ministry of Science and Technology of China [2018ZX09711001004-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (81903734 and 81973299) and the Ministry of Science and Technology of China (2018ZX09711001004-006).	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui TT, 2018, ACTA PHARMACOL SIN, V39, P331, DOI 10.1038/aps.2017.152; Danso-Abeam D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-79; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Duchatelet S, 2014, JAMA DERMATOL, V150, P303, DOI 10.1001/jamadermatol.2013.8709; Eytan O, 2014, J INVEST DERMATOL, V134, P1752, DOI 10.1038/jid.2014.37; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Hanson SM, 2015, BIOPHYS J, V108, P1425, DOI 10.1016/j.bpj.2015.02.013; He YQ, 2015, J INVEST DERMATOL, V135, P907, DOI 10.1038/jid.2014.429; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Imura K, 2007, BIOCHEM BIOPH RES CO, V363, P479, DOI 10.1016/j.bbrc.2007.08.170; Kariminejad A, 2014, CLIN EXP DERMATOL, V39, P492, DOI 10.1111/ced.12318; Kuhn FJP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07652-4; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lievremont JP, 2005, MOL PHARMACOL, V68, P758, DOI 10.1124/mol.105.012856; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu Q, 2021, ELIFE, V10, DOI 10.7554/eLife.68128; McGoldrick LL, 2018, NATURE, V553, P233, DOI 10.1038/nature25182; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nadezhdin KD, 2021, NAT STRUCT MOL BIOL, V28, P564, DOI 10.1038/s41594-021-00615-4; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Qu YX, 2019, MOL PHARMACOL, V96, P393, DOI 10.1124/mol.119.116962; Shioya Takanobu, 2008, Folia Pharmacologica Japonica, V131, P417, DOI 10.1254/fpj.131.417; Singh AK, 2019, NAT STRUCT MOL BIOL, V26, P994, DOI 10.1038/s41594-019-0318-7; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Nguyen THD, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01776-0; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Wen H, 2018, BIOPHYS J, V114, P40, DOI 10.1016/j.bpj.2017.10.034; Wen H, 2016, PROTEINS, V84, P1938, DOI 10.1002/prot.25177; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245; Zhang H, 2019, J PHARMACOL EXP THER, V368, P21, DOI 10.1124/jpet.118.254045; Zheng Wenjun, 2019, Temperature (Austin), V6, P120, DOI 10.1080/23328940.2019.1578634; Zubcevic L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07117-w	46	2	2	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101706	10.1016/j.jbc.2022.101706	http://dx.doi.org/10.1016/j.jbc.2022.101706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150742	gold, Green Published			2022-12-26	WOS:000821054100006
J	Wang, CC; Hao, KY; Dong, LX; Wang, JN; Zhao, LC; Xu, LJ; Xia, Y; Jiang, Q; Qin, JZ				Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Xia, Yin; Jiang, Qing; Qin, Jinzhong			The MuvB complex safeguards embryonic stem cell identity through regulation of the cell cycle machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-MYB; TRANSCRIPTION; GENES; IDENTIFICATION; PHASE; LIN54; LIN-9	Increasing evidences indicate that unlimited capacity for self-renewal and pluripotency, two unique properties of embryonic stem cells (ESCs), are intrinsically linked to cell cycle control. However, the precise mechanisms coordinating cell fate decisions and cell cycle regulation remain to be fully explored. Here, using CRISPR/Cas9-mediated genome editing, we show that in ESCs, deficiency of components of the cell cycle regulatory MuvB complex Lin54 or Lin52, but not Lin9 or Lin37, triggers G2/M arrest, loss of pluripotency, and spontaneous differentiation. Further dissection of these phenotypes demonstrated that this cell cycle arrest is accompanied by the gradual activation of mesoendodermal lineage-specifying genes. Strikingly, the abnormalities observed in Lin54-null ESCs were partially but significantly rescued by ectopic coexpression of genes encoding G2/M proteins Cyclin B1 and Cdk1. Thus, our study provides new insights into the mechanisms by which the MuvB complex determines cell fate through regulation of the cell cycle machinery.	[Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Qin, Jinzhong] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China; [Wang, Congcong; Hao, Kunying; Dong, Lixia; Wang, Jingnan; Zhao, Linchun; Xu, Lijun; Qin, Jinzhong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China; [Qin, Jinzhong] Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Peoples R China	Nanjing University; Nanjing University; Chinese University of Hong Kong; Nanjing University; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Med Sch, Nanjing, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Med Sch, Nanjing, Peoples R China.	qinjz@nju.edu.cn	Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31970810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31970810) to J. Q.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Guiley KZ, 2018, P NATL ACAD SCI USA, V115, P10016, DOI 10.1073/pnas.1808136115; Huang YK, 2021, STEM CELL REP, V16, P566, DOI 10.1016/j.stemcr.2021.01.009; Huang YK, 2018, CELL REP, V22, P3032, DOI 10.1016/j.celrep.2018.02.072; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Marceau AH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12301; Matsuo T, 2012, CELL CYCLE, V11, P3227, DOI 10.4161/cc.21569; Muller GA, 2014, NUCLEIC ACIDS RES, V42, P10331, DOI 10.1093/nar/gku696; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Qin JZ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5689; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Schmit F, 2009, FEBS J, V276, P5703, DOI 10.1111/j.1742-4658.2009.07261.x; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Walston H, 2021, ANNU REV GENET, V55, P309, DOI 10.1146/annurev-genet-071819-103836; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131	29	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101701	10.1016/j.jbc.2022.101701	http://dx.doi.org/10.1016/j.jbc.2022.101701			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35148988	gold, Green Published			2022-12-26	WOS:000821054100002
J	Gardiner, LJ; Carrieri, AP; Bingham, K; Macluskie, G; Bunton, D; McNeil, M; Pyzer-Knapp, EO				Gardiner, Laura-Jayne; Carrieri, Anna Paola; Bingham, Karen; Macluskie, Graeme; Bunton, David; McNeil, Marian; Pyzer-Knapp, Edward O.			Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLUCOCORTICOID-RECEPTOR; PERSONALIZED MEDICINE; EXPRESSION ANALYSIS; CODON OPTIMALITY; P38 MAPK; PATHOGENESIS	Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn's disease, affect several million individuals worldwide. These diseases are heterogeneous at the clinical, immunological and genetic levels and result from complex host and environmental interactions. Investigating drug efficacy for IBD can improve our understanding of why treatment response can vary between patients. We propose an explainable machine learning (ML) approach that combines bioinformatics and domain insight, to integrate multi-modal data and predict inter-patient variation in drug response. Using explanation of our models, we interpret the ML models' predictions to infer unique combinations of important features associated with pharmacological responses obtained during preclinical testing of drug candidates in ex vivo patient-derived fresh tissues. Our inferred multi-modal features that are predictive of drug efficacy include multi-omic data (genomic and transcriptomic), demographic, medicinal and pharmacological data. Our aim is to understand variation in patient responses before a drug candidate moves forward to clinical trials. As a pharmacological measure of drug efficacy, we measured the reduction in the release of the inflammatory cytokine TNFa from the fresh IBD tissues in the presence/absence of test drugs. We initially explored the effects of a mitogen-activated protein kinase (MAPK) inhibitor; however, we later showed our approach can be applied to other targets, test drugs or mechanisms of interest. Our best model predicted TNF alpha levels from demographic, medicinal and genomic features with an error of only 4.98% on unseen patients. We incorporated transcriptomic data to validate insights from genomic features. Our results showed variations in drug effectiveness (measured by ex vivo assays) between patients that differed in gender, age or condition and linked new genetic polymorphisms to patient response variation to the anti-inflammatory treatment BIRB796 (Doramapimod). Our approach models IBD drug response while also identifying its most predictive features as part of a transparent ML precision medicine strategy.	[Gardiner, Laura-Jayne; Carrieri, Anna Paola; Pyzer-Knapp, Edward O.] Hartree Ctr, IBM Res Europe Daresbury, Warrington, Cheshire, England; [Bingham, Karen; Macluskie, Graeme; Bunton, David] REPROCELL Europe Ltd, Glasgow, Lanark, Scotland; [McNeil, Marian] Queen Elizabeth Univ Hosp, Precis Med Scotland Innovat Ctr, Teaching & Learning Bldg, Glasgow, Lanark, Scotland	Queen Elizabeth University Hospital (QEUH)	Gardiner, LJ; Carrieri, AP (corresponding author), Hartree Ctr, IBM Res Europe Daresbury, Warrington, Cheshire, England.	Laura-Jayne.Gardiner@ibm.com; acarrieri@uk.ibm.com	Gardiner, Laura-Jayne/ABD-3850-2020	Gardiner, Laura-Jayne/0000-0002-9177-4452; Bunton, David/0000-0001-9262-1696	Science and Technologies facilities Council (STFC) - UK Research and Innovation (UKRI); IBM - UK Research and Innovation (UKRI); Precision Medicine Scotland Innovation Centre (PMS-IC); Scottish Funding Council; Scottish Enterprise	Science and Technologies facilities Council (STFC) - UK Research and Innovation (UKRI)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); IBM - UK Research and Innovation (UKRI); Precision Medicine Scotland Innovation Centre (PMS-IC); Scottish Funding Council; Scottish Enterprise	This work was supported by the Hartree National Centre for Digital Innovation, a collaboration between the Science and Technologies facilities Council (STFC) and IBM (LJG, APC, EPK) that is funded by the UK Research and Innovation (UKRI) funding agency. The functional pharmacology experiments and whole exome sequencing for this study were part-funded via a project grant from Precision Medicine Scotland Innovation Centre (PMS-IC), provided to REPROCELL Europe Ltd (KB, GM, DB). PMS-IC is funded by the Scottish Funding Council and Scottish Enterprise.	Agyeman AA, 2015, J PHARM BIOALLIED SC, V7, P239, DOI 10.4103/0975-7406.160040; Alatab S, 2020, LANCET GASTROENTEROL, V5, P17, DOI 10.1016/S2468-1253(19)30333-4; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 2019, PIC TOOLK; [Anonymous], NG130 NICE; [Anonymous], NICE GUIDELINE NG129; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brunet S, 2014, TRAFFIC, V15, P803, DOI 10.1111/tra.12183; Carlton S.M, 2013, ENCY PAIN, DOI [10.1007/978-3-642-28753-4_1945, DOI 10.1007/978-3-642-28753-4_1945]; Carrieri AP, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83922-6; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Chang HC, 2018, J DERMATOL SCI, V92, P151, DOI 10.1016/j.jdermsci.2018.08.011; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen YX, 2016, J PERS MED, V6, DOI 10.3390/jpm6040020; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cowan K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226564; Denson LA, 2019, INFLAMM BOWEL DIS, V25, pS31, DOI 10.1093/ibd/izz078; Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X; Galeotti N, 2012, NEUROPHARMACOLOGY, V62, P289, DOI 10.1016/j.neuropharm.2011.07.020; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Kim JA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122680; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kumar M, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02174-1; Gardiner LJ, 2021, bioRxiv, DOI 10.1101/2021.02.04.429826; Lea S, 2020, J MOL MED, V98, P361, DOI 10.1007/s00109-020-01873-3; Lee SH, 2020, CYTOKINE, V126, DOI 10.1016/j.cyto.2019.154872; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lucafo M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040277; Lundberg SM, 2017, ADV NEUR IN, V30; Mandrekar SJ, 2011, J THORAC ONCOL, V6, P658, DOI 10.1097/JTO.0b013e31820e17cb; Moden O, 2014, ADV CANCER RES, V122, P199, DOI 10.1016/B978-0-12-420117-0.00006-2; Morampudi V, 2015, AM J PHYSIOL-GASTR L, V308, pG389, DOI 10.1152/ajpgi.00195.2014; Morgan P, 2012, DRUG DISCOV TODAY, V17, P419, DOI 10.1016/j.drudis.2011.12.020; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; Nelson G, 2003, J CELL SCI, V116, P2495, DOI 10.1242/jcs.00461; Nicora G, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01030; Olsen T, 2007, SCAND J GASTROENTERO, V42, P1312, DOI 10.1080/00365520701409035; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Plevy SE, 1997, J IMMUNOL, V159, P6276; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roden DM, 2013, CLIN PHARMACOL THER, V94, P168, DOI 10.1038/clpt.2013.101; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schapire Robert E., 2013, EXPLAINING ADABOOST, P37, DOI DOI 10.1007/978-3-642-41136-6_5; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Stocco G, 2007, INFLAMM BOWEL DIS, V13, P57, DOI 10.1002/ibd.20004; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Trusheim MR, 2011, NAT REV DRUG DISCOV, V10, P817, DOI 10.1038/nrd3557	56	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263248	10.1371/journal.pone.0263248	http://dx.doi.org/10.1371/journal.pone.0263248			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196350	Green Published, gold			2022-12-26	WOS:000835161600011
J	Liang, HL; Peng, JW				Liang, Hanlin; Peng, Jiewen			LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway	PLOS ONE			English	Article							LUNG-CANCER; IMMUNE; SURVIVAL; LONG	Long noncoding RNA (LncRNA) is a new type of regulatory RNA. LncRNA HOX antisense intergenic RNA (HOTAIR), as an oncogene in non-small cell lung cancer (NSCLC), is one of the key determinants of tumor progression. However, its possible molecular mechanism and the immunomodulatory pathway involved in NSCLC are still unclear. This study aims to explore whether HOTAIR promotes proliferation, migration and invasion of the NSCLC cells by inhibiting the expression of C-C Motif Chemokine Ligand 22 (CCL22). We collected 30 clinical samples of cancer and adjacent normal tissues from the patients with NSCLC, using real-time quantitative polymerase chain reaction (RT-qPCR) to detect the LncRNA HOTAIR and CCL22 mRNA expression in tissues. Immunohistochemistry was used to detect the protein expression of CCL22 in cancer and adjacent normal tissues. Cell experiments were conducted to verify that LncRNA HOTAIR regulates the expression of CCL22 and participates in the progress of NSCLC. The antisense oligonucleotide (ASO) probe interfering with LncRNA HOTAIR and the interference fragment of CCL22 (si-CCL22) were constructed. A549 cells were co-transfected with ASO-HOTAIR and si-CCL22. We used RT-qPCR to detect the expression of LncRNA HOTAIR and CCL22 mRNA in the cells, enzyme-linked immunosorbent assay (ELISA) used to detect the CCL22 protein level in the cell supernatant. 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay was applied to detect cell proliferation, the Flow cytometry to detect cell apoptosis. Finally, the Transwell test was utilized to detect cell migration and invasion. In conclusion, this study suggests that HOTAIR may promote proliferation, migration and invasion of the NSCLC cells by inhibiting CCL22 expression, which may play a key role in NSCLC cell immunity.	[Liang, Hanlin; Peng, Jiewen] Zhongshan City Peoples Hosp, Chemotherapy Dept, Zhongshan, Guangdong, Peoples R China	Sun Yat Sen University	Liang, HL (corresponding author), Zhongshan City Peoples Hosp, Chemotherapy Dept, Zhongshan, Guangdong, Peoples R China.	lianghanlin@gmai.com			Zhongshan Science and Technology Bureau	Zhongshan Science and Technology Bureau	This project is funded by Zhongshan Science and Technology Bureau. Hanlin Liang and Jiewen Peng received the award. No conflicts of interest. The website of Zhongshan Science and Technology Bureau was listed as follow: http://kj.zs.gov.cn/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodelon C, 2013, ANN ONCOL, V24, P2073, DOI 10.1093/annonc/mdt175; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao L, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0267-1; Chen SS, 2019, EUR REV MED PHARMACO, V23, P670, DOI 10.26355/eurrev_201901_16905; Chen YH, 2016, ONCOL REP, V36, P2017, DOI 10.3892/or.2016.4995; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Liu MH, 2018, CANCER SCI, V109, P2717, DOI 10.1111/cas.13745; Liu W, 2017, BIOCHEM BIOPH RES CO, V488, P196, DOI 10.1016/j.bbrc.2017.05.034; Martinenaite E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238541; Menetrier-Caux C, 2012, ONCOIMMUNOLOGY, V1, P759, DOI 10.4161/onci.19680; Moritz R, 2016, ONCOIMMUNOLOGY, V5, P680; Munir S, 2013, CANCER RES, V73, P1764, DOI 10.1158/0008-5472.CAN-12-3507; Parums DV, 2021, MED SCI MONITOR, V27, DOI 10.12659/MSM.934854; Rebelo SP, 2018, BIOMATERIALS, V163, P185, DOI 10.1016/j.biomaterials.2018.02.030; Sun YJ, 2019, EUR REV MED PHARMACO, V23, P4226, DOI 10.26355/eurrev_201905_17927; Wiedemann GM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1175794; Wu JJ, 2019, J ETHNOPHARMACOL, V237, P128, DOI 10.1016/j.jep.2019.03.027; Yang Y, 2018, BIOCHEM BIOPH RES CO, V497, P1003, DOI 10.1016/j.bbrc.2018.02.141; Yu CT, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01555-5; Zaynagetdinov R, 2015, CANCER RES, V75, P1624, DOI 10.1158/0008-5472.CAN-14-2379; Zhang Kun, 2019, Zhongguo Fei Ai Za Zhi, V22, P82, DOI 10.3779/j.issn.1009-3419.2019.02.02; Zhou M, 2015, INT J CANCER, V137, P826, DOI 10.1002/ijc.29441; Ziolkowska-Suchanek I, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094302	23	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263997	10.1371/journal.pone.0263997	http://dx.doi.org/10.1371/journal.pone.0263997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176085	gold, Green Published			2022-12-26	WOS:000777505200059
J	Lv, ZY; Zhang, WD; Zhang, YJ; Zhong, GS; Zhang, XF; Yang, Q; Li, Y				Lv, Zhenye; Zhang, Wendan; Zhang, Yingjiao; Zhong, Guansheng; Zhang, Xiaofei; Yang, Qiong; Li, Ying			Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study	PLOS ONE			English	Article							ELDERLY-PATIENTS; WOMEN OLDER; IMPACT; STATISTICS; SURVIVAL; SYSTEM; STAGE; AGE	Background Breast cancer may differ biologically in patients aged over 80 years. The objective of the current study was to analyze the metastasis patterns and prognosis of elderly patients with metastatic breast cancer (MBC) and compare it to patients of other ages. Methods The Surveillance, Epidemiology, and End Results (SEER) database was utilized to select MBC patients from 2010 to 2015. Chi-squared test was used to compare clinicopathological characteristics among different aged groups. The Kaplan-Meier method and multivariate Cox model were utilized for survival analysis. Results A total of 10479 MBC patients were included, among which 1036 (9.9%) patients were aged over 80 years. Compared with other aged group, the elderly patients tended to have a higher proportion of HR+/Her2- subtype, white race, lower tumor differentiation, and receive less treatment, including surgery, chemotherapy and radiotherapy (P<0.001). MBC patients with different age presented with distinctive metastatic patterns. The older patients were more likely to have lung metastasis, but less likely to have bone, brain, liver and multiple sites metastasis than the younger group (P<0.001). The proportion of TNBC subtype increased substantially in the older patients with brain metastasis, compared to the younger and middle-aged group. The old age was demonstrated to significantly associate with worse prognosis of MBC patients. Additionally, our findings also showed that older MBC patients could achieve dramatical overall survival benefit from surgery (HR = 0.58; P < 0.001) and chemotherapy (HR = 0.59; P < 0.001), but not the radiotherapy (HR = 0.96; P = 0.097). Conclusion The elderly MBC patients presented with distinctive metastatic patterns, clinical characteristics, and prognostic outcomes compared with younger patients. Our findings could assist clinicians in making appropriate therapeutic decision.	[Lv, Zhenye; Zhang, Xiaofei; Yang, Qiong; Li, Ying] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Canc Ctr,Dept Gen Surg,Div Breast Surg, Hangzhou, Zhejiang, Peoples R China; [Zhang, Wendan] 903 Hosp Joint Logist Support Force Chinese Peopl, Dept Gynaecol & Obstet, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yingjiao] 903 Hosp Joint Logist Support Force Chinese Peopl, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Zhong, Guansheng] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China	Hangzhou Medical College; Zhejiang Provincial People's Hospital; Zhejiang University	Yang, Q; Li, Y (corresponding author), Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Canc Ctr,Dept Gen Surg,Div Breast Surg, Hangzhou, Zhejiang, Peoples R China.	yangqiong@hmc.edu.cn; lying_breast@sina.com			Zhejiang Provincial Natural Science Foundation of China [LQ20H160030]; National Natural Science Foundation of China [NSFC-82002184]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Grants LQ20H160030 from Zhejiang Provincial Natural Science Foundation of China, and Grants NSFC-82002184 from National Natural Science Foundation of China.	AUGUST DA, 1994, ANN SURG ONCOL, V1, P45, DOI 10.1007/BF02303540; Azim HA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0427-5; Balducci L, 2016, J ONCOL PRACT, V12, P133, DOI 10.1200/JOP.2015.010405; Bertolo A, 2020, EUR J BREAST HEALTH, V16, P208, DOI 10.5152/ejbh.2020.5659; Cronin KA, 2014, CANCER-AM CANCER SOC, V120, P3755, DOI 10.1002/cncr.29049; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Debled M, 2011, CRIT REV ONCOL HEMAT, V80, P171, DOI 10.1016/j.critrevonc.2010.10.002; Eng LG, 2016, BREAST CANCER RES TR, V160, P145, DOI 10.1007/s10549-016-3974-x; Fulop T, 2010, ANN NY ACAD SCI, V1197, P158, DOI 10.1111/j.1749-6632.2009.05370.x; Gampenrieder SP, 2020, CANCER MANAG RES, V12, P10615, DOI 10.2147/CMAR.S235121; Guilfoyle C, 2012, BREAST J, V18, P650, DOI 10.1111/tbj.12030; Hinyard L, 2017, BREAST, V32, P13, DOI 10.1016/j.breast.2016.12.008; Kuzan TY, 2013, J BUON, V18, P328; Martin AM, 2017, JAMA ONCOL, V3, P1069, DOI 10.1001/jamaoncol.2017.0001; McCarthy N, 2009, NAT REV CANCER, V9, P609, DOI 10.1038/nrc2720; Miki C, 2008, SURG TODAY, V38, P873, DOI 10.1007/s00595-008-3766-y; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Noone AM, 2018, SEER CANC STAT REV 1; PAGET S, 1989, CANCER METAST REV, V8, P98; Purushotham A, 2014, EUR J CANCER, V50, P1697, DOI 10.1016/j.ejca.2014.04.002; Raica M, 2014, ANTICANCER RES, V34, P1435; Shachar SS, 2016, J ONCOL PRACT, V12, P123, DOI 10.1200/JOP.2015.010207; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175; Tong ZJ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170121; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Wanebo HJ, 1997, ANN SURG, V225, P579, DOI 10.1097/00000658-199705000-00014; Wang Z, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920932674; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Xie J, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919889003; YANCIK R, 1989, CANCER, V63, P976, DOI 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A; Yao ZX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0798-y; Yood MU, 2008, J AM COLL SURGEONS, V206, P66, DOI 10.1016/j.jamcollsurg.2007.07.015; Zheng YJ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00148; Zouzoulas D, 2020, ARCH GYNECOL OBSTET, V302, P721, DOI 10.1007/s00404-020-05695-z	36	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263104	10.1371/journal.pone.0263104	http://dx.doi.org/10.1371/journal.pone.0263104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176034	gold, Green Published			2022-12-26	WOS:000777505200014
J	Savla, C; Palmer, AF				Savla, Chintan; Palmer, Andre F.			Lyophilized annelid mega-hemoglobin retains its' quaternary structure and oxygen equilibrium properties after room temperature storage for over 6 months	PLOS ONE			English	Article							LIPOSOME ENCAPSULATED HEMOGLOBIN; POLYETHYLENE-GLYCOL; NEW-GENERATION; STABILITY; PROTEIN; ERYTHROCRUORIN; PARTICLES	The long-term storage stability and portability of hemoglobin (Hb)-based oxygen carriers are important design criteria in the development of these therapeutics. Lyophilization or storing proteins in a freeze-dried form is known to increase storage lifetime and reduce overall weight. In this study, we lyophilized the extracellular mega-hemoglobin of the annelid Lumbricus terrestris and tested the storage stability at different temperatures and oxygenation conditions. Storage in refrigerated conditions for over 6 months in the presence of N-2 reduced oxidation by 50% while storage at room temperature in the presence of N-2 reduced oxidation by 60%, all while maintaining the structural stability of the mega-hemoglobin. We also demonstrated a reliable strategy to freeze dry Hbs in the presence of a minimally non-reducing disaccharide sugar that could be easily re-solubilized in deionized water. Overall, this study made significant advances towards long term storage stability of oxygen therapeutics for direct applications in transfusion medicine.	[Savla, Chintan; Palmer, Andre F.] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Palmer, AF (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu		Savla, Chintan/0000-0001-7538-8861	National Institutes of Health [R01HL126945, R01HL138116, R01HL156526, R01EB021926]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AFP: National Institutes of Health grants R01HL126945, R01HL138116, R01HL156526, and R01EB021926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SA, 2005, ARTIF CELL BLOOD SUB, V33, P239, DOI 10.1081/BIO-200066365; Baumler H, 2014, ARTIF ORGANS, V38, P708, DOI 10.1111/aor.12331; Bian YZ, 2016, ARTIF CELL NANOMED B, V44, P41, DOI 10.3109/21691401.2015.1110871; Brogna R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234502; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; CLIFF RO, 1992, BIOMAT ARTIF CELL IM, V20, P619, DOI 10.3109/10731199209119691; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Elmer J, 2012, TRANSFUSION, V52, P1729, DOI 10.1111/j.1537-2995.2011.03523.x; Funaki R, 2020, POLYM ADVAN TECHNOL, V31, P1122, DOI 10.1002/pat.4846; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; JOHNSTON DS, 1989, THERMOCHIM ACTA, V144, P195, DOI 10.1016/0040-6031(89)85100-7; Le Gall T, 2014, J BIOTECHNOL, V187, P1, DOI 10.1016/j.jbiotec.2014.07.008; Lewis LM, 2010, AAPS PHARMSCITECH, V11, P1580, DOI 10.1208/s12249-010-9530-9; Manjula BN, 2005, PROTEIN J, V24, P133, DOI 10.1007/s10930-005-7837-2; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Meng FT, 2018, BIOCONJUGATE CHEM, V29, P1560, DOI 10.1021/acs.bioconjchem.8b00093; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P189, DOI 10.1002/btpr.119; RUDOLPH AS, 1988, CRYOBIOLOGY, V25, P277, DOI 10.1016/0011-2240(88)90036-3; Sakai H, 2009, ARTIF ORGANS, V33, P139, DOI 10.1111/j.1525-1594.2008.00698.x; Savla C, 2021, BIOMACROMOLECULES, V22, P2081, DOI 10.1021/acs.biomac.1c00196; Savla C, 2020, ACS BIOMATER SCI ENG, V6, P4957, DOI 10.1021/acsbiomaterials.0c01146; Winslow RM, 2004, ARTIF ORGANS, V28, P800, DOI 10.1111/j.1525-1594.2004.07392.x; Wollocko H, 2017, ARTIF CELL NANOMED B, V45, P1350, DOI 10.1080/21691401.2017.1339052; Xiong Y, 2013, ACS NANO, V7, P7454, DOI 10.1021/nn402073n; Zaza M, 2020, DAMAGE CONTROL RESUS, P145, DOI DOI 10.1007/978-3-030-20820-2%5F8	25	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263996	10.1371/journal.pone.0263996	http://dx.doi.org/10.1371/journal.pone.0263996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176086	gold, Green Published			2022-12-26	WOS:000777505200058
J	Wu, SN; Tsai, MS; Huang, CH; Chen, WJ				Wu, Shih-Ni; Tsai, Min-Shan; Huang, Chien-Hua; Chen, Wen-Jone			Omecamtiv mecarbil treatment improves post-resuscitation cardiac function and neurological outcome in a rat model	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; REVERSIBLE MYOCARDIAL DYSFUNCTION; ARREST; RESUSCITATION; CARDIOPULMONARY; ASSOCIATION; SURVIVAL; CARE; PROGNOSTICATION; INCREASE	Background Myocardial dysfunction is a major cause of poor outcomes in the post-cardiac arrest period. Omecamtiv mecarbil (OM) is a selective small molecule activator of cardiac myosin that prolongs myocardial systole and increases stroke volume without apparent effects on myocardial oxygen demand. OM administration is safe and improves cardiac function in patients with acute heart failure. Whether OM improves post-resuscitation myocardial dysfunction remains unclear. This study investigated the effect of OM treatment on post-resuscitation myocardial dysfunction and outcomes. Methods and results Adult male rats were resuscitated after 9.5 min of asphyxia-induced cardiac arrest. OM and normal saline was continuously intravenously infused after return of spontaneous circulation (ROSC) at 0.25 mg/kg/h for 4 h in the experimental group and control group, respectively (n = 20 in each group). Hemodynamic parameters were measured hourly and monitored for 4 h after cardiac arrest. Recovery of neurological function was evaluated by neurological functioning scores (0-12; favorable: 11-12) for rats 72 h after cardiac arrest. OM treatment prolonged left ventricular ejection time and improved post-resuscitation cardiac output. Post-resuscitation heart rate and left ventricular systolic function (dp/dt40) were not different between groups. Kaplan-Meier analysis showed non-statistically higher 72-h survival in the OM group (72.2% [13/18] and 58.8% [10/17], p = 0.386). The OM group had a higher chance of having favorable neurological outcomes in surviving rats 72 h after cardiac arrest (84.6% [11/13] vs. 40% [4/10], p = 0.026). The percentage of damaged neurons was lower in the OM group in a histology study at 72 h after cardiac arrest (55.5 +/- 2.3% vs. 76.2 +/- 10.2%, p = 0.004). Conclusions OM treatment improved post-resuscitation myocardial dysfunction and neurological outcome in an animal model. These findings support further pre-clinical studies to improve outcomes in post-cardiac arrest care.	[Wu, Shih-Ni; Tsai, Min-Shan; Huang, Chien-Hua; Chen, Wen-Jone] Natl Taiwan Univ, Dept Emergency Med, Med Coll & Hosp, Taipei, Taiwan; [Chen, Wen-Jone] Natl Taiwan Univ, Dept Internal Med, Div Cardiol, Med Coll & Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University	Huang, CH (corresponding author), Natl Taiwan Univ, Dept Emergency Med, Med Coll & Hosp, Taipei, Taiwan.	chhuang5940@ntu.edu.tw	TSAI, MIN-SHAN/AHE-3825-2022	TSAI, MIN-SHAN/0000-0002-2862-7572; CHEN, WEN-JONE/0000-0002-2098-5922; HUANG, CHIEN-HUA/0000-0003-2981-4537	Ministry of Science and Technology [105-2314-B-002-125-MY3, 104-2314-B-002-204]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The study was supported by research grant (105-2314-B-002-125-MY3 & 104-2314-B-002-204) from the Ministry of Science and Technology.	Aronson D, 2012, PHARMACOL THERAPEUT, V135, P1, DOI 10.1016/j.pharmthera.2012.03.002; Becker L B, 1997, New Horiz, V5, P145; Bigham BL, 2011, RESUSCITATION, V82, P979, DOI 10.1016/j.resuscitation.2011.03.024; Chalkias A, 2012, HEART FAIL REV, V17, P117, DOI 10.1007/s10741-011-9255-1; Chang WT, 2007, INTENS CARE MED, V33, P88, DOI 10.1007/s00134-006-0442-9; Dragancea I, 2013, RESUSCITATION, V84, P337, DOI 10.1016/j.resuscitation.2012.09.015; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; Howard Robin S, 2011, Pract Neurol, V11, P4, DOI 10.1136/jnnp.2010.235218; Huang CH, 2007, SHOCK, V28, P53, DOI 10.1097/shk.0b013e31802f0218; Huang CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166324; Huang CH, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0516-3; Huang L, 2005, J LAB CLIN MED, V146, P256, DOI 10.1016/j.lab.2005.07.005; Jentzer JC, 2018, RESUSCITATION, V123, P15, DOI 10.1016/j.resuscitation.2017.12.004; Jentzer JC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/314796; Kaplinsky Edgardo, 2018, Drugs Context, V7, P212518, DOI 10.7573/dic.212518; Kern KB, 1997, CIRCULATION, V95, P2610, DOI 10.1161/01.CIR.95.12.2610; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; Kim MJ, 2015, RESUSCITATION, V97, P115, DOI 10.1016/j.resuscitation.2015.08.019; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Lemiale V, 2008, RESUSCITATION, V76, P17, DOI 10.1016/j.resuscitation.2007.06.028; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Menasche P, 2001, SHOCK, V16, P20, DOI 10.1097/00024382-200116001-00005; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Niemann JT, 2003, CIRCULATION, V108, P3031, DOI 10.1161/01.CIR.0000101925.37174.85; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Ruiz-Bailen M, 2005, RESUSCITATION, V66, P175, DOI 10.1016/j.resuscitation.2005.01.012; Tariq S, 2015, INT J MOL SCI, V16, P29060, DOI 10.3390/ijms161226147; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2009, HEART FAIL REV, V14, P243, DOI 10.1007/s10741-009-9153-y; Tsai MS, 2019, RESUSCITATION, V137, P52, DOI 10.1016/j.resuscitation.2019.01.040; Uray T, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018657; Uray T, 2018, CRIT CARE MED, V46, pE508, DOI 10.1097/CCM.0000000000003070; Vaagenes P, 1997, RESUSCITATION, V35, P41, DOI 10.1016/S0300-9572(97)01108-8; Vasquez A, 2004, RESUSCITATION, V61, P199, DOI 10.1016/j.resuscitation.2004.01.002; Wang CH, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016139; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Xanthos T, 2009, AM J EMERG MED, V27, P651, DOI 10.1016/j.ajem.2008.05.004; Yeo D, 2020, GEROSCIENCE, V42, P963, DOI 10.1007/s11357-020-00171-7	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264165	10.1371/journal.pone.0264165	http://dx.doi.org/10.1371/journal.pone.0264165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176110	Green Published, gold			2022-12-26	WOS:000777505200089
J	Cairo, A; Iorio, MV; Spena, S; Tagliabue, E; Peyvandi, F				Cairo, Andrea; Iorio, Marilena, V; Spena, Silvia; Tagliabue, Elda; Peyvandi, Flora			Worldwide SARS-CoV-2 haplotype distribution in early pandemic	PLOS ONE			English	Article							MUTATIONS	The world is experiencing one of the most severe viral outbreaks in the last few years, the pandemic infection by SARS-CoV-2, the causative agent of COVID-19 disease. As of December 10th 2021, the virus has spread worldwide, with a total number of more than 267 million of confirmed cases (four times more in the last year), and more than 5 million deaths. A great effort has been undertaken to molecularly characterize the virus, track the spreading of different variants across the globe with the aim to understand the potential effects in terms of transmission capability and different fatality rates. Here we focus on the genomic diversity and distribution of the virus in the early stages of the pandemic, to better characterize the origin of COVID-19 and to define the geographical and temporal evolution of genetic clades. By performing a comparative analysis of 75401 SARS-CoV-2 reported sequences (as of December 2020), using as reference the first viral sequence reported in Wuhan in December 2019, we described the existence of 26538 genetic variants, the most frequent clustering into four major clades characterized by a specific geographical distribution. Notably, we found the most frequent variant, the previously reported missense p.Asp614Gly in the S protein, as a single mutation in only three patients, whereas in the large majority of cases it occurs in concomitance with three other variants, suggesting a high linkage and that this variant alone might not provide a significant selective advantage to the virus. Moreover, we evaluated the presence and the distribution in our dataset of the mutations characterizing the so called "british variant", identified at the beginning of 2021, and observed that 9 out of 17 are present only in few sequences, but never in linkage with each other, suggesting a synergistic effect in this new viral strain. In summary, this is a large-scale analysis of SARS-CoV-2 deposited sequences, with a particular focus on the geographical and temporal evolution of genetic clades in the early phase of COVID-19 pandemic.	[Cairo, Andrea; Spena, Silvia; Peyvandi, Flora] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bon Hemophilia & Thrombosis Ctr &, Milan, Italy; [Iorio, Marilena, V; Tagliabue, Elda] Fdn IRCCS Ist Nazl Tumori, Res Dept, Milan, Italy; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Peyvandi, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bon Hemophilia & Thrombosis Ctr &, Milan, Italy.; Peyvandi, F (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	flora.peyvandi@unimi.it	Tagliabue, Elda/B-9377-2017	Tagliabue, Elda/0000-0001-9877-2903	Italian Ministry of Health - Bando Ricerca Corrente; Italian Ministry of Health [N.GR-201602361750]; Berlucchi Foundation	Italian Ministry of Health - Bando Ricerca Corrente; Italian Ministry of Health(Ministry of Health, Italy); Berlucchi Foundation	This work was supported by the Italian Ministry of Health -Bando Ricerca Corrente. (RC2020 to Dr. F. Peyvandi). Dr. Iorio MV is supported by the Young Researcher Grant from the Italian Ministry of Health (grant N.GR-201602361750) and by a Career Foundation Grant from Berlucchi Foundation.	Becerra-Flores M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13525; Bhattacharyya C., 2020, BIORXIV, DOI [DOI 10.2807/1560-7917.ES.2020.25.3.2000045, 10.1101/2020.05.04.075911, DOI 10.1101/2020.05.04.075911]; Biswas NK, 2020, INDIAN J MED RES, V151, P450, DOI 10.4103/ijmr.IJMR_1125_20; Chen JH, 2020, J MOL BIOL, V432, P5212, DOI 10.1016/j.jmb.2020.07.009; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Creech CB, 2021, JAMA-J AM MED ASSOC, V325, P1318, DOI 10.1001/jama.2021.3199; Dong YT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00352-y; European Centre for Disease Prevention and Control, 2020, RAP INCR SARS COV 2; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Han XC, 2022, J MED VIROL, V94, P1366, DOI 10.1002/jmv.27513; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Zahradník J, 2021, bioRxiv, DOI 10.1101/2021.01.06.425392; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maslo C, 2022, JAMA-J AM MED ASSOC, V327, P583, DOI 10.1001/jama.2021.24868; McKinney W., 2010, 9 PYTHON SCI C, V445, P51; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Toyoshima Y, 2020, J HUM GENET, V65, P1075, DOI 10.1038/s10038-020-0808-9; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Wang N, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00298; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P., 2020, Nature, V579, P270, DOI 10.1038/s41586-020-2012-7	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263705	10.1371/journal.pone.0263705	http://dx.doi.org/10.1371/journal.pone.0263705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171928	gold, Green Published			2022-12-26	WOS:000795889700034
J	Kakiuchi, K; Miyasaka, T; Harii, N; Takeoka, S				Kakiuchi, Kenta; Miyasaka, Takehiro; Harii, Norikazu; Takeoka, Shinji			Development of quantitative and concise measurement method of oxygen in fine bubble dispersion	PLOS ONE			English	Article							PALLADIUM-CATALYZED HYDROGENATION; NANOBUBBLES; WATER; MICROBUBBLE; STABILITY; STRATEGY	Fine bubbles (FBs) have attracted significant attention in several research fields. Although some reports have argued that FB dispersion is useful as an oxygen (gas) carrier, only a few reports have examined its properties as an oxygen carrier using experimental data. As one of the reasons for this, there are no standard methods for measuring the oxygen content in FB dispersions. Conventional oxygen measurement methods have certain drawbacks in accuracy or speed; thus, it is difficult to use oxygen content as the primary outcome. In this study, we introduce a Clark-type polarographic oxygen electrode device (OXYG1-PLUS) for oxygen measurement, allowing the dilution of FB dispersion without the influence of ambient air and the adhesion of FBs on the electrode surface due to its special shape. First, the accuracy of our dilution method was evaluated using pure water as a sample, and it was confirmed that our method could measure with an accuracy of +/- 0.5 mg/L from the results with conventional dissolved oxygen meters. Second, the oxygen content in FB dispersion was evaluated with our method and a chemical titration method (Winkler's method), and it was found that our method could measure the oxygen content in FB dispersions quantitively. This method satisfies the easiness (4 steps) and quickness (within 8 min) for a wide range of oxygen contents (0 to 332 mg/L, theoretical range) with low coefficient variation (< 4.7%) and requires a small sample volume (50-500 mu L); thus, it is a useful method for measuring the oxygen in FB dispersions.	[Kakiuchi, Kenta; Takeoka, Shinji] Waseda Univ TWIns, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Miyasaka, Takehiro] Shonan Inst Technol, Dept Mat & Human Environm Sci, Fujisawa, Kanagawa, Japan; [Harii, Norikazu] Univ Yamanashi, Fac Med, Dept Community & Family Med, Chou, Yamanashi, Japan; [Takeoka, Shinji] Waseda Univ, Inst Adv Res Biosyst Dynam, Res Inst Sci & Engn, Shinjuku Ku, Tokyo, Japan	Waseda University; University of Yamanashi; Waseda University	Takeoka, S (corresponding author), Waseda Univ TWIns, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan.; Takeoka, S (corresponding author), Waseda Univ, Inst Adv Res Biosyst Dynam, Res Inst Sci & Engn, Shinjuku Ku, Tokyo, Japan.	takeoka@waseda.jp	Kakiuchi, Kenta/GWM-8751-2022	Kakiuchi, Kenta/0000-0002-9102-0669; Takeoka, Shinji/0000-0002-6230-1517	JSPS KAKENHI [P18K08913]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) [Grant number: P18K08913] to N.H (Collaborators: S.T., T.M.). The funders had no role in study design, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Alheshibri M, 2021, CURR OPIN COLLOID IN, V55, DOI 10.1016/j.cocis.2021.101470; Alheshibri M, 2016, LANGMUIR, V32, P11086, DOI 10.1021/acs.langmuir.6b02489; Benson BB., 1984, DEEP SEA RES B, V31, P859, DOI [10.1016/0198-0254(84)93289-8, DOI 10.1016/0198-0254(84)93289-8]; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Ebina K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065339; Feshitan JA, 2014, BIOMATERIALS, V35, P2600, DOI 10.1016/j.biomaterials.2013.12.070; Ghaani MR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0094; Gotoh E, 2018, PLANT PHYSIOL, V178, P1358, DOI 10.1104/pp.18.00484; Jadhav AJ, 2020, LANGMUIR, V36, P1699, DOI 10.1021/acs.langmuir.9b03532; Kakiuchi K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73768-9; Kakiuchi K, 2015, J ARTIF ORGANS, V18, P220, DOI 10.1007/s10047-015-0835-z; Kheir JN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003679; Khuntia S, 2012, REV CHEM ENG, V28, P191, DOI 10.1515/revce-2012-0007; Kikuchi K, 2009, J COLLOID INTERF SCI, V329, P306, DOI 10.1016/j.jcis.2008.10.009; Li YL, 2019, J PHYS CHEM B, V123, P4025, DOI 10.1021/acs.jpcb.9b01057; Mase N, 2017, SYNLETT, V28, P2184, DOI 10.1055/s-0036-1588869; Mase N, 2013, SYNLETT, V24, P2225, DOI 10.1055/s-0033-1339798; Mase N, 2011, CHEM COMMUN, V47, P2086, DOI 10.1039/c0cc04377j; Matsuki N, 2012, EUR BIOPHYS J BIOPHY, V41, P571, DOI 10.1007/s00249-012-0811-y; Matsuoka H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051395; Nirmalkar N, 2018, SOFT MATTER, V14, P9643, DOI 10.1039/c8sm01949e; Nirmalkar N, 2018, LANGMUIR, V34, P10964, DOI 10.1021/acs.langmuir.8b01163; Oh SH, 2017, LANGMUIR, V33, P3818, DOI 10.1021/acs.langmuir.7b00510; Ohmori M., 2015, J ENV BIOTECHNOL, V15, P41; Oshita S., 2020, JPN J MULTIPHASE FLO, V34, P194; Srithongouthai S, 2006, FISHERIES SCI, V72, P485, DOI 10.1111/j.1444-2906.2006.01176.x; Swanson EJ, 2010, LANGMUIR, V26, P15726, DOI 10.1021/la1029432; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Takahashi M, 2003, J PHYS CHEM B, V107, P2171, DOI 10.1021/jp022210z; Tanaka S, 2021, CHEM-ING-TECH, V93, P168, DOI 10.1002/cite.202000143; Trasaka K., 2016, UNION FINE BUBBLE SC; Ulatowski K, 2020, WATER ENVIRON J, V34, P772, DOI 10.1111/wej.12577; Ulatowski K, 2019, CHEM ENG PROCESS, V136, P62, DOI 10.1016/j.cep.2018.12.010; Ushikubo FY, 2010, COLLOID SURFACE A, V361, P31, DOI 10.1016/j.colsurfa.2010.03.005; Yasui K, 2016, LANGMUIR, V32, P11101, DOI 10.1021/acs.langmuir.5b04703; Zhao WC, 2014, CHEM PHYS LETT, V608, P224, DOI 10.1016/j.cplett.2014.05.079	37	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0264083	10.1371/journal.pone.0264083	http://dx.doi.org/10.1371/journal.pone.0264083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171962	gold, Green Published			2022-12-26	WOS:000795889700062
J	Motes-Rodrigo, A; McPherron, SP; Archer, W; Hernandez-Aguilar, RA; Tennie, C				Motes-Rodrigo, Alba; McPherron, Shannon P.; Archer, Will; Hernandez-Aguilar, R. Adriana; Tennie, Claudio			Experimental investigation of orangutans' lithic percussive and sharp stone tool behaviours	PLOS ONE			English	Article							RAW-MATERIAL SELECTIVITY; WEST TURKANA; NUT-CRACKING; LOMEKWI 3; PAN; CHIMPANZEES; OLDOWAN; TECHNOLOGY; OBJECTS; APES	Early stone tools, and in particular sharp stone tools, arguably represent one of the most important technological milestones in human evolution. The production and use of sharp stone tools significantly widened the ecological niche of our ancestors, allowing them to exploit novel food resources. However, despite their importance, it is still unclear how these early lithic technologies emerged and which behaviours served as stepping-stones for the development of systematic lithic production in our lineage. One approach to answer this question is to collect comparative data on the stone tool making and using abilities of our closest living relatives, the great apes, to reconstruct the potential stone-related behaviours of early hominins. To this end, we tested both the individual and the social learning abilities of five orangutans to make and use stone tools. Although the orangutans did not make sharp stone tools initially, three individuals spontaneously engaged in lithic percussion, and sharp stone pieces were produced under later experimental conditions. Furthermore, when provided with a human-made sharp stone, one orangutan spontaneously used it as a cutting tool. Contrary to previous experiments, social demonstrations did not considerably improve the stone tool making and using abilities of orangutans. Our study is the first to systematically investigate the stone tool making and using abilities of untrained, unenculturated orangutans showing that two proposed pre-requisites for the emergence of early lithic technologies-lithic percussion and the recognition of sharp-edged stones as cutting tools-are present in this species. We discuss the implications that ours and previous great ape stone tool experiments have for understanding the initial stages of lithic technologies in our lineage.	[Motes-Rodrigo, Alba; Tennie, Claudio] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [McPherron, Shannon P.; Archer, Will; Tennie, Claudio] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Archer, Will] Max Planck Partner Grp, Natl Museum, Dept Archaeol & Anthropol, Bloemfontein, South Africa; [Hernandez-Aguilar, R. Adriana] Univ Barcelona, Dept Social Psychol & Quantitat Psychol, Barcelona, Spain; [Hernandez-Aguilar, R. Adriana] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, Oslo, Norway	Eberhard Karls University of Tubingen; Max Planck Society; University of Barcelona; University of Oslo	Motes-Rodrigo, A (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.	albamotes7@gmail.com		Motes Rodrigo, Alba/0000-0002-4444-7723	European Research Council (ERC) under the European Union [714658]	European Research Council (ERC) under the European Union(European Research Council (ERC))	CT and AMR were funded by the European Research Council (ERC, https://erc.europa.eu) Starting grant awarded to CT (project STONECULT) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 714658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer W, 2020, J HUM EVOL, V142, DOI 10.1016/j.jhevol.2020.102740; Bandini Elisa, 2021, Open Res Eur, V1, P20, DOI 10.12688/openreseurope.13186.2; Bandini E, 2020, PEERJ, V8, DOI 10.7717/peerj.9877; Bandini E, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0122; Barnes AS, 1939, AM ANTHROPOL, V41, P99, DOI 10.1525/aa.1939.41.1.02a00080; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; Bjorklund D. F., 2010, OBJECT PLAY TOOL USE, DOI [10.1093/oxfordhb/9780195393002.013.0013, DOI 10.1093/OXFORDHB/9780195393002.013.0013, 10.1093/oxfordhb/9780195393002. 013.0013]; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Braun DR, 2008, J ARCHAEOL SCI, V35, P2329, DOI 10.1016/j.jas.2008.03.004; Braun DR, 2019, P NATL ACAD SCI USA, V116, P11712, DOI 10.1073/pnas.1820177116; Braun DR, 2009, J ARCHAEOL SCI, V36, P1605, DOI 10.1016/j.jas.2009.03.025; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Clay Z, 2018, CHILD DEV, V89, P1535, DOI 10.1111/cdev.12857; Davidson I, 2005, J ROY ANTHROPOL INST, V11, P793, DOI 10.1111/j.1467-9655.2005.00262.x; Davidson I., 2019, SQUEEZING MINDS STON, P79; de Beaune SA, 2004, CURR ANTHROPOL, V45, P139, DOI 10.1086/381045; de la Torre I, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P45; Debenath A., 1994, HANDBOOK; Dominguez-Rodrigo M, 2016, PALEOANTHROPOLOGY, V2016, P46, DOI DOI 10.4207/PA.2016.ART99; Dominguez-Rodrigo M, 2019, J AFR ARCHAEOL, V17, P173, DOI 10.1163/21915784-20190006; DominguezRodrigo M, 2012, STONE TOOLS AND FOSSIL BONES: DEBATES IN THE ARCHAEOLOGY OF HUMAN ORIGINS, P1, DOI 10.1017/CBO9781139149327; Falotico T, 2019, NAT ECOL EVOL, V3, P1034, DOI 10.1038/s41559-019-0904-4; Falotico T, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22629; Fleiss J.L., 2013, STAT METHODS RATES P; Fox EA., 1999, MENTALITIES GORILLAS; Furlong EE, 2008, ANIM COGN, V11, P83, DOI 10.1007/s10071-007-0091-6; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Harmand S, 2009, VERTEBR PALEOBIOL PA, P85, DOI 10.1007/978-1-4020-9060-8_8; Haslam M, 2017, NAT ECOL EVOL, V1, P1431, DOI 10.1038/s41559-017-0286-4; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Heyes C., 2018, COGNITIVE GADGETS, DOI DOI 10.4159/9780674985155/HTML; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Key AJM, 2016, ETHNOARCHAEOLOGY, V8, P69, DOI 10.1080/19442890.2016.1150626; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11356; Koops K, 2010, PRIMATES, V51, P175, DOI 10.1007/s10329-009-0178-6; Luncz LV, 2014, AM J PRIMATOL, V76, P649, DOI 10.1002/ajp.22259; Marchant LF., 2005, STONE KNAPPING NECES; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; McGrew WC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0422; McGrew WC., 2003, PALEOANTHROPOLOGY, P9; McPherron SP, 2014, J ARCHAEOL SCI, V49, P70, DOI 10.1016/j.jas.2014.04.003; Meulman EJM, 2012, EVOL ANTHROPOL, V21, P58, DOI 10.1002/evan.21304; Miles H. Lyn, 1996, P278; O'Malley RC, 2000, FOLIA PRIMATOL, V71, P334, DOI 10.1159/000021756; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Proffitt T, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171904; Revelle W, 2020, **DATA OBJECT**; Riede F, 2018, EVOL ANTHROPOL, V27, P46, DOI 10.1002/evan.21555; RIJKSEN H D, 1974, Biological Conservation, V6, P20, DOI 10.1016/0006-3207(74)90037-8; Roffman I, 2012, P NATL ACAD SCI USA, V109, P14500, DOI 10.1073/pnas.1212855109; Rolian C., 2017, CHIMPANZEES HUMAN EV, P602; Savage-Rumbaugh S, 2006, OLDOWAN CASE STUDIES, P223; Savage-Rumbaugh S, 2007, J APPL ANIM WELF SCI, V10, P7, DOI 10.1080/10888700701277261; Schick KD, 1999, J ARCHAEOL SCI, V26, P821, DOI 10.1006/jasc.1998.0350; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Stout D, 2005, J HUM EVOL, V48, P365, DOI 10.1016/j.jhevol.2004.10.006; Tennie C, 2020, BIOL PHILOS, V35, DOI 10.1007/s10539-020-09769-9; Tennie C, 2019, BEHAV BRAIN SCI, V42, P37, DOI 10.1017/S0140525X19001055; Tennie C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041548; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Thompson JC, 2019, CURR ANTHROPOL, V60, P1, DOI 10.1086/701477; Tomasello M, 2004, ANIM COGN, V7, P213, DOI 10.1007/s10071-004-0227-x; TOTH N, 1993, J ARCHAEOL SCI, V20, P81, DOI 10.1006/jasc.1993.1006; Toth N., 1982, THESIS; Toth N., 2006, OLDOWAN CASE STUDIES; Toth N, 2018, AZANIA, V53, P3, DOI 10.1080/0067270X.2018.1439558; van Schaik Carel P., 2009, P299; vanSchaik CP, 1996, NATURWISSENSCHAFTEN, V83, P186, DOI 10.1007/s001140050271; VISALBERGHI E, 1987, FOLIA PRIMATOL, V49, P168, DOI 10.1159/000156320; Visalberghi E, 2003, INT J PRIMATOL, V24, P653, DOI 10.1023/A:1023700800113; WALKER PL, 1978, AM ANTIQUITY, V43, P710, DOI 10.2307/279502; WESTERGAARD GC, 1994, J HUM EVOL, V27, P399, DOI 10.1006/jhev.1994.1055; Wright RVS., 1972, MANKIND, V8, P296, DOI DOI 10.1111/J.1835-9310.1972.TB00451.X; Zink KD, 2016, NATURE, V531, P500, DOI 10.1038/nature16990	78	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263343	10.1371/journal.pone.0263343	http://dx.doi.org/10.1371/journal.pone.0263343			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171926	Green Published, gold			2022-12-26	WOS:000795889700022
J	Zhang, H; Yang, HM; Bandyopadhyay, S; Milano, MT; Fung, C; Messing, EM; Chen, Y				Zhang, Hong; Yang, Hongmei; Bandyopadhyay, Sanjukta; Milano, Michael T.; Fung, Chunkit; Messing, Edward M.; Chen, Yuhchyau			Increased risk of high-grade prostate cancer among testicular cancer survivors	PLOS ONE			English	Article							STAGE; SEMINOMA	Introduction Testicular cancer survivors (TCS) have an increased risk of additional cancers, including prostate cancer. Our understanding of the natural history of prostate cancer in testicular cancer survivors is very limited due to its rare incidence. Methods Using the Surveillance, Epidemiology, and End Results (SEER) Registry from 1978 to 2011, we identified 282 TCS with subsequent prostate cancer and examined the tumor grade and clinical outcomes in contrast to men with primary prostate cancer in the general population. Results TCS with a subsequent prostate cancer diagnosis were more likely to be diagnosed at a younger age than men with primary prostate cancer (65.2% vs. 37.6% for age <65, 34.8% vs. 62.4% for age >65, p<0.001) and were more likely to have grade III/IV tumors (46.2% vs. 37.0%, p<0.002). Longer latency between testicular and prostate cancer diagnoses was associated with a higher risk of grade III/IV (p<0.001) cancer. Despite the increased risk for high-grade tumors, 10-year prostate cancer-specific survival and overall survival were not significantly different between TCS and men with primary prostate cancer. Based on the available information in SEER, we found that prior history of radiotherapy for testicular cancer had no impact on tumor grade or survival outcomes. Conclusions Prostate cancer in TCS was more likely to be diagnosed at a younger age and with higher grades. Risks of grade III/IV disease increased with longer latency between testicular and prostate cancer diagnoses. Radiotherapy for testicular cancer did not appear to have a significant impact on the outcome of subsequent prostate cancer.	[Zhang, Hong; Milano, Michael T.; Chen, Yuhchyau] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Yang, Hongmei; Bandyopadhyay, Sanjukta] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Fung, Chunkit] Univ Rochester, Med Ctr, Dept Med, Div Hematol & Oncol, Rochester, NY 14642 USA; [Messing, Edward M.] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Zhang, H (corresponding author), Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA.	Hong_Zhang@urmc.rochester.edu		Zhang, Hong/0000-0003-3631-9163				Alibhai SMH, 2004, BJU INT, V94, P303, DOI 10.1111/j.1464-410X.2004.04883.x; [Anonymous], 2021, CANC STAT, DOI [10.3322/caac.21654, DOI 10.3322/CAAC.21654]; [Anonymous], CANC STAT FACTS TEST; Boyle P, 2016, BJU INT, V118, P731, DOI 10.1111/bju.13417; Fossa SD, 1999, J CLIN ONCOL, V17, P1146, DOI 10.1200/JCO.1999.17.4.1146; Fung C, 2013, J CLIN ONCOL, V31, P3807, DOI 10.1200/JCO.2013.50.3409; Fung C, 2012, J NATL COMPR CANC NE, V10, P545, DOI 10.6004/jnccn.2012.0052; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Greenland S., 2008, APPL STRATIFIED ANAL; Groot HJ, 2020, CANCER-AM CANCER SOC, V126, P628, DOI 10.1002/cncr.32538; Howard R, 2008, ANN EPIDEMIOL, V18, P416, DOI 10.1016/j.annepidem.2008.01.003; Jensen MV, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0349; Jones WG, 2005, J CLIN ONCOL, V23, P1200, DOI 10.1200/JCO.2005.08.003; Kurobe M, 2018, INT J UROL, V25, P457, DOI 10.1111/iju.13537; La Vignera S, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00264; Lackner JE, 2009, UROLOGY, V74, P825, DOI 10.1016/j.urology.2009.03.051; Nur U, 2008, BRIT J CANCER, V99, pS80, DOI 10.1038/sj.bjc.6604597; Richiardi L, 2007, INT J CANCER, V120, P623, DOI 10.1002/ijc.22345; Sun L, 2009, J UROLOGY, V182, P2242, DOI 10.1016/j.juro.2009.07.034; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263573	10.1371/journal.pone.0263573	http://dx.doi.org/10.1371/journal.pone.0263573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157714	gold, Green Published			2022-12-26	WOS:000788004500014
J	Beckingham, BA; Wischusen, K; Walker, JP				Beckingham, Barbara A.; Wischusen, Kerry; Walker, Joanna P.			Phthalate exposure among US college-aged women: Biomonitoring in an undergraduate student cohort (2016-2017) and trends from the National Health and Examination Survey (NHANES, 2005-2016)	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; METABOLITE CONCENTRATIONS; TEMPORAL VARIABILITY; PREGNANT-WOMEN; URINARY; POPULATION; CREATININE; ESTERS; ADULTS	Importance Phthalates are ubiquitous and many are known or suspected human reproductive and endocrine-disrupting toxicants. A data gap exists in reporting on biomonitoring of phthalate biomarkers in college-aged adults. Objective To analyze phthalate exposure in a cross-sectional sample of female college students using urinary phthalate metabolite concentrations and compare to reference populations including college-aged women sampled in the National Health and Nutrition Examination Survey (NHANES). Methods Nine monoester phthalate metabolites were analyzed in spot urine collected from 215 female undergraduates (age 18-22, 2016-2017) at a public university in Charleston, SC USA and a subset of participants completed a questionnaire detailing demographics and behaviors including personal care and cosmetic product use (e.g. in the past 6 or 24 hrs). Urine specific gravity was used to assess effect of urine dilution. Phthalate metabolite concentrations were compared to reference populations and the temporal trends of the same age-group in the National Health and Nutrition Examination Survey (NHANES) were analyzed. Results Total urinary phthalate metabolite concentrations in individuals ranged three orders of magnitude (geometric mean 56.6 ng/mL, IQR 26.6-114 ng/mL). A third of urine samples had relatively high urine specific gravity levels indicating potential dehydration status. All geometric mean concentrations were similar to the U.S. female population in the most recent NHANES cycle (2015-2016) except for MEP and mono-isobutyl phthalate (MiBP). Relatively low MEP and MiBP may be explained by a time trend of declining MEP in the general U.S. population, the sociocultural character of this cohort, and the time of day of spot sampling in evening. NHANES data indicate a significant effect of sample timing on phthalate metabolite concentrations and decline in most, but not all, phthalate metabolites sampled in women aged 18-22 years over the decade (2005-2016). Significance This study reports phthalate metabolites in college-aged women, an understudied group, emphasizes the benefit of survey information for interpreting biomonitoring data, and is a useful case study for communicating phthalate chemical exposure risks to college students.	[Beckingham, Barbara A.] Coll Charleston, Dept Geol & Environm Geosci, Charleston, SC 29401 USA; [Wischusen, Kerry] Coll Charleston, Dept Biochem, Charleston, SC 29401 USA; [Walker, Joanna P.] Coll Charleston, Dept Hlth & Human Performance, Charleston, SC 29401 USA	College of Charleston; College of Charleston; College of Charleston	Beckingham, BA (corresponding author), Coll Charleston, Dept Geol & Environm Geosci, Charleston, SC 29401 USA.	beckinghamba@cofc.edu		Beckingham, Barbara/0000-0003-4755-816X	Undergraduate Research and Creative Activities (URCA) Program; Departments of Geology & Environmental Geoscience and Health & Human Performance at the College of Charleston	Undergraduate Research and Creative Activities (URCA) Program; Departments of Geology & Environmental Geoscience and Health & Human Performance at the College of Charleston	The authors (BB, KW, JW) received funding from the Undergraduate Research and Creative Activities (URCA) Program and the Departments of Geology & Environmental Geoscience and Health & Human Performance at the College of Charleston to support this work.	Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r; Braun JM, 2014, J EXPO SCI ENV EPID, V24, P459, DOI 10.1038/jes.2013.69; Calafat Antonia M, 2016, Curr Epidemiol Rep, V3, P145, DOI 10.1007/s40471-016-0075-7; CDC, 2009, 4 CDCP; Center for Disease Control and Prevention (CDC), 2012, 630303 CDC; Cook JD, 2002, J ANAL TOXICOL, V26, P424, DOI 10.1093/jat/26.7.424; Dodson RE, 2012, ENVIRON HEALTH PERSP, V120, P935, DOI 10.1289/ehp.1104052; Frederiksen H, 2013, ENVIRON SCI TECHNOL, V47, P958, DOI 10.1021/es303640b; Goen T, 2011, INT J HYG ENVIR HEAL, V215, P36, DOI 10.1016/j.ijheh.2011.07.011; Hahn RG, 2013, INT J SPORT NUTR EXE, V23, P303, DOI 10.1123/ijsnem.23.4.303; Harley KG, 2016, ENVIRON HEALTH PERSP, V124, P1600, DOI 10.1289/ehp.1510514; Hart LB, 2020, J EXPO SCI ENV EPID, V30, P97, DOI 10.1038/s41370-019-0170-1; Hart LB, 2018, GEOHEALTH, V2, P313, DOI 10.1029/2018GH000146; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hauser R, 2016, ENVIRON HEALTH PERSP, V124, P831, DOI 10.1289/ehp.1509760; Hubinger JC, 2010, J COSMET SCI, V61, P457; Johns LE, 2015, ENVIRON INT, V85, P27, DOI 10.1016/j.envint.2015.08.005; Kay VR, 2013, CRIT REV TOXICOL, V43, P200, DOI 10.3109/10408444.2013.766149; Kobrosly RW, 2012, ENVIRON RES, V115, P11, DOI 10.1016/j.envres.2012.03.008; Koch HM, 2012, ARCH TOXICOL, V86, P1829, DOI 10.1007/s00204-012-0908-1; Koch HM, 2013, INT J HYG ENVIR HEAL, V216, P672, DOI 10.1016/j.ijheh.2012.12.002; Krais AM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112514; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; McPherson RA, 2011, HENRYS CLIN DIAGNOSI; Mortamais M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-29; Pacyga DC, 2019, ADV NUTR, V10, P803, DOI 10.1093/advances/nmz029; Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4; Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231; Rodriguez-Carmona Y, 2020, J EXPO SCI ENV EPID, V30, P56, DOI 10.1038/s41370-019-0168-8; Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004; Sauve JF, 2015, J OCCUP ENVIRON HYG, V12, P123, DOI 10.1080/15459624.2014.955179; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Swan SH, 2015, HUM REPROD, V30, P963, DOI 10.1093/humrep/deu363; U.S. EPA, 2017, AMERICAS CHILDREN EN, VThird; Wang Y, 2019, TOXICS, V7, DOI 10.3390/toxics7020021; Wenzel AG, 2018, CHEMOSPHERE, V193, P394, DOI 10.1016/j.chemosphere.2017.11.019; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Xu HL, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114279; Zota AR, 2014, ENVIRON HEALTH PERSP, V122, P235, DOI 10.1289/ehp.1306681	44	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263578	10.1371/journal.pone.0263578	http://dx.doi.org/10.1371/journal.pone.0263578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148339	gold, Green Published			2022-12-26	WOS:000800108800021
J	Rezaei, S; Mohammadi, A; Malakoutikhah, S; Khosravi, R				Rezaei, Sahar; Mohammadi, Alireza; Malakoutikhah, Shima; Khosravi, Rasoul			Combining multiscale niche modeling, landscape connectivity, and gap analysis to prioritize habitats for conservation of striped hyaena (Hyaena hyaena)	PLOS ONE			English	Article							ENDANGERED ASIATIC CHEETAH; LIONS PANTHERA-LEO; LARGE CARNIVORES; CLIMATE-CHANGE; GENETIC DIFFERENTIATION; SPECIES DISTRIBUTION; SELECTION FUNCTIONS; MOVEMENT BEHAVIOR; CENTRAL IRAN; SCALE	Identifying spatial gaps in conservation networks requires information on species-environment relationships, and prioritization of habitats and corridors. We combined multi-extent niche modeling, landscape connectivity, and gap analysis to investigate scale-dependent environmental relationships, and identify core habitats and corridors for a little-known carnivore in Iran, the striped hyaena (Hyaena hyaena). This species is threatened in Iran by road vehicle collisions and direct killing. Therefore, understanding the factors that affect its habitat suitability, spatial pattern of distribution, and connectivity among them are prerequisite steps to delineate strategies aiming at human-striped hyaena co-existence. The results showed that the highest predictive power and extent of habitats was obtained at the extent sizes of 4 and 2 km, respectively. Also, connectivity analysis revealed that the extent and number of core habitats and corridors changed with increasing dispersal distance, and approximately 21% of the landscape was found to support corridors. The results of gap analysis showed that 15-17% of the core habitats overlapped with conservation areas. Given the body size of the species, its mobility, and lack of significant habitat specialization we conclude that this species would be more strongly influenced by changes in habitat amount rather than landscape configuration. Our approach showed that the scale of variables and dispersal ability must be accounted for in conservation efforts to prioritize habitats and corridors, and designing conservation areas. Our results could facilitate the conservation of striped hyaena through the identification and prioritization of habitats, establishment of conservation areas, and mitigating conflicts in corridors.	[Rezaei, Sahar] Univ Arkansas, Dept Biol Sci, Fac Sci Engn, Fayetteville, AR 72701 USA; [Mohammadi, Alireza] Univ Jiroft, Fac Nat Resources, Dept Environm Sci & Engn, Jiroft, Iran; [Malakoutikhah, Shima] Isfahan Univ Technol, Fac Nat Resources, Dept Environm Sci, Esfahan, Iran; [Khosravi, Rasoul] Shiraz Univ, Coll Agr, Dept Nat Resources & Environm Engn, Shiraz, Iran	University of Arkansas System; University of Arkansas Fayetteville; Isfahan University of Technology; Shiraz University	Khosravi, R (corresponding author), Shiraz Univ, Coll Agr, Dept Nat Resources & Environm Engn, Shiraz, Iran.	r-khosravi@shirazu.ac.ir		Khosravi, Rasoul/0000-0002-7231-563X	Markazi Provincial Office of Department of Environment	Markazi Provincial Office of Department of Environment	We are grateful to Markazi Provincial Office of Department of Environment (DoE) for permission to enter PAs and to Dr. Dylan Schwilk from Texas Tech University for his valuable and constructive comments on an earlier version of the manuscript, improving its quality.	Abi-Said Mounir R., 2007, Zoology in the Middle East, V42, P3; Ahmadi M, 2020, LANDSCAPE ECOL, V35, P1505, DOI 10.1007/s10980-020-01033-5; Ahmadi M, 2017, DIVERS DISTRIB, V23, P592, DOI 10.1111/ddi.12560; Alam MS, 2015, J ARID LAND, V7, P860, DOI 10.1007/s40333-015-0007-2; Alam MS, 2014, ASIAN J GEOINFORMATI, V14; Alam S., 2011, STATUS ECOLOGY CONSE; Almasieh K., 2019, EUR J WILDLIFE RES, V65, P1; Ansari A, 2019, INT SOIL WATER CONSE, V7, P346, DOI 10.1016/j.iswcr.2019.08.004; Ansari HM, 2018, URSUS, V29, P13, DOI 10.2192/URSUS-D-16-00017.1; Ash E, 2020, LAND-BASEL, V9, DOI 10.3390/land9110415; Ashrafzadeh MR, 2020, BIOL CONSERV, V245, DOI 10.1016/j.biocon.2020.108523; Ashrafzadeh MR, 2019, MAMMAL RES, V64, P39, DOI 10.1007/s13364-018-0384-y; Jalilian MA, 2020, ENVIRON MONIT ASSESS, V192, DOI 10.1007/s10661-020-8145-1; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Baker PJ, 2008, MAMMAL REV, V38, P123, DOI 10.1111/j.1365-2907.2008.00122.x; Boitani Luigi, 1999, Ursus, V11, P123; Bopanna I., 2013, THESIS SAURASTRA U R; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Chambers CL, 2016, LANDSCAPE ECOL, V31, P1299, DOI 10.1007/s10980-016-0343-4; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Croes BM, 2011, BIOL CONSERV, V144, P3064, DOI 10.1016/j.biocon.2011.09.013; Cushman SA., 2018, MACHINE LEARNING ECO, P185, DOI [10.1007/978-3-319-96978-7_9, DOI 10.1007/978-3-319-96978-7_9, DOI 10.1007/978-3-319]; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196213; Cushman S, 2017, LANDSCAPE ECOL, V32, P1581, DOI 10.1007/s10980-017-0520-0; Cushman SA, 2016, LANDSCAPE ECOL, V31, P1337, DOI 10.1007/s10980-015-0292-3; Cushman Samuel A., 2014, Diversity-Basel, V6, P844; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2013, CONSERV GENET, V14, P263, DOI 10.1007/s10592-012-0396-0; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Cushman SA, 2010, LANDSCAPE ECOL, V25, P1613, DOI 10.1007/s10980-010-9534-6; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P369, DOI 10.1007/978-4-431-87771-4_20; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Darvishsefat A. A., 2006, ATLAS PROTECTED AREA; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Dickson BG, 2019, CONSERV BIOL, V33, P239, DOI 10.1111/cobi.13230; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Evans J.S., ARCGIS TOOLBOX SURFA; Farhadinia MS, 2015, BIOL CONSERV, V191, P770, DOI 10.1016/j.biocon.2015.08.027; Foltete JC, 2012, ENVIRON MODELL SOFTW, V38, P316, DOI 10.1016/j.envsoft.2012.07.002; Fournier A, 2017, GLOB ECOL CONSERV, V12, P215, DOI 10.1016/j.gecco.2017.11.002; Ghoddousi A, 2020, LANDSCAPE ECOL, V35, P1809, DOI 10.1007/s10980-020-01062-0; Grand J, 2004, CONSERV BIOL, V18, P1063, DOI 10.1111/j.1523-1739.2004.00555.x; Hattab T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1417, DOI 10.1111/geb.12217; Hearn AJ, 2019, LANDSCAPE ECOL, V34, P275, DOI 10.1007/s10980-018-0758-1; Hearn AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200828; Hoechstetter S., 2008, LANDSC ONLINE, V3, P1, DOI [10.3097/LO.200803, DOI 10.3097/L0.200803, DOI 10.3097/LO.200803]; Kanagaraj R, 2013, BIOL CONSERV, V167, P298, DOI 10.1016/j.biocon.2013.08.030; Karami P, 2020, J MT SCI-ENGL, V17, P68, DOI 10.1007/s11629-019-5418-7; Kaszta Z, 2020, ANIM CONSERV, V23, P607, DOI 10.1111/acv.12575; Khosravi R., 2017, J WILDLIFE BIODIVERS, V1, P60; Khosravi R, 2021, BIOL CONSERV, V255, DOI 10.1016/j.biocon.2021.109018; Khosravi R, 2019, LANDSCAPE ECOL, V34, P2451, DOI 10.1007/s10980-019-00900-0; Khosravi R, 2018, DIVERS DISTRIB, V24, P193, DOI 10.1111/ddi.12672; Khosravi R, 2016, TURK J ZOOL, V40, P574, DOI 10.3906/zoo-1505-38; Klaassen B, 2018, ECOL EVOL, V8, P7611, DOI 10.1002/ece3.4269; Krishnamurthy R, 2016, LANDSCAPE ECOL, V31, P1355, DOI 10.1007/s10980-016-0363-0; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Lima VMM., 2012, MODELAO DISTRIBUIO G; Liu CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206071; Macdonald DW, 2019, DIVERS DISTRIB, V25, P1639, DOI 10.1111/ddi.12967; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; Mateo-Sanchez MC, 2015, LANDSCAPE ECOL, V30, P1405, DOI 10.1007/s10980-015-0194-4; Mateo-Sanchez MC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00387.1; McClure ML, 2017, ECOL EVOL, V7, P3762, DOI 10.1002/ece3.2939; McGarigal, 2002, FRAGSTATS SPATIAL PA; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Mohammadi A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79970-z; Mohammadi A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91921-w; Mohammadi A, 2018, J NAT CONSERV, V43, P8, DOI 10.1016/j.jnc.2018.02.011; Mohammadi A, 2016, HUM-WILDL INTERACT, V10, P103; Moqanaki EM, 2017, ANIM CONSERV, V20, P29, DOI 10.1111/acv.12281; MUNGUIRA ML, 1992, J APPL ECOL, V29, P316, DOI 10.2307/2404501; Panzacchi M, 2016, J ANIM ECOL, V85, P32, DOI 10.1111/1365-2656.12386; Paradis E., 2015, MESQUITE MODULAR SYS, V2, P4; Parchizadeh J, 2021, GLOB ECOL CONSERV, V27, DOI 10.1016/j.gecco.2021.e01618; Parchizadeh J, 2019, ECOL EVOL, V9, P11972, DOI 10.1002/ece3.5673; Pascual-Hortal L, 2008, EUR J FOREST RES, V127, P23, DOI 10.1007/s10342-006-0165-z; Philips S., 2010, MAXENT SOFTWARE VERS; Primack R.B., 1993, ESSENTIALS CONSERVAT; Reding DM, 2013, LANDSCAPE ECOL, V28, P471, DOI 10.1007/s10980-012-9844-y; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Rieger I., 1979, REV BIOL STRIPED HYA; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Santini L, 2016, CONSERV SCI PRACT, V15, P122; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Shahnaseri G, 2019, LANDSCAPE ECOL, V34, P1263, DOI 10.1007/s10980-019-00831-w; Tourani M, 2012, ZOOL MIDDLE EAST, V56, P133, DOI 10.1080/09397140.2012.10648948; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Vergara M, 2016, LANDSCAPE ECOL, V31, P1241, DOI 10.1007/s10980-015-0307-0; Wagner A. P., 2006, BEHAV ECOLOGY STRIPE; Wan HY, 2019, LANDSCAPE ECOL, V34, P503, DOI 10.1007/s10980-019-00788-w; Wan HY, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080403; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yusefi GH, 2019, J MAMMAL, V100, P55, DOI 10.1093/jmammal/gyz002; Zeller KA, 2018, DIVERS DISTRIB, V24, P868, DOI 10.1111/ddi.12742; Ziaie H, 2008, FIELD GUIDE MAMMALS	100	3	3	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0260807	10.1371/journal.pone.0260807	http://dx.doi.org/10.1371/journal.pone.0260807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143518	gold, Green Published			2022-12-26	WOS:000797657800005
J	Jin, CS; Teneberg, S				Jin, Chunsheng; Teneberg, Susann			Characterization of novel nonacid glycosphingolipids as biomarkers of human gastric adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP ANTIGENS; HELICOBACTER-PYLORI; MASS-SPECTROMETRY; TN ANTIGEN; BINDING GANGLIOSIDES; CANCER; EXPRESSION; GLYCOLIPIDS; ADHESIN; GLYCOPROTEIN	degenerative changes appear leading to premalignant conditions as atrofic gastritis, metaplasia, and dysplasia. binding of bacterial adhesins to carbohydrate receptors on the gastric epithelium. A number of different carbohydrate receptor been reported (reviewed in Ref. (2)). Despite the multitude of candidate H. pylori glycan receptors, only three carbohydratebinding adhesins have been characterized to date; the blood group antigen-binding BabA adhesin, the sialic acid-binding SabA adhesin, and the LabA adhesin (reviewed in Ref. (3)). adhesin BabA (4). H. pylori strains expressing BabA together with VacA and CagA (triple-positive strains) are highly associated with severe gastric diseases, as peptic ulcer or gastric adenocarcinoma. BabA mediates the initial attachment of H. pylori to the human gastric mucosa. The first observation recognized by H. pylori BabA was followed by a division of BabA-producing H. pylori strains into specialist and generalist strains, depending on their mode of binding to Leb and related carbohydrate sequences (5). BabA of specialist strains binds	[Jin, Chunsheng; Teneberg, Susann] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Cancer Foundation [20 0759 PjF 01 H]	Swedish Cancer Foundation	This work was supported by the Swedish Cancer Foundation (grant no.: 20 0759 PjF 01 H; to S. T.).	Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Barone A, 2013, J BIOL CHEM, V288, P10035, DOI 10.1074/jbc.M112.436162; Benktander J, 2018, VIRULENCE, V9, P738, DOI 10.1080/21505594.2018.1440171; Benktander J, 2012, J BIOL CHEM, V287, P31712, DOI 10.1074/jbc.M112.387654; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BREIMER ME, 1980, CANCER RES, V40, P897; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; Ciopraga J, 2000, J BIOCHEM, V128, P855, DOI 10.1093/oxfordjournals.jbchem.a022824; DAVID L, 1992, APMIS, V100, P162; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Doohan D, 2021, TOXINS, V13, DOI 10.3390/toxins13070485; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; HAKOMORI S, 1977, P NATL ACAD SCI USA, V74, P3023, DOI 10.1073/pnas.74.7.3023; Hakomori S., 1989, GANGLIOSIDES CANC, P57; HATTORI H, 1987, CANCER RES, V47, P1968; HATTORI H, 1981, BIOCHIM BIOPHYS ACTA, V666, P361, DOI 10.1016/0005-2760(81)90295-2; HIROHASHI S, 1985, P NATL ACAD SCI USA, V82, P7039, DOI 10.1073/pnas.82.20.7039; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Jacob F., 2014, GLYCOSPHINGOLIPID P1; Javaheri A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.189; Jin CS, 2018, J BIOL CHEM, V293, P17248, DOI 10.1074/jbc.RA118.004854; Johansson MM, 2015, GLYCOCONJUGATE J, V32, P393, DOI 10.1007/s10719-015-9604-8; KANNAGI R, 1982, CANCER RES, V42, P5249; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Kawaguchi T, 2006, BREAST CANCER RES TR, V98, P31, DOI 10.1007/s10549-005-9115-6; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; Koniger V, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.188; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; LEVINE P, 1976, ANN NY ACAD SCI, V277, P428, DOI 10.1111/j.1749-6632.1976.tb41719.x; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MATIASGUIU X, 1988, PATHOL RES PRACT, V183, P476, DOI 10.1016/S0344-0338(88)80096-7; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; Mthembu YH, 2020, MOL OMICS, V16, P243, DOI 10.1039/c9mo00175a; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4831, DOI 10.1021/bi00693a009; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Padda J, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15165; Paraskevopoulou V., 2021, STRUCTURAL BINDING C; Pearce OMT, 2018, GLYCOBIOLOGY, V28, P670, DOI 10.1093/glycob/cwy023; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Roche N, 2001, GLYCOBIOLOGY, V11, P935, DOI 10.1093/glycob/11.11.935; Roche N, 2007, MICROBES INFECT, V9, P605, DOI 10.1016/j.micinf.2007.01.023; Rossez Y, 2014, J INFECT DIS, V210, P1286, DOI 10.1093/infdis/jiu239; SAKAMOTO J, 1989, CANCER RES, V49, P745; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Teneberg S, 2002, J BIOL CHEM, V277, P19709, DOI 10.1074/jbc.M201113200; Teneberg S, 2009, TOP CURR CHEM, V288, P121, DOI 10.1007/128_2008_14; TORRADO J, 1992, GASTROENTEROLOGY, V102, P424, DOI 10.1016/0016-5085(92)90086-E; UEMURA K, 1989, JPN J EXP MED, V59, P239; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Victorzon M, 1996, INT J CANCER, V65, P295, DOI 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; YAMADA T, 1995, CANCER, V76, P1529, DOI 10.1002/1097-0142(19951101)76:9<1529::AID-CNCR2820760905>3.0.CO;2-G	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101732	10.1016/j.jbc.2022.101732	http://dx.doi.org/10.1016/j.jbc.2022.101732			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35176282	Green Published, gold			2022-12-26	WOS:000793694800008
J	Prusa, J; Zhu, DX; Flynn, AJ; Jensen, D; Manzano, AR; Galburt, EA; Stallings, CL				Prusa, Jerome; Zhu, Dennis X.; Flynn, Aidan J.; Jensen, Drake; Manzano, Ana Ruiz; Galburt, Eric A.; Stallings, Christina L.			Molecular dissection of RbpA-mediated regulation of fidaxomicin sensitivity in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; SIGMA-SUBUNIT; OPEN COMPLEXES; LID ELEMENT; TRANSCRIPTION; CARD; STABILIZES; BINDING; PROTEIN	RNA polymerase (RNAP) binding protein A (RbpA) is essential for mycobacterial viability and regulates transcription initiation by increasing the stability of the RNAP-promoter open complex (RPo). RbpA consists of four domains: an N-terminal tail (NTT), a core domain (CD), a basic linker, and a sigma interaction domain. We have previously shown that truncation of the RbpA NTT and CD increases RPo stabilization by RbpA, implying that these domains inhibit this activity of RbpA. Previously published structural studies showed that the NTT and CD are positioned near multiple RNAP-sigma(A) holoenzyme functional domains and predict that the RbpA NTT contributes specific amino acids to the binding site of the antibiotic fidaxomicin (Fdx), which inhibits the formation of the RPo complex. Furthermore, deletion of the NTT results in decreased Mycobacterium smegmatis sensitivity to Fdx, but whether this is caused by a loss in Fdx binding is unknown. We generated a panel of rbpA mutants and found that the RbpA NTT residues predicted to directly interact with Fdx are partially responsible for RbpA-dependent Fdx activity in vitro, while multiple additional RbpA domains contribute to Fdx activity in vivo. Specifically, our results suggest that the RPostabilizing activity of RbpA decreases Fdx activity in vivo. In support of the association between RPo stability and Fdx activity, we find that another factor that promotes RP(o-)stability in bacteria, CarD, also impacts to Fdx sensitivity. Our findings highlight how RbpA and other factors may influence RNAP dynamics to affect Fdx sensitivity.	[Prusa, Jerome; Zhu, Dennis X.; Flynn, Aidan J.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Jensen, Drake; Manzano, Ana Ruiz; Galburt, Eric A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Stallings, CL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	stallings@wustl.edu		Jensen, Drake/0000-0002-4227-8241; Flynn, Aidan/0000-0003-0607-9381	NIH NIGMS [GM007067, GM107544, GM134362]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award; Stephen I. Morse Graduate Fellowship; NIH NIAID [T32A1007172]; Gary K. Ackers Fellowship; Elliot L. Elson Education and Training Fellowship	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Stephen I. Morse Graduate Fellowship; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gary K. Ackers Fellowship; Elliot L. Elson Education and Training Fellowship	This work was supported by the NIH NIGMS grant GM107544 awarded to E. A. G. and C. L. S., NIH NIGMS grant GM134362 awarded to E. A. G., and a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award awarded to C. L. S. J. P. is supported by NIH NIGMS grant GM007067 and a Stephen I. Morse Graduate Fellowship. D. X. Z. is supported by NIH NIAID grant T32A1007172. D. J. is supported by the Gary K. Ackers Fellowship and Elliot L. Elson Education and Training Fellowship. This publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2014, TUBERCULOSIS, V94, P397, DOI 10.1016/j.tube.2014.03.008; Bortoluzzi A, 2013, J BIOL CHEM, V288, P14438, DOI 10.1074/jbc.M113.459883; Boyaci H, 2019, NATURE, V565, P382, DOI 10.1038/s41586-018-0840-5; Boyaci H, 2018, ELIFE, V7, DOI 10.7554/eLife.34823; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Davis E, 2015, NUCLEIC ACIDS RES, V43, P433, DOI 10.1093/nar/gku1231; Dove SL, 2003, MOL MICROBIOL, V48, P863, DOI 10.1046/j.1365-2958.2003.03467.x; Galburt EA, 2018, P NATL ACAD SCI USA, V115, pE11604, DOI 10.1073/pnas.1809454115; Garner AL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00698-16; Garner AL, 2014, MOL MICROBIOL, V93, P682, DOI 10.1111/mmi.12681; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hu YB, 2014, NUCLEIC ACIDS RES, V42, P10399, DOI 10.1093/nar/gku742; Hu YB, 2012, NUCLEIC ACIDS RES, V40, P6547, DOI 10.1093/nar/gks346; Hubin EA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16072; Hubin EA, 2017, ELIFE, V6, DOI 10.7554/eLife.22520; Hubin EA, 2015, P NATL ACAD SCI USA, V112, P7171, DOI 10.1073/pnas.1504942112; Jensen D, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00512-20; Jensen D, 2019, NUCLEIC ACIDS RES, V47, P6685, DOI 10.1093/nar/gkz449; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Lin W, 2018, MOL CELL, V70, P60, DOI 10.1016/j.molcel.2018.02.026; Morichaud Z, 2016, J MOL BIOL, V428, P463, DOI 10.1016/j.jmb.2015.12.017; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Perumal AS, 2018, NUCLEIC ACIDS RES, V46, P10106, DOI 10.1093/nar/gky714; Prusa J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00690-17; Pupov D, 2018, NUCLEIC ACIDS RES, V46, P11477, DOI 10.1093/nar/gky919; Pupov D, 2014, NUCLEIC ACIDS RES, V42, P4494, DOI 10.1093/nar/gkt1384; Rammohan J, 2016, NUCLEIC ACIDS RES, V44, P7304, DOI 10.1093/nar/gkw577; Rammohan J, 2015, NUCLEIC ACIDS RES, V43, P3272, DOI 10.1093/nar/gkv078; Shi W, 2020, EMBO J, V39, DOI 10.15252/embj.2020104389; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Stefan MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78269-3; Tabib-Salazar A, 2013, NUCLEIC ACIDS RES, V41, P5679, DOI 10.1093/nar/gkt277; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vishwakarma RK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01798; Weiss LA, 2012, J BACTERIOL, V194, P5621, DOI 10.1128/JB.00879-12; Yuzenkova Y, 2011, EMBO J, V30, P3766, DOI 10.1038/emboj.2011.252; Zhu DX, 2019, P NATL ACAD SCI USA, V116, P13573, DOI 10.1073/pnas.1900176116	40	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101752	10.1016/j.jbc.2022.101752	http://dx.doi.org/10.1016/j.jbc.2022.101752			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35189142	Green Published, gold			2022-12-26	WOS:000793560400010
J	Chambers, CA; Dadelahi, AS; Moley, CR; Olson, RM; Logue, CM; Skyberg, JA				Chambers, Catherine A.; Dadelahi, Alexis S.; Moley, Charles R.; Olson, Rachel M.; Logue, Catherine M.; Skyberg, Jerod A.			Nucleotide receptors mediate protection against neonatal sepsis and meningitis caused by alpha-hemolysin expressing Escherichia coli K1	FASEB JOURNAL			English	Article						hemolysin; inflammasome; neonatal immunity; neonatal meningitis-associated Escherichia coli (NMEC); NLRP3; nucleotide receptor	BACTERIAL-MENINGITIS; MULTIDRUG-RESISTANT; NLRP3 INFLAMMASOME; ATP RELEASE; MACROPHAGES; ACTIVATION; INHIBITION; PYROPTOSIS; DAMAGE; MODEL	Neonatal meningitis-associated Escherichia coli (NMEC) is among the leading causes of bacterial meningitis and sepsis in newborn infants. Several virulence factors have been identified as common among NMEC, and have been shown to play an important role in the development of bacteremia and/or meningitis. However, there is significant variability in virulence factor expression between NMEC isolates, and relatively little research has been done to assess the impact of variable virulence factor expression on immune cell activation and the outcome of infection. Here, we investigated the role of NMEC strain-dependent P2X receptor (P2XR) signaling on the outcome of infection in neonatal mice. We found that alpha-hemolysin (HlyA)-expressing NMEC (HlyA(+)) induced robust P2XR-dependent macrophage cell death in vitro, while HlyA(-) NMEC did not. P2XR-dependent cell death was inflammasome independent, suggesting an uncoupling of P2XR and inflammasome activation in the context of NMEC infection. In vivo inhibition of P2XRs was associated with increased mortality in neonatal mice infected with HlyA(+) NMEC, but had no effect on the survival of neonatal mice infected with HlyA(-) NMEC. Furthermore, we found that P2XR-dependent protection against HlyA(+) NMEC in vivo required macrophages, but not neutrophils or NLRP3. Taken together, these data suggest that HlyA(+) NMEC activates P2XRs which in turn confers macrophage-dependent protection against infection in neonates. In addition, our findings indicate that strain-dependent virulence factor expression should be taken into account when studying the immune response to NMEC.	[Chambers, Catherine A.; Dadelahi, Alexis S.; Moley, Charles R.; Olson, Rachel M.; Skyberg, Jerod A.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Logue, Catherine M.] Univ Georgia, Coll Vet Med, Dept Populat Heath, Athens, GA USA	University of Missouri System; University of Missouri Columbia; University System of Georgia; University of Georgia	Skyberg, JA (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	skybergj@missouri.edu		Olson, Rachel/0000-0002-6973-4331; Logue, Catherine/0000-0002-6098-2662	University of Missouri College of Veterinary Medicine Committee on Research	University of Missouri College of Veterinary Medicine Committee on Research	University of Missouri College of Veterinary Medicine Committee on Research	Benz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112248; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; Blake KJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02448-6; Borges JP., 2021, GLYCINE TARGETS NINJ, DOI 10.1101/2021.12.12.471765; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chambers CA, 2021, IMMUNOL CELL BIOL, V99, P596, DOI 10.1111/imcb.12445; Chang AC, 2016, VIRULENCE, V7, P806, DOI 10.1080/21505594.2016.1192730; Cole BK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219352; Demirel I, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00081; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Di Virgilio F, 1998, CELL DEATH DIFFER, V5, P191; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DiPeso L, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.70; Fabbri A, 2010, TOXINS, V2, P283, DOI [10.3390/toxins2020283, 10.3390/toxins2020282]; Feldman Elana A, 2017, Hosp Pediatr, DOI 10.1542/hpeds.2016-0162; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Greve AS, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00113; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Iqbal J, 2016, INFECT DIS-NOR, V48, P461, DOI 10.3109/23744235.2016.1144142; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jo S, 2011, MOL PHARMACOL, V80, P247, DOI 10.1124/mol.110.070276; Johnson JR, 2002, J INFECT DIS, V185, P774, DOI 10.1086/339343; Johnson TJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01913-18; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; KIM KS, 1992, J CLIN INVEST, V90, P897, DOI 10.1172/JCI115965; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Kong Qiongman, 2005, Purinergic Signal, V1, P337, DOI 10.1007/s11302-005-7145-5; Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004; Lacey CA, 2019, J LEUKOCYTE BIOL, V106, P27, DOI 10.1002/JLB.4MIA1018-409R; Lieberman J, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav1447; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Logue CM, 2012, APPL ENVIRON MICROB, V78, P5824, DOI 10.1128/AEM.07869-11; Lu K, 2013, NEURAL REGEN RES, V8, P599, DOI 10.3969/j.issn.1673-5374.2013.07.003; Maitre B, 2015, J IMMUNOL, V194, P739, DOI 10.4049/jimmunol.1401786; Mittal R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001203; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Muendlein HI, 2020, CELL REP, V30, P699, DOI 10.1016/j.celrep.2019.12.073; Murthy AMV, 2019, FASEB J, V33, P7437, DOI 10.1096/fj.201802100R; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Nicholson BA, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01239-16; Pelegrin P, 2021, BIOCHEM PHARMACOL, V187, DOI 10.1016/j.bcp.2020.114385; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathkey JK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat2738; Ribes S, 2013, INFECT IMMUN, V81, P1810, DOI 10.1128/IAI.01349-12; Rincon JC, 2021, SHOCK, V55, P274, DOI 10.1097/SHK.0000000000001623; RYNING FW, 1978, INFECT IMMUN, V20, P739, DOI 10.1128/IAI.20.3.739-743.1978; Samir P, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00238; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Schneider KS, 2017, CELL REP, V21, P3846, DOI 10.1016/j.celrep.2017.12.018; Sharma AA, 2015, EUR J IMMUNOL, V45, P238, DOI 10.1002/eji.201444707; Skals M, 2014, J BIOL CHEM, V289, P19098, DOI 10.1074/jbc.M114.571414; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Skyberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021978; SPANJAARD L, 1985, J INFECTION, V11, P259, DOI 10.1016/S0163-4453(85)93327-4; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Sukumaran SK, 2003, INFECT IMMUN, V71, P5951, DOI 10.1128/IAI.71.10.5951-5961.2003; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Therkildsen JR, 2019, AM J PATHOL, V189, P1201, DOI 10.1016/j.ajpath.2019.02.013; Tivendale KA, 2010, INFECT IMMUN, V78, P3412, DOI 10.1128/IAI.00347-10; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; Verma V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69501-1; Wang CY, 2020, MUCOSAL IMMUNOL, V13, P22, DOI 10.1038/s41385-019-0225-6; Wang JJ, 2013, J GEN PHYSIOL, V141, P649, DOI 10.1085/jgp.201310966; Wang XC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2197-2; Weissman SJ, 2016, J PEDIAT INF DIS SOC, V5, P269, DOI 10.1093/jpids/piv013; Werner S, 2019, J MED CHEM, V62, P11194, DOI 10.1021/acs.jmedchem.9b01304; Wijetunge DSS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0547-9; Wijetunge DSS, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00804-15; Woll C, 2018, J PEDIATR-US, V200, P210, DOI 10.1016/j.jpeds.2018.04.033; Yang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01987; Yusef D, 2018, PEDIATR NEONATOL, V59, P35, DOI 10.1016/j.pedneo.2017.06.001	79	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22197	10.1096/fj.202101485R	http://dx.doi.org/10.1096/fj.202101485R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35147989	hybrid			2022-12-26	WOS:000761250800010
J	Tran, HNTL; McMahon, KR; Deuis, J; Vetter, II; Schroeder, C				Tran, Hue N. T. L.; McMahon, Kirsten R.; Deuis, Jennifer; Vetter, Irina I.; Schroeder, Christina			Structural and functional insights into the inhibition of human voltage-gated sodium channels by mu-conotoxin KIIIA disulfide isomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR CHEMICAL-SHIFTS; CONUS-STRIATUS; NEUROPATHIC PAIN; BOND FORMATION; CYSTINE KNOT; NA-V; PEPTIDE; BLOCK; TOXINS; NA(V)1.7	mu-Conotoxins are components of cone snail venom, well-known for their analgesic activity through potent inhibition of voltage-gated sodium channel (Na-V) subtypes, including Na(V)1.7. These small, disulfide-rich peptides are typically stabilized by three disulfide bonds arranged in a 'native' CysI-CysIV, CysII-CysV, CysIII-CysVI pattern of disulfide connectivity. However, mu-conotoxin KIIIA, the smallest and most studied mu-conotoxin with inhibitory activity at Na(V)1.7, forms two distinct disulfide bond isomers during thermodynamic oxidative folding, including Isomer 1 (CysI-CysV, CysII-CysIV, CysIII-CysVI) and Isomer 2 (CysI-CysVI, CysII-CysIV, CysIII-CysV), but not the native mu-conotoxin arrangement. To date, there has been no study on the structure and activity of KIIIA comprising the native mu-conotoxin disulfide bond arrangement. Here, we evaluated the synthesis, potency, sodium channel subtype selectivity, and 3D structure of the three isomers of KIIIA. Using a regioselective disulfide bond-forming strategy, we synthetically produced the three mu-conotoxin KIIIA isomers displaying distinct bioactivity and Na-V subtype selectivity across human NaV channel subtypes 1.2, 1.4, and 1.7. We show that Isomer 1 inhibits NaV subtypes with a rank order of potency of Na(V)1.4 > 1.2 > 1.7 and Isomer 2 in the order of Na(V)1.4 approximate to 1.2 > 1.7, while the native isomer inhibited Na(V)1.4 > 1.7 approximate to 1.2. The three KIIIA isomers were further evaluated by NMR solution structure analysis and molecular docking with hNa(V)1.2. Our study highlights the importance of investigating alternate disulfide isomers, as disulfide connectivity affects not only the overall structure of the peptides but also the potency and subtype selectivity of mu-conotoxins targeting therapeutically relevant Na-V subtypes.	[Tran, Hue N. T. L.; McMahon, Kirsten R.; Vetter, Irina I.; Schroeder, Christina] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Vetter, Irina I.] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia; [Schroeder, Christina] NCI, Ctr Canc Res, NIH, Frederick, MD USA	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vetter, II; Schroeder, C (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.; Vetter, II (corresponding author), Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia.; Schroeder, C (corresponding author), NCI, Ctr Canc Res, NIH, Frederick, MD USA.	i.vetter@imb.uq.edu.au; christina.schroeder@nih.gov	Schroeder, Christina/K-2042-2014; Deuis, Jennifer/R-2440-2017	Schroeder, Christina/0000-0002-6737-6374; Tran, Hue Ngoc Thi/0000-0001-5181-1899; Deuis, Jennifer/0000-0002-5107-8938	Career Development Fellowship [APP1162503]; Australian Research Council (ARC) [FT160100055]; Australian Government Research Training Program Scholarships through the University of Queensland; Early Career Fellowship [APP1139961]	Career Development Fellowship; Australian Research Council (ARC)(Australian Research Council); Australian Government Research Training Program Scholarships through the University of Queensland(Australian Government); Early Career Fellowship	This work was funded by a Career Development Fellowship (APP1162503) awarded to I. V. andan Early Career Fellowship (APP1139961) awarded to J. R. D. C. I. S was an Australian Research Council (ARC) Future Fellow(FT160100055). Australian Government Research Training Program Scholarships supported H. N. T. T. and K. L. M. through the University of Queensland.	Agwa AJ, 2020, J BIOL CHEM, V295, P5067, DOI 10.1074/jbc.RA119.012281; Agwa AJ, 2018, BIOCONJUGATE CHEM, V29, P3309, DOI 10.1021/acs.bioconjchem.8b00505; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Barton ME, 2004, EPILEPSY RES, V59, P1, DOI 10.1016/j.eplepsyres.2003.12.010; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Boulegue C., 2007, CHEMINFORM, V38, P24; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Dekan Z, 2014, ANGEW CHEM INT EDIT, V53, P2931, DOI 10.1002/anie.201310103; Denis B, 2000, J PEPT SCI, V6, P372, DOI 10.1002/1099-1387(200008)6:8<372::AID-PSC264>3.3.CO;2-1; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Eliasen R, 2012, PEPTIDES, V37, P144, DOI 10.1016/j.peptides.2012.06.016; Gajewiak J, 2014, P NATL ACAD SCI USA, V111, P2758, DOI 10.1073/pnas.1324189111; Gali H, 2002, BIOCONJUGATE CHEM, V13, P224, DOI 10.1021/bc010062u; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; Green BR, 2014, FUTURE MED CHEM, V6, P1677, DOI [10.4155/fmc.14.107, 10.4155/FMC.14.107]; Hains BC, 2003, J NEUROSCI, V23, P8881; He BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085188; Hoffmann T, 2018, PAIN, V159, P496, DOI 10.1097/j.pain.0000000000001119; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jin AH, 2017, ANGEW CHEM INT EDIT, V56, P14973, DOI 10.1002/anie.201708927; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Knapp O, 2012, TOXINS, V4, P1236, DOI 10.3390/toxins4111236; Knuhtsen A., 2020, PEPTIDE SCI, V113, P1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Lehmann-Horn Frank, 2002, Curr Neurol Neurosci Rep, V2, P61, DOI 10.1007/s11910-002-0055-9; Markgraf R, 2012, BRIT J PHARMACOL, V167, P576, DOI 10.1111/j.1476-5381.2012.02004.x; Maxwell M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01333; McArthur JR, 2011, MOL PHARMACOL, V80, P573, DOI 10.1124/mol.111.073460; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; McMahon KL, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100391; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Minett MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9967; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Namadurai S., 2015, BIOL OPEN, V5, P1; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pan XJ, 2019, SCIENCE, V363, P1309, DOI 10.1126/science.aaw2999; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Schroeder CI, 2008, J BIOL CHEM, V283, P21621, DOI 10.1074/jbc.M802852200; Schulz A, 2005, BIOPOLYMERS, V80, P34, DOI 10.1002/bip.20193; Seong B. L., 2001, BIOTECHNOL BIOPROC E, V6, P244; Sharpe IA, 2003, J BIOL CHEM, V278, P40317, DOI 10.1074/jbc.M213030200; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shon KJ, 1998, J NEUROSCI, V18, P4473; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Szabo I, 2007, BIOPOLYMERS, V88, P20, DOI 10.1002/bip.20616; Takahata T, 2003, LIFE SCI, V72, P2391, DOI 10.1016/S0024-3205(03)00121-8; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Tran HNT, 2020, BIOCONJUGATE CHEM, V31, P64, DOI 10.1021/acs.bioconjchem.9b00744; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Vetter I, 2012, BIOCHEM PHARMACOL, V84, P540, DOI 10.1016/j.bcp.2012.05.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Wilson MJ, 2011, P NATL ACAD SCI USA, V108, P10302, DOI 10.1073/pnas.1107027108; Wu FZ, 2017, J ORG CHEM, V82, P3506, DOI 10.1021/acs.joc.6b03078; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2013, BRIT J PHARMACOL, V168, P1597, DOI 10.1111/bph.12051; Zhang MM, 2010, BIOCHEMISTRY-US, V49, P4804, DOI 10.1021/bi100207k; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	96	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101728	10.1016/j.jbc.2022.101728	http://dx.doi.org/10.1016/j.jbc.2022.101728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35167877	gold, Green Published			2022-12-26	WOS:000789398100001
J	Yuan, XH; Wu, Y; Lin, J; Weng, QY; Wu, LQ; Yang, S; Li, X; Tan, M; Lin, ZX; Lian, XL; Chen, YZ				Yuan, Xiaohong; Wu, Yong; Lin, Jia; Weng, Qinyong; Wu, Linqing; Yang, Shu; Li, Xin; Tan, Ming; Lin, Zhenxing; Lian, Xiaolan; Chen, Yuanzhong			Plasma fibronectin can affect the cytokine profile and monocytes/macrophages function in addition to predicting the prognosis of advanced sepsis	FASEB JOURNAL			English	Article						cytokine storm; fibronectin; immunosuppression; macrophage; sepsis	INDUCED LIVER-INJURY; STAPHYLOCOCCUS-AUREUS; PARTIAL-HEPATECTOMY; HEPATIC-FAILURE; ENDOTOXIN; IMMUNOSUPPRESSION; POLARIZATION; PROGRESSION; DEFICIENCY; FIBRINOGEN	The value of plasma fibronectin (pFN) in the diagnosis and prognosis of sepsis has not been fully established. Previous studies finding that pFN is significantly reduced in sepsis, however, whether reduced pFn affects the prognosis of sepsis has not been clarified. Here, we detected and analyzed pFN and other conventional inflammatory markers in advanced sepsis patients and performed correlation analysis with SOFA score. We also used Fn gene conditional knockout mice which were performed by cecum ligation and puncture (CLP) to investigate the effect of FN deficiency on sepsis prognosis. We found, compared with procalcitonin, c-reactive protein, and interleukin-6, pFN was more correlated with SOFA score in advanced sepsis patients (r -.720, p < .001). In animal experiments, Fn gene knockout mice showed significantly greater mortality after CLP compared with the control group because of inhibited phagocytosis and bacterial clearance ability of macrophages, with double cytokine storm. Furthermore, FN can regulate macrophages through the integrin alpha 5 beta 1/Fak/Src signaling pathway. Overall, we found pFN can more accurately reflect the severity and prognosis of advanced sepsis. The absence of FN altered the cytokine storm and phagocytic function of macrophages, suggesting that FN could be a potential therapeutic target in sepsis.	[Yuan, Xiaohong; Wu, Yong; Lin, Jia; Yang, Shu; Li, Xin; Tan, Ming; Lin, Zhenxing; Lian, Xiaolan; Chen, Yuanzhong] Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, 29 Xinquan Rd, Fuzhou, Peoples R China; [Weng, Qinyong] Fujian Med Univ Union Hosp, Dept Crit Care Med, Fuzhou, Peoples R China; [Wu, Linqing] Fujian Med Univ, Dept Immunol, Fuzhou, Peoples R China	Fujian Medical University	Chen, YZ (corresponding author), Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, 29 Xinquan Rd, Fuzhou, Peoples R China.	chenyz@fjmu.edu.cn		Yuan, Xiaohong/0000-0003-3658-3001	Science and Technology Innovation Joint Fund Project of Fujian Province [2018Y9062]; Natural Science Foundation of Fujian Province [2020J011011]; Construction Project of Fujian Medical Center of Hematology [Min 2017-04]; National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	Science and Technology Innovation Joint Fund Project of Fujian Province; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Construction Project of Fujian Medical Center of Hematology; National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	This work was supported by the Science and Technology Innovation Joint Fund Project of Fujian Province (2018Y9062), Natural Science Foundation of Fujian Province (2020J011011), Construction Project of Fujian Medical Center of Hematology (Min 2017-04), and National and Fujian Provincial Key Clinical Specialty Discipline Construction Program of China	Abshire MY, 2011, J LEUKOCYTE BIOL, V89, P251, DOI 10.1189/jlb.0710395; Almeida JF, 2016, VACCINE, V34, P1312, DOI 10.1016/j.vaccine.2016.01.022; AlRawahi AN, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2669-1; Bauer M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02950-2; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; BRODIN B, 1985, SCAND J CLIN LAB INV, V45, P57; BRODIN B, 1986, ACTA CHIR SCAND, V152, P721; Choi, 2014, INFECT CHEMOTHER, V46, p1; Delano MJ, 2016, IMMUNOL REV, V274, P330, DOI 10.1111/imr.12499; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; ERIKSEN HO, 1984, HAEMATOLOGIA, V17, P93; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kwon AH, 2004, TRANSPLANT P, V36, P1985, DOI 10.1016/j.transproceed.2004.08.074; Li CL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01962; Lin FB, 2020, J INVEST DERMATOL, V140, P1480, DOI 10.1016/j.jid.2019.10.021; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Lysenko L, 2017, POSTEP HIG MED DOSW, V71, P703; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Martin GR, 2004, INT J INFECT DIS, V8, P236, DOI 10.1016/j.ijid.2003.10.005; Maurer LM, 2016, CRIT REV BIOCHEM MOL, V51, P213, DOI 10.1080/10409238.2016.1184224; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Qiu ZY, 2006, SHOCK, V25, P80, DOI 10.1097/01.shk.0000185797.04589.5c; Plaza JQ, 2016, INJURY, V47, pS15, DOI 10.1016/S0020-1383(16)30601-5; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; SABA TM, 1986, AM J MED, V80, P229, DOI 10.1016/0002-9343(86)90014-8; Saito T, 2005, J SURG RES, V124, P79, DOI 10.1016/j.jss.2004.10.018; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shen C, 2018, J IMMUNOL, V201, P2986, DOI 10.4049/jimmunol.1700954; Sikkema AH, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1238-x; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stemberk V, 2014, J BIOL CHEM, V289, P12842, DOI 10.1074/jbc.M113.543546; STEVENS LE, 1986, SURG GYNECOL OBSTET, V162, P222; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Szederjesi J, 2015, J CRIT CARE MED, V1, P147, DOI 10.1515/jccm-2015-0022; Tang NH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-552; Toscano MG, 2011, JOVE-J VIS EXP, DOI 10.3791/2860; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Vardon-Bounes F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143494; Vincent JL, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2478-6; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang YM, 2016, CURR OPIN HEMATOL, V23, P280, DOI 10.1097/MOH.0000000000000237; Wang YM, 2015, BLOOD, V125, P3043, DOI 10.1182/blood-2015-03-630855; Wang YM, 2014, J CLIN INVEST, V124, P4281, DOI 10.1172/JCI74630; Wu Y, 2004, ACTA PHARMACOL SIN, V25, P783; YODER MC, 1991, CLIN PERINATOL, V18, P325, DOI 10.1016/S0095-5108(18)30526-8; Yuan XH, 2020, PEERJ, V8, DOI 10.7717/peerj.10224; Zhou JF, 2017, CRIT CARE MED, V45, P1168, DOI 10.1097/CCM.0000000000002414; Zou Qi-lian, 2009, Zhonghua Yi Xue Za Zhi, V89, P3425	60	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22179	10.1096/fj.202100760RRR	http://dx.doi.org/10.1096/fj.202100760RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35182399	hybrid			2022-12-26	WOS:000761250800035
J	Humbert, PO; Pryjda, TZ; Pranjic, B; Farrell, A; Fujikura, K; Simoes, RD; Karim, R; Kozieradzki, I; Cronin, SJF; Neely, GG; Meyer, TF; Hagelkruys, A; Richardson, HE; Penninger, JM				Humbert, Patrick O.; Pryjda, Tamara Zoranovic; Pranjic, Blanka; Farrell, Andrew; Fujikura, Kohei; de Matos Simoes, Ricardo; Karim, Rezaul; Kozieradzki, Ivona; Cronin, Shane J. F.; Neely, G. Gregory; Meyer, Thomas F.; Hagelkruys, Astrid; Richardson, Helena E.; Penninger, Josef M.			TSPAN6 is a suppressor of Ras-driven cancer	ONCOGENE			English	Article							CELL POLARITY; EXPRESSION; TETRASPANINS; ACTIVATION; MUTATIONS; JUNCTIONS; RESPONSES; INVASION; MODULE; GROWTH	Oncogenic mutations in the small GTPase RAS contribute to similar to 30% of human cancers. In a Drosophila genetic screen, we identified novel and evolutionary conserved cancer genes that affect Ras-driven tumorigenesis and metastasis in Drosophila including confirmation of the tetraspanin Tsp29Fb. However, it was not known whether the mammalian Tsp29Fb orthologue, TSPAN6, has any role in RAS-driven human epithelial tumors. Here we show that TSPAN6 suppressed tumor growth and metastatic dissemination of human RAS activating mutant pancreatic cancer xenografts. Whole-body knockout as well as tumor cell autonomous inactivation using floxed alleles of Tspan6 in mice enhanced Kras(G12D)-driven lung tumor initiation and malignant progression. Mechanistically, TSPAN6 binds to the EGFR and blocks EGFR-induced RAS activation. Moreover, we show that inactivation of TSPAN6 induces an epithelial-to-mesenchymal transition and inhibits cell migration in vitro and in vivo. Finally, low TSPAN6 expression correlates with poor prognosis of patients with lung and pancreatic cancers with mesenchymal morphology. Our results uncover TSPAN6 as a novel tumor suppressor receptor that controls epithelial cell identify and restrains RAS-driven epithelial cancer.	[Humbert, Patrick O.; Farrell, Andrew; Richardson, Helena E.] La Trobe Univ, Sch Mol Sci, Dept Biochem Genet, Bundoora, Vic 3086, Australia; [Humbert, Patrick O.; Pryjda, Tamara Zoranovic; Pranjic, Blanka; Karim, Rezaul; Kozieradzki, Ivona; Cronin, Shane J. F.; Neely, G. Gregory; Hagelkruys, Astrid; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria; [Pryjda, Tamara Zoranovic; Meyer, Thomas F.] Max Planck Inst Infect Biol, Charite Pl 1, D-10117 Berlin, Germany; [Fujikura, Kohei; Kozieradzki, Ivona; Penninger, Josef M.] Univ British Columbia, Inst Life Sci, Dept Med Genet, Vancouver, BC, Canada; [de Matos Simoes, Ricardo] Ctr Integrat Bioinformat Vienna, Max F Perusetz Labs, Dr Bohr Gasse 9-6, A-1030 Vienna, Austria; [Neely, G. Gregory] Univ Sydney, Sch Life & Environm Sci, Dr John & Anne Chong Lab Funct Genom, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Meyer, Thomas F.] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Lab Infect Oncol, Kiel, Germany; [Pryjda, Tamara Zoranovic; Pranjic, Blanka] Univ Hosp Schleswig Holstein Campus Kiel, Kiel, Germany	La Trobe University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Max Planck Society; University of British Columbia; University of Sydney; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Humbert, PO; Richardson, HE (corresponding author), La Trobe Univ, Sch Mol Sci, Dept Biochem Genet, Bundoora, Vic 3086, Australia.; Humbert, PO; Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.; Penninger, JM (corresponding author), Univ British Columbia, Inst Life Sci, Dept Med Genet, Vancouver, BC, Canada.	P.Humbert@latrobe.edu.au; H.Richardson@latrobe.edu.au; josef.penninger@ubc.ca	; Humbert, Patrick/L-4264-2016; Penninger, Josef/I-6860-2013	zoranovic, tamara/0000-0002-5369-6385; Humbert, Patrick/0000-0002-1366-6691; Penninger, Josef/0000-0002-8194-3777	IMBA; ERC Advanced Investigator grant; Era of Hope; T. von Zastrow foundation; Canada 150 Chair in Functional Genetics; Marie Curie Excellence grant; Infla-Care grant; Infect-ERA grant; Invest [RD0412515]; Cancer Council Victoria (Australia); National Health & Medical Research Council (NHMRC), Australia; La Trobe University	IMBA; ERC Advanced Investigator grant; Era of Hope; T. von Zastrow foundation; Canada 150 Chair in Functional Genetics; Marie Curie Excellence grant(European Commission); Infla-Care grant; Infect-ERA grant; Invest; Cancer Council Victoria (Australia)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health & Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); La Trobe University	We thank all members of our laboratories for helpful discussions as well as VDRC and IMP/IMBA core facilities for excellent technical support. We also acknowledge Life Science Editors for editorial support (www.lifescienceeditors.com).JMP was supported by IMBA, ERC Advanced Investigator grant, an Innovator Award from Era of Hope, the T. von Zastrow foundation, and a Canada 150 Chair in Functional Genetics. TZP was supported by a Marie Curie Excellence grant. RK was supported by Infla-Care and Infect-ERA grants. RdMS was supported by a grant from Invest NI RD0412515. AF was supported from funds from the Cancer Council Victoria (Australia) to HER, POH, and JMP. HER and POH were supported by fellowships from the National Health & Medical Research Council (NHMRC), Australia, and by funds from La Trobe University.	Andrijes R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2011411118; Aubrey BJ, 2018, CELL DEATH DIFFER, V25, P104, DOI 10.1038/cdd.2017.169; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Bar-Sagi D, 1992, Semin Cell Biol, V3, P93; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Caddy J, 2010, DEV CELL, V19, P138, DOI 10.1016/j.devcel.2010.06.008; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chen JD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026104; Chen SJ, 2019, CURR PHARM DESIGN, V25, P1105, DOI 10.2174/1381612825666190506122228; Cho JH, 2020, CELL DEATH DIFFER, V27, P2681, DOI 10.1038/s41418-020-0537-9; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; DiMauro T, 2010, CURR CANCER DRUG TAR, V10, P869, DOI 10.2174/156800910793357998; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fox RM, 2015, BIOL OPEN, V4, P317, DOI 10.1242/bio.201411205; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Kummer D, 2020, MED MICROBIOL IMMUN, V209, P397, DOI 10.1007/s00430-020-00673-3; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; La Marca JE, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00042; Lang T, 2020, CURR BIOL, V30, pR204, DOI 10.1016/j.cub.2020.01.007; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Rizzotto D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910883; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Sacco E, 2012, EXPERT OPIN THER PAT, V22, P1263, DOI 10.1517/13543776.2012.728586; Schramek D, 2011, TRENDS ENDOCRIN MET, V22, P188, DOI 10.1016/j.tem.2011.02.007; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Stephens R, 2018, J MOL BIOL, V430, P3585, DOI 10.1016/j.jmb.2018.01.011; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu CW, 2019, CELL REP, V26, P670, DOI 10.1016/j.celrep.2018.12.079; Yamamoto M, 2017, NATURE, V542, P246, DOI 10.1038/nature21033; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Zoranovic T, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007688	51	1	1	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2095	2105		10.1038/s41388-022-02223-y	http://dx.doi.org/10.1038/s41388-022-02223-y		FEB 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35184157	Green Published, hybrid			2022-12-26	WOS:000757918900001
J	Prinsenberg, T; Illidge, J; Zantkuijl, P; Bedert, M; Prins, M; van der Valk, M; Davidovich, U				Prinsenberg, Tamara; Illidge, Joel; Zantkuijl, Paul; Bedert, Maarten; Prins, Maria; van der Valk, Marc; Davidovich, Udi			Usability, acceptability, and self-reported impact of an innovative hepatitis C risk reduction intervention for men have sex with men: A mixed methods study	PLOS ONE			English	Article							INFECTED MEN; NEGATIVE MEN; HIV; VIRUS; TRANSMISSION	Hepatitis C virus (HCV) elimination among men who have sex with men (MSM) is unlikely to be feasible without effective behavioural interventions. We developed a multilevel intervention to reduce HCV transmission among MSM in Amsterdam. The intervention includes a toolbox to facilitate risk reduction among MSM and support health care professionals in risk reduction counselling. To assess the use of the toolbox and its impact on behavior, we conducted a mixed-methods study. We collected data through online questionnaires (n = 49), and in-depth interviews with MSM at risk of HCV (n = 15) and health care professionals (n = 7). We found that the toolbox has been well received by MSM, increased awareness of HCV risks and has facilitated preventive behaviours and risk-reduction communication with peers. Professionals reported the toolbox to be a useful aid for discussions about HCV risk and risk reduction strategies with their clients.	[Prinsenberg, Tamara; Illidge, Joel; Prins, Maria; Davidovich, Udi] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [Prinsenberg, Tamara; Bedert, Maarten; Prins, Maria; van der Valk, Marc] Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst, Dept Infect Dis, Amsterdam, Netherlands; [Zantkuijl, Paul] SOA Aids Nederland, Amsterdam, Netherlands; [van der Valk, Marc] Stichting HIV Monitoring, Amsterdam, Netherlands; [Davidovich, Udi] Univ Amsterdam, Dept Social Psychol, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; University of Amsterdam	Prinsenberg, T (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands.; Prinsenberg, T (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst, Dept Infect Dis, Amsterdam, Netherlands.	TPrinsenberg@ggd.amsterdam.nl		Bedert, Maarten/0000-0002-5899-0663; Prinsenberg, Tamara/0000-0001-5894-5646	Gilead Sciences; AbbVie; Janssen-Cilag; Merck Sharpe Dohme; Roche Diagnostics; Gilead; Johnson Johnson; ViiV Health Care	Gilead Sciences(Gilead Sciences); AbbVie(AbbVie); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Sharpe Dohme(Merck & Company); Roche Diagnostics; Gilead(Gilead Sciences); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); ViiV Health Care	This study was performed within the MC Free consortium. MC Free is funded by grants from Gilead Sciences, AbbVie, Janssen-Cilag, Merck Sharpe & Dohme, and Roche Diagnostics. The funders had no involvement in the study design, writing of the manuscript, and decision to submit the article for publication. TP and MP report speaker fees and grants from Gilead Sciences, Merck Sharpe & Dohme, and AbbVie paid to their institute. MvdV's institute received unrestricted research grants and consultancy fees from AbbVie, Gilead, Johnson & Johnson, Merck Sharpe & Dohme, and ViiV Health Care.	Boesecke C., 2020, AIDS LONDON; Braun DL., 2020, TREATMENT PREVENTION; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cornman DH, 2008, JAIDS-J ACQ IMM DEF, V48, P553, DOI 10.1097/QAI.0b013e31817bebd7; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Ghisla V, 2017, INFECTION, V45, P309, DOI 10.1007/s15010-016-0975-y; He JY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05003-9; Hoornenborg E, 2020, J HEPATOL, V72, P855, DOI 10.1016/j.jhep.2019.11.022; Illa L, 2010, AIDS EDUC PREV, V22, P138, DOI 10.1521/aeap.2010.22.2.138; Jin FY, 2021, LANCET GASTROENTEROL, V6, P39, DOI 10.1016/S2468-1253(20)30303-4; Jin FY, 2017, SEX HEALTH, V14, P28, DOI [10.1071/SH16141, 10.1071/sh16141]; Kunzler-Heule P, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4456-7; Kunzler-Heule P, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06003-z; Margolin A, 2003, HEALTH PSYCHOL, V22, P223, DOI 10.1037/0278-6133.22.2.223; Newsum AM., 2020, CLIN INFECT DIS OFFI; Nijmeijer BM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25348; Prinsenberg T, 2020, JMIR FORM RES, V4, DOI 10.2196/19100; Salazar-Vizcaya L, 2016, HEPATOLOGY, V64, P1856, DOI 10.1002/hep.28769; Simoni JM, 2011, AIDS BEHAV, V15, P1589, DOI 10.1007/s10461-011-9963-5; Smit C, 2021, LANCET HIV, V8, pE96, DOI 10.1016/S2352-3018(20)30301-5; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263654	10.1371/journal.pone.0263654	http://dx.doi.org/10.1371/journal.pone.0263654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180246	Green Published, gold			2022-12-26	WOS:000796435800024
J	Zeng, Z; Zhang, X; Jiang, CQ; Zhang, YG; Wu, X; Li, J; Tang, S; Li, L; Gu, LJ; Xie, XY; Jiang, YA				Zeng, Zhi; Zhang, Xu; Jiang, Cong-Qing; Zhang, Yong-Gang; Wu, Xue; Li, Jin; Tang, Shan; Li, Lang; Gu, Li-Juan; Xie, Xiao-Yu; Jiang, Ying-An			Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening	ONCOGENE			English	Article							CRISPR/CAS9 LIBRARY; GENETIC SCREENS; PROMOTES; CARCINOMA	Genome-scale CRISPR-Cas9 screening technology is a powerful tool to systematically identify genes essential for cancer cell survival. Herein, TKOv3, a genome-scale CRISPR-Cas9 knock-out library, was screened in the gastric cancer (GC) cells, and relevant validation experiments were performed. We obtained 854 essential genes for the AGS cell line, and 184 were novel essential genes. After knocking down essential genes: SPC25, DHX37, ABCE1, SNRPB, TOP3A, RUVBL1, CIT, TACC3 and MTBP, cell viability and proliferation were significantly decreased. Then, we analysed the detected essential genes at different time points and proved more characteristic genes might appear with the extension of selection. After progressive selection using a series of open datasets, 41 essential genes were identified as potential drug targets. Among them, methyltransferase 1 (METTL1) was over expressed in GC tissues. High METTL1 expression was associated with poor prognosis among 3 of 6 GC cohorts. Furthermore, GC cells growth was significantly inhibited after the down-regulation of METTL1 in vitro and in vivo. Function analysis revealed that METTL1 might play a role in the cell cycle through AKT/STAT3 pathways. In conclusion, compared with existing genome-scale screenings, we obtained 184 novel essential genes. Among them, METTL1 was validated as a potential therapeutic target of GC.	[Zeng, Zhi] Wuhan Univ, Dept Pathol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Zhang, Xu; Zhang, Yong-Gang; Gu, Li-Juan] Wuhan Univ, Cent Lab, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Jiang, Cong-Qing; Xie, Xiao-Yu] Wuhan Univ, Dept Colorectal & Anal Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Wu, Xue; Li, Jin; Tang, Shan; Li, Lang] Ohio State Univ, Dept Biomed Informat, Columbus, OH USA; [Jiang, Ying-An] Wuhan Univ, Dept Infect Dis, Renmin Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University; University System of Ohio; Ohio State University; Wuhan University	Xie, XY (corresponding author), Wuhan Univ, Dept Colorectal & Anal Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.; Jiang, YA (corresponding author), Wuhan Univ, Dept Infect Dis, Renmin Hosp, Wuhan, Hubei, Peoples R China.	ZN004356@whu.edu.cn; jiangya_cn@aliyun.com		Tang, Shan/0000-0002-8224-2809; Zeng, Zhi/0000-0003-4131-050X				Balusamy SR, 2018, BIOMED PHARMACOTHER, V108, P1835, DOI 10.1016/j.biopha.2018.10.028; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen ZY, 2018, BIOCHEM BIOPH RES CO, V498, P579, DOI 10.1016/j.bbrc.2018.03.022; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa R, 2016, ONCOTARGET, V7, P55924, DOI 10.18632/oncotarget.10482; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Ho SWT, 2019, CANCER SCI, V110, P3405, DOI 10.1111/cas.14191; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kurata M, 2018, J HUM GENET, V63, P179, DOI 10.1038/s10038-017-0376-9; Li CS, 2016, GENE, V587, P42, DOI 10.1016/j.gene.2016.04.029; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Liu Y, 2020, LIFE SCI, V249, DOI 10.1016/j.lfs.2020.117480; Lu X, 2019, ONCOTARGETS THER, V12, P7489, DOI 10.2147/OTT.S208848; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Okamoto M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004639; Orellana EA, 2021, MOL CELL, V81, P3323, DOI 10.1016/j.molcel.2021.06.031; Pandolfini L, 2019, MOL CELL, V74, P1278, DOI 10.1016/j.molcel.2019.03.040; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shang WJ, 2021, J PATHOL, V253, P148, DOI 10.1002/path.5568; Sheng Y, 2018, CANCER MANAG RES, V10, P6205, DOI 10.2147/CMAR.S176147; Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1; Tian QH, 2019, J MOL MED, V97, P1535, DOI 10.1007/s00109-019-01830-9; Tsai MM, 2012, CANCER SCI, V103, P1136, DOI 10.1111/j.1349-7006.2012.02243.x; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Venerito M, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12643; Wang BB, 2019, NAT PROTOC, V14, P756, DOI 10.1038/s41596-018-0113-7; Wang C, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2021.12591; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yuan L, 2021, WORLD J GASTROENTERO, V27, P1785, DOI 10.3748/wjg.v27.i16.1785; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	38	1	1	8	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2069	2078		10.1038/s41388-022-02177-1	http://dx.doi.org/10.1038/s41388-022-02177-1		FEB 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35177812				2022-12-26	WOS:000757138900002
J	Dorr, JO; Kinne, J; Lenz, D; Licht, G; Winker, P				Doerr, Julian Oliver; Kinne, Jan; Lenz, David; Licht, Georg; Winker, Peter			An integrated data framework for policy guidance during the coronavirus pandemic: Towards real-time decision support for economic policymakers	PLOS ONE			English	Article							PREDICTION; AGREEMENT; IMPACT	Usually, official and survey-based statistics guide policymakers in their choice of response instruments to economic crises. However, in an early phase, after a sudden and unforeseen shock has caused unexpected and fast-changing dynamics, data from traditional statistics are only available with non-negligible time delays. This leaves policymakers uncertain about how to most effectively manage their economic countermeasures to support businesses, especially when they need to respond quickly, as in the COVID-19 pandemic. Given this information deficit, we propose a framework that guided policymakers throughout all stages of this unforeseen economic shock by providing timely and reliable sources of firm-level data as a basis to make informed policy decisions. We do so by combining early stage 'ad hoc' web analyses, 'follow-up' business surveys, and 'retrospective' analyses of firm outcomes. A particular focus of our framework is on assessing the early effects of the pandemic, using highly dynamic and large-scale data from corporate websites. Most notably, we show that textual references to the coronavirus pandemic published on a large sample of company websites and state-of-the-art text analysis methods allowed to capture the heterogeneity of the pandemic's effects at a very early stage and entailed a leading indication on later movements in firm credit ratings. While the proposed framework is specific to the COVID-19 pandemic, the integration of results obtained from real-time online sources in the design of subsequent surveys and their value in forecasting firm-level outcomes typically targeted by policy measures, is a first step towards a more timely and holistic approach for policy guidance in times of economic shocks.	[Doerr, Julian Oliver; Kinne, Jan; Licht, Georg] ZEW Leibniz Ctr European Econ Res, Dept Econ Innovat & Ind Dynam, Mannheim, Germany; [Doerr, Julian Oliver; Lenz, David; Winker, Peter] Justus Liebig Univ Giessen, Dept Econometr & Stat, Giessen, Germany; [Kinne, Jan; Lenz, David] Istariai, Mannheim, Germany	Zentrum fur Europaische Wirtschaftsforschung (ZEW); Justus Liebig University Giessen	Dorr, JO (corresponding author), ZEW Leibniz Ctr European Econ Res, Dept Econ Innovat & Ind Dynam, Mannheim, Germany.; Dorr, JO (corresponding author), Justus Liebig Univ Giessen, Dept Econometr & Stat, Giessen, Germany.	julian.doerr@zew.de	Winker, Peter/D-1389-2011	Winker, Peter/0000-0003-3412-4207; Dorr, Julian Oliver/0000-0002-6465-181X	German Federal Ministry of Economic Affairs and Energy [15/20]; Ministry of Science, Research and the Arts of the government of Baden Wuerttemberg	German Federal Ministry of Economic Affairs and Energy; Ministry of Science, Research and the Arts of the government of Baden Wuerttemberg	The study extends upon a project analyzing the economic effects on SMEs in the COVID-19 crisis which was funded by the German Federal Ministry of Economic Affairs and Energy (https://www.bmwi.de) under the grant agreement No 15/20 (GL). Funding covered the collection of webdata and the analysis of both webdata and survey data. Moreover, the project received support by the Ministry of Science, Research and the Arts of the government of Baden Wuerttemberg (https://mwk.baden-wuerttemberg.de) as part of its Science Data Center program under the grant "Business and Economic Research Data Center (BERD)" (GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abay K, 2020, WORLD BANK POLICY RE, P9268; Al Baghal T, 2021, EPJ DATA SCI, V10, DOI 10.1140/epjds/s13688-021-00286-7; Altman EI, 2013, HANDB RES METH APPL, P428; ALTMAN EI, 1968, J FINANC, V23, P589, DOI 10.2307/2978933; [Anonymous], 2021, ECONOMIST 1023; Athey S, 2017, SCIENCE, V355, P483, DOI 10.1126/science.aal4321; Axenbeck J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249583; Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Arrieta AB, 2020, INFORM FUSION, V58, P82, DOI 10.1016/j.inffus.2019.12.012; Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117; Blazquez D, 2018, TECHNOL FORECAST SOC, V130, P99, DOI 10.1016/j.techfore.2017.07.027; Brown G., 2017, ENCY MACHINE LEARNIN, P393; Chazan G, 2020, FINANC TIMES; Chetty R., 2020, EC IMPACTS COVID 19; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Conrad FG, 2021, SOC SCI COMPUT REV, V39, P489, DOI 10.1177/0894439319875692; Creditreform, 2015, CRED COMM REP INT CR; Creditreform, IN PRESS; Devlin J., 2018, ARXIV181004805; Didier T, 2021, J FINANC STABIL, V53, DOI 10.1016/j.jfs.2020.100837; Ding WZ, 2021, J FINANC ECON, V141, P802, DOI 10.1016/j.jfineco.2021.03.005; Dorr JO, 2022, SMALL BUS ECON, V58, P887, DOI 10.1007/s11187-021-00514-4; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Eck A, 2021, SOC SCI COMPUT REV, V39, P484, DOI 10.1177/0894439319883393; European Commission, 2003, OFFICIAL J EUROPEAN, P36; European Union, 2006, OFF J EUR UNION, V393, P1; Fairlie R, 2020, J ECON MANAGE STRAT, V29, P727, DOI 10.1111/jems.12400; Federal Ministry of Finance, 2020, GERM STAB PROGR; Gok A, 2015, SCIENTOMETRICS, V102, P653, DOI 10.1007/s11192-014-1434-0; Goolsbee A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104311; Gourinchas PO, 2021, AEA PAP P, V111, P282, DOI 10.1257/pandp.20211109; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; KING G, 2001, POLITICAL ANAL, V0009; Kinne J, 2020, ZEW SHORT EXPERT, P20, DOI [10.13140/RG.2.2.11366.37441, DOI 10.13140/RG.2.2.11366.37441]; Kinne J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249071; Kinne J, 2020, SCIENTOMETRICS, V125, P2011, DOI 10.1007/s11192-020-03726-9; Krosnick, 2018, PALGRAVE HDB SURVEY, P175, DOI [10.1007/978-3-319-54395-6_23, DOI 10.1007/978-3-319-54395-6_23]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mirtsch M, 2021, IEEE T ENG MANAGE, V68, P87, DOI 10.1109/TEM.2020.2977815; Niefert, 2014, 14104 ZEW, DOI [10.2139/ssrn.2548385, DOI 10.2139/SSRN.2548385]; Njindan Iyke B, 2020, ASIAN EC LETT, V1, P2, DOI [10.46557/001c.17665, DOI 10.46557/001C.17665]; Ramelli S, 2020, REV CORP FINANC STUD, V9, P622, DOI 10.1093/rcfs/cfaa012; Ratadiya P, 2019, ARXIV191007370; Resch B, 2018, CARTOGR GEOGR INF SC, V45, P362, DOI 10.1080/15230406.2017.1356242; Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014; Ruder S, 2019, P 57 ANN MEET ASS CO; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Wang W, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3293318; Weible CM, 2020, POLICY SCI, V53, P225, DOI 10.1007/s11077-020-09381-4; Westerholt R, 2015, INT J GEOGR INF SCI, V29, P868, DOI 10.1080/13658816.2014.1002499; White JJD, 2010, TWIN SCREW EXTRUSION	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263898	10.1371/journal.pone.0263898	http://dx.doi.org/10.1371/journal.pone.0263898			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0U9YZ	35157731	Green Published, gold			2022-12-26	WOS:000788004500028
J	Nguyen, NT; Chinn, J; Kirby, K; Hohmann, SF; Amin, A				Nguyen, Ninh T.; Chinn, Justine; Kirby, Katherine; Hohmann, Samuel F.; Amin, Alpesh			Outcomes of COVID-19 adults managed in an outpatient versus hospital setting	PLOS ONE			English	Article								Introduction The coronavirus disease 2019 (COVID-19) pandemic continues to spread globally and as of February 4, 2021, there are more than 26 million confirmed cases and more than 440,000 deaths in the United States (US). A top priority of the Centers for Disease Control and Prevention (CDC) is to identify risk factors for severe COVID-19 illness. The objective of this study was to analyze the characteristics and outcomes of COVID-19 adults who were managed in an outpatient setting compared to patients who required hospitalization at US academic centers. Methods Using the Vizient clinical database, Discharge records of adults with a diagnosis of COVID-19 between March 1, 2020 and January 31, 2021 were reviewed. Outcome measures included demographics, characteristics, rate of hospitalization, and mortality, and data were analyzed based on inpatient versus outpatient management. Results Among COVID-19 adults, 1,360,078 patients were managed in an outpatient setting while 545,635 patients required hospitalization. Compared to hospitalized COVID-19 adults, COVID-19 adults who were managed in an outpatient setting were more likely to be female (56.1% vs 47.5%, p <0.001), white (57.7% vs 54.8%, p <0.001), within younger age group of 18-50 years (p<0.001) and have lower rate of comorbidities. Mortality was significantly lower in outpatient group compared to hospitalized group (0.2% vs 12.2%, respectively, p <0.01%). For outpatient group, mortality increased with increasing age group: 0.02% (52 of 295,112) for patients 18-30 years and 1.2% (1,373 of 117,866) for patients >75 years. The rate of hospitalization was lowest for age group 18-30 years at 10.6% (35,607 of 330,719) and highest for age group >75 years at 56.1% (150,381 of 268,247). Conclusion This analysis of US academic centers showed that 28.6% of COVID-19 adults who sought care at one of the hospitals reporting data to the Vizient clinical database required in-patient treatment. The rate of hospitalization in our study was lowest for the youngest age group of 18-30 years and highest for age group >75 years. Beside older age, other factors associated with outpatient management included female gender, white race, and having commercial insurance.	[Nguyen, Ninh T.; Chinn, Justine] Univ Calif Irvine, Med Ctr, Dept Surg, Orange, CA 92868 USA; [Kirby, Katherine] Univ Calif Irvine, Med Ctr, Dept Stat, Orange, CA USA; [Hohmann, Samuel F.] Rush Univ, Vizient, Ctr Adv Analyt & Informat, Chicago, IL 60612 USA; [Amin, Alpesh] Rush Univ, Dept Hlth Syst Management, Chicago, IL 60612 USA; Univ Calif Irvine, Med Ctr, Dept Med, Orange, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Rush University; Rush University; University of California System; University of California Irvine	Nguyen, NT (corresponding author), Univ Calif Irvine, Med Ctr, Dept Surg, Orange, CA 92868 USA.	ninhn@uci.edu						[Anonymous], CTR DIS CONTROL PREV; Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1; National Institutes of Health (NIH), 2021, COVID 19 TREATM GUID; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039	7	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263813	10.1371/journal.pone.0263813	http://dx.doi.org/10.1371/journal.pone.0263813			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157718	gold, Green Published			2022-12-26	WOS:000788004500018
J	Badgal, P; Chowdhary, P; Bhat, MA; Soodan, AS				Badgal, Priya; Chowdhary, Poonam; Bhat, Mudassir Ahmad; Soodan, Amarjit Singh			Phytolith profile of Acrachne racemosa (B. Heyne ex Roem. & Schult.) Ohwi (Cynodonteae, Chloridoideae, Poaceae)	PLOS ONE			English	Article							EPIDERMAL ANATOMY; SILICA DEPOSITION; NATIVE PLANTS; GRASSES; CLASSIFICATION; WHEAT; LEAF; VEGETATION; AESTIVUM; SOILS	Acrachne racemosa (B. Heyne. ex Roem. & Schult.) Ohwi of the subfamily Chloridoideae of the family Poaceae is an economically important grass species. Grasses are characterized by deposits of silica in the cells or tissues in the form of phytoliths which protect them from various types of biotic and abiotic stresses. Owing to variable shape and specificity of morphotypes, phytolith helps in taxonomical studies, reconstruction of paleoenvironments and prediction of climate changes. The present study focussed on developing a phytolith profile of the selected species. For isolation of phytolith, Dry Ashing Method was employed, and by epidermal peeling, in-situ location of phytoliths was deciphered. In the present study, silica percentage was studied from different parts of the plant and the maximum amount was found in the leaf. Frequency and morphometric data of phytolith morphotypes from different parts of the plants were also collected and analyzed. The strongest correlation was found between phytolith types of root and culm by Pearson's correlation coefficient supported by cluster analysis. The saddle type of phytoliths had the highest frequency in the leaf; other types of phytoliths in different parts of the plant were bilobate, blocky types, elongate types, trapezoids, triangular, cross, sinuate elongate, tabular types, globular types. Functional groups and amorphous polymorphic phases of silica were also analyzed by FTIR and XRD. It was concluded that phytolith types are controlled by parts of plant body and by anatomical and environmental factors.	[Badgal, Priya; Chowdhary, Poonam; Bhat, Mudassir Ahmad; Soodan, Amarjit Singh] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Plant Systemat & Biodivers Lab, Amritsar, Punjab, India; [Bhat, Mudassir Ahmad] Cent Univ Jammu, Dept Bot, Jammu, Jammu & Kashmir, India	Guru Nanak Dev University; Central University of Jammu	Badgal, P; Bhat, MA (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Plant Systemat & Biodivers Lab, Amritsar, Punjab, India.; Bhat, MA (corresponding author), Cent Univ Jammu, Dept Bot, Jammu, Jammu & Kashmir, India.	priyabadgal123@gmail.com; mabhat90@gmail.com						Abbasi MA., 2011, ASIAN J PHARM BIOLOG, V1; Ahmad F, 2011, J MED PLANTS RES, V5, P81; Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; Alexandre A, 2015, BIOGEOSCIENCES, V12, P863, DOI 10.5194/bg-12-863-2015; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Ball TB, 2009, BREEDING SCI, V59, P505, DOI 10.1270/jsbbs.59.505; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Barboni D, 2007, PALAEOGEOGR PALAEOCL, V246, P454, DOI 10.1016/j.palaeo.2006.10.012; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BARTOLI F, 1980, SOIL SCI SOC AM J, V44, P873, DOI 10.2136/sssaj1980.03615995004400040043x; BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2; Bhat MA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00864; Bonnett OT., 1972, BULLETIN, V742; Bozarth SR., 1992, PHYTOLITH SYSTEMATIC, P193, DOI DOI 10.1007/978-1-4899-1155-1_10; Bremond L, 2004, REV PALAEOBOT PALYNO, V129, P213, DOI 10.1016/j.revpalbo.2004.02.002; Bremond L, 2008, GLOBAL PLANET CHANGE, V61, P209, DOI 10.1016/j.gloplacha.2007.08.016; Brinker C. J., 2013, SOL GEL SCI PHYS CHE; Carnelli AL, 2004, REV PALAEOBOT PALYNO, V129, P39, DOI 10.1016/j.revpalbo.2003.11.002; Carnelli AL, 2001, ANN BOT-LONDON, V87, P425, DOI 10.1006/anbo.2000.1355; Carter JA, 1999, MICROPALEONTOLOGY, V45, P56, DOI 10.2307/1486202; Chauhan D.K., 2011, INT J INNOVATIONS BI, V1, P22; Chen I, 2020, BOT STUD, V61, DOI 10.1186/s40529-020-0282-x; CLARKE J, 1960, STAIN TECHNOL, V35, P35, DOI 10.3109/10520296009114713; Clayton WD., 2016, GRASSBASE ONLINE WOR; Collura LV, 2017, QUATERN INT, V434, P142, DOI 10.1016/j.quaint.2015.12.070; Contreras SA, 2019, QUATERN INT, V505, P21, DOI 10.1016/j.quaint.2018.03.002; Corbineau R, 2013, REV PALAEOBOT PALYNO, V197, P179, DOI 10.1016/j.revpalbo.2013.06.001; da Silva DPC, 2020, PLANT CELL TISS ORG, V141, P77, DOI 10.1007/s11240-020-01768-8; Dabney C, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0108-8; Danu M, 2019, QUATERN INT, V504, P128, DOI 10.1016/j.quaint.2018.03.033; Desai R. J., 2009, Notulae Scientia Biologicae, V1, P37; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Espindola-Gonzalez A, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/956945; Espindola-Gonzalez A, 2010, NANOSCALE RES LETT, V5, P1408, DOI 10.1007/s11671-010-9654-6; Exley C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00853; Folorunso A. E., 2007, Notulae Botanicae, Horti Agrobotanici, Cluj-Napoca, V35, P7; Fraysse F, 2006, GEOCHIM COSMOCHIM AC, V70, P1939, DOI 10.1016/j.gca.2005.12.025; FREDLUND GG, 1994, J BIOGEOGR, V21, P321, DOI 10.2307/2845533; Gallaher TJ, 2020, NEW PHYTOL, V228, P376, DOI 10.1111/nph.16677; Gao GZ, 2018, QUATERNARY SCI REV, V201, P1, DOI 10.1016/j.quascirev.2018.10.020; Ge Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72547-w; Ge Y, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01736; Ge Y, 2018, ARCHAEOL ANTHROP SCI, V10, P61, DOI 10.1007/s12520-016-0341-0; Gopal NO, 2004, SPECTROCHIM ACTA A, V60, P2441, DOI 10.1016/j.saa.2003.12.021; Gul Jan, 2010, Pakistan Journal of Weed Science Research, V16, P81; Hodson MJ, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00167; Hodson MJ, 2016, J ARCHAEOL SCI, V68, P62, DOI 10.1016/j.jas.2015.09.002; HODSON MJ, 1988, ANN BOT-LONDON, V62, P463, DOI 10.1093/oxfordjournals.aob.a087681; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; HODSON MJ, 1986, ANN BOT-LONDON, V58, P167, DOI 10.1093/oxfordjournals.aob.a087194; Hodson MJ., 1990, SCANNING MICROSCOPY, V4, P20; HOLM JL, 1967, GEOCHIM COSMOCHIM AC, V31, P2289, DOI 10.1016/0016-7037(67)90003-8; Hoskova K, 2021, ANN BOT-LONDON, V127, P191, DOI 10.1093/aob/mcaa102; Jattisha P. I., 2012, ISRN Botany, V2012, P246057; Jattisha P. I., 2015, Webbia, V70, P115, DOI 10.1080/00837792.2015.1005908; JONES L. H. P., 1965, Plant and Soil, V23, P79, DOI 10.1007/BF01349120; Kamal M., 2009, PAKISTAN J PLANT SCI, V15, P87; Karunakaran G, 2013, IET NANOBIOTECHNOL, V7, P70, DOI 10.1049/iet-nbt.2012.0048; Kow KW, 2014, POWDER TECHNOL, V254, P206, DOI 10.1016/j.powtec.2014.01.018; Krishnan S, 2000, BOT J LINN SOC, V132, P241, DOI 10.1111/j.1095-8339.2000.tb01529.x; Kumar S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00438; Kumar S, 2018, NEW PHYTOL, V217, P1137, DOI 10.1111/nph.14867; LANNING FC, 1989, ANN BOT-LONDON, V64, P395, DOI 10.1093/oxfordjournals.aob.a087858; LANNING FC, 1987, ANN BOT-LONDON, V60, P361, DOI 10.1093/oxfordjournals.aob.a087456; Li ZM, 2020, GEODERMA, V360, DOI 10.1016/j.geoderma.2019.114037; Li ZM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00529; Lima JF, 2021, PHYTOKEYS, P135, DOI 10.3897/phytokeys.172.59506; Lisztes-Szabo Z, 2015, ACTA SOC BOT POL, V84, P369, DOI 10.5586/asbp.2015.027; Lisztes-Szabo Z, 2014, TURK J BOT, V38, P851, DOI 10.3906/bot-1311-8; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2003, ESTUAR COAST SHELF S, V58, P587, DOI 10.1016/S0272-7714(03)00137-9; Lux A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010111; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma ZY, 2006, COLLOID SURFACE A, V275, P87, DOI 10.1016/j.colsurfa.2005.04.045; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Matichenkov, 1997, AGROCHEM, V1, P76; MATOH T, 1986, SOIL SCI PLANT NUTR, V32, P295, DOI 10.1080/00380768.1986.10557506; McKEAGUE J. A., 1963, CANADIAN JOUR SOIL SCI, V43, P83; Metcalfe CR., 1960, ANATOMY MONOCOTYLEDO; Morcote-Rios G, 2016, BOT J LINN SOC, V182, P348, DOI 10.1111/boj.12438; Morris RV, 2016, P NATL ACAD SCI USA, V113, P7071, DOI 10.1073/pnas.1607098113; Mourhly A, 2015, NANOMATER NANOTECHNO, V5, DOI 10.5772/62033; Mulholland S.C., 1992, PHYTOLITH SYSTEMATIC, P65, DOI DOI 10.1007/978-1-4899-1155-1_4; MULHOLLAND SC, 1989, J ARCHAEOL SCI, V16, P489, DOI 10.1016/0305-4403(89)90070-8; Murungi ML, 2020, REV PALAEOBOT PALYNO, V275, DOI 10.1016/j.revpalbo.2020.104189; Naskar M, 2018, NORD J BOT, V36, DOI 10.1111/njb.01695; Neumann K, 2019, ANN BOT-LONDON, V124, P189, DOI 10.1093/aob/mcz064; Ogie-Odia EA., 2010, OZEAN J APPL SCI, V3, P29; Out WA, 2017, QUATERN INT, V434, P1, DOI 10.1016/j.quaint.2015.07.017; PARRY DW, 1984, PHILOS T ROY SOC B, V304, P537, DOI 10.1098/rstb.1984.0045; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D. R., 1998, SILICA BODIES TROPIC; Piperno DR, 2020, QUATERN INT, V565, P54, DOI 10.1016/j.quaint.2020.10.043; Prychid CJ, 2003, BOT REV, V69, P377, DOI 10.1663/0006-8101(2004)069[0377:SABOSB]2.0.CO;2; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Rosen A.M., 1992, PHYTOLITH SYSTEMATIC, P129; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; Sahebi M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/396010; Shaheen S, 2011, J MED PLANTS RES, V5, P4279; Shakoor S.A., 2014, U J PLANT SCI, V2, P107, DOI DOI 10.13189/UJPS.2014.020602; Shakoor SA., 2014, INT J BOT RES, V4, P1; Shakoor SA, 2016, FLORA, V224, P130, DOI 10.1016/j.flora.2016.07.011; Shillito LM, 2013, VEG HIST ARCHAEOBOT, V22, P71, DOI 10.1007/s00334-011-0341-z; Silantyeva M, 2018, REV PALAEOBOT PALYNO, V250, P1, DOI 10.1016/j.revpalbo.2017.12.002; SMITHSON F, 1956, NATURE, V178, P107, DOI 10.1038/178107a0; Socrates G., 2004, INFRARED RAMAN CHARA; Sommer M, 2006, J PLANT NUTR SOIL SC, V169, P310, DOI 10.1002/jpln.200521981; Song ZL, 2016, EARTH-SCI REV, V158, P19, DOI 10.1016/j.earscirev.2016.04.007; Soreng RJ, 2017, J SYST EVOL, V55, P259, DOI 10.1111/jse.12262; Soreng RJ, 2015, J SYST EVOL, V53, P117, DOI 10.1111/jse.12150; SRIVASTAVA A K, 1978, Journal of the Indian Botanical Society, V57, P155; Stace CA., 1984, CURRENT CONCEPTPLA, V25, P67; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Teste M, 2020, REV PALAEOBOT PALYNO, V272, DOI 10.1016/j.revpalbo.2019.104130; Tomlinson PB., 1969, ANATOMY MONOCOTYLEDO; Tripathi DK, 2012, AGR RES, V1, P352, DOI 10.1007/s40003-012-0042-6; Tripathi DK, 2013, P NATL A SCI INDIA B, V83, P97, DOI 10.1007/s40011-012-0066-5; Tripathi DK, 2012, NATL ACAD SCI LETT, V35, P285, DOI 10.1007/s40009-012-0050-x; Twiss P.C., 1992, PHYTOLITH SYSTEMATIC, P113, DOI [10.1007/978-1-4899-1155-1_6, DOI 10.1007/978-1-4899-1155-1_6]; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; WANG YC, 1993, PROCEEDINGS OF THE 1993 SEM 50TH ANNIVERSARY SPRING CONFERENCE ON EXPERIMENTAL MECHANICS, P1; Watling J, 2020, QUATERN INT, V550, P85, DOI 10.1016/j.quaint.2020.03.045; Watling KM, 2011, SPECTROCHIM ACTA A, V80, P106, DOI 10.1016/j.saa.2011.03.002; Watson L., 1992, The grass genera of the world.; Yost CL, 2018, J HUM EVOL, V116, P75, DOI 10.1016/j.jhevol.2017.11.005; Zhang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019726; Zhang XD, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00581; Zuo XX, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01302; Zurro D, 2016, J ARCHAEOL SCI, V68, P112, DOI 10.1016/j.jas.2015.11.014	132	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263721	10.1371/journal.pone.0263721	http://dx.doi.org/10.1371/journal.pone.0263721			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148333	gold, Green Published			2022-12-26	WOS:000800108800025
J	Mota, A; Oltra, SS; Selenica, P; Moiola, CP; Casas-Arozamena, C; Lopez-Gil, C; Diaz, E; Gatius, S; Ruiz-Miro, M; Calvo, A; Rojo-Sebastian, A; Hurtado, P; Pineiro, R; Colas, E; Gil-Moreno, A; Reis-Filho, JS; Muinelo-Romay, L; Abal, M; Matias-Guiu, X; Weigelt, B; Moreno-Bueno, G				Mota, Alba; Oltra, Sara S.; Selenica, Pier; Moiola, Cristian P.; Casas-Arozamena, Carlos; Lopez-Gil, Carlos; Diaz, Eva; Gatius, Sonia; Ruiz-Miro, Maria; Calvo, Ana; Rojo-Sebastian, Alejandro; Hurtado, Pablo; Pineiro, Roberto; Colas, Eva; Gil-Moreno, Antonio; Reis-Filho, Jorge S.; Muinelo-Romay, Laura; Abal, Miguel; Matias-Guiu, Xavier; Weigelt, Britta; Moreno-Bueno, Gema			Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression	ONCOGENE			English	Article							SYNCHRONOUS PRIMARY CANCERS; GENOMIC CHARACTERIZATION; INTERNATIONAL SOCIETY; MUTATIONAL PROCESSES; TUMOR HETEROGENEITY; OVARIAN CANCERS; CELL CARCINOMAS; BREAST; RECOMMENDATIONS; CHEMOTHERAPY	Analyzing different tumor regions by next generation sequencing allows the assessment of intratumor genetic heterogeneity (ITGH), a phenomenon that has been studied widely in some tumor types but has been less well explored in endometrial carcinoma (EC). In this study, we sought to characterize the spatial and temporal heterogeneity of 9 different ECs using whole-exome sequencing, and by performing targeted sequencing validation of the 42 primary tumor regions and 30 metastatic samples analyzed. In addition, copy number alterations of serous carcinomas were assessed by comparative genomic hybridization arrays. From the somatic mutations, identified by whole-exome sequencing, 532 were validated by targeted sequencing. Based on these data, the phylogenetic tree reconstructed for each case allowed us to establish the tumors' evolution and correlate this to tumor progression, prognosis, and the presence of recurrent disease. Moreover, we studied the genetic landscape of an ambiguous EC and the molecular profile obtained was used to guide the selection of a potential personalized therapy for this patient, which was subsequently validated by preclinical testing in patient-derived xenograft models. Overall, our study reveals the impact of analyzing different tumor regions to decipher the ITGH in ECs, which could help make the best treatment decision.	[Mota, Alba; Oltra, Sara S.; Diaz, Eva; Moreno-Bueno, Gema] MD Anderson Int Fdn, Madrid 28033, Spain; [Mota, Alba; Oltra, Sara S.; Moreno-Bueno, Gema] Univ Autonoma Madrid UAM, Inst Invest Biomed Alberto Sols CSIC UAM, Biochem Dept, IdiPaz, Madrid 28029, Spain; [Oltra, Sara S.; Moiola, Cristian P.; Rojo-Sebastian, Alejandro; Colas, Eva; Gil-Moreno, Antonio; Muinelo-Romay, Laura; Abal, Miguel; Matias-Guiu, Xavier; Moreno-Bueno, Gema] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain; [Selenica, Pier; Reis-Filho, Jorge S.; Weigelt, Britta] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Moiola, Cristian P.; Lopez-Gil, Carlos; Rojo-Sebastian, Alejandro; Colas, Eva; Gil-Moreno, Antonio] Univ Autonoma Barcelona, Vall Hebron Inst Res, Biomed Res Grp Gynecol, Barcelona 08035, Spain; [Casas-Arozamena, Carlos; Muinelo-Romay, Laura; Abal, Miguel] Univ Hosp Santiago de Compostela SERGAS, Hlth Res Inst Santiago de Compostela IDIS, Translat Med Oncol Grp Oncomet, Trav Choupana S-N, Santiago De Compostela 15706, Spain; [Gatius, Sonia; Matias-Guiu, Xavier] Univ Lleida, Hosp U Arnau de Vilanova, Dept Pathol, Lleida, Spain; [Ruiz-Miro, Maria] IRBLLEIDA, Biobank, Lleida, Spain; [Calvo, Ana] Hosp U Arnau de Vilanova, Dept Gynecol, IRBLLEIDA, Lleida, Spain; [Rojo-Sebastian, Alejandro] MD Anderson Canc Ctr, Madrid, Spain; [Hurtado, Pablo; Pineiro, Roberto] Hlth Res Inst Santiago de Compostela IDIS, Roche Chus Joint Unit, Translat Med Oncol Grp Oncomet, Travesia Da Choupana S-N, Santiago De Compostela 15706, Spain; [Gil-Moreno, Antonio] Vall Hebron Univ Hosp, Gynaecol Dept, Barcelona 08035, Spain; [Matias-Guiu, Xavier] Univ Lleida, Hosp U Bellvitge, Dept Pathol, Lleida, Spain; [Matias-Guiu, Xavier] Univ Barcelona, Hosp U Bellvitge, Dept Pathol, Barcelona, Spain; [Matias-Guiu, Xavier] IDIBELL Lleida & Barcelona, Barcelona, Spain	University of Texas System; UTMD Anderson Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Memorial Sloan Kettering Cancer Center; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Complexo Hospitalario Universitario de Santiago de Compostela; Universitat de Lleida; University of Texas System; UTMD Anderson Cancer Center; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari Vall d'Hebron; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Universitat de Lleida; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Moreno-Bueno, G (corresponding author), MD Anderson Int Fdn, Madrid 28033, Spain.; Moreno-Bueno, G (corresponding author), Univ Autonoma Madrid UAM, Inst Invest Biomed Alberto Sols CSIC UAM, Biochem Dept, IdiPaz, Madrid 28029, Spain.; Moreno-Bueno, G (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain.	gmoreno@iib.uam.es	Oltra, Sara/Y-4002-2019; Moreno-Bueno, Gema/K-9354-2016; Piñeiro, Roberto/AAN-5561-2020; Selenica, Pier/GQY-8678-2022	Moreno-Bueno, Gema/0000-0002-5030-6687; Piñeiro, Roberto/0000-0001-9479-139X; Casas-Arozamena, Carlos/0000-0002-3279-2482	MD Anderson Foundation Biobank [B.0000745]; "Plataforma de Biobancos" ISCIII [PT13/0010/0014, B.000609]; Spanish Ministry of Economy and Innovation [PID2019-104644RB-I00]; Instituto de Salud Carlos III (ISCIII, CIBERONC) [FEDER funds] [CB16/12/00295 - GMB, CB16/12/00328 -EC, CB16/12/00231 -XMG]; AECC Scientific Foundation [FC_AECC PROYE19036MOR -GMB]; AECC; Breast Cancer Research Foundation; NIH/NCI [P50 CA247749 01, P30CA008748]	MD Anderson Foundation Biobank; "Plataforma de Biobancos" ISCIII; Spanish Ministry of Economy and Innovation(Spanish Government); Instituto de Salud Carlos III (ISCIII, CIBERONC) [FEDER funds]; AECC Scientific Foundation; AECC; Breast Cancer Research Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all those at the Translational Research Laboratory of the MD Anderson Cancer Center Madrid for their invaluable help with this study. Tissue samples were obtained with the support of the MD Anderson Foundation Biobank (record number B.0000745, ISCIII National Biobank Record), the "Xarxa Catalana de Bancs de Tumors" and "Plataforma de Biobancos" ISCIII (PT13/0010/0014, B.000609). This study has been supported by the Spanish Ministry of Economy and Innovation (PID2019-104644RB-I00 (GMB), the Instituto de Salud Carlos III (ISCIII, CIBERONC, CB16/12/00295 - GMB-, CB16/12/00328 -EC, AGM- and CB16/12/00231 -XMG- [all partly supported by FEDER funds]) and by the AECC Scientific Foundation (FC_AECC PROYE19036MOR -GMB- and Coordinated groups 2018 -XMG, AGM, GMB-). SO is funded by an AECC-postdoctoral grant (2020). JSR-F and BW are funded in part by the Breast Cancer Research Foundation and in part by the NIH/NCI P50 CA247749 01 grant. Research reported in this publication was supported in part by a Cancer Center Support Grant of the NIH/NCI (Grant No. P30CA008748; MSK). We thank the Eurofins Megalab laboratory for helping us to perform the analysis of DNA HPV detection.	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anglesio MS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv428; Ashley CW, 2019, GYNECOL ONCOL, V152, P11, DOI 10.1016/j.ygyno.2018.10.032; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Beck-Engeser GB, 2015, EUR J IMMUNOL, V45, P695, DOI 10.1002/eji.201445218; Belhadj H, 2014, INT J GYNECOL OBSTET, V125, P97, DOI 10.1016/j.ijgo.2014.02.003; Bell DW, 2019, ANNU REV PATHOL-MECH, V14, P339, DOI 10.1146/annurev-pathol-020117-043609; Bestvina CM, 2016, ONCOLOGIST, V21, P1250, DOI 10.1634/theoncologist.2016-0062; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Budczies J, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1526613; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cannataro VL, 2019, ONCOGENE, V38, P3475, DOI 10.1038/s41388-018-0657-6; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Casas-Arozamena C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020585; Chao A, 2016, GYNECOL ONCOL, V143, P60, DOI 10.1016/j.ygyno.2016.07.114; Chiang YC, 2008, INT J GYNECOL CANCER, V18, P159, DOI 10.1111/j.1525-1438.2007.00975.x; Choi M, 2016, MOL CANCER THER, V15, P1781, DOI 10.1158/1535-7163.MCT-15-0945; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Connell PP, 1999, GYNECOL ONCOL, V74, P74, DOI 10.1006/gyno.1999.5415; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Demeulemeester J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1109-7; Dessources K, 2020, JCO PRECIS ONCOL, V4, P1217, DOI 10.1200/PO.20.00044; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eritja N, 2017, ADV EXP MED BIOL, V943, P149, DOI 10.1007/978-3-319-43139-0_6; Espinosa I, 2016, AM J SURG PATHOL, V40, P972, DOI 10.1097/PAS.0000000000000640; Evans T, 2016, J NATL COMPR CANC NE, V14, P1165, DOI 10.6004/jnccn.2016.0123; GALL JG, 1986, SCIENCE, V233, P1367, DOI 10.1126/science.233.4771.1367-e; Garg K, 2010, MODERN PATHOL, V23, P80, DOI 10.1038/modpathol.2009.153; Gatius S, 2018, PATHOBIOLOGY, V85, P35, DOI 10.1159/000475529; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Grondin CJ, 2016, ENVIRON HEALTH PERSP, V124, P1592, DOI 10.1289/EHP174; Guerini-Rocco E, 2015, J PATHOL, V237, P166, DOI 10.1002/path.4566; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Heitz F, 2014, INT J GYNECOL CANCER, V24, P54, DOI 10.1097/IGC.0000000000000019; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Irving JA, 2005, HUM PATHOL, V36, P605, DOI 10.1016/j.humpath.2005.03.005; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jette NR, 2020, CANCERS, V12, DOI 10.3390/cancers12030687; Jiang TT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-876; Kiess AP, 2012, GYNECOL ONCOL, V127, P321, DOI 10.1016/j.ygyno.2012.07.112; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kommoss S, 2018, ANN ONCOL, V29, P1180, DOI 10.1093/annonc/mdy058; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kurman RJ, 2014, WORLD HLTH ORG CLASS; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Le Gallo M, 2014, CLIN CHEM, V60, P98, DOI 10.1373/clinchem.2013.205740; Lee JY, 2019, CLIN CANCER RES, V25, P674, DOI 10.1158/1078-0432.CCR-18-1103; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marquard AM, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0130-0; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Mota A, 2017, MODERN PATHOL, V30, P134, DOI 10.1038/modpathol.2016.143; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; NIKZAINAL S, 2012, CELL, V149; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Peterson LE, 2019, MOLECULES, V24, DOI 10.3390/molecules24030645; Priestley P, 2019, NATURE, V575, P210, DOI 10.1038/s41586-019-1689-y; Rabban JT, 2019, INT J GYNECOL PATHOL, V38, pS25, DOI 10.1097/PGP.0000000000000512; Reijnen C, 2020, INT J CANCER, V147, P478, DOI 10.1002/ijc.32907; Reiter JG, 2019, NAT REV CANCER, V19, P639, DOI 10.1038/s41568-019-0185-x; Roberts NJ, 2016, CANCER DISCOV, V6, P166, DOI 10.1158/2159-8290.CD-15-0402; Robertson AG, 2018, CELL, V174, P1033, DOI 10.1016/j.cell.2018.07.036; Rosa-Rosa JM, 2016, MODERN PATHOL, V29, P1594, DOI 10.1038/modpathol.2016.184; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Rye IH, 2018, MOL ONCOL, V12, P1838, DOI 10.1002/1878-0261.12375; Ryu D, 2016, HUM GENET, V135, P635, DOI 10.1007/s00439-016-1670-x; Saber A, 2017, CARCINOGENESIS, V38, P144, DOI 10.1093/carcin/bgw128; Santacana M, 2014, HUM PATHOL, V45, P2394, DOI 10.1016/j.humpath.2014.06.031; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schmitt A, 2017, CANCER RES, V77, P3040, DOI 10.1158/0008-5472.CAN-16-3398; Schultheis AM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv427; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shi WW, 2018, CELL REP, V25, P1446, DOI 10.1016/j.celrep.2018.10.046; Siegel RL., 2020, CA-CANCER J CLIN, V70; Soliman PT, 2004, GYNECOL ONCOL, V94, P456, DOI 10.1016/j.ygyno.2004.05.006; Soslow RA, 2019, INT J GYNECOL PATHOL, V38, pS64, DOI 10.1097/PGP.0000000000000518; Soslow RA, 2010, SEMIN DIAGN PATHOL, V27, P261, DOI 10.1053/j.semdp.2010.09.003; Talhouk A, 2017, CANCER-AM CANCER SOC, V123, P802, DOI 10.1002/cncr.30496; Tang Wan, 2015, Shanghai Arch Psychiatry, V27, P62, DOI 10.11919/j.issn.1002-0829.215010; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Uchi R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005778; Vermij L, 2020, HISTOPATHOLOGY, V76, P52, DOI 10.1111/his.14015; Weigelt B, 2018, JNCI-J NATL CANCER I, V110, P1030, DOI 10.1093/jnci/djy028; Weinreb I, 2014, NAT GENET, V46, P1166, DOI 10.1038/ng.3096; Wilkerson MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku489; Wu H, 2017, ONCOGENE, V36, P2857, DOI 10.1038/onc.2016.438; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yi K, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0112-3; Zapatka M, 2020, NAT GENET, V52, P320, DOI 10.1038/s41588-019-0558-9; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang W, 2020, ONCOLOGIST, V25, P375, DOI 10.1634/theoncologist.2019-0498	104	0	0	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1835	1850		10.1038/s41388-022-02221-0	http://dx.doi.org/10.1038/s41388-022-02221-0		FEB 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35145232	hybrid, Green Published			2022-12-26	WOS:000754012300003
J	Guan, GY; Xie, JJ; Dai, YM; Han, H				Guan, Guoying; Xie, Jinjiao; Dai, Yamei; Han, Hui			TFPI2 suppresses the interaction of TGF-beta 2 pathway regulators to promote endothelial-mesenchymal transition in diabetic nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR PATHWAY; GROWTH-FACTOR-BETA; SMURF2 UBIQUITIN LIGASE; KIDNEY FIBROSIS; RENAL FIBROSIS; CROSS-TALK; CELLS; INHIBITOR-2; APOPTOSIS; EXPRESSION	Endothelial-mesenchymal transition (EndMT) is an important source of myofibroblasts, but also contributes to the progression of diabetic nephropathy (DN). By several differential gene expression analyses from the Gene Expression Omnibus (GEO) database, the tissue factor pathway inhibitor 2 (TFPI2) gene, known as a tumor suppressor, was shown to be dysregulated in DN; however, the potential role and regulatory mechanism of TFPI2 in DN are unclear. Here, we found abnormal upregulation of TFPI2 in the renal cortex of diabetic mice, accompanied by impaired renal function. We also injected a single dose of adeno-associated virus (AAV)2 carrying shRNA targeting TFPI2 intravenously into these mice and found that knockdown of TFPI2 improved renal function and reduced renal fibrosis and cell apoptosis in experimental DN. Furthermore, hyperglycemia-induced EndMT was inhibited in the absence of TFPI2, as evidenced by increased expression of endothelial markers (VE-cadherin and CD31) and decreased expression of mesenchymal markers (alpha-SMA, des-min, and FSP-1). To further explore the mechanism in vitro, human renal glomerular endothelial cells (hRGECs) were incubated in the presence of high glucose or transforming growth factor beta (TGF-beta)2. TFPI2 deficiency inhibited high glucose-induced cell apoptosis and TGF-beta 2-induced EndMT in hRGECs, while overexpression of TFPI2 had the opposite effects. Importantly, TGF-beta 2 is a crucial driver of EndMT, and we found that TFPI2 promoted TGF-beta 2/Smad signaling activation by interferring the interaction of TGF-beta pathway regulators (SMURF2 with SMAD7). Our results show that TFPI2 regulates EndMT and the TGF-beta 2 signaling pathway and is a potential promoter of DN pathogenesis.	[Guan, Guoying; Xie, Jinjiao; Han, Hui] Harbin Med Univ, Dept Geriatr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China; [Dai, Yamei] Harbin Med Univ, Hlth Management Ctr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Han, H (corresponding author), Harbin Med Univ, Dept Geriatr, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China.	hydyyqkgp@163.com	han, han/HDL-7807-2022		Youth Project of National Natural Science Foundation of China [81600629]; Surface Project of National Natural Science Foundation of China [81671383]	Youth Project of National Natural Science Foundation of China; Surface Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Youth Project of National Natural Science Foundation of China (No. 81600629) and the Surface Project of National Natural Science Foundation of China (No. 81671383) .	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Azushima K, 2018, NAT REV NEPHROL, V14, P48, DOI 10.1038/nrneph.2017.142; Bai YJM, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00128; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Eleftheriadis T, 2018, INT UROL NEPHROL, V50, P179, DOI 10.1007/s11255-017-1733-5; Ferreira FU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030458; Fu J, 2015, AM J PHYSIOL-RENAL, V308, pF287, DOI 10.1152/ajprenal.00533.2014; Giordo R, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.683594; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Iino M, 1998, ARTERIOSCL THROM VAS, V18, P40, DOI 10.1161/01.ATV.18.1.40; Ivanciu L, 2007, ARTERIOSCL THROM VAS, V27, P310, DOI 10.1161/01.ATV.0000254147.89321.cf; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kawanami D, 2016, HISTOL HISTOPATHOL, V31, P1059, DOI 10.14670/HH-11-777; Kempaiah P, 2008, APOPTOSIS, V13, P702, DOI 10.1007/s10495-008-0207-8; Kushioka J, 2020, BONE RES, V8, DOI 10.1038/s41413-020-00115-z; Lam BQ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113077; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Liang W, 2009, PEPTIDES, V30, P2330, DOI 10.1016/j.peptides.2009.08.016; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin YF, 2007, APOPTOSIS, V12, P2163, DOI 10.1007/s10495-007-0136-y; Liu X, 2018, J CELL MOL MED, V22, P808, DOI 10.1111/jcmm.13360; Loeffler I, 2018, CELL TISSUE RES, V372, P115, DOI 10.1007/s00441-017-2754-1; Mallat RK, 2017, CRIT REV CL LAB SCI, V54, P458, DOI 10.1080/10408363.2017.1394267; Massague J, 2000, GENE DEV, V14, P627; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; MIYAGI Y, 1994, J BIOCHEM-TOKYO, V116, P939, DOI 10.1093/oxfordjournals.jbchem.a124648; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Okazaki Yuko, 2007, Clin Exp Nephrol, V11, P77, DOI 10.1007/s10157-006-0456-1; Pardali E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102157; Pedone E, 2020, EXPLORE MED, V1, P314, DOI [10.37349/emed.2020.00021, DOI 10.37349/EMED.2020.00021]; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sabbineni H, 2018, J CELL PHYSIOL, V233, P8418, DOI 10.1002/jcp.26801; Sierko E, 2007, SEMIN THROMB HEMOST, V33, P653, DOI 10.1055/s-2007-991532; Sniegon I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112290; Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Thomas B, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1133-6; Tsai YC, 2020, MOL THER, V28, P963, DOI 10.1016/j.ymthe.2020.01.014; Tuleta I, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.166044; Vigili de Kreutzenberg S.., 2021, EXPLOR MED, V2, P1; Wang ZJ, 2017, J CELL MOL MED, V21, P2359, DOI 10.1111/jcmm.13157; Wojtukiewicz MZ, 2003, THROMB HAEMOSTASIS, V90, P140; Xu BH, 2020, METABOLISM, V103, DOI 10.1016/j.metabol.2019.154013; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yu CH, 2017, EXP MOL PATHOL, V102, P377, DOI 10.1016/j.yexmp.2017.03.007; Yuan Q, 2019, ADV EXP MED BIOL, V1165, P253, DOI 10.1007/978-981-13-8871-2_12; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeng LF, 2019, ADV EXP MED BIOL, V1165, P49, DOI 10.1007/978-981-13-8871-2_4; Zeng LF, 2013, J BIOL CHEM, V288, P31853, DOI 10.1074/jbc.M113.463745; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	69	2	2	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101725	10.1016/j.jbc.2022.101725	http://dx.doi.org/10.1016/j.jbc.2022.101725			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35157852	Green Published, gold			2022-12-26	WOS:000789394500011
J	Matsuoka, K; Imahashi, N; Ohno, M; Ode, H; Nakata, Y; Kubota, M; Sugimoto, A; Imahashi, M; Yokomaku, Y; Iwatani, Y				Matsuoka, Kazuhiro; Imahashi, Nobuhiko; Ohno, Miki; Ode, Hirotaka; Nakata, Yoshihiro; Kubota, Mai; Sugimoto, Atsuko; Imahashi, Mayumi; Yokomaku, Yoshiyuki; Iwatani, Yasumasa			SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; HORSESHOE BATS; CHAPERONES; EXPRESSION; INDUCTION; ALIGNMENT; SEVERITY; DELETION; ENCODES; GENOME	ORF8 is an accessory protein encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Consensus regarding the biological functions of ORF8 is lacking, largely because the fundamental characteristics of this protein in cells have not been determined. To clarify these features, we herein established an ORF8 expression system in 293T cells. Using this system, approximately 41% of the ORF8 expressed in 293T cells were secreted extracellularly as a glycoprotein homodimer with inter/intramolecular disulfide bonds. Intracellular ORF8 was sensitive to the glycosidase Endo H, whereas the secreted portion was Endo-H-resistant, suggesting that secretion occurs via a conventional pathway. Additionally, immunoblotting analysis showed that the total amounts of the major histocompatibility complex class I (MHC-I), angiotensin-converting enzyme 2 (ACE2), and SARS-CoV-2 spike (CoV-2 S) proteins coexpressed in cells were not changed by the increased ORF8 expression, although FACS analysis revealed that the expression of the cell surface MHC-I protein, but not that of ACE2 and CoV-2 S proteins, was reduced by ORF8 expression. Finally, we demonstrate by RNA-seq analysis that ORF8 had no significant stimulatory effects in human primary monocytederived macrophages (MDMs). Taken together, our results provide fundamental evidence that the ORF8 glycoprotein acts as a secreted homodimer, and its functions are likely associated with the intracellular transport and/or extracellular signaling in SARS-CoV-2 infection.	[Matsuoka, Kazuhiro; Ohno, Miki; Nakata, Yoshihiro; Kubota, Mai; Sugimoto, Atsuko; Imahashi, Mayumi; Yokomaku, Yoshiyuki; Iwatani, Yasumasa] Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi, Japan; [Imahashi, Nobuhiko] Nagoya Med Ctr, Natl Hosp Org, Dept Hematol, Nagoya, Aichi, Japan; [Nakata, Yoshihiro; Iwatani, Yasumasa] Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi, Japan	Nagoya Medical Center; Nagoya University	Iwatani, Y (corresponding author), Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi, Japan.; Iwatani, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept AIDS Res, Nagoya, Aichi, Japan.	iwatani.yasumasa.cp@mail.hosp.go.jp	; Iwatani, Yasumasa/A-8675-2016	Imahashi, Nobuhiko/0000-0002-1398-2002; Iwatani, Yasumasa/0000-0001-9269-4828; Ode, Hirotaka/0000-0001-8624-2382; Matsuoka, Kazuhiro/0000-0003-1217-3550	Japan Society for the Promotion of Science [JP20K07533, JP19H03482]; Japan Agency for Medical Research and Development (AMED) [20fk0108293h0001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Japan Society for the Promotion of Science (grant numbers JP20K07533 (K. M.) and JP19H03482 (Y. I.) ) and by the Research Programs on COVID-19 from Japan Agency for Medical Research and Development (AMED grant numbers 20fk0108293h0001 (Y. I.) ) .	Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Chen MF, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01948-2020; Chen SY, 2020, J INFECT DIS, V222, P223, DOI 10.1093/infdis/jiaa278; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Davies NG, 2021, NATURE, V593, P270, DOI [10.1038/s41586-021-03426-1, 10.1101/2021.02.01.21250959]; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Echavarria-Consuegra L, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009644; Flower TG, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021785118; Gamage AM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009130; Geng H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.679482; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Halperin L, 2014, IUBMB LIFE, V66, P318, DOI 10.1002/iub.1272; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Jungreis I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22905-7; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lau SKP, 2015, J VIROL, V89, P10532, DOI 10.1128/JVI.01048-15; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Li WW, 1997, MOL CELL BIOL, V17, P54, DOI 10.1128/MCB.17.1.54; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin XY, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102293; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; MELNICK J, 1992, J BIOL CHEM, V267, P21303; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Mohammad S, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090677; Muth D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33487-8; Mwimanzi F, 2018, J VIROL, V92, DOI 10.1128/JVI.01409-17; Nakashima M, 2016, J VIROL, V90, P1034, DOI 10.1128/JVI.02369-15; Ninagawa S, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129812; Oostra M, 2007, J VIROL, V81, P13876, DOI 10.1128/JVI.01631-07; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Pereira F, 2021, GENE, V784, DOI 10.1016/j.gene.2021.145596; PETERSON PA, 1974, P NATL ACAD SCI USA, V71, P35, DOI 10.1073/pnas.71.1.35; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Rashid F, 2021, VIRUS RES, V296, DOI 10.1016/j.virusres.2021.198350; Redondo N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708264; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shuai HP, 2022, NATURE, V603, P693, DOI 10.1038/s41586-022-04442-5; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Stukalov A, 2021, NATURE, V594, P246, DOI 10.1038/s41586-021-03493-4; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Vohringer HS, 2021, NATURE, V600, P506, DOI 10.1038/s41586-021-04069-y; Wang XH, 2020, MBIO, V11, DOI 10.1128/mBio.02431-20; Wolter N, 2022, LANCET, V399, P437, DOI 10.1016/S0140-6736(22)00017-4; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu ZG, 2016, J INFECT DIS, V213, P579, DOI 10.1093/infdis/jiv476; Xiong Y., 2021, UNCONVENTIONAL SECRE, DOI 10; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8; Zhang YW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024202118	64	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101724	10.1016/j.jbc.2022.101724	http://dx.doi.org/10.1016/j.jbc.2022.101724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35157849	Green Published, gold			2022-12-26	WOS:000789394500006
J	Johnson, NJ; Roman, CG				Johnson, Nicole J.; Roman, Caterina G.			Community correlates of change: A mixed-effects assessment of shooting dynamics during COVID-19	PLOS ONE			English	Article							DRUG MARKETS; SOCIAL-DISORGANIZATION; VIOLENT CRIME; GUN VIOLENCE; TRENDS; RACE; NEIGHBORHOODS; INEQUALITY; ECOMETRICS; SCIENCE	This study examines changes in gun violence at the census tract level in Philadelphia, PA before and after the onset of the COVID-19 pandemic. Piecewise generalized linear mixed effects models are used to test the relative impacts of social-structural and demographic factors, police activity, the presence of and proximity to drug markets, and physical incivilities on shooting changes between 2017 and June, 2021. Model results revealed that neighborhood structural characteristics like concentrated disadvantage and racial makeup, as well as proximity to drug markets and police activity were associated with higher shooting rates. Neighborhood drug market activity and police activity significantly predicted changes in shooting rates over time after the onset of COVID-19. This work demonstrates the importance of understanding whether there are unique factors that impact the susceptibility to exogenous shocks like the COVID-19 pandemic. The increasing risk of being in a neighborhood with an active drug market during the pandemic suggests efforts related to disrupting drug organizations, or otherwise curbing violence stemming from drug markets, may go a long way towards quelling citywide increases in gun violence.	[Johnson, Nicole J.; Roman, Caterina G.] Temple Univ, Dept Criminal Justice, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Johnson, NJ (corresponding author), Temple Univ, Dept Criminal Justice, Philadelphia, PA 19122 USA.	njohnson@temple.edu		Johnson, Nicole/0000-0003-4423-9497	Temple University Libraries Open Access Publishing Fund	Temple University Libraries Open Access Publishing Fund	We would like to thank Ralph Taylor, Jeff Ward, Alyssa Mendlein, and four anonymous reviewers for their insightful comments and suggestions on earlier versions of this article. We also thank the Philadelphia District Attorney's Office for providing the arrest data used in this work. Publication of this article was funded in part by the Temple University Libraries Open Access Publishing Fund.	Abdallah HO, 2021, J AM COLL SURGEONS, V232, DOI 10.1016/j.jamcollsurg.2020.09.028; Abrams DS, 2021, J PUBLIC ECON, V194, DOI 10.1016/j.jpubeco.2020.104344; Agnew R, 1999, J RES CRIME DELINQ, V36, P123, DOI 10.1177/0022427899036002001; Anderson E., 2000, CODE STREET DECENCY; [Anonymous], 2013, CRIME MODELING MAPPI; [Anonymous], NEW YORK TIMES; Ashby MPJ, 2020, CRIME SCI, V9, DOI 10.1186/s40163-020-00117-6; Ashby MPJ, 2017, JUSTICE Q, V34, P109, DOI 10.1080/07418825.2015.1103380; Beard JH, 2021, JAMA-J AM MED ASSOC, V325, P1327, DOI 10.1001/jama.2021.1534; Beard JH, 2017, AM J PUBLIC HEALTH, V107, P371, DOI 10.2105/AJPH.2016.303620; Biesanz JC, 2004, PSYCHOL METHODS, V9, P30, DOI 10.1037/1082-989X.9.1.30; Blumstein A, 1995, J CRIM LAW CRIM, V86, P10, DOI 10.2307/1143998; Braga AA, 2014, JUSTICE Q, V31, P633, DOI 10.1080/07418825.2012.673632; Braga AA, 2010, J QUANT CRIMINOL, V26, P33, DOI 10.1007/s10940-009-9082-x; Brantingham P., 1995, EUR J CRIM POLICY RE, V13, P5, DOI [10.1007/BF02242925, DOI 10.1007/BF02242925]; Briz-Redon A, 2020, INT J GEOGR INF SCI, V34, P1283, DOI 10.1080/13658816.2019.1703994; Brown BB, 2004, J ENVIRON PSYCHOL, V24, P359, DOI 10.1016/j.jenvp.2004.01.001; Bursik R.J., 2002, NEIGHBORHOODS CRIME; Campedelli GM, 2020, CRIME SCI, V9, DOI 10.1186/s40163-020-00131-8; Campedelli GM, 2021, AM J CRIM JUSTICE, V46, P704, DOI 10.1007/s12103-020-09578-6; Centers for Disease Control and Prevention, 2020, COVID 19 YOUR HLTH; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; Eck J., 1995, CRIME PLACE, V4, P67; Fagan J, 2007, CAMB HANDB PSYCHOL, P688; Galea S, 2005, SOC SCI MED, V60, P2417, DOI 10.1016/j.socscimed.2004.11.028; George Leckie, 2020, Arxiv, DOI arXiv:1911.06888; Giommoni L, 2020, INT J DRUG POLICY, V83, DOI 10.1016/j.drugpo.2020.102834; Goldstein P, 1997, WORLD DRUG REP; Gross J., 2020, NEW YORK TIMES; Halford E, 2020, CRIME SCI, V9, DOI 10.1186/s40163-020-00121-w; Harding DJ, 2009, AM SOCIOL REV, V74, P445, DOI 10.1177/000312240907400306; Hatchimonji JS, 2020, ANN SURG, V272, pE53, DOI 10.1097/SLA.0000000000003996; Hawley A., 1950, HUMAN ECOLOGY THEORY; Jackson C., 2020, PHILADELPHIA INQUIRE; Jacques S., 2015, CRIMINAL JUSTICE REV, V40, P87; Jacques S, 2011, CRIMINOLOGY, V49, P729, DOI 10.1111/j.1745-9125.2011.00234.x; Brantingham PJ, 2021, CRIMINOL PUBLIC POL, V20, P423, DOI 10.1111/1745-9133.12541; Johnson LT, 2018, CRIME DELINQUENCY, V64, P143, DOI 10.1177/0011128716682228; Johnson LT, 2016, CRIME DELINQUENCY, V62, P1465, DOI 10.1177/0011128714568302; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Kim DY, 2021, J CRIM JUST, V73, DOI 10.1016/j.jcrimjus.2021.101783; Kirk DS, 2011, AM J SOCIOL, V116, P1190, DOI 10.1086/655754; Kubrin CE, 2003, SOCIOL QUART, V44, P329, DOI 10.1525/tsq.2003.44.3.329; Leroux AJ, 2019, J EXP EDUC, V87, P430, DOI 10.1080/00220973.2018.1465384; Liao Y, 2015, J ADOLESCENCE, V44, P219, DOI 10.1016/j.adolescence.2015.07.011; LONGFORD NT, 1993, CONTEMP SOCIOL, V22, P293, DOI 10.2307/2075823; Lopez, 2020, COVID 19 HOMICIDE FI; Magee LA, 2020, J URBAN HEALTH, V97, P296, DOI 10.1007/s11524-020-00424-y; Martinez R, 2008, URBAN AFF REV, V43, P846, DOI 10.1177/1078087408314774; McCord ES, 2007, AUST NZ J CRIMINOL, V40, P43, DOI 10.1375/acri.40.1.43; Mears DP, 2006, CRIMINOLOGY, V44, P509, DOI 10.1111/j.1745-9125.2006.00056.x; Melamed Samantha, 2020, PHILADELPHIA INQUIRE; de la Miyar JRB, 2021, J CRIM JUST, V72, DOI 10.1016/j.jcrimjus.2020.101745; Mohler G, 2020, J CRIM JUST, V68, DOI 10.1016/j.jcrimjus.2020.101692; Morenoff JD, 2001, CRIMINOLOGY, V39, P517, DOI 10.1111/j.1745-9125.2001.tb00932.x; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; O'Brien DT, 2015, SOCIOL METHODOL, V45, P101, DOI 10.1177/0081175015576601; Ousey GC, 2004, J RES CRIME DELINQ, V41, P352, DOI 10.1177/0022427803262059; Palmer C., 2020, PHILADELPHIA INQUIRE; Payne JL, 2022, J EXP CRIMINOL, V18, P89, DOI 10.1007/s11292-020-09441-y; Peterson R.D., 2010, DIVERGENT SOCIAL WOR; Pratt TC, 2005, CRIME JUSTICE, V32, P373, DOI 10.1086/655357; Ramey DM, 2014, CRIMINOL PUBLIC POL, V13, P193, DOI 10.1111/1745-9133.12074; Ratcliffe JH, 2004, INT J GEOGR INF SCI, V18, P61, DOI 10.1080/13658810310001596076; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Roman CG, 2002, SCH GENERATORS CRIME; Rosenfeld R., 2020, PANDEMIC SOCIAL UNRE; Rosenfeld R, 2018, CRIMINOLOGY, V56, P5, DOI 10.1111/1745-9125.12170; SAMPSON RJ, 1989, AM J SOCIOL, V94, P774, DOI 10.1086/229068; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ., 2012, GREAT AMERICAN CITY; Sampson RJ, 2018, DU BOIS REV, V15, P13, DOI 10.1017/S1742058X18000140; Sampson RobertJ., 1995, CRIME INEQUALITY, P37, DOI DOI 10.1016/J.CITIES.2004.07.008; Schuetz J, 2012, REG SCI URBAN ECON, V42, P269, DOI 10.1016/j.regsciurbeco.2011.09.005; Shaw C., 1942, JUVENILE DELINQUENCY; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Stickle B, 2020, AM J CRIM JUSTICE, V45, P525, DOI 10.1007/s12103-020-09546-0; Sutherland M, 2021, AM J EMERG MED, V39, P225, DOI 10.1016/j.ajem.2020.05.006; Taniguchi TA, 2009, JUSTICE Q, V26, P670, DOI 10.1080/07418820802593378; Taylor R. B., 2001, BREAKING AWAY BROKEN; TAYLOR RB, 1985, J ARCHIT PLAN RES, V2, P261; Taylor RB, 2015, COMMUNITY CRIMINOLOG; TAYLOR RB, 1999, MEAS WHAT MATT P POL; U.S. Census Bureau, QUICKFACTS PHIL CIT; Velez MB, 2012, CRIMINOLOGY, V50, P1025, DOI 10.1111/j.1745-9125.2012.00287.x; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Warner BD, 2003, J RES CRIME DELINQ, V40, P123, DOI 10.1177/0022427802251018; Weisburd D, 2015, CRIMINOLOGY, V53, P133, DOI 10.1111/1745-9125.12070; Wheeler AP, 2018, CRIME DELINQUENCY, V64, P1882, DOI 10.1177/0011128717714974; Wilcox P., 2018, COMMUNITIES CRIME EN; Williams S, 2021, PHILADELPHIA POLICE; Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017; Wolf T., 2020, GOV WOLF HLTH SECR I; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Zhang WJ, 2016, URBAN STUD, V53, P3007, DOI 10.1177/0042098015605222	96	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263777	10.1371/journal.pone.0263777	http://dx.doi.org/10.1371/journal.pone.0263777			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196358	Green Published, gold			2022-12-26	WOS:000835161600017
J	Mandadi, S; Pulluru, H; Annie, F				Mandadi, Subhadra; Pulluru, Harish; Annie, Frank			Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients	PLOS ONE			English	Article								Remdesivir (RDV) reduces time to clinical improvement in hospitalized COVID-19 patients requiring supplemental oxygen. Dexamethasone improves survival in those requiring oxygen support. Data is lacking on the efficacy of combination therapy in patients on mechanical ventilation. We analyzed for comparative outcomes between Corticosteroid (CS) therapy with combined Corticosteroid and Remdesivir (CS-RDV) therapy. We conducted an observational cohort study of patients aged 18 to 90 with COVID-19 requiring ventilatory support using TriNetX (COVID-19 Research Network) between January 20, 2020, and February 9, 2021. We compared patients who received at least 48 hours of CS-RDV combination therapy to CS monotherapy. The primary outcome was 28-day all-cause mortality rates in propensity-matched (PSM) cohorts. Secondary outcomes were Length of Stay (LOS), Secondary Bacterial Infections (SBI), and MRSA (Methicillin-Resistant Staphylococcus aureus), and Pseudomonas infections. We used univariate and multivariate Cox proportional hazards models and stratified log-rank tests. Of 388 patients included, 91 (23.5%) received CS-RDV therapy, and 297 (76.5%) received CS monotherapy. After propensity score matching, with 74 patients in each cohort, all-cause mortality was 36.4% and 29.7% in the CS-RDV and CS therapy, respectively (P = 0.38). We used a Kaplan-Meier with a log-rank test on follow up period (P = 0.23), and a Hazards Ratio model (P = 0.26). SBI incidence was higher in the CS group (13.5% vs. 35.1%, P = 0.02) with a similar LOS (13.4 days vs. 13.4 days, P = 1.00) and similar incidence of MRSA/Pseudomonas infections (13.5% vs. 13.5%, P = 1.00) in both the groups. Therefore, CS-RDV therapy is non-inferior to CS therapy in reducing 28-day all-cause in-hospital mortality but associated with a significant decrease in the incidence of SBI in critically ill COVID-19 patients.	[Mandadi, Subhadra] Charleston Area Med Ctr, Dept Infect Dis, Charleston, WV 25301 USA; [Pulluru, Harish] Charleston Area Med Ctr, Dept Hosp Med, Charleston, WV USA; [Annie, Frank] Charleston Area Med Ctr, Hlth Educ & Res Inst, Charleston, WV USA		Mandadi, S (corresponding author), Charleston Area Med Ctr, Dept Infect Dis, Charleston, WV 25301 USA.	Subhadra.mandadi@gmail.com	Annie, Frank/AAQ-1779-2021	Annie, Frank/0000-0001-8423-4119				Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Bhimraj Adarsh, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa478; Elezkurtaj S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82862-5; FDA, FDA WEBSITE; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Janiaud P, 2021, JAMA-J AM MED ASSOC, V325, P1185, DOI 10.1001/jama.2021.2747; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Piscoya A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243705; Punjabi CD, 2021, INFECT CONT HOSP EP, V42, P1156, DOI 10.1017/ice.2020.440; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Russell AM, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0171-y; Salazar E, 2020, AM J PATHOL, V190, P2290, DOI 10.1016/j.ajpath.2020.08.001; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Vazzana N, 2022, ACTA CLIN BELG, V77, P268, DOI 10.1080/17843286.2020.1824749; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264301	10.1371/journal.pone.0264301	http://dx.doi.org/10.1371/journal.pone.0264301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196344	gold, Green Published			2022-12-26	WOS:000835161600035
J	Taniguchi, Y; Seino, S; Headey, B; Hata, T; Ikeuchi, T; Abe, T; Shinkai, S; Kitamura, A				Taniguchi, Yu; Seino, Satoshi; Headey, Bruce; Hata, Toshiki; Ikeuchi, Tomoko; Abe, Takumi; Shinkai, Shoji; Kitamura, Akihiko			Evidence that dog ownership protects against the onset of disability in an older community-dwelling Japanese population	PLOS ONE			English	Article							COMPANION ANIMALS; FRAILTY; HEALTH; METAANALYSIS; CONSUMPTION; MORTALITY	Objectives This study examined the association between dog and cat ownership, the onset of disability and all-cause mortality in an older population. Dog and cat owners take more regular exercise and have closer social relationships than non-owners. We further assess the beneficial effects of these moderating variables on the onset of disability and mortality. Methods Dog and cat ownership data were collected from 11233 community-dwelling adults age 65 years and older. These data were matched with data about the onset of disability held by the Japanese long-term care insurance system. Local registry data were used to ascertain all-cause mortality. Results During the approximately 3.5 year follow-up period, 17.1% of the sample suffered onset of disability, and 5.2% died. Logistic regression analysis indicated that, compared with a reference group of those who had never owned a dog (odds ratio fixed at 1.0), older adults who were currently dog owners had a significantly lower odds ratio of onset of disability (OR = 0.54 95% CI: 0.37-0.79). Our results further show that regular exercise interacts with dog ownership to reduce the risk of disability. The association of dog and/or cat ownership with all-cause mortality was not statistically significant. Conclusions Dog ownership appears to protect against incident disability among older Japanese adults. Additional benefits are gained from ownership combined with regular exercise. Daily dog care may have an important role to play in health promotion and successful aging.	[Taniguchi, Yu] Natl Inst Environm Studies, Japan Environm & Childrens Study Programme Off, Tsukuba, Ibaraki, Japan; [Taniguchi, Yu; Seino, Satoshi; Hata, Toshiki; Abe, Takumi; Shinkai, Shoji; Kitamura, Akihiko] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo, Japan; [Headey, Bruce] Univ Melbourne, Melbourne Inst Appl Econ & Social Res, Melbourne, Vic, Australia; [Ikeuchi, Tomoko] Tokyo Metropolitan Inst Gerontol, Human Care Res Team, Tokyo, Japan; [Shinkai, Shoji] Kagawa Nutr Univ, Fac Nutr, Saitama, Japan	National Institute for Environmental Studies - Japan; Tokyo Metropolitan Institute of Gerontology; University of Melbourne; Tokyo Metropolitan Institute of Gerontology; Kagawa Nutrition University	Taniguchi, Y (corresponding author), Natl Inst Environm Studies, Japan Environm & Childrens Study Programme Off, Tsukuba, Ibaraki, Japan.; Taniguchi, Y (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Tokyo, Japan.	taniguchi.yu@nies.go.jp		Taniguchi, Yu/0000-0002-2442-2406; Hata, Toshiki/0000-0001-5454-8774	Ota City; Japan Health Promotion & Fitness Foundation; Sugiura Memorial Foundation; Japan Foundation for Aging and Health; JSPS KAKEN Grant [16K16615]	Ota City; Japan Health Promotion & Fitness Foundation; Sugiura Memorial Foundation; Japan Foundation for Aging and Health; JSPS KAKEN Grant	This study was supported by grants from Ota City, Japan Health Promotion & Fitness Foundation, Sugiura Memorial Foundation, The Japan Foundation for Aging and Health, and JSPS KAKEN Grant number 16K16615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Snih S, 2009, J REHABIL MED, V41, P892, DOI 10.2340/16501977-0424; Andrew MK, 2012, INT PSYCHOGERIATR, V24, P1347, DOI 10.1017/S1041610212000269; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Ding D, 2018, AM J PREV MED, V54, P289, DOI 10.1016/j.amepre.2017.09.012; Fancourt D, 2019, J EPIDEMIOL COMMUN H, V73, P906, DOI 10.1136/jech-2019-212372; Gillum RF, 2010, INT J ENV RES PUB HE, V7, P2452, DOI 10.3390/ijerph7062452; Headey B, 2007, SOC INDIC RES, V80, P297, DOI 10.1007/s11205-005-5072-z; Hoshi T., 2017, AM J MED MED SCI, V7, P156, DOI [10.5923/j.ajmms.20170703.09, DOI 10.5923/J.AJMMS.20170703.09]; Ikeuchi T, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030595; Kim SH, 2017, RES AGING, V39, P657, DOI 10.1177/0164027516656040; Kitamura A, 2021, J CACHEXIA SARCOPENI, V12, P30, DOI 10.1002/jcsm.12651; Kojima G, 2020, GERIATRICS-BASEL, V5, DOI 10.3390/geriatrics5040089; Kojima G, 2018, J NUTR HEALTH AGING, V22, P1010, DOI 10.1007/s12603-018-1069-6; Kojima G, 2018, AGE AGEING, V47, P26, DOI 10.1093/ageing/afx086; Kojima G, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0134-9; Makizako H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008462; Mubanga M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16118-6; Ogechi I, 2016, HIGH BLOOD PRESS CAR, V23, P245, DOI 10.1007/s40292-016-0156-1; Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x; Seino S, 2021, J EPIDEMIOL, V31, P401, DOI 10.2188/jea.JE20210047; Seino S, 2019, MED SCI SPORT EXER, V51, P1146, DOI 10.1249/MSS.0000000000001884; Seino S, 2019, J EPIDEMIOL, V29, P73, DOI 10.2188/jea.JE20170109; Seino S, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0679-z; Shinkai S, 2016, GERIATR GERONTOL INT, V16, P87, DOI 10.1111/ggi.12726; Taniguchi Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54955-9; Taniguchi Y, 2019, J GERONTOL A-BIOL, V74, P211, DOI 10.1093/gerona/gly024; Taniguchi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206399; Taniguchi Y, 2018, GERIATR GERONTOL INT, V18, P1108, DOI 10.1111/ggi.13323; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Urtamo Annele, 2019, Acta Biomed, V90, P359, DOI 10.23750/abm.v90i2.8376; Westgarth C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41254-6; Yoshizaki T., 2019, Japanese Journal of Nutrition and Dietetics, V77, P19, DOI 10.5264/eiyogakuzashi.77.19	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263791	10.1371/journal.pone.0263791	http://dx.doi.org/10.1371/journal.pone.0263791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196354	Green Published, gold			2022-12-26	WOS:000835161600019
J	Beaumont, J; Gambarota, G; Prior, M; Fripp, J; Reid, LB				Beaumont, Jeremy; Gambarota, Giulio; Prior, Marita; Fripp, Jurgen; Reid, Lee B.			Avoiding data loss: Synthetic MRIs generated from diffusion imaging can replace corrupted structural acquisitions for freesurfer-seeded tractography	PLOS ONE			English	Article							HUMAN BRAIN; WHITE-MATTER; B-VALUE; REGISTRATION; CHILDREN	Magnetic Resonance Imaging (MRI) motion artefacts frequently complicate structural and diffusion MRI analyses. While diffusion imaging is easily 'scrubbed' of motion affected volumes, the same is not true for T1w or T2w 'structural' images. Structural images are critical to most diffusion-imaging pipelines thus their corruption can lead to disproportionate data loss. To enable diffusion-image processing when structural images are missing or have been corrupted, we propose a means by which synthetic structural images can be generated from diffusion MRI. This technique combines multi-tissue constrained spherical deconvolution, which is central to many existing diffusion analyses, with the Bloch equations that allow simulation of MRI intensities for given scanner parameters and magnetic resonance (MR) tissue properties. We applied this technique to 32 scans, including those acquired on different scanners, with different protocols and with pathology present. The resulting synthetic T1w and T2w images were visually convincing and exhibited similar tissue contrast to acquired structural images. These were also of sufficient quality to drive a Freesurfer-based tractographic analysis. In this analysis, probabilistic tractography connecting the thalamus to the primary sensorimotor cortex was delineated with Freesurfer, using either real or synthetic structural images. Tractography for real and synthetic conditions was largely identical in terms of both voxels encountered (Dice 0.88-0.95) and mean fractional anisotropy (intrasubject absolute difference 0.00-0.02). We provide executables for the proposed technique in the hope that these may aid the community in analysing datasets where structural image corruption is common, such as studies of children or cognitively impaired persons.	[Beaumont, Jeremy; Fripp, Jurgen; Reid, Lee B.] CSIRO, Australian Hlth Res Ctr, St Lucia, Qld, Australia; [Beaumont, Jeremy; Gambarota, Giulio] Univ Rennes, INSERM, LTSI UMR1099, Rennes, France; [Prior, Marita] Royal Brisbane & Womens Hosp, Dept Med Imaging, Herston, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Royal Brisbane & Women's Hospital	Beaumont, J (corresponding author), CSIRO, Australian Hlth Res Ctr, St Lucia, Qld, Australia.; Beaumont, J (corresponding author), Univ Rennes, INSERM, LTSI UMR1099, Rennes, France.	jeremy.beaumont.2@gmail.com	Reid, Lee/M-4801-2014; Fripp, Jurgen/A-8763-2011	Reid, Lee/0000-0002-3585-8141; Fripp, Jurgen/0000-0001-9705-0079; Beaumont, Jeremy/0000-0003-1198-2217	Advance Queensland Research Fellowship [R-09964-01]; 'Region Bretagne' (France ARED_BITRAST)	Advance Queensland Research Fellowship; 'Region Bretagne' (France ARED_BITRAST)	This research was partially supported by an Advance Queensland Research Fellowship (R-09964-01) and by the 'Region Bretagne' (France ARED_BITRAST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.Ceslis, 2020, medRxiv, DOI 10.1101/2020.05.04.20091140; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baumann F, 2010, AMYOTROPH LATERAL SC, V11, P486, DOI 10.3109/17482961003774428; Boyd RN, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0381-6; Boyd RN, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002853; Bydder M, 2002, MAGN RESON MED, V47, P677, DOI 10.1002/mrm.10093; Bydder M, 2017, MAGN RESON IMAGING, V43, P88, DOI 10.1016/j.mri.2017.07.015; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Cheng H, 2020, MAGN RESON IMAGING, V69, P1, DOI 10.1016/j.mri.2020.02.010; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Dhollander T, 2016, 24 INT SOC MAGNETIC; Dhollander T, 2016, ISMRM WORKSHOP BREAK; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Garcia-Galant M, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-019-1904-x; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kerbler GM, 2013, NEUROIMAGE, V66, P133, DOI 10.1016/j.neuroimage.2012.10.075; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Laporta-Hoyos O, 2017, NEUROIMAGE-CLIN, V15, P789, DOI 10.1016/j.nicl.2017.05.005; LAUZON ML, 1993, MAGNET RESON MED, V30, P438, DOI 10.1002/mrm.1910300406; Lu HZ, 2005, J MAGN RESON IMAGING, V22, P13, DOI 10.1002/jmri.20356; Malinsky M, 2013, J DIGIT IMAGING, V26, P774, DOI 10.1007/s10278-012-9561-8; McLean B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1217-5; Pannek K, 2012, NEUROIMAGE, V63, P835, DOI 10.1016/j.neuroimage.2012.07.022; Peters AM, 2007, MAGN RESON IMAGING, V25, P748, DOI 10.1016/j.mri.2007.02.014; Reid LB., 2020, MEDRXIV, DOI [10.1101/2020.07.16.20155598, DOI 10.1101/2020.07.16.20155598]; Reid LB, 2020, NEUROIMAGE, V211, DOI 10.1016/j.neuroimage.2020.116646; Reid LB, 2017, HUM BRAIN MAPP, V38, P4302, DOI 10.1002/hbm.23514; Reid LB, 2017, INT J DEV NEUROSCI, V58, P17, DOI 10.1016/j.ijdevneu.2017.01.010; Reid LB, 2015, NAT REV NEUROL, V11, P390, DOI 10.1038/nrneurol.2015.97; Roy S, 2016, LECT NOTES COMPUT SC, V9968, P146, DOI 10.1007/978-3-319-46630-9_15; Spijkerman JM, 2018, MAGN RESON MATER PHY, V31, P415, DOI 10.1007/s10334-017-0659-3; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096899; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150	47	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0247343	10.1371/journal.pone.0247343	http://dx.doi.org/10.1371/journal.pone.0247343			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180211	gold, Green Published, Green Submitted			2022-12-26	WOS:000796435800001
J	Cardona-Arias, JA; Carmona-Fonseca, J				Cardona-Arias, Jaiberth Antonio; Carmona-Fonseca, Jaime			Congenital malaria: Frequency and epidemiology in Colombia, 2009-2020	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PLACENTAL MALARIA; PREGNANT-WOMEN; DIAGNOSIS; VIVAX; MICROSCOPY; PREVALENCE; RISK	Congenital Malaria (CM) is an underestimated and under-researched problem in Colombia, despite its severe clinical, epidemiological, economic, and public health consequences. The objective was to determine the general frequency of CM, the specific frequency of CM by diagnostic test and plasmodial species, and identify its associated factors. A retrospective study was carried out using the records of 567 newborns. qPCR and Thick Blood Smear (TBS) were performed. The frequency of infection was determined with a 95% confidence interval. Associated factors were identified by non-parametric tests and odds ratios; the confusion was controlled with a logistic regression model. All cases corresponded to submicroscopic CM (negative with TBS and positive with PCR), and the frequency was 12.2% (95%CI = 9.4-14.9). The detection was statistically higher in the umbilical cord with 16,2% (95%CI = 12.4-19.9) versus peripheral blood of the newborn with 2.2% (95%CI = 0.7-4.9). CM was statistically higher in newborn whose mothers had malaria in the last year, gestational and placental malaria. The median birth weight in newborn infected with CM was lower compared to the one of healthy neonates. Because the control program in Colombia is based on TBS, it must be improved with the inclusion of other tests that allow the detection of submicroscopic CM. In addition, the program has other limitations such as do not have specific actions for pregnant women and have a passive surveillance system. These difficulties do not allow to show the magnitude of CM, its consequences on neonatal and infant health, constituting a serious problem of health injustice.	[Cardona-Arias, Jaiberth Antonio] Univ Antioquia, Sch Microbiol, Medellin, Colombia; [Cardona-Arias, Jaiberth Antonio; Carmona-Fonseca, Jaime] Univ Antioquia, Fac Med, Grp Invest Cesar Uribe Piedrahita, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Cardona-Arias, JA (corresponding author), Univ Antioquia, Sch Microbiol, Medellin, Colombia.; Cardona-Arias, JA (corresponding author), Univ Antioquia, Fac Med, Grp Invest Cesar Uribe Piedrahita, Medellin, Colombia.	jaiberth.cardona@udea.edu.co	Cardona, Jaiberth/GZL-3892-2022	Cardona Arias, Jaiberth/0000-0002-7101-929X	Colciencias project [111 577 757 447, 755-2017]; Universidad de Antioquia	Colciencias project(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia	1) Colciencias project 111 577 757 447, contract 755-2017. Jaime Carmona-Fonseca. 2) Universidad de Antioquia. Jaiberth Antonio Cardona Arias and Jaime Carmona-Fonseca received a salary from this funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Larrotta C, 2019, CLIN EXP IMMUNOL, V195, P96, DOI 10.1111/cei.13213; [Anonymous], 1995, INFECT DIS FETUS NEW; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Arango EM, 2013, AM J TROP MED HYG, V89, P178, DOI 10.4269/ajtmh.12-0669; Bardaj A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005606; Bilal JA, 2020, EUR J OBSTET GYN R B, V252, P534, DOI 10.1016/j.ejogrb.2020.06.025; Campos IM, 2011, AM J TROP MED HYG, V84, P929, DOI 10.4269/ajtmh.2011.10-0507; Carmona-Fonseca J., 2017, SALUD UIS, V49, P577, DOI [10.18273/REVSAL.V49N4-2017007, DOI 10.18273/REVSAL.V49N4-2017007]; Carmona-Fonseca J, 2013, AM J TROP MED HYG, V88, P1093, DOI 10.4269/ajtmh.12-0363; Carmona-Fonseca J, 2010, IATREIA, V23, P137; Carmona-Fonseca Jaime, 2009, Rev Colomb Obstet Ginecol, V60, P19; Chaikitgosiyakul S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-4; Restrepo-Posada DC, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03472-6; Danwang C, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03373-8; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fitri LE, 2014, KOREAN J PARASITOL, V52, P639, DOI 10.3347/kjp.2014.52.6.639; Fried Michal, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025551; Gabriel DCJ, 2020, REV CHIL PEDIATR-CHI, V91, P749, DOI 10.32641/rchped.vi91i5.1283; Gulasi S, 2016, TURKISH J PEDIATR, V58, P195; Hangi M, 2019, AM J TROP MED HYG, V100, P1158, DOI 10.4269/ajtmh.17-0341; Hassanpour G, 2017, J ARTHROPOD-BORNE DI, V11, P172; Instituto Nacional de SaludINS, 2020, INF EV MAL PER EP 12; López-Guzmán Carolina, 2020, Rev. perú. med. exp. salud publica, V37, P220, DOI 10.17843/rpmesp.2020.372.4759; Ma R, 2021, NAT MICROBIOL, V6, P380, DOI 10.1038/s41564-020-00858-9; Agudelo-Garcia OM, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/3680758; Michaels M, 2019, GLEASON JUUL AVERY E, P527; Moya-Alvarez V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-271; Omer S, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03580-x; Omer SA, 2020, J TROP PEDIATRICS, V66, P428, DOI 10.1093/tropej/fmz083; Organizacin Mundial de la Salud Ministerio de Salud y Proteccin Social, 2020, AD PARC GUA PRCTIC C; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Romani L, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2614-9; Singh J, 2014, INDIAN PEDIATR, V51, P285, DOI 10.1007/s13312-014-0402-3; Tahirou I, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/7802560; Uneke CJ, 2007, PARASITOL RES, V101, P835, DOI 10.1007/s00436-007-0577-9; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39; Uneke Chigozie J, 2008, Yale J Biol Med, V81, P1; World Health Organization, 2015, GUID TREATM MAL, Vthird; Zakama AK, 2020, CURR TROP MED REP, V7, P162, DOI 10.1007/s40475-020-00213-2; Zheng Z, 2017, ADV CLIN CHEM, V80, P155, DOI 10.1016/bs.acc.2016.11.006	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263451	10.1371/journal.pone.0263451	http://dx.doi.org/10.1371/journal.pone.0263451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180230	gold, Green Published			2022-12-26	WOS:000796435800018
J	Dickmark, M; Agren, J; Hellstrom-Westas, L; Jonsson, M				Dickmark, Malin; Agren, Johan; Hellstrom-Westas, Lena; Jonsson, Maria			Risk factors for seizures in the vigorous term neonate: A population-based register study of singleton births in Sweden	PLOS ONE			English	Article							HARRIS COUNTY; AGE; WOMEN; COMPLICATIONS; EPIDEMIOLOGY; MORBIDITY; ETIOLOGY; DYSTOCIA; INFANTS; TEXAS	Background Neonatal seizures have been associated with increased mortality and impaired neurodevelopment and, knowledge about risk factors may be useful for prevention. Clear associations have been established between labor-related risk factors and seizures in asphyxiated neonates. However, there is limited information about why some vigorous term-born infants experience seizures. Objectives Our aim was to assess antepartum and intrapartum risk factors for seizures in vigorous term-born neonates. Methods This was a national cohort study of singleton infants born at term in Sweden from 2009-2015. Vigorous was defined as an Apgar score of at least 7 at 5 and 10 minutes. Data on the mothers and infants were obtained from the Swedish Medical Birth Register and the Swedish Neonatal Quality Register. A diagnosis of neonatal seizures was the main outcome measure and the exposures were pregnancy and labor variables. Logistic regression analysis was used and the results are expressed as adjusted odds ratios (aOR) with 95% confidence intervals (CI). Results The incidence of neonatal seizures was 0.81/1,000 for 656 088 births. Seizures were strongly associated with obstetric emergencies (aOR 4.0, 95% CI 2.2-7.4), intrapartum fever and/or chorioamnionitis (aOR 3.4, 95% CI 2.1-5.3), and intrapartum fetal distress (aOR 3.0, 95% CI 2.4-3.7). Other associated intrapartum factors were: labor dystocia, occiput posterior position, operative vaginal delivery, and Cesarean delivery. Some maternal factors more than doubled the risk: a body mass of more than 40 (aOR 2.6, 95% CI 1.4-4.8), hypertensive disorders (aOR 2.3, 95% CI 1.7-3.1) and diabetes mellitus (aOR 2.6, 95% CI 1.7-4.1). Conclusion A number of intrapartum factors were associated with an increased risk of seizures in vigorous term-born neonates. Obstetric emergencies, intrapartum fever and/or chorioamnionitis and fetal distress were the strongest associated risks. The presence of such factors, despite a reassuring Apgar score could prompt close surveillance.	[Dickmark, Malin] Uppsala Univ Hosp, Dept Obstet & Gynecol, Uppsala, Sweden; [Agren, Johan; Hellstrom-Westas, Lena; Jonsson, Maria] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University	Jonsson, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	maria.jonsson@kbh.uu.se			Perinatal Foundation	Perinatal Foundation	The study was funded by grants from the Perinatal Foundation (https://fodelsefonden.se).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; American College of Obstetrics and Gynecology, 2014, TASK FORC NEON ENC A, V2nd; Bashambu MT, 2012, PEDIATRICS, V130, pE982, DOI 10.1542/peds.2012-0368; Berglund S, 2010, ACTA OBSTET GYN SCAN, V89, P39, DOI 10.3109/00016340903418751; Chauhan SP, 2017, OBSTET GYNECOL, V130, P511, DOI [10.1097/aog.0000000000002199, 10.1097/AOG.0000000000002199]; Chen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202183; CURTIS PD, 1988, ARCH DIS CHILD, V63, P1065, DOI 10.1136/adc.63.9.1065; Doty MS, 2020, OBSTET GYNECOL, V135, P1417, DOI 10.1097/AOG.0000000000003866; Draper ES, 2002, ARCH DIS CHILD-FETAL, V87, P176; Ekeus C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-36; Glass HC, 2009, CURR TREAT OPTION NE, V11, P405, DOI 10.1007/s11940-009-0045-1; Glass HC, 2009, J PEDIATR-US, V154, P24, DOI 10.1016/j.jpeds.2008.07.008; Hall DA, 2006, J CHILD NEUROL, V21, P795, DOI 10.1177/08830738060210092001; Hill MG, 2016, WOMENS HEALTH, V12, P251, DOI 10.2217/whe.15.103; Homko Carol J, 2003, Curr Diab Rep, V3, P313, DOI 10.1007/s11892-003-0023-z; Howarth C, 2007, DIABETIC MED, V24, P1229, DOI 10.1111/j.1464-5491.2007.02254.x; Johansson S, 2018, J PERINATOL, V38, P1144, DOI 10.1038/s41372-018-0144-5; Jonsson M, 2009, BJOG-INT J OBSTET GY, V116, P1453, DOI 10.1111/j.1471-0528.2009.02269.x; Jonsson M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.027; KAPPEL B, 1987, ACTA OBSTET GYN SCAN, V66, P153, DOI 10.3109/00016348709083038; Kjaergaard H, 2010, J OBSTET GYNAECOL, V30, P25, DOI 10.3109/01443610903276417; Kullen B., 2003, SWEDISH MED BIRTH RE; LANSKA MJ, 1995, NEUROLOGY, V45, P724, DOI 10.1212/WNL.45.4.724; Lena Hellstrom-Westas, 2006, LA KARTIDNINGEN, V103, P1320; Liljestrom L, 2018, ACTA OBSTET GYN SCAN, V97, P615, DOI 10.1111/aogs.13316; Loman AMW, 2014, EUR J PAEDIATR NEURO, V18, P360, DOI 10.1016/j.ejpn.2014.01.014; Lundgren C, 2018, J MATERN-FETAL NEO M, V31, P1595, DOI 10.1080/14767058.2017.1321628; MacDonald SC, 2015, JAMA NEUROL, V72, P981, DOI 10.1001/jamaneurol.2015.1017; Madden JV, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.02.008; Malmqvist O, 2020, J MATERN-FETAL NEO M, V33, P799, DOI 10.1080/14767058.2018.1505853; Marchi J, 2015, OBES REV, V16, P621, DOI 10.1111/obr.12288; MINCHOM P, 1987, BRIT J OBSTET GYNAEC, V94, P431, DOI 10.1111/j.1471-0528.1987.tb03121.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Norman M, 2019, ACTA PAEDIATR, V108, P1411, DOI 10.1111/apa.14823; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Parker SJ, 2018, J PEDIATR-US, V203, P163, DOI 10.1016/j.jpeds.2018.08.028; PATTERSON CA, 1989, OBSTET GYNECOL, V74, P361; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Ronen GM, 1999, J PEDIATR-US, V134, P71, DOI 10.1016/S0022-3476(99)70374-4; Saliba RM, 2001, AM J EPIDEMIOL, V154, P14, DOI 10.1093/aje/154.1.14; Saliba RM, 1999, AM J EPIDEMIOL, V150, P763, DOI 10.1093/oxfordjournals.aje.a010079; Shellhaas RA, 2011, J CLIN NEUROPHYSIOL, V28, P611, DOI 10.1097/WNP.0b013e31823e96d7; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; TSU VD, 1992, INT J EPIDEMIOL, V21, P941, DOI 10.1093/ije/21.5.941; Vasudevan C, 2013, SEMIN FETAL NEONAT M, V18, P185, DOI 10.1016/j.siny.2013.05.008; Walsh J, 2011, J MATERN-FETAL NEO M, V24, P817, DOI 10.3109/14767058.2010.531313; Weissmann-Brenner A, 2012, ACTA OBSTET GYN SCAN, V91, P844, DOI 10.1111/j.1600-0412.2012.01412.x; World Health Organization, BOD MASS IND BMI	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264117	10.1371/journal.pone.0264117	http://dx.doi.org/10.1371/journal.pone.0264117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176121	Green Published, gold			2022-12-26	WOS:000777505200080
J	Mitsakos, AT; Irish, W; Parikh, AA; Snyder, RA				Mitsakos, Anastasios T.; Irish, William; Parikh, Alexander A.; Snyder, Rebecca A.			The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer	PLOS ONE			English	Article							RACIAL DISPARITIES; ETHNIC DISPARITIES; OUTCOMES; STAGE; IMPROVEMENT; MORTALITY	Background Black patients and underinsured patients with colorectal cancer (CRC) present with more advanced disease and experience worse outcomes. The study aim was to evaluate the interaction of health insurance status and race with treatment and survival in metastatic CRC. Materials and methods Patients diagnosed with metastatic CRC within NCDB from 2006-2016 were included. Primary outcomes included receipt of chemotherapy and 3-year all-cause mortality. Multivariable logistic regression and Cox-regression (MVR) including a two-way interaction term of race and insurance were performed to evaluate the differential association of race and insurance with receipt of chemotherapy and mortality, respectively. Results 128,031 patients were identified; 70.6% White, 14.4% Black, 5.7% Hispanic, and 9.3% Other race. Chemotherapy use was higher among White compared to Black patients. 3year mortality rate was higher for Blacks and lower for Hispanics, in comparison with White patients. By MVR, Black patients were less likely to receive chemotherapy. When stratified by insurance status, Black patients with private and Medicare insurance were less likely to receive chemotherapy than White patients. All-cause mortality was higher in Black patients and lower in Hispanic patients, and these differences persisted after controlling for insurance and receipt of chemotherapy. Conclusion Black patients and uninsured or under-insured patients with metastatic CRC are less likely to receive chemotherapy and have increased mortality. The effect of health insurance among Blacks and Whites differs, however, and improving insurance alone does not appear to fully mitigate racial disparities in treatment and outcomes.	[Mitsakos, Anastasios T.; Parikh, Alexander A.; Snyder, Rebecca A.] East Carolina Univ, Dept Surg, Div Surg Oncol, Brody Sch Med, Greenville, NC 27858 USA; [Irish, William] East Carolina Univ, Dept Surg, Div Surg Res, Brody Sch Med, Greenville, NC 27858 USA; [Irish, William; Snyder, Rebecca A.] East Carolina Univ, Dept Publ Hlth, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Snyder, RA (corresponding author), East Carolina Univ, Dept Surg, Div Surg Oncol, Brody Sch Med, Greenville, NC 27858 USA.; Snyder, RA (corresponding author), East Carolina Univ, Dept Publ Hlth, Brody Sch Med, Greenville, NC 27858 USA.	snyderre19@ecu.edu						Aizer AA, 2014, CANCER-AM CANCER SOC, V120, P1532, DOI 10.1002/cncr.28617; Boffa DJ, 2017, JAMA ONCOL, V3, P1722, DOI 10.1001/jamaoncol.2016.6905; Castleberry AW, 2014, J GASTROINTEST SURG, V18, P1194, DOI 10.1007/s11605-014-2515-3; Coughlin SS, 2020, INT J COLORECTAL DIS, V35, P985, DOI 10.1007/s00384-020-03585-z; Coughlin SS, 2016, J RACIAL ETHN HEALTH, V3, P555, DOI 10.1007/s40615-015-0174-z; Daniel CL, 2017, FRONT BIOSCI-LANDMRK, V22, P465, DOI 10.2741/4495; Ellis L, 2018, J CLIN ONCOL, V36, P25, DOI 10.1200/JCO.2017.74.2049; Emmons KM, 2009, HEALTH AFFAIR, V28, P169, DOI 10.1377/hlthaff.28.1.169; Fitzgerald TL, 2014, RURAL REMOTE HEALTH, V14; Green PM, 2004, CANCER NURS, V27, P206, DOI 10.1097/00002820-200405000-00004; Jackson CS, 2016, J GASTROINTEST ONCOL, V7, pS32, DOI 10.3978/j.issn.2078-6891.2015.039; Jayakrishnan Thejus T, 2020, Cancer Treat Res Commun, V24, P100204, DOI 10.1016/j.ctarc.2020.100204; Lai YZ, 2016, GASTROENTEROLOGY, V150, P1135, DOI 10.1053/j.gastro.2016.01.030; Lau-Min K, 2020, CLIN COLORECTAL CANC, V19, pE49, DOI 10.1016/j.clcc.2019.09.002; Martini G, 2017, WORLD J GASTROENTERO, V23, P4675, DOI 10.3748/wjg.v23.i26.4675; Modest DP, 2019, EUR J CANCER, V109, P70, DOI 10.1016/j.ejca.2018.12.019; Mohan G, 2020, JAMA ONCOL, V6, P1434, DOI 10.1001/jamaoncol.2020.1460; National Cancer Institute, 2019, CANC DISP; Polite BN, 2005, MED CLIN N AM, V89, P771, DOI 10.1016/j.mcna.2005.03.001; Rhoads KF, 2015, J CLIN ONCOL, V33, P854, DOI 10.1200/JCO.2014.56.8642; Robbins AS, 2012, J CLIN ONCOL, V30, P401, DOI 10.1200/JCO.2011.37.5527; Sanoff HK, 2009, J CLIN ONCOL, V27, P4109, DOI 10.1200/JCO.2009.21.9527; Scally BJ, 2018, CANCER CAUSE CONTROL, V29, P527, DOI 10.1007/s10552-018-1027-y; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Simpson DR, 2013, JNCI-J NATL CANCER I, V105, P1814, DOI 10.1093/jnci/djt318; Sineshaw HM, 2018, GASTROENTEROLOGY, V154, P906, DOI 10.1053/j.gastro.2017.11.005; Sineshaw HM, 2014, CANCER CAUSE CONTROL, V25, P419, DOI 10.1007/s10552-014-0344-z; Tammana VS, 2014, WORLD J GASTROENTERO, V20, P869, DOI 10.3748/wjg.v20.i4.869; Tapan U, 2017, CANCER EPIDEMIOL, V49, P30, DOI 10.1016/j.canep.2017.05.003; Tawk R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010048; Thornblade LW, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16019; United States Census Bureau, QUICK FACTS; Vassos N, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0563-8; Wallace K, 2017, CLIN COLORECTAL CANC, V16, P178, DOI 10.1016/j.clcc.2016.11.006	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263818	10.1371/journal.pone.0263818	http://dx.doi.org/10.1371/journal.pone.0263818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176030	Green Published, gold			2022-12-26	WOS:000777505200033
J	Uymaz, P; Uymaz, AO				Uymaz, Pelin; Uymaz, Ali Osman			Assessing acceptance of augmented reality in nursing education	PLOS ONE			English	Article							NEURAL NETWORK APPROACH; INFORMATION-TECHNOLOGY; MANAGEMENT-SYSTEM; COMPUTER ANXIETY; USER ACCEPTANCE; HYBRID SEM; ADOPTION; DETERMINANTS; MODEL; EXTENSION	The Covid-19 pandemic has negatively affected every aspect of human life. In these challenging times nursing students, facing academic and psychological issues, are advised to use augmented reality applications in the field of health sciences for increasing their motivations and academic performances. The main motive of the study was to examine the acceptance status of nursing students in implementing augmented reality technology in their education and training. The study is a quantitative research study, and it uses the causal-comparative screening method. The data used in the study was collected online from 419 nursing students. The hybrid method was preferred. First, the hypotheses based on the linear relationships were defined between the variables which were then tested by the method of structural equation modeling. Second, the method of artificial neural networks was used to determine the non-linear relationships between the variables. The results show that the nursing students have a high intention of using augmented reality technology as a way of self-learning. It was also found that the most emphasized motive behind this intention is the expectation that using augmented reality technology will increase their academic performance. They also think that AR technology has many potential benefits to offer in the future. It was observed that a considerable number of students already use augmented reality technology for its usefulness and with a hedonic motivation. In conclusion, nursing students have a high acceptance of using augmented reality technology during their education and training process. Since we live in a world where e-learning and self-learning education/training have become widespread, it is estimated that students will demand augmented reality applications as a part of holistic education, and as an alternative to traditional textbooks.	[Uymaz, Pelin] Alanya Alaaddin Keykubat Univ, Fac Hlth Sci, Dept Nursing, Antalya, Turkey; [Uymaz, Ali Osman] Alanya Alaaddin Keykubat Univ, Fac Econ Adm & Social Sci, Dept Human Resources Management, Antalya, Turkey; [Uymaz, Pelin] Alanya Alaaddin Keykubat Univ, Fac Hlth Sci, Antalya, Turkey; [Uymaz, Ali Osman] Alanya Alaaddin Keykubat Univ, Fac Econ Adm & Social Sci, Antalya, Turkey	Alanya Alaaddin Keykubat University; Alanya Alaaddin Keykubat University; Alanya Alaaddin Keykubat University; Alanya Alaaddin Keykubat University	Uymaz, AO (corresponding author), Alanya Alaaddin Keykubat Univ, Fac Econ Adm & Social Sci, Dept Human Resources Management, Antalya, Turkey.; Uymaz, AO (corresponding author), Alanya Alaaddin Keykubat Univ, Fac Econ Adm & Social Sci, Antalya, Turkey.	ali.uymaz@alanya.edu.tr		Uymaz, Pelin/0000-0002-3535-6141; UYMAZ, Ali Osman/0000-0002-2572-0085				Acarli DS, 2015, PROCD SOC BEHV, V176, P709, DOI 10.1016/j.sbspro.2015.01.530; Aebersold M, 2018, CLIN SIMUL NURS, V15, P34, DOI 10.1016/j.ecns.2017.09.008; Ain N, 2016, INFORM DEV, V32, P1306, DOI 10.1177/0266666915597546; Akgul Y, APPL ARTIFICIAL NEUR, V2021, P117, DOI [10.4018/978-1-7998-4042-8.ch006, DOI 10.4018/978-1-7998-4042-8.CH006]; Alamaki A, 2021, INT J INF LEARN TECH, V38, P196, DOI 10.1108/IJILT-05-2020-0072; Alsop T., 2021, AUGMENTED REALITY AR; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; Balian S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02205; Baysal AC, 2004, BEHAV SCI, P67; Bernacki ML, 2020, CONTEMP EDUC PSYCHOL, V60, DOI 10.1016/j.cedpsych.2019.101827; Brown J, 2015, CIN COMPUT INFORMATI, V33; Brown SA, 2005, MIS QUART, V29, P399; Chang CY, 2018, COMPUT EDUC, V116, P28, DOI 10.1016/j.compedu.2017.09.001; Chassiakos Y. L. R., 2020, TECHNOLOGY ADOLESCEN, P25; Chiang WYK, 2006, DECIS SUPPORT SYST, V41, P514, DOI 10.1016/j.dss.2004.08.016; Chin WW, 1998, QUANT METH SER, P295; Chong AYL, 2015, INT J PROD ECON, V159, P66, DOI 10.1016/j.ijpe.2014.09.034; Chong AYL, 2013, EXPERT SYST APPL, V40, P1240, DOI 10.1016/j.eswa.2012.08.067; Christensen L. B., 2014, RES METHODS DESIGN A; Cobanoglu C., 2015, HOSPITALITY REV, V31, P1; Cohen J., 2013, S AFR COMPUT J, V50, P43, DOI [10.18489/sacj.v50i1.175, DOI 10.18489/SACJ.V50I1.175]; Cohn Jenae, 2016, Computers and Composition, V42, P80, DOI 10.1016/j.compcom.2016.08.008; Conrad RC, 2021, J PSYCHIATR RES, V136, P117, DOI 10.1016/j.jpsychires.2021.01.054; Council of Higher Education, PROCEDURES PRINCIPLE; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Deng SL, 2011, ONLINE INFORM REV, V35, P789, DOI 10.1108/14684521111176507; Derevensky JL, 2019, PEDIATR CLIN N AM, V66, P1163, DOI 10.1016/j.pcl.2019.08.008; Donmez-Turan Aygul, 2019, Procedia Computer Science, V158, P715, DOI 10.1016/j.procs.2019.09.107; El-Ghandour NMF, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.9.FOCUS20634; Faccio M, 2020, J RISK INSUR, V87, P815, DOI 10.1111/jori.12301; Fan WJ, 2020, ANN OPER RES, V294, P567, DOI 10.1007/s10479-018-2818-y; Fernandez-Garcia C, 2021, ELECTR J INF SYS DEV, V87, DOI 10.1002/isd2.12169; Fernandez-Llamas C, 2018, COMPUT HUM BEHAV, V80, P460, DOI 10.1016/j.chb.2017.09.028; Fidani A, 2012, INVESTIGATING STUDEN; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Hair Jr J. F., 2016, PRIMER PARTIAL LEAST; Harley JM, 2016, ETR&D-EDUC TECH RES, V64, P359, DOI 10.1007/s11423-015-9420-7; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; He ZY, 2018, TOURISM MANAGE, V68, P127, DOI 10.1016/j.tourman.2018.03.003; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Herbert VM, 2021, CLIN SIMUL NURS, V54, P77, DOI 10.1016/j.ecns.2021.02.003; Huang TC, 2016, COMPUT EDUC, V96, P72, DOI 10.1016/j.compedu.2016.02.008; Jahanmir SF, 2018, J BUS RES, V88, P337, DOI 10.1016/j.jbusres.2018.01.058; Jamu JT, 2016, NURSE EDUC PRACT, V19, P107, DOI 10.1016/j.nepr.2016.03.007; Kaur DP., 2020, PROCED COMPUT SCI, V172, P881, DOI [10.1016/j. procs.2020.05.127, DOI 10.1016/J.PROCS.2020.05.127]; Kipper G., 2013, AUGMENTED REALITY EM, V1st; Krishnaraju V, 2013, AMCIS; Lai Chin-Yuan, 2016, Comput Inform Nurs, V34, P535; Lee VH, 2020, EXPERT SYST APPL, V157, DOI 10.1016/j.eswa.2020.113477; LESO T, 1992, J EDUC COMPUT RES, V8, P469, DOI 10.2190/Q1TJ-8JCU-LDAP-84H8; Lew SS, 2020, TECHNOL SOC, V63, DOI 10.1016/j.techsoc.2020.101430; Lewis C.C., 2013, INT J HIGHER ED, V2, P22, DOI [10.5430/ijhe.v2n2p22, DOI 10.5430/IJHE.V2N2P22]; Liebana-Cabanillas F, 2017, INT J INFORM MANAGE, V37, P14, DOI 10.1016/j.ijinfomgt.2016.10.008; Mendez KJW, 2020, NURS EDUC TODAY, V93, DOI 10.1016/j.nedt.2020.104531; MILGRAM P, 1994, IEICE T INF SYST, VE77D, P1321; Nguyen N, 2018, INT J EDUC TECHNOL H, V15, DOI 10.1186/s41239-018-0118-x; Parady G., 2020, TRANSPORTATION RES I, V7, DOI [10.1016/j.trip.2020.100181, DOI 10.1016/J.TRIP.2020.100181]; Park B, 2017, SOC COGN AFFECT NEUR, V12, P1083, DOI 10.1093/scan/nsx047; Paulo RM, 2021, MATH ENTHUS, V18, P641; Priyadarshinee P, 2017, COMPUT HUM BEHAV, V76, P341, DOI 10.1016/j.chb.2017.07.027; Radwan E, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05807; Raman A., 2013, INT ED STUDIES, V6, P157, DOI [10.5539/ies.v6n7p157, DOI 10.5539/IES.V6N7P157]; Saade RG, 2009, J INF TECHNOL EDUC-R, V8, P177; Sadiq R, 2019, NRIAGU JBT E EH, VSecond, P324, DOI [10.1016/B978-0-12-409548-9.11193-5, DOI 10.1016/B978-0-12-409548-9.11193-5]; Samaha M, 2016, COMPUT HUM BEHAV, V57, P321, DOI 10.1016/j.chb.2015.12.045; Sharma SK, 2019, INFORM SYST FRONT, V21, P815, DOI 10.1007/s10796-017-9775-x; Sharma SK, 2019, INFORM SYST MANAGE, V36, P243, DOI 10.1080/10580530.2019.1620504; Shorey S, 2021, NURS EDUC TODAY, V98, DOI 10.1016/j.nedt.2020.104662; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Maldonado UPT, 2011, ONLINE INFORM REV, V35, P66, DOI 10.1108/14684521111113597; Tsai HT, 2014, ANTHROPOLOGIST, V17, P845, DOI 10.1080/09720073.2014.11891499; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2012, MIS QUART, V36, P157; Wazirali R, 2021, COMPUT SYST SCI ENG, V36, P339, DOI 10.32604/csse.2021.014301; Wu Po-Han, 2011, Nurse Educ Today, V31, pe8, DOI 10.1016/j.nedt.2010.12.001; Wu TT, 2014, CIN-COMPUT INFORM NU, V32, P497, DOI 10.1097/CIN.0000000000000089; Yale School of Nursing, 2019, YALE NURSING MATTERS; Yoke SK, 2019, INT J ED, V4, P13, DOI [10.35631/IJEPC.433002, DOI 10.35631/IJEPC.433002]; Yuen S. C. Y., 2011, J ED TECHNOLOGY DEV, V4, P11; Zhu ZX, 2018, INFORM HEALTH SOC CA, V43, P22, DOI 10.1080/17538157.2016.1255631	82	2	2	14	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263937	10.1371/journal.pone.0263937	http://dx.doi.org/10.1371/journal.pone.0263937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176073	Green Published, gold			2022-12-26	WOS:000777505200050
J	Younas, H; Ijaz, T; Choudhry, N				Younas, Hooria; Ijaz, Tahira; Choudhry, Nakhshab			Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population	PLOS ONE			English	Article							ACE2; ASSOCIATION; SYSTEM; ANGIOTENSIN-I-CONVERTING-ENZYME-2; HYPERTENSION; DISEASE; HAN	Background Type 2 diabetes mellitus is a multifactorial disease that escalates the risk of other associated complications such as diabetic neuropathy, retinopathy, and nephropathy. Diabetic nephropathy is a microvascular condition that leads to end-stage renal disease (ESRD). There are several genes involved in disease development and it is a challenging task to investigate all of these. Nonetheless, identifying individual gene roles can assist in evaluating the combinatorial effects with other genes. Angiotensin-1 converting enzyme 2 (ACE2), is the key regulator of blood pressure in the Renin-Angiotensin-Aldosterone System that hydrolyzes angiotensin II (vasoconstrictor) into angiotensin 1-7 (vasodilator). The association of different variants of the ACE2 with the risk of type 2 diabetes mellitus has been determined in various populations with susceptibility to other complications. This study was aimed to investigate the association of Angiotensin-1 converting enzyme 2 polymorphism, G8790A, with the increased risk of type 2 diabetes mellitus (T2DM) development with the complication of diabetic nephropathy (DN) in the Pakistani population. Methods In this case-control study, a total of 100 healthy controls and 100 patients of type 2 diabetes mellitus aged > 40 years, having disease duration >= 10 years were compared. The G8790A polymorphism in ACE2 was analyzed by allele-specific polymerase chain reaction (AS-PCR). The urinary albumin excretion (UAE), urinary creatinine, and albumin to creatinine ratios (ACR) were determined to assess renal function status. Pearson bivariate correlation coefficients were calculated to investigate the relationship among all the parameters. Crude and adjusted odds ratios were found to determine any risk association between ACE2 G8790A polymorphisms and disease development. The p-values < 0.05 were considered significant. Results A homogeneity was obtained regarding the distribution of data by sex, BMI, diastolic blood pressure, pulse rate and urinary creatinine levels between case and control groups. The ACR showed a significant correlation with UAE (r = 0.524, p = 0.001), urinary creatinine (r = -0.375, p = 0.001) and random blood sugar levels (r = 0.323, p = 0.005) with the complication of diabetic nephropathy in T2DM patient. Females with the AA genotype had a 10-fold increased risk for the development of type 2 Diabetes (OR = 9.5 [95% CI = 2.00-21.63] p< 0.002). Males having A allele showed a significant association for susceptibility of type 2 Diabetes (OR = 3.807 [95% CI = 1.657-8.747] p< 0.002). However, none of the genotypes or alleles revealed an association for diabetic nephropathy in male and female patients. Urinary ACR was also found to be positively correlated with UAE (r = 0.642 p = 0.001 & 0.524, p = 0.001) and random blood sugar levels (r = 0.302, p = 0.002 & r = 0.323, p = 0.005) in T2DM and T2DM+DN groups, respectively. Conclusion The study finding indicated that female AG/AA genotype and male A genotype of G8790A polymorphism in the ACE2 gene were associated with type 2 diabetes mellitus as a genetic risk factor but are not associated with diabetic nephropathy in the Pakistani population.	[Younas, Hooria; Ijaz, Tahira] Kinnaird Coll Women, Dept Biochem, Lahore, Punjab, Pakistan; [Choudhry, Nakhshab] King Edward Med Univ, Dept Biochem, Lahore, Punjab, Pakistan		Younas, H (corresponding author), Kinnaird Coll Women, Dept Biochem, Lahore, Punjab, Pakistan.	hooria.younas@kinnaird.edu.pk		Younas, Hooria/0000-0002-1533-7680				Batlle D, 2010, DIABETES, V59, P2994, DOI 10.2337/db10-1205; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chaoxin J, 2013, EUR REV MED PHARMACO, V17, P2654; Chawla T, 2010, WORLD J DIABETES, V1, P141, DOI 10.4239/wjd.v1.i5.141; Currie D, 2010, DIABETIC MED, V27, P1188, DOI 10.1111/j.1464-5491.2010.03097.x; Devaux CA, 2020, J MICROBIOL IMMUNOL, V53, P425, DOI 10.1016/j.jmii.2020.04.015; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Firouzabadi N, 2022, ACTA NEUROPSYCHIATR, V34, P30, DOI 10.1017/neu.2021.32; Frojdo S, 2005, DIABETOLOGIA, V48, P2278, DOI 10.1007/s00125-005-1955-4; Gintoni I, 2021, ANTICANCER RES, V41, P4021, DOI 10.21873/anticanres.15201; Gomez J, 2020, GENE, V762, DOI 10.1016/j.gene.2020.145102; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Idowu Ademola A, 2017, Ghana Med J, V51, P56; Ingelfinger JR, 2006, J AM SOC NEPHROL, V17, P2957, DOI 10.1681/ASN.2006090986; Li YY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00364; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; [孟晶茜 Meng Jingqian], 2018, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V23, P661; Patel SK, 2012, AM J HYPERTENS, V25, P216, DOI 10.1038/ajh.2011.188; Patnaik M, 2014, ANN HUM BIOL, V41, P143, DOI 10.3109/03014460.2013.837195; Pinheiro DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221248; Rahimi Z, 2016, CAN J DIABETES, V40, P178, DOI 10.1016/j.jcjd.2015.08.016; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Soler MJ, 2008, EXP PHYSIOL, V93, P549, DOI 10.1113/expphysiol.2007.041350; UGOZZOLI L, 1992, GENOMICS, V12, P670, DOI 10.1016/0888-7543(92)90292-Z; Wang G, 2009, AM J NEPHROL, V29, P524, DOI 10.1159/000185629; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wu YH, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22033; Wysocki J, 2006, DIABETES, V55, P2132, DOI 10.2337/db06-0033; Yan Quan-nang, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1365; Yang W, 2006, CLIN SCI, V111, P333, DOI 10.1042/CS20060020; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264038	10.1371/journal.pone.0264038	http://dx.doi.org/10.1371/journal.pone.0264038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176079	gold, Green Published			2022-12-26	WOS:000777505200068
J	Fournier, A; Laurent, A; Lheureux, F; Ribeiro-Marthoud, MA; Ecarnot, F; Binquet, C; Quenot, JP				Fournier, Alicia; Laurent, Alexandra; Lheureux, Florent; Ribeiro-Marthoud, Marie Adele; Ecarnot, Fiona; Binquet, Christine; Quenot, Jean-Pierre			Impact of the COVID-19 pandemic on the mental health of professionals in 77 hospitals in France	PLOS ONE			English	Article							EMOTION REGULATION STRATEGIES; PERITRAUMATIC DISTRESS; QUESTIONNAIRE GHQ-12; COPING STRATEGIES; SCALE; POPULATION; RESILIENCE; VALIDATION; DEPRESSION; SYMPTOMS	The COVID-19 pandemic has led to significant re-organisation of healthcare delivery in hospitals, with repercussions on all professionals working in healthcare. We aimed to assess the impact of the pandemic on the mental health of professionals working in health care institutions and to identify individual and environmental factors influencing the risk of mental health disorders. From 4 June to 22 September 2020, a total of 4370 professionals responded to an online questionnaire evaluating psychological distress, severity of post-traumatic stress symptoms, stress factors, and coping strategies. About 57% of the professionals suffered from psychological distress, and 21% showed symptoms of potential post-traumatic stress. Professionals working in radiology, those working in quality/hygiene/security and nurses' aides were the most affected groups. The media focus on the crisis, and a high workload were the most prevalent stress factors, followed by uncertainty regarding the possibility of containing the epidemic, the constantly changing hygiene recommendations/protocols, and the lack of personal protective equipment. The use of coping strategies, notably positive thinking, helped to mitigate the relation between perceived stress and mental health disorders. The COVID-19 pandemic has had far-reaching negative repercussions for all professionals, with some sectors more markedly affected. To prevent mental health disorders in professionals during a public health crisis, support services and management strategies within hospitals should take account of the importance of positive thinking and social support.	[Fournier, Alicia; Laurent, Alexandra] Univ Bourgogne Franche Comte, Lab Psychol Dynam Relat & Proc Identitaires PsyDR, Dijon, France; [Laurent, Alexandra] CHU Francois Mitterrand, Dept Anesthesie & Med Chirurg, Dijon, France; [Lheureux, Florent] Univ Burgundy Franche Comte, Psychol Lab, Besancon, France; [Ribeiro-Marthoud, Marie Adele] Ctr Hosp Univ Dijon Bourgogne, Direct Soins, Dijon, France; [Ecarnot, Fiona] Univ Hosp Besancon, Dept Cardiol, Besancon, France; [Ecarnot, Fiona] Univ Burgundy Franche Comte, EA3920, Besancon, France; [Binquet, Christine] INSERM, CIC1432, Module Epidemiol Clin, Dijon, France; [Binquet, Christine] CHU Dijon Bourgogne, Ctr Invest Clin Epidemiol Clin, Essais Clin, Dijon, France; [Quenot, Jean-Pierre] CHU Dijon Bourgogne, Serv Med Intens Reanimat, Dijon, France; [Quenot, Jean-Pierre] Univ Bourgogne Franche Comte, Ctr Rech, Lipness, UMR1231 Lipides Nutr Canc,INSERM,Equipe Lipness, Dijon, France; [Quenot, Jean-Pierre] FCS Bourgogne Franche Comte, LipST LabEx, Dijon, France; [Quenot, Jean-Pierre] Espace Reflex Eth Bourgogne Franche Comte EREBFC, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Fournier, A (corresponding author), Univ Bourgogne Franche Comte, Lab Psychol Dynam Relat & Proc Identitaires PsyDR, Dijon, France.	alicia.fournier@u-bourgone.fr	Binquet, Christine/E-8953-2018; Lheureux, Florent/Y-6001-2019	Binquet, Christine/0000-0002-9417-5754; Lheureux, Florent/0000-0002-1740-0356; Laurent, Alexandra/0000-0002-8982-1803; Fournier, Alicia/0000-0003-3637-5982; Ecarnot, Fiona/0000-0002-4224-9731	French Ministry for Health	French Ministry for Health	Supported in part by funds from J-P. Quenot provided through the French Ministry for Health, who partially funded this study through the national programme for hospital research (Programme Hospitalier de Recherche Clinique National, PHRC-COVID 2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the French Ministry for Health, who funded this study through the national programme for hospital research (Programme Hospitalier de Recherche Clinique National, PHRC-COVID 2019). There was no additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Association nationale pour la formation permanente du personnel hospitalier (ANFH), 2017, CART MTIERS, P919; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Axelsson E, 2020, JAMA PSYCHIAT, V77, P915, DOI 10.1001/jamapsychiatry.2020.0940; Azoulay E, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00722-3; Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumstarck K, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0581-9; Beck AT, 2016, BEHAV THER, V47, P776, DOI 10.1016/j.beth.2016.11.003; Brunet A, 2003, CAN J PSYCHIAT, V48, P56, DOI 10.1177/070674370304800111; Caillet A, 2020, ANAESTH CRIT CARE PA, V39, P717, DOI 10.1016/j.accpm.2020.08.006; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; da Silva Neto Raimundo Monteiro, 2021, Prog Neuropsychopharmacol Biol Psychiatry, V104, P110062, DOI 10.1016/j.pnpbp.2020.110062; Dean DJ, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113593; Demartini B, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.561345; Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791; Elovanio M, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.112973; Erku DA, 2021, RES SOC ADMIN PHARM, V17, P1954, DOI 10.1016/j.sapharm.2020.04.032; Fdration hospitalire de France, NOUV MOD REC TLTRAV; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 2010, OXFORD HDB STRESS HL, DOI [10.1093/oxfordhb/9780195375343.001.0001, DOI 10.1093/OXFORDHB/9780195375343.001.0001]; Fournier A., 2021, M DECINE INTENSIVE R, V30, DOI [10.37051/mir-00038, DOI 10.37051/MIR-00038]; Galbraith Niall, 2021, BJPsych Bull, V45, P93, DOI 10.1192/bjb.2020.44; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-7; Garnefski N, 2002, EUR J PERSONALITY, V16, P403, DOI 10.1002/per.458; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gregory J, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2058-y; Haute Autorit de Sant (HAS), TOUS TRAV HASCOVID 1; Hummel S., 2021, CROSS SECTIONAL SURV, V23, pe24983, DOI [10.2196/24983, DOI 10.2196/24983]; Jamieson JP, 2012, J EXP PSYCHOL GEN, V141, P417, DOI 10.1037/a0025719; Kato T., 2013, INT PERSPECTIVEPSY, V2, P100, DOI [10.1037/ipp0000002, DOI 10.1037/IPP0000002]; Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303; Lahav Y, 2020, J AFFECT DISORDERS, V277, P129, DOI 10.1016/j.jad.2020.07.141; Laurent A., 2021, MED INTENSIVE REANIM, V30, P69, DOI 10.37051/mir-00075; Laurent A, 2022, EUR J PSYCHOTRAUMATO, V13, DOI 10.1080/20008198.2021.2011603; Laurent A, 2021, ANN INTENSIVE CARE, V11, DOI 10.1186/s13613-021-00880-y; Leaune E, 2021, EARLY INTERV PSYCHIA, V15, P149, DOI 10.1111/eip.12923; Lee SH, 2005, GEN HOSP PSYCHIAT, V27, P352, DOI 10.1016/j.genhosppsych.2005.04.007; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Maciaszek J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082527; Marvaldi M, 2021, NEUROSCI BIOBEHAV R, V126, P252, DOI 10.1016/j.neubiorev.2021.03.024; Megalakaki O, 2021, J PSYCHIATR RES, V137, P81, DOI 10.1016/j.jpsychires.2021.02.035; Mehta S, 2021, LANCET RESP MED, V9, P226, DOI 10.1016/S2213-2600(21)00068-0; Merecz D, 2012, INT J OCCUP MED ENV, V25, P166, DOI 10.2478/S13382-012-0020-z; Muller L, 2003, ENCEPHALE, V29, P507; Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009; Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116; Ogundipe OA, 2014, ASIAN J PSYCHIATR, V10, P27, DOI 10.1016/j.ajp.2014.02.010; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Santabarbara J, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2021.110244; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Skoda EM, 2020, J PUBLIC HEALTH-UK, V42, P688, DOI 10.1093/pubmed/fdaa124; Sordes F, 2021, EUR J TRAUMA DISSOC, V5, DOI 10.1016/j.ejtd.2020.100189; Spijkerman MPJ, 2016, CLIN PSYCHOL REV, V45, P102, DOI 10.1016/j.cpr.2016.03.009; Sun P, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.626547; Veer IM, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01150-4; Weiss Daniel S., 1997, P399; World Health Organization, MAN COVID 19 INF PRO; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Xu C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00858; Yu H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02826-3; Zamarro G, 2021, REV ECON HOUSEHOLD, V19, P11, DOI 10.1007/s11150-020-09534-7; Zandifar A, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.101990	67	6	6	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263666	10.1371/journal.pone.0263666	http://dx.doi.org/10.1371/journal.pone.0263666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171915	Green Published, gold			2022-12-26	WOS:000795889700032
J	Uwimana, P; Mukamana, D; Babenko-Mould, Y; Adejumo, O				Uwimana, Philomene; Mukamana, Donatilla; Babenko-Mould, Yolanda; Adejumo, Oluyinka			Exploring factors affecting the facilitation of nursing students to learn paediatric pain management in Rwanda: A descriptive qualitative study	PLOS ONE			English	Article							PERCEIVED CHALLENGES; EDUCATION; CHILDREN	Nurse educators and nurse preceptors play a fundamental role in facilitating nursing students' acquisition and utilization of professional competencies. Previous studies about key elements for teaching and learning about pain in nursing education programs include students' personal characteristics and previous experiences; educators' knowledge, skills, and beliefs; learners' exposure to leaders in pain education; and curricular pain content and delivery approaches. These studies were mainly carried out in developed countries, with a context of educational and health care systems different from those of developing countries. The current study explores academics', clinical nurse preceptors', and nursing students' perceptions about factors influencing the facilitation of nursing students' competency for paediatric pain management in Rwanda. A qualitative descriptive exploratory design was used in this study that utilized in-depth interviews with six nurse educators and eight nurse preceptors, and focus group discussions with nineteen senior year nursing students. The study setting included five sites: two academic institutions and three clinical settings. Narratives from participants were transcribed verbatim and analysed using thematic analysis. The analysis yielded six themes describing factors that affected the facilitation of students' learning about paediatric pain management. The themes included student motivation, facilitators' attributes, collaboration between academics and clinicians, nurses' limited autonomy for decision-making regarding PPM practices, shortage of human and material resources, and educational qualification. Knowing these factors is essential as it provides an opportunity to design targeted interventions aimed to enhance the capacity of nurse educators and clinical nurse preceptors involved in teaching nursing students about paediatric pain management.	[Uwimana, Philomene; Mukamana, Donatilla; Adejumo, Oluyinka] Univ Rwanda, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Kigali, Rwanda; [Babenko-Mould, Yolanda] Western Univ, Fac Hlth Sci, Arthur Labatt Family Sch Nursing, London, ON, Canada	University of Rwanda; Western University (University of Western Ontario)	Uwimana, P (corresponding author), Univ Rwanda, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Kigali, Rwanda.	philouwim@gmail.com			Global Affairs Canada	Global Affairs Canada(CGIAR)	The Training Support Access Model (TSAM/MNCH) for Rwanda (https://tsam.uwo.ca/), a Western University project funded by Global Affairs Canada, financially supported the study data collection related expenses. There was no involvement of funders in designing the study protocol, data collection and analysis, or in writing the manuscript.	Alreshidi N., 2016, IMPACT INTERACTIVE E; Amponsah AK., 2020, PAIN RES MANAG, V2020, P1; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Bawa Monika, 2015, J Pain Palliat Care Pharmacother, V29, P353, DOI 10.3109/15360288.2015.1082010; Bengtsson M, 2010, NURS EDUC TODAY, V30, P150, DOI 10.1016/j.nedt.2009.07.005; Birnie KA, 2014, PAIN RES MANAG, V19, P198, DOI 10.1155/2014/614784; Bradshaw C, 2017, EMPLOYING QUALITATIV; Brant JM, 2017, PAIN MANAG NURS, V18, P214, DOI 10.1016/j.pmn.2017.04.003; Cederbaum J, 2009, J NURS EDUC, V48, P422, DOI 10.3928/01484834-20090518-01; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Cousins MJ, 2011, PAIN, V152, P2673, DOI 10.1016/j.pain.2011.09.012; DeJonckheere M, 2019, FAM MED COMMUNITY HE, V7, DOI 10.1136/fmch-2018-000057; Dev MDB, 2020, NURS HEALTH SCI, V22, P1131, DOI 10.1111/nhs.12782; Doyle L, 2020, J RES NURS, V25, P443, DOI 10.1177/1744987119880234; Drasiku A, 2021, BMC NURS, V20, DOI 10.1186/s12912-020-00528-5; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Friedrichsdorf SJ, 2016, CHILDREN-BASEL, V3, DOI 10.3390/children3040042; Friedrichsdorf Stefan J, 2015, Hosp Pediatr, V5, P18, DOI 10.1542/hpeds.2014-0084; Fusch PI, 2015, QUAL REP, V20, P1408; Gadallah MA, 2017, J NURS ED PRACT, V7, P100, DOI [10.5430/jnep.v7n6p100, DOI 10.5430/JNEP.V7N6P100]; Gordon DB, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000663; Guba E., 1989, 4 GENERATION EVALUAT; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Harerimana A., 2015, BR J MED HEAL RSEARC, V2, P1; International Association for the Study of Pain, 2018, CURR OUTL PAIN NURS; Jones MP, 2015, J NURS ED PRACT, V5, P19; Kahsay H., 2017, CURR PEDIAT RES, V21, P148; Kholowa ET., 2017, J BIOSCI MED, V5, P46; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Liossi C, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0331; Mediani HS, 2017, J CHILD HEALTH CARE, V21, P273, DOI 10.1177/1367493517715146; Mukamana D., 2015, RWANDA J SER F MED H, V2, P9; Mwale OG, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0153-7; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; NOWELL L, 2017, INT J QUAL METH, V16, P1, DOI [DOI 10.1177/1609406917733847, 10.1177/1609406917733847]; Nyumba TO, 2018, METHODS ECOL EVOL, V9, P20, DOI 10.1111/2041-210X.12860; Phuma-Ngaiyaye E, 2017, Int J Nurs Sci, V4, P164, DOI 10.1016/j.ijnss.2017.03.001; Polit D.F., 2017, RESOURCE MANUAL NURS; Rhodes M., 2011, ONLINE J ISSUES NURS, V16; Roberts K, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0707-y; Rwanda Law Reform Commision, 2012, OFFICIAL GAZETT 0409, P1; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Scanlan CL., 2020, PREPARING UNANTICIPA; Thompson K, 2018, PAIN, V159, P2146, DOI 10.1097/j.pain.0000000000001352; Uwimana P., 2020, J NURS ED PRACT, V10, P21; Watt-Watson J, 2013, PAIN MANAG, V3, P351, DOI [10.2217/pmt.13.39, 10.2217/PMT.13.39]; Yang CI, 2018, JPN J NURS SCI, V15, P50, DOI 10.1111/jjns.12167; Younas A, 2019, NURS EDUC TODAY, V81, P39, DOI 10.1016/j.nedt.2019.07.002; Zamawe FC, 2015, MALAWI MED J, V27, P13, DOI 10.4314/mmj.v27i1.4	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263609	10.1371/journal.pone.0263609	http://dx.doi.org/10.1371/journal.pone.0263609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171933	gold, Green Published			2022-12-26	WOS:000795889700030
J	Saposnik, G; Diaz-Abos, P; Sanchez-Menendez, V; Alvarez, C; Terzaghi, M; Maurino, J; Branas-Pampillon, M; Malaga, I				Saposnik, Gustavo; Diaz-Abos, Paola; Sanchez-Menendez, Victoria; Alvarez, Carmen; Terzaghi, Maria; Maurino, Jorge; Branas-Pampillon, Maria; Malaga, Ignacio			Therapeutic decisions under uncertainty for spinal muscular atrophy: The DECISIONS-SMA study protocol	PLOS ONE			English	Article							PHYSICIANS REACTIONS; CARE; MANAGEMENT; DIAGNOSIS; HEALTH; RISK	Background The therapeutic landscape for spinal muscular atrophy has changed in the last few years, encompassing respiratory/motor function and life expectancy benefits. However, physicians still have the challenge of tailoring individuals' treatment to therapeutic goals, disease progression, patient/caregiver's preferences, and personal experience to achieve an optimal risk/benefit balance. This study aims to provide insight into the preferred treatment choices of pediatric neurologists managing spinal muscular atrophy in their daily practice and to recognize behavioral factors that may influence decision-making. Methods This is a noninterventional, cross-sectional pilot study involving 50 pediatric neurologists managing spinal muscular atrophy in Spain. We designed an online platform that contains 13 simulated case scenarios of common presentations of patients with spinal muscular atrophy. The primary study outcome will be treatment preferences according to the percentages of participants who select treatment initiation when recommended, switch therapies when there is evidence of disease progression, and select treatment discontinuation when disease progression puts patients outside treatment recommendation (11 case scenarios). Secondary outcomes include therapeutic inertia prevalence (11 case scenarios), herding phenomenon prevalence (2 case scenarios), care-related regret prevalence (specific questions) and intensity (10-item Regret Intensity Scale), occupational burnout prevalence (nonproprietary single-item measure), and risk preferences (uncertainty test and risk aversion assessment). Conclusions The study findings will contribute to better understand relevant factors associated with therapeutic decisions of pediatric neurologists in spinal muscular atrophy, identifying treatment preferences and evaluating the role of behavioral aspects such as therapeutic inertia, herding, regret, and workplace burnout.	[Saposnik, Gustavo; Terzaghi, Maria] NeuroEconSolut Neuroeconsolutions Com, Toronto, ON, Canada; [Saposnik, Gustavo; Terzaghi, Maria] Univ Toronto, Li Ka Shing Inst, Clin Outcomes & Decis Neurosci Unit, Toronto, ON, Canada; [Saposnik, Gustavo] Univ Toronto, Dept Med, Div Neurol, St Michaels Hosp, Toronto, ON, Canada; [Diaz-Abos, Paola; Sanchez-Menendez, Victoria; Alvarez, Carmen; Maurino, Jorge; Branas-Pampillon, Maria] Roche Farma, Med Dept, Madrid, Spain; [Malaga, Ignacio] Hosp Univ Cent Asturias, Dept Pediat Neurol, Oviedo, Spain	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Central University Hospital Asturias	Diaz-Abos, P (corresponding author), Roche Farma, Med Dept, Madrid, Spain.	paola.diaz_abos@roche.com	Saposnik, Gustavo/M-3937-2017	Saposnik, Gustavo/0000-0002-5950-9886; Maurino, Jorge/0000-0001-9858-3555; Malaga, Ignacio/0000-0003-4074-6870	Roche Medical Department, Spain [SL42765]	Roche Medical Department, Spain	The study was funded by Roche Medical Department, Spain (SL42765). The funding source had no role in the design, analysis and interpretation of the data, review or approval of the manuscript, and decision to submit for publication.	Annoussamy M, 2021, ANN CLIN TRANSL NEUR, V8, P359, DOI 10.1002/acn3.51281; Beernaert K, 2019, J CHILD NEUROL, V34, P210, DOI 10.1177/0883073818822900; Belter L, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01498-2; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Courvoisier DS, 2013, MED CARE, V51, P285, DOI 10.1097/MLR.0b013e318280f02c; Cruz R, 2019, CLIN THER, V41, P943, DOI 10.1016/j.clinthera.2019.03.012; Cunningham BA, 2014, MED CARE, V52, P728, DOI 10.1097/MLR.0000000000000157; Cusco I, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000530; Djulbegovic M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134038; Dolan ED, 2015, J GEN INTERN MED, V30, P582, DOI 10.1007/s11606-014-3112-6; Dyrbye LN, 2020, J GEN INTERN MED, V35, P1465, DOI 10.1007/s11606-019-05376-x; Finkel RS, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00783; Finkel RS, 2018, NEUROMUSCULAR DISORD, V28, P197, DOI 10.1016/j.nmd.2017.11.004; GERRITY MS, 1990, MED CARE, V28, P724, DOI 10.1097/00005650-199008000-00005; Gerrity MS, 1995, MOTIV EMOTION, V19, P175, DOI 10.1007/BF02250510; Glascock J, 2020, J NEUROMUSCULAR DIS, V7, P97, DOI 10.3233/JND-190468; Kirschner J, 2020, EUR J PAEDIATR NEURO, V28, P38, DOI 10.1016/j.ejpn.2020.07.001; Kolb SJ, 2015, NEUROL CLIN, V33, P831, DOI 10.1016/j.ncl.2015.07.004; Landfeldt E, 2019, EUR J PAEDIATR NEURO, V23, P347, DOI 10.1016/j.ejpn.2019.03.004; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Madruga-Garrido M, 2021, NEUROL THER, V10, P361, DOI 10.1007/s40120-020-00229-w; Mercuri E, 2018, NEUROMUSCULAR DISORD, V28, P103, DOI 10.1016/j.nmd.2017.11.005; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P126, DOI 10.1016/j.nmd.2015.10.006; Messina S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072222; Messina S, 2019, NEUROMUSCULAR DISORD, V29, P940, DOI 10.1016/j.nmd.2019.10.001; Michelson D, 2018, NEUROLOGY, V91, P923, DOI 10.1212/WNL.0000000000006502; Monnette A, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-020-01667-3; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Pechmann A, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-0998-4; Rice T, 2013, ANNU REV PUBL HEALTH, V34, P431, DOI 10.1146/annurev-publhealth-031912-114353; Rouault F, 2017, NEUROMUSCULAR DISORD, V27, P428, DOI 10.1016/j.nmd.2017.01.018; Saposnik Gustavo, 2018, Front Neurol, V9, P174, DOI 10.3389/fneur.2018.00174; Saposnik G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00065; Saposnik G, 2017, PATIENT PREFER ADHER, V11, P175, DOI 10.2147/PPA.S124192; Saposnik G, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0577-4; Scheepers R, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038466; Schorling DC, 2020, J NEUROMUSCULAR DIS, V7, P1, DOI 10.3233/JND-190424; Slayter J, 2021, J NEUROMUSCULAR DIS, V8, P579, DOI 10.3233/JND-200617; Terzaghi MA, 2020, MULT SCLER RELAT DIS, V39, DOI 10.1016/j.msard.2019.101887; van Kruijsbergen M, 2021, DEV MED CHILD NEUROL, V63, P816, DOI 10.1111/dmcn.14825; Verhaart IEC, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0671-8; Waldrop MA, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0568-z	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264006	10.1371/journal.pone.0264006	http://dx.doi.org/10.1371/journal.pone.0264006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167619	Green Published, gold			2022-12-26	WOS:000802227200032
J	Su, SD; Zhu, TF; Su, J; Li, J; Zhao, Q; Kang, XY; Zheng, RH				Su, Shunde; Zhu, Tengfei; Su, Jun; Li, Jian; Zhao, Qing; Kang, Xiangyang; Zheng, Renhua			Transcriptome analysis of gibberellins and abscisic acid during the flooding response in Fokienia hodginsii	PLOS ONE			English	Article							MEDIATES CROSSTALK; SUBMERGENCE; STRESS; RICE; ADAPTATION; ELONGATION; TOLERANCE	Flooding is one of the main abiotic stresses suffered by plants. Plants respond to flooding stress through regulating their morphological structure, endogenous hormone biosynthesis, and genetic signaling transduction. We previously found that Fokienia hodginsii varieties originating from Gutian exhibited typical flooding tolerance traits compared to three other provenances (Yongzhou, Sanming, Nanping), expressed as increased height, longer diameter at breast height (DBH), and smaller branch angle. Herein, the changes in endogenous gibberellins (GA) and abscisic acid (ABA) contents were measured under flooding stress in F. hodginsii, and ABA was found to decrease, whereas GA increased with time. Furthermore, the GA and ABA contents of the varieties originating from Gutian and the three other provenances were measured, and the results indicated that F. hodginsii from Gutian could respond more rapidly to flooding stress. The transcriptomes of the varieties originating from Gutian and the other three provenances were compared using RNA sequencing to explore the underlying genetic mechanisms of the flood-resistant phenotypes in F. hodginsii. The results indicated that two flood-stress response genes (TRINITY_DN142_c0_g2 and TRINITY_DN7657_c0_g1) were highly related to both the ABA and GA response in F. hodginsii.	[Su, Shunde; Kang, Xiangyang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Natl Engn Lab Tree Breeding,Minist Educ,Key Lab G, Beijing, Peoples R China; [Su, Shunde; Zheng, Renhua] Key Lab Forest Culture & Forest Prod Proc Utiliza, Key Lab Timber Forest Breeding & Cultivat Mt Area, Fuzhou, Peoples R China; [Zhu, Tengfei; Su, Jun] Fujian Agr & Forestry Univ, Coll Forestry, Basic Forestry & Prote Res Ctr, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Fuzhou, Peoples R China; [Li, Jian; Zhao, Qing] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China	Beijing Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Kang, XY (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Natl Engn Lab Tree Breeding,Minist Educ,Key Lab G, Beijing, Peoples R China.; Zheng, RH (corresponding author), Key Lab Forest Culture & Forest Prod Proc Utiliza, Key Lab Timber Forest Breeding & Cultivat Mt Area, Fuzhou, Peoples R China.	kangxy@bjfu.edu.cn; zrh08@126.com		Zhu, Tengfei/0000-0002-9826-4738	Department of Human Resources and Social Security of Fujian Province; Department of Science and Technology of Fujian Province [2021R1010004]	Department of Human Resources and Social Security of Fujian Province; Department of Science and Technology of Fujian Province	the "Eagle Program" of Fujian Province, funded by the Department of Human Resources and Social Security of Fujian Province; 2. the "Fujian Cypress Generation 1 Core Breeding Population Construction Research" (No. 2021R1010004), funded by the Department of Science and Technology of Fujian Province. Role played by the funder in the research: is the one who sets the direction of the research and provides financial support. No author receives a salary from the research project, all funds are used for research.	Alpuerto JB, 2016, PLANT CELL ENVIRON, V39, P672, DOI 10.1111/pce.12661; Arif Y, 2020, ENVIRON EXP BOT, V175, DOI 10.1016/j.envexpbot.2020.104040; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Bashar KK, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020043; Benschop JJ, 2006, PLANT PHYSIOL, V141, P1644, DOI 10.1104/pp.106.082636; Carvalho RF, 2011, J INTEGR PLANT BIOL, V53, P920, DOI 10.1111/j.1744-7909.2011.01081.x; Chang SJ, 2009, MOL BIOL REP, V36, P2165, DOI 10.1007/s11033-008-9430-1; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Ding MY, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1600152; Else MA, 2009, ANN BOT-LONDON, V103, P313, DOI 10.1093/aob/mcn208; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gonzalez-Guzman M, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.661789; Hartman S, 2021, NEW PHYTOL, V229, P64, DOI 10.1111/nph.16378; Hartman S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12045-4; Hayat Q, 2010, ENVIRON EXP BOT, V68, P14, DOI 10.1016/j.envexpbot.2009.08.005; He F, 2018, PLANT BIOTECHNOL J, V16, P1514, DOI 10.1111/pbi.12893; He JN, 2012, PLANT CELL, V24, P1815, DOI 10.1105/tpc.112.098707; Hu Z., 2016, ROLES PHYTOHORMONES, P117; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kreuzwieser J, 2014, PLANT CELL ENVIRON, V37, P2245, DOI 10.1111/pce.12310; Kuroh T, 2018, SCIENCE, V361, P181, DOI 10.1126/science.aat1577; Li JX, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1524-x; Li L., 2020, J SYST EVOL; Li YH, 2020, PEST MANAG SCI, V76, P1588, DOI 10.1002/ps.5681; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelissen H, 2012, CURR BIOL, V22, P1183, DOI 10.1016/j.cub.2012.04.065; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Oh MW, 2014, PROTEIN PEPTIDE LETT, V21, P911, DOI 10.2174/0929866521666140403122602; Pan JW, 2021, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.627331; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Phukan UJ, 2016, CRIT REV BIOTECHNOL, V36, P956, DOI 10.3109/07388551.2015.1064856; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Purwoko D, 2019, BREEDING SCI, V69, P1, DOI 10.1270/jsbbs.18061; Ross JJ, 2011, PHYSIOL PLANTARUM, V141, P299, DOI 10.1111/j.1399-3054.2011.01444.x; Sasidharan R, 2015, PLANT PHYSIOL, V169, P3, DOI 10.1104/pp.15.00387; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Tzatzani TT, 2020, J PLANT NUTR, V43, P327, DOI 10.1080/01904167.2019.1683192; Vwioko E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00632; Wang GuiLin, 2015, Journal of Fruit Science, V32, P872; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilson ID, 2005, J CHROMATOGR B, V817, P67, DOI 10.1016/j.jchromb.2004.07.045; Wu H, 2019, PLANT GROWTH REGUL, V87, P109, DOI 10.1007/s10725-018-0457-6; Yamauchi T, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9050610; Yin QY, 2018, ECOL EVOL, V8, P10938, DOI 10.1002/ece3.4560; Zhaowei Gao., 1994, J FUJIAN FORESTRY SC; Zhou WG, 2020, PLANT PHYSIOL BIOCH, V148, P228, DOI 10.1016/j.plaphy.2020.01.020; Zhou ZS, 2009, ENVIRON EXP BOT, V65, P27, DOI 10.1016/j.envexpbot.2008.06.001; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	52	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263530	10.1371/journal.pone.0263530	http://dx.doi.org/10.1371/journal.pone.0263530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148337	gold, Green Published			2022-12-26	WOS:000800108800020
J	Lee, JI; Lim, JS; Hong, JH; Kim, S; Lee, SW; Ji, HD; Won, KS; Song, BI; Kim, HW				Lee, Jung-In; Lim, Ji Sun; Hong, Jeong-Ho; Kim, Shin; Lee, Sang-Woo; Ji, Hyun Dong; Won, Kyoung Sook; Song, Bong-Il; Kim, Hae Won			Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats	PLOS ONE			English	Article							CHRONIC BRAIN HYPOPERFUSION; WHITE-MATTER LESIONS; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; MOUSE MODEL; MEMORY; DEMENTIA; HYPOXIA; ACTIVATION; PATHOLOGY	Background Chronic cerebral hypoperfusion (CCH) is known to induce Alzheimer's disease (AD) pathology, but its mechanism remains unclear. The purpose of this study was to identify the cerebral regions that are affected by CCH, and to evaluate the development of AD pathology in a rat model of CCH. Methods A rat model of CCH was established by bilaterally ligating the common carotid arteries in adult male rats (CCH group). The identical operations were performed on sham rats without arteries ligation (control group). Regional cerebral glucose metabolism was evaluated at 1 and 3 months after bilateral CCA ligation using positron emission tomography with F-18 fluorodeoxyglucose. The expression levels of amyloid beta 40 (A beta 40), amyloid beta 42 (A beta 42), and hyperphosphorylated tau were evaluated using western blots at 3 months after the ligation. Cognitive function was evaluated using the Y-maze test at 3 months after the ligation. Results At 1 month after the ligation, cerebral glucose metabolism in the entorhinal, frontal association, motor, and somatosensory cortices were significantly decreased in the CCH group compared with those in the control group. At 3 months after the ligation, cerebral glucose metabolism was normalized in all regions except for the anterodorsal hippocampus, which was significantly decreased compared with that of the control group. The expression of A beta 42 and the A beta 42/40 ratio were significantly higher in the CCH group than those in the control group. The phosphorylated-tau levels of the hippocampus in the CCH group were significantly lower than those in the control group. Cognitive function was more impaired in the CCH group than that in the control group. Conclusion Our findings suggest that CCH causes selective neurodegeneration of the anterodorsal hippocampus, which may be a trigger point for the development of AD pathology.	[Lee, Jung-In; Lim, Ji Sun; Won, Kyoung Sook; Song, Bong-Il; Kim, Hae Won] Keimyung Univ, Dept Nucl Med, Dongsan Hosp, Daegu, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Dept Neurol, Dongsan Hosp, Daegu, South Korea; [Kim, Shin] Keimyung Univ, Dept Immunol, Sch Med, Daegu, South Korea; [Lee, Sang-Woo; Ji, Hyun Dong] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea; [Kim, Hae Won] Keimyung Univ, Sch Med, Dept Nucl Med, Daegu, South Korea; [Kim, Hae Won] Keimyung Univ, Inst Med Sci, Daegu, South Korea	Keimyung University; Keimyung University; Keimyung University; Kyungpook National University; Keimyung University; Keimyung University	Kim, HW (corresponding author), Keimyung Univ, Dept Nucl Med, Dongsan Hosp, Daegu, South Korea.; Kim, HW (corresponding author), Keimyung Univ, Sch Med, Dept Nucl Med, Daegu, South Korea.; Kim, HW (corresponding author), Keimyung Univ, Inst Med Sci, Daegu, South Korea.	hwkim.nm@gmail.com		Song, Bong-il/0000-0002-3106-6112	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by the research promoting grant from the Keimyung University Dongsan Medical Center in 2021.	Balsara RD, 2014, JOVE-J VIS EXP, DOI 10.3791/51495; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Bruner E, 2013, J ALZHEIMERS DIS, V35, P227, DOI 10.3233/JAD-122299; Choi EJ, 2018, J CLIN NEUROL, V14, P158, DOI 10.3988/jcn.2018.14.2.158; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Duits FH, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-020-00713-3; Escribano L, 2009, BIOCHEM BIOPH RES CO, V379, P406, DOI 10.1016/j.bbrc.2008.12.071; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hattori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32179; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Jing Z, 2015, J CEREBR BLOOD F MET, V35, P1249, DOI 10.1038/jcbfm.2015.55; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Koike MA, 2010, AM J PATHOL, V177, P300, DOI 10.2353/ajpath.2010.090750; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Lee JS, 2011, NEUROSCI LETT, V489, P84, DOI 10.1016/j.neulet.2010.11.071; Liu CC, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5378540; Lu YJ, 2016, AM J ALZHEIMERS DIS, V31, P333, DOI 10.1177/1533317515617725; Massaad CA, 2011, CURR NEUROPHARMACOL, V9, P662, DOI 10.2174/157015911798376244; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Mufson EJ, 2012, J NEUROPATH EXP NEUR, V71, P1018, DOI 10.1097/NEN.0b013e318272caab; Mulas A., 1970, PHARMACOL RES COMMUN, V2, P169; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nasrallah IM, 2014, J NUCL MED, V55, P2003, DOI 10.2967/jnumed.114.141416; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Okamoto Y, 2012, ACTA NEUROPATHOL, V123, P381, DOI 10.1007/s00401-011-0925-9; Park JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50681-4; Park JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36479-w; Pimentel-Coelho PM, 2013, NEUROBIOL AGING, V34, P679, DOI 10.1016/j.neurobiolaging.2012.06.025; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Rajan V, 2009, LASER MED SCI, V24, P269, DOI 10.1007/s10103-007-0524-0; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Safouris A, 2015, J ALZHEIMERS DIS, V43, P23, DOI 10.3233/JAD-141203; Schmidt-Kastner R, 2015, NEUROSCIENCE, V309, P259, DOI 10.1016/j.neuroscience.2015.08.034; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sun LH, 2015, J NEUROCHEM, V134, P1139, DOI 10.1111/jnc.13212; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Toyama K, 2014, ARTERIOSCL THROM VAS, V34, P616, DOI 10.1161/ATVBAHA.113.302440; TSUCHIYA M, 1992, EXP BRAIN RES, V89, P87; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Xie XM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00549; Yamada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016567; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9; Yata K, 2014, NEUROL CLIN NEUROSCI, V2, P129, DOI 10.1111/ncn3.124; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhao Y, 2015, CELL MOL NEUROBIOL, V35, P101, DOI 10.1007/s10571-014-0127-9; Zhao Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00010	55	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0262224	10.1371/journal.pone.0262224	http://dx.doi.org/10.1371/journal.pone.0262224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143502	Green Published, gold			2022-12-26	WOS:000797657800012
J	Hamel, CC; Snijders, MPLM; Coppus, SFPJ; Vandenbussche, FPHA; Braat, DDM; Adang, EMM				Hamel, Charlotte C.; Snijders, Marcus P. L. M.; Coppus, Sjors F. P. J.; Vandenbussche, Frank P. H. A.; Braat, Didi D. M.; Adang, Eddy M. M.			Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss	PLOS ONE			English	Article							EXPECTANT MANAGEMENT; INCOMPLETE EVACUATION; COST-EFFECTIVENESS; MISCARRIAGE; WOMEN; CURETTAGE; LIFE; ABORTION; FAILURE; UTERUS	Background In case of early pregnancy loss (EPL) women can either choose for expectant, medical or surgical management. One week of expectant management is known to lead to spontaneous abortion in approximately 50% of women. Medical treatment with misoprostol is known to be safe and less costly than surgical management, however less effective in reaching complete evacuation of the uterus. Recently, a number of trials showed that prompt treatment with the sequential combination of mifepristone with misoprostol is superior to misoprostol alone in reaching complete evacuation. In this analysis we evaluate whether the sequential combination of mifepristone with misoprostol is cost-effective compared to misoprostol alone, in the treatment of EPL. Methods and findings A cost-effectiveness analysis (CEA) from a healthcare perspective was performed alongside a randomised controlled trial (RCT) in which standard treatment with misoprostol only was compared with a combination of mifepristone and misoprostol, in women with EPL after a minimum of one week of unsuccessful management. A limited societal perspective scenario was added. This RCT, the Triple M trial, was a multicentre, randomized, double-blinded, placebo-controlled trial executed at 17 hospitals in the Netherlands. The trial started on June 27th 2018, and ended prematurely in January 2020 due to highly significant outcomes from the predefined interim-analysis. We included 351 women with a diagnosis of EPL between 6 and 14 weeks gestation after at least one week of unsuccessful expectant management. They were randomized between double blinded pre-treatment with oral mifepristone 600mg (N = 175) or placebo (N = 176) taken on day one, both followed by misoprostol orally. In both groups, an intention-to-treat analysis was performed for 172 patients, showing a significant difference in success rates between participants treated with mifepristone and misoprostol versus those treated with misoprostol alone (79.1% vs 58.7% respectively). In this cost-effective analysis we measured the direct, medical costs related to treatment (planned and unplanned hospital visits, medication, additional treatment) and indirect costs based on the IMTA Productivity Cost Questionnaire (iPCQ). Quality Adjusted Life Years (QALY's) were calculated from participants' scores on the SF-36 questionnaires sent digitally at treatment start, and one, two and six weeks later. We found medical treatment with placebo followed by misoprostol to be 26% more expensive compared to mifepristone followed by misoprostol (p = 0.001). Mean average medical costs per patient were significantly lower in the mifepristone group compared to the placebo group ((sic)528.95 +/- 328.93 vs (sic)663.77 +/- 456.03, respectively; absolute difference (sic)134.82, 95% CI 50,46-219,18, p = 0.002). Both indirect costs and QALY's were similar between both groups. Conclusion The sequential combination of mifepristone with misoprostol is cost-effective compared with misoprostol alone, for treatment of EPL after a minimum of one week of unsuccessful expectant management.	[Hamel, Charlotte C.; Vandenbussche, Frank P. H. A.; Braat, Didi D. M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, GA, Netherlands; [Hamel, Charlotte C.; Snijders, Marcus P. L. M.] Canisius Wilhelmina Hosp, Dept Obstet & Gynaecol, Nijmegen, GS, Netherlands; [Coppus, Sjors F. P. J.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, DB, Netherlands; [Vandenbussche, Frank P. H. A.] Helios Klinikum Duisburg, Dept Obstet & Gynaecol, Duisburg, Germany; [Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, GA, Netherlands	Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Maxima Medical Center; Helios Kliniken; Radboud University Nijmegen	Hamel, CC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, GA, Netherlands.; Hamel, CC (corresponding author), Canisius Wilhelmina Hosp, Dept Obstet & Gynaecol, Nijmegen, GS, Netherlands.	lotte.hamel@radboudumc.nl			Healthcare Insurers Innovation Foundation [3080 B15-191]; Radboud University Medical Centre; Canisius Wilhelmina Hospital	Healthcare Insurers Innovation Foundation; Radboud University Medical Centre; Canisius Wilhelmina Hospital	This study was funded by Healthcare Insurers Innovation Foundation (grant number: 3080 B15-191) awarded to CH. Additional funding, in the form of part of the salary of CH, was provided by Radboud University Medical Centre and Canisius Wilhelmina Hospital.	ACOG, 2019, OBSTET GYNECOL, V133, P168; [Anonymous], 2018, OBSTET GYNECOL SURV, V73, P398, DOI 10.1097/01.ogx.0000540046.38424.1c; Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Bagratee JS, 2004, HUM REPROD, V19, P266, DOI 10.1093/humrep/deh049; Berkley HH, 2020, OBSTET GYNECOL, V136, P774, DOI 10.1097/AOG.0000000000004063; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Chu JJ, 2020, LANCET, V396, P770, DOI 10.1016/S0140-6736(20)31788-8; Committee for Medicinal Products for Human Use (CHMP), 2010, LONDON EUR MED AGENC, V44, P1; Elbasha EH, 2016, PHARMACOECONOMICS, V34, P13, DOI 10.1007/s40273-015-0337-0; Fernlund A, 2018, ULTRASOUND OBST GYN, V51, P24, DOI 10.1002/uog.18940; Graziosi GCM, 2004, HUM REPROD, V19, P1894, DOI 10.1093/humrep/deh344; Hamel C., 2020, ECLINICALMEDICINE; Hamel CC., MANUSCR SUBMITT PUBL; Lemmers M, 2016, HUM REPROD, V31, P34, DOI 10.1093/humrep/dev274; Lemmers M, 2015, HUM REPROD, V30, P185; Lemmers M, 2017, EUR J OBSTET GYN R B, V211, P83, DOI 10.1016/j.ejogrb.2017.01.019; Louis GMB, 2016, FERTIL STERIL, V106, P180, DOI 10.1016/j.fertnstert.2016.03.009; Luise C, 2002, BMJ-BRIT MED J, V324, P873, DOI 10.1136/bmj.324.7342.873; Milingos DS, 2009, BJOG-INT J OBSTET GY, V116, P1268, DOI 10.1111/j.1471-0528.2009.02223.x; Nagendra D, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1594; Neilson JP., 2009, MED TREATMENTS INCOM; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Niinimaki M., 2006, FERTIL STERIL INTERN, V2, DOI [10.1002/central/CN-00565786/full, DOI 10.1002/CENTRAL/CN-00565786/FULL]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pfizer Limited, CYTOTEC UK SPC SUMMA; Saurel-Cubizolles MJ, 2015, EUR J OBSTET GYN R B, V194, P212, DOI 10.1016/j.ejogrb.2015.09.025; Schreiber CA, 2018, NEW ENGL J MED, V378, P2161, DOI 10.1056/NEJMoa1715726; Tasnim N, 2011, J PAK MED ASSOC, V61, P149; The National Institute for Health and Care Excellence, 2012, ECT PREGN MISC DIAGN; van den Berg J, 2014, EUR J OBSTET GYN R B, V183, P16, DOI 10.1016/j.ejogrb.2014.10.010; Wieringa-de Waard M, 2002, HUM REPROD, V17, P2445, DOI 10.1093/humrep/17.9.2445; You JHS, 2005, HUM REPROD, V20, P2873, DOI 10.1093/humrep/dei163; Zorginstituut Nederland., 2016, RICHTL UITV EC EV GE	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0262894	10.1371/journal.pone.0262894	http://dx.doi.org/10.1371/journal.pone.0262894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139105	Green Published, gold			2022-12-26	WOS:000821499100014
J	Kirley, TL; Norman, AB; Greis, KD				Kirley, Terence L.; Norman, Andrew B.; Greis, Kenneth D.			Oxidation of specific tryptophan residues inhibits high-affinity binding of cocaine and its metabolites to a humanized anticocaine mAb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; DYE	Cocaine addiction remains a serious problem lacking an effective pharmacological treatment. Thus, we have developed a high-affinity anti-cocaine monoclonal antibody (mAb), h2E2, for the treatment of cocaine use disorders. We show that selective tryptophan (Trp) oxidation by 2,20-azobis(2-amidino propane) dihydrochloride (AAPH) resulted in a loss of high affinity binding of cocaine to this mAb. The newly developed use of excess methionine (Met) to protect mAb met residues from AAPH oxidation did not substantially attenuate the effects of oxidation on cocaine binding but greatly decreased the modification of met residues in the mAb. Similar large decreases in ligand affinity (5000-10,000-fold) upon oxidation were observed using cocaine and two cocaine metabolites, cocaethylene and benzoylecgonine, which also bind with nanomolar affinity to this h2E2 mAb. The decrease in binding affinity was accompanied by a decrease of approximately 50% in Trp fluorescence, and increases in mAb 310 to 370 nm absorbance were consistent with the presence of oxidized forms of Trp. Finally, mass spectral analysis of peptides derived from control and AAPH-oxidized mAb indicated that excess free met did effectively protect mAb met residues from oxidation, and that AAPH-oxidized mAb heavy-chain Trp33 and light-chain Trp91 residues are important for cocaine binding, consistent with a recently derived h2E2 Fab fragment crystal structure containing bound benzoylecgonine. Thus, protection of the anti-cocaine h2E2 mAb from Trp oxidation prior to its clinical administration is critical for its proposed therapeutic use in the treatment of cocaine use disorders.	[Kirley, Terence L.; Norman, Andrew B.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA; [Greis, Kenneth D.] Univ Cincinnati, Coll Med, Dept Canc Biol, Prote Lab, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kirley, TL (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA.	terry.kirley@uc.edu			National Institutes of Health National Institute on Drug Abuse [U01DA050330]; National Institutes of Health high-end instrumentation grant [S10OD026717-01]	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health high-end instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health National Institute on Drug Abuse (grant no.: U01DA050330 [to A. B. N.] ) . Mass spectrometry data for this study were collected on an Orbitrap mass spectrometer that was obtained in part through a National Institutes of Health high-end instrumentation grant (grant no.: S10OD026717-01; to K. D. G.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck A, 2019, ANTIBODIES, V8, DOI 10.3390/antib8010018; Dion MZ, 2018, J PHARM SCI-US, V107, P550, DOI 10.1016/j.xphs.2017.09.022; Dwivedi P, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0015-8; Folzer E, 2015, J PHARM SCI-US, V104, P2824, DOI 10.1002/jps.24509; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Hageman T, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-018-2545-8; Kirley TL, 2021, J IMMUNOL METHODS, V496, DOI 10.1016/j.jim.2021.113103; Kirley TL, 2021, BIOCHEM BIOPH RES CO, V535, P93, DOI 10.1016/j.bbrc.2020.12.034; Kirley TL, 2020, J IMMUNOL METHODS, V476, DOI 10.1016/j.jim.2019.112676; Kirley TL, 2018, BIOCHEM BIOPHYS REP, V16, P138, DOI 10.1016/j.bbrep.2018.10.004; Kirley TL, 2018, BIOCHEM BIOPH RES CO, V503, P944, DOI 10.1016/j.bbrc.2018.06.100; Kirley TL, 2015, HUM VACC IMMUNOTHER, V11, P458, DOI 10.4161/21645515.2014.990856; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Norman AB, 2014, DRUG METAB DISPOS, V42, P1125, DOI 10.1124/dmd.114.057034; Tan KM, 2019, ACTA CRYSTALLOGR F, V75, P697, DOI 10.1107/S2053230X19013608; Vocci F, 2005, PHARMACOL THERAPEUT, V108, P94, DOI 10.1016/j.pharmthera.2005.06.010; Wetzel HN, 2017, BIOCHEM BIOPH RES CO, V487, P690, DOI 10.1016/j.bbrc.2017.04.117; Wetzel HN, 2014, INT IMMUNOPHARMACOL, V23, P387, DOI 10.1016/j.intimp.2014.10.025; Wong JJH, 2016, J BIOMOL SCREEN, V21, P842, DOI 10.1177/1087057116646553; Zheng K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083952	20	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101689	10.1016/j.jbc.2022.101689	http://dx.doi.org/10.1016/j.jbc.2022.101689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143837	Green Published, gold			2022-12-26	WOS:000789400700006
J	Fan, ZW; Chiong, R; Hu, ZY; Keivanian, F; Chiong, F				Fan, Zongwen; Chiong, Raymond; Hu, Zhongyi; Keivanian, Farshid; Chiong, Fabian			Body fat prediction through feature extraction based on anthropometric and laboratory measurements	PLOS ONE			English	Article							COMPONENT ANALYSIS; FEATURE-SELECTION; MACHINE; UNDERWEIGHT; PERCENTAGE; OBESITY; INDEX	Obesity, associated with having excess body fat, is a critical public health problem that can cause serious diseases. Although a range of techniques for body fat estimation have been developed to assess obesity, these typically involve high-cost tests requiring special equipment. Thus, the accurate prediction of body fat percentage based on easily accessed body measurements is important for assessing obesity and its related diseases. By considering the characteristics of different features (e.g. body measurements), this study investigates the effectiveness of feature extraction for body fat prediction. It evaluates the performance of three feature extraction approaches by comparing four well-known prediction models. Experimental results based on two real-world body fat datasets show that the prediction models perform better on incorporating feature extraction for body fat prediction, in terms of the mean absolute error, standard deviation, root mean square error and robustness. These results confirm that feature extraction is an effective pre-processing step for predicting body fat. In addition, statistical analysis confirms that feature extraction significantly improves the performance of prediction methods. Moreover, the increase in the number of extracted features results in further, albeit slight, improvements to the prediction models. The findings of this study provide a baseline for future research in related areas.	[Fan, Zongwen; Chiong, Raymond; Keivanian, Farshid] Univ Newcastle, Sch Informat & Phys Sci, Callaghan, NSW, Australia; [Fan, Zongwen] Huaqiao Univ, Coll Comp Sci & Technol, Xiamen, Peoples R China; [Hu, Zhongyi] Wuhan Univ, Sch Informat Management, Wuhan, Peoples R China; [Chiong, Fabian] Alice Springs Hosp, The Gap, NT, Australia	University of Newcastle; Huaqiao University; Wuhan University	Chiong, R (corresponding author), Univ Newcastle, Sch Informat & Phys Sci, Callaghan, NSW, Australia.	Raymond.Chiong@newcastale.edu.au		Chiong, Raymond/0000-0002-8285-1903; Keivanian, Farshid/0000-0002-9425-9018	Australian Government Research Training Program through PhD scholarships	Australian Government Research Training Program through PhD scholarships(Australian Government)	This research was supported by the Australian Government Research Training Program through PhD scholarships awarded to ZF and FK.	Ablin P., 2018, IEEE T SIGNAL PROCES, V66, P4040, DOI DOI 10.1109/TSP.2018.2844203; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahmad J, 2019, INFRARED PHYS TECHN, V98, P45, DOI 10.1016/j.infrared.2019.02.006; Bolon-Canedo V, 2016, PROG ARTIF INTELL, V5, P65, DOI 10.1007/s13748-015-0080-y; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; cdc gov W, 2013, NATL HLTH NUTR EXAMI; Chiong R, 2021, IEEE INTELL SYST, V36, P99, DOI 10.1109/MIS.2021.3093660; Chiong R, 2021, COMPUT BIOL MED, V135, DOI 10.1016/j.compbiomed.2021.104499; Chiong R, 2021, COMPUT METH PROG BIO, V198, DOI 10.1016/j.cmpb.2020.105749; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Dandu SR, 2018, IEEE J BIOMED HEALTH, V22, P40, DOI 10.1109/JBHI.2017.2773629; Dara S., 2018, INT J PURE APPL MATH, V120, P305; Das Himansu, 2020, Informatics in Medicine Unlocked, V18, DOI 10.1016/j.imu.2019.100288; De Vito R, 2019, BIOMETRICS, V75, P337, DOI 10.1111/biom.12974; DeGregory KW, 2018, OBES REV, V19, P668, DOI 10.1111/obr.12667; Ding SF, 2012, ARTIF INTELL REV, V37, P169, DOI 10.1007/s10462-011-9225-y; Dobner J, 2018, CLIN MICROBIOL INFEC, V24, P24, DOI 10.1016/j.cmi.2017.02.013; Tran D, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01052; Edelman CL., 2017, HLTH PROMOTION LIFE; Fan ZW, 2022, APPL INTELL, V52, P2359, DOI 10.1007/s10489-021-02421-3; Fan ZW, 2020, COMPUT STRUCT, V230, DOI 10.1016/j.compstruc.2019.106171; Fan ZW, 2019, J INTELL FUZZY SYST, V36, P6219, DOI 10.3233/JIFS-182518; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Ferenci T, 2018, APPL SOFT COMPUT, V67, P834, DOI 10.1016/j.asoc.2017.05.063; Franzmeier N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd1327; Garcia-Jimenez C, 2016, BRIT J CANCER, V114, P716, DOI 10.1038/bjc.2016.37; Georganos S, 2018, IEEE GEOSCI REMOTE S, V15, P607, DOI 10.1109/LGRS.2018.2803259; Greer MM, 2018, J PEDIATR ADOL GYNEC, V31, P238, DOI 10.1016/j.jpag.2017.12.005; Huk M, 2012, INT J AP MAT COM-POL, V22, P449, DOI 10.2478/v10006-012-0034-5; Ilager S, 2021, IEEE T PARALL DISTR, V32, P1044, DOI 10.1109/TPDS.2020.3040800; Inbarani HH, 2014, COMPUT METH PROG BIO, V113, P175, DOI 10.1016/j.cmpb.2013.10.007; Jantaratnotai N, 2017, OBES RES CLIN PRACT, V11, P1, DOI 10.1016/j.orcp.2016.07.003; Johnson RW, 1995, BODY FAT DATASET; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Ke GL, 2017, ADV NEUR IN, V30; Keivanian F, 2019, 2019 3RD INTERNATIONAL CONFERENCE ON BIO-ENGINEERING FOR SMART TECHNOLOGIES (BIOSMART); Keivanian F, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION AND IMAGE ANALYSIS (IPRIA); Khalid S, 2014, 2014 SCIENCE AND INFORMATION CONFERENCE (SAI), P372, DOI 10.1109/SAI.2014.6918213; Kupusinac A, 2014, COMPUT METH PROG BIO, V113, P610, DOI 10.1016/j.cmpb.2013.10.013; Langlois D, 2010, TUTOR QUANT METHODS, V6, P31, DOI 10.20982/tqmp.06.1.p031; Lim J, 2016, INT J CLIN PRACT, V70, P462, DOI 10.1111/ijcp.12801; Lo SL, 2016, DECIS SUPPORT SYST, V85, P34, DOI 10.1016/j.dss.2016.02.010; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Manrique Jorge, 2017, Arthroplast Today, V3, P57, DOI 10.1016/j.artd.2016.03.005; Murakami H, 2015, STATISTICS-ABINGDON, V49, P781; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Polsterl S, 2016, ARTIF INTELL MED, V72, P1, DOI 10.1016/j.artmed.2016.07.004; Porizka P, 2018, SPECTROCHIM ACTA B, V148, P65, DOI 10.1016/j.sab.2018.05.030; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Salas-Gonzalez D, 2010, MED PHYS, V37, P6084, DOI 10.1118/1.3488894; Shukla SMPSA., 2018, INT J RECENT INNOVAT, V6, P117; Sihag P, 2018, MODEL EARTH SYST ENV, V4, P61, DOI 10.1007/s40808-017-0410-0; Sudharsan M., 2021, MATER TODAY-PROC, DOI [10.1016/j.matpr.2021.03.061, DOI 10.1016/J.MATPR.2021.03.061]; Tharwat Alaa, 2020, APPL COMPUTING INFOR, DOI [DOI 10.1016/J.ACI.2018.08.006, 10.1016/j.aci.2018.08.006]; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Ucar MK, 2021, MEASUREMENT, V167, DOI 10.1016/j.measurement.2020.108173; Urbanowicz RJ, 2018, J BIOMED INFORM, V85, P189, DOI 10.1016/j.jbi.2018.07.014; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Varshni D., 2019, P 2019 3 IEEE INT C, P1; Wang H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32511-1; Widodo A, 2007, MECH SYST SIGNAL PR, V21, P2560, DOI 10.1016/j.ymssp.2006.12.007; Witten IH, 2011, MOR KAUF D, P1; Xie JY, 2017, IEEE GEOSCI REMOTE S, V14, P1213, DOI 10.1109/LGRS.2017.2703611; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Zahedi P, 2018, POWDER TECHNOL, V338, P983, DOI 10.1016/j.powtec.2018.07.055; Zhang YD, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0525-2	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263333	10.1371/journal.pone.0263333	http://dx.doi.org/10.1371/journal.pone.0263333			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192644	Green Published, gold			2022-12-26	WOS:000812552500020
J	Schmidbauer, V; Nenning, KH; Schwarz, M; Foesleitner, O; Mayr-Geisl, G; Yildirim, MS; Pirker, S; Moser, D; Denk, D; Prayer, D; Trimmel, K; Langs, G; Baumgartner, C; Pataraia, E; Kasprian, G; Bonelli, S				Schmidbauer, Victor; Nenning, Karl-Heinz; Schwarz, Michelle; Foesleitner, Olivia; Mayr-Geisl, Gudrun; Yildirim, Mehmet Salih; Pirker, Susanne; Moser, Doris; Denk, Daniela; Prayer, Daniela; Trimmel, Karin; Langs, Georg; Baumgartner, Christoph; Pataraia, Ekaterina; Kasprian, Gregor; Bonelli, Silvia			Imaging visuospatial memory in temporal lobe epilepsy-Results of an fMRI study	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; HIPPOCAMPUS; NETWORKS; PATTERNS; DEFICITS	Purpose Impairment of cognitive functions is commonly observed in temporal lobe epilepsy (TLE). The aim of this study was to assess visuospatial memory functions and memory-related networks using an adapted version of Roland's Hometown Walking (RHWT) functional MRI (fMRI) task in patients with TLE. Methods We used fMRI to study activation patterns based on a visuospatial memory paradigm in 32 TLE patients (9 right; 23 left) and also within subgroups of lesional and non-lesional TLE. To test for performance, a correlational analysis of fMRI activation patterns and out-of-scanner neuropsychological visuospatial memory testing was performed. Additionally, we assessed memory-related networks using functional connectivity (FC). Results Greater contralateral than ipsilateral mesiotemporal (parahippocampal gyrus/hippocampus) activation was observed in left (n = 23)/right (n = 9) TLE. In lesional left TLE (n = 17), significant activations were seen in right more than left mesiotemporal areas (parahippocampal gyrus), while non-lesional left TLE patients (n = 6) showed significant bilateral (left>right) activations in mesiotemporal structures (parahippocampal gyrus). In left TLE, visuospatial cognitive testing correlated with fMRI activations in left (parahippocampal gyrus) and right mesiotemporal structures (hippocampus), characterized by greater fMRI activation being associated with better memory scores. In right TLE, higher scores in visuospatial memory testing were associated with greater fMRI activations in left and right insular regions. FC patterns of memory-related networks differ in right and left TLE. Conclusion While TLE in general leads to asymmetrical mesiotemporal activation, lesion-induced and non-lesional TLE patients reveal different memory fMRI activation patterns. In right TLE, insular regions try to compensate for impaired right mesiotemporal structures during the performance of visuospatial tasks. Underlying functional visuospatial memory networks differ in right and left TLE.	[Schmidbauer, Victor; Nenning, Karl-Heinz; Foesleitner, Olivia; Yildirim, Mehmet Salih; Prayer, Daniela; Langs, Georg; Kasprian, Gregor] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Schwarz, Michelle; Moser, Doris; Trimmel, Karin; Pataraia, Ekaterina; Bonelli, Silvia] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Mayr-Geisl, Gudrun] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Pirker, Susanne; Denk, Daniela; Baumgartner, Christoph] Gen Hosp Hietzing, Neurol Ctr Rosenhuegel, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Hietzing Hospital	Bonelli, S (corresponding author), Med Univ Vienna, Dept Neurol, Vienna, Austria.	silvia.bonelli@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Schmidbauer, Victor/AAB-6410-2021	Kasprian, Gregor/0000-0003-3858-3347; Schmidbauer, Victor/0000-0002-3599-1436; Yildirim, Mehmet Salih/0000-0003-4190-7277				Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; Amelang M, 2006, PSYCHOL DIAGNOSTIK I; Bernhardt BC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00624; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bonelli SB, 2010, BRAIN, V133, P1186, DOI 10.1093/brain/awq006; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cavalcante LES, 2017, BEHAV BRAIN RES, V334, P129, DOI 10.1016/j.bbr.2017.07.044; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Doucet G, 2013, BRAIN CONNECT, V3, P398, DOI 10.1089/brain.2013.0158; Englot DJ, 2017, J NEUROL NEUROSUR PS, V88, P925, DOI 10.1136/jnnp-2017-315732; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gogolla N, 2017, CURR BIOL, V27, pR580, DOI 10.1016/j.cub.2017.05.010; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Iwasaki M, 2016, NEUROL MED-CHIR, V56, P632, DOI 10.2176/nmc.ra.2016-0186; James GA, 2013, J NEUROSURG, V119, P288, DOI 10.3171/2013.3.JNS121041; Janszky T, 2005, EPILEPSIA, V46, P244, DOI 10.1111/j.0013-9580.2005.10804.x; Jokeit H, 2001, NEUROLOGY, V57, P1786, DOI 10.1212/WNL.57.10.1786; Kircher T., 2008, NEUROPSYCHOLOGIE SCH; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Limotai C, 2018, J CLIN NEUROSCI, V55, P38, DOI 10.1016/j.jocn.2018.06.020; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Muhlhofer W, 2017, EPILEPSIA, V58, P727, DOI 10.1111/epi.13699; Porcu M, 2019, EUR J RADIOL, V110, P233, DOI 10.1016/j.ejrad.2018.12.007; Porteus SD., 1959, MAZE TEST CLIN PSYCH; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Reyes A, 2016, EPILEPSIA, V57, P1475, DOI 10.1111/epi.13456; Rogowski S., 2017, THERAPIEASSOZIIERTE, V1st; ROLAND PE, 1987, J NEUROSCI, V7, P2373; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Schacher M, 2006, NEUROLOGY, V66, P81, DOI 10.1212/01.wnl.0000191303.91188.00; Sideman N, 2018, EPILEPSY BEHAV, V81, P70, DOI 10.1016/j.yebeh.2018.01.027; Tellez-Zenteno Jose F, 2012, Epilepsy Res Treat, V2012, P630853, DOI 10.1155/2012/630853; Tewes U., 1994, HAWIE R HAMBURG WECH; Toller G, 2015, NEUROPSYCHOLOGIA, V78, P80, DOI 10.1016/j.neuropsychologia.2015.09.010; Towgood K, 2015, HUM BRAIN MAPP, V36, P1595, DOI 10.1002/hbm.22726; Vatansever D, 2015, NEUROIMAGE, V122, P96, DOI 10.1016/j.neuroimage.2015.07.053; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yeung AWK, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00337; Zhang J, 2014, NEUROPSYCH DIS TREAT, V10, P71, DOI 10.2147/NDT.S56404	43	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264349	10.1371/journal.pone.0264349	http://dx.doi.org/10.1371/journal.pone.0264349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192676	gold, Green Published			2022-12-26	WOS:000812552500052
J	Vitalis, S; Labetski, A; Ledoux, H; Stoter, J				Vitalis, Stelios; Labetski, Anna; Ledoux, Hugo; Stoter, Jantien			From road centrelines to carriageways-A reconstruction algorithm	PLOS ONE			English	Article							GENERATION	Roads are important for many urban planning applications, such as traffic modelling and delivery vehicle routing. At present, most available datasets represent roads only as centrelines. This is particularily true for OpenStreetMap which provides, among many features, road networks at worldwide coverage. Furthermore, most approaches for creating more detailed networks, such as carriageways or lanes, focus on doing so from sources that are not easy to acquire, such as satellite imagery or LiDAR scans. In this paper we present a methodology to create carriageways based on OpenStreetMap's centrelines and open access areal representations (i.e. polygons) to determine which roads should be represented as two individual carriageways. We applied our methodology in five areas across four different countries with different built environments. We analysed the outcome in a delivery routing problem to evaluate the validity of our results. Our results suggest that this method can be effectively applied to create carriageways anywhere in the world, as long as there is sufficient coverage by OpenStreetMap and an areal representation dataset of roads.	[Vitalis, Stelios; Labetski, Anna; Ledoux, Hugo; Stoter, Jantien] Delft Univ Technol, 3D Geoinformat Grp, Delft, Netherlands	Delft University of Technology	Vitalis, S (corresponding author), Delft Univ Technol, 3D Geoinformat Grp, Delft, Netherlands.	s.vitalis@tudelft.nl		Vitalis, Stelios/0000-0003-1886-0722; Stoter, Jantien/0000-0002-1393-7279	European Research Council under the European Union's Horizon2020 ERC Agreement [677312]	European Research Council under the European Union's Horizon2020 ERC Agreement	The research leading to this paper has received funding from the European Research Council under the European Union's Horizon2020 ERC Agreement no. 677312 UMnD: Urban modelling in higher dimensions which was granted to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzan ALC, 1999, LECT NOTES ARTIF INT, V1701, P303; Beil C., 2017, ISPRS ANN PHOTOGRAM, P9, DOI [10.5194/isprs-annals-IV-4-W5-9-2017, DOI 10.5194/ISPRS-ANNALS-IV-4-W5-9-2017]; Biljecki F, 2020, ISPRS ANN PHOTO REM, V6-4, P37, DOI 10.5194/isprs-annals-VI-4-W1-2020-37-2020; Biljecki F, 2016, COMPUT ENVIRON URBAN, V59, P25, DOI 10.1016/j.compenvurbsys.2016.04.005; Block D, 2006, PUBLIC HEALTH NUTR, V9, P837, DOI 10.1017/PHN2005924; Boeing G., 2021, CITY STREET NETWORK; Boeing G., 2020, ARXIV PREPRINT ARXIV; Boeing G, 2019, URBAN SCI, V3, DOI 10.3390/urbansci3010028; Boeing G, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0189-1; Boeing G, 2017, COMPUT ENVIRON URBAN, V65, P126, DOI 10.1016/j.compenvurbsys.2017.05.004; Boersma F., 2019, EXPLORING MODELLING; Dey TK, 2019, 27TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2019), P520, DOI 10.1145/3347146.3359348; Dey TK, 2017, 25TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2017), DOI 10.1145/3139958.3140031; Greibe P, 2003, ACCIDENT ANAL PREV, V35, P273, DOI 10.1016/S0001-4575(02)00005-2; Grippa T, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7070246; Gwon GP, 2017, IEEE T VEH TECHNOL, V66, P4517, DOI 10.1109/TVT.2016.2535210; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hoffmans W., 2020, BREEDTESCRIPT BGT WE; Huang JC, 2018, IEEE ACCESS, V6, P71965, DOI 10.1109/ACCESS.2018.2882581; Jordahl K., 2020, GEOPANDASGEOPANDAS V, DOI [10.5281/zenodo.3946761, DOI 10.5281/ZENODO.3946761, 10.5281/ZENODO.3946761]; Joshi A, 2015, IEEE INTEL TRANSP SY, V7, P19, DOI 10.1109/MITS.2014.2364081; Labetski A., 2018, ISPRS ANN PHOTOGRAMM, P89, DOI [10.5194/isprs-archives-XLII-4-W10-89-2018, DOI 10.5194/ISPRS-ARCHIVES-XLII-4-W10-89-2018]; Ledoux Hugo, 2019, Open Geospatial Data, Software and Standards, V4, DOI 10.1186/s40965-019-0064-0; Li HF, 2016, CIKM'16: PROCEEDINGS OF THE 2016 ACM CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P1523, DOI 10.1145/2983323.2983797; Minghini Marco, 2019, Open Geospatial Data, Software and Standards, V4, DOI 10.1186/s40965-019-0067-x; Mooney P., 2010, P 18 SIGSPATIAL INT, P514; Neis P, 2012, FUTURE INTERNET, V4, P1, DOI 10.3390/fi4010001; Open Geospatial Consortium, 2012, OGC CITY GEOGRAPHY M; OpenStreetMap, 2021, EL OP; OSM, 2020, OP; Pillac V, 2013, EUR J OPER RES, V225, P1, DOI 10.1016/j.ejor.2012.08.015; Raffler C., 2018, QNEAT3 QGIS NETWORK, DOI 10.13140/RG.2.2.13042.02248; Raifer Martin, 2019, Open Geospatial Data, Software and Standards, V4, DOI 10.1186/s40965-019-0061-3; Shapely, 2021, SHAPELY SHAPELY 171; Spielmann M, 2005, INT J LIFE CYCLE ASS, V10, P85, DOI 10.1065/lca2004.10.181.10; Unsalan C, 2012, IEEE T GEOSCI REMOTE, V50, P4441, DOI 10.1109/TGRS.2012.2190078; van der Lely B, 2021, PROVINCIE NOORD BRAB; Wang M., 2013, ISPRS INT ARCH PHOTO, V2, pW1; Zhang LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212606; Zhang ZX, 2018, IEEE GEOSCI REMOTE S, V15, P749, DOI 10.1109/LGRS.2018.2802944; Zheng L, 2019, ISPRS INT GEO-INF, V8, DOI 10.3390/ijgi8090416; Zheng L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11164511	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0262801	10.1371/journal.pone.0262801	http://dx.doi.org/10.1371/journal.pone.0262801			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192631	Green Published, gold			2022-12-26	WOS:000812552500012
J	Wagnon, GS; Pletcher, OM; Brown, CR				Wagnon, Gigi S.; Pletcher, Olivia M.; Brown, Charles R.			Change in beak overhangs of cliff swallows over 40 years: Partly a response to parasites?	PLOS ONE			English	Article							GROUP-SIZE; DAILY SURVIVAL; ECTOPARASITES; MORPHOLOGY; TRAITS; TITS; BILL	Some birds exhibit a maxillary overhang, in which the tip of the upper beak projects beyond the lower mandible and may curve downward. The overhang is thought to help control ectoparasites on the feathers. Little is known about the extent to which the maxillary overhang varies spatially or temporally within populations of the same species. The colonial cliff swallow (Petrochelidon pyrrhonota) has relatively recently shifted to almost exclusive use of artificial structures such as bridges and highway culverts for nesting and consequently has been exposed to higher levels of parasitism than on its ancestral cliff nesting sites. We examined whether increased ectoparasitism may have favored recent changes in the extent of the maxillary overhang. Using a specimen collection of cliff swallows from western Nebraska, USA, spanning 40 years and field data on live birds, we found that the extent of the maxillary overhang increased across years in a nonlinear way, peaking in the late 2000's, and varied inversely with cliff swallow colony size for unknown reasons. The number of fleas on nestling cliff swallows declined in general over this period. Those birds with perceptible overhangs had fewer swallow bugs on the outside of their nest, but they did not have higher nesting success than birds with no overhangs. The intraspecific variation in the maxillary overhang in cliff swallows was partly consistent with it having a functional role in combatting ectoparasites. The temporal increase in the extent of the overhang may be a response by cliff swallows to their relatively recent increased exposure to parasitism. Our results demonstrate that this avian morphological trait can change rapidly over time.	[Wagnon, Gigi S.; Pletcher, Olivia M.; Brown, Charles R.] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA	University of Tulsa	Brown, CR (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.	charles-brown@utulsa.edu			National Science Foundation [BSR8600608, BSR-9015734, DEB-9613638, IBN9974733, DEB-0075199, DEB-0514824, DEB1019423, DEB-1453971, IOS-1556356, DEB1930803]; National Institutes of Health [R01AI057569]; National Geographic Society; Erna and Victor Hasselblad Foundation; National Academy of Sciences; Chapman Fund of the American Museum of Natural History; American Philosophical Society; Sigma Xi; University of Tulsa; Yale University; Princeton University	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Society(National Geographic Society); Erna and Victor Hasselblad Foundation; National Academy of Sciences; Chapman Fund of the American Museum of Natural History; American Philosophical Society; Sigma Xi; University of Tulsa; Yale University; Princeton University(Princeton University)	This work was supported by grants to C. R.B. from the National Science Foundation (BSR8600608, BSR-9015734, DEB-9613638, IBN9974733, DEB-0075199, DEB-0514824, DEB1019423, DEB-1453971, IOS-1556356, DEB1930803), the National Institutes of Health (R01AI057569) the National Geographic Society, the Erna and Victor Hasselblad Foundation, the National Academy of Sciences, the Chapman Fund of the American Museum of Natural History, the American Philosophical Society, Sigma Xi, the University of Tulsa, Yale University, and Princeton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Bardwell E, 2001, ECOLOGY, V82, P2617, DOI 10.1890/0012-9658(2001)082[2617:AGVIWS]2.0.CO;2; Benedict L, 2021, J ORNITHOL, V162, P155, DOI 10.1007/s10336-020-01810-8; Brown C. R., 2020, BIRDS OF THE WORLD, DOI 10.2173/bow.cliswa.01; Brown C. R., 1996, COLONIALITY CLIFF SW; Brown CR, 2006, CAN J ZOOL, V84, P1307, DOI 10.1139/Z06-110; Brown CR, 2021, ECOL MONOGR, V91, DOI 10.1002/ecm.1446; Brown CR, 2018, J EVOLUTION BIOL, V31, P254, DOI 10.1111/jeb.13218; Brown CR, 2016, BEHAV ECOL SOCIOBIOL, V70, P1613, DOI 10.1007/s00265-016-2196-x; Brown CR, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140508; Brown CR, 2013, ECOL MONOGR, V83, P511, DOI 10.1890/12-2001.1; Brown CR, 2013, CURR BIOL, V23, pR233, DOI 10.1016/j.cub.2013.02.023; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Brown CR, 2004, BEHAV ECOL SOCIOBIOL, V56, P498, DOI 10.1007/s00265-004-0813-6; Brown CR, 2002, J EVOLUTION BIOL, V15, P1067, DOI 10.1046/j.1420-9101.2002.00474.x; Brown CR, 1995, P ROY SOC B-BIOL SCI, V262, P313, DOI 10.1098/rspb.1995.0211; BROWN CR, 1992, ECOLOGY, V73, P1718, DOI 10.2307/1940023; Brown CR, 2000, P NATL ACAD SCI USA, V97, P14825, DOI 10.1073/pnas.97.26.14825; Brown MB, 2011, AUK, V128, P69, DOI 10.1525/auk.2011.10219; Bush SE, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0196; Bush SE, 2012, J PARASITOL, V98, P256, DOI 10.1645/GE-2888.1; Christe P, 1996, ANIM BEHAV, V52, P1087, DOI 10.1006/anbe.1996.0256; Clayton Dale H., 2010, Open Ornithology Journal, V3, P41, DOI 10.2174/1874453201003010041; Clayton DH, 2005, P ROY SOC B-BIOL SCI, V272, P811, DOI 10.1098/rspb.2004.3036; Clayton DH, 2001, OIKOS, V94, P455, DOI 10.1034/j.1600-0706.2001.940308.x; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Gustafsson DR, 2017, ZOOTAXA, V4313, P1, DOI 10.11646/zootaxa.4313.1.1; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; Moore AT, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0117; Moyer BR, 2002, CONDOR, V104, P675, DOI 10.1650/0010-5422(2002)104[0675:IOBSOE]2.0.CO;2; Rannala BH, 1995, THESIS YALE U; Robitzsch A, 2020, FRONT EDUC, V5, DOI 10.3389/feduc.2020.589965; RUBENSTEIN DI, 1989, OIKOS, V55, P312, DOI 10.2307/3565589; SAS Institute, 2004, SAS STAT US GUID VER; Tripet F, 2002, IBIS, V144, P461, DOI 10.1046/j.1474-919X.2002.00018.x; Urano Y, 2019, J ANAT, V235, P299, DOI 10.1111/joa.12998; Villa SM, 2018, EVOL ECOL, V32, P443, DOI 10.1007/s10682-018-9949-0; Wagnon GS, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0264; Waite JL, 2012, INT J PARASITOL, V42, P463, DOI 10.1016/j.ijpara.2012.03.005; Zar J.H., 2010, BIOSTAT ANAL	41	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263422	10.1371/journal.pone.0263422	http://dx.doi.org/10.1371/journal.pone.0263422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192650	Green Published, gold			2022-12-26	WOS:000812552500021
J	Veziari, Y; Kumar, S; Leach, MJ				Veziari, Yasamin; Kumar, Saravana; Leach, Matthew J.			An exploration of barriers and enablers to the conduct and application of research among complementary and alternative medicine stakeholders in Australia and New Zealand: A qualitative descriptive study	PLOS ONE			English	Article							ACUTE STROKE CARE; FEE-FOR-SERVICE; CLINICAL-PRACTICE; HEALTH-PROFESSIONALS; FACULTY-DEVELOPMENT; RESEARCH CAPACITY; SAMPLE-SIZE; IMPLEMENTATION; KNOWLEDGE; ATTITUDES	Background Most studies examining complementary and alternative medicine (CAM) stakeholder engagement with evidence-based practice have relied on quantitative research methods, which often fail to capture the nuances of this phenomena. Using qualitative methods, this study aimed to explore the experiences of CAM stakeholders regarding the barriers and enablers to the conduct and application of research. Methods This research was guided by a qualitative descriptive framework. CAM practitioners and researchers of multiple CAM disciplines from across Australia and New Zealand were invited to share their personal perspectives of the study phenomena. Semi-structured interviews were conducted via Zoom, which were audio-recorded and transcribed verbatim. Rigour strategies were applied to ensure the credibility of results. The transcript was analysed using thematic analysis. Results CAM stakeholders identified an array of barriers and enablers to the conduct and application of research within their disciplines. The barriers and enablers that emerged were found to be inter-connected with two similar constructs: capacity and culture. Captured within the construct of capacity were five themes-lack of resources, inadequate governance/leadership, lack of competency, bias directed from outside and within CAM, and lack of time for research. Within the construct of culture were two themes-intrinsic perceptions in CAM, and lack of communication within and outside CAM. Conclusions Promoting evidence-based practice and engaging with research in CAM continues to face challenges. This study, for the first time, has highlighted the multitude of interlinked barriers that confront CAM stakeholders when engaging with research. These findings highlight the need for a concerted and targeted approach to tackle these challenges.	[Veziari, Yasamin; Kumar, Saravana] Univ South Australia, UniSA Allied Hlth & Human Performance, North Terrace, Adelaide, SA, Australia; [Leach, Matthew J.] Southern Cross Univ, Natl Ctr Naturopath Med, East Lismore, NSW, Australia	University of South Australia; Southern Cross University	Kumar, S (corresponding author), Univ South Australia, UniSA Allied Hlth & Human Performance, North Terrace, Adelaide, SA, Australia.	saravana.kumar@unisa.edu.au	Kumar, Saravana/B-8876-2009	Kumar, Saravana/0000-0002-4003-4411	Australian Government Research Training Program Scholarship; Commonwealth Scholarships Program of South Australia	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Commonwealth Scholarships Program of South Australia	We acknowledge the participation of all the participants who participated in this study for giving up their time to share their perspectives on the issue of barriers and enablers to the conduct and application of research in complementary and alternative medicine. We would like to also thank the CAM organisations, Professional CAM associations, university alumni, CAM schools from Australia and New Zealand, the Tertiary and Further Education institutions from Australia, practice-based research networks, research organisations and CAM social media groups on Twitter, Facebook and LinkedIn who helped with the overall broader body of this research. Ms. Veziari acknowledges the Australian Government Research Training Program Scholarship and the Commonwealth Scholarships Program of South Australia that fund her PhD.	Abbott R., 2014, DOCUMENTING TRADITIO; Allen ES, 2011, EXPLORE-NY, V7, P88, DOI 10.1016/j.explore.2010.12.001; [Anonymous], 1999, NUD 1 VIVO N VIVO, V10; Ataee M, 2015, J Med Life, V8, P12; Australian Bureau of Statistics, 2011, 85700 AUSTR BUR STAT; Avila C, 2020, COMPLEMENT THER MED, V49, DOI 10.1016/j.ctim.2020.102317; Baatiema L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0599-3; Bach-Mortensen AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0789-7; Bakken S, 2009, J AM BOARD FAM MED, V22, P436, DOI 10.3122/jabfm.2009.04.090017; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barrett B, 2004, ANN FAM MED, V2, P253, DOI 10.1370/afm.81; Barriers and Bridges to Evidence-Based Clinical Practice, 2002, GETTING RES FINDINGS, P11522; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bridges Diane R, 2011, Med Educ Online, V16, DOI 10.3402/meo.v16i0.6035; Brownson RC, 2006, PUBLIC HEALTH REP, V121, P97, DOI 10.1177/003335490612100118; Bussieres Andre E, 2015, J Can Chiropr Assoc, V59, P332; Cant S., 2020, SOC CULTURE S ASIA, V6, P31, DOI DOI 10.1177/2393861719883064; Castillo-Montoya M., 2016, PREPARING INTERVIEW, V21, P811, DOI [10.1016/j.circir.2016.05.008, DOI 10.1016/J.CIRCIR.2016.05.008]; Chhotray S, 2018, J INT ENTREP, V16, P38, DOI 10.1007/s10843-017-0201-8; Chrystal Kathryn, 2003, N Z Med J, V116, pU296; Coulter ID, 2004, MED J AUSTRALIA, V180, P587, DOI 10.5694/j.1326-5377.2004.tb06099.x; Cramer GD., 2015, MED SCI EDUC, V25, P27; Creswell JW., 1994, RES DESIGN QUALITATI, P228; Crowe S, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0643-3; Curtis K, 2017, J CLIN NURS, V26, P862, DOI 10.1111/jocn.13586; Dale S, 2015, WORLDV EVID-BASED NU, V12, P41, DOI 10.1111/wvn.12078; Dean KS, 2010, STRATEGIES BENEFITS; Dizon JM, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0243-3; Donnellan C, 2013, HEALTH POLICY, V111, P245, DOI 10.1016/j.healthpol.2013.05.002; Ekor M., 2014, Y, V4, P177; Evans R, 2011, EXPLORE-NY, V7, P265, DOI 10.1016/j.explore.2011.04.014; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fischer FH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-46; Forero R, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2915-2; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Friesen EL, 2017, AUST J PRIM HEALTH, V23, P123, DOI 10.1071/PY15131; Gaboury I, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-131; Glasziou P, 2017, LANCET, V390, P169, DOI 10.1016/S0140-6736(16)30946-1; Goodman MS, 2017, TRANSL BEHAV MED, V7, P486, DOI 10.1007/s13142-017-0495-z; Greenhalgh T., 2004, BMJ-BRIT MED J, V328, P529, DOI [10.1136/bmj.328.7438.529, DOI 10.1136/BMJ.328.7438.529]; Greenhalgh T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0437-x; Haas M, 2012, J MANIP PHYSIOL THER, V35, P701, DOI 10.1016/j.jmpt.2012.10.014; Hao PP, 2017, J AM COLL CARDIOL, V69, P2952, DOI 10.1016/j.jacc.2017.04.041; Hawk C, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/528487; Herman PM, 2015, COMPLEMENTARY ALTERN; Hofseth LJ, 2018, CARCINOGENESIS, V39, P21, DOI 10.1093/carcin/bgx085; Hunt K, 2009, J HEALTH SERV RES PO, V14, P219, DOI 10.1258/jhsrp.2009.009009; Ikegami N, 2015, INT J HEALTH POLICY, V4, P57, DOI 10.15171/ijhpm.2015.26; Jabbour M, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0832-8; Jagtenberg T, 2006, J ALTERN COMPLEM MED, V12, P323, DOI 10.1089/acm.2006.12.323; Jang A, 2017, J ALTERN COMPLEM MED, V23, P362, DOI 10.1089/acm.2016.0289; Kaiser RB, 2008, AM PSYCHOL, V63, P96, DOI 10.1037/0003-066X.63.2.96; Karimian Z., 2012, Eastern Mediterranean Health Journal, V18, P1143; Khazaal Y, 2014, J MED INTERNET RES, V16, P44, DOI 10.2196/jmir.2759; Kinsel JE, 2003, ANNU REV PHARMACOL, V43, P463, DOI 10.1146/annurev.pharmtox.43.100901.135757; Koch T, 2006, J ADV NURS, V53, P91, DOI 10.1111/j.1365-2648.2006.03681.x; Laird S, 2010, J AM OSTEOPATH ASSOC, V110, P593; Leach MJ, 2008, J EVAL CLIN PRACT, V14, P792, DOI 10.1111/j.1365-2753.2008.01046.x; Leach MJ, 2018, COMPLEMENT THER CLIN, V31, P38, DOI 10.1016/j.ctcp.2018.01.011; Leach MJ, 2017, EXPLORE-NY, V13, P53, DOI 10.1016/j.explore.2016.10.005; Leach MJ, 2013, COMPLEMENT THER MED, V21, P364, DOI 10.1016/j.ctim.2013.04.004; Leach MJ, 2011, COMPLEMENT THER MED, V19, P128, DOI 10.1016/j.ctim.2011.04.002; Lemonnier N., 2017, PROGR PREVENTIVE MED, V2, DOI [10.1097/pp9.0000000000000010, DOI 10.1097/PP9.0000000000000010]; Leung K, 2016, NURS EDUC TODAY, V39, P189, DOI 10.1016/j.nedt.2016.01.026; Long CR, 2014, J ALTERN COMPLEM MED, V20, P563, DOI 10.1089/acm.2013.0385; Luckson M, 2018, J CLIN NURS, V27, pE1462, DOI 10.1111/jocn.14264; MacArtney JI, 2014, QUAL HEALTH RES, V24, P114, DOI 10.1177/1049732313518977; Magill MK, 2016, ANN FAM MED, V14, P400, DOI 10.1370/afm.1977; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Marian F, 2006, FORSCH KOMP KLAS NAT, V13, P70, DOI 10.1159/000090735; Mason M., 2010, FORUM QUAL SOC RES, V11; Mathieson A, 2018, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423618000488; Matus J, 2019, J MULTIDISCIP HEALTH, V12, P83, DOI 10.2147/JMDH.S178696; Mazzotta C, 2016, J NURSING ED PRACTIC, V6; Mc Goldrick EL, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1858-8; McCarty RL, 2011, EXPLORE-NY, V7, P249, DOI 10.1016/j.explore.2011.04.003; McGrath C, 2019, MED TEACH, V41, P1002, DOI 10.1080/0142159X.2018.1497149; Miles A, 2008, J EVAL CLIN PRACT, V14, P621, DOI 10.1111/j.1365-2753.2008.01094.x; Mills SY, 2001, BRIT MED J, V322, P158, DOI 10.1136/bmj.322.7279.158; Milstein M, 2000, CAN VET J, V41, P769; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nancarrow SA, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-19; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; O'Leary D, 2021, SYNTHESE, V199, P1977, DOI 10.1007/s11229-020-02869-9; Okoduwa SIR., 2018, ATTITUDES PERCEPTION, V3; Olaussen A, 2017, EMERG MED AUSTRALAS, V29, P204, DOI 10.1111/1742-6723.12734; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Patwardhan B, 2009, DRUG DISCOV TODAY, V14, P804, DOI 10.1016/j.drudis.2009.05.009; Polit D., 2012, NURSING RESEARCHGENE; Power M, 2011, J ROY SOC MED, V104, P155, DOI 10.1258/jrsm.2011.100271; Raheim M, 2016, INT J QUAL STUD HEAL, V11, DOI 10.3402/qhw.v11.30996; Ray CE, 2013, SEMIN INTERVENT RAD, V30, P331, DOI 10.1055/s-0033-1359725; Richards H, 2000, FAM PRACT, V17, P71, DOI 10.1093/fampra/17.1.71; Robson C, 2017, REAL WORLD RES, V4th; Roecker CB, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-43; Ross JS, 2009, AM J MED, V122, P955, DOI 10.1016/j.amjmed.2009.04.013; Ryan JC, 2019, J INNOV KNOWL, V4, P47, DOI 10.1016/j.jik.2017.10.004; Sandelowski M., 2000, WHATEVER HAPPENED QU, V23, P334; Schneider MJ, 2015, CHIROPR MAN THER, V23, DOI 10.1186/s12998-015-0060-0; Shahvisi A, 2016, BIOETHICS, V30, P69, DOI 10.1111/bioe.12228; Sharplin G, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7040142; Shayan SJ., 2019, BARRIERS ASS EVIDENC, V16, P12; Shifaza F., 2014, ADV IN NURSING, V2014; Shim JM, 2016, ASIA-PAC J PUBLIC HE, V28, P51, DOI 10.1177/1010539515613411; Steel A., 2014, AUSTR J HERBAL MED, V26, P136; Stokke K, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-8; Stoneman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053174; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; STRUTZEL E, 1968, NURS RES, V17, P364; Stub T, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1770-8; Sullivan B., 2013, EXPLORE-NY, V9, P323; Sullivan T., 1998, COLLABORATION HEATHC; Sundberg T., 2019, ADV INTEGR MED, V6, pS44; Tabish Syed Amin, 2008, Int J Health Sci (Qassim), V2, pV; Tilburt JC, 2009, ARCH INTERN MED, V169, P670, DOI 10.1001/archinternmed.2009.49; Tonelli MR, 2001, ACAD MED, V76, P1213, DOI 10.1097/00001888-200112000-00011; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Verhoef Marja J, 2006, BMC Complement Altern Med, V6, P6; Veziari Y, 2021, COMPLEMENT THER MED, V60, DOI 10.1016/j.ctim.2021.102752; Veziari Y, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1660-0; von Conrady DM, 2017, AUST FAM PHYSICIAN, V46, P315; Wade C, 2008, J WOMENS HEALTH, V17, P829, DOI 10.1089/jwh.2007.0579; Walker BF, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-44; Wardle J., 2015, AUSTR J HERBAL MED, V27, P47; Wayne PM, 2008, ALTERN THER HEALTH M, V14, P52; Wieland LS, 2011, ALTERN THER HEALTH M, V17, P50; Wiese M., 2016, FOCUS ALTERNATIVE CO, V21, P143; World Health Organzation, 2013, WHO TRADITIONAL MED; Zank S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174731; Zwickey H, 2014, J ALTERN COMPLEM MED, V20, P925, DOI 10.1089/acm.2014.0087; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	132	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264221	10.1371/journal.pone.0264221	http://dx.doi.org/10.1371/journal.pone.0264221			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180276	Green Accepted, gold, Green Published			2022-12-26	WOS:000796435800054
J	Guijarro, E; Babiloni, E; Cardos, M				Guijarro, Ester; Babiloni, Eugenia; Cardos, Manuel			On the estimation of the fill rate for the continuous (s, S) inventory system for the lost sales context	PLOS ONE			English	Article							UP-TO-LEVEL; REORDER POINT; DEMAND; ORDER; DISTRIBUTIONS; UNDERSHOOT	In the continuous review reorder point, base-stock (s, S) policy, the replenishment order is launched when the inventory position reaches the reorder point, s. It is commonly assumed that the inventory position is exactly equal to the reorder point at the moment the order is launched, when actually it could be lower at that moment. This implies neglecting the possible undershoots at the reorder point, which has a direct impact on the calculation of the expected shortages per replenishment cycle. This article presents a method for an exact calculation of the fill rate (fraction of demand that is immediately satisfied from shelf) which takes explicit account of the existence of undershoots and is applicable to any discrete demand distribution function in a context of lost sales. This method is based on the determination of the stock probability vector at the moment the replenishment order is launched. Furthermore, neglecting the undershoots is shown to lead to an overestimation of the fill rate, particularly when we move farther away from the unitary demand assumption. From a practical point of view, this behaviour involves underestimating the base-stock level, S, when a target fill rate is set for its determination. The method proposed in this paper overcomes these shortcomings.	[Guijarro, Ester; Babiloni, Eugenia; Cardos, Manuel] Univ Politecn Valencia, Valencia, Spain	Universitat Politecnica de Valencia	Babiloni, E (corresponding author), Univ Politecn Valencia, Valencia, Spain.	mabagri@doe.upv.es	Guijarro, Ester/I-1180-2015; Babiloni, Eugenia/I-1627-2015	Guijarro, Ester/0000-0003-1988-0397; Babiloni, Eugenia/0000-0002-7949-3703	European Regional Development Fund; Junta de Comunidades de Castilla-La Mancha (JCCM/FEDER, UE);  [SBPLY/19/180501/000151]	European Regional Development Fund(European Commission); Junta de Comunidades de Castilla-La Mancha (JCCM/FEDER, UE); 	Initials of authors that receive the grant: E.G. and E. B. Grant number: SBPLY/19/180501/000151. Funder: European Regional Development Fund and Junta de Comunidades de Castilla-La Mancha (JCCM/FEDER, UE). URL: https://fondosestructurales.castillalamancha.es/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni Eugenia, 2020, Advances in Engineering Networks. Proceedings of the 12th International Conference on Industrial Engineering and Industrial Management. Lecture Notes in Management and Industrial Engineering (LNMIE), P129, DOI 10.1007/978-3-030-44530-0_16; Babiloni E, 2020, CENT EUR J OPER RES, V28, P35, DOI 10.1007/s10100-018-0546-7; Baganha MP, 1999, NAV RES LOG, V46, P435, DOI 10.1002/(SICI)1520-6750(199906)46:4<435::AID-NAV6>3.0.CO;2-I; Baganha MP, 1996, INT J PROD ECON, V45, P311, DOI 10.1016/0925-5273(96)00004-7; Bijvank M, 2011, EUR J OPER RES, V215, P1, DOI 10.1016/j.ejor.2011.02.004; Brown RG., 1962, SMOOTHING FORECASTIN; Cardos M, 2011, INT J PROD ECON, V133, P251, DOI 10.1016/j.ijpe.2010.09.017; COHEN MA, 1988, MANAGE SCI, V34, P482, DOI 10.1287/mnsc.34.4.482; Gutgutia A, 2018, OPER RES-GER, V18, P159, DOI 10.1007/s12351-016-0258-5; Gutierrez M, 2021, APPL MATH MODEL, V91, P791, DOI 10.1016/j.apm.2020.09.014; de Frutos EH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230152; Johansen SG, 2000, INT J PROD ECON, V68, P279, DOI 10.1016/S0925-5273(00)00051-7; Kouki C., 2009, IFAC P, V42, P1573; Larsen C, 2014, INT J PROD ECON, V147, P13, DOI 10.1016/j.ijpe.2012.07.021; Luo PY, 2014, OPER RES LETT, V42, P414, DOI 10.1016/j.orl.2014.07.004; Moors JJA, 2002, J OPER RES SOC, V53, P1268, DOI 10.1057/palgrave.jors.2601441; SCHNEIDER H, 1981, INT J PROD RES, V19, P615, DOI 10.1080/00207548108956694; Silver EA, 2012, J OPER RES SOC, V63, P941, DOI 10.1057/jors.2011.102; Silver EA, 2009, J OPER RES SOC, V60, P1244, DOI 10.1057/palgrave.jors.2602655; Silver E. A., 2017, INVENTORY PRODUCTION, V4th, DOI 10.1201/9781315374406; Silver E.A., 2017, INVENTORY PRODUCTION, V4; Syntetos AA, 2012, INT J PROD RES, V50, P2101, DOI 10.1080/00207543.2011.562561; Syntetos AA, 2005, J OPER RES SOC, V56, P495, DOI 10.1057/palgrave.jors.2601841; Tempelmeier H, 2007, EUR J OPER RES, V181, P184, DOI 10.1016/j.ejor.2006.06.009; Thomopoulos N., 2004, J BUS EC RES, V2, P87, DOI [10.19030/jber.v2i11.2942, DOI 10.19030/JBER.V2I11.2942]; TIJMS HC, 1984, EUR J OPER RES, V17, P175, DOI 10.1016/0377-2217(84)90232-7; VINCENT PA, 1985, INFOR, V23, P171	27	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263655	10.1371/journal.pone.0263655	http://dx.doi.org/10.1371/journal.pone.0263655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176051	Green Published, gold			2022-12-26	WOS:000777505200026
J	He, FP; Shen, MX; Zhao, ZX; Liu, YC; Zhang, SP; Tang, Y; Xie, HF; Chen, X; Li, J				He, Fanping; Shen, Minxue; Zhao, Zhixiang; Liu, Yicong; Zhang, Shuping; Tang, Yan; Xie, Hongfu; Chen, Xiang; Li, Ji			Epidemiology and disease burden of androgenetic alopecia in college freshmen in China: A population-based study	PLOS ONE			English	Article							PATTERN HAIR LOSS; PREVALENCE; MEN; ASSOCIATION; ADOLESCENTS; SMOKING; WOMEN	Objective To evaluate the epidemiology and disease burden of androgenetic alopecia (AGA) in college freshmen in China. Methods This population-based cross-sectional survey was carried out among 9227 freshmen of two comprehensive universities in two cities of China (Changsha and Xiamen) from September 2018 to October 2018. Questionnaires covering basic issues, surrounding demographic information, history of diseases, living habits, comorbidities, etc. were completed online in a self-reported manner Dermatological examination was performed by certified dermatologists. The disease burden of AGA, which includes health-related quality of life, symptoms of anxiety, symptoms of depression and quality of sleep, was measured by EQ-5D-3L, PHQ-2, GAD-2 and PSQI, respectively. Results The prevalence of AGA in college freshmen in China was 5.3/1000. Male was significantly associated with higher prevalence of AGA (7.9/1000, P<0.01) while female with lower risk of AGA (OR = 0.29, P = 0.002). There was no significant association between BMI and AGA, nor predilection of AGA in the Han nationality or the other ethnic minorities. Annual household income or parental highest educational level exerted no significant influence on the prevalence of AGA. Rosacea (OR = 3.22, P = 0.019) was significantly associated with higher prevalence of AGA while acne seemed not to be related to AGA. The scores of EQ-5D, GAD-2, PHQ-2 and PSQI were not significantly different between students with and without AGA. Conclusion The onset of AGA in Chinese college freshmen differ between genders and was significantly associated with rosacea.	[He, Fanping; Shen, Minxue; Zhao, Zhixiang; Liu, Yicong; Zhang, Shuping; Tang, Yan; Xie, Hongfu; Chen, Xiang; Li, Ji] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [He, Fanping; Zhao, Zhixiang; Tang, Yan; Xie, Hongfu; Li, Ji] Cent South Univ, Xiangya Hosp, Hunan Key Lab Aging Biol, Changsha, Hunan, Peoples R China; [He, Fanping; Li, Ji] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, X; Li, J (corresponding author), Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China.; Li, J (corresponding author), Cent South Univ, Xiangya Hosp, Hunan Key Lab Aging Biol, Changsha, Hunan, Peoples R China.; Li, J (corresponding author), Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Hunan, Peoples R China.	chenxiangck@126.com; liji_xy@csu.edu.cn	Shen, Minxue/P-5140-2019	Shen, Minxue/0000-0003-0441-9303; He, Fanping/0000-0002-6973-8789	Chinese government [2016YFC0900802]	Chinese government	This study was supported by a national grant by Chinese government called the National Key Research and Development Program Precision Medicine Initiative (2016YFC0900802) without financial conflicts.	[Anonymous], 2018, J PEDIATR-US; Bienenfeld A, 2019, J AM ACAD DERMATOL, V80, P1497, DOI 10.1016/j.jaad.2018.08.062; Birch MP, 2006, BRIT J DERMATOL, V154, P85, DOI 10.1111/j.1365-2133.2005.06953.x; Birch MP, 2001, EUR J DERMATOL, V11, P309; Blume-Peytavi U, 2011, BRIT J DERMATOL, V164, P5, DOI 10.1111/j.1365-2133.2010.10011.x; BONNAR E, 1993, J AM ACAD DERMATOL, V28, P443, DOI 10.1016/0190-9622(93)70065-2; Buysse D J, 1989, Psychiatry Res, V28, P193; Carmina E, 2019, J CLIN ENDOCR METAB, V104, P2875, DOI 10.1210/jc.2018-02548; Cousen P, 2010, BRIT J DERMATOL, V162, P1135, DOI 10.1111/j.1365-2133.2010.09661.x; Danesh-Shakiba M, 2020, CLIN COSMET INV DERM, V13, P137, DOI 10.2147/CCID.S231940; Davis D S, 2018, Int J Womens Dermatol, V4, P18, DOI 10.1016/j.ijwd.2017.11.007; Ding Q, 2020, J INT MED RES, V48, DOI 10.1177/0300060519897190; Fortes C, 2017, INT J DERMATOL, V56, P862, DOI 10.1111/ijd.13652; Forton F, 1998, AM J DERMATOPATH, V20, P536, DOI 10.1097/00000372-199810000-00023; Gan DC., 2005, MARYBOROUGH J INVEST, V10, P184, DOI [10.1111/j.1087-0024.2005.10102.x, DOI 10.1111/J.1087-0024.2005.10102.X]; Inui S, 2013, EXP DERMATOL, V22, P168, DOI 10.1111/exd.12024; Kim BJ, 2006, J DERMATOL, V33, P696, DOI 10.1111/j.1346-8138.2006.00161.x; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Liu LY, 2016, J AM ACAD DERMATOL, V75, P806, DOI 10.1016/j.jaad.2016.04.035; Millikan LE, 2001, INT J DERMATOL, V40, P475, DOI 10.1046/j.1365-4362.2001.01173-4.x; Nargis T, 2017, EARLY ONSET ANDROGEN; Norwood OTT., 2010, DERMATOL SURG, V26, P679; Ozturk P, 2014, J TRACE ELEM MED BIO, V28, P266, DOI 10.1016/j.jtemb.2014.03.003; Paik JH, 2001, BRIT J DERMATOL, V145, P95, DOI 10.1046/j.1365-2133.2001.04289.x; Price VH, 2003, J INVEST DERM SYMP P, V8, P24, DOI 10.1046/j.1523-1747.2003.12168.x; Qiuling Shi., 2013, J INVEST DERM SYMP P; Rajan A, 2019, CLIN EXP DERMATOL, V44, pE39, DOI 10.1111/ced.13848; Redler S, 2017, EXP DERMATOL, V26, P510, DOI 10.1111/exd.13373; Rencz F, 2016, BRIT J DERMATOL, V175, P561, DOI 10.1111/bjd.14497; Sawaya ME, 1997, J INVEST DERMATOL, V109, P296, DOI 10.1111/1523-1747.ep12335779; Schmidt TH, 2015, J AM ACAD DERMATOL, V73, P672, DOI 10.1016/j.jaad.2015.05.026; Severi G, 2003, BRIT J DERMATOL, V149, P1207, DOI 10.1111/j.1365-2133.2003.05565.x; Sinclair R, 2005, BRIT J DERMATOL, V152, P466, DOI 10.1111/J.1365-2133.2005.06218.X; Sinclair R, 1998, BRIT MED J, V317, P865, DOI 10.1136/bmj.317.7162.865; Singal A, 2013, INDIAN J DERMATOL VE, V79, P626, DOI 10.4103/0378-6323.116732; Staples LG, 2019, GEN HOSP PSYCHIAT, V56, P13, DOI 10.1016/j.genhosppsych.2018.11.003; Starace M, 2020, AM J CLIN DERMATOL, V21, P69, DOI 10.1007/s40257-019-00479-x; Su LH, 2007, ARCH DERMATOL, V143, P1401, DOI 10.1001/archderm.143.11.1401; Tabolli S, 2013, AM J CLIN DERMATOL, V14, P139, DOI 10.1007/s40257-013-0010-3; Wang TL, 2010, BRIT J DERMATOL, V162, P843, DOI 10.1111/j.1365-2133.2010.09640.x; Xiao Y, 2019, ACTA DERM-VENEREOL, V99, P321, DOI 10.2340/00015555-3104; Xu F, 2009, BRIT J DERMATOL, V160, P629, DOI 10.1111/j.1365-2133.2008.08909.x; Yamazaki M, 2011, J DERMATOL, V38, P773, DOI 10.1111/j.1346-8138.2010.01126.x; Zari Javidi, 2008, Indian J Dermatol, V53, P64, DOI 10.4103/0019-5154.41647; Zhao YE, 2010, ARCH DERMATOL, V146, P896, DOI 10.1001/archdermatol.2010.196	45	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263912	10.1371/journal.pone.0263912	http://dx.doi.org/10.1371/journal.pone.0263912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171966	Green Published, gold			2022-12-26	WOS:000795889700045
J	Kim, SS; Kycia, I; Karski, M; Ma, RK; Bordt, EA; Kwan, J; Karki, A; Winter, E; Aktas, RG; Wu, YX; Emili, A; Bauer, DE; Sethupathy, P; Vakili, K				Kim, Stephanie S.; Kycia, Ina; Karski, Michael; Ma, Rosanna K.; Bordt, Evan A.; Kwan, Julian; Karki, Anju; Winter, Elle; Aktas, Ranan G.; Wu, Yuxuan; Emili, Andrew; Bauer, Daniel E.; Sethupathy, Praveen; Vakili, Khashayar			DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROTEIN-KINASE; CYCLIC-AMP; TUMOR; LIVER; FUSION; BAG-1; INHIBITION; TRANSCRIPT; PROVIDES	Fibrolamellar carcinoma (FLC) is a primary liver cancer that most commonly arises in adolescents and young adults in a background of normal liver tissue and has a poor prognosis due to lack of effective chemotherapeutic agents. The DNAJB1-PRKACA gene fusion (DP) has been reported in the majority of FLC tumors; however, its oncogenic mechanisms remain unclear. Given the paucity of cellular models, in particular FLC tumor cell lines, we hypothesized that engineering the DP fusion gene in HEK293T cells would provide insight into the cellular effects of the fusion gene. We used CRISPR/ Cas9 to engineer HEK293T clones expressing DP fusion gene (HEK-DP) and performed transcriptomic, proteomic, and mitochondrial studies to characterize this cellular model. Proteomic analysis of DP interacting partners identified mitochondrial proteins as well as proteins in other subcellular compartments. HEK-DP cells demonstrated significantly elevated mitochondrial fission, which suggests a role for DP in altering mitochondrial dynamics. Transcriptomic analysis of HEK-DP cells revealed a significant increase in LINC00473 expression, similar to what has been observed in primary FLC samples. LINC00473 overexpression was reversible with siRNA targeting of PRKACA as well as pharmacologic targeting of PKA and Hsp40 in HEK-DP cells. Therefore, our model suggests that LINC00473 is a candidate marker for DP activity.	[Kim, Stephanie S.; Kycia, Ina; Karski, Michael; Karki, Anju; Winter, Elle; Aktas, Ranan G.; Vakili, Khashayar] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Ma, Rosanna K.; Sethupathy, Praveen] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Bordt, Evan A.] Harvard Med Sch, Lurie Ctr Autism, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Kwan, Julian; Emili, Andrew] Boston Univ, Sch Med, Dept Biochem, Ctr Networks Syst Biol, Boston, MA 02118 USA; [Wu, Yuxuan; Bauer, Daniel E.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Wu, Yuxuan; Bauer, Daniel E.] Broad Inst, Harvard Stem Cell Inst, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA; [Wu, Yuxuan; Bauer, Daniel E.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Cornell University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Vakili, K (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.	khashayar.vakili@children.harvard.edu			Tisch Families' Faculty Development Fund; CHMC Surgical Foundation, Inc.	Tisch Families' Faculty Development Fund; CHMC Surgical Foundation, Inc.	This work was supported by the Tisch Families' Faculty Development Fund and CHMC Surgical Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer YO, 2018, BBA-BIOENERGETICS, V1859, P868, DOI 10.1016/j.bbabio.2018.04.005; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Chen ZR, 2016, J CLIN INVEST, V126, P2267, DOI 10.1172/JCI85250; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; CRAIG JR, 1980, CANCER, V46, P372, DOI 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S; Dinh TA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.073; Dinh TA, 2019, CELL MOL GASTROENTER, V7, P803, DOI 10.1016/j.jcmgh.2019.01.008; Dinh TA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44653; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engelholm LH, 2017, GASTROENTEROLOGY, V153, P1662, DOI 10.1053/j.gastro.2017.09.008; FARHI DC, 1983, CANCER, V52, P1516, DOI 10.1002/1097-0142(19831015)52:8<1516::AID-CNCR2820520831>3.0.CO;2-N; Graham Rondell P, 2018, Surg Pathol Clin, V11, P377, DOI 10.1016/j.path.2018.02.006; He J, 2019, CANCER LETT, V450, P98, DOI 10.1016/j.canlet.2019.02.033; Hohfeld J, 1998, BIOL CHEM, V379, P269; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Jewell ML, 2020, AM J PATHOL, V190, P93, DOI 10.1016/j.ajpath.2019.09.018; Karki A, 2019, ONCOL REP, V42, P1487, DOI 10.3892/or.2019.7241; Kastenhuber ER, 2017, P NATL ACAD SCI USA, V114, P13076, DOI 10.1073/pnas.1716483114; Katzenstein HM, 2003, CANCER-AM CANCER SOC, V97, P2006, DOI 10.1002/cncr.11292; Kwan J, 2016, GENE DEV, V30, P2696, DOI 10.1101/gad.284539.116; LaQuaglia MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30238; Li YW, 2019, MOL MED REP, V19, P3367, DOI 10.3892/mmr.2019.10041; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Meng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.32; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Mo JG, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109403; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Reitmair A, 2012, PHYSIOL GENOMICS, V44, P152, DOI 10.1152/physiolgenomics.00089.2011; Reitmair A, 2010, PHYSIOL GENOMICS, V42, P348, DOI 10.1152/physiolgenomics.00012.2010; Riggle KM, 2016, PEDIATR RES, V80, P110, DOI 10.1038/pr.2016.36; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Suzuki M, 2011, CANCER LETT, V303, P65, DOI 10.1016/j.canlet.2011.01.019; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Turnham RE, 2019, ELIFE, V8, DOI 10.7554/eLife.44187; Wang L, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180790; Weeda VB, 2013, EUR J CANCER, V49, P2698, DOI 10.1016/j.ejca.2013.04.012; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xu L, 2015, HUM MOL GENET, V24, P50, DOI 10.1093/hmg/ddu418; Yao RW, 2019, NAT CELL BIOL, V21, P542, DOI 10.1038/s41556-019-0311-8; Yokota S, 2000, CANCER RES, V60, P2942; Zhou WY, 2019, J CELL PHYSIOL, V234, P23176, DOI 10.1002/jcp.28884	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263829	10.1371/journal.pone.0263829	http://dx.doi.org/10.1371/journal.pone.0263829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167623	Green Submitted, gold, Green Published			2022-12-26	WOS:000802227200020
J	Roberts, HA; Clark, DA; Kalina, C; Sherman, C; Brislin, S; Heitzeg, MM; Hicks, BM				Roberts, Hannah A.; Clark, D. Angus; Kalina, Claire; Sherman, Carter; Brislin, Sarah; Heitzeg, Mary M.; Hicks, Brian M.			To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability	PLOS ONE			English	Article							PUBLIC-HEALTH; DEPRESSION	The novel coronavirus (COVID-19) is a highly contagious disease responsible for millions of deaths worldwide. Effective vaccines against COVID-19 are now available, however, an extreme form of vaccine hesitancy known as anti-vaxattitudes challenge vaccine acceptance and distribution efforts. To understand these anti-vax attitudes and their associated psychological characteristics, we examined several predictors of vaccine hesitancy for COVID-19 and anti-vax attitudes generally. We surveyed 1004 adults (M = 47.0 years, SD = 17.1 years, range 18-98 years) in September-October 2020 across the United States (51% female, 49% male; 76.5% White, 23.5% non-White), prior to widespread availability of the COVID-19 vaccines. Attitudes toward vaccinations were influenced by a variety of factors, especially political attitudes. We should therefore anticipate and attempt to mitigate these challenges to achieving widespread vaccination to reduce the spread of COVID-19 and other communicable diseases.	[Roberts, Hannah A.] Temple Univ, Dept Psychol & Neurosci, Philadelphia, PA 19122 USA; [Clark, D. Angus; Kalina, Claire; Sherman, Carter; Heitzeg, Mary M.; Hicks, Brian M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Brislin, Sarah] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan; Virginia Commonwealth University	Roberts, HA (corresponding author), Temple Univ, Dept Psychol & Neurosci, Philadelphia, PA 19122 USA.; Hicks, BM (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	hannah.roberts0005@temple.edu; brianhic@med.umich.edu		, Hannah/0000-0003-4518-3210; , Carter/0000-0003-4837-9534	United States Public Health Service [R01 AA024433, R01 AA02579, T32 AA007477]; National Institute on Alcohol Abuse and Alcoholism	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Public Health Service grants R01 AA024433 (BH), R01 AA02579 (MH), and T32 AA007477 (Blow) from the National Institute on Alcohol Abuse and Alcoholism.	Allington D, 2021, PSYCHOL MED, DOI 10.1017/S0033291721001434; Altemeyer R., 1981, RIGHT WING AUTHORITA; [Anonymous], 2022, NYTIMES; [Anonymous], 2020, CHANG US EL RAC ED R; Artiga S., 2020, ADDRESSING RACIAL EQ; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Brennen J, 2020, US; Bulatao RA, 2004, UNDERSTANDING RACIAL; Callaghan T, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113638; Carpiano RM, 2019, PREV MED, V123, P278, DOI 10.1016/j.ypmed.2019.03.033; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Centers for Disease Control and Prevention (CDC), 2011, SUST ESS INN FUT; Chang J, 2020, AUTISM RES, V13, P1790, DOI 10.1002/aur.2339; Eggertson L, 2010, CAN MED ASSOC J, V182, pE199, DOI 10.1503/cmaj.109-3179; Falk CF, 2018, STRUCT EQU MODELING, V25, P244, DOI 10.1080/10705511.2017.1367254; Fronstin P., 2020, MANY AMERICANS HAVE; Gellin BG, 2000, PEDIATRICS, V106, P1097, DOI 10.1542/peds.106.5.1097; Germani F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247642; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Hellinger D. C., 2018, CONSPIRACIES CONSPIR; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Houts C., 2020, FLEXIBLE MULTILEVEL; Jones J., 2019, GALLUP NEWS SERVICE; Joslyn MR, 2019, AM POLIT RES, V47, P628, DOI 10.1177/1532673X17745342; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Kumar S., 2007, FITNESS PRACTICE PAN, P1; Ladouceur C. D., 2020, COVID 19 ADOLESCENT; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; MacFarquhar N., 2021, NYTIMES; Makarovs K, 2017, SOC SCI MED, V188, P1, DOI 10.1016/j.socscimed.2017.06.039; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Meghani SH, 2012, PAIN MED, V13, P150, DOI 10.1111/j.1526-4637.2011.01310.x; Motta M, 2018, AM POLIT RES, V46, P465, DOI 10.1177/1532673X17719507; Muthen LK., 2017, MPLUS, VEight; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONS SMOK 50 YE; Ndugga Nambi, 2022, LATEST DATA COVID 19; Noonan AS, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0025-4; Olive JK, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002578; Parker K., 2020, EC FALLOUT COVID 19; Ranji U., 2020, RACIAL DISPARITIES M; Reich JA, 2014, GENDER SOC, V28, P679, DOI 10.1177/0891243214532711; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Shearer E, 2021, NEWS USE SOCIAL MEDI; Soto CJ, 2017, J RES PERS, V68, P69, DOI 10.1016/j.jrp.2017.02.004; Stern AM, 2005, HEALTH AFFAIR, V24, P611, DOI 10.1377/hlthaff.24.3.611; Tyson A., 2020, REPUBLICANS REMAIN F; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265; Watson D, 2007, PSYCHOL ASSESSMENT, V19, P253, DOI 10.1037/1040-3590.19.3.253; WHO, 2019, 10 HLTH ISSUES WHO W; Wolfe RM, 2002, BMJ-BRIT MED J, V325, P430, DOI 10.1136/bmj.325.7361.430; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248	51	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264019	10.1371/journal.pone.0264019	http://dx.doi.org/10.1371/journal.pone.0264019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167612	Green Published, gold			2022-12-26	WOS:000802227200034
J	Ashcroft, P; Lehtinen, S; Bonhoeffer, S				Ashcroft, Peter; Lehtinen, Sonja; Bonhoeffer, Sebastian			Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification	PLOS ONE			English	Article							TRANSMISSION	The test-trace-isolate-quarantine (TTIQ) strategy, where confirmed-positive pathogen carriers are isolated from the community and their recent close contacts are identified and pre-emptively quarantined, is used to break chains of transmission during a disease outbreak. The protocol is frequently followed after an individual presents with disease symptoms, at which point they will be tested for the pathogen. This TTIQ strategy, along with hygiene and social distancing measures, make up the non-pharmaceutical interventions that are utilised to suppress the ongoing COVID-19 pandemic. Here we develop a tractable mathematical model of disease transmission and the TTIQ intervention to quantify how the probability of detecting and isolating a case following symptom onset, the fraction of contacts that are identified and quarantined, and the delays inherent to these processes impact epidemic growth. In the model, the timing of disease transmission and symptom onset, as well as the frequency of asymptomatic cases, is based on empirical distributions of SARS-CoV-2 infection dynamics, while the isolation of confirmed cases and quarantine of their contacts is implemented by truncating their respective infectious periods. We find that a successful TTIQ strategy requires intensive testing: the majority of transmission is prevented by isolating symptomatic individuals and doing so in a short amount of time. Despite the lesser impact, additional contact tracing and quarantine increases the parameter space in which an epidemic is controllable and is necessary to control epidemics with a high reproductive number. TTIQ could remain an important intervention for the foreseeable future of the COVID-19 pandemic due to slow vaccine rollout and highly-transmissible variants with the potential for vaccine escape. Our results can be used to assess how TTIQ can be improved and optimised, and the methodology represents an improvement over previous quantification methods that is applicable to future epidemic scenarios.	[Ashcroft, Peter; Lehtinen, Sonja; Bonhoeffer, Sebastian] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ashcroft, P; Bonhoeffer, S (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	peter.ashcroft@env.ethz.ch; seb@env.ethz.ch	Ashcroft, Peter/U-6951-2018	Ashcroft, Peter/0000-0003-4067-7692; Lehtinen, Sonja/0000-0002-4236-828X	Swiss National Science Foundation [310030B_176401]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (grant no. 310030B_176401, awarded to SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Alizon S., 2021, MEDRXIV, DOI [10.1101/2021.06.16.21259052, DOI 10.1101/2021.06.16.21259052]; Althaus CL., 2021, TALE 2 VARIANTS SPRE, DOI [10.1101/2021.06.10.21258468, DOI 10.1101/2021.06.10.21258468V1]; [Anonymous], 2020, PEDIATR MED RODZ, V16, P33, DOI 10.15557/PiMR.2020.0005; Ashcroft P, 2021, ELIFE, V10, DOI 10.7554/eLife.63704; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Contreras S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20699-8; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Grantz KH, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003585; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hill EM, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009058; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Ledda V., 2020, TIMING COVID 19 TRAN, DOI [10.1101/2020.09.04.20188516, DOI 10.1101/2020.09.04.20188516, DOI 10.1101/2020.09.04.20188516V2]; Lehtinen S, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2020.0756; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Marcel S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20225; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; Pavelka M, 2021, SCIENCE, V372, P635, DOI 10.1126/science.abf9648; Peter A, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20336; Quilty BJ, 2021, LANCET PUBLIC HEALTH, V6, pE175, DOI 10.1016/S2468-2667(20)30308-X; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Sonabend R, 2021, LANCET, V398, P1825, DOI 10.1016/S0140-6736(21)02276-5	29	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263597	10.1371/journal.pone.0263597	http://dx.doi.org/10.1371/journal.pone.0263597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148359	Green Published, gold			2022-12-26	WOS:000800108800022
J	Balasubramanian, SL; Krishnamurthi, G				Balasubramanian, Swathi Lakshmi; Krishnamurthi, Ganapathy			X-ray scintillator lens-coupled with CMOS camera for pre-clinical cardiac vascular imaging-A feasibility study	PLOS ONE			English	Article							MICRO-CT; ANGIOGRAPHY; EFFICIENCY; DETECTORS	We present the design and characterization of an X-ray imaging system consisting of an off-the-shelf CMOS sensor optically coupled to a CsI scintillator. The camera can perform both high-resolution and functional cardiac imaging. High-resolution 3D imaging requires microfocus X-ray tubes and expensive detectors, while pre-clinical functional cardiac imaging requires high flux pulsed (clinical) X-ray tubes and high-end cameras. Our work describes an X-ray camera, namely an "optically coupled X-ray(OCX) detector," used for both the aforementioned applications with no change in the specifications. We constructed the imaging detector with two different CMOS optical imaging cameras called CMOS sensors, 1.A monochrome CMOS sensor coupled with an f1.4 lens and 2.an RGB CMOS sensor coupled with an f0.95 prime lens. The imaging system consisted of our X-ray camera, micro-focus X-ray source (50kVp and 1mA), and a rotary stage controlled from a personal computer (PC) and LabVIEW interface. The detective quantum efficiency (DQE) of the imaging system(monochrome) estimated using a cascaded linear model was 17% at 10 lp/mm. The system modulation transfer function (MTF) and the noise power spectrum (NPS) were inputs to the DQE estimation. Because of the RGB camera's low quantum efficiency (QE), the OCX detector DQE was 19% at 5 lp/mm. The contrast to noise ratio (CNR) at different frame rates was studied using the capillary tubes filled with various dilutions of iodinated contrast agents. In-vivo cardiac angiography demonstrated that blood vessels of the order of 100 microns or above were visible at 40 frames per second despite the low X-ray flux. For high-resolution 3D imaging, the system was characterized by imaging a cylindrical micro-CT contrast phantom and comparing it against images from a commercial scanner.	[Balasubramanian, Swathi Lakshmi; Krishnamurthi, Ganapathy] Indian Inst Technol Madras, Dept Engn Design, Chennai, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Krishnamurthi, G (corresponding author), Indian Inst Technol Madras, Dept Engn Design, Chennai, Tamil Nadu, India.	gankrish@iitm.ac.in			Department of science technology [EMR/2016/007723, IDP/MED/57/2016]	Department of science technology(Department of Science & Technology (India))	This research was fully funded by Department of science & technology, sanction number: EMR/2016/007723 and IDP/MED/57/2016. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea C, 2004, MED PHYS, V31, P3324, DOI 10.1118/1.1812604; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; Bartling SH, 2007, INVEST RADIOL, V42, P704, DOI 10.1097/RLI.0b013e318070dcad; De Lin M, 2006, MED PHYS, V33, P4249, DOI 10.1118/1.2356646; Dinkel J, 2008, CIRC-CARDIOVASC IMAG, V1, P235, DOI 10.1161/CIRCIMAGING.108.784702; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Ganguly A, 2003, MED PHYS, V30, P3029, DOI 10.1118/1.1617550; Gruner SM, 2002, REV SCI INSTRUM, V73, P2815, DOI 10.1063/1.1488674; Guo X, 2002, AM J PHYSIOL-HEART C, V283, pH1829, DOI 10.1152/ajpheart.00224.2002; Helen XF, 2015, THESIS U ARIZONA; Howansky A, 2015, PROC SPIE, V9412, DOI 10.1117/12.2082101; Jain A, 2011, MED PHYS, V38, P4112, DOI 10.1118/1.3599751; Jerrold TB., 2011, ESSENTIAL PHYS MED I, V3 rd; Jing ZX, 1998, P SOC PHOTO-OPT INS, V3336, P583, DOI 10.1117/12.317062; Kanefuji T, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.29; KOCH A, 1994, NUCL INSTRUM METH A, V348, P654, DOI 10.1016/0168-9002(94)90818-4; Kuntz J, 2010, PHYS MED BIOL, V55, P2069, DOI 10.1088/0031-9155/55/7/018; Lakshmi BS, 2017, PROC SPIE, V10132, DOI 10.1117/12.2254541; Larsson JC, 2016, MED PHYS, V43, P2731, DOI 10.1118/1.4948687; LIU H, 1994, MED PHYS, V21, P1193, DOI 10.1118/1.597352; METZ CE, 1979, PHYS MED BIOL, V24, P1079, DOI 10.1088/0031-9155/24/6/001; Nagarkar VV, 1998, IEEE T NUCL SCI, V45, P492, DOI 10.1109/23.682433; Nikl M, 2006, MEAS SCI TECHNOL, V17, pR37, DOI 10.1088/0957-0233/17/4/R01; Ren Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/495729; Rocha JG, 2004, IEEE SENSOR, P1257, DOI 10.1109/ICSENS.2004.1426409; Sato M, 2018, J PHARMACOL SCI, V137, P177, DOI 10.1016/j.jphs.2018.06.009; Sawall S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73735-4; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Tapiovaara M, 2003, MEAS SCI TECHNOL; Uesugi K, 2011, J SYNCHROTRON RADIAT, V18, P217, DOI 10.1107/S0909049510044523; Vedantham S, 2004, MED PHYS, V31, P1258, DOI 10.1118/1.1689014; Wang XL, 2011, MED PHYS, V38, P1534, DOI 10.1118/1.3553401; Xie HL, 2019, J SYNCHROTRON RADIAT, V26, P1631, DOI 10.1107/S1600577519010075; Yang K, 2006, MED PHYS, V33, P1695, DOI 10.1118/1.2198187; Yang M., 2006, MED IMAGING, V6142, P1, DOI [10.1117/12.656690, DOI 10.1117/12.656690]; Zhu SP, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/960573	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0262913	10.1371/journal.pone.0262913	http://dx.doi.org/10.1371/journal.pone.0262913			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148354	gold, Green Published			2022-12-26	WOS:000800108800015
J	Aeschimann, E; Sanchez, O; Birraux, J; Wildhaber, BE; Manzano, S				Aeschimann, Eva; Sanchez, Oliver; Birraux, Jacques; Wildhaber, Barbara E.; Manzano, Sergio			How useful is a complete urinary tract ultrasound in orchiepididymitis?	PLOS ONE			English	Article							ACUTE EPIDIDYMITIS; CHILDREN; BOYS; MANAGEMENT; ANOMALIES; INFANTS	Orchiepididymitis (OE) is a frequent cause of pediatric emergency department attendance in boys presenting with acute scrotum. The etiology of most episodes of OE remains unclear and there is no consensus regarding the correlation between OE and underlying genitourinary malformations. Whether imaging evaluation should comprise complete urinary tract ultrasonography (US) or voiding cystography is a subject of debate. The aim of this retrospective, single-center study was to analyze i) the number/type of urinary tract malformations detected by US following a first episode of OE in boys with no previously known malformation and ii) the frequency of associated urinary tract infection (UTI). We reviewed the records of 495 boys <16 years presenting to our pediatric emergency department with acute scrotum between January 2012 and December 2017. Patients with incomplete radiological data were excluded. Of 119 boys with a radiologically-confirmed first episode of OE, 99 had a complete urinary tract US and were included in the study. No genitourinary malformation was detected (0%). Urinary cultures showed UTI in 3/98 (3.1%) patients. Mean age at presentation was 9.7 years (standard deviation, 3.9) with a three-peak incidence of OE at 10-13 years, 4-5 years, and during infancy. Conclusion: Complete urinary tract US does not appear to be useful during a first episode of OE in countries with an antenatal US screening rate similar to Switzerland. The very low UTI rate suggests that a urinalysis is sufficient to investigate a first episode of OE and antibiotics should be reserved for positive urinalysis only.	[Aeschimann, Eva; Manzano, Sergio] Univ Geneva, Geneva Univ Hosp, Dept Pediat Gynecol & Obstet, Pediat Emergency Div, Geneva, Switzerland; [Sanchez, Oliver] Univ Ctr Pediat Surg Western Switzerland, Dept Pediat Gynecol & Obstet, Div Childs & Adolescents Surg, Lausanne, Switzerland; [Birraux, Jacques; Wildhaber, Barbara E.] Univ Geneva, Univ Ctr Pediat Surg Western Switzerland, Dept Pediat Gynecol & Obstet, Div Childs & Adolescents Surg, Geneva, Switzerland	University of Geneva; University of Geneva	Aeschimann, E (corresponding author), Univ Geneva, Geneva Univ Hosp, Dept Pediat Gynecol & Obstet, Pediat Emergency Div, Geneva, Switzerland.	eva.aeschimann@hcuge.ch	Manzano, Sergio/ABG-6281-2020	Manzano, Sergio/0000-0001-9603-5520; Sanchez, Oliver/0000-0003-0008-7436				Al-Taheini KM, 2008, UROLOGY, V71, P826, DOI 10.1016/j.urology.2007.10.071; BUKOWSKI TP, 1995, J UROLOGY, V154, P762, DOI 10.1016/S0022-5347(01)67156-8; Cappele O, 2000, EUR UROL, V38, P627, DOI 10.1159/000020343; Confederation S, 2014, FED ACT RES INV HUM, P122; Cristoforo TA., 2017, PEDIAT EMERGENCY CAR, V00, P1; GISLASON T, 1980, J UROLOGY, V124, P533, DOI 10.1016/S0022-5347(17)55528-7; Gkentzis A, 2014, ANN ROY COLL SURG, V96, P181, DOI 10.1308/003588414X13814021679311; Graumann LA, 2010, EUR J PEDIATR SURG, V20, P247, DOI 10.1055/s-0030-1253356; Haecker FM, 2005, EUR J PEDIATR SURG, V15, P180, DOI 10.1055/s-2004-830355; Halachmi SKN., 2013, EPIDEMIOLOGY ETIOLOG, V2013, P96; Joo JM, 2013, KOREAN J UROL, V54, P135, DOI 10.4111/kju.2013.54.2.135; Karmazyn B, 2009, PEDIATR RADIOL, V39, P1054, DOI 10.1007/s00247-009-1326-2; Kwong J, 2013, UROLOGY, V82, P225, DOI 10.1016/j.urology.2013.01.032; Lee YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194761; LEWIS AG, 1995, J PEDIATR SURG, V30, P277, DOI 10.1016/0022-3468(95)90574-X; McAndrew HF, 2002, PEDIATR SURG INT, V18, P435, DOI 10.1007/s00383-002-0806-3; Mcconaghy JR., 2016, EPIDIDYMITIS OVERVIE; Merlini E, 1998, SCAND J UROL NEPHROL, V32, P273; O'Brien M., 2008, SURGERY, V26, P279; Raveenthiran V, 2011, J UROLOGY, V186, P1467, DOI 10.1016/j.juro.2011.05.066; Redshaw JD, 2014, J UROLOGY, V192, P1203, DOI 10.1016/j.juro.2014.04.002; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Santillanes G, 2011, PEDIATR EMERG CARE, V27, P174, DOI 10.1097/PEC.0b013e31820d647a; SIEGEL A, 1987, J UROLOGY, V138, P1100, DOI 10.1016/S0022-5347(17)43514-2; Somekh E, 2004, J UROLOGY, V171, P391, DOI 10.1097/01.ju.0000102160.55494.1f	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263934	10.1371/journal.pone.0263934	http://dx.doi.org/10.1371/journal.pone.0263934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143594	gold, Green Published			2022-12-26	WOS:000797657800091
J	Bassi, J; Giannini, O; Silacci-Fregni, C; Pertusini, L; Hitz, P; Terrot, T; Franzosi, Y; Muoio, F; Saliba, C; Meury, M; Dellota, EA; Dillen, JR; Hernandez, P; Czudnochowski, N; Cameroni, E; Beria, N; Ventresca, M; Badellino, A; Lavorato-Hadjeres, S; Lecchi, E; Bonora, T; Mattiolo, M; Trinci, G; Garzoni, D; Bonforte, G; Forni-Ogna, V; Giunzioni, D; Berwert, L; Gupta, RK; Ferrari, P; Ceschi, A; Cippa, P; Corti, D; Lanzavecchia, A; Piccoli, L				Bassi, Jessica; Giannini, Olivier; Silacci-Fregni, Chiara; Pertusini, Laura; Hitz, Paolo; Terrot, Tatiana; Franzosi, Yves; Muoio, Francesco; Saliba, Christian; Meury, Marcel; Dellota, Exequiel A., Jr.; Dillen, Josh R.; Hernandez, Patrick; Czudnochowski, Nadine; Cameroni, Elisabetta; Beria, Nicola; Ventresca, Mariangela; Badellino, Alberto; Lavorato-Hadjeres, Soraya; Lecchi, Elisabetta; Bonora, Tecla; Mattiolo, Matteo; Trinci, Guido; Garzoni, Daniela; Bonforte, Giuseppe; Forni-Ogna, Valentina; Giunzioni, Davide; Berwert, Lorenzo; Gupta, Ravindra K.; Ferrari, Paolo; Ceschi, Alessandro; Cippa, Pietro; Corti, Davide; Lanzavecchia, Antonio; Piccoli, Luca			Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; KIDNEY-TRANSPLANT; COVID-19; IMMUNOGENICITY; MORTALITY	Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is required to guide prophylactic and therapeutic COVID-19 interventions in this frail population. By analyzing plasma samples from 130 hemodialysis and 13 peritoneal dialysis patients after two doses of BNT162b2 or mRNA-1273 vaccines, we found that 35% of the patients had low-level or undetectable IgG antibodies to SARS-CoV-2 Spike (S). Neutralizing antibodies against the vaccine-matched SARS-CoV-2 and Delta variant were low or undetectable in 49% and 77% of patients, respectively, and were further reduced against other emerging variants. The fraction of non-responding patients was higher in SARS-CoV2-nafive hemodialysis patients immunized with BNT162b2 (66%) than those immunized with m RNA 1273 (23%). The reduced neutralizing activity correlated with low antibody avidity. Patients followed up to 7 months after vaccination showed a rapid decay of the antibody response with an average 21- and 10-fold reduction of neutralizing antibodies to vaccinematched SARS-CoV-2 and Delta variant, which increased the fraction of non-responders to 84% and 90%, respectively. These data indicate that dialysis patients should be prioritized for additional vaccination boosts. Nevertheless, their antibody response to SARS-CoV-2 must be continuously monitored to adopt the best prophylactic and therapeutic strategy.	[Bassi, Jessica; Silacci-Fregni, Chiara; Muoio, Francesco; Saliba, Christian; Cameroni, Elisabetta; Corti, Davide; Lanzavecchia, Antonio; Piccoli, Luca] Humabs BioMed SA, Subsidiary Vir Biotechnol, Bellinzona, Switzerland; [Giannini, Olivier; Hitz, Paolo; Ferrari, Paolo; Ceschi, Alessandro] Univ Svizzera Italiana, Fac Biomed Sci, Lugano, Switzerland; [Giannini, Olivier; Cippa, Pietro] Ente Osped Cantonale, Dept Med, Bellinzona, Switzerland; [Pertusini, Laura; Beria, Nicola; Ventresca, Mariangela; Badellino, Alberto; Lavorato-Hadjeres, Soraya; Lecchi, Elisabetta; Bonora, Tecla; Mattiolo, Matteo; Trinci, Guido; Garzoni, Daniela; Bonforte, Giuseppe; Forni-Ogna, Valentina; Giunzioni, Davide; Berwert, Lorenzo; Ferrari, Paolo; Cippa, Pietro] Ente Osped Cantonale, Div Nephrol, Lugano, Switzerland; [Terrot, Tatiana; Franzosi, Yves; Ceschi, Alessandro] Ente Osped Cantonale, Clin Trial Unit, Lugano, Switzerland; [Meury, Marcel; Dellota, Exequiel A., Jr.; Dillen, Josh R.; Hernandez, Patrick; Czudnochowski, Nadine] Vir Biotechnol, San Francisco, CA 94158 USA; [Gupta, Ravindra K.] Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England; [Gupta, Ravindra K.] Univ Cambridge, Dept Med, Cambridge, England; [Ferrari, Paolo] Univ New South Wales, Clin Sch, Sydney, NSW, Australia; [Ceschi, Alessandro] Ente Osped Cantonale, Inst Pharmacol Sci Southern Switzerland, Div Clin Pharmacol & Toxicol, Lugano, Switzerland; [Ceschi, Alessandro] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland; [Cippa, Pietro] Univ Zurich, Fac Med, Zurich, Switzerland	Universita della Svizzera Italiana; University of Cambridge; University of New South Wales Sydney; University of Zurich; University Zurich Hospital; University of Geneva; University of Zurich	Piccoli, L (corresponding author), Humabs BioMed SA, Subsidiary Vir Biotechnol, Bellinzona, Switzerland.; Forni-Ogna, V (corresponding author), Ente Osped Cantonale, Div Nephrol, Lugano, Switzerland.; Hernandez, P (corresponding author), Vir Biotechnol, San Francisco, CA 94158 USA.	patrick.hernandez1@gmail.com; valentina.forniogna@eoc.ch; lpiccoli@vir.bio		Muoio, Francesco/0000-0003-4963-8665	Swiss Kidney Foundation; G2P-UK National Virology consortium - MRC/UKRI [MR/W005611/1]	Swiss Kidney Foundation; G2P-UK National Virology consortium - MRC/UKRI	The project was partially funded by the Swiss Kidney Foundation (to O.G.). R.K.G. received support from the G2P-UK National Virology consortium funded by MRC/UKRI (grant ref. MR/W005611/1).	Abe KT., 2021, MEDRXIV, DOI [10.1101/2021.08.06.21261721, DOI 10.1101/2021.08.06.21261721]; Alcazar-Arroyo R, 2021, CLIN KIDNEY J, V14, P1835, DOI 10.1093/ckj/sfab048; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Anderegg MA, 2021, KIDNEY INT, V100, P474, DOI 10.1016/j.kint.2021.05.016; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bauer G, 2021, J MED VIROL, V93, P3092, DOI 10.1002/jmv.26863; Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P2204, DOI 10.1001/jama.2021.7489; Butt AA, 2021, ANN INTERN MED, V174, P1404, DOI 10.7326/M21-1577; Carr EJ, 2021, LANCET, V398, P1038, DOI 10.1016/S0140-6736(21)01854-7; Chan LL, 2021, CLIN J AM SOC NEPHRO, V16, P1258, DOI 10.2215/CJN.04080321; Chapin-Bardales J, 2021, JAMA-J AM MED ASSOC, V325, P2201, DOI 10.1001/jama.2021.5374; Chaves SS, 2011, VACCINE, V29, P9618, DOI 10.1016/j.vaccine.2011.10.057; Cippa PE, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016877118; Clarke CL, 2021, KIDNEY INT, V99, P1470, DOI 10.1016/j.kint.2021.03.009; Cohn BA, 2022, SCIENCE, V375, P331, DOI 10.1126/science.abm0620; Corbett RW, 2020, J AM SOC NEPHROL, V31, P1815, DOI 10.1681/ASN.2020040534; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Danthu C, 2021, J AM SOC NEPHROL, V32, P2154, DOI 10.1681/ASN.2021040490; Dekervel M, 2021, CLIN KIDNEY J, V14, P2349, DOI 10.1093/ckj/sfab152; Ducloux D, 2021, KIDNEY INT, V100, P702, DOI 10.1016/j.kint.2021.06.025; Espi M, 2022, KIDNEY INT, V101, P390, DOI 10.1016/j.kint.2021.10.040; Forloni Matteo, 2018, Cold Spring Harb Protoc, V2018, DOI 10.1101/pdb.prot097758; Gaspar EB, 2021, VACCINE, V39, P1473, DOI 10.1016/j.vaccine.2021.02.003; Genco F, 2019, NEW MICROBIOL, V42, P88; Gregson J, 2020, J INFECT DIS, V222, P1108, DOI 10.1093/infdis/jiz631; Grupper A, 2021, CLIN J AM SOC NEPHRO, V16, P1037, DOI 10.2215/CJN.03500321; Hazell Stuart L, 2007, Expert Opin Med Diagn, V1, P511, DOI 10.1517/17530059.1.4.511; Henry BM, 2020, INT UROL NEPHROL, V52, P1193, DOI 10.1007/s11255-020-02451-9; Hilbrands LB, 2020, NEPHROL DIAL TRANSPL, V35, P1973, DOI 10.1093/ndt/gfaa261; Ikizler TA, 2021, KIDNEY INT, V99, P1275, DOI 10.1016/j.kint.2021.04.007; Jager KJ, 2020, KIDNEY INT, V98, P1540, DOI 10.1016/j.kint.2020.09.006; Jahn M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040360; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7; Kliger AS, 2018, J AM SOC NEPHROL, V29, P1083, DOI 10.1681/ASN.2018020132; Krueger KM, 2020, AM J KIDNEY DIS, V75, P417, DOI 10.1053/j.ajkd.2019.06.014; Lacson E, 2021, J AM SOC NEPHROL, V32, P2735, DOI [10.1681/ASN.2021040432, 10.1101/2021.04.08.21254779]; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Longlune N, 2021, NEPHROL DIAL TRANSPL, V36, P1704, DOI 10.1093/ndt/gfab193; Louapre C, 2022, J NEUROL NEUROSUR PS, V93, P24, DOI 10.1136/jnnp-2021-326904; Malard F, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00534-z; Massa F, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103679; McCallum M, 2021, SCIENCE, V373, P648, DOI 10.1126/science.abi7994; Mlcochova P, 2021, NATURE, V599, P114, DOI 10.1038/s41586-021-03944-y; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, 2021, IMM INF DIS GREEN BO; Puranik A., 2021, MEDRXIV, DOI [10.1101/2021.08.06.21261707v3, DOI 10.1101/2021.08.06.21261707, 10.1101/2021.08.06.21261707]; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Richards NE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.24331; Rincon-Arevalo H, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1031; Robert T, 2022, NEPHROL DIAL TRANSPL, V37, P390, DOI 10.1093/ndt/gfab299; Robinson BM, 2021, KIDNEY MED, V3, P619, DOI 10.1016/j.xkme.2021.03.006; Roltgen K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0240; Schrezenmeier E, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.690698; Speer C, 2021, KIDNEY INT, V100, P700, DOI 10.1016/j.kint.2021.07.002; Steensels D, 2021, JAMA-J AM MED ASSOC, V326, P1533, DOI 10.1001/jama.2021.15125; Stumpf J, 2021, LANCET REG HEALTH-EU, V9, DOI 10.1016/j.lanepe.2021.100178; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Teimouri A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00505-20; The Renal Association B UK. UK Renal Registry, 2020, COVID 19 SURV REP RE; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Windpessl M, 2021, NAT REV NEPHROL, V17, P291, DOI 10.1038/s41581-021-00406-6; Zitt E, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.704773; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	67	8	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263328	10.1371/journal.pone.0263328	http://dx.doi.org/10.1371/journal.pone.0263328			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143540	Green Published, gold			2022-12-26	WOS:000797657800036
J	Riggs, GJ; Joshi, O; Loss, SR				Riggs, Georgia J.; Joshi, Omkar; Loss, Scott R.			Stakeholder perceptions of bird-window collisions	PLOS ONE			English	Article							BIOENERGY DEVELOPMENT; MORTALITY; CONSERVATION; SWOT; ANP; MANAGEMENT; CONFLICT; CATS; RISK	Bird-window collisions are a major source of human-caused avian mortality for which many mitigation and prevention options are available. However, because very little research has characterized human perspectives related to this issue, there is limited understanding about the most effective ways to engage the public in collision reduction efforts. To address this research need, we: (1) evaluated how two stakeholder groups, homeowners and conservation practitioners, prioritize potential benefits and obstacles related to bird-window collision management, (2) compared priorities between these groups, and (3) evaluated potential conflicts and collective strength of opinions within groups. We addressed these objectives by merging the strengths, weaknesses, opportunities, and threats (SWOT) and analytic hierarchy process (AHP) survey approaches. Specifically, survey respondents made pairwise comparisons between strengths and weaknesses (respectively, direct outcomes and barriers related to management, such as fewer collisions and increased costs) and opportunities and threats (indirect outcomes and barriers, such as increased bird populations and fewer resources for other building-related expenses). Both homeowners and conservation practitioners ranked strengths and opportunities higher than weaknesses and threats, indicating they have an overall positive perception toward reducing bird-window collisions. However, key obstacles that were identified included costs of management and a lack of policy and guidelines to require or guide management. These results suggest that substantial advances can be made to reduce bird-window collisions because both homeowners and conservation practitioners had positive views, suggesting their receptivity toward collision management measures. However, because of more neutral views and conflicting responses within the homeowner group, results also highlight the importance of targeting homeowners with education materials that provide information about bird-window collisions and solutions that reduce them. Because bird-window collisions are a human-caused phenomenon, such information about human perspectives and priorities will be crucial to addressing this threat and thus benefitting bird populations.	[Riggs, Georgia J.; Joshi, Omkar; Loss, Scott R.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Riggs, GJ (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	georgia.riggs@okstate.edu		Loss, Scott/0000-0002-8753-2995; Riggs, Georgia/0000-0002-3651-3727	Oklahoma State University Department of Natural Resource Ecology and Management; Hatch Grant from the USDA National Institute of Food and Agriculture [OKL02915, OKL03150]; SRL	Oklahoma State University Department of Natural Resource Ecology and Management; Hatch Grant from the USDA National Institute of Food and Agriculture; SRL	This research was funded by Oklahoma State University Department of Natural Resource Ecology and Management (https://go.okstate.edu/undergraduate-academics/majors/naturalresource-ecology-and-management.html) and Hatch Grant funding (grant numbers: OKL02915, OKL03150) from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/).Funding was obtained by SRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Bird Conservancy, 2022, GLASS COLL PREV BIRD; Arsic S, 2017, FOREST POLICY ECON, V80, P11, DOI 10.1016/j.forpol.2017.02.003; Aymi Raul, 2017, Revista Catalana d'Ornitologia, V33, P17; Bernard H. R., 2017, RES METHODS ANTHR; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Catron J, 2013, FOREST POLICY ECON, V28, P38, DOI 10.1016/j.forpol.2012.12.003; City of Toronto, 2021, BIRD FRIENDL GUID; Darko A, 2019, INT J CONSTR MANAG, V19, P436, DOI 10.1080/15623599.2018.1452098; Darshini D, 2013, ENERG POLICY, V62, P1128, DOI 10.1016/j.enpol.2013.07.017; Dillman D.A., 2014, TAILORED DESIGN METH; Dwivedi P, 2009, ENERG POLICY, V37, P1999, DOI 10.1016/j.enpol.2009.02.004; Facebook, 2022, US; Fatal Light Awareness Program Canada, 2019, US; Getzner M, 2018, FORESTS, V9, DOI 10.3390/f9090537; Gomez-Martinez MA, 2019, URBAN ECOSYST, V22, P699, DOI 10.1007/s11252-019-00858-6; Gramza A, 2016, CONSERV BIOL, V30, P276, DOI 10.1111/cobi.12631; Hager SB, 2017, BIOL CONSERV, V212, P209, DOI 10.1016/j.biocon.2017.06.014; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hedblom M., 2017, ECOLOGY CONSERVATION, P287; Hoffman AJ, 2008, ORGAN ENVIRON, V21, P390, DOI 10.1177/1086026608326129; Joshi O, 2022, INTERACT LEARN ENVIR, V30, P1402, DOI 10.1080/10494820.2020.1725896; Joshi O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203106; Kahle LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144600; Kim EM, 2013, FORKTAIL, P145; KLEM D, 1989, WILSON BULL, V101, P606; Klem D, 2015, J APPL ANIM WELF SCI, V18, pS11, DOI 10.1080/10888705.2015.1075832; Klem D, 2009, WILSON J ORNITHOL, V121, P314, DOI 10.1676/08-118.1; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Krejci J, 2018, EXPERT SYST APPL, V114, P97, DOI 10.1016/j.eswa.2018.06.060; Kudryavtsev A, 2012, ENVIRON EDUC RES, V18, P229, DOI 10.1080/13504622.2011.609615; Kummer JA, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00787-100206; Kurttila M., 2000, Forest Policy and Economics, V1, P41, DOI 10.1016/S1389-9341(99)00004-0; Lao S, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108358; Loss SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224164; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Lute ML, 2018, BIOL CONSERV, V218, P223, DOI 10.1016/j.biocon.2017.12.035; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Manfredo M., 2003, HUMAN DIMENSIONS WIL, V8, P219, DOI [10.1080/10871200304310, DOI 10.1080/10871200304310]; Margles S. W., 2010, Journal of Sustainable Forestry, V29, P613, DOI 10.1080/10549811003769483; Menacho-Odio R. M., 2018, UNED RES J, V10, P33; National Audubon Society, 2021, RED COLL GLASS; Nichols KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201558; Nielsen-Pincus M, 2017, SOC NATUR RESOUR, V30, P1423, DOI 10.1080/08941920.2017.1347976; Nyhus PJ, 2016, ANNU REV ENV RESOUR, V41, P143, DOI 10.1146/annurev-environ-110615-085634; Qualtrics, 2022, US; Regents of the University of Minnesota, 2017, B3 BUILD BENCHM; Riding Corey S., 2020, Condor, V122, P1; Saaty T. L., 2004, Journal of Systems Science and Systems Engineering, V13, P1, DOI 10.1007/s11518-006-0151-5; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; San Francisco Planning, 2019, STAND BIRD SAF BUILD; Santos LPS, 2017, REV BRAS ORNITOL, V25, P90; Sekercioglu C. H., 2016, WHY BIRDS MATTER AVI; Sheppard C., 2011, BIRD FRIENDLY BUILDI; Sheppard CD, 2019, GLOB ECOL CONSERV, V20, DOI 10.1016/j.gecco.2019.e00795; Snep RPH, 2016, URBAN ECOSYST, V19, P1535, DOI 10.1007/s11252-015-0442-z; Starr M, 2019, LAND USE POLICY, V81, P523, DOI 10.1016/j.landusepol.2018.11.004; Steven R, 2017, BIRD CONSERV INT, V27, P224, DOI 10.1017/S0959270916000174; Tan D.J.X., 2017, INT J TROPICAL VET B, V2, P17; Tsi E., 2008, AFR J ENV SCI TECHNO, V2, P51; Tumpach C, 2018, J ENVIRON MANAGE, V213, P374, DOI 10.1016/j.jenvman.2018.02.045; Twitter, 2022, US; U.S. Fish and Wildlife Service, 2021, BUILD GLASS; UN (United Nations Department of Economic and Social Affairs Population Division), 2019, STESASERA427 UN POP; United States Congress, 2021, H R 1986 BIRD SAF BU; Vaske JJ, 2010, LEISURE SCI, V32, P240, DOI 10.1080/01490401003712648; Wald DM, 2013, BIOL CONSERV, V167, P414, DOI 10.1016/j.biocon.2013.07.034; Warren EJ., 2013, CLEAR THREAT CONSERV; Winger BM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0364; YouTube, 2022, US; Zander KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100411	71	0	0	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263447	10.1371/journal.pone.0263447	http://dx.doi.org/10.1371/journal.pone.0263447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143530	Green Published, gold			2022-12-26	WOS:000797657800045
J	Torres-Ronda, L; Gamez, I; Robertson, S; Fernandez, J				Torres-Ronda, Lorena; Gamez, Ignacio; Robertson, Sam; Fernandez, Jose			Epidemiology and injury trends in the National Basketball Association: Pre-and per-COVID-19 (2017-2021)	PLOS ONE			English	Article								Purpose The aim this study was to provide an epidemiological injury analysis of the National Basketball Association, detailing aspects such as frequency rate, characteristics and impact on performance (missed games), including COVID-19 related and non-related injuries. Methods A retrospective study was conducted from the 2017-18 to 2020-2021 season. Publicly available records from the official website of the National Basketball Association were collected, including player's profiling data, minutes played per game until the injury occurred, unique injuries and injury description [location (body area), diagnosis (or mechanism)], and missed games due to injury. Results A total of 625 players and 3543 unique injuries were registered during the period analyzed. There was an increased incidence of missed games and unique injuries ratios, from 2017-18 until 2020-21, even when excluding COVID-19 related cases. The main body areas of injuries corresponded to lower body injuries, specifically knee, ankle and foot. The tendon/ ligament group, for both games missed and unique injuries, showed the higher ratios (1.16 and 0.21, respectively), followed by muscle (0.69 and 0.16, respectively) and bones (0.30 and 0.03, respectively). Irrespective of season, the higher percentage of unique injuries occurred in the group of players playing in the 26-35 minutes, followed by the 16-25 minutes played. Guards showed the highest injury ratios compared to other playing positions. Most injuries and missed games due to injury occurred from mid-season to the end of the regular season. The majority of both injuries and missed games were concentrated in the two central experience groups (from 6 to 15 years). Conclusions Despite previous efforts to better understand injury risk factors, there has been an increase in unique injuries and missed games. The distribution by body area, type of injury, when they occurred, minutes played and outcomes by play position, age a or years of experience vary between season and franchises.	[Torres-Ronda, Lorena; Robertson, Sam] Spanish Basketball Federat, Madrid, Spain; [Torres-Ronda, Lorena] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Gamez, Ignacio] BBVA Adv Analyt Dept, Madrid, Spain; [Fernandez, Jose] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia	Victoria University; Australian Catholic University	Torres-Ronda, L (corresponding author), Spanish Basketball Federat, Madrid, Spain.; Torres-Ronda, L (corresponding author), Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia.	lorenatorres07@yahoo.es		Torres-Ronda, Lorena/0000-0002-4589-7961				Andreoli CV, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000468; Baska, US; clutchpoints, KEY NBAS NEW 2016201; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Esteves PT, 2021, EUR J SPORT SCI, V21, P26, DOI 10.1080/17461391.2020.1736179; Fong DTP, 2007, SPORTS MED, V37, P73, DOI 10.2165/00007256-200737010-00006; Guss Michael S, 2016, Hand (N Y), V11, P427, DOI 10.1177/1558944716628500; Harper DJ, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000379; Herzog MM, 2019, AM J SPORT MED, V47, P2651, DOI 10.1177/0363546519864678; Jackson TJ, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113499130; Khan M, 2018, SPORTS HEALTH, V10, P169, DOI 10.1177/1941738117738988; Lemme NJ, 2019, AM J SPORT MED, V47, P2360, DOI 10.1177/0363546519858609; Minhas SV, 2016, SPORTS HEALTH, V8, P43, DOI 10.1177/1941738115608361; Patel BH, 2020, PHYSICIAN SPORTSMED, V48, P450, DOI 10.1080/00913847.2020.1746978; Petway AJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229212; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; Schelling X, 2013, STRENGTH COND J, V35, P89, DOI 10.1519/SSC.0000000000000018; Teramoto M, 2017, J SCI MED SPORT, V20, P230, DOI 10.1016/j.jsams.2016.08.020	18	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263354	10.1371/journal.pone.0263354	http://dx.doi.org/10.1371/journal.pone.0263354			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143536	Green Published, gold			2022-12-26	WOS:000797657800040
J	Klakattawi, H; Alsulami, D; Abd Elaal, M; Dey, S; Baharith, L				Klakattawi, Hadeel; Alsulami, Dawlah; Abd Elaal, Mervat; Dey, Sanku; Baharith, Lamya			A new generalized family of distributions based on combining Marshal-Olkin transformation with T-X family	PLOS ONE			English	Article							WEIBULL DISTRIBUTION; PARETO DISTRIBUTION; REGRESSION	Data analysis in real life often relies mainly on statistical probability distributions. However, data arising from different fields such as environmental, financial, biomedical sciences and other areas may not fit the classical distributions. Therefore, the need arises for developing new distributions that would capture high degree of skewness and kurtosis and enhance the goodness-of-fit in empirical distribution. In this paper, we introduce a novel family of distributions which can extend some popular classes of distributions to include different new versions of the baseline distributions. The proposed family of distributions is referred as the Marshall-Olkin Weibull generated family. The proposed family of distributions is a combination of Marshall-Olkin transformation and the Weibull generated family. Two special members of the proposed family are investigated. A variety of shapes for the densities and hazard rate are presented of the considered sub-models. Some of the main mathematical properties of this family are derived. The estimation for the parameters is obtained via the maximum likelihood method. Moreover, the performance of the estimators for the considered members is examined through simulation studies in terms of bias and root mean square error. Besides, based on the new generated family, the log Marshall-Olkin Weibull-Weibull regression model for censored data is proposed. Finally, COVID-19 data and three lifetime data sets are used to demonstrate the importance of the newly proposed family. Through such an applications, it is shown that this family of distributions provides a better fit when compared with other competitive distributions.	[Klakattawi, Hadeel; Alsulami, Dawlah; Abd Elaal, Mervat; Baharith, Lamya] King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia; [Dey, Sanku] St Anthonys Coll, Dept Stat, Shillong, Meghalaya, India	King Abdulaziz University	Baharith, L (corresponding author), King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia.	lbaharith@kau.edu.sa	Baharith, Lamya A/B-5824-2016; Alsulami, Dawlah/GXH-2324-2022; Baharith, Lamya A/Q-4605-2019	Baharith, Lamya A/0000-0001-8070-956X; Baharith, Lamya A/0000-0001-8070-956X; Alsulami, Dawlah/0000-0002-5887-8858	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [G: 1467-247-1440]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This study is funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. (G: 1467-247-1440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aako O., 2020, BENIN J STAT, V3, P33; Afify AZ, 2021, IEEE ACCESS, V9, P4376, DOI 10.1109/ACCESS.2020.3044156; Ahmad A., 2017, APPL MATH INF SCI LE, V5, P71, DOI DOI 10.18576/AMISL/050206; Ahmad HAH, 2020, PAK J STAT OPER RES, V16, P21, DOI 10.18187/pjsor.v16i1.2935; Ahmad HH, 2017, J STAT THEORY APPL, V16, P1; Al-Aqtash R., 2021, INT J STAT PROBABILI, V10, P1, DOI [10.5539/ijsp.v10n6p31, DOI 10.5539/IJSP.V10N6P31]; Alizadeh, 2017, PAK J STAT, V33; Almetwally EM, 2021, AXIOMS, V10, DOI 10.3390/axioms10010025; Alzaatreh A, 2015, J STAT THEORY APPL, V14, P169, DOI 10.2991/jsta.2015.14.2.5; Alzaatreh A, 2013, METRON, V71, P63, DOI 10.1007/s40300-013-0007-y; Alzaatreh A, 2013, COMMUN STAT-THEOR M, V42, P1673, DOI 10.1080/03610926.2011.599002; Alzaghal A., 2013, INT J STAT PROBABILI, V2, P31, DOI [10.5539/ijsp.v2n3p31, DOI 10.5539/IJSP.V2N3P31]; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Bader M.G., 1982, PROGR SCI ENG COMPOS, P1129, DOI DOI 10.12691/AJAMS-6-5-5; Carrasco JMR, 2008, COMPUT STAT DATA AN, V52, P4021, DOI 10.1016/j.csda.2008.01.027; Chakraborty S., 2017, J DATA SCI, V15, P391, DOI 10.6339/JDS.201707_15(3).0003; Cordeiro GM, 2013, STAT PAP, V54, P333, DOI 10.1007/s00362-012-0431-8; Cordeiro GM., 2016, J STAT DISTRIB APPL, V3, P1, DOI [10.1186/s40488-016-0043-2, DOI 10.1186/S40488-016-0043-2]; De Santana TVF., 2012, J STAT THEOR APPL, V11, P265; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Ghitany ME, 2007, COMMUN STAT-THEOR M, V36, P1855, DOI 10.1080/03610920601126571; Ghitany M.E., 2005, INT J APPL MATH, V18, P17; Ghitany ME, 2005, J APPL STAT, V32, P1025, DOI 10.1080/02664760500165008; Gui W., 2013, APPL MATH SCI, V7, P3947, DOI [DOI 10.12988/AMS.2013.35268, 10.12988/ams.2013.35268]; Gupta RC, 1998, COMMUN STAT-THEOR M, V27, P887, DOI 10.1080/03610929808832134; Gupta RD, 2001, BIOMETRICAL J, V43, P117, DOI 10.1002/1521-4036(200102)43:1<117::AID-BIMJ117>3.0.CO;2-R; Haq MAU., 2020, INT J STAT PROB, V9, P1; Hashmi S., 2018, PAK J STAT, V34; Hassan AS, 2016, ADV APPL STAT, V48, P205, DOI 10.17654/AS048030205; Jamal F, 2019, PUNJAB UNIV J MATH, V51, P111; Javed M, 2019, J KING SAUD UNIV SCI, V31, P684, DOI 10.1016/j.jksus.2018.01.001; Jose K., 2011, PROBSTAT FORUM, V4, P78; Khaleel MA, 2020, SCI AFR, V8, DOI 10.1016/j.sciaf.2020.e00470; Klakattawi HS, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21050438; Lawless J.F, 1982, STAT MODELS METHODS; Marshall AW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-68477-2; Marshall AW, 1997, BIOMETRIKA, V84, P641, DOI 10.1093/biomet/84.3.641; Mudholkar GS, 1996, J AM STAT ASSOC, V91, P1575, DOI 10.2307/2291583; Nadarajah S, 2006, ACTA APPL MATH, V92, P97, DOI 10.1007/s10440-006-9055-0; Nadarajah S, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i10; Nassar M, 2019, J COMPUT APPL MATH, V351, P41, DOI 10.1016/j.cam.2018.10.052; Nwezza EE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03569; Oluyede BO, 2018, AUST J STAT, V47, P45, DOI 10.17713/ajs.v47i1.155; Ortega EMM, 2011, BRAZ J PROBAB STAT, V25, P64, DOI 10.1214/09-BJPS110; PROSCHAN F, 1963, TECHNOMETRICS, V5, P375, DOI 10.2307/1266340; R Core Team, 2021, R LANGUAGE ENV STAT; Ristic MM., 2007, STRESS ANXIETY RES S, V11, P107; Santos-Neto M., 2014, J STAT DISTRIBUTIONS, V1, P9, DOI [10.1186/2195-5832-1-9, DOI 10.1186/2195-5832-1-9]; SMITH RL, 1987, J R STAT SOC C-APPL, V36, P358, DOI 10.2307/2347795; Tomy L., 2018, BIOM BIOSTAT INT J, V7	50	4	4	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263673	10.1371/journal.pone.0263673	http://dx.doi.org/10.1371/journal.pone.0263673			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139133	gold, Green Published			2022-12-26	WOS:000821499100043
J	Tiyoula, FN; Aryapour, H				Tiyoula, Fereshteh Noroozi; Aryapour, Hassan			Reconstruction of the unbinding pathways of noncovalent SARS-CoV and SARS-CoV-2 3CLpro inhibitors using unbiased molecular dynamics simulations	PLOS ONE			English	Article							CORONAVIRUS; DISCOVERY; PROTEASE; SUMD	The main protease (3CLpro) is one of the essential components of the SARS-CoVs viral life cycle, which makes it an interesting target for overpowering these viruses. Although many covalent and noncovalent inhibitors have been designed to inhibit this molecular target, none have gained FDA approval as a drug. Because of the high rate of COVID-19 pandemic development, in addition to laboratory research, we require in silico methods to accelerate rational drug design. The unbinding pathways of two SARS-CoV and SARS-CoV-2 3CLpro noncovalent inhibitors with the PDB IDs: 3V3M, 4MDS, 6W63, 5RF7 were explored from a comparative perspective using unbiased molecular dynamics (UMD) simulations. We uncovered common weak points for selected inhibitors that could not interact significantly with a binding pocket at specific residues by all their fragments. So water molecules entered the free binding S regions and weakened protein-inhibitor fundamental interactions gradually. N142, G143, and H163 are the essential residues, which cause key protein-ligand interactions in the binding pocket. We believe that these results will help design new potent inhibitors against SARS-CoV-2.	[Tiyoula, Fereshteh Noroozi; Aryapour, Hassan] Golestan Univ, Dept Biol, Fac Sci, Gorgan, Golestan, Iran		Aryapour, H (corresponding author), Golestan Univ, Dept Biol, Fac Sci, Gorgan, Golestan, Iran.	hassan.aryapour@gmail.com	Noroozi, Fereshteh/N-3791-2017		Golestan University, Gorgan, Iran [99-213-1]	Golestan University, Gorgan, Iran	This investigation was supported by grant number 99-213-1 from Golestan University, Gorgan, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Crawshaw A.D., 2020, PANDDA ANAL GROUP DE; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jacobs J, 2013, J MED CHEM, V56, P534, DOI 10.1021/jm301580n; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; Li QX, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081250; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maier HJ, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7; Mesecar A.D., 2020, FRACT CALC APPL ANAL, V23, P635; Mollica L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11539; Niu YZ, 2016, PHYS CHEM CHEM PHYS, V18, P5622, DOI 10.1039/c5cp06257h; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pathak N, 2021, ACS NANO, V15, P857, DOI 10.1021/acsnano.0c07383; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rydzewski J, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5108638; Sabbadin D, 2018, METHODS MOL BIOL, V1824, P287, DOI 10.1007/978-1-4939-8630-9_17; Sabbadin D, 2014, J CHEM INF MODEL, V54, P372, DOI [10.1021/ci400766b, 10.1021/ci4007t6b]; Sohraby F, 2021, SEMIN CANCER BIOL, V68, P249, DOI 10.1016/j.semcancer.2020.04.007; Sohraby F, 2020, BIOINFORMATICS, V36, P4714, DOI 10.1093/bioinformatics/btaa565; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Tiwary P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700014; Tiwary P, 2015, P NATL ACAD SCI USA, V112, pE386, DOI 10.1073/pnas.1424461112; Turlington M, 2013, BIOORG MED CHEM LETT, V23, P6172, DOI 10.1016/j.bmcl.2013.08.112; ul Qamar MT, 2020, J PHARM ANAL, V10, P313, DOI 10.1016/j.jpha.2020.03.009; W. H. Organization, WHO; Wu YT, 2020, LANCET, V395, P949, DOI 10.1016/S0140-6736(20)30557-2; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zangrillo A, 2020, CRIT CARE RESUSC, V22, P91; Zheng J, 2020, INT J BIOL SCI, V16, P1678, DOI 10.7150/ijbs.45053; Zhu HB, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00135-6	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263251	10.1371/journal.pone.0263251	http://dx.doi.org/10.1371/journal.pone.0263251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139108	gold, Green Published			2022-12-26	WOS:000821499100024
J	McKie, GL; Medak, KD; Shamshoum, H; Wright, DC				McKie, Greg L.; Medak, Kyle D.; Shamshoum, Hesham; Wright, David C.			Topical application of the pharmacological cold mimetic menthol stimulates brown adipose tissue thermogenesis through a TRPM8, UCP1, and norepinephrine dependent mechanism in mice housed at thermoneutrality	FASEB JOURNAL			English	Article						menthol; thermoneutral; topical; TRPM8; UCP1	DIET-INDUCED OBESITY; ENERGY-EXPENDITURE; RECEPTOR TRPM8; WHITE FAT; ACTIVATION; ADIPOCYTES; AGONIST; TEMPERATURE; SKIN; PGC-1-ALPHA	Increasing whole-body energy expenditure via the pharmacological activation of uncoupling protein 1 (UCP1)-dependent brown adipose tissue (BAT) thermogenesis is a promising weight management strategy, yet most therapeutics studied in rodents to date either induce compensatory increases in energy intake, have thermogenic effects that are confounded by sub-thermoneutral housing temperatures or are not well tolerated in humans. Here, we sought to determine whether the non-invasive topical application of the pharmacological cold mimetic and transient receptor potential (TRP) cation channel subfamily M member 8 (TRPM8) agonist L-menthol (MNTH), could be used to stimulate BAT thermogenesis and attenuate weight gain in mice housed at thermoneutrality. Using three different strains of mice and multiple complimentary approaches to quantify thermogenesis in vivo, coupled with ex vivo models to quantify direct thermogenic effects, we were able to convincingly demonstrate the following: (1) acute topical MNTH application induces BAT thermogenesis in a TRPM8- and UCP1-dependent manner; (2) MNTH-induced BAT thermogenesis is sufficient to attenuate weight gain over time without affecting energy intake in lean and obese mice; (3) the ability of topical MNTH application to stimulate BAT thermogenesis is mediated, in part, by a central mechanism involving the release of norepinephrine. These data collectively suggest that topical application of MNTH may be a promising weight management strategy.	[McKie, Greg L.; Medak, Kyle D.; Shamshoum, Hesham; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada	University of Guelph	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca		Wright, David/0000-0003-3867-8901; McKie, Greg/0000-0002-6469-0747	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Canada Graduate Scholarship; NSERC Postgraduate Scholarships	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Postgraduate Scholarships(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to DCW, who was a Tier II Canada Research Chair in Lipids, Metabolism, and Health. GLM was supported by an NSERC Canada Graduate Scholarship; KDM and HS were supported by NSERC Postgraduate Scholarships	Aldiss P., 2021, 789289 BIORXIV; Aldiss P, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00097; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Beukema P, 2018, J COMP NEUROL, V526, P1444, DOI 10.1002/cne.24418; Blondin DP, 2020, CELL METAB, V32, P287, DOI 10.1016/j.cmet.2020.07.005; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Buemann B, 2000, INT J OBESITY, V24, P1553, DOI 10.1038/sj.ijo.0801452; Campero M, 2009, J PHYSIOL-LONDON, V587, P5633, DOI 10.1113/jphysiol.2009.176040; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; Clemmensen C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06769-y; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fan L, 2016, TOB CONTROL, V25, pii50, DOI 10.1136/tobaccocontrol-2016-053209; Fernandez-Carvajal A, 2020, EXPERT OPIN INV DRUG, V29, P1209, DOI 10.1080/13543784.2020.1825680; Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892; Finlin BS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121510; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; GALBO H, 1986, Diabetes Metabolism Reviews, V1, P385; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Gkika D, 2010, ONCOGENE, V29, P4611, DOI 10.1038/onc.2010.210; Greaney JL, 2017, J NEUROPHYSIOL, V118, P2181, DOI 10.1152/jn.00283.2017; Grolez GP, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1891-8; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Hanssen MJW, 2016, DIABETES, V65, P1179, DOI 10.2337/db15-1372; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Hao L, 2019, J PHARMACOL EXP THER, V369, P419, DOI 10.1124/jpet.118.255778; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Jiang CY, 2017, ONCOTARGET, V8, P75114, DOI 10.18632/oncotarget.20540; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kaur J, 2022, INT J OBESITY, V46, P153, DOI 10.1038/s41366-021-00967-3; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Keijer J, 2019, MOL METAB, V25, P168, DOI 10.1016/j.molmet.2019.04.001; Keipert S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14069-2; Khare P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050383; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Labbe SM, 2018, AM J PHYSIOL-ENDOC M, V315, pE815, DOI 10.1152/ajpendo.00210.2018; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Larsen TM, 2002, AM J CLIN NUTR, V76, P780, DOI 10.1093/ajcn/76.4.780; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Vizin RCL, 2018, J APPL PHYSIOL, V124, P672, DOI 10.1152/japplphysiol.00770.2017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh RKC, 2019, DIABETES OBES METAB, V21, P276, DOI 10.1111/dom.13516; LOMAX P, 1966, NATURE, V210, P854, DOI 10.1038/210854a0; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McKie GL, 2022, J PHYSIOL-LONDON, V600, P829, DOI 10.1113/JP281774; McKie GL, 2021, BIOL LETTERS, V17, DOI 10.1098/rsbl.2021.0171; McKie GL, 2019, J PHYSIOL-LONDON, V597, P4581, DOI 10.1113/JP278221; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126; Ohlson KBE, 2003, ANESTHESIOLOGY, V98, P437, DOI 10.1097/00000542-200302000-00025; OHLSON KBE, 1994, ANESTHESIOLOGY, V81, P176, DOI 10.1097/00000542-199407000-00024; Potapova TA, 2011, B EXP BIOL MED+, V151, P223, DOI 10.1007/s10517-011-1294-z; Putri M, 2015, BIOCHEM BIOPH RES CO, V457, P520, DOI 10.1016/j.bbrc.2014.12.124; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P527, DOI 10.1210/jc.2006-1740; Richard JE, 2017, AM J PHYSIOL-ENDOC M, V313, pE344, DOI 10.1152/ajpendo.00418.2016; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Roesler A, 2020, BIOCHEM J, V477, P709, DOI 10.1042/BCJ20190463; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Trayhurn P, 2017, BIOCHIMIE, V134, P62, DOI 10.1016/j.biochi.2016.09.007; Valente A, 2015, FOOD CHEM TOXICOL, V86, P262, DOI 10.1016/j.fct.2015.09.018; Valgas P, 2021, CLIN EXP PHARMACOL P, V48, P1477; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vaughan CH, 2014, METHOD ENZYMOL, V537, P199, DOI 10.1016/B978-0-12-411619-1.00011-2; Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357; Yamamura H, 2008, AM J PHYSIOL-CELL PH, V295, pC296, DOI 10.1152/ajpcell.00499.2007; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; ZARORBEHRENS G, 1983, AM J PHYSIOL, V244, pE361, DOI 10.1152/ajpendo.1983.244.4.E361; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	85	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22205	10.1096/fj.202101905RR	http://dx.doi.org/10.1096/fj.202101905RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35157333				2022-12-26	WOS:000761250800046
J	Yue, W; Wang, Y; Meng, TG; Zhang, HY; Zhang, XR; Ouyang, YC; Hou, Y; Schatten, H; Wang, ZB; Sun, QY				Yue, Wei; Wang, Yue; Meng, Tie-Gang; Zhang, Hong-Yong; Zhang, Xin-Ran; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Wang, Zhen-Bo; Sun, Qing-Yuan			Kinetochore scaffold 1 regulates SAC function during mouse oocyte meiotic maturation	FASEB JOURNAL			English	Article						kinetochore-microtubule attachment; KNL1; meiosis; oocyte; spindle assembly checkpoint	SPINDLE-ASSEMBLY CHECKPOINT; MICROTUBULE-BINDING; MEIOSIS-I; OUTER KINETOCHORE; CYCLIN-A; COMPLEX; KNL1; PHOSPHORYLATION; SEGREGATION; APC/C-CDC20	Precise regulation of chromosome separation through spindle assembly checkpoint (SAC) during oocyte meiosis is critical for mammalian reproduction. The kinetochore plays an important role in the regulation of SAC through sensing microtubule tension imbalance or missing microtubule connections. Here, we report that kinetochore scaffold 1 (KNL1, also known as CASC5), an outer kinetochore protein, plays a critical role in the SAC function of mouse oocytes. KNL1 localized at kinetochores from GVBD to the MII stage, and microinjection of KNL1-siRNA caused accelerated metaphase-anaphase transition and premature first meiosis completion, producing aneuploid eggs. The SAC was prematurely silenced in the presence of unstable kinetochore-microtubule attachments and misaligned chromosomes in KNL1-depleted oocytes. Additionally, KNL1 and MPS1 had a synergistic effect on the activation and maintenance of SAC. Taken together, our results suggest that KNL1, as a kinetochore platform protein, stabilizes SAC to ensure timely anaphase entry and accurate chromosome segregation during oocyte meiotic maturation.	[Yue, Wei; Meng, Tie-Gang; Zhang, Xin-Ran; Ouyang, Ying-Chun; Hou, Yi; Wang, Zhen-Bo] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Yue, Wei; Zhang, Xin-Ran; Wang, Zhen-Bo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Yue] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Zhang, Hong-Yong] Peking Univ Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Reprod Med, Shenzhen, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Sun, Qing-Yuan] Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangdong Hong Kong Metab & Reprod Joint Lab, Guangzhou 510317, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Agricultural University; Hong Kong University of Science & Technology; Peking University; University of Missouri System; University of Missouri Columbia	Wang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Sun, QY (corresponding author), Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangdong Hong Kong Metab & Reprod Joint Lab, Guangzhou 510317, Peoples R China.	wangzb@ioz.ac.cn; sunqy@gd2h.org.cn		Sun, Qing-Yuan/0000-0002-0148-2414	National Natural Science Foundation of China [32570854]; Natural Science Foundation of Shandong Province [ZR2021ZD33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	National Natural Science Foundation of China, Grant/Award Number: 32570854; Natural Science Foundation of Shandong Province, Grant/Award Number: ZR2021ZD33	Caldas GV, 2013, J CELL BIOL, V203, P957, DOI 10.1083/jcb.201306054; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Corbett KD, 2017, PROG MOL SUBCELL BIO, V56, P429, DOI 10.1007/978-3-319-58592-5_18; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Ding Y, 2013, CANCER DISCOV, V3, P198, DOI 10.1158/2159-8290.CD-12-0353; Dumont J, 2010, NAT CELL BIOL, V12, P894, DOI 10.1038/ncb2093; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Espeut J, 2012, J CELL BIOL, V196, P469, DOI 10.1083/jcb.201111107; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gerton JL, 2007, GENE DEV, V21, P238, DOI 10.1101/gad.1523107; Gorbsky GJ, 2015, FEBS J, V282, P2458, DOI 10.1111/febs.13166; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Hached K, 2011, DEVELOPMENT, V138, P2261, DOI 10.1242/dev.061317; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Homer HA, 2006, HISTOL HISTOPATHOL, V21, P873, DOI 10.14670/HH-21.873; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jones KT, 2013, DEVELOPMENT, V140, P3719, DOI 10.1242/dev.090589; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kerres A, 2004, MOL BIOL CELL, V15, P5255, DOI 10.1091/mbc.E04-06-0443; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109; Lane SIR, 2012, DEVELOPMENT, V139, P1947, DOI 10.1242/dev.077040; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Ma JY, 2020, J GENET GENOMICS, V47, P659, DOI 10.1016/j.jgg.2020.04.003; Ma RJ, 2014, FASEB J, V28, P4026, DOI 10.1096/fj.14-250886; MacLennan M, 2015, SEMIN CELL DEV BIOL, V45, P68, DOI 10.1016/j.semcdb.2015.10.005; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; McGulnness BE, 2009, CURR BIOL, V19, P369, DOI 10.1016/j.cub.2009.01.064; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Pagliuca C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007640; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schittenhelm RB, 2009, EMBO J, V28, P2374, DOI 10.1038/emboj.2009.188; Sebestova J, 2012, CELL CYCLE, V11, P3011, DOI 10.4161/cc.21398; Sen Aritro, 2013, Front Biosci (Schol Ed), V5, P451; Seo DW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15431; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Touati SA, 2016, CHROMOSOMA, V125, P321, DOI 10.1007/s00412-015-0536-7; Touati SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7946; van Zon W, 2010, BIOCHEM SOC T, V38, P72, DOI 10.1042/BST0380072; Varma D, 2012, J CELL SCI, V125, P5927, DOI 10.1242/jcs.093724; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoshida S, 2015, DEV CELL, V33, P589, DOI 10.1016/j.devcel.2015.04.020; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	58	0	0	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22210	10.1096/fj.202101586RR	http://dx.doi.org/10.1096/fj.202101586RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35167144				2022-12-26	WOS:000761250800040
J	Zivic, Z; Strmsek, Z; Novinec, M; Lah, J; Hadzi, S				Zivic, Zala; Strmsek, Ziga; Novinec, Marko; Lah, Jurij; Hadzi, San			Structural polymorphism of coiled-coils from the stalk domain of SARS-CoV-2 spike protein	FASEB JOURNAL			English	Article						coiled-coil; SARS-CoV-2; spike; thermodynamics; X-ray		Spike trimer plays a key role in SARS-CoV-2 infection and vaccine development. It consists of a globular head and a flexible stalk domain that anchors the protein into the viral membrane. While the head domain has been extensively studied, the properties of the adjoining stalk are poorly understood. Here, we characterize the coiled-coil formation and thermodynamic stability of the stalk domain and its segments. We find that the N-terminal segment of the stalk does not form coiled-coils and remains disordered in solution. The C-terminal stalk segment forms a trimeric coiled-coil in solution, which becomes significantly stabilized in the context of the full-length stalk. Its crystal structure reveals a novel antiparallel tetramer coiled-coil with an unusual combination of a-d and e-a-d hydrophobic core packing. Structural analysis shows that a subset of hydrophobic residues stabilizes different coiled-coil structures: trimer, tetramer, and heterohexamer, underscoring a highly polymorphic nature of the SARS-CoV-2 stalk sequence.	[Zivic, Zala; Novinec, Marko; Lah, Jurij; Hadzi, San] Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana, Slovenia; [Strmsek, Ziga; Hadzi, San] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia	University of Ljubljana; National Institute of Chemistry - Slovenia	Lah, J; Hadzi, S (corresponding author), Univ Ljubljana, Fac Chem & Chem Technol, Vecna Pot 113, Ljubljana, Slovenia.	jurij.lah@fkkt.uni-lj.si; san.hadzi@fkkt.uni-lj.si		Hadzi, San/0000-0002-5615-7918; Novinec, Marko/0000-0003-1824-1649; Zivic, Zala/0000-0001-9044-3064	Javna Agencija za Raziskovalno Dejavnost RS (ARRS) [J1-1709, P1-0201]	Javna Agencija za Raziskovalno Dejavnost RS (ARRS)(Slovenian Research Agency - Slovenia)	Javna Agencija za Raziskovalno Dejavnost RS (ARRS), Grant/Award Number: J1-1709 and P1-0201	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Casalino L, 2020, ACS CENTRAL SCI, V6, P1722, DOI 10.1021/acscentsci.0c01056; Celigoy J, 2011, PROTEIN SCI, V20, P2125, DOI 10.1002/pro.736; Choi YK, 2021, J CHEM THEORY COMPUT, V17, P2479, DOI 10.1021/acs.jctc.0c01144; Deng YQ, 2006, STRUCTURE, V14, P889, DOI 10.1016/j.str.2006.03.007; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Durr E, 2000, PROTEIN SCI, V9, P1410; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gradisar H, 2011, J PEPT SCI, V17, P100, DOI 10.1002/psc.1331; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Ingallinella P, 2004, P NATL ACAD SCI USA, V101, P8709, DOI 10.1073/pnas.0402753101; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Sammito M, 2013, NAT METHODS, V10, P1099, DOI [10.1038/nmeth.2644, 10.1038/NMETH.2644]; Turonova B, 2020, SCIENCE, V370, P203, DOI 10.1126/science.abd5223; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang MY, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.587269; Wang XH, 2019, J MOL MODEL, V25, DOI 10.1007/s00894-018-3886-2; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018	28	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22199	10.1096/fj.202101670R	http://dx.doi.org/10.1096/fj.202101670R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35157347	Green Published, hybrid			2022-12-26	WOS:000761250800013
J	Beresford, NA; Wood, MD; Gashchak, S; Barnett, CL				Beresford, Nicholas A.; Wood, Michael D.; Gashchak, Sergey; Barnett, Catherine L.			Current ionising radiation doses in the Chernobyl Exclusion Zone do not directly impact on soil biological activity	PLOS ONE			English	Article							BAIT-LAMINA TEST; FEEDING-ACTIVITY; METAL POLLUTION; NONHUMAN BIOTA; RATES; DECOMPOSITION; ECOSYSTEM; EXPOSURE; FAUNA; CONTAMINATION	Although soil organisms are essential for ecosystem function, the impacts of radiation on soil biological activity at highly contaminated sites has been relatively poorly studied. In April-May 2016, we conducted the first largescale deployment of bait lamina to estimate soil organism (largely soil invertebrate) feeding activity in situ at study plots in the Chernobyl Exclusion Zone (CEZ). Across our 53 study plots, estimated weighted absorbed dose rates to soil organisms ranged from 0.7 mu Gy h(-1) to 1753 mu Gy h(-1). There was no significant relationship between soil organism feeding activity and estimated weighted absorbed dose rate. Soil biological activity did show significant relationships with soil moisture content, bulk density (used as a proxy for soil organic matter) and pH. At plots in the Red Forest (an area of coniferous plantation where trees died because of high radiation exposure in 1986) soil biological activity was low compared to plots elsewhere in the CEZ. It is possible that the lower biological activity observed in the Red Forest is a residual consequence of what was in effect an acute high exposure to radiation in 1986.	[Beresford, Nicholas A.; Barnett, Catherine L.] Lancaster Environm Ctr, UK Ctr Ecol & Hydrol, Lancaster, England; [Beresford, Nicholas A.; Wood, Michael D.] Univ Salford, Sch Sci Engn & Environm, Manchester, Lancs, England; [Gashchak, Sergey] Chornobyl Ctr Nucl Safety Radioact Waste & Radioe, Int Radioecol Lab, Kiev, Ukraine	Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); University of Salford	Beresford, NA (corresponding author), Lancaster Environm Ctr, UK Ctr Ecol & Hydrol, Lancaster, England.; Beresford, NA (corresponding author), Univ Salford, Sch Sci Engn & Environm, Manchester, Lancs, England.	nab@ceh.ac.uk		Beresford, Nick/0000-0002-8722-0238; Wood, Mike/0000-0002-0635-2387	Natural Environment Research Council; Environment Agency; Radioactive Waste Management Ltd. [NE/L000318/1, NE/L000520/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Environment Agency; Radioactive Waste Management Ltd.	The work described in this paper was conducted as part of the TREE project (www.ceh.ac.uk/TREE), which was funded under the RATE Programme (https://www2.bgs.ac.uk/rate/home.html) by the Natural Environment Research Council, the Environment Agency and Radioactive Waste Management Ltd. (grant codes: NE/L000318/1 and NE/L000520/1). All authors received funding via this route. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S. E., 1974, Chemical analysis of ecological materials.; Andersson P, 2009, J ENVIRON RADIOACTIV, V100, P1100, DOI 10.1016/j.jenvrad.2009.05.010; Andre A, 2009, ENVIRON POLLUT, V157, P2368, DOI 10.1016/j.envpol.2009.03.023; Antwis RE, 2021, J ANIM ECOL, V90, P2172, DOI 10.1111/1365-2656.13507; Barnett CL., 2021, **DATA OBJECT**, DOI 10.5285/19babe1c-b3a3-488c-b4fe-ebb4ab9237d8; Batlle JVI, 2007, RADIAT ENVIRON BIOPH, V46, P349, DOI 10.1007/s00411-007-0124-1; Beaugelin-Seiller K, 2014, J ENVIRON RADIOACTIV, V138, P60, DOI 10.1016/j.jenvrad.2014.07.027; Beaugelin-Seiller K, 2020, J ENVIRON RADIOACTIV, V211, DOI 10.1016/j.jenvrad.2018.10.006; Beresford NA, 2020, J ENVIRON RADIOACTIV, V211, DOI 10.1016/j.jenvrad.2019.106033; Beresford NA, 2020, J ENVIRON RADIOACTIV, V211, DOI 10.1016/j.jenvrad.2019.01.005; Beresford NA, 2020, J ENVIRON RADIOACTIV, V211, DOI 10.1016/j.jenvrad.2018.02.007; Beresford NA, 2008, APPL RADIAT ISOTOPES, V66, P1745, DOI 10.1016/j.apradiso.2008.04.009; Beresford NA, 2021, INTEGR ENVIRON ASSES, V17, P1141, DOI 10.1002/ieam.4424; Bispo A., 2009, Integrated Environmental Assessment and Management, V5, P717, DOI 10.1897/IEAM-2009-064.1; Bondarkov MD, 2011, HEALTH PHYS, V101, P383, DOI 10.1097/HP.0b013e318224bb2b; Bondarkov MD, 2011, HEALTH PHYS, V101, P362, DOI 10.1097/HP.0b013e3182166472; Bondarkov MN., 2002, NUCL PHYS AT ENERGY, V8, P162; Bonzom JM, 2016, SCI TOTAL ENVIRON, V562, P596, DOI 10.1016/j.scitotenv.2016.04.006; Boshoff M, 2014, ENVIRON RES, V134, P169, DOI 10.1016/j.envres.2014.06.024; Brown JE, 2008, J ENVIRON RADIOACTIV, V99, P1371, DOI 10.1016/j.jenvrad.2008.01.008; Brown JE, 2016, J ENVIRON RADIOACTIV, V153, P141, DOI 10.1016/j.jenvrad.2015.12.011; Chapon V, 2012, APPL GEOCHEM, V27, P1375, DOI 10.1016/j.apgeochem.2011.08.011; Chesser RK, 2006, AM SCI, V94, P542, DOI 10.1511/2006.62.542; Copplestone D., 2001, IMPACT ASSESSMENT IO; Curry James P., 2004, P91; Domene X, 2014, SOIL BIOL BIOCHEM, V72, P152, DOI 10.1016/j.soilbio.2014.01.035; Environment Agency (EA), 2008, SCO70009SR2C EA; Fesenko S, 2019, J RADIOL PROT, V39, pR1, DOI 10.1088/1361-6498/aafa92; Filzek PDB, 2004, ECOTOXICOLOGY, V13, P807, DOI 10.1007/s10646-003-4478-0; Forster B, 2004, ECOTOXICOLOGY, V13, P129, DOI 10.1023/B:ECTX.0000012410.99020.97; Gaschak SP, 2011, HEALTH PHYS, V101, P409, DOI 10.1097/HP.0b013e31821d0b81; Geissen V, 1999, BIOL FERT SOILS, V29, P335, DOI 10.1007/s003740050562; Geras'kin SA, 2008, ENVIRON INT, V34, P880, DOI 10.1016/j.envint.2007.12.012; Gongalsky KB, 2003, ENVIRON MONIT ASSESS, V89, P197, DOI 10.1023/A:1026031224658; Gongalsky KB, 2008, APPL SOIL ECOL, V39, P84, DOI 10.1016/j.apsoil.2007.11.007; Gunstone T, 2021, FRONT ENV SCI-SWITZ, V9, DOI 10.3389/fenvs.2021.643847; Haanes H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247793; Hamel C, 2007, APPL SOIL ECOL, V36, P199, DOI 10.1016/j.apsoil.2007.02.004; HARRISON AF, 1981, J APPL ECOL, V18, P919, DOI 10.2307/2402382; Helling B, 1998, APPL SOIL ECOL, V7, P207, DOI 10.1016/S0929-1393(97)00065-6; Holiaka DM, 2020, NUCL PHYS ATOM ENERG, V21, P256, DOI 10.15407/jnpae2020.03.256; Holiaka DM, 2020, NUCL PHYS ATOM ENERG, V21, P157, DOI 10.15407/jnpae2020.02.157; International Organization for Standardization (ISO), 2016, 183112016 ISO; Jackson D., 2005, RADIOPROTECTION, V40, pS857, DOI [DOI 10.1051/RADI0PR0:2005S1-126, 10.1051/radiopro:2005s1-126, DOI 10.1051/RADIOPRO:2005S1-126]; Jansch S, 2017, EURO-MEDITERR J ENVI, V2, DOI 10.1007/s41207-017-0015-z; Jones HE, 2004, THESIS U NOTTINGHAM; Jones OAH, 2014, ENVIRON TOXICOL CHEM, V33, P61, DOI 10.1002/etc.2418; Kratz W, 1998, ENVIRON SCI POLLUT R, V5, P94, DOI 10.1007/BF02986394; KRIVOLUTZKII DA, 1992, SCI TOTAL ENVIRON, V112, P69, DOI 10.1016/0048-9697(92)90239-O; Lecomte-Pradines C, 2014, SCI TOTAL ENVIRON, V490, P161, DOI 10.1016/j.scitotenv.2014.04.115; Lehmann P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19974; Levchuk SE., **DATA OBJECT**, DOI 10.5285/72c05810-eb66-49e1-9107-dec8cde3b07e; MARINISSEN JCY, 1992, OECOLOGIA, V91, P371, DOI 10.1007/BF00317626; Mbodj I., 2010, INT J BIOL CHEM SCI, V4, P122, DOI [10.4314/ijbcs.v4i1.54238, DOI 10.4314/IJBCS.V4I1.54238]; Menezes-Oliveira VB, 2013, ENVIRON TOXICOL CHEM, V32, P2678, DOI 10.1002/etc.2345; Moller AP, 2013, ECOL INDIC, V26, P112, DOI 10.1016/j.ecolind.2012.10.025; Moller AP, 2009, BIOL LETTERS, V5, P356, DOI 10.1098/rsbl.2008.0778; MORGAN JE, 1988, ENVIRON POLLUT, V54, P123, DOI 10.1016/0269-7491(88)90142-X; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; Newbold LK, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113238; Paulus R, 1999, PEDOBIOLOGIA, V43, P120; Riutta T, 2016, ECOSYSTEMS, V19, P534, DOI 10.1007/s10021-015-9939-9; Robinson CA, 2010, J RADIOL PROT, V30, P161, DOI 10.1088/0952-4746/30/2/005; Rombke J, 2014, PLANT SOIL, V383, P43, DOI 10.1007/s11104-014-2195-5; Rogiers T, 2021, ENVIRON MICROBIOL, V23, P1670, DOI 10.1111/1462-2920.15394; Siebert J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36777-3; Simpson JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029616; Smith J., 2005, CHERNOBYL CATASTROPH, DOI [10.1007/3-540-28079-0, DOI 10.1007/3-540-28079-0]; Spurgeon DJ, 2003, PEDOBIOLOGIA, V47, P588; Stark K, 2015, ENVIRON POLLUT, V196, P201, DOI 10.1016/j.envpol.2014.10.012; Thomsen M, 2012, ECOL INDIC, V16, P67, DOI 10.1016/j.ecolind.2011.05.012; UNSCEAR, 2000, SOURC EFF RISKS ION; van Gestel CAM, 2001, ENVIRON TOXICOL CHEM, V20, P1438, DOI [10.1897/1551-5028(2001)020&lt;1438:TUOAAC&gt;2.0.CO;2, 10.1002/etc.5620200705]; van Gestel CAM, 2009, ENVIRON POLLUT, V157, P895, DOI 10.1016/j.envpol.2008.11.002; Batlle JVI, 2011, RADIAT ENVIRON BIOPH, V50, P231, DOI 10.1007/s00411-010-0346-5; Walter J, 2013, SOIL BIOL BIOCHEM, V60, P10, DOI 10.1016/j.soilbio.2013.01.018; Weil R.R., 2017, NATURE PROPERTIES SO, V15th ed.; Zaitsev AS, 2014, PEDOBIOLOGIA, V57, P5, DOI 10.1016/j.pedobi.2013.09.005	78	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263600	10.1371/journal.pone.0263600	http://dx.doi.org/10.1371/journal.pone.0263600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196340	Green Accepted, Green Published, gold			2022-12-26	WOS:000835161600015
J	Castelli, G; Semenzato, U; Lococo, S; Cocconcelli, E; Bernardinello, N; Fichera, G; Giraudo, C; Spagnolo, P; Cattelan, A; Balestro, E				Castelli, Gioele; Semenzato, Umberto; Lococo, Sara; Cocconcelli, Elisabetta; Bernardinello, Nicol; Fichera, Giulia; Giraudo, Chiara; Spagnolo, Paolo; Cattelan, Annamaria; Balestro, Elisabetta			Brief communication: Chest radiography score in young COVID-19 patients: Does one size fit all?	PLOS ONE			English	Article								During the SARS-CoV-2 pandemic, chest X-Ray (CXR) scores are essential to rapidly assess patients' prognoses. This study evaluates a published CXR score in a different national healthcare system. In our study, this CXR score maintains a prognostic role in predicting length of hospital stay, but not disease severity. However, our results show that the predictive role of CXR score could be influenced by socioeconomic status and healthcare system.	[Castelli, Gioele; Semenzato, Umberto; Lococo, Sara; Cocconcelli, Elisabetta; Bernardinello, Nicol; Spagnolo, Paolo; Balestro, Elisabetta] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy; [Castelli, Gioele; Semenzato, Umberto; Lococo, Sara; Cocconcelli, Elisabetta; Bernardinello, Nicol; Spagnolo, Paolo; Balestro, Elisabetta] Padova City Hosp, Padua, Italy; [Fichera, Giulia; Giraudo, Chiara] Univ Padua, Inst Radiol, Dept Med, Padua, Italy; [Cattelan, Annamaria] Univ Padua, Div Infect & Trop Dis, Padua, Italy; [Cattelan, Annamaria] Univ Padua, Azienda Osped, Padua, Italy	University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova	Balestro, E (corresponding author), Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy.; Balestro, E (corresponding author), Padova City Hosp, Padua, Italy.	elisabetta.balestro@aopd.veneto.it	Semenzato, Umberto/AAX-5043-2020; Castelli, Gioele/AAS-4201-2020	Semenzato, Umberto/0000-0002-6739-8629; Castelli, Gioele/0000-0002-5925-4035; Balestro, Elisabetta/0000-0003-1373-8197				Bonifazi M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061218; Borghesi A, 2020, INT J INFECT DIS, V96, P291, DOI 10.1016/j.ijid.2020.05.021; Cocconcelli E, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092990; Giraudo C, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00359-2020; Hawkins RB, 2020, PUBLIC HEALTH, V189, P129, DOI 10.1016/j.puhe.2020.09.016; Maroldi R, 2021, EUR RADIOL, V31, P4016, DOI 10.1007/s00330-020-07504-2; Monaco Cristian Giuseppe, 2020, Eur Radiol Exp, V4, P68, DOI 10.1186/s41747-020-00195-w; National Research Council; Institute of Medicine, 2013, US HLTH INT PERSP SH; Petite Felipe D J, 2021, Radiologia (Engl Ed), V63, P324, DOI 10.1016/j.rxeng.2021.03.006; Toussie D, 2020, RADIOLOGY, V297, pE197, DOI 10.1148/radiol.2020201754; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Warren MA, 2018, THORAX, V73, P840, DOI 10.1136/thoraxjnl-2017-211280; Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160; Xiao N, 2021, EUR RADIOL, V31, P2825, DOI 10.1007/s00330-020-07354-y	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264172	10.1371/journal.pone.0264172	http://dx.doi.org/10.1371/journal.pone.0264172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196335	Green Published, gold			2022-12-26	WOS:000835161600026
J	Ashoti, A; Limone, F; van Kranenburg, M; Alemany, A; Baak, M; Vivie, J; Piccioni, F; Dijkers, PF; Creyghton, M; Eggan, K; Geijsen, N				Ashoti, Ator; Limone, Francesco; van Kranenburg, Melissa; Alemany, Anna; Baak, Mirna; Vivie, Judith; Piccioni, Frederica; Dijkers, Pascale F.; Creyghton, Menno; Eggan, Kevin; Geijsen, Niels			Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen	PLOS ONE			English	Article							VIRUS ENTRY REQUIRES; DUX4 EXPRESSION; RESTRICTION ENZYMES; CANDIDATE GENE; DNA-CLEAVAGE; CELL; MODEL; SEQUENCE; RECEPTOR; LINE	Genome-wide screens that have viability as a readout have been instrumental to identify essential genes. The development of gene knockout screens with the use of CRISPR-Cas has provided a more sensitive method to identify these genes. Here, we performed an exhaustive genome-wide CRISPR/Cas9 phenotypic rescue screen to identify modulators of cytotoxicity induced by the pioneer transcription factor, DUX4. Misexpression of DUX4 due to a failure in epigenetic repressive mechanisms underlies facioscapulohumeral muscular dystrophy (FHSD), a complex muscle disorder that thus far remains untreatable. As the name implies, FSHD generally starts in the muscles of the face and shoulder girdle. Our CRISPR/Cas9 screen revealed no key effectors other than DUX4 itself that could modulate DUX4 cytotoxicity, suggesting that treatment efforts in FSHD should be directed towards direct modulation of DUX4 itself. Our screen did however reveal some rare and unexpected genomic events, that had an important impact on the interpretation of our data. Our findings may provide important considerations for planning future CRISPR/Cas9 phenotypic survival screens.	[Ashoti, Ator; van Kranenburg, Melissa; Alemany, Anna; Baak, Mirna; Vivie, Judith; Dijkers, Pascale F.; Creyghton, Menno; Geijsen, Niels] Hubrecht Inst, Dev Biol & Stem Cell Res, Utrecht, Netherlands; [Limone, Francesco; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Limone, Francesco; Eggan, Kevin] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Vivie, Judith] Single Cell Discoveries, Utrecht, Netherlands; [Piccioni, Frederica] Broad Inst, Cambridge, MA USA; [Alemany, Anna; Dijkers, Pascale F.] Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands; [Creyghton, Menno] Erasmus MC, Dept Dev Embryol, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Ashoti, A; Geijsen, N (corresponding author), Hubrecht Inst, Dev Biol & Stem Cell Res, Utrecht, Netherlands.; Limone, F; Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Limone, F; Eggan, K (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	a.r.o.ashoti@uu.nl; francesco_limone@fas.harvard.edu; eggan@mcb.harvard.edu; n.geijsen@lumc.nl		PICCIONI, FEDERICA/0000-0003-1210-3210	FSHD Foundation; SingelSwim Utrecht Foundation	FSHD Foundation; SingelSwim Utrecht Foundation	AA was supported by The FSHD Foundation (https://www.fshd.nl) and the SingelSwim Utrecht Foundation (https://www.singelswimutrecht.nl) Funders did not play a role in study design, data collection or publication of the manuscript.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; ANDERSSON BS, 1987, CANCER GENET CYTOGEN, V24, P335, DOI 10.1016/0165-4608(87)90116-6; Ansseau E, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030093; Banerji CRS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01200-4; Banerji CRS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0797; Banerji CRS, 2019, LYMPHOCYTES CONTRIBU, DOI [10.1101/717652, DOI 10.1101/717652]; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2002, GENETICS, V161, P1169; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Bosnakovski D, 2017, J CELL SCI, V130, P3685, DOI 10.1242/jcs.205427; Bosnakovski D, 2017, DIS MODEL MECH, V10, P1211, DOI 10.1242/dmm.030064; Bosnakovski D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00730-1; Bosnakovski D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-4; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Choi SH, 2016, NUCLEIC ACIDS RES, V44, P5161, DOI 10.1093/nar/gkw141; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cullot G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09006-2; Das S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160022; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2016, FREE RADICAL BIO MED, V99, P244, DOI 10.1016/j.freeradbiomed.2016.08.007; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Feng Q, 2015, ELIFE, V4, DOI 10.7554/eLife.04996; Ferreboeuf M, 2014, HUM MOL GENET, V23, P171, DOI 10.1093/hmg/ddt409; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gerhards NM, 2018, MOL ONCOL, V12, P953, DOI 10.1002/1878-0261.12307; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jagannathan S, 2016, HUM MOL GENET, V25, P4419, DOI 10.1093/hmg/ddw271; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jones TI, 2017, NEUROMUSCULAR DISORD, V27, P221, DOI 10.1016/j.nmd.2016.12.007; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kim YG, 1997, P NATL ACAD SCI USA, V94, P12875, DOI 10.1073/pnas.94.24.12875; Knopp P, 2016, J CELL SCI, V129, P3816, DOI 10.1242/jcs.180372; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lek A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay0271; Lemmers RJLF, 2018, EUR J HUM GENET, V26, P94, DOI 10.1038/s41431-017-0015-0; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luteijn RD, 2019, J VIROL, V93, DOI 10.1128/JVI.02160-18; Mezzadra R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212053; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Olbrich T, 2019, CELL REP, V28, P597, DOI 10.1016/j.celrep.2019.06.060; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Pastorello E, 2012, CLIN NEUROL NEUROSUR, V114, P230, DOI 10.1016/j.clineuro.2011.10.022; Rashnonejad A, 2021, MOL THER-NUCL ACIDS, V23, P476, DOI 10.1016/j.omtn.2020.12.004; Rickard AM, 2015, HUM MOL GENET, V24, P5901, DOI 10.1093/hmg/ddv315; Robert C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0734-x; Rong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138553; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Shadle SC, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006658; Shen MW, 2018, NATURE, V563, P646, DOI 10.1038/s41586-018-0686-x; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Soutourina J, 2018, NAT REV MOL CELL BIO, V19, P262, DOI 10.1038/nrm.2017.115; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van Attekum MHA, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.20; van den Heuvel A, 2019, HUM MOL GENET, V28, P1064, DOI 10.1093/hmg/ddy400; Vuoristo S, 2019, DUX4 REGULATES OOCYT, DOI [10.1101/732289, DOI 10.1101/732289]; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Whiddon JL, 2017, NAT GENET, V49, P935, DOI 10.1038/ng.3846; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Yu JSL, 2019, METHODS, V164, P29, DOI 10.1016/j.ymeth.2019.04.015	86	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263262	10.1371/journal.pone.0263262	http://dx.doi.org/10.1371/journal.pone.0263262			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176052	Green Published, gold			2022-12-26	WOS:000777505200017
J	Foa, RS; Fabian, M; Gilbert, S				Foa, Roberto Stefan; Fabian, Mark; Gilbert, Sam			Subjective well-being during the 2020-21 global coronavirus pandemic: Evidence from high frequency time series data	PLOS ONE			English	Article							COVID-19 LOCKDOWN; NEGATIVE AFFECT; MENTAL-HEALTH	We investigate how subjective well-being varied over the course of the global COVID-19 pandemic, with a special attention to periods of lockdown. We use weekly data from YouGov's Great Britain Mood Tracker Poll, and daily reports from Google Trends, that cover the entire period from six months before until eighteen months after the global spread of COVID-19. Descriptive trends and time-series models suggest that negative mood associated with the imposition of lockdowns returned to baseline within 1-3 weeks of lockdown implementation, whereas pandemic intensity, measured by the rate of fatalities from COVID-19 infection, was persistently associated with depressed affect. The results support the hypothesis that country-specific pandemic severity was the major contributor to increases in negative affect observed during the COVID-19 pandemic, and that lockdowns likely ameliorated rather than exacerbated this effect.	[Foa, Roberto Stefan; Gilbert, Sam] Univ Cambridge, Bennett Inst Publ Policy, Dept Polit Sci & Int Studies, Cambridge, England; [Fabian, Mark] Univ Tasmania, Inst Social Change, Hobart, Tas, Australia	University of Cambridge; University of Tasmania	Fabian, M (corresponding author), Univ Tasmania, Inst Social Change, Hobart, Tas, Australia.	mark.fabian@utas.edu.au		Foa, Roberto Stefan/0000-0001-8867-7566				A.Steptoe, 2020, medRxiv, DOI 10.1101/2020.06.03.20120923; A.Steptoe, 2020, medRxiv, DOI 10.1101/2020.05.29.20116657; Aknin L.B., IN PRESS, DOI 10.1177/17456916211029964; Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263; Breunig R., 2014, ASIA PACIFIC POLICY, V1, P1; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Courtet P, 2020, J CLIN PSYCHIAT, V81, DOI 10.4088/JCP.20com13370; Craig L, 2021, GENDER WORK ORGAN, V28, P66, DOI 10.1111/gwao.12497; Daly M, 2021, J PSYCHIATR RES, V136, P603, DOI 10.1016/j.jpsychires.2020.10.035; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Etile F, 2021, J ECON BEHAV ORGAN, V191, P598, DOI 10.1016/j.jebo.2021.09.004; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Feddersen J, 2016, J R STAT SOC A STAT, V179, P203, DOI 10.1111/rssa.12118; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Foa R.S., COVID 19 SUBJECTIVE; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Giurge LM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018494118; Graham C., 2017, HAPPINESS ALL UNEQUA; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Jones S.P., 2020, IMPERIAL COLL LONDON; Kofman YB, 2020, PSYCHOL TRAUMA-US, V12, pS199, DOI 10.1037/tra0000866; Lamu AN, 2016, SOC SCI MED, V152, P176, DOI 10.1016/j.socscimed.2016.01.046; Lombardo P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5235-x; Lorenz O, 2018, J TRANSP GEOGR, V66, P180, DOI 10.1016/j.jtrangeo.2017.11.019; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; Mackinnon A, 1999, PERS INDIV DIFFER, V27, P405, DOI 10.1016/S0191-8869(98)00251-7; McNair D., 1971, MANUAL PROFILE MOOD; Mellon J, 2013, PS-POLIT SCI POLIT, V46, P280, DOI 10.1017/S1049096513000279; Nie P, 2018, CHINA ECON REV, V48, P188, DOI 10.1016/j.chieco.2016.03.002; Niedzwiedz Claire L, 2021, J Epidemiol Community Health, V75, P224, DOI 10.1136/jech-2020-215060; OECD, GUIDELINES MEASURING; Office of National Statistics (ONS), DEATHS CAUS SUIC QUA; Pieraccini M, 2020, LEGAL PERSPECTIVES ON SUSTAINABILITY, P1, DOI 10.1016/S2215-0366(20)30308-4; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Poppelaars ES, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00962; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Proto E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244419; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; Recchi E, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100508; Sheldon KM, 2014, STABILITY OF HAPPINESS: THEORIES AND EVIDENCE ON WHETHER HAPPINESS CAN CHANGE, P1; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stone A. A., 2013, SUBJECTIVE WELL BEIN; United States Centres for Disease Control and Prevention 2021, COVID 19 DEATH RAT R; VanderWeele TJ, 2021, J GEN INTERN MED, V36, P248, DOI 10.1007/s11606-020-06274-3; Vosen S, 2011, J FORECASTING, V30, P565, DOI 10.1002/for.1213; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zacher H, 2021, AM PSYCHOL, V76, P50, DOI 10.1037/amp0000702; Zhang SX, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112958	56	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263570	10.1371/journal.pone.0263570	http://dx.doi.org/10.1371/journal.pone.0263570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171919	gold, Green Published			2022-12-26	WOS:000795889700027
J	Guilmoto, CZ				Guilmoto, Christophe Z.			An alternative estimation of the death toll of the Covid-19 pandemic in India	PLOS ONE			English	Article							MORTALITY	The absence of reliable registration of Covid-19 deaths in India has prevented proper assessment and monitoring of the coronavirus pandemic. In addition, India's relatively young age structure tends to conceal the severity of Covid-19 mortality, which is concentrated in older age groups. In this paper, we present four different demographic samples of Indian populations for which we have information on both their demographic structures and death outcomes. We show that we can model the age distribution of Covid-19 mortality in India and use this modeling to estimate Covid-19 mortality in the country. Our findings point to a death toll of approximately 3.2-3.7 million persons by early November 2021. Once India's age structure is factored in, these figures correspond to one of the most severe cases of Covid-19 mortality in the world. India has recorded after February 2021 the second outbreak of coronavirus that has affected the entire country. The accuracy of official statistics of Covid-19 mortality has been questioned, and the real number of Covid-19 deaths is thought to be several times higher than reported. In this paper, we assembled four independent population samples to model and estimate the level of Covid-19 mortality in India. We first used a population sample with the age and sex of Covid-19 victims to develop a Gompertz model of Covid-19 mortality in India. We applied and adjusted this mortality model on two other national population samples after factoring in the demographic characteristics of these samples. We finally derive from these samples the most reasonable estimate of Covid-19 mortality level in India and confirm this result using a fourth population sample. Our findings point to a death toll of about 3.2-3.7 million persons by late May 2021. This is by far the largest number of Covid-19 deaths in the world. Once standardized for age and sex structure, India's Covid-19 mortality rate is above Brazil and the USA. Our analysis shows that existing population samples allow an alternative estimation of deaths due to Covid-19 in India. The results imply that only one out of 7-8 deaths appear to have been recorded as a Covid-19 death in India. The estimates also point to a very high Covid-19 mortality rate, which is even higher after age and sex standardization. The magnitude of the pandemic in India requires immediate attention. In the absence of effective remedies, this calls for a strong response based on a combination of non-pharmaceutical interventions and the scale-up of vaccination to make them accessible to all, with an improved surveillance system to monitor the progression of the pandemic and its spread across India's regions and social groups.	[Guilmoto, Christophe Z.] Ctr Sci Humaines, Delhi, India; [Guilmoto, Christophe Z.] Univ Paris, Ceped, INSERM, IRD, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Guilmoto, CZ (corresponding author), Ctr Sci Humaines, Delhi, India.; Guilmoto, CZ (corresponding author), Univ Paris, Ceped, INSERM, IRD, Paris, France.	czguilmoto@gmail.com						Anand A., 2021, CTR GLOBAL DEV; [Anonymous], 2021, LANCET, V397, P1683, DOI 10.1016/S0140-6736(21)01052-7; [Anonymous], WORLD POPULATION PRO; [Anonymous], 2021, TIMES INDIA; [Anonymous], 2021, COV 19 COR PAND; [Anonymous], 2021, HINDU; [Anonymous], 2021, INDIAN EXPRESS; [Anonymous], PROVISIONAL COVID 19; [Anonymous], ECONOMIST; [Anonymous], 2021, DEMOGRAPHY COVID 19; [Anonymous], LOKDHABA IND EL DAT; [Anonymous], 2017, 13 REPORT STANDING C; [Anonymous], 2020, BBC 0803; [Anonymous], 2021, CORONAVIRUS OUTBREAK; [Anonymous], 2021, LIST MEMBERS RAJYA S; [Anonymous], 2021, ECONOMIST 0515; [Anonymous], BIT COM SUSP CONF CO; Aquino M., 2021, REZUTERS 0601; Basavaraj KA, 2021, POLIT PSYCHOL, V42, P827, DOI 10.1111/pops.12774; Banaji M., 2021, MEDRXIV, DOI [10.1101/2021.09.30.21264376v1, DOI 10.1101/2021.09.30.21264376V1]; Banaji M., 2021, INDIA FORUM 0510; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; Bhagat SV., 2021, NEW YORK TIMES; Bhattacharya P, 2020, INDIAN J PSYCHOL MED, V42, P382, DOI 10.1177/0253717620935578; Bhattacharya S., 2021, FEDERAL FEB; Department of Primary and Secondary Education, 2020, SCH ED KARN 2018 19; Gamio L., 2021, NEW YORK TIMES; Government of Kerala, STAT DASHB; Gowda K, 2012, 455 STANF U STANF; Guilmoto, 2020, COVID 19 DEATH RATES, DOI DOI 10.1101/2020.05.17.20097410; Gupta A., 2021, HINDU; Gupta A., 2021, SOCARXIV; Gupta A, 2022, GENUS, V78, DOI 10.1186/s41118-021-00149-z; Heuveline P, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042934; Indian Railways, 2020, YB 2019 20; Institute for Health Metrics and Evaluation, 2021, EST TOT EXC MORT DUE; Islam A, 2021, SOC SCI MED, V278, DOI 10.1016/j.socscimed.2021.113966; Jadhav R., 2021, REUTERS 0514; Jha P., 2021, INDIAN EXPRESS; Jha P, 2022, SCIENCE, V375, P667, DOI 10.1126/science.abm5154; Joshi B, 2021, CURR SOCIOL, V69, P492, DOI 10.1177/0011392121990023; Kisa S, 2020, INT J HEALTH PLAN M, V35, P1009, DOI 10.1002/hpm.3031; Kumar GA, 2019, INDIAN J MED RES, V149, P740, DOI 10.4103/ijmr.IJMR_1620_17; Leffler CT., 2021, MEDRXIV, DOI [10.1101/2021.08.04.21261604, DOI 10.1101/2021.08.04.21261604, 10.1101/2021.08.04.21261604v2]; Mukherji R, 2020, J DEMOCR, V31, P91, DOI 10.1353/jod.2020.0058; Prado Marcelo Freitas do, 2020, Rev. bras. ter. intensiva, V32, P224, DOI [10.5935/0103-507X.20200030, 10.5935/0103-507x.20200030]; Pulla P., 2020, WIRE; R. J. Acosta, 2021, medRxiv, DOI 10.1101/2021.08.22.21262432; Reevel P., 2020, ABC NEWS; Saikia N., 2021, INDIAN EXPRESS; Sasson I, 2021, DEMOGR RES, V44, P379, DOI 10.4054/DemRes.2021.44.16; Seventeen Lok Sabha, 2021, MEMB BIOGR SKETCH; Shapiro V., 2021, SOCARXIV 5C8BD, DOI [10.31235/osf.io/5c8bd, DOI 10.31235/OSF.IO/5C8BD]; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Zimmermann LV, 2021, AM J PUBLIC HEALTH, V111, pS59, DOI 10.2105/AJPH.2021.306419	55	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263187	10.1371/journal.pone.0263187	http://dx.doi.org/10.1371/journal.pone.0263187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171925	Green Published, gold			2022-12-26	WOS:000795889700015
J	Moron-Garcia, O; Garzon-Martinez, GA; Martinez-Martin, MJP; Brook, J; Corke, FMK; Doonan, JH; Rodriguez, AVC				Moron-Garcia, Odin; Garzon-Martinez, Gina A.; Pilar Martinez-Martin, M. J.; Brook, Jason; Corke, Fiona M. K.; Doonan, John H.; Camargo Rodriguez, Anyela, V			Genetic architecture of variation in Arabidopsis thaliana rosettes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ECO-EVO-DEVO; NATURAL VARIATION; G-PROTEIN; DEVELOPMENTAL PLASTICITY; PLANT ARCHITECTURE; SHAPE DESCRIPTORS; SHADE-AVOIDANCE; SUBUNIT AGG3; QTL ANALYSIS	Rosette morphology across Arabidopsis accessions exhibits considerable variation. Here we report a high-throughput phenotyping approach based on automatic image analysis to quantify rosette shape and dissect the underlying genetic architecture. Shape measurements of the rosettes in a core set of Recombinant Inbred Lines from an advanced mapping population (Multiparent Advanced Generation Inter-Cross or MAGIC) derived from intercrossing 19 natural accessions. Image acquisition and analysis was scaled to extract geometric descriptors from time stamped images of growing rosettes. Shape analyses revealed heritable morphological variation at early juvenile stages and QTL mapping resulted in over 116 chromosomal regions associated with trait variation within the population. Many QTL linked to variation in shape were located near genes related to hormonal signalling and signal transduction pathways while others are involved in shade avoidance and transition to flowering. Our results suggest rosette shape arises from modular integration of sub-organ morphologies and can be considered a functional trait subjected to selective pressures of subsequent morphological traits. On an applied aspect, QTLs found will be candidates for further research on plant architecture.	[Moron-Garcia, Odin; Garzon-Martinez, Gina A.; Pilar Martinez-Martin, M. J.; Brook, Jason; Corke, Fiona M. K.; Doonan, John H.; Camargo Rodriguez, Anyela, V] Aberystwyth Univ, Natl Plant Phen Ctr, Inst Biol Rural & Environm Sci IBERS, Aberystwyth, Dyfed, Wales; [Moron-Garcia, Odin] Earlham Inst, Norfolk, England; [Garzon-Martinez, Gina A.] Corp Colombiana Invest Agr Agrosavia, Ctr Invest Tibaitata, Mosquera, Cundinamarca, Colombia; [Camargo Rodriguez, Anyela, V] Natl Inst Agr Bot NIAB, John Bingham Lab, Genet & Breeding, Cambridge, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA	Doonan, JH; Rodriguez, AVC (corresponding author), Aberystwyth Univ, Natl Plant Phen Ctr, Inst Biol Rural & Environm Sci IBERS, Aberystwyth, Dyfed, Wales.; Rodriguez, AVC (corresponding author), Natl Inst Agr Bot NIAB, John Bingham Lab, Genet & Breeding, Cambridge, England.	john.doonan@aber.ac.uk; anyela.camargorodriguez@niab.com		Moron-Garcia, Odin/0000-0002-5275-4520; Corke, Fiona/0000-0001-5304-6713; Brook, Jason/0000-0001-9491-4900; Garzon Martinez, Gina Alessandra/0000-0001-5620-9055; Martinez-Martin, MJ Pilar/0000-0002-5859-6113	Biotechnology and Biological Sciences Research Council [BB/J004464/1, BBS/E/W0012844A]; Horizon2020 support via project EPPN2020 Grant [731013]; Aberystwyth University	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horizon2020 support via project EPPN2020 Grant; Aberystwyth University	JHD and AC acknowledge support from Biotechnology and Biological Sciences Research Council for grants BB/J004464/1 and BBS/E/W0012844A (https://www.ukri.org/councils/bbsrc/).JHD acknowledges Horizon2020 support via project EPPN2020 Grant agreement ID: 731013. OM-G and GG-M acknowledge receipt of an AberDoc scholarship from Aberystwyth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 2014, ADV EXP MED BIOL, V781, P107, DOI [10.1007/978-94-007-7347-9__6, 10.1007/978-94-007-7347-9_6]; Ahfock D, 2014, GENETICS, V198, P117, DOI 10.1534/genetics.114.167577; Al-Thelaya K, 2021, COMPUT GRAPH-UK, V98, P105, DOI 10.1016/j.cag.2021.04.037; Alizadeh E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217346; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Apelt F, 2015, PLANT J, V82, P693, DOI 10.1111/tpj.12833; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Bac-Molenaar JA, 2015, J EXP BOT, V66, P5567, DOI 10.1093/jxb/erv176; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Balduzzi M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00117; Ballare CL, 2017, PLANT CELL ENVIRON, V40, P2530, DOI 10.1111/pce.12914; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Bhatia N, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.149336; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Blackman BK, 2017, PLANT PHYSIOL, V173, P16, DOI 10.1104/pp.16.01683; Bongers FJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007253; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buendia-Monreal M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01349; Burger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02347-w; Bush MS, 2016, PLANT PHYSIOL, V172, P128, DOI 10.1104/pp.16.00435; Camargo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096889; Cartolano M, 2015, P NATL ACAD SCI USA, V112, P10539, DOI 10.1073/pnas.1419791112; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chartier M, 2014, NEW PHYTOL, V204, P841, DOI 10.1111/nph.12969; Cheng CY, 2017, PLANT J, V89, P789, DOI 10.1111/tpj.13415; Chenu K, 2005, FUNCT PLANT BIOL, V32, P1123, DOI 10.1071/FP05091; Chitwood DH, 2016, PLANT PHYSIOL, V170, P1480, DOI 10.1104/pp.15.01825; Chitwood DH, 2016, NEW PHYTOL, V210, P343, DOI 10.1111/nph.13754; Cockram J, 2018, ADV BIOCHEM ENG BIOT, V164, P109, DOI 10.1007/10_2017_48; Coen E, 2017, DEVELOPMENT, V144, P4203, DOI 10.1242/dev.151910; Conn A, 2017, CURR BIOL, V27, P2078, DOI 10.1016/j.cub.2017.06.009; Crouse WL, 2020, GENETICS, V216, P957, DOI 10.1534/genetics.120.303393; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Domjanic J, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-27; Dornbusch T, 2012, FUNCT PLANT BIOL, V39, P860, DOI 10.1071/FP12018; Durrant C, 2010, GENETICS, V184, P839, DOI 10.1534/genetics.109.113183; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Fagny M, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.606285; Ferrero-Serrano A, 2019, NAT ECOL EVOL, V3, P274, DOI 10.1038/s41559-018-0754-5; Ford ED, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00275; Fujita N, 2015, ECOL RES, V30, P517, DOI 10.1007/s11284-015-1249-3; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; George AW, 2015, THEOR APPL GENET, V128, P1163, DOI 10.1007/s00122-015-2497-x; Geuten K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00381; Gilbert SF, 2015, NAT REV GENET, V16, P611, DOI 10.1038/nrg3982; Gnan S, 2014, GENETICS, V198, P1751, DOI 10.1534/genetics.114.170746; Godin C, 1999, ANN BOT-LONDON, V84, P343, DOI 10.1006/anbo.1999.0923; Godin C, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.165878; Gonzalez R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74723-4; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Gupta PK, 2019, ADV GENET, V104, P75, DOI 10.1016/bs.adgen.2018.12.001; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hayes Ben, 2013, Methods Mol Biol, V1019, P149, DOI 10.1007/978-1-62703-447-0_6; Herrera-Navarro AM, 2013, COMPUT SIST, V17, P515, DOI 10.13053/CyS-17-4-2013-005; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Huang BE, 2013, THEOR APPL GENET, V126, P379, DOI 10.1007/s00122-012-1986-4; Huang BE, 2011, BIOINFORMATICS, V27, P727, DOI 10.1093/bioinformatics/btq719; Hutchings MJ, 2004, ANN BOT-LONDON, V94, P1, DOI 10.1093/aob/mch111; Huttegger SM, 2011, EVOL BIOL, V38, P335, DOI 10.1007/s11692-011-9123-x; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Julkowska MM, 2016, J EXP BOT, V67, P2127, DOI 10.1093/jxb/erw015; Kasulin L, 2013, ANN BOT-LONDON, V111, P811, DOI 10.1093/aob/mct038; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Klein LL, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2269; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0249; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Ladejobi O, 2016, APPL TRANSL GENOM, V11, P9, DOI 10.1016/j.atg.2016.10.002; Ledevin R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015470; Legris M, 2016, SCIENCE, V354, P897, DOI 10.1126/science.aaf5656; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Lestrel PE, 2017, BIOL SHAP AN P 4 INT; Lestrel PE, 2011, P 1 INT S; Li SJ, 2012, PLANT SIGNAL BEHAV, V7, P1357, DOI 10.4161/psb.21620; Li SJ, 2012, NEW PHYTOL, V194, P690, DOI 10.1111/j.1469-8137.2012.04083.x; Li YL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0241528; Lievre M, 2013, WIRES DEV BIOL, V2, P809, DOI 10.1002/wdev.119; Lobet G, 2013, PLANT METHODS, V9, DOI [10.1186/1746-4811-9-1, 10.1186/1746-4811-9-38]; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Mandel T, 2014, DEVELOPMENT, V141, P830, DOI 10.1242/dev.104687; Marchadier E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007954; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Migicovsky Z, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02185; Mitteroecker Philipp, 2009, Biology Theory, V4, P54, DOI 10.1162/biot.2009.4.1.54; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mundermann L, 2005, PLANT PHYSIOL, V139, P960, DOI 10.1104/pp.105.060483; Nakayama H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01717; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Paradis E., 2019, ANALYSES PHYLOGENETI, V2; Patel D, 2013, PLANT J, V73, P980, DOI 10.1111/tpj.12088; Pavicic M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00416; Perez-Perez JM, 2002, GENETICS, V162, P893; Peura M, 1997, P 3 INT WORKSHOP VIS; Pinheiro J, 2020, R PACKAGE VERSION 31; Pires ND, 2012, PHILOS T R SOC B, V367, P508, DOI 10.1098/rstb.2011.0252; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; R Core Team, 2021, R LANG ENV STAT; Rahaman MM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00619; Ritter N, 2009, J MATH IMAGING VIS, V35, P117, DOI 10.1007/s10851-009-0158-x; Rosin PL, 2003, MACH VISION APPL, V14, P172, DOI 10.1007/s00138-002-0118-6; Runcie DE, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007978; Rutishauser R, 2005, THEOR BIOSCI, V124, P213, DOI 10.1016/j.thbio.2005.09.005; Rutishauser R, 2020, PHILOSOPHIES, V5, DOI 10.3390/philosophies5040041; Sattler R, 1997, ANN BOT-LONDON, V80, P571, DOI 10.1006/anbo.1997.0474; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Scott MF, 2020, HEREDITY, V125, P396, DOI 10.1038/s41437-020-0336-6; Sen S, 2001, GENETICS, V159, P371; Sen S, 2009, GENETICS, V181, P1613, DOI 10.1534/genetics.108.094607; Shapiro L., 2001, COMPUTER VISION, V2001; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Sparks R, 2013, MED IMAGE ANAL, V17, P997, DOI 10.1016/j.media.2013.06.002; SUNDBERG P, 1989, SYST ZOOL, V38, P166, DOI 10.2307/2992385; Takou M, 2019, J EXP BOT, V70, P1141, DOI 10.1093/jxb/ery447; Tisne S, 2011, ANN BOT-LONDON, V108, P159, DOI 10.1093/aob/mcr091; Tisne S, 2010, PLANT CELL ENVIRON, V33, P1875, DOI 10.1111/j.1365-3040.2010.02191.x; Tonsor SJ, 2005, PLANT CELL ENVIRON, V28, P2, DOI 10.1111/j.1365-3040.2004.01264.x; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Trotta A, 2011, PLANT PHYSIOL, V156, P1464, DOI 10.1104/pp.111.178442; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Verbyla AP, 2014, G3-GENES GENOM GENET, V4, P1569, DOI 10.1534/g3.114.012971; Verbyla AP, 2014, THEOR APPL GENET, V127, P1753, DOI 10.1007/s00122-014-2337-4; Vofely RV, 2019, NEW PHYTOL, V221, P540, DOI 10.1111/nph.15461; Wang LY, 2009, PLANT PHYSIOL, V149, P1632, DOI 10.1104/pp.108.134072; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Wieters B, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1008748; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xu D, 2008, PATTERN RECOGN, V41, P240, DOI 10.1016/j.patcog.2007.05.001; Xu H, 2020, ANNU REV GENET, V54, P417, DOI 10.1146/annurev-genet-022620-094553; Yano K, 2019, P NATL ACAD SCI USA, V116, P21262, DOI 10.1073/pnas.1904964116; Zargar S. M., 2015, Journal of Crop Science and Biotechnology, V18, P293, DOI 10.1007/s12892-015-0037-5; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008; Zhang ZJ, 2014, GENETICS, V198, P139, DOI 10.1534/genetics.114.166249	147	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263985	10.1371/journal.pone.0263985	http://dx.doi.org/10.1371/journal.pone.0263985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171969	Green Published, gold			2022-12-26	WOS:000795889700055
J	Vitale, DS; Lahni, P; Hornung, L; Thompson, T; Farrell, PR; Lin, TK; Nathan, JD; Wong, HR; Abu-El-Haija, M				Vitale, David S.; Lahni, Patrick; Hornung, Lindsey; Thompson, Tyler; Farrell, Peter R.; Lin, Tom K.; Nathan, Jaimie D.; Wong, Hector R.; Abu-El-Haija, Maisam			Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis	PLOS ONE			English	Article							SERUM MATRIX-METALLOPROTEINASE-9; LUNG INJURY; PREDICT; MANAGEMENT; NECROSIS; LEAKAGE; MARKER; MMP-9	Background Acute pancreatitis (AP) is increasing in incidence in adult and pediatric patients. Identification of patients at high risk for progression to severe acute pancreatitis (SAP) is crucial, as it can lead to increased mortality and health system cost. Matrix metalloproteinases (MMPs) are endopeptidases which degrade extracellular matrix proteins and increase activity of proinflammatory cytokines. Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity. Prior limited studies of MMPs and TIMPs have found some to be associated with development of SAP. The aim of this study was to further investigate the role of MMPs and TIMPs in detecting pediatric patients at risk for developing moderately severe AP or SAP. Methods Plasma samples were prospectively collected for patients <21 years of age presenting with AP between November 2015 and October 2019, along with healthy controls. Bead-based multiplex assays were utilized to test levels of 12 MMPs and TIMPs. Results Samples were collected from 7 subjects who developed SAP, 7 with moderately severe AP, 45 with mild AP and 44 healthy controls. MMP-9 (p = 0.04) and TIMP-1 (p = 0.01) levels were significantly higher in SAP patients. A multivariable logistic regression model using MMP-9 and TIMP-1 predicted SAP (AUROC 0.87, 95% CI 0.76-0.98). Conclusion We have demonstrated that MMP9 and TIMP1 levels are increased at AP presentation in pediatric patients who developed SAP during the course of illness. Further studies are needed to validate the use of MMPs and TIMPs as predictive tools for development of SAP in pediatric pancreatitis.	[Vitale, David S.; Lahni, Patrick; Farrell, Peter R.; Lin, Tom K.; Wong, Hector R.; Abu-El-Haija, Maisam] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Vitale, David S.; Thompson, Tyler; Farrell, Peter R.; Lin, Tom K.; Abu-El-Haija, Maisam] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Lahni, Patrick; Wong, Hector R.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Hornung, Lindsey] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Nathan, Jaimie D.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gen & Thorac Surg, Cincinnati, OH 45229 USA; [Nathan, Jaimie D.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Vitale, DS (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.; Vitale, DS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA.	david.vitale@cchmc.org			NIDDK [1K23DK118190-01]	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial Support: MAH is supported by NIDDK, grant number 1K23DK118190-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-El-Haija M, 2020, PANCREATOLOGY, V20, P1103, DOI 10.1016/j.pan.2020.07.008; Abu-El-Haija M, 2017, J PEDIATR GASTR NUTR, V64, P984, DOI 10.1097/MPG.0000000000001583; Abu-El-Haija M, 2014, J PEDIATR GASTR NUTR, V58, P689, DOI 10.1097/MPG.0000000000000360; Aynaci M, 2006, ANZ J SURG, V76, P801, DOI 10.1111/j.1445-2197.2006.03871.x; Brumann M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/435463; Chen P, 2006, TOHOKU J EXP MED, V208, P261, DOI 10.1620/tjem.208.261; Coffey MJ, 2013, J PEDIATR GASTR NUTR, V56, P602, DOI 10.1097/MPG.0b013e31828b36d8; Farrell PR, 2020, J PEDIATR GASTR NUTR, V71, P536, DOI 10.1097/MPG.0000000000002807; Fic P, 2011, POSTEP HIG MED DOSW, V65, P16, DOI 10.5604/17322693.931536; Guo J, 2012, HEPATO-GASTROENTEROL, V59, P1594, DOI 10.5754/hge11563; Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494; Hornung L, 2017, PANCREAS, V46, P1111, DOI 10.1097/MPA.0000000000000918; Hsu AT, 2015, SHOCK, V44, P128, DOI 10.1097/SHK.0000000000000386; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Kurzepa J, 2014, HEPATOB PANCREAT DIS, V13, P570, DOI 10.1016/S1499-3872(14)60261-7; Lautz TB, 2011, J PEDIATR SURG, V46, P1144, DOI 10.1016/j.jpedsurg.2011.03.044; Ling L, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015831; Manjari KS, 2013, INDIAN J GASTROENTER, V32, P103, DOI 10.1007/s12664-012-0299-5; Mikami Y, 2009, SURGERY, V145, P147, DOI 10.1016/j.surg.2008.08.036; Morinville VD, 2012, J PEDIATR GASTR NUTR, V55, P261, DOI 10.1097/MPG.0b013e31824f1516; Morinville VD, 2010, PANCREAS, V39, P5, DOI 10.1097/MPA.0b013e3181baac47; Muhs BE, 2003, J SURG RES, V109, P110, DOI 10.1016/S0022-4804(02)00084-7; Nawacki L, 2019, ACTA GASTRO-ENT BELG, V82, P501; Nukarinen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161480; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Orkin SH, 2019, J PEDIATR-US, V213, P143, DOI 10.1016/j.jpeds.2019.06.028; Parniczky A, 2018, PANCREATOLOGY, V18, P146, DOI 10.1016/j.pan.2018.01.001; Suzuki M, 2015, PEDIATR INT, V57, P113, DOI 10.1111/ped.12449; Sweeny KF, 2019, J PEDIATR GASTR NUTR, V68, P104, DOI 10.1097/MPG.0000000000002145; Szabo FK, 2016, PANCREATOLOGY, V16, P358, DOI 10.1016/j.pan.2016.03.002; Szabo FK, 2015, J PEDIATR-US, V167, P397, DOI 10.1016/j.jpeds.2015.05.030; Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08; Venkateshwari A, 2011, INDIAN J CLIN BIOCHE, V26, P136, DOI 10.1007/s12291-010-0103-1; Vitale DS, 2019, PANCREAS, V48, P363, DOI 10.1097/MPA.0000000000001265; Wereszczynska-Siemiatkowska U, 2015, Z GASTROENTEROL, V53, P199, DOI 10.1055/s-0034-1385705; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0261708	10.1371/journal.pone.0261708	http://dx.doi.org/10.1371/journal.pone.0261708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157709	Green Published, gold			2022-12-26	WOS:000788004500003
J	Animut, A; Horstmann, S				Animut, Abebe; Horstmann, Sebastian			Residual efficacy of Fludora Fusion against Anopheles arabiensis in simple huts in Ethiopia	PLOS ONE			English	Article							DELTAMETHRIN	Emergence and spread of malaria vectors resistant to the available insecticides required a new and efficacious insecticide. Residual efficacy of Fludora (R) Fusion was evaluated against insecticide susceptible Anopheles arabiensis in ten circular huts similar to the residential huts. Fludora (R) Fusion WP-SB 56.25, FICAM WP80 and Clothianidin WG70 were sprayed, by experienced technician, on interior wall surfaces: paint, dung, smooth mud, and rough mud. WHO cone bioassays were carried out a month after spraying and thereafter on monthly intervals for 12 months. Knockdown was recorded at 60 minutes and mortality at 24 hours, 48 hours and 72 hours holding time post-exposure. Fludora Fusion induced 100% An. arabiensis mortality during the first four months post-treated on all surface types at 24 hours holding time post-exposure. Its activity remained over 80% from the fifth to the twelfth month post-treated on the surfaces with the exception of two assessment points, at seventh month and eleventh month, on paint and smooth mud surfaces. FICAM induced 100% mortality rate during the first 4 months and 92% mortality during the fifth month post-treatment on painted surfaces. Its activity was over 96% mortality 1-month post-treatment on smooth mud and rough mud surfaces and 92% mortality 2-month post-treatment on dung surfaces. Clothianidin caused 89% and 86% mortality 1-month post-treatment on smooth mud and rough mud surfaces. Fludora Fusion can be used as alternative indoor residual insecticide spraying against An. arabiensis in Ethiopia.	[Animut, Abebe] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Med Entomol, Addis Ababa, Ethiopia; [Horstmann, Sebastian] Bayer AG Crop Sci, Field Testing, Lab Vector Control, Res & Dev, Monheim, Germany	Addis Ababa University	Animut, A (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Med Entomol, Addis Ababa, Ethiopia.	animut2004@yahoo.com			Bayer (PTY) LTD, Johannesburg	Bayer (PTY) LTD, Johannesburg	This study was financially supported by Bayer (PTY) LTD, Johannesburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2011, TROP MED INT HEALTH, V16, P486, DOI 10.1111/j.1365-3156.2011.02728.x; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Agossa FR, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2633-6; Animut A, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2172-1; [Anonymous], 2014, NAT MAL PROGR MON EV; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Etang J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-333; Fuseini G, 2019, ACTA TROP, V196, P42, DOI 10.1016/j.actatropica.2019.05.006; Girum T, 2019, TROP DIS TRAVEL MED, V5, DOI 10.1186/s40794-019-0090-z; Messenger LA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2115-2; Ngufor C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189575; Randriamaherijaona S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1345-z; WHO, 2019, GUID MAL VECT CONTR; WHO, 2018, WORLD MAL REP 2018; WHO, 2006, GUIDELINES TESTING M; WHO, 2015, OP MAN IND RES SPRAY; WHO, 2021, WORLD MALARIA REPORT; WHO, 2013, TEST PROC INREMO; WHO, 2003, SPAC SPR APPL INS VE; World Health Organization, 2007, MAN IND RES SPRAYING; Yeebiyo Y, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1549-7; Yewhalaw D, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2122-3; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263840	10.1371/journal.pone.0263840	http://dx.doi.org/10.1371/journal.pone.0263840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148353	Green Submitted, Green Published, gold			2022-12-26	WOS:000800108800035
J	Chernyavsky, A; Khylynskyi, MM; Patel, KG; Grando, SA				Chernyavsky, Alex; Khylynskyi, Mykhailo M.; Patel, Krupa G.; Grando, Sergei A.			Chronic exposure to the anti-M3 muscarinic acetylcholine receptor autoantibody in pemphigus vulgaris contributes to disease pathophysiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINERGIC-RECEPTORS; NICOTINIC RECEPTOR; CELLS; DESMOGLEIN; M-3; DIFFERENTIATION; IDENTIFICATION; ACANTHOLYSIS; MECHANISMS; ANTIBODIES	Pemphigus vulgaris (PV) is a potentially lethal autoimmune mucocutaneous blistering disease characterized by binding of IgG autoantibodies (AuAbs) to keratinocytes (KCs). In addition to AuAbs against adhesion molecules desmogleins 1 and 3, PV patients also produce an AuAb against the M3 muscarinic acetylcholine (ACh) receptor (M3AR) that plays an important role in regulation of vital functions of KCs upon binding endogenous ACh. This anti-M3AR AuAb is pathogenic because its adsorption eliminates the acantholytic activity of PV IgG; however, the molecular mechanism of its action is unclear. In the present study, we sought to elucidate the mode of immunopharmacologic action of the anti-M3AR AuAb in PV. Shortterm exposures of cultured KCs to PV IgG or the muscarinic agonist muscarine both induced changes in the expression of keratins 5 and 10, consistent with the inhibition of proliferation and upregulated differentiation and in keeping with the biological function of M3AR. In contrast, long-term incubations induced a keratin expression pattern consistent with upregulated proliferation and decreased differentiation, in keeping with the hyperproliferative state of KCs in PV. This change could result from desensitization of the M3AR, representing the net antagonist-like effect of the AuAb. Therefore, chronic exposure of KCs to the anti-M3AR AuAb interrupts the physiological regulation of KCs by endogenous ACh, contributing to the onset of acantholysis. Since cholinergic agents have already demonstrated antiacantholytic activity in a mouse model of PV and in PV patients, our results have translational significance and can guide future development of therapies for PV patients employing cholinergic drugs.	[Chernyavsky, Alex; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA USA; [Khylynskyi, Mykhailo M.] Municipal Dept Hlth, Unit Dermato venereol, Kiev, Ukraine; [Patel, Krupa G.] Oakland Univ, Dept Neurol, William Beaumont Sch Med, Rochester, MI USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; Oakland University; University of California System; University of California Irvine; University of California System; University of California Irvine	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA USA.; Grando, SA (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA USA.; Grando, SA (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA USA.	sgrando@uci.edu			Dysimmune Diseases Foundation	Dysimmune Diseases Foundation	This work was supported in part by a research grant from Dysimmune Diseases Foundation (to S. A. G.) .	Ahmed AR, 2016, EXP DERMATOL, V25, P839, DOI 10.1111/exd.13106; AHMED AR, 1982, J AM ACAD DERMATOL, V7, P221; Alexandroff AB, 2009, BRIT J DERMATOL, V160, P502, DOI 10.1111/j.1365-2133.2008.08857.x; Amber KT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01190; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2005, AM J PATHOL, V166, P597, DOI 10.1016/S0002-9440(10)62281-X; Arredondo J, 2003, LIFE SCI, V72, P2063, DOI 10.1016/S0024-3205(03)00084-5; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Bhatia SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233957; Buchli R, 2001, MOL CELL BIOCHEM, V228, P57, DOI 10.1023/A:1013368509855; Bystryn JC, 2009, GIORN ITAL DERMAT V, V144, P351; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chernyavsky AI, 2009, INT J IMMUNOPATH PH, V22, P461, DOI 10.1177/039463200902200223; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Chernyavsky A, 2019, J BIOL CHEM, V294, P4520, DOI 10.1074/jbc.RA118.006743; Chernyavsky A, 2015, INT IMMUNOPHARMACOL, V29, P76, DOI 10.1016/j.intimp.2015.04.046; Chernyaysky A, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2019.106149; Daoud YJ, 2006, INT IMMUNOPHARMACOL, V6, P600, DOI 10.1016/j.intimp.2005.11.002; ESAKI C, 1995, J INVEST DERMATOL, V105, P329, DOI 10.1111/1523-1747.ep12319948; FISHER SK, 1988, MOL PHARMACOL, V33, P414; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando S. A., 2009, EXP; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Grando SA, 2004, J INVEST DERM SYMP P, V9, P84, DOI 10.1111/j.1087-0024.2004.00826.x; Grando SA, 2003, J AM ACAD DERMATOL, V48, P86, DOI 10.1067/mjd.2003.39; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grando SA, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106385; Grando SA, 2019, INT J DERMATOL, V58, P114, DOI 10.1111/ijd.14143; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Gualtieri B, 2021, ITAL J DERMATOL VENE, V156, P134, DOI 10.23736/S2784-8671.20.06619-5; Hannh R, 2022, ORAL DIS, V28, P1760, DOI 10.1111/odi.13937; Herbst A, 2000, J AM ACAD DERMATOL, V42, P422, DOI 10.1016/S0190-9622(00)90213-5; Kalantari-Dehaghi M., 2013, PEMPHIGUS; Kalantari-Dehaghi M, 2013, J BIOL CHEM, V288, P16916, DOI 10.1074/jbc.M113.472100; Kalantari-Dehaghi M, 2011, EXP DERMATOL, V20, P154, DOI 10.1111/j.1600-0625.2010.01193.x; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lin MS, 1997, CLIN EXP IMMUNOL, V107, P9; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Ndoye A, 1998, J INVEST DERMATOL, V111, P410, DOI 10.1046/j.1523-1747.1998.00299.x; Nguyen V. T., 2004, EXP CELL RES; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Qian J, 2011, GENES IMMUN, V12, P222, DOI 10.1038/gene.2010.72; ROSENBERG FR, 1976, ARCH DERMATOL, V112, P962, DOI 10.1001/archderm.112.7.962; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Schmitt T, 2021, BRIT J DERMATOL, V185, P595, DOI 10.1111/bjd.20091; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sell S., 1996, IMMUNOLOGY IMMUNOPAT, V5th, P299; Shafer SH, 2004, MOL PHARMACOL, V65, P1080, DOI 10.1124/mol.65.5.1080; Shafer SH, 1999, EXP CELL RES, V248, P148, DOI 10.1006/excr.1998.4385; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Toosi R, 2021, CLIN EXP DERMATOL, V46, P1230, DOI 10.1111/ced.14645; Wan XL, 2001, ANTICANCER RES, V21, P2657; Wei B, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/2471518; WILLIAMS CL, 1993, J CELL BIOL, V121, P643, DOI 10.1083/jcb.121.3.643; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; YAMAMURA HI, 1974, P NATL ACAD SCI USA, V71, P1725, DOI 10.1073/pnas.71.5.1725	61	2	2	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101687	10.1016/j.jbc.2022.101687	http://dx.doi.org/10.1016/j.jbc.2022.101687			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143842	gold, Green Published			2022-12-26	WOS:000789400700003
J	Tavasoli, M; Feridooni, T; Feridooni, H; Sokolenko, S; Mishra, A; Lefsay, A; Srinivassane, S; Reid, SA; Rowell, J; Praest, M; MacKinnon, A; Mammoliti, M; Maloney, AA; Moraca, M; Uaesoontrachoon, KP; Nagaraju, KR; Hoffman, E; Pasumarthi, KBS; McMaster, C				Tavasoli, Mahtab; Feridooni, Tiam; Feridooni, Hirad; Sokolenko, Stanislav; Mishra, Abhishek; Lefsay, Abir; Srinivassane, Sadish; Reid, Sarah Anne; Rowell, Joyce; Praest, Molly; MacKinnon, Alexandra; Mammoliti, Melissa; Maloney, Ashley Alyssa; Moraca, Marina; Uaesoontrachoon, Kitipong P.; Nagaraju, Kanneboyina R.; Hoffman, Eric; Pasumarthi, Kishore B. S.; McMaster, Christopher			A mouse model of inherited choline kinase beta-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CONGENITAL MUSCULAR-DYSTROPHY; HEART-FAILURE; SURVIVAL; LIPIDS; ACYLCARNITINES; CONTRACTION; PLASMA; GROWTH; DEFECT	The CHKB gene encodes choline kinase beta, which catalyzes the first step in the biosynthetic pathway for the major phospholipid phosphatidylcholine. Homozygous loss-of-function variants in human CHKB are associated with a congenital muscular dystrophy. Dilated cardiomyopathy is present in some CHKB patients and can cause heart failure and death. Mechanisms underlying a cardiac phenotype due to decreased CHKB levels are not well characterized. We determined that there is cardiac hypertrophy in Chkb(-/-) mice along with a decrease in left ventricle size, internal diameter, and stroke volume compared with wildtype and Chkb(+/-) mice. Unlike wildtype mice, 60% of the Chkb(+/-) and all Chkb(-/-) mice tested displayed arrhythmic events when challenged with isoproterenol. Lipidomic analysis revealed that the major change in lipid level in Chkb(+/-) and Chkb(-/-) hearts was an increase in the arrhythmogenic lipid acylcarnitine. An increase in acylcarnitine level is also associated with a defect in the ability of mitochondria to use fatty acids for energy and we observed that mitochondria from Chkb(-/-) hearts had abnormal cristae and inefficient electron transport chain activity. Atrial natriuretic peptide (ANP) is a hormone produced by the heart that protects against the development of heart failure including ventricular conduction defects. We determined that there was a decrease in expression of ANP, its receptor NPRA, as well as ventricular conduction system markers in Chkb(+/-) and Chkb(-/-) mice.	[Tavasoli, Mahtab; Feridooni, Tiam; Mishra, Abhishek; Reid, Sarah Anne; Nagaraju, Kanneboyina R.; Pasumarthi, Kishore B. S.; McMaster, Christopher] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Sokolenko, Stanislav] Dalhousie Univ, Dept Proc Engn & Appl Sci, Halifax, NS, Canada; [Lefsay, Abir] Dalhousie Univ, Mass Spectrometry Core Facil, Halifax, NS, Canada; [Srinivassane, Sadish; Rowell, Joyce; Praest, Molly; MacKinnon, Alexandra; Mammoliti, Melissa; Maloney, Ashley Alyssa; Moraca, Marina; Uaesoontrachoon, Kitipong P.; Hoffman, Eric] Agada Biosci Inc, Halifax, NS, Canada; [Nagaraju, Kanneboyina R.; Hoffman, Eric] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA	Dalhousie University; Dalhousie University; Dalhousie University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	McMaster, C (corresponding author), Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada.	christopher.mcmaster@dal.ca		Feridooni, Tiam/0000-0002-9480-9737; Mishra, Abhishek kumar/0000-0002-8903-2644	Canadian Institutes of Health Research grant [SOP-159230]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research grant SOP-159230 to C. R. M.	Ahmad T, 2016, J AM COLL CARDIOL, V67, P291, DOI 10.1016/j.jacc.2015.10.079; Aitken-Buck HM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.577856; Boutagy NE, 2015, JOVE-J VIS EXP, DOI 10.3791/53216; Chan SHS, 2020, NEUROMUSCULAR DISORD, V30, P47, DOI 10.1016/j.nmd.2019.10.009; Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Bold AJ, 2011, CAN J PHYSIOL PHARM, V89, P527, DOI [10.1139/Y11-019, 10.1139/y11-019]; Desai AJ, 2018, BRIT J PHARMACOL, V175, P4009, DOI 10.1111/bph.13943; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Elmariah S, 2018, JAMA CARDIOL, V3, P242, DOI 10.1001/jamacardio.2017.4873; Escriba PV, 1997, P NATL ACAD SCI USA, V94, P11375, DOI 10.1073/pnas.94.21.11375; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gallo S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092164; Govindapillai A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25292-0; Haliloglu G, 2015, J INHERIT METAB DIS, V38, P1099, DOI 10.1007/s10545-015-9856-2; Hotchkiss A, 2015, AM J PHYSIOL-CELL PH, V308, pC557, DOI 10.1152/ajpcell.00323.2014; Hunter WG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003190; Verdonschot JAJ, 2020, J CARD FAIL, V26, P212, DOI 10.1016/j.cardfail.2019.09.004; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095; Lai L, 2014, CIRC-HEART FAIL, V7, P1022, DOI 10.1161/CIRCHEARTFAILURE.114.001469; Lanfear DE, 2017, JACC-HEART FAIL, V5, P823, DOI 10.1016/j.jchf.2017.07.009; Mahmaljy H., 2021, DILATED CARDIOMYOPAT; Milani-Nejad N, 2014, PHARMACOL THERAPEUT, V141, P235, DOI 10.1016/j.pharmthera.2013.10.007; Miquerol L, 2010, CIRC RES, V107, P153, DOI 10.1161/CIRCRESAHA.110.218156; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Molnar P, 2014, METHODS MOL BIOL, V1183, P253, DOI 10.1007/978-1-4939-1096-0_16; Muallem S, 2017, EMBO REP, V18, P1893, DOI 10.15252/embr.201744331; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; Preble JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51682; Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002; Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029; Ruiz M, 2017, AM J PHYSIOL-HEART C, V313, pH768, DOI 10.1152/ajpheart.00820.2016; Sayed-Zahid AA, 2019, HUM MOL GENET, V28, P2635, DOI 10.1093/hmg/ddz068; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; STEVENS TL, 1995, J CLIN INVEST, V95, P1101, DOI 10.1172/JCI117757; Sunshine H, 2017, CURR OPIN LIPIDOL, V28, P408, DOI 10.1097/MOL.0000000000000443; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Torres M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072322; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vanlander AV, 2016, MITOCHONDRION, V27, P32, DOI 10.1016/j.mito.2016.02.001; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang D, 2014, HYPERTENSION, V63, P514, DOI 10.1161/HYPERTENSIONAHA.113.02164; WEIBEL ER, 1981, RESP PHYSIOL, V44, P39, DOI 10.1016/0034-5687(81)90076-1; WEIBEL ER, 1981, J HISTOCHEM CYTOCHEM, V29, P1043, DOI 10.1177/29.9.7026667; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Yasuno S, 2009, AM J PHYSIOL-HEART C, V296, pH1804, DOI 10.1152/ajpheart.01033.2008; Zordoky BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124844	53	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101716	10.1016/j.jbc.2022.101716	http://dx.doi.org/10.1016/j.jbc.2022.101716			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151687	Green Published, gold			2022-12-26	WOS:000789394500002
J	Solomon, D; Bekele, K; Atlaw, D; Mamo, A; Gezahegn, H; Regasa, T; Negash, G; Nigussie, E; Zenbaba, D; Teferu, Z; Nugusu, F; Atlie, G				Solomon, Damtew; Bekele, Kebebe; Atlaw, Daniel; Mamo, Ayele; Gezahegn, Habtamu; Regasa, Tadele; Negash, Getahun; Nigussie, Eshetu; Zenbaba, Demissu; Teferu, Zinash; Nugusu, Fikadu; Atlie, Gela			Prevalence of anemia and associated factors among adult diabetic patients attending Bale zone hospitals, South-East Ethiopia	PLOS ONE			English	Article								Background Anemia found in diabetes patients is often unrecognized like many other chronic diseases. The occurrence of anemia is also an additional burden to the micro vascular complications of patients with diabetes. In the selected study structure no published data were found on the prevalence of anemia and associated factors in diabetic patients. Hence, the findings of this study are very fruitful as an input for further studies and after the repetition of similar studies in different frameworks. It is helpful as input for the development of guidelines at diabetes clinics to request the laboratory assessment of hemoglobin as a routine activity. Objective This study aimed to assess the prevalence of anemia and its associated factors among diabetic patients who attended Bale zone hospitals. Methods A cross-sectional study design was conducted from September 2020-to January 2021 GC among adult diabetic patients who had follow-up at Bale zone hospitals. A total of 238 study participants were determined by single population proportion sample size calculation formula taking prevalence of anemia among adult diabetic patients 19.0%. Systematic random sampling technique was used to select the study participants. Information on demographic and associated factors of anemia in diabetic patients was collected using an interviewer-administered questionnaire. Blood sample collection was performed under aseptic conditions by a licensed medical laboratory professional. Data were entered into EpiData version 3.1, cleaned and exported to statistical package for the social sciences (SPSS) version 25 software tools. Logistic regression was used to assess factors associated with anemia in diabetic patients. P-value less than 0.05 and 95% CI were considered as statistically significant. The odds ratios were reported to indicate the strength of associations. Frequencies, percentages, charts and tables were used to summarize the characteristics of study participants. Results In this study anemia among adult diabetic patients is 18.1% (95% CI (13.2, 23.0%). Multivariable logistic regression analysis revealed that the sex of the study participants and the type of diabetes mellitus were found to be statistically significant to associate with anemia. The odds of having anemia among females are nearly three times higher when compared with males (AOR 2.78, 95% CI 1.40-5.52). In addition, the odds of having anemia among adult diabetic patients who had type II diabetes mellitus (AOR 2.18, 95%CI 1.04-4.54) were 2.18 times higher than those who had type I diabetes mellitus patients. Conclusion Nearly one out of five adult diabetic patients had anemia. Sex of the patients and the type of diabetes are associated with anemia among adult diabetic patients.	[Solomon, Damtew; Atlaw, Daniel] Madda Walabu Univ, Dept Anat, Oromia, Ethiopia; [Bekele, Kebebe] Madda Walabu Univ, Dept Surg, Oromia, Ethiopia; [Mamo, Ayele] Madda Walabu Univ, Dept Pharm, Oromia, Ethiopia; [Gezahegn, Habtamu] Madda Walabu Univ, Dept Physiol, Oromia, Ethiopia; [Regasa, Tadele] Madda Walabu Univ, Dept Biochem, Oromia, Ethiopia; [Negash, Getahun; Nigussie, Eshetu] Madda Walabu Univ, Dept Lab Med, Oromia, Ethiopia; [Zenbaba, Demissu; Teferu, Zinash; Nugusu, Fikadu] Madda Walabu Univ, Dept Publ Hlth, Oromia, Ethiopia; [Atlie, Gela] Madda Walabu Univ, Dept Internal Med, Oromia, Ethiopia		Solomon, D (corresponding author), Madda Walabu Univ, Dept Anat, Oromia, Ethiopia.	fraolsolomon675@gmail.com	Atlaw, Daniel/ACX-8977-2022; Zenbaba, Demisu/AEA-6930-2022	Atlaw, Daniel/0000-0002-2968-4958; Zenbaba, Demisu/0000-0002-7733-7627	Madda Walabu University	Madda Walabu University	The authors would like to acknowledge Madda Walabu University and also the study participants, data collectors, and staff of the diabetic clinic of each hospitals.	Abate Alemayehu, 2013, BMC Hematol, V13, P6, DOI 10.1186/2052-1839-13-6; ADA, 2018, J CLIN APPL RES ED, V41, P1; Adejumo B. I., 2012, Health, V4, P304, DOI 10.4236/health.2012.46050; AlDallal SM, 2018, J HEMATOL, V7, P57, DOI 10.14740/jh411w; Barbieri J, 2015, ANEMIA, V2015, DOI 10.1155/2015/354737; Bekele A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225725; Engidaw MT, 2020, DIABET METAB SYND OB, V13, P5017, DOI 10.2147/DMSO.S286365; Fiseha T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222111; Hailu NA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240678; Harrison TR KD., 2011, HARRISONS PRINCIPLES, V16th; Hoffbrand AV., 2006, ESSENTIAL HAEMATOLOG, V5th ed; Hosseini Mahboobeh Sadat, 2014, Nephrourol Mon, V6, pe19976, DOI 10.5812/numonthly.19976; Idris I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025125; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Kaushik D., 2018, INT J RES MED SCI, V6, P1529; Sharif A., 2015, PREVALENCE RISK ANEM; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Taderegew MM, 2020, J BLOOD MED, V11, P47, DOI 10.2147/JBM.S243234; Tim H., 2010, ABC DIABETES, Vsixth; WHO, 2007, ASS IRON STATUS POP, VSecond	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264007	10.1371/journal.pone.0264007	http://dx.doi.org/10.1371/journal.pone.0264007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180254	Green Published, gold			2022-12-26	WOS:000796435800041
J	Nieto-Garcia, L; Carpio-Perez, A; Moreiro-Barroso, MT; Ruiz-Antunez, E; Nieto-Garcia, A; Alonso-Sardon, M				Nieto-Garcia, Leticia; Carpio-Perez, Adela; Teresa Moreiro-Barroso, Maria; Ruiz-Antunez, Emilia; Nieto-Garcia, Ainhoa; Alonso-Sardon, Montserrat			Are there differences between COVID-19 and non-COVID-19 inpatient pressure injuries? Experiences in Internal Medicine Units	PLOS ONE			English	Article							ULCERS; MORTALITY	Background Pressure Injuries (PIs) are major worldwide public health threats within the different healthcare settings. Objective To describe and compare epidemiological and clinical features of PIs in COVID-19 patients and patients admitted for other causes in Internal Medicine Units during the first wave of COVID-19 pandemic. Design A descriptive longitudinal retrospective study. Setting This study was conducted in Internal Medicine Units in Salamanca University Hospital Complex, a tertiary hospital in the Salamanca province, Spain. Participants All inpatients.18-year-old admitted from March 1, 2020 to June 1, 2020 for more than 24 hours in the Internal Medicine Units with one or more episodes of PIs. Results A total of 101 inpatients and 171 episodes were studied. The prevalence of PI episodes was 6% and the cumulative incidence was 2.9% during the first-wave of COVID-19. Risk of acute wounds was four times higher in the COVID-19 patient group (p< 0.001). Most common locations were sacrum and heels. Among hospital acquired pressure injuries a significant association was observed between arterial hypertension and diabetes mellitus in patients with COVID-19 diagnosis. Conclusion During the first wave of COVID-19, COVID-19 patients tend to present a higher number of acute wounds, mainly of hospital origin, compared to the profile of the non-COVID group. Diabetes mellitus and arterial hypertension were identified as main associated comorbidities in patients with COVID-19 diagnosis.	[Nieto-Garcia, Leticia; Nieto-Garcia, Ainhoa] Univ Salamanca, Sch Nursing & Physiotherapy, Salamanca, Spain; [Carpio-Perez, Adela] Univ Salamanca CIETUS, Univ Hosp Salamanca, Inst Biomed Res Salamanca IBSAL, Internal Med Serv,Trop Dis Res Ctr, Salamanca, Spain; [Teresa Moreiro-Barroso, Maria] Univ Hosp Salamanca, Internal Med Serv, Salamanca, Spain; [Ruiz-Antunez, Emilia] Univ Hosp Salamanca, Training Dev & Innovat Area, Salamanca, Spain; [Alonso-Sardon, Montserrat] Univ Salamanca CIETUS, Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Prevent Med & Publ Hlth Area,Trop Dis Res Ctr, Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca	Alonso-Sardon, M (corresponding author), Univ Salamanca CIETUS, Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Prevent Med & Publ Hlth Area,Trop Dis Res Ctr, Salamanca, Spain.	sardonm@usal.es		Alonso-Sardon, Montserrat/0000-0003-1829-5858; Nieto Garcia, Leticia/0000-0002-5227-4076; Nieto Garcia, Ainhoa/0000-0002-5514-3696; Rubio Gil, Francisco Javier/0000-0002-4813-2761				Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2; Bellosta R, 2020, J VASC SURG, V72, P1864, DOI 10.1016/j.jvs.2020.04.483; Black J, 2020, UNAVOIDABLE PRESSURE; Bloomfield R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008095.pub2; Boyko TV, 2018, ADV WOUND CARE, V7, P57, DOI 10.1089/wound.2016.0697; Chen JK, 2022, POSTGRAD MED J, V98, P515, DOI 10.1136/postgradmedj-2021-140674; Colling ME, 2020, VASC MED, V25, P471, DOI 10.1177/1358863X20932640; Cuker A., 2020, CORONAVIRUS DIS 2019; Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281; Gefen A, 2020, J WOUND CARE, V29, P540, DOI 10.12968/jowc.2020.29.10.540; Guerin C, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.63; Haesler E., 2019, EUR PRESS ULC ADV PA; Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018; Jaul E, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0997-7; Junta de Castilla y Leon, SIT EP COR COVID 19; Labeau SO, 2021, INTENS CARE MED, V47, P160, DOI 10.1007/s00134-020-06234-9; Lima-Martinez MM, 2021, CLIN INVEST ARTERIOS, V33, P151, DOI 10.1016/j.arteri.2020.10.001; Livesley NJ, 2002, CLIN INFECT DIS, V35, P1390, DOI 10.1086/344059; Miesbach W, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620938149; Moore Z, 2019, J WOUND CARE, V28, P710, DOI 10.12968/jowc.2019.28.11.710; Munshi L, 2017, ANN AM THORAC SOC, V14, pS280, DOI 10.1513/AnnalsATS.201704-343OT; Pancorbo-Hidalgo Pedro L., 2019, Gerokomos, V30, P76; World Health Organization, 133 WHO; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263900	10.1371/journal.pone.0263900	http://dx.doi.org/10.1371/journal.pone.0263900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176083	gold, Green Published			2022-12-26	WOS:000777505200042
J	Hochnadel, I; Hoenicke, L; Petriv, N; Neubert, L; Reinhard, E; Hirsch, T; Alfonso, JCL; Suo, HZ; Longerich, T; Geffers, R; Lichtinghagen, R; Guzman, CA; Wedemeyer, H; Lenzen, H; Manns, MP; Bruder, D; Yevsa, T				Hochnadel, Inga; Hoenicke, Lisa; Petriv, Nataliia; Neubert, Lavinia; Reinhard, Elena; Hirsch, Tatjana; Alfonso, Juan Carlos Lopez; Suo, Huizhen; Longerich, Thomas; Geffers, Robert; Lichtinghagen, Ralf; Guzman, Carlos Alberto; Wedemeyer, Heiner; Lenzen, Henrike; Manns, Michael Peter; Bruder, Dunja; Yevsa, Tetyana			Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers	ONCOGENE			English	Article							IMMUNE-RESPONSES; SURVEILLANCE; CELLS; MANAGEMENT; SORAFENIB; FIBROSIS	Primary liver cancer (PLC) comprising hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) represents the third deadliest cancer worldwide with still insufficient treatment options. We have previously found that CD4 T helper 1 (Th1) response is indispensable for the protection against PLC. In the present research, we aimed to test the potent inducers of Th1 responses, live-attenuated Listeria monocytogenes Delta actA/Delta inlB strain as preventive/therapeutic vaccine candidate in liver fibrosis, HCC, and CCA. Studies were performed using autochthonous models of HCC and CCA, highly reflecting human disease. L monocytogenes Delta actA/Delta inlB demonstrated strong safety/efficacy in premalignant and malignant liver diseases. The protective mechanism relied on the induction of strong tumor-specific immune responses that keep the development of hepatobiliary cancers under control. Combination therapy, comprising Listeria vaccination and a checkpoint inhibitor blockade significantly extended the survival of HCC-bearing mice even at the advanced stages of the disease. This is the first report on the safety and efficacy of Listeria-based vaccine in liver fibrosis, as well as the first proof of principle study on Listeria-based vaccines in CCA. Our study paves the way for the use of live-attenuated Listeria as safe and efficient vaccine and a potent inducer of protective immune responses in liver fibrosis and hepatobiliary malignancies.	[Hochnadel, Inga; Hoenicke, Lisa; Petriv, Nataliia; Suo, Huizhen; Wedemeyer, Heiner; Lenzen, Henrike; Manns, Michael Peter; Yevsa, Tetyana] Hannover Med Sch MHH, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Neubert, Lavinia] MHH, Inst Pathol, Hannover, Germany; [Reinhard, Elena; Guzman, Carlos Alberto] Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Hirsch, Tatjana; Bruder, Dunja] HZI, Immune Regulat Grp, Braunschweig, Germany; [Hirsch, Tatjana; Bruder, Dunja] Otto von Guericke Univ, Inst Med Microbiol & Hosp Hyg, Infect Immunol Grp, Magdeburg, Germany; [Alfonso, Juan Carlos Lopez] Tech Univ Carolo Wilhelmina Braunschweig, Dept Syst Immunol, Braunschweig, Germany; [Alfonso, Juan Carlos Lopez] HZI, Braunschweig, Germany; [Longerich, Thomas] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany; [Geffers, Robert] HZI, Genome Analyt, Braunschweig, Germany; [Lichtinghagen, Ralf] MHH, Dept Clin Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Yevsa, T (corresponding author), Hannover Med Sch MHH, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Yevsa.Tetyana@mh-hannover.de		Hoenicke, Lisa/0000-0003-0613-8337	German Research Foundation (DFG) [YE 151/21, AOBJ: 618426]; Young Academy MHH; Ellen Schmidt Program MHH; Niedersachsische Krebsgesellschaft e.V.; DFG [LO-1676/4-1, SFB/TR209]; German Academic Exchange Service (DAAD) [91736778]; Fritz Thyssen Foundation [REF.10.16.1.031MN]; Wilhelm-Sander Foundation [2013.107.1]; Gilead Sciences International Research Scholars Program in Liver Disease; Projekt DEAL; HiLFII MHH	German Research Foundation (DFG)(German Research Foundation (DFG)); Young Academy MHH; Ellen Schmidt Program MHH; Niedersachsische Krebsgesellschaft e.V.; DFG(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fritz Thyssen Foundation; Wilhelm-Sander Foundation; Gilead Sciences International Research Scholars Program in Liver Disease; Projekt DEAL; HiLFII MHH	This work was supported by the German Research Foundation (DFG) (grant YE 151/21, AOBJ: 618426) (TY), Young Academy MHH (TY), HiLFII MHH (TY), Ellen Schmidt Program MHH (TY) and by a grant support of Niedersachsische Krebsgesellschaft e.V. TL acknowledges the support by the DFG (LO-1676/4-1 and SFB/TR209 project B08). NP acknowledges the funding of the German Academic Exchange Service (DAAD) in the scope of the Doctoral Program in Germany (Project-ID 91736778). This work was supported in part by: Fritz Thyssen Foundation (grant REF.10.16.1.031MN) (TY), Wilhelm-Sander Foundation (grant 2013.107.1) (TY, MPM), Gilead Sciences International Research Scholars Program in Liver Disease (Research Award to TY). Open Access funding enabled and organized by Projekt DEAL.	Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Buonaguro L, 2019, ANN HEPATOL, V18, P291, DOI 10.1016/j.aohep.2019.04.003; Chen Y, 2012, ONCOGENE, V31, P2140, DOI 10.1038/onc.2011.395; Crowther MD, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071588; Cui M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.613530; Dauch D, 2016, NAT MED, V22, P744, DOI 10.1038/nm.4107; Deng WW, 2018, P NATL ACAD SCI USA, V115, P8179, DOI 10.1073/pnas.1801910115; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Flickinger JC, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030048; Garaud S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02660; Gilley Ryan P, 2020, Oncotarget, V11, P740, DOI 10.18632/oncotarget.27490; Gu Y, 2019, NAT MED, V25, P312, DOI 10.1038/s41591-018-0309-y; Hochnadel I, 2017, HUM VACC IMMUNOTHER, V13, P2931, DOI 10.1080/21645515.2017.1359362; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim VM, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0601-5; Kramer ES, 2009, DIGEST DIS SCI, V54, P2016, DOI 10.1007/s10620-009-0867-4; Le DT, 2019, CLIN CANCER RES, V25, P5493, DOI 10.1158/1078-0432.CCR-18-2992; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Lee HW, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e11; Ley C., 2019, ONKOL HEUTE, V11, P51; Liau LM, 2002, CANCER RES, V62, P2287; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Nault JC, 2020, J HEPATOL, V72, P209, DOI 10.1016/j.jhep.2019.11.006; O'Rourke JM, 2018, WORLD J GASTROENTERO, V24, P4436, DOI 10.3748/wjg.v24.i39.4436; Petriv N, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1874159; Roni DA, 2013, ADV VIROL, V2013, DOI 10.1155/2013/196704; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Seavey MM, 2009, J IMMUNOL, V182, P5537, DOI 10.4049/jimmunol.0803742; Seehawer M, 2018, NATURE, V562, P69, DOI 10.1038/s41586-018-0519-y; Shalapour S, 2017, NATURE, V551, P340, DOI 10.1038/nature24302; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Valle JW, 2016, ANN ONCOL, V27, pv28, DOI 10.1093/annonc/mdw324; Walcher L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01280; Wallecha A, 2009, CLIN VACCINE IMMUNOL, V16, P96, DOI 10.1128/CVI.00274-08; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.227; WHO, 2021, CANC; Xu GL, 2020, ONCOGENE, V39, P1429, DOI 10.1038/s41388-019-1072-3; Yang Y, 2014, CELL MOL IMMUNOL, V11, P184, DOI 10.1038/cmi.2013.64; Yevsa T, 2012, ONCOIMMUNOLOGY, V1, P397, DOI 10.4161/onci.19128; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	48	1	2	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2039	2053		10.1038/s41388-022-02222-z	http://dx.doi.org/10.1038/s41388-022-02222-z		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35173308	hybrid, Green Published			2022-12-26	WOS:000756457400004
J	Gonzalez, CJ; Hogan, CJ; Rajan, M; Wells, MT; Safford, MM; Pinheiro, LC; Ghosh, AK; Choi, JJ; Burchenal, CA; Shah, PD; Shapiro, MF				Gonzalez, Christopher J.; Hogan, Cameron J.; Rajan, Mangala; Wells, Martin T.; Safford, Monika M.; Pinheiro, Laura C.; Ghosh, Arnab K.; Choi, Justin J.; Burchenal, Clare A.; Shah, Pooja D.; Shapiro, Martin F.			Predictors of life-threatening complications in relatively lower-risk patients hospitalized with COVID-19	PLOS ONE			English	Article							COMORBIDITY; DISEASE; STATES	Older individuals with chronic health conditions are at highest risk of adverse clinical outcomes from COVID-19, but there is widespread belief that risk to younger, relatively lower-risk individuals is negligible. We assessed the rate and predictors of life-threatening complications among relatively lower-risk adults hospitalized with COVID-19. Of 3766 adults hospitalized with COVID-19 to three hospitals in New York City from March to May 2020, 963 were relatively lower-risk based on absence of preexisting health conditions. Multivariable logistic regression models examined in-hospital development of life-threatening complications (major medical events, intubation, or death). Covariates included age, sex, race/ethnicity, hypertension, weight, insurance type, and area-level sociodemographic factors (poverty, crowdedness, and limited English proficiency). In individuals >= 55 years old (n = 522), 33.3% experienced a life-threatening complication, 17.4% were intubated, and 22.6% died. Among those <55 years (n = 441), 15.0% experienced a life-threatening complication, 11.1% were intubated, and 5.9% died. In multivariable analyses among those >= 55 years, age (OR 1.03 [95%CI 1.01-1.06]), male sex (OR 1.72 [95%CI 1.14-2.64]), being publicly insured (versus commercial insurance: Medicare, OR 2.02 [95%CI 1.22-3.38], Medicaid, OR 1.87 [95%CI 1.10-3.20]) and living in areas with relatively high limited English proficiency (highest versus lowest quartile: OR 3.50 [95%CI 1.74-7.13]) predicted life-threatening complications. In those <55 years, no sociodemographic factors significantly predicted life-threatening complications. A substantial proportion of relatively lower-risk patients hospitalized with COVID-19 experienced life-threatening complications and more than 1 in 20 died. Public messaging needs to effectively convey that relatively lower-risk individuals are still at risk of serious complications.	[Gonzalez, Christopher J.; Rajan, Mangala; Safford, Monika M.; Pinheiro, Laura C.; Ghosh, Arnab K.; Choi, Justin J.; Burchenal, Clare A.; Shah, Pooja D.; Shapiro, Martin F.] Cornell Univ, Dept Med, Weill Med Coll, New York, NY 14850 USA; [Hogan, Cameron J.; Wells, Martin T.] Cornell Univ, Dept Stat & Data Sci, Ithaca, NY USA	Cornell University; Cornell University	Gonzalez, CJ (corresponding author), Cornell Univ, Dept Med, Weill Med Coll, New York, NY 14850 USA.	cjg7003@med.cornell.edu		Gonzalez, Christopher/0000-0003-2916-4175	Diversity Center of Excellence (from the Health Resources and Services Administration) [D34HP31879]; Clinical and Translational Science Center (from the National Institutes of Health) [UL1 TR000457]; New York-Presbyterian Hospital; Weill Cornell Medicine	Diversity Center of Excellence (from the Health Resources and Services Administration); Clinical and Translational Science Center (from the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York-Presbyterian Hospital; Weill Cornell Medicine	CJG was supported by the Diversity Center of Excellence (grant D34HP31879 from the Health Resources and Services Administration), the Clinical and Translational Science Center (grant UL1 TR000457 from the National Institutes of Health), New York-Presbyterian Hospital, and Weill Cornell Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; [Anonymous], NEW YORK TIMES; Berkowitz SA, 2015, HEALTH SERV RES, V50, P398, DOI 10.1111/1475-6773.12229; Bonito AJ, 2008, CREATION NEW RACE ET; Bosman J., NEW YORK TIMES; Burr JA, 2010, J GERONTOL B-PSYCHOL, V65, P772, DOI 10.1093/geronb/gbq069; CDC, AM I HIGH RISK SEV I; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; DeBiasi RL, 2020, J PEDIATR-US, V223, P199, DOI 10.1016/j.jpeds.2020.05.007; Furuse Y, 2020, EMERG INFECT DIS, V26, P2176, DOI 10.3201/eid2609.202272; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Glasheen WP, 2019, AM HEALTH DRUG BENEF, V12, P188; Goyal P, 2020, ANN INTERN MED, V173, P855, DOI 10.7326/M20-2730; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Gutierrez-Gonzalez E, 2019, J INFECT PUBLIC HEAL, V12, P486, DOI 10.1016/j.jiph.2018.11.011; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Kass DA, 2020, ANN INTERN MED, V173, P840, DOI 10.7326/M20-5677; Kass DA, 2020, LANCET, V395, P1544, DOI 10.1016/S0140-6736(20)31024-2; Klang E, 2020, OBESITY, V28, P1595, DOI 10.1002/oby.22913; Liao JQ, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.04.001; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; NYC Department of City Planning, LANG ACC; Pew Research Center, REC 64 MILL AM LIV M; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schaeffer K., 2020, LOOK AM WHO BELIEVE; Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4; Sorci G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75848-2; Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742; Thrush G, NEW YORK TIMES, V22, P2020; Torres E., ABC NEWS; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; World Health Organization, 2010, CONC FRAM ACT SOC DE; Zaiets K., USA TODAY	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263995	10.1371/journal.pone.0263995	http://dx.doi.org/10.1371/journal.pone.0263995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167610	Green Published, gold			2022-12-26	WOS:000802227200030
J	Omenai, SA; Ajani, MA; Okolo, CA				Omenai, Sebastian A.; Ajani, Mustapha A.; Okolo, Clement A.			Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients	PLOS ONE			English	Article							PD-L1 EXPRESSION; CANCER; IMMUNITY; CELLS; TUMOR	Background The programme death ligand1 and its receptor (PD-1/PD-L1) interaction is a target for blockage by immunotherapy that uses the body's own immune system. Some studies show that PD-L1 expressing tumours are also more aggressive with poor prognosis. This study evaluated the immunohistochemical expression of PD-L1 in uterine cervical carcinomas. Women with cervical cancer would benefit from its use as a marker in therapy and prognosis. Methods Hospital-based cross-sectional retrospective study was conducted. The study materials included 183 archived formalin fixed and paraffin embedded (FFPE) tissue blocks with histological diagnosis of cervical carcinoma diagnosed in our facility within a five-year period (January 2012 and December 2016) that met the study criteria. Data were extracted from records in the Department and immunohistochemistry was done using polyclonal antibodies to PD-L1 (GTX104763, Genetex). Obtained data were analysed using SPSS version 23. P < 0.05 was considered significant. Results A hundred and eighty-three cases of cervical cancer were studied. PD-L1 was positive in 57.4% of all cases. The diffuse pattern of staining was the major pattern accounting for 88.5% of positive cases. Poorly differentiated cervical carcinomas are less likely to express PD-L1. Within the histologic types, the squamous cell carcinomas expressed PD-L1 in 58.7%, and 50% of adenocarcinomas were positive. PD-L1 was not expressed in all cases of adenoid cystic carcinomas and basaloid squamous cell carcinomas. Conclusion A significant population of cervical carcinoma expresses PD-L1 by immunohistochemistry. PD-L1 prevalence is lower amongst the poorly differentiated cancers compared to other grades.	[Omenai, Sebastian A.; Ajani, Mustapha A.; Okolo, Clement A.] Univ Coll Hosp, Dept Pathol, Ibadan, Oyo State, Nigeria; [Omenai, Sebastian A.] Edo State Univ, Dept Anat Pathol, Uzairue, Edo State, Nigeria	University of Ibadan; University College Hospital, Ibadan	Omenai, SA (corresponding author), Univ Coll Hosp, Dept Pathol, Ibadan, Oyo State, Nigeria.; Omenai, SA (corresponding author), Edo State Univ, Dept Anat Pathol, Uzairue, Edo State, Nigeria.	sebeanom@gmail.com	Omenai, Sebastian Anebuokhae/AAP-1636-2021	Omenai, Sebastian Anebuokhae/0000-0002-1841-1487				Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen H, 2020, INT J BIOL MARKER, V35, P65, DOI 10.1177/1724600819888771; Chen JJ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8164365; Chung HC, 2019, J CLIN ONCOL, V37, P1470, DOI 10.1200/JCO.18.01265; de Ruiter EJ, 2021, MODERN PATHOL, V34, P1125, DOI 10.1038/s41379-020-0644-7; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Enwere EK, 2017, MODERN PATHOL, V30, P577, DOI 10.1038/modpathol.2016.221; Eskander RN, 2015, CLIN THER, V37, P20, DOI 10.1016/j.clinthera.2014.11.010; Feng M, 2018, INT J CLIN EXP PATHO, V11, P5370; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gu XB, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0861-7; Heeren AM, 2016, MODERN PATHOL, V29, P753, DOI 10.1038/modpathol.2016.64; Howitt BE, 2016, JAMA ONCOL, V2, P518, DOI 10.1001/jamaoncol.2015.6326; Jedy-Agba E, 2012, CANCER EPIDEMIOL, V36, pE271, DOI 10.1016/j.canep.2012.04.007; Karpathiou G, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2019.152782; Kumar S, 2009, ARCH GYNECOL OBSTET, V280, P25, DOI 10.1007/s00404-008-0851-9; Kurman RJ, 2014, WORLD HLTH ORG CLASS; Lin PL, 2017, CANCER MED-US, V6, P2052, DOI 10.1002/cam4.1143; Lin YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142656; Loharamtaweethong K., 2019, ASIAN PAC J ALLERGY, V10, P1; Ndiaye C, 2012, TROP MED INT HEALTH, V17, P1432, DOI 10.1111/tmi.12004; Noguchi T, 2017, CANCER IMMUNOL RES, V5, P106, DOI 10.1158/2326-6066.CIR-16-0391; Otter SJ, 2019, CLIN ONCOL-UK, V31, P834, DOI 10.1016/j.clon.2019.07.003; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Reddy OL, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0631-6; Rotman J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.596825; Saglam Ozlen, 2018, Integr Cancer Sci Ther, V5, DOI 10.15761/ICST.1000272; Vinh-Hung V, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-164; WENTZ WB, 1959, CANCER, V12, P384, DOI 10.1002/1097-0142(195903/04)12:2<384::AID-CNCR2820120222>3.0.CO;2-C; Witkiewicz AK., 2011, BLAUSTEINS PATHOLOGY, V6th, P156; Wu SF, 2017, ONCOTARGET, V8, P16421, DOI 10.18632/oncotarget.14851; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101; Zhang QQ, 2021, ONCOTARGETS THER, V14, P4275, DOI 10.2147/OTT.S318082; Zhang YX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000515	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263615	10.1371/journal.pone.0263615	http://dx.doi.org/10.1371/journal.pone.0263615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139126	gold, Green Published			2022-12-26	WOS:000821499100036
J	Legare, S; Heide, F; Bailey-Elkin, B; Stetefeld, J				Legare, Scott; Heide, Fabian; Bailey-Elkin, Ben A.; Stetefeld, Jorg			Improved SARS-CoV-2 main protease high-throughput screening assay using a 5-carboxyfluorescein substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONAVIRUS; INHIBITORS	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a global threat to human health has highlighted the need for the development of novel therapies targeting current and emerging coronaviruses with pandemic potential. The coronavirus main protease (M-pro, also called 3CL(pro)) is a validated drug target against coronaviruses and has been heavily studied since the emergence of SARS-CoV-2 in late 2019. Here, we report the biophysical and enzymatic characterization of native M-pro, then characterize the steadystate kinetics of several commonly used FRET substrates, fluorogenic substrates, and six of the 11 reported SARS-CoV-2 polyprotein cleavage sequences. We then assessed the suitability of these substrates for high-throughput screening. Guided by our assessment of these substrates, we developed an improved 5-carboxyfluorescein-based FRET substrate, which is better suited for high-throughput screening and is less susceptible to interference and false positives than existing substrates. This study provides a useful framework for the design of coronavirus M-pro enzyme assays to facilitate the discovery and development of therapies targeting M-pro.	[Legare, Scott; Heide, Fabian; Bailey-Elkin, Ben A.; Stetefeld, Jorg] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada	University of Manitoba	Legare, S; Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB, Canada.	legares@myumanitoba.ca; jorg.stetefeld@umanitoba.ca		Heide, Fabian/0000-0002-6849-3177	Canadian Institutes of Health Research [201610PJT-152935]; Natural Sciences and Engineering Research Council of Canada [RGPIN-004954-2017]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is funded by the Canadian Institutes of Health Research (grant number: 201610PJT-152935) and the Natural Sciences and Engineering Research Council of Canada (grant number: RGPIN-004954-2017).	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Abian O, 2020, INT J BIOL MACROMOL, V164, P1693, DOI 10.1016/j.ijbiomac.2020.07.235; [Anonymous], MMWR MORB MORTAL WKL, V70, P792; Breidenbach J, 2021, ANGEW CHEM INT EDIT, V60, P10423, DOI 10.1002/anie.202016961; Coelho C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240079; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Drazic T, 2021, SLAS DISCOV, V26, P1189, DOI 10.1177/24725552211020681; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ferreira JC, 2021, FASEB J, V35, DOI 10.1096/fj.202100994; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hattori S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20900-6; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jo S, 2020, J ENZYM INHIB MED CH, V35, P1539, DOI 10.1080/14756366.2020.1801672; Koudelka T, 2021, PROTEOMICS, V21, DOI 10.1002/pmic.202000246; Kuzikov M, 2021, ACS PHARMACOL TRANSL, V4, P1096, DOI 10.1021/acsptsci.0c00216; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Li Z, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024937118; Li Z, 2020, P NATL ACAD SCI USA, V117, P27381, DOI 10.1073/pnas.2010470117; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Ma CL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024420118; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Pablos I, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109892; Rut W, 2021, NAT CHEM BIOL, V17, P222, DOI 10.1038/s41589-020-00689-z; Simeonov A., 2004, ASSAY GUIDANCE MANUA; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Solowiej J, 2008, BIOCHEMISTRY-US, V47, P2617, DOI 10.1021/bi702107v; Su HX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23751-3; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vuong W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18096-2; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhang LL, 2020, J MED CHEM, V63, P4562, DOI 10.1021/acs.jmedchem.9b01828; Zhu W, 2020, ACS PHARMACOL TRANSL, V3, P1008, DOI 10.1021/acsptsci.0c00108	41	0	0	6	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101739	10.1016/j.jbc.2022.101739	http://dx.doi.org/10.1016/j.jbc.2022.101739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2U4BW	35182525	Green Published, gold			2022-12-26	WOS:000823106100003
J	Yu, D; Dai, N; Wolf, EJ; Correa, IR; Zhou, JJ; Wu, T; Blumenthal, RM; Zhang, X; Cheng, XD				Yu, Dan; Dai, Nan; Wolf, Eric J.; Correa, Ivan R., Jr.; Zhou, Jujun; Wu, Tao; Blumenthal, Robert M.; Zhang, Xing; Cheng, Xiaodong			Enzymatic characterization of mRNA cap adenosine-N6 methyltransferase PCIF1 activity on uncapped RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; CIS-ACTING SIGNALS; NUCLEAR-ENVELOPE; PROTEIN; METHYLATION; CELL; N6-METHYLADENOSINE; DEMETHYLATION; RECOGNITION; TERMINATION	The phosphorylated RNA polymerase II CTD interacting factor 1 (PCIF1) is a methyltransferase that adds a methyl group to the N6-position of 20O-methyladenosine (Am), generating N6, 20O-dimethyladenosine (m6Am) when Am is the cap-proximal nucleotide. In addition, PCIF1 has ancillary methylation activities on internal adenosines (both A and Am), although with much lower catalytic efficiency relative to that of its preferred cap substrate. The PCIF1 preference for 20Omethylated Am over unmodified A nucleosides is due mainly to increased binding affinity for Am. Importantly, it was recently reported that PCIF1 can methylate viral RNA. Although some viral RNA can be translated in the absence of a cap, it is unclear what roles PCIF1 modifications may play in the functionality of viral RNAs. Here we show, using in vitro assays of binding and methyltransfer, that PCIF1 binds an uncapped 50-Am oligonucleotide with approximately the same affinity as that of a cap analog (KM = 0.4 versus 0.3 mu M). In addition, PCIF1 methylates the uncapped 50-Am with activity decreased by only fivefold to sixfold compared with its preferred capped substrate. We finally discuss the relationship between PCIF1-catalyzed RNA methylation, shown here to have broader substrate specificity than previously appreciated, and that of the RNA demethylase fat mass and obesity-associated protein (FTO), which demonstrates PCIF1-opposing activities on capped RNAs.	[Yu, Dan; Zhou, Jujun; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Dai, Nan; Wolf, Eric J.; Correa, Ivan R., Jr.] New England Biolabs Inc, Ipswich, MA USA; [Wu, Tao] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Blumenthal, Robert M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Blumenthal, Robert M.] Univ Toledo, Program Bioinformat, Coll Med & Life Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Texas System; UTMD Anderson Cancer Center; New England Biolabs; Baylor College of Medicine; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Zhang, X; Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	XZhang21@mdanderson.org; XCheng5@mdanderson.org	; Wu, Tao/A-1063-2013	Cheng, Xiaodong/0000-0002-6967-6362; Zhou, Jujun/0000-0003-4104-7158; Correa, Ivan/0000-0002-3169-6878; Wu, Tao/0000-0002-9859-4534	US National Institutes of Health [R35GM134744]; Cancer Prevention and Research Institute of Texas [RR160029]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas	This work was supported by US National Institutes of Health (grant no.: R35GM134744; to X. C.); Cancer Prevention and Research Institute of Texas (grant no.: RR160029; to X. C., who is a Cancer Prevention and Research Institute of Texas Scholar in Cancer Research). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080; An YY, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01500-4; Barr JN, 1997, J VIROL, V71, P8718, DOI 10.1128/JVI.71.11.8718-8725.1997; Berger MR, 2019, FEBS LETT, V593, P670, DOI 10.1002/1873-3468.13349; Boulias K., 2019, IDENTIFICATION M 6 A; Cohen S, 2012, INT REV CEL MOL BIO, V299, P117, DOI 10.1016/B978-0-12-394310-1.00003-5; Covelo-Molares H, 2021, NUCLEIC ACIDS RES, V49, P10895, DOI 10.1093/nar/gkab900; Cowling VH, 2019, TRENDS BIOCHEM SCI, V44, P183, DOI 10.1016/j.tibs.2019.01.002; Fan H, 2003, BIOCHEM BIOPH RES CO, V301, P378, DOI 10.1016/S0006-291X(02)03015-2; Fernandez-Alvarez A, 2017, TRENDS CELL BIOL, V27, P255, DOI 10.1016/j.tcb.2016.11.005; Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Li ZC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009055; Liu L, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01508-w; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Lu JN, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-021-00741-y; Lu ZL, 2021, GENOME RES, V31, P51, DOI 10.1101/gr.264325.120; Malka Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02099-7; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Mettenleiter TC, 2016, J MOL BIOL, V428, P1949, DOI 10.1016/j.jmb.2015.10.001; Morales DD, 2020, NUCLEIC ACIDS RES, V48, P3806, DOI 10.1093/nar/gkaa046; MOYER SA, 1976, VIROLOGY, V70, P339, DOI 10.1016/0042-6822(76)90276-2; Niedzwiecka A., 2002, BIOPHYSICAL STUDIES; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038; Peng LM, 2022, CELL BIOL INT, V46, P711, DOI 10.1002/cbin.11773; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Relier S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21758-4; Ringeard M, 2019, NATURE, V565, P500, DOI 10.1038/s41586-018-0841-4; Sendinc E, 2019, MOL CELL, V75, P620, DOI 10.1016/j.molcel.2019.05.030; Stillman EA, 1997, J VIROL, V71, P2127, DOI 10.1128/JVI.71.3.2127-2137.1997; Sugita A., 2021, J BIOCHEM, V170, P203; Tamarkin-Ben-Harush A, 2017, ELIFE, V6, DOI 10.7554/eLife.21907; Tartell MA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025769118; Wang DX, 2018, NUCLEIC ACIDS RES, V46, P3864, DOI 10.1093/nar/gkx1274; Wang JT, 2007, J VIROL, V81, P11499, DOI 10.1128/JVI.01057-07; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14665-7; Woodcock CB, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0136-4; Worpenberg L, 2022, BIOESSAYS, V44, DOI 10.1002/bies.202100174; Yu Dan, 2021, Nucleic Acids Res, V49, P11629, DOI 10.1093/nar/gkab460; Yu D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100270; Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	54	1	1	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101751	10.1016/j.jbc.2022.101751	http://dx.doi.org/10.1016/j.jbc.2022.101751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D2DW	35189146	Green Published, gold			2022-12-26	WOS:000793617400011
J	Mamuti, S; Tabu, C; Marete, I; Opili, D; Jalang'o, R; Abade, A				Mamuti, Stella; Tabu, Collins; Marete, Irene; Opili, Davies; Jalang'o, Rose; Abade, Ahmed			Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya	PLOS ONE			English	Article								Introduction Measles is a vaccine-preventable disease whose elimination depends on the measles-containing vaccine (MCV) coverage of >= 95% in the population. In 2020, Kenya reported 597 cases, an increase of 158 cases from those reported in 2019. This study aimed to estimate the measles vaccine coverage and factors associated with its uptake in Cherangany Sub County. Methods We conducted a cross-sectional study using cluster sampling in the Cherangany Sub County of Trans Nzoia County in May 2021. We enrolled eligible children aged between 24-59 months and interviewed their caregivers using a structured questionnaire. We conducted descriptive, bivariate, and multivariate analyses. We used Prevalence Odds Ratio (POR) at bivariate and adjusted POR (aPOR) at multivariate with their corresponding 95% confidence interval as the measure of association. We regarded the variables with a p-value of less <0.05 at the multivariate level as independently associated with immunization status. Results We recruited 536 eligible children. The median age of the participants was 39 months (Interquartile Range 31-50). The coverage was 96.6% (518/536) for MCV dose one (MCV 1), and 56.2% (301/536) MCV dose two (MCV 2). At the bivariate level, family monthly income (POR 2.32, 95% CI 1.14-4.72), child vaccination status for other scheduled vaccines (POR 0.21, 95% CI 0.07-0.66), caregiver's level of education (POR = 1.82, 95% CI 1.29-2.57), knowledge of the vaccine-preventable diseases (POR = 0.55, 95% CI 0.38-0.80), and knowledge of the number of MCV scheduled doses (POR = 0.13, 95% CI 0.09-0.02) were significantly associated with MCV uptake. The Caregiver's knowledge on the number of MCV scheduled doses (POR = 5.73, 95% CI 3.48-9.45) and children whose birth order was <= 5th born (POR = 0.5, 95% CI 0.22-0.95) were significantly associated with MCV uptake at the multivariate analysis. Conclusion The MCV 2 coverage was lower than the WHO recommended > 95%. Lack of knowledge of the number of MCV scheduled doses and the child's birth order in the family are factors associated with not being fully vaccinated against measles. Recommendation There is a need to strengthen the defaulter tracing system to follow up the children who default after receiving MCV 1, focusing interventions on the identified factors.	[Mamuti, Stella; Abade, Ahmed] Kenya Field Epidemiol & Lab Training Program, Minist Hlth, Nairobi, Kenya; [Mamuti, Stella; Opili, Davies] Trans Nzoia Cty, Dept Hlth, Kitale, Kenya; [Tabu, Collins; Jalang'o, Rose] Natl Vaccine & Immunizat Program, Minist Hlth, Nairobi, Kenya; [Marete, Irene] Moi Univ, Dept Child Hlth & Pediat, Eldoret, Kenya	Moi University	Mamuti, S (corresponding author), Kenya Field Epidemiol & Lab Training Program, Minist Hlth, Nairobi, Kenya.; Mamuti, S (corresponding author), Trans Nzoia Cty, Dept Hlth, Kitale, Kenya.	stellammochi@gmail.com			Faculty of Field Epidemiology and Laboratory Training Program, Ministry of Health, Kenya	Faculty of Field Epidemiology and Laboratory Training Program, Ministry of Health, Kenya	The authors would like to thank: the Faculty of Field Epidemiology and Laboratory Training Program, Ministry of Health, Kenya, for sponsorship. The National Vaccines and Immunization Program, Ministry of Health and the School of Public Health, College of Health Sciences, Moi University for instructions and supervision. The Trans Nzoia County Department of Health for permission to conduct the study and all study participants for their cooperation during data collection.	Abdou M., 2017, DETERMINANTS COMPLET, P1; Adedokun ST, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4137-7; Anichukwu OI, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026324; [Anonymous], DHIS 2 PIVOT TABLES; [Anonymous], MEASLES NUMBER REPOR; [Anonymous], EPI INFO TM CDC; Compaore WICZ., 2019, BMC RES NOTES, P1, DOI [10.1186/s13104-018-4038-6, DOI 10.1186/S13104-018-4038-6]; County TN, 2018, T NZOIA COUNTY INTEG; de Figueiredo A, 2016, LANCET GLOB HEALTH, V4, pE726, DOI 10.1016/S2214-109X(16)30167-X; Debie A., 2014, SCI J PUBLIC HLTH, V2, P342, DOI [10.11648/j.sjph.20140204.26, DOI 10.11648/J.SJPH.20140204.26]; Debnath A, 2018, J BIOSOC SCI, V50, P312, DOI 10.1017/S0021932017000402; Ekouevi DK., 2018, INCOMPLETE IMMUNIZAT, P1; Forson JA, 2018, GLOB SOC WELFARE, V5, P189, DOI 10.1007/s40609-017-0094-4; Girmay A, 2019, INT J PEDIAT, V2019, DOI 10.1155/2019/1924941; Hajizadeh M, 2018, J EPIDEMIOL COMMUN H, V72, P719, DOI 10.1136/jech-2017-210296; Herliana P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015790; Hu Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6226-7; Hu Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091086; Ijarotimi IT., 2018, URBAN RURAL DIFFEREN, P1; Jama AA., 2020, DETERMINANTS COMPLET; Jani J V., 2008, RISK FACTORS INCOMPL, V7, P1; Kisangau N, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.65.16309; KNBS, 2014, KEN NAT BUR STAT KNB, V8, P1; Manakongtreecheep Kasidet, 2017, Pan Afr Med J, V27, P15, DOI 10.11604/pamj.supp.2017.27.3.12118; Mugali RR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4193-z; Negussie A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2678-1; Noh JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206766; Obanewa OA, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8170-6; Orenstein WA, 2018, VACCINE, V36, pA1, DOI 10.1016/j.vaccine.2017.09.026; Pramada S. K., 2021, ISH Journal of Hydraulic Engineering, V27, P442, DOI 10.1080/09715010.2018.1553642; Russo G., 2015, BMC PUBLIC HEALTH, P1, DOI [10.1186/1471-2458-15-1, DOI 10.1186/1471-2458-15-1]; Scott AJ., 1991, BIOMETRICS, V47, P1632, DOI [10.2307/2532419, DOI 10.2307/2532419]; Vonasek BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150131; WHO, 2015, VACCINATION COVERAGE, P3; Zewdie A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3904-1	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263780	10.1371/journal.pone.0263780	http://dx.doi.org/10.1371/journal.pone.0263780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196355	gold, Green Published			2022-12-26	WOS:000835161600018
J	Pasquini, G; Ferguson, G; Bouklas, I; Vu, H; Zamani, M; Zhaoyang, RX; Harrington, KD; Roque, NA; Mogle, J; Schwartz, HA; Scott, SB				Pasquini, Giancarlo; Ferguson, Giselle; Bouklas, Isabella; Vu, Huy; Zamani, Mohammadzaman; Zhaoyang, Ruixue; Harrington, Karra D.; Roque, Nelson A.; Mogle, Jacqueline; Schwartz, H. Andrew; Scott, Stacey B.			The where and when of COVID-19: Using ecological and Twitter-based assessments to examine impacts in a temporal and community context	PLOS ONE			English	Article							PERSONALITY; LANGUAGE; STRENGTH; EMOTION; HEALTH; MEDIA	In March 2020, residents of the Bronx, New York experienced one of the first significant community COVID-19 outbreaks in the United States. Focusing on intensive longitudinal data from 78 Bronx-based older adults, we used a multi-method approach to (1) examine 2019 to early pandemic (February-June 2020) changes in momentary psychological well-being of Einstein Aging Study (EAS) participants and (2) to contextualize these changes with community distress scores collected from public Twitter posts posted in Bronx County. We found increases in mean loneliness from 2019 to 2020; and participants that were higher in neuroticism had greater increases in thought unpleasantness and feeling depressed. Twitter-based Bronx community scores of anxiety, depressivity, and negatively-valenced affect showed elevated levels in 2020 weeks relative to 2019. Integration of EAS participant data and community data showed week-to-week fluctuations across 2019 and 2020. Results highlight how community-level data can characterize a rapidly changing environment to supplement individual-level data at no additional burden to individual participants.	[Pasquini, Giancarlo; Ferguson, Giselle; Bouklas, Isabella; Scott, Stacey B.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Vu, Huy; Zamani, Mohammadzaman; Schwartz, H. Andrew] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Zhaoyang, Ruixue; Harrington, Karra D.] Penn State Univ, Ctr Healthy Aging, University Pk, PA 16802 USA; [Roque, Nelson A.] Univ Cent Florida, Dept Psychol, Orlando, FL USA; [Mogle, Jacqueline] Penn State Univ, Edna Bennett Pierce Prevent Res Ctr, Coll Hlth & Human Dev, University Pk, PA 16802 USA; [Bouklas, Isabella] Duke Univ, Dept Sociol, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University System of Florida; University of Central Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Duke University	Pasquini, G (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	giancarlo.pasquini@stonybrook.edu		Pasquini, Giancarlo/0000-0002-0647-1415	National Institute on Aging at the National Institutes of Health [P01 AG003949, R01 AG060933, R03 AG067006, T32 AG049676]; National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [R01 AA028032]; SUNY Responds COVID Research Seed Grant	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); SUNY Responds COVID Research Seed Grant	This research was supported by the National Institute on Aging at the National Institutes of Health (P01 AG003949 to M.J.S, R01 AG060933 and Administrative Supplement to S.B.S., R03 AG067006 to R.Z., and T32 AG049676 to The Pennsylvania State University); the National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health (R01 AA028032 to H.A.S.), and the SUNY Responds COVID Research Seed Grant.	[Anonymous], TIMELINE WHOS COVID; [Anonymous], COVID 19 DATA TRENDS; Bajema KL, 2020, MMWR-MORBID MORTAL W, V69, P166, DOI 10.15585/mmwr.mm6906e1; BALTES PB, 1980, ANNU REV PSYCHOL, V31, P65, DOI 10.1146/annurev.ps.31.020180.000433; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bondi MW, 2014, J ALZHEIMERS DIS, V42, P275, DOI 10.3233/JAD-140276; Brose A, 2021, J PERS, V89, P468, DOI 10.1111/jopy.12592; Carstensen LL, 2020, PSYCHOL SCI, V31, P1374, DOI 10.1177/0956797620967261; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; CBS Minnesota,, 2020, FORM MPD OFF DER CHA; Charles ST, 2010, PSYCHOL BULL, V136, P1068, DOI 10.1037/a0021232; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cho G., 2019, OXFORD RES ENCY PSYC, DOI [10.1093/acrefore/9780190236557.013.348, DOI 10.1093/ACREFORE/9780190236557.013.348]; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Dozois DJA, 2021, CAN PSYCHOL, V62, P136, DOI 10.1037/cap0000251; Eichstaedt JC, 2015, PSYCHOL SCI, V26, P159, DOI 10.1177/0956797614557867; Fried EI, 2022, CLIN PSYCHOL SCI, V10, P340, DOI 10.1177/21677026211017839; Gadermann AC, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042871; Giorgi Salvatore., PAPER PRESENTED 2018, P1167; Health Human Services, 2020, SECR AZ DECL PUBL HL; Holingue C, 2020, PREV MED, V139, DOI 10.1016/j.ypmed.2020.106231; Jacobson NC, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19347; Jaidka K, 2020, P NATL ACAD SCI USA, V117, P10165, DOI 10.1073/pnas.1906364117; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kern M., 2014, CLPSYCH, P118; Kern ML, 2014, ASSESSMENT, V21, P158, DOI 10.1177/1073191113514104; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Ma LN, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00009; Monroe BL, 2008, POLIT ANAL, V16, P372, DOI 10.1093/pan/mpn018; Mroczek DK, 2007, PSYCHOL SCI, V18, P371, DOI 10.1111/j.1467-9280.2007.01907.x; Nir S., 2021, NEW YORK TIMES; Park G, 2015, J PERS SOC PSYCHOL, V108, P934, DOI 10.1037/pspp0000020; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Preotiuc-Pietro D., 2016, P 7 WORKSH COMP APPR, DOI [10.18653/v1/W16-0404, DOI 10.18653/V1/W16-0404]; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; SAS Institute Inc, 2013, SAS ACCESS 9 4 INT A; Schwartz HA, 2015, ANN AM ACAD POLIT SS, V659, P78, DOI 10.1177/0002716215569197; Schwartz HA., 2013, 7 INT ASS ADVANCEMEN, P1; Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512; Sliwinski MJ, 2021, J GERONTOL B-PSYCHOL, V76, P1104, DOI 10.1093/geronb/gbaa174; Son Y, 2021, PSYCHOL MED, DOI 10.1017/S0033291721002294; Whitehead BR, 2021, J GERONTOL B-PSYCHOL, V76, pE59, DOI 10.1093/geronb/gbaa153; Wojcik S., 2019, TWITTER USERS COMPAR; Wolfe HE, 2022, AGING MENT HEALTH, V26, P890, DOI 10.1080/13607863.2021.1910797; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Young NA, 2021, GERONTOLOGIST, V61, P217, DOI 10.1093/geront/gnaa196; Zamani Mohammadzaman, 2020, Proc Conf Empir Methods Nat Lang Process, V2020, P193, DOI 10.18653/v1/2020.nlpcss-1.21; Zhaoyang Ruixue, 2021, J Gerontol B Psychol Sci Soc Sci, DOI 10.1093/geronb/gbab019; Zheng JS, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2021.113687	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264280	10.1371/journal.pone.0264280	http://dx.doi.org/10.1371/journal.pone.0264280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196353	Green Published, gold			2022-12-26	WOS:000835161600033
J	Alimam, HMS; Moosa, DA; Ajaj, EA; Dahl, MO; Al-Robaiee, IA; Allah, SFH; Al-Jumaa, ZM; Hadi, ED				Alimam, Hussam M. S.; Moosa, Dhiyaa A.; Ajaj, Eva A.; Dahl, Mohammad O.; Al-Robaiee, Israa A.; Allah, Semaa F. Hasab; Al-Jumaa, Zahraa M.; Hadi, Eman D.			Proportion and seasonality of blood parasites in animals in Mosul using the Veterinary Teaching Hospital Lab data	PLOS ONE			English	Article							ANAPLASMOSIS	Several local studies have examined evidence of blood parasites in different animals in Mosul; however, information about the most prevalent parasite and the seasonality of the infection remains limited. The objective of the study conducted here was to investigate the proportion and seasonality of blood parasites in animals in Mosul using the Veterinary Teaching Hospital Lab data. Laboratory records for a period of 25 months were used for data retrieval. In all included animals, Giemsa-stained blood smears were examined by an attending clinical pathologist for the presence of parasites. Seasons were assigned on a basis of examination date, and the seasonality was quantified by estimating season-to-season ratio. The results indicated that 61.77% of examined animals were tested positive for blood parasites. The most evident parasites were Trypanosoma spp., Theileria spp., Babesia spp., and then Anaplasma spp., with evidence of mixed infection. The odds of the infection did not significantly vary in different age groups. There was a marked linear pattern in the seasonality of the infection with Trypanosoma spp. and Anaplasma spp. An increase of the infection during spring and autumn with Theileria spp. and Babesia spp. was also evident. In conclusion, infection with blood parasites in different animals in Mosul is common with substantial burden, the effect of age-related infection is negligible, and the seasonality of the infection is evident.	[Alimam, Hussam M. S.; Moosa, Dhiyaa A.; Ajaj, Eva A.; Dahl, Mohammad O.; Al-Robaiee, Israa A.; Allah, Semaa F. Hasab; Al-Jumaa, Zahraa M.; Hadi, Eman D.] Univ Mosul, Coll Vet Med, Dept Internal & Prevent Med, Mosul, Nineveh, Iraq; [Allah, Semaa F. Hasab] Univ Al Hamdaniya, Off Vice President Sci Affairs, Bartella, Nineveh, Iraq	University of Mosul; University of Al-Hamdaniya	Hadi, ED (corresponding author), Univ Mosul, Coll Vet Med, Dept Internal & Prevent Med, Mosul, Nineveh, Iraq.	mdahl@uomosul.edu.iq	Ajaj, Eva A/AAZ-7521-2021; Dahl, Mohammad/Q-3382-2019; moosa, dhiyaa abdullah/AFV-1019-2022; Alimam, Hussam/AFV-1056-2022	Ajaj, Eva A/0000-0002-6487-6728; Dahl, Mohammad/0000-0002-3595-1397; Alimam, Hussam/0000-0002-8452-8122	College of Veterinary Medicine, University of Mosul	College of Veterinary Medicine, University of Mosul	The authors thank the College of Veterinary Medicine, University of Mosul, for supporting this work.	Al-Abadi B. H., 2012, Research Opinions in Animal and Veterinary Sciences, V2, P535; Al-Badrani B. A., 2012, Research Opinions in Animal and Veterinary Sciences, V2, P92; Al-Obaidi Q.T., 2021, Bulgarian Journal of Veterinary Medicine, V24, P422, DOI 10.15547/bjvm.2293; Al-Obaidi Q T., 2006, IRAQI J VET SCI, V20, P284; Al-Obaidi QT., 2004, IRAQI J VET SCI, V18, P165; Al-Saad K. M., 2006, Iraqi Journal of Veterinary Sciences, V20, P211; Al-Saad KM., 2006, IRAQI J VET SCI, V20, P89, DOI [10.33899/ijvs.2006.45787, DOI 10.33899/IJVS.2006.45787]; Alsaad KM, 2009, J ANIM VET ADV, V8, P2106; Alsaad KM., 1990, THESIS U MOSUL MOSUL; Alsaad KM., 2012, ASSIUT VET MED J, V58, P1; Alsaad KM., 2009, IRAQI J VET SCI, V20, P101; Alsaad KM., 1997, IRAQI J VET MED, V21, P143; Alsaad KM., 2013, BAS J VET RES, V12, P25; Asmaa N.M., 2014, BENI SUEF U J BASIC, V3, P68, DOI 10.1016/j.bjbas.2014.02.009; Ayadi O., 2016, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V69, P161, DOI 10.19182/remvt.31201; Canever MF, 2014, KOREAN J PARASITOL, V52, P507, DOI 10.3347/kjp.2014.52.5.507; Christiansen CF, 2012, CLIN MICROBIOL INFEC, V18, P963, DOI 10.1111/j.1469-0691.2012.03966.x; Constable P.H., 2017, VET MED TXB DIS CATT, V11th, DOI DOI 10.1016/B978-0-7020-5246-0.00011-5; Dahl M. O., 2021, Iraqi Journal of Veterinary Sciences, V35, P541, DOI 10.33899/ijvs.2020.127141.1468; Ferreira FC, 2020, J DAIRY SCI, V103, P8161, DOI 10.3168/jds.2019-18138; Gardiner CH, 1998, ATLAS PROTOZOAN PARA; Hargrove John W., 2004, P113, DOI 10.1079/9780851994758.0113; Hasan M. H., 2012, Iraqi Journal of Veterinary Sciences, V26, P57; Lemeshow, 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Lempereur L, 2012, PARASITOL RES, V110, P1525, DOI 10.1007/s00436-011-2657-0; Mohammed H. A., 2020, Basrah Journal of Veterinary Research, V19, P288; Nnko HJ, 2017, J VECTOR ECOL, V42, P24, DOI 10.1111/jvec.12236; Rhaymah M. S. H., 2012, Research Opinions in Animal and Veterinary Sciences, V2, P23; Sulaiman E. G., 2010, Iraqi Journal of Veterinary Sciences, V24; Vieira LL, 2019, PARASITE EPIDEM CONT, V6, DOI 10.1016/j.parepi.2019.e00114	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264121	10.1371/journal.pone.0264121	http://dx.doi.org/10.1371/journal.pone.0264121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192671	gold, Green Published			2022-12-26	WOS:000812552500036
J	Ciraku, L; Bacigalupa, ZA; Ju, J; Moeller, RA; Minh, GL; Lee, RH; Smith, MD; Ferrer, CM; Trefely, S; Izzo, LT; Doan, MT; Gocal, WA; D'Agostino, L; Shi, WY; Jackson, JG; Katsetos, CD; Wellen, KE; Snyder, NW; Reginato, MJ				Ciraku, Lorela; Bacigalupa, Zachary A.; Ju, Jing; Moeller, Rebecca A.; Giang Le Minh; Lee, Rusia H.; Smith, Michael D.; Ferrer, Christina M.; Trefely, Sophie; Izzo, Luke T.; Doan, Mary T.; Gocal, Wiktoria A.; D'Agostino, Luca; Shi, Wenyin; Jackson, Joshua G.; Katsetos, Christos D.; Wellen, Kathryn E.; Snyder, Nathaniel W.; Reginato, Mauricio J.			O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation	ONCOGENE			English	Article							CYCLIN-DEPENDENT KINASE-5; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; CYTOSOLIC PROTEINS; EXPRESSION; INHIBITOR; CDK5; DINACICLIB; SURVIVAL; NUCLEAR	Glioblastomas (GBMs) preferentially generate acetyl-CoA from acetate as a fuel source to promote tumor growth. O-GlcNAcylation has been shown to be elevated by increasing O-GlcNAc transferase (OGT) in many cancers and reduced O-GlcNAcylation can block cancer growth. Here, we identify a novel mechanism whereby OGT regulates acetate-dependent acetyl-CoA and lipid production by regulating phosphorylation of acetyl-CoA synthetase 2 (ACSS2) by cyclin-dependent kinase 5 (CDK5). OGT is required and sufficient for GBM cell growth and regulates acetate conversion to acetyl-CoA and lipids. Elevating O-GlcNAcylation in GBM cells increases phosphorylation of ACSS2 on Ser-267 in a CDK5-dependent manner. Importantly, we show that ACSS2 Ser-267 phosphorylation regulates its stability by reducing polyubiquitination and degradation. ACSS2 Ser-267 is critical for OGT-mediated GBM growth as overexpression of ACSS2 Ser-267 phospho-mimetic rescues growth in vitro and in vivo. Importantly, we show that pharmacologically targeting OGT and CDK5 reduces GBM growth ex vivo. Thus, the OGT/CDK5/ACSS2 pathway may be a way to target altered metabolic dependencies in brain tumors.	[Ciraku, Lorela; Bacigalupa, Zachary A.; Ju, Jing; Moeller, Rebecca A.; Giang Le Minh; Lee, Rusia H.; Smith, Michael D.; Ferrer, Christina M.; Gocal, Wiktoria A.; Reginato, Mauricio J.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA; [Trefely, Sophie; Doan, Mary T.; Snyder, Nathaniel W.] Temple Univ, Ctr Metab Dis Res, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Izzo, Luke T.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Izzo, Luke T.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [D'Agostino, Luca; Katsetos, Christos D.] Drexel Univ, Dept Pathol & Lab Med, Coll Med, Philadelphia, PA 19102 USA; [Shi, Wenyin] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Jackson, Joshua G.] Drexel Univ, Dept Pharmacol & Physiol, Coll Med, Philadelphia, PA 19102 USA; [Reginato, Mauricio J.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Translat Cellular Oncol Program, Philadelphia, PA 19107 USA	Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University; Jefferson University; Drexel University; Jefferson University	Reginato, MJ (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA.; Reginato, MJ (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Translat Cellular Oncol Program, Philadelphia, PA 19107 USA.	mjr53@drexel.edu		Izzo, Luke/0000-0002-6217-9240; , Jing/0000-0002-1901-6980; Gocal, Wiktoria/0000-0001-8894-8047; Jackson, Joshua/0000-0003-4166-9213; Doan, Mary/0000-0001-6295-4895	PA CURE grant [UO1CA244303]; Drexel University Dean's Fellowship award;  [R01CA228339];  [2-T32-CA-115299-14]	PA CURE grant; Drexel University Dean's Fellowship award; ; 	This work was supported by PA CURE grant (to MJR, NWS and JGJ), UO1CA244303 (to MJR), Drexel University Dean's Fellowship award (to ZAB and LC). KEW acknowledges R01CA228339. LTI is supported by 2-T32-CA-115299-14. The authors thank Chaitali Bhadiadra for technical assistance, Dr. Valerie Sodi and Dr. Edward Hartsough for helpful discussions. In memoriam Christos D. Katsetos.	Antoniou X, 2011, BRAIN RES, V1381, P1, DOI 10.1016/j.brainres.2010.10.071; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Catania A, 2001, NEURO-ONCOLOGY, V3, P89, DOI 10.1093/neuonc/3.2.89; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen XX, 2015, ONCOTARGET, V6, P14926, DOI 10.18632/oncotarget.3717; Ciraku L, J VIS EXP, V2021, P175; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Feldmann G, 2011, CANCER BIOL THER, V12, P598, DOI 10.4161/cbt.12.7.16475; Ferraro GB, 2021, NAT CANCER, V2, P414, DOI 10.1038/s43018-021-00183-y; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hothi P, 2012, ONCOTARGET, V3, P1124; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jin X, 2020, NATURE, V588, P331, DOI 10.1038/s41586-020-2969-2; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Lenjisa JL, 2017, FUTURE MED CHEM, V9, P1939, DOI 10.4155/fmc-2017-0097; Lewis CA, 2015, ONCOGENE, V34, P5128, DOI 10.1038/onc.2014.439; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Lindqvist J, 2015, MOL BIOL CELL, V26, P1971, DOI 10.1091/mbc.E14-12-1634; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Ning XJ, 2017, CELL MOL NEUROBIOL, V37, P527, DOI 10.1007/s10571-016-0391-y; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Pozo K, 2016, TRENDS CANCER, V2, P606, DOI 10.1016/j.trecan.2016.09.001; Schild T, 2018, CANCER CELL, V33, P347, DOI 10.1016/j.ccell.2018.02.001; Schug ZT, 2016, NAT REV CANCER, V16, P708, DOI 10.1038/nrc.2016.87; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Sharma S, 2020, P NATL ACAD SCI USA, V117, P8001, DOI 10.1073/pnas.1912617117; Sodi VL, 2018, ONCOGENE, V37, P924, DOI 10.1038/onc.2017.395; Sodi VL, 2015, MOL CANCER RES, V13, P923, DOI 10.1158/1541-7786.MCR-14-0536; Thompson JW, 2018, METHOD ENZYMOL, V598, P101, DOI 10.1016/bs.mie.2017.06.009; Trefely S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1360-7; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Yushan R., 2015, WORLD J SURG ONCOL, V13; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	53	6	6	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2122	2136		10.1038/s41388-022-02237-6	http://dx.doi.org/10.1038/s41388-022-02237-6		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35190642	Green Accepted, Green Submitted			2022-12-26	WOS:000758961200001
J	Schneider, JM; Zabel, F; Schunemann, F; Delzeit, R; Mauser, W				Schneider, Julia M.; Zabel, Florian; Schunemann, Franziska; Delzeit, Ruth; Mauser, Wolfram			Global cropland could be almost halved: Assessment of land saving potentials under different strategies and implications for agricultural markets	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; SUSTAINABLE INTENSIFICATION; FOOD-PRODUCTION; CARBON SEQUESTRATION; BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; TRADE-OFFS; YIELD-GAP; PRICES; WATER	The pressure on land resources continuously increases not only with the rising demand for agricultural commodities, but also with the growing need for action on global challenges, such as biodiversity loss or climate change, where land plays a crucial role. Land saving as a strategy, where agricultural productivity is increased to allow a reduction of required cropland while sustaining production volumes and meeting demand, could address this tradeoff. With our interdisciplinary model-based study, we globally assess regional potentials of land saving and analyze resulting effects on agricultural production, prices and trade. Thereby, different land saving strategies are investigated that (1) minimize required cropland (2) minimize spatial marginalization induced by land saving and (3) maximize the attainable profit. We find that current cropland requirements could be reduced between 37% and 48%, depending on the applied land saving strategy. The generally more efficient use of land would cause crop prices to fall in all regions, but also trigger an increase in global agricultural production of 2.8%. While largest land saving potentials occur in regions with high yield gaps, the impacts on prices and production are strongest in highly populated regions with already high pressure on land. Global crop prices and trade affect regional impacts of land saving on agricultural markets and can displace effects to spatially distant regions. Our results point out the importance of investigating the potentials and effects of land saving in the context of global markets within an integrative, global framework. The resulting land saving potentials can moreover reframe debates on global potentials for afforestation and carbon sequestration, as well as on how to reconcile agricultural production and biodiversity conservation and thus contribute to approaching central goals of the 21st century, addressed for example in the Sustainable Development Goals, the Paris Agreement or the post-2020 global biodiversity framework.	[Schneider, Julia M.; Zabel, Florian; Mauser, Wolfram] Ludwig Maximilians Univ Munchen, Dept Geog, Munich, Germany; [Schunemann, Franziska] Univ Hohenheim, Dept Bioecon & Computat Sci Lab, Stuttgart, Germany; [Delzeit, Ruth] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Delzeit, Ruth] Kiel Inst World Econ, Kiel, Germany	University of Munich; University Hohenheim; University of Basel; Institut fur Weltwirtschaft an der Universitat Kiel (IFW)	Schneider, JM (corresponding author), Ludwig Maximilians Univ Munchen, Dept Geog, Munich, Germany.	Schneider.ju@lmu.de		Zabel, Florian/0000-0002-2923-4412; Schneider, Julia Maximiliane/0000-0001-9588-3157	German Federal Ministry of Education and Research [031B0230B, 031B0788B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This project was supported by the German Federal Ministry of Education and Research (grant 031B0230B and grant 031B0788B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar A, 2016, J GLOB ECON ANAL, V1, P181, DOI 10.21642/JGEA.010103AF; Alexander P, 2015, GLOBAL ENVIRON CHANG, V35, P138, DOI 10.1016/j.gloenvcha.2015.08.011; Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; [Anonymous], 2012, AGR FOOD SECURITY; [Anonymous], 2011, WHY HAS AFRICA BECOM; [Anonymous], 2020, CBDPOST2020PREP21; [Anonymous], 2015, PARIS AGREEMENT UN F; Anriquez G, 2013, FOOD POLICY, V38, P190, DOI 10.1016/j.foodpol.2012.02.010; Arias P., 2013, SMALLHOLDER INTEGRAT; Badolo F, 2015, DEV POLICY REV, V33, P221, DOI 10.1111/dpr.12099; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Balmford A, 2018, NAT SUSTAIN, V1, P477, DOI 10.1038/s41893-018-0138-5; Balmford B, 2019, J APPL ECOL, V56, P73, DOI 10.1111/1365-2664.13282; Bastin JF, 2019, SCIENCE, V365, P76, DOI 10.1126/science.aax0848; Beckmann M, 2019, GLOBAL CHANGE BIOL, V25, P1941, DOI 10.1111/gcb.14606; Bongiovanni R., 2004, Precision Agriculture, V5, P359, DOI 10.1023/B:PRAG.0000040806.39604.aa; BORLAUG NE, 1972, BIOSCIENCE, V22, P41, DOI 10.2307/1296186; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Butsic V, 2015, ECOL APPL, V25, P589, DOI 10.1890/14-1927.1; Byerlee D, 2014, GLOB FOOD SECUR-AGR, V3, P92, DOI 10.1016/j.gfs.2014.04.001; Calzadilla A., 2014, DART BIO MODELLING I; Carlson KM, 2017, NAT CLIM CHANGE, V7, P63, DOI [10.1038/nclimate3158, 10.1038/NCLIMATE3158]; Challinor AJ, 2014, NAT CLIM CHANGE, V4, P287, DOI [10.1038/NCLIMATE2153, 10.1038/nclimate2153]; Collier P, 2014, WORLD DEV, V63, P92, DOI 10.1016/j.worlddev.2013.10.001; Conant RT, 2017, ECOL APPL, V27, P662, DOI 10.1002/eap.1473; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Cunningham SA, 2013, AGR ECOSYST ENVIRON, V173, P20, DOI 10.1016/j.agee.2013.04.007; Davis KF, 2017, NAT GEOSCI, V10, P919, DOI 10.1038/s41561-017-0004-5; de Hoyos RE, 2011, REV DEV ECON, V15, P387, DOI 10.1111/j.1467-9361.2011.00615.x; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Delzeit R, 2019, SCIENCE, V366, P316, DOI 10.1126/science.aaz0705; Delzeit R, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aa9da2; Desa U, 2016, TRANSF OUR WORLD 203; Desquilbet M, 2017, ENVIRON MODEL ASSESS, V22, P185, DOI 10.1007/s10666-016-9531-5; Emmerson M, 2016, ADV ECOL RES, V55, P43, DOI 10.1016/bs.aecr.2016.08.005; Erb KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11382; Ewers RM, 2009, GLOBAL CHANGE BIOL, V15, P1716, DOI 10.1111/j.1365-2486.2009.01849.x; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; FAO, 2012, SMALLH FAM FARM; FAOSTAT, US; Fermont AM, 2009, FIELD CROP RES, V112, P24, DOI 10.1016/j.fcr.2009.01.009; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Folberth C, 2020, NAT SUSTAIN, V3, P281, DOI 10.1038/s41893-020-0505-x; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gilroy JJ, 2014, GLOBAL CHANGE BIOL, V20, P2162, DOI 10.1111/gcb.12482; Gleeson T, 2012, NATURE, V488, P197, DOI 10.1038/nature11295; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Haberl H, 2015, ECOL ECON, V119, P424, DOI 10.1016/j.ecolecon.2014.10.002; Haberl H, 2014, STRUNGMANN FORUM REP, P35; Hansen JW, 2002, AGR SYST, V74, P309, DOI 10.1016/S0308-521X(02)00043-4; Hansis E, 2015, GLOBAL BIOGEOCHEM CY, V29, P1230, DOI 10.1002/2014GB004997; Headey DD, 2018, WORLD BANK ECON REV, V32, P676, DOI 10.1093/wber/lhw064; Hertel T., 2012, IMPLICATIONS AGR PRO; Hertel TW, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab0d33; Hertel TW, 2014, P NATL ACAD SCI USA, V111, P13799, DOI 10.1073/pnas.1403543111; Hillocks RJ, 2014, OUTLOOK AGR, V43, P85, DOI 10.5367/oa.2014.0163; Hodges RJ, 2011, J AGR SCI, V149, P37, DOI 10.1017/S0021859610000936; IIASA and FAO, 2012, GLOB AGR ZON GAEZ V3, P196; IPCC, 2018, GLOB WARM 1 5 DEGR I; Ivanic M., 2011, ESTIMATING SHORT RUN; Ivanic M, 2008, AGR ECON-BLACKWELL, V39, P405, DOI 10.1111/j.1574-0862.2008.00347.x; Jiren TS, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12429; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kleijn D, 2009, P R SOC B, V276, P903, DOI 10.1098/rspb.2008.1509; Koh LP, 2013, PEERJ, V1, DOI 10.7717/peerj.188; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Lamb A, 2016, NAT CLIM CHANGE, V6, P488, DOI [10.1038/nclimate2910, 10.1038/NCLIMATE2910]; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lenton TM, 2014, ISS ENVIRON SCI TECH, V38, P52; Liao C, 2018, CURR OPIN ENV SUST, V32, P53, DOI 10.1016/j.cosust.2018.04.013; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lowder SK, 2016, WORLD DEV, V87, P16, DOI 10.1016/j.worlddev.2015.10.041; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mauser W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9946; McGill BM, 2018, GLOBAL CHANGE BIOL, V24, P5948, DOI 10.1111/gcb.14472; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Mukumbuta I, 2020, SOIL SCI PLANT NUTR, V66, P76, DOI 10.1080/00380768.2019.1676135; Nakelse T, 2018, FOOD POLICY, V79, P213, DOI 10.1016/j.foodpol.2018.07.006; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Phalan B, 2016, SCIENCE, V351, P450, DOI 10.1126/science.aad0055; Phalan B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0285; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan BT, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061760; Plevin RJ, 2015, ENVIRON SCI TECHNOL, V49, P2656, DOI 10.1021/es505481d; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Pradhan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129487; Pretty J, 2014, ANN BOT-LONDON, V114, P1571, DOI 10.1093/aob/mcu205; Ramankutty N, 2004, GLOBAL LAND USE LAND; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sainju UM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148527; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Schleicher J, 2019, NAT SUSTAIN, V2, P1094, DOI 10.1038/s41893-019-0423-y; Schlesinger WH, 2000, AGR ECOSYST ENVIRON, V82, P121, DOI 10.1016/S0167-8809(00)00221-8; Seppelt R, 2013, CURR OPIN ENV SUST, V5, P458, DOI 10.1016/j.cosust.2013.05.002; Singh R B., 2002, SMALLHOLDER FARMERS; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0; Stehfest E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09945-w; Stevenson JR, 2013, P NATL ACAD SCI USA, V110, P8363, DOI 10.1073/pnas.1208065110; Thomson AM, 2019, CURR OPIN ENV SUST, V38, P37, DOI 10.1016/j.cosust.2019.04.011; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Trost B, 2013, AGRON SUSTAIN DEV, V33, P733, DOI 10.1007/s13593-013-0134-0; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Turner PA, 2018, CLIMATIC CHANGE, V148, P1, DOI 10.1007/s10584-018-2189-z; Verma MV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228369; Williams DR, 2018, CURR BIOL, V28, P2500, DOI 10.1016/j.cub.2018.05.087; Zabel F, 2021, GLOBAL CHANGE BIOL, V27, P3870, DOI 10.1111/gcb.15649; Zabel F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10775-z; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114	118	2	2	9	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263063	10.1371/journal.pone.0263063	http://dx.doi.org/10.1371/journal.pone.0263063			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192630	gold, Green Accepted, Green Published			2022-12-26	WOS:000812552500016
J	Tong, GJ; Qian, H; Li, DL; Li, J; Chen, J; Li, XF				Tong, Guojun; Qian, Hai; Li, Dongli; Li, Jing; Chen, Jing; Li, Xiongfeng			Establishment and evaluation of a specific antibiotic-induced inflammatory bowel disease model in rats	PLOS ONE			English	Article							GUT MICROBIOTA; FAECALIBACTERIUM-PRAUSNITZII; DYSBIOSIS; PATHOGENESIS; EXPRESSION; CELLS	Physical and chemical methods for generating rat models of enteritis have been established; however, antibiotic induction has rarely been used for this purpose. The present study aimed to establish and evaluate a rat model of inflammatory bowel disease (IBD) using antibiotics. A total of 84 Sprague-Dawley (SD) rats were divided into the following groups, according to the dosage and method of administration of the antibiotics: A, control; B, low-dose clindamycin; C, medium-dose clindamycin; D, high-dose clindamycin; E, low-dose clindamycin, ampicillin and streptomycin; F, medium-dose clindamycin, ampicillin and streptomycin; and G, high-dose clindamycin, ampicillin and streptomycin. Antibiotic administration was stopped on day 7; the modeling period covered days 1-7, and the recovery period covered days 8-15. Half of the animals were dissected on day 11, with the remaining animals dissected on day 15. Food andwater intake, body weight and fecal weight were recorded. Intestinal flora was analyzed via microbial culture and quantitative PCR. The content of TNF-alpha, IL1-beta, IL-6 and C-reactive protein (CRP) was assessed in abdominal aorta blood. Colonic and rectal tissues were examined pathologically via hematoxylin-eosin staining to assess leukocyte infiltration and intestinal mucosal changes as indicators of inflammation. Rat weight, food intake, water intake and 2-h fecal weight were significantly different across the experimental groups (P = 0.040, P = 0.016, P<0.001 and P = 0.009, respectively). Microbial cultures revealed no significant differences between group A and B,C (P = 0.546,0.872) but significant differences betwenn group A and the other experimental groups (all P< 0.001). Furthermore, significant differences in the levels of Bacteroides, Faecalibacterium prausnitzii and Dialister invisus on day 4 between groups A, C and F (P = 0.033, P = 0.025 and P = 0.034, respectively). Significant differences were detected in the levels of TNF-alpha, IL1-beta, IL-6 and CRP between the groups (all P< 0.001). The colonic and rectal pathological inflammation scores of the experimental groups were significantly different compared with group A (B vs. A, P = 0.002; others, all P< 0.001). These findings indicated that an antibiotic-induced IBD model was successfully established in SD rats; this animal model may serve as a useful model for clinical IBD research.	[Tong, Guojun; Qian, Hai] Huzhou Cent Hosp, Dept Gen Surg, Huzhou, Zhejiang, Peoples R China; [Tong, Guojun; Li, Dongli; Li, Jing; Chen, Jing] Huzhou Cent Hosp, Cent Lab, Huzhou, Zhejiang, Peoples R China; [Li, Xiongfeng] Huzhou Cent Hosp, Orthoped Surg, Huzhou, Zhejiang, Peoples R China	Huzhou University; Huzhou University; Huzhou University	Tong, GJ (corresponding author), Huzhou Cent Hosp, Dept Gen Surg, Huzhou, Zhejiang, Peoples R China.; Tong, GJ (corresponding author), Huzhou Cent Hosp, Cent Lab, Huzhou, Zhejiang, Peoples R China.	tgj97114@sina.com			Technology and Science Project of Zhejiang [2018C37090]	Technology and Science Project of Zhejiang	YES. The present study was supported by Technology and Science Project of Zhejiang (grant no. 2018C37090). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Ahmad A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0823-3; Almohazey D, 2017, CELL DEATH DIFFER, V24, P855, DOI 10.1038/cdd.2017.27; Amoroso C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051234; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Arivarasu N., 2018, TISSUE BARRIES, V6; Balasubramanian D, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx005; Bastaki SMA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1057-5; Caputi V, 2017, BRIT J PHARMACOL, V174, P3623, DOI 10.1111/bph.13965; Catana CS, 2018, ADV CLIN EXP MED, V27, P599, DOI 10.17219/acem/69134; CHEN Suao., 2020, CHIN J COMP MED, V30, P142, DOI [10.1093/ppar/praa023, DOI 10.1093/PPAR/PRAA023]; Coelho-Santos V, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-103; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Czaja Krzysztof., 2017, J NUTR HLTH FOOD SCI, V5, P1, DOI [10.15226/jnhfs.2017.001102, DOI 10.15226/JNHFS.2017.001102]; De Zuani M, 2018, EUR J IMMUNOL, V48, P1929, DOI 10.1002/eji.201847504; Dotel R, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3452-y; Dzialo MC, 2017, FEMS MICROBIOL REV, V41, pS95, DOI 10.1093/femsre/fux031; Farzi A, 2018, NEUROTHERAPEUTICS, V15, P5, DOI 10.1007/s13311-017-0600-5; Feng SC, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/AEM.02696-18, 10.1128/aem.02696-18]; Frohlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020; Gajdacs M, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6040025; Ghai I, 2018, J BIOL CHEM, V293, P7030, DOI 10.1074/jbc.RA117.000705; Ghattamaneni NKR, 2019, PHARMACOL REP, V71, P149, DOI 10.1016/j.pharep.2018.10.006; Golinska E, 2013, WORLD J GASTROENTERO, V19, P3562, DOI 10.3748/wjg.v19.i23.3562; Green N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050947; Hagihara M, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100772; He C., MIR 301A PROMOTES IN; HU Tingting C.H., 2019, J CLIN ONCOL, V24, P584; Inglin RC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4601-5; Jacobs JP, 2016, CELL MOL GASTROENTER, V2, P750, DOI 10.1016/j.jcmgh.2016.06.004; Jenkins SV, 2019, CANCER RES, V79, P5999, DOI 10.1158/0008-5472.CAN-18-4108; Jianmei Z., 2017, CHINA PHARMACY, V28, P1353; Jiminez JA, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0076-y; Saez-Lara MJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/505878; Kanamori Y, 2017, J BIOL CHEM, V292, P10275, DOI 10.1074/jbc.M116.770974; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kanwal S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081003; Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126; Kim BJ, 2014, ANGEW CHEM INT EDIT, V53, P14443, DOI 10.1002/anie.201408454; Kuriyama T, 2020, REGEN THER, V14, P1, DOI 10.1016/j.reth.2019.12.005; Lanfeng Zhang., 2011, J ADV NURSING ED, V26, P2117; Lee PT, 2017, FISH SHELLFISH IMMUN, V65, P42, DOI 10.1016/j.fsi.2017.03.037; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3; Liu X, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01151; Lopez-Siles M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00281; Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176; Matowicka-Karna Joanna, 2016, Postepy Hig Med Dosw (Online), V70, P305; Mendes-Soares H, 2014, J BACTERIOL, V196, P1458, DOI 10.1128/JB.01439-13; Miyoshi J, 2017, CELL REP, V20, P491, DOI 10.1016/j.celrep.2017.06.060; Munukka E, 2017, ISME J, V11, P1667, DOI 10.1038/ismej.2017.24; National Research Council (US) Institute for Laboratory Animal Research, 1996, GUIDE CARE USE LAB A; O'Connor KM, 2019, EBIOMEDICINE, V44, P618, DOI 10.1016/j.ebiom.2019.03.029; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Peloquin JM, 2013, ANAEROBE, V24, P102, DOI 10.1016/j.anaerobe.2013.04.006; Pindling S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny188; Rakoff-Nahoum S, 2016, NATURE, V533, P255, DOI 10.1038/nature17626; Rosean CB, 2019, CANCER RES, V79, P3662, DOI 10.1158/0008-5472.CAN-18-3464; Roulis M, 2016, MUCOSAL IMMUNOL, V9, P787, DOI 10.1038/mi.2015.102; Sangfelt P, 2001, AM J GASTROENTEROL, V96, P1085; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; Singh AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135035; Sokol H, 2008, INFLAMM BOWEL DIS, V14, P858, DOI 10.1002/ibd.20392; Sondberg E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02053; Srikanth CV, 2007, IMMUNOL RES, V37, P61, DOI 10.1007/BF02686090; Sudhakar M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01167; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Uzal FA, 2015, VET MICROBIOL, V179, P23, DOI 10.1016/j.vetmic.2015.02.013; Vaughn AC, 2017, ACTA NEUROBIOL EXP, V77, P18; Vineis JH, 2016, MBIO, V7, DOI [10.1128/mBio.01713-16, 10.1128/mbio.01713-16]; Whittemore JC, 2019, GUT MICROBES, V10, P521, DOI 10.1080/19490976.2018.1560754; Wu HL, 2020, ARCH ORAL BIOL, V114, DOI 10.1016/j.archoralbio.2020.104730; Yang CH, 2019, INT J NANOMED, V14, P8875, DOI 10.2147/IJN.S210315; Yu M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46551; Yu SY, 2019, INT J SYST EVOL MICR, V69, P3824, DOI 10.1099/ijsem.0.003690; Zafar H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208151; Zhou BL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00575; Zhou YT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5828959	77	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264194	10.1371/journal.pone.0264194	http://dx.doi.org/10.1371/journal.pone.0264194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192646	gold, Green Submitted, Green Published			2022-12-26	WOS:000812552500043
J	Berhane, A; Belachew, T				Berhane, Anteneh; Belachew, Tefera			Trend and burden of neural tube defects among cohort of pregnant women in Ethiopia: Where are we in the prevention and what is the way forward?	PLOS ONE			English	Article							FOLIC-ACID; FORTIFICATION	Introduction Neural tube defect is one of the top five most serious birth defects in the world. In Ethiopia an accurate estimate of the trend and burden of neural tube defects is still unknown. There hasn't been much research done on the prevalence and trend of neural tube defects in Eastern Ethiopia. To complement previous efforts of studies, the purpose of this study is to estimate the trend and burden of neural tube defects in Eastern Ethiopia as well as to investigate the epidemiological implications of the findings. Methods A facility-based retrospective cohort study was carried out from cohort pregnant women who delivered in selected hospitals. File records of all babies who were found to have neural tube defects could be reached between 2017 and 2019. A structured checklist was used to collect data. The incidence of each case was calculated by dividing the number of cases per year by the total number of live births in each hospital. To determine the linear trend of neural tube defects over time, linear trend of Extended Mantel-Haenszel chi-square was performed. Data were presented using frequencies and percentages. Data were analyzed using SPSS for windows version 25. Results A total of 48,750 deliveries were recorded during the three years of the study considered for analyses with 522 women having neural tube defect giving an incidence rate of 107.5 per 10,000 live births in the three years. The most common types of neural tube defects found in the area were anencephaly and spina bifida accounting for 48.1% and 22.6%, respectively. The distribution of neural tube defects varied across the study hospitals, with Adama Medical College Hospital having the highest proportion (46.6%). Over half of the mothers (56.7%) live in cities. Mothers in the age group 25-34 (46.9%) and multigravida mothers had higher proportions (64.4%).of neural tube defects. None of the mothers took folic acid before conception, and only 19% took iron folic acid supplementation during their pregnancy. Conclusion and recommendation The findings showed that an increasing trend and burden of neural tube defects and preconception folic acid supplementation is insignificant in the region which showed that where we are in the prevention of neural tube defects. The finding suggests that preconception folic acid supplementation in conjunction with health care services should be considered to reduce the risk of neural tube defects in the region. Aside from that, intensive prevention efforts for long-term folate intake through dietary diversification and appropriate public health interventions are required. Furthermore, data must be properly recorded in order to address disparities in neonatal death due to neural tube defects, and the determinants of neural tube defects should be investigated using large scale prospective studies with biomarkers.	[Berhane, Anteneh] Dire Dawa Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dire Dawa, Ethiopia; [Berhane, Anteneh; Belachew, Tefera] Jimma Univ, Inst Hlth Sci, Fac Publ Hlth, Dept Nutr & Dietet, Jimma, Ethiopia	Jimma University	Berhane, A (corresponding author), Dire Dawa Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dire Dawa, Ethiopia.	antishaction@gmail.com		Berhane, Anteneh/0000-0001-5078-8703	Dire Dawa University; Jimma University	Dire Dawa University; Jimma University	This study obtained funds from Dire Dawa University and Jimma University for data collection only. The authors declare that they have no fund for the publication of this manuscript. The funders have no role in the study design, data analysis and decision to publish for preparation of the manuscript.	AIREDE KI, 1992, J TROP PEDIATRICS, V38, P27, DOI 10.1093/tropej/38.1.27; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Arth A., 2016, CLIN MOL TERATOLOGY, V106, P520, DOI [10.1002/bdra.23529, DOI 10.1002/BDRA.23529]; Atlaw D., 2019, J PREG CHILD HLTH, V6; Berihu BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206212; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2010, FOOD NUTR BULL, V31, pS22, DOI 10.1177/15648265100311S103; Bitew Zebenay Workneh, 2020, Glob Pediatr Health, V7, p2333794X20939423, DOI 10.1177/2333794X20939423; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Botto L.D., 2012, BIRTH DEFECT PREVENT; Butterworth CE, 1996, ANNU REV NUTR, V16, P73, DOI [10.1146/annurev.nutr.16.1.73, 10.1146/annurev.nu.16.070196.000445]; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P264; De Marco P, 2011, CHILD NERV SYST, V27, P1073, DOI 10.1007/s00381-010-1372-y; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Ebrahimi S., 2013, Shiraz E Medical Journal, V14, P54; Forci K, 2021, BMC PEDIATR, V21, DOI 10.1186/s12887-021-02584-5; Gedefaw A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4829023; Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354; Haidar J, 2010, S AFR J CLIN NUTR, V23, P132; Lazareff J.A., 2010, NEURAL TUBE DEFECTS; Persad VL, 2002, CAN MED ASSOC J, V167, P241; Samson GR, 2003, J TROP PEDIATRICS, V49, P256, DOI 10.1093/tropej/49.4.256; Sharma V.M., 2018, AGE, V20, P14; Sorri Gemechu, 2015, Ethiop Med J, V53, P119; Tadesse AW, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/5635267; Taye Kefyalew, 2009, Ethiop Med J, V47, P71; Wasant Pornswan, 2005, J Med Assoc Thai, V88 Suppl 8, pS92; WHO, 2008, FOOD NUTR BULL, P29; WHO, 2000, WORLD MEDICAL ASS DE; Williams J, 2015, MMWR-MORBID MORTAL W, V64, P1; Yi YN, 2011, EUR J PEDIATR, V170, P1391, DOI 10.1007/s00431-011-1492-8; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586	32	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264005	10.1371/journal.pone.0264005	http://dx.doi.org/10.1371/journal.pone.0264005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180245	gold, Green Published			2022-12-26	WOS:000796435800040
J	Moutoussamy, I; Taconnat, L; Pothier, K; Toussaint, L; Fay, S				Moutoussamy, Ilona; Taconnat, Laurence; Pothier, Kristell; Toussaint, Lucette; Fay, Severine			Episodic memory and aging: Benefits of physical activity depend on the executive resources required for the task	PLOS ONE			English	Article							HEALTHY OLDER-ADULTS; GRAY-MATTER VOLUME; COGNITIVE FUNCTION; PREFRONTAL CORTEX; AGE-DIFFERENCES; RECALL; EXERCISE; YOUNG; PERFORMANCE; FITNESS	Physical activity has beneficial effects on executive functions and episodic memory, two processes affected by aging. These benefits seem to depend on the type of memory task, but only a few studies have evaluated them despite their importance in understanding aging. This study aimed to confirm that the benefits of physical activity on episodic memory in older adults vary according to the executive resources required by the memory task, comparing free recall and cued recall. Thirty-seven young adults and 37 older adults performed two memory tasks and an updating task. The two groups had a similar level of physical activity over the preceding 12 months, assessed by a questionnaire. Both the memory and the updating tasks were performed better by the younger than the older adults. A similar cueing effect was observed in the two groups. Physical activity was positively correlated with updating and free recall, but not with cued-recall, and only in older adults. Regression analyses indicated that physical activity accounted for 24% of the variance in free recall in older adults. Updating did not predict free recall (ns) when physical activity was entered in the analysis. The present results show that the benefits of physical activity vary with age and episodic memory task. Only free-recall performance, which relies on updating, seems to depend on physical activity, suggesting that the executive resources required for the task play an important role in the effect of physical activity on memory performance. This should be investigated in greater depth in subsequent studies.	[Moutoussamy, Ilona; Taconnat, Laurence; Fay, Severine] Univ Tours & Poitiers, Ctr Natl Rech Scientif, Ctr Recherches Cognit & IApprentissage, Dept Psychol,UMR 7295, Tours, France; [Moutoussamy, Ilona; Pothier, Kristell] Univ Tours, Psychol Ages Vie & Adaptat EA 2114, Tours, France; [Toussaint, Lucette] Univ Tours & Poitiers, Ctr Natl Rech Scientif, Ctr Recherches Cognit & IApprentissage UMR 7295, Dept Sci sport, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Universite de Poitiers	Moutoussamy, I (corresponding author), Univ Tours & Poitiers, Ctr Natl Rech Scientif, Ctr Recherches Cognit & IApprentissage, Dept Psychol,UMR 7295, Tours, France.	ilona.moutoussamy@univ-tours.fr	Toussaint, Lucette/GOH-0425-2022	Toussaint, Lucette/0000-0003-3945-2146	ANR (Agence National de la Rercherche) [ANR-17CE28-0003-02]	ANR (Agence National de la Rercherche)(French National Research Agency (ANR))	Authors received funding from ANR (Agence National de la Rercherche); n degrees ANR-17CE28-0003-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; Angel L, 2010, BRAIN RES, V1335, P41, DOI 10.1016/j.brainres.2010.03.040; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Barha CK, 2017, FRONT NEUROENDOCRIN, V46, P71, DOI 10.1016/j.yfrne.2017.04.002; Bherer L., 2021, COGNITIVE TRAINING, P319, DOI [10.1007/978-3-030-39292-5_22, DOI 10.1007/978-3-030-39292-5_22]; Bigard A. X., 1992, Science and Sports, V7, P215, DOI 10.1016/S0765-1597(05)80093-0; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Bopp KL, 2020, J GERONTOL B-PSYCHOL, V75, P229, DOI 10.1093/geronb/gby024; Bouazzaoui B, 2014, CAN J EXP PSYCHOL, V68, P59, DOI 10.1037/cep0000005; Bouazzaoui B, 2013, CAN J EXP PSYCHOL, V67, P100, DOI 10.1037/a0028517; Bouazzaoui B, 2010, ACTA PSYCHOL, V135, P59, DOI 10.1016/j.actpsy.2010.05.007; Boucard GK, 2012, J SPORT EXERCISE PSY, V34, P808, DOI 10.1123/jsep.34.6.808; Boujut A, 2016, MEMORY, V24, P1231, DOI 10.1080/09658211.2015.1091893; Bugaiska A, 2007, CONSCIOUS COGN, V16, P797, DOI 10.1016/j.concog.2006.11.007; Burger L, 2017, ACTA PSYCHOL, V175, P50, DOI 10.1016/j.actpsy.2017.02.003; Butler KM, 2004, PSYCHON B REV, V11, P921, DOI 10.3758/BF03196722; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; CAULEY JA, 1987, AM J CLIN NUTR, V45, P14, DOI 10.1093/ajcn/45.1.14; Chan AS, 2005, J AM GERIATR SOC, V53, P1754, DOI 10.1111/j.1532-5415.2005.53513.x; CHODZKOZAJKO WJ, 1992, INT J AGING HUM DEV, V35, P265, DOI 10.2190/UJAQ-4LK5-2WAN-11DL; Clarys D, 2009, MEMORY, V17, P158, DOI 10.1080/09658210802188301; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; CONTENT A, 1990, ANN PSYCHOL, V90, P551; Cox EP, 2016, J SCI MED SPORT, V19, P616, DOI 10.1016/j.jsams.2015.09.003; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Crawford JR, 2000, AGING NEUROPSYCHOL C, V7, P9, DOI 10.1076/anec.7.1.9.806; Daly M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01044; Danckert SL, 2013, PSYCHOL AGING, V28, P902, DOI 10.1037/a0033263; Deltour JJ., 1993, ADAPTATION FRANAISE; Durnin J., 1967, ENERGY WORK LEISURE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Froger C, 2009, J CLIN EXP NEUROPSYC, V31, P312, DOI 10.1080/13803390802112554; Gajewski PD, 2015, BRAIN COGNITION, V98, P87, DOI 10.1016/j.bandc.2015.06.004; Gajewski PD, 2015, NEUROPSYCHOLOGIA, V73, P195, DOI 10.1016/j.neuropsychologia.2015.04.031; Hall P., 2015, FRONT HUM NEUROSCI, P9, DOI [10.3389/fnhum.2015.00009, DOI 10.3389/FNHUM.2015.00009]; Haverkamp BF, 2020, J SPORT SCI, V38, P2637, DOI 10.1080/02640414.2020.1794763; Hayes SM, 2015, J INT NEUROPSYCH SOC, V21, P780, DOI 10.1017/S1355617715000910; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Isingrini A, 2008, REV NEUROL-FRANCE, V164, pS91, DOI 10.1016/S0035-3787(08)73297-1; Jones S, 2006, NEUROSCI BIOBEHAV R, V30, P864, DOI 10.1016/j.neubiorev.2006.06.012; Kamijo K, 2010, INT J PSYCHOPHYSIOL, V75, P304, DOI 10.1016/j.ijpsycho.2010.01.002; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kirchhoff BA, 2014, NEUROIMAGE, V90, P326, DOI 10.1016/j.neuroimage.2013.12.052; Loprinzi PD, 2019, MED HYPOTHESES, V126, P51, DOI 10.1016/j.mehy.2019.03.010; Margolis R, 2013, J HEALTH SOC BEHAV, V54, P353, DOI 10.1177/0022146513489312; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Nouchi R, 2014, AGE, V36, P787, DOI 10.1007/s11357-013-9588-x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Petrides M, 2002, NEUROBIOL LEARN MEM, V78, P528, DOI 10.1006/nlme.2002.4107; Quigley Adria, 2020, J Aging Res, V2020, P1407896, DOI 10.1155/2020/1407896; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Rouillard M, 2017, J CLIN EXP NEUROPSYC, V39, P142, DOI 10.1080/13803395.2016.1207755; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Ruscheweyh R, 2013, HUM BRAIN MAPP, V34, P3333, DOI 10.1002/hbm.22146; Sanders LMJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210036; Sastoque LG, 2019, ACTA PSYCHOL, V192, P73, DOI 10.1016/j.actpsy.2018.11.002; Segaert K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24972-1; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taconnat L, 2007, BRAIN COGNITION, V64, P1, DOI 10.1016/j.bandc.2006.09.011; Taconnat L, 2009, EUR J COGN PSYCHOL, V21, P347, DOI 10.1080/09541440802296413; Tannenbaum C, 2005, CAN MED ASSOC J, V173, P153, DOI 10.1503/cmaj.050059; Troyer A.K., 1994, AGING NEUROPSYCHOL C, V1, P45, DOI [10.1080/09289919408251449, DOI 10.1080/09289919408251449]; Tsai C., 2017, FRONT AGING NEUROSCI, P9, DOI [10.3389/fnagi.2017.00009, DOI 10.3389/FNAGI.2017.00009]; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Verhaeghen P, 1998, PSYCHOL AGING, V13, P120, DOI 10.1037/0882-7974.13.1.120; Wasylyshyn C, 2011, PSYCHOL AGING, V26, P15, DOI 10.1037/a0020912; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Wilbur J, 2012, J GERONTOL B-PSYCHOL, V67, P525, DOI 10.1093/geronb/gbr137; Woo E, 2003, EDUC GERONTOL, V29, P327, DOI 10.1080/713844341; Xiong J, 2021, INT J NURS STUD, V114, DOI 10.1016/j.ijnurstu.2020.103810; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	78	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263919	10.1371/journal.pone.0263919	http://dx.doi.org/10.1371/journal.pone.0263919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180252	Green Published, gold			2022-12-26	WOS:000796435800036
J	Yamasako, J; Kiritani, K; Makihara, H; Yamanaka, T				Yamasako, Junsuke; Kiritani, Keizi; Makihara, Hiroshi; Yamanaka, Takehiko			Long-term survey of longhorn beetles revealed changes in faunal features in Ito on the Izu peninsula	PLOS ONE			English	Article							POPULATION TRENDS; CERAMBYCIDAE; DISTENIIDAE; BUTTERFLIES; COLEOPTERA; INSECTS	Long-term biodiversity monitoring is essential for unveiling the impact of environmental changes on local fauna. Although private local records can contribute significantly to biodiversity evaluation, they are seldom published in scientific journals. In this study, a retired scientist recorded the longhorn beetles (Distiniidae and Cerambycidae) present in Ito on the Izu peninsula, Japan, for 12 years. The records showed the dynamical changes in longhorn beetles, which indicated the environmental changes around the survey site over 12 years. We also compared the longhorn beetle composition in the Ito study site to those in the survey records in 13 other locations in Kanto, Japan. We found that the species composition in Ito was stable throughout the 12 years, while the general composition in Ito reflected the land-use pattern of urban areas and the collecting methods. The species composition in the Ito study site differed from that in some of the other satoyama locations (human-influenced natural environment), but this was possibly due to methodological differences. Long-term backyard biodiversity surveys, especially those conducted by retired professionals, can play important roles in future investigations of insect groups, such as longhorn beetles, even if they are not agricultural pests nor endangered species.	[Yamasako, Junsuke] NARO, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan; [Kiritani, Keizi] 1020 292 Futo, Shizuoka, Japan; [Makihara, Hiroshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Yamanaka, Takehiko] NARO, Res Ctr Agr Informat Technol, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; Forestry & Forest Products Research Institute - Japan; National Agriculture & Food Research Organization - Japan	Yamanaka, T (corresponding author), NARO, Res Ctr Agr Informat Technol, Tsukuba, Ibaraki, Japan.	apple@affrc.go.jp			JSPS KAKENHI [18K14776]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI (grant number 18K14776) awarded to JY.	Akesse EN., 2018, J ENTOMOL ZOOL STUD, V6, P1064; Andow David, 2020, American Entomologist, V66, P61, DOI 10.1093/ae/tmaa019; Baba K., 1991, ENTOMOSYLLEGOLOGY; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Fujita Hiroshi, 1988, Special Bulletin of the Japanese Society of Coleopterology, V3, P72; Gao Ruitong, 1997, Forest Research, V10, P619; Gross J., 2003, R NEWS, V3, P13; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Holland JD, 2007, BIODIVERS CONSERV, V16, P2599, DOI 10.1007/s10531-006-9066-1; Jeppsson T, 2010, BIOL CONSERV, V143, P1940, DOI 10.1016/j.biocon.2010.04.015; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kawatsu K, 2020, POPUL ECOL, V62, P5, DOI 10.1002/1438-390X.12025; Kishi Y., 1995, PINE WILT DIS; Kishimoto-Yamada K, 2017, BIODIVERS DATA J, V5, DOI 10.3897/BDJ.5.e22296; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2011, METHODS ECOL EVOL, V2, P269, DOI 10.1111/j.2041-210X.2010.00078.x; Maeto K, 2002, BIODIVERS CONSERV, V11, P1919, DOI 10.1023/A:1020849012649; Makihara H., 2011, KANAGAWA CHUHO, V191, P31; Makino S, 2007, ECOL RES, V22, P372, DOI 10.1007/s11284-007-0359-y; Matsumoto Kazuma, 2014, Bulletin of the Forestry and Forest Products Research Institute, V13, P255; Nomura S., 2000, MEMOIRS NATL MUSEUM, V39, P183; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Okada K., 2013, REPORT 2 GEN SURVEY, P283; Okland RH, 2003, J VEG SCI, V14, P693, DOI 10.1111/j.1654-1103.2003.tb02201.x; Oksanen J, 2019, VEGAN R PACKAGE VERS; Osada Y, 2018, J ANIM ECOL, V87, P1512, DOI 10.1111/1365-2656.12884; POLLARD E, 1995, J APPL ECOL, V32, P9, DOI 10.2307/2404411; R Core Team, 2021, R LANGUAGE ENV STAT; Saito A, 2005, MEMOIRS NATL MUSEUM, V36, P287; Sakurai H., 2008, USUBASHIRO, V37, P1; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Takano K., 2015, KANAGAWA CH H, V187, P34; Takeuchi K, 2010, ECOL RES, V25, P891, DOI 10.1007/s11284-010-0745-8; Tavakilian G, 2018, TITAN DATABASE LONGH; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thomas JA, 2005, PHILOS T R SOC B, V360, P339, DOI 10.1098/rstb.2004.1585; van Klink R, 2020, SCIENCE, V368, P417, DOI 10.1126/science.aax9931; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Yagishita J., 2008, USUBASHIRO, V36, P1; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201	44	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263761	10.1371/journal.pone.0263761	http://dx.doi.org/10.1371/journal.pone.0263761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180253	Green Published, gold			2022-12-26	WOS:000796435800030
J	Havranek, MM; Ondrej, J; Bollmann, S; Widmer, PK; Spika, S; Boes, S				Havranek, Michael M.; Ondrej, Josef; Bollmann, Stella; Widmer, Philippe K.; Spika, Simon; Boes, Stefan			Identification and assessment of a comprehensive set of structural factors associated with hospital costs in Switzerland	PLOS ONE			English	Article							STAY	Structural factors can influence hospital costs beyond case-mix differences. However, accepted measures on how to distinguish hospitals with regard to cost-related organizational and regional differences are lacking in Switzerland. Therefore, the objective of this study was to identify and assess a comprehensive set of hospital attributes in relation to average case-mix adjusted costs of hospitals. Using detailed hospital and patient-level data enriched with regional information, we derived a list of 23 cost predictors, examined how they are associated with costs, each other, and with different hospital types, and identified principal components within them. Our results showed that attributes describing size, complexity, and teaching-intensity of hospitals (number of beds, discharges, departments, and rate of residents) were positively related to costs and showed the largest values in university (i.e., academic teaching) and central general hospitals. Attributes related to rarity and financial risk of patient mix (ratio of rare DRGs, ratio of children, and expected loss potential based on DRG mix) were positively associated with costs and showed the largest values in children's and university hospitals. Attributes characterizing the provision of essential healthcare functions in the service area (ratio of emergency/ambulance admissions, admissions during weekends/ nights, and admissions from nursing homes) were positively related to costs and showed the largest values in central and regional general hospitals. Regional attributes describing the location of hospitals in large agglomerations (in contrast to smaller agglomerations and rural areas) were positively associated with costs and showed the largest values in university hospitals. Furthermore, the four principal components identified within the hospital attributes fully explained the observed cost variations across different hospital types. These uncovered relationships may serve as a foundation for objectifying discussions about cost-related heterogeneity in Swiss hospitals and support policymakers to include structural characteristics into cost benchmarking and hospital reimbursement.	[Havranek, Michael M.; Ondrej, Josef; Bollmann, Stella; Boes, Stefan] Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland; [Widmer, Philippe K.] Spital Limmattal Zurich, Zurich, Switzerland; [Spika, Simon] Univ Hosp Zurich, Zurich, Switzerland	University of Lucerne; University of Zurich; University Zurich Hospital	Havranek, MM (corresponding author), Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland.	michael.havranek@unilu.ch			Swiss Innovation Agency (Innosuisse) [38988.1 IP-SBM]	Swiss Innovation Agency (Innosuisse)	This study (MMH) was funded by the Research Grant 38988.1 IP-SBM of the Swiss Innovation Agency (Innosuisse, https://www.innosuisse.ch/inno/de/home.html), which promotes science-based innovations commissioned by the Swiss Confederation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Busse R, 2011, DIAGNOSIS RELATED GR; Einkaufsgemeinschaft HSK, 2020, BENCHM SWISSDRG TAR, DOI [10.4414/smw.2020.20180, DOI 10.4414/SMW.2020.20180]; Garvey Melissa, 2013, Midwifery Today Int Midwife, P68; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Longo F, 2019, EUR J HEALTH ECON, V20, P7, DOI 10.1007/s10198-017-0935-1; Meacock R, 2015, HEALTH ECON, V24, P907, DOI 10.1002/hec.3207; Merenstein D, 2005, PEDIATRICS, V115, P839, DOI 10.1542/peds.2004-1622; Raol N, 2016, OTOLARYNG HEAD NECK, V154, P486, DOI 10.1177/0194599815621739; Robinson BRH, 2014, SURGERY, V156, P814, DOI 10.1016/j.surg.2014.06.071; Scarf V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149463; Short Heather L, 2018, Hosp Pediatr, V8, P753, DOI 10.1542/hpeds.2017-0152; Silber JH, 2020, ANN SURG, V271, P412, DOI 10.1097/SLA.0000000000003602; Skolasky RL, 2015, SPINE, V40, pE936, DOI 10.1097/BRS.0000000000000910; Solberg BCJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6903; Thompson RT, 2013, PEDIATRICS, V131, pE805, DOI 10.1542/peds.2012-2015; Verein SpitalBenchmark, 2020, BENCHM SCHWEIZ SPIT; Wang L, 2011, SURGERY, V150, P727, DOI 10.1016/j.surg.2011.08.019; Watanabe Y, 2018, INT J HEALTH CARE Q, V31, P265, DOI 10.1108/IJHCQA-03-2017-0043; Widmer P., 2015, POLYNOMICS; Widmer P., 2017, POLYNOMICS; Widmer P., 2010, 52 U ZUR DEP EC	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264212	10.1371/journal.pone.0264212	http://dx.doi.org/10.1371/journal.pone.0264212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176112	gold, Green Published			2022-12-26	WOS:000777505200091
J	Hodrea, J; Saeed, A; Molnar, A; Fintha, A; Barczi, A; Wagner, LJ; Szabo, AJ; Fekete, A; Balogh, DB				Hodrea, Judit; Saeed, Adar; Molnar, Agnes; Fintha, Attila; Barczi, Adrienn; Wagner, Laszlo J.; Szabo, Attila J.; Fekete, Andrea; Balogh, Dora B.			SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEART-FAILURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL FIBROSIS; BLOOD-PRESSURE; KLOTHO; DYSFUNCTION; MECHANISMS; RISK; CARDIOMYOPATHY	Introduction Cardiovascular disease (CVD) is two to five times more prevalent in diabetic patients and is the leading cause of death. Therefore, identification of novel therapeutic strategies that reduce the risk of CVD is a research priority. Clinical trials showed that reduction in the relative risk of heart failure by sodium-glucose cotransporter 2 inhibitors (SGLT2i) are partly beyond their glucose lowering effects, however, the molecular mechanisms are still elusive. Here we investigated the role of SGLT2i dapagliflozin (DAPA) in the prevention of diabetes-induced cardiovascular complications. Methods Type 1 diabetes was induced with streptozotocin (65 mg/bwkg, ip.) in adult, male Wistar rats. Following the onset of diabetes rats were treated for six weeks with DAPA (1 mg/bwkg/day, po.). Results DAPA decreased blood glucose levels (D: 37 +/- 2.7 vs. D+DAPA: 18 +/- 5.6 mmol/L; p<0.05) and prevented metabolic decline. Aortic intima-media thickening was mitigated by DAPA. DAPA abolished cardiac hypertrophy, and myocardial damage. Cardiac inflammation and fibrosis were also moderated after DAPA treatment. Conclusions These data support the preventive and protective role of SGLT2i in diabetes-associated cardiovascular disease. SGLT2i may provide novel therapeutic strategy to hinder the development of cardiovascular diseases in type 1 diabetes, thereby improve the outcomes.	[Hodrea, Judit; Saeed, Adar; Molnar, Agnes; Barczi, Adrienn; Fekete, Andrea; Balogh, Dora B.] Semmelweis Univ, MTA SE Lendulet Diabet Res Grp, Budapest, Hungary; [Hodrea, Judit; Saeed, Adar; Molnar, Agnes; Szabo, Attila J.; Fekete, Andrea; Balogh, Dora B.] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Fintha, Attila] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary; [Wagner, Laszlo J.] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary; [Szabo, Attila J.] Hungarian Acad Sci, ELKH SE Pediat & Nephrol Res Grp, Budapest, Hungary; [Szabo, Attila J.] Semmelweis Univ, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Balogh, DB (corresponding author), Semmelweis Univ, MTA SE Lendulet Diabet Res Grp, Budapest, Hungary.; Balogh, DB (corresponding author), Semmelweis Univ, Dept Pediat 1, Budapest, Hungary.	dorabiankabalogh@gmail.com		Balogh, Dora Bianka/0000-0001-6554-2634	National Research, Development and Innovation Office [FK-124491, 2017-1.3.1-VKE-2017-00006]; Ministry for Innovation and Technology in Hungary [2020-4.1.1.TKP2020, 6183169273]; Semmelweis University [6183069269]; Ministry for Innovation and Technology [UNKP-19-3-III-SE-6, LP2021-3/2021]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Ministry for Innovation and Technology in Hungary; Semmelweis University; Ministry for Innovation and Technology	Funding for this study was provided by National Research, Development and Innovation Office (FK-124491, 2017-1.3.1-VKE-2017-00006), Thematic Excellence Program (2020-4.1.1.TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the 6183169273 thematic program, and the 6183069269 institutional excellence program of the Semmelweis University, and Ministry for Innovation and Technology UNKP-19-3-III-SE-6), Lendulet LP2021-3/2021.	Abbas NAT, 2018, N-S ARCH PHARMACOL, V391, P1347, DOI 10.1007/s00210-018-1544-y; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Aragon-Herrera A, 2019, BIOCHEM PHARMACOL, V170, DOI 10.1016/j.bcp.2019.113677; Armstrong AC, 2017, DIABETES CARE, V40, P405, DOI 10.2337/dc16-1889; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Berezin AE, 2019, DIABETES METAB SYND, V13, P995, DOI 10.1016/j.dsx.2019.01.018; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Collaborators GCD., 2018, LANCET, V392, P392; Dinh W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-58; Ellmers LJ, 2002, AM J PHYSIOL-HEART C, V283, pH707, DOI 10.1152/ajpheart.00677.2001; Fazlinezhad A, 2011, CLIN MED INSIGHTS-CA, V5, P77, DOI 10.4137/CMC.S7189; Frati G, 2017, CARDIOVASC RES, V113, P378, DOI 10.1093/cvr/cvx011; Fredersdorf S, 2004, CARDIOVASC PATHOL, V13, P11, DOI 10.1016/S1054-8807(03)00109-1; Guo Y, 2018, BBA-MOL BASIS DIS, V1864, P238, DOI 10.1016/j.bbadis.2017.09.029; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harrington J, 2010, J PEDIATR-US, V156, P237, DOI 10.1016/j.jpeds.2009.08.036; Heilman K, 2009, DIABETES RES CLIN PR, V84, P168, DOI 10.1016/j.diabres.2009.01.014; Hicks KK, 1998, J AUTONOM NERV SYST, V69, P21, DOI 10.1016/S0165-1838(98)00004-6; Hodrea J, 2020, AM J PHYSIOL-RENAL, V318, pF1017, DOI 10.1152/ajprenal.00021.2020; Irace C, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0695-y; Januzzi JL, 2017, J AM COLL CARDIOL, V70, P704, DOI 10.1016/j.jacc.2017.06.016; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jiang W, 2019, MOL CELL ENDOCRINOL, V494, DOI 10.1016/j.mce.2019.110490; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Kang S, 2020, CAN J CARDIOL, V36, P543, DOI 10.1016/j.cjca.2019.08.033; Katakami N, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01079-4; Keles N, 2015, TOHOKU J EXP MED, V237, P17, DOI 10.1620/tjem.237.17; Korkmaz-Icoz S, 2016, AM J PHYSIOL-HEART C, V311, pH958, DOI 10.1152/ajpheart.00956.2015; Koyani CN, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104870; Kusaka H, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0473-7; Lee TM, 2017, FREE RADICAL BIO MED, V104, P298, DOI 10.1016/j.freeradbiomed.2017.01.035; Li CG, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0816-2; Li XL, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116773; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; Mizuno M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13741; Nasiri-Ansari N, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0749-1; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nie F, 2017, J DIABETES COMPLICAT, V31, P594, DOI 10.1016/j.jdiacomp.2016.11.008; Nomiyama T, 2018, ENDOCR J, V65, P859, DOI 10.1507/endocrj.EJ18-0022; Nunes S, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-44; Oyama J, 1998, J CLIN INVEST, V101, P2207, DOI 10.1172/JCI986; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Raj GM, 2020, FUTUR CARDIOL, V17, P355, DOI 10.2217/fca-2020-0087; Rosenfeld ME, 2008, CURR DRUG TARGETS, V9, P210, DOI 10.2174/138945008783755575; Saleh S, 2020, J GENET, V99, DOI 10.1007/s12041-020-01196-9; Schaan BD, 1997, BRAZ J MED BIOL RES, V30, P1081, DOI 10.1590/S0100-879X1997000900006; Schofield J, 2019, DIABETES THER, V10, P773, DOI 10.1007/s13300-019-0612-8; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Sharma S, 2004, J CLIN PATHOL, V57, P1025, DOI 10.1136/jcp.2003.015420; Skilton MR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081201; Takasu T, 2019, LIFE SCI, V230, P19, DOI 10.1016/j.lfs.2019.05.051; Veseli BE, 2017, EUR J PHARMACOL, V816, P3, DOI 10.1016/j.ejphar.2017.05.010; Segre CAW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0051-z; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang Y, 2016, DIABETIC MED, V33, P1732, DOI 10.1111/dme.13107; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wen HL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-50; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Wolsk E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004743; Wu M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00855; Ye YM, 2017, CARDIOVASC DRUG THER, V31, P119, DOI 10.1007/s10557-017-6725-2	65	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263285	10.1371/journal.pone.0263285	http://dx.doi.org/10.1371/journal.pone.0263285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176041	gold, Green Published			2022-12-26	WOS:000777505200018
J	Kesar, A; Baluch, A; Barber, O; Hoffmann, H; Jovanovic, M; Renz, D; Stopak, BL; Wicks, P; Gilbert, S				Kesar, Ajay; Baluch, Adel; Barber, Omer; Hoffmann, Henry; Jovanovic, Milan; Renz, Daniel; Stopak, Bernard Leon; Wicks, Paul; Gilbert, Stephen			Actionable absolute risk prediction of atherosclerotic cardiovascular disease based on the UK Biobank	PLOS ONE			English	Article							GLOBAL BURDEN; CARE	Cardiovascular diseases (CVDs) are the primary cause of all death globally. Timely and accurate identification of people at risk of developing an atherosclerotic CVD and its sequelae is a central pillar of preventive cardiology. One widely used approach is risk prediction models; however, currently available models consider only a limited set of risk factors and outcomes, yield no actionable advice to individuals based on their holistic medical state and lifestyle, are often not interpretable, were built with small cohort sizes or are based on lifestyle data from the 1960s, e.g. the Framingham model. The risk of developing atherosclerotic CVDs is heavily lifestyle dependent, potentially making many occurrences preventable. Providing actionable and accurate risk prediction tools to the public could assist in atherosclerotic CVD prevention. Accordingly, we developed a benchmarking pipeline to find the best set of data preprocessing and algorithms to predict absolute 10-year atherosclerotic CVD risk. Based on the data of 464,547 UK Biobank participants without atherosclerotic CVD at baseline, we used a comprehensive set of 203 consolidated risk factors associated with atherosclerosis and its sequelae (e.g. heart failure). Our two best performing absolute atherosclerotic risk prediction models provided higher performance, (AUROC: 0.7573, 95% CI: 0.755-0.7595) and (AUROC: 0.7544, 95% CI: 0.7522-0.7567), than Framingham (AUROC: 0.680, 95% CI: 0.6775-0.6824) and QRisk3 (AUROC: 0.725, 95% CI: 0.7226-0.7273). Using a subset of 25 risk factors identified with feature selection, our reduced model achieves similar performance (AUROC 0.7415, 95% CI: 0.7392-0.7438) while being less complex. Further, it is interpretable, actionable and highly generalizable. The model could be incorporated into clinical practice and might allow continuous personalized predictions with automated intervention suggestions.	[Kesar, Ajay; Baluch, Adel; Barber, Omer; Hoffmann, Henry; Jovanovic, Milan; Renz, Daniel; Stopak, Bernard Leon; Wicks, Paul; Gilbert, Stephen] Ada Hlth GmbH, Berlin, Germany; [Gilbert, Stephen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus Dresden, EKFZ Digital Hlth, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Kesar, A (corresponding author), Ada Hlth GmbH, Berlin, Germany.	science@ada.com		Kesar, Ajay/0000-0003-0036-5993	Ada Health GmbH [34802]	Ada Health GmbH	This research was funded by Ada Health GmbH and has been conducted using the UK Biobank under application id 34802.	Adadi Amina, 2020, Embedded Systems and Artificial Intelligence. Proceedings of ESAI 2019. Advances in Intelligent Systems and Computing (AISC 1076), P327, DOI 10.1007/978-981-15-0947-6_31; Alaa AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213653; [Anonymous], US INTERNET; [Anonymous], CARDIOVASCULAR DIS 1; [Anonymous], QRISK3 INTERNET; [Anonymous], CARDIOVASCULAR DIS C; [Anonymous], ETHICS; [Anonymous], XGBOOST DOCUMENTATIO; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Bui QT, 2009, INT J BIOCHEM CELL B, V41, P2109, DOI 10.1016/j.biocel.2009.06.002; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins R., UK BIOBANK PROTOCOL, P112; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; Cunningham R, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0221521, 10.1371/journal.pone.0221521.r001, 10.1371/journal.pone.0221521.r002, 10.1371/journal.pone.0221521.r003, 10.1371/journal.pone.0221521.r004]; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Evsikova CM, 2019, J PERS MED, V9, DOI 10.3390/jpm9020021; Dolezalova N., 2021, EUR HEART J DIGIT HL, V2, P528; Doupe P, 2019, VALUE HEALTH, V22, P808, DOI 10.1016/j.jval.2019.02.012; Eriksen CU., 2021, WHO HLTH EVIDENCE NE; Espinoza Juan, 2020, JMIR Public Health Surveill, V6, pe18808, DOI 10.2196/18808; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b; Gao W, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202101548; Ghayvat H., 2020, P 2 INT C DAT ENG AP, P1; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hageman S, 2021, EUR HEART J, V42, P2439, DOI 10.1093/eurheartj/ehab309; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heron N, 2016, BRIT J GEN PRACT, V66, pE747, DOI 10.3399/bjgp16X686617; Herrington W, 2016, CIRC RES, V118, P535, DOI 10.1161/CIRCRESAHA.115.307611; Hinton, 1990, MACH LEARN, P555, DOI DOI 10.1016/B978-0-08-051055-2.50029-8; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Insull W, 2009, AM J MED, V122, pS3, DOI 10.1016/j.amjmed.2008.10.013; Jackson R, 2000, BMJ-BRIT MED J, V320, P659, DOI 10.1136/bmj.320.7236.659; Jiang XC, 2019, J MED INTERNET RES, V21, DOI 10.2196/13166; Kopitar L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68771-z; Lemmen C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18189879; Leon-Mimila P, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00091; Lim LS, 2011, AM J PREV MED, V40, DOI 10.1016/j.amepre.2010.11.021; Ngiam KY, 2019, LANCET ONCOL, V20, pE262, DOI 10.1016/S1470-2045(19)30149-4; Nichols GA, 2010, AM J MANAG CARE, V16, pE86; Omohundro SM., 1989, 5 BALLTREE CONSTRUCT; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peeters JM, 2016, JMIR MED INF, V4, P24, DOI 10.2196/medinform.4515; Perez MV, 2019, NEW ENGL J MED, V381, P1909, DOI 10.1056/NEJMoa1901183; Picard M, 2021, COMPUT STRUCT BIOTEC, V19, P3735, DOI [10.1016/j.csbj.2021.06.030, 10.1016/j.csbj.2021.06.0302001-0370/]; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Roth GA, 2020, J AM COLL CARDIOL, V76, P2982, DOI 10.1016/j.jacc.2020.11.010; Sedgwick JEC, 2001, HEART, V85, P491, DOI 10.1136/heart.85.5.491; Shah APK, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.762303; Srivastava S, 2007, J MACH LEARN RES, V8, P1277; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trust for America's Health, 2008, ISSUE REPORT PREVENT; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Zhang JQ, 2004, 18TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 1 (LONG PAPERS), PROCEEDINGS, P562; Zhang T., 2004, P 21 INT C MACH LEAR, DOI 10.1145/1015330.1015332; Zhu J, 2009, STAT INTERFACE, V2, P349; Zipes DP, 2018, BRAUNWALDS HEART DIS	65	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263940	10.1371/journal.pone.0263940	http://dx.doi.org/10.1371/journal.pone.0263940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148360	gold, Green Published			2022-12-26	WOS:000800108800045
J	Bird, L; Miles, M; Quade, A; Spafford, H				Bird, Lisa; Miles, Melina; Quade, Adam; Spafford, Helen			Insecticide resistance in Australian Spodoptera frugiperda (JE Smith) and development of testing procedures for resistance surveillance	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; HELICOVERPA-ARMIGERA LEPIDOPTERA; INDUCED HORMESIS; NOCTUIDAE; SUSCEPTIBILITY; MODE; CHLORANTRANILIPROLE; METHOXYFENOZIDE; MANAGEMENT; SUBLETHAL	Spodoptera frugiperda (J.E. Smith) is a highly invasive noctuid pest first reported in northern Australia during early 2020. To document current status of resistance in S. frugiperda in Australia, insecticide toxicity was tested in field populations collected during the first year of establishment, between March 2020 and March 2021. Dose-response was measured by larval bioassay in 11 populations of S. frugiperda and a susceptible laboratory strain of Helicoverpa armigera. Emamectin benzoate was the most efficacious insecticide (LC50 0.023 mu g/ml) followed by chlorantraniliprole (LC50 0.055 mu g/ml), spinetoram (LC50 0.098 mu g/ml), spinosad (LC50 0.526 mu g/ml), and methoxyfenozide (1.413 mu g/ml). lndoxacarb was the least toxic selective insecticide on S. frugiperda (LC50 3.789 mu g/ml). Emamectin benzoate, chlorantraniliprole and methoxyfenozide were 2- to 7-fold less toxic on S. frugiperda compared with H. armigera while spinosyns were equally toxic on both species. Indoxacarb was 28-fold less toxic on S. frugiperda compared with H. armigera. There was decreased sensitivity to Group 1 insecticides and synthetic pyrethroids in S. frugiperda compared with H. armigera: toxicity was reduced up to 11-fold for methomyl, 56 to 199-fold for cyhalothrin, and 44 to 132-fold for alpha cypermethrin. Synergism bioassays with metabolic inhibitors suggest involvement of mixed function oxidase in pyrethroid resistance. Recommended diagnostic doses for emamectin benzoate, chlorantraniliprole, spinetoram, spinosad, methoxyfenozide and indoxacarb are 0.19, 1.0, 0.75, 6, 12 and 48 mu g/mu l, respectively.	[Bird, Lisa] Tamworth Agr Inst, NSW Dept Primary Ind, Calala, NSW, Australia; [Miles, Melina; Quade, Adam] Queensland Dept Agr & Fisheries, Toowoomba, Qld, Australia; [Spafford, Helen] Frank Wise Inst Trop Agr, Dept Primary Ind & Reg Dev, Kununurra, WA, Australia	NSW Department of Primary Industries	Bird, L (corresponding author), Tamworth Agr Inst, NSW Dept Primary Ind, Calala, NSW, Australia.	lisa.bird@dpi.nsw.gov.au			Australian Cotton Research and Development Corporation (CRDC) [DAN2003]	Australian Cotton Research and Development Corporation (CRDC)(Cotton R&D Corp)	This work was supported by the Australian Cotton Research and Development Corporation (CRDC) (Project DAN2003). Insect collections were made possible through investment by the Queensland Government into the Department of Agriculture and Fisheries initiative: Fall Armyworm Response 2020-21. Competing interests:	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Australian Pesticides and Veterinary Medicines Authority (APVMA), 2021, PUBL CHEM REG INF SY; Barchia I, 2001, GENST 2001 C PROGR S; Barros EM, 2010, ENTOMOL EXP APPL, V137, P237, DOI 10.1111/j.1570-7458.2010.01058.x; Bateman ML, 2018, J APPL ENTOMOL, V142, P805, DOI 10.1111/jen.12565; Belay DK, 2012, FLA ENTOMOL, V95, P476, DOI 10.1653/024.095.0232; Bielza P, 2008, PEST MANAG SCI, V64, P1131, DOI 10.1002/ps.1620; Bird L, 2018, SCI RESISTANCE MANAG; Bird LJ, 2018, B ENTOMOL RES, V108, P781, DOI 10.1017/S0007485317001316; Bird LJ, 2015, J ECON ENTOMOL, V108, P294, DOI 10.1093/jee/tou042; Boaventura D, 2021, PEST MANAG SCI, V77, P3713, DOI 10.1002/ps.6061; Boaventura D, 2020, INSECTS, V11, DOI 10.3390/insects11080545; Boaventura D, 2020, PEST MANAG SCI, V76, P47, DOI 10.1002/ps.5505; Bolzan A, 2019, PEST MANAG SCI, V75, P2682, DOI 10.1002/ps.5376; Campos SO, 2019, ECOTOX ENVIRON SAFE, V183, DOI 10.1016/j.ecoenv.2019.109577; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cutler GC, 2017, ACS SYM SER, V1249, P101; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Deshmukh S, 2020, FLA ENTOMOL, V103, P221, DOI 10.1653/024.103.0211; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Ding JF, 2018, J ECON ENTOMOL, V111, P2809, DOI 10.1093/jee/toy254; FINNEY D J, 1971, P333; FORRESTER NW, 1993, B ENTOMOL RES, pR1; Ganiger PC, 2018, CURR SCI INDIA, V115, P621, DOI 10.18520/cs/v115/i4/621-623; Gimenez S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01382-6; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Guedes RNC, 2019, J PEST SCI, V92, P1329, DOI 10.1007/s10340-019-01086-9; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Gui FR, 2022, PROTEIN CELL, V13, P513, DOI 10.1007/s13238-020-00795-7; Gutierrez-Moreno R, 2019, J ECON ENTOMOL, V112, P792, DOI 10.1093/jee/toy372; Hardke JT, 2011, FLA ENTOMOL, V94, P272, DOI 10.1653/024.094.0221; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; He FL, 2019, CHEMOSPHERE, V225, P182, DOI 10.1016/j.chemosphere.2019.03.025; Huang FN, 2021, INSECT SCI, V28, P574, DOI 10.1111/1744-7917.12826; IRAC (Insecticide Resistance Action Committee), 2021, IRAC; Ishaaya I, 2002, PEST MANAG SCI, V58, P1091, DOI 10.1002/ps.535; Jing DP, 2020, INSECT SCI, V27, P780, DOI 10.1111/1744-7917.12700; Kearns S, 2020, FALL ARMYWORM CONTIN; Lira EC, 2020, PEST MANAG SCI, V76, P2674, DOI 10.1002/ps.5812; Maino James L, 2021, Curr Res Insect Sci, V1, P100010, DOI 10.1016/j.cris.2021.100010; McComic SE, 2020, PESTIC BIOCHEM PHYS, V169, DOI 10.1016/j.pestbp.2020.104652; Mota-Sanchez D., 2021, ARTHROPOD PESTICIDE; Muthusamy R, 2014, J ASIA-PAC ENTOMOL, V17, P865, DOI 10.1016/j.aspen.2014.09.001; Nagoshi RN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58249-3; Nagoshi RN, 2014, J ECON ENTOMOL, V107, P1462, DOI 10.1603/EC14124; Nguyen DT, 2021, AUSTRAL ENTOMOL, V60, P782, DOI 10.1111/aen.12570; Okuma DM, 2018, PEST MANAG SCI, V74, P1441, DOI 10.1002/ps.4829; Oliveira RL, 2019, CHEMOSPHERE, V219, P678, DOI 10.1016/j.chemosphere.2018.12.058; Parsaeyan E, 2020, ECOTOXICOLOGY, V29, P1052, DOI 10.1007/s10646-020-02235-y; Perez-Hedo M, 2016, ADV INSECT CONTROL R; Pineda S, 2004, J ECON ENTOMOL, V97, P1906, DOI 10.1603/0022-0493-97.6.1906; PITRE HN, 1988, FLA ENTOMOL, V71, P56, DOI 10.2307/3494893; Prasanna B.M., 2018, FALL ARMYWORM AFRICA; Rabelo MM, 2020, CROP PROT, V132, DOI 10.1016/j.cropro.2020.105129; Salgado VL, 1998, PESTIC BIOCHEM PHYS, V60, P91, DOI 10.1006/pest.1998.2332; Sawicki R.M., 1987, COMBATING RESISTANCE, P105; Schneider M.I., 2003, IOBC-WPRS Bulletin, V26, P111; Schneider MI, 2003, J ECON ENTOMOL, V96, P1054, DOI 10.1603/0022-0493-96.4.1054; Shimokawatoko Y., 2012, DEV NOVEL INSECTICID; Shylesha A. N., 2018, Journal of Biological Control, V32, P145, DOI 10.18311/jbc/2018/21707; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Westbrook J, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2919; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Wing KD., 2004, COMPREHENSIVE INSECT, P31, DOI DOI 10.1016/B0-44-451924-6/00070-3; Wu Chao, 2019, Plant Diseases and Pests, V10, P10; Xiao HM, 2020, MOL ECOL RESOUR, V20, P1050, DOI 10.1111/1755-0998.13182; Yainna S, 2021, INSECTS, V12, DOI 10.3390/insects12050468; Yu SJ, 2003, PESTIC BIOCHEM PHYS, V77, P1, DOI 10.1016/S0048-3575(03)00079-8; Zhao YX, 2020, PESTIC BIOCHEM PHYS, V168, DOI 10.1016/j.pestbp.2020.104623	76	0	0	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263677	10.1371/journal.pone.0263677	http://dx.doi.org/10.1371/journal.pone.0263677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143580	Green Published, gold, Green Accepted			2022-12-26	WOS:000797657800069
J	Chen, FT; Chou, AH; Chan, YH; Wu, VCC; Lin, CP; Hung, KC; Chu, PH; Cheng, YT; Chen, SW				Chen, Fang-Ting; Chou, An-Hsun; Chan, Yi-Hsin; Wu, Victor Chien-Chia; Lin, Chia-Pin; Hung, Kuo-Chun; Chu, Pao-Hsien; Cheng, Yu-Ting; Chen, Shao-Wei			Sex-related differences on the risks of in-hospital and late outcomes after acute aortic dissection: A nationwide population-based cohort study	PLOS ONE			English	Article							INTERNATIONAL REGISTRY; GENDER-DIFFERENCES; ASSOCIATION; INSIGHTS; SURGERY; HISTORY	Objective The aim of this study is to evaluate the sex-related differences on the risks of perioperative and late outcomes for adult acute aortic dissection (AAD) patients following surgical management. Methods and results By using Taiwan National Health Insurance Research Database, totally 1,410 female and 3,432 male patients were identified to first-ever receive type A AAD open surgery or type B AAD stenting treatment from 2004 to 2013. We assessed the sex-related difference on outcomes, including in-hospital mortality, all-cause mortality, aortic death, redo aortic surgery, ischemic stroke, and depression during the follow-up period. The analysis was done separately for type A and type B surgeries. Results On average, female patients diagnosed with AAD were older than males. There was no significant sex difference of in-hospital mortality or all-cause mortality for both type A open and type B stent surgeries. The risk of redo aortic surgery was significantly greater in males than females (7.8% vs. 4%; unadjusted subdistribution hazard ratio [SHR] 0.51, 95% CI 0.38-0.69) for type A open surgery, but not for type B stent surgery. Noticeably, the risk of newly-diagnosed depression was significantly greater in females than males (8% vs. 5.1%; unadjusted SHR 1.6, 95% CI 1.24-2.06) for type A open surgery, but not for type B stent surgery. Conclusions No significant sex-related difference was found for the in-hospital mortality or accumulative all-cause mortality. However, there were more redo aortic surgeries for males and more postoperative depression for females in type A AAD population.	[Chen, Fang-Ting; Chou, An-Hsun] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Anesthesiol, Taoyuan, Taiwan; [Chou, An-Hsun] Chang Gung Univ, Dept Med, Taipei, Taiwan; [Chou, An-Hsun] Xiamen Chang Gung Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Chan, Yi-Hsin; Wu, Victor Chien-Chia; Lin, Chia-Pin; Hung, Kuo-Chun; Chu, Pao-Hsien] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiol, Taoyuan, Taiwan; [Cheng, Yu-Ting; Chen, Shao-Wei] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Div Thorac & Cardiovasc Surg,Dept Surg, Taoyuan, Taiwan; [Chen, Shao-Wei] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, SW (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Div Thorac & Cardiovasc Surg,Dept Surg, Taoyuan, Taiwan.; Chen, SW (corresponding author), Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan.	josephchen0314@gmail.com	Wu, Victor Chien-Chia/GXF-4623-2022	Wu, Victor Chien-Chia/0000-0002-9918-4369; LIN, CHIA-PIN/0000-0001-7959-7804	Chang Gung Memorial Hospital, Taiwan [CMRPG3L0101]; Ministry of Science and Technology [Most MOST-110-2314-B182A-114]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a grant from Chang Gung Memorial Hospital, Taiwan CMRPG3L0101 (SWC) and the Ministry of Science and Technology grant Most MOST-110-2314-B182A-114 (SWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, HEALTH REP, V19, P7; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Chemtob Raphaelle A, 2019, Aorta (Stamford), V7, P7, DOI 10.1055/s-0039-1687900; Chen CC, 2018, ANN THORAC SURG, V106, P85, DOI 10.1016/j.athoracsur.2018.01.067; Chen SW, 2020, J AM COLL CARDIOL, V76, P1181, DOI 10.1016/j.jacc.2020.07.028; Chen SW, 2018, CIRC J, V82, P2041, DOI 10.1253/circj.CJ-18-0003; Chou AH, 2019, J VASC SURG, V69, P1395, DOI 10.1016/j.jvs.2018.06.225; Chung J, 2019, CIRCULATION, V139, P1177, DOI 10.1161/CIRCULATIONAHA.118.035805; Evangelista A, 2018, CIRCULATION, V137, P1846, DOI 10.1161/CIRCULATIONAHA.117.031264; Fattori R, 2008, JACC-CARDIOVASC INTE, V1, P395, DOI 10.1016/j.jcin.2008.04.009; Friedrich C, 2020, J CARDIOTHORAC SURG, V15, DOI 10.1186/s13019-020-01189-w; Fukui T, 2015, J THORAC CARDIOV SUR, V150, P581, DOI 10.1016/j.jtcvs.2015.06.031; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Grubb KJ, 2011, SEMIN THORAC CARDIOV, V23, P124, DOI 10.1053/j.semtcvs.2011.08.009; Hsu ME, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017147; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Landenhed M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001513; Lee HA, 2018, J THORAC CARDIOV SUR, V156, P1473, DOI 10.1016/j.jtcvs.2018.04.064; Liang NL, 2017, ANN VASC SURG, V38, P78, DOI 10.1016/j.avsg.2016.06.006; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Rylski B, 2021, J THORAC CARDIOV SUR, V162, P528, DOI 10.1016/j.jtcvs.2019.11.039; Serpytis P, 2018, ARQ BRAS CARDIOL, V111, P676, DOI 10.5935/abc.20180161; Smedberg C, 2020, EUR HEART J, V41, P2430, DOI 10.1093/eurheartj/ehaa446; Suzuki T, 2018, INTERACT CARDIOV TH, V26, P944, DOI 10.1093/icvts/ivy005; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Tsai TT, 2007, CIRCULATION, V116, pI150, DOI 10.1161/CIRCULATIONAHA.106.681510; Vaccarino V, 2017, NEUROSCI BIOBEHAV R, V74, P297, DOI 10.1016/j.neubiorev.2016.04.023; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	29	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263717	10.1371/journal.pone.0263717	http://dx.doi.org/10.1371/journal.pone.0263717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143568	gold, Green Published			2022-12-26	WOS:000797657800072
J	Srikantha, N; Teijeiro-Gonzalez, Y; Simpson, A; Elsaid, N; Somavarapu, S; Suhling, K; Jackson, TL				Srikantha, Nishanthan; Teijeiro-Gonzalez, Yurema; Simpson, Andrew; Elsaid, Naba; Somavarapu, Satyanarayana; Suhling, Klaus; Jackson, Timothy L.			Determining vitreous viscosity using fluorescence recovery after photobleaching	PLOS ONE			English	Article							INTRAVITREAL TRIAMCINOLONE ACETONIDE; MACULAR DEGENERATION; BEVACIZUMAB; VISCOELASTICITY; RANIBIZUMAB; RHEOLOGY; DELIVERY; MOBILITY; SHAPE; BODY	Purpose Vitreous humor is a complex biofluid whose composition determines its structure and function. Vitreous viscosity will affect the delivery, distribution, and half-life of intraocular drugs, and key physiological molecules. The central pig vitreous is thought to closely match human vitreous viscosity. Diffusion is inversely related to viscosity, and diffusion is of fundamental importance for all biochemical reactions. Fluorescence Recovery After Photobleaching (FRAP) may provide a novel means of measuring intravitreal diffusion that could be applied to drugs and physiological macromolecules. It would also provide information about vitreous viscosity, which is relevant to drug elimination, and delivery. Methods Vitreous viscosity and intravitreal macromolecular diffusion of fluorescently labelled macromolecules were investigated in porcine eyes using fluorescence recovery after photobleaching (FRAP). Fluorescein isothiocyanate conjugated (FITC) dextrans and ficolls of varying molecular weights (MWs), and FITC-bovine serum albumin (BSA) were employed using FRAP bleach areas of different diameters. Results The mean (+/- standard deviation) viscosity of porcine vitreous using dextran, ficoll and BSA were 3.54 +/- 1.40, 2.86 +/- 1.13 and 4.54 +/- 0.13 cP respectively, with an average of 3.65 +/- 0.60 cP. Conclusions FRAP is a feasible and practical optical method to quantify the diffusion of macromolecules through vitreous.	[Srikantha, Nishanthan; Simpson, Andrew; Jackson, Timothy L.] Kings Coll London, Sch Med, London, England; [Srikantha, Nishanthan; Simpson, Andrew; Jackson, Timothy L.] Kings Coll Hosp London, Dept Ophthalmol, London, England; [Teijeiro-Gonzalez, Yurema; Suhling, Klaus] Kings Coll London, Dept Phys, London, England; [Elsaid, Naba] Anglia Ruskin Univ, Bishop Hall Lane, Chelmsford, Essex, England; [Somavarapu, Satyanarayana] UCL, Dept Pharmaceut, Sch Pharm, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Anglia Ruskin University; University of London; University College London; University of London School of Pharmacy	Srikantha, N (corresponding author), Kings Coll London, Sch Med, London, England.; Srikantha, N (corresponding author), Kings Coll Hosp London, Dept Ophthalmol, London, England.	nish.srikantha@nhs.net		Jackson, Timothy/0000-0001-7618-1555; suhling, klaus/0000-0001-8797-5430	Fight for Sight [1874]; BBSRC [BB/R004803/1]	Fight for Sight; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by Fight for Sight Grant Number 1874 and BBSRC Grant Number BB/R004803/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. N. Srikantha is a Fight for Sight Research Fellow. K. Suhling acknowledges BBSRC grant BB/R004803/1.	Ambati J, 2002, PROG RETIN EYE RES, V21, P145, DOI 10.1016/S1350-9462(01)00018-0; AXELROD D, 1976, BIOPHYS J, V16, pA217; Balazs EA., 1982, AGING CHANGES VITRE, pP45; BETTELHEIM FA, 1976, EXP EYE RES, V23, P435, DOI 10.1016/0014-4835(76)90172-X; Black J, 1988, HDB BIOMATERIAL PROP; Burchard W, 1999, ADV POLYM SCI, V143, P113; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Chin HS, 2005, RETINA-J RET VIT DIS, V25, P556, DOI 10.1097/00006982-200507000-00002; Connelly K, 2016, BIORHEOLOGY, V53, P221, DOI 10.3233/BIR-16112; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Filas BA, 2014, INVEST OPHTH VIS SCI, V55, P55, DOI 10.1167/iovs.13-13026; Fissell WH, 2010, AM J PHYSIOL-RENAL, V298, pF205, DOI 10.1152/ajprenal.00312.2009; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Gisladottir S, 2009, GRAEF ARCH CLIN EXP, V247, P1677, DOI 10.1007/s00417-009-1141-3; Hirvonen LM, 2016, PHARM RES-DORDR, V33, P2025, DOI 10.1007/s11095-016-1940-2; Huang D, 2018, EUR J PHARM SCI, V118, P124, DOI 10.1016/j.ejps.2018.03.023; Kakinoki M, 2012, INVEST OPHTH VIS SCI, V53, P5877, DOI 10.1167/iovs.12-10164; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Kim H, 2009, PHARM RES-DORDR, V26, P329, DOI 10.1007/s11095-008-9745-6; Kleinberg TT, 2011, SURV OPHTHALMOL, V56, P300, DOI 10.1016/j.survophthal.2010.09.001; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003; LAVRENKO PN, 1986, VYSOKOMOL SOEDIN A+, V28, P517; LEE B, 1992, BIORHEOLOGY, V29, P521; LEE B, 1994, BIORHEOLOGY, V31, P327; Lee SS, 2010, INVEST OPHTH VIS SCI, V51, P2135, DOI 10.1167/iovs.09-3582; Li SK, 2011, J PHARMACEUT BIOMED, V55, P603, DOI 10.1016/j.jpba.2010.12.027; Los LI, 2003, INVEST OPHTH VIS SCI, V44, P2828, DOI 10.1167/iovs.02-0588; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Missel PJ, 2010, PHARM RES-DORDR, V27, P1530, DOI 10.1007/s11095-010-0163-1; Nickerson CS, 2008, J BIOMECH, V41, P1840, DOI 10.1016/j.jbiomech.2008.04.015; NORDMEIER E, 1993, J PHYS CHEM-US, V97, P5770, DOI 10.1021/j100123a050; Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165; Piccirelli M, 2012, NMR BIOMED, V25, P59, DOI 10.1002/nbm.1713; Pokki J, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9988-z; Pucadyil TJ, 2006, J FLUORESC, V16, P87, DOI 10.1007/s10895-005-0019-y; Ramasamy P, 2007, LANGMUIR, V23, P2021, DOI 10.1021/la062365o; Rangchian A, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043358; Rossi T, 2012, EXP EYE RES, V99, P98, DOI 10.1016/j.exer.2012.03.014; Ruponen M, 1999, BBA-BIOMEMBRANES, V1415, P331, DOI 10.1016/S0005-2736(98)00199-0; Schulz A, 2021, CURR OPIN OPHTHALMOL, V32, P288, DOI 10.1097/ICU.0000000000000745; Sharif-Kashani P, 2011, J BIOMECH, V44, P419, DOI 10.1016/j.jbiomech.2010.10.002; Silva AF, 2017, RHEOL ACTA, V56, P377, DOI 10.1007/s00397-017-0997-0; Soman N, 2003, BIO-MED MATER ENG, V13, P59; Srikantha N, 2012, EXP EYE RES, V102, P85, DOI 10.1016/j.exer.2012.07.007; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Stefansson E, 2006, ACTA OPHTHALMOL SCAN, V84, P718, DOI 10.1111/j.1600-0420.2006.00778.x; Stein S, 2018, EUR J PHARM BIOPHARM, V131, P82, DOI 10.1016/j.ejpb.2018.07.021; Stewart MW, 2012, RETINA-J RET VIT DIS, V32, P434, DOI 10.1097/IAE.0B013E31822C290F; Swindle KE, 2007, EXPERT REV OPHTHALMO, V2, P255, DOI 10.1586/17469899.2.2.255; Thakur SS, 2020, EXP EYE RES, V194, DOI 10.1016/j.exer.2020.108006; Tram NK, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00199; Tuteja A, 2007, NANO LETT, V7, P1276, DOI 10.1021/nl070192x; Walton KA, 2002, EXP EYE RES, V74, P173, DOI 10.1006/exer.2001.1136; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Wen H, 2013, J PHARM SCI-US, V102, P892, DOI 10.1002/jps.23387; WU C, 1993, MACROMOLECULES, V26, P3821, DOI 10.1021/ma00067a016; ZIMMERMAN RL, 1980, BIOPHYS J, V29, P539, DOI 10.1016/S0006-3495(80)85152-6	61	1	1	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0261925	10.1371/journal.pone.0261925	http://dx.doi.org/10.1371/journal.pone.0261925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143514	Green Published, gold			2022-12-26	WOS:000797657800011
J	Zamani, M; Poustchi, H; Shayanrad, A; Pourfarzi, F; Farjam, M; Noemani, K; Ghaderi, E; Mohammadkarimi, V; Kahnooji, M; Mansour-Ghanaei, F; Rastegar, A; Mousavizadeh, A; Rafati, S; Johari, MG; Moosazadeh, M; Salehifardjouneghani, A; Ostadrahimi, A; Mohebbi, I; Khorram, A; Ardakani, FE; Sharafkhah, M; Pasdar, Y; Sadeghi, A; Malekzadeh, R				Zamani, Mohammad; Poustchi, Hossein; Shayanrad, Amaneh; Pourfarzi, Farhad; Farjam, Mojtaba; Noemani, Kourosh; Ghaderi, Ebrahim; Mohammadkarimi, Vahid; Kahnooji, Mahmood; Mansour-Ghanaei, Fariborz; Rastegar, Ayoob; Mousavizadeh, Ali; Rafati, Shideh; Johari, Masoumeh Ghoddusi; Moosazadeh, Mahmood; Salehifardjouneghani, Alizamen; Ostadrahimi, Alireza; Mohebbi, Iraj; Khorram, Alireza; Ardakani, Fatemeh Ezzodini; Sharafkhah, Maryam; Pasdar, Yahya; Sadeghi, Anahita; Malekzadeh, Reza			Prevalence and determinants of anemia among Iranian population aged >= 35 years: A PERSIAN cohort-based cross-sectional study	PLOS ONE			English	Article							IRON-DEFICIENCY; BURDEN; PATHOPHYSIOLOGY; MANAGEMENT	Background So far, no comprehensive studies have been performed to assess burden and determinants of anemia in Iran. In the present study, we aimed to answer this query using the data obtained from the Prospective Epidemiological Research Studies in IrAN (PERSIAN). Methods In this cross-sectional study, we included 161,686 adult participants (aged 35 years and older) from 16 provinces of Iran. Anemia was defined as a hemoglobin concentration of <13 g/dL in males and <12 g/dL in females. To evaluate the association between anemia and different factors, we used the multivariable Poisson regression analysis with robust variance by applying adjusted prevalence ratio (PR) with 95% confidence interval (CI). Results Of the total number of subjects, 72,387 (44.77%) were male and others were female. Mean age was 49.39 +/- 9.15 years old. The overall age- and sex-standardized prevalence of anemia was 8.83% (95% CI: 8.70-8.96%) in the included population. The highest and the lowest age- and sex-standardized prevalence of anemia pertained to Hormozgan (37.41%, 95% CI: 35.97-38.85%) and Kurdistan (4.57%, 95% CI: 3.87-5.27%) provinces, respectively. Being female (PR = 2.97), rural residence (PR = 1.24), being retired (PR = 1.53) and housewife (PR = 1.11), third and fourth wealth status quartiles (PR = 1.09 and PR = 1.11, respectively), being underweight (PR = 1.49), drug user (PR = 1.35), inadequate sleep (PR = 1.16), poor physical activity (PR = 1.15), diabetes (PR = 1.09), renal failure (PR = 2.24), and cancer (PR = 1.35) were associated with increased risk of anemia. On the other hand, illiteracy (PR = 0.79) and abdominal obesity (PR = 0.77) decreased the risk of anemia. Conclusions According to the results, a variable prevalence of anemia was observed across the included provinces. We tried to provide an informative report on anemia prevalence for health professionals and authorities to take measures for identification and management of the cases of anemia in high-prevalence areas.	[Zamani, Mohammad] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Dis Res Ctr, Tehran, Iran; [Poustchi, Hossein; Shayanrad, Amaneh; Sharafkhah, Maryam] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran; [Pourfarzi, Farhad] Ardabil Univ Med Sci, Digest Dis Res Ctr, Ardebil, Iran; [Farjam, Mojtaba] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Noemani, Kourosh] Ahvaz Jundishapur Univ Med Sci, Dept Dis Prevent & Control, Deputy Hlth Ctr, Ahvaz, Iran; [Ghaderi, Ebrahim] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Social Determinants Hlth Res Ctr, Sanandaj, Iran; [Mohammadkarimi, Vahid] Shiraz Univ Med Sci, Sch Med, Dept Internal Med, Shiraz, Iran; [Kahnooji, Mahmood] Rafsanjan Univ Med Sci, Fac Med, Dept Internal Med, Rafsanjan, Iran; [Mansour-Ghanaei, Fariborz] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran; [Rastegar, Ayoob] Sabzevar Univ Med Sci, Noncommunicable Dis Res Ctr, Sabzevar, Iran; [Mousavizadeh, Ali] Yasuj Univ Med Sci, Social Determinants Hlth Res Ctr, Yasuj, Iran; [Rafati, Shideh] Hormozgan Univ Med Sci, Fac Hlth, Social Determinants Hlth Promot Res Ctr, Bandar Abbas, Iran; [Johari, Masoumeh Ghoddusi] Shiraz Univ Med Sci, Breast Dis Res Ctr, Shiraz, Iran; [Moosazadeh, Mahmood] Mazandaran Univ Med Sci, Noncommunicable Dis Inst, Gastrointestinal Canc Res Ctr, Sari, Iran; [Salehifardjouneghani, Alizamen] Shahrekord Univ Med Sci, Modeling Hlth Res Ctr, Shahrekord, Iran; [Salehifardjouneghani, Alizamen] Shahrekord Univ Med Sci, Coll Med, Dept Pediat, Shahrekord, Iran; [Ostadrahimi, Alireza] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran; [Mohebbi, Iraj] Urmia Univ Med Sci, Social Determinants Hlth Res Ctr, Orumiyeh, Iran; [Khorram, Alireza] Zahedan Univ Med Sci, Hlth Promot Res Ctr, Zahedan, Iran; [Ardakani, Fatemeh Ezzodini] Shahid Sadoughi Univ Med Sci, Fac Dent, Dept Oral & Maxillofacial Radiol, Yazd, Iran; [Pasdar, Yahya] Kermanshah Univ Med Sci, Hlth Inst, Res Ctr Environm Determinants Hlth RCEDH, Kermanshah, Iran; [Sadeghi, Anahita] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ardabil University of Medical Sciences; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Kurdistan University of Medical Sciences; Shiraz University of Medical Science; Yasouj University; Shiraz University of Medical Science; Mazandaran University Medical Sciences; Shahrekord University Medical Sciences; Shahrekord University Medical Sciences; Tabriz University of Medical Science; Urmia University of Medical Sciences; Zahedan University of Medical Sciences; Kermanshah University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran.	dr.reza.malekzadeh@gmail.com	Rafati, Shideh/ABB-3051-2020; moosazadeh, mahmood/F-3730-2017; Khorram, Alireza/GQH-2716-2022; Mansour-Ghanaei, Fariborz/ABC-0170-2022	Rafati, Shideh/0000-0003-3461-0555; moosazadeh, mahmood/0000-0002-5452-514X; Khorram, Alireza/0000-0002-5790-7768; Mansour-Ghanaei, Fariborz/0000-0001-6747-0232; ghoddusi johari, masoumeh/0000-0003-3486-7182; Zamani, Mohammad/0000-0003-1916-3873				Adamu AL, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0128-2; [Anonymous], 2007, IR ISL REP DAT AN IN; Ausk KJ, 2008, OBESITY, V16, P2356, DOI 10.1038/oby.2008.353; Aydogan G, 2019, J PEDIAT HEMATOL ONC, V41, pE221, DOI 10.1097/MPH.0000000000001382; Baker WF, 2000, HEMATOL ONCOL CLIN N, V14, P1061, DOI 10.1016/S0889-8588(05)70171-4; Bang SM, 2013, ANN HEMATOL, V92, P59, DOI 10.1007/s00277-012-1563-6; Barbieri J, 2015, ANEMIA, V2015, DOI 10.1155/2015/354737; Bloxham E, 2011, POSTGRAD MED J, V87, P596, DOI 10.1136/pgmj.2011.117507; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Chaput JP, 2018, NAT SCI SLEEP, V10, P421, DOI 10.2147/NSS.S163071; Collins A, 2020, ETHIOP J HEALTH SCI, V30, P661, DOI 10.4314/ejhs.v30i5.4; Dehshal MH, 2019, HEMOGLOBIN, V43, P166, DOI 10.1080/03630269.2019.1628774; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P2664, DOI 10.1093/ndt/gfs265; Eftekharzadeh-Mashhadi Iman, 2015, Acta Med Iran, V53, P186; ESCHBACH JW, 1989, KIDNEY INT, V35, P134, DOI 10.1038/ki.1989.18; Goodnough LT, 2014, AM J HEMATOL, V89, P88, DOI 10.1002/ajh.23598; Hu M, 2012, ACTA HAEMATOL-BASEL, V127, P156, DOI 10.1159/000335620; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kibret KT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027276; Leifert JA, 2008, INT J LAB HEMATOL, V30, P177, DOI 10.1111/j.1751-553X.2008.01067.x; Liu XX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22407-5; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Martinsson A, 2014, EUR J EPIDEMIOL, V29, P489, DOI 10.1007/s10654-014-9929-9; Miri Maedehsadat., 2013, IRANIAN J BLOOD CANC, V6, P11; Newman K, 2013, AUTOIMMUN REV, V12, P784, DOI 10.1016/j.autrev.2013.02.001; Pouraram H, 2018, ARCH IRAN MED, V21, P137; Poustchi H, 2018, AM J EPIDEMIOL, V187, P647, DOI 10.1093/aje/kwx314; Smits J, 2015, SOC INDIC RES, V122, P65, DOI 10.1007/s11205-014-0683-x; Ugwuja EI, 2015, J CLIN DIAGN RES, V9, pLC4, DOI 10.7860/JCDR/2015/9811.5485; Wakabayashi I, 2019, ACTA HAEMATOL-BASEL, V142, P154, DOI 10.1159/000499102; WHO, 2011, WHO TECH REP SER, V959, P1; Worku MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241342; Wu SQ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-100	37	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263795	10.1371/journal.pone.0263795	http://dx.doi.org/10.1371/journal.pone.0263795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139138	gold, Green Published			2022-12-26	WOS:000821499100054
J	Woodland, L; Mowbray, F; Smith, LE; Webster, RK; Amlot, R; Rubin, GJ				Woodland, Lisa; Mowbray, Fiona; Smith, Louise E.; Webster, Rebecca K.; Amlot, Richard; Rubin, G. James			What influences whether parents recognise COVID-19 symptoms, request a test and self-isolate: A qualitative study	PLOS ONE			English	Article								Background Using test, trace and isolate systems can help reduce the spread of COVID-19. Parents have the additional responsibility of using these systems for themselves and acting on behalf of their children to help control COVID-19. We explored factors associated with the use of England's NHS Test and Trace service among parents of school-aged children. Methods One-to-one telephone interviews with parents (n = 18) of school-aged (4 to 18 years) children living in England between 30 November to 11 December 2020. Data were explored using thematic analysis. Results Three themes and eight sub-themes emerged. In terms of recognising symptoms of COVID-19, parents needed prompting before recalling the main symptoms described by the NHS. Parents suggested several factors relating to the nature of the symptom(s) and contextual information that might lead to or prevent them from seeking a test. Although parents supported symptomatic testing and described trusting official sources of information (e.g., Government and NHS websites). However, some concerns were raised regarding the accuracy of test results, safety at testing centres and logistics of testing but none of the concerns appeared to prevent engagement with testing. Parents perceived adherence to testing and self-isolation as pro-social behaviour, although family resources and circumstances impacted their ability to adhere fully. Conclusions Our study identified several barriers to parents using NHS Test and Trace as needed. Information about the eligibility of testing (main symptoms of COVID-19 and the age of eligibility) needs to be more precise and resources provided to enable families to adhere to self-isolation if the efficiency of test, trace and isolate systems is to be optimised.	[Woodland, Lisa; Mowbray, Fiona; Smith, Louise E.; Rubin, G. James] Kings Coll London, Dept Psychol Med, London, England; [Woodland, Lisa; Mowbray, Fiona; Smith, Louise E.; Amlot, Richard; Rubin, G. James] NIHR Hlth Protect Res Unit Emergency Preparedness, London, England; [Webster, Rebecca K.] Univ Sheffield, Dept Psychol, Sheffield, S Yorkshire, England; [Amlot, Richard] UK Hlth Secur Agcy, Behav Sci & Insights Unit, Salisbury, Wilts, England	University of London; King's College London; University of Sheffield	Woodland, L (corresponding author), Kings Coll London, Dept Psychol Med, London, England.; Woodland, L (corresponding author), NIHR Hlth Protect Res Unit Emergency Preparedness, London, England.	lisa.woodland@kcl.ac.uk		, Lisa/0000-0003-2440-3210; Smith, Louise/0000-0002-1277-2564	Economic and Social Research Council [ES/P000703/1]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response [NIHR200890]; UK Health Security Agency, King's College London; University of East Anglia	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response; UK Health Security Agency, King's College London; University of East Anglia	This study was funded by the Economic and Social Research Council [grant number ES/P000703/1] and the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) [grant number NIHR200890] in Emergency Preparedness and Response, a partnership between UK Health Security Agency, King's College London and the University of East Anglia. The views expressed are those of the authors and not necessarily those of the NIHR, Public Health England or the Department of Health and Social Care.	Adam B., 2020, NHS TEST TRACE JOURN; Aiano F, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100120; Angelfish Fieldwork, US; [Anonymous], 2021, NHS TEST TRACE MEETS; Bergen N, 2020, QUAL HEALTH RES, V30, P783, DOI 10.1177/1049732319889354; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Crozier A, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1625; Earnshaw VA, 2020, STIGMA HEALTH, V5, P390, DOI 10.1037/sah0000255; Fugard AJB, 2015, INT J SOC RES METHOD, V18, P669, DOI 10.1080/13645579.2015.1005453; Gov.UK,, 2021, COVID 19 RESP AUT WI; Government of Canada, 2021, COVID 19 DAIL EP UPD; HM Government, 2021, NHS TEST TRAC WHAT Y; Hodson A, 2021, PUBLIC HEALTH, V194, P29, DOI 10.1016/j.puhe.2021.02.013; Masonbrink AR, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1440; Mowbray F, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.716421; Neville FG, 2021, SOC PERSONAL PSYCHOL, V15, DOI 10.1111/spc3.12596; QSR International, 1999, NVIVO QUAL DAT AN SO; Roxby P, 2021, BBC NEWS 1014; Shevlin M, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.109; Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608; Smith LE, 2020, BMJ PAEDIATR OPEN, V4, DOI 10.1136/bmjpo-2020-000825; Smith LE, 2020, PSYCHOSOM MED, V82, P187, DOI 10.1097/PSY.0000000000000767; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Woodland L, 2021, BMJ PAEDIATR OPEN, V5, DOI 10.1136/bmjpo-2020-001014	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263537	10.1371/journal.pone.0263537	http://dx.doi.org/10.1371/journal.pone.0263537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196349	gold, Green Accepted, Green Published			2022-12-26	WOS:000835161600014
J	Ozkaya, AB; Geyik, C				Ozkaya, Ali Burak; Geyik, Caner			From viability to cell death: Claims with insufficient evidence in high-impact cell culture studies	PLOS ONE			English	Article							REPRODUCIBILITY	Background Reliability of preclinical research is of critical concern. Prior studies have demonstrated the low reproducibility of research results and recommend implementing higher standards to improve overall quality and robustness of research. One understudied aspect of this quality issue is the harmony between the research hypotheses and the experimental design in published work. Methods and findings In this study we focused on highly cited cell culture studies and investigated whether commonly asserted cell culture claims such as viability, cytotoxicity, proliferation rate, cell death and apoptosis are backed with sufficient experimental evidence or not. We created an open access database containing 280 claims asserted by 103 different high-impact articles as well as the results of this study. Our findings revealed that only 64% of all claims were sufficiently supported by evidence and there were concerning misinterpretations such as considering the results of tetrazolium salt reduction assays as indicators of cell death or apoptosis. Conclusions Our analysis revealed a discordance between experimental findings and the way they were presented and discussed in the manuscripts. To improve quality of pre-clinical research, we require clear nomenclature by which different cell culture claims are distinctively categorized; materials and methods sections to be written more meticulously; and cell culture methods to be selected and utilized more carefully. In this paper we recommend a nomenclature for selected cell culture claims as well as a methodology for collecting evidence to support those claims.	[Ozkaya, Ali Burak] Izmir Univ Econ, Fac Med, Dept Med Biochem, Izmir, Turkey; [Geyik, Caner] Istinye Univ, Fac Med, Dept Med Biochem, Istanbul, Turkey; [Geyik, Caner] Istinye Univ, ISUMKAM Mol Canc Res Ctr, Istanbul, Turkey	Izmir Ekonomi Universitesi; Istinye University; Istinye University	Ozkaya, AB (corresponding author), Izmir Univ Econ, Fac Med, Dept Med Biochem, Izmir, Turkey.	ali.ozkaya@ieu.edu.tr	Geyik, Caner/I-8384-2014	Geyik, Caner/0000-0002-8382-2186				Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Holman L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002190; Hsieh JH, 2016, METHODS MOL BIOL, V1473, P143, DOI 10.1007/978-1-4939-6346-1_15; Huang P, 2017, J AM CHEM SOC, V139, P1275, DOI 10.1021/jacs.6b11846; Ioannidis JPA, 2018, NAT BIOMED ENG, V2, P797, DOI 10.1038/s41551-018-0314-y; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jost APT, 2019, J CELL BIOL, V218, P1452, DOI 10.1083/jcb.201812109; Miller I, 2018, CELL REP, V24, P1105, DOI 10.1016/j.celrep.2018.06.110; O'Donoghue SI, 2018, ANNU REV BIOMED DA S, V1, P275, DOI 10.1146/annurev-biodatasci-080917-013424; OECD, 2018, GUID DOC GOOD IN VIT; Peers IS, 2012, NAT REV DRUG DISCOV, V11, P733, DOI 10.1038/nrd3849; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Riss TL, 2004, ASSAY GUIDANCE MANUA; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Takebe T, 2018, CTS-CLIN TRANSL SCI, V11, P597, DOI 10.1111/cts.12577; VISTICA DT, 1991, CANCER RES, V51, P2515; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416	21	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0250754	10.1371/journal.pone.0250754	http://dx.doi.org/10.1371/journal.pone.0250754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192623	Green Published, gold			2022-12-26	WOS:000812552500002
J	McKay, DR; Nguyen, P; Wang, A; Hanna, TP				McKay, Douglas R.; Nguyen, Paul; Wang, Ami; Hanna, Timothy P.			A population-based study of administrative data linkage to measure melanoma surgical and pathology quality	PLOS ONE			English	Article							SENTINEL-NODE BIOPSY; EARLY-STAGE MELANOMA; CUTANEOUS MELANOMA; MSLT-I; LYMPHADENECTOMY; STANDARDIZATION; VALIDATION; IPILIMUMAB; ASSURANCE; ACCURACY	Background Continuous quality improvement is important for cancer systems. However, collecting and compiling quality indicator data can be time-consuming and resource-intensive. Here we explore the utility and feasibility of linked routinely collected health data to capture key elements of quality of care for melanoma in a single-payer, universal health care setting. Method This pilot study utilized a retrospective population-based cohort from a previously developed linked administrative data set, with a 65% random sample of all invasive cutaneous melanoma cases diagnosed 2007-2012 in the province of Ontario. Data from the Ontario Cancer Registry was utilized, supplemented with linked pathology report data from Cancer Care Ontario, and other linked administrative data describing health care utilization. Quality indicators identified through provincial guidelines and international consensus were evaluated for potential collection with administrative data and measured where possible. Results A total of 7,654 cases of melanoma were evaluated. Ten of 25 (40%) candidate quality indicators were feasible to be collected with the available administrative data. Many indicators (8/25) could not be measured due to unavailable clinical information (e.g. width of clinical margins). Insufficient pathology information (6/25) or health structure information (1/25) were less common reasons. Reporting of recommended variables in pathology reports varied from 65.2% (satellitosis) to 99.6% (body location). For stage IB-II or T1b-T4a melanoma patients where SLNB should be discussed, approximately two-thirds met with a surgeon experienced in SLNB. Of patients undergoing full lymph node dissection, 76.2% had adequate evaluation of the basin. Conclusions We found that use of linked administrative data sources is feasible for measurement of melanoma quality in some cases. In those cases, findings suggest opportunities for quality improvement. Consultation with surgeons offering SLNB was limited, and pathology report completeness was sub-optimal, but was prior to routine synoptic reporting. However, to measure more quality indicators, text-based data sources will require alternative approaches to manual collection such as natural language processing or standardized collection. We recommend development of robust data platforms to support continuous re-evaluation of melanoma quality indicators, with the goal of optimizing quality of care for melanoma patients on an ongoing basis.	[McKay, Douglas R.] Queens Univ, Div Plast Surg, Dept Surg, Kingston, ON, Canada; [Nguyen, Paul; Hanna, Timothy P.] Queens Univ, ICES, Kingston, ON, Canada; [Wang, Ami] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Hanna, Timothy P.] Queens Univ, Dept Oncol, Kingston, ON, Canada; [Hanna, Timothy P.] Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada	Hanna, TP (corresponding author), Queens Univ, ICES, Kingston, ON, Canada.; Hanna, TP (corresponding author), Queens Univ, Dept Oncol, Kingston, ON, Canada.; Hanna, TP (corresponding author), Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON, Canada.	tim.hanna@kingstonhsc.ca		Hanna, Timothy/0000-0003-3228-6042	Kingston Health Sciences Centre Foundation [70174]; Ontario Ministry of Health and Long-Term Care (MOHLTC); Government of Ontario [IA-035]	Kingston Health Sciences Centre Foundation; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Government of Ontario	This study was supported by Kingston Health Sciences Centre Foundation (Fund 70174). Awarded to DM, TH, AW (www.uhkf.ca).The sponsor played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. T.P.H. holds a research chair provided by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario (#IA-035).	Alawad M, 2020, J AM MED INFORM ASSN, V27, P89, DOI 10.1093/jamia/ocz153; Bilimoria KY, 2009, J CLIN ONCOL, V27, P5445, DOI 10.1200/JCO.2008.20.9965; Brundage M, 2013, RADIOTHER ONCOL, V107, P339, DOI 10.1016/j.radonc.2013.04.023; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Durham AB, 2014, FUTURE ONCOL, V10, P1121, DOI 10.2217/fon.14.67; Eggermont AMM, 2019, EUR J CANCER, V119, P1, DOI 10.1016/j.ejca.2019.07.001; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Hong NJL, 2018, J SURG ONCOL, V117, P597, DOI 10.1002/jso.24936; Karim RZ, 2008, HISTOPATHOLOGY, V52, P130, DOI 10.1111/j.1365-2559.2007.02921.x; Kielhorn BA, 2019, AM J SURG, V217, P527, DOI 10.1016/j.amjsurg.2018.10.025; Kralj B, 2009, MEASURING RURALITYRI; Leiter U, 2019, J CLIN ONCOL, V37, P3000, DOI 10.1200/JCO.18.02306; Leong Stanley P L, 2004, Curr Treat Options Oncol, V5, P185, DOI 10.1007/s11864-004-0010-x; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Mavor Meaghan E, 2018, CMAJ Open, V6, pE502, DOI 10.9778/cmajo.20180089; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton DL, 1999, ANN SURG, V230, P453, DOI 10.1097/00000658-199910000-00001; Morton DL, 2012, CLIN EXP METASTAS, V29, P699, DOI 10.1007/s10585-012-9503-3; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nennecke A, 2014, CANCER EPIDEMIOL, V38, P259, DOI 10.1016/j.canep.2014.02.011; Parvez E., 2020, J CLIN ONC, V38, pe22076; Pasquali S, 2017, EJSO-EUR J SURG ONC, V43, P561, DOI 10.1016/j.ejso.2016.06.397; Reintgen DS, 2004, ANN SURG ONCOL, V11, p186S, DOI 10.1245/ASO.2004.12.935; Renshaw AA, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00088; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Rossi CR, 2014, JAMA SURG, V149, P700, DOI 10.1001/jamasurg.2013.5676; Sommariva A, 2015, EJSO-EUR J SURG ONC, V41, P148, DOI 10.1016/j.ejso.2014.07.035; Tran JM, 2016, CANCER CAUSE CONTROL, V27, P137, DOI 10.1007/s10552-015-0690-5; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wright F, 2010, PROGRAM EVIDENCE BAS, V82	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263713	10.1371/journal.pone.0263713	http://dx.doi.org/10.1371/journal.pone.0263713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180251	gold, Green Published			2022-12-26	WOS:000796435800027
J	Chang, CW; Christian, M; Chang, DH; Lai, FP; Liu, TJ; Chen, YS; Chen, WJ				Chang, Che Wei; Christian, Mesakh; Chang, Dun Hao; Lai, Feipei; Liu, Tom J.; Chen, Yo Shen; Chen, Wei Jen			Deep learning approach based on superpixel segmentation assisted labeling for automatic pressure ulcer diagnosis	PLOS ONE			English	Article								A pressure ulcer is an injury of the skin and underlying tissues adjacent to a bony eminence. Patients who suffer from this disease may have difficulty accessing medical care. Recently, the COVID-19 pandemic has exacerbated this situation. Automatic diagnosis based on machine learning (ML) brings promising solutions. Traditional ML requires complicated preprocessing steps for feature extraction. Its clinical applications are thus limited to particular datasets. Deep learning (DL), which extracts features from convolution layers, can embrace larger datasets that might be deliberately excluded in traditional algorithms. However, DL requires large sets of domain specific labeled data for training. Labeling various tissues of pressure ulcers is a challenge even for experienced plastic surgeons. We propose a super-pixel-assisted, region-based method of labeling images for tissue classification. The boundary-based method is applied to create a dataset for wound and re-epithelialization (re-ep) segmentation. Five popular DL models (U-Net, DeeplabV3, PsPNet, FPN, and Mask R-CNN) with encoder (ResNet-101) were trained on the two datasets. A total of 2836 images of pressure ulcers were labeled for tissue classification, while 2893 images were labeled for wound and re-ep segmentation. All five models had satisfactory results. DeeplabV3 had the best performance on both tasks with a precision of 0.9915, recall of 0.9915 and accuracy of 0.9957 on the tissue classification; and a precision of 0.9888, recall of 0.9887 and accuracy of 0.9925 on the wound and re-ep segmentation task. Combining segmentation results with clinical data, our algorithm can detect the signs of wound healing, monitor the progress of healing, estimate the wound size, and suggest the need for surgical debridement.	[Chang, Che Wei; Lai, Feipei; Liu, Tom J.; Chen, Wei Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Chang, Che Wei; Chang, Dun Hao; Chen, Yo Shen] Far Eastern Mem Hosp, Dept Surg, Div Plast & Reconstruct Surg, New Taipei, Taiwan; [Christian, Mesakh; Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan; [Chang, Dun Hao] Yuan Ze Univ, Dept Informat Management, Taoyuan, Taiwan; [Liu, Tom J.] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Surg, Div Plast Surg, New Taipei, Taiwan	National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; Yuan Ze University; Fu Jen Catholic University; Fu Jen Catholic University Hospital	Chang, CW (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan.; Chang, CW (corresponding author), Far Eastern Mem Hosp, Dept Surg, Div Plast & Reconstruct Surg, New Taipei, Taiwan.	b92401068@gmail.com		Lai, Feipei/0000-0001-7147-8122; Chang, Che wei/0000-0002-5864-017X	Innovation Project of Far Eastern Memorial Hospital [PI20200002]	Innovation Project of Far Eastern Memorial Hospital	This work was supported by the Innovation Project of Far Eastern Memorial Hospital (Grant No. PI20200002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich F, 2019, J MULTIVARIATE ANAL, V174, DOI 10.1016/j.jmva.2019.104536; Achanta R., 2010, 149300 EPFL; Adam G, 2020, NPJ PRECIS ONCOL, V4, DOI 10.1038/s41698-020-0122-1; Ali A., 2013, INT J ADV SOFT COMPU, V5; Bauer K, 2016, OSTOMY WOUND MANAG, V62, P30; Baumgarten Mona, 2003, Adv Skin Wound Care, V16, P299, DOI 10.1097/00129334-200311000-00012; Cabitza F, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10114014; Chen LB, 2017, IEEE INT SYMP NANO, P1, DOI 10.1109/NANOARCH.2017.8053709; DINSDALE SM, 1974, ARCH PHYS MED REHAB, V55, P147; Elmogy M, 2018, 2018 24 INT C PATT R; Garci V, 2006, INT C INT DAT ENG AU; Garcia-Zapirain B, 2018, MED BIOL ENG COMPUT, V56, P2245, DOI 10.1007/s11517-018-1835-y; Gholami P, 2018, IEEE J BIOMED HEALTH, V22, P1269, DOI 10.1109/JBHI.2017.2743526; Gong YJ, 2018, IEEE T IMAGE PROCESS, V27, P1390, DOI 10.1109/TIP.2017.2778569; Hashemi S, 2009, IEEE T KNOWL DATA EN, V21, P624, DOI 10.1109/TKDE.2008.181; He K., 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, DOI 10.1109/ICCV.2017.322]; Horn SD, 2004, J AM GERIATR SOC, V52, P359, DOI 10.1111/j.1532-5415.2004.52106.x; Irving B, 2016, MED IMAGE ANAL, V32, P69, DOI 10.1016/j.media.2016.03.002; Johnson JM, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0192-5; Kanavati F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66333-x; Li D, 2017, J CLIN NURS, V26, P3564, DOI 10.1111/jocn.13726; Li ZQ, 2015, PROC CVPR IEEE, P1356, DOI 10.1109/CVPR.2015.7298741; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Lu SL, 2021, NEURO-ONCOLOGY, V23, P1560, DOI 10.1093/neuonc/noab071; Maghsoudi OH, 2017, 2017 IEEE SIGN PROC; Marijanovic D, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10217613; Mervis JS, 2019, J AM ACAD DERMATOL, V81, P881, DOI 10.1016/j.jaad.2018.12.069; Mesa H, 2008, 2008 8 INT C HYBR IN; Morilla-Herrera JC, 2015, NEUROCOMPUTING, V164, P112, DOI [DOI 10.1016/J.NEUCOM.2014.12.091, DOI 10.1016/j.neucom.2014.12.091]; Nizam K, 2018, IEEE ST CONF RES DEV; Nogales A, 2021, ARTIF INTELL MED, V112, DOI 10.1016/j.artmed.2021.102020; Rajathi V, 2019, IMAGING SCI J, V67, P374, DOI 10.1080/13682199.2019.1663083; Rani P, 2017, IEEE ENG MED BIO, P1437, DOI 10.1109/EMBC.2017.8037104; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Rousselle P, 2019, ADV DRUG DELIVER REV, V146, P344, DOI 10.1016/j.addr.2018.06.019; Seixas JL, 2014, 2014 IEEE 16TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATIONS AND SERVICES (HEALTHCOM), P387, DOI 10.1109/HealthCom.2014.7001874; Silveira M, 2009, IEEE J-STSP, V3, P35, DOI 10.1109/JSTSP.2008.2011119; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Sungkrityayan K, 2015, IEEE COMMUNICATIONS; Trabelsi O, 2013, 2013 INT C EL ENG SO; Vanderwee K, 2007, J EVAL CLIN PRACT, V13, P227, DOI 10.1111/j.1365-2753.2006.00684.x; Veredas F, 2010, IEEE T MED IMAGING, V29, P410, DOI 10.1109/TMI.2009.2033595; Wang QW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218808; Wannous H, 2007, P ANN INT IEEE EMBS, P6032; Yu Z., 2020, ARXIV PREPRINT ARXIV; Zahia S, 2020, ARTIF INTELL MED, V102, DOI 10.1016/j.artmed.2019.101742; Zahia S, 2018, COMPUT METH PROG BIO, V159, P51, DOI 10.1016/j.cmpb.2018.02.018; Zhang CY, 2021, COMMUN ACM, V64, P107, DOI 10.1145/3446776; Zhang HW, 2020, IEEE IMAGE PROC, P693, DOI 10.1109/ICIP40778.2020.9191282; Zhang JC, 2021, PATTERN RECOGN, V112, DOI 10.1016/j.patcog.2020.107705; Zhang YX, 2021, VISUAL COMPUT, V37, P1061, DOI 10.1007/s00371-020-01852-2; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660	53	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264139	10.1371/journal.pone.0264139	http://dx.doi.org/10.1371/journal.pone.0264139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176101	gold, Green Published			2022-12-26	WOS:000777505200086
J	Marchini, F; Caputo, A; Langher, V; Giuliani, C; Convertino, A; Mazzilli, R; Faggiano, A; Napoli, A				Marchini, Francesco; Caputo, Andrea; Langher, Viviana; Giuliani, Chiara; Convertino, Alessio; Mazzilli, Rossella; Faggiano, Antongiulio; Napoli, Angela			Understanding care relationships in diabetes practice: A psychodynamic interview-based exploratory study	PLOS ONE			English	Article							COMPASSION	Objective To explore the subjective experience of physicians working in diabetic settings about their care relationships in order to find some unique clues contributing to physician professional health and capacity to manage patients' adherence. Research design and methods An interview-based exploratory study has been carried out involving 18 physicians (77.8% female) with at least 3 years of clinical practice in diabetes care. In-depth interviews about the emotional experience with patients with diabetes were conducted and audio recorded. Interviews transcripts were analyzed through a computer-based text analysis which allowed the identification of thematic domains (Cluster Analysis) and latent factors (Correspondence Analysis) viewed through a psychodynamic and constructivist lens. Results Six thematic domains emerged respectively referring to: Concern (8.43%), Control (14.42%), Ambivalence (22.08%), Devotion (22.49%), Guilt (19.29%) and Strive for Achievement (13.30%). Moreover, three latent dimensions were taken into account, which explained 69.20% of data variance: Affect Repression (28.50%), Tendency to Repair (22.70%) and Anxiety Pattern (18.00%). Conclusions Overall, the results of the present study confirm the challenging nature of diabetes care. In particular, physicians ongoing effort to restore patients' psychological integrity in chronic condition constitute the most novel finding above all. In this regard, the need for emotional labor in physicians' education and training is suggested in order to both prevent burnout symptoms (e.g. depersonalization) and promote shared decision making in care relationships. However, findings should be treated as preliminary given the convenience nature of the sample and its reduced size.	[Marchini, Francesco; Caputo, Andrea; Langher, Viviana] Sapienza Univ Rome, Dept Dynam & Clin Psychol, Rome, Italy; [Marchini, Francesco] CIPA, Italian Ctr Analyt Psychol, Rome, Italy; [Giuliani, Chiara; Convertino, Alessio; Mazzilli, Rossella; Faggiano, Antongiulio; Napoli, Angela] Sapienza Univ Rome, Dept Clin & Mol Med, Endocrinol Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Marchini, F (corresponding author), Sapienza Univ Rome, Dept Dynam & Clin Psychol, Rome, Italy.; Marchini, F (corresponding author), CIPA, Italian Ctr Analyt Psychol, Rome, Italy.	francescomarchini93@gmail.com						[Anonymous], 1961, ACHIEVING SOC; Benroubi M, 2011, DIABETES RES CLIN PR, V93, pS97, DOI 10.1016/S0168-8227(11)70021-3; Beverly EA, 2011, DIABETES CARE, V34, P1086, DOI 10.2337/dc10-2298; Bhutani Jaikrit, 2012, Indian J Psychol Med, V34, P332, DOI 10.4103/0253-7176.108206; Caputo A, 2021, ARCH SUICIDE RES, V25, P862, DOI 10.1080/13811118.2020.1768990; Caputo A, 2020, INT J EDUC VOCAT GUI, V20, P263, DOI 10.1007/s10775-019-09403-5; Caputo A, 2020, PSYCHODYN PRACT, V26, P136, DOI 10.1080/14753634.2020.1745676; Caputo A, 2019, MEDITERR J CLIN PSYC, V7, DOI 10.6092/2282-1619/2019.7.2009; Caputo A, 2014, PSYCHOL HEALTH MED, V19, P211, DOI 10.1080/13548506.2013.793372; Caputo A, 2013, PSYCHOL HEALTH MED, V18, P145, DOI 10.1080/13548506.2012.687828; Carli R, 2003, ANALISI DOMANDA TEOR; Craven M, 2019, DIABETES RES CLIN PR, V150, P211, DOI 10.1016/j.diabres.2019.03.018; Fornari F., 1979, FONDAMENTI TEORIA PS; Gabbay RA, 2020, J CLIN ENDOCR METAB, V105, pE2652, DOI 10.1210/clinem/dgaa230; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Greenacre M., 2007, CORRES ANAL PRACTICE; Gupta JA, 2008, J BIOETHIC INQ, V5, P239, DOI 10.1007/s11673-008-9112-7; Kalra Sanjay, 2020, J Pak Med Assoc, V70, P366; Kerasidou A, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0091-7; Kot W., 2006, DIABETOLOGIA PRAKTYC, V7, P396; Lancia F., 2004, STRUMENTI ANALISI TE; Langher V, 2019, EUR J PSYCHOL, V15, P292, DOI 10.5964/ejop.v15i2.1736; Lebart Ludovic, 1995, STAT EXPLORATOIRE MU, V3; Levy K, 2009, PSYCHOLOGY, V12, P505; Lief H. I., 1963, PSYCHOL BASIS MED PR, P12; Marchini F., 2020, PSYCHOL HUB, V37, P23, DOI [10.13133/2724-2943/17160, DOI 10.13133/2724-2943/17160]; Marchini F, 2021, PSYCHOANAL PSYCHOTHE, V35, P5, DOI 10.1080/02668734.2021.1922492; Marchini F, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.661211; Marchini F, 2018, MEDITERR J CLIN PSYC, V6, DOI 10.6092/2282-1619/2018.6.1981; Morrissey J, 2019, J CLIN NURS, V28, P947, DOI 10.1111/jocn.14717; Paniccia R.M., 2002, ANALISI EMOZIONALE T; Patel RS, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8110098; Perlo J, 2017, CISC VIS NETW IND GL; Priya G., 2019, US ENDOCRINOL, V15, P13; Roberts VZ, 1994, SELF ASSIGNED IMPOSS; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Sanchez-Reilly Sandra, 2013, J Support Oncol, V11, P75; Schaefer-Graf U, 2018, DIABETOLOGIA, V61, P1012, DOI 10.1007/s00125-018-4545-y; Seehusen DA, 2018, PATIENT EDUC COUNS, V101, P894, DOI 10.1016/j.pec.2017.12.007; Sorensen M, 2020, SCAND J PRIM HEALTH, V38, P12, DOI 10.1080/02813432.2020.1714145; Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7; Willaing I., 2014, J PSYCHOL PSYCHOTHER, V4, P1, DOI 10.4172/2161-0487.1000141	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263226	10.1371/journal.pone.0263226	http://dx.doi.org/10.1371/journal.pone.0263226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176064	gold, Green Published			2022-12-26	WOS:000777505200016
J	Powell, AA; Ireland, G; Baawuah, F; Beckmann, J; Okike, IO; Ahmad, S; Garstang, J; Brent, AJ; Brent, B; Aiano, F; Hargreaves, J; Langan, SM; Mangtani, P; Nguipdop-Djomo, P; Sturgess, J; Oswald, W; Halliday, K; Rourke, E; Dawe, F; Amin-Chowdhury, Z; Kall, M; Zambon, M; Poh, J; Ijaz, S; Lackenby, A; Elli, J; Brown, KE; Diamond, SI; Ramsay, ME; Ladhani, SN				Powell, Annabel A.; Ireland, Georgina; Baawuah, Frances; Beckmann, Joanne; Okike, Ifeanyichukwu O.; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J.; Brent, Bernadette; Aiano, Felicity; Hargreaves, James; Langan, Sinead M.; Mangtani, Punam; Nguipdop-Djomo, Patrick; Sturgess, Joanna; Oswald, William; Halliday, Katherine; Rourke, Emma; Dawe, Fiona; Amin-Chowdhury, Zahin; Kall, Meaghan; Zambon, Maria; Poh, John; Ijaz, Samreen; Lackenby, Angie; Elli, Joanna; Brown, Kevin E.; Diamond, Sir Ian; Ramsay, Mary E.; Ladhani, Shamez N.			Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England	PLOS ONE			English	Article							HEALTH-CARE WORKERS; SARS-COV-2; IMPACT	Background Following the full re-opening of schools in England and emergence of the SARS-CoV-2 Alpha variant, we investigated the risk of SARS-CoV-2 infection in students and staff who were contacts of a confirmed case in a school bubble (school groupings with limited interactions), along with their household members. Methods Primary and secondary school bubbles were recruited into sKIDsBUBBLE after being sent home to self-isolate following a confirmed case of COVID-19 in the bubble. Bubble participants and their household members were sent home-testing kits comprising nasal swabs for RT-PCR testing and whole genome sequencing, and oral fluid swabs for SARS-CoV-2 antibodies. Results During November-December 2020, 14 bubbles were recruited from 7 schools, including 269 bubble contacts (248 students, 21 staff) and 823 household contacts (524 adults, 299 children). The secondary attack rate was 10.0% (6/60) in primary and 3.9% (4/102) in secondary school students, compared to 6.3% (1/16) and 0% (0/1) among staff, respectively. The incidence rate for household contacts of primary school students was 6.6% (12/183) and 3.7% (1/27) for household contacts of primary school staff. In secondary schools, this was 3.5% (11/317) and 0% (0/1), respectively. Household contacts were more likely to test positive if their bubble contact tested positive although there were new infections among household contacts of uninfected bubble contacts. Interpretation Compared to other institutional settings, the overall risk of secondary infection in school bubbles and their household contacts was low. Our findings are important for developing evidence-based infection prevention guidelines for educational settings.	[Powell, Annabel A.; Ireland, Georgina; Baawuah, Frances; Okike, Ifeanyichukwu O.; Aiano, Felicity; Amin-Chowdhury, Zahin; Kall, Meaghan; Zambon, Maria; Poh, John; Ijaz, Samreen; Lackenby, Angie; Elli, Joanna; Brown, Kevin E.; Ramsay, Mary E.; Ladhani, Shamez N.] UK Hlth Secur Agcy, London, England; [Beckmann, Joanne] East London NHS Fdn Trust, London, England; [Okike, Ifeanyichukwu O.] Univ Hosp Derby & Burton NHS Fdn Trust, Derby, England; [Ahmad, Shazaad] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England; [Garstang, Joanna] Birmingham Community Healthcare NHS Trust, Aston, England; [Brent, Andrew J.; Brent, Bernadette] Oxford Univ Hosp NHS Fdn Trust, Nuffield Dept Med, Oxford, England; [Brent, Andrew J.] Univ Oxford, Oxford, England; [Hargreaves, James] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Langan, Sinead M.; Mangtani, Punam; Nguipdop-Djomo, Patrick; Sturgess, Joanna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Oswald, William; Halliday, Katherine] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Rourke, Emma; Dawe, Fiona; Diamond, Sir Ian] Off Natl Stat, Newport, Shrops, England; [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; St Georges University London	Ladhani, SN (corresponding author), UK Hlth Secur Agcy, London, England.; Ladhani, SN (corresponding author), St Georges Univ London, Paediat Infect Dis Res Grp, London, England.	shamez.ladhani@phe.gov.uk		Poh, John/0000-0003-2874-4290; Ireland, Georgina/0000-0001-8932-2783; Garstang, Joanna/0000-0001-9268-0581; Hargreaves, James/0000-0002-3509-3572; Langan, Sinead/0000-0002-7022-7441; Mangtani, Punam/0000-0001-7074-2999; Ijaz, Samreen/0000-0001-6658-3542; Nguipdop-Djomo, Patrick/0000-0002-3429-0259; Lackenby, Angie/0000-0002-1557-0415; Aiano, Felicity/0000-0002-0746-1075				Aiano F, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100120; [Anonymous], COVID 19 SCH INFECT; [Anonymous], EVERYTHING YOU NEED; [Anonymous], NHS INVITES ALL ADUL; [Anonymous], BACK SCH WILL BUBBLE; [Anonymous], SELF ISOLATE WHAT DO; [Anonymous], 2021, JCVI ISSUES UPDATED; Chan J, 2021, PUBLIC HEALTH REP, V136, P375, DOI 10.1177/0033354921999385; Department for Education, ATT ED EARL YEARS SE; Falk A, 2021, MMWR-MORBID MORTAL W, V70, P136, DOI [10.15585/mmwr.mm7004e3, 10.15585/mmwr.mm7004e3externalicon]; Hoschler K., SARS COV 2 IGG DETEC, V2021; Institute for Government, TIM UK COR LOCKD MAR; Ismail SA., 2020, SARS COV 2 INFECT TR; Ladhani SN, 2021, LANCET CHILD ADOLESC, V5, P417, DOI 10.1016/S2352-4642(21)00061-4; Ladhani SN, 2021, ECLINICALMEDICINE, V37, DOI 10.1016/j.eclinm.2021.100948; Ladhani SN, 2020, ECLINICALMEDICINE, V28, DOI 10.1016/j.eclinm.2020.100597; Ladhani SN, 2020, ARCH DIS CHILD, V105, P1180, DOI 10.1136/archdischild-2020-320042; Levinson M, 2020, NEW ENGL J MED, V383, P981, DOI 10.1056/NEJMms2024920; Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; Martyn EM, 2021, J INFECTION, V82, P283, DOI 10.1016/j.jinf.2021.02.027; Mensah AA, 2021, J INFECTION, V82, P67, DOI 10.1016/j.jinf.2021.02.022; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Niu PH, 2020, CHINA CDC WEEKLY, V2, P453, DOI 10.46234/ccdcw2020.116; Office for National Statistics (ONS), 2020, COR COVID 19 INF SUR; Openshaw JJ, 2021, CLIN INFECT DIS, V72, P153, DOI 10.1093/cid/ciaa692; Public Health England, NEW NAT SURV POSS CO; Thompson HA, 2021, CLIN INFECT DIS, V73, pE754, DOI 10.1093/cid/ciab100; Tu YP, 2020, NEW ENGL J MED, V383, P494, DOI 10.1056/NEJMc2016321; Ulyte A., 2021, CLUSTERING LONGITUDI, V372, pn616; Varma JK., 2021, COVID 19 INFECT STUD, V147, DOI [10.1542/peds.2021-050605, DOI 10.1542/PEDS.2021-050605]; Viner R., 2021, IMPACTS SCH CLOSURES, DOI [10.1101/2021.02.10.21251526v1, DOI 10.1101/2021.02.10.21251526]; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Young BC., CLUSTER RANDOMISED T, V2021; Zimmerman KO, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-048090	34	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0262515	10.1371/journal.pone.0262515	http://dx.doi.org/10.1371/journal.pone.0262515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171942	Green Accepted, Green Published, gold			2022-12-26	WOS:000795889700005
J	Rodrigues, FM; Rato, JR; Mineiro, A; Holmstrom, I				Rodrigues, Filipa M.; Rato, Joana R.; Mineiro, Ana; Holmstrom, Ingela			Unveiling teachers' beliefs on visual cognition and learning styles of deaf and hard of hearing students: A Portuguese-Swedish study	PLOS ONE			English	Article							CROSS-MODAL PLASTICITY; EDUCATION; NEUROSCIENCE; CHILDREN; NEUROMYTHS; ATTENTION; FATIGUE	Vision is considered a privileged sensory channel for deaf and hard of hearing (DHH) students to learn, and, naturally, they recognize themselves as visual learners. This assumption also seems widespread among schoolteachers, which led us to analyse the intersection between teachers' beliefs on deaf and hard of hearing students' academic achievement, visual skills, attentional difficulties, and the perceived importance of image display in class. An online survey was designed to analyse the beliefs of the schoolteachers about the deaf and hard of hearing students learning in educational settings from Portugal and Sweden. Participated 133 teachers, 70 Portuguese and 63 Swedish, from the preschool to the end of mandatory education (ages 3-18) with several years of experience. The content analysis and the computed SPSS statistical significance tests reveal that surveyed teachers believe that deaf and hard of hearing students have better visual skills when compared with their hearing peers yet show divergent beliefs about visual attentional processes. Within the teachers' perceptions on learning barriers to DHH students, the distractibility and cognitive effort factors were highlighted, among communicational difficulties in class. Conclusions about the prevalence of learning misconceptions in teachers from both countries analysed, corroborate previous studies on neuromyths in education, and bring novelty to Deaf Education field. The work of translation of scientific knowledge, teacher training updating, and partnership between researchers and educators are also urgently needed in special education.	[Rodrigues, Filipa M.; Rato, Joana R.; Mineiro, Ana] Univ Catolica Portuguesa, Inst Hlth Sci, Lisbon, Portugal; [Rodrigues, Filipa M.] Polytech Inst Leiria, Sch Educ & Social Sci, Leiria, Portugal; [Rodrigues, Filipa M.; Rato, Joana R.; Mineiro, Ana] Univ Catolica Portuguesa, Ctr Interdisciplinary Res Hlth, Lisbon, Portugal; [Holmstrom, Ingela] Stockholm Univ, Dept Linguist, Stockholm, Sweden	Universidade Catolica Portuguesa; Universidade Catolica Portuguesa; Stockholm University	Rodrigues, FM (corresponding author), Univ Catolica Portuguesa, Inst Hlth Sci, Lisbon, Portugal.; Rodrigues, FM (corresponding author), Polytech Inst Leiria, Sch Educ & Social Sci, Leiria, Portugal.; Rodrigues, FM (corresponding author), Univ Catolica Portuguesa, Ctr Interdisciplinary Res Hlth, Lisbon, Portugal.	s-farrodrigues@ucp.pt	Rodrigues, Filipa Machado/GLV-3036-2022	Rodrigues, Filipa Machado/0000-0002-3834-2458; Rato, Joana/0000-0002-7298-4892; Mineiro, Ana/0000-0003-0508-7785	National Funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P. [UIDB/04279/2020]	National Funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P.(Portuguese Foundation for Science and Technology)	This work is financially supported by National Funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P., under the project UIDB/04279/2020.	Alferink LA, 2010, EXCEPTIONALITY, V18, P42, DOI 10.1080/09362830903462573; Bagga-Gupta S., 2016, J COMMUNICATION DISO, V3, P4, DOI [10.4172/2375-4427.1000145, DOI 10.4172/2375-4427.1000145]; Baptista JA., 2008, EXCLUS O PELA INCLUS; Bissessar S, 2021, TRENDS NEUROSCI EDUC, V23, DOI 10.1016/j.tine.2021.100155; Carvalho PV., 2011, HIST EDUCACAO SURDOS; Davies P, 1999, BRIT J EDUC STUD, V47, P108, DOI 10.1111/1467-8527.00106; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; Dye MWG, 2008, ANN NY ACAD SCI, V1145, P71, DOI 10.1196/annals.1416.013; Dye MWG., 2008, DEAF COGNITION FDN O, P250, DOI [10.1093/acprof:oso/9780195368673.003.0009, DOI 10.1093/ACPROF:OSO/9780195368673.003.0009]; EMMOREY K, 1993, COGNITION, V46, P139, DOI 10.1016/0010-0277(93)90017-P; Falcao LA., 2014, COGNICAO VISUAL LIBR, V4a Ed; Ferrero M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00496; Glick H, 2017, HEARING RES, V343, P191, DOI 10.1016/j.heares.2016.08.012; Grospietsch F, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00020; Hendar O, 2016, DEAF EDUC INT, V18, P47, DOI 10.1080/14643154.2016.1142045; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Holmstrm I, 2018, VISUELLA STRATEGIE 3; Holmstrom I., 2018, APPL LINGUIST REV, V9, P90, DOI [10.1515/applirev-2017-0078, DOI 10.1515/APPLIREV-2017-0078]; Hornsby BWY, 2014, AM J AUDIOL, V23, P129, DOI 10.1044/1059-0889(2013/13-0017); Howard-Jones PA, 2014, NAT REV NEUROSCI, V15, P817, DOI 10.1038/nrn3817; Im SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192163; Marques T., 2012, CADERNOS SA DE, V5, P96; Marschark M., 2005, ED INTERPRETING SIGN, P57; Marschark M, 2019, SUMMARY REPORT ACHIE; Marschark M, 2017, J DEV PHYS DISABIL, V29, P153, DOI 10.1007/s10882-016-9494-0; Mather SM., 2012, ODYSSEY NEW DIRECTIO, V13, P20; Monroy C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209265; NEVILLE H J, 1988, P327; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Newton PM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00444; Papadatou-Pastou M., 2018, FRONT ED LAUSANNE, V3, P105, DOI [org/10.3389/feduc.2018.00105, DOI 10.3389/FEDUC.2018.00105, 10.3389/feduc.2018.00105]; Papadatou-Pastou M, 2021, EUR J PSYCHOL EDUC, V36, P511, DOI 10.1007/s10212-020-00485-2; Pashler Harold, 2008, Psychol Sci Public Interest, V9, P105, DOI 10.1111/j.1539-6053.2009.01038.x; Pasquinelli E, 2012, MIND BRAIN EDUC, V6, P89, DOI 10.1111/j.1751-228X.2012.01141.x; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Rato JR, 2011, PROCD SOC BEHV, V29, DOI 10.1016/j.sbspro.2011.11.317; Rato JR, 2013, EDUC RES-UK, V55, P441, DOI 10.1080/00131881.2013.844947; Rodrigues PFS, 2018, J EXP CHILD PSYCHOL, V176, P140, DOI 10.1016/j.jecp.2018.07.014; Rogowsky BA, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00164; Rousseau L, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.719692; Simmonds A., 2014, NEUROSCIENCE IS AFFE; Spencer P.E., 2010, EVIDENCE BASED PRACT; Svartholm K, 2010, INT J BILING EDUC BI, V13, P159, DOI 10.1080/13670050903474077	43	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263216	10.1371/journal.pone.0263216	http://dx.doi.org/10.1371/journal.pone.0263216			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167582	Green Published, gold			2022-12-26	WOS:000802227200004
J	Villatoro, AJ; Alcoholado, C; Martin-Astorga, MD; Rubio, N; Blanco, J; Garrido, CP; Becerra, J				Villatoro, Antonio J.; Alcoholado, Cristina; del Carmen Martin-Astorga, Maria; Rubio, Nuria; Blanco, Jeronimo; Pilar Garrido, Cristina; Becerra, Jose			Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity	PLOS ONE			English	Article							ADIPOSE-TISSUE; STROMAL CELLS	The role played by certain domestic species such as dogs as a translational model in comparative oncology shows great interest to develop new therapeutic strategies in brain tumors. Gliomas are a therapeutic challenge that represents the most common form of malignant primary brain tumors in humans and the second most common form in dogs. Gene-directed enzyme/prodrug therapy using adipose mesenchymal stem cells (Ad-MSCs) expressing the herpes simplex virus thymidine kinase (TK) has proven to be a promising alternative in glioblastoma therapy, through its capacity to migrate and home to the tumor and delivering local cytotoxicity avoiding other systemic administration. In this study, we demonstrate the possibility for canine Ad-MSCs (cAd-MSCs) to be genetically engineered efficiently with a lentiviral vector to express TK (TK-cAd-MSCs) and in combination with ganciclovir (GCV) prodrug demonstrated its potential antitumor efficacy in vitro and in vivo in a mice model with the human glioblastoma cell line U87. TK-cAd-MSCs maintained cell proliferation, karyotype stability, and MSCs phenotype. Genetic modification significantly affects its secretory profile, both the analyzed soluble factors and exosomes. TK-cAd-MSCs showed a high secretory profile of some active antitumor immune response cytokines and a threefold increase in the amount of secreted exosomes, with changes in their protein cargo. We also found that the prodrug protein is not released directly into the culture medium by TK-cAd-MSCs. We believe that our work provides new perspectives for glioblastoma gene therapy in dogs and a better understanding of this therapy in view of its possible implantation in humans.	[Villatoro, Antonio J.; Alcoholado, Cristina; del Carmen Martin-Astorga, Maria; Pilar Garrido, Cristina; Becerra, Jose] Univ Malaga, Lab Bioengn & Tissue Regenerat LABRET, Dept Cell Biol Genet & Physiol, Fac Sci, Malaga, Spain; [Alcoholado, Cristina; Pilar Garrido, Cristina; Becerra, Jose] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain; [Rubio, Nuria; Blanco, Jeronimo; Pilar Garrido, Cristina] Catalonian Inst Adv Chem IQAC CSIC, Cell Therapy Grp, Barcelona, Spain; [Becerra, Jose] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC)	Villatoro, AJ (corresponding author), Univ Malaga, Lab Bioengn & Tissue Regenerat LABRET, Dept Cell Biol Genet & Physiol, Fac Sci, Malaga, Spain.	antoniojvillatoro@gmail.com	Martín Astorga, María del Carmen/AFO-2575-2022	Martín Astorga, María del Carmen/0000-0003-4784-9944; Villatoro, Antonio Jose/0000-0003-3407-0616				Alieva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035148; Bago JR, 2013, MOL THER, V21, P1758, DOI 10.1038/mt.2013.145; Bonomi A, 2017, VET J, V223, P45, DOI 10.1016/j.tvjl.2017.05.005; Cicchelero L, 2017, VET COMP ONCOL, V15, P1187, DOI 10.1111/vco.12255; COLOMBO BM, 1995, HUM GENE THER, V6, P763, DOI 10.1089/hum.1995.6.6-763; Durinikova E, 2018, CANCER GENE THER, V25, P285, DOI 10.1038/s41417-018-0030-5; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Finocchiaro LME, 2012, CANCER GENE THER, V19, P852, DOI 10.1038/cgt.2012.72; Gardner HL, 2016, ANNU REV ANIM BIOSCI, V4, P199, DOI 10.1146/annurev-animal-022114-110911; Gounder AP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007001; Guerra-Rebollo M, 2018, MOL THER-ONCOLYTICS, V11, P39, DOI 10.1016/j.omto.2018.09.002; Jiang T, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1163462; Villatoro AJ, 2018, VET REC, V183, P654, DOI 10.1136/vr.104867; Matuskova M, 2010, CANCER LETT, V290, P58, DOI 10.1016/j.canlet.2009.08.028; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Niess H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1241-x; Nowakowski A, 2016, STEM CELLS DEV, V25, P1513, DOI 10.1089/scd.2016.0120; Palu G, 1999, GENE THER, V6, P330, DOI 10.1038/sj.gt.3300805; Pastorakova A, 2020, CANCERS, V12, DOI 10.3390/cancers12051096; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Sato T, 2015, METHODS MOL BIOL, V1317, P55, DOI 10.1007/978-1-4939-2727-2_4; Truve K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006000; Van Dillen Ingrid J., 2002, Current Gene Therapy, V2, P307, DOI 10.2174/1566523023347733; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Villatoro AJ, 2019, VET IMMUNOL IMMUNOP, V208, P6, DOI 10.1016/j.vetimm.2018.12.003; Villatoro AJ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1413-4; Villatoro AJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/527926; Xiao JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067662; Yamamoto S, 1997, CANCER GENE THER, V4, P91; Yi QY, 2018, ONCOL REP, V40, P682, DOI 10.3892/or.2018.6454; Yoshimura T, 2018, CELL MOL IMMUNOL, V15, P335, DOI 10.1038/cmi.2017.135	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264001	10.1371/journal.pone.0264001	http://dx.doi.org/10.1371/journal.pone.0264001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167620	Green Published, gold			2022-12-26	WOS:000802227200031
J	Bischof, EA; Schluter, N; Lehmann, J				Bischof, Eva Alexandra; Schlueter, Nils; Lehmann, Jens			Geometric morphometric analysis of morphologic disparity, intraspecific variation and ontogenetic allometry of beyrichitine ammonoids	PLOS ONE			English	Article							HETEROCHRONY; EVOLUTION; VARIABILITY; MORPHOSPACE; DIVERSITY; DYNAMICS; PATTERNS; SPACE; SHAPE	Beyrichitine ammonoids of NV Nevada reveal a high taxonomic diversity of Anisian (Middle Triassic). This diversity is, however, in contrast to their relatively low morphologic disparity. Depending on the exact definition, morphologic disparity of a data set is a direct consequence of the sum of all ontogenetic changes. In the past, however, the interplay of both morphological processes has only rarely been addressed. Using geometric morphometric methods, this study aims at a quantification of allometric processes and the morphologic disparity of beyrichitine ammonoids. The multivariate statistical analysis revealed that morphologic disparity, intraspecific variation respectively, within and between the studied species seems to be the result of deviations in the ontogenetic allometric growth pattern (i.e. heterochrony). During deposition of the studied stratigraphic sequence, a general progressive pedomorphism (juvenilization) was observed. The intraspecific variability pattern coincides with the total morphologic disparity of the analyzed species, which suggests that intraspecific variability facilitated morphologic disparity. The comparison of ontogenetic allometric patterns and changes in intraspecific variation and morphologic disparity are likely to refine our understanding of the intrinsic factors influencing the speciation of this group.	[Bischof, Eva Alexandra; Lehmann, Jens] Univ Bremen, Fachbereich Geowissensch, Geowissenschaftl Sammlung, Bremen, Germany; [Schlueter, Nils] Humboldt Univ, Museum Nat Kunde, Nat Hist Forschungsinst, Berlin, Germany	University of Bremen; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Bischof, EA (corresponding author), Univ Bremen, Fachbereich Geowissensch, Geowissenschaftl Sammlung, Bremen, Germany.	eva.bischof@hotmail.com		Bischof, Eva Alexandra/0000-0003-4564-8217	German Science Foundation (DFG) [LE 1241/3-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This research received support from the German Science Foundation (DFG), project "Nevammonoidea"' (LE 1241/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D C, 2020, GEOMETRIC MORPHOMETR; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Bischof EA., 2021, THESIS U BREMEN US; Bischof EA, 2020, J PALEONTOL, V94, P829, DOI 10.1017/jpa.2020.25; Bischof EA, 2021, PEERJ, V9, DOI 10.7717/peerj.10931; Bucher Hugo, 1996, Topics in Geobiology, V13, P407; Ciampaglio CN, 2001, PALEOBIOLOGY, V27, P695, DOI 10.1666/0094-8373(2001)027<0695:DCIMOP>2.0.CO;2; Collyer ML, 2020, EVOL BIOL, V47, P193, DOI 10.1007/s11692-020-09503-z; Collyer ML, 2018, METHODS ECOL EVOL, V9, P1772, DOI 10.1111/2041-210X.13029; Cronier C, 2013, PALAEONTOLOGY, V56, P1263, DOI 10.1111/pala.12024; De Baets K, 2015, TOP GEOBIOL, V43, P359, DOI 10.1007/978-94-017-9630-9_9; De Baets K, 2013, PALEOBIOLOGY, V39, P75, DOI 10.1666/0094-8373-39.1.75; Eble GJ, 1998, BIODIVERSITY DYNAMICS, P132; Eble GJ, 2000, PALEOBIOLOGY, V26, P56, DOI 10.1666/0094-8373(2000)026<0056:CEFISG>2.0.CO;2; Eble GJ., 2002, MULTIVARIATE APPROAC, P78; Eble Gunther J., 2003, P33; Esquerre D, 2017, EVOLUTION, V71, P2829, DOI 10.1111/evo.13382; Ev Mojsisovics., 1879, VERHANDLUNGEN KAISER, V1879, P133; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Fruciano C., 2019, GEOMETRICMORPHOMETRI; Gerber S, 2008, EVOLUTION, V62, P1450, DOI 10.1111/j.1558-5646.2008.00370.x; Gerber S, 2007, EVOL DEV, V9, P472, DOI 10.1111/j.1525-142X.2007.00185.x; Gerber S, 2011, PALEOBIOLOGY, V37, P369, DOI 10.1666/10005.1; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hoffmann R, 2019, PALAEOGEOGR PALAEOCL, V520, P1, DOI 10.1016/j.palaeo.2019.01.020; Hopkins MJ., 2017, EVOLUTIONARY DEV BIO, P1, DOI 10.1007/978-3-319-33038-9_132-1; Hyatt A., 1877, REPORT US GEOLOGICAL, P110; Kant R, 1973, Neues Jb Geol Paleont Abh, V142, P97; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Klingenberg CP., 1996, MULTIVARIATE ALLOMET, P49; Knauss M.J., 2014, PALAEONTOL ELECTRON, V17, p19A, DOI [10.13140/2.1.4557.3760, DOI 10.13140/2.1.4557.3760]; Korn D., 2004, PALAONTOLOGISCHE Z, V78, P425; Korn D, 2012, EVOL DEV, V14, P501, DOI 10.1111/ede.12003; Korn Dieter, 1992, Acta Palaeontologica Polonica, V37, P21; KULLMANN J, 1970, LETHAIA, V3, P397, DOI 10.1111/j.1502-3931.1970.tb00831.x; Landman Neil H., 1996, Topics in Geobiology, V13, P343; Landman Neil H., 1993, Geobios Memoire Special (Villeurbanne), V15, P247; LANDMAN NH, 1991, LETHAIA, V24, P409, DOI 10.1111/j.1502-3931.1991.tb01495.x; Lecuyer C., 2006, eEarth, V1, P1; McNamara K.J., 1990, P111; McNamara Kenneth J., 2012, Evolution Education and Outreach, V5, P203; McNamara KJ, 2005, PALEOBIOLOGY, V31, P17, DOI 10.1666/0094-8373(2005)031[0017:HDAM]2.0.CO;2; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Monnet C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-115; R Core Team, 2021, R LANGUAGE ENV STAT; Rohlf F, 2010, TPSDIG2 PROGRAM LAND; Schlager S., 2017, MORPHO RVCGSHAPE ANA, P56; Schmidt H., 1926, PALAEONTOL Z, V7, P197; Schuter N, 2018, CRETACEOUS RES, V87, P194, DOI 10.1016/j.cretres.2017.05.019; Seilacher A., 1988, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V177, P41; Silberling N.J., 1982, U S Geological Survey Professional Paper, P1; SMITH JAMES PERRIN, 1932, U S DEPT INTERIOR GEOL SURVEY PROF PAPER, V167, P1; Spath LF, 1934, CATALOGUE FOSSIL C 4, P521; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yacobucci MM, 2015, TOP GEOBIOL, V44, P189, DOI 10.1007/978-94-017-9633-0_8; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zelditch ML, 2003, PALEOBIOLOGY, V29, P139, DOI 10.1666/0094-8373(2003)029<0139:TODOSD>2.0.CO;2	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263524	10.1371/journal.pone.0263524	http://dx.doi.org/10.1371/journal.pone.0263524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143539	gold, Green Published			2022-12-26	WOS:000797657800053
J	Pineau, JC; Rozzi, FVR				Pineau, Jean-Claude; Rozzi, Fernando V. Ramirez			Measuring body fat-How accurate is the extrapolation of predictive models in epidemiology?	PLOS ONE			English	Article							MASS INDEX; WEIGHT; HEIGHT; GUIDELINES; EQUATIONS; HEALTH; AGE	Excess fat is a risk factor for many chronic diseases which can lead to premature mortality. Many studies have proposed predictive equations for body fat mass and body fat mass percentage based on anthropometric measures in relation to age and sex. However, the use of these predictive equations on other subject samples may not be relevant. Our objective is to assess whether the predictive equations proposed in the literature are generalizable to any population. We obtained fat mass and fat percentage on a reference population using Absorptiometry DXA. The predictive equations were applied to our population and the mean and individual differences between actual and estimated values were obtained. Predictive equations obtained from a reduced number of subjects have a very high Standard Error of Estimate (>3) and therefore their accuracy is not acceptable. Only the formulae established from a large number of individuals allow the estimation of values whose Standard Error of Estimate is less than 3. These equations, thanks to the large sample size, include a sufficiently large variability in anthropometric measurements covering the diversity of anthropometric values for the same fat value. However, predictive equations based on a large sample size, while exhibiting no current difference in variances, can show a shift in mean values. This mean-shift is the result of differences in DXA devices and needs to be corrected. It means that DXA values from a few individuals in the population under study must be obtained to calculate a corrective factor.	[Pineau, Jean-Claude] Univ Paris, BABEL, CNRS, Paris, France; [Rozzi, Fernando V. Ramirez] MNHN, CNRS, UMR 7206 Ecoanthropology, Paris, France; [Rozzi, Fernando V. Ramirez] Fac Chirurg Dent, UR 2496, UP, Montrouge, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Rozzi, FVR (corresponding author), MNHN, CNRS, UMR 7206 Ecoanthropology, Paris, France.; Rozzi, FVR (corresponding author), Fac Chirurg Dent, UR 2496, UP, Montrouge, France.	fernando.ramirez-rozzi@mnhn.fr		Ramirez Rozzi, Fernando/0000-0002-8537-3839				Black E, 2002, OBES RES, V10, P69, DOI 10.1038/oby.2002.12; Cui ZH, 2014, MED SCI SPORT EXER, V46, P1147, DOI 10.1249/MSS.0000000000000213; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; HEITMANN BL, 1990, EUR J CLIN NUTR, V44, P831; Heo M, 2013, INT J OBESITY, V37, P1154, DOI 10.1038/ijo.2012.201; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Lantz H, 1999, INT J OBESITY, V23, P764, DOI 10.1038/sj.ijo.0800905; Larsson I, 2006, AM J CLIN NUTR, V83, P252; Lee DH, 2017, BRIT J NUTR, V118, P858, DOI [10.1017/S0007114517002665, 10.1017/s0007114517002665]; Lhoman TG., 1996, HUMAN BODY COMPOSITR, P63; Mills TC, 2008, J APPL STAT, V35, P1131, DOI 10.1080/02664760802264707; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; Shepherd JA, 2008, J CLIN DENSITOM, V11, P237, DOI 10.1016/j.jocd.2008.02.001; van der Ploeg GE, 2003, EUR J CLIN NUTR, V57, P1009, DOI 10.1038/sj.ejcn.1601636; WHO, 2011, FACTSH OB OV; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; World Health Organisation, 1998, PREVENTION MANAGEMEN; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0	23	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263590	10.1371/journal.pone.0263590	http://dx.doi.org/10.1371/journal.pone.0263590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143559	Green Published, gold			2022-12-26	WOS:000797657800060
J	Rao, VS; Gu, QY; Tzschentke, S; Lin, KL; Ganig, N; Thepkaysone, ML; Wong, FC; Polster, H; Seifert, L; Seifert, AM; Buck, N; Riediger, C; Weisse, J; Gutschner, T; Michen, S; Temme, A; Schneider, M; Baenke, F; Weitz, J; Kahlert, C				Rao, Venkatesh Sadananda; Gu, Qianyu; Tzschentke, Sandra; Lin, Kuailu; Ganig, Nicole; Thepkaysone, May-Linn; Wong, Fang Cheng; Polster, Heike; Seifert, Lena; Seifert, Adrian M.; Buck, Nathalie; Riediger, Carina; Weisse, Jonas; Gutschner, Tony; Michen, Susanne; Temme, Achim; Schneider, Martin; Baenke, Franziska; Weitz, Juergen; Kahlert, Christoph			Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases	ONCOGENE			English	Article							TISSUE INHIBITOR; EXTRACELLULAR VESICLES; CANCER; MATRIX; METALLOPROTEINASES-1; PLASMA; NICHE	Molecular reprogramming of stromal microarchitecture by tumour-derived extracellular vesicles (EVs) is proposed to favour pre-metastatic niche formation. We elucidated the role of extravesicular tissue inhibitor of matrix metalloproteinase-1 (TIMP1(EV)) in pro-invasive extracellular matrix (ECM) remodelling of the liver microenvironment to aid tumour progression in colorectal cancer (CRC). Immunohistochemistry analysis revealed a high expression of stromal TIMP1 in the invasion front that was associated with poor progression-free survival in patients with colorectal liver metastases. Molecular analysis identified TIMP1(EV) enrichment in CRC-EVs as a major factor in the induction of TIMP1 upregulation in recipient fibroblasts. Mechanistically, we proved that EV-mediated TIMP1 upregulation in recipient fibroblasts induced ECM remodelling. This effect was recapitulated by human serum-derived EVs providing strong evidence that CRC release active EVs into the blood circulation of patients for the horizontal transfer of malignant traits to recipient cells. Moreover, EV-associated TIMP1 binds to HSP90AA, a heat-shock protein, and the inhibition of HSP90AA on human-derived serum EVs attenuates TIMP1(EV)-mediated ECM remodelling, rendering EV-associated TIMP1 a potential therapeutic target. Eventually, in accordance with REMARK guidelines, we demonstrated in three independent cohorts that EV-bound TIMP1 is a robust circulating biomarker for a non-invasive, preoperative risk stratification in patients with colorectal liver metastases.	[Rao, Venkatesh Sadananda; Gu, Qianyu; Lin, Kuailu; Ganig, Nicole; Thepkaysone, May-Linn; Wong, Fang Cheng; Polster, Heike; Seifert, Lena; Seifert, Adrian M.; Buck, Nathalie; Riediger, Carina; Baenke, Franziska; Weitz, Juergen; Kahlert, Christoph] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Tzschentke, Sandra] Goethe Univ, Univ Hosp Frankfurt, Dept Med Haematol Oncol, Frankfurt, Germany; [Seifert, Lena; Seifert, Adrian M.; Weitz, Juergen; Kahlert, Christoph] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Seifert, Lena; Seifert, Adrian M.; Weitz, Juergen; Kahlert, Christoph] Natl Ctr Tumor Dis, Partner Site Dresden, Heidelberg, Germany; [Weisse, Jonas; Gutschner, Tony] Martin Luther Univ Halle Wittenberg, Med Fac, Jr Res Grp RNA Biol & Pathogenesis, Halle An Der Saale, Germany; [Michen, Susanne; Temme, Achim] Tech Univ Dresden, Dept Neurosurg, Sect Expt Neurosurg & Tumour Immunol, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Schneider, Martin] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg	Kahlert, C (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.; Kahlert, C (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.	Christoph.Kahlert@uniklinikum-dresden.de	Seifert, Adrian M./AAL-3453-2021	Seifert, Adrian M./0000-0002-5329-3164	Roland-Ernst-Foundation, Dresden [5/15]; Deutsche Forschungsgemeinschaft (DFG) [KA 3511/3-1]	Roland-Ernst-Foundation, Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank all the patients and their families for agreeing to the use of their samples. We also thank the surgeons of the VTG department who performed the surgeries. Special thanks to Falk Zakrewski for his assistance with the digital slide scanner. This work was funded by the Roland-Ernst-Foundation, Dresden (project no. 5/15) and Deutsche Forschungsgemeinschaft (DFG) (KA 3511/3-1).	Aaberg-Jessen C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4179-y; Abdouh M, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0587-0; Angioni R, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1757900; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Baker-Williams AJ, 2019, CELL REP, V28, P1894, DOI 10.1016/j.celrep.2019.07.045; Bockelman C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4589-x; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Engstrand J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3925-x; Forte D, 2017, ONCOTARGET, V8, P2261, DOI 10.18632/oncotarget.13664; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Galindo-Hernandez O, 2013, ARCH MED RES, V44, P208, DOI 10.1016/j.arcmed.2013.03.002; Gong YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077366; Han L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0980-8; Hanamura N, 1997, INT J CANCER, V73, P10, DOI 10.1002/(SICI)1097-0215(19970926)73:1<10::AID-IJC2>3.0.CO;2-4; Holten-Andersen MN, 2005, INT J CANCER, V113, P198, DOI 10.1002/ijc.20566; Huang T, 2019, INT J BIOL SCI, V15, P1, DOI 10.7150/ijbs.27796; Kahlert C, 2008, ANTICANCER RES, V28, P1459; Kaushik S, 2016, CANCER METAST REV, V35, P655, DOI 10.1007/s10555-016-9650-0; Kim H, 2019, PROTEOME SCI, V17, DOI 10.1186/s12953-019-0154-z; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Kur P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082620; Lachowski D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43759-6; Lee JH, 2011, J GASTROINTEST LIVER, V20, P287; Liu LX, 2003, WORLD J GASTROENTERO, V9, P193, DOI 10.3748/wjg.v9.i2.193; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Park HK, 2020, EXP MOL MED, V52, P79, DOI 10.1038/s12276-019-0360-x; Pretzsch E, 2019, J ONCOL, V2019, DOI 10.1155/2019/7407190; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Robinson BK, 2016, BIOL OPEN, V5, P875, DOI 10.1242/bio.017632; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Sontake V, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91454; Takawale A, 2017, HYPERTENSION, V69, P1092, DOI 10.1161/HYPERTENSIONAHA.117.09045; Terpos E, 2010, LEUKEMIA RES, V34, P399, DOI 10.1016/j.leukres.2009.08.035; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tommelein J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00063; Vong Sylvia, 2011, Genes Cancer, V2, P1139, DOI 10.1177/1947601911423940; Weidle UH, 2017, CANCER GENOM PROTEOM, V14, P1, DOI 10.21873/cgp.20015; Wendler F, 2017, ONCOGENE, V36, P877, DOI 10.1038/onc.2016.253; Wurtz SO, 2008, MOL CELL PROTEOMICS, V7, P424, DOI 10.1074/mcp.M700305-MCP200; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9	42	4	4	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1809	1820		10.1038/s41388-022-02218-9	http://dx.doi.org/10.1038/s41388-022-02218-9		FEB 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35140332	Green Published, hybrid			2022-12-26	WOS:000753256900002
J	Gasilina, A; Yoon, HY; Jian, XY; Luo, RB; Randazzo, PA				Gasilina, Anjelika; Yoon, Hye-Young; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.			A lysine-rich cluster in the N-BAR domain of ARF GTPase-activating protein ASAP1 is necessary for binding and bundling actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; STRUCTURAL BASIS; TARGET PROTEIN; CELL MOTILITY; GAP; FAMILY; REGULATOR; IRSP53	Actin filament maintenance is critical for both normal cell homeostasis and events associated with malignant transformation. The ADP-ribosylation factor GTPase-activating protein ASAP1 regulates the dynamics of filamentous actin-based structures, including stress fibers, focal adhesions, and circular dorsal ruffles. Here, we have examined the molecular basis for ASAP1 association with actin. Using a combination of structural modeling, mutagenesis, and in vitro and cell-based assays, we identify a putative-binding interface between the N-Bin-Amphiphysin-Rvs (BAR) domain of ASAP1 and actin filaments. We found that neutralization of charges and charge reversal at positions 75, 76, and 79 of ASAP1 reduced the binding of ASAP1 BAR-pleckstrin homology tandem to actin filaments and abrogated actin bundle formation in vitro. In addition, overexpression of actin-binding defective ASAP1 BAR-pleckstrin homology [K75, K76, K79] mutants prevented cellular actin remodeling in U2OS cells. Exogenous expression of [K75E, K76E, K79E] mutant of full-length ASAP1 did not rescue the reduction of cellular actin fibers consequent to knockdown of endogenous ASAP1. Taken together, our results support the hypothesis that the lysine-rich cluster in the N-BAR domain of ASAP1 is important for regulating actin filament organization.	[Gasilina, Anjelika; Yoon, Hye-Young; Jian, Xiaoying; Luo, Ruibai; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gasilina, Anjelika] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Gasilina, Anjelika] NHLBI, Cell & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov		Yoon, Hye-Young/0000-0002-0526-0958	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [BC007365]	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services (project number BC007365 to P. A. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreev J, 1999, MOL CELL BIOL, V19, P2338; Beck MR, 2013, J MOL BIOL, V425, P3325, DOI 10.1016/j.jmb.2013.06.016; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Boraas LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195588; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Carman Peter J, 2018, Biophys Rev, V10, P1587, DOI 10.1007/s12551-018-0467-7; Chen PW, 2020, J BIOL CHEM, V295, P11303, DOI 10.1074/jbc.RA119.009903; Chen PW, 2016, J BIOL CHEM, V291, P7517, DOI 10.1074/jbc.M115.701292; Cui J, 2021, TUBERCULOSIS, V129, DOI 10.1016/j.tube.2021.102090; Tien DN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05094; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Drager NM, 2017, EMBO REP, V18, P2051, DOI 10.15252/embr.201744137; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Furman C, 2002, J BIOL CHEM, V277, P7962, DOI 10.1074/jbc.M109149200; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gasilina A, 2019, ISCIENCE, V22, P166, DOI 10.1016/j.isci.2019.11.015; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Haque A, 2011, CANCER IMMUNOL IMMUN, V60, P1439, DOI 10.1007/s00262-011-1048-9; He JC, 2020, ONCOGENE, V39, P4118, DOI 10.1038/s41388-020-1279-3; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Jian XY, 2015, STRUCTURE, V23, P1977, DOI 10.1016/j.str.2015.08.008; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; King FJ, 1999, MOL CELL BIOL, V19, P2330; Kostan J, 2014, EMBO REP, V15, P1154, DOI 10.15252/embr.201439267; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Misra A, 2012, INT J BIOCHEM CELL B, V44, P928, DOI 10.1016/j.biocel.2012.02.020; Muller T, 2010, ONCOGENE, V29, P2393, DOI 10.1038/onc.2010.6; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Oda A, 2003, J BIOL CHEM, V278, P6456, DOI 10.1074/jbc.M210817200; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Schevzov G, 2015, MOL BIOL CELL, V26, P2475, DOI 10.1091/mbc.E14-10-1453; Schreiber C, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008216; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Stanishneva-Konovalova TB, 2016, ACTA NATURAE, V8, P60, DOI 10.32607/20758251-2016-8-4-60-69; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9; Zhang T, 2018, ONCOL LETT, V15, P4432, DOI 10.3892/ol.2018.7834	52	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101700	10.1016/j.jbc.2022.101700	http://dx.doi.org/10.1016/j.jbc.2022.101700			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35143843	Green Published, gold			2022-12-26	WOS:000821054100001
J	Silva, RP; DiVenere, AM; Amengor, D; Maynard, JA				Silva, Rui P.; DiVenere, Andrea M.; Amengor, Dzifa; Maynard, Jennifer A.			Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P.69 PERTACTIN; IMMUNOLOGICAL-PROPERTIES; REGIONS; PARAPERTUSSIS; POLYMORPHISM; ADHERENCE; VACCINES; STRAINS; ADHESIN	Infection by the bacterium Bordetella pertussis continues to cause considerable morbidity and mortality worldwide. Many current acellular pertussis vaccines include the antigen pertactin, which has presumptive adhesive and immunomodulatory activities, but is rapidly lost from clinical isolates after the introduction of these vaccines. To better understand the contributions of pertactin antibodies to protection and pertactin's role in pathogenesis, we isolated and characterized recombinant antibodies binding four distinct epitopes on pertactin. We demonstrate that four of these antibodies bind epitopes that are conserved across all three classical Bordetella strains, and competition assays further showed that antibodies binding these epitopes are also elicited by B. pertussis infection of baboons. Surprisingly, we found that representative antibodies binding each epitope protected mice against experimental B. pertussis infection. A cocktail of antibodies from each epitope group protected mice against a subsequent lethal dose of B. pertussis and greatly reduced lung colonization levels after sublethal challenge. Each antibody reduced B. pertussis lung colonization levels up to 100-fold when administered individually, which was significantly reduced when antibody effector functions were impaired, with no antibody mediating antibody-dependent complement-induced lysis. These data suggest that antibodies binding multiple pertactin epitopes protect primarily by the same bactericidal mechanism, which overshadows contributions from blockade of other pertactin functions. These antibodies expand the available tools to further dissect pertactin's role in infection and understand the impact of antipertactin antibodies on bacterial fitness.	[Silva, Rui P.; Amengor, Dzifa; Maynard, Jennifer A.] Univ Texas, Dept Mol Biosci, Austin, TX USA; [DiVenere, Andrea M.] Univ Texas, Dept Chem Engn, Austin, TX USA; [Maynard, Jennifer A.] Univ Texas, LaMontagne Ctr Infect Dis, Austin, TX USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas, Dept Mol Biosci, Austin, TX USA.; Maynard, JA (corresponding author), Univ Texas, LaMontagne Ctr Infect Dis, Austin, TX USA.	maynard@che.utexas.edu		DiVenere, Andrea/0000-0001-9254-5347; Amengor, Dzifa/0000-0001-5705-3259	National Institutes of Health [AI122753, AI155453]; Welch Foundation [F-1767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by the National Institutes of Health (grant nos.: AI122753 and AI155453; to J. A. M.) and the Welch Foundation (grant no.: F-1767;to J. A. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NationalInstitutes of Health	Aase A, 2011, CLIN VACCINE IMMUNOL, V18, P1269, DOI 10.1128/CVI.05067-11; Arduin E, 2015, MOL IMMUNOL, V63, P456, DOI 10.1016/j.molimm.2014.09.017; Barkoff AM, 2019, EUROSURVEILLANCE, V24, P39, DOI 10.2807/1560-7917.ES.2019.24.7.1700832; Barnes MG, 2003, FEMS MICROBIOL LETT, V220, P271, DOI 10.1016/S0378-1097(03)00132-0; Barnes MG, 2002, INFECT IMMUN, V70, P403, DOI 10.1128/IAI.70.1.403-406.2002; Boehm DT, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00857-17; Boursaux-Eude C, 2000, INFECT IMMUN, V68, P4815, DOI 10.1128/IAI.68.8.4815-4817.2000; Brookes C, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0084-3; Carriquiriborde F, 2019, EMERG INFECT DIS, V25, P2048, DOI 10.3201/eid2511.190329; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Georgieva M, 2018, MBIO, V9, DOI 10.1128/mBio.00264-18; Goldsmith JA, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009920; GOTTO JW, 1993, INFECT IMMUN, V61, P2211, DOI 10.1128/IAI.61.5.2211-2215.1993; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Harvill ET, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01075-13; Hellwig SMM, 2003, J INFECT DIS, V188, P738, DOI 10.1086/377283; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hijnen M, 2004, INFECT IMMUN, V72, P3716, DOI 10.1128/IAI.72.7.3716-3723.2004; Hijnen M, 2007, VACCINE, V25, P5902, DOI 10.1016/j.vaccine.2007.05.039; Hovingh ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170027; Hovingh ES, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0039-8; Huang J., 2021, INFECT IMMUN, V89, P1; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kubler-Kielb J, 2011, P NATL ACAD SCI USA, V108, P4087, DOI 10.1073/pnas.1100782108; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Lesne E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02108; Ma LH, 2021, EMERG INFECT DIS, V27, P1561, DOI 10.3201/eid2706.203850; Martin SW, 2015, CLIN INFECT DIS, V60, P223, DOI 10.1093/cid/ciu788; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Nguyen AW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9258; Nguyen AW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0966; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Olin P, 2001, CLIN INFECT DIS, V33, pS288, DOI 10.1086/322564; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pawloski LC, 2014, CLIN VACCINE IMMUNOL, V21, P119, DOI 10.1128/CVI.00717-13; Plotkin SA, 2013, CLIN INFECT DIS, V56, P1458, DOI 10.1093/cid/cit048; Rodriguez ME, 2001, J IMMUNOL, V167, P6545, DOI 10.4049/jimmunol.167.11.6545; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Shin EK, 2007, J VET MED SCI, V69, P771, DOI 10.1292/jvms.69.771; Skopova K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00937-16; Thiriard A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00777; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6; Weingart CL, 2000, INFECT IMMUN, V68, P7175, DOI 10.1128/IAI.68.12.7175-7179.2000; Weiss AA, 2004, INFECT IMMUN, V72, P7346, DOI 10.1128/IAI.72.12.7346-7351.2004; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101715	10.1016/j.jbc.2022.101715	http://dx.doi.org/10.1016/j.jbc.2022.101715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151691	gold, Green Published			2022-12-26	WOS:000789394500003
J	Wu, RF; Cao, ST; Li, F; Feng, SC; Shu, G; Wang, LN; Gao, P; Zhu, XT; Zhu, CJ; Wang, SB; Jiang, QY				Wu, Ruifan; Cao, Shuting; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan			RNA-binding protein YBX1 promotes brown adipogenesis and thermogenesis via PINK1/PRKN-mediated mitophagy	FASEB JOURNAL			English	Article						adipogenesis; mitophagy; PINK1; PRKN; thermogenesis; YBX1	MESSENGER-RNA; ADIPOSE-TISSUE; YB-1; TRANSLATION; AUTOPHAGY	Promoting the thermogenic function of brown adipose tissue (BAT) is a promising strategy to combat obesity and metabolic disorders. While much is known about the transcriptional regulation of BAT activation, however, the underlying mechanism of post-transcriptional control by RNA binding proteins remains largely unknown. Here, we found that RNA binding protein Y-box binding protein 1 (YBX1) expression was abundant in BAT and induced by cold exposure and a beta-adrenergic agonist in mice. Loss-of-function experiments showed that YBX1 deficiency inhibited mouse primary brown adipocyte differentiation and thermogenic function. Further study showed that YBX1 positively regulates thermogenesis through enhancing mitophagy. Mechanistically, RNA immunoprecipitation identified that YBX1 directly targeted the transcripts of PTEN-induced kinase 1 (Pink1) and parkin RBR E3 ubiquitin-protein ligase (Prkn), two key regulators of mitophagy. RNA decay assay proved that loss of YBX1 decreased mRNA stability of Pink1 and Prkn, leading to reduced protein expression, thereby alleviating mitophagy and inhibiting thermogenic program. Importantly, in vivo experiments demonstrated that YBX1 overexpression in BAT promoted thermogenesis and mitophagy in mice. Collectively, our results reveal novel insight into the molecular mechanism of YBX1 in post-transcriptional regulation of PINK1/PRKN-mediated mitophagy and highlight the critical role of YBX1 in brown adipogenesis and thermogenesis.	[Wu, Ruifan; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou 510642, Peoples R China; [Wu, Ruifan; Li, Fan; Feng, Shengchun; Shu, Gang; Wang, Lina; Gao, Ping; Zhu, Xiaotong; Zhu, Canjun; Wang, Songbo; Jiang, Qingyan] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Peoples R China; [Cao, Shuting] Guangdong Acad Agr Sci, Guangdong Key Lab Anim Breeding & Nutr, Key Lab Anim Nutr & Feed Sci South China,Guangdon, Maoming Branch,Minist Agr,Inst Anim Sci,State Key, Guangzhou, Peoples R China	South China Agricultural University; South China Agricultural University; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Guangdong Lab Lingnan Modern Agr, Guangdong Prov Key Lab Anim Nutr Regulat, Guangzhou 510642, Peoples R China.; Jiang, QY (corresponding author), South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, Guangzhou 510642, Peoples R China.	qyjiang@scau.edu.cn	Wu, Ruifan/AHH-6097-2022	Wu, Ruifan/0000-0003-4917-5197	National Natural Science Foundation of China [31790411, 31972636]; China Postdoctoral Science Foundation [2021M691073]; GuangDong Basic and Applied Basic Research Foundation [2021A1515111085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); GuangDong Basic and Applied Basic Research Foundation	National Natural Science Foundation of China, Grant/Award Number: 31790411 and 31972636; China Postdoctoral Science Foundation, Grant/Award Number: 2021M691073; GuangDong Basic and Applied Basic Research Foundation, Grant/Award Number: 2021A1515111085	Altshuler-Keylin S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai9248; Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z; Cheng H, 2019, BBA-MOL BASIS DIS, V1865, P1451, DOI 10.1016/j.bbadis.2019.02.017; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; Drew BG, 2014, DIABETES, V63, P1488, DOI 10.2337/db13-0665; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Ferhat M, 2019, ANTIOXID REDOX SIGN, V31, P487, DOI 10.1089/ars.2018.7626; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Inagaki T, 2017, NAT REV MOL CELL BIO, V18, DOI 10.1038/nrm.2017.72; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143520; Ko MS, 2021, AUTOPHAGY, V17, P1205, DOI 10.1080/15548627.2020.1753002; Kwon E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04092-0; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26394-5; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Martinez-Lopez N, 2016, CELL METAB, V23, P113, DOI 10.1016/j.cmet.2015.10.008; Matsumoto S, 2012, BIOCHEM J, V443, P573, DOI 10.1042/BJ20111728; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mordovkina D, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040591; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Rabiee A, 2021, MOL METAB, V44, DOI 10.1016/j.molmet.2020.101137; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Seillier M, 2015, EMBO MOL MED, V7, P802, DOI 10.15252/emmm.201404318; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Wang T, 2019, EMBO REP, V20, DOI 10.15252/embr.201947892; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wu H, 2019, AUTOPHAGY, V15, P1882, DOI 10.1080/15548627.2019.1596482; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779; Xu D, 2017, DIABETES, V66, P2987, DOI 10.2337/db17-0655; Yau WW, 2019, AUTOPHAGY, V15, P131, DOI 10.1080/15548627.2018.1511263	38	1	1	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22219	10.1096/fj.202101810RR	http://dx.doi.org/10.1096/fj.202101810RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195911				2022-12-26	WOS:000761250800030
J	Gao, Q; Ming, DL				Gao, Qi; Ming, Dangling			Protein-protein interactions enhance the thermal resilience of SpyRing-cyclized enzymes: A molecular dynamic simulation study	PLOS ONE			English	Article							HOT-SPOTS; DIRECTED EVOLUTION; CYCLIZATION; SPYTAG/SPYCATCHER; SPYCATCHER; THERMOSTABILITY; OPTIMIZATION; RESIDUES; DOCKING; SPYTAG	Recently a technique based on the interaction between adhesion proteins extracted from Streptococcus pyogenes, known as SpyRing, has been widely used to improve the thermal resilience of enzymes, the assembly of biostructures, cancer cell recognition and other fields. It was believed that the covalent cyclization of protein skeleton caused by SpyRing reduces the conformational entropy of biological structure and improves its rigidity, thus improving the thermal resilience of the target enzyme. However, the effects of SpyTag/SpyCatcher interaction with this enzyme are poorly understood, and their regulation of enzyme properties remains unclear. Here, for simplicity, we took the single domain enzyme lichenase from Bacillus subtilis 168 as an example, studied the interface interactions in the SpyRing by molecular dynamics simulations, and examined the effects of the changes of electrostatic interaction and van der Waals interaction on the thermal resilience of target enzyme. The simulations showed that the interface between SpyTag/SpyCatcher and the target enzyme is different from that found by geometric matching method and highlighted key mutations at the interface that might have effect on the thermal resilience of the enzyme. Our calculations highlighted interfacial interactions between enzyme and SpyTag/SpyCatcher, which might be useful in rational designs of the SpyRing.	[Gao, Qi; Ming, Dangling] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University	Ming, DL (corresponding author), Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	dming@njtech.edu.cn			National Key Research and Development Program of China [2019YFA0905700, 2017YFC1600900]	National Key Research and Development Program of China	This work was supported, in part, by the National Key Research and Development Program of China (Grant No. 2019YFA0905700, 2017YFC1600900) to DM. We are grateful to the High Performance Computing Center of Nanjing Tech University for supporting the computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Cao Y, 2017, CHEM COMMUN, V53, P8830, DOI 10.1039/c7cc04507g; Cisneros G Andres, 2013, Methods Mol Biol, V924, P243, DOI 10.1007/978-1-62703-017-5_10; Community A, 2018, STUDENT SUPER COMPUT, P193; Dai WT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0351-7; Deschuyteneer G, 2010, ACS CHEM BIOL, V5, P691, DOI 10.1021/cb100072u; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Keeble AH, 2019, P NATL ACAD SCI USA, V116, P26523, DOI 10.1073/pnas.1909653116; Keeble AH, 2017, ANGEW CHEM INT EDIT, V56, P16521, DOI 10.1002/anie.201707623; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717; Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021; Li Shuang, 2012, Comput Struct Biotechnol J, V2, pe201209017, DOI 10.5936/csbj.201209017; Liu YJ, 2017, CHEM SCI, V8, P6577, DOI 10.1039/c7sc02686b; Marze NA, 2018, BIOINFORMATICS, V34, P3461, DOI 10.1093/bioinformatics/bty355; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Porebski BT, 2016, PROTEIN ENG DES SEL, V29, P245, DOI 10.1093/protein/gzw015; Reddington SC, 2015, CURR OPIN CHEM BIOL, V29, P94, DOI 10.1016/j.cbpa.2015.10.002; Reetz MT, 2009, ANGEW CHEM INT EDIT, V48, P8268, DOI 10.1002/anie.200904209; Schoene C, 2016, METHOD ENZYMOL, V580, P149, DOI 10.1016/bs.mie.2016.05.004; Schoene C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21151; Schoene C, 2014, ANGEW CHEM INT EDIT, V53, P6101, DOI 10.1002/anie.201402519; Schumann FH, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00026; Si M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162318; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Sun XB, 2019, NEW BIOTECHNOL, V49, P28, DOI 10.1016/j.nbt.2018.12.003; Tam JP, 2012, J BIOL CHEM, V287, P27020, DOI 10.1074/jbc.R111.323568; Tian JW, 2021, BIOTECHNOL LETT, V43, P1075, DOI 10.1007/s10529-021-03098-x; Tsai MY, 2016, PROTEIN SCI, V25, P255, DOI 10.1002/pro.2751; Wang JD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0490-5; Wang YD, 2019, BIOTECHNOL LETT, V41, P987, DOI 10.1007/s10529-019-02689-z; Wang Y, 2020, PROCESS BIOCHEM, V95, P260, DOI 10.1016/j.procbio.2020.02.019; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Wu Z, 2019, P NATL ACAD SCI USA, V116, P8852, DOI 10.1073/pnas.1901979116; Xu Q, 2019, PROCESS BIOCHEM, V80, P64, DOI 10.1016/j.procbio.2019.02.008; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Yang HQ, 2015, CHEMBIOENG REV, V2, P87, DOI 10.1002/cben.201400032; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001; Zhou YB, 2020, WORLD J MICROB BIOT, V36, DOI 10.1007/s11274-020-2809-4	53	1	1	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263792	10.1371/journal.pone.0263792	http://dx.doi.org/10.1371/journal.pone.0263792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176056	Green Submitted, gold, Green Published			2022-12-26	WOS:000777505200032
J	Mignan, A; Spada, M; Burgherr, P; Wang, ZQ; Sornette, D				Mignan, Arnaud; Spada, Matteo; Burgherr, Peter; Wang, Ziqi; Sornette, Didier			Dynamics of severe accidents in the oil & gas energy sector derived from the authoritative ENergy-related severe accident database	PLOS ONE			English	Article							RISK-ASSESSMENT; VULNERABILITY; INDUSTRIES; STRATEGIES; CENTRALITY; NETWORKS; FAILURE; ANALYZE; MODELS; IMPACT	Organized into a global network of critical infrastructures, the oil & gas industry remains to this day the main energy contributor to the world's economy. Severe accidents occasionally occur resulting in fatalities and disruption. We build an oil & gas accident graph based on more than a thousand severe accidents for the period 1970-2016 recorded for refineries, tankers, and gas networks in the authoritative ENergy-related Severe Accident Database (ENSAD). We explore the distribution of potential chains-of-events leading to severe accidents by combining graph theory, Markov analysis and catastrophe dynamics. Using centrality measures, we first verify that human error is consistently the main source of accidents and that explosion, fire, toxic release, and element rupture are the principal sinks, but also the main catalysts for accident amplification. Second, we quantify the space of possible chains-of-events using the concept of fundamental matrix and rank them by defining a likelihood-based importance measure.. We find that chains of up to five events can play a significant role in severe accidents, consisting of feedback loops of the aforementioned events but also of secondary events not directly identifiable from graph topology and yet participating in the most likely chains-of-events.	[Mignan, Arnaud; Sornette, Didier] Southern Univ Sci & Technol SUSTech, Acad Adv Interdisciplinary Studies, Inst Risk Anal Predict & Management Risks X, Shenzhen, Peoples R China; [Mignan, Arnaud] Southern Univ Sci & Technol SUSTech, Dept Earth & Space Sci, Shenzhen, Peoples R China; [Mignan, Arnaud; Spada, Matteo; Burgherr, Peter] Paul Scherrer Inst PSI, Lab Energy Syst Anal, Villigen, Switzerland; [Spada, Matteo] Zurich Univ Appl Sci ZHAW, Inst Sustainable Dev, Winterthur, Switzerland; [Wang, Ziqi] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Sornette, Didier] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland	Southern University of Science & Technology; Southern University of Science & Technology; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Zurich University of Applied Sciences; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mignan, A (corresponding author), Southern Univ Sci & Technol SUSTech, Acad Adv Interdisciplinary Studies, Inst Risk Anal Predict & Management Risks X, Shenzhen, Peoples R China.; Mignan, A (corresponding author), Southern Univ Sci & Technol SUSTech, Dept Earth & Space Sci, Shenzhen, Peoples R China.; Mignan, A (corresponding author), Paul Scherrer Inst PSI, Lab Energy Syst Anal, Villigen, Switzerland.	mignana@sustech.edu.cn		Wang, Ziqi/0000-0002-2610-2158; Mignan, Arnaud/0000-0002-2167-7534	National Natural Science Foundation of China [42074054]; Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE); Future Resilient Systems (FRS) I program at the Singapore-ETH Centre (SEC) [FI 370074011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE); Future Resilient Systems (FRS) I program at the Singapore-ETH Centre (SEC)	A.M. received funding from the National Natural Science Foundation of China (grant no. 42074054) as well as from the Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE, http://www.sccer-soe.ch).P.B.and M.S. acknowledge additional support from the Future Resilient Systems (FRS) I program at the Singapore-ETH Centre (SEC), which was established collaboratively between ETH Zurich and Singapore's National Research Foundation (FI 370074011) under its Campus for Research Excellence and Technological Enterprise programme. Competing interests: The authors have declared that no competing interests exist.	Baalisampang T, 2019, PROCESS SAF ENVIRON, V128, P259, DOI 10.1016/j.psep.2019.06.005; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Burgherr P, 2019, P 29 EUR SAF REL C S, P1525; Burgherr P, 2008, HUM ECOL RISK ASSESS, V14, P947, DOI 10.1080/10807030802387556; Burgherr P, 2018, SAFETY AND RELIABILITY - SAFE SOCIETIES IN A CHANGING WORLD, P1681; Burgherr P, 2014, ENERG POLICY, V74, pS45, DOI 10.1016/j.enpol.2014.01.035; Cheng CW, 2013, J LOSS PREVENT PROC, V26, P1269, DOI 10.1016/j.jlp.2013.07.002; Chernov D, 2016, MAN MADE CATASTROPHE; Cinelli M, 2019, ENERGIES, V12, DOI 10.3390/en12214178; Cochran JK, 2001, COMPUT OPER RES, V28, P1, DOI 10.1016/S0305-0548(99)00082-9; Esposito S, 2020, J INFRASTRUCT SYST, V26, DOI 10.1061/(ASCE)IS.1943-555X.0000520; Farrell AE, 2004, ANNU REV ENV RESOUR, V29, P421, DOI 10.1146/annurev.energy.29.062403.102238; Felder FA, 2009, ENERG POLICY, V37, P5744, DOI 10.1016/j.enpol.2009.08.059; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Helbing D, 2003, PHYSICA A, V328, P584, DOI 10.1016/S0378-4371(03)00519-3; Hirschberg S, 2004, J HAZARD MATER, V111, P57, DOI 10.1016/j.jhazmat.2004.02.009; Inhaber H, 1981, MEASUREMENT RISKS EN, V21, P295; Isimite J, 2016, J LOSS PREVENT PROC, V40, P496, DOI 10.1016/j.jlp.2016.01.025; Khakzad N, 2015, RELIAB ENG SYST SAFE, V143, P63, DOI 10.1016/j.ress.2015.04.015; Khan FI, 2007, J LOSS PREVENT PROC, V20, P387, DOI 10.1016/j.jlp.2007.04.037; Khan FI, 1999, J LOSS PREVENT PROC, V12, P361, DOI 10.1016/S0950-4230(98)00062-X; Khan FI, 1998, J LOSS PREVENT PROC, V11, P261, DOI 10.1016/S0950-4230(97)00051-X; Khan FI, 1998, PROCESS SAF PROG, V17, P107, DOI 10.1002/prs.680170207; Kim W, 2018, BIG EARTH DATA, V2, P368, DOI 10.1080/20964471.2019.1586276; Krausmann E, 2013, NAT HAZARDS, V67, P811, DOI 10.1007/s11069-013-0607-0; McCollum DL, 2020, NAT ENERGY, V5, P104, DOI 10.1038/s41560-020-0555-3; Meel A, 2007, J LOSS PREVENT PROC, V20, P113, DOI 10.1016/j.jlp.2006.10.003; Mignan A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197317; Mignan A, 2016, DISASTER PREV MANAG, V25, P329, DOI 10.1108/DPM-06-2015-0137; Mignan A, 2014, NAT HAZARDS, V73, P1999, DOI 10.1007/s11069-014-1178-4; Moura R, 2017, SAFETY SCI, V99, P196, DOI 10.1016/j.ssci.2017.05.001; Nwankwo CD, 2022, INT J OCCUP SAF ERGO, V28, P1642, DOI 10.1080/10803548.2021.1916238; Otto C, 2020, NAT ENERGY, V5, P111, DOI 10.1038/s41560-020-0562-4; Qin RS, 2020, INT J DISAST RISK RE, V45, DOI 10.1016/j.ijdrr.2019.101453; Rocha JC, 2018, SCIENCE, V362, P1379, DOI 10.1126/science.aat7850; Sornette D, 2013, INT J DISAST RISK RE, V6, P59, DOI 10.1016/j.ijdrr.2013.04.002; Sovacool BK, 2008, ENERG POLICY, V36, P1802, DOI 10.1016/j.enpol.2008.01.040; Spada M, 2018, SAFETY AND RELIABILITY - SAFE SOCIETIES IN A CHANGING WORLD, P1673; Spada M, 2019, P 29 EUR SAF REL C S, P1423; Spada M, 2021, GEOTHERMICS, V95, DOI 10.1016/j.geothermics.2021.102142; Spada M, 2018, INT J HYDROGEN ENERG, V43, P9470, DOI 10.1016/j.ijhydene.2018.04.004; Stergiopoulos G, 2015, INT J CRIT INFR PROT, V10, P34, DOI 10.1016/j.ijcip.2015.05.003; Swanson L, 2001, INT J PROD ECON, V70, P237, DOI 10.1016/S0925-5273(00)00067-0; Tang P, 2019, INT J DISAST RISK RE, V35, DOI 10.1016/j.ijdrr.2019.101065; Ugurlu O, 2015, J MAR SCI TECH-TAIW, V23, P748, DOI 10.6119/JMST-015-0615-1; Wan Z, 2018, NATURE, V560, P161, DOI 10.1038/d41586-018-05852-0; Woo G, 2018, SEISMOL RES LETT, V89, P2266, DOI 10.1785/0220180138; Yuan CF, 2019, J HAZARD TOXIC RADIO, V23, DOI 10.1061/(ASCE)HZ.2153-5515.0000432; Zio E, 2016, RELIAB ENG SYST SAFE, V152, P137, DOI 10.1016/j.ress.2016.02.009	49	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263962	10.1371/journal.pone.0263962	http://dx.doi.org/10.1371/journal.pone.0263962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176103	Green Published, gold			2022-12-26	WOS:000777505200053
J	Mizuno, H; Sekine, A; Suwabe, T; Ikuma, D; Yamanouchi, M; Hasegawa, E; Sawa, N; Ubara, Y; Hoshino, J				Mizuno, Hiroki; Sekine, Akinari; Suwabe, Tatsuya; Ikuma, Daisuke; Yamanouchi, Masayuki; Hasegawa, Eiko; Sawa, Naoki; Ubara, Yoshifumi; Hoshino, Junichi			Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use	PLOS ONE			English	Article							KIDNEY-DISEASE; SOMATOSTATIN ANALOGS; BILIARY EPITHELIUM; POOLED ANALYSIS; HEPATIC CYSTS; THERAPY; DIAGNOSIS	Polycystic liver disease (PLD) is a common extrarenal complication of autosomal dominant polycystic kidney disease (ADPKD), which causes compression-related syndrome and ultimately leads to liver dysfunction. Tolvaptan, a V2 receptor antagonist, is widely used to protect kidney function in ADPKD but its effect on PLD remains unknown. An observational cohort study was conducted to evaluate tolvaptan's effect on patients with PLD due to ADPKD. After screening 902 patients, we found the 107 ADPKD patients with PLD who met the criteria of tolvaptan use in Japan. Among them, tolvaptan was prescribed for 62 patients (tolvaptan group), while the other was defined as the non-tolvaptan group. Compared with the non-tolvaptan group, the tolvaptan group had larger height-adjusted total kidney volume (median 994(range 450-4152) mL/m, 513 (405-1928) mL/m, p = 0.01), lower albumin level (mean 3.9 +/- SD 0.4 g/dL, 4.3 +/- 0.4g/dL, p<0.01), and higher serum creatinine level (1.2 +/- 0.4 mg/dL, 0.9 +/- 0.2 mg/dL, p<0.01). Although the median change in annual growth rate of total liver volume (TLV) was not statistically different between the tolvaptan group (-0.8 (-15.9, 16.7) %/year) and the non-tolvaptan group (1.7 (-15.6-18.7) %/year)(p = 0.52), 20 (43.5%) patients in the tolvaptan group experienced a decrease in the growth rate of TLV (responders). A multivariable logistic regression model adjusting for related variables showed that older age (odds ratio 1.15 [95% CI 1.01-1.32]) and a higher growth rate of TLV in the non-tolvaptan period (odds 1.45 95% CI 1.10-1.90) were significantly associated with responders. In conclusion, the change in annual growth rate of TLV in ADPKD patients taking tolvaptan was not statistically different compared with that in ADPKD patients without taking tolvaptan. However, tolvaptan may have the potential to suppress the growth rate of TLV in some PLD patients due to ADPKD, especially in older patients or those that are rapid progressors of PLD. Several limitations were included in this study, therefore well-designed prospective studies were required to confirm the effect of tolvaptan on PLD.	[Mizuno, Hiroki; Suwabe, Tatsuya; Ikuma, Daisuke; Yamanouchi, Masayuki; Sawa, Naoki; Ubara, Yoshifumi] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan; [Mizuno, Hiroki; Hoshino, Junichi] Okinaka Mem Inst Med Res, Tokyo, Japan; [Sekine, Akinari; Hasegawa, Eiko; Hoshino, Junichi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan	Toranomon Hospital	Mizuno, H (corresponding author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan.; Mizuno, H (corresponding author), Okinaka Mem Inst Med Res, Tokyo, Japan.	hilomiz@yahoo.co.jp			Otuska pharmaceutical company [IST-JPN-000230]	Otuska pharmaceutical company	This study was supported by the grant from Otuska pharmaceutical company (IST-JPN-000230), however, this does not alter our adherence to PLOS ONE policies on sharing data and materials.	Alvaro D, 2000, GASTROENTEROLOGY, V119, P1681, DOI 10.1053/gast.2000.20184; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Bennett H, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1290-5; Bernts LHP, 2019, SURG ENDOSC, V33, P691, DOI 10.1007/s00464-018-6490-8; Chebib FT, 2016, NEPHROL DIAL TRANSPL, V31, P952, DOI 10.1093/ndt/gfw008; Chrispijn M, 2012, ALIMENT PHARM THER, V35, P266, DOI 10.1111/j.1365-2036.2011.04923.x; Cornec-Le Gall E, 2018, NEPHROL DIAL TRANSPL, V33, P645, DOI 10.1093/ndt/gfx188; D'Agnolo HMA, 2017, TRANSPL INT, V30, P76, DOI 10.1111/tri.12875; Drenth JPH, 2010, HEPATOLOGY, V52, P2223, DOI 10.1002/hep.24036; Gevers TJG, 2015, LIVER INT, V35, P1607, DOI 10.1111/liv.12726; Gevers TJG, 2013, GASTROENTEROLOGY, V145, P357, DOI 10.1053/j.gastro.2013.04.055; Gevers TJG, 2013, NAT REV GASTRO HEPAT, V10, P101, DOI 10.1038/nrgastro.2012.254; Hogan MC, 2015, MAYO CLIN PROC, V90, P1030, DOI 10.1016/j.mayocp.2015.05.011; Hogan MC, 2012, NEPHROL DIAL TRANSPL, V27, P3532, DOI 10.1093/ndt/gfs152; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Hoshino J, 2014, AM J KIDNEY DIS, V63, P937, DOI 10.1053/j.ajkd.2014.01.422; Irazabal MV, 2016, KIDNEY INT REP, V1, P213, DOI 10.1016/j.ekir.2016.08.001; Mancinelli R, 2016, LAB INVEST, V96, P1147, DOI 10.1038/labinvest.2016.93; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mizuno H, 2017, CASE REP NEPHROL DIA, V7, P108, DOI 10.1159/000477664; Mutig K, 2007, AM J PHYSIOL-RENAL, V293, pF1166, DOI 10.1152/ajprenal.00196.2007; Neijenhuis MK, 2015, ALIMENT PHARM THER, V42, P591, DOI 10.1111/apt.13301; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Sakai K, 2020, BIOCHEM BIOPH RES CO, V524, P710, DOI 10.1016/j.bbrc.2020.01.142; Takenaka T, 2020, CLIN MOL HEPATOL, V26, P70, DOI 10.3350/cmh.2019.0026; Torres VE, 2017, NEW ENGL J MED, V377, P1930, DOI 10.1056/NEJMoa1710030; Torres VE, 2016, CLIN J AM SOC NEPHRO, V11, P803, DOI 10.2215/CJN.06300615; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; van Aerts RMM, 2019, GASTROENTEROLOGY, V157, P481, DOI 10.1053/j.gastro.2019.04.018; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; VANSONNENBERG E, 1994, RADIOLOGY, V190, P387, DOI 10.1148/radiology.190.2.8284385	32	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264065	10.1371/journal.pone.0264065	http://dx.doi.org/10.1371/journal.pone.0264065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176098	Green Published, gold			2022-12-26	WOS:000777505200072
J	Teo, KY; Daescu, O; Cederberg, K; Sengupta, A; Leavey, PJ				Teo, Ka Yaw; Daescu, Ovidiu; Cederberg, Kevin; Sengupta, Anita; Leavey, Patrick J.			Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy	PLOS ONE			English	Article							PEDIATRIC MUSCULOSKELETAL TUMORS; NEOADJUVANT CHEMOTHERAPY; EWING SARCOMA; BONE-TUMORS; ADJUVANT CHEMOTHERAPY; NECROSIS; SURVIVAL; MRI; METASTASES; RESISTANCE	Background Osteosarcoma, which is the most common malignant pediatric bone cancer, remains dependent on an imprecise systemic treatment largely unchanged in 30 years. In this study, we correlated histopathology with magnetic resonance imaging (MRI), used the correlation to extract MRI-specific features representative of tumor necrosis, and subsequently developed a novel classification model for predicting tumor response to neoadjuvant chemotherapy in pediatric patients with osteosarcoma using multi-modal MRI. The model could ultimately serve as a testable biomarker for a high-risk malignancy without successful precision treatments. Methods Patients with newly diagnosed high-grade appendicular osteosarcoma were enrolled in a single-center observational study, wherein patients underwent pre-surgical evaluation using both conventional MRI (post-contrast T1-weighted with fat saturation, pre-contrast T1-weighted, and short inversion-time inversion recovery (STIR)) and advanced MRI (diffusion weighted (DW) and dynamic contrast enhanced (DCE)). A classification model was established based on a direct correlation between histopathology and MRI, which was achieved through histologic-MR image co-registration and subsequent extraction of MR image features for identifying histologic tumor necrosis. By operating on the MR image features, tumor necrosis was estimated from different combinations of MR images using a multi-feature fuzzy clustering technique together with a weighted majority ruling. Tumor necrosis calculated from MR images, for either an MRI plane of interest or whole tumor volume, was compared to pathologist-estimated necrosis and necrosis quantified from digitized histologic section images using a previously described deep learning classification method. Results 15 patients were enrolled, of whom two withdrew, one became ineligible, and two were subjected to inadequate pre-surgical imaging. MRI sequences of n = 10 patients were subsequently used for classification model development. Different MR image features, depending on the modality of MRI, were shown to be significant in distinguishing necrosis from viable tumor. The scales at which MR image features optimally signified tumor necrosis were different as well depending on the MR image type. Conventional MRI was shown capable of differentiating necrosis from viable tumor with an accuracy averaging above 90%. Conventional MRI was equally effective as DWI in distinguishing necrotic from viable tumor regions. The accuracy of tumor necrosis prediction by conventional MRI improved to above 95% when DCE-MRI was added into consideration. Volume-based tumor necrosis estimations tended to be lower than those evaluated on an MRI plane of interest. Conclusions The study has shown a proof-of-principle model for interpreting chemotherapeutic response using multi-modal MRI for patients with high-grade osteosarcoma. The model will continue to be evaluated as MR image features indicative of tumor response are now computable for the disease prior to surgery.	[Teo, Ka Yaw; Daescu, Ovidiu] Univ Texas Dallas, Dept Comp Sci, Richardson, TX 75083 USA; [Cederberg, Kevin] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA; [Sengupta, Anita] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Leavey, Patrick J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Teo, KY (corresponding author), Univ Texas Dallas, Dept Comp Sci, Richardson, TX 75083 USA.	ka.teo@utdallas.edu		Leavey, Patrick/0000-0002-0541-2536	Cancer Prevention and Research Institute of Texas (CPRIT) [RP150164]	Cancer Prevention and Research Institute of Texas (CPRIT)	This research was supported by the Cancer Prevention and Research Institute of Texas (CPRIT) under Grant No. RP150164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Priyadarshi, 2015, Indian J Radiol Imaging, V25, P269, DOI 10.4103/0971-3026.161452; Armaselu B, 2016, P INT C BIOINF COMP, P67; Armaselu B, 2019, P INT C IM PROC COMP, P65; Arunachalam HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210706; Arunachalam HB, 2017, BIOCOMPUT-PAC SYM, P195, DOI 10.1142/9789813207813_0020; Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Baunin C, 2012, SKELETAL RADIOL, V41, P1141, DOI 10.1007/s00256-012-1360-2; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BONNEROT V, 1992, INVEST RADIOL, V27, P847, DOI 10.1097/00004424-199210000-00016; Byun BH, 2013, J NUCL MED, V54, P1053, DOI 10.2967/jnumed.112.115964; Cademartiri Filippo, 2008, Acta Biomed, V79, P85; Campanacci M., BONE SOFT TISSUE TUM; Cormier JN, 2004, CA-CANCER J CLIN, V54, P94, DOI 10.3322/canjclin.54.2.94; Dasarathy BV, 2012, INFORM FUSION, V13, P1, DOI 10.1016/j.inffus.2011.06.003; DEBAERE T, 1992, RADIOLOGY, V185, P587, DOI 10.1148/radiology.185.2.1410378; Degnan AJ, 2018, CLIN IMAG, V47, P9, DOI 10.1016/j.clinimag.2017.08.003; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eftekhari F, 2009, CANCER TREAT RES, V152, P33, DOI 10.1007/978-1-4419-0284-9_3; EILBER F, 1987, J CLIN ONCOL, V5, P21, DOI 10.1200/JCO.1987.5.1.21; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; ERLEMANN R, 1990, RADIOLOGY, V175, P791, DOI 10.1148/radiology.175.3.2188300; FLETCHER BD, 1991, AM J ROENTGENOL, V157, P825, DOI 10.2214/ajr.157.4.1892044; FLETCHER BD, 1992, RADIOLOGY, V184, P243, DOI 10.1148/radiology.184.1.1319075; Fukuda T, 2019, J MAGN RESON IMAGING, V50, P702, DOI 10.1002/jmri.26672; Galban CJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3458; GOLFIERI R, 1990, BRIT J RADIOL, V63, P251, DOI 10.1259/0007-1285-63-748-251; Guo J, 2015, BRIT J CANCER, V113, P1282, DOI 10.1038/bjc.2015.351; Guo JY, 2012, CANCER-AM CANCER SOC, V118, P3776, DOI 10.1002/cncr.26701; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hayashida Y, 2006, EUR RADIOL, V16, P2637, DOI 10.1007/s00330-006-0342-y; Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111; HOLSCHER HC, 1992, RADIOLOGY, V182, P839, DOI 10.1148/radiology.182.3.1535905; HUVOS AG, 1977, ARCH PATHOL LAB MED, V101, P14; James AP, 2014, INFORM FUSION, V19, P4, DOI 10.1016/j.inffus.2013.12.002; James AP, 2017, MULTISENS DATA FUSIO, P491; Kang JW, 2017, INT J CLIN EXP PATHO, V10, P359; Kubo T, 2017, MOL CLIN ONCOL, V7, P88, DOI 10.3892/mco.2017.1273; Kubo T, 2016, SKELETAL RADIOL, V45, P1235, DOI 10.1007/s00256-016-2410-y; Lee MJ, 2019, MAGN RESON IMAGING C, V27, P341, DOI 10.1016/j.mric.2019.01.010; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu LP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001998; Materka Andrzej, 2004, Dialogues Clin Neurosci, V6, P243; Mishra R, 2018, J COMPUT BIOL, V25, P313, DOI 10.1089/cmb.2017.0153; Monsky WL, 2012, ANTICANCER RES, V32, P4951; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; Oka K, 2010, SKELETAL RADIOL, V39, P141, DOI 10.1007/s00256-009-0830-7; Reischauer C, 2016, J MAGN RESON IMAGING, V43, P1407, DOI 10.1002/jmri.25102; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Saifuddin A, 2019, SKELETAL RADIOL, V48, P503, DOI 10.1007/s00256-018-3079-1; Shapeero L G, 2000, Semin Musculoskelet Radiol, V4, P137, DOI 10.1055/s-2000-6861; Shapeero Lorraine G., 1999, Semin Musculoskelet Radiol, V3, P101, DOI 10.1055/s-2008-1080055; Silva FD, 2014, CURR RADIOL REP, V2, P77; Smeland S, 2019, EUR J CANCER, V109, P36, DOI 10.1016/j.ejca.2018.11.027; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stitzlein RN, 2017, JBJS REV, V5, DOI 10.2106/JBJS.RVW.17.00030; Subhawong TK, 2014, RADIOGRAPHICS, V34, P1163, DOI 10.1148/rg.345140190; SZYMKIEWICZ DEZYDERY, 1934, ACTA SOC BOT POLON, V11, P249; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tokuda O, 2004, J MAGN RESON IMAGING, V19, P475, DOI 10.1002/jmri.20031; Torricelli P, 2001, Radiol Med, V101, P145; Uhl M, 2006, INVEST RADIOL, V41, P618, DOI 10.1097/01.rli.0000225398.17315.68; Uhl M, 2006, PEDIATR RADIOL, V36, P1306, DOI 10.1007/s00247-006-0324-x; van der Woude HJ, 1998, SKELETAL RADIOL, V27, P57, DOI 10.1007/s002560050339; VANDERWOUDE HJ, 1995, AM J ROENTGENOL, V165, P593, DOI 10.2214/ajr.165.3.7645476; VERSTRAETE KL, 1994, RADIOLOGY, V192, P835, DOI 10.1148/radiology.192.3.8058957; Verstraete KL, 1996, JMRI-J MAGN RESON IM, V6, P311, DOI 10.1002/jmri.1880060210; Wang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072679; Yaghmai V, 2011, AM J ROENTGENOL, V197, P18, DOI 10.2214/AJR.11.6581; Yao K, 2016, CLIN RADIOL, V71, P1071, DOI 10.1016/j.crad.2016.07.007; Zhang B. T., 2019, SN COMPREHENSIVE CLI, V1, P319, DOI [10.1007/s42399-019-00059-4, DOI 10.1007/S42399-019-00059-4]	71	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0259564	10.1371/journal.pone.0259564	http://dx.doi.org/10.1371/journal.pone.0259564			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157711	Green Published, gold			2022-12-26	WOS:000788004500002
J	Lin, YZ; De Araujo, I; Stanley, G; Small, D; Geha, P				Lin, Yezhe; De Araujo, Ivan; Stanley, Gelsina; Small, Dana; Geha, Paul			Chronic pain precedes disrupted eating behavior in low-back pain patients	PLOS ONE			English	Article							DOPAMINE D2 RECEPTORS; NUCLEUS-ACCUMBENS; PHYSICAL-ACTIVITY; PRELIMINARY VALIDATION; REWARD; OBESITY; BRAIN; FOOD; QUESTIONNAIRE; PLEASURE	Chronic pain is associated with anhedonia and decreased motivation. These behavioral alterations have been linked to alterations in the limbic brain and could explain the increased risk for obesity in pain patients. The mechanism of these behavioral changes and how they set in in relation to the development of chronic pain remain however poorly understood. Here we asked how eating behavior was affected in low-back pain patients before and after they transitioned to chronic pain, compared to patients whose pain subsided. Additionally, we assessed how the hedonic perception of fat-rich food, which is altered in chronic pain patients, related to the properties of the nucleus accumbens in this patients' population. We hypothesized that the accumbens would be directly implicated in the hedonic processing of fat-rich food in pain patients because of its well-established role in hedonic feeding and fat ingestion, and its emerging role in chronic pain. Accordingly, we used behavioral assays and structural brain imaging to test sub-acute back pain patients (SBPr) and healthy control subjects at baseline and at approximately one-year follow-up. We also studied a sample of chronic low-back pain patients (CLBP) at one time point only. We found that SBP patients who recovered at follow-up (SBPr) and CLBP patients showed disrupted eating behaviors. In contrast, SBP patients who persisted in having pain at follow-up (SBPp) showed intact eating behavior. From a neurological standpoint, only SBPp and CLBP patients showed a strong and direct relationship between hedonic perception of fat-rich food and nucleus accumbens volume. This suggests that accumbens alterations observed in SBPp patients in previous works might protect them from hedonic eating disruptions during the early course of the illness. We conclude that disrupted eating behavior specifically sets in after pain chronification and is accompanied by structural changes in the nucleus accumbens.	[Lin, Yezhe; Geha, Paul] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [De Araujo, Ivan] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Stanley, Gelsina; Small, Dana; Geha, Paul] John B Pierce Lab, New Haven, CT USA; [Stanley, Gelsina; Small, Dana; Geha, Paul] Yale Univ, Dept Psychiat, Yale Sch Med, New Haven, CT 06520 USA	University of Rochester; Icahn School of Medicine at Mount Sinai; Yale University; The John B Pierce Laboratory, Inc; Yale University	Geha, P (corresponding author), Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA.; Geha, P (corresponding author), Yale Univ, Dept Psychiat, Yale Sch Med, New Haven, CT 06520 USA.	paul_geha@urmc.rochester.edu	Lin, Yezhe Bee/AAG-9770-2019	Lin, Yezhe Bee/0000-0001-6652-2109; Geha, Paul/0000-0002-0537-7216	National Institute on Drug Abuse [5K08DA037525]	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse 5K08DA037525 Dr. Paul Geha Department of Psychiatry at the Yale School of Medicine Dr. Paul Geha School fo Medicine and Dentistry, University of Rochester Dr. Paul Geha The Del Monte Neuroscience Institute Dr. Paul Geha The Funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen SA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3696-3; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baldo BA., 2010, CONTROL FAT INTAKE S; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beck A., 1993, MANUAL BECK ANXIETY; Beck A., 1993, BECK DEPRESSION INVE; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Berthoud HR, 2017, GASTROENTEROLOGY, V152, P1728, DOI 10.1053/j.gastro.2016.12.050; Boehme R, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050306; Bousema EJ, 2007, PAIN, V130, P279, DOI 10.1016/j.pain.2007.03.024; Brady SRE, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1953-4; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Case LK, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0138-15.2016; Cho JH, 2018, J ADOLESCENT HEALTH, V63, P81, DOI 10.1016/j.jadohealth.2017.12.022; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Araujo IE, 2020, ANNU REV PSYCHOL, V71, P139, DOI 10.1146/annurev-psych-122216-011643; De Lorenzo A, 2013, INT J CARDIOL, V166, P111, DOI 10.1016/j.ijcard.2011.10.006; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Elman I, 2016, NEURON, V89, P11, DOI 10.1016/j.neuron.2015.11.027; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Garland EL, 2020, PSYCHOL MED, V50, P1977, DOI 10.1017/S0033291719002010; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Geha P, 2014, PAIN, V155, P712, DOI 10.1016/j.pain.2013.12.027; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hagelberg N, 2004, EUR J PHARMACOL, V500, P187, DOI 10.1016/j.ejphar.2004.07.024; Hagelberg N, 2003, PAIN, V106, P43, DOI 10.1016/S0304-3959(03)00275-6; Hagelberg N, 2003, PAIN, V101, P149, DOI 10.1016/S0304-3959(02)00323-8; Hall KD, 2018, OBESITY, V26, P11, DOI 10.1002/oby.22073; Ibrahim M, 2016, EAT BEHAV, V21, P214, DOI 10.1016/j.eatbeh.2016.03.009; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kaneko H, 2017, SPINE, V42, P844, DOI 10.1097/BRS.0000000000001930; Karlsson HK, 2015, J NEUROSCI, V35, P3959, DOI 10.1523/JNEUROSCI.4744-14.2015; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Keranen AM, 2010, APPETITE, V55, P726, DOI 10.1016/j.appet.2010.08.012; Kong J, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-43; Kuhn S, 2012, NEUROIMAGE, V61, P289, DOI 10.1016/j.neuroimage.2012.02.065; Laurent V, 2015, BRIT J PHARMACOL, V172, P449, DOI 10.1111/bph.12818; Lim J, 2009, CHEM SENSES, V34, P739, DOI 10.1093/chemse/bjp054; Lin CWC, 2011, PAIN, V152, P607, DOI 10.1016/j.pain.2010.11.034; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; Makary MM, 2020, P NATL ACAD SCI USA, V117, P10015, DOI 10.1073/pnas.1918682117; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; Mao CP, 2013, NEURAL REGEN RES, V8, P2981, DOI 10.3969/j.issn.1673-5374.2013.32.001; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mennella JA, 2012, INT J OBESITY, V36, P1285, DOI 10.1038/ijo.2012.51; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; Nummenmaa L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03848-y; Okifuji A, 2015, J PAIN RES, V8, P399, DOI 10.2147/JPR.S55598; Okun A, 2016, PAIN, V157, P2731, DOI 10.1097/j.pain.0000000000000695; Patel KV, 2013, PAIN MANAG, V3, P467, DOI [10.2217/PMT.13.46, 10.2217/pmt.13.46]; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Porreca F, 2017, PAIN, V158, pS43, DOI 10.1097/j.pain.0000000000000798; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Snitker S, 2010, MAYO CLIN PROC, V85, P1057, DOI 10.4065/mcp.2010.0583; Stice E, 2011, CURR TOP BEHAV NEURO, V6, P81, DOI 10.1007/7854_2010_89; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Treede RD, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000643; Tukey JW, 1977, EXPLORATORY DATA ANA; Vachon-Presseau E, 2016, BRAIN, V139, P1958, DOI 10.1093/brain/aww100; Vainik U, 2019, EUR J NEUROSCI, V50, P2430, DOI 10.1111/ejn.14352; van Galen KA, 2018, METABOLISM, V85, P325, DOI 10.1016/j.metabol.2017.09.007; van Steenbergen H, 2019, COGN AFFECT BEHAV NE, V19, P435, DOI 10.3758/s13415-019-00710-6; van Weering MGH, 2009, EUR J PAIN, V13, P649, DOI 10.1016/j.ejpain.2008.07.005; VANSTRIEN T, 1986, INT J OBESITY, V10, P29; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Verbunt JA, 2001, ARCH PHYS MED REHAB, V82, P726, DOI 10.1053/apmr.2001.23182; West EA, 2016, J NEUROSCI, V36, P1128, DOI 10.1523/JNEUROSCI.2976-15.2016; Wilson AC, 2010, CLIN J PAIN, V26, P705, DOI 10.1097/AJP.0b013e3181e601fa; Xie P, 2016, FRONT NEUROANAT, V10, DOI [10.3382/fnana.2016.00122, 10.3389/fnana.2016.00122]; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908	82	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263527	10.1371/journal.pone.0263527	http://dx.doi.org/10.1371/journal.pone.0263527			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143525	gold, Green Published			2022-12-26	WOS:000797657800054
J	Zhang, XC; Hu, YB; Pan, YL; Xiong, YX; Zhang, YX; Han, MZ; Dong, KS; Song, J; Liang, HF; Ding, ZY; Zhang, XW; Zhu, H; Liu, QM; Lu, X; Feng, YD; Chen, XP; Zhang, ZG; Zhang, BX				Zhang, Xiaochao; Hu, Yabing; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Feng, Yongdong; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang			DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6	ONCOGENE			English	Article							DOMAIN RECEPTOR 1; TYROSINE KINASES; GROWTH-FACTOR; DISCOIDIN; EXPRESSION; INHIBITION; OVEREXPRESSION; ACTIVATION; SURVIVAL; ROLES	Discoidin domain receptor 1 (DDR1) is a member of the receptor tyrosine kinase family, and its ligand is collagen. Previous studies demonstrated that DDR1 is highly expressed in many tumors. However, its role in hepatocellular carcinoma (HCC) remains obscure. In this study, we found that DDR1 was upregulated in HCC tissues, and the expression of DDR1 in TNM stage II-IV was higher than that in TNM stage I in HCC tissues, and high DDR1 expression was associated with poor prognosis. Gene expression analysis showed that DDR1 target genes were functionally involved in HCC metastasis. DDR1 positively regulated the migration and invasion of HCC cells and promoted lung metastasis. Human Phospho-Kinase Array showed that DDR1 activated ERK/MAPK signaling pathway. Mechanically, DDR1 interacted with ARF6 and activated ARF6 through recruiting PSD4. The kinase activity of DDR1 was required for ARF6 activation and its role in metastasis. High expression of PSD4 was associated with poor prognosis in HCC. In summary, our findings indicate that DDR1 promotes HCC metastasis through collagen induced DDR1 signaling mediated PSD4/ARF6 signaling, suggesting that DDR1 and ARF6 may serve as novel prognostic biomarkers and therapeutic targets for metastatic HCC.	[Zhang, Xiaochao; Hu, Yabing; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China; [Zhang, Xiaochao; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang] ChinaClin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China; [Zhang, Xiaochao; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang] Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China; [Zhang, Xiaochao; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang] Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China; [Zhang, Xiaochao; Pan, Yonglong; Xiong, Yixiao; Zhang, Yuxin; Han, Mengzhen; Dong, Keshuai; Song, Jia; Liang, Huifang; Ding, Zeyang; Zhang, Xuewu; Zhu, He; Liu, Qiumeng; Lu, Xun; Chen, Xiaoping; Zhang, Zhanguo; Zhang, Bixiang] Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China; [Zhang, Xiaochao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dermatol, Wuhan, Peoples R China; [Hu, Yabing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Biochem & Mol Biol, Wuhan, Hubei, Peoples R China; [Feng, Yongdong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Canc Res Inst, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, ZG; Zhang, BX (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China.; Zhang, ZG; Zhang, BX (corresponding author), ChinaClin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China.; Zhang, ZG; Zhang, BX (corresponding author), Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China.; Zhang, ZG; Zhang, BX (corresponding author), Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China.; Zhang, ZG; Zhang, BX (corresponding author), Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China.	zhanguo_tjh@hust.edu.cn; bixiangzhang@163.com	Ding, Ze-yang/HHC-6329-2022; yuxin, Zhang/GNH-2283-2022	Ding, Ze-yang/0000-0001-5826-0970; Liang, Huifang/0000-0001-6874-3634	National Natural Science Foundation of China [81372327, 81874149, 81874189, 81572855, 81572427, 81874065]; State Key Project on Infection Disease of China [2018ZX10723204-003]; National Key Research and Development Program of China [2018YFA0208904]; Hepato-BiliaryPancreatic Investigation Fund of Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH11800001-2018356]; HCP project of Huazhong University of Science and Technology [5001540059, 5001540006]; Major Technological Innovation Projects of Hubei Province [2018ACA137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project on Infection Disease of China; National Key Research and Development Program of China; Hepato-BiliaryPancreatic Investigation Fund of Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province; HCP project of Huazhong University of Science and Technology; Major Technological Innovation Projects of Hubei Province	This research was supported by grants from the National Natural Science Foundation of China (No.81372327, 81874149, 81874189, 81572855, 81572427, 81874065), the State Key Project on Infection Disease of China (No. 2018ZX10723204-003), the National Key Research and Development Program of China (2018YFA0208904), the Hepato-BiliaryPancreatic Investigation Fund of Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province (CXPJJH11800001-2018356), the HCP project of Huazhong University of Science and Technology (No. 5001540059, 5001540006), Major Technological Innovation Projects of Hubei Province (2018ACA137).	Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; Aguilera KY, 2017, MOL CANCER THER, V16, P2473, DOI 10.1158/1535-7163.MCT-16-0834; ALVES F, 1995, ONCOGENE, V10, P609; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dai W, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00563-x; Ding ZY, 2014, HEPATOLOGY, V60, P1620, DOI 10.1002/hep.27273; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Gao H, 2016, CELL, V166, P47, DOI 10.1016/j.cell.2016.06.009; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hongu T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8925; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; Jeitany M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201707918; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P10891, DOI 10.1073/pnas.90.22.10891; Juin A, 2014, J CELL BIOL, V207, P517, DOI 10.1083/jcb.201404079; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Romayor I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75395-w; Tsochatzis EA, 2012, NEW ENGL J MED, V366, P92, DOI 10.1056/NEJMc1112501; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Vehlow A, 2019, CELL REP, V26, P3672, DOI 10.1016/j.celrep.2019.02.096; Villalba M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51066-3; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Wei S, 2012, CARCINOGENESIS, V33, P538, DOI 10.1093/carcin/bgr319; Weiner HL, 2000, NEUROSURGERY, V47, P1400, DOI 10.1097/00006123-200012000-00028; Yang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40358; Yang J, 2019, THERANOSTICS, V9, P5810, DOI 10.7150/thno.34973; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Zangari J, 2014, CANCER RES, V74, P5493, DOI 10.1158/0008-5472.CAN-14-0298; Zhavoronkov A, 2019, NAT BIOTECHNOL, V37, P1038, DOI 10.1038/s41587-019-0224-x; Zhou L, 2008, WORLD J SURG, V32, P1748, DOI 10.1007/s00268-008-9615-8	44	1	1	10	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 18	2022	41	12					1821	1834		10.1038/s41388-022-02212-1	http://dx.doi.org/10.1038/s41388-022-02212-1		FEB 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ZV6UV	35140331	Green Published, hybrid			2022-12-26	WOS:000753256900001
J	Legg, MSG; Hager-Mair, FF; Krauter, S; Gagnon, SML; Lopez-Guzman, A; Lim, C; Blaukopf, M; Kosma, P; Schaeffer, C; Evans, SV				Legg, Max S. G.; Hager-Mair, Fiona F.; Krauter, Simon; Gagnon, Susannah M. L.; Lopez-Guzman, Arturo; Lim, Charlie; Blaukopf, Markus; Kosma, Paul; Schaeffer, Christina; Evans, Stephen, V			The S-layer homology domains of Paenibacillus alvei surface protein SpaA bind to cell wall polysaccharide through the terminal monosaccharide residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLH DOMAINS; BACTERIAL; GLYCOSYLATION; MECHANISM; DISPLAY	Self-assembling (glyco)protein surface layers (S-layers) are ubiquitous prokaryotic cell-surface structures involved in structural maintenance, nutrient diffusion, host adhesion, virulence, and other processes, which makes them appealing targets for therapeutics and biotechnological applications as biosensors or drug delivery systems. However, unlocking this potential requires expanding our understanding of S-layer properties, especially the details of surface-attachment. S-layers of Gram-positive bacteria often are attached through the interaction of S-layer homology (SLH) domain trimers with peptidoglycan-linked secondary cell wall polymers (SCWPs). Cocrystal structures of the SLH domain trimer from the Paenibacillus alvei S-layer protein SpaA (SpaASLH) with synthetic, terminal SCWP disaccharide and trisaccharide analogs, together with isothermal titration calorimetry binding analyses, reveal that while SpaA(SLH) accommodates longer biologically relevant SCWP ligands within both its primary (G2) and secondary (G1) binding sites, the terminal pyruvylated ManNAc moiety serves as the nearly exclusive SCWP anchoring point. Binding is accompanied by displacement of a flexible loop adjacent to the receptor site that enhances the complementarity between protein and ligand, including electrostatic complementarity with the terminal pyruvate moiety. Remarkably, binding of the pyruvylated monosaccharide SCWP fragment alone is sufficient to cause rearrangement of the receptor-binding sites in a manner necessary to accommodate longer SCWP fragments. The observation of multiple conformations in longer oligosaccharides bound to the protein, together with the demonstrated functionality of two of the three SCWP receptor-binding sites, reveals how the SpaA(SLH-) SCWP interaction has evolved to accommodate longer SCWP ligands and alleviate the strain inherent to bacterial S-layer adhesion during growth and division.	[Legg, Max S. G.; Gagnon, Susannah M. L.; Evans, Stephen, V] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Hager-Mair, Fiona F.; Lopez-Guzman, Arturo; Schaeffer, Christina] Univ Bodenkultur Wien, Dept NanoBiotechnol, NanoGlycobiol Unit, Vienna, Austria; [Krauter, Simon; Lim, Charlie; Blaukopf, Markus; Kosma, Paul] Univ Bodenkultur Wien, Inst Organ Chem, Dept Chem, Vienna, Austria	University of Victoria; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	svevans@uvic.ca		Blaukopf, Markus/0000-0002-9649-1064; Kosma, Paul/0000-0001-5342-7161; Legg, Max/0000-0002-9065-7019; Hager-Mair, Fiona/0000-0001-9586-5127	Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund FWF [P27374-B22, P32521-B22]; Hochschuljubilaumsstiftung der Stadt Wien [H 318348/2018]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Hochschuljubilaumsstiftung der Stadt Wien	This work was supported by the Natural Sciences and Engineering Research Council of Canada (to M. S. G. L. and S. V. E.), the Austrian Science Fund FWF, projects P27374-B22 and P32521-B22 (to C. S.), and the Hochschuljubilaumsstiftung der Stadt Wien, project H 318348/2018 (to F. F. H.-M.).	Albers SV, 2011, NAT REV MICROBIOL, V9, P414, DOI 10.1038/nrmicro2576; Awram P, 2001, MICROBIOL-SGM, V147, P1451, DOI 10.1099/00221287-147-6-1451; Bharat TAM, 2021, TRENDS MICROBIOL, V29, P405, DOI 10.1016/j.tim.2020.09.009; Blackler RJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05471-3; Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Gerbino E, 2015, WORLD J MICROB BIOT, V31, P1877, DOI 10.1007/s11274-015-1952-9; Huber C, 2006, SMALL, V2, P142, DOI 10.1002/smll.200500147; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Janesch B, 2013, J BACTERIOL, V195, P565, DOI 10.1128/JB.01487-12; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Krauter S, 2021, ARKIVOC, P137, DOI 10.24820/ark.5550190.p011.358; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; MESSNER P, 1992, ADV MICROB PHYSIOL, V33, P213, DOI 10.1016/S0065-2911(08)60218-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodrigues-Oliveira T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02597; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schaffer C, 2007, SMALL, V3, P1549, DOI 10.1002/smll.200700200; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schaffer C, 2000, GLYCOCONJUGATE J, V17, P681, DOI 10.1023/A:1011062302889; Schuster B, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8020040; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SLEYTR UB, 1993, MOL MICROBIOL, V10, P911, DOI 10.1111/j.1365-2958.1993.tb00962.x; Sleytr UB, 1997, TRENDS BIOTECHNOL, V15, P20, DOI 10.1016/S0167-7799(96)10063-9; Sleytr UB, 2007, FEMS MICROBIOL LETT, V267, P131, DOI 10.1111/j.1574-6968.2006.00573.x; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063; Sychantha D, 2018, BIOCHEMISTRY-US, V57, P1949, DOI 10.1021/acs.biochem.8b00060; Usenik A, 2017, STRUCTURE, V25, P514, DOI 10.1016/j.str.2016.12.018; Vollenkle C, 2004, APPL ENVIRON MICROB, V70, P1514, DOI 10.1128/AEM.70.3.1514-1521.2004; Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Zarschler K, 2010, CARBOHYD RES, V345, P1422, DOI 10.1016/j.carres.2010.04.010; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	41	5	4	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101745	10.1016/j.jbc.2022.101745	http://dx.doi.org/10.1016/j.jbc.2022.101745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D3HP	35189140	gold, Green Published			2022-12-26	WOS:000793694800003
J	Alata, W; Yogi, A; Brunette, E; Delaney, CE; van Faassen, H; Hussack, G; Iqbal, U; Kemmerich, K; Haqqani, AS; Moreno, MJ; Stanimirovic, DB				Alata, Wael; Yogi, Alvaro; Brunette, Eric; Delaney, Christie E.; van Faassen, Henk; Hussack, Greg; Iqbal, Umar; Kemmerich, Kristin; Haqqani, Arsalan S.; Moreno, Maria J.; Stanimirovic, Danica B.			Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics	FASEB JOURNAL			English	Article						blood-brain barrier; galanin; inflammatory pain; in situ brain perfusion; insulin growth factor 1 receptor; receptor-mediated transcytosis	TRANSFERRIN RECEPTOR; BISPECIFIC ANTIBODY; ALZHEIMERS-DISEASE; HIGH-AFFINITY; BARRIER; TRANSCYTOSIS; TRANSPORT; PENETRATION; RECRUITMENT; FRAGMENTS	The blood-brain barrier (BBB) prevents the majority of drugs from crossing into the brain and reaching neurons. To overcome this challenge, safe and non-invasive technologies targeting receptor-mediated pathways have been developed. In this study, three single-domain antibodies (sdAbs; IGF1R3, IGF1R4, and IGF1R5) targeting the extracellular domain of the human insulin-like growth factor-1 receptor (IGF1R), generated by llama immunization, showed enhanced transmigration across the rat BBB model (SV-ARBEC) in vitro. The rate of brain uptake of these sdAbs fused to mouse Fc (sdAb-mFc) in vivo was estimated using the fluorescent in situ brain perfusion (ISBP) technique followed by optical brain imaging and distribution volume evaluation. Compared to the brains perfused with the negative control A20.1-mFc, the brains perfused with anti-IGF1R sdAbs showed a significant increase of the total fluorescence intensity (similar to 2-fold, p < .01) and the distribution volume (similar to 4-fold, p < .01). The concentration curve for IGF1R4-mFc demonstrated a linear accumulation plateauing at approximately 400 mu g (similar to 1 mu M), suggesting a saturable mechanism of transport. Capillary depletion and mass spectrometry analyses of brain parenchyma post-ISBP confirmed the IGF1R4-mFc brain uptake with similar to 25% of the total amount being accumulated in the parenchymal fraction in contrast to undetectable levels of A20.1-mFc after a 5-min perfusion protocol. Systemic administration of IGF1R4-mFc fused with the non-BBB crossing analgesic peptide galanin (2 and 5 mg/kg) induced a dose-dependent suppression of thermal hyperalgesia in the Hargreaves pain model. In conclusion, novel anti-IGF1R sdAbs showed receptor-mediated brain uptake with pharmacologically effective parenchymal delivery of non-permeable neuroactive peptides.	[Alata, Wael; Yogi, Alvaro; Brunette, Eric; Delaney, Christie E.; van Faassen, Henk; Hussack, Greg; Iqbal, Umar; Kemmerich, Kristin; Haqqani, Arsalan S.; Moreno, Maria J.; Stanimirovic, Danica B.] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 1200 Montreal Rd,M54, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Alata, W; Stanimirovic, DB (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 1200 Montreal Rd,M54, Ottawa, ON K1A 0R6, Canada.	waelalata@yahoo.com; Danica.Stanimirovic@nrc-cnrc.gc.ca		ALATA, WAEL/0000-0003-4443-9173	Gouvernement du Canada \ National Research Council Canada (NRC)	Gouvernement du Canada \ National Research Council Canada (NRC)	Gouvernement du Canada vertical bar National Research Council Canada (NRC)	Abulrob A, 2011, METHODS MOL BIOL, V763, P423, DOI 10.1007/978-1-61779-191-8_29; Alata W, 2014, MOL PHARMACEUT, V11, P243, DOI 10.1021/mp400421a; Aleksic T, 2018, CANCER RES, V78, P3497, DOI 10.1158/0008-5472.CAN-17-3498; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Alwatban M, 2019, J NEUROIMAGING, V29, P493, DOI 10.1111/jon.12606; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Bickel Ulrich, 2005, NeuroRx, V2, P15, DOI 10.1007/BF03206639; Bourassa P, 2019, MOL PHARMACEUT, V16, P583, DOI 10.1021/acs.molpharmaceut.8b00870; Bulaj G, 2008, J MED CHEM, V51, P8038, DOI 10.1021/jm801088x; Cai WK, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00417-7, 10.1038/ncomms14892]; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Dagenais C, 2000, J CEREBR BLOOD F MET, V20, P381, DOI 10.1097/00004647-200002000-00020; Do TM, 2014, NEUROPHARMACOLOGY, V81, P311, DOI 10.1016/j.neuropharm.2014.02.010; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Friden PM, 1996, J PHARMACOL EXP THER, V278, P1491; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gosk T, 2004, J CEREBR BLOOD F MET, V24, P1193, DOI 10.1097/01.WCB.0000135592.28823.47; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; Haqqani AS, 2013, MOL PHARMACEUT, V10, P1542, DOI 10.1021/mp3004995; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Iqbal U, 2011, METHODS MOL BIOL, V686, P465, DOI 10.1007/978-1-60761-938-3_24; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Manich G, 2013, EUR J PHARM SCI, V49, P556, DOI 10.1016/j.ejps.2013.05.027; Metcalf CS, 2017, EPILEPSIA, V58, P239, DOI 10.1111/epi.13647; Moreno MJ, 2020, EXPERT OPIN DRUG DIS, V15, P903, DOI 10.1080/17460441.2020.1759549; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2016, EXPERT OPIN BIOL TH, V16, P1455, DOI 10.1080/14712598.2016.1230195; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; Pothin E, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12100937; Robertson CR, 2011, NAT PROD REP, V28, P741, DOI 10.1039/c0np00048e; Rossotti MA, 2019, BIOCHEM J, V476, P39, DOI 10.1042/BCJ20180795; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Selles MC, 2020, MOL NEUROBIOL, V57, P1473, DOI 10.1007/s12035-019-01827-y; Sheff J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83198-w; Martins AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019846; Stanimirovic D., 2015, INSULIN LIKE GROWTH; Stanimirovic DB, 2018, BIODRUGS, V32, P547, DOI 10.1007/s40259-018-0309-y; Stocki P, 2021, FASEB J, V35, DOI 10.1096/fj.202001787R; Sumbria RK, 2013, MOL PHARMACEUT, V10, P3507, DOI 10.1021/mp400348n; Tanha Jamshid, 2003, Methods Mol Med, V89, P435; Thom G, 2018, MOL PHARMACEUT, V15, P1420, DOI 10.1021/acs.molpharmaceut.7b00937; Do TM, 2016, J ALZHEIMERS DIS, V49, P287, DOI 10.3233/JAD-150350; Wang D, 2000, NEUROSCIENCE, V96, P767, DOI 10.1016/S0306-4522(00)00005-1; Wang YY, 2009, IMMUNOTHERAPY-UK, V1, P983, DOI 10.2217/IMT.09.75; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Werner H, 2014, EUR NEUROPSYCHOPHARM, V24, P1947, DOI 10.1016/j.euroneuro.2014.01.020; Wu XL, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136855; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang WD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00209-0; Zhang Y, 2019, NEUROSCI LETT, V706, P93, DOI 10.1016/j.neulet.2019.05.016; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109; Zhou QH, 2011, J PHARMACOL EXP THER, V339, P618, DOI 10.1124/jpet.111.185876; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	67	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22208	10.1096/fj.202101644R	http://dx.doi.org/10.1096/fj.202101644R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35192204	hybrid			2022-12-26	WOS:000761250800049
J	Ghosh, A; Coffin, M; West, R; Fowler, VM				Ghosh, Arit; Coffin, Megan; West, Richard; Fowler, Velia M.			Erythroid differentiation in mouse erythroleukemia cells depends on Tmod3-mediated regulation of actin filament assembly into the erythroblast membrane skeleton	FASEB JOURNAL			English	Article						actin; cell survival; erythrocyte membrane skeleton; tropomodulin; tropomyosin	RED-BLOOD-CELLS; MECHANICAL-BEHAVIOR; F-ACTIN; TROPOMYOSIN; DISRUPTION; SPECTRIN; POLYMERIZATION; ELLIPTOCYTOSIS; CYTOSKELETON; MORPHOLOGY	Erythroid differentiation (ED) is a complex cellular process entailing morphologically distinct maturation stages of erythroblasts during terminal differentiation. Studies of actin filament (F-actin) assembly and organization during terminal ED have revealed essential roles for the F-actin pointed-end capping proteins, tropomodulins (Tmod1 and Tmod3). Tmods bind tropomyosins (Tpms), which enhance Tmod capping and F-actin stabilization. Tmods can also nucleate F-actin assembly, independent of Tpms. Tmod1 is present in the red blood cell (RBC) membrane skeleton, and deletion of Tmod1 in mice leads to a mild compensated anemia due to mis-regulated F-actin lengths and membrane instability. Tmod3 is not present in RBCs, and global deletion of Tmod3 leads to embryonic lethality in mice with impaired ED. To further decipher Tmod3's function during ED, we generated a Tmod3 knockout in a mouse erythroleukemia cell line (Mel ds19). Tmod3 knockout cells appeared normal prior to ED, but showed defects during progression of ED, characterized by a marked failure to reduce cell and nuclear size, reduced viability, and increased apoptosis. Tmod3 does not assemble with Tmod1 and Tpms into the Triton X-100 insoluble membrane skeleton during ED, and loss of Tmod3 had no effect on alpha 1,beta 1-spectrin and protein 4.1R assembly into the membrane skeleton. However, F-actin, Tmod1 and Tpms failed to assemble into the membrane skeleton during ED in absence of Tmod3. We propose that Tmod3 nucleation of F-actin assembly promotes incorporation of Tmod1 and Tpms into membrane skeleton F-actin, and that this is integral to morphological maturation and cell survival during erythroid terminal differentiation.	[Ghosh, Arit; Coffin, Megan; Fowler, Velia M.] Univ Delaware, Dept Biol Sci, 105 Green,118 Wolf Hall, Newark, DE 19716 USA; [West, Richard] Delaware Biotechnol Inst, Newark, DE USA	University of Delaware	Fowler, VM (corresponding author), Univ Delaware, Dept Biol Sci, 105 Green,118 Wolf Hall, Newark, DE 19716 USA.	vfowler@udel.edu		Ghosh, Arit/0000-0002-6582-8146	National Institute of Heart Lung and Blood at the National Institutes of Health [HL083464]	National Institute of Heart Lung and Blood at the National Institutes of Health	This research was supported by a grant from the National Institute of Heart Lung and Blood at the National Institutes of Health (HL083464) to V.M.F.	Andolfo I, 2016, HAEMATOLOGICA, V101, P1284, DOI 10.3324/haematol.2016.142463; Basu A, 2015, J PROTEOMICS, V128, P298, DOI 10.1016/j.jprot.2015.08.004; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Chan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054902; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chhabra D, 2005, PROTEOMICS, V5, P3131, DOI 10.1002/pmic.200401127; Ciana A, 2017, CELL PHYSIOL BIOCHEM, V42, P1139, DOI 10.1159/000478769; Da Costa L, 2013, BLOOD REV, V27, P167, DOI 10.1016/j.blre.2013.04.003; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Fowler VM, 2013, CURR TOP MEMBR, V72, P39, DOI 10.1016/B978-0-12-417027-8.00002-7; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Ghosh A, 2021, CURR BIOL, V31, pR501, DOI 10.1016/j.cub.2021.01.055; Gokhin DS, 2016, CURR OPIN HEMATOL, V23, P206, DOI 10.1097/MOH.0000000000000227; Gokhin DS, 2015, MOL BIOL CELL, V26, P1699, DOI 10.1091/mbc.E14-12-1583; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Konstantinidis DG, 2010, TRANSFUS CLIN BIOL, V17, P126, DOI 10.1016/j.tracli.2010.05.002; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj.cdd.4401002; Kumari R, 2020, CURR BIOL, V30, P767, DOI 10.1016/j.cub.2019.12.049; LAZARIDES E, 1989, ANNU REV CELL BIOL, V5, P427; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Lu YZ, 2016, BLOOD, V128, P93, DOI 10.1182/blood-2016-01-692251; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Nowak RB, 2017, BLOOD, V130, P1144, DOI 10.1182/blood-2017-05-787051; Pal K, 2020, BLOOD, V135, P1887, DOI 10.1182/blood.2019003064; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Parreno Justin, 2018, Biophys Rev, V10, P1605, DOI 10.1007/s12551-018-0481-9; PFEFFER SR, 1986, J CELL BIOL, V103, P103, DOI 10.1083/jcb.103.1.103; RABINOVITCH PS, 1994, METHOD CELL BIOL, V41, P263; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Smith AS, 2019, AM J HEMATOL, V94, P667, DOI 10.1002/ajh.25472; Sui ZH, 2017, MOL BIOL CELL, V28, P2531, DOI 10.1091/mbc.E16-10-0699; Sui ZH, 2014, BLOOD, V123, P758, DOI 10.1182/blood-2013-03-492710; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Weber KL, 2007, J CELL SCI, V120, P3625, DOI 10.1242/jcs.011445; WICKREMA A, 1994, J CELL PHYSIOL, V160, P417, DOI 10.1002/jcp.1041600304; WOODS CM, 1985, CELL, V40, P959, DOI 10.1016/0092-8674(85)90356-3; Yamashiro S, 2014, J BIOL CHEM, V289, P11616, DOI 10.1074/jbc.M114.555128; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031; Yamashiro S, 2010, J BIOL CHEM, V285, P33265, DOI 10.1074/jbc.M110.144873; Yien YY, 2017, P NATL ACAD SCI USA, V114, pE8045, DOI 10.1073/pnas.1700632114; Yik JJ, 2018, METHODS MOL BIOL, V1698, P245, DOI 10.1007/978-1-4939-7428-3_15; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	52	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22220	10.1096/fj.202101011R	http://dx.doi.org/10.1096/fj.202101011R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195928				2022-12-26	WOS:000761250800025
J	Zhang, X; Abel, T; Su, S; Herrmann, A; Ludwig, K; Veit, M				Zhang, Xu; Abel, Tim; Su, Shuo; Herrmann, Andreas; Ludwig, Kai; Veit, Michael			Structural and functional analysis of the roles of influenza C virus membrane proteins in assembly and budding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORD-LIKE STRUCTURES; ESTERASE-FUSION GLYCOPROTEIN; MATRIX PROTEIN; A VIRUS; M1 PROTEIN; M2 PROTEIN; CYTOPLASMIC TAILS; CM2 PROTEIN; HEMAGGLUTININ; DOMAIN	Assembly and budding of the influenza C virus is mediated by three membrane proteins: the hemagglutinin-esterase-fusion glycoprotein (HEF), the matrix protein (CM1), and the ion channel (CM2). Here we investigated whether the forma-tion of the hexagonal HEF arrangement, a distinctive feature of influenza C virions is important for virus budding. We used super resolution microscopy and found 250-nm sized HEF clusters at the plasma membrane of transfected cells, which were insensitive to cholesterol extraction and cytochalasin treatment. Overexpression of either CM1, CM2, or HEF caused the release of membrane-enveloped particles. Cryo-electron microscopy of the latter revealed spherical vesicles exhibiting the hexagonal HEF clusters. We subsequently used reverse genetics to identify elements in HEF required for this clus-tering. We found that deletion of the short cytoplasmic tail of HEF reduced virus titer and hexagonal HEF arrays, suggesting that an interaction with CM1 stabilizes the HEF clusters. In addition, we substituted amino acids at the surface of the closed HEF conformation and identified specific mutations that prevented virus rescue, others reduced virus titers and the number of HEF clusters in virions. Finally, mutation of two regions that mediate contacts between trimers in the in-situ structure of HEF was shown to prevent rescue of infectious virus particles. Mutations at residues thought to mediate lateral interactions were revealed to promote intracellular trafficking defects. Taken together, we propose that lateral interactions between the ectodomains of HEF trimers are a driving force for virus budding, although CM2 and CM1 also play important roles in this process.	[Zhang, Xu; Su, Shuo] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Engn Lab Anim Immun Jiangsu Prov, Nanjing, Peoples R China; [Zhang, Xu; Veit, Michael] Free Univ Berlin, Inst Virol, Berlin, Germany; [Abel, Tim; Herrmann, Andreas] Humboldt Univ, Inst Biol Molekulare Biophys, Berlin, Germany; [Herrmann, Andreas] Free Univ Berlin, Inst Chem & Biochem, Biophys Chem, Berlin, Germany; [Ludwig, Kai] Free Univ Berlin, Dept Chem & Biochem & Core Facil BioSupraMol, Res Ctr Electron Microscopy, Berlin, Germany	Nanjing Agricultural University; Free University of Berlin; Humboldt University of Berlin; Free University of Berlin; Free University of Berlin	Su, S (corresponding author), Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Engn Lab Anim Immun Jiangsu Prov, Nanjing, Peoples R China.; Veit, M (corresponding author), Free Univ Berlin, Inst Virol, Berlin, Germany.	shuosu@njau.edu.cn; mveit@zedat.fu-berlin.de		Ludwig, Kai/0000-0001-6808-8107; Herrmann, Andreas/0000-0002-6716-2026	German Research Foundation (DFG) [Ve 141/18-1, SFB 1449]; Fundamental Research Funds for the Central Universities [Y0201900459]; Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China [NY-045]; China Scholarship Council fellowship; Bioinformatics Center of Nanjing Agricultural University	German Research Foundation (DFG)(German Research Foundation (DFG)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China; China Scholarship Council fellowship(China Scholarship Council); Bioinformatics Center of Nanjing Agricultural University	This work was supported by the German Research Foundation (DFG) , grant Ve 141/18-1 and SFB 1449 (Dynamic hydrogels at biointerfaces) , by the Fundamental Research Funds for the Central Universities (grant No. Y0201900459) , The Young Top-Notch Talents of National Ten Thousand Talent Program Six Talent Peaks Project of Jiangsu Province of China (grant No. NY-045) , the China Scholarship Council fellowship, and the Bioinformatics Center of Nanjing Agricultural University.	Andronov L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24084; Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Barnard TR, 2021, TRENDS BIOCHEM SCI, V46, P378, DOI 10.1016/j.tibs.2020.12.007; Bethune J, 2018, ANNU REV BIOPHYS, V47, P63, DOI 10.1146/annurev-biophys-070317-033259; Bottcher C, 1999, FEBS LETT, V463, P255, DOI 10.1016/S0014-5793(99)01475-1; Cao S, 2014, J VIROL, V88, P7464, DOI 10.1128/JVI.00794-14; Cao S, 2012, J VIROL, V86, P4883, DOI 10.1128/JVI.06586-11; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chlanda P, 2016, FEBS LETT, V590, P1940, DOI 10.1002/1873-3468.12118; Chlanda P, 2015, J VIROL, V89, P8957, DOI 10.1128/JVI.00592-15; Crescenzo-Chaigne B, 2007, J VIROL, V81, P11282, DOI 10.1128/JVI.00910-07; Dahmani I, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191024; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Flewett T H, 1967, J Gen Virol, V1, P297; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Halldorsson S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21818-9; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; HERRLER G, 1985, EMBO J, V4, P1503, DOI 10.1002/j.1460-2075.1985.tb03809.x; HERRLER G, 1991, ADV VIRUS RES, V40, P213; HERRLER G, 1981, VIROLOGY, V113, P439, DOI 10.1016/0042-6822(81)90173-2; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hofer CT, 2019, BBA-BIOMEMBRANES, V1861, P1123, DOI 10.1016/j.bbamem.2019.03.013; HONGO S, 1994, J GEN VIROL, V75, P3503, DOI 10.1099/0022-1317-75-12-3503; Hongo S, 1997, J VIROL, V71, P2786, DOI 10.1128/JVI.71.4.2786-2792.1997; Hu B, 2020, J VIROL, V94, DOI 10.1128/JVI.01605-19; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Muraki Y, 2004, J GEN VIROL, V85, P1885, DOI 10.1099/vir.0.79937-0; Muraki Y, 2007, J VIROL, V81, P8766, DOI 10.1128/JVI.00075-07; Muraki Y, 2010, JPN J INFECT DIS, V63, P157; Nakatsu S, 2018, J VIROL, V92, DOI 10.1128/JVI.02084-17; NISHIMURA H, 1994, VIROLOGY, V200, P140, DOI 10.1006/viro.1994.1172; NISHIMURA H, 1990, VIROLOGY, V179, P179, DOI 10.1016/0042-6822(90)90287-2; OCALLAGHAN RJ, 1977, J VIROL, V24, P875, DOI 10.1128/JVI.24.3.875-882.1977; Pachler Karin, 2010, J Mol Genet Med, V4, P239; Pekosz A, 1997, VIROLOGY, V237, P439, DOI 10.1006/viro.1997.8788; Peukes J, 2020, NATURE, V587, P495, DOI 10.1038/s41586-020-2696-8; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Saletti D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40801; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Sederdahl BK, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010089; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Snead WT, 2017, P NATL ACAD SCI USA, V114, pE3258, DOI 10.1073/pnas.1616199114; Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411; Stewart SM, 2012, J VIROL, V86, P1277, DOI 10.1128/JVI.05681-11; Stewart SM, 2011, J VIROL, V85, P12179, DOI 10.1128/JVI.05970-11; Su S, 2017, VIRULENCE, V8, P1580, DOI 10.1080/21505594.2017.1365216; SUGAWARA K, 1991, J GEN VIROL, V72, P103, DOI 10.1099/0022-1317-72-1-103; Takashita E, 2012, J VIROL, V86, P13108, DOI 10.1128/JVI.01925-12; Thaa B, 2009, VIROLOGY, V383, P150, DOI 10.1016/j.virol.2008.10.001; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Veit M, 2013, CELL MICROBIOL, V15, P179, DOI 10.1111/cmi.12045; Wang D, 2010, J VIROL, V84, P4673, DOI 10.1128/JVI.02306-09; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang MY, 2016, CELL MICROBIOL, V18, P692, DOI 10.1111/cmi.12541; Wang MY, 2016, PROTEIN CELL, V7, P28, DOI 10.1007/s13238-015-0193-x; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wolff T., 2021, ENCY VIROLOGY, V2021, P561, DOI DOI 10.1016/B978-0-12-809633-8.21505-7; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Yondola MA, 2011, J VIROL, V85, P2480, DOI 10.1128/JVI.02188-10; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	70	1	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101727	10.1016/j.jbc.2022.101727	http://dx.doi.org/10.1016/j.jbc.2022.101727			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0HS	35157850	Green Published, gold			2022-12-26	WOS:000789398100008
J	Zhou, Y; Liu, XY; Ma, SQ; Zhang, N; Yang, DC; Wang, L; Ye, SM; Zhang, QY; Ruan, J; Ma, J; Wang, SY; Jiang, N; Zhao, ZY; Zhao, SJ; Zheng, CF; Fan, XF; Gong, YS; Razak, MYA; Hu, WT; Pan, JY; Wang, XC; Fan, JM; Li, JM; Liu, R; Shentu, YP				Zhou, Ying; Liu, Xiaoyuan; Ma, Shuqing; Zhang, Nan; Yang, Dichen; Wang, Ling; Ye, Simin; Zhang, Qiongying; Ruan, Jing; Ma, Jun; Wang, Shiyi; Jiang, Nan; Zhao, Zongyuan; Zhao, Shujue; Zheng, Chenfei; Fan, Xiaofang; Gong, Yongsheng; Razak, Mahaman Yacoubou Abdoul; Hu, Wenting; Pan, Jingye; Wang, Xiaochuan; Fan, Junming; Li, Jianmin; Liu, Rong; Shentu, Yangping			ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; astrogliosis; ChK1; CIP2A; STAT3	NEUROINFLAMMATION; PHOSPHORYLATION; CELLS; STAT3; PP2A; TAU	Cancerous Inhibitor of PP2A (CIP2A), an endogenous PP2A inhibitor, is upregulated and causes reactive astrogliosis, synaptic degeneration, and cognitive deficits in Alzheimer's disease (AD). However, the mechanism underlying the increased CIP2A expression in AD brains remains unclear. We here demonstrated that the DNA damage-related Checkpoint kinase 1 (ChK1) is activated in AD human brains and 3xTg-AD mice. ChK1-mediated CIP2A overexpression drives inhibition of PP2A and activates STAT3, then leads to reactive astrogliosis and neurodegeneration in vitro. Infection of mouse brain with GFAP-ChK1-AAV induced AD-like cognitive deficits and exacerbated AD pathologies in vivo. In conclusion, we showed that ChK1 activation induces reactive astrogliosis, degeneration of neurons, and exacerbation of AD through the CIP2A-PP2A-STAT3 pathway, and inhibiting ChK1 may be a potential therapeutic approach for AD treatment.	[Zhou, Ying; Zheng, Chenfei] Wenzhou Med Univ, Dept Nephrol, Affiliated Hosp 1, Wenzhou, Peoples R China; [Liu, Xiaoyuan; Ma, Shuqing; Zhang, Nan; Yang, Dichen; Ye, Simin; Wang, Shiyi; Jiang, Nan; Zhao, Zongyuan; Zhao, Shujue] Wenzhou Med Univ, Wenzhou, Peoples R China; [Wang, Ling] Wenzhou Med Univ, Dept Nucl Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhang, Qiongying; Ruan, Jing; Ma, Jun; Li, Jianmin; Shentu, Yangping] Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 1, Fanhai West Rd 1, Wenzhou 325035, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Fan, Junming] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou, Peoples R China; [Razak, Mahaman Yacoubou Abdoul] Shenzhen Univ, Affiliated Hosp 3, Cognit Impairment Ward Neurol Dept, Shenzhen, Peoples R China; [Razak, Mahaman Yacoubou Abdoul; Hu, Wenting; Wang, Xiaochuan; Liu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Hongkong Rd 13, Wuhan 430030, Peoples R China; [Pan, Jingye; Shentu, Yangping] Key Lab Crit Emergency & Artificial Intelligence, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Shenzhen University; Huazhong University of Science & Technology	Shentu, YP (corresponding author), Wenzhou Med Univ, Dept Pathol, Affiliated Hosp 1, Fanhai West Rd 1, Wenzhou 325035, Peoples R China.; Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Hongkong Rd 13, Wuhan 430030, Peoples R China.	rong.liu@hust.edu.cn; styp@wmu.edu.cn	Yacoubou Abdoul Razak, Mahaman/GWZ-6737-2022; LI, JIAN/GRY-2197-2022; Li, Jing/GYU-5036-2022; li, jian/GSE-0245-2022	Yacoubou Abdoul Razak, Mahaman/0000-0002-9278-4185; Liu, Rong/0000-0001-7477-6520	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) [LQ19H050002]; Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province) [LGF19h180012]; National Natural Science Foundation of China (NSFC) [31900685, 31771189, 31970964]; Wenzhou Municipal Science and Technology Bureau (WMSTB) [Y20210079, ZS2017008, Y20180159]	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation); Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau (WMSTB)	Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation), Grant/Award Number: LQ19H050002; Zhejiang Province Public Welfare Technology Application Research Project (Public Welfare Technology Application Research Project of Zhejiang Province), Grant/Award Number: LGF19h180012; National Natural Science Foundation of China (NSFC), Grant/Award Numbers: 31900685, 31771189 and 31970964; Wenzhou Municipal Science and Technology Bureau (WMSTB), Grant/Award Numbers: Y20210079, ZS2017008 and Y20180159	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chen ZQ, 2018, J BIOMED NANOTECHNOL, V14, P2172, DOI 10.1166/jbn.2018.2645; Frost GR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170228; Fujiki H, 2018, J CANCER RES CLIN, V144, P2339, DOI 10.1007/s00432-018-2765-7; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Gruol DL, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020019; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hung CC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1508-2; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2013, CANCER RES, V73, P6757, DOI 10.1158/0008-5472.CAN-13-1002; Liu CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11798; Michalska P, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080740; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Munger EL, 2019, J COMP NEUROL, V527, P1179, DOI 10.1002/cne.24610; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; O'Connor CM, 2018, INT J BIOCHEM CELL B, V96, P182, DOI 10.1016/j.biocel.2017.10.008; Patil M, 2013, CELL MOL LIFE SCI, V70, P4009, DOI 10.1007/s00018-013-1307-3; Pooler AM, 2014, NEUROPHARMACOLOGY, V76, P1, DOI 10.1016/j.neuropharm.2013.09.018; Qiu M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182150; Reichenbach N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809665; Shentu YP, 2019, NEUROBIOL AGING, V75, P198, DOI 10.1016/j.neurobiolaging.2018.11.023; Shentu YP, 2018, CELL REP, V24, P713, DOI 10.1016/j.celrep.2018.06.009; Song I, 2018, BRAIN RES BULL, V136, P101, DOI 10.1016/j.brainresbull.2017.03.003; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Tam JHK, 2012, CAN J NEUROL SCI, V39, P286, DOI 10.1017/S0317167100013408; Tamma R, 2019, TRANSL ONCOL, V12, P545, DOI 10.1016/j.tranon.2018.12.008; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Toral-Rios D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207458; Valles SL, 2019, INT J MED SCI, V16, P1473, DOI 10.7150/ijms.37769; Zhou SL, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4937689	37	0	0	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22209	10.1096/fj.202101625R	http://dx.doi.org/10.1096/fj.202101625R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35195302	Green Submitted			2022-12-26	WOS:000761250800045
J	Gayatri, M; Utomo, B; Budiharsana, M; Dasvarma, G				Gayatri, Maria; Utomo, Budi; Budiharsana, Meiwita; Dasvarma, Gouranga			Pregnancy resumption following contraceptive discontinuation: Hazard survival analysis of the Indonesia Demographic and Health Survey Data 2007, 2012 and 2017	PLOS ONE			English	Article							FERTILITY; WOMEN; REMOVAL; RETURN; BENEFITS; IMPLANTS; MYTHS; OLDER	Objective The objective of this research is to estimate the probability of pregnancy resumption after discontinuing reversible contraceptives-pills, injectables, implants and IUDs, and to examine the factors associated with the resumption of fertility. Method The study uses pregnancy calendar data from Indonesia Demographic and Health Surveys (IDHS) of 2007, 2012 and 2017. A hazard model survival method is used for estimating the time needed to resume pregnancy since discontinuing reversible contraceptives. Retrospective data on 4,573; 5,183 and 5,989 episodes of reversible contraceptive discontinuation at the three surveys respectively have been analysed. Results This study shows that women regained fecundity within one year of discontinuing IUD, pill, injectables or implants. Women using IUD could resume their pregnancy faster than those using implants, pills and injectables. Over the three IDHS 2007, 2012 and 2017 the age-specific percentages of women becoming pregnant after one year of contraceptive discontinuation vary between 72 and 85 for IUD, 75 and 81 for pills, 72 and 76 for implants and 64 and 67 for injectables, with the percentages being higher among younger women. The analysis further shows that length of contraceptive use, parity, prior sexually transmitted infections, knowledge of fertile period, household wealth status and place of residence have no impact on occurrence of pregnancy after contraceptive discontinuation. Conclusion The analysis disproves a myth that reversible contraceptives make women infertile. Depending on the type of reversible contraceptive used, 65% to 85% of the women were able to conceive after one year of discontinuation.	[Gayatri, Maria] Badan Kependudukan & Keluarga Berencana Nasl, Ctr Res & Dev Family Planning & Family Welf, East Jakarta, Indonesia; [Utomo, Budi; Budiharsana, Meiwita] Univ Indonesia, Fac Publ Hlth, Depok, Indonesia; [Dasvarma, Gouranga] Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia	University of Indonesia; Flinders University South Australia	Gayatri, M (corresponding author), Badan Kependudukan & Keluarga Berencana Nasl, Ctr Res & Dev Family Planning & Family Welf, East Jakarta, Indonesia.	maria.gayatri.bkkbn@gmail.com		Dasvarma, Gouranga/0000-0002-1784-7967; Gayatri, Maria/0000-0002-2792-5586				[Anonymous], 2014, Obstet Gynecol, V123, P719, DOI [10.1016/j.fertnstert.2013.12.032, 10.1097/01.AOG.0000444440.96486.61]; Amnesty International, 2010, TAK AD PIL RINT AT K; Bahamondes L, 2015, HUM REPROD UPDATE, V21, P640, DOI 10.1093/humupd/dmv023; Barnhart K, 2009, FERTIL STERIL, V91, P1654, DOI 10.1016/j.fertnstert.2008.02.122; Barzilai-Pesach V, 2006, J OCCUP ENVIRON MED, V48, P56, DOI 10.1097/01.jom.0000183099.47127.e9; *BPS, 2008, IND DEM HLTH SURV 20; BUCKSHEE K, 1995, CONTRACEPTION, V51, P237, DOI 10.1016/0010-7824(95)00039-D; Cleves M., 2008, INTRO SURVIVAL ANAL; Cornelius ME, 2015, TOB CONTROL, V24, P4, DOI 10.1136/tobaccocontrol-2013-051376; Cronin M, 2009, OBSTET GYNECOL, V114, P616, DOI 10.1097/AOG.0b013e3181b46f54; Daniluk JC, 2012, FERTIL STERIL, V97, P420, DOI 10.1016/j.fertnstert.2011.11.046; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; Delbarge W, 2002, EUR J CONTRACEP REPR, V7, P24, DOI 10.1080/713604288; Farley TMM, 2001, CONTRACEPTION, V63, P167; Farrow A, 2002, HUM REPROD, V17, P2754, DOI 10.1093/humrep/17.10.2754; Girum T, 2018, CONTRACEP REPROD MED, V3, DOI 10.1186/s40834-018-0064-y; Gray R H, 1979, J Biosoc Sci Suppl, P97; Gueye A, 2015, INT PERSPECT SEX R H, V41, P191, DOI 10.1363/4119115; Hyttel M, 2012, REPROD HEALTH MATTER, V20, P148, DOI 10.1016/S0968-8080(12)40654-1; Issa AA, 1998, CURR THER RES CLIN E, V59, P257, DOI 10.1016/S0011-393X(98)85080-7; Klein J, 2001, AM J OBSTET GYNECOL, V185, P758, DOI 10.1067/mob.2001.114689; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Laufer N, 2004, FERTIL STERIL, V81, P1328, DOI 10.1016/j.fertnstert.2003.09.056; Mansour D, 2011, CONTRACEPTION, V84, P465, DOI 10.1016/j.contraception.2011.04.002; Najafi-Sharjabad Fatemeh, 2013, Glob J Health Sci, V5, P181, DOI 10.5539/gjhs.v5n5p181; Population National. and Family Planning Board Statistics Indonesia.  Ministry of Health ICF, 2018, IND DEM HLTH SURV 20; Russo JA, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2013.02.003; Rutstein S., 2006, GUIDE DHS STAT DEMOG; Schindler AE, 2013, INT J ENDOCRINOL MET, V11, P41, DOI 10.5812/ijem.4158; Sedgh G, 2014, STUD FAMILY PLANN, V45, P151, DOI 10.1111/j.1728-4465.2014.00382.x; SPIRA A, 1986, HUM REPROD, V1, P111, DOI 10.1093/oxfordjournals.humrep.a136353; Statistics Indonesia National Population and Family Planning Board Ministry of Health of the Republic of Indonesia and ICF International, 2013, IND DEM HLTH SURV 20; Stoddard AM, 2015, EUR J CONTRACEP REPR, V20, P223, DOI 10.3109/13625187.2015.1010639; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; USAID, 2018, DHS CONTR CAL TUR DE; Utomo B, 2021, POPUL HEALTH METR, V19, DOI 10.1186/s12963-020-00245-w; Vathiny O, 2011, RECLAIMING REDEFININ, P45; Wiegratz I., 2006, FERTILITY DISCONTINU, P85; World Health Organization, 2016, SEL PRACT REC CONTR; World Health Organization Department of Reproductive Health and Research, 2018, FAMILY PLANNING GLOB; Zhu HL, 2013, CONTRACEPTION, V87, P416, DOI 10.1016/j.contraception.2012.11.002; Zinaman M, 2012, CURR MED RES OPIN, V28, P749, DOI 10.1185/03007995.2012.681638	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264318	10.1371/journal.pone.0264318	http://dx.doi.org/10.1371/journal.pone.0264318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196329	gold, Green Published			2022-12-26	WOS:000835161600037
J	Irawati, Y; Kusnoputranto, H; Achmadi, UF; Safrudin, A; Sitorus, A; Risandi, R; Wangsamuda, S; Asih, PBS; Syafruddin, D				Irawati, Yana; Kusnoputranto, Haryoto; Achmadi, Umar Fahmi; Safrudin, Ahmad; Sitorus, Alfred; Risandi, Rifqi; Wangsamuda, Suradi; Asih, Puji Budi Setia; Syafruddin, Din			Blood lead levels and lead toxicity in children aged 1-5 years of Cinangka Village, Bogor Regency	PLOS ONE			English	Article							ANEMIA; GROWTH; METALS	Lead is one of ten hazardous chemicals of public health concern and is used in more than 900 occupations, including the battery, smelting, and mining industries. Lead toxicity accounts for 1.5% (900,000) of deaths annually in the world. In Indonesia, reports of high Blood Lead Level (BLL) were associated with residency in Used Lead Acid Battery (ULAB) recycling sites. The present study aims to investigate the BLL and the evidence of lead toxicity of children living in an ULAB recycling site in Bogor Regency, Indonesia. A cross-sectional study involving 128 children aged 1-5 years was conducted in September-October 2019. The socio-economic factors, BLL, nutritional status, and hematological parameters, were evaluated. Data were analyzed by univariate and bivariate using the Chi-Square test. Socio-economic factors revealed only 2.3% children have pica and 10.9% children have hand-to-mouth habits. Majority of parents had low income, education, and have stayed in the village for years. Analysis on BLL revealed that 69.5% children had BLL of >10 mu g/dL, 25% had abnormal BMI, 23.4% had underweight, 53.9% had stunting, 33.6% had anemia, and 22.6% had basophilic stippling. The average BLL and hemoglobin levels of respondents were 17.03 mu g/dL and 11.48 g/dL, respectively. Bivariate analysis revealed that children with high BLL had double risk of having underweight and protected from stunting. Analysis on the association between BLL and BMI for age revealed a higher risk to have abnormal BMI. The high BLL also had 1.017 times risk of developing anemia, and almost doubled risk of having basophilic stippling, although they were not statistically significant. In conclusion, the high BLL of children living in the ULAB recycling indicates that lead exposure as well as lead toxicity are still occurring in Cinangka Village, and alerts to the need for a systematic action to mitigate the exposure.	[Irawati, Yana] Univ Indonesia, Fac Publ Hlth, Depok, Indonesia; [Irawati, Yana] Balai Besar Pelatihan Kesehatan Jakarta, Minist Hlth, Jakarta, Indonesia; [Kusnoputranto, Haryoto; Achmadi, Umar Fahmi] Univ Indonesia, Fac Publ Hlth, Dept Environm Hlth, Depok, Indonesia; [Safrudin, Ahmad; Sitorus, Alfred] Komite Penghapusan Bensin Bertimbal, Jakarta, Indonesia; [Risandi, Rifqi; Wangsamuda, Suradi; Asih, Puji Budi Setia; Syafruddin, Din] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Syafruddin, Din] Hasanuddin Univ Med Res Unit HUMRC, Makassar, Indonesia	University of Indonesia; Ministry of Health - Indonesia; University of Indonesia; Eijkman Institute	Irawati, Y (corresponding author), Univ Indonesia, Fac Publ Hlth, Depok, Indonesia.; Irawati, Y (corresponding author), Balai Besar Pelatihan Kesehatan Jakarta, Minist Hlth, Jakarta, Indonesia.	mllentu@gmail.com		Irawati, Yana/0000-0002-4264-2277	Ministry of Research and Technology/National Agency for Research and Innovation (RISTEKBRIN), through Eijkman Institute for Molecular Biology; Indonesia Endowment Fund for Education, abbreviated LPDP (Lembaga Pengelola Dana Pendidikan), Ministry of Finance, Indonesia [PRJ-26/LPDP.4/2020]	Ministry of Research and Technology/National Agency for Research and Innovation (RISTEKBRIN), through Eijkman Institute for Molecular Biology; Indonesia Endowment Fund for Education, abbreviated LPDP (Lembaga Pengelola Dana Pendidikan), Ministry of Finance, Indonesia	This research funding was supported Ministry of Research and Technology/National Agency for Research and Innovation (RISTEKBRIN), through Eijkman Institute for Molecular Biology, and Indonesia Endowment Fund for Education, abbreviated LPDP (Lembaga Pengelola Dana Pendidikan), Ministry of Finance, Indonesia (PRJ-26/LPDP.4/2020) Yes. Eijkman Institute for Molecular Biology support in the field assistances, laboratory consumables and equipment facilities during the research.	Ahamed M, 2007, CLIN CHIM ACTA, V377, P92, DOI 10.1016/j.cca.2006.08.032; Annashr NN., 2019, INDIAN J PUBLIC HEAL, V10, P738; [Anonymous], 2012, LOW LEV LEAD EXP HAR; ATSDR (Agency for Toxic Substances and Disease Registry), 2007, TOXICOLOGICAL PROFIL, DOI DOI 10.1201/9781420061888_CH33; Bagaswoto HP., 2015, SARI PEDIAT, V17, P297; Bas P, 2012, INT J HYG ENVIR HEAL, V215, P383, DOI 10.1016/j.ijheh.2011.10.011; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Chiarelli LR, 2005, BLOOD, V105, P3340, DOI 10.1182/blood-2004-10-3895; Daniell WE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/193715; Erdenebayar E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6486-x; Ericson B, 2016, ANN GLOB HEALTH, V82, P686, DOI 10.1016/j.aogh.2016.10.015; Galazyn-Sidorczuk M, 2008, ENVIRON MONIT ASSESS, V137, P481, DOI 10.1007/s10661-007-9783-2; Hegazy Amal A, 2010, BMC Res Notes, V3, P133, DOI 10.1186/1756-0500-3-133; Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP; Jain NB, 2005, AM J EPIDEMIOL, V161, P968, DOI 10.1093/aje/kwi126; Juffrie M, 2020, ASIA PAC J CLIN NUTR, V29, pS18, DOI 10.6133/apjcn.202012_29(S1).03; Kafourou A, 1997, ARCH ENVIRON HEALTH, V52, P377, DOI 10.1080/00039899709602214; Karrari P, 2012, DARU, V20, DOI 10.1186/1560-8115-20-2; Kerr BT, 2019, ENVIRON RES, V170, P65, DOI 10.1016/j.envres.2018.12.003; Ksatriyadi P, 2019, PENANGANAN PELEBURAN; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Min KB, 2008, INT J HYG ENVIR HEAL, V211, P82, DOI 10.1016/j.ijheh.2007.03.003; Parween A., 2018, NAT ENVIRON POLLUT T, V17, P703; Pasha R, 2019, PENGARUH FAKTOR RISI; Pemerintah Republik Indonesia, 2021, LAMP 13 PER PEM NOM; POUNDS JG, 1991, ENVIRON HEALTH PERSP, V91, P17, DOI 10.2307/3430978; Prihartono NA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071276; Rees DC, 2003, BRIT J HAEMATOL, V120, P375, DOI 10.1046/j.1365-2141.2003.03980.x; Rees N., 2020, TOXIC TRUTH CHILDREN, V2 nd, P1; Republik Indonesia, 2015, PERAT PEM RI NOM 78; SCHWARTZ J, 1986, PEDIATRICS, V77, P281; Symeonides C, 2020, MED J AUSTRALIA, V212, P169, DOI 10.5694/mja2.50427; The World Bank, 2020, POV EQ BRIEF; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2020, 10 CHEM PUBL HLTH, VVolume 2021; World Health Organization, 2019, LEAD POIS HLTH; Yunofri Andriyani VE, 2020, PROD DOM REG BRUT PR	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264209	10.1371/journal.pone.0264209	http://dx.doi.org/10.1371/journal.pone.0264209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196330	Green Published, gold			2022-12-26	WOS:000835161600027
J	Baker, SC; Mason, AS; Slip, RG; Skinner, KT; Macdonald, A; Masood, O; Harris, RS; Fenton, TR; Periyasamy, M; Ali, S; Southgate, J				Baker, Simon C.; Mason, Andrew S.; Slip, Raphael G.; Skinner, Katie T.; Macdonald, Andrew; Masood, Omar; Harris, Reuben S.; Fenton, Tim R.; Periyasamy, Manikandan; Ali, Simak; Southgate, Jennifer			Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer	ONCOGENE			English	Article							TRANSPLANT RECIPIENTS; MUTATIONAL SIGNATURES; DEAMINASE APOBEC3B; GENE-EXPRESSION; JC VIRUS; RISK; PROLIFERATION; INFECTION; CELLS; REPLICATION	Limited understanding of bladder cancer aetiopathology hampers progress in reducing incidence. Mutational signatures show the anti-viral apolipoprotein B mRNA editing enzyme catalytic polypeptide (APOBEC) enzymes are responsible for the preponderance of mutations in bladder tumour genomes, but no causative viral agent has been identified. BK polyomavirus (BKPyV) is a common childhood infection that remains latent in the adult kidney, where reactivation leads to viruria. This study provides missing mechanistic evidence linking reactivated BKPyV-infection to bladder cancer risk. We used a mitotically-quiescent, functionally-differentiated model of normal human urothelium to examine BKPyV-infection. BKPyV-infection led to significantly elevated APOBEC3A and APOBEC3B protein, increased deaminase activity and greater numbers of apurinic/apyrimidinic sites in the host urothelial genome. BKPyV Large T antigen (LT-Ag) stimulated re-entry from G0 into the cell cycle through inhibition of retinoblastoma protein and activation of EZH2, E2F1 and FOXM1, with cells arresting in G2. The single-stranded DNA displacement loops formed in urothelial cells during BKPyV-infection interacted with LT-Ag to provide a substrate for APOBEC3-activity. Addition of interferon gamma (IFN gamma) to infected urothelium suppressed expression of the viral genome. These results support reactivated BKPyV infections in adults as a risk factor for bladder cancer in immune-insufficient populations.	[Baker, Simon C.; Mason, Andrew S.; Slip, Raphael G.; Skinner, Katie T.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Baker, Simon C.; Mason, Andrew S.; Slip, Raphael G.; Skinner, Katie T.; Southgate, Jennifer] Univ York, York Biomed Res Inst, York YO10 5DD, N Yorkshire, England; [Macdonald, Andrew] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Pathol, Leeds, W Yorkshire, England; [Masood, Omar] St James Univ Hosp, Leeds Kidney Unit, Leeds, W Yorkshire, England; [Harris, Reuben S.] Univ Minnesota, Coll Biol Sci, Minneapolis, MN 55455 USA; [Fenton, Tim R.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Periyasamy, Manikandan; Ali, Simak] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England; [Fenton, Tim R.] Univ Southampton, Fac Med, Sch Canc Sci, Canc Res UK Ctr, Southampton SO16 6YD, Hants, England; [Periyasamy, Manikandan] Inst Mol & Cell Biol IMCB, Dis Intervent Technol Lab DITL, Neuros Immunos, 8A Biomedical Grove,Neuros Immunos 06-04-05, Singapore 060405, Singapore	University of York - UK; University of York - UK; University of Leeds; Saint James's University Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Kent; Imperial College London; Cancer Research UK; University of Southampton; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Baker, SC (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.; Baker, SC (corresponding author), Univ York, York Biomed Res Inst, York YO10 5DD, N Yorkshire, England.	simon.baker@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021; Ali, Simak/M-6912-2018	Southgate, Jennifer/0000-0002-0135-480X; Fenton, Tim/0000-0002-4737-8233; Ali, Simak/0000-0002-1320-0816; Baker, Simon/0000-0002-2755-6012; Slip, Raphael Grettir/0000-0002-5218-2251; Harris, Reuben/0000-0002-9034-9112; Macdonald, Andrew/0000-0002-5978-4693	York Against Cancer	York Against Cancer	This study was funded by York Against Cancer.	Abend JR, 2007, J VIROL, V81, P272, DOI 10.1128/JVI.01571-06; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Baker SC, 2020, EUR UROL, V78, P143, DOI 10.1016/j.eururo.2020.03.049; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Caller LG, 2019, J VIROL, V93, DOI 10.1128/JVI.00595-19; Chen X, 2013, MOL CELL BIOL, V33, P227, DOI 10.1128/MCB.00881-12; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Cortez LM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008545; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; Erickson KD, 2019, VIROLOGY, V528, P198, DOI 10.1016/j.virol.2018.12.014; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Fulciniti M, 2018, CELL REP, V25, P3693, DOI 10.1016/j.celrep.2018.12.016; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gupta G, 2018, AM J TRANSPLANT, V18, P245, DOI 10.1111/ajt.14530; Jalili P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16802-8; KATAJA V, 1993, AM J EPIDEMIOL, V138, P735, DOI 10.1093/oxfordjournals.aje.a116911; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kesherwani V, 2019, VACCINE, V37, P3457, DOI 10.1016/j.vaccine.2019.04.096; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Lawson ARJ, 2020, SCIENCE, V370, P75, DOI 10.1126/science.aba8347; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RM, 2013, VIROLOGY, V440, P41, DOI 10.1016/j.virol.2013.01.024; Linke SP, 2003, CANCER RES, V63, P2596; Llewellyn MA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29438-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Mohammadi MH, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01582-4; Nickeleit V, 1999, J AM SOC NEPHROL, V10, P1080; Panou MM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030902; Periyasamy M, 2017, NUCLEIC ACIDS RES, V45, P11056, DOI 10.1093/nar/gkx721; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Roelofs PA, 2020, ELIFE, V9, DOI 10.7554/eLife.61287; Solovjeva L, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0046-4; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Starrett GJ, 2019, MBIO, V10, DOI 10.1128/mBio.02690-18; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Tylden GD, 2015, ANTIMICROB AGENTS CH, V59, P3306, DOI 10.1128/AAC.00238-15; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Verhalen B, 2016, J VIROL, V90, P6379, DOI 10.1128/JVI.00771-16; Weinreb DB, 2006, DIAGN CYTOPATHOL, V34, P201, DOI 10.1002/dc.20429; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Yu J, 2019, CANCER MANAG RES, V11, P157, DOI 10.2147/CMAR.S185796; Zapatka M, 2020, NAT GENET, V52, P320, DOI 10.1038/s41588-019-0558-9; Zareei N, 2019, MICROB PATHOGENESIS, V129, P187, DOI 10.1016/j.micpath.2019.02.015	51	3	3	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 8	2022	41	15					2139	2151		10.1038/s41388-022-02235-8	http://dx.doi.org/10.1038/s41388-022-02235-8		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J8DX	35194151	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000759404700002
J	Rios, V; Denova-Gutierrez, E; Barquera, S				Rios, Viridiana; Denova-Gutierrez, Edgar; Barquera, Simon			Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico	PLOS ONE			English	Article							DISPARITIES; RATES; RISK	Background The World Health Organization stated a pandemic by severe acute respiratory syndrome coronavirus SARS-Cov2 (COVID-19) on March, 2020 with devastating implications for populations, healthcare systems, and economies globally. Objective The present study explores the association between patients living in municipalities with crowding conditions and poverty and mortality from COVID-19 in Mexico; specifically evaluating the socioeconomic characteristics of the municipality in which the patients reside and some individual characteristics. Methods In the present study, we examined public information collected from the National Epidemiological Surveillance System informing all persons tested for SARS-CoV-2 and published by the Ministry of Health. The present analysis was restricted to those with the date of registration to October 12, 2021. The association between the main exposures (overcrowded conditions and poverty) and the outcomes of interest (death by COVID-19) was explored using Cox proportional hazard regression models, including frailty penalties to accommodate multilevel data and random effects for the municipality of case occurrence. Results A total of 9619917 subjects were included in the Epidemiological Surveillance System for viral respiratory disease platform. Of those for which results were available, 6141403 were negative for COVID-19 and 3478514 were positive for COVID-19; with a total of 273216 deaths in those who tested positive. Among those positive to COVID-19 mean age was 46.9. Patients living in municipalities with high rates of crowding conditions increased the risk of dying from COVID-19 by 8% (95% CI: 1.03, 1.14). Individuals living in municipalities with indigenous background was associated with an increased risk of dying from COVID-19 (HR = 1.10; 95% CI: 1.04, 1.17). Individuals living in municipalities with illiteracy (HR = 1.09; 95% CI: 1.03, 1.11), poverty (HR =1.17; 95% CI: 1.14, 1.19), food insecurity (HR = 1.094; 95% CI 1.02, 1.06), limited access to social security (HR = 1.10; 95% CI: 1.08, 1.13) and health services (HR = 1.06; 95% CI: 1.04, 1.08) had a higher risk of mortality from COVID-19. Conclusion Our data suggest that patients living in municipalities with higher rates of crowding conditions and higher rates of poverty had elevated risk of mortality from COVID-19. In Mexico, the COVID-19 pandemic is a systemic crisis linked to human development since we have seen that it affects less developed and more vulnerable municipalities. Policies to reduce vulnerabilities and develop strategies to deal with health crises like the current one needs to be considered.	[Denova-Gutierrez, Edgar; Barquera, Simon] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica	Barquera, S (corresponding author), Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Cuernavaca, Morelos, Mexico.	sbarquera@insp.mx	DENOVA-GUTIERREZ, EDGAR/E-4600-2011	DENOVA-GUTIERREZ, EDGAR/0000-0001-9671-9682	Habitat para la Humanidad, Mexico	Habitat para la Humanidad, Mexico	VR received funding form Habitat para la Humanidad, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; Bello-Chavolla OY, 2021, J GERONTOL A-BIOL, V76, pE52, DOI 10.1093/gerona/glaa163; Borde E, 2019, GLOB PUBLIC HEALTH, V14, P847, DOI 10.1080/17441692.2018.1551913; Brown C. S., 2020, INEQUALITY CORONAVIR; Cardoso MRA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-19; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Consejo Nacional de Evaluacion de la Politica de Desarrollo Social CONEVAL, 2020, MEDICION POBREZA; Consejo Nacional de Poblacion, 2021, IND MARG ENT FED MUN; de Lusignan S, 2020, J INFECTION, V81, P785, DOI 10.1016/j.jinf.2020.08.037; Denova-Gutierrez E, 2020, OBESITY, V28, P1826, DOI 10.1002/oby.22946; Direccion General de Epidemiologia, 2021, DAT AB; Douglas M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1557; Antonio-Villa NE, 2022, CLIN INFECT DIS, V74, P785, DOI 10.1093/cid/ciab577; Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Fielding-Miller RK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240151; de Souza CDF, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00743-x; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Greene SK, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302741; Gutierrez E, 2020, COVID EC, V1, P116; Gutierrez JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240394; H.Nishiura, 2020, medRxiv, DOI 10.1101/2020.02.28.20029272; Hubbard D, 2019, DIABETES CARE, V42, P2322, DOI 10.2337/dc19-1074; Ibarra-Nava I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0239168; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N, 2020, AM J PUBLIC HEALTH, V110, P1850, DOI 10.2105/AJPH.2020.305913; Lin EJD, 2015, PSYCHONEUROENDOCRINO, V51, P318, DOI 10.1016/j.psyneuen.2014.10.007; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Mulholland RH, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01669-9; Niedzwiedz CL, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01640-8; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Raisi-Estabragh Z, 2020, J PUBLIC HEALTH-UK, V42, P451, DOI 10.1093/pubmed/fdaa095; Raju S, 2019, AM J RESP CRIT CARE, V199, P961, DOI 10.1164/rccm.201807-1374OC; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Singleton R, 2017, INDOOR AIR, V27, P478, DOI 10.1111/ina.12315; Soltan M., 2020, BMC PUBLIC HEALTH; Sosa-Rubi SG, 2021, DIABETES CARE, V44, P373, DOI 10.2337/dc20-2192; Spiegel JM, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0091-2; Townend J, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01880-2016; Waitzkin H, 2001, AM J PUBLIC HEALTH, V91, P1592, DOI 10.2105/AJPH.91.10.1592; Williams Michelle A., COVID 19 SOCIAL DETE; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; Bello-Chavolla OY, 2020, J CLIN ENDOCR METAB, V105, P2752, DOI 10.1210/clinem/dgaa346; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0264137	10.1371/journal.pone.0264137	http://dx.doi.org/10.1371/journal.pone.0264137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192660	Green Published, gold			2022-12-26	WOS:000812552500038
J	Jung, J; Lee, J; Bae, E; Kim, YC; Kim, EY; Lee, J; Shin, SJ; Kim, YS; Lee, JP; Park, JY				Jung, Jiyun; Lee, Jeonghwan; Bae, Eunjin; Kim, Yong Chul; Kim, Eun Young; Lee, Jangwook; Shin, Sung Joon; Kim, Yon Su; Lee, Jung Pyo; Park, Jae Yoon			Association between behavioral patterns and mortality among US adults: National Health and Nutrition Examination Survey, 2007-2014	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; SITTING TIME; SEDENTARY TIME; RISK; DISEASE; CANCER; EXERCISE	Few large-scale studies have been conducted to show the joint effects of mortality associated with physical activity and sedentarism. Therefore, we examined the relationship between all-cause mortality and behavioral patterns among adults in the United States. Data of 17,730 non-institutionalized US civilians aged >= 20 years were extracted from the 2007-2014 National Health and Nutrition Examination Survey. We set the criteria for metabolic equivalents as 600 according to the WHO guideline, and sedentary time as 300 min/day according to the median. The Cox proportional hazards model was adjusted for demographic and lifestyle characteristics. During the 58.54 +/- 28.18 months follow-up, all-cause mortality rate was 4% and heart-related and cancer mortality rate was 1%. Participants in the high metabolic equivalents and low sedentary time group had a lower risk of all-cause (hazard ratio = 0.41, 95% confidence interval = 0.34-0.50), cardiovascular (hazard ratio = 0.36; 95% confidence interval = 0.23-0.55), and cancer (hazard ratio = 0.55; 95% confidence interval = 0.37-0.83) mortality, compared to those in the low metabolic equivalents and high sedentary time group. Sufficient physical activity and less sedentary behavior reduce all-cause and cause-specific mortality in adults in the United States, especially cardiovascular mortality among the elderly. Additional nationwide policies to improve behavioral patterns among adults need to be implemented in the United States.	[Jung, Jiyun; Park, Jae Yoon] Dongguk Univ, Ilsan Hosp, Data Management & Stat Inst, Goyang, South Korea; [Jung, Jiyun; Lee, Jangwook; Park, Jae Yoon] Dongguk Univ, Coll Med, Res Ctr Chron Dis & Environm Med, Goyang, South Korea; [Lee, Jeonghwan; Lee, Jung Pyo] Seoul Natl Univ Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Bae, Eunjin] Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Chang Won, South Korea; [Kim, Eun Young; Kim, Yon Su] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Hlth Care Ctr, Mental Hlth Ctr, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Coll Med, Dept Human Syst Med, Seoul, South Korea; [Lee, Jangwook; Shin, Sung Joon; Park, Jae Yoon] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea; [Shin, Sung Joon; Park, Jae Yoon] Dongguk Univ, Coll Med, Dept Internal Med, Goyang, South Korea	Dongguk University; NHIS Ilsan Hospital; Dongguk University; Seoul National University (SNU); Seoul National University Hospital; Gyeongsang National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Dongguk University; NHIS Ilsan Hospital; Dongguk University	Park, JY (corresponding author), Dongguk Univ, Coll Med, Res Ctr Chron Dis & Environm Med, Goyang, South Korea.; Park, JY (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea.; Park, JY (corresponding author), Dongguk Univ, Coll Med, Dept Internal Med, Goyang, South Korea.	nephrojyp@gmail.com		Park, Jae Yoon/0000-0001-8986-7492	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2020R1A6A3A01099724]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A6A3A01099724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Bull Fiona C, 2020, Br J Sports Med, V54, P1451, DOI 10.1136/bjsports-2020-102955; Cabanas-Sanchez V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00898; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Centres for Disease Control and Prevention (CDC), 2020, NAT HLTH NUTR EX SUR, P20; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Du Y, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7597; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Ferreira de Moraes AC, 2015, INT J CARDIOL, V180, P165, DOI 10.1016/j.ijcard.2014.11.175; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kiuchi MG, 2017, KIDNEY RES CLIN PRAC, V36, P167, DOI 10.23876/j.krcp.2017.36.2.167; Kiuchi MG, 2017, KIDNEY RES CLIN PRAC, V36, P264, DOI 10.23876/j.krcp.2017.36.3.264; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Leitzmann MF, 2009, CANCER CAUSE CONTROL, V20, P765, DOI 10.1007/s10552-008-9291-x; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2014, AM J EPIDEMIOL, V180, P394, DOI 10.1093/aje/kwu142; Myers J, 2015, PROG CARDIOVASC DIS, V57, P306, DOI 10.1016/j.pcad.2014.09.011; Nomura SJO, 2016, CANCER CAUSE CONTROL, V27, P1239, DOI 10.1007/s10552-016-0803-9; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Stamatakis E, 2019, J AM COLL CARDIOL, V73, P2062, DOI 10.1016/j.jacc.2019.02.031; Stiglic N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023191; Sylvester BD, 2017, SUPPORT CARE CANCER, V25, P3305, DOI 10.1007/s00520-017-3745-1; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Wannamethee SG, 2001, BRIT J CANCER, V85, P1311, DOI 10.1054/bjoc.2001.2096; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Wanner Miriam, 2016, Prev Med Rep, V3, P177, DOI 10.1016/j.pmedr.2016.01.007; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264213	10.1371/journal.pone.0264213	http://dx.doi.org/10.1371/journal.pone.0264213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180280	gold, Green Published			2022-12-26	WOS:000796435800051
J	Thornley, JHM; Newman, JA				Thornley, John H. M.; Newman, Jonathan A.			Climate sensitivity of the complex dynamics of the green spruce aphid-Spruce plantation interactions: Insight from a new mechanistic model	PLOS ONE			English	Article							CEREAL APHIDS; POPULATION-DYNAMICS; RESPONSES; ABUNDANCE; CO2	Aphids can have a significant impact on the growth and commercial yield of spruce plantations. Here we develop a mechanistic deterministic mathematical model for the dynamics of the green spruce aphid (Elatobium abietum Walker) growing on Sitka spruce (Picea sitchensis (Bong.) Carr.). These grow in a northern British climate in managed plantations, with planting, thinning and a 60-year rotation. Aphid infestation rarely kills the tree but can reduce growth by up to 55%. We used the Edinburgh Forest Model (efm) to simulate spruce tree growth. The aphid sub-model is described in detail in an appendix. The only environmental variable which impacts immediately on aphid dynamics is air temperature which varies diurnally and seasonally. The efm variables that are directly significant for the aphid are leaf area and phloem nitrogen and carbon. Aphid population predictions include dying out, annual, biennual and other complex patterns, including chaos. Predicted impacts on plantation yield of managed forests can be large and variable, as has been observed; they are also much affected by temperature, CO2 concentration and other climate variables. However, in this system, increased CO2 concentration appears to ameliorate the severity of the effects of increasing temperatures coupled to worsening aphid infestations on plantation yield.	[Thornley, John H. M.] Univ Guelph, Ctr Nutr Modelling, Dept Anim Biosci, Guelph, ON, Canada; [Newman, Jonathan A.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada	University of Guelph; Wilfrid Laurier University	Newman, JA (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada.	jonathannewman@wlu.ca	Newman, Jonathan/A-5932-2008	Newman, Jonathan/0000-0003-3155-4084				Acheson D., 1997, CALCULUS CHAOS INTRO; Aljaryian R, 2016, CROP PROT, V88, P137, DOI 10.1016/j.cropro.2016.06.008; Aris R., 1995, MATH MODELLING TECHN; Baker G. L., 1996, CHAOTIC DYNAMICS INT, V2nd; Barlow N., 1980, SIMULATION LIME APHI; BARLOW ND, 1981, NEW ZEAL J ECOL, V4, P52; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Day KR, 2010, POPUL ECOL, V52, P317, DOI 10.1007/s10144-009-0190-0; Day KR, 1998, FORESTRY COMMISSION, V4; DeAngelis DL, 2017, ECOSYSTEMS, V20, P284, DOI 10.1007/s10021-016-0066-z; Dixon AF G, 1998, APHID ECOLOGY; DIXON AFG, 1979, ZOOL J LINN SOC-LOND, V67, P225, DOI 10.1111/j.1096-3642.1979.tb01113.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hjelkrem AGR, 2017, ECOL MODEL, V359, P80, DOI 10.1016/j.ecolmodel.2017.05.015; Hoover JK, 2004, GLOBAL CHANGE BIOL, V10, P1197, DOI 10.1111/j.1529-8817.2003.00796.x; Ma Z. S., 2009, Entomological Research, V39, P175, DOI 10.1111/j.1748-5967.2009.00216.x; Macfadyen S, 2018, AGR ECOSYST ENVIRON, V253, P208, DOI 10.1016/j.agee.2016.08.029; MARTINEZLOZANO JA, 1984, AGR FOREST METEOROL, V33, P109, DOI 10.1016/0168-1923(84)90064-9; McBurnett M., 1997, CHAOS THEORY SOCIAL, P31; Meteorological Office, 1980, TABL TEMP REL HUM PR; Newman JA, 2005, GLOBAL CHANGE BIOL, V11, P940, DOI 10.1111/j.1365-2486.2005.00946.x; Newman JA, 2004, GLOBAL CHANGE BIOL, V10, P5, DOI 10.1111/j.1365-2486.2003.00709.x; Newman JA, 2003, J ANIM ECOL, V72, P556, DOI 10.1046/j.1365-2656.2003.00725.x; Newman JA, 2006, GLOBAL CHANGE BIOL, V12, P1634, DOI 10.1111/j.1365-2486.2006.01192.x; Organizacion Meteorologica Mundial (Ginebra Suiza)., 1996, CLIM NORM CLINO PER; Parry H, 2004, INT C ENV MOD SOFTW, P153; Picaza AR, 2018, INT J ENV AGRI BIOTE, V3, DOI [10. 22161/ijeab/3.2.43, DOI 10.22161/IJEAB/3.2.43]; Piyaratne Mkdk, 2014, Computational Ecology and Software, V4, P135; Piyaratne M, 2014, EUROPEAN SCI J, V10; Piyaratne MKDK, 2013, ECOL MODEL, V253, P9, DOI 10.1016/j.ecolmodel.2012.12.032; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Randle TJ, 1998, GREEN SPRUCE APHID W, P32; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Scott JK, 1999, B ENTOMOL RES, V89, P97, DOI 10.1017/S0007485399000127; Skirvin DJ, 1997, GLOB CHANGE BIOL, V3, P1, DOI 10.1046/j.1365-2486.1997.00087.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Straw N, 1998, GREEN SPRUCE APHID W, P15; Straw N. A., 1995, Scottish Forestry, V49, P134; Thierry H, 2017, ECOL INFORM, V40, P62, DOI 10.1016/j.ecoinf.2017.05.006; Thornley J. H. M., 2007, P342, DOI 10.1079/9781845931742.0342; Thornley J.H.M., 1998, GRASSLAND DYNAMICS E, DOI 10.1079/9780851992273.0000; Thornley JHM, 1997, ANN BOT-LONDON, V80, P205, DOI 10.1006/anbo.1997.0430; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Wieczorek K, 2014, AGR FOREST ENTOMOL, V16, P434, DOI 10.1111/afe.12073; Wiest R, 2021, AGR FOREST ENTOMOL, V23, P59, DOI 10.1111/afe.12404; Wu WQ, 2014, ECOL MODEL, V288, P55, DOI 10.1016/j.ecolmodel.2014.05.017; Wyckhuys KAG, 2009, BIOL INVASIONS, V11, P857, DOI 10.1007/s10530-008-9299-x	50	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0252911	10.1371/journal.pone.0252911	http://dx.doi.org/10.1371/journal.pone.0252911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176013	Green Published, gold			2022-12-26	WOS:000777505200001
J	Wankaew, N; Chariyavilaskul, P; Chamnanphon, M; Assawapitaksakul, A; Chetruengchai, W; Pongpanich, M; Shotelersuk, V				Wankaew, Natnicha; Chariyavilaskul, Pajaree; Chamnanphon, Monpat; Assawapitaksakul, Adjima; Chetruengchai, Wanna; Pongpanich, Monnat; Shotelersuk, Vorasuk			Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population	PLOS ONE			English	Article							TRANSPORTING POLYPEPTIDE 1B1; CONSORTIUM CPIC GUIDELINES; GENETIC-POLYMORPHISM; CANCER; CYP2A6; SLCO1B1; PHARMACOKINETICS; NICOTINE; UGT1A1; VARIABILITY	Differences in drug responses in individuals are partly due to genetic variations in pharmacogenes, which differ among populations. Here, genome sequencing of 171 unrelated Thai individuals from all regions of Thailand was used to call star alleles of 51 pharmacogenes by Stargazer, determine allele and genotype frequencies, predict phenotype and compare high-impact variant frequencies between Thai and other populations. Three control genes, EGFR, VDR, and RYR1, were used, giving consistent results. Every individual had at least three genes with variant or altered phenotype. Forty of the 51 pharmacogenes had at least one individual with variant or altered phenotype. Moreover, thirteen genes had at least 25% of individuals with variant or altered phenotype including SLCO1B3 (97.08%), CYP3A5 (88.3%), CYP2C19 (60.82%), CYP2A6 (60.2%), SULT1A1 (56.14%), G6PD (54.39%), CYP4B1 (50.00%), CYP2D6 (48.65%), CYP2F1 (46.41%), NAT2 (40.35%), SLCO2B1 (28.95%), UGT1A1 (28.07%), and SLCO1B1 (26.79%). Allele frequencies of high impact variants from our samples were most similar to East Asian. Remarkably, we identified twenty predicted high impact variants which have not previously been reported. Our results provide information that contributes to the implementation of pharmacogenetic testing in Thailand and other Southeast Asian countries, bringing a step closer to personalized medicine.	[Wankaew, Natnicha] Chulalongkorn Univ, Grad Sch, Program Bioinformat & Computat Biol, Bangkok, Thailand; [Chariyavilaskul, Pajaree; Chamnanphon, Monpat] Chulalongkorn Univ, Fac Med, Clin Pharmacokinet & Pharmacogen Res Unit, Bangkok, Thailand; [Chariyavilaskul, Pajaree] Chulalongkorn Univ, Fac Med, Dept Pharmacol, Bangkok, Thailand; [Chamnanphon, Monpat] Srinakharinwirot Univ, Fac Med, Dept Pathol, Nakornnayok, Thailand; [Assawapitaksakul, Adjima; Chetruengchai, Wanna; Shotelersuk, Vorasuk] Chulalongkorn Univ, Fac Med, Ctr Excellence Med Genom, Dept Pediat, Bangkok, Thailand; [Assawapitaksakul, Adjima; Chetruengchai, Wanna; Shotelersuk, Vorasuk] King Chulalongkorn Mem Hosp, Excellence Ctr Genom & Precis Med, Thai Red Cross Soc, Bangkok, Thailand; [Pongpanich, Monnat] Chulalongkorn Univ, Fac Sci, Dept Math & Comp Sci, Bangkok, Thailand; [Pongpanich, Monnat] Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Srinakharinwirot University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University	Pongpanich, M (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Math & Comp Sci, Bangkok, Thailand.; Pongpanich, M (corresponding author), Chulalongkorn Univ, Age Related Inflammat & Degenerat Res Unit, Bangkok, Thailand.	monnat.p@chula.ac.th	Chamnanphon, Monpat/GNP-8714-2022	Chamnanphon, Monpat/0000-0003-3917-6567; Shotelersuk, Vorasuk/0000-0002-1856-0589	Chulalongkorn University [764002-HE01]; Thailand Science Research and Innovation Fund [CU_FRB640001_01_30_10]; Thailand Research Fund [DPG6180001]; Health Systems Research Institute [64-132]	Chulalongkorn University(Chulalongkorn University); Thailand Science Research and Innovation Fund; Thailand Research Fund(Thailand Research Fund (TRF)); Health Systems Research Institute	This work was supported by Chulalongkorn University Graduate Scholarship to Commemorate the 72nd Anniversary of His Majesty King Bhumibol Adulyadej to NW, Ratchadapiseksompotch Fund, Chulalongkorn University [764002-HE01], Thailand Science Research and Innovation Fund [CU_FRB640001_01_30_10], Thailand Research Fund [DPG6180001], and Health Systems Research Institute [64-132]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaba K, 1999, J HUM GENET, V44, P22, DOI 10.1007/s100380050100; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Birdwell KA, 2015, CLIN PHARMACOL THER, V98, P19, DOI 10.1002/cpt.113; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; Boyd MA, 2006, PHARMACOGENET GENOM, V16, P321, DOI 10.1097/01.fpc.0000197465.14340.d4; Brown JT, 2019, CLIN PHARMACOL THER, V106, P94, DOI 10.1002/cpt.1409; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carlini EJ, 2001, PHARMACOGENETICS, V11, P57, DOI 10.1097/00008571-200102000-00007; Choi JH, 2008, CLIN PHARMACOL THER, V83, P251, DOI 10.1038/sj.clpt.6100267; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; de Lima LT, 2015, HEMATOLOGY, V20, P137, DOI 10.1179/1607845414Y.0000000181; Del Tredici AL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00305; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fujita K, 2008, CANCER SCI, V99, P1049, DOI 10.1111/j.1349-7006.2008.00773.x; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Hebbring SJ, 2007, HUM MOL GENET, V16, P463, DOI 10.1093/hmg/ddl468; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hildebrandt M, 2009, PHARMACOGENET GENOM, V19, P404, DOI 10.1097/FPC.0b013e32832e042e; Hiratsuka Masahiro, 2004, Drug Metab Pharmacokinet, V19, P114, DOI 10.2133/dmpk.19.114; Ide T, 2009, J CLIN PHARMACOL, V49, P1309, DOI 10.1177/0091270009341960; Jada SR, 2007, CANCER SCI, V98, P1461, DOI 10.1111/j.1349-7006.2007.00541.x; Jitueakul S, 2018, J ASS MED SCI, P51; Katz DA, 2006, CLIN PHARMACOL THER, V79, P186, DOI 10.1016/j.clpt.2005.11.003; Kim JY, 2014, YONSEI MED J, V55, P232, DOI 10.3349/ymj.2014.55.1.232; Kim KP, 2011, BRIT J CANCER, V104, P605, DOI 10.1038/bjc.2011.17; Lacko M, 2010, INT J CANCER, V127, P2815, DOI 10.1002/ijc.25296; Lee SB, 2019, CLIN PHARMACOL THER, V106, P1328, DOI 10.1002/cpt.1552; Lee SB, 2019, GENET MED, V21, P361, DOI 10.1038/s41436-018-0054-0; Leitao LPC, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030262; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LM, 2012, MOL MED REP, V6, P75, DOI 10.3892/mmr.2012.900; Lim SYM, 2020, HUM EXP TOXICOL, V39, P785, DOI 10.1177/0960327120905959; Lingenhel A, 2008, EXP GERONTOL, V43, P1102, DOI 10.1016/j.exger.2008.08.047; Liu HX, 2019, EUR J CLIN PHARMACOL, V75, P1533, DOI 10.1007/s00228-019-02726-w; Liu JX, 2017, J STEROID BIOCHEM, V174, P169, DOI 10.1016/j.jsbmb.2017.08.017; LLerena A, 2014, EXPERT OPIN DRUG MET, V10, P1569, DOI 10.1517/17425255.2014.964204; Lopez-Flores LA, 2017, EXCLI J, V16, P174, DOI 10.17179/excli2016-847; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mauleekoonphairoj J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76085-3; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Niemi M, 2011, PHARMACOL REV, V63, P157, DOI 10.1124/pr.110.002857; Numanagic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03273-1; Oates J T, 2018, Int J Biomed Investig, V1, DOI 10.31531/2581-4745.1000111; Oh ES, 2013, DRUG METAB PHARMACOK, V28, P196, DOI 10.2133/dmpk.DMPK-12-RG-068; Onoue M, 2009, INT J CLIN ONCOL, V14, P136, DOI 10.1007/s10147-008-0821-z; Peamkrasatam S, 2006, DRUG METAB PHARMACOK, V21, P475, DOI 10.2133/dmpk.21.475; Pei Q, 2018, EUR J CLIN PHARMACOL, V74, P1021, DOI 10.1007/s00228-018-2477-6; Picard N, 2010, CLIN PHARMACOL THER, V87, P100, DOI 10.1038/clpt.2009.205; Ramsey LB, 2014, CLIN PHARMACOL THER, V96, P423, DOI 10.1038/clpt.2014.125; Relling MV, 2014, CLIN PHARMACOL THER, V96, P169, DOI 10.1038/clpt.2014.97; Sagar M, 2000, ALIMENT PHARM THER, V14, P1495, DOI 10.1046/j.1365-2036.2000.00835.x; Sasaki T, 2008, JPN J CLIN ONCOL, V38, P634, DOI 10.1093/jjco/hyn081; Shibuya A, 1999, INT J HEMATOL, V70, P233; Shitara Y, 2013, BIOPHARM DRUG DISPOS, V34, P45, DOI 10.1002/bdd.1823; Shotelersuk V, 2021, CLIN GENET, V100, P703, DOI 10.1111/cge.14060; Shotelersuk V, 2019, AM J MED GENET C, V181, P245, DOI 10.1002/ajmg.c.31694; Shotelersuk V, 2014, MOL GENET GENOM MED, V2, P210, DOI 10.1002/mgg3.83; Soejima M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2134; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suvichapanich S, 2018, PHARMACOGENET GENOM, V28, P167, DOI [10.1097/FPC.0000000000000339, 10.1097/fpc.0000000000000339]; Suwannakul S, 2008, J HUM GENET, V53, P899, DOI 10.1007/s10038-008-0324-9; Tang KS, 2005, WORLD J GASTROENTERO, V11, P3250, DOI 10.3748/wjg.v11.i21.3250; Tanigawara Y, 1999, CLIN PHARMACOL THER, V66, P528, DOI 10.1016/S0009-9236(99)70017-2; Tanii H, 2011, EUR J CLIN PHARMACOL, V67, P1017, DOI 10.1007/s00228-011-1042-3; Thervet E, 2003, TRANSPLANTATION, V76, P1233, DOI 10.1097/01.TP.0000090753.99170.89; Tournel G, 2007, MUTAT RES-FUND MOL M, V617, P79, DOI 10.1016/j.mrfmmm.2007.01.007; Twesigomwe D, 2021, CLIN PHARMACOL THER, V110, P741, DOI 10.1002/cpt.2173; Twist GP, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.7; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1; Yee J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60467-8; Yoshida R, 2002, BRIT J CLIN PHARMACO, V54, P511, DOI 10.1046/j.1365-2125.2002.01667.x; Zhang HH, 2019, CLIN PHARMACOL THER, V106, P338, DOI 10.1002/cpt.1491; Zhang JJ, 2013, EUR J CLIN PHARMACOL, V69, P807, DOI 10.1007/s00228-012-1432-1; Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690	76	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263621	10.1371/journal.pone.0263621	http://dx.doi.org/10.1371/journal.pone.0263621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176049	gold, Green Published			2022-12-26	WOS:000777505200025
J	Wu, CI; Lin, YJ; Lee, IH; Lo, MT; Hsieh, YC; Chen, AYY; Wang, WK; Chang, SL; Lo, LW; Hu, YF; Chung, FP; Tuan, TC; Chao, TF; Liao, JN; Hsieh, WH; Chang, TY; Lin, CY; Feng, AN; How, CK; Chen, SA				Wu, Cheng-, I; Lin, Yenn-Jiang; Lee, I-Hsin; Lo, Men-Tzung; Hsieh, Yu-Cheng; Chen, Amelia Yun-Yu; Wang, Wei-Kai; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chung, Fa-Po; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Hsieh, Wan-Hsin; Chang, Ting-Yung; Lin, Chin-Yu; Feng, An-Ning; How, Chorng-Kuang; Chen, Shih-Ann			Using QRS loop descriptors to characterize the risk of sudden cardiac death in patients with structurally normal hearts	PLOS ONE			English	Article							T-WAVE MORPHOLOGY; SHOCKABLE RHYTHM; ARREST; DURATION; FAILURE; DISEASE	The predictive value of non-invasive electrocardiographic examination findings for the risk of sudden cardiac death (SCD) in populations with structurally normal hearts remains unclear. This study aimed to investigate the characteristics of the QRS vectorcardiography of surface electrocardiography in patients with structurally normal hearts who experienced SCD. We consecutively enrolled patients who underwent vectorcardiography between March 2017 and December 2018 in a tertiary referral medical center. These patients didn't have structural heart diseases, histories of congestive heart failure, or reduced ejection fraction, and they were classified into SCD (with aborted SCD history and cerebral performance category score of 1) and control groups (with an intervention for atrioventricular node reentrant tachycardia and without SCD history). A total of 162 patients (mean age, 54.3 +/- 18.1 years; men, 75.9%), including 59 in the SCD group and 103 in the control group, underwent propensity analysis. The baseline demographic variables, underlying diseases, QRS loop descriptors (the percentage of the loop area, loop dispersion, and inter-lead QRS dispersion), and other electrocardiographic parameters were compared between the two groups. In the univariate and multivariate analyses, a smaller percentage of the loop area (odds ratio, 0.0003; 95% confidence interval, 0.00-0.02; p<0.001), more significant V4-5 dispersion (odds ratio, 1.04; 95% confidence interval, 1.02-1.07; p = 0.002), and longer QRS duration (odds ratio, 1.05; 95% confidence interval, 1.00-1.10; p = 0.04) were associated with SCD. In conclusion, the QRS loop descriptors of surface electrocardiography could be used as non-invasive markers to identify patients experiencing aborted SCD from a healthy population. A decreased percentage of loop area and elevated V4-5 QRS dispersion values assessed using vectorcardiography were associated with an increased risk of SCD in patients with structurally normal hearts.	[Wu, Cheng-, I; Lin, Yenn-Jiang; Chen, Amelia Yun-Yu; Wang, Wei-Kai; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chung, Fa-Po; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Chang, Ting-Yung; Lin, Chin-Yu] Taipei Vet Gen Hosp, Heart Rhythm Ctr, Dept Med, Div Cardiol, Taipei, Taiwan; [Wu, Cheng-, I; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chung, Fa-Po; Tuan, Ta-Chuan; Chao, Tze-Fan; Liao, Jo-Nan; Lin, Chin-Yu; Chen, Shih-Ann] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan; [Lee, I-Hsin; How, Chorng-Kuang] Taipei Vet Gen Hosp, Dept Emergency, Taipei, Taiwan; [Lo, Men-Tzung; Hsieh, Wan-Hsin] Natl Cent Univ, Inst Translat & Interdisciplinary Med, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Hsieh, Yu-Cheng; Chen, Shih-Ann] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan; [Chen, Amelia Yun-Yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Feng, An-Ning] Cheng Hsin Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Central University; Taichung Veterans General Hospital; National Taiwan University; Cheng Hsin General Hospital	Lin, YJ (corresponding author), Taipei Vet Gen Hosp, Heart Rhythm Ctr, Dept Med, Div Cardiol, Taipei, Taiwan.; Lin, YJ; Chen, SA (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan.; Chen, SA (corresponding author), Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung, Taiwan.	linyennjiang@gmail.com; epsachen@ms41.hinet.net	Hu, Yu-Feng/V-1401-2019	Hu, Yu-Feng/0000-0001-5715-2070	Ministry of Science and Technology of Taiwan [MOST 109-2314-B-010-058-MY2, MOST 1102314-B-A49A-541-MY3]; Grant of TVGH [V109D48-001-MY2-2, C19-027, C13-092]; Research Foundation of Cardiovascular Medicine [109-02-012]; Szu-Yuan Research Foundation of Internal Medicine [110001]; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program [107-V-B-014, 108-V-A013]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Grant of TVGH; Research Foundation of Cardiovascular Medicine; Szu-Yuan Research Foundation of Internal Medicine; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program	This study received support from the Ministry of Science and Technology of Taiwan (MOST 109-2314-B-010-058-MY2 and MOST 1102314-B-A49A-541 -MY3), Grant of TVGH (V109D48-001-MY2-2, C19-027, and C13-092), Research Foundation of Cardiovascular Medicine (109-02-012), Szu-Yuan Research Foundation of Internal Medicine (No. 110001), and Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program (No. 107-V-B-014, and No. 108-V-A013).	Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Al-Khatib SM, 2018, CIRCULATION, V138, pE210, DOI [10.1161/CIR.0000000000000548, 10.1161/CIR.0000000000000549]; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Castells F, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/74580; Chavez-Gonzalez E, 2017, MED INTENSIVA, V41, P347, DOI [10.1016/j.medin.2016.09.008, 10.1016/j.medine.2017.04.003]; Chung FP, 2017, HEART RHYTHM, V14, P508, DOI 10.1016/j.hrthm.2017.01.006; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Hoogendijk MG, 2011, HEART RHYTHM, V8, P111, DOI 10.1016/j.hrthm.2010.09.066; Hoogendijk MG, 2010, HEART RHYTHM, V7, P238, DOI 10.1016/j.hrthm.2009.10.007; Hsieh WH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182364; Huikuri HV, 2003, CIRCULATION, V108, P110, DOI 10.1161/01.CIR.0000077519.18416.43; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kentta TV, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.117.005762; Lin YN, 2017, MAYO CLIN PROC, V92, P347, DOI 10.1016/j.mayocp.2016.10.029; Lopshire JC, 2006, CIRCULATION, V114, P1134, DOI 10.1161/CIRCULATIONAHA.106.647933; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Moore B, 2018, INT J CARDIOL, V254, P101, DOI 10.1016/j.ijcard.2017.11.117; Oving I, 2020, RESUSCITATION, V151, P67, DOI 10.1016/j.resuscitation.2020.03.014; Porthan K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P690, DOI 10.1161/CIRCEP.113.000356; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Teodorescu C, 2011, HEART RHYTHM, V8, P1562, DOI 10.1016/j.hrthm.2011.06.011; Terho HK, 2018, IJC HEART VASC, V20, P50, DOI 10.1016/j.ijcha.2018.08.002; Vaduganathan M, 2017, J AM COLL CARDIOL, V69, P556, DOI 10.1016/j.jacc.2016.10.078; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Zabel M, 2000, CIRCULATION, V102, P1252, DOI 10.1161/01.CIR.102.11.1252; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263894	10.1371/journal.pone.0263894	http://dx.doi.org/10.1371/journal.pone.0263894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171953	gold, Green Published			2022-12-26	WOS:000795889700043
J	Zelka, MA; Jimma, MS; Wondashu, PJ; Aldo, AM; Abshoko, ND; Sadi, DA; Gibina, WK				Zelka, Muluwas Amentie; Jimma, Melkamu Senbeta; Wondashu, Paulos Jaleta; Aldo, Atnafu Morka; Abshoko, Nigatu Disassa; Sadi, Dula Ayana; Gibina, Wagari Kelbessa			Practice of people towards COVID-19 infection prevention strategies in Benishangul Gumuz Region, North-West Ethiopia: Multilevel analysis	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES; OUTBREAK	Introduction Coronavirus 2019 (COVID- 19) is an acute respiratory viral infectious disease in human being caused by RNA virus that belonged to the family of corona virus. The incidence of this disease was growing exponentially and affects millions of the world population that leads to expose thousands of peoples for death. Thus, this study was targeted to assess the practice of people on COVID-19 infections prevention strategies in the region. Methods A community based cross sectional study design was conducted in Benishangul Gumuz Region from May 25 -June 15, 2020. Multistage sampling technique was carried out to select 21 kebeles/ketena and 422 study participants. Data were collected by face to face interview using semi-structured questionnaires. The collected data were entered, cleaned and analyzed using STATA software version 14.0. Descriptive, bi-variable and multivariable multilevel models were applied. Variables with p value < 0.25 in bi-variable analysis were selected as candidates for multivariable analysis. Finally, the variables with p-value < 0.5 were considered as statistically significant, then variables with odds ratio, 95% CI were used to interpret the effect of association. Results The magnitude of good practice on prevention strategies of COVID- 19 infections was 62.1%. The most frequently practiced prevention strategies for COVID-19 infections were hand washing with water and soap (80.7%), alcohol-based hand rub (68.8%), maintaining social/physical distance (74.2%) and avoiding touching eyes. Individual and community level factors that affecting practice of COVID- 19 infection prevention strategies were discovered. Hence, community level factor was place of origin (AOR = 0.1; 95%CI: 0.03, 0.35) whereas individual level factors were able to read and write (AOR = 0.18; 95%CI: 0.04, 0.81) and being merchant (AOR = 2.07; 95%CI: 1.01, 4.28). Conclusion The level of practice of community towards COVID-19 infections prevention strategies were low as compared with the expected outcome. Individual and community level factors were identified. This implies that social mobilization and community engagement was not effective. Thus, designing appropriate strategies to improve of practice prevention strategies are strongly recommend.	[Zelka, Muluwas Amentie; Sadi, Dula Ayana; Gibina, Wagari Kelbessa] Assosa Univ, Coll Hlth Sci, Dept Publ Hlth, Assosa, Ethiopia; [Jimma, Melkamu Senbeta; Wondashu, Paulos Jaleta] Assosa Univ, Coll Hlth Sci, Dept Nursing, Assosa, Ethiopia; [Aldo, Atnafu Morka] Assosa Univ, Coll Social Sci & Humanities, Dept Geog & Environm Studies, Assosa, Ethiopia; [Abshoko, Nigatu Disassa] Assosa Univ, Coll Agr, Dept Anim Hlth, Assosa, Ethiopia		Zelka, MA (corresponding author), Assosa Univ, Coll Hlth Sci, Dept Publ Hlth, Assosa, Ethiopia.	muluwas12@gmail.com	Amentie, Muluwas/AAH-7708-2019; Atnafu, Morka/ADE-1450-2022	Amentie, Muluwas/0000-0003-4298-7061; Ayana, Dula/0000-0002-1975-2347				Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Anwar S., 2020, FRONT PUBLIC HEALTH, V8; Asemahagn MA, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00254-3; Asraf Hussain, 2020, Asian Journal of Medical Sciences, V11, P6, DOI 10.3126/ajms.v11i3.28485; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Benshangul Gumuz Regional State (BGRS), 2002, REV REG CON; Byanaku A., 2020, MEDRXIV; China National Health Commission, 2020, DIAGN TREATM COVID 1; Chirwa GC, 2020, SCI AFR, V7, DOI 10.1016/j.sciaf.2019.e00213; Chirwa GC, 2019, MALAWI MED J, V31, P104, DOI 10.4314/mmj.v31i2.1; Culture and truism of Benshangul Gumuz Region, 2007, FACTS BENSHANGUL GUM; Gao HM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09961-2; Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744; Huiming Gao RH, 2020, KNOWLEDGE ATTITUDES; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Podder D, 2019, INDIAN J PUBLIC HLTH, V63, P178, DOI 10.4103/ijph.IJPH_321_19; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Sengeh P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040328; Singhal T, 2020, INDIAN J PEDIATR; Tadesse DB, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100787; Tomar B.S., 2020, MEDRXIV; World Health Organization, 2020, PNEUM UNKN CAUSECHIN; World Health Orgnanization (WHO), 2021, WHO CORONA VIRUS COV; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263572	10.1371/journal.pone.0263572	http://dx.doi.org/10.1371/journal.pone.0263572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171932	gold, Green Published			2022-12-26	WOS:000795889700028
J	Ligneau, C; Sovilla, B; Gaume, J				Ligneau, Camille; Sovilla, Betty; Gaume, Johan			Numerical investigation of the effect of cohesion and ground friction on snow avalanches flow regimes	PLOS ONE			English	Article							PARTICLE-SIZE SEGREGATION; FRENCH ALPS; CLIMATE; TEMPERATURE; IMPACT; MODEL; ICE	With ongoing global warming, snow avalanche dynamics may change as snow cohesion and friction strongly depend on temperature. In the field, a diversity of avalanche flow regimes has been reported including fast, sheared flows and slow plugs. While the significant role of cohesion and friction has been recognized, it is unclear how these mechanical properties affect avalanche flow regimes. Here, we model granular avalanches on a periodic inclined plane, using the distinct element method to better understand and quantify how inter-particle cohesion and ground friction influences avalanche velocity profiles. The cohesion between particles is modeled through bonds that can subsequently break and form, thus representing fragmentation and aggregation potentials, respectively. The implemented model shows a good ability to reproduce the various flow regimes and transitions as observed in nature: for low cohesion, highly sheared and fast flows are obtained while slow plugs form above a critical cohesion value and for lower ground frictions. Simulated velocity profiles are successfully compared to experimental measurements from the real-scale test site of Vallee de la Sionne in Switzerland. Even though the model represents a strong simplification of the reality, it offers a solid basis for further investigation of relevant processes happening in snow avalanches, such as segregation, erosion and entrainment, with strong impacts on avalanche dynamics research, especially in a climate change context.	[Ligneau, Camille; Sovilla, Betty] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Ligneau, Camille; Gaume, Johan] Ecole Polytech Fed Lausanne, Snow & Avalanche Simulat Lab SLAB, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ligneau, C (corresponding author), WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland.; Ligneau, C (corresponding author), Ecole Polytech Fed Lausanne, Snow & Avalanche Simulat Lab SLAB, Lausanne, Switzerland.	camille.ligneau@slf.ch		Gaume, Johan/0000-0001-8931-752X; Sovilla, Betty/0000-0001-8771-6439; Ligneau, Camille/0000-0002-1159-0873	WSL's strategic initiative Climate Change Impacts on Alpine Mass Movements (CCAMM); canton of Valais; Swiss National Science Foundation [PCEFP2_181227, CRSK-2_195914]	WSL's strategic initiative Climate Change Impacts on Alpine Mass Movements (CCAMM); canton of Valais; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	CL and BS are funded by WSL's strategic initiative Climate Change Impacts on Alpine Mass Movements (CCAMM, ccamm.slf.ch) and the canton of Valais. JG is funded by the Swiss National Science Foundation (Eccellenza project: grant number PCEFP2_181227; SPARK project grant number CRSK-2_195914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann WJ, 1999, COLD REG SCI TECHNOL, V30, P3, DOI 10.1016/S0165-232X(99)00010-5; Ancey C, 2015, REV GEOPHYS, V53, P745, DOI 10.1002/2015RG000491; ANDREOTTI B., 2013, GRANULAR MEDIA FLUID; Avalanches Mellor M, 1968, THIS DIGITAL RESOURC; Barker T, 2021, J FLUID MECH, V909, DOI 10.1017/jfm.2020.973; Bartelt P, 2009, J GLACIOL, V55, P829, DOI 10.3189/002214309790152384; Bobillier G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90910-3; Bobillier G, 2020, CRYOSPHERE, V14, P39, DOI 10.5194/tc-14-39-2020; Brewster R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061301; CASASSA G, 1991, J APPL PHYS, V69, P3745, DOI 10.1063/1.348469; Castebrunet H, 2014, CRYOSPHERE, V8, P1673, DOI 10.5194/tc-8-1673-2014; Colbeck S.C., 1992, CRREL MONOGRAPH; Comola F, 2017, GEOPHYS RES LETT, V44, P4195, DOI 10.1002/2017GL073039; Cuellar P, 2015, 4 INT C PART BAS MET, P1121; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; da Cruz F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021309; Eckert N, 2013, J GLACIOL, V59, P93, DOI 10.3189/2013JoG12J091; Faug T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021305; Fischer JT, 2018, GEOPHYS RES LETT, V45, P11219, DOI 10.1029/2018GL079585; Gauer P, 2004, ANN GLACIOL-SER, V38, P384, DOI 10.3189/172756404781815068; GAUER P, 2008, P INT SNOW SCI WORKS, P717; Gaume J, 2015, CRYOSPHERE, V9, P1915, DOI 10.5194/tc-9-1915-2015; Gaume J, 2017, CRYOSPHERE, V11, P217, DOI 10.5194/tc-11-217-2017; Gray JMNT, 2011, J FLUID MECH, V678, P535, DOI 10.1017/jfm.2011.138; Hestnes E, 1998, ANN GLACIOL, V26, P370; Issler D, 2003, LN APP C M, V11, P109; Jaedicke C, 2008, COLD REG SCI TECHNOL, V51, P156, DOI 10.1016/j.coldregions.2007.03.011; Kabore BW, 2021, GRANUL MATTER, V23, DOI 10.1007/s10035-020-01083-1; Kern MA, 2010, ANN GLACIOL, V51, P27, DOI 10.3189/172756410791386643; Kohler A, 2018, J GEOPHYS RES-EARTH, V123, P1272, DOI 10.1002/2017JF004375; Kohler A, 2018, CRYOSPHERE, V12, P3759, DOI 10.5194/tc-12-3759-2018; Kyburz ML, 2020, J GEOPHYS RES-EARTH, V125, DOI 10.1029/2019JF005192; Lang T. E., 1983, Annals of Glaciology, V4, P158; Li XY, 2021, LANDSLIDES, V18, P3393, DOI 10.1007/s10346-021-01692-8; Lowe H, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL085491; Luding S, 2008, GRANUL MATTER, V10, P235, DOI 10.1007/s10035-008-0099-x; Martin E, 2001, ANN GLACIOL, V32, P163, DOI 10.3189/172756401781819292; McClung D., 2006, AVALANCHE HDB; Mellor M., 1974, REV BASIC SNOW MECH; MiDi GDR, 2004, EUR PHYS J E, V14, P341, DOI [10.1140/epje/i2004-10022-4, 10.1140/epje/i2003-10153-0]; Miller DA, 2003, COLD REG SCI TECHNOL, V37, P213, DOI 10.1016/j.coldregions.2003.07.001; Mulak D, 2019, COMPUT PART MECH, V6, P439, DOI 10.1007/s40571-019-00224-5; Naaim M, 2016, HOUILLE BLANCHE, P12, DOI 10.1051/lhb/2016055; Naaim M, 2013, J GLACIOL, V59, P771, DOI 10.3189/2013JoG12J205; Nakamura T, 2010, J GLACIOL, V56, P333, DOI 10.3189/002214310791968502; Petrovic JJ, 2003, J MATER SCI, V38, P1, DOI 10.1023/A:1021134128038; Potyondy DO, 2004, INT J ROCK MECH MIN, V41, P1329, DOI 10.1016/j.ijrmms.2004.09.011; Pouliquen O, 1999, PHYS FLUIDS, V11, P542, DOI 10.1063/1.869928; Rognon PG, 2008, J FLUID MECH, V596, P21, DOI [10.1017/S0022112007009329, 10.1017/S0022l12007009329]; SAVAGE SB, 1988, J FLUID MECH, V189, P311, DOI 10.1017/S002211208800103X; SAVAGE SB, 1989, J FLUID MECH, V199, P177, DOI 10.1017/S0022112089000340; Schweizer J, 2002, COLD REG SCI TECHNOL, V35, P55, DOI 10.1016/S0165-232X(02)00030-7; Schweizer J, 1999, COLD REG SCI TECHNOL, V30, P43, DOI 10.1016/S0165-232X(99)00025-7; Sigrist C., 2006, THESIS ETH ZURICH; Sovilla B, 2018, J GEOPHYS RES-EARTH, V123, P2525, DOI 10.1029/2018JF004678; Sovilla B, 2002, NAT HAZARD EARTH SYS, V2, P169, DOI 10.5194/nhess-2-169-2002; Sovilla B, 2013, ISSW P, P8; Sovilla B, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2006JF000688; Sovilla B, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000391; Sovilla B, 2015, CR PHYS, V16, P97, DOI 10.1016/j.crhy.2014.11.005; Steinkogler W, 2015, CRYOSPHERE, V9, P1819, DOI 10.5194/tc-9-1819-2015; Steinkogler W, 2015, J GEOPHYS RES-EARTH, V120, P1107, DOI 10.1002/2014JF003294; Steinkogler W, 2014, COLD REG SCI TECHNOL, V97, P121, DOI 10.1016/j.coldregions.2013.10.002; Szabo D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721391; Teufelsbauer H, 2009, GRANUL MATTER, V11, P209, DOI 10.1007/s10035-009-0142-6; van Herwijnen A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040389; van Herwijnen A, 2013, J GLACIOL, V59, P269, DOI 10.3189/2013JoG12J094; Vera Valero C, 2015, J GLACIOL, V61, P173, DOI 10.3189/2015JoG14J117; Weinhart T, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4812809	69	1	1	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264033	10.1371/journal.pone.0264033	http://dx.doi.org/10.1371/journal.pone.0264033			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167595	Green Published, gold			2022-12-26	WOS:000802227200036
J	Padmanabhan, H; Hassan, NT; Wong, SW; Lee, YQ; Lim, J; Hasan, SN; Yip, CH; Teo, SH; Thong, MK; Taib, NAM; Yoon, SY				Padmanabhan, Heamanthaa; Hassan, Nur Tiara; Wong, Siu-Wan; Lee, Yong-Quan; Lim, Joanna; Hasan, Siti Norhidayu; Yip, Cheng-Har; Teo, Soo-Hwang; Thong, Meow-Keong; Taib, Nur Aishah Mohd; Yoon, Sook-Yee			Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk	PLOS ONE			English	Article							FAMILY-HISTORY; OVARIAN-CANCER; WOMEN; PERCEPTION; MUTATIONS; OLAPARIB; CARRIERS; IMPACT	There is an increasing number of cancer patients undertaking treatment-focused genetic testing despite not having a strong family history or high a priori risk of being carriers because of the decreasing cost of genetic testing and development of new therapies. There are limited studies on the psychosocial outcome of a positive result among breast cancer patients who are at low a priori risk, particularly in women of Asian descent. Breast cancer patients enrolled under the Malaysian Breast Cancer Genetic Study between October 2002 and February 2018 were tested for BRCA1, BRCA2 and PALB2 genes. All 104 carriers identified were invited by a research genetic counsellor for result disclosure. Of the 104 carriers, 64% (N = 66) had low a priori risk as determined by PENN II scores. Psychosocial, risk perception and health behaviour measures survey were conducted at baseline (pre-result disclosure), and at two to six weeks after result disclosure. At baseline, younger carriers with high a priori risk had higher Cancer Worry Scale scores than those with low a priori risk but all scores were within acceptable range. Around 75% and 55% of high a priori risk carriers as well as 80% and 67% of low a priori risk carriers had problems in the "living with cancer" and "children" psychosocial domains respectively. All carriers regardless of their a priori risk demonstrated an improved risk perception that also positively influenced their intent to undergo risk management procedures. This study has shown that with sufficient counselling and support, low a priori risk carriers are able to cope psychologically, have improved perceived risk and increased intent for positive health behaviour despite having less anticipation from a family history prior to knowing their germline carrier status.	[Padmanabhan, Heamanthaa; Hassan, Nur Tiara; Wong, Siu-Wan; Lee, Yong-Quan; Yoon, Sook-Yee] Canc Res Malaysia, Genet Counselling Unit, Subang Jaya, Selangor, Malaysia; [Lim, Joanna; Hasan, Siti Norhidayu] Canc Res Malaysia, Core Lab Unit, Subang Jaya, Selangor, Malaysia; [Yip, Cheng-Har] Subang Jaya Med Ctr, Subang Jaya, Selangor, Malaysia; [Teo, Soo-Hwang] Canc Res Malaysia, Canc Prevent & Populat Sci Unit, Subang Jaya, Selangor, Malaysia; [Thong, Meow-Keong] Univ Malaya, Fac Med, Dept Paediat, Genet Med Unit,Med Ctr, Kuala Lumpur, Malaysia; [Taib, Nur Aishah Mohd] Univ Malaya, Fac Med, Dept Surg, Med Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Yoon, SY (corresponding author), Canc Res Malaysia, Genet Counselling Unit, Subang Jaya, Selangor, Malaysia.; Thong, MK (corresponding author), Univ Malaya, Fac Med, Dept Paediat, Genet Med Unit,Med Ctr, Kuala Lumpur, Malaysia.	thongmk@um.edu.my; sookyee.yoon@cancerresearch.my	Thong, Meow-Keong/B-9960-2010; Taib, Nur Aishah/B-2370-2010	Thong, Meow-Keong/0000-0002-7288-7910; Taib, Nur Aishah/0000-0001-8419-0478; Lee, Yong Quan/0000-0003-2714-3821	Yayasan Sime Darby; Malaysian Ministry of Higher Education High Impact Research Grant [UM.C/HIR/MOHE/06]; Yayasan PETRONAS; Malaysian Ministry of Science	Yayasan Sime Darby; Malaysian Ministry of Higher Education High Impact Research Grant; Yayasan PETRONAS; Malaysian Ministry of Science	Yayasan Sime Darby, Yayasan PETRONAS, Malaysian Ministry of Science, and the Malaysian Ministry of Higher Education High Impact Research Grant [grant no: UM.C/HIR/MOHE/06] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, BREAST CANC ASIATHE; Beitsch PD, 2019, J CLIN ONCOL, V37, P453, DOI 10.1200/JCO.18.01631; Bredart A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029926; Chen Z, 2018, GENET MED, V20, P428, DOI 10.1038/gim.2017.118; Custers JAE, 2018, PSYCHO-ONCOLOGY, V27, P2609, DOI 10.1002/pon.4782; Domchek SM, 2016, GYNECOL ONCOL, V140, P199, DOI 10.1016/j.ygyno.2015.12.020; Dorling L, 2021, NEW ENGL J MED, V384, P428, DOI 10.1056/NEJMoa1913948; Edib Z, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0428-4; Eijzenga W, 2014, PSYCHO-ONCOLOGY, V23, P862, DOI 10.1002/pon.3485; EVANS DGR, 1994, BRIT J CANCER, V70, P934, DOI 10.1038/bjc.1994.423; Golan T, 2019, NEW ENGL J MED, V381, P317, DOI 10.1056/NEJMoa1903387; Haas JS, 2005, J WOMENS HEALTH, V14, P845, DOI 10.1089/jwh.2005.14.845; Haber G, 2012, AM J PUBLIC HEALTH, V102, P2322, DOI 10.2105/AJPH.2012.300786; Halbert CH, 2011, J CLIN ONCOL, V29, P4302, DOI 10.1200/JCO.2010.33.1561; Hamilton JG, 2009, HEALTH PSYCHOL, V28, P510, DOI 10.1037/a0014778; Katapodi MC, 2009, ONCOL NURS FORUM, V36, P306, DOI 10.1188/09.ONF.306-314; Laing SS, 2008, J NATL MED ASSOC, V100, P1309, DOI 10.1016/S0027-9684(15)31510-8; Litton JK, 2018, NEW ENGL J MED, V379, P753, DOI 10.1056/NEJMoa1802905; Manchanda R, 2020, CANCERS, V12, DOI 10.3390/cancers12071929; Meiser B, 2018, EUR J HUM GENET, V26, P972, DOI 10.1038/s41431-017-0057-3; Metcalfe K, 2019, BRIT J CANCER, V121, P15, DOI 10.1038/s41416-019-0446-1; Morgan R, 2018, AM J SURG, V215, P899, DOI 10.1016/j.amjsurg.2018.02.010; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; NICE, 2013, FAM BREAST CANC CLAS; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P652, DOI 10.1001/jama.2019.10987; Panchal SM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-116; Rao NY, 2009, BREAST CANCER RES TR, V116, P563, DOI 10.1007/s10549-008-0181-4; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Samadder NJ, 2021, JAMA ONCOL, V7, P230, DOI 10.1001/jamaoncol.2020.6252; Shkedi-Rafid S, 2012, GENET MED, V14, P688, DOI 10.1038/gim.2012.31; Tan MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203469; Tung N, 2021, J CLIN ONCOL, V39, P3415, DOI 10.1200/JCO.21.01761; Tutt ANJ, 2021, NEW ENGL J MED, V384, P2394, DOI 10.1056/NEJMoa2105215; Van Campen KS., 2010, CULTURAL DIFFERENCES; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; Wen WX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215381; Yoon SY, 2022, J MED GENET, V59, P220, DOI 10.1136/jmedgenet-2020-107416; Zhang LR, 2011, EUR J CANCER PREV, V20, P255, DOI 10.1097/CEJ.0b013e3283447467	38	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263675	10.1371/journal.pone.0263675	http://dx.doi.org/10.1371/journal.pone.0263675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167615	gold, Green Published			2022-12-26	WOS:000802227200013
J	Schrumpf, T; Behrens, HM; Haag, J; Kruger, S; Rocken, C				Schrumpf, Thorben; Behrens, Hans-Michael; Haag, Jochen; Krueger, Sandra; Roecken, Christoph			FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR 2; FIBROBLAST-GROWTH-FACTOR-RECEPTOR-2 GENE AMPLIFICATION; PROGNOSTIC-SIGNIFICANCE; TUMOR EVOLUTION; K-SAM; EXPRESSION; ADENOCARCINOMA; HETEROGENEITY; HER2	The significance of fibroblast growth factor receptor 2 (FGFR2) in gastric cancer (GC) has been studied predominantly in Asian patient cohorts. Data on White patients are scarce. Here, we aimed to independently validate the expression and putative tumor biological significance of FGFR2 in a large non-Asian GC cohort. Immunohistochemistry (IHC) was performed on large-area tissue sections from 493 patients with GC and evaluated using the HScore. GCs with moderate and strong FGFR2 expression were studied for Fgfr2 amplification using chromogenic in situ hybridization (CISH). Median overall survival was determined using the Kaplan-Meier method. The majority [240 (99.1%)] of FGFR2-positive GCs showed a variable combination of staining intensities with marked intratumoral heterogeneity, including weak [198 (40.2%) cases], moderate [145 (29.4%)], and strong [108 (21.9%)] staining in diverse combinations. 250 (50.9%) GCs expressed no FGFR2. Fgfr2 gene amplification was found in 40% of selected cases with high protein expression and was also heterogeneous at the cell level. FGFR2 protein expression did not correlate with patient survival in the entire cohort However, using different cutoff values, a negative correlation between FGFR2-expression and patient outcome was found for diffuse-type GC. FGFR2 expression was associated with a lower tumor grade and intestinal phenotype (p <= 0.0001). FGFR2-positive diffuse-type GCs classify a small subset of patients with a poor tumor specific survival (5.29 +/- 1.3 vs. 14.67 +/- 1.9 months; p = 0.004).	[Schrumpf, Thorben; Behrens, Hans-Michael; Haag, Jochen; Krueger, Sandra; Roecken, Christoph] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Pathol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Rocken, C (corresponding author), Univ Kiel, Univ Hosp Schleswig Holstein, Dept Pathol, Kiel, Germany.	christoph.roecken@uksh.de	Röcken, Christoph/A-9239-2010	Röcken, Christoph/0000-0002-6989-8002				Ahn S, 2016, MODERN PATHOL, V29, P1095, DOI 10.1038/modpathol.2016.96; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Bartley AN, 2017, J CLIN ONCOL, V35, P446, DOI 10.1200/JCO.2016.69.4836; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Betts G, 2014, VIRCHOWS ARCH, V464, P145, DOI 10.1007/s00428-013-1517-y; Boger C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1293215; Boger C, 2016, ONCOTARGET, V7, P24269, DOI 10.18632/oncotarget.8169; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Das K, 2014, CANCER LETT, V353, P167, DOI 10.1016/j.canlet.2014.07.021; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Ferlaym J., 2018, GLOBAL CANC OBSERVAT; Han N, 2015, PATHOBIOLOGY, V82, P269, DOI 10.1159/000441149; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; Hierro C, 2017, ANN ONCOL, V28, P1207, DOI 10.1093/annonc/mdx081; Hosoda K, 2018, ONCOL LETT, V15, P1853, DOI 10.3892/ol.2017.7515; Hur JY, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.152878; Inokuchi M, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-016-1081-4; Jia YX, 2016, ONCOTARGETS THER, V9, P5919, DOI 10.2147/OTT.S111778; Jung EJ, 2012, HUM PATHOL, V43, P1559, DOI 10.1016/j.humpath.2011.12.002; Kaatsch P, 2013, KREBS DEUTSCHL 2009; Kim HS, 2019, J CANCER, V10, P20, DOI 10.7150/jca.28204; Klempner SJ, 2019, ONCOLOGIST, V24, P1462, DOI 10.1634/theoncologist.2019-0121; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Matsunobu T, 2006, INT J ONCOL, V28, P307; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Metzger ML, 2016, HISTOPATHOLOGY, V68, P241, DOI 10.1111/his.12745; Murase H, 2014, MOL CLIN ONCOL, V2, P509, DOI 10.3892/mco.2014.293; Nagatsuma AK, 2015, GASTRIC CANCER, V18, P227, DOI 10.1007/s10120-014-0360-4; Ooki A, 2021, GASTRIC CANCER, V24, P1169, DOI 10.1007/s10120-021-01235-z; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Rocken C, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00975-y; Rocken C, 2016, J CLIN PATHOL, V69, P70, DOI 10.1136/jclinpath-2015-202980; Seo S, 2017, ONCOTARGET, V8, P33844, DOI 10.18632/oncotarget.12953; Smyth EC, 2016, ANN ONCOL, V27, pv38, DOI 10.1093/annonc/mdw350; Smyth EC, 2020, LANCET, V396, P635, DOI 10.1016/S0140-6736(20)31288-5; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Tokunaga R, 2016, ONCOTARGET, V7, P19748, DOI 10.18632/oncotarget.7782; Toyokawa T, 2009, ONCOL REP, V21, P875, DOI 10.3892/or_00000297; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; UEKI T, 1995, J PATHOL, V177, P353, DOI 10.1002/path.1711770405; Van Cutsem E, 2017, ANN ONCOL, V28, P1316, DOI 10.1093/annonc/mdx107; Wagner AD, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5675-4; Wang HY, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3177-9; Wang Y, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03079-8; Warneke VS, 2013, ANN ONCOL, V24, P725, DOI 10.1093/annonc/mds528; Warneke VS, 2013, DIAGN MOL PATHOL, V22, P127, DOI 10.1097/PDM.0b013e318284188e; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wittekind C., 2017, TNM CLASSIFICATION M, V8th, P272; Yuan DD, 2016, ONCOL REP, V35, P1245, DOI 10.3892/or.2015.4528	54	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0264011	10.1371/journal.pone.0264011	http://dx.doi.org/10.1371/journal.pone.0264011			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167603	gold, Green Published			2022-12-26	WOS:000802227200033
J	Mcbride, CM; Campbell, GP; Zhao, JS; Pentz, RD; Escoffery, C; Komonos, M; Cannova, K; Byrne, JLB; Paris, NM; Shepperd, JR; Guan, Y				Mcbride, Colleen M.; Campbell, Gavin P.; Zhao, Jingsong; Pentz, Rebecca D.; Escoffery, Cam; Komonos, Michael; Cannova, Kelly; Byrne, Janice L. B.; Paris, Nancy M.; Shepperd, James R.; Guan, Yue			Applying citizen science to engage families affected by ovarian cancer in developing genetic service outreach strategies	PLOS ONE			English	Article							HEALTH	Citizen science (CS) approaches involving non-professional researchers (citizens) as research collaborators has been used infrequently in health promotion generally and specifically, in cancer prevention. Standardized CS approaches may be especially useful for developing communication interventions to encourage families to consider cancer genetic services. We engaged survivors of ovarian cancer and their close relatives as CS collaborators to collect and help interpret data to inform content for a website, printed invitation materials, and short-message reminders. We applied an implementation quality framework, and posed four research questions regarding the feasibility of CS: recruitment, data collection, data quality and evaluation of the experience. CS members were recruited through three networks: clinical sites, local and national cancer support organizations, and online ovarian cancer patient support groups. The professional research team operationalized theory-aligned CS tasks, five data collection options, question banks/scripts for creating surveys, structured interviews, online training and ongoing support from research coaches. 14 CS members agreed to the 12-week and 20-hour commitment for an honorarium. CS members opted to do both qualitative and quantitative assessments. CS members collected 261 surveys and 39 structured interviews. The largest number of surveys were collected for Task 1 (n = 102) to assess survivors' reactions to different possible options for motivating survivors to visit a study website; 77% of this data were complete (i.e., no missing values). Data collected for tasks 2, 3, 4, and 5 (e.g., assessment of survivors' and relatives' respective communication preferences) ranged from 10 to 58 surveys (80% to 84% completeness). All data were collected within the specified time frame. CSs reported 17 hours of work on average and regarded the experience positively. Our experience suggests that CS engagement is feasible, can yield comprehensive quantitative and qualitative data, and is achievable in a relatively a short timeline.	[Mcbride, Colleen M.; Campbell, Gavin P.; Zhao, Jingsong; Escoffery, Cam; Guan, Yue] Emory Univ, Dept Behav Social & Hlth Educ Sci, Atlanta, GA 30322 USA; [Pentz, Rebecca D.] Emory Sch Med, Dept Hematol & Oncol, Atlanta, GA USA; [Komonos, Michael] Emory Sch Med, Atlanta, GA USA; [Cannova, Kelly] OVERRUN Ovarian Canc Fdn, Overland Pk, KS USA; [Byrne, Janice L. B.] Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Paris, Nancy M.] Georgia Ctr Oncol Res & Educ, Atlanta, GA USA; [Shepperd, James R.] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA	Emory University; Emory University; Emory University; Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida	Mcbride, CM (corresponding author), Emory Univ, Dept Behav Social & Hlth Educ Sci, Atlanta, GA 30322 USA.	cmmcbri@emory.edu	Campbell, Gavin/GPX-2305-2022	Escoffery, Cam/0000-0003-4445-009X	National Cancer Institute (NCI) of the NIH	National Cancer Institute (NCI) of the NIH	The research was funded by a grant from the National Cancer Institute (NCI) of the NIH that has been acknowledged in the text. The following authors received some salary support from the NCI grant: Drs. McBride, Guan, Pentz, Shepperd; Mr. Campbell, Ms. Zhao and Mr. Komonos. The additional authors did not receive salary support from the NCI grant. However, Ms. Cannova and Dr. Byrne served as Citizen Scientists and received an honorarium from the NCI grant for their service. Ms. Paris volunteered her efforts. The NCI had no role in study design, data collection, data analysis, the decision to publish, or preparation of the manuscript.	Adler FR, 2020, ANN NY ACAD SCI, V1469, P52, DOI 10.1111/nyas.14340; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Banna J, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0829-6; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Brewer LC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218724; Brunton G, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4958-4; Burger J M, 1999, Pers Soc Psychol Rev, V3, P303, DOI 10.1207/s15327957pspr0304_2; Carter RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085508; Crocker JC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4738; Den Broeder L, 2018, HEALTH PROMOT INT, V33, P505, DOI 10.1093/heapro/daw086; Etikan I, BIOMETRICS BIOSTATIS, V3, P55; FREEDMAN JL, 1966, J PERS SOC PSYCHOL, V4, P195, DOI 10.1037/h0023552; Greenberg S, 2019, J COMMUN GENET, V10, P51, DOI 10.1007/s12687-018-0357-5; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Heigl F., 2020, CITIZEN SCI THEORY P, V5, P23; Henrikson NB, 2021, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa071; Joule RV, 2007, SOC PERSONAL PSYCHOL, V1, P493, DOI 10.1111/j.1751-9004.2007.00018.x; Kelly R, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0461; Lee YJ, 2017, CANCER MED-US, V6, P2595, DOI 10.1002/cam4.1165; Linnan LA, 2014, AM J PREV MED, V47, P77, DOI 10.1016/j.amepre.2014.02.007; Lopez MP, 2020, CITIZEN SCI THEORY P, V5; Menko FH, 2019, FAM CANCER, V18, P127, DOI 10.1007/s10689-018-0089-z; Newell KW, 1975, HLTH PEOPL; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Nunn JS, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00079; Ocloo J, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-020-00644-3; Organization WH., 1978, PRIMARY HLTH CARE RE; Pozzar RA, 2017, GYNECOL ONCOL, V147, P714, DOI 10.1016/j.ygyno.2017.10.004; Rifkin SB, 2014, HEALTH POLICY PLANN, V29, P98, DOI 10.1093/heapol/czu076; Roberts MC, 2018, HEALTH AFFAIR, V37, P801, DOI 10.1377/hlthaff.2017.1630; Schaefer T., 2021, SCI CITIZEN SCI, P495, DOI DOI 10.1007/978-3-030-58278-4_25; Wiggins A, 2019, AM J BIOETHICS, V19, P3, DOI 10.1080/15265161.2019.1619859	32	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0262575	10.1371/journal.pone.0262575	http://dx.doi.org/10.1371/journal.pone.0262575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157722	gold, Green Published			2022-12-26	WOS:000788004500006
J	Morel, PS; Duvivier, V; Bertin, F; Provost, N; Hammoutene, A; Hubert, EL; Gonzalez, A; Tupinon-Mathieu, I; Paradis, V; Delerive, P				Morel, Patricia Sansilvestri; Duvivier, Valerie; Bertin, Florence; Provost, Nicolas; Hammoutene, Adel; Hubert, Edwige-Ludiwyne; Gonzalez, Arantxa; Tupinon-Mathieu, Isabelle; Paradis, Valerie; Delerive, Philippe			Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression	PLOS ONE			English	Article							COLLAGEN; EXPRESSION; DISEASE; STEATOHEPATITIS; ACCUMULATION; MECHANISMS; HEALTHY; MODEL; NO	Background and aims Nonalcoholic Steatohepatitis (NASH) is a major cause of end-stage liver diseases such as cirrhosis and hepatocellular carcinoma resulting ultimately in increased liver-related mortality. Fibrosis is the main driver of mortality in NASH. Procollagen C-Proteinase Enhancer-1 (PCPE-1) plays a key role in procollagen maturation and collagen fibril formation. To assess its role in liver fibrosis and NASH progression, knock-out mice were evaluated in a dietary NASH model. Methods Global constitutive Pcolce(-/-) and WT male mice were fed with a Choline Deficient Amino acid defined High Fat Diet (CDA HFD) for 8 weeks. Liver triglycerides, steatosis, inflammation and fibrosis were assessed at histological, biochemical and gene expression levels. In addition, human liver samples from control and NASH patients were used to evaluate the expression of PCPE-1 at both mRNA and protein levels. Results Pcolce gene deficiency prevented diet-induced liver enlargement but not liver dysfunction. Furthermore, liver triglycerides, steatosis and inflammation were not modified in Pcolce(-/-) male mice compared to WT under CDA HFD. However, a significant decrease in liver fibrosis was observed in Pcolce(-/-) mice compared to WT under NASH diet, associated with a decrease in total and insoluble collagen content without any significant modifications in the expression of genes involved in fibrosis and extracellular matrix remodeling. Finally, PCPE-1 protein expression was increased in cirrhotic liver samples from both NASH and Hepatitis C patients. Conclusions Pcolce deficiency limits fibrosis but not NASH progression in CDA HFD fed mice.	[Morel, Patricia Sansilvestri; Duvivier, Valerie; Bertin, Florence; Provost, Nicolas; Hammoutene, Adel; Hubert, Edwige-Ludiwyne; Delerive, Philippe] Inst Rech Servier, Cardiovasc & Metab Dis Res, Suresnes, France; [Hammoutene, Adel; Paradis, Valerie] Hop Beaujon, Pathol Dept, Paris, France; [Gonzalez, Arantxa] CIMA Univ Navarra, IdiSNA, Program Cardiovasc Dis, Pamplona, Spain; [Gonzalez, Arantxa] CIBERCV, Pamplona, Spain; [Tupinon-Mathieu, Isabelle] Inst Rech Int Servier, Cardiovasc & Metab Dis, Suresnes, France	Servier; Institut de Recherches Internationales Servier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Servier; Institut de Recherches Internationales Servier	Morel, PS (corresponding author), Inst Rech Servier, Cardiovasc & Metab Dis Res, Suresnes, France.	patricia.sansilvestri-morel@servier.com	González, Arantxa/D-6860-2017	González, Arantxa/0000-0001-5986-6528; Sansilvestri-Morel, Patricia/0000-0003-3685-4473; HAMMOUTENE, Adel/0000-0001-6928-7431				Abe N, 2019, BIOL OPEN, V8, DOI 10.1242/bio.041251; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Angulo P, 2015, SEMIN LIVER DIS, V35, P132, DOI 10.1055/s-0035-1550065; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH234, DOI 10.1152/ajpheart.00227.2012; Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Drescher HK, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00770; Francone OL, 2011, J LIPID RES, V52, P1974, DOI 10.1194/jlr.M016527; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Gokce O, 2018, EUR J GASTROEN HEPAT, V30, P918, DOI 10.1097/MEG.0000000000001123; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hansen HH, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01356-2; Hassoun E, 2017, DATA BRIEF, V14, P777, DOI 10.1016/j.dib.2017.08.047; Hassoun E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159606; Heintz MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229896; Ippolito DL, 2016, TOXICOL SCI, V149, P67, DOI 10.1093/toxsci/kfv214; Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lagoutte Priscillia, 2021, Matrix Biol Plus, V11, P100062, DOI 10.1016/j.mbplus.2021.100062; Malecaze F, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.13-13800; Massey VL, 2017, HEPATOLOGY, V65, P969, DOI 10.1002/hep.28918; Massoudi D, 2017, CELL TISSUE RES, V370, P461, DOI 10.1007/s00441-017-2689-6; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Ogata I, 1997, HEPATOLOGY, V26, P611, DOI 10.1002/hep.510260312; Ozkan G, 2019, NEPHROLOGY, V24, P938, DOI 10.1111/nep.13521; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Pollard RD, 2015, J BIOL CHEM, V290, P15496, DOI 10.1074/jbc.M115.646240; Pulido D, 2018, STRUCTURE, V26, P1384, DOI 10.1016/j.str.2018.06.011; Sansilvestri-Morel P, 2021, J CARDIOVASC PHARM, V78, pe703, DOI 10.1097/FJC.0000000000001122; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Schiller HB, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156123; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311; Steiglitz BM, 2006, MOL CELL BIOL, V26, P238, DOI 10.1128/MCB.26.1.238-249.2006; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028	43	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263828	10.1371/journal.pone.0263828	http://dx.doi.org/10.1371/journal.pone.0263828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148334	Green Published, gold			2022-12-26	WOS:000800108800032
J	Yanagisawa, S; Nagasaki, K; Chea, C; Ando, T; Ayuningtyas, NF; Inubushi, T; Ishikado, A; Imanaka, H; Sugiyama, E; Takahashi, I; Miyauchi, M; Takata, T				Yanagisawa, Shunryou; Nagasaki, Karin; Chea, Chanbora; Ando, Toshinori; Ayuningtyas, Nurina Febriyanti; Inubushi, Toshihiro; Ishikado, Atsushi; Imanaka, Hiromichi; Sugiyama, Eiji; Takahashi, Ichiro; Miyauchi, Mutsumi; Takata, Takashi			Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model	PLOS ONE			English	Article							TNF-ALPHA; AUTOIMMUNE ARTHRITIS; RECEPTOR; MECHANISMS; PREVENTION; CELLS	Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammatory bone destruction in which tumor necrosis factor alpha (TNF-alpha) plays a key role. Bovine lactoferrin (bLF) is a multifunctional protein with anti-inflammatory and immunomodulatory properties. This study aimed to clarify the inhibitory effects of bLF on the pathological progression of RA. The mannan-induced arthritis model in SKG mice (genetic RA model) was used. Orally applied liposomal bLF (LbLF) markedly reduced ankle joint swelling and bone destruction. Histologically, pannus formation and osteoclastic bone destruction were prevented in the LbLF-treated animals. Moreover, orally administered LbLF improved the balance between Th17 cells and regulatory T cells isolated from the spleen of mannan-treated SKG mice. In an in vitro study, the anti-inflammatory effects of bLF on TNF-alpha-induced TNF-alpha production and downstream signaling pathways were analyzed in human synovial fibroblasts from RA patients (RASFs). bLF suppressed TNF-alpha production from RASFs by inhibiting the nuclear factor kappa B and mitogen-activated protein kinase pathways. The intracellular accumulation of bLF in RASFs increased in an applied bLF dose-dependent manner. Knockdown of the lipoprotein receptor-related protein-1 (LRP1) siRNA gene reduced bLF expression in RASFs, indicating that exogenously applied bLF was mainly internalized through LRP-1. Immunoprecipitated proteins with anti-TNF receptor-associated factor 2 (TRAF2; an adapter protein/ubiquitin ligase) included bLF, indicating that bLF binds directly to the TRAF2-TRADD-RIP complex. This indicates that LbLF may effectively prevent the pathological progression of RA by suppressing TNF-alpha production by binding to the TRAF2-TRADD-RIP complex from the RASFs in the pannus. Therefore, supplemental administration of LbLF may have a beneficial effect on preventive/therapeutic reagents for RA.	[Yanagisawa, Shunryou; Nagasaki, Karin; Chea, Chanbora; Ando, Toshinori; Miyauchi, Mutsumi; Takata, Takashi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan; [Nagasaki, Karin] Tohoku Univ, Dept Periodontol & Endodontol, Grad Sch Dent, Sendai, Miyagi, Japan; [Chea, Chanbora] Univ Puthisastra, Fac Dent, Phnom Penh, Cambodia; [Ando, Toshinori] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima, Japan; [Ayuningtyas, Nurina Febriyanti] Airlangga Univ, Fac Dent Med, Surabaya, Indonesia; [Inubushi, Toshihiro] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Osaka, Japan; [Ishikado, Atsushi; Imanaka, Hiromichi] Sunstar Inc, R&D Dept, Osaka, Japan; [Sugiyama, Eiji] Hiroshima Univ, Hiroshima, Japan; [Takahashi, Ichiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mucosal Immunol, Hiroshima, Japan; [Takata, Takashi] Tokuyama Univ, Shunan, Japan	Hiroshima University; Tohoku University; Hiroshima University; Airlangga University; Osaka University; Hiroshima University; Hiroshima University	Miyauchi, M; Takata, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima, Japan.; Takata, T (corresponding author), Tokuyama Univ, Shunan, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@tokuyama-u.ac.jp	Ando, Toshinori/AAA-6401-2021	Ando, Toshinori/0000-0002-3141-8173; Nagasaki, Karin/0000-0003-0528-4025	 [24659814]		This work was mainly supported by Grants-in-Aid for Scientific Research (Challenging Exploratory Research). Research Project number: 24659814. The funder provided support in the form of salaries for authors AI and HI but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; BROCK J, 1995, IMMUNOL TODAY, V16, P417, DOI 10.1016/0167-5699(95)80016-6; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33; Doyle MS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4071; Gibofsky A., 2012, AM J MANAG CARE, V18, P295; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hata H, 2004, J CLIN INVEST, V114, P582, DOI 10.1172/JCI200421795; Hayashida K, 2004, J VET MED SCI, V66, P149, DOI 10.1292/jvms.66.149; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Inubushi T, 2012, J BIOL CHEM, V287, P23527, DOI 10.1074/jbc.M111.324673; Ishikado A, 2005, BIOL PHARM BULL, V28, P1717, DOI 10.1248/bpb.28.1717; Kalliolias GD, 2012, ARTHRITIS RES THER, V14; Kim KW, 2015, AM J PATHOL, V185, P3011, DOI 10.1016/j.ajpath.2015.07.017; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Komatsu N, 2015, PROG MOL BIOL TRANSL, V136, P207, DOI 10.1016/bs.pmbts.2015.07.021; Lauterbach Ryszard, 2016, Dev Period Med, V20, P118; Lopez V, 2008, BIOCHEM J, V411, P271, DOI 10.1042/BJ20070393; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P393, DOI 10.1038/icb.2013.15; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Oda H, 2013, APPL ENVIRON MICROB, V79, P1843, DOI 10.1128/AEM.03343-12; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Peltonen R, 1997, BRIT J RHEUMATOL, V36, P64; PELTONEN R, 1994, BRIT J RHEUMATOL, V33, P638, DOI 10.1093/rheumatology/33.7.638; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Talukder MJR, 2003, J VET MED A, V50, P123, DOI 10.1046/j.1439-0442.2003.00512.x; Troost FJ, 2001, J NUTR, V131, P2101, DOI 10.1093/jn/131.8.2101; Tsuda H, 2002, BIOCHEM CELL BIOL, V80, P131, DOI 10.1139/o01-239; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vash B, 1998, BLOOD, V92, P3277, DOI 10.1182/blood.V92.9.3277.421k50_3277_3285; Wakabayashi H, 2014, J INFECT CHEMOTHER, V20, P666, DOI 10.1016/j.jiac.2014.08.003; Yamano E, 2010, LAB INVEST, V90, P1236, DOI 10.1038/labinvest.2010.80; Yuan H, 2007, COLLOID SURFACE B, V58, P157, DOI 10.1016/j.colsurfb.2007.03.002	40	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263254	10.1371/journal.pone.0263254	http://dx.doi.org/10.1371/journal.pone.0263254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148358	Green Published, gold			2022-12-26	WOS:000800108800018
J	Guan, YY; Li, XM; Li, SB; Sun, H; Liu, H				Guan, Yingying; Li, Xueming; Li, Songbo; Sun, He; Liu, He			Effect of Urban fringes green space fragmentation on ecosystem service value	PLOS ONE			English	Article							THERMAL ENVIRONMENT; IMPACT; PROVISION; INFRASTRUCTURE; LANDSCAPES; SIMULATION; EVOLUTION; TOURISM; QUALITY; CHINESE	In this study, an urban fringe green space classification system was established to explore the spatiotemporal variation of green space landscape and ecosystem service value (ESV) based on multi-source land-use data of Ganjingzi district from 2000 to 2018. (1) Results show that the total green space area declined from 359.57 to 213.46 km(2) over the study period. Green space large plaque index (LPI) and class area both gradually declined, whereas the number of plaques (NP) and plaque density (PD) gradually increased, indicating green space landscape fragmentation. (2) Additionally, the value of green space ecosystem services reduced from 397.42 to 124.93 million yuan. The dynamic degree of ESV change in green space increased or decreased moderately, always being < 0 and showing a decreasing trend of ESV. From a spatial variation perspective, dynamic degrees of ESV variation in the western and northern regions with relatively intensive green space were higher than those in the east. Regarding ESV of various green space types, forest land had the highest functional values of ecological regulation and support, whereas arable land provided the highest functional values of production supply. (3) The ecological service function value of green space system is negatively correlated with PD, NP, edge density, landscape shape index, and Shannon's diversity index, and positively correlated with aggregation index, contagion metrics, and LPI. The correlation coefficient between the climate regulation function of forest and the change of number of plaques is -0.874. The correlation coefficient of the recreation and culture of the wetland to the plaque density change is no less than -0.214.	[Guan, Yingying; Li, Xueming; Li, Songbo; Sun, He; Liu, He] Liaoning Normal Univ, Human Settlements Res Ctr, Dalian, Peoples R China; [Guan, Yingying; Li, Xueming; Li, Songbo; Sun, He; Liu, He] Liaoning Normal Univ, Liaoning Key Lab Phys Geog & Geomat, Dalian, Peoples R China	Liaoning Normal University; Liaoning Normal University	Guan, YY (corresponding author), Liaoning Normal Univ, Human Settlements Res Ctr, Dalian, Peoples R China.; Guan, YY (corresponding author), Liaoning Normal Univ, Liaoning Key Lab Phys Geog & Geomat, Dalian, Peoples R China.	GYY9418@126.com		Guan, Yingying/0000-0003-1175-3342; Sun, He/0000-0002-0646-8961	National Natural Science Foundation of China [41471140, 41171137,41671158]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research study was supported by the National Natural Science Foundation of China (grant no.41471140, 41171137,41671158). Yingying Guan wrote the main manuscript text, conducted the experiment and analyzed the data;Xueming Li contributed to all aspects of this work; Songbo Li, He Liu, He Sun revised the paper. All authors reviewed the manuscript.	Andersson E, 2014, AMBIO, V43, P445, DOI 10.1007/s13280-014-0506-y; Barcena JF, 2017, ECOL INDIC, V76, P159, DOI 10.1016/j.ecolind.2017.01.015; Blanco V, 2017, ECOSYST SERV, V23, P174, DOI 10.1016/j.ecoser.2016.12.003; Cai DL, 2017, SCI TOTAL ENVIRON, V589, P200, DOI 10.1016/j.scitotenv.2017.02.148; Calderon-Contreras R, 2017, ECOSYST SERV, V23, P127, DOI 10.1016/j.ecoser.2016.12.004; Chang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11559-5; Chen F, 2017, CHINESE GEOGR SCI, V27, P648, DOI 10.1007/s11769-017-0892-8; Ciftcioglu GC, 2017, LANDSCAPE ECOL, V32, P897, DOI 10.1007/s10980-017-0494-y; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Delgado-Aguilar MJ, 2017, ECOL INDIC, V73, P460, DOI 10.1016/j.ecolind.2016.10.020; Dennis M, 2016, ECOSYST SERV, V21, P120, DOI 10.1016/j.ecoser.2016.08.003; Dou YH, 2019, SCI TOTAL ENVIRON, V646, P685, DOI 10.1016/j.scitotenv.2018.07.205; Ferrarini A, 2017, RENEW SUST ENERG REV, V73, P277, DOI 10.1016/j.rser.2017.01.052; Florke M, 2018, NAT SUSTAIN, V1, P51, DOI 10.1038/s41893-017-0006-8; Huang A, 2019, ECOL INDIC, V104, P604, DOI 10.1016/j.ecolind.2019.05.027; Jaung WG, 2019, ECOSYST SERV, V40, DOI 10.1016/j.ecoser.2019.101038; Kain JH, 2016, ECOL INDIC, V70, P615, DOI 10.1016/j.ecolind.2016.02.062; Kmail AB, 2020, APPL GEOMAT, V12, P491, DOI 10.1007/s12518-020-00314-7; Lai DY, 2019, SCI TOTAL ENVIRON, V661, P337, DOI 10.1016/j.scitotenv.2019.01.062; Li YY, 2019, J GEOGR SCI, V29, P323, DOI 10.1007/s11442-019-1600-7; Li ZR, 2019, SCI TOTAL ENVIRON, V672, P370, DOI 10.1016/j.scitotenv.2019.03.486; Liu JY, 2017, SCI TOTAL ENVIRON, V586, P522, DOI 10.1016/j.scitotenv.2017.02.005; Liu J, 2019, TOURISM MANAGE, V70, P262, DOI 10.1016/j.tourman.2018.08.021; Liu J, 2018, HABITAT INT, V79, P74, DOI 10.1016/j.habitatint.2018.07.005; Liu L, 2018, SCI TOTAL ENVIRON, V628-629, P103, DOI 10.1016/j.scitotenv.2018.02.016; Liu YP, 2020, LANDSCAPE ECOL, V35, P2587, DOI 10.1007/s10980-020-01084-8; McCaughey JW, 2018, NAT SUSTAIN, V1, P38, DOI 10.1038/s41893-017-0002-z; Mouchet MA, 2017, ECOL INDIC, V73, P23, DOI 10.1016/j.ecolind.2016.09.026; Paralkar S, 2017, ECOL INDIC, V74, P10, DOI 10.1016/j.ecolind.2016.11.009; Pili S, 2017, ECOL INDIC, V76, P71, DOI 10.1016/j.ecolind.2017.01.008; Sun JF, 2019, ECOL INDIC, V107, DOI 10.1016/j.ecolind.2019.105660; Tan M, 2020, ENVIRON SCI POLLUT R, V27, P18640, DOI 10.1007/s11356-020-08182-9; Tolessa T, 2017, ECOSYST SERV, V23, P47, DOI 10.1016/j.ecoser.2016.11.010; Vaz AS, 2017, ECOSYST SERV, V23, P94, DOI 10.1016/j.ecoser.2016.11.017; Wang JW, 2020, INT J REMOTE SENS, V41, P2986, DOI 10.1080/01431161.2019.1697009; Wang J, 2018, REMOTE SENS ENVIRON, V205, P166, DOI 10.1016/j.rse.2017.11.019; [谢高地 Xie Gaodi], 2015, [资源科学, Resources Science], V37, P1740; [谢高地 Xie Gaodi], 2015, [自然资源学报, Journal of Natural Resources], V30, P1243; [徐洁 Xu Jie], 2019, [生态学报, Acta Ecologica Sinica], V39, P3039; Yang CB, 2017, FORESTS, V8, DOI 10.3390/f8050153; Yang J, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101487; Yang J, 2019, GISCI REMOTE SENS, V56, P388, DOI 10.1080/15481603.2018.1533680; Yang J, 2018, SCI TOTAL ENVIRON, V639, P1453, DOI 10.1016/j.scitotenv.2018.05.253; [杨俊 Yang Jun], 2018, [生态学报, Acta Ecologica Sinica], V38, P778; Yu L, 2019, J GEOGR SCI, V29, P1923, DOI 10.1007/s11442-019-1697-8; Yuan SF, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071124; Zhang F, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.133593; Zhang Y, 2018, REMOTE SENS ENVIRON, V205, P276, DOI 10.1016/j.rse.2017.12.009; Zhou WQ, 2018, SCI TOTAL ENVIRON, V627, P1572, DOI 10.1016/j.scitotenv.2018.01.335	49	0	0	16	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263452	10.1371/journal.pone.0263452	http://dx.doi.org/10.1371/journal.pone.0263452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143529	Green Submitted, Green Published, gold			2022-12-26	WOS:000797657800046
J	de Graaf, JF; van Nieuwkoop, S; Bestebroer, T; Groeneveld, D; van Eijck, CHJ; Fouchier, RAM; van den Hoogen, BG				de Graaf, J. Frederique; van Nieuwkoop, Stefan; Bestebroer, Theo; Groeneveld, Daphne; van Eijck, Casper H. J.; Fouchier, Ron A. M.; van den Hoogen, Bernadette G.			Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes	PLOS ONE			English	Article							FUSION PROTEIN; CLEAVAGE SITE; INTERFERON; PATHOGENICITY; REPLICATION; DETERMINANT; EXPRESSION; INDUCTION; VIRULENCE; ALPHA	Newcastle Disease Virus (NDV) is an avian RNA virus, which was shown to be effective and safe for use in oncolytic viral therapy for several tumour malignancies. The presence of a multi basic cleavage site (MBCS) in the fusion protein improved its oncolytic efficacy in vitro and in vivo. However, NDV with a MBCS can be virulent in poultry. We aimed to develop an NDV with a MBCS but with reduced virulence for poultry while remaining effective in killing human tumour cells. To this end, the open reading frame of the V protein, an avian specific type I interferon antagonist, was disrupted by introducing multiple mutations. NDV with a mutated V gene was attenuated in avian cells and chicken and duck eggs. Although this virus still killed tumour cells, the efficacy was reduced compared to the virulent NDV. Introduction of various mutations in the fusion (F) and hemagglutinin-neuraminidase (HN) genes slightly improved this efficacy. Taken together, these data demonstrated that NDV with a MBCS but with abrogation of the V protein ORF and mutations in the F and HN genes can be safe for evaluation in oncolytic viral therapy.	[de Graaf, J. Frederique; van Nieuwkoop, Stefan; Bestebroer, Theo; Groeneveld, Daphne; Fouchier, Ron A. M.; van den Hoogen, Bernadette G.] Erasmus MC, Virosci Dept, Rotterdam, Netherlands; [van Eijck, Casper H. J.] Erasmus MC, Dept Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van den Hoogen, BG (corresponding author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.	b.vandenhoogen@erasmusmc.nl		Groeneveld, Daphne/0000-0001-6614-9586; van den Hoogen, Bernadette/0000-0003-1996-8559	Dutch Foundation "Overleven with alvleesklierkanker"; NWO-TTW grant (NWO-domein Toegepaste en Technische Wetenschappen) [15414]	Dutch Foundation "Overleven with alvleesklierkanker"; NWO-TTW grant (NWO-domein Toegepaste en Technische Wetenschappen)	JFG and DG obtained funding from the Dutch Foundation "Overleven with alvleesklierkanker"; https://www.supportcasper.nl/nl/over-support-casper/stichting/RF and SN obtained funding from NWO-TTW grant #15414 (NWO-domein Toegepaste en Technische Wetenschappen; https://www.nwo.nl/toegepasteen-technische-wetenschappen-ttw).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US; Buijs PRA, 2014, CANCER GENE THER, V21, P463, DOI 10.1038/cgt.2014.51; Buijs PRA, 2014, CANCER GENE THER, V21, P24, DOI 10.1038/cgt.2013.78; Buijs P, 2015, VIRUSES-BASEL, V7, P2980, DOI 10.3390/v7062756; Burke S, 2020, CANCER IMMUNOL IMMUN, V69, P1015, DOI 10.1007/s00262-020-02495-x; Cheng X, 2016, J VIROL, V90, P5343, DOI 10.1128/JVI.00136-16; de Graaf JF, 2018, CYTOKINE GROWTH F R, V41, P28, DOI 10.1016/j.cytogfr.2018.03.006; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; Elankumaran S, 2006, J VIROL, V80, P7522, DOI 10.1128/JVI.00241-06; Engel-Herbert I, 2003, J VIROL METHODS, V108, P19, DOI 10.1016/S0166-0934(02)00247-1; Fournier P, 2012, INT J ONCOL, V40, P840, DOI 10.3892/ijo.2011.1265; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; GELB J, 1979, AVIAN DIS, V23, P534, DOI 10.2307/1589585; Hotte SJ, 2007, CLIN CANCER RES, V13, P977, DOI 10.1158/1078-0432.CCR-06-1817; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Karsunke J, 2019, VIRUS RES, V263, P207, DOI 10.1016/j.virusres.2019.02.003; King DJ, 1998, AVIAN DIS, V42, P507, DOI 10.2307/1592677; Koks CA, 2015, INT J CANCER, V136, pE313, DOI 10.1002/ijc.29202; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Laurie SA, 2006, CLIN CANCER RES, V12, P2555, DOI 10.1158/1078-0432.CCR-05-2038; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENCE RM, 1988, J NATL CANCER I, V80, P1305, DOI 10.1093/jnci/80.16.1305; Mariappan Asok Kumar, 2018, VirusDisease, V29, P180, DOI 10.1007/s13337-018-0445-5; Mebatsion T, 2003, J VIROL, V77, P9259, DOI 10.1128/JVI.77.17.9259-9265.2003; Mebatsion T, 2001, J VIROL, V75, P420, DOI 10.1128/JVI.75.1.420-428.2001; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Pecora AL, 2002, J CLIN ONCOL, V20, P2251, DOI 10.1200/JCO.2002.08.042; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Qiu XS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148560; Rangaswamy US, 2017, J VIROL, V91, DOI [10.1128/JVI.00770-17, 10.1128/jvi.00770-17]; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13	36	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263707	10.1371/journal.pone.0263707	http://dx.doi.org/10.1371/journal.pone.0263707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139115	Green Published, gold			2022-12-26	WOS:000821499100045
J	Rai, A; Shrivastava, R; Vang, D; Ritt, M; Sadler, F; Bhaban, S; Salapaka, M; Sivaramakrishnan, S				Rai, Ashim; Shrivastava, Rachit; Vang, Duha; Ritt, Michael; Sadler, Fredrik; Bhaban, Shreyas; Salapaka, Murti; Sivaramakrishnan, Sivaraj			Multimodal regulation of myosin VI ensemble transport by cargo adaptor protein GIPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL MYOSIN; PDZ DOMAIN; MOTOR; BINDING; DIMERIZATION; PROCESSIVITY; MELANOPHILIN; COMPLEXES; MECHANISM; FILAMENTS	A range of cargo adaptor proteins are known to recruit cytoskeletal motors to distinct subcellular compartments. However, the structural impact of cargo recruitment on motor function is poorly understood. Here, we dissect the multimodal regulation of myosin VI activity through the cargo adaptor GAIP-interacting protein, C terminus (GIPC), whose over-expression with this motor in cancer enhances cell migration. Using a range of biophysical techniques, including motility assays, FRET-based conformational sensors, optical trapping, and DNA origami-based cargo scaffolds to probe the individ-ual and ensemble properties of GIPC-myosin VI motility, we report that the GIPC myosin-interacting region (MIR) releases an autoinhibitory interaction within myosin VI. We show that the resulting conformational changes in the myosin lever arm, including the proximal tail domain, increase the flexibility of the adaptor-motor linkage, and that increased flexibility cor-relates with faster actomyosin association and dissociation rates. Taken together, the GIPC MIR-myosin VI interaction stimulates a twofold to threefold increase in ensemble cargo speed. Furthermore, the GIPC MIR-myosin VI ensembles yield similar cargo run lengths as forced processive myosin VI di-mers. We conclude that the emergent behavior from these individual aspects of myosin regulation is the fast, processive, and smooth cargo transport on cellular actin networks. Our study delineates the multimodal regulation of myosin VI by the cargo adaptor GIPC, while highlighting linkage flexibility as a novel biophysical mechanism for modulating cellular cargo motility.	[Rai, Ashim; Ritt, Michael; Sadler, Fredrik; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Shrivastava, Rachit; Bhaban, Shreyas; Salapaka, Murti] Univ Minnesota Twin Cities, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	sivaraj@umn.edu		Bhaban, Shreyas/0000-0001-9265-1617; Vang, Duha/0000-0002-8990-8968; Sivaramakrishnan, Sivaraj/0000-0002-9541-6994	National Institutes of Health [R35GM126940]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grant no.: R35GM126940; to S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Batters C, 2016, P NATL ACAD SCI USA, V113, pE1162, DOI 10.1073/pnas.1519435113; Bhaban S, 2018, IEEE-ASME T MECH, V23, P1532, DOI 10.1109/TMECH.2018.2852367; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; de Jonge JJ, 2019, FEBS LETT, V593, P1494, DOI 10.1002/1873-3468.13486; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Fili N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02050-w; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hariadi RF, 2015, NAT NANOTECHNOL, V10, P696, DOI [10.1038/NNANO.2015.132, 10.1038/nnano.2015.132]; Hariadi RF, 2015, ELIFE, V4, DOI 10.7554/eLife.05472; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Rai A, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.012703; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sarshar M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.11.115001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shang GJ, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27322; Shrivastava R, 2019, BIOCHEMISTRY-US, V58, P4721, DOI 10.1021/acs.biochem.9b00422; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Sommese RF, 2016, PROTEIN SCI, V25, P2089, DOI 10.1002/pro.3020; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025	48	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101688	10.1016/j.jbc.2022.101688	http://dx.doi.org/10.1016/j.jbc.2022.101688			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35143838	Green Published, gold			2022-12-26	WOS:000789400700014
J	Marcalo, R; Neto, S; Pinheiro, M; Rodrigues, AJ; Sousa, N; Santos, MAS; Simao, P; Valente, C; Andrade, L; Marques, A; Moura, GR				Marcalo, Rui; Neto, Sonya; Pinheiro, Miguel; Rodrigues, Ana J.; Sousa, Nuno; Santos, Manuel A. S.; Simao, Paula; Valente, Carla; Andrade, Lilia; Marques, Alda; Moura, Gabriela R.			Evaluation of the genetic risk for COVID-19 outcomes in COPD and differences among worldwide populations	PLOS ONE			English	Article							GENOTYPE IMPUTATION	Background Populations seem to respond differently to the global pandemic of severe acute respiratory syndrome coronavirus 2. Recent studies show individual variability in both susceptibility and clinical response to COVID-19 infection. People with chronic obstructive pulmonary disease (COPD) constitute one of COVID-19 risk groups, being already associated with a poor prognosis upon infection. This study aims contributing to unveil the underlying reasons for such prognosis in people with COPD and the variability in the response observed across worldwide populations, by looking at the genetic background as a possible answer to COVID-19 infection response heterogeneity. Methods SNPs already associated with susceptibility to COVID-19 infection (rs286914 and rs12329760) and severe COVID-19 with respiratory failure (rs657152 and rs11385942) were assessed and their allelic frequencies used to calculate the probability of having multiple risk alleles. This was performed on a Portuguese case-control COPD cohort, previously clinically characterized and genotyped from saliva samples, and also on worldwide populations (European, Spanish, Italian, African, American and Asian), using publicly available frequencies data. A polygenic risk analysis was also conducted on the Portuguese COPD cohort for the two mentioned phenotypes, and also for hospitalization and survival to COVID-19 infection. Findings No differences in genetic risk for COVID-19 susceptibility, hospitalization, severity or survival were found between people with COPD and the control group (all p-values > 0.01), either considering risk alleles individually, allelic combinations or polygenic risk scores. All populations, even those with European ancestry (Portuguese, Spanish and Italian), showed significant differences from the European population in genetic risk for both COVID-19 susceptibility and severity (all p-values < 0.0001). Conclusion Our results indicate a low genetic contribution for COVID-19 infection predisposition or worse outcomes observed in people with COPD. Also, our study unveiled a high genetic heterogeneity across major world populations for the same alleles, even within European sub-populations, demonstrating the need to build a higher resolution European genetic map, so that differences in the distribution of relevant alleles can be easily accessed and used to better manage diseases, ultimately, safeguarding populations with higher genetic predisposition to such diseases.	[Marcalo, Rui; Neto, Sonya; Pinheiro, Miguel; Santos, Manuel A. S.; Moura, Gabriela R.] Univ Aveiro, Inst Biomed IBIMED, Dept Med Sci, Genome Med Lab, Aveiro, Portugal; [Marcalo, Rui; Marques, Alda] Univ Aveiro, Sch Hlth Sci ESSUA, Lab3R Resp Res & Rehabil, Aveiro, Portugal; [Marcalo, Rui; Marques, Alda] Univ Aveiro, Inst Biomed IMIMED, Aveiro, Portugal; [Rodrigues, Ana J.; Sousa, Nuno] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Braga, Portugal; [Simao, Paula] Unidade Local Sau prime Matosinhos Porto, Dept Pulmonol, Porto, Portugal; [Valente, Carla; Andrade, Lilia] Ctr Hosp Baixo Vouga Aveiro, Dept Pulmonol, Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade do Minho	Marcalo, R (corresponding author), Univ Aveiro, Inst Biomed IBIMED, Dept Med Sci, Genome Med Lab, Aveiro, Portugal.; Marcalo, R (corresponding author), Univ Aveiro, Sch Hlth Sci ESSUA, Lab3R Resp Res & Rehabil, Aveiro, Portugal.; Marcalo, R (corresponding author), Univ Aveiro, Inst Biomed IMIMED, Aveiro, Portugal.	ruifilipemarcalo@ua.pt	Moura, Gabriela/GPF-9079-2022	Moura, Gabriela/0000-0003-2243-6123; Marcalo, Rui/0000-0003-0699-335X	FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020, Operational Programme for Competitiveness and Internationalization (POCI) [POCI-01-0145-FEDER-028806, POCI-01-0145-FEDER-016428]; CENTRO 2020 CENTRO 2020 [CENTRO-01-0246-FEDER-000018]; Portuguese national funds via Fundacao para a Ciencia e a Tecnologia, I.P. (FCT) [PTDC/DTP-PIC/2284/2014, PTDC/SAU-SER/28806/2017, PTDC/BIA-MIC/31849/2017, UI/BD/151337/2021]; FCT [UIDP/04501/2020]	FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020, Operational Programme for Competitiveness and Internationalization (POCI); CENTRO 2020 CENTRO 2020; Portuguese national funds via Fundacao para a Ciencia e a Tecnologia, I.P. (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FEDER (Fundo Europeu de Desenvolvimento Regional) funds through the COMPETE 2020, Operational Programme for Competitiveness and Internationalization (POCI) (POCI-01-0145-FEDER-028806; POCI-01-0145-FEDER-016428), CENTRO 2020 CENTRO 2020 (CENTRO-01-0246-FEDER-000018) and by Portuguese national funds via Fundacao para a Ciencia e a Tecnologia, I.P. (FCT) under the projects PTDC/DTP-PIC/2284/2014; PTDC/SAU-SER/28806/2017; PTDC/BIA-MIC/31849/2017, and the PhD fellowship UI/BD/151337/2021. The iBiMED is supported by FCT funds under UIDP/04501/2020.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Attaway AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100515; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; CDC, PEOPL CERT MED COND; Choi SW, 2020, NAT PROTOC, V15, P2759, DOI 10.1038/s41596-020-0353-1; Choi SW., 2018, BIORXIV, DOI [10.1101/416545, DOI 10.1101/416545, DOI 10.1257/aer.100.2.234]; Chu JY, 2022, CAN J NEUROL SCI, V49, P504, DOI 10.1017/cjn.2021.148; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; Cui YA, 2018, INT J CHRONIC OBSTR, V13, P3813, DOI 10.2147/COPD.S181246; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2019, GLOB STRAT DIAGN MAN; Hou Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01673-z; Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w; Kachuri Linda, 2020, Genome Med, V12, P93, DOI [10.1101/2020.05.01.20088054, 10.1186/s13073-020-00790-x]; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Lawaczeck R, 2020, ACS CHEM NEUROSCI, V11, P3996, DOI 10.1021/acschemneuro.0c00572; Leung JM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02108-2020; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marees AT, 2018, INT J METH PSYCH RES, V27, DOI 10.1002/mpr.1608; Mohammadpour S, 2021, J CELL PHYSIOL, V236, P49, DOI 10.1002/jcp.29868; Naj Adam C, 2019, Curr Protoc Hum Genet, V102, pe84, DOI 10.1002/cphg.84; NATIONAL HEART LUNG ABI, GRASP GEN WID REP AS; Pereira NL, 2021, MAYO CLIN PROC, V96, P446, DOI 10.1016/j.mayocp.2020.11.024; Phan L., 2010, US NATL LIB MED; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racanelli AC, 2018, AUTOPHAGY, V14, P221, DOI 10.1080/15548627.2017.1389823; Santos NC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00021; Santos NC, 2013, AGE, V35, P1983, DOI 10.1007/s11357-012-9482-y; Sharpe DE., 2015, PRACT ASSESS RES EVA, V20, P1; Stawicki S., 2020, J GLOB INFECT DIS; Tan HW, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2122; Wang R, 2020, J PHYS CHEM LETT, V11, P10007, DOI 10.1021/acs.jpclett.0c02765; World Health Organization, 1948, PREAMBL CONST WHO AD; World Health Statistics, 2018, WORLD HLTH STAT 2018	37	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264009	10.1371/journal.pone.0264009	http://dx.doi.org/10.1371/journal.pone.0264009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196333	Green Published, gold			2022-12-26	WOS:000835161600022
J	Beyene, MM; Shimbre, MS; Ukke, GG; Gebremichael, MA; Gurara, MK				Beyene, Maechel Maile; Shimbre, Mulugeta Shegaze; Ukke, Gebresilasea Gendisha; Gebremichael, Mathewos Alemu; Gurara, Mekdes Kondale			Factors associated with antenatal exercise in Arba Minch town, Southern Ethiopia: A community-based cross-sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GUIDELINES; PREGNANCY; DISEASES; WOMEN	Background Many health risks in pregnant women and their foetuses can be reduced by practicing antenatal exercise. However, the adequate practice of antenatal exercise among pregnant women is low in Ethiopia. Therefore, this study aimed to assess the practice of antenatal exercise and its associated factors among pregnant women in Arba Minch town. Methods A community-based cross-sectional study design was conducted. Data were collected by using a structured questionnaire from 422 pregnant women selected by a simple random sampling technique. Descriptive statistics were computed and a binary logistic regression model was fitted. In multivariable logistic-regression adjusted odds ratio (AOR) with 95% confidence intervals were used to determine the strength of associations. The significance level was declared at a p-value < 0.05. Results Among 410 participants, 32.9% (95% CI 28%-37%) adequately practiced antenatal exercise. Factors negatively associated with an adequate antenatal exercise were husband's primary school level [Adjusted odds ratio (AOR) = 0.3, (95% CI: 0.1, 0.7)], history of miscarriage [AOR = 0.3, (95% CI: 0.1, 0.7)], inadequate knowledge [AOR = 0.2, (95% CI: 0.1, 0.3)], and unfavorable attitude [AOR = 0.3, (95% CI 0.2, 0.5)]. Whereas, factors positively associated with an adequate antenatal exercise were employment status of women [AOR = 4.8, (95% CI: 1.8, 13.1)], and a practice of regular exercise before current pregnancy [AOR = 1.9, (95% CI: 1.1, 3.2)]. Conclusions The findings of this study indicated that adequate practice of antenatal exercise was found to be low. Appropriate measures should be taken to improve the husband's educational level, mother's occupation, knowledge, and attitudes towards antenatal exercise. Special consideration should be given to those with a history of miscarriage and women should be encouraged to practice regular exercise before pregnancy.	[Beyene, Maechel Maile; Ukke, Gebresilasea Gendisha] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia; [Shimbre, Mulugeta Shegaze; Gebremichael, Mathewos Alemu; Gurara, Mekdes Kondale] Arba Minch Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Beyene, MM (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia.	maechelmaile11@gmail.com		Kondale, Mekdes/0000-0001-8977-8772; Alemu, Mathewos/0000-0003-3652-9013; Maile, Maechel/0000-0003-3656-9357; Shimbre, Mulugeta Shegaze/0000-0001-5633-1309	Arba Minch University, college of Medicine and Health sciences	Arba Minch University, college of Medicine and Health sciences	Funding was obtained from Arba Minch University, college of Medicine and Health sciences.https://www.amu.edu.et/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bongaarts J, 2016, POPUL DEV REV, V42, P726, DOI 10.1111/padr.12033; Evenson KR, 2019, OBSTET GYNECOL SURV, V74, P481, DOI 10.1097/OGX.0000000000000693; Evenson KR, 2014, AM J LIFESTYLE MED, V8, P102, DOI 10.1177/1559827613498204; Janakiraman B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247533; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; May LE, 2010, EARLY HUM DEV, V86, P213, DOI 10.1016/j.earlhumdev.2010.03.002; Mbada CE, 2015, INT J WOMEN HEAL REP, V3, P93, DOI 10.15296/ijwhr.2015.18; My A., 2015, PHYS ACTIVITY EXERCI; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Nkhata LA., 2014, J SCI RES REPORTS, P1986; Nkhata LA., 2015, SCI J PUBL HLTH, V3, P361; Okafor UB, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03439-0; Pasanen T, 2017, BRIT J SPORT MED, V51, P1459, DOI 10.1136/bjsports-2016-097132; Puchalski S, 2017, J PREGNANCY REPROD, V1, DOI [10.15761/JPR.1000107, DOI 10.15761/JPR.1000107]; Ribeiro CP, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-31; Sarfraz M., 2013, PAKISTAN J MED DENT, V1, P34; Sujindra E., 2015, INT J ED PSYCHOL RES, V1, P234, DOI [10.4103/2395-2296.158347, DOI 10.4103/2395-2296.158347]; Timar R, 2016, PATIENT PREFER ADHER, V10, P2471, DOI 10.2147/PPA.S124858; Todorovic J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041366; Walsh JM, 2011, INT J GYNECOL OBSTET, V114, P154, DOI 10.1016/j.ijgo.2011.02.016; Wijesiriwardana W., 2016, SRI LANKA J OBSTET G, V37; Zavorsky GS, 2011, SPORTS MED, V41, P345, DOI 10.2165/11583930-000000000-00000	23	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0260840	10.1371/journal.pone.0260840	http://dx.doi.org/10.1371/journal.pone.0260840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192634	gold, Green Published			2022-12-26	WOS:000812552500005
J	Toraldo, DM; Satriano, F; Rollo, R; Verdastro, G; Imbriani, G; Rizzo, E; Argentiero, A; Falco, A; Ambrosino, P; Miani, A; Piscitelli, P				Toraldo, Domenico Maurizio; Satriano, Francesco; Rollo, Rodolfo; Verdastro, Gabriella; Imbriani, Giovanni; Rizzo, Emanuele; Argentiero, Alberto; Falco, Andrea; Ambrosino, Paolo; Miani, Alessandro; Piscitelli, Prisco			COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months	PLOS ONE			English	Article							ANTIBODIES; IGM	Background COVID-19 pandemic resulted in about 165 million infections and 3.4 million deaths all over the world across 15 months. The most severe clinical presentation of COVID-19 diseases is interstitial pneumonia. Methods In this paper we describe clinical outcomes based on radiological features as well as the pattern of haematochemical parameters and IgG/IgM antibodies in 75 patients hospitalized due to COVID-related interstitial pneumonia not requiring intensive care assistance. Each patient underwent routine laboratory tests, including inflammatory markers and coagulation profile at baseline. Computed Tomography (CT) was performed at baseline and after 3 months to assess the persistence of radiological sequelae. A Generalized Linear Model (GLM) was used to test for each patient the association between individual haematochemical parameters at the time of hospital admission and the subsequent radiological features after three months. The presence of IgG antibodies was quantitatively determined in 70 patients at the time of hospital admission and after 3 months. A subgroup of 49 and 21 patients underwent additional dosage of IgG after 6 and 12 months, respectively. IgM serological antibodies were available for 17 patients at baseline and 61 at T3, with additional follow-up for 51 and 20 subjects after 6 and 12 months, respectively. Results Only 28 out of 75 patients discharged from the hospital were totally healed after 3 months, while 47 patients (62.7%) still presented radiological sequelae. According to the GLM model, specific haematochemical baseline parameters-such as IL-6, GPT, platelets and eosinophil count-showed a statistically significant association with the presence of radiological sequelae at month 3 highlighting an OR = 0.5, thus meaning that subjects completely healed after 3 months presented half levels of IL-6 at baseline compared to patients with sequelae. In general, IgG serum levels were always higher than IgM at the time of hospitalization (75% at T0; n = 12 out of 16 patients with data available in both visits), after 3 months (72.1%; n = 44 out of 61 pts.), after 6 months (56.8%; 25 out of 44 pts.), and one year after hospitalization (60%; 12 out of 20 pts.). Overall, IgG and IgM serum levels presented a statistically significant decreasing trend from the baseline to month 3, 6 and 12. One patient presented an increase in IgM between baseline and month 3 but negative PCR test for SARS-COV2 on throat swab. Conclusions As supported by our findings on 75 patients, COVID-related interstitial pneumonia triggers early IgG levels (higher than IgM) that gradually decrease over 12 months. Mid-term sequelae are still detectable at lung Computed Tomography after 3 months from the hospital admission. Occasionally, it is possible to observe increase of IgM levels in presence of low concentrations of IgG and negative PCR ELISA tests for SARS-COV2 RNA. Baseline levels of IL-6 could be proposed as predictor of radiological mid/long-term sequelae after COVID-related interstitial pneumonia.	[Toraldo, Domenico Maurizio] Local Hlth Author ASL Le, V Fazzi Hosp, Cardioresp Rehabil Unit, Dept Rehabil, Lecce, Italy; [Satriano, Francesco] Local Hlth Author ASL Le, V Fazzi Hosp, Covid Sub Intens Resp Unit, Lecce, Italy; [Rollo, Rodolfo; Verdastro, Gabriella; Piscitelli, Prisco] ASL Le, Local Hlth Author, Lecce, Italy; [Imbriani, Giovanni; Rizzo, Emanuele] Univ Salento, Lecce, Italy; [Argentiero, Alberto] Univ Parma, Parma, Italy; [Falco, Andrea; Ambrosino, Paolo] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Miani, Alessandro] Univ Milan, Dept Environm Sci & Policy, Milan, Italy; [Miani, Alessandro; Piscitelli, Prisco] Italian Soc Environm Med SIMA, Milan, Italy	University of Salento; University of Parma; University of Sannio; University of Milan	Falco, A (corresponding author), Univ Sannio, Dept Sci & Technol, Benevento, Italy.	falco.and@gmail.com	Argentiero, Alberto/ACW-5026-2022	TORALDO, Domenico Maurizio/0000-0003-0023-0212; ARGENTIERO, ALBERTO/0000-0002-6597-5461; Ambrosino, Paolo/0000-0002-7761-5551				Atal S, 2020, PHARM MED, V34, P223, DOI 10.1007/s40290-020-00342-z; Carsetti R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.610300; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Crisafulli S, 2020, BIODRUGS, V34, P415, DOI 10.1007/s40259-020-00430-1; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Gupta V, 2021, CLIN INFECT DIS, V73, pE2823, DOI 10.1093/cid/ciaa1451; Han H, 2020, EMERG MICROBES INFEC, V9, P1123, DOI 10.1080/22221751.2020.1770129; Herold T., 2020, J ALLERGY CLIN IMMUN, DOI 10.1101/2020.04.01.20047381; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Kabak M, 2021, INT IMMUNOPHARMACOL, V93, DOI 10.1016/j.intimp.2021.107390; Kowitdamrong E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240502; Lee YL, 2020, J INFECTION, V81, pE55, DOI 10.1016/j.jinf.2020.04.019; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Maine GN, 2020, J CLIN VIROL, V133, DOI 10.1016/j.jcv.2020.104663; Orner EP, 2021, DIAGN MICR INFEC DIS, V99, DOI 10.1016/j.diagmicrobio.2020.115300; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Stefanelli P, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.013; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Sun BQ, 2020, EMERG MICROBES INFEC, V9, P940, DOI 10.1080/22221751.2020.1762515; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Ward H., 2020, MEDRXIV, DOI [10.1101/2020.10.26.20219725, DOI 10.1101/2020.10.26.20219725, 2020.10.26.20219725]; Zhao M, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105982; Zhou W, 2021, J MED VIROL, V93, P924, DOI 10.1002/jmv.26353	25	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0262911	10.1371/journal.pone.0262911	http://dx.doi.org/10.1371/journal.pone.0262911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192635	Green Published, gold			2022-12-26	WOS:000812552500014
J	Yagai, Y; Miura, A; Mishima, H; Furuyama, N				Yagai, Yusuke; Miura, Akito; Mishima, Hiroyuki; Furuyama, Nobuhiro			Involvement of global coordinative structure in achieving the local pendulum swinging task	PLOS ONE			English	Article							INCREASED MUSCULAR TENSION; PHASE-TRANSITIONS; POSTURAL EQUILIBRIUM; DYNAMICS; VARIABLES; SYMMETRY; MODEL	In the literature on inter-limb coordination, the coordination among "focal" body parts (i.e., the two limbs) directly engaged in a pendulum swinging task has been studied by immobilizing other body parts to reduce "noise," while putting aside questions of how one maintains posture while performing the task. However, in practical performance of musical instruments, for example, performers must coordinate different body parts in sync with the music while maintaining the whole body's balance. This study demonstrates the effectiveness and necessity of understanding inter-limb coordination in whole-body coordination. Participants were asked to move two pendulums either in sync or alternatively with metronome beeps under two conditions: immobile (fixed forearms) and mobile (forearms not fixed). The explorative analyses focused on whether and how coordinative structures emerged and whether the degree of task achievement differed according to the phase mode, frequency, and mobility conditions. The motion similarity and phase difference between different parts and the pendulums showed that task-specific coordinative structures emerged in both immobile and mobile conditions. In the in-phase mobile condition, the emergent coordinative structure may have improved task achievement, shown by the phase difference between the left and right pendulums. These findings suggest that the global coordinative structure is involved in achieving the local pendulum swinging task.	[Yagai, Yusuke] Waseda Univ, Adv Res Ctr Human Sci, Tokorozawa, Saitama, Japan; [Miura, Akito; Mishima, Hiroyuki; Furuyama, Nobuhiro] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan	Waseda University; Waseda University	Yagai, Y (corresponding author), Waseda Univ, Adv Res Ctr Human Sci, Tokorozawa, Saitama, Japan.	yagai.yusuke@gmail.com		Mishima, Hiroyuki/0000-0002-8709-9386	JSPS KAKENHI [15K12053, 19K12740]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (15K12053) and a Grant-in-Aid for Scientific Research (C) (19K12740) (https://www.jsps.go.jp/english/e-grants/index.html) awarded to FF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, DYNAMIC PATTERNS SEL; Avitabile D, 2016, BIOL CYBERN, V110, P201, DOI 10.1007/s00422-016-0691-9; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Batschelet E, 1981, CIRCULAR STAT BIOL; Beek PJ, 2002, BRAIN COGNITION, V48, P149, DOI 10.1006/brcg.2001.1310; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernstein N, 1967, COORDINATION REGULAT; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hamaoui A, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00032; Hamaoui A, 2014, GAIT POSTURE, V39, P333, DOI 10.1016/j.gaitpost.2013.07.131; Hamaoui A, 2011, GAIT POSTURE, V34, P457, DOI 10.1016/j.gaitpost.2011.06.017; Harrison D., 1988, J APPL STAT, V15, P197, DOI [10.1080/02664768800000026, DOI 10.1080/02664768800000026]; JEKA JJ, 1995, J EXP PSYCHOL HUMAN, V21, P360, DOI 10.1037/0096-1523.21.2.360; KELSO JAS, 1992, J EXP PSYCHOL HUMAN, V18, P645, DOI 10.1037/0096-1523.18.3.645; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; Le Bozec S, 2004, EXP BRAIN RES, V158, P427, DOI 10.1007/s00221-004-1918-x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2007, BIOL CYBERN, V96, P59, DOI 10.1007/s00422-006-0104-6; SCHMIDT RC, 1994, ECOL PSYCHOL, V6, P159, DOI 10.1207/s15326969eco0603_1; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; Verrel J, 2013, EXP BRAIN RES, V224, P323, DOI 10.1007/s00221-012-3314-2; Yagai Y, 2019, STUDIES PERCEPTION A, V13, P57; Zhang MS, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0360	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0262525	10.1371/journal.pone.0262525	http://dx.doi.org/10.1371/journal.pone.0262525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192624	gold, Green Published			2022-12-26	WOS:000812552500009
J	Arney, J; Gray, C; Clark, JA; Smith, D; Swank, A; Matlock, DD; Melcher, J; Kanwal, F; Naik, AD				Arney, Jennifer; Gray, Caroline; Clark, Jack A.; Smith, Donna; Swank, Annie; Matlock, Daniel D.; Melcher, Jennifer; Kanwal, Fasiha; Naik, Aanand D.			Prognosis conversations in advanced liver disease: A qualitative interview study with health professionals and patients	PLOS ONE			English	Article							SERIOUS ILLNESS; CARE; COMMUNICATION; INDICATORS; CIRRHOSIS; GOALS; TOOL	Advanced Liver Disease (AdvLD) is common, morbid, and associated with high likelihood of death. Patients may not fully understand their prognosis and are often unprepared for the course of illness. Little is known about how and when to deliver prognosis-related information to patients with AdvLD, who should participate, and what should be discussed. We conducted in-depth interviews with a multi-profession sample of Hepatology clinicians and patients with AdvLD. Participants were drawn from three geographically diverse facilities (New England, Texas, California). We used inductive and deductive qualitative data analysis approaches to identify themes related to AdvLD prognosis discussions. Thematic analysis focused on content, timing, and participants' roles in prognosis discussions. In total, 31 patients with AdvLD and 26 multi-profession clinicians completed interviews. Most participants provided a broad conceptualization of prognosis beyond predictions of survival, including expectations about illness course, ways to manage or avoid complications and a need to address patients' emotions. Patients favored initiating discussions early in the AdvLD course and welcomed a multi-profession approach to conducting discussions. Clinicians favored a larger role for specialty physicians. All participants recognized that AdvLD prognosis discussions occur infrequently and favored a structured, standardized approach to broadly discussing prognosis. Patients with AdvLD and their clinicians favored a multifaceted approach to prognosis conversations including discussions of life expectancy, predictions about likely course of liver disease, and expected changes in function and capabilities over time. Structured and early prognosis discussions should be part of routine AdvLD care.	[Arney, Jennifer; Smith, Donna; Melcher, Jennifer; Kanwal, Fasiha; Naik, Aanand D.] Michael E DeBakey VA Med Ctr, VA Hlth Serv Res & Dev Ctr Innovat Qual Effect &, Houston, TX 77030 USA; [Arney, Jennifer; Swank, Annie] Univ Houston Clear Lake, Dept Sociol, Houston, TX USA; [Gray, Caroline] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA; [Clark, Jack A.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Smith, Donna; Melcher, Jennifer; Kanwal, Fasiha; Naik, Aanand D.] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA; [Matlock, Daniel D.] Univ Colorado, Sch Med, Dept Med, Div Geriatr Med, Aurora, CO USA; [Kanwal, Fasiha] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [Naik, Aanand D.] Baylor Coll Med, Dept Med, Sect Geriatr & Palliat Med, Houston, TX 77030 USA; [Naik, Aanand D.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Management Policy & Community Hlth, Houston, TX 77030 USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Houston Clear Lake; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Boston University; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Naik, AD (corresponding author), Michael E DeBakey VA Med Ctr, VA Hlth Serv Res & Dev Ctr Innovat Qual Effect &, Houston, TX 77030 USA.; Naik, AD (corresponding author), Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA.; Naik, AD (corresponding author), Baylor Coll Med, Dept Med, Sect Geriatr & Palliat Med, Houston, TX 77030 USA.; Naik, AD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Management Policy & Community Hlth, Houston, TX 77030 USA.	Aanand.Naik@uth.tmc.edu		Naik, Aanand/0000-0001-6936-7984	VA U.S. Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development [I01 HX002204-01]; Veterans Administration Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center [CIN13-413]	VA U.S. Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development(US Department of Veterans Affairs); Veterans Administration Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center	FK, AN-I01 HX002204-01 VA U.S. Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development https://www.hsrd.research.va.gov/JA, DS, JM, FK, AN -CIN13-413 Veterans Administration Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey VA Medical Center https://www.houston.hsrd.research.va.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back AL, 2014, J PALLIAT MED, V17, P141, DOI 10.1089/jpm.2013.0197; Berger R, 2015, QUAL RES, V15, P219, DOI 10.1177/1468794112468475; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Blaum CS, 2018, J AM GERIATR SOC, V66, P2009, DOI 10.1111/jgs.15465; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cole CA, 2020, J PAIN SYMPTOM MANAG, V60, P101, DOI 10.1016/j.jpainsymman.2020.03.008; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Fiscella K, 2017, JT COMM J QUAL PATIE, V43, P361, DOI 10.1016/j.jcjq.2017.03.009; Geerse OP, 2019, J PALLIAT MED, V22, P773, DOI 10.1089/jpm.2018.0487; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Highet G, 2014, BMJ SUPPORT PALLIAT, V4, P285, DOI 10.1136/bmjspcare-2013-000488; Hudson BE, 2017, FRONTLINE GASTROENTE, V8, P45, DOI 10.1136/flgastro-2016-100734; Kanwal F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.23780; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Kaplan DE, 2015, CLIN GASTROENTEROL H, V13, P2333, DOI 10.1016/j.cgh.2015.07.010; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kimbell B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009241; Lakin JR, 2017, HEALTH AFFAIR, V36, P1258, DOI 10.1377/hlthaff.2017.0219; Lakin JR, 2016, JAMA INTERN MED, V176, P1380, DOI 10.1001/jamainternmed.2016.3212; Low J, 2022, FRONTLINE GASTROENTE, V13, P211, DOI 10.1136/flgastro-2020-101709; Low J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016887; Low JTS, 2018, J HEPATOL, V69, P1260, DOI 10.1016/j.jhep.2018.08.028; Mack JW, 2007, J CLIN ONCOL, V25, P5636, DOI 10.1200/JCO.2007.12.6110; Mandel EI, 2017, CLIN J AM SOC NEPHRO, V12, P854, DOI 10.2215/CJN.05760516; Marchesini G, 2001, GASTROENTEROLOGY, V120, P170, DOI 10.1053/gast.2001.21193; Morse JM, 1998, QUAL HEALTH RES, V8, P147, DOI 10.1177/104973239800800201; Naik AD, 2020, CLIN GASTROENTEROL H, V18, P1015, DOI 10.1016/j.cgh.2019.07.043; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Tinetti ME, 2019, JAMA INTERN MED, V179, P1688, DOI 10.1001/jamainternmed.2019.4235; Tulsky JA, 2017, JAMA INTERN MED, V177, P1361, DOI 10.1001/jamainternmed.2017.2005; Ufere NN, 2019, CLIN GASTROENTEROL H, V17, P2592, DOI 10.1016/j.cgh.2019.03.022	32	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263874	10.1371/journal.pone.0263874	http://dx.doi.org/10.1371/journal.pone.0263874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180233	Green Published, gold			2022-12-26	WOS:000796435800035
J	Diaz, K; Stegemoller, EEL				Diaz, Kasandra; Stegemoeller, Elizabeth E. L.			Electromyographic measures of asymmetric muscle control of swallowing in Parkinson's disease	PLOS ONE			English	Article							DYSPHAGIA; VARIABILITY; DYSFUNCTION; MANAGEMENT; DISORDERS	Introduction During the early stages, Parkinson's disease (PD) is well recognized as an asymmetric disease with unilateral onset of resting tremor with varying degrees of rigidity, and bradykinesia. However, it remains unknown if other impairments, such as swallowing impairment (i.e., dysphagia), also present asymmetrically. Purpose The primary aim of this study was to examine muscle activity associated with swallow on the most affected side (MAS) and least affected side (LAS) in persons with PD. A secondary aim was to explore the relationship between differences in muscle activity associated with swallow and subjective reports of swallowing impairment and disease severity. Methods Function of muscles associated with swallowing was assessed using surface electromyography placed over the right and left submental and laryngeal regions during three swallows for a THIN and THICK condition. The Swallowing Quality of Life (SWAL-QOL) questionnaire and the Unified Parkinson's Disease Rating Scale (UPDRS) were collected as measures of subjective swallow impairment and disease severity, respectively. Results Thirty-five participants diagnosed with idiopathic PD and on a stable antiparkinsonian medication regimen completed this study. Results revealed no significant mean difference in muscle activity during swallow between the more and less affected side. For the laryngeal muscle region, a significant difference in coefficient of variation between the MAS and LAS was revealed for peak amplitude for the THIN swallow condition. For the laryngeal muscle region, a significant association was revealed between muscle activity and disease severity but not subjective reports of swallowing impairment. Conclusion Superficially it appears that swallowing impairment present symmetrical during the early stages of PD, however, our variability data indicates otherwise. These results will be used to inform future studies in specific types of swallowing impairment (i.e., oral dysphagia, pharyngeal dysphagia, and esophageal dysphagia), disease progression, and overall asymmetry.	[Diaz, Kasandra; Stegemoeller, Elizabeth E. L.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA	Iowa State University	Diaz, K (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	kdiaz@iastate.edu		Diaz, kasandra/0000-0002-1486-1368	Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatment Innovations; Iowa State University	Parkinson Study Group; Parkinson's Disease Foundation's Advancing Parkinson's Treatment Innovations; Iowa State University	This study was supported by the Parkinson Study Group and the Parkinson's Disease Foundation's Advancing Parkinson's Treatment Innovations and in part by Iowa State University Extension and Outreach and joint Iowa agricultural extension districts. The grants provided financial support for the purchase of materials and participant reimbursement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Albani G, 2003, FUNCT NEUROL, V18, P165; Baker KK, 1998, NEUROLOGY, V51, P1592, DOI 10.1212/WNL.51.6.1592; BIRD MR, 1994, AGE AGEING, V23, P251, DOI 10.1093/ageing/23.3.251; Born LJ, 1996, MOVEMENT DISORD, V11, P53, DOI 10.1002/mds.870110110; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DeMaagd George, 2015, P T, V40, P504; Hamdy S, 1998, GASTROENTEROLOGY, V115, P1104, DOI 10.1016/S0016-5085(98)70081-2; Hunter PC, 1997, J NEUROL NEUROSUR PS, V63, P579, DOI 10.1136/jnnp.63.5.579; KEMPSTER PA, 1989, J NEUROL NEUROSUR PS, V52, P72, DOI 10.1136/jnnp.52.1.72; Khan A, 2014, CLIN GERIATR MED, V30, P43, DOI 10.1016/j.cger.2013.10.009; Matsuo K, 2008, PHYS MED REH CLIN N, V19, P691, DOI 10.1016/j.pmr.2008.06.001; Miller RA, 1996, ELECTROMYOGR MOTOR C, V101, P1, DOI 10.1016/0013-4694(95)00209-X; Nagaya M, 2000, SCAND J REHABIL MED, V32, P11; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Palmer PM, 2008, J SPEECH LANG HEAR R, V51, P828, DOI 10.1044/1092-4388(2008/060); Pfann KD, 2001, MOVEMENT DISORD, V16, P1048, DOI 10.1002/mds.1220; Plowman-Prine EK, 2009, MOVEMENT DISORD, V24, P1352, DOI 10.1002/mds.22617; Polychronis S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214352; Scharoun SM, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/307474; Stegemoller EL, 2017, COMPLEMENT THER MED, V31, P127, DOI 10.1016/j.ctim.2017.03.002; Sura L, 2012, CLIN INTERV AGING, V7, P287, DOI 10.2147/CIA.S23404; Suttrup I, 2016, DYSPHAGIA, V31, P24, DOI 10.1007/s00455-015-9671-9; Tawadros PB, 2012, MOVEMENT DISORD, V27, P1811, DOI 10.1002/mds.25262; Tomita S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197608; van Hooren MRA, 2014, PARKINSONISM RELAT D, V20, P800, DOI 10.1016/j.parkreldis.2014.03.026; Wang JL, 2015, PARKINSONISM RELAT D, V21, P590, DOI 10.1016/j.parkreldis.2015.03.012; Wirth R, 2016, CLIN INTERV AGING, V11, P189, DOI 10.2147/CIA.S97481	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0262424	10.1371/journal.pone.0262424	http://dx.doi.org/10.1371/journal.pone.0262424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180221	gold, Green Published			2022-12-26	WOS:000796435800004
J	Gisen, DC; Schutz, C; Weichert, RB				Gisen, David C.; Schuetz, Cornelia; Weichert, Roman B.			Development of behavioral rules for upstream orientation of fish in confined space	PLOS ONE			English	Article							LAGRANGIAN-AGENT METHOD; VERTICAL-SLOT FISHWAY; BROWN TROUT; PASSAGE STRUCTURES; LATERAL-LINE; PERFORMANCE; MOVEMENT; MODEL; TURBULENCE; BARRIERS	Improving the effectiveness of fishways requires a better understanding of fish behavior near hydraulic structures, especially of upstream orientation. One of the most promising approaches to this problem is the use of model behavioral rules. We developed a three-dimensional individual-based model based on observed brown trout (Salmo trutta fario) movement in a laboratory flume and tested it against two hydraulically different flume setups. We used the model to examine which of five behavioral rule versions would best explain upstream trout orientation. The versions differed in the stimulus for swim angle selection. The baseline stimulus was positive rheotaxis with a random component. It was supplemented by attraction towards either lower velocity magnitude, constant turbulence kinetic energy, increased flow acceleration, or shorter wall distance. We found that the baseline stimulus version already explained large parts of the observed behavior. Mixed results for velocity magnitude, turbulence kinetic energy, and flow acceleration indicated that the brown trout did not orient primarily by means of these flow features. The wall distance version produced significantly improved results, suggesting that wall distance was the dominant orientation stimulus for brown trout in our hydraulic conditions. The absolute root mean square error (RMSE) was small for the best parameter set (RMSE = 9 for setup 1, RMSE = 6 for setup 2). Our best explanation for these results is dominance of the visual sense favored by absence of challenging hydraulic stimuli. We conclude that under similar conditions (moderate flow and visible walls), wall distance could be a relevant stimulus in confined space, particularly for fishway studies and design in IBMs, laboratory, and the field.	[Gisen, David C.; Schuetz, Cornelia; Weichert, Roman B.] Bundesanstalt Wasserbau, Waterways & Environm Unit, Karlsruhe, Germany; [Schuetz, Cornelia] Bundesanstalt Gewasserkunde, Anim Eol Unit, Koblenz, Germany		Gisen, DC (corresponding author), Bundesanstalt Wasserbau, Waterways & Environm Unit, Karlsruhe, Germany.	david.gisen@baw.de			German Federal Ministry of Transport and Digital Infrastructure (BMVI)	German Federal Ministry of Transport and Digital Infrastructure (BMVI)	This work was funded by the German Federal Ministry of Transport and Digital Infrastructure (BMVI, https://www.bmvi.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2015, ECOL MODEL, V312, P292, DOI 10.1016/j.ecolmodel.2015.05.015; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Bleckmann H, 2009, INTEGR ZOOL, V4, P13, DOI 10.1111/j.1749-4877.2008.00131.x; Bunt CM, 2016, RIVER RES APPL, V32, P2125, DOI 10.1002/rra.3095; Bunt CM, 2012, RIVER RES APPL, V28, P457, DOI 10.1002/rra.1565; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Castro-Santos T, 2004, CAN J FISH AQUAT SCI, V61, P1602, DOI 10.1139/F04-094; Castro-Santos T, 2013, CAN J FISH AQUAT SCI, V70, P280, DOI 10.1139/cjfas-2012-0186; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Coombs S, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.223008; Cotel AJ, 2006, T AM FISH SOC, V135, P610, DOI 10.1577/T04-196.1; Dockery DR, 2017, J FISH BIOL, V90, P980, DOI 10.1111/jfb.13217; Douglas R.H., 1990, P373; Ebel G, 2014, WASSERWIRTSCHAFT, V104, P40, DOI 10.1365/s35147-014-1095-1; Elder J, 2015, J COMP PHYSIOL A, V201, P667, DOI 10.1007/s00359-015-1014-7; Fuentes-Perez JF, 2018, ECOL ENG, V125, P131, DOI 10.1016/j.ecoleng.2018.10.014; Gao Z, 2016, ECOL ENG, V88, P217, DOI 10.1016/j.ecoleng.2015.12.038; Gisen D, 2018, THESIS U BUNDESWEHR; Goettel MT, 2015, ECOL ENG, V74, P230, DOI 10.1016/j.ecoleng.2014.10.012; Goodwin RA, 2014, P NATL ACAD SCI USA, V111, P5277, DOI 10.1073/pnas.1311874111; Goodwin RA, 2006, ECOL MODEL, V192, P197, DOI 10.1016/j.ecolmodel.2005.08.004; Grimm V., 2005, INDIVIDUAL BASED MOD; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2020, JASSS-J ARTIF SOC S, V23, DOI 10.18564/jasss.4259; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Jones MJ, 2017, FISHERIES MANAG ECOL, V24, P177, DOI 10.1111/fme.12205; Kasumyan A.O., 2011, J ICHTHYOL+, V51, P1035, DOI [10.1134/S003294521111004X, DOI 10.1134/S003294521111004X]; Kemp PS, 2016, RIVER RES APPL, V32, P2116, DOI 10.1002/rra.3082; Kemp PS, 2006, RIVER RES APPL, V22, P429, DOI 10.1002/rra.913; Kerr JR, 2016, J EXP BIOL, V219, P3480, DOI 10.1242/jeb.134775; Lacey RWJ, 2012, RIVER RES APPL, V28, P429, DOI 10.1002/rra.1584; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liao JC, 2006, J EXP BIOL, V209, P4077, DOI 10.1242/jeb.02487; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Padgett TE, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191505; Przybilla A, 2010, J EXP BIOL, V213, P2976, DOI 10.1242/jeb.041632; Rodriguez A, 2015, J HYDROINFORM, V17, P275, DOI 10.2166/hydro.2014.034; Roth M.S., 2021, J ECOHYDRAULICS, V6, P1, DOI [10.1080/24705357.2020.1869916, DOI 10.1080/24705357.2020.1869916]; Schutz C, 2021, ECOL ENG, V167, DOI 10.1016/j.ecoleng.2021.106257; Silva AT, 2018, FISH FISH, V19, P340, DOI 10.1111/faf.12258; Silva AT, 2012, ECOL ENG, V44, P314, DOI 10.1016/j.ecoleng.2012.04.015; Smith DL., 2014, P 10 INT S ECOHYDRAU; Tan JJ, 2018, WATER-SUI, V10, DOI 10.3390/w10111511; The OpenFOAM Foundation, 2014, OPENFOAM; Thiele JC, 2014, JASSS-J ARTIF SOC S, V17, DOI 10.18564/jasss.2503; Wang H, 2018, RIVER RES APPL, V34, P244, DOI 10.1002/rra.3245; WEIHS D, 1977, FORTS ZOOL, V24, P171; Willis J, 2011, ECOL MODEL, V222, P3869, DOI 10.1016/j.ecolmodel.2011.10.004; Windsor SP, 2010, J EXP BIOL, V213, P3832, DOI 10.1242/jeb.040790; Zielinski DP, 2018, ECOL MODEL, V382, P18, DOI 10.1016/j.ecolmodel.2018.05.004	50	0	0	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263964	10.1371/journal.pone.0263964	http://dx.doi.org/10.1371/journal.pone.0263964			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180239	Green Published, gold			2022-12-26	WOS:000796435800038
J	Gylfadottir, SS; Itani, M; Kristensen, AG; Karlsson, P; Kroigard, T; Bennett, DL; Tankisi, H; Andersen, NT; Jensen, TS; Sindrup, SH; Finnerup, NB				Gylfadottir, Sandra Sif; Itani, Mustapha; Kristensen, Alexander Gramm; Karlsson, Pall; Kroigard, Thomas; Bennett, David L.; Tankisi, Hatice; Andersen, Niels Trolle; Jensen, Troels Staehelin; Sindrup, Soren Hein; Finnerup, Nanna Brix			The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy	PLOS ONE			English	Article							SPINAL-CORD-INJURY; NEUROPATHIC PAIN; DIAGNOSTIC-CRITERIA; MECHANISMS; DEPRESSION; PREDICTOR; PHENOTYPE; PROTOCOL; ILLNESS; BURDEN	Introduction/aims Patients with diabetic polyneuropathy (DPN) may experience paresthesia, dysesthesia, and pain. We aimed to characterize the predictors, symptoms, somatosensory profile, neuropathy severity, and impact of painful DPN and dysesthetic DPN. Methods This study was a cross-sectional study of type 2 diabetes patients with confirmed DPN, diagnosed using widely accepted methods including a clinical examination, skin biopsy, and nerve conduction studies. Findings Of 126 patients with confirmed DPN, 52 had DPN without pain or dysesthesia, 21 had dysesthetic DPN, and 53 painful DPN. Patients with painful DPN were less physically active and suffered from more pain elsewhere than in the feet compared to patients with DPN without pain. Patients with painful DPN had the largest loss of small and large sensory fiber function, and there was a gradient of larger spatial distribution of sensory loss from DPN without dysesthesia/pain to dysesthetic DPN and to painful DPN. This could indicate that patients with dysesthesia had more severe neuropathy than patients without dysesthesia but less than patients with painful DPN. Patients with dysesthetic and painful DPN had higher symptom scores for depression and fatigue than those without dysesthesia/pain with no difference between dysesthetic and painful DPN. Conclusions There was a gradient of increasing sensory loss from DPN without dysesthesia/pain to dysesthetic DPN and to painful DPN. Pain and dysesthesia are common in DPN and both interfere with daily life. It is therefore important to consider dysesthesia when diagnosing and treating patients with neuropathy.	[Gylfadottir, Sandra Sif; Karlsson, Pall; Jensen, Troels Staehelin; Finnerup, Nanna Brix] Aarhus Univ, Danish Pain Res Ctr, Dept Clin Med, Aarhus, Denmark; [Gylfadottir, Sandra Sif; Jensen, Troels Staehelin; Finnerup, Nanna Brix] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Itani, Mustapha; Kroigard, Thomas; Sindrup, Soren Hein] Odense Univ Hosp, Dept Neurol, Odense, Denmark; [Kristensen, Alexander Gramm; Tankisi, Hatice] Aarhus Univ Hosp, Dept Clin Neurophysiol, Aarhus, Denmark; [Karlsson, Pall] Aarhus Univ, Core Ctr Mol Morphol, Sect Stereol & Microscopy, Aarhus, Denmark; [Bennett, David L.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Andersen, Niels Trolle] Aarhus Univ, Dept Publ Hlth, Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University; University of Oxford; Aarhus University	Gylfadottir, SS (corresponding author), Aarhus Univ, Danish Pain Res Ctr, Dept Clin Med, Aarhus, Denmark.; Gylfadottir, SS (corresponding author), Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark.	sifgyl@clin.au.dk		Gylfadottir, Sandra Sif/0000-0003-0411-4403; Kristensen, Alexander Gramm/0000-0001-9658-4108; Karlsson, Pall/0000-0001-7082-9576	Novo Nordisk Foundation [NNF14SA0006]; European Commission [ID633491]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is part of the International Diabetic Neuropathy Consortium (IDNC) research program which was supported by the Novo Nordisk Foundation (NNF14SA0006), https://novonordiskfonden.dk/en/. D.L.B., T.S.J, and N.B.F. are members of the DOLORisk Consortium funded by the European Commission Horizon 2020 (ID633491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; ANDERSEN G, 1995, PAIN, V61, P187, DOI 10.1016/0304-3959(94)00144-4; BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8; Bogduk HMaN, IASP TAXONOMY 1994; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Bouhassira D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074195; Cardinez N, 2018, J DIABETES COMPLICAT, V32, P660, DOI 10.1016/j.jdiacomp.2018.05.001; Christensen DH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017273; Costa YM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37041-4; D'Amato C, 2016, DIABETES VASC DIS RE, V13, P418, DOI 10.1177/1479164116653240; DAVIDOFF G, 1987, PAIN, V29, P39, DOI 10.1016/0304-3959(87)90176-X; Dyck PJ, 2011, DIABETES-METAB RES, V27, P620, DOI 10.1002/dmrr.1226; Feldman EL, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0092-1; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Finnerup NB, 2014, J PAIN, V15, P40, DOI 10.1016/j.jpain.2013.09.008; Finnerup NB, 2003, BRAIN, V126, P57, DOI 10.1093/brain/awg007; Giannopoulos S, 2007, J PAIN, V8, P530, DOI 10.1016/j.jpain.2007.04.001; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Gore M, 2006, J PAIN, V7, P892, DOI 10.1016/j.jpain.2006.04.013; Gylfadottir SS, 2020, EUR J NEUROL, V27, P2575, DOI 10.1111/ene.14469; Gylfadottir SS, 2020, PAIN, V161, P574, DOI 10.1097/j.pain.0000000000001744; HealthMeasures, PROMIS HLTH MEAS; Hebert HL, 2017, PAIN, V158, P560, DOI 10.1097/j.pain.0000000000000785; Itani M, 2021, J PERIPHER NERV SYST, V26, P55, DOI 10.1111/jns.12424; Klit H, 2014, PAIN, V155, P2699, DOI 10.1016/j.pain.2014.09.037; Klit H, 2011, PAIN, V152, P818, DOI 10.1016/j.pain.2010.12.030; Landerholm AH, 2011, EUR J PAIN, V15, P498, DOI 10.1016/j.ejpain.2010.10.003; Lauria G, 2010, EUR J NEUROL, V17, P903, DOI 10.1111/j.1468-1331.2010.03023.x; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; Mogyoros I, 2000, MUSCLE NERVE, V23, P310, DOI 10.1002/(SICI)1097-4598(200003)23:3<310::AID-MUS2>3.0.CO;2-A; OCHOA JL, 1980, BRAIN, V103, P835, DOI 10.1093/brain/103.4.835; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Prescott SA, 2014, NAT NEUROSCI, V17, P183, DOI 10.1038/nn.3629; Raja SN, 2020, PAIN, V161, P1976, DOI 10.1097/j.pain.0000000000001939; Raputova J, 2017, PAIN, V158, P2340, DOI 10.1097/j.pain.0000000000001034; RCore Team, 2020, R LANG ENV STAT COMP; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Shillo P, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1150-5; Stalberg E, 2019, CLIN NEUROPHYSIOL, V130, P1688, DOI 10.1016/j.clinph.2019.05.008; Stormer S, 1997, SPINAL CORD, V35, P446, DOI 10.1038/sj.sc.3100411; Tankisi H, 2005, CLIN NEUROPHYSIOL, V116, P1571, DOI 10.1016/j.clinph.2005.04.003; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Themistocleous AC, 2016, PAIN, V157, P1132, DOI 10.1097/j.pain.0000000000000491; Truini A, 2018, PAIN, V159, P2658, DOI 10.1097/j.pain.0000000000001378; Vileikyte L, 2009, DIABETOLOGIA, V52, P1265, DOI 10.1007/s00125-009-1363-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263831	10.1371/journal.pone.0263831	http://dx.doi.org/10.1371/journal.pone.0263831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176062	Green Published, gold			2022-12-26	WOS:000777505200037
J	Han, L; Jara, CP; Wang, O; Shi, Y; Wu, XR; Thibivilliers, S; Woycicki, RK; Carlson, MA; Velander, WH; Araujo, EP; Libault, M; Zhang, C; Lei, YG				Han, Li; Jara, Carlos P.; Wang, Ou; Shi, Yu; Wu, Xinran; Thibivilliers, Sandra; Woycicki, Rafal K.; Carlson, Mark A.; Velander, William H.; Araujo, Eliana P.; Libault, Marc; Zhang, Chi; Lei, Yuguo			Isolating and cryopreserving pig skin cells for single-cell RNA sequencing study	PLOS ONE			English	Article							EXPRESSION; GENERATION; DISEASE; TECHNOLOGIES; BURDEN; MODELS	The pig skin architecture and physiology are similar to those of humans. Thus, the pig model is very valuable for studying skin biology and testing therapeutics. The single-cell RNA sequencing (scRNA-seq) technology allows quantitatively analyzing cell types, compositions, states, signaling, and receptor-ligand interactome at single-cell resolution and at high throughput. scRNA-seq has been used to study mouse and human skins. However, studying pig skin with scRNA-seq is still rare. A critical step for successful scRNA-seq is to obtain high-quality single cells from the pig skin tissue. Here we report a robust method for isolating and cryopreserving pig skin single cells for scRNA-seq. We showed that pig skin could be efficiently dissociated into single cells with high cell viability using the Miltenyi Human Whole Skin Dissociation kit and the Miltenyi gentleMACS Dissociator. Furthermore, the obtained single cells could be cryopreserved using 90% FBS + 10% DMSO without causing additional cell death, cell aggregation, or changes in gene expression profiles. Using the developed protocol, we were able to identify all the major skin cell types. The protocol and results from this study are valuable for the skin research scientific community.	[Han, Li; Shi, Yu; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Han, Li; Wang, Ou; Velander, William H.; Lei, Yuguo] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Han, Li; Wu, Xinran; Lei, Yuguo] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Han, Li; Wu, Xinran; Lei, Yuguo] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Jara, Carlos P.; Araujo, Eliana P.] Univ Estadual Campinas, Nursing Sch, Campinas, SP, Brazil; [Jara, Carlos P.; Araujo, Eliana P.] Univ Estadual Campinas, Lab Cell Signaling, Campinas, SP, Brazil; [Thibivilliers, Sandra; Woycicki, Rafal K.; Libault, Marc] Univ Nebraska, Ctr Plant Sci Innovat, Dept Agron & Hort, Lincoln, NE 68588 USA; [Carlson, Mark A.; Lei, Yuguo] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA; [Carlson, Mark A.; Lei, Yuguo] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Carlson, Mark A.; Lei, Yuguo] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE 68198 USA; [Lei, Yuguo] Penn State Univ, Sartorius Mammalian Cell Culture Facil, University Pk, PA 16802 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Estadual de Campinas; Universidade Estadual de Campinas; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.; Lei, YG (corresponding author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.; Lei, YG (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.; Lei, YG (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.; Libault, M (corresponding author), Univ Nebraska, Ctr Plant Sci Innovat, Dept Agron & Hort, Lincoln, NE 68588 USA.; Lei, YG (corresponding author), Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA.; Lei, YG (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA.; Lei, YG (corresponding author), VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE 68198 USA.; Lei, YG (corresponding author), Penn State Univ, Sartorius Mammalian Cell Culture Facil, University Pk, PA 16802 USA.	marc.libault@unl.edu; zhang.chi@unl.edu; yxl6034@psu.edu	Han, Li/AGZ-0451-2022	Han, Li/0000-0001-7303-5739; Velander, William/0000-0002-8020-5174; Shi, Yu/0000-0003-1272-8392	University of Nebraska Research Initiative [20182019]; Nebraska DHHS Stem Cell Grant 2019; National Cancer Institute grant [1R33CA235326]; U.S. Army [GRANT10824516]; Pennsylvania State University start-up; Department of Defense, USA [W81XWH-BAA-11-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [88882.434714/2019-01]; Single Cell Genomics Core Facility at the University of Nebraska-Lincoln	University of Nebraska Research Initiative; Nebraska DHHS Stem Cell Grant 2019; National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Army(United States Department of DefenseUnited States Army); Pennsylvania State University start-up; Department of Defense, USA(United States Department of Defense); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Single Cell Genomics Core Facility at the University of Nebraska-Lincoln	This research was supported by the University of Nebraska Research Initiative 20182019 (YL and WV); the Nebraska DHHS Stem Cell Grant 2019 (YL and WV); National Cancer Institute grant 1R33CA235326 (YL); the U.S. Army GRANT10824516 (WV); the Pennsylvania State University start-up (YL); the Department of Defense, USA, W81XWH-BAA-11-1 (WV). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) -Finance Code 88882.434714/2019-01 (EPA and LAV). This work was partially supported by the Single Cell Genomics Core Facility at the University of Nebraska-Lincoln. Confocal microscopy imaging was done in the Morrison Microscopy Core Research Facility at the University of Nebraska, Lincoln. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsiferova M, 2013, J IMMUNOL, V191, P6147, DOI 10.4049/jimmunol.1301350; Attar M, 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Baldan V, 2015, BRIT J CANCER, V112, P1510, DOI 10.1038/bjc.2015.96; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Botting RA, 2017, J LEUKOCYTE BIOL, V101, P1393, DOI 10.1189/jlb.4A1116-496R; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cha ST, 2005, MICROVASC RES, V70, P198, DOI 10.1016/j.mvr.2005.08.002; Chen ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.416; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Cheuk S, 2014, J IMMUNOL, V192, P3111, DOI 10.4049/jimmunol.1302313; Chovatiya G, 2020, EXP DERMATOL, P1; Denisenko E, 2019, BIORXIV, P1; Denisenko E, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02048-6; Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x; Eidsmo L, 2009, J IMMUNOL, V182, P3165, DOI 10.4049/jimmunol.0802950; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; FDA Wound Healing Clin Focus Grp, 2001, WOUND REPAIR REGEN, V9, P258; Goltsev Y, 2018, CELL, V174, P968, DOI 10.1016/j.cell.2018.07.010; Grada A, 2018, J INVEST DERMATOL, V138, P2095, DOI 10.1016/j.jid.2018.08.005; Gu DS, 2013, JOVE-J VIS EXP, DOI 10.3791/50311; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Haensel D, 2020, CELL REP, V30, P3932, DOI 10.1016/j.celrep.2020.02.091; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Hughes TK, 2020, IMMUNITY, V53, P878, DOI 10.1016/j.immuni.2020.09.015; Huschtscha LI, 2012, BIOTECHNIQUES, V53, P239, DOI 10.2144/0000113939; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Ji AL, 2020, CELL, V182, P497, DOI 10.1016/j.cell.2020.05.039; Joost S, 2020, CELL STEM CELL, V26, P441, DOI 10.1016/j.stem.2020.01.012; Joost S, 2018, CELL REP, V25, P585, DOI 10.1016/j.celrep.2018.09.059; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; Kim D, 2020, J DERMATOL SCI, V99, P74, DOI 10.1016/j.jdermsci.2020.06.002; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Levy SE, 2016, ANNU REV GENOM HUM G, V17, P95, DOI 10.1146/annurev-genom-083115-022413; Lim HW, 2017, J AM ACAD DERMATOL, V76, P958, DOI 10.1016/j.jaad.2016.12.043; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Matson KJE, 2018, JOVE-J VIS EXP, DOI 10.3791/58413; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meeson A, 2013, STEM CELL REV REP, V9, P731, DOI 10.1007/s12015-013-9440-9; Mirizio E, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02343-4; Moncada R, 2020, NAT BIOTECHNOL, V38, P333, DOI 10.1038/s41587-019-0392-8; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078365; Nguyen QH, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00108; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Seaton M, 2015, ILAR J, V56, P127, DOI 10.1093/ilar/ilv016; Shao X, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100882; Sinha M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03208-w; Sole-Boldo L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0922-4; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Tellechea A, 2020, J INVEST DERMATOL, V140, P901, DOI 10.1016/j.jid.2019.08.449; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tung PY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39921; Vorstandlechner V, 2020, FASEB J, V34, P3677, DOI 10.1096/fj.201902001RR; Wang SX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18075-7; Wang X., 2020, SOLOV2 DYNAMIC FAST; Wilbrey-Clark A, 2020, BIOCHEM J, V477, P1427, DOI 10.1042/BCJ20190341; Wohnhaas CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46932-z; Xue D, 2020, J DERMATOL SCI, V97, P41, DOI [10.1016/j.dermsci.2019.11.012, 10.1016/j.jdermsci.2019.11.012]; Zhang JY, 2017, ANIMAL MODELS FOR THE STUDY OF HUMAN DISEASE, 2ND EDITION, P357; Zheng Y, 2010, DEV DYNAM, V239, P2619, DOI 10.1002/dvdy.22398; Zou ZR, 2021, DEV CELL, V56, P383, DOI 10.1016/j.devcel.2020.11.002	64	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263869	10.1371/journal.pone.0263869	http://dx.doi.org/10.1371/journal.pone.0263869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176067	gold, Green Submitted, Green Published			2022-12-26	WOS:000777505200040
J	Panzera, Y; Calleros, L; Goni, N; Marandino, A; Techera, C; Grecco, S; Ramos, N; Frabasile, S; Tomas, G; Condon, E; Cortinas, MN; Ramas, V; Coppola, L; Sorhouet, C; Mogdasy, C; Chiparelli, H; Arbiza, J; Delfraro, A; Perez, R				Panzera, Yanina; Calleros, Lucia; Goni, Natalia; Marandino, Ana; Techera, Claudia; Grecco, Sofia; Ramos, Natalia; Frabasile, Sandra; Tomas, Gonzalo; Condon, Emma; Cortinas, Maria Noel; Ramas, Viviana; Coppola, Leticia; Sorhouet, Cecilia; Mogdasy, Cristina; Chiparelli, Hector; Arbiza, Juan; Delfraro, Adriana; Perez, Ruben			Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes	PLOS ONE			English	Article							CORONAVIRUS; SARS; GENOME; INFECTION	Deletions frequently occur in the six accessory genes of SARS-CoV-2, but most genomes with deletions are sporadic and have limited spreading capability. Here, we analyze deletions in the ORF7a of the N.7 lineage, a unique Uruguayan clade from the Brazilian B.1.1.33 lineage. Thirteen samples collected during the early SARS-CoV-2 wave in Uruguay had deletions in the ORF7a. Complete genomes were obtained by Illumina next-generation sequencing, and deletions were confirmed by Sanger sequencing and capillary electrophoresis. The N.7 lineage includes several individuals with a 12-nucleotide deletion that removes four amino acids of the ORF7a. Notably, four individuals underwent an additional 68-nucleotide novel deletion that locates 44 nucleotides downstream in the terminal region of the same ORF7a. The simultaneous occurrence of the 12 and 68-nucleotide deletions fuses the ORF7a and ORF7b, two contiguous accessory genes that encode transmembrane proteins with immune-modulation activity. The fused ORF retains the signal peptide and the complete Ig-like fold of the 7a protein and the transmembrane domain of the 7b protein, suggesting that the fused protein plays similar functions to original proteins in a single format. Our findings evidence the remarkable dynamics of SARS-CoV-2 and the possibility that single and consecutive deletions occur in accessory genes and promote changes in the genomic organization that help the virus explore genetic variations and select for new, higher fit changes.	[Panzera, Yanina; Calleros, Lucia; Marandino, Ana; Techera, Claudia; Grecco, Sofia; Tomas, Gonzalo; Condon, Emma; Perez, Ruben] Univ Republica, Fac Ciencias, Inst Biol, Dept Biol Anim,Secc Genet Evolut, Montevideo, Uruguay; [Goni, Natalia; Cortinas, Maria Noel; Ramas, Viviana; Coppola, Leticia; Mogdasy, Cristina; Chiparelli, Hector] Minist Salud Publ, Dept Labs Salud Publ, Ctr Nacl Referencia Influenza & Otros Virus Resp, Montevideo, Uruguay; [Ramos, Natalia; Frabasile, Sandra; Arbiza, Juan; Delfraro, Adriana] Univ Republica, Fac Ciencias, Inst Biol & Inst Quim Biol, Secc Virol, Montevideo, Uruguay; [Sorhouet, Cecilia] Mutualista Med Uruguaya, Lab Biol Mol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Perez, R (corresponding author), Univ Republica, Fac Ciencias, Inst Biol, Dept Biol Anim,Secc Genet Evolut, Montevideo, Uruguay.; Delfraro, A (corresponding author), Univ Republica, Fac Ciencias, Inst Biol & Inst Quim Biol, Secc Virol, Montevideo, Uruguay.	adelfraro@fcien.edu.uy; rperez@fcien.edu.uy			Facultad de Ciencias and Comision Sectorial de Investigacion Cientifica (CSIC); Fundacio n Manuel Pe rez, UdelaR	Facultad de Ciencias and Comision Sectorial de Investigacion Cientifica (CSIC); Fundacio n Manuel Pe rez, UdelaR	This work was supported by the Facultad de Ciencias and Comision Sectorial de Investigacion Cientifica (CSIC) (Grant CSIC Equipamiento) Plataforma Genomica Facultad de Ciencias. Responsable YP. Fundacio n Manuel Pe rez, UdelaR (Grant Fondo Manuel Perez). Responsable RP, JA and CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addetia A, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104523; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Edara VV, 2021, CELL HOST MICROBE, V29, P516, DOI 10.1016/j.chom.2021.03.009; Fogeron ML., 2021, SARS COV 2 ORF7B BAT, DOI [10.1101/2021.02.05.428650, DOI 10.1101/2021.02.05.428650]; Garry RF, 2021, SPIKE PROTEIN MUTATI, V789, P1; Garry RF, 2020, NATURALLY OCCURRING; Grubaugh ND, 2020, NAT MICROBIOL, V5, P529, DOI 10.1038/s41564-020-0690-4; Islam MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70812-6; Joonlasak K, 2021, VIRUS RES, V292, DOI [10.1016/j.viruses.2020.198233, 10.1016/j.virusres.2020.198233]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Liu DX, 2014, ANTIVIR RES, V109, P97, DOI 10.1016/j.antiviral.2014.06.013; Mazur-Panasiuk N, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.39.2100902; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Michel CJ, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01402-1; Mohammed Mohammed Elimam Ahamed, 2021, J Proteins Proteom, V12, P81, DOI 10.1007/s42485-021-00060-3; Narayanan K, 2008, VIRUS RES, V133, P113, DOI 10.1016/j.virusres.2007.10.009; Nelson CA, 2005, STRUCTURE, V13, P75, DOI 10.1016/j.str.2004.10.010; Nemudryi A, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109197; O'Toole A, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab064; Panzera Y, 2021, MEM I OSWALDO CRUZ, V116, DOI 10.1590/0074-02760210275; Panzera Y, 2021, TRANSBOUND EMERG DIS, V68, P3075, DOI 10.1111/tbed.14002; Peacock TP, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001584; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pyke AT, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13061087; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rennick LJ, 2021, DELETION DISRUPTS CO, DOI [10.1101/2021.03.05.434168, DOI 10.1101/2021.03.05.434168]; Schaecher SR, 2008, J VIROL, V82, P9477, DOI 10.1128/JVI.00784-08; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Su YCF, 2020, MBIO, V11, DOI 10.1128/mBio.01610-20; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tse H, 2021, CLIN INFECT DIS, V73, P1696, DOI 10.1093/cid/ciab198; Wu AP, 2021, CELL HOST MICROBE, V29, P503, DOI 10.1016/j.chom.2021.02.017; Yan HM, 2004, J MED VIROL, V73, P323, DOI 10.1002/jmv.20094; Yeh SH, 2004, P NATL ACAD SCI USA, V101, P2542, DOI 10.1073/pnas.0307904100; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou ZL, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102187; Zinzula L, 2021, BIOCHEM BIOPH RES CO, V538, P116, DOI 10.1016/j.bbrc.2020.10.045	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263563	10.1371/journal.pone.0263563	http://dx.doi.org/10.1371/journal.pone.0263563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176063	gold, Green Published			2022-12-26	WOS:000777505200023
J	Qiao, GL; Kone, LB; Phillips, EH; Lee, SSY; Brown, GE; Khetani, SR; Thakur, A; Lum, LG; Prabhakar, BS; Maker, AV				Qiao, Guilin; Kone, Lyonell B.; Phillips, Evan H.; Lee, Steve Seung-Young; Brown, Grace E.; Khetani, Salman R.; Thakur, Archana; Lum, Lawrence G.; Prabhakar, Bellur S.; Maker, Ajay, V			LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer	ONCOGENE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; CYTOLYTIC ACTIVITY; IMMUNE CELLS; HIGH-RISK; SURVIVAL; ERADICATION; METASTASIS; BLOCKADE	Increased tumor infiltrating lymphocytes (TIL) are associated with improved patient responses to immunotherapy. As a result, there is interest in enhancing lymphocyte trafficking particularly to colon cancers since the majority are checkpoint blockade-resistant and microsatellite stable. Here, we demonstrate that activated T-cells (ATC) armed with anti-CD3 x anti-EGFR bispecific antibody increases TIL and mediate anti-tumor cytotoxicity while decreasing tumor cell viability. Furthermore, treatment induces endogenous anti-tumor immunity that resisted tumor rechallenge and increased memory T-cell subsets in the tumor. When combined with targeted tumor expression of the tumor necrosis factor superfamily member LIGHT, activated T-cell proliferation and infiltration were further enhanced, and human colorectal tumor regressions were observed. Our data indicate that tumor-targeted armed bispecific antibody increases TIL trafficking and is a potentially potent strategy that can be paired with combination immunotherapy to battle microsatellite stable colon cancer. Significance Enhancing trafficking of tumor infiltrating lymphocytes (TILs) to solid tumors has been shown to improve outcomes. Unfortunately, few strategies have been successful in the clinical setting for solid tumors, particularly for "cold" microsatellite stable colon cancers. In order to address this gap in knowledge, this study combined TNFSF14/LIGHT immunomodulation with a bispecific antibody armed with activated T-cells targeted to the tumor. This unique T-cell trafficking strategy successfully generated anti-tumor immunity in a microsatellite stable colon cancer model, stimulated T-cell infiltration, and holds promise as a combination immunotherapy for treating advanced and metastatic colorectal cancer.	[Qiao, Guilin; Maker, Ajay, V] Univ Calif San Francisco, Dept Surg, Div Surg Oncol, San Francisco, CA 94143 USA; [Kone, Lyonell B.; Maker, Ajay, V] Univ Illinois, Coll Med, Dept Surg, Div Surg Oncol, Chicago, IL 60612 USA; [Phillips, Evan H.; Lee, Steve Seung-Young] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60612 USA; [Brown, Grace E.; Khetani, Salman R.] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Thakur, Archana; Lum, Lawrence G.] Univ Virginia, Dept Med, Div Hematol Oncol, Canc Ctr, Charlottesville, VA USA; [Prabhakar, Bellur S.; Maker, Ajay, V] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Virginia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Maker, AV (corresponding author), Univ Calif San Francisco, Dept Surg, Div Surg Oncol, San Francisco, CA 94143 USA.; Maker, AV (corresponding author), Univ Illinois, Coll Med, Dept Surg, Div Surg Oncol, Chicago, IL 60612 USA.; Maker, AV (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	Ajay.Maker@ucsf.edu		Prabhakar, Bellur S./0000-0001-9815-9850	 [R37CA238435];  [K08CA190855];  [R00EB022636];  [R01CA140314];  [R01CA092344];  [P30CA044579]	; ; ; ; ; 	R37CA238435 (AVM), K08CA190855 (AVM); R00EB022636 (SSYL); R01CA140314, R01CA092344, P30CA044579 (LGL).	Bhutani D, 2015, CURR OPIN HEMATOL, V22, P476, DOI 10.1097/MOH.0000000000000176; Bibeau F, 2006, VIRCHOWS ARCH, V449, P281, DOI 10.1007/s00428-006-0247-9; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Chung KY, 2010, J CLIN ONCOL, V28, P3485, DOI 10.1200/JCO.2010.28.3994; Ciardiello D, 2019, CANCER TREAT REV, V76, P22, DOI 10.1016/j.ctrv.2019.04.003; Correale P, 2012, CLIN CANCER RES, V18, P850, DOI 10.1158/1078-0432.CCR-10-3186; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Flaherty DC, 2016, J AM COLL SURGEONS, V223, P134, DOI 10.1016/j.jamcollsurg.2016.03.003; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Giordano G, 2019, CANCERS, V11, DOI 10.3390/cancers11081089; Grabert RC, 2006, CLIN CANCER RES, V12, P569, DOI 10.1158/1078-0432.CCR-05-2005; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Huang CW, 2017, ONCOTARGET, V8, P114663, DOI 10.18632/oncotarget.23072; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee SSY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16987-x; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; Lin Christine, 2017, Curr Protoc Toxicol, V72, DOI 10.1002/cptx.23; Lum LG, 2014, BONE MARROW TRANSPL, V49, P73, DOI 10.1038/bmt.2013.133; Lum LG, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4108; Lum LG, 2016, BIOL BLOOD MARROW TR, V22, P869, DOI 10.1016/j.bbmt.2015.12.030; Lum Lawrence G, 2003, Clin Breast Cancer, V4, P212, DOI 10.3816/CBC.2003.n.028; Lum LG, 2013, BIOL BLOOD MARROW TR, V19, P925, DOI 10.1016/j.bbmt.2013.03.010; Lum LG, 2011, BIODRUGS, V25, P365, DOI 10.2165/11595950-000000000-00000; Maker AV, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1069937; Maker AV, 2015, CANCER IMMUNOL RES, V3, P380, DOI 10.1158/2326-6066.CIR-14-0212; Maker AV, 2005, ANN SURG ONCOL, V12, P1005, DOI 10.1245/ASO.2005.03.536; Naito Y, 1998, CANCER RES, V58, P3491; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Prall F, 2004, HUM PATHOL, V35, P808, DOI 10.1016/j.humpath.2004.01.022; Qiao GL, 2017, CANCER RES, V77, P1880, DOI 10.1158/0008-5472.CAN-16-1655; Qin JZ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-70; Qin JZ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.473; Reusch U, 2006, CLIN CANCER RES, V12, P183, DOI 10.1158/1078-0432.CCR-05-1855; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sen M, 2001, J HEMATOTH STEM CELL, V10, P247, DOI 10.1089/15258160151134944; Shibutani M, 2018, IN VIVO, V32, P151, DOI 10.21873/invivo.11218; Siegel RL, 2017, JAMA-J AM MED ASSOC, V318, P572, DOI 10.1001/jama.2017.7630; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun ZC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11782-w; Thakur A, 2018, BLOOD REV, V32, P339, DOI 10.1016/j.blre.2018.02.004; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Vasu C, 2003, INT IMMUNOL, V15, P641, DOI 10.1093/intimm/dxg061; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yankelevich M, 2012, PEDIATR BLOOD CANCER, V59, P1198, DOI 10.1002/pbc.24237; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Yu P, 2008, CYTOKINE GROWTH F R, V19, P285, DOI 10.1016/j.cytogfr.2008.04.004; Zboralski D, 2017, CANCER IMMUNOL RES, V5, P950, DOI 10.1158/2326-6066.CIR-16-0303; Zitron IM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-83; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	56	1	1	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2054	2068		10.1038/s41388-022-02209-w	http://dx.doi.org/10.1038/s41388-022-02209-w		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35177811	hybrid, Green Published			2022-12-26	WOS:000757138900001
J	Rush, EC; Coppinger, T; Jalili-Moghaddam, S; Tautolo, ES; Plank, LD				Rush, Elaine C.; Coppinger, Tara; Jalili-Moghaddam, Shabnam; Tautolo, El-Shadan; Plank, Lindsay D.			Relationships between physical function, body composition and metabolic health in Pacific Island youth	PLOS ONE			English	Article							FITNESS; CHILDREN; ADOLESCENTS; FAMILIES; GROWTH; MAORI	The Pacific Islands Families (PIF) study is a birth cohort study designed to increase knowledge about the growth and development of Pacific children living in Auckland, New Zealand. Adolescence is a critical time of growth and development, yet the roles of physical function and body composition in metabolic health at this life stage are not clear. We aimed to investigate associations between measures of physical function (the 6-minute-walk-test (6MWT)), heart rate changes before and after the 6MWT, handgrip strength, body composition including appendicular skeletal muscle mass (ASMM) measured by dual-energy X-ray absorptiometry and biomarkers of metabolic health from a fasting blood sample.A total of 200 youth (98 girls, 102 boys) aged 14-15 years, from the birth-cohort of children in the Pacific Islands families study were measured. In girls, the proportion of ASMM was lower and fat higher than in boys. Controlling for age, a 1% increase in ASMM predicted a longer walk distance (+6.3, 95%CI 2.2, 10.4 m in girls; +7.1, 95%CI 4.4, 9.1 m in boys) and lower heart rate following the 6MWT. ASMM and fat mass were independently predictive of maximal handgrip strength which was increased by 1.4 (1.0,1.8) kg in girls and 1.7 (1.3, 2.0) kg in boys for each kg increase in ASMM and reduced by 0.23 (0.08, 0.38) kg in girls and 0.26 (0.14, 0.37) kg in boys for each kg increase in fat mass. Lower total cholesterol and LDL were associated with an increase in distance walked in boys only. For each year of age, distance walked was reduced by 34 (15, 53) m in girls and 59 (36,84) m in boys. These findings should be explored further in the context of other influences such as food security, opportunities for physical activity and cultural expectations.	[Rush, Elaine C.; Jalili-Moghaddam, Shabnam] Auckland Univ Technol, Sch Sport & Recreat, Auckland, New Zealand; [Rush, Elaine C.; Jalili-Moghaddam, Shabnam; Tautolo, El-Shadan] Auckland Univ Technol, Ctr Pacific Hlth & Dev Res, Auckland, New Zealand; [Coppinger, Tara] Munster Technol Univ, Dept Sport Leisure & Childhood Studies, Cork, Ireland; [Plank, Lindsay D.] Univ Auckland, Dept Surg, Auckland, New Zealand	Auckland University of Technology; Auckland University of Technology; University of Auckland	Rush, EC (corresponding author), Auckland Univ Technol, Sch Sport & Recreat, Auckland, New Zealand.; Rush, EC (corresponding author), Auckland Univ Technol, Ctr Pacific Hlth & Dev Res, Auckland, New Zealand.	elaine.rush@aut.ac.nz	Rush, Elaine/J-9237-2013	Rush, Elaine/0000-0001-7713-6203; Coppinger, Tara/0000-0002-7251-4516				BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Boreham Colin, 2004, Int J Behav Nutr Phys Act, V1, P14, DOI 10.1186/1479-5868-1-14; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Deutsch J, 2020, PHYS EDUC-US, V77, P257, DOI 10.18666/TPE-2020-V77-I2-9483; Dong YB, 2010, PEDIATRICS, V125, P1104, DOI 10.1542/peds.2009-2055; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fraser BJ, 2019, SCAND J MED SCI SPOR, V29, P1909, DOI 10.1111/sms.13529; Garcia-Hermoso A, 2020, JAMA PEDIATR, V174, P952, DOI 10.1001/jamapediatrics.2020.2400; Garcia-Hermoso A, 2019, SPORTS MED, V49, P1079, DOI 10.1007/s40279-019-01098-6; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; Houghton P, 2009, PEOPLE GREAT OCEAN A; Li AM, 2007, AM J RESP CRIT CARE, V176, P174, DOI 10.1164/rccm.200607-883OC; Ministry of Health, 2021, ANN DAT EXPL 2019 NZ; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Park Jinkook, 2013, J Exerc Nutrition Biochem, V17, P143, DOI 10.5717/jenb.2013.17.4.143; Paterson J, 2008, INT J EPIDEMIOL, V37, P273, DOI 10.1093/ije/dym171; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Plank LD, 2019, PEDIATR OBES, V14, DOI 10.1111/ijpo.12497; Raghuveer G, 2020, CIRCULATION, V142, pE101, DOI 10.1161/CIR.0000000000000866; Riebe D, 2018, ACSMS GUIDELINES EXE, P111; Rush E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013407; Rush EC, 2009, EUR J CLIN NUTR, V63, P627, DOI 10.1038/ejcn.2008.15; Rush E, 2015, NEW ZEAL MED J, V128, P24; Rush E, 2013, ANN HUM BIOL, V40, P406, DOI 10.3109/03014460.2013.793391; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Saeedi P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040548; Statistics New Zealand, 2020, PAC PEOPL ETHN GROUP; Stodden D, 2017, AM J LIFESTYLE MED, V11, P232, DOI 10.1177/1559827615619577; Tarp J, 2016, J SPORT HEALTH SCI, V5, P145, DOI 10.1016/j.jshs.2016.03.004; True L, 2021, MEAS PHYS EDUC EXERC, V25, P22, DOI 10.1080/1091367X.2020.1729767; Ubuane PO., 2018, J XIANGYA MED, V3, P40, DOI [DOI 10.21037/JXYM.2018.11.01, 10.21037/jxym.2018.11.01]; Valtuena J, 2013, QJM-INT J MED, V106, P809, DOI 10.1093/qjmed/hct089; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wittekind SG, 2020, MED SCI SPORT EXER, V52, P2574, DOI 10.1249/MSS.0000000000002424; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	36	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0260203	10.1371/journal.pone.0260203	http://dx.doi.org/10.1371/journal.pone.0260203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176027	Green Published, gold			2022-12-26	WOS:000777505200004
J	Stoffers, P; Guckenbiehl, S; Welker, MW; Zeuzem, S; Lange, CM; Trebicka, J; Herrmann, E; Welsch, C				Stoffers, Philipp; Guckenbiehl, Sabrina; Welker, Martin Walter; Zeuzem, Stefan; Lange, Christian Markus; Trebicka, Jonel; Herrmann, Eva; Welsch, Christoph			Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation	PLOS ONE			English	Article							CHRONIC LIVER-FAILURE; NATURAL-HISTORY; PATHOGENESIS; INFLAMMATION; INDICATORS; SURVIVAL; NECROSIS; RELEASE	Background The transition from compensated to decompensated liver cirrhosis is a hallmark of disease progression, however, reliable predictors to assess the risk of decompensation in individual patients from routine diagnostics are lacking. Here, we characterize serum levels of cell death-associated markers and routine biochemistry from patients with chronic liver disease with and without decompensation. Methods A post-hoc analysis was based on prospectively collected clinical data from 160 patients with chronic liver disease, stably compensated or decompensated at baseline or during follow-up, over a median period of 721 days. Serum levels of damage-associated molecular patterns (DAMPs) and routine biochemistry are quantified at baseline (for all patients) and during follow-up (for patients with acute decompensation). The panel of DAMPs assessed in this study comprises high-mobility group-box protein 1 (HMGB1), cytochrome C (cyt C), soluble Fas-ligand (sFasL), interleukin 6 (IL-6), soluble cytokeratin-18 (CK18-M65) and its caspase-cleaved fragment CK18-M30. Results In this cohort study, 80 patients (50%) were diagnosed with alcoholic liver cirrhosis, 60 patients (37.5%) with hepatitis C virus- and 20 patients (13.5%) with hepatitis B virus-related liver cirrhosis. At baseline, 17 patients (10.6%) showed decompensated liver disease and another 28 patients (17.5%) developed acute decompensation during follow-up (within 24 months). One hundred fifteen patients showed stable liver disease (71.9%). We found DAMPs significantly elevated in patients with decompensated liver disease versus compensated liver disease. Patients with acute decompensation during follow-up showed higher baseline levels of IL-6, sFasL, CK18-M65 and -M30 (P<0.01) compared to patients with stably compensated liver disease. In multivariate analyses, we found an independent association of baseline serum levels of sFasL (P = 0.02; OR = 2.67) and gamma-glutamyl transferase (GGT) (P<0.001; OR = 2.1) with acute decompensation. Accuracy of the marker combination for predicting acute decompensation was high (AUC = 0.79). Elevated aminotransferase levels did not correlate with decompensated liver disease and acute decompensation. Conclusions DAMPs are elevated in patients with decompensated liver disease and patients developing acute decompensation. The prognostic value of a marker combination with soluble Fasligand and GGT in patients with liver cirrhosis should be further evaluated.	[Stoffers, Philipp; Welker, Martin Walter; Zeuzem, Stefan; Trebicka, Jonel; Welsch, Christoph] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Guckenbiehl, Sabrina; Lange, Christian Markus] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Guckenbiehl, Sabrina; Lange, Christian Markus] Univ Duisburg Essen, Essen, Germany; [Herrmann, Eva] Goethe Univ, Fac Med, Inst Biostat & Math Modelling, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Duisburg Essen; University of Duisburg Essen; Goethe University Frankfurt	Stoffers, P; Welsch, C (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.	philipp.stoffers@kgu.de; christoph.welsch@kgu.de			research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP)	research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP)	This research was supported by the research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP) in the form of funds to CML, SZ, and CW.	Berzigotti A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0966-6; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen RC, 2013, MOL MED, V19, P357, DOI 10.2119/molmed.2013.00099; Codina R, 2010, APOPTOSIS, V15, P139, DOI 10.1007/s10495-009-0412-0; Costa D, 2021, J HEPATOL, V74, P819, DOI 10.1016/j.jhep.2020.10.004; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Dufour DR, 2000, CLIN CHEM, V46, P2027; Eguchi A, 2014, J HEPATOL, V60, P1063, DOI 10.1016/j.jhep.2013.12.026; Eleftheriadis T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00279; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gronbaek H, 2021, J GASTROEN HEPATOL, V36, P240, DOI 10.1111/jgh.15125; Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020; HABER MM, 1995, AM J GASTROENTEROL, V90, P1250; Hernaez R, 2017, GUT, V66, P541, DOI 10.1136/gutjnl-2016-312670; Irvine KM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00293; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Jiang WW, 2007, NAT CLIN PRACT RHEUM, V3, P52, DOI 10.1038/ncprheum0379; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; KALLAI L, 1964, ACTA MED SCAND, V175, P49; Koenig G, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/818570; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Kubesch A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207162; Lewis DR, 2017, CANCER-AM CANCER SOC, V123, P2524, DOI 10.1002/cncr.30630; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Contreras-Zentella ML, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3529149; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Macdonald S, 2018, HEPATOLOGY, V67, P989, DOI 10.1002/hep.29581; Matsumoto H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.334; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Muir AJ, 2015, CLIN THER, V37, P1822, DOI 10.1016/j.clinthera.2015.05.507; Organisation for Economic Co-operation and Development, 2015, TACKLING HARMFUL ALC; Pimpin L, 2018, J HEPATOL, V69, P718, DOI 10.1016/j.jhep.2018.05.011; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Relja B, 2020, EUR J TRAUMA EMERG S, V46, P751, DOI 10.1007/s00068-019-01235-w; Remmler J, 2018, CLIN GASTROENTEROL H, V16, P730, DOI 10.1016/j.cgh.2017.09.017; Ripoll C, 2015, J CLIN GASTROENTEROL, V49, P784, DOI 10.1097/MCG.0000000000000283; Roh JS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e27; Sato K, 1996, BRIT J HAEMATOL, V94, P379, DOI 10.1046/j.1365-2141.1996.d01-1799.x; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Tacke F, 2020, LIVER INT, V40, P539, DOI 10.1111/liv.14186; Trebicka J, 2020, J HEPATOL, V73, P842, DOI 10.1016/j.jhep.2020.06.013; Vanden Berghe T, 2006, CELL SIGNAL, V18, P328, DOI 10.1016/j.cellsig.2005.05.003; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Wallach-Dayan SB, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042177; Welsch C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171755; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Zipprich A, 2012, LIVER INT, V32, P1407, DOI 10.1111/j.1478-3231.2012.02830.x	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263989	10.1371/journal.pone.0263989	http://dx.doi.org/10.1371/journal.pone.0263989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176084	Green Published, gold			2022-12-26	WOS:000777505200057
J	Veryaskina, YA; Titov, SE; Ivanov, MK; Ruzankin, PS; Tarasenko, AS; Shevchenko, SP; Kovynev, IB; Stupak, EV; Pospelova, TI; Zhimulev, IF				Veryaskina, Yuliya A.; Titov, Sergei E.; Ivanov, Mikhail K.; Ruzankin, Pavel S.; Tarasenko, Anton S.; Shevchenko, Sergei P.; Kovynev, Igor B.; Stupak, Evgenij, V; Pospelova, Tatiana, I; Zhimulev, Igor F.			Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; ENHANCES CHEMOSENSITIVITY; CELL CARCINOMA; IDENTIFICATION; NORMALIZATION; QUANTIFICATION; DIAGNOSIS; BIOMARKER; LEUKEMIA	MicroRNAs (miRNAs) are promising biomarkers in cancer research. Quantitative PCR (qPCR), also known as real-time PCR, is the most frequently used technique for measuring miRNA expression levels. The use of this technique, however, requires that expression data be normalized against reference genes. The problem is that a universal internal control for quantitative analysis of miRNA expression by qPCR has yet to be known. The aim of this work was to find the miRNAs with stable expression in the thyroid gland, brain and bone marrow according to NanoString nCounter miRNA quantification data. As a results, the most stably expressed miRNAs were as follows: miR-361-3p, -151a-3p and -29b-3p in the thyroid gland; miR-15a-5p, -194-5p and -532-5p in the brain; miR-140-5p, -148b-3p and -362-5p in bone marrow; and miR-423-5p, -28-5p and -532-5p, no matter what tissue type. These miRNAs represent promising reference genes for miRNA quantification by qPCR.	[Veryaskina, Yuliya A.] Russian Acad Sci, Inst Cytol & Genet, Lab Gene Engn, Siberian Branch, Novosibirsk, Russia; [Veryaskina, Yuliya A.; Titov, Sergei E.; Zhimulev, Igor F.] Russian Acad Sci, Inst Mol & Cellular Biol, Dept Struct & Funct Chromosomes, Lab Mol Genet,Siberian Branch, Novosibirsk, Russia; [Titov, Sergei E.; Ivanov, Mikhail K.] AO Vector Best, Novosibirsk, Russia; [Ruzankin, Pavel S.; Tarasenko, Anton S.] Russian Acad Sci, Sobolev Inst Math, Siberian Branch, Novosibirsk, Russia; [Ruzankin, Pavel S.; Tarasenko, Anton S.] Novosibirsk State Univ, Dept Math & Mech, Novosibirsk, Russia; [Shevchenko, Sergei P.] Novosibirsk Municipal Clin Hosp 1, Novosibirsk, Russia; [Kovynev, Igor B.; Pospelova, Tatiana, I] Novosibirsk State Med Univ, Dept Therapy Hematol & Transfusiol, Novosibirsk, Russia; [Stupak, Evgenij, V] YaL Tsivyan Novosibirsk Res Inst Traumatol & Orth, Dept Neurosurg, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Sciences; Russian Academy of Sciences; Sobolev Institute of Mathematics; Novosibirsk State University; Novosibirsk State Medical University; Novosibirsk Research Institute of Traumatology & Orthopaedics	Veryaskina, YA (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Lab Gene Engn, Siberian Branch, Novosibirsk, Russia.	microrna@inbox.ru	Stupak, Evgeniy ms/Q-6425-2018; Ruzankin, Pavel S./I-8485-2014	Stupak, Evgeniy ms/0000-0001-5161-3817; Ruzankin, Pavel S./0000-0002-5262-3037; Veryaskina, Yuliya/0000-0002-3799-9407; Ivanov, Mikhail/0000-0001-7503-2435; Zhimulev, Igor/0000-0002-6220-3028				Anauate AC, 2017, GENE, V621, P59, DOI 10.1016/j.gene.2017.04.016; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Babion I, 2017, J MOL DIAGN, V19, P625, DOI 10.1016/j.jmoldx.2017.04.010; Bediaga NG, 2013, BRIT J CANCER, V109, P2404, DOI 10.1038/bjc.2013.623; Bignotti E, 2016, J CELL MOL MED, V20, P2341, DOI 10.1111/jcmm.12927; Chen CF, 2011, METHODS MOL BIOL, V687, P113, DOI 10.1007/978-1-60761-944-4_8; Costa-Pinheiro P, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0076-2; Coste E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74685-7; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dettmer M, 2013, J CLIN ENDOCR METAB, V98, pE1, DOI 10.1210/jc.2012-2694; Dettmer MS, 2014, J MOL ENDOCRINOL, V52, P181, DOI 10.1530/JME-13-0266; dos Santos MT, 2018, THYROID, V28, P1618, DOI 10.1089/thy.2018.0254; Drobna M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102858; Dwivedi S, 2019, INDIAN J CLIN BIOCHE, V34, P243, DOI 10.1007/s12291-019-00844-x; Fochi S, 2021, GENE, V769, DOI 10.1016/j.gene.2020.145336; Foye C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189165; Fromm B, 2020, NUCLEIC ACIDS RES, V48, pD132, DOI 10.1093/nar/gkz885; Leitao MDG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111021; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Han IB, 2016, ANTICANCER RES, V36, P6691, DOI 10.21873/anticanres.11280; Jacobsen Kari Stougaard, 2016, BMC Res Notes, V9, P38, DOI 10.1186/s13104-016-1848-2; Jiang Y, 2018, ONCOL LETT, V16, P1243, DOI 10.3892/ol.2018.8727; Kovynev IB, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8120607; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Lamba Vishal, 2014, BMC Res Notes, V7, P129, DOI 10.1186/1756-0500-7-129; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lou G, 2015, INT J MOL MED, V36, P1400, DOI 10.3892/ijmm.2015.2338; Lozada-Delgado EL, 2018, CANCERS, V10, DOI 10.3390/cancers10100382; Ludwig N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05070-0; Luo YQ, 2019, INT J MOL MED, V44, P1172, DOI 10.3892/ijmm.2019.4278; Mase M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41127; Morenos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042951; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rohan T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191814; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Titov SE, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6154-7; Titov SE, 2016, ONCOL REP, V36, P2501, DOI 10.3892/or.2016.5113; Toda H, 2020, MOL ONCOL, V14, P426, DOI 10.1002/1878-0261.12602; Valera VA, 2020, J CANCER, V11, P4106, DOI 10.7150/jca.37842; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verboon LJ, 2016, ONCOTARGET, V7, P48412, DOI 10.18632/oncotarget.10270; Veryaskina YA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102318; Wang L, 2019, YONSEI MED J, V60, P924, DOI 10.3349/ymj.2019.60.10.924; Wong LLK, 2010, APPL BIOSYSTEMS APPL; Wotschofsky Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148746; Xiao Y, 2017, ONCOL LETT, V13, P4986, DOI 10.3892/ol.2017.6076; Xiong XH, 2017, ONCOL LETT, V14, P4455, DOI 10.3892/ol.2017.6735; Yanokura M, 2020, INT J ONCOL, V57, P1145, DOI 10.3892/ijo.2020.5127; Yusof AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00158; Zhang XL, 2015, TOHOKU J EXP MED, V235, P161, DOI 10.1620/tjem.235.161; Zhao GP, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4601-5; Zhu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052393	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0254304	10.1371/journal.pone.0254304	http://dx.doi.org/10.1371/journal.pone.0254304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176014	Green Published, gold			2022-12-26	WOS:000777505200002
J	Wakjira, MK; Sandy, PT; Mavhandu-Mudzusi, AH				Wakjira, Mengistu K.; Sandy, Peter T.; Mavhandu-Mudzusi, A. H.			Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; EXTENSIVELY DRUG-RESISTANT; MANAGEMENT; PROGRESS; DISEASE; BURDEN; CARE	Background There is limited empirical evidence in Ethiopia on the determinants of treatment outcomes of patients with multidrug-resistant tuberculosis (MDR-TB) who were enrolled to second-line anti-tuberculosis drugs. Thus, this study investigated the determinants of treatment outcomes in patients with MDR-TB at referral hospitals in Ethiopia. Design and methods This study was underpinned by a cross-sectional quantitative research design that guided both data collection and analysis. Data is collected using structured questionnaire and data analyses was performed using the Statistical Package for Social Sciences. Multi-variable logistic regression was used to control for confounders in determining the association between treatment outcomes of patients with MDR-TB and selected predictor variables, such as co-morbidity with MDR-TB and body mass index. Results From the total of 136 patients with MDR-TB included in this study, 31% had some co-morbidity with MDR-TB at baseline, and 64% of the patients had a body mass index of less than 18.5 kg/m2. At 24 months after commencing treatment, 76 (69%), n = 110), of the patients had successfully completed treatment, while 30 (27%) died of the disease. The odds of death was significantly higher among patients with low body mass index (AOR = 2.734, 95% CI: 1.01-7.395; P<0.048) and those with some co-morbidity at baseline (AOR = 4.260, 95% CI: 1.607-11.29; p<0.004). Conclusion The higher proportion of mortality among patients treated for MDR-TB at Adama and Nekemte Hospitals, central Ethiopia, is attributable to co-morbidities with MDR-TB, including HIV/AIDS and malnutrition. Improving socio-economic and nutritional support and provision of integrated care for MDR-TB and HIV/AIDS is recommended to mitigate the higher level of death among patients treated for MDR-TB.	[Wakjira, Mengistu K.] Abt Associates Inc Ethiopia, Addis Ababa, Ethiopia; [Sandy, Peter T.] Buckinghamshire New Univ, Uxbridge Campus, London, England; [Mavhandu-Mudzusi, A. H.] Univ South Africa, Coll Human Sci, Off Grad Studies & Res, Pretoria, South Africa	ABT Associates; Buckinghamshire New University; University of South Africa	Wakjira, MK (corresponding author), Abt Associates Inc Ethiopia, Addis Ababa, Ethiopia.	mengistukenea@gmail.com		WAKJIRA, MENGISTU/0000-0002-1032-2594				Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Ayles HM, 2009, INT J TUBERC LUNG D, V13, P1450; Babatunde OA, 2013, INT REV SOCIAL SCI H, V4, P209; Bahmanpour S., 2013, GOOD CLIN PRACT E; Becerra MC, 2011, LANCET, V377, P147, DOI 10.1016/S0140-6736(10)61972-1; Behera D, 2012, Indian J Tuberc, V59, P190; Biadglegne F, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-31; CIOMS, 2016, INT ETH GUID HLTH RE; Dheda K, 2014, LANCET RESP MED, V2, P321, DOI 10.1016/S2213-2600(14)70031-1; Dheda K, 2012, LANCET, V379, P773, DOI 10.1016/S0140-6736(11)61062-3; Djibuti M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-88; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Federal Ministry of Health of Ethiopia, 2014, GUID PROGR MAN DRUG, V2nd; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Government of India, 2018, GUIDELINES CLIN OPER; Hatfull GF, 2014, MOL GENETICS MYCOBAC, P81; Heemskerk D, 2015, SPRBRIEF PUB HEALT, P1, DOI 10.1007/978-3-319-19132-4; Hichey AJ., 2016, DRUG DELIVERY SYSTEM; Kendall EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172748; Kurbatova EV, 2015, EMERG INFECT DIS, V21, P977, DOI 10.3201/eid2106.141329; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lewis JM, 2015, THER CLIN RISK MANAG, V11, P779, DOI 10.2147/TCRM.S71076; Longest B.B., 2015, HLTH PROGRAM MANAGEM; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Migliori GB, 2014, LANCET, V383, P2026, DOI 10.1016/S0140-6736(14)60032-5; Molla Yohannes, 2017, J Clin Tuberc Other Mycobact Dis, V7, P28, DOI 10.1016/j.jctube.2017.03.001; Munsab A, 2013, IJRAP, V3, P123; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Raviglione MC., 2010, TUBERCULOSIS 4 EDITI; Rusen I D, 2010, Expert Rev Respir Med, V4, P163, DOI 10.1586/ers.10.11; Scardigli A, 2013, CURR PULMONOL REP, V2, P208, DOI 10.1007/s13665-013-0063-z; Singh Y. K., 2006, FUNDAMENTALS RES MET; Siroka A, 2016, LANCET INFECT DIS, V16, P473, DOI 10.1016/S1473-3099(15)00401-6; Tadolini M, 2012, BREATHE, V9, P101, DOI 10.1183/20734735.025312; Udwadia Z, 2016, J ASS CHEST PHYS, V4, P41; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Vishakha KK., 2013, GUJARAT MED J, V68, P52; WHO, 2014, GLOBAL TUBERCULOSIS; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2010, WHOHTMTB20103; Yuan XL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-315; Zwerling A, 2016, AM J EPIDEMIOL, V183, P407, DOI 10.1093/aje/kwv176	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0262318	10.1371/journal.pone.0262318	http://dx.doi.org/10.1371/journal.pone.0262318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176035	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000777505200008
J	Ikeda, A; Kanakogi, Y; Hirai, M				Ikeda, Ayaka; Kanakogi, Yasuhiro; Hirai, Masahiro			Visual perspective-taking ability in 7-and 12-month-old infants	PLOS ONE			English	Article							YOUNG CHILDRENS KNOWLEDGE; JOINT ATTENTION; INDIVIDUAL-DIFFERENCES; GAZE; EYES; PERCEPTION; LOOKING; UNDERSTAND; SPEECH; OBJECT	Understanding how we see the world is different from how other people see it is a crucial part of social cognition and is known as visual perspective-taking. Although previous studies have demonstrated that 14-month-old infants have the capacity to compute the visual perspectives of others, it remains unknown whether infants under 12 months also have this ability. In this study, we modified a conventional gaze-following experimental setting in which one toy was placed in front of a model and was hidden by a barrier (Blocked Line of Sight Condition), and another toy was placed without a barrier (Clear Line of Sight Condition). We examined the visual perspective-taking abilities of 48 infants aged 7 and 12 months by measuring the infants' gaze shift towards the gaze-cued toy object with and without a barrier. The results demonstrated that 12-month-old infants could correctly follow a model's gaze if the model's line of sight was clear. In contrast, 7-month-old infants showed no evidence of such capacity. Our findings indicate that 12-month-old infants seem to have the capacity to compute the visual perspective of others.	[Ikeda, Ayaka; Hirai, Masahiro] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Ikeda, Ayaka] Senshu Univ, Dept Psychol, Kawasaki, Kanagawa, Japan; [Kanakogi, Yasuhiro] Osaka Univ, Grad Sch Human Sci, Dept Comparat & Dev Psychol, Osaka, Japan; [Hirai, Masahiro] Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan; [Hirai, Masahiro] Jichi Med Univ, Dept Pediat, Kawasaki, Tochigi, Japan	Jichi Medical University; Osaka University; Nagoya University	Hirai, M (corresponding author), Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan.; Hirai, M (corresponding author), Nagoya Univ, Grad Sch Informat, Dept Cognit & Psychol Sci, Nagoya, Aichi, Japan.; Hirai, M (corresponding author), Jichi Med Univ, Dept Pediat, Kawasaki, Tochigi, Japan.	hirai@i.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [15H05310, 15KK0129]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.H.: Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 15H05310 and 15KK0129 Japan https://www.jsps.go.jp/english/e-grants/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S., 1995, MINDBLINDNESS; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Butler SC, 2000, J COGN DEV, V1, P359, DOI 10.1207/S15327647JCD0104_01; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; Caron AJ, 2002, J COGN DEV, V3, P445, DOI 10.1207/S15327647JCD3,4-04; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Choi YJ, 2018, J EXP CHILD PSYCHOL, V172, P96, DOI 10.1016/j.jecp.2018.03.004; Corkum V, 1998, DEV PSYCHOL, V34, P28, DOI 10.1037/0012-1649.34.1.28; Corkum V., 1995, JOINT ATTENTION ITS; Csibra G, 2008, BRIT J DEV PSYCHOL, V26, P1, DOI 10.1348/026151007X185987; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FLAVELL JH, 1981, DEV PSYCHOL, V17, P99, DOI 10.1037/0012-1649.17.1.99; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; FLAVELL JH, 1980, DEV PSYCHOL, V16, P10, DOI 10.1037/0012-1649.16.1.10; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; Hirai M, 2020, CHILD DEV, V91, P214, DOI 10.1111/cdev.13172; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Kampis D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1683; Kessler K, 2010, COGNITION, V114, P72, DOI 10.1016/j.cognition.2009.08.015; Koster M, 2016, PSYCHOL SCI, V27, P542, DOI 10.1177/0956797615627426; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Lange-Kuttner C, 2009, ACTA PAEDIATR, V98, P1553, DOI 10.1111/j.1651-2227.2009.01422.x; LEMPERS JD, 1977, GENET PSYCHOL MONOGR, V95, P3; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Luo YY, 2011, DEVELOPMENTAL SCI, V14, P453, DOI 10.1111/j.1467-7687.2010.00995.x; MASANGKAY ZS, 1974, CHILD DEV, V45, P357, DOI 10.2307/1127956; Moll H, 2004, DEVELOPMENTAL SCI, V7, pF1, DOI 10.1111/j.1467-7687.2004.00315.x; Moll H, 2006, BRIT J DEV PSYCHOL, V24, P603, DOI 10.1348/026151005X55370; Moll H, 2011, CHILD DEV, V82, P661, DOI 10.1111/j.1467-8624.2010.01571.x; Moore C, 1998, BRIT J DEV PSYCHOL, V16, P495, DOI 10.1111/j.2044-835X.1998.tb00767.x; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Mundy P, 2007, CHILD DEV, V78, P938, DOI 10.1111/j.1467-8624.2007.01042.x; Mundy P, 2016, J AUTISM DEV DISORD, V46, P2555, DOI 10.1007/s10803-016-2785-6; Mundy P, 2009, AUTISM RES, V2, P2, DOI 10.1002/aur.61; Okumura Y, 2020, COGNITION, V195, DOI 10.1016/j.cognition.2019.104082; Okumura Y, 2017, COGNITION, V166, P418, DOI 10.1016/j.cognition.2017.06.005; Okumura Y, 2013, COGNITION, V128, P127, DOI 10.1016/j.cognition.2013.03.011; Piaget J., 1956, CHILDS CONCEPT SPACE; PILLOW BH, 1986, CHILD DEV, V57, P125, DOI 10.2307/1130644; SALATAS H, 1976, CHILD DEV, V47, P103; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Schurz M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00712; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Slaughter V, 2003, J GENET PSYCHOL, V164, P54, DOI 10.1080/00221320309597503; Sodian B, 2007, DEVELOPMENTAL SCI, V10, P199, DOI 10.1111/j.1467-7687.2007.00580.x; Song HJ, 2008, DEV PSYCHOL, V44, P1789, DOI 10.1037/a0013774; Tomasello M., 1995, JOINT ATTENTION ITS, P103; Vouloumanos A, 2014, DEVELOPMENTAL SCI, V17, P872, DOI 10.1111/desc.12170; Vouloumanos A, 2012, P NATL ACAD SCI USA, V109, P12933, DOI 10.1073/pnas.1121057109; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263653	10.1371/journal.pone.0263653	http://dx.doi.org/10.1371/journal.pone.0263653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171927	gold, Green Published			2022-12-26	WOS:000795889700031
J	Park, YL; Kim, HP; Ock, CY; Min, DW; Kang, JK; Lim, YJ; Song, SH; Han, SW; Kim, TY				Park, Ye-Lim; Kim, Hwang-Phill; Ock, Chan-Young; Min, Dong-Wook; Kang, Jun Kyu; Lim, Yoo Joo; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You			EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer	ONCOGENE			English	Article							NF-KAPPA-B; CETUXIMAB RESISTANCE; TUMOR HETEROGENEITY; MUTATIONS; ACTIVATION; EXPRESSION; CYTOKINES; GROWTH; TRANSACTIVATION; CHEMOTHERAPY	The emergence of RAS/RAF mutant clone is the main feature of EGFR inhibitor resistance in KRAS wild-type colon cancer. However, its molecular mechanism is thought to be multifactorial, mainly due to cellular heterogeneity. In order to better understand the resistance mechanism in a single clone level, we successfully isolated nine cells with cetuximab-resistant (CR) clonality from in vitro system. All CR cells harbored either KRAS or BRAF mutations. Characteristically, these cells showed a higher EMT (Epithelial to mesenchymal transition) signature, showing increased EMT markers such as SNAI2. Moreover, the expression level of CXCL1/5, a secreted protein, was significantly higher in CR cells compared to the parental cells. In these CR cells, CXCL1/5 expression was coordinately regulated by SNAI2/NFKB and transactivated EGFR through CXCR/MMPI/EGF axis via autocrine singling. We also observed that combined cetuximab/MEK inhibitor not only showed growth inhibition but also reduced the secreted amounts of CXCL1/5. We further found that serum CXCL1/5 level was positively correlated with the presence of RAS/RAF mutation in colon cancer patients during cetuximab therapy, suggesting its role as a biomarker. These data indicated that the application of serum CXCL1/5 could be a potential serologic biomarker for predicting resistance to EGFR therapy in colorectal cancer.	[Park, Ye-Lim; Kim, Hwang-Phill; Kang, Jun Kyu; Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Park, Ye-Lim; Kim, Hwang-Phill; Min, Dong-Wook; Kang, Jun Kyu; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kim, Hwang-Phill] IMBDx Inc, Seoul, South Korea; [Ock, Chan-Young; Lim, Yoo Joo; Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, YL; Kim, TY (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea.; Park, YL; Kim, TY (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.; Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	yelim_park@snu.ac.kr; kimty@snu.ac.kr		Lim, Yoojoo/0000-0002-4181-2916; PARK, YE-LIM/0000-0002-3043-9984	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI14C1277, HI13C2096]; Ministry of Science, ICT & Future Planning [2016M3A9B6026918, 2018R1C1B6005264]; National Research Foundation of Korea [2017M3C9A5029978]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [NRF-2017M3A9A7050610]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare; Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	We thank H. Nikki March, Ph.D., from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. The authors are grateful to all members of our group for their helpful advice. This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (HI14C1277, HI13C2096), by the Ministry of Science, ICT & Future Planning (2016M3A9B6026918, 2018R1C1B6005264), and by the National Research Foundation of Korea (2017M3C9A5029978), and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (NRF-2017M3A9A7050610).	Arena S, 2015, CLIN CANCER RES, V21, P2157, DOI 10.1158/1078-0432.CCR-14-2821; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Bommarito A, 2011, ENDOCR-RELAT CANCER, V18, P669, DOI 10.1530/ERC-11-0076; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Chen C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1431-6; Choi YH, 2019, MOL CELLS, V42, P189, DOI 10.14348/molcells.2019.2446; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cremolini C, 2015, NAT REV CLIN ONCOL, V12, P607, DOI 10.1038/nrclinonc.2015.129; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Goldman SL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00008; Grepin R, 2014, CANCER RES, V74, P873, DOI 10.1158/0008-5472.CAN-13-1267; Grisanti LA, 2017, J CARDIOVASC PHARM, V70, P3, DOI 10.1097/FJC.0000000000000462; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hsu HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/oncotarget.8076; Hu BW, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0562-7; Jones VS, 2016, BBA-REV CANCER, V1865, P255, DOI 10.1016/j.bbcan.2016.03.005; Kogan-Sakin I, 2009, CARCINOGENESIS, V30, P698, DOI 10.1093/carcin/bgp043; Kuo PL, 2012, CARCINOGENESIS, V33, P2477, DOI 10.1093/carcin/bgs299; Lawson DA, 2018, NAT CELL BIOL, V20, P1349, DOI 10.1038/s41556-018-0236-7; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Mangahas CR, 2005, J INVEST DERMATOL, V125, P307, DOI 10.1111/j.0022-202X.2005.23820.x; MILNE GWA, 1994, J CHEM INF COMP SCI, V34, P1219, DOI 10.1021/ci00021a032; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mishra J, 2013, CRIT REV ONCOL HEMAT, V86, P232, DOI 10.1016/j.critrevonc.2012.09.014; Mizumoto Y, 2011, CLIN CANCER RES, V17, P1341, DOI 10.1158/1078-0432.CCR-10-2291; Nolen BM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2096; Park MH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020015; Park YL, 2019, INT J CANCER, V144, P389, DOI 10.1002/ijc.31662; Pommier AJC, 2014, BRIT J CANCER, V111, P1590, DOI 10.1038/bjc.2014.436; Ramesh G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/480739; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Shaw VE, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-114; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Spaks A, 2017, J THORAC DIS, V9, pS164, DOI 10.21037/jtd.2017.03.61; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Susek KH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02159; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van Brummelen EMJ, 2017, ONCOLOGIST, V22, P864, DOI 10.1634/theoncologist.2017-0031; Wang ZX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010095; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xu JM, 2017, CLIN CANCER RES, V23, P4602, DOI 10.1158/1078-0432.CCR-16-2738; Yako YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154016; Yamazaki N, 2017, CANCER SCI, V108, P1022, DOI 10.1111/cas.13226; Yuan M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6530410; Yun J, 2016, NUCLEIC ACIDS RES, V44, P558, DOI 10.1093/nar/gkv933; Zhao B, 2017, ONCOTARGET, V8, P3980, DOI 10.18632/oncotarget.14012	55	4	4	3	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 1	2022	41	14					2026	2038		10.1038/s41388-021-01920-4	http://dx.doi.org/10.1038/s41388-021-01920-4		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0F2FY	35173310				2022-12-26	WOS:000756457400003
J	Okada, M; Okada, K; Kakehashi, M				Okada, Masahiro; Okada, Kosuke; Kakehashi, Masayuki			Eating habit patterns may predict maximum occlusal force: A preliminary study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BITE FORCE; MASTICATORY BEHAVIOR; PRESCHOOL-CHILDREN; JAPANESE; ASSOCIATION; MORPHOLOGY; SLEEP; FOOD	Masticatory function is thought to be related to various eating habits, but it is difficult to evaluate overall masticatory function by assessing complex eating habits. Maximum occlusal force is an important indicator of masticatory function that is affected by age and sex. This preliminary study focused on the maximum occlusal force of young women and their eating habits, excluding food and nutritional factors, and investigated whether individual eating habits and eating habit patterns predict maximum occlusal force. We measured the maximum occlusal force for the whole dentition of 53 healthy young women before they ate lunch. The participants also completed a 12-item questionnaire about their eating habits. Scores were determined from the relationship between each item and increased maximum occlusal force. We found a significant but weak relationship between maximum occlusal force and some questions. The total questionnaire scores for the participants' eating habits showed an almost normal distribution (mean +/- standard deviation: 22.7 +/- 2.6, median: 23.0, mode: 23.0, range of total scores: 17-28). The accuracy of the linear regression between the total scores for eating habits and maximum occlusal force was high but not perfect (beta: standardized regression coefficient = 0.527, P< 0.001). Although further research is needed, our findings confirm that eating habit patterns are significantly associated with maximum occlusal force and may help predict occlusal force. Our results provide important information about eating patterns in humans.	[Okada, Masahiro] Hiroshima Bunka Gakuen Two Year Coll, Dept Food & Dietet, Hiroshima, Japan; [Okada, Kosuke] Coop Saeki Hosp, Dept Internal Med, Saeki Ku, Hiroshima, Japan; [Kakehashi, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Okada, M (corresponding author), Hiroshima Bunka Gakuen Two Year Coll, Dept Food & Dietet, Hiroshima, Japan.	okada@hbg.ac.jp		Okada, Masahiro/0000-0002-1876-3482				BAKKE M, 1990, Scandinavian Journal of Dental Research, V98, P149; BAKKE M, 1993, SCAND J DENT RES, V101, P314; Canabarro SD, 2006, INT J PROSTHODONT, V19, P177; Castelo PM, 2010, ANN ANAT, V192, P23, DOI 10.1016/j.aanat.2009.10.002; Chen X, 2005, CHILD CARE HLTH DEV, V31, P433, DOI 10.1111/j.1365-2214.2005.00529.x; Scudine KGD, 2016, PHYSIOL BEHAV, V163, P115, DOI 10.1016/j.physbeh.2016.04.053; Frecka JM, 2008, EUR J CLIN NUTR, V62, P1231, DOI 10.1038/sj.ejcn.1602838; Hatch JP, 2001, ARCH ORAL BIOL, V46, P641, DOI 10.1016/S0003-9969(01)00023-1; Iinuma T, 2017, J ORAL SCI, V59, P207, DOI 10.2334/josnusd.16-0414; Inomata C, 2014, J DENT, V42, P556, DOI 10.1016/j.jdent.2014.02.015; Iwasaki M, 2018, J ORAL REHABIL, V45, P17, DOI 10.1111/joor.12578; Karakis D, 2015, CRANIO, V33, P32, DOI 10.1179/2151090314Y.0000000009; Kono Rei, 2009, Nihon Ronen Igakkai Zasshi, V46, P55; Kuwano T, 1998, Nihon Eiseigaku Zasshi, V52, P624; Loginova KN., 1999, STOMATOLOGIIA MOSK, V78, P12; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Ohira A, 2012, INT J PAEDIATR DENT, V22, P146, DOI 10.1111/j.1365-263X.2011.01162.x; Okada M, 2014, INT J BIOMETEOROL, V58, P1973, DOI 10.1007/s00484-014-0800-1; Paphangkorakit J, 2019, EUR J ORAL SCI, V127, P40, DOI 10.1111/eos.12583; Pedroni-Pereira A, 2018, PHYSIOL BEHAV, V184, P220, DOI 10.1016/j.physbeh.2017.12.001; Pedroni-Pereira A, 2016, APPETITE, V107, P527, DOI 10.1016/j.appet.2016.08.122; Pigno MA, 2001, INT J PROSTHODONT, V14, P65; Sato N., 2010, Japanese Journal of Nutrition and Dietetics, V68, P253, DOI 10.5264/eiyogakuzashi.68.253; Sato N, 2011, J NUTR SCI VITAMINOL, V57, P258, DOI 10.3177/jnsv.57.258; Tasaka A, 2018, J PROSTHODONT RES, V62, P50, DOI 10.1016/j.jpor.2017.05.003; Tatsumi Y., 2010, J JPN HLTH MED ASS, V19, P16; Tsuga K, 1998, J ORAL REHABIL, V25, P117; Tuxen A, 1999, ARCH ORAL BIOL, V44, P509, DOI 10.1016/S0003-9969(99)00008-4; Ulrich-Lai YM, 2015, STRESS, V18, P381, DOI 10.3109/10253890.2015.1062981; Usui T, 2007, ORTHOD CRANIOFAC RES, V10, P226, DOI 10.1111/j.1601-6343.2007.00405.x; Westerterp-Plantenga MS, 2016, P NUTR SOC, V75, P431, DOI 10.1017/S0029665116000227; Yamanaka R, 2009, J ORAL REHABIL, V36, P584, DOI 10.1111/j.1365-2842.2009.01971.x; Yoshino Y., 2005, J MASTICAT HLTH SOC, V15, P2	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263647	10.1371/journal.pone.0263647	http://dx.doi.org/10.1371/journal.pone.0263647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167601	gold, Green Published			2022-12-26	WOS:000802227200011
J	Nagura, Y; Matsuura, K; Iio, E; Fujita, K; Inoue, T; Matsumoto, A; Tanaka, E; Nishiguchi, S; Kang, JH; Matsui, T; Enomoto, M; Ikeda, H; Watanabe, T; Okuse, C; Tsuge, M; Atsukawa, M; Tateyama, M; Kataoka, H; Tanaka, Y				Nagura, Yoshihito; Matsuura, Kentaro; Iio, Etsuko; Fujita, Koji; Inoue, Takako; Matsumoto, Akihiro; Tanaka, Eiji; Nishiguchi, Shuhei; Kang, Jong-Hon; Matsui, Takeshi; Enomoto, Masaru; Ikeda, Hiroki; Watanabe, Tsunamasa; Okuse, Chiaki; Tsuge, Masataka; Atsukawa, Masanori; Tateyama, Masakuni; Kataoka, Hiromi; Tanaka, Yasuhito			Serum miR-1 92-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B	PLOS ONE			English	Article							SUSTAINED RESPONSE; PEGINTERFERON ALPHA-2A; I TREAT; LAMIVUDINE; GUIDELINES; MICRORNAS	We examined the association between serum miRNA (-192-5p, -122-3p, -320a and -6126-5p) levels and the efficacy of pegylated interferon (Peg-IFN) monotherapy for chronic hepatitis B (CHB) patients. We enrolled 61 CHB patients treated with Peg-IFN alpha-2a weekly for 48 weeks, of whom 12 had a virological response (VR) and 49 did not VR (non-VR). A VR was defined as HBV DNA < 2,000 I U/ml, hepatitis B e antigen (HBeAg)-negative, and nucleos(t)ide analogue free at 48 weeks after the end of treatment. The non-VR group showed a significantly higher HBeAg-positivity rate, ALT, HBV DNA, and serum miR-192-5p levels at baseline (P = 0.024, P = 0.020, P = 0.007, P = 0.021, respectively). Serum miR-192-5p levels at 24-weeks after the start of treatment were also significantly higher in the non-VR than the VR group (P= 0.011). Multivariate logistic regression analysis for predicting VR showed that miR-192-5p level at baseline was an independent factor (Odds 4.5, P= 0.041). Serum miR-192-5p levels were significantly correlated with the levels of HBV DNA, hepatitis B core-related antigen, and hepatitis B surface antigen (r = 0.484, 0.384 and 0.759, respectively). The serum miR-192-5p level was useful as a biomarker for the therapeutic efficacy of Peg-IFN in CHB treatment.	[Nagura, Yoshihito; Iio, Etsuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Nagura, Yoshihito; Iio, Etsuko; Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan; [Nagura, Yoshihito; Matsuura, Kentaro; Kataoka, Hiromi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Fujita, Koji] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Miki, Kagawa, Japan; [Inoue, Takako] Nagoya City Univ Hosp, Dept Clin Lab Med, Nagoya, Aichi, Japan; [Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Dept Internal Med, Sch Med, Matsumoto, Nagano, Japan; [Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, Nishinomiya, Hyogo, Japan; [Kang, Jong-Hon; Matsui, Takeshi] Teine Keijinkai Hosp, Div Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Enomoto, Masaru] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Osaka, Japan; [Ikeda, Hiroki; Watanabe, Tsunamasa] St Marianna Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Okuse, Chiaki] Kawasaki Municipal Tama Hosp, Dept Internal Med, Div Gen Internal Med, Kawasaki, Kanagawa, Japan; [Tsuge, Masataka] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Hiroshima, Japan; [Atsukawa, Masanori] Nippon Med Sch, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Tateyama, Masakuni; Tanaka, Yasuhito] Kumamoto Univ, Fac Life Sci, Dept Gastroenterol & Hepatol, Kumamoto, Kumamoto, Japan	Nagoya City University; Nagoya City University; Nagoya City University; Kagawa University; Nagoya City University; Shinshu University; Hyogo College of Medicine; Teine Keijinkai Hospital; Osaka Metropolitan University; Saint Marianna University; Hiroshima University; Nippon Medical School; Kumamoto University	Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan.; Tanaka, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan.; Tanaka, Y (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Gastroenterol & Hepatol, Kumamoto, Kumamoto, Japan.	ytanaka@kumamoto-u.ac.jp	ENOMOTO, Masaru/I-3864-2019	ENOMOTO, Masaru/0000-0002-4028-4381; Tanaka, Yasuhito/0000-0002-2473-6966	Research Program on Hepatitis from the Japan Agency for Medical Research and Development [AMED JP20fk0310101, JP21fk0310101]	Research Program on Hepatitis from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Y.T was supported by a grant-in-aid from the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED JP20fk0310101, JP21fk0310101). URL: https://www.amed.go.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2020, HEPATOL RES, V50, P892, DOI 10.1111/hepr.13504; Argyropoulos C, 2015, J CLIN MED, V4, P1498, DOI 10.3390/jcm4071498; Baker MA, 2019, HYPERTENSION, V73, P399, DOI 10.1161/HYPERTENSIONAHA.118.11875; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonino F, 2007, GUT, V56, P699, DOI 10.1136/gut.2005.089722; Brunetto MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110782; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chuaypen N, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.07.016; Flammang I, 2020, CANCERS, V12, DOI 10.3390/cancers12061693; Fontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885; Fujita K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071940; Gu YZ, 2019, CANCER RES, V79, P941, DOI 10.1158/0008-5472.CAN-18-1675; Lampertico P, 2013, LIVER INT, V33, P157, DOI 10.1111/liv.12064; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liu XL, 2020, HEPATOLOGY, V72, P454, DOI 10.1002/hep.31050; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mao Q, 2019, EXP THER MED, V18, P3053, DOI 10.3892/etm.2019.7887; Marcellin P, 2009, GASTROENTEROLOGY, V136, P2169, DOI 10.1053/j.gastro.2009.03.006; Martinot-Peignoux M, 2014, LIVER INT, V34, P97, DOI 10.1111/liv.12403; Matsuura K, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy268; Motawi TK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120794; Nielsen KO, 2018, EXP CELL RES, V371, P92, DOI 10.1016/j.yexcr.2018.07.044; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Piratvisuth T, 2008, HEPATOL INT, V2, P102, DOI 10.1007/s12072-007-9022-5; Pirola CJ, 2015, GUT, V64, P800, DOI 10.1136/gutjnl-2014-306996; Ren FJ, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.614068; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Shin KH, 2018, J CLIN VIROL, V101, P47, DOI 10.1016/j.jcv.2018.01.012; Tavakolian S, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05071-9; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; van der Ree MH, 2017, J INFECT DIS, V215, P1421, DOI 10.1093/infdis/jix140; Vlachogiannakos J, 2014, LIVER INT, V34, P127, DOI 10.1111/liv.12404; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zou P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56018-5	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263844	10.1371/journal.pone.0263844	http://dx.doi.org/10.1371/journal.pone.0263844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157730	gold, Green Published, Green Submitted			2022-12-26	WOS:000788004500023
J	Power, EA; Fernandez-Torres, J; Zhang, L; Yaun, RY; Lucien, F; Daniels, DJ				Power, Erica A.; Fernandez-Torres, Jenelys; Zhang, Liang; Yaun, Ruiyi; Lucien, Fabrice; Daniels, David J.			Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma	PLOS ONE			English	Article							BRAIN-TUMORS; SUBGROUPS; H3K27ME3; MUTATION; THERAPY; H3F3A	Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain tumor. While there are a number of in vivo rodent models for evaluating tumor biology and response to therapy, these models require significant time and resources. Here, we established the chick-embryo chorioallantoic (CAM) assay as an affordable and time efficient xenograft model for testing a variety of treatment approaches for DIPG. We found that patient-derived DIPG tumors develop in the CAM and maintain the same genetic and epigenetic characteristics of native DIPG tumors. We monitored tumor response to pharmaco- and radiation therapy by 3-D ultrasound volumetric and vasculature analysis. In this study, we established and validated the CAM model as a potential intermediate xenograft model for DIPG and its use for testing novel treatment approaches that include pharmacotherapy or radiation.	[Power, Erica A.; Fernandez-Torres, Jenelys; Zhang, Liang; Yaun, Ruiyi; Daniels, David J.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Power, Erica A.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Lucien, Fabrice] Mayo Clin, Dept Urol, Rochester, MN USA; [Daniels, David J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Daniels, DJ (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.; Daniels, DJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA.	Daniels.David@mayo.edu			NCATS [TL1 TR002380]; NINDS [K08 NS092891]; Brains Together for a Cure; Humor to Fight the Tumor	NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Brains Together for a Cure; Humor to Fight the Tumor	E.A.P. -TL1 TR002380 (NCATS) D.J.D. K08 NS092891 (NINDS) D.J.D. -Brains Together for a Cure D.J.D. -Humor to Fight the Tumor.	Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Capdevielle C, 2020, NEURO-ONCOLOGY, V22, P550, DOI 10.1093/neuonc/noz215; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Conway AE, 2014, NEURORADIOLOGY, V56, P405, DOI 10.1007/s00234-014-1348-9; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fang D, 2018, ELIFE, V7, DOI 10.7554/eLife.36696; Gallitto M, 2019, ADV RADIAT ONCOL, V4, P520, DOI 10.1016/j.adro.2019.03.009; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Himes BT, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00031; Huang CW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41373-0; Jansen MHA, 2012, CANCER TREAT REV, V38, P27, DOI 10.1016/j.ctrv.2011.06.007; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Larson JD, 2019, CANCER CELL, V35, P140, DOI 10.1016/j.ccell.2018.11.015; Li M, 2015, JOVE-J VIS EXP, DOI 10.3791/52411; Lin GL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw0064; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maury E, 2017, EPIGENETICS-US, V12, P353, DOI 10.1080/15592294.2016.1278095; Merchant TE, 2010, SEMIN RADIAT ONCOL, V20, P58, DOI 10.1016/j.semradonc.2009.09.005; Qin EY, 2017, CELL, V170, P845, DOI 10.1016/j.cell.2017.07.016; Rechberger JS, 2020, CHILD NERV SYST, V36, P39, DOI 10.1007/s00381-019-04363-1; Ribatti D, 2014, EXP CELL RES, V328, P314, DOI 10.1016/j.yexcr.2014.06.010; Rovithi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44686; Skowron MA, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2017.05.003; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Vitanza NA, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0577-y; Welby JP, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00092; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xiao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130935; Zhang L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220569	30	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263822	10.1371/journal.pone.0263822	http://dx.doi.org/10.1371/journal.pone.0263822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157705	Green Published, gold			2022-12-26	WOS:000788004500020
J	Li, BS; Kang, HY; Xiao, YF; Du, YX; Xiao, YH; Song, GJ; Zhang, Y; Guo, Y; Yang, F; He, FT; Yang, SM				Li, Bosheng; Kang, Houyi; Xiao, Yufeng; Du, Yexiang; Xiao, Yunhua; Song, Guojing; Zhang, Yan; Guo, Yu; Yang, Fan; He, Fengtian; Yang, Shiming			LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1	ONCOGENE			English	Article							GLUCOSE; SUMOYLATION; INTERACTS	Colorectal cancer liver metastasis (CRLM) is the leading cause of colorectal cancer-related deaths and remains a clinical challenge. Enhancement of glucose uptake is involved in CRLM; however, whether long noncoding RNAs (lncRNAs) participate in these molecular events remains largely unclear. Here, we report an lncRNA, GAL (glucose transporter 1 (GLUT1) associated lncRNA), that was upregulated in CRLM tissues compared with primary colorectal cancer (CRC) tissues or matched normal tissues and was associated with the overall survival rates of CRLM patients. Functionally, GAL served as an oncogene because it promoted CRC cell migration and invasion in vitro and enhanced the ability of CRC cells to metastasize from the intestine to the liver in vivo. Mechanistically, GAL interacted with the GLUT1 protein to increase GLUT1 SUMOylation, inhibiting the effect of the ubiquitin-proteasome system on the GLUT1 protein. GLUT1-knockout (-/+) repressed the GAL-mediated increase in CRC cell uptake of glucose, migrate, and invade in vitro, as well as metastasis from the intestine to the liver in vivo, and enforced expression of GLUT1 rescued GAL knockout-induced biological functions in CRC cells. Taken together, our findings demonstrated that GAL promotes CRLM by stabilizing GLUT1, suggesting that the GAL-GLUT1 complex may act as a potential therapeutic target for CRLM.	[Li, Bosheng; Zhang, Yan; Yang, Fan; He, Fengtian] Army Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China; [Li, Bosheng; Xiao, Yufeng; Du, Yexiang; Yang, Shiming] Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400037, Peoples R China; [Kang, Houyi; Guo, Yu] Army Med Univ, Daping Hosp, Dept Radiol, Chongqing 400042, Peoples R China; [Xiao, Yunhua] Army Med Univ, Southwest Hosp, Dept Radiol, Chongqing 400038, Peoples R China; [Song, Guojing] Army Med Univ, Southwest Hosp, Dept Urol, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	He, FT (corresponding author), Army Med Univ, Coll Basic Med Sci, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China.; Yang, SM (corresponding author), Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing 400037, Peoples R China.	hefengtian06@aliyun.com; yangshiming@tmmu.edu.cn	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744; Xiao, Yu-Feng/0000-0002-4410-4448; Xiao, Yunhua/0000-0002-2898-7180	Natural Science Foundation of China [81773037]; Chongqing Science and Technology Commission Fund [cstc2019jcyj-msxmX0378, cstc2019jcyj-bshX0040]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission Fund	This work was supported by grants from the Natural Science Foundation of China (81773037) and the Chongqing Science and Technology Commission Fund (cstc2019jcyj-msxmX0378 and cstc2019jcyj-bshX0040).	Actis Dato V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84090-3; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bu PC, 2018, CELL METAB, V27, P1249, DOI 10.1016/j.cmet.2018.04.003; Bu PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7879; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Chen HR, 2021, GASTROENTEROLOGY, V160, P1284, DOI 10.1053/j.gastro.2020.11.013; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Fang YW, 2016, GENOM PROTEOM BIOINF, V14, P42, DOI 10.1016/j.gpb.2015.09.006; Fernandes R, 2004, MOL VIS, V10, P618; Ferre F, 2016, BRIEF BIOINFORM, V17, P106, DOI 10.1093/bib/bbv031; Gil N, 2020, NAT REV GENET, V21, P102, DOI 10.1038/s41576-019-0184-5; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gras D, 2014, REV NEUROL-FRANCE, V170, P91, DOI 10.1016/j.neurol.2013.09.005; Graziano F, 2017, PHARMACOGENOMICS J, V17, P258, DOI 10.1038/tpj.2016.13; Gu J, 2006, DIGEST DIS SCI, V51, P2198, DOI 10.1007/s10620-006-9428-2; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; Han X, 2015, GRAEF ARCH CLIN EXP, V253, P1279, DOI 10.1007/s00417-015-2999-x; Huang HJ, 2015, AM J CANCER RES, V5, P309; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; Li SJ, 2020, CELL SIGNAL, V73, DOI 10.1016/j.cellsig.2020.109686; Liao ZM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.641343; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nickels KC, 2016, NAT REV NEUROL, V12, P465, DOI 10.1038/nrneurol.2016.98; Salvi AM, 2021, NAT CELL BIOL, V23, P457, DOI 10.1038/s41556-021-00677-y; Sarropoulos I, 2019, NATURE, V571, P510, DOI 10.1038/s41586-019-1341-x; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shen CQ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01190-w; Tang JY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11447-8; Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4; Zambrano A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133374; Zhang MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36238-x; Zhang YC, 2020, ACTA PHARMACOL SIN B, V10, P79, DOI 10.1016/j.apsb.2019.12.005	34	2	2	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1882	1894		10.1038/s41388-022-02230-z	http://dx.doi.org/10.1038/s41388-022-02230-z		FEB 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35149838				2022-12-26	WOS:000754149100001
J	Kanamarlapudi, V; Tamaddon-Jahromi, S; Murphy, K				Kanamarlapudi, Venkateswarlu; Tamaddon-Jahromi, Salman; Murphy, Kate			ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GLIOMA-CELL INVASION; CHROMAFFIN CELLS; PLASMA-MEMBRANE; REGULATED EXOCYTOSIS; PHOSPHOLIPASE-D; ARF6; ACTIVATION; GAPS; GEFS	ADP-ribosylation factor 6 small GTPase plays an important role in cell migration, invasion and angiogenesis, which are the hallmarks of cancer. Although alterations in ARF6 expression and activity have been linked to metastatic cancer in one or two tissues, the expression of ARF6 in cancers over a wide range of tissues has not been studied so far. In this report, we analysed the expression of ARF6 mRNA in cancers and corresponding healthy controls from 17 different tissues by real-time qualitative polymerase chain reaction (RT-qPCR). We further evaluated ARF6 protein expression in oesophageal adenocarcinoma (EAC) tissue microarray cores by immunohistochemistry. The ARF6 gene expression levels are highly variable between healthy and cancer tissues. Our findings suggest that the ARF6 gene expression is up-regulated highest in oesophageal cancer. In EAC TMAs, ARF6 protein expression increase correlated with EAC progression. This is the first study to investigate ARF6 gene expression in a wide array of cancer tissues and demonstrate that ARF6 expression, at both mRNA and protein levels, is significantly upregulated in higher grades of EAC, which may be useful in targeting ARF6 for cancer diagnostic and therapeutic purposes.	[Kanamarlapudi, Venkateswarlu; Tamaddon-Jahromi, Salman] Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales; [Murphy, Kate] Swansea Bay Univ Hlth Board, Singleton Hosp, Cellular Pathol, Swansea, W Glam, Wales	Swansea University; Singleton Hospital	Kanamarlapudi, V (corresponding author), Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483; Murphy, Kate/0000-0003-2870-3018; Tamaddon-Jahromi, Salman/0000-0002-7543-9670	BBSRC UK [BB/F017596/1, BB/C515455/2, BB/S019588/1]; MRC UK [G0401232]	BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	VK: BBSRC UK (BB/F017596/1, BB/C515455/2 and BB/S019588/1) and MRC UK (G0401232) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Caumon AS, 2000, J BIOL CHEM, V275, P15637, DOI 10.1074/jbc.M908347199; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Creemers A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31548-6; Davies JCB, 2014, BIOCHEM PHARMACOL, V92, P651, DOI 10.1016/j.bcp.2014.09.023; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Funakoshi Y, 2011, J CELL PHYSIOL, V226, P888, DOI 10.1002/jcp.22482; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ha VL, 2008, ADV CANCER RES, V101, P1, DOI 10.1016/S0065-230X(08)00401-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hashimoto S, 2019, P NATL ACAD SCI USA, V116, P17450, DOI 10.1073/pnas.1901765116; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Kanamarlapudi V, 2014, J BIOL CHEM, V289, P33378, DOI 10.1074/jbc.M113.534156; Kanamarlapudi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037954; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Knizhnik A V, 2011, Mol Biol (Mosk), V45, P307; Li M, 2006, CANCER RES, V66, P1583, DOI 10.1158/0008-5472.CAN-05-2424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2019, CANCER RES, V79, P4426, DOI 10.1158/0008-5472.CAN-19-0237; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Munkley J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05489-5; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Otsuka Y, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-017-0212-z; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Sakagami H, 2016, BIOCHEM BIOPH RES CO, V477, P868, DOI 10.1016/j.bbrc.2016.06.150; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Tamaddon-Jahromi S., 2017, ENCY SIGNALING MOL, P1; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vijayvergia N, 2015, J PERS MED, V5, P243, DOI 10.3390/jpm5030243; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z; Xu LZ, 2003, MOL CELL BIOL, V23, P645, DOI 10.1128/MCB.23.2.645-654.2003; Zangari J, 2014, CANCER RES, V74, P5493, DOI 10.1158/0008-5472.CAN-14-0298; Zhang YJ, 2015, ONCOTARGET, V6, P7244, DOI 10.18632/oncotarget.3133; Zheng Q, 2004, NEUROCHEM INT, V45, P633, DOI 10.1016/j.neuint.2004.03.028	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263845	10.1371/journal.pone.0263845	http://dx.doi.org/10.1371/journal.pone.0263845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143561	Green Published, gold			2022-12-26	WOS:000797657800086
J	Matos, S; Silva, AR; Sousa, D; Picanco, A; Amorim, IR; Ashby, S; Gabriel, R; Arroz, AM				Matos, Sonia; Silva, Alexandra R.; Sousa, Duarte; Picanco, Ana; Amorim, Isabel R.; Ashby, Simone; Gabriel, Rosalina; Arroz, Ana Moura			Cultural probes for environmental education: Designing learning materials to engage children and teenagers with local biodiversity	PLOS ONE			English	Article							SCIENCE	Direct contact with nature is paramount in deepening children's and teenagers' interest in biodiversity. Learning materials chosen to convey information and engage participants during outings in nature-rich environments are varied and can support rich learning experiences. For this purpose, learning materials can be acquired "off-the-shelf" or developed for site-specific locations or projects. However, there is little guidance on potential techniques for those wishing to generate contextually relevant materials. With the view of responding to this challenge, we propose the cultural probes technique. We demonstrate that the technique, commonly used in qualitative research to generate novel insights in conversation with participants, can instigate innovative and thoughtful approaches to materials designed for children and teenagers to explore nature. We present a toolkit that draws on the literature on cultural probes, inquiry-based learning, and the value of sensory, emotional, and aesthetic experiences in environmental education for structuring interactions with participants. To test our approach, we applied a descriptive research design and mixed-methods approach for collecting questions from youths between the ages of 10 and 18, inspired by a nature walk and a set of exploratory tasks executed through the toolkit. Specifically, we tested our toolkit along a trail in the Nature Park of Terceira, situated in the Azores, a Portuguese volcanic archipelago in the North Atlantic. Here, we present and reflect on the data collected during one visit organized over two days with two groups of participants and one post-trail activity directed at both groups. Results demonstrate that the open-ended and playful nature of cultural probes offers a novel way to engage youths with nature-rich environments through questioning. This contribution further highlights the potential of cultural probes for instigating encounters that tap into the value of sensory, emotional, and aesthetic experience in nature, with positive outcomes for participants.	[Matos, Sonia; Silva, Alexandra R.; Sousa, Duarte; Ashby, Simone] Interact Technol Inst ITI LARSyS, Polo Cient & Tecnol Madeira, Caminho Penteada, Funchal, Portugal; [Matos, Sonia] Univ Edinburgh, Edinburgh Coll Art, Sch Design, Edinburgh, Midlothian, Scotland; [Silva, Alexandra R.; Picanco, Ana; Amorim, Isabel R.; Gabriel, Rosalina; Arroz, Ana Moura] Univ Azores, cE3c Ctr Ecol Evolut & Environm Changes, Azorean Biodivers Grp, Azores, Portugal; [Ashby, Simone] Tilburg Univ, Tilburg Sch Humanities & Digital Sci Language Com, Tilburg, Netherlands	Edinburgh College of Art; University of Edinburgh; Universidade dos Acores; Tilburg University	Matos, S (corresponding author), Interact Technol Inst ITI LARSyS, Polo Cient & Tecnol Madeira, Caminho Penteada, Funchal, Portugal.; Matos, S (corresponding author), Univ Edinburgh, Edinburgh Coll Art, Sch Design, Edinburgh, Midlothian, Scotland.	sonia.matos@iti.larsys.pt	Amorim do Rosario, Isabel/AAW-2610-2020; Picanço, Ana/I-1618-2019	Amorim do Rosario, Isabel/0000-0001-6847-3320; Picanço, Ana/0000-0002-1188-6519; Arroz, Ana/0000-0001-8279-4470; Matos, Sonia/0000-0003-3902-9823; Rocha Silva, Alexandra Filipa/0000-0003-0360-2755; Ashby, Simone/0000-0003-1050-5013; Sousa, Duarte Luis/0000-0002-3044-0109	FCT Fundacao para a Ciencia e a Tecnologia a Portuguese [PTDC/CED/EDG/31182/2017]; Portuguese funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P., under the Norma Transitoria [DL57/2016/CP1375/CT0003]	FCT Fundacao para a Ciencia e a Tecnologia a Portuguese; Portuguese funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P., under the Norma Transitoria	Field Guide is supported by FCT Fundacao para a Ciencia e a Tecnologia a Portuguese public agency that supports science, technology and innovation, in all scientific domains. FCT project reference number: PTDC/CED/EDG/31182/2017. Isabel R. Amorim participation was funded by Portuguese funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P., under the Norma Transitoria DL57/2016/CP1375/CT0003.	Alves-Mazzotti AJ., 2007, REPRESENTACOES IDENT; Andrews E., 2002, NATL RES COUNCIL NEW, P161, DOI [10.17226/10401, DOI 10.17226/10401]; [Anonymous], FIELD GUIDE; Ardoin NM, 2013, ENVIRON EDUC RES, V19, P499, DOI 10.1080/13504622.2012.709823; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Borges P.A.V., 2010, LIST TERRESTRIAL MAR, P9; Borges PAV, 2019, ENCY WORLDS BIOMES E, P1, DOI DOI 10.1016/B978-0-12-409548-9.11949-9; Brauman Kate A., 2020, GLOBAL ASSESSMENT RE, DOI [10.5281/zenodo.3832035, DOI 10.5281/ZENODO.3832035]; Braus J., 1994, ENV ED SCH CREATING; Caeiro A., AQUELA SENHORA TEM P; Celikoglu OM, 2017, DES ISSUES, V33, P84, DOI 10.1162/DESI_a_00441; Chou J., 2003, APPL ENV ED COMMUNIC, V2, P161, DOI [10.1080/15330150390218289, DOI 10.1080/15330150390218289]; Cornelius-White J, 2007, REV EDUC RES, V77, P113, DOI 10.3102/003465430298563; Ferreira MT, 2016, CLIMATIC CHANGE, V138, P603, DOI 10.1007/s10584-016-1754-6; Gabriel R., 2014, ARQUIPEL LIFE MAR SC, V31, P45; Garrard G, 2010, ENVIRON EDUC RES, V16, P233, DOI 10.1080/13504621003624704; Gaspar C, 2011, J INSECT CONSERV, V15, P671, DOI 10.1007/s10841-010-9365-4; Gaver B., 1999, INTERACTIONS, V6, P21, DOI [10.1145/291224.291235, DOI 10.1145/291224.291235]; Gaver W., 2014, WAYS KNOWING HCI, P143, DOI [10.1007/978-1-4939-0378-8_7, DOI 10.1007/978-1-4939-0378-8_7]; Gaver W.W., 2004, INTERACTIONS, V11, P53, DOI DOI 10.1145/1015530.1015555; Iared VG, 2017, ENVIRON EDUC RES, V23, P1273, DOI 10.1080/13504622.2017.1312290; Iared VG, 2016, J ENVIRON EDUC, V47, P191, DOI 10.1080/00958964.2015.1063472; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jickling B., 2004, CANADIAN J ENV ED, V9, P11; Jorgensen KA, 2016, ENVIRON EDUC RES, V22, P1139, DOI 10.1080/13504622.2015.1068277; Kidman G., 2017, INQUIRY BASED TEACHI, DOI [10.1057/978-1-137-53463-7_3, DOI 10.1057/978-1-137-53463-7_3]; KING A, 1992, EDUC PSYCHOL, V27, P111, DOI 10.1207/s15326985ep2701_8; KING A, 1994, AM EDUC RES J, V31, P338, DOI 10.3102/00028312031002338; Lazonder AW, 2016, REV EDUC RES, V86, P681, DOI 10.3102/0034654315627366; Lindholm M, 2018, SCI EDUC-NETHERLANDS, V27, P987, DOI 10.1007/s11191-018-0015-7; LITFIN KT, 1995, MILLENNIUM-J INT ST, V24, P251, DOI 10.1177/03058298950240020501; Lyotard Jean-Francois., 1984, POSTMODERN CONDITION; Mcclam S., 2015, J ED SUSTAINABLE DEV, V9, P126, DOI [10.1177/0973408215588243, DOI 10.1177/0973408215588243]; Monroe M. C., 2008, APPL ENV ED COMMUNIC, V6, P205, DOI [10.1080/15330150801944416, DOI 10.1080/15330150801944416]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nappi JS., 2017, DELTA KAPPA GAMMA B, V84, P30; Patino J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29156; Peace Corps, 1999, AD ENV ED MAT; Presidncia do Governo-Regio Autnoma dos Aores, 2011, DECR REG REG; Ratinaud P., 2009, IRAMUTEQ INTERFACE R; Saari A, 2020, ENVIRON EDUC RES, V26, P1466, DOI 10.1080/13504622.2018.1522618; Sauve L., 2005, CAN J ENVIRON EDUC, V10, P11; Silva L., 2008, FLORA FAUNA TERRESTR; Silva L, 2006, BIODIVERS CONSERV, V15, P1661, DOI 10.1007/s10531-004-5015-z; Simmons B., 1996, ENV ED MAT GUIDELINE; Stevenson RJ, 2007, DEV PSYCHOL, V43, P253, DOI 10.1037/0012-1649.43.1.253; Thoring K, 2013, 5 INT C INT ASS SOC; Tolppanen S, 2018, J ENVIRON EDUC, V49, P375, DOI 10.1080/00958964.2017.1417816; Varela P, 2015, J PHYS CONF SER, V605, DOI 10.1088/1742-6596/605/1/012041; Borges PAV, 2019, BIODIVERS DATA J, V7, DOI 10.3897/BDJ.7.e32530; Xavier H, 2021, STAT EE ACTIONS SCH	51	1	1	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0262853	10.1371/journal.pone.0262853	http://dx.doi.org/10.1371/journal.pone.0262853			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143505	gold, Green Published			2022-12-26	WOS:000797657800019
J	Rodriguez-Enriquez, A; Herrera-Camacho, I; Millan-Perez-Pena, L; Reyes-Leyva, J; Santos-Lopez, G; Rivera-Benitez, JF; Rosas-Murrieta, NH				Rodriguez-Enriquez, Alan; Herrera-Camacho, Irma; Millan-Perez-Pena, Lourdes; Reyes-Leyva, Julio; Santos-Lopez, Gerardo; Francisco Rivera-Benitez, Jose; Hilda Rosas-Murrieta, Nora			Predicted 3D model of the M protein of Porcine Epidemic Diarrhea Virus and analysis of its immunogenic potential	PLOS ONE			English	Article							B-CELL EPITOPE; MEMBRANE-PROTEIN; BINDING PROTEIN; IDENTIFICATION; RECOMBINANT; CORONAVIRUS; ENVELOPE; SEQUENCE; STRAINS; WEB	The membrane protein M of the Porcine Epidemic Diarrhea Virus (PEDV) is the most abundant component of the viral envelope. The M protein plays a central role in the morphogenesis and assembly of the virus through protein interactions of the M-M, M-Spike (S) and M-nucleocapsid (N) type. The M protein is known to induce protective antibodies in pigs and to participate in the antagonistic response of the cellular antiviral system coordinated by the type I and type III interferon pathways. The 3D structure of the PEDV M protein is still unknown. The present work exposes a predicted 3D model of the M protein generated using the Robetta protocol. The M protein model is organized into a transmembrane and a globular region. The obtained 3D model of the PEDV M protein was compared with 3D models of the SARS-CoV-2 M protein created using neural networks and with initial machine learning-based models created using trRosetta. The 3D model of the present study predicted four linear B-cell epitopes (RSVNASSGTG and KHGDYSAVSNPSALT peptides are noteworthy), six discontinuous B-cell epitopes, forty weak binding and fourteen strong binding T-cell epitopes in the CV777 M protein. A high degree of conservation of the epitopes predicted in the PEDV M protein was observed among different PEDV strains isolated in different countries. The data suggest that the M protein could be a potential candidate for the development of new treatments or strategies that activate protective cellular mechanisms against viral diseases.	[Rodriguez-Enriquez, Alan; Herrera-Camacho, Irma; Millan-Perez-Pena, Lourdes; Hilda Rosas-Murrieta, Nora] Benemerita Univ Autonoma Puebla, Lab Biochem & Mol Biol, Ctr Chem, Inst Sci, Puebla, Mexico; [Rodriguez-Enriquez, Alan] Benemerita Univ Autonoma Puebla, Postgrad Chem Sci, Puebla, Mexico; [Reyes-Leyva, Julio; Santos-Lopez, Gerardo] Metepec, Mol Biol & Virol Lab, Ctr Invest Biomed Oriente, Inst Mexicano Seguro Social IMSS, Mexico City, DF, Mexico; [Francisco Rivera-Benitez, Jose] Inst Nacl Invest Forestales Agr & Pecuarias, Ctr Nacl Invest Disciplinaria Salud Anim & Inocui, Mexico City, DF, Mexico	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Mexicano del Seguro Social	Rosas-Murrieta, NH (corresponding author), Benemerita Univ Autonoma Puebla, Lab Biochem & Mol Biol, Ctr Chem, Inst Sci, Puebla, Mexico.	nora.rosas@correo.buap.mx	Santos-López, Gerardo/M-2122-2014	Santos-López, Gerardo/0000-0002-3793-3117; Rosas-Murrieta, Nora-Hilda/0000-0002-4605-670X	Consejo Nacional de Ciencia y Tecnologia [FONSEC SADER-CONACYT 2017-06-292826]; Vice-Rectory for Research and Postgraduate Studies [VIEP] [100429633-VIEP2021]; CONACYT [BUAP: 219470378, 2019-000037-02NACF]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Vice-Rectory for Research and Postgraduate Studies [VIEP]; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Grant number: JFR-B and IH-C (FONSEC SADER-CONACYT 2017-06-292826, Consejo Nacional de Ciencia y Tecnologia). NHR-M and IHC (100429633-VIEP2021, Vice-Rectory for Research and Postgraduate Studies [VIEP]). Alan Rodriguez Enriquez (BUAP: 219470378) was supported by CONACYT (2019-000037-02NACF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; ARMSTRONG J, 1984, NATURE, V308, P751, DOI 10.1038/308751a0; Arndt AL, 2010, J VIROL, V84, P11418, DOI 10.1128/JVI.01131-10; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Chen NH, 2017, VIRUS RES, V242, P90, DOI 10.1016/j.virusres.2017.09.013; Chung HC, 2016, VIRUS RES, V226, P14, DOI 10.1016/j.virusres.2016.06.013; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; FLEMING JO, 1989, VIROLOGY, V168, P162, DOI 10.1016/0042-6822(89)90415-7; Haas J, 2019, PROTEINS, V87, P1378, DOI 10.1002/prot.25815; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; He YX, 2005, J CLIN MICROBIOL, V43, P3718, DOI 10.1128/JCM.43.8.3718-3726.2005; Heo L., 2020, BIORXIV, DOI [10.1101/2020.03.25.008904, DOI 10.1101/2020.03.25.008904]; Herraez A, 2006, BIOCHEM MOL BIOL EDU, V34, P255, DOI 10.1002/bmb.2006.494034042644; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Hsueh FC, 2020, TRANSBOUND EMERG DIS, V67, P417, DOI 10.1111/tbed.13365; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Jumper J., 2022, COMPUTATIONAL PREDIC; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kern DM, 2021, NAT STRUCT MOL BIOL, V28, P573, DOI 10.1038/s41594-021-00619-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li SS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050367; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Nefedeva M, 2019, ARCH VIROL, V164, P1199, DOI 10.1007/s00705-019-04166-4; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Qian C, 2006, VIRUS GENES, V33, P147, DOI 10.1007/s11262-005-0050-8; Reveles-Felix S, 2020, TRANSBOUND EMERG DIS, V67, P1035, DOI 10.1111/tbed.13426; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato T, 2011, VIRUS GENES, V43, P72, DOI 10.1007/s11262-011-0617-5; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sorensen MR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00701; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Tian PF, 2014, EMERG INFECT DIS, V20, P1735, DOI 10.3201/eid2010.140338; VENNEMA H, 1991, VIROLOGY, V181, P327, DOI 10.1016/0042-6822(91)90499-2; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang HN, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa049; Wang RY, 2020, VET MICROBIOL, V246, DOI 10.1016/j.vetmic.2020.108729; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wrapp D, 2019, J VIROL, V93, DOI 10.1128/JVI.00923-19; Xing JJ, 2009, J MICROBIOL, V47, P589, DOI 10.1007/s12275-009-0104-z; Yang SL, 2018, APPL MICROBIOL BIOT, V102, P8931, DOI 10.1007/s00253-018-9324-7; Ye G, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020240; Zeng Z, 2018, J VIROL, V92, DOI 10.1128/JVI.00692-18; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zhang QZ, 2018, J VIROL, V92, DOI 10.1128/JVI.01677-17; Zhang QZ, 2016, VIROLOGY, V489, P252, DOI 10.1016/j.virol.2015.12.010; Zhang ZB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-225; ZUCKERKANDL EMILE, 1965, P97	59	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263582	10.1371/journal.pone.0263582	http://dx.doi.org/10.1371/journal.pone.0263582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139120	Green Published, gold			2022-12-26	WOS:000821499100034
J	Abdelsaid, K; Sudhahar, V; Harris, RA; Das, A; Youn, SW; Liu, YT; McMenamin, M; Hou, YL; Fulton, D; Hamrick, MW; Tang, YL; Fukai, T; Ushio-Fukai, M				Abdelsaid, Kareem; Sudhahar, Varadarajan; Harris, Ryan A.; Das, Archita; Youn, Seock-Won; Liu, Yutao; McMenamin, Maggie; Hou, Yali; Fulton, David; Hamrick, Mark W.; Tang, Yaoliang; Fukai, Tohru; Ushio-Fukai, Masuko			Exercise improves angiogenic function of circulating exosomes in type 2 diabetes: Role of exosomal SOD3	FASEB JOURNAL			English	Article						exercise; exosome; SOD3; type 2 diabetes	EXTRACELLULAR-SUPEROXIDE DISMUTASE; VASCULAR SMOOTH-MUSCLE; COPPER TRANSPORTER ATP7A; SKELETAL-MUSCLE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; EXPRESSION; VESICLES; COMMUNICATION; PROTECTION	Exosomes, key mediators of cell-cell communication, derived from type 2 diabetes mellitus (T2DM) exhibit detrimental effects. Exercise improves endothelial function in part via the secretion of exosomes into circulation. Extracellular superoxide dismutase (SOD3) is a major secretory copper (Cu) antioxidant enzyme that catalyzes the dismutation of O-2(center dot-) to H2O2 whose activity requires the Cu transporter ATP7A. However, the role of SOD3 in exercise-induced angiogenic effects of circulating plasma exosomes on endothelial cells (ECs) in T2DM remains unknown. Here, we show that both SOD3 and ATP7A proteins were present in plasma exosomes in mice, which was significantly increased after two weeks of volunteer wheel exercise. A single bout of exercise in humans also showed a significant increase in SOD3 and ATP7A protein expression in plasma exosomes. Plasma exosomes from T2DM mice significantly reduced angiogenic responses in human ECs or mouse skin wound healing models, which was associated with a decrease in ATP7A, but not SOD3 expression in exosomes. Exercise training in T2DM mice restored the angiogenic effects of T2DM exosomes in ECs by increasing ATP7A in exosomes, which was not observed in exercised T2DM/SOD3(-/-) mice. Furthermore, exosomes overexpressing SOD3 significantly enhanced angiogenesis in ECs by increasing local H2O2 levels in a heparin-binding domain-dependent manner as well as restored defective wound healing and angiogenesis in T2DM or SOD3(-/-) mice. In conclusion, exercise improves the angiogenic potential of circulating exosomes in T2DM in a SOD3-dependent manner. Exosomal SOD3 may provide an exercise mimetic therapy that supports neovascularization and wound repair in cardiometabolic disease.	[Abdelsaid, Kareem; Sudhahar, Varadarajan; Das, Archita; Youn, Seock-Won; McMenamin, Maggie; Hou, Yali; Fulton, David; Tang, Yaoliang; Fukai, Tohru; Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA; [Abdelsaid, Kareem; Sudhahar, Varadarajan; Fukai, Tohru] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Sudhahar, Varadarajan; Das, Archita; Fulton, David; Fukai, Tohru] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Harris, Ryan A.] Georgia Prevent Inst, Augusta, GA USA; [Youn, Seock-Won] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Liu, Yutao; Hamrick, Mark W.] Augusta Univ, Med Coll Georgia, Dept Cell Biol, Augusta, GA 30912 USA; [Tang, Yaoliang; Ushio-Fukai, Masuko] Augusta Univ, Med Coll Georgia, Dept Med Cardiol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Fukai, T; Ushio-Fukai, M (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA.	tfukai@augusta.edu; mfukai@augusta.edu		Abdelsaid, Kareem/0000-0002-5759-4714; Varadarajan, Sudhahar/0000-0002-9675-0097; Youn, Seock-Won/0000-0003-3275-2170	National Institute of Health [R01HL135584, R01HL147550, R01HL133613, R01HL116976, R01HL070187, R01HL134354]; Veterans Administration Merit [2I01BX001232]; Augusta University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit(US Department of Veterans Affairs); Augusta University	National Institute of Health, Grant/Award Number: R01HL135584, R01HL147550, R01HL133613, R01HL116976, R01HL070187 and R01HL134354; Veterans Administration Merit, Grant/Award Number: 2I01BX001232; Augusta University	Ashino T, 2010, CIRC RES, V107, P787, DOI 10.1161/CIRCRESAHA.110.225334; Bouviere J, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040537; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Carlsson LM, 1996, P NATL ACAD SCI USA, V93, P5219, DOI 10.1073/pnas.93.11.5219; Cheng ZJ, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.019755; Cho YE, 2013, AM J PHYSIOL-CELL PH, V305, pC1033, DOI 10.1152/ajpcell.00234.2013; Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9; Chu Y, 2006, ARTERIOSCL THROM VAS, V26, P1985, DOI 10.1161/01.ATV.0000234921.88489.5c; Cianciaruso C, 2017, DIABETES, V66, P460, DOI 10.2337/db16-0671; Cypryk W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02188; Das A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33783; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1; Fortunato RS, 2020, ANTIOXID REDOX SIGN, V33, P539, DOI 10.1089/ars.2020.8095; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fruhbeis C, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28239; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Fukai T, 1998, J CLIN INVEST, V101, P2101, DOI 10.1172/JCI2105; Fukai T, 2018, AM J PHYSIOL-CELL PH, V315, pC186, DOI 10.1152/ajpcell.00132.2018; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gao F, 2008, ANTIOXID REDOX SIGN, V10, P343, DOI 10.1089/ars.2007.1908; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Harris RA, 2008, OBESITY, V16, P578, DOI 10.1038/oby.2007.87; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hitomi Y, 2008, REDOX REP, V13, P213, DOI 10.1179/135100008X308894; Hou ZX, 2019, CIRC RES, V124, P1386, DOI 10.1161/CIRCRESAHA.118.314635; Huang-Doran I, 2017, TRENDS ENDOCRIN MET, V28, P3, DOI 10.1016/j.tem.2016.10.003; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Ji LL, 2015, ADV PHYSIOL EDUC, V39, P352, DOI 10.1152/advan.00106.2014; Juul K, 2004, CIRCULATION, V109, P59, DOI 10.1161/01.CIR.0000105720.28086.6C; Kander MC, 2017, J CELL MOL MED, V21, P1024, DOI 10.1111/jcmm.13038; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Kim YM, 2018, CELL REP, V23, P3565, DOI 10.1016/j.celrep.2018.05.054; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kobylecki CJ, 2015, EBIOMEDICINE, V2, P2010, DOI 10.1016/j.ebiom.2015.11.026; Kranendonk MEG, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-37; Kusuyama J, 2021, CELL METAB, V33, P939, DOI 10.1016/j.cmet.2021.03.004; Lawson C, 2016, J ENDOCRINOL, V228, pR57, DOI 10.1530/JOE-15-0201; Li GH, 2019, J CELL PHYSIOL, V234, P14896, DOI 10.1002/jcp.28319; Lund DD, 2007, J PHYSIOL-LONDON, V584, P583, DOI 10.1113/jphysiol.2007.140830; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Sudhahar V, 2018, ARTERIOSCL THROM VAS, V38, P529, DOI 10.1161/ATVBAHA.117.309819; Sudhahar V, 2013, DIABETES, V62, P3839, DOI 10.2337/db12-1228; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Wadley AJ, 2019, J APPL PHYSIOL, V127, P858, DOI 10.1152/japplphysiol.00340.2019; Wedgwood S, 2011, ANTIOXID REDOX SIGN, V15, P1497, DOI 10.1089/ars.2010.3630; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; Yan Z, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101508; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Youn SW, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8010018; Yuan Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00547; Zelko IN, 2011, AM J RESP CELL MOL, V45, P953, DOI 10.1165/rcmb.2011-0012OC; Zhang HN, 2018, P NATL ACAD SCI USA, V115, pE6927, DOI 10.1073/pnas.1721521115; Zhang TR, 2021, J CARDIOVASC TRANSL, V14, P824, DOI 10.1007/s12265-020-10082-9	64	1	1	5	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22177	10.1096/fj.202101323R	http://dx.doi.org/10.1096/fj.202101323R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35142393				2022-12-26	WOS:000761250800041
J	Chen, YY; Sotomayor, M; Capponi, S; Hariharan, B; Sahu, ID; Haase, M; Lorigan, GA; Kuhn, A; White, SH; Dalbey, RE				Chen, Yuanyuan; Sotomayor, Marcos; Capponi, Sara; Hariharan, Balasubramani; Sahu, Indra D.; Haase, Maximilian; Lorigan, Gary A.; Kuhn, Andreas; White, Stephen H.; Dalbey, Ross E.			A hydrophilic microenvironment in the substrate-translocating groove of the YidC membrane insertase is essential for enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; PROTEIN FORCE-FIELD; SYNTHASE SUBUNIT-C; PF3 COAT PROTEIN; TRANSMEMBRANE PROTEIN; SECYEG; BIOGENESIS; RECONSTITUTION; VALIDATION; BACTERIAL	The YidC family of proteins are membrane insertases that catalyze the translocation of the periplasmic domain of membrane proteins via a hydrophilic groove located within the inner leaflet of the membrane. All homologs have a strictly conserved, positively charged residue in the center of this groove. In Bacillus subtilis, the positively charged residue has been proposed to be essential for interacting with negatively charged residues of the substrate, supporting a hypothesis that YidC catalyzes insertion via an early-step electrostatic attraction mechanism. Here, we provide data suggesting that the positively charged residue is important not for its charge but for increasing the hydrophilicity of the groove. We found that the positively charged residue is dispensable for Escherichia coli YidC function when an adjacent residue at position 517 was hydrophilic or aromatic, but was essential when the adjacent residue was apolar. Additionally, solvent accessibility studies support the idea that the conserved positively charged residue functions to keep the top and middle of the groove sufficiently hydrated. Moreover, we demonstrate that both the E. coli and Streptococcus mutans YidC homologs are functional when the strictly conserved arginine is replaced with a negatively charged residue, provided proper stabilization from neighboring residues. These combined results show that the positively charged residue functions to maintain a hydrophilic microenvironment in the groove necessary for the insertase activity, rather than to form electrostatic interactions with the substrates.	[Chen, Yuanyuan; Sotomayor, Marcos; Hariharan, Balasubramani; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH USA; [Capponi, Sara] IBM Almaden Res Ctr, IBM & Cognit Software Org, Dept Ind & Appl Genom, San Jose, CA USA; [Capponi, Sara] Univ Calif San Francisco, NSF Ctr Cellular Construct, San Francisco, CA USA; [Sahu, Indra D.; Lorigan, Gary A.] Miami Univ, Dept Chem & Biochem, Oxford, OH USA; [Sahu, Indra D.] Campbellsville Univ, Nat Sci Div, Campbellsville, KY USA; [Haase, Maximilian; Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, Stuttgart, Germany; [White, Stephen H.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA	University System of Ohio; Ohio State University; International Business Machines (IBM); University of California System; University of California San Francisco; University System of Ohio; Miami University; University Hohenheim; University of California System; University of California Irvine	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH USA.	dalbey@chemistry.ohio-state.edu	Sotomayor, Marcos/J-4898-2012; Chen, Yuanyuan/GXG-2130-2022; White, Stephen/B-1053-2009; Capponi, Sara/R-6145-2016	Sotomayor, Marcos/0000-0002-3333-1805; White, Stephen/0000-0001-8540-7907; Capponi, Sara/0000-0001-8117-7526	National Science Foundation [MCB-1052033]; Deutsche Forschungsgemeinschaft [Ku 749/6]; NSF [MRI-1725502, MCB2040917]; NIGMS/NIH Maximizing Investigator's Research Award (MIRA) [R35 GM126935]; Miami University; NIH [RO1 GM-74637, R35 GM-139652]; John W. Steube Professorship	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NIGMS/NIH Maximizing Investigator's Research Award (MIRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John W. Steube Professorship	This work was supported by grants from National Science Foundation Grant MCB-1052033 to R. E. D. and from the Deutsche Forschungsgemeinschaft Ku 749/6 to A. K. Simulations were performed at the Ohio Supercomputer Center (PAS1037 to M. S.). G. A. L. would like to acknowledge NSF (MRI-1725502) grant, NIGMS/NIH Maximizing Investigator's Research Award (MIRA) R35 GM126935 award the Ohio Board of Regents, and Miami University. G. A. L. would also like to acknowledge support from the John W. Steube Professorship. I. D. S. would also like to acknowledge support from the NSF MCB2040917 award. S. W. is pleased to acknowledge the support of NIH grants RO1 GM-74637 and R35 GM-139652. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chen YY, 2018, TRENDS BIOCHEM SCI, V43, P151, DOI 10.1016/j.tibs.2017.12.005; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Chen YY, 2014, J BIOL CHEM, V289, P35656, DOI 10.1074/jbc.M114.595082; Coey AT, 2011, BIOCHEMISTRY-US, V50, P10851, DOI 10.1021/bi2009294; Dalbey RE, 2015, STRUCTURE, V23, P1559, DOI 10.1016/j.str.2015.08.002; Dalbey RE, 2014, NAT STRUCT MOL BIOL, V21, P435, DOI 10.1038/nsmb.2823; Dong Y, 2008, J BACTERIOL, V190, P2458, DOI 10.1128/JB.01366-07; He HZ, 2020, J MOL BIOL, V432, P484, DOI 10.1016/j.jmb.2019.10.010; Hennon SW, 2015, J BIOL CHEM, V290, P14866, DOI 10.1074/jbc.R115.638171; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Laskowski PR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27315-3; Lundquist K, 2018, P NATL ACAD SCI USA, V115, pE7942, DOI 10.1073/pnas.1722530115; McDowell MA, 2021, NAT STRUCT MOL BIOL, V28, P234, DOI 10.1038/s41594-021-00567-9; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Petriman NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19019-w; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sachelaru I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00109-8; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Shimokawa-Chiba N, 2015, P NATL ACAD SCI USA, V112, P5063, DOI 10.1073/pnas.1423817112; Soman R, 2014, J BIOL CHEM, V289, P1023, DOI 10.1074/jbc.M113.522250; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wu XD, 2021, TRENDS CELL BIOL, V31, P473, DOI 10.1016/j.tcb.2021.01.002; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	42	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101690	10.1016/j.jbc.2022.101690	http://dx.doi.org/10.1016/j.jbc.2022.101690			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0IS	35148995	Green Published, gold			2022-12-26	WOS:000789400700016
J	Kwiatkowski, S; Bozko, M; Zarod, M; Witecka, A; Kocdemir, K; Jagielski, AK; Drozak, J				Kwiatkowski, Sebastian; Bozko, Maria; Zarod, Michal; Witecka, Apolonia; Kocdemir, Kubra; Jagielski, Adam K.; Drozak, Jakub			Recharacterization of the mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase as 4-oxo-L-proline reductase (EC 1.1.1.104)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; CIS-HYDROXYPROLINE; PROLINE; PROLIFERATION; METABOLISM; SURVIVAL; COLLAGEN; ENZYME	Early studies revealed that chicken embryos incubated with a rare analog of L-proline, 4-oxo-L-proline, showed increased levels of the metabolite 4-hydroxy-L-proline. In 1962, 4-oxo-L-proline reductase, an enzyme responsible for the reduction of 4-oxo-L-proline, was partially purified from rabbit kidneys and characterized biochemically. However, only recently was the molecular identity of this enzyme solved. Here, we report the purification from rat kidneys, identification, and biochemical characterization of 4-oxo-L-proline reductase. Following mass spectrometry analysis of the purified protein preparation, the previously annotated mammalian cytosolic type 2 (R)-beta-hydroxybutyrate dehydrogenase (BDH2) emerged as the only candidate for the reductase. We subsequently expressed rat and human BDH2 in Escherichia coli, then purified it, and showed that it catalyzed the reversible reduction of 4-oxo-L-proline to cis-4-hydroxy-L-proline via chromatographic and tandem mass spectrometry analysis. Specificity studies with an array of compounds carried out on both enzymes showed that 4-oxo-L-proline was the best substrate, and the human enzyme acted with 12,500-fold higher catalytic efficiency on 4-oxo-L-proline than on (R)-beta-hydroxybutyrate. In addition, human embryonic kidney 293T (HEK293T) cells efficiently metabolized 4-oxo-L-proline to cis-4-hydroxy-L-proline, whereas HEK293T BDH2 KO cells were incapable of producing cis-4-hydroxy-L-proline. Both WT and KO HEK293T cells also produced trans-4-hydroxy-L-proline in the presence of 4-oxo-L-proline, suggesting that the latter compound might interfere with the trans-4-hydroxy-L-proline breakdown in human cells. We conclude that BDH2 is a mammalian 4-oxo-L-proline reductase that converts 4-oxo-L-proline to cis-4-hydroxy-L-proline and not to trans-4-hydroxy-L-proline, as originally thought. We also hypothesize that this enzyme may be a potential source of cis-4-hydroxy-L-proline in mammalian tissues.	[Kwiatkowski, Sebastian; Bozko, Maria; Zarod, Michal; Witecka, Apolonia; Kocdemir, Kubra; Jagielski, Adam K.; Drozak, Jakub] Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Warsaw, Poland	University of Warsaw	Drozak, J (corresponding author), Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Warsaw, Poland.	jdrozak@biol.uw.edu.pl		Witecka, Apolonia/0000-0002-7171-3222; Jagielski, Adam/0000-0002-4331-1816; Drozak, Jakub/0000-0002-3601-3845; Kwiatkowski, Sebastian/0000-0003-4908-1633	Foundation for Polish Science; Erasmus+ traineeship from the European Commission	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Erasmus+ traineeship from the European Commission	S. K. was supported by the Foundation for Polish Science, and K. K. was awarded the Erasmus+ traineeship from the European Commission.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Collard F, 2016, NAT CHEM BIOL, V12, P601, DOI [10.1038/NCHEMBIO.2104, 10.1038/nchembio.2104]; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; den Ouden H, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0930-4; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dickens H, 2008, MOL MED REP, V1, P459; Drozak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064805; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hara R, 2009, BIOCHEM BIOPH RES CO, V379, P882, DOI 10.1016/j.bbrc.2008.12.158; Hu SD, 2022, AMINO ACIDS, V54, P513, DOI 10.1007/s00726-021-03056-x; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kuttan R, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1303-1; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; Langrock T, 2007, J CHROMATOGR B, V847, P282, DOI 10.1016/j.jchromb.2006.10.015; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Liu ZM, 2014, MOL CELL BIOL, V34, P2533, DOI 10.1128/MCB.00231-14; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pan L, 2018, MOLECULES, V23, DOI 10.3390/molecules23040735; PATCHETT AA, 1957, J AM CHEM SOC, V79, P185, DOI 10.1021/ja01558a050; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Rausch T, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6635-8; ROSENBLOOM J, 1971, J BIOL CHEM, V246, P1549; Semsary S, 2018, CHEMBIOCHEM, V19, P706, DOI 10.1002/cbic.201700666; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SMITH TE, 1959, SCIENCE, V129, P95, DOI 10.1126/science.129.3341.95; SMITH TE, 1962, J BIOL CHEM, V237, P1177; Sturm D, 2010, INT J COLORECTAL DIS, V25, P921, DOI 10.1007/s00384-010-0946-1; Summitt CB, 2015, BIOCHEM J, V466, P273, DOI 10.1042/BJ20141159; Bach TMH, 2013, APPL MICROBIOL BIOT, V97, P6623, DOI 10.1007/s00253-013-5022-7; Walejko JM, 2018, INT J CARDIOL, V271, P336, DOI 10.1016/j.ijcard.2018.04.074; Yoo JS, 1997, INVEST OPHTH VIS SCI, V38, P520	38	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101708	10.1016/j.jbc.2022.101708	http://dx.doi.org/10.1016/j.jbc.2022.101708			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150746	gold, Green Published			2022-12-26	WOS:000821054100008
J	McKee, CM; Chapski, DJ; Wehling-Henricks, M; Rosa-Garrido, M; Kuro-O, M; Vondriska, TM; Tidball, JG				McKee, Cynthia M.; Chapski, Douglas J.; Wehling-Henricks, Michelle; Rosa-Garrido, Manuel; Kuro-O, Makoto; Vondriska, Thomas M.; Tidball, James G.			The anti-aging protein Klotho affects early postnatal myogenesis by downregulating Jmjd3 and the canonical Wnt pathway	FASEB JOURNAL			English	Article						development; myogenesis; skeletal muscle	SATELLITE CELLS; BETA-CATENIN; STEM-CELLS; READ ALIGNMENT; SELF-RENEWAL; MUSCLE; GENE; DIFFERENTIATION; ADULT; UTX	Modulating the number of muscle stems cells, called satellite cells, during early postnatal development produces long-term effects on muscle growth. We tested the hypothesis that high expression levels of the anti-aging protein Klotho in early postnatal myogenesis increase satellite cell numbers by influencing the epigenetic regulation of genes that regulate myogenesis. Our findings show that elevated klotho expression caused a transient increase in satellite cell numbers and slowed muscle fiber growth, followed by a period of accelerated muscle growth that leads to larger fibers. Klotho also transcriptionally downregulated the H3K27 demethylase Jmjd3, leading to increased H3K27 methylation and decreased expression of genes in the canonical Wnt pathway, which was associated with a delay in muscle differentiation. In addition, Klotho stimulation and Jmjd3 downregulation produced similar but not additive reductions in the expression of Wnt4, Wnt9a, and Wnt10a in myogenic cells, indicating that inhibition occurred through a common pathway. Together, our results identify a novel pathway through which Klotho influences myogenesis by reducing the expression of Jmjd3, leading to reductions in the expression of Wnt genes and inhibition of canonical Wnt signaling.	[McKee, Cynthia M.; Tidball, James G.] Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA; [Chapski, Douglas J.; Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA; [Wehling-Henricks, Michelle; Tidball, James G.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rosa-Garrido, Manuel] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Birmingham, AL 35294 USA; [Rosa-Garrido, Manuel] Univ Alabama Birmingham, Sch Engn, Birmingham, AL USA; [Kuro-O, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Tochigi, Japan; [Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Vondriska, Thomas M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Tidball, James G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Jichi Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tidball, JG (corresponding author), Univ Calif Los Angeles, Mol Cellular & Integrat Physiol Program, Los Angeles, CA 90095 USA.	jtidball@physci.ucla.edu	Rosa-Garrido, Manuel/AAE-4188-2019	Rosa-Garrido, Manuel/0000-0002-2169-3972; Tidball, James/0000-0003-1202-8038; Chapski, Douglas/0000-0002-6730-7627	National Institutes of Health [F31AR071782, RO1HL105699, RO1AR075768, RO1AR062579, RO1AR066036, T32GM065823]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health to C.M.M. [F31AR071782]; T.M.V. [RO1HL105699] and J.G.T. [RO1AR075768, RO1AR062579, RO1AR066036, and T32GM065823]	Adhikari A, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0217-x; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ahrens HE, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0166-x; Akiyama T, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7215010; Akiyama T, 2016, DEVELOPMENT, V143, P3674, DOI 10.1242/dev.139360; Bachman JF, 2022, FEBS J, V289, P2710, DOI 10.1111/febs.15856; Bachman JF, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101760; Bachman JF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167197; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bernardi H, 2011, AM J PHYSIOL-CELL PH, V300, pC1122, DOI 10.1152/ajpcell.00214.2010; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cornelison DDW, 2018, CURR TOP DEV BIOL, V126, P205, DOI 10.1016/bs.ctdb.2017.08.006; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Dilworth FJ, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt59; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Faralli H, 2016, J CLIN INVEST, V126, P1555, DOI 10.1172/JCI83239; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Gattazzo F, 2020, STEM CELL REP, V15, P597, DOI 10.1016/j.stemcr.2020.07.011; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hildyard JCW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211384; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kurosaka M, 2009, J SPORT SCI MED, V8, P51; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; Ohtani K, 2013, CIRC RES, V113, P856, DOI 10.1161/CIRCRESAHA.113.302035; ONTELL M, 1984, ANAT REC, V208, P159, DOI 10.1002/ar.1092080203; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rawls A, 1998, DEVELOPMENT, V125, P2349; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sahu A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07253-3; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sherr CJ, 2000, CANCER RES, V60, P3689; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Team BC., 2016, TXDB MMUSCULUS UCSC; Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; van der Velden JLJ, 2008, J BIOL CHEM, V283, P358, DOI 10.1074/jbc.M707812200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Vivian JL, 2000, DEV BIOL, V224, P29, DOI 10.1006/dbio.2000.9788; Wehling-Henricks M, 2016, HUM MOL GENET, V25, P2465, DOI 10.1093/hmg/ddw111; Welc SS, 2020, EXP PHYSIOL, V105, P132, DOI 10.1113/EP088142; White JP, 2009, J APPL PHYSIOL, V107, P1420, DOI 10.1152/japplphysiol.00668.2009; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Zhang B, 2015, STEM CELL TRANSL MED, V4, P513, DOI 10.5966/sctm.2014-0267; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	78	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22192	10.1096/fj.202101298R	http://dx.doi.org/10.1096/fj.202101298R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35174906	hybrid, Green Published			2022-12-26	WOS:000761250800007
J	Zhao, YH; Liang, YY; Xu, ZX; Liu, JN; Liu, XY; Ma, JY; Sun, C; Yang, YM				Zhao, Yahong; Liang, Yunyun; Xu, Zhixin; Liu, Jina; Liu, Xiaoyu; Ma, Jinyu; Sun, Cheng; Yang, Yumin			Exosomal miR-673-5p from fibroblasts promotes Schwann cell-mediated peripheral neuron myelination by targeting the TSC2/mTORC1/SREBP2 axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; OLIGODENDROCYTE DIFFERENTIATION; NERVE REGENERATION; MTORC1 ACTIVITY; GROWTH; GALACTOCEREBROSIDE; METABOLISM; ACTIVATION; MIGRATION; MEMBRANE	Peripheral myelination is a complicated process, wherein Schwann cells (SCs) promote the formation of the myelin sheath around the axons of peripheral neurons. Fibroblasts are the second resident cells in the peripheral nerves; however, the precise function of fibroblasts in SC-mediated myelination has rarely been examined. Here, we show that exosomes derived from fibroblasts boost myelination-related gene expression in SCs. We used exosome sequencing, together with bioinformatic analysis, to demonstrate that exosomal microRNA miR-673-5p is capable of stimulating myelin gene expression in SCs. Subsequent functional studies revealed that miR-6735p targets the regulator of mechanistic target of the rapamy2 in SCs, leading to the activation of downstream signaling pathways including mTORC1 and sterol-regulatory element binding protein 2. In vivo experiments further confirmed that miR-673-5p activates the tuberous sclerosis complex 2/ mTORC1/sterol-regulatory element binding protein 2 axis, thus promoting the synthesis of cholesterol and related lipids and subsequently accelerating myelin sheath maturation in mediated cross talk between fibroblasts and SCs that plays a pivotal role in peripheral myelination. We propose that exosomes derived from fibroblasts and miR-673-5p might be useful for promoting peripheral myelination in translational medicine.	[Zhao, Yahong; Liang, Yunyun; Xu, Zhixin; Liu, Jina; Liu, Xiaoyu; Ma, Jinyu; Sun, Cheng; Yang, Yumin] Nantong Univ, Key Lab Neuroregenerat Jiangsu & Minist Educ, Coinnovat Ctr Neurogenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong, Peoples R China	Nantong University	Zhao, YH; Sun, C; Yang, YM (corresponding author), Nantong Univ, Key Lab Neuroregenerat Jiangsu & Minist Educ, Coinnovat Ctr Neurogenerat, NMPA Key Lab Res & Evaluat Tissue Engn Technol Pr, Nantong, Peoples R China.	zhaoyh108@ntu.edu.cn; suncheng1975@ntu.edu.cn; yangym@ntu.edu.cn			National Natural Science Foundation of China [81970747, 81701835]; National Key Research and Development Program of China [2017YFA0701304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was provided by the National Natural Science Foundation of China (Nos. 81970747, 81701835) and the National Key Research and Development Program of China (Grant No. 2017YFA0701304).	Beirowski B, 2017, P NATL ACAD SCI USA, V114, pE4261, DOI 10.1073/pnas.1620761114; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Cai S, 2017, STEM CELL REP, V9, P1097, DOI 10.1016/j.stemcr.2017.08.004; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Clarke BA, 2019, ELIFE, V8, DOI 10.7554/eLife.51067; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Deng CL, 2021, CELL DEATH DIFFER, V28, P1041, DOI 10.1038/s41418-020-00636-4; Dimas P, 2019, ELIFE, V8, DOI 10.7554/eLife.44702; Dreesmann L, 2009, EUR J CELL BIOL, V88, P285, DOI 10.1016/j.ejcb.2009.01.001; Figlia G, 2017, ELIFE, V6, DOI 10.7554/eLife.29241; Furusho M, 2017, J NEUROSCI, V37, P2931, DOI 10.1523/JNEUROSCI.3316-16.2017; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Genschmer KR, 2019, CELL, V176, P113, DOI 10.1016/j.cell.2018.12.002; Hackett AR, 2020, GLIA, V68, P963, DOI 10.1002/glia.23755; Henriques-Antunes H, 2019, ACS NANO, V13, P8694, DOI 10.1021/acsnano.9b00376; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsieh CCJ, 2021, BRAIN PATHOL, V31, P4, DOI 10.1111/bpa.12870; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeppesen DK, 2019, CELL, V177, P428, DOI 10.1016/j.cell.2019.02.029; Jiang MQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12185; Jiang N, 2017, ACS NANO, V11, P7736, DOI 10.1021/acsnano.7b01087; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Keller MD, 2020, NATURE, V579, P260, DOI 10.1038/s41586-020-2066-6; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; LeBleu VS, 2020, FASEB J, V34, P3519, DOI 10.1096/fj.201903188R; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Liu XY, 2017, MOL NEUROBIOL, V54, P3554, DOI 10.1007/s12035-016-9913-3; Lu XY, 2020, NATURE, V588, P479, DOI 10.1038/s41586-020-2928-y; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Mahmoudi S, 2019, NATURE, V574, P553, DOI 10.1038/s41586-019-1658-5; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; McLane LE, 2017, J NEUROSCI, V37, P7534, DOI 10.1523/JNEUROSCI.3454-16.2017; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Monnerie H, 2017, J NEUROCHEM, V140, P53, DOI 10.1111/jnc.13721; Montani L, 2018, J CELL BIOL, V217, P1352, DOI 10.1083/jcb.201706010; Morad G, 2019, ACS NANO, V13, P13853, DOI 10.1021/acsnano.9b04397; Norrmen C, 2018, J NEUROSCI, V38, P4811, DOI 10.1523/JNEUROSCI.3619-17.2018; Norrmen C, 2014, CELL REP, V9, P646, DOI 10.1016/j.celrep.2014.09.001; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Plikus MV, 2021, CELL, V184, P3852, DOI 10.1016/j.cell.2021.06.024; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Salzer JL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020529; Sawade L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16696-6; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Sharpe LJ, 2020, J BIOL CHEM, V295, P17549, DOI 10.1074/jbc.REV120.010723; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; Song H, 2019, NANO LETT, V19, P3040, DOI 10.1021/acs.nanolett.9b00287; Su T, 2019, ACS NANO, V13, P2450, DOI 10.1021/acsnano.8b09375; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; THOMAS PK, 1963, J ANAT, V97, P35; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Neerven SGA, 2013, NEUROSCIENCE, V252, P144, DOI 10.1016/j.neuroscience.2013.08.009; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; WOOD JG, 1976, J NEUROCYTOL, V5, P605, DOI 10.1007/BF01175573; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yi JM, 2020, P NATL ACAD SCI USA, V117, P31189, DOI 10.1073/pnas.2017152117; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang RR, 2021, GLIA, V69, P765, DOI 10.1002/glia.23928; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282; Zhang YZ, 2021, J CELL PHYSIOL, V236, P1345, DOI 10.1002/jcp.29942; Zhang ZH, 2016, GLIA, V64, P374, DOI 10.1002/glia.22934; Zhao YH, 2017, BIOMATERIALS, V134, P64, DOI 10.1016/j.biomaterials.2017.02.026; Zhou XJ, 2020, ACS NANO, V14, P12732, DOI 10.1021/acsnano.0c03064; Zhou X, 2021, ELIFE, V10, DOI 10.7554/eLife.60467	78	1	1	7	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101718	10.1016/j.jbc.2022.101718	http://dx.doi.org/10.1016/j.jbc.2022.101718			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151688	Green Published, gold			2022-12-26	WOS:000789394500009
J	Aljandal, S; Doyle, SM; Bera, G; Wade, TL; Knap, AH; Sylvan, JB				Aljandal, Shahd; Doyle, Shawn M.; Bera, Gopal; Wade, Terry L.; Knap, Anthony H.; Sylvan, Jason B.			Mesopelagic microbial community dynamics in response to increasing oil and Corexit 9500 concentrations	PLOS ONE			English	Article							CRUDE-OIL; BIODEGRADATION; DEGRADATION; DISPERSANT; BIOREMEDIATION; ALKANES; HYDROCARBONS; TEMPERATURE; MACONDO; SPILLS	Marine microbial communities play an important role in biodegradation of subsurface plumes of oil that form after oil is accidentally released from a seafloor wellhead. The response of these mesopelagic microbial communities to the application of chemical dispersants following oil spills remains a debated topic. While there is evidence that contrasting results in some previous work may be due to differences in dosage between studies, the impacts of these differences on mesopelagic microbial community composition remains unconstrained. To answer this open question, we exposed a mesopelagic microbial community from the Gulf of Mexico to oil alone, three concentrations of oil dispersed with Corexit 9500, and three concentrations of Corexit 9500 alone over long periods of time. We analyzed changes in hydrocarbon chemistry, cell abundance, and microbial community composition at zero, three and six weeks. The lowest concentration of dispersed oil yielded hydrocarbon concentrations lower than oil alone and microbial community composition more similar to control seawater than any other treatments with oil or dispersant. Higher concentrations of dispersed oil resulted in higher concentrations of microbe-oil microaggregates and similar microbial composition to the oil alone treatment. The genus Colweffia was more abundant when exposed to multiple concentrations of dispersed oil, but not when exposed to dispersant alone. Conversely, the most abundant Marinobacteramplicon sequence variant (ASV) was not influenced by dispersant when oil was present and showed an inverse relationship to the summed abundance of A/canivorax ASVs. As a whole, the data presented here show that the concentration of oil strongly impacts microbial community response, more so than the presence of dispersant, confirming the importance of the concentrations of both oil and dispersant in considering the design and interpretation of results for oil spill simulation experiments.	[Aljandal, Shahd; Doyle, Shawn M.; Wade, Terry L.; Knap, Anthony H.; Sylvan, Jason B.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Bera, Gopal; Wade, Terry L.; Knap, Anthony H.] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sylvan, JB (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	jasonsylvan@tamu.edu		Doyle, Shawn/0000-0001-9818-0115; Sylvan, Jason/0000-0001-7361-7472	American Petroleum Institute, Oil Spill Emergency Preparedness and Response Subcommittee	American Petroleum Institute, Oil Spill Emergency Preparedness and Response Subcommittee	Funding for this work was provided by the American Petroleum Institute, Oil Spill Emergency Preparedness and Response Subcommittee. We thank API's Science and Technology Work Group for their comments on the draft. The decision to incorporate such comments in the manuscript was at the discretion of the authors. The views expressed herein belong solely to the authors and may not represent the views of API or its members. Members of the Technical Advisory Committee (TAC) provided input, review and comment on the approach, assumptions and data inputs as the study progressed.	Atlas R, 2009, MICROB BIOTECHNOL, V2, P213, DOI 10.1111/j.1751-7915.2008.00079.x; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Bera G, 2018, ENVIRON TOXICOL CHEM, V37, P2810, DOI 10.1002/etc.4263; Brakstad OG, 2015, MAR POLLUT BULL, V93, P144, DOI 10.1016/j.marpolbul.2015.02.006; Brakstad Odd Gunnar, 2008, P389, DOI 10.1007/978-3-540-74335-4_23; Bruheim P, 1999, APPL ENVIRON MICROB, V65, P1658; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chakraborty R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00357; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Doyle SM, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00668-20; Doyle SM., 2018, FRONT MICROBIOL; FOGHT JM, 1982, CAN J MICROBIOL, V28, P117, DOI 10.1139/m82-012; Fuentes S, 2014, APPL MICROBIOL BIOT, V98, P4781, DOI 10.1007/s00253-014-5684-9; Hamdan LJ, 2011, AQUAT MICROB ECOL, V63, P101, DOI 10.3354/ame01482; Hassanshahian M, 2010, SOIL SEDIMENT CONTAM, V19, P277, DOI 10.1080/15320381003695215; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hu P, 2017, P NATL ACAD SCI USA, V114, P7432, DOI 10.1073/pnas.1703424114; Kleindienst S, 2016, ISME J, V10, P400, DOI 10.1038/ismej.2015.121; Kleindienst S, 2015, P NATL ACAD SCI USA, V112, P14900, DOI 10.1073/pnas.1507380112; Ko SH, 1999, J APPL MICROBIOL, V87, P72, DOI 10.1046/j.1365-2672.1999.00797.x; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Macias-Zamora JV, 2014, ENVIRON MONIT ASSESS, V186, P1051, DOI 10.1007/s10661-013-3438-2; Mason OU, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00332; McFarlin KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084297; McGenity Terry J, 2012, Aquat Biosyst, V8, P10, DOI 10.1186/2046-9063-8-10; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Morales-McDevitt ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228554; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Overton EB, 2016, OCEANOGRAPHY, V29, P50, DOI 10.5670/oceanog.2016.62; Perry JJ., 1984, PETROLEUM MICROBIOLO, P61; Prince RC, 2017, ENVIRON SCI TECHNOL, V51, P1278, DOI 10.1021/acs.est.6b03207; Prince RC, 2013, CHEMOSPHERE, V90, P521, DOI 10.1016/j.chemosphere.2012.08.020; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi DW, 2020, MAR POLLUT BULL, V151, DOI 10.1016/j.marpolbul.2019.110804; Singer E, 2011, APPL ENVIRON MICROB, V77, P2763, DOI 10.1128/AEM.01866-10; Smith J.E., 1968, TORREY CANYON POLLUT; Stewart FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037118; Syutsubo K, 2001, ENVIRON MICROBIOL, V3, P371, DOI 10.1046/j.1462-2920.2001.00204.x; Techtmann SM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03462-16; United States. Coast Guard & National Response Team (US), 2011, SCENE COORDINATOR RE; Valentine DL, 2012, P NATL ACAD SCI USA, V109, P20286, DOI 10.1073/pnas.1108820109; Wade TL, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00419; WALKER JD, 1976, CAN J MICROBIOL, V22, P1209, DOI 10.1139/m76-179; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARD DM, 1980, AMBIO, V9, P277; Yoshida A, 2006, MAR POLLUT BULL, V52, P89, DOI 10.1016/j.marpolbul.2005.08.015; Zahed MA, 2010, B ENVIRON CONTAM TOX, V84, P438, DOI 10.1007/s00128-010-9954-7	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0263420	10.1371/journal.pone.0263420	http://dx.doi.org/10.1371/journal.pone.0263420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196352	Green Published, gold			2022-12-26	WOS:000835161600012
J	Klakattawi, HS				Klakattawi, Hadeel S.			Survival analysis of cancer patients using a new extended Weibull distribution	PLOS ONE			English	Article							INVERTED EXPONENTIAL-DISTRIBUTION; KUMARASWAMY; FAMILY; REGRESSION; MODEL	One of the most important applications of statistical analysis is in health research and applications. Cancer studies are mostly required special statistical considerations in order to find the appropriate model for fitting the survival data. Existing classical distributions rarely fit such data well and an increasing interest has been shown recently in developing more flexible distributions by introducing some additional parameters to the basic model. In this paper, a new five-parameters distribution referred as alpha power Kumaraswamy Weibull distribution is introduced and studied. Particularly, this distribution extends the Weibull distribution based on a novel technique that combines two well known generalisation methods, namely, alpha power and T-X transformations. Different characteristics of the proposed distribution, including moments, quantiles, Renyi entropy and order statistics are obtained. The method of maximum likelihood is applied in order to estimate the model parameters based on complete and censored data. The performance of these estimators are examined via conducting some simulation studies. The potential importance and applicability of the proposed distribution is illustrated empirically by means of six datasets that describe the survival of some cancer patients. The results of the analysis indicated to the promising performance of the alpha power Kumaraswamy Weibull distribution in practice comparing to some other competing distributions.	[Klakattawi, Hadeel S.] King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia	King Abdulaziz University	Klakattawi, HS (corresponding author), King Abdulaziz Univ, Dept Stat, Fac Sci, Jeddah, Saudi Arabia.	hklakattawi@kau.edu.sa		Klakattawi, Hadeel S./0000-0001-6617-2081				Al-Dayian G., 2014, INT J STAT PROBABILI, V3, P80, DOI [10.5539/ijsp.v3n3p80, DOI 10.5539/IJSP.V3N3P80]; Al-Saiary ZA, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22101144; Ali M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245253; Baharith LA, 2021, SYMMETRY-BASEL, V13, DOI 10.3390/sym13040726; Basheer AM, 2019, J TAIBAH UNIV SCI, V13, P423, DOI 10.1080/16583655.2019.1588488; Cordeiro GM, 2012, STAT METHOD APPL-GER, V21, P139, DOI 10.1007/s10260-011-0183-y; Cordeiro GM, 2011, J STAT COMPUT SIM, V81, P883, DOI 10.1080/00949650903530745; Cordeiro GM, 2010, J FRANKLIN I, V347, P1399, DOI 10.1016/j.jfranklin.2010.06.010; Cordeiro GM., 2013, J DATA SCI, V11, P777, DOI 10.6339/JDS.2013.11(1).1086; Dey S, 2019, ANN DATA SCI, V6, P623, DOI [10.1007/s40745-018-0163-2, DOI 10.1007/S40745-018-0163-2]; Dey S., 2017, ANN DATA SCI, V4, P31, DOI [10.1007/s40745-016-0094-8, DOI 10.1007/S40745-016-0094-8]; Dey S, 2019, J COMPUT APPL MATH, V348, P130, DOI 10.1016/j.cam.2018.03.037; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Eissa FH, 2017, INT J STAT PROBABILI, V6, P167, DOI [10.5539/ijsp.v6n6p167, DOI 10.5539/IJSP.V6N6P167]; EL-Helbawy AA, 2016, PAK J STAT OPER RES, V12, P407, DOI 10.18187/pjsor.v12i3.1171; Erdogan N., 2021, J MATH MODELING, P1; Eugene N, 2002, COMMUN STAT-THEOR M, V31, P497, DOI 10.1081/STA-120003130; Fachini-Gomes JB, 2018, COMMUN STAT APPL MET, V25, P523, DOI 10.29220/CSAM.2018.25.5.523; George R, 2019, COMMUN STAT-THEOR M, V48, P1920, DOI 10.1080/03610926.2018.1440594; Ghitany ME, 2005, J APPL STAT, V32, P1025, DOI 10.1080/02664760500165008; Gomes AE, 2014, J STAT COMPUT SIM, V84, P290, DOI 10.1080/00949655.2012.706813; Gupta RC, 1998, COMMUN STAT-THEOR M, V27, P887, DOI 10.1080/03610929808832134; Hamdeni T, 2022, COMMUN STAT-SIMUL C, V51, P6511, DOI 10.1080/03610918.2020.1804937; Hassan A.S., 2018, J NONLINEAR SCI APP, V12, P239, DOI [10.22436/jnsa.012.04.05, DOI 10.22436/JNSA.012.04.05]; Hassan AS, 2019, J PROBAB STAT, V2019, DOI 10.1155/2019/8024769; Hibatullah R., 2018, JURNAL RISET DAN APL, V2, P84, DOI [10.26740/jram.v2n2.p84-92, DOI 10.26740/JRAM.V2N2.P84-92]; Ian R.C. Buckley, 2009, Arxiv, DOI arXiv:0901.0434; Ibrahim NA., 2018, JURNAL KARYA ASLI LO, V11, P015; Ijaz M, 2021, J APPL STAT, V48, pI, DOI 10.1080/02664763.2020.1870673; Ishaq AI., 2020, ANN DATA SCI, V7, P639, DOI [10.1007/s40745-020-00288-8, DOI 10.1007/S40745-020-00288-8]; Khan MS, 2020, J STAT THEORY APPL, V19, P487, DOI 10.2991/jsta.d.201016.003; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; Mahdavi A, 2017, COMMUN STAT-THEOR M, V46, P6543, DOI 10.1080/03610926.2015.1130839; Mahmoud MR, 2015, PAK J STAT OPER RES, V11, P159; Mahmoud MR, 2016, PAK J STAT OPER RES, V12, P165; Mandouh R, 2016, INT J CONT MATH SCI, V11, P119, DOI [10.12988/ijcms.2016.51162, DOI 10.12988/IJCMS.2016.51162]; Mansour M., 2020, J NONLINEAR SCI APP, V13, P223, DOI [10.22436/jnsa.013.05.01, DOI 10.22436/JNSA.013.05.01]; Mansour M. M., 2020, CONTRIBUTIONS MATH, V1, P57; Marshall AW, 1997, BIOMETRIKA, V84, P641, DOI 10.1093/biomet/84.3.641; MUDHOLKAR GS, 1993, IEEE T RELIAB, V42, P299, DOI 10.1109/24.229504; Nassar M, 2017, COMMUN STAT-THEOR M, V46, P10236, DOI 10.1080/03610926.2016.1231816; Nassar M., 2018, ANN DATA SCI, V5, P421, DOI [10.1007/s40745-018-0144-5, DOI 10.1007/S40745-018-0144-5]; Nassar MM, 2016, PAK J STAT OPER RES, V12, P609, DOI 10.18187/pjsor.v12i4.1485; Olumolade O, 2005, J STAT THEORY APPL, V4, P121; Paranaiba PF, 2013, J STAT COMPUT SIM, V83, P2117, DOI 10.1080/00949655.2012.683003; Ramadan DA., 2018, INT J COMPUTER APPL, V975, P8887; Saulo H, 2012, J STAT THEORY PRACT, V6, P745, DOI 10.1080/15598608.2012.719814; Silva Ronaldo, 2019, Rev.Colomb.Estad., V42, P1, DOI 10.15446/rce.v42n1.66205; Sule I., 2020, J BIOSTATISTICS EPID, V6, P37; Tahir MH, 2021, AUST J STAT, V50, P1, DOI 10.17713/ajs.v50i5.96; Unal C, 2018, GAZI U J SCI, V31, P954; Usman R.M., 2017, J STAT APPL PROBAB, V6, P597, DOI 10.18576/jsap/060315; Vila R, 2022, J APPL STAT, V49, P3044, DOI 10.1080/02664763.2021.1931822; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; ZeinEldin RA, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/1860813	55	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2022	17	2							e0264229	10.1371/journal.pone.0264229	http://dx.doi.org/10.1371/journal.pone.0264229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3M0QE	35196331	Green Published, gold			2022-12-26	WOS:000835161600030
J	Meyer, S; Cignacco, E; Monteverde, S; Trachsel, M; Raio, L; Oelhafen, S				Meyer, Stephanie; Cignacco, Eva; Monteverde, Settimio; Trachsel, Manuel; Raio, Luigi; Oelhafen, Stephan			'We felt like part of a production system': A qualitative study on women's experiences of mistreatment during childbirth in Switzerland	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SHARED DECISION-MAKING; RESPECTFUL CARE; PREVALENCE; PERCEPTIONS; PRESSURES; SERVICES; LEVERAGE; BIRTH	Introduction Mistreatment during childbirth is an issue of global magnitude that not only violates fundamental human rights but also seriously impacts women's well-being. The purpose of this study was to gain a better understanding of the phenomenon by exploring the individual experiences of women who reported mistreatment during childbirth in Switzerland. Materials and methods This project used a mixed methods approach to investigate women's experiences of mistreatment during childbirth in general and informal coercion specifically: The present qualitative study expands on the findings from a nationwide online survey on childbirth experience. It combines inductive with theoretical thematic analysis to study the 7,753 comments women wrote in the survey and the subsequent interviews with 11 women who reported being mistreated during childbirth. Results The women described a wide range of experiences of mistreatment during childbirth in both the survey comments and the interviews. Out of all survey participants who wrote at least one comment (n = 3,547), 28% described one or more experiences of mistreatment. Six of the seven types of mistreatment listed in Bohren and colleagues' typology of mistreatment during childbirth were found, the most frequent of which were ineffective communication and lack of informed consent. Five additional themes were identified in the interviews: Informal coercion, risk factors for mistreatment, consequences of mistreatment, examples of good care, and what's needed to improve maternity care. Conclusion The findings from this study show that experiences of mistreatment are a reality in Swiss maternity care and give insight into women's individual experiences as well as how these affect them during and after childbirth. This study emphasises the need to respect women's autonomy in order to prevent mistreatment and empower women to actively participate in decisions. Both individual and systemic efforts are required to prevent mistreatment and guarantee respectful, dignified, and high-quality maternity care for all.	[Meyer, Stephanie; Cignacco, Eva; Oelhafen, Stephan] Bern Univ Appl Sci, Dept Hlth Profess, Appl Res Dev Midwifery, Bern, Switzerland; [Monteverde, Settimio; Trachsel, Manuel] Univ Zurich, Inst Biomed Ethics & Hist Med, Zurich, Switzerland; [Monteverde, Settimio] Bern Univ Appl Sci, Sch Nursing, Dept Hlth Profess, Bern, Switzerland; [Trachsel, Manuel] Univ Hosp Basel & Psychiat Univ Clin Basel, Clin Ethics Unit, Basel, Switzerland; [Raio, Luigi] Univ Hosp Bern, Dept Obstet & Gynaecol, Bern, Switzerland	University of Zurich; University of Bern; University Hospital of Bern	Oelhafen, S (corresponding author), Bern Univ Appl Sci, Dept Hlth Profess, Appl Res Dev Midwifery, Bern, Switzerland.	stephan.oelhafen@bfh.ch	Monteverde, Settimio/AAA-8661-2021	Monteverde, Settimio/0000-0002-7041-2663; Oelhafen, Stephan/0000-0002-4238-6728	Kathe-Zingg-Schwichtenberg-Fund of the Swiss Academy of Medical Sciences (SAMS) [KZS 13/18]; Lindenhof Foundation Bern Research Teaching Fund [19-05-F]	Kathe-Zingg-Schwichtenberg-Fund of the Swiss Academy of Medical Sciences (SAMS); Lindenhof Foundation Bern Research Teaching Fund	SO received funding from the Kathe-Zingg-Schwichtenberg-Fund of the Swiss Academy of Medical Sciences (SAMS, https://www.samw.ch/en/Funding/Kaethe-Zingg-SchwichtenbergFund.html) (grant number KZS 13/18) and from the Lindenhof Foundation Bern Research & Teaching Fund (https://www.stiftunglindenhof.ch/de/foerderung/fonds-lehre-und-forschung/) (grant number 19-05-F). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123606; Alcorn KL, 2010, PSYCHOL MED, V40, P1849, DOI 10.1017/S0033291709992224; ATLAS.ti Scientific Software Development GmbH, 2002, US; Ayers Susan, 2006, Psychol Health Med, V11, P389, DOI 10.1080/13548500600708409; Ayers S, 2007, BIRTH-ISS PERINAT C, V34, P253, DOI 10.1111/j.1523-536X.2007.00178.x; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bastos MH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007194.pub2; Baxter JD, 2014, MIDWIFERY, V30, P194, DOI 10.1016/j.midw.2013.12.013; Beatty JR, 2014, DRUG ALCOHOL DEPEN, V134, P280, DOI 10.1016/j.drugalcdep.2013.10.016; Beck CT, 2018, JOGNN-J OBST GYN NEO, V47, P94, DOI 10.1016/j.jogn.2016.08.015; Begley K, 2019, J EVAL CLIN PRACT, V25, P1113, DOI 10.1111/jep.13243; Blue Jeans Network Inc, 2009, US; Bohren MA, 2020, BEST PRACT RES CL OB, V67, P113, DOI 10.1016/j.bpobgyn.2020.02.005; Bohren MA, 2019, LANCET, V394, P1750, DOI 10.1016/S0140-6736(19)31992-0; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bowser D, 2010, EXPLORING EVIDENCE D; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Byrne V, 2017, MIDWIFERY, V51, P1, DOI 10.1016/j.midw.2017.04.017; Canvin K, 2013, INT J LAW PSYCHIAT, V36, P100, DOI 10.1016/j.ijlp.2013.01.002; Cook N, 2018, J AFFECT DISORDERS, V225, P18, DOI 10.1016/j.jad.2017.07.045; Czarnocka J, 2000, BRIT J CLIN PSYCHOL, V39, P35, DOI 10.1348/014466500163095; Davis Dana-Ain, 2020, Reprod Biomed Soc Online, V11, P56, DOI 10.1016/j.rbms.2020.10.001; de Graaff LF, 2018, ACTA OBSTET GYN SCAN, V97, P648, DOI 10.1111/aogs.13291; Dekel S, 2020, ARCH WOMEN MENT HLTH, V23, P557, DOI 10.1007/s00737-019-01006-x; Dekel S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00560; Dey A, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0409-z; Downe Soo, 2018, Reprod Health, V15, P23, DOI 10.1186/s12978-018-0466-y; dr. dresing & pehl GmbH, US; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Grekin R, 2014, CLIN PSYCHOL REV, V34, P389, DOI 10.1016/j.cpr.2014.05.003; Harris R, 2012, PSYCHOL HEALTH, V27, P1166, DOI 10.1080/08870446.2011.649755; Helfferich C., 2011, QUALIT T QUALITATIVE, V4th; Hollander MH, 2017, ARCH WOMEN MENT HLTH, V20, P515, DOI 10.1007/s00737-017-0729-6; Khosla R, 2016, HEALTH HUM RIGHTS, V18, P131; Kruk ME, 2018, HEALTH POLICY PLANN, V33, pE26, DOI 10.1093/heapol/czu079; Megregian M, 2018, J MIDWIFERY WOM HEAL, V63, P340, DOI 10.1111/jmwh.12747; Mena-Tudela D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217726; Oelhafen S, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-03826-1; Qualtrics, 2005, US; Ravaldi C, 2018, EUR J OBSTET GYN R B, V224, P208, DOI 10.1016/j.ejogrb.2018.03.055; Reed R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1197-0; Shakibazadeh E, 2018, BJOG-INT J OBSTET GY, V125, P932, DOI 10.1111/1471-0528.15015; Simonovic D, 2019, HUMAN RIGHTS BASED A; Swiss Academy of Medical Sciences (SAMS), 2017, MED ETH GUID COERC M; Szmukler G, 2008, J MENT HEALTH, V17, P233, DOI 10.1080/09638230802052203; United Nations General Assembly, 1993, DECL EL VIOL WOM; United Nations General Assembly, 1976, INT COVENANT EC SOCI; van der Pijl MSG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233114; Vedam S, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0729-2; Vogel JP, 2016, BJOG-INT J OBSTET GY, V123, P671, DOI 10.1111/1471-0528.13750; What Women Want Campaign, 2019, WHAT WOM WANT DEM QU; White Ribbon Alliance, 2011, RESPECTFUL MATERNITY; Wijma K, 1997, J ANXIETY DISORD, V11, P587, DOI 10.1016/S0887-6185(97)00041-8; Williams CR, 2018, BJOG-INT J OBSTET GY, V125, P1208, DOI 10.1111/1471-0528.15270; World Health Organization, WHO REC INTR CAR POS; World Health Organization, 2015, WHO STAT PREV EL DIS; Zapf A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0200-9	57	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264119	10.1371/journal.pone.0264119	http://dx.doi.org/10.1371/journal.pone.0264119			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180269	gold, Green Published			2022-12-26	WOS:000796435800046
J	Zemp, M; Friedrich, AS; Holzmeier, L; Seebacher, S; Rossler, M; Nater, UM				Zemp, Martina; Friedrich, Amos-Silvio; Holzmeier, Lorena; Seebacher, Simone; Rossler, Maggie; Nater, Urs M.			Effects of clown visits on stress and mood in children and adolescents in psychiatric care-Protocol for a pilot study	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; PREOPERATIVE ANXIETY; PSYCHOMETRIC PROPERTIES; INTERVENTION; HUMOR; STRENGTHS; PEDIATRICS; PARENTS; MODEL; KINDL	Scientific evidence has shown that healthcare clowning can decrease the level of stress and anxiety in pediatric patients. However, little attention has been devoted to the potentially beneficial impact of clown visits in the child and adolescent psychiatry setting. Therefore, this pilot study aims at investigating short-term effects of clown visits by RED NOSES Clowndoctors Austria on stress and mood levels of children and adolescents in psychiatric care. The sample will consist of approximately 50 children and adolescents in inpatient psychiatric wards who receive clown visits on a weekly basis over four consecutive weeks. The examined intervention, i.e., the clown visits, is an integral part within the selected psychiatric institutions. Using a non-controlled pre-/post-test design, the level of salivary cortisol and self-reported stress and mood will be measured as primary outcomes before and immediately after each clown visit. Additionally, self-reported effects on care staff at the health care facilities will be assessed based on a questionnaire after each clown visit within the same time period of four weeks. Secondary outcome measures (i.e., health-related quality of life, emotional and conduct problems, perceived chronic stress) will be assessed at baseline and at close-out assessment after the four intervention weeks. Further control variables and potential moderators are included at baseline. Due to the nested data structure, multilevel modeling will be used to analyze the data. To our knowledge, this is the first study to examine the stress-reducing and mood-improving effects of clown visits on inpatients in child and adolescent psychiatry. Results will be relevant for the design of future large-scale RCTs and might provide valuable implications for the use of healthcare clowning to reduce stress and improve mood in children and adolescents in psychiatric care. The study is registered at ClinicalTrials.gov (Identifier: NCT04844398).	[Zemp, Martina; Friedrich, Amos-Silvio; Holzmeier, Lorena; Nater, Urs M.] Univ Vienna, Dept Clin & Hlth Psychol, Vienna, Austria; [Zemp, Martina; Nater, Urs M.] Univ Vienna, Res Platform Stress Life Processes & Mech Underly, Vienna, Austria; [Seebacher, Simone] RED NOSES Clowndoctors, Dept Res & Learning, Vienna, Austria; [Rossler, Maggie] RED NOSES Int, Dept Res & Learning, Vienna, Austria	University of Vienna; University of Vienna	Zemp, M (corresponding author), Univ Vienna, Dept Clin & Hlth Psychol, Vienna, Austria.	martina.zemp@univie.ac.at		Nater, Urs/0000-0002-2430-5090; Friedrich, Amos-Silvio/0000-0003-1970-4668	RED NOSES Clowndoctors Austria; IBL International GmbH, a Tecan Group Company	RED NOSES Clowndoctors Austria; IBL International GmbH, a Tecan Group Company	RED NOSES Clowndoctors Austria provided financial support including travel expenses for the examiners and research materials (i.e., Salicaps collection devices). The IBL International GmbH, a Tecan Group Company, sponsored the test kits for the saliva analyses. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Mohammad I., 2011, Middle East Journal of Anesthesiology, V21, P153; Auerbach S., 2016, TRANSL ISSUES PSYCHO, V2, P14, DOI [10.1037/tps0000055, DOI 10.1037/TPS0000055]; Barkmann C, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-166; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P17, DOI 10.1007/s00787-004-2004-4; Ben-Pazi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blain S., 2012, ARTS HEALTH, V4, P26, DOI [10.1080/17533015.2011.561359, DOI 10.1080/17533015.2011.561359]; Bullinger M, 2008, EUR CHILD ADOLES PSY, V17, P125, DOI 10.1007/s00787-008-1014-z; Chammas F, 2021, ANN MED-PSYCHOL, V179, P487, DOI 10.1016/j.amp.2020.11.003; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Delvecchio E, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00250; Dionigi A, 2014, J HEALTH PSYCHOL, V19, P369, DOI 10.1177/1359105312471567; Eschenbeck H, 2006, DIAGNOSTICA, V52, P131, DOI 10.1026/0012-1924.52.3.131; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandes SC, 2010, J HEALTH PSYCHOL, V15, P405, DOI 10.1177/1359105309350231; GELKOPF M, 1994, J SOC PSYCHOL, V134, P175, DOI 10.1080/00224545.1994.9711380; Ghaffari Fatemeh, 2015, Med J Islam Repub Iran, V29, P182; Goldberg A, 2014, ALLERGY, V69, P1372, DOI 10.1111/all.12463; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gruber A, 2015, ISR J PSYCHIATR REL, V52, P20; Higueras A, 2006, INT J CLIN HLTH PSYC, V6, P53; Johnson DR, 2011, J MARRIAGE FAM, V73, P926, DOI 10.1111/j.1741-3737.2011.00861.x; Kain ZN, 1996, ARCH PEDIAT ADOL MED, V150, P1238, DOI 10.1001/archpedi.1996.02170370016002; Kim K-H., 1999, KOREAN J REHABIL NUR, V2, P95; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Koller D, 2008, EVID-BASED COMPL ALT, V5, P17, DOI 10.1093/ecam/nem033; Lohaus A., 2006, FRAGEBOGEN ERHEBUNG; Lohbeck A, 2015, DIAGNOSTICA, V61, P222, DOI 10.1026/0012-1924/a000153; Lopes LC, 2020, CANCER NURS, V43, P290, DOI 10.1097/NCC.0000000000000690; Markova G, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.653884; Masetti M, 2019, J HEALTH PSYCHOL, V24, P166, DOI 10.1177/1359105316650274; McCann ME, 2001, ANESTH ANALG, V93, P98; Price J, 2016, J PEDIATR PSYCHOL, V41, P86, DOI 10.1093/jpepsy/jsv074; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; RED NOSES CLOWNDOCTORS International, RED NOSES; Rei ALDP, 2012, J NERV MENT DIS, V200, P88, DOI 10.1097/NMD.0b013e31823fafb9; Rennick JE, 2009, J CHILD HEALTH CARE, V13, P128, DOI 10.1177/1367493509102472; Rimon A., 2016, MEDICAL CLOWNS CORTI, V18, P680; Leguizamon CR, 2017, BRIT J ANAESTH, V119, P847, DOI 10.1093/bja/aex278; Ruckgaber C., 2016, HUMOR PSYCHIAT PSYCH, P290; Saliba FG, 2016, PEDIATRIC REP, V8, P12, DOI 10.4081/pr.2016.6188; Sanchez Julio C, 2017, Hosp Pediatr, V7, P46, DOI 10.1542/hpeds.2016-0128; Smerling AJ., 1999, ANESTH ANALG, V88, p306S, DOI [10.1097/00000539-199902001-00303, DOI 10.1097/00000539-199902001-00303]; Sridharan K, 2016, EUR J PEDIATR, V175, P1353, DOI 10.1007/s00431-016-2764-0; Steyer, 1997, MEHRDIMENSIONALE BEF; Steyer R., 1994, DIAGNOSTICA, V40, P320; Thoma MV, 2015, INT J BEHAV MED, V22, P498, DOI 10.1007/s12529-014-9439-x; Tiedeman M E, 1990, J Pediatr Nurs, V5, P334; Vagnoli L, 2005, PEDIATRICS, V116, pE563, DOI 10.1542/peds.2005-0466; Viggiano MP, 2015, PEDIATRIC REP, V7, DOI 10.4081/pr.2015.5682; Vilaythong AP, 2003, HUMOR, V16, P79, DOI 10.1515/humr.2003.006; Wild B, 2007, NERVENARZT, V78, P571, DOI 10.1007/s00115-006-2076-0; Wilson ME, 2010, J PEDIATR HEALTH CAR, V24, P95, DOI 10.1016/j.pedhc.2009.02.008; Woerner W, 2002, Z KINDER JUG-PSYCH, V30, P105, DOI 10.1024//1422-4917.30.2.105; Wolyniez I, 2013, CLIN PEDIATR, V52, P1168, DOI 10.1177/0009922813502257; Zhang QH, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00415; Zhang YF, 2017, J PAEDIATR CHILD H, V53, P237, DOI 10.1111/jpc.13369	59	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264012	10.1371/journal.pone.0264012	http://dx.doi.org/10.1371/journal.pone.0264012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180260	gold, Green Published			2022-12-26	WOS:000796435800042
J	Tshering, K; Dema, K				Tshering, Kezang; Dema, Kezang			Psychological impact during COVID-19 pandemic: A web-based cross-sectional study among students studying at College of Science and Technology (CST), Phuentsholing, Bhutan	PLOS ONE			English	Article							DEPRESSION; PREVALENCE; ANXIETY; PHQ-9; INTERVENTIONS; EPIDEMIC; VALIDITY	The unprecedented experience of national lockdowns and uncertainty of academic career due to the COVID-19 pandemic has multifaceted impacts on mental health among university students worldwide. This study determined its impact on depression and anxiety level, and associated risk factors among engineering students studying at College of Science and Technology (CST), Phuentsholing, Bhutan during the first lockdown in the country. Self-reported depression and anxiety levels were assessed using Patient Health Questionnaire ( PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) respectively. Data was collected using an e-questionnaire link generated in Google form and the link was shared with students via the student's official email group. A total of 278 students (response rate, 26.9%) completed the questionnaire. The majority of respondents were male (69.8%) and were aged from 18 to 30 (Mean: 21.7 +/- SD 2.07) years. The prevalence of self- reported moderate to severe depression and anxiety were 44.2% (95% CI, 38.5-49.6) and 27.3% (95% CI, 22.3-32.4) respectively. Participants having their family members as frontline workers reported a significantly higher level of anxiety (.2 = 4.85, p = 0.028). In multivariable logistic regression analysis, students who were academically lagging showed a higher risk of depression (AOR = 5.36, 95% CI = 2.86-10.04) and anxiety (AOR = 3.83, 95%CI = 1.86-7.88) as compared to students who were not academically behind. A high percentage of depression and anxiety was reported by students of CST during the COVID-19 pandemic. Findings from the study highlight the importance of adopting appropriate online-based teaching and learning methods to ensure timely academic and professional achievements. Moreover, the relevant stakeholders should put health system strategies in place to provide psychological support to university students during the COVID-19 pandemic.	[Tshering, Kezang] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Pharm, Thimphu, Bhutan; [Dema, Kezang] Coll Sci & Technol, Dept Informat Technol, Phuentsholing, Bhutan		Tshering, K (corresponding author), Jigme Dorji Wangchuck Natl Referral Hosp, Dept Pharm, Thimphu, Bhutan.	kezangtshe07@gmail.com		tshering, kezang/0000-0001-9619-3625				Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chi XL, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00803; Dill E, CHRON HIGHER EDUC; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Ghazawy ER, 2021, HEALTH PROMOT INT, V36, P1116, DOI 10.1093/heapro/daaa147; Hasannia E, 2021, ASIAN J SOC HEAL BEH, V4, P163, DOI 10.4103/shb.shb_68_21; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai AYK, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.584240; LeVine S, 2020, AM J TROP MED HYG, V102, P1205, DOI 10.4269/ajtmh.20-0259; Lu MY, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.705657; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1036; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Meo SA, 2020, EUR REV MED PHARMACO, V24, P2012, DOI 10.26355/eurrev_202002_20379; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Olashore AA, 2021, ASIAN J SOC HEAL BEH, V4, P85, DOI 10.4103/shb.shb_32_21; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Qin ZG, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35487; Radwan E, 2021, BMC PSYCHOL, V9, DOI 10.1186/s40359-021-00688-2; Royal Government of Bhutan, 2020, NAT PREP RESP PLAN O; Salman M, 2020, PSYCHOL IMPACT COVID, DOI [10.1101/2020.05.21.20108647, DOI 10.1101/2020.05.21.20108647]; Simbulan N., 2020, HIGHER ED SE ASIA, V8, P15; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sun SF, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00663-x; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034; Wathelet M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25591; Xiao CF, 2020, PSYCHIAT INVEST, V17, P175, DOI 10.30773/pi.2020.0047; Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1	35	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263999	10.1371/journal.pone.0263999	http://dx.doi.org/10.1371/journal.pone.0263999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0F6ZJ	35176080	Green Published, gold			2022-12-26	WOS:000777505200060
J	van der Meulen, MP; Toes-Zoutendijk, E; Spaander, MCW; Dekker, E; Bonfrer, JMG; van Vuuren, AJ; Kuipers, EJ; van Kemenade, FJ; van Velthuysen, MF; Thomeer, MGJ; van Veldhuizen, H; de Koning, HJ; Lansdorp-Vogelaar, I; van Leerdam, ME				van der Meulen, Miriam P.; Toes-Zoutendijk, Esther; Spaander, Manon C. W.; Dekker, Evelien; Bonfrer, Johannes M. G.; van Vuuren, Anneke J.; Kuipers, Ernst J.; van Kemenade, Folkert J.; van Velthuysen, M. F.; Thomeer, Maarten G. J.; van Veldhuizen, Harriet; de Koning, Harry J.; Lansdorp-Vogelaar, Iris; van Leerdam, Monique E.			Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing	PLOS ONE			English	Article							OCCULT BLOOD-TEST; BREAST	Background CRC mortality rates are higher for individuals with a lower socioeconomic status (SES). Screening could influence health inequalities. We therefore aimed to investigate SES differences in participation and diagnostic yield of FIT screening. Methods All invitees in 2014 and 2015 in the Dutch national CRC screening programme were included in the analyses. We used area SES as a measure for SES and divided invitees into quintiles, with Quintile 1 being the highest SES. Logistic regression analysis was used to compare the participation rate, positivity rate, colonoscopy uptake, positive predictive value (PPV) and detection rate across the SES groups. Results Participation to FIT screening was significantly lower for Quintile 5 (67.0%) compared to the other Quintiles (73.0% to 75.1%; adjusted OR quintile 5 versus quintile 1: 0.73, 95%CI: 0.72-0.74), as well as colonoscopy uptake after a positive FIT (adjusted OR 0.73, 95%CI: 0.69-0.77). The detection rate per FIT participant for advanced neoplasia gradually increased from 3.3% in Quintile 1 to 4.0% in Quintile 5 (adjusted OR 1.20%, 95%CI 1.16-1.24). As a result of lower participation, the yield per invitee was similar for Quintile 5 (2.04%) and Quintile 1 (2.00%), both being lower than Quintiles 2 to 4 (2.20%-2.28%). Conclusions Screening has the potential to reduce health inequalities in CRC mortality, because of a higher detection in participants with a lower SES. However, in the Dutch screening programme, this is currently offset by the lower participation in this group.	[van der Meulen, Miriam P.; Toes-Zoutendijk, Esther; de Koning, Harry J.; Lansdorp-Vogelaar, Iris] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Spaander, Manon C. W.; Kuipers, Ernst J.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Dekker, Evelien] Acad Univ Med Ctr, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Bonfrer, Johannes M. G.] Netherlands Canc Inst, Dept Clin Chem, Antoni Van Leeuwenhoek Hosp, Amsterdam, Netherlands; [van Vuuren, Anneke J.; van Kemenade, Folkert J.; van Velthuysen, M. F.] Erasmus MC Univ Med Ctr, Dept Pathol, Rotterdam, Netherlands; [Thomeer, Maarten G. J.] Erasmus MC Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands; [van Veldhuizen, Harriet] Erasmus MC Univ Med Ctr, Dept Qual Improvement, Rotterdam, Netherlands; [van Leerdam, Monique E.] Netherlands Canc Inst, Dept Gastroenterol & Hepatol, Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute	Toes-Zoutendijk, E (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	e.toes-zoutendijk@erasmusmc.nl		Kuipers, Ernst J./0000-0002-0633-3098	National Institute of Public Health and Environment (Rijksinstituut voor Volksgezondheid en Milieu (RIVM))	National Institute of Public Health and Environment (Rijksinstituut voor Volksgezondheid en Milieu (RIVM))	This analysis was performed as part of the national monitoring and evaluation of the Dutch colorectal cancer screening programme, funded by the National Institute of Public Health and Environment (Rijksinstituut voor Volksgezondheid en Milieu (RIVM)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts MJ, 2011, BREAST CANCER RES TR, V128, P517, DOI 10.1007/s10549-011-1363-z; Aarts MJ, 2010, EUR J CANCER, V46, P2681, DOI 10.1016/j.ejca.2010.04.026; Brenner H, 2010, JAMA-J AM MED ASSOC, V304, P2513, DOI 10.1001/jama.2010.1773; de Klerk CM, 2018, GUT, V67, P679, DOI 10.1136/gutjnl-2016-313311; Decker KM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009470; Deutekom M, 2009, EUR J PUBLIC HEALTH, V19, P400, DOI 10.1093/eurpub/ckp051; Eurostat, REV EUR STAND POP 20; Gupta S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju032; Javanparast S, 2010, PREV MED, V50, P165, DOI 10.1016/j.ypmed.2010.02.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Hurtado JL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2370-5; Mansouri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066063; Moss S, 2012, ENDOSCOPY, V44, pSE49, DOI 10.1055/s-0032-1309788; Pornet C, 2010, J EPIDEMIOL COMMUN H, V64, P318, DOI 10.1136/jech.2008.081117; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Research TNIfS, STAT; Sasaki K, 2001, HEPATO-GASTROENTEROL, V48, P445; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Statistics Netherlands, STATL; Toes-Zoutendijk E, 2018, GUT, V67, P1745, DOI 10.1136/gutjnl-2017-315111; Toes-Zoutendijk E, 2017, GASTROENTEROLOGY, V152, P767, DOI 10.1053/j.gastro.2016.11.022; van Dam L, 2013, EUR J CANCER, V49, P2321, DOI 10.1016/j.ejca.2013.03.007; von Wagner C, 2009, BRIT J CANCER, V101, pS60, DOI 10.1038/sj.bjc.6605392; Wardle J, 2016, LANCET, V387, P751, DOI 10.1016/S0140-6736(15)01154-X; Wee LE, 2012, PREV MED, V55, P61, DOI 10.1016/j.ypmed.2012.04.011	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264067	10.1371/journal.pone.0264067	http://dx.doi.org/10.1371/journal.pone.0264067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176116	gold, Green Published			2022-12-26	WOS:000777505200074
J	Chen, M; Liu, CF; Dai, MZ; Wang, QW; Li, CQ; Hung, WL				Chen, Meng; Liu, Chinfeng; Dai, Mingzhu; Wang, Qinwen; Li, Chunqi; Hung, Weilian			Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in zebrafish models	PLOS ONE			English	Article							GASTROINTESTINAL MICROBIOTA; IMMUNE-RESPONSE; ACID BACTERIA; PROBIOTICS; AQUACULTURE; TOXICITY; MOTILITY; TRANSIT; SHRIMP; DRUGS	This study was designed to explore the therapeutics and the mechanisms of a patented and marked gastric acid and intestine juice-resistant probiotics Bifidobacterium lactis BL-99 (B. lactis BL-99) on the intestinal inflammation and functions in the zebrafish models. After feeding for 6 hours, B. lactis BL-99 was fully retained in the larval zebrafish intestinal tract and stayed for over 24 hours. B. lactis BL-99 promoted the intestinal motility and effectively alleviated aluminum sulfate-induced larval zebrafish constipation (p < 0.01). Irregular high glucose diet induced adult zebrafish intestinal functional and metabolic disorders. After fed with B. lactis BL-99, IL-1 beta gene expression was significantly down-regulated, and IL-10 and IL-12 gene levels were markedly up-regulated in this model (p < 0.05). The intestinal lipase activity was elevated in the adult zebrafish intestinal functional disorder model after B. lactis BL-99 treatment (p < 0.05), but tryptase content had no statistical changes (p > 0.05). B. lactis BL-99 improved the histopathology of the adult zebrafish intestinal inflammation, increased the goblet cell numbers, and up-and-down metabolites were markedly recovered after treatment of B. lactis BL-99 (p < 0.05). These results suggest that B. lactis BL-99 could relieve intestinal inflammation and promote intestinal functions, at least in part, through modulating intestinal and microbial metabolism to maintain intestinal health.	[Chen, Meng; Liu, Chinfeng; Hung, Weilian] Inner Mongolia Dairy Technol Res Inst Co Ltd, Hohhot, Peoples R China; [Chen, Meng; Liu, Chinfeng; Hung, Weilian] Inner Mongolia Yili Ind Grp Co Ltd, Yili Innovat Ctr, Hohhot, Peoples R China; [Dai, Mingzhu; Wang, Qinwen; Li, Chunqi] Hunter Biotechnol Inc, F1A, Hangzhou, Peoples R China	Inner Mongolia Yili Industrial Group Co Ltd	Hung, WL (corresponding author), Inner Mongolia Dairy Technol Res Inst Co Ltd, Hohhot, Peoples R China.; Hung, WL (corresponding author), Inner Mongolia Yili Ind Grp Co Ltd, Yili Innovat Ctr, Hohhot, Peoples R China.	hongweilian@yili.com						Amoah K, 2019, FISH SHELLFISH IMMUN, V87, P796, DOI 10.1016/j.fsi.2019.02.029; Araujo C, 2016, DIS AQUAT ORGAN, V119, P129, DOI 10.3354/dao02992; Azad MAK, 2019, AQUAC RES, V50, P644, DOI 10.1111/are.13942; Balcazar JL, 2008, AQUACULTURE, V278, P188, DOI 10.1016/j.aquaculture.2008.03.014; Basili D, 2020, MICROB ECOL, V79, P933, DOI 10.1007/s00248-019-01468-7; Bentzon-Tilia M, 2016, MICROB BIOTECHNOL, V9, P576, DOI 10.1111/1751-7915.12392; Butt UD, 2021, FISH SHELLFISH IMMUN, V114, P263, DOI 10.1016/j.fsi.2021.05.003; Chen JB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04841; Chen LG, 2020, ENVIRON SCI TECHNOL, V54, P7494, DOI 10.1021/acs.est.0c02345; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Corazziari E, 2004, BEST PRACT RES CL GA, V18, P613, DOI 10.1016/j.bpg.2004.04.012; de los Reyes-Gavilan CG, 2011, RES MICROBIOL, V162, P514, DOI 10.1016/j.resmic.2011.03.009; Dimidi E, 2017, ADV NUTR, V8, P484, DOI 10.3945/an.116.014407; Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761; El-Saadony MT, 2021, FISH SHELLFISH IMMUN, V117, P36, DOI 10.1016/j.fsi.2021.07.007; Filippone RT, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13391; Hai NV, 2015, J APPL MICROBIOL, V119, P917, DOI 10.1111/jam.12886; Han SY, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.609722; Hernandez-Chirlaque C, 2016, J CROHNS COLITIS, V10, P1324, DOI 10.1093/ecco-jcc/jjw096; Hoffmann DE, 2014, FOOD DRUG LAW J, V69, P237; Hung WL., 2020, Patent No. [CN1109646557A, 1109646557]; Hung WL., 2020, Patent No. [CN110964655A, 110964655]; Kazama JJ, 2009, BONE, V45, pS8, DOI 10.1016/j.bone.2009.01.005; Khan S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay6218; Lee CY, 2015, J ANIM PHYSIOL AN N, V99, P317, DOI 10.1111/jpn.12247; Li QQ, 2010, J SCI FOOD AGR, V90, P1340, DOI 10.1002/jsfa.3942; Li ZQ, 2019, FISH PHYSIOL BIOCHEM, V45, P1393, DOI 10.1007/s10695-019-00635-4; Liu MY, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114832; Lu HY, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.686541; Lu YY, 2019, FOOD FUNCT, V10, P7416, DOI [10.1039/c9fo02129a, 10.1039/C9FO02129A]; Lu YY, 2019, FOOD FUNCT, V10, P2075, DOI [10.1039/c8fo02523a, 10.1039/C8FO02523A]; Balcazar JL, 2007, BRIT J NUTR, V97, P522, DOI 10.1017/S0007114507432986; Merrifield DL, 2010, AQUACULTURE, V302, P1, DOI 10.1016/j.aquaculture.2010.02.007; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Nayak SK, 2021, REV AQUACULT, V13, P862, DOI 10.1111/raq.12503; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Quines CB, 2017, FOOD CHEM TOXICOL, V107, P122, DOI 10.1016/j.fct.2017.06.038; Rich A, 2009, NEUROGASTROENT MOTIL, V21, P225, DOI 10.1111/j.1365-2982.2008.01251.x; Ringo E., 2009, AQUAC RES, DOI [10.1111/j.1365-2109.2009.02434.x, DOI 10.1111/J.1365-2109.2009.02434.X]; Ringo Einar, 2020, Aquaculture and Fisheries, V5, P1, DOI 10.1016/j.aaf.2019.12.001; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Shen B, 2015, J APPL TOXICOL, V35, P1473, DOI 10.1002/jat.3134; Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Venkat HK, 2004, AQUAC RES, V35, P501, DOI 10.1111/j.1365-2109.2004.01045.x; Vieco-Saiz N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00057; Wang N, 2017, INT J ANTIMICROB AG, V50, P572, DOI 10.1016/j.ijantimicag.2017.04.007; Wang N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06595-0; Wang T, 2020, ZEBRAFISH, V17, P382, DOI 10.1089/zeb.2020.1877; [王之怡 Wang Zhiyi], 2020, [生物学杂志, Journal of Biology], V37, P76; Yue YC, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5281639; Zhao W., 2020, CHINA DAIRY IND, V18, P4; Zhou J, 2014, NEUROGASTROENT MOTIL, V26, P589, DOI 10.1111/nmo.12306; Zhou J, 2015, J PHARMACOL TOX MET, V72, P47, DOI 10.1016/j.vascn.2014.12.002; Zhu XY, 2020, EUR J PHARMACOL, V889, DOI 10.1016/j.ejphar.2020.173292; Zhu XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40866-2; Zhu XY, 2016, ZEBRAFISH, V13, P335, DOI 10.1089/zeb.2016.1263	57	2	2	23	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0262942	10.1371/journal.pone.0262942	http://dx.doi.org/10.1371/journal.pone.0262942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171916	gold, Green Published			2022-12-26	WOS:000795889700009
J	Li, M; Trencher, G; Asuka, J				Li, Mei; Trencher, Gregory; Asuka, Jusen			The clean energy claims of BP, Chevron, ExxonMobil and Shell: A mismatch between discourse, actions and investments	PLOS ONE			English	Article							FOSSIL-FUEL; CLIMATE-CHANGE; GAS COMPANIES; OIL; POLICY; TRANSITION; PRODUCERS	The energy products of oil and gas majors have contributed significantly to global greenhouse gas emissions (GHG) and planetary warming over the past century. Decarbonizing the global economy by mid-century to avoid dangerous climate change thus cannot occur without a profound transformation of their fossil fuel-based business models. Recently, several majors are increasingly discussing clean energy and climate change, pledging decarbonization strategies, and investing in alternative energies. Some even claim to be transforming into clean energy companies. Given a history of obstructive climate actions and "greenwashing", there is a need to objectively evaluate current and historical decarbonization efforts and investment behavior. This study focuses on two American (Chevron, ExxonMobil) and two European majors (BP, Shell). Using data collected over 2009-2020, we comparatively examine the extent of decarbonization and clean energy transition activity from three perspectives: (1) keyword use in annual reports (discourse); (2) business strategies (pledges and actions); and (3) production, expenditures and earnings for fossil fuels along with investments in clean energy (investments). We found a strong increase in discourse related to "climate", "low-carbon" and "transition", especially by BP and Shell. Similarly, we observed increasing tendencies toward strategies related to decarbonization and clean energy. But these are dominated by pledges rather than concrete actions. Moreover, the financial analysis reveals a continuing business model dependence on fossil fuels along with insignificant and opaque spending on clean energy. We thus conclude that the transition to clean energy business models is not occurring, since the magnitude of investments and actions does not match discourse. Until actions and investment behavior are brought into alignment with discourse, accusations of greenwashing appear well-founded.	[Li, Mei] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi, Japan; [Trencher, Gregory] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Asuka, Jusen] Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi, Japan	Tohoku University; Kyoto University; Tohoku University	Trencher, G (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	trencher.gregory.2s@kyoto-u.ac.jp	Trencher, Gregory/H-3302-2016	Trencher, Gregory/0000-0001-8130-9146; , Mei/0000-0002-1940-0464	Kakenhi funds [19H04333]; Japan Society for the Promotion of Science	Kakenhi funds; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Kakenhi funds (grant number 19H04333) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminjonov F, 2020, SOC SCI QUART, V101, P2398, DOI 10.1111/ssqu.12909; Ayling J, 2017, CLIM POLICY, V17, P131, DOI 10.1080/14693062.2015.1094729; Bach M, 2019, ENVIRON POLIT, V28, P87, DOI 10.1080/09644016.2019.1521911; Bashir MF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242412; BBC, BBC; Beck C., 2021, BIG CHOICES OIL GAS; Blondeel M, 2018, CLIMATIC CHANGE, V150, P89, DOI 10.1007/s10584-017-2135-5; Bousso R., 2021, SPECIAL REPORT BP GA; BP, 2012, BP SUST REV 2011; BP, 2011, BP SUST REV 2010; BP, 2012, BP ANN REP FORM 20 F; BP, ANN REP FORM 20F 201; BP, 2021, ANN REP FORM 20F 202; BP, SUST REP; BP, 2019, SUST REP; BP, 2018, SUSTAINABILITY REPOR; Breetz H, 2018, BUS POLIT, V20, P492, DOI 10.1017/bap.2018.14; Brulle RJ, 2020, CLIMATIC CHANGE, V159, P87, DOI 10.1007/s10584-019-02582-8; Butler D., 2021, WASH POST; Carbon Tracker Initiative, 2020, HEDGE ELEPHANT RWES; Carbon Tracker Initiative, 2019, BREAK HAB WHY NON LA; Carley S, 2020, NAT ENERGY, V5, P569, DOI 10.1038/s41560-020-0641-6; CBO, 2021, C BUDGET OFFICE PUBL, V57019; CDP, 2020, CDP CLIM CHANG 2019; Chevron, 2020, 2019 ANN REP; Chevron, 2017, CHEVR 2016 CORP RESP; Chevron, UPD CLIM CHANG RES; Chevron, 2021, CHEVR ANN REP 2020; Choquet PL, 2019, ANTHROPOCENE REV, V6, P243, DOI 10.1177/2053019619865925; Christophers B., BIG OIL CO ARE DRIVE; Christophers B, 2022, NEW POLIT ECON, V27, P146, DOI 10.1080/13563467.2021.1926957; Coffin M., 2020, ABSOLUTE IMPACT WHY; de Jong MDT, 2020, J BUS TECH COMMUN, V34, P38, DOI 10.1177/1050651919874105; Dietz S, 2021, SCIENCE, V374, P405, DOI 10.1126/science.abh0687; Edwardes-Evans H., 2020, E SLAWINSKI CROSS CU; Erickson P, 2018, NAT CLIM CHANGE, V8, P1037, DOI 10.1038/s41558-018-0337-0; ExxonMobil, 2021, UPD 2021 EN CARB SUM; ExxonMobil, EN CARB MAN RISKS; ExxonMobil, 2018, 2017 SUST REP HIGHL; ExxonMobil, 2016, 2015 FIN OP REV; ExxonMobil, 2021, 2021 EN CARB SUMM; ExxonMobil, 2012, 2011 SUMM ANN REP; ExxonMobil, EXXONMOBIL 2009 CIT; Farulla GA, 2021, ENERGIES, V14, DOI 10.3390/en14185676; Fattouh Bassam, 2019, Energy Transitions, V3, P45, DOI 10.1007/s41825-019-00013-x; Fogarassy C., 2018, ADMIN MANAGE, V31, P52, DOI 10.24818/amp/2018.31-04; Fouquet R, 2016, ENERGY RES SOC SCI, V22, P7, DOI 10.1016/j.erss.2016.08.014; Frumhoff PC, 2015, CLIMATIC CHANGE, V132, P157, DOI 10.1007/s10584-015-1472-5; Gandel S., EXXON MOBIL DROPPED; Gatti L, 2021, J BUS RES, V127, P228, DOI 10.1016/j.jbusres.2021.01.028; Gaulin N, 2020, CLIM POLICY, V20, P888, DOI 10.1080/14693062.2020.1725409; Grant A., DIVERGING OIL GAS CO; Grasso M, 2020, ENERGY RES SOC SCI, V62, DOI 10.1016/j.erss.2019.101383; Grasso M, 2019, ENERGY RES SOC SCI, V50, P106, DOI 10.1016/j.erss.2018.11.017; Green F, 2018, CLIMATIC CHANGE, V150, P103, DOI 10.1007/s10584-017-2134-6; Green J, 2022, REV INT POLIT ECON, V29, P2036, DOI 10.1080/09692290.2021.1946708; Grumbach JM, 2015, BUS POLIT, V17, P633, DOI 10.1515/bap-2015-0012; Hansen GH, 2015, ENVIRON INNOV SOC TR, V17, P1, DOI 10.1016/j.eist.2015.05.001; Heede R, 2014, CLIMATIC CHANGE, V122, P229, DOI 10.1007/s10584-013-0986-y; Hertwich EG, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae19a; House Committee on Oversight and Reform, 2021, OV COMM LAUNCH INV F; IEA, 2021, NET ZER 2050; IEA, 2020, ACH NET ZER EM 2050; IEA, 2022, OIL GAS IND ENERGY T, DOI 10.1787/aef89fbd-en; IEA, ENERGY TECHNOLOGY PE; Intergovernmental panel on climate change, 2018, IPCC SPECIAL REPORT; Jaworska S, 2018, INT J BUS COMMUN, V55, P194, DOI 10.1177/2329488417753951; Johnsson F, 2020, RENEW SUST ENERG REV, V131, DOI 10.1016/j.rser.2020.110029; Johnston RJ., ENERGY HE ROLE OIL G; Kenner D, 2021, ENERGY RES SOC SCI, V79, DOI 10.1016/j.erss.2021.102049; Krane J, 2017, MRS ENERGY SUSTAIN, V4, DOI 10.1557/mre.2017.3; Kulagin Vyatcheslav A., 2020, [Russian Journal of Economics, Russian Journal of Economics], V6, P424, DOI 10.32609/j.ruje.6.55177; Lamb WF, 2020, GLOB SUSTAIN, V3, DOI 10.1017/sus.2020.13; Lamb WF, 2020, ENERGY RES SOC SCI, V64, DOI 10.1016/j.erss.2020.101429; Le Billon P, 2020, ENVIRON PLANN A, V52, P1072, DOI 10.1177/0308518X18816702; Lenzen M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235654; Leskovec J, 2014, MINING OF MASSIVE DATASETS, 2ND EDITION, P1; Lieberman MB, 2017, STRATEGIC MANAGE J, V38, P526, DOI 10.1002/smj.2501; Lu HF, 2019, SCI TOTAL ENVIRON, V686, P1202, DOI 10.1016/j.scitotenv.2019.06.014; Makitie T, 2019, ENERG POLICY, V127, P269, DOI 10.1016/j.enpol.2018.12.015; Maloney C., 2021, OVERSIGHT COMMITTEE; Map Influence, 2021, CLIM CHANG DIG ADV; Map Influence, BIG TECH CLIM POL AR; Map Influence, BIG OILS REAL AG CLI; Marcell, 2018, CYCLE WHICH OIL GAS; McGreal C., EXXONMOBIL LOBBYISTS; Meckling J, 2019, ENERG POLICY, V126, P470, DOI 10.1016/j.enpol.2018.11.031; Mulvey K., 2017, CLIMATE ACCOUNTABILI; Naimoli S., 2019, OIL GAS IND ENGAGEME; Newell P., 2020, FOSSIL FUEL NONPROLI, V20, P1043, DOI [10.1080/14693062.2019.1636759, DOI 10.1080/14693062.2019.1636759]; OGCI, 2021, OGCI PROGR REP 2020; Pickl MJ, 2019, ENERGY STRATEG REV, V26, DOI 10.1016/j.esr.2019.100370; Piggot G, 2020, CLIM POLICY, V20, P881, DOI 10.1080/14693062.2020.1804315; Pinko N., 2020, UNION CONCERNED SCIE; Pinko N., 2019, 2018 CLIMATE ACCOUNT; Rowlands IH, 2000, ENVIRON PLANN C, V18, P339, DOI 10.1068/c9752; Saeverud IA, 2007, GLOBAL ENVIRON POLIT, V7, P42, DOI 10.1162/glep.2007.7.3.42; Scanlan SJ, 2017, LOCAL ENVIRON, V22, P1311, DOI 10.1080/13549839.2017.1345877; Schmuck D, 2018, J ADVERTISING, V47, P127, DOI 10.1080/00913367.2018.1452652; Shaw F., 2021, J INSURANCE FINANCIA, V4, P16; Sheehan Kim., 2018, INTELLECTUAL PROPERT, P301; Shell, 2016 SHELL ANN REP F; Shell, 2021, SHELL ANN REP 2020; Shell, SUSTAINABILITY REPOR; Shell, 2017, SHELL ANN REPORT; Shell, 2010, ANN REP 20 F; Shell, 2021, SHELL EN TRANS STRAT; Shell, 2010, ANN REP 2009; Shell, 2019, SHELL ANN REPORT; Shell, SHELL EN TRANS REP; Shell, 2018, SHELL ANN REPORT; Shojaeddini Ensieh, 2019, Progress in Energy, V1, DOI 10.1088/2516-1083/ab2503; Skjaerseth JB., 2003, COMMON PROBLEM DIFFE; Solnit R., 2021, THE GUARDIAN 0823; Stockman L., BURNING GAS BRIDGE F; Supran G, 2021, ONE EARTH, V4, P696, DOI 10.1016/j.oneear.2021.04.014; Supran G, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa815f; SUPREME COURT OF THE STATE OF NEW YORK, 2021, BLOOMBERG LAW 0712; Tindall D., 2021, CLIMATE CHANGE DENIA; Tong D., BIG OIL REALITY CHEC; Tong D, 2019, NATURE, V572, P373, DOI 10.1038/s41586-019-1364-3; van D., 2016, J BUS ETHICS, V133, P567, DOI [10.1007/s10551-014-2400-8, DOI 10.1007/S10551-014-2400-8]; van der Ploeg F., 2020, MACROFINANCIAL IMPLI; van der Ploeg F, 2016, OXFORD REV ECON POL, V32, P206, DOI 10.1093/oxrep/grw004; Volcovici V., 2020, MINNESOTA SUES EXXON; Vormedal I, 2020, GLOBAL ENVIRON POLIT, V20, P143, DOI 10.1162/glep_a_00565; Walsh D., 2021, NPR; World Benchmarking Alliance, WBA CLIM EN BENCHM M; World Economic Forum, FOST EFF EN TRANS 20; Zhang MM, 2019, APPL ENERG, V240, P1049, DOI 10.1016/j.apenergy.2019.01.205	130	12	12	33	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263596	10.1371/journal.pone.0263596	http://dx.doi.org/10.1371/journal.pone.0263596			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171938	Green Published, gold			2022-12-26	WOS:000795889700029
J	Limpuangthip, N; Komin, O; Tatiyapongpaiboon, T				Limpuangthip, Nareudee; Komin, Orapin; Tatiyapongpaiboon, Teerawut			A simplified method for evaluating swallowing ability and estimating malnutrition risk: A pilot study in older adults	PLOS ONE			English	Article							TONGUE PRESSURE; OBJECTIVE MEASURES; DYSPHAGIA; SARCOPENIA; STRENGTH	Objectives The aim of this pilot study was to develop a Thai-version of a simple swallowing questionnaire, called the T-SSQ, and to evaluate the association between malnutrition risk and swallowing ability, determined objectively by tongue strength and subjectively by the T-SSQ. Sensitivity analysis was also performed to determine which swallowing indices better estimate malnutrition in older adults. Methods This cross-sectional study comprised two phases: Phase I, development and cross-cultural translation of the T-SSQ; and Phase II, application of the T-SSQ in 60 older adults. In Phase I, content and face validity of the T-SSQ was evaluated by 10 experts and 15 older adults. In Phase II, the convergent validity of the T-SSQ was evaluated by determining its association with objective tongue strength. Nutritional status was evaluated using the Thai-version of the Mini-Nutritional Assessment. Covariates included sociodemographic characteristics, and oral and health-related status. Adjusting for covariates, the associations between the two swallowing indices and malnutrition risk were determined using multivariable regression analyses. A cut-off value for low tongue strength was determined using a receiver operating characteristic (ROC) curve, and sensitivity analysis between the swallowing indices and malnutrition risk was performed. Results The T-SSQ comprised 4-items of common signs and symptoms of a swallowing problem. Its content and face validity were verified. Older adults were considered as having a swallowing problem when at least one item was reported. Convergent validity of the subjective index was shown by significantly different tongue strength values between the participants with and without a swallowing problem (p for independent t-test = 0.014). Based on the highest area under the ROC curve, an 18-kPa cut-off value was chosen to classify low tongue strength. Having a swallowing problem and low tongue strength was significantly associated with malnutrition risk. The positive predictive value of the subjective swallowing index was 1.8-fold higher than objective tongue strength. Conclusions Self-reported swallowing problems determined by the T-SSQ can be used as a subjective index for evaluating swallowing ability in older adults. Subjective swallowing problems and objective tongue strength were associated with malnutrition risk. However, the T-SSQ estimated malnutrition risk better than the objective index.	[Limpuangthip, Nareudee; Komin, Orapin] Chulalongkorn Univ, Fac Dent, Dept Prosthodont, Bangkok, Thailand; [Tatiyapongpaiboon, Teerawut] Thungyai Hosp, Nakhon Si Thammarat, Thailand	Chulalongkorn University	Komin, O (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Prosthodont, Bangkok, Thailand.	Orapin.geriatric@gmail.com	Limpuangthip, Nareudee/GOV-6639-2022	Komin, Orapin/0000-0001-6831-9382; Limpuangthip, Nareudee/0000-0001-9347-1132	Chulalongkorn University [CU_GR_63_11_32_04]	Chulalongkorn University(Chulalongkorn University)	Yes. This research is funded by Chulalongkorn University, Grant number CU_GR_63_11_32_04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HDB STANDARD OPERATI; Chatindiara I, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0771-x; Clark HM, 2003, AM J SPEECH-LANG PAT, V12, P40, DOI 10.1044/1058-0360(2003/051); Hansen T, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01384-2; Hara K, 2019, J ORAL REHABIL, V46, P134, DOI 10.1111/joor.12737; Hara K, 2014, ARCH PHYS MED REHAB, V95, P867, DOI 10.1016/j.apmr.2013.09.005; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Higa C, 2020, J DENT SCI, V15, P265, DOI 10.1016/j.jds.2020.05.027; Jensen B, 2019, APPL PHYSIOL NUTR ME, V44, P619, DOI 10.1139/apnm-2018-0276; Kikutani T, 2009, ODONTOLOGY, V97, P38, DOI 10.1007/s10266-008-0094-z; Kletzien H, 2019, EXP GERONTOL, V118, P45, DOI 10.1016/j.exger.2019.01.006; Lim SHB, 2001, DYSPHAGIA, V16, P1, DOI 10.1007/s004550000038; Limpuangthip N, 2021, J PROSTHET DENT, V125, P287, DOI 10.1016/j.prosdent.2020.01.001; Machida N, 2017, GERIATR GERONTOL INT, V17, P295, DOI 10.1111/ggi.12715; Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y; Malagelada J., 2014, DYSPHAGIA GLOBAL GUI; Minakuchi S, 2018, GERODONTOLOGY, V35, P317, DOI 10.1111/ger.12347; Nakazawa Y, 2020, J PROSTHODONT RES, V64, P188, DOI 10.1016/j.jpor.2019.07.004; Namasivayam-MacDonald AM, 2017, DYSPHAGIA, V32, P785, DOI 10.1007/s00455-017-9825-z; Nawaz S, 2018, OTOLARYNG CLIN N AM, V51, P769, DOI 10.1016/j.otc.2018.03.006; Nishiwaki K, 2005, J REHABIL MED, V37, P247, DOI 10.1080/16501970510026999; Panutat S., 2017, J RACHATHANI INNOVAT, V1, P1; Rasheed S, 2013, AGEING RES REV, V12, P561, DOI 10.1016/j.arr.2012.11.003; Razak P Abdul, 2014, J Int Oral Health, V6, P110; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sura L, 2012, CLIN INTERV AGING, V7, P287, DOI 10.2147/CIA.S23404; Tanaka Y., 2015, JPN J DYSPHAGIA REHA, V19; Thai Cognitive Test Development Committee, 2002, MINI MENT STAT EX TH; Walker HK., 1990, DYSPHAGIA CLIN METHO, V3rd; WHO: World Health Organization, 2013, PROC TRANSL AD INSTR; Wilmskoetter J, 2019, DISABIL REHABIL, V41, P549, DOI 10.1080/09638288.2017.1398787	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263896	10.1371/journal.pone.0263896	http://dx.doi.org/10.1371/journal.pone.0263896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171950	Green Published, gold			2022-12-26	WOS:000795889700044
J	Lucas, A; Kumakamba, C; Saylors, K; Obel, E; Kamenga, R; Makuwa, M; Clary, C; Miningue, G; McIver, DJ; Lange, CE; Kingebeni, PM; Muyembe-Tamfum, JJ				Lucas, Ashley; Kumakamba, Charles; Saylors, Karen; Obel, Erby; Kamenga, Reggiani; Makuwa, Maria; Clary, Catherine; Miningue, Guy; McIver, David J.; Lange, Christian E.; Kingebeni, Placide Mbala; Muyembe-Tamfum, Jean J.			Risk perceptions and behaviors of actors in the wild animal value chain in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							BUSHMEAT CONSUMPTION; DISEASE RISK; PRIMATES; TRADE	In the Democratic Republic of Congo (DRC) which contains the greatest area of the second largest rainforest on Earth, people have long been connected to the forest for subsistence and livelihood from wild animals and bushmeat. This qualitative study sought to characterize the bushmeat movement-from hunting wild animals to market sale-and the roles of participants in the animal value chain, as well as their beliefs surrounding zoonotic disease and occupational risk. Actors in in eight bushmeat markets and two ports in Kinshasa, DRC completed semi-structured interviews between 2016 and 2018 in which they expressed belief in transmission of illness from domestic animals to humans, but not from wild animals to humans. Wild animals were viewed as pure and natural, in contrast to domestic animals which were considered tainted by human interference. Participants reported cutting themselves during the process of butchering yet did not consider butchering bushmeat to be a risky activity. Instead, they adopted safety practices learned over time from butchering experts and taught themselves how to butcher in a fashion that reduced the frequency of cutting. In general, butcherers rejected the idea of personal protective equipment use. Port markets were identified as important access points for meat coming from the Congo river and plane transport was identified as important for fresh and live meat coming from Equateur province. Most participants reported having heard about Ebola, but their mistrust in government messaging privileged a word-of-mouth story of witchcraft to be propagated about Ebola's origins. It is critical to better understand how public health messaging about outbreaks can successfully reach high risk communities, and to develop creative risk mitigation strategies for populations in regular contact with animal blood and body fluids. In this paper, we offer suggestions for formal and informal trusted channels through which health messages surrounding zoonotic risk could be conveyed to high-risk populations in Kinshasa.	[Lucas, Ashley; Saylors, Karen; Makuwa, Maria; Lange, Christian E.] Labyrinth Global Hlth, St Petersburg, FL 33704 USA; [Lucas, Ashley; Saylors, Karen; Obel, Erby; Kamenga, Reggiani; Makuwa, Maria; Clary, Catherine] Metabiota Inc, San Francisco, CA 94104 USA; [Kumakamba, Charles; Miningue, Guy; Kingebeni, Placide Mbala] Metabiota Inc, Kinshasa, DEM REP CONGO; [McIver, David J.; Lange, Christian E.] Metabiota Inc, Nanaimo, BC, Canada; [McIver, David J.] UCSF, San Francisco, CA USA; [Muyembe-Tamfum, Jean J.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	University of California System; University of California San Francisco; Institute Nacional de Recherche Biomedical	Lucas, A (corresponding author), Labyrinth Global Hlth, St Petersburg, FL 33704 USA.; Lucas, A (corresponding author), Metabiota Inc, San Francisco, CA 94104 USA.	alucas@labyrinthgh.com			United States Agency for International Development [AID-OAA-A-14-00102]; USAID	United States Agency for International Development(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This study was supported by the generous support of the American people through the United States Agency for International Development (cooperative agreement number AID-OAA-A-14-00102). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. AL, KS, EO, RK, MM, CC, DJM, CEL, CK, PMK, GM were associated with the commercial entities Metabiota Inc., and Labyrinth Global Health. The funder, USAID, provided support to these entities in the form of salaries for authors AL, KS, EO, RK, MM, CC, DJM, CEL, CK, PMK, GM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bedrosian SR, 2016, MMWR-MORBID MORTAL W, V65, P68, DOI 10.15585/mmwr.su6503a10; Bonwitt J, 2018, SOC SCI MED, V200, P166, DOI 10.1016/j.socscimed.2017.12.028; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Central African Regional Program for the Environment, 2001, BUSHM CRIS CAUS CONS; Chancellor RL, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22624; Cheung EYL, 2015, INTERVENTION, V13, P70, DOI 10.1097/WTF.0000000000000079; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; de Merode E, 2006, CONSERV BIOL, V20, P1262, DOI 10.1111/j.1523-1739.2006.00425.x; Dinde A.O., 2017, AGR FOOD SECUR, V6, P28, DOI [10.1186/s40066-017-0105-9, DOI 10.1186/S40066-017-0105-9]; Doty JB, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100283; Dupain J, 2012, BIOL CONSERV, V146, P32, DOI 10.1016/j.biocon.2011.11.025; Durski KN, 2018, MMWR-MORBID MORTAL W, V67, P306, DOI 10.15585/mmwr.mm6710a5; Eskew EA, 2020, LANCET PLANET HEALTH, V4, pE215, DOI 10.1016/S2542-5196(20)30123-6; Estrada A, 2018, PEERJ, V6, DOI 10.7717/peerj.4869; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab36fa; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Johnson CK, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2736; Kasereka MC, 2019, PATHOG GLOB HEALTH, V113, P149, DOI 10.1080/20477724.2019.1650227; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kilonzo C, 2013, VIRAL INFECT GLOBAL, P179, DOI [10.1002/9781118297469.ch10, DOI 10.1002/9781118297469.CH10]; Lebov J, 2017, ONE HEALTH-AMSTERDAM, V3, P44, DOI 10.1016/j.onehlt.2017.03.004; LeBreton M, 2006, ANIM CONSERV, V9, P357, DOI 10.1111/j.1469-1795.2006.00030.x; LeBreton M, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.7; Lucas A, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa295; Magouras I, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.582743; Misilu M.N.E., 2010, J SUSTAINABLE DEV, V3, P242; Munster VJ, 2018, NEW ENGL J MED, V379, P1198, DOI 10.1056/NEJMp1807691; Omidian P., 2014, MEDICAL ANTHR STUDY; Phua Kai-Lit, 2015, Infect Dis (Auckl), V8, P39, DOI 10.4137/IDRT.S31568; Rushton J., 2011, ANIMAL PRODUCTION HL; Saldana J, 2021, CODING MANUAL QUALIT; Saylors K, 2021, ONE HEALTH OUTLOOK, V3, DOI 10.1186/s42522-021-00036-9; Saylors KE, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113358; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Shultz JM, 2016, B ATOM SCI, V72, P304, DOI 10.1080/00963402.2016.1216515; Subramanian M, 2012, ECOHEALTH, V9, P471, DOI 10.1007/s10393-012-0807-1; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; United States Agency for International Development, 2019, EM PAND THREATS 2 PR; van Vliet N, 2015, ORYX, V49, P165, DOI 10.1017/S0030605313000549; van Vliet Nathalie, 2011, Human Dimensions of Wildlife, V16, P45, DOI 10.1080/10871209.2010.523924; Weyer J, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0480-y; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Wolfe ND, 2004, EMERG INFECT DIS, V10, P2094, DOI 10.3201/eid1012.040062; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2016, STAT 9 M IHR EM COMM; World Health Organization, 2018, SIT REP DECL END OUT; Yamagiwa J., 2003, Journal of Sustainable Forestry, V16, P115, DOI 10.1300/J091v16n03_06; Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0261601	10.1371/journal.pone.0261601	http://dx.doi.org/10.1371/journal.pone.0261601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171910	gold, Green Published			2022-12-26	WOS:000795889700003
J	Petrova, T; Bennett, K; Nanda, S; Strickson, S; Scudamore, CL; Prescott, AR; Cohen, P				Petrova, Tsvetana; Bennett, Kyle; Nanda, Sambit; Strickson, Sam; Scudamore, Cheryl L.; Prescott, Alan R.; Cohen, Philip			Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?	PLOS ONE			English	Article							DEFECTIVE INTERLEUKIN-1; MOLECULAR-MECHANISM; NEGATIVE REGULATOR; UBIQUITIN LIGASE; KAPPA-B; CELL; DEFICIENCY; OSTEOPETROSIS; BINDING; LEADS	The expression of TNF-Receptor Associated Factor 6 (TRAF6) is essential for many physiological processes. Here we studied the phenotype of TRAF6[L74H] knock-in mice which are devoid of TRAF6 E3 ligase activity in every cell of the body, but express normal levels of the TRAF6 protein. Remarkably, TRAF6[L74H] mice have none of the phenotypes seen in TRAF6 KO mice. Instead TRAF6[L74H] mice display an entirely different phenotype, exhibiting autoimmunity, and severe inflammation of the skin and modest inflammation of the liver and lungs. Similar to mice with a Treg-specific knockout of TRAF6, or mice devoid of TRAF6 in all T cells, the CD4(+) and CD8(+) T cells in the spleen and lymph nodes displayed an activated effector memory phenotype with CD44(high)/CD62L(low) expression on the cell surface. In contrast, T cells from WT mice exhibited the CD44(low)/CD62L(high) phenotype characteristic of naive T cells. The onset of autoimmunity and autoinflammation in TRAF6[L74H] mice (two weeks) was much faster than in mice with a Treg-specific knockout of TRAF6 or lacking TRAF6 expression in all T cells (2-3 months) and we discuss whether this may be caused by secondary inflammation of other tissues. The distinct phenotypes of mice lacking TRAF6 expression in all cells appears to be explained by their inability to signal via TNF Receptor Superfamily members, which does not seem to be impaired significantly in TRAF6[L74H] mice.	[Petrova, Tsvetana; Bennett, Kyle; Nanda, Sambit; Strickson, Sam; Cohen, Philip] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland; [Bennett, Kyle] Univ Dundee, Sch Life Sci, Div Cell Signalling, Dundee, Scotland; [Scudamore, Cheryl L.] Exepathology, Exeter, Devon, England; [Prescott, Alan R.] Univ Dundee, Sch Life Sci, Dundee Imaging Facil, Dundee, Scotland; [Prescott, Alan R.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee	Cohen, P (corresponding author), Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland.	p.cohen@dundee.ac.uk		Strickson, Sam/0000-0002-9208-2028	Wellcome Trust Investigator Award [209380/Z/17/Z]; EastBio PhD Studentship Award [BB/M010996/1]	Wellcome Trust Investigator Award(Wellcome Trust); EastBio PhD Studentship Award	The work in this study was funded by by Wellcome Trust Investigator Award 209380/Z/17/Z to P.C. and EastBio PhD Studentship Award BB/M010996/1 to K.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Bonito AJ, 2013, J CLIN INVEST, V123, P3510, DOI 10.1172/JCI65414; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hadaschik EN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0538-0; Heissmeyer V, 2013, IMMUNOL REV, V253, P273, DOI 10.1111/imr.12056; King CG, 2008, J IMMUNOL, V180, P34, DOI 10.4049/jimmunol.180.1.34; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lomaga MA, 2000, J NEUROSCI, V20, P7384; Malireddi RKS, 2020, J EXP MED, V217, DOI 10.1084/jem.20191644; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Muto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074639; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nanda SK, 2021, EMBO REP, V22, DOI 10.15252/embr.202050743; Nanda SK, 2016, J IMMUNOL, V197, P4266, DOI 10.4049/jimmunol.1600788; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Nanda SK, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900533; Sanjo H, 2019, J IMMUNOL, V203, P783, DOI 10.4049/jimmunol.1900202; Scudamore CL., 2014, PRACTICAL APPROACHED; Sharma R, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-20; Strickson S, 2017, P NATL ACAD SCI USA, V114, pE3481, DOI 10.1073/pnas.1702367114; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	38	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263151	10.1371/journal.pone.0263151	http://dx.doi.org/10.1371/journal.pone.0263151			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157702	gold, Green Published			2022-12-26	WOS:000788004500009
J	Geue, JC; Rotter, PJ; Gross, C; Benko, Z; Kovacs, I; Fantana, C; Veres-Szaszka, J; Domsa, C; Baltag, E; Daroczi, SJ; Bone, GM; Popescu, VD; Thomassen, HA				Geue, Julia C.; Rotter, Paula J.; Gross, Caspar; Benko, Zoltan; Kovacs, Istvan; Fantana, Ciprian; Veres-Szaszka, Judit; Domsa, Cristi; Baltag, Emanuel; Daroczi, Szilard J.; Bone, Gabor M.; Popescu, Viorel D.; Thomassen, Henri A.			Limited reciprocal surrogacy of bird and habitat diversity and inconsistencies in their representation in Romanian protected areas	PLOS ONE			English	Article							ENVIRONMENTAL DIVERSITY; BIODIVERSITY CONSERVATION; AGRICULTURAL LANDSCAPES; CHARISMATIC MEGAFAUNA; RESERVE SELECTION; SPECIES RICHNESS; INDICATOR GROUPS; PRIORITY AREAS; GEODIVERSITY; TAXA	Because it is impossible to comprehensively characterize biodiversity at all levels of organization, conservation prioritization efforts need to rely on surrogates. As species distribution maps of relished groups as well as high-resolution remotely sensed data increasingly become available, both types of surrogates are commonly used. A good surrogate should represent as much of biodiversity as possible, but it often remains unclear to what extent this is the case. Here, we aimed to address this question by assessing how well bird species and habitat diversity represent one another. We conducted our study in Romania, a species-rich country with high landscape heterogeneity where bird species distribution data have only recently started to become available. First, we prioritized areas for conservation based on either 137 breeding bird species or 36 habitat classes, and then evaluated their reciprocal surrogacy performance. Second, we examined how well these features are represented in already existing protected areas. Finally, we identified target regions of high conservation value for the potential expansion of the current network of reserves (as planned under the new EU Biodiversity Strategy for 2030). We found a limited reciprocal surrogacy performance, with bird species performing slightly better as a conservation surrogate for habitat diversity than vice versa. We could also show that areas with a high conservation value based on habitat diversity were represented better in already existing protected areas than areas based on bird species, which varied considerably between species. Our results highlight that taxonomic and environmental (i.e., habitat types) data may perform rather poorly as reciprocal surrogates, and multiple sources of data are required for a full evaluation of protected areas expansion.	[Geue, Julia C.; Rotter, Paula J.; Thomassen, Henri A.] Univ Tubingen, Inst Evolut & Ecol, Comparat Zool, Tubingen, Germany; [Gross, Caspar] Univ Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany; [Benko, Zoltan; Fantana, Ciprian; Veres-Szaszka, Judit; Domsa, Cristi] Romanian Ornithol Soc BirdLife Romania, Cluj Napoca, Romania; [Kovacs, Istvan; Baltag, Emanuel; Daroczi, Szilard J.; Bone, Gabor M.] Bird & Nat Protect Assoc, Milvus Grp, Targu Mures, Romania; [Baltag, Emanuel] Alexandru Ioan Cuza Univ, Marine Biol Stn Prof Dr Ioan Borcea, Iasi, Romania; [Popescu, Viorel D.] Ohio Univ, Dept Biol Sci & Sustainabil Studies Theme, Athens, OH 45701 USA; [Popescu, Viorel D.] Univ Bucharest, Ctr Environm Res, Bucharest, Romania; [Geue, Julia C.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Alexandru Ioan Cuza University; University System of Ohio; Ohio University; University of Bucharest; Umea University	Geue, JC (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Comparat Zool, Tubingen, Germany.; Geue, JC (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	Julia.geue@umu.se		Baltag, Emanuel/0000-0002-3107-0349; Gross, Caspar/0000-0002-9009-5458; Geue, Julia/0000-0002-1038-8614	MAVA Foundation [KST 10103 MAVA]; Milvus Group Association; Romanian Ornithological Society	MAVA Foundation; Milvus Group Association; Romanian Ornithological Society	This work was supported by the MAVA Foundation, project number KST 10103 MAVA. The Romanian National Breeding Bird Atlas was financed by Milvus Group Association (https://milvus.ro), the Romanian Ornithological Society and the Swiss Ornithological Institute through a grant from MAVA Foundation (KST 10103 MAVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Arponen A, 2008, J APPL ECOL, V45, P1436, DOI 10.1111/j.1365-2664.2008.01513.x; Bailey JJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P763, DOI 10.1111/geb.12574; Banko GJTP, 2018, ECOSYSTEM TYPE MAP V, V11, P2018; Beier P, 2015, CONSERV BIOL, V29, P668, DOI 10.1111/cobi.12509; Bertrand Y, 2006, SYST BIODIVERS, V4, P149, DOI 10.1017/S1477200005001908; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bonn A, 2005, BIODIVERS CONSERV, V14, P1083, DOI 10.1007/s10531-004-8410-6; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Carmel Y, 2006, ISR J ECOL EVOL, V52, P11, DOI 10.1560/IJEE.52.1.11; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; D'Amen M, 2013, ANIM CONSERV, V16, P370, DOI 10.1111/acv.12016; de Albuquerque FS, 2016, ECOL EVOL, V6, P4032, DOI 10.1002/ece3.2190; Di Minin E, 2014, J APPL ECOL, V51, P281, DOI 10.1111/1365-2664.12203; Di Minin E, 2012, BIOL CONSERV, V153, P187, DOI 10.1016/j.biocon.2012.04.015; eBird, 2018, EBIRD ONL DAT BIRD D; Engelbrecht I, 2016, BIOL CONSERV, V197, P171, DOI 10.1016/j.biocon.2016.02.028; European Commission, 2020, COM202066 EUR COMM; European Commission, 2007, NAT NEWSL, V23, P11; European Environment Agency, 2019, MAPP ASS COND EUR EC; Faith DP, 2011, ECOL INDIC, V11, P745, DOI 10.1016/j.ecolind.2010.06.019; Faith DP, 2004, J BIOGEOGR, V31, P1207, DOI 10.1111/j.1365-2699.2004.01145.x; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fntn C., 2020, ROMANIAN BREEDING BI; Franco AMA, 2009, J APPL ECOL, V46, P82, DOI 10.1111/j.1365-2664.2008.01598.x; Garson J, 2002, J BIOSCIENCES, V27, P347, DOI 10.1007/BF02704965; Gaston KJ, 2008, ANN NY ACAD SCI, V1134, P97, DOI 10.1196/annals.1439.006; Gill JL, 2015, CONSERV BIOL, V29, P640, DOI 10.1111/cobi.12504; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hortal J, 2009, ECOL INDIC, V9, P138, DOI 10.1016/j.ecolind.2008.02.005; Hunter M, 2016, ECOL INDIC, V63, P121, DOI 10.1016/j.ecolind.2015.11.049; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; Ioras F, 2003, BIODIVERS CONSERV, V12, P9, DOI 10.1023/A:1021254615841; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Juutinen A, 2004, ECOL ECON, V50, P35, DOI 10.1016/j.ecolecon.2004.02.006; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Larsen FW, 2012, J APPL ECOL, V49, P349, DOI 10.1111/j.1365-2664.2011.02094.x; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Lawler JJ, 2015, CONSERV BIOL, V29, P618, DOI 10.1111/cobi.12505; Lehtomaki J, R PACKAGE VERSION 06; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; Lund MP, 2002, ANIM CONSERV, V5, P163, DOI 10.1017/S1367943002002226; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; Manolache S., 2020, BIORXIV, DOI [10.1016/j.jenvman.2020.111152, DOI 10.1016/J.JENVMAN.2020.111152]; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Miu IV, 2018, ZOOKEYS, P133, DOI 10.3897/zookeys.792.25314; Miu IV., 2020, BIORXIV, DOI [10.7717/peerj.10067, DOI 10.7717/PEERJ.10067]; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A., 2012, SPATIAL CONSERVATION; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Niculae MI, 2017, ANN FOR RES, V60, P19, DOI 10.15287/afr.2016.793; Nita A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217638; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Oliver I, 2004, ECOL APPL, V14, P485, DOI 10.1890/02-5181; Opermanis O, 2014, ENVIRON MANAGE, V53, P702, DOI 10.1007/s00267-013-0212-8; Ornitodata, 2018, ORNITODATA; Parks KE, 2010, BIODIVERS CONSERV, V19, P2751, DOI 10.1007/s10531-010-9876-z; Pechanec V, 2018, NAT CONSERV-BULGARIA, P21, DOI 10.3897/natureconservation.24.21608; Phillips SJ., 2017, MAXENT SOFTWARE MODE; Popescu VD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64501-7; Popescu VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113648; Popescu VD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079330; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Read QD, 2020, GLOBAL ECOL BIOGEOGR, V29, P696, DOI 10.1111/geb.13061; Reyers B, 2002, AFR ZOOL, V37, P185; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rombird, 2018, ROMBIRD; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rozylowicz L, 2011, BIODIVERS CONSERV, V20, P561, DOI 10.1007/s10531-010-9967-x; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Sauberer N, 2004, BIOL CONSERV, V117, P181, DOI 10.1016/S0006-3207(03)00291-X; Schmitt T, 2007, DIVERS DISTRIB, V13, P855, DOI 10.1111/j.1472-4642.2007.00347.x; Secretary of State, 2009, 09ATE59226 DEM EUR S; Sibarani MC, 2019, J APPL ECOL, V56, P1220, DOI 10.1111/1365-2664.13360; Tozer DC, 2010, WETL ECOL MANAG, V18, P679, DOI 10.1007/s11273-010-9187-x; Trakhtenbrot A, 2006, CONSERV BIOL, V20, P1087, DOI 10.1111/j.1523-1739.2006.00500.x; Tukiainen H, 2017, CONSERV BIOL, V31, P364, DOI 10.1111/cobi.12799; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Weiss M., 2018, EUROPEAN ENV AGENCY, P79; Wiens JA, 2008, BIOSCIENCE, V58, P241, DOI 10.1641/B580310; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Zarnetske PL, 2019, GLOBAL ECOL BIOGEOGR, V28, P548, DOI 10.1111/geb.12887	94	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0251950	10.1371/journal.pone.0251950	http://dx.doi.org/10.1371/journal.pone.0251950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148309	Green Submitted, Green Published, gold			2022-12-26	WOS:000800108800001
J	Maor, Y; Caspi, S				Maor, Yasmin; Caspi, Shaked			Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population	PLOS ONE			English	Article							SEASONAL INFLUENZA; UNITED-STATES; REFUSAL; IMMUNIZATION; VACCINATION; MORTALITY; YOUNG	Background Vaccine hesitancy is increasing. We assessed attitudes toward influenza and COVID-19 vaccines and the relation between hesitancy to influenza vaccine and hesitancy towards COVID-19 vaccines. Methods A structured questionnaire administered during September 2020 to a representative sample of the Jewish Israeli population assessed attitudes and acceptance of influenza and COVID-19 vaccines. Factors for vaccine hesitancy were determined using logistic regression. Questionnaires were administered prior to the release of clinical data regarding efficacy and safety of COVID-19 vaccines and prior to vaccine rollout. Results We approached 10,625 people, of these 2,080 responded (19%), and 2,024 completed the questionnaire (97.3%), 64.9% aged 15-64 years and 35.1% aged >= 65 years. 37% had co-morbidities. 43.5% experienced financial deterioration due to the pandemic. 65.9% received influenza vaccine >= 1 time in the past. Influenza vaccination rates were higher in the elderly (81.8%). Reasons for influenza vaccine hesitancy were opinions that the vaccine is ineffective (27.1%), and fear of side effects (29.3%). 8.2% of people aged 16-64 and 13.8% of people aged >= 65 refused to be vaccinated at least once over the course of one's lifetime. Percent of responders willing to receive a COVID-19 vaccine were higher than percent of responders willing to receive the influenza vaccine both in people aged 16-64 years (942 (72.3%) vs. 38.4%, respectively) and in people 65 years and older (84.0% vs. 76.8%, respectively). Hesitancy towards COVID-19 vaccine was associated with hesitancy towards other vaccines. Only 26.8% would participate in a COVID-19 vaccine trial. Conclusions Willingness to receive COVID-19 vaccine was higher than willingness to receive influenza vaccine. The results point to areas of fear from influenza vaccines side effects and lack of knowledge regarding influenza vaccines effectiveness that can be addressed to increase acceptance. Hesitancy towards other vaccines was associated with hesitancy towards COVID-19 vaccination.	[Maor, Yasmin] Wolfson Med Ctr, Infect Dis Unit, Holon, Israel; [Maor, Yasmin] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Caspi, Shaked] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Caspi, Shaked] Tel Aviv Univ, Sch Math Sci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Maor, Y (corresponding author), Wolfson Med Ctr, Infect Dis Unit, Holon, Israel.; Maor, Y (corresponding author), Tel Aviv Univ, Fac Med, Tel Aviv, Israel.	yasminm@wmc.gov.il		Maor, Yasmin/0000-0001-7258-3434	Pfizer [62105947]	Pfizer(Pfizer)	This study was funded by Pfizer to YM (ID 62105947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez-Block MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243833; [Anonymous], CENTRAL BUREAU STAT; [Anonymous], POPULATION ISRAEL EV; Banach DB, 2012, J COMMUN HEALTH, V37, P10, DOI 10.1007/s10900-011-9409-z; Berenguer J, 2020, CLIN MICROBIOL INFEC, V26, P1525, DOI 10.1016/j.cmi.2020.07.024; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Ganaim Asmaa N., 2018, INTERNET ARAB SOC; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Glatman-Freedman A, 2019, ISR J HEALTH POLICY, V8, DOI 10.1186/s13584-019-0349-x; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Grohskopf LA, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6803a1; Henderson L, 2008, J ROY SOC MED, V101, P244, DOI 10.1258/jrsm.2008.070363; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Kilbourne ED, 2006, J INFECT DIS, V193, P7, DOI 10.1086/498984; Lee K, 2009, GLOB INST, P1; Lissitsa S, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0260-x; McNutt LA, 2016, VACCINE, V34, P1733, DOI 10.1016/j.vaccine.2015.11.063; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Ozceylan G, 2020, HUM VACC IMMUNOTHER, V16, P1034, DOI 10.1080/21645515.2020.1717182; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Roller-Wirnsberger R, 2021, AGING CLIN EXP RES, V33, P2123, DOI 10.1007/s40520-021-01793-3; Rozbroj T, 2019, PATIENT EDUC COUNS, V102, P172, DOI 10.1016/j.pec.2018.08.027; Sherman SM, 2021, HUM VACC IMMUNOTHER, V17, P1612, DOI 10.1080/21645515.2020.1846397; Society in Israel, 2018, 10 SOC ISR; Sondagar Chandni, 2020, Can Commun Dis Rep, V46, P155, DOI 10.14745/ccdr.v46i05a09; Southern J, 2015, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-015-0193-8; Stein-Zamir C, 2019, EUROSURVEILLANCE, V24, P30, DOI 10.2807/1560-7917.ES.2019.24.1800004; Taylor S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.575950; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van der Plas JL, 2021, BRIT J CLIN PHARMACO, V87, P2167, DOI 10.1111/bcp.14435; Verger P, 2021, VACCINE, V39, P4481, DOI 10.1016/j.vaccine.2021.06.053; Wake AD, 2021, RISK MANAG HEALTHC P, V14, P2609, DOI 10.2147/RMHP.S311074; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0255495	10.1371/journal.pone.0255495	http://dx.doi.org/10.1371/journal.pone.0255495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148322	gold, Green Published			2022-12-26	WOS:000800108800002
J	Han, L; Lin, X; Yan, Q; Gu, CC; Li, MS; Pan, L; Meng, Y; Zhao, XM; Liu, SD; Li, AM				Han, Lu; Lin, Xin; Yan, Qun; Gu, Chuncai; Li, Mengshu; Pan, Lei; Meng, Yan; Zhao, Xinmei; Liu, Side; Li, Aimin			PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; SORAFENIB; PROTEIN; VEGF; EXPRESSION; MIGRATION; PATHWAY; DISEASE; GROWTH	Sustained anti-angiogenesis therapy increases the level of tumor hypoxia, leading to increased expression of HIF-1a, thereby contributing to the resistance to anti-angiogenesis therapy in hepatocellular carcinoma (HCC). Here, we report that phenazine biosynthesis-like domain-containing protein (PBLD) inhibits hypoxia-induced angiogenesis via ERK/HIF-1a/VEGF axis in HCC cells. Bioinformatic analysis of the TCGA database and clinical samples validation also identify a negative correlation between PBLD and angiogenesis-related genes expression including HIF-1a. Apart from the downregulation of HIF-1a/VEGF expression in HCC cells, PBLD also blocks VEGF receptor 2 (VEGFR2) on endothelial cells via HCC-derived exosomal miR-940. PBLD also activates TCF4 transcriptional promotion effects on miR-940 by directly interacting with it. Together, PBLD exerts an inhibitory effect on angiogenesis not only via blocking the VEGFR2 expression in endothelial cells, but also through downregulating HIF-1a-induced VEGF expression and secretion in HCC cells. These explorations may provide a theoretical basis for exploring new targets and strategies to overcome resistance to anti-angiogenesis therapy.	[Han, Lu; Lin, Xin; Yan, Qun; Gu, Chuncai; Li, Mengshu; Pan, Lei; Meng, Yan; Zhao, Xinmei; Liu, Side; Li, Aimin] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [Han, Lu] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Gastroenterol, Guangzhou 510120, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou University of Chinese Medicine	Zhao, XM; Liu, SD; Li, AM (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China.	xmzhao914@163.com; liuside2011@163.com; lam0725@163.com	Meng, Yan/HGC-0394-2022	zhao, Xinmei/0000-0003-3940-788X	National Natural Science Foundation of China [81402028, 82072758, 12026605]; Guangdong Science and Technology Project [2017A020215046]; Guangdong Gastrointestinal Disease Research Center [2017B020209003, 2017B030314037]; Major National Science and Technology Special Fund Projects [2020ZX09201017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Project; Guangdong Gastrointestinal Disease Research Center; Major National Science and Technology Special Fund Projects	This work was supported by grants from the National Natural Science Foundation of China (grant numbers 81402028, 82072758, 12026605), Guangdong Science and Technology Project (grant numbers 2017A020215046), Guangdong Gastrointestinal Disease Research Center (grant numbers 2017B020209003 and 2017B030314037), and the Major National Science and Technology Special Fund Projects (grant numbers 2020ZX09201017).	Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Arderiu G, 2019, CIRC RES, V125, P74, DOI 10.1161/CIRCRESAHA.118.314290; Bayly R, 2004, J BIOL CHEM, V279, P55362, DOI 10.1074/jbc.M408654200; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chappell JC, 2019, J CLIN INVEST, V129, P442, DOI 10.1172/JCI120855; Chen HF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112668; Chen X, 2017, ONCOL REP, V38, P522, DOI 10.3892/or.2017.5697; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Conigliaro A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0426-x; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Gu CC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1962-x; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; Huang AX, 2015, INT J BIOL SCI, V11, P961, DOI 10.7150/ijbs.11943; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Kurokawa Y, 2004, J EXP CLIN CANC RES, V23, P135; Li AM, 2016, ONCOTARGET, V7, P524, DOI 10.18632/oncotarget.6358; Li P, 2019, J CELL MOL MED, V23, P2475, DOI 10.1111/jcmm.14121; Li QY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1330-9; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Long JA, 2010, HEPATOB PANCREAT DIS, V9, P296; Lonne GK, 2009, J BIOL CHEM, V284, P33456, DOI 10.1074/jbc.M109.036186; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Mashouri L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0991-5; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Meurette O, 2018, CANCER CELL, V34, P536, DOI 10.1016/j.ccell.2018.07.009; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Tang WM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08225-3; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Yen C, 2017, LIVER CANCER, V6, P313, DOI 10.1159/000480441; Zhang JS, 2004, SCIENCE, V305, P1286, DOI 10.1126/science.1097937; Zhao J, 2020, ONCOGENE, V39, P1724, DOI 10.1038/s41388-019-1093-y; Zhao Shaorong, 2019, Cell Physiol Biochem, V53, P19, DOI 10.33594/000000118	43	2	2	7	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1851	1865		10.1038/s41388-022-02197-x	http://dx.doi.org/10.1038/s41388-022-02197-x		FEB 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35140333	Green Published, hybrid			2022-12-26	WOS:000753256400001
J	Jiang, WL; Block, ME; Boosani, CS				Jiang, Wanlin; Block, Megan E.; Boosani, Chandra S.			Short communication: TNF-alpha and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10	PLOS ONE			English	Article							HISTONE DEACETYLASE; DNA METHYLTRANSFERASE; AUTOPHAGY; METHYLATION; DECITABINE; INHIBITORS; STENT	Vascular restenosis often presents as a consequence of injury to the vessel wall, resulting from stenting and other interventional procedures. Such injury to the arteries induces proliferation of Vascular Smooth Muscle Cells (VSMCs), resulting in cellular hyperplasia and restenosis. We and others have previously reported de-novo production of different cytokines and growth factors such as Tumor Necrosis Factor Alpha (TNF-alpha) and Insulin like Growth Factor 1 (IGF-1), after vascular injury. As complex as it is, the profuse proliferation of VSMCs appears to be occurring due to several induced factors which initiate molecular mechanisms and exacerbate disease conditions. In many pathological events, the deleterious effects of TNF-alpha and IGF-1 in initiating disease mechanisms was reported. In the present work, we explored whether TNF-alpha and IGF-1 can regulate epigenetic mechanisms that promote proliferation of VSMCs. We investigated the mechanistic roles of proteins which can structurally interact with DNMT1 and initiate cellular pathways that promote proliferation of VSMCs. Our findings here, identify a novel molecular mechanism that is initiated by TNF-alpha and IGF-1. It was previously reported that DNMT1 expression is directly induced by TNF-alpha and IGF-1 treatment and increased/induced expression of DNMT1 causes silencing of genes that are essential to maintaining cellular homeostasis such as the tumor suppressor genes. We have earlier reported that TNF-alpha and IGF-1 treatment elevates DNMT1 expression in VSMCs and causes increased VSMC proliferation. However, the molecular mechanisms involved were not fully deciphered. Interestingly, in the present study we found that TNF-alpha and IGF-1 treatment failed to elevate DNMT1 expression levels in absence of HDAC2 and HDAC10. Also, while HDAC2 expression was not affected by HDAC10 knockdown, HDAC2 is essentially required for HDAC10 expression. Further, in TNF-alpha and IGF-1 induced epigenetic signaling mechanism, the expression of two important proteins EZH2 and PCNA seem to be regulated in an HDAC2-HDAC10 dependent manner. Our results show an inter-dependence of epigenetic mediators in inducing proliferation in VSMCs. To our knowledge, this is the first report that shows HDAC2 dependent expression of HDAC10, and suggests a novel mechanistic link between DNMT1, HDAC10 and HDAC2 that regulates EZH2 and PCNA to enhance cell proliferation of VSMCs which is the underlying cause for neointimal hyperplasia and restenosis.	[Jiang, Wanlin; Block, Megan E.; Boosani, Chandra S.] Creighton Univ, Dept Clin & Translat Sci, Sch Med, Omaha, NE 68178 USA; [Jiang, Wanlin] Harvard Med Sch, Cardiovasc Res Ctr, Massachusetts Gen Hosp, Dept Med,Div Cardiol, Boston, MA 02115 USA; [Block, Megan E.] Providence Portland Med Ctr, Portland, OR USA; [Boosani, Chandra S.] Univ Missouri, Dept Anim Sci, Columbia, MO 65201 USA; [Boosani, Chandra S.] MU Healthcare, Univ Hosp, Columbia, MO 65201 USA; [Boosani, Chandra S.] Soma Life Sci Solut, Technol & Platform Dev, Winston Salem, NC 27103 USA	Creighton University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Providence Portland Medical Center; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Boosani, CS (corresponding author), Creighton Univ, Dept Clin & Translat Sci, Sch Med, Omaha, NE 68178 USA.; Boosani, CS (corresponding author), Univ Missouri, Dept Anim Sci, Columbia, MO 65201 USA.; Boosani, CS (corresponding author), MU Healthcare, Univ Hosp, Columbia, MO 65201 USA.; Boosani, CS (corresponding author), Soma Life Sci Solut, Technol & Platform Dev, Winston Salem, NC 27103 USA.	chandra.boosani@missouri.edu		Jiang, Wanlin/0000-0001-9631-2540	State of Nebraska Creighton University Clinical & Translational Research Grant [LB692]; Creighton University	State of Nebraska Creighton University Clinical & Translational Research Grant; Creighton University	The work presented in this manuscript was supported by State of Nebraska, LB692 Creighton University Clinical & Translational Research Grant to Dr. Chandra Boosani, grant title "Epigenetics in Cardiovascular Diseases". The funding institute Creighton University conducted faculty review and allowed us with their decision to publish this manuscript.	Ali D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/2379546; Alp H, 2013, CAN J CARDIOL, V29, P1118, DOI 10.1016/j.cjca.2012.07.846; Awada H, 2020, BRIT J HAEMATOL, V188, P924, DOI 10.1111/bjh.16281; Ballestar E, 2017, NAT REV RHEUMATOL, V13, P593, DOI 10.1038/nrrheum.2017.147; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Boosani CS, 2018, CAN J PHYSIOL PHARM, V96, P1030, DOI 10.1139/cjpp-2018-0111; Boosani CS, 2015, MOL BIOL REP, V42, P1365, DOI 10.1007/s11033-015-3882-x; Boosani CS, 2015, MOL BIOL REP, V42, P853, DOI 10.1007/s11033-015-3860-3; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cai SF, 2019, SEMIN HEMATOL, V56, P84, DOI 10.1053/j.seminhematol.2018.08.001; Cavalli G, 2019, NATURE, V571, P489, DOI 10.1038/s41586-019-1411-0; Cheng SL, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.918528; Dhar K, 2013, AM J PHYSIOL-HEART C, V304, pH776, DOI 10.1152/ajpheart.00570.2012; Dobesh PP, 2004, PHARMACOTHERAPY, V24, P1554, DOI 10.1592/phco.24.16.1554.50955; El-Hayek G, 2017, JACC-CARDIOVASC INTE, V10, P462, DOI 10.1016/j.jcin.2016.12.002; Ermolaeva M, 2018, NAT REV MOL CELL BIO, V19, P594, DOI 10.1038/s41580-018-0020-3; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Freese K, 2019, CANCERS, V11, DOI 10.3390/cancers11101587; Furumai R, 2002, CANCER RES, V62, P4916; Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Herbst-Gervasoni CJ, 2020, ACS CHEM BIOL, V15, P2154, DOI 10.1021/acschembio.0c00362; Hwang JY, 2017, NAT REV NEUROSCI, V18, P347, DOI 10.1038/nrn.2017.46; Joosten SC, 2018, NAT REV UROL, V15, P430, DOI 10.1038/s41585-018-0023-z; Khalil CA, 2014, THER ADV CHRONIC DIS, V5, P178, DOI 10.1177/2040622314529325; Klein K, 2015, CURR OPIN RHEUMATOL, V27, P76, DOI 10.1097/BOR.0000000000000128; Lee JH, 2010, MOL CELLS, V30, P107, DOI 10.1007/s10059-010-0094-z; Li R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0213-2; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Liu YF, 2020, ADV EXP MED BIOL, V1255, P63, DOI 10.1007/978-981-15-4494-1_5; Lkhagva B, 2018, EPIGENETICS-US, V13, P376, DOI 10.1080/15592294.2018.1460032; Ma YY, 2019, HEMATOLOGY, V24, P507, DOI 10.1080/16078454.2019.1632407; Medina-Franco JL, 2013, CURR PHARM DESIGN, V19, P2138; Mehran R, 1996, AM J CARDIOL, V78, P618, DOI 10.1016/S0002-9149(96)00381-5; Moore-Morris T, 2018, PHYSIOL REV, V98, P2453, DOI 10.1152/physrev.00048.2017; Mukherjee D, 2017, NEW ENGL J MED, V376, P2388, DOI 10.1056/NEJMe1703202; Nguyen TTT, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071661; Obayashi H, 2020, BIOCHEM BIOPH RES CO, V523, P246, DOI 10.1016/j.bbrc.2019.12.048; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pinto G, 2016, J NUTR BIOCHEM, V27, P171, DOI 10.1016/j.jnutbio.2015.08.031; Potaczek DP, 2017, EPIGENOMICS-UK, V9, P539, DOI 10.2217/epi-2016-0162; Ren J, 2019, BBA-MOL BASIS DIS, V1865, P1715, DOI 10.1016/j.bbadis.2019.02.005; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saunthararajah Y, 2015, J CLIN INVEST, V125, P1043, DOI 10.1172/JCI78789; Stoccoro A, 2018, NEURODEGENER DIS MAN, V8, P181, DOI 10.2217/nmt-2018-0004; Tan XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147816; Xu RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30922; Yang YW, 2016, ONCOTARGET, V7, P59388, DOI 10.18632/oncotarget.10673; Yoo J, 2012, ADV PROTEIN CHEM STR, V87, P219, DOI 10.1016/B978-0-12-398312-1.00008-1; Yu J, 2018, J CLIN INVEST, V128, P2376, DOI 10.1172/JCI97924; Zheng B, 2011, CELL RES, V21, P1487, DOI 10.1038/cr.2011.34; Zhou ZH, 2018, CURR TOP MED CHEM, V18, P2448, DOI 10.2174/1568026619666181120150122	55	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263190	10.1371/journal.pone.0263190	http://dx.doi.org/10.1371/journal.pone.0263190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143520	gold, Green Published			2022-12-26	WOS:000797657800029
J	Perez-Lu, JE; Guerrero, F; Carcamo, CP; Alburqueque, M; Chiappe, M; Hindin, MJ; Habib, N; Say, L; Gonsalves, L; Bayer, AM				Perez-Lu, Jose E.; Guerrero, Fiorella; Carcamo, Cesar P.; Alburqueque, Monica; Chiappe, Marina; Hindin, Michelle J.; Habib, Ndema; Say, Lale; Gonsalves, Lianne; Bayer, Angela M.			The ARMADILLO text message intervention to improve the sexual and reproductive health knowledge of adolescents in Peru: Results of a randomized controlled trial	PLOS ONE			English	Article							PROGRAM	Background The ARMADILLO Study determined whether adolescents able to access SRH information on-demand via SMS were better able to reject contraception-related myths and misconceptions as compared with adolescents receiving pushed SMS or no intervention. Trial design This trial was an unblinded, three-arm, parallel-group, individual RCT with a 1:1:1 allocation. Trial registration: ISRCTN85156148. Methods This study was conducted in Lima, Peru among participants ages 13-17 years. Eligible participants were randomized into one of three arms: Arm 1: access to ARMADILLO's SMS information on-demand; Arm 2 access to ARMADILLO SMS information pushed to their phone; Arm 3 control (no SMS). The intervention period lasted seven weeks. At baseline, endline, and follow-up (eight weeks following endline), participants were assessed on a variety of contraception-related myths and misconceptions. An index of myths-believed was generated. The primary outcome assessed the subject-specific change in the mean score between baseline and endline. Knowledge retention from endline to follow-up was also assessed, as was a 'content exposure' outcome, which assessed change in participants' knowledge based on relevant SMS received. Results In total, 712 participants were randomized to the three arms: 659 completed an endline assessment and were included in the primary analysis. Arm 2 participants believed fewer myths at endline compared with control arm participants (estimated subject-specific mean difference of -3.69% [-6.17%, -1.21%], p = 0.004). There was no significant difference between participants in Arm 1 vs. the control Arm, or between participants in Arm 1 vs. Arm 2. A further decrease in myths believed between endline and follow-up (knowledge retention) was observed in all arms; however, there was no difference between arms. The content exposure analysis saw significant reductions in myths believed for Arm 1 (estimated subject-specific mean difference of -9.47% [-14.83%, -4.11%], p = .001) and Arm 2 (-5.93% [-8.57%, -3.29%], p < .001) as compared with the control arm; however Arm l's reduced sample size (n = 28) is a severe limitation. Discussion The ARMADILLO SMS content has a significant (but small) effect on participants' contraception-related knowledge. Standalone, adolescent SRH digital health interventions may affect only modest change. Instead, digital is probably best used a complementary channel to expand the reach of existing validated SRH information and service programs.	[Perez-Lu, Jose E.; Guerrero, Fiorella; Carcamo, Cesar P.; Alburqueque, Monica; Chiappe, Marina; Bayer, Angela M.] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Lima, Peru; [Hindin, Michelle J.] Populat Council, Reprod Hlth Program, 1230 York Ave, New York, NY 10021 USA; [Habib, Ndema; Say, Lale; Gonsalves, Lianne] WHO, Dept Sexual & Reprod Hlth & Res Including UNDP UN, World Bank Special Programme Res Dev & Res Traini, Geneva, Switzerland	Universidad Peruana Cayetano Heredia; Population Council; The World Bank; World Health Organization	Gonsalves, L (corresponding author), WHO, Dept Sexual & Reprod Hlth & Res Including UNDP UN, World Bank Special Programme Res Dev & Res Traini, Geneva, Switzerland.	gonsalvesl@who.int		Guerrero, Fiorella/0000-0002-9534-4767; Gonsalves, Lianne/0000-0003-2409-5043	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO)(World Health Organization)	The ARMADILLO Study was implemented with the financial support of the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The corresponding author (a member of HRP) was the global coordinator of the study and was involved in the study's design and interpretation of the data and drafting of the manuscript. Data collection and analysis, as well as manuscript drafting was led by the Universidad Peruana Cayetano Heredia team. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication.	Agarwal S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1174; [Anonymous], 2013, FONDO POBLACIN NACIO; Chandra-Mouli V, 2015, GLOB HEALTH-SCI PRAC, V3, P333, DOI 10.9745/GHSP-D-15-00126; Costa GPO., 2014, OPEN J OBSTET GYNECO, V04, P9; Defensora del Pueblo UNFPA., 2019, RESULTADOS SUPERVISI; Dutch Centre for Youth Health, 2020, DIG TECHN SOL STAND; Engel DMC, 2019, J ADOLESCENT HEALTH, V65, pS41, DOI 10.1016/j.jadohealth.2019.09.014; Gonsalves L, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13005; Gonsalves L, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0568-6; Guerrero F, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-00943-6; Gueye A, 2015, INT PERSPECT SEX R H, V41, P191, DOI 10.1363/4119115; Hightow-Weidman LB, 2015, CURR HIV-AIDS REP, V12, P500, DOI 10.1007/s11904-015-0280-x; Instituto Nacional de Estadstica e I, 2019, ENCUESTA DEMOGRFICA; Instituto Nacional de Estadstica e I. Per, 2015, COMP EST; Juzang I, 2011, J TELEMED TELECARE, V17, P150, DOI 10.1258/jtt.2010.091107; L'Engle KL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0884; Lim MSC, 2012, J EPIDEMIOL COMMUN H, V66, P69, DOI 10.1136/jech.2009.100396; Mendoza Walter, 2013, Rev Peru Med Exp Salud Publica, V30, P471; Pew Research C, 2014, EMERGING NATIONS EMB; Pew Research C, 2015, CELL PHONES AFRICA C; Situacin del Embarazo Adolescente, 2012, AVANCES DESAFOS SALU; Suffoletto B, 2013, J ADOLESCENT HEALTH, V53, P387, DOI 10.1016/j.jadohealth.2013.04.006; UNFPA, 2014, STATE WORLD POPULATI, DOI DOI 10.18356/281344F5-EN; United Nations Educational Scientific Cultural Organisation, 2019, FAC FACTS CAS COMPR, P2019; WHO, 2019, WHO GUID REC DIG INT	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0262986	10.1371/journal.pone.0262986	http://dx.doi.org/10.1371/journal.pone.0262986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1J1AU	35143513	gold, Green Published			2022-12-26	WOS:000797657800020
J	Yeshanew, AG; Lankir, D; Wondimu, J; Solomon, S				Yeshanew, Addisu Gize; Lankir, Damtie; Wondimu, Jimmawork; Solomon, Samrawit			Pertussis outbreak investigation in Northwest Ethiopia: A community based study	PLOS ONE			English	Article							GLOBAL BURDEN; RISK-FACTORS	Background Pertussis or whooping cough is a vaccine-preventable, highly contagious, respiratory illness caused by Bordetella pertussis or Bordetella parapertussis. Infants and young children have remained most susceptible to pertussis-related morbidity and mortality. The aim of this study was to investigate pertussis infection and analyze the associated factors involved in the occurrence of the cases. Methods Community-based case-control was conducted in Dahena district, Northwest Ethiopia, from March 27-April 30, 2019. All cases ages 1-18 years old were identified by using the clinical standard case definition of pertussis adopted from World Health Organization (WHO). Data was collected using a structured questionnaire via face-to-face interviews. The data collected was cleaned, coded and entered into Epi info version 7.2.1.0 and exported to SPSS version 23 for statistical analysis. Bivariable and multivariable logistic regression analysis were employed to identify predictors. Factors with a p-value of < 0.05 were considered as independent risk factors of pertussis infection in multivariable logistic regression analysis. Result A total of 122 pertussis cases were enrolled from the Azila cluster of the Dahena district. Of these figures, 64 (52.5%) were females. The overall attack rate (AR) of pertussis cases in the cluster was 8.6/10000 population. The sex-specific AR of females was 8.9/10000 population. The multivariable logistic regression analysis showed that; being unvaccinated 4.17 (AOR, 4.17, 95% CI, 1.914-9.091), contact to cases 2.93 (AOR: 2.93, 95% CI 1.223-6.996), and living in a house with no window 2.6 (AOR: 2.6(95% CI 1.071 to 6.322) were the independent significantly risk factors for pertussis infection. Conclusion The contributing factor for pertussis infection was associated with case-contact, living in the house without windows and being unvaccinated. Wag Hemra Zone and Dahena district health office should encourage the vaccination activities of the cluster health center and awareness for the community should be practiced to limit disease transmission.	[Yeshanew, Addisu Gize] St Pauls Hosp, Dept Microbiol, Millennium Med Coll, Addis Ababa, Ethiopia; [Lankir, Damtie] Publ Hlth Emergency Management PHEM Directorate, Amhara Publ Hlth Inst, Bahir Dar, Ethiopia; [Wondimu, Jimmawork; Solomon, Samrawit] St Pauls Hosp, Dept Publ Hlth, Millennium Med Coll, Addis Ababa, Ethiopia		Yeshanew, AG (corresponding author), St Pauls Hosp, Dept Microbiol, Millennium Med Coll, Addis Ababa, Ethiopia.	addisu.gize@sphmmc.edu.et						Abebe AM, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4104-8; Abubakar Ahmed, 2019, Pan Afr Med J, V32, P9, DOI 10.11604/pamj.supp.2019.32.1.13352; Alamaw SD., 2017, BMC RES NOTES, V10, P1, DOI 10.1186/s13104-016-2345-3; Almaw L, 2019, PAN AFR MED J, V34, DOI 10.11604/pamj.2019.34.65.19612; Chan MH, 2012, J PEDIAT INF DIS SOC, V1, P47, DOI [10.1093/JPIDS/PIS007, 10.1093/jpids/pis007]; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; Gastanaduy PA., 2008, PREVENTION MANUAL SU; Hamborsky J., 2015, EPIDEMIOLOGY PREVENT; Hughes MM, 2017, J PEDIAT INF DIS SOC, V6, P33, DOI 10.1093/jpids/piw079; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Kline JM, 2013, AM FAM PHYSICIAN, V88, P507; Mitiku AD, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09303-2; Mosser JF, 2019, LANCET, V393, P1843, DOI 10.1016/S0140-6736(19)30226-0; Muloiwa R, 2018, VACCINE, V36, P2385, DOI 10.1016/j.vaccine.2018.03.025; Muloiwa R, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0053-z; Ochi M, 2017, CLIN CASE REP, V5, P241, DOI 10.1002/ccr3.765; Organization WH, 2009, WHO VACC PREV DIS MO; Pertussis Guideline Working Group, 2016, PHE GUID PUBL HLTH M; Ryu S, 2018, CLIN EXP VACCINE RES, V7, P70, DOI 10.7774/cevr.2018.7.1.70; Suryadevara M, 2015, HUM VACC IMMUNOTHER, V11, P1744, DOI 10.1080/21645515.2015.1038442; Taye S., 2020, INT J MICROBIOL, V2020; Wensley A, 2017, EPIDEMIOL INFECT, V145, P1025, DOI 10.1017/S0950268816002983; Wolter N, 2021, CLIN INFECT DIS, V73, pE745, DOI 10.1093/cid/ciab089; Yeung KHT, 2017, LANCET INFECT DIS, V17, P974, DOI 10.1016/S1473-3099(17)30390-0	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263708	10.1371/journal.pone.0263708	http://dx.doi.org/10.1371/journal.pone.0263708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143575	gold, Green Published			2022-12-26	WOS:000797657800071
J	Grass, M; McDougal, AD; Blazeski, A; Kamm, RD; Garcia-Cardena, G; Dewey, CF				Grass, Matthias; McDougal, Anthony D.; Blazeski, Adriana; Kamm, Roger D.; Garcia-Cardena, Guillermo; Dewey, C. Forbes, Jr.			A computational model of cardiomyocyte metabolism predicts unique reperfusion protocols capable of reducing cell damage during ischemia/reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; OXYGEN SPECIES PRODUCTION; CYTOCHROME BC(1) COMPLEX; ISCHEMIA-REPERFUSION; MYOCARDIAL-ISCHEMIA; OXIDATIVE-PHOSPHORYLATION; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; INDUCED CARDIOPROTECTION; SUPEROXIDE GENERATION	If a coronary blood vessel is occluded and the neighboring cardiomyocytes deprived of oxygen, subsequent reperfusion of the ischemic tissue can lead to oxidative damage due to excessive generation of reactive oxygen species. Cardiomyocytes and their mitochondria are the main energy producers and consumers of the heart, and their metabolic changes during ischemia seem to be a key driver of reperfusion injury. Here, we hypothesized that tracking changes in cardiomyocyte metabolism, such as oxygen and ATP concentrations, would help in identifying points of metabolic failure during ischemia and reperfusion. To track some of these changes continuously from the onset of ischemia through reperfusion, we developed a system of differential equations representing the chemical reactions involved in the production and consumption of 67 molecular species. This model was validated and used to identify conditions present during periods of critical transition in ischemia and reperfusion that could lead to oxidative damage. These simulations identified a range of oxygen concentrations that lead to reverse mitochondrial electron transport at complex I of the respiratory chain and a spike in mitochondrial membrane potential, which are key suspects in the generation of reactive oxygen species at the onset of reperfusion. Our model predicts that a short initial reperfusion treatment with reduced oxygen content (5% of physiological levels) could reduce the cellular damage from both of these mechanisms. This model should serve as an open-source platform to test ideas for treatment of the ischemia reperfusion process by following the temporal evolution of molecular concentrations in the cardiomyocyte.	[Grass, Matthias] Swiss Fed Inst Technol, Dept Mech Engn, Zurich, Switzerland; [Grass, Matthias; Blazeski, Adriana; Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Grass, Matthias; Blazeski, Adriana; Garcia-Cardena, Guillermo] Harvard Med Sch, Program Human Biol & Translat Med, Boston, MA 02115 USA; [McDougal, Anthony D.; Blazeski, Adriana; Kamm, Roger D.; Dewey, C. Forbes, Jr.] MIT, Dept Mech Eng, Cambridge, MA 02139 USA; [Kamm, Roger D.; Dewey, C. Forbes, Jr.] MIT, Dept Biol Eng, Cambridge, MA 02139 USA; [Garcia-Cardena, Guillermo] Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Garcia-Cardena, G (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Garcia-Cardena, G (corresponding author), Harvard Med Sch, Program Human Biol & Translat Med, Boston, MA 02115 USA.; Dewey, CF (corresponding author), MIT, Dept Mech Eng, Cambridge, MA 02139 USA.; Dewey, CF (corresponding author), MIT, Dept Biol Eng, Cambridge, MA 02139 USA.; Garcia-Cardena, G (corresponding author), Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA.	guillermo_garcia-cardena@hms.harvard.edu; cfdewey@mit.edu		McDougal, Anthony/0000-0002-9980-4193	Zeno Karl Schindler Foundation; National Institutes of Health [T32 HL007627]	Zeno Karl Schindler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by a grant from the Zeno Karl Schindler Foundation to M. G. and a Post-Doctoral Research Fellowship to A. B. from the National Institutes of Health (T32 HL007627). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Rahman U, 2009, J THORAC CARDIOV SUR, V137, P978, DOI 10.1016/j.jtcvs.2008.09.025; Abdel-Rahman Ulf, 2003, Med Sci Monit, V9, pCR389; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Angelova PR, 2016, FREE RADICAL BIO MED, V100, P81, DOI 10.1016/j.freeradbiomed.2016.06.005; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Atkinson C, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI DOI 10.1001/JAMA.2013.13805; Babiker FA, 2017, J PHYSIOL BIOCHEM, V73, P175, DOI 10.1007/s13105-016-0535-z; Bazil JN, 2016, BIOPHYS J, V110, P962, DOI 10.1016/j.bpj.2015.09.036; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Beretta M, 2020, EMBO J, V39, DOI 10.15252/embj.2019103530; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Borutaite V, 1995, BBA-MOL BASIS DIS, V1272, P154, DOI 10.1016/0925-4439(95)00080-1; Cadenas S, 2018, FREE RADICAL BIO MED, V117, P76, DOI 10.1016/j.freeradbiomed.2018.01.024; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; CLARKE K, 1987, AM J PHYSIOL, V253, pH412, DOI 10.1152/ajpheart.1987.253.2.H412; Cohen MV, 2007, CIRCULATION, V115, P1895, DOI 10.1161/CIRCULATIONAHA.106.675710; Cortassa S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00201; Del Re DP, 2019, PHYSIOL REV, V99, P1763, DOI 10.1152/physrev.00022.2018; del Rio CL, 2005, J APPL PHYSIOL, V99, P1576, DOI 10.1152/japplphysiol.00830.2004; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Douzinas EE, 2003, CRIT CARE MED, V31, P2183, DOI 10.1097/01.CCM.0000080488.30157.D8; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Endeward V, 2012, J APPL PHYSIOL, V112, P1466, DOI 10.1152/japplphysiol.00835.2011; Gateau-Roesch O, 2006, CARDIOVASC RES, V70, P264, DOI 10.1016/j.cardiores.2006.02.024; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Glancy B, 2017, CELL REP, V19, P487, DOI 10.1016/j.celrep.2017.03.063; Guillaud F, 2014, BBA-BIOENERGETICS, V1837, P1643, DOI 10.1016/j.bbabio.2014.05.358; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; Henry Timothy D., 1993, American Journal of Physiology, V264, pH1478; Heusch G, 2010, BASIC RES CARDIOL, V105, P151, DOI 10.1007/s00395-009-0080-9; Hirschhauser C, 2015, ANTIOXID REDOX SIGN, V23, P1106, DOI 10.1089/ars.2014.6238; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; JENNINGS RB, 1969, AM J CARDIOL, V24, P753, DOI 10.1016/0002-9149(69)90464-0; Kalogeris T, 2017, COMPR PHYSIOL, V7, P113, DOI 10.1002/cphy.c160006; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; Korge P, 2017, J BIOL CHEM, V292, P9882, DOI 10.1074/jbc.M116.768317; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Korzeniewski B, 2001, BBA-BIOENERGETICS, V1504, P31, DOI 10.1016/S0005-2728(00)00237-1; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Luo X, 2015, ANESTHESIOLOGY, V123, P1122, DOI 10.1097/ALN.0000000000000859; Maldonado EN, 2014, MITOCHONDRION, V19, P78, DOI 10.1016/j.mito.2014.09.002; Malyala S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006719; McDougal AD, 2017, J BIOL CHEM, V292, P11760, DOI 10.1074/jbc.M116.751826; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Muntean DM, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8254942; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nowbar AN, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005375; Orlowski P, 2011, INTERFACE FOCUS, V1, P408, DOI 10.1098/rsfs.2010.0025; Padmaraj D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101793; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; SCHAPER J, 1988, Cardiovascular Drugs and Therapy, V2, P17, DOI 10.1007/BF00054248; SCHAPER J, 1979, J MOL CELL CARDIOL, V11, P521, DOI 10.1016/0022-2828(79)90428-0; SCHWARTZ GG, 1990, CIRC RES, V67, P490, DOI 10.1161/01.RES.67.2.490; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Starkov AA, 2013, MOL CELL NEUROSCI, V55, P13, DOI 10.1016/j.mcn.2012.07.005; Sun HY, 2005, AM J PHYSIOL-HEART C, V288, pH1900, DOI 10.1152/ajpheart.01244.2003; Suski J, 2018, METHODS MOL BIOL, V1782, P357, DOI 10.1007/978-1-4939-7831-1_22; Tasoulis MK, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0220-0; Tretter L, 2007, J NEUROCHEM, V100, P650, DOI 10.1111/j.1471-4159.2006.04223.x; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; VANERP HE, 1988, EUR J CELL BIOL, V47, P388; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; Winslow RL, 2011, WIRES SYST BIOL MED, V3, P392, DOI 10.1002/wsbm.122; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497; Xu AJ, 2013, BIOCHEM BIOPH RES CO, V435, P627, DOI 10.1016/j.bbrc.2013.05.033; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Yaniv Y, 2010, ANN NY ACAD SCI, V1188, P133, DOI 10.1111/j.1749-6632.2009.05093.x; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	88	0	0	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101693	10.1016/j.jbc.2022.101693	http://dx.doi.org/10.1016/j.jbc.2022.101693			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35157851	Green Published, gold			2022-12-26	WOS:000860390500001
J	Mikroulis, A; Ledri, M; Ruffolo, G; Palma, E; Sperk, G; Dalli, J; Vezzani, A; Kokaia, M				Mikroulis, Apostolos; Ledri, Marco; Ruffolo, Gabriele; Palma, Eleonora; Sperk, Guenther; Dalli, Jesmond; Vezzani, Annamaria; Kokaia, Merab			Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor	FASEB JOURNAL			English	Article						antiepileptic mechanism; GABA(A) receptors; mouse hippocampus; PD1(n-3DPA); perisomatic inhibition	BLOOD-BRAIN-BARRIER; IMMUNOCYTOCHEMICAL DISTRIBUTION; EXCITABILITY; DIVERSITY; SUBUNITS	Epilepsy is a severe neurological disease manifested by spontaneous recurrent seizures due to abnormal hyper-synchronization of neuronal activity. Epilepsy affects about 1% of the population and up to 40% of patients experience seizures that are resistant to currently available drugs, thus highlighting an urgent need for novel treatments. In this regard, anti-inflammatory drugs emerged as potential therapeutic candidates. In particular, specific molecules apt to resolve the neuroinflammatory response occurring in acquired epilepsies have been proven to counteract seizures in experimental models, and humans. One candidate investigational molecule has been recently identified as the lipid mediator n-3 docosapentaenoic acid-derived protectin D1 (PD1(n-3DPA)) which significantly reduced seizures, cell loss, and cognitive deficit in a mouse model of acquired epilepsy. However, the mechanisms that mediate the PD1(n-3DPA) effect remain elusive. We here addressed whether PD1(n-3DPA) has direct effects on neuronal activity independent of its anti-inflammatory action. We incubated, therefore, hippocampal slices with PD1(n-3DPA) and investigated its effect on excitatory and inhibitory synaptic inputs to the CA1 pyramidal neurons. We demonstrate that inhibitory drive onto the perisomatic region of the pyramidal neurons is increased by PD1(n-3DPA), and this effect is mediated by pertussis toxin-sensitive G-protein coupled receptors. Our data indicate that PD1(n-3DPA) acts directly on inhibitory transmission, most likely at the presynaptic site of inhibitory synapses as also supported by Xenopus oocytes and immunohistochemical experiments. Thus, in addition to its anti-inflammatory effects, PD1(n-3DPA) anti-seizure and neuroprotective effects may be mediated by its direct action on neuronal excitability by modulating their synaptic inputs.	[Mikroulis, Apostolos; Ledri, Marco; Kokaia, Merab] Lund Univ, Fac Med, Epilepsy Ctr, Dept Clin Sci, Lund, Sweden; [Ruffolo, Gabriele; Palma, Eleonora] Univ Rome Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Physiol & Pharmacol, Rome, Italy; [Ruffolo, Gabriele] IRCCS San Raffaele Pisana, Rome, Italy; [Sperk, Guenther] Med Univ Innsbruck, Dept Pharmacol, Innsbruck, Austria; [Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Dalli, Jesmond] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London, England; [Vezzani, Annamaria] Mario Negri Inst Pharmacol Res IRCCS, Milan, Italy	Lund University; Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS San Raffaele Pisana; Medical University of Innsbruck; University of London; Queen Mary University London; University of London; Queen Mary University London; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Ledri, M (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Solvegatan 17,BMC A11, Lund, Sweden.	Marco.Ledri@med.lu.se	; Palma, Eleonora/A-2775-2010; RUFFOLO, GABRIELE/A-9273-2019	Dalli, Jesmond/0000-0001-6328-3640; Palma, Eleonora/0000-0001-6026-927X; Ledri, Marco/0000-0001-8317-7976; RUFFOLO, GABRIELE/0000-0002-6554-5496; Sperk, Guenther/0000-0001-6561-8360	Vetenskapsradet (VR) [2017-00921]; Austrian Science Fund (FWF) [P 19464]; Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy); Wellcome Trust (Wellcome) [107613/Z/15/Z]; Royal Society [107613/Z/15/Z]; Stiftelsen Olle Engkvist Byggmastare	Vetenskapsradet (VR)(Swedish Research Council); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Wellcome Trust (Wellcome); Royal Society(Royal Society of London); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	Vetenskapsradet (VR), Grant/Award Number: 2017-00921; Austrian Science Fund (FWF), Grant/Award Number: P 19464; Sapienza Universita di Roma (Sapienza University of Rome); Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: Ricerca corrente; Wellcome Trust (Wellcome), Grant/Award Number: 107613/Z/15/Z; Royal Society, Grant/Award Number: 107613/Z/15/Z; Stiftelsen Olle Engkvist Byggmastare	Cascino GD, 2021, NEUROL CLIN, V39, P181, DOI 10.1016/j.ncl.2020.09.010; Conti L, 2011, EPILEPSIA, V52, P1635, DOI 10.1111/j.1528-1167.2011.03111.x; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dawit S, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01061-3; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Drexel M, 2017, J NEUROSCI, V37, P8166, DOI 10.1523/JNEUROSCI.3456-16.2017; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Khayenko V, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00162; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mikroulis A., XPSC DETECTION TEMPL; Palma E, 2002, P NATL ACAD SCI USA, V99, P15078, DOI 10.1073/pnas.232574499; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Roseti C, 2015, NEUROBIOL DIS, V82, P311, DOI 10.1016/j.nbd.2015.07.003; Ruffolo G, 2018, EPILEPSIA, V59, P2106, DOI 10.1111/epi.14574; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Taha AY, 2013, BRAIN RES, V1537, P9, DOI 10.1016/j.brainres.2013.09.004; van Vliet EA, 2018, NEUROPATH APPL NEURO, V44, P91, DOI 10.1111/nan.12444; Vezzani A, 2019, NAT REV NEUROL, V15, P459, DOI 10.1038/s41582-019-0217-x; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6	30	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2022	36	3							e22203	10.1096/fj.202101815R	http://dx.doi.org/10.1096/fj.202101815R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZH9LM	35188290	Green Published			2022-12-26	WOS:000761250800053
J	Khan, J; Gholizadeh, S; Zhang, DJ; Wang, G; Guo, Y; Zheng, XY; Wu, ZD; Wu, Y				Khan, Jehangir; Gholizadeh, Saber; Zhang, Dongjing; Wang, Gang; Guo, Yan; Zheng, Xiaoying; Wu, Zhongdao; Wu, Yu			Identification of a biological form in the Anopheles stephensi laboratory colony using the odorant-binding protein 1 intron I sequence	PLOS ONE			English	Article							MALARIA VECTOR; DIPTERA; CULICIDAE; POPULATIONS; GENETICS; STRAINS; LISTON	Background Anopheles stephensi Listen (1901) is a major vector of malaria in Asia and has recently been found in some regions of Africa. The An. stepehnsi species complex is suspected to have three sibling species: type, intermediate, and mysorensis, each with its own vector competence to the malaria parasite and ecology. To identify the members of the species complex in our An. stephensi insectary colony, we used the morphological features of eggs and genetic markers such as AnsteObp1 (Anopheles stephensi odorant binding protein 1), mitochondrial oxidases subunit 1 and 2 (COI and COII), and nuclear internal transcribed spacer 2 locus (ITS2). Methods Eggs were collected from individual mosquitoes (n = 50) and counted for the number of ridges under stereomicroscope. Genomic DNA was extracted from female mosquitoes. After the amplification of partial fragments of AnsteObp1, COI, COII and ITS2 genes, the PCR products were purified and sequenced. Phylogenetic analysis was performed after aligning query sequences against the submitted sequences in GenBank using MEGA 7. Results The range of ridges number on each egg float was 12-13 that corresponds to the mysorensis form of An. stephensi. The generated COI, COII and ITS2 sequences showed 100%, 99.46% and 99.29% similarity with the sequences deposited for Chinese, Indian and Iranian strains of An. stephensi, respectively. All the generated AnsteObp1 intron I region sequences matched 100% with the sequences deposited for An. stephensi sibling species C (mysorensis form) from Iran and Afghanistan. Conclusions This manuscript precisely describes the morphological and molecular details of the 'var mysorensis' form of An. stephensi that could be exploited in elucidating its classification as well as in differentiation from other biotypes of the same or other anopheline species. Based on our findings, we recommend AnsteObp1 as a robust genetic marker for rapid and accurate discrimination (taxonomic identification) of the An. stephensi species complex, rather than the COI, COII, and ITS2 marker, which could only be utilized for interspecies (Anopheles) differentiation.	[Khan, Jehangir; Zhang, Dongjing; Wang, Gang; Guo, Yan; Zheng, Xiaoying; Wu, Zhongdao; Wu, Yu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China; [Khan, Jehangir; Zhang, Dongjing; Wang, Gang; Guo, Yan; Zheng, Xiaoying; Wu, Zhongdao; Wu, Yu] Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Khan, Jehangir] Abdul Wali Khan Univ Mardan, Dept Zool, Khyber Pakhtunkhwa, Pakistan; [Khan, Jehangir; Zhang, Dongjing; Wang, Gang; Zheng, Xiaoying; Wu, Zhongdao; Wu, Yu] Sun Yat Sen Univ, Chinese Atom Energy Agcy, Ctr Excellence Nucl Technol Applicat Insect Contr, Guangzhou, Peoples R China; [Gholizadeh, Saber] Urmia Univ Med Sci, Cellular & Mol Res Ctr, Cellular & Mol Med Inst, Orumiyeh, Iran; [Gholizadeh, Saber] Urmia Univ Med Sci, Sch Publ Hlth, Med Entomol & Vector Control Dept, Orumiyeh, Iran	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Urmia University of Medical Sciences; Urmia University of Medical Sciences	Khan, J; Wu, ZD; Wu, Y (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China.; Khan, J; Wu, ZD; Wu, Y (corresponding author), Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Khan, J (corresponding author), Abdul Wali Khan Univ Mardan, Dept Zool, Khyber Pakhtunkhwa, Pakistan.; Khan, J; Wu, ZD; Wu, Y (corresponding author), Sun Yat Sen Univ, Chinese Atom Energy Agcy, Ctr Excellence Nucl Technol Applicat Insect Contr, Guangzhou, Peoples R China.	abu_amna2013@hotmail.com; wuzhd@mail.sysu.edu.cn; wuyu@mail.sysu.edu.cn	Khan, Jehangir/HIR-2247-2022	Khan, Jehangir/0000-0003-4328-5459	National Key R&D Program of China [2020YFC1200100]; National Natural Science Foundation of China [82002168, 82072308, 20201192]; 111 project [B12003]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	This study is supported by the National Key R&D Program of China (no. 2020YFC1200100), National Natural Science Foundation of China (nos. 82002168 and 82072308), the 6th Nuclear Energy R&D Project (no. 20201192), and 111 project (no. B12003).	Alam MT, 2008, PARASITOL RES, V103, P75, DOI 10.1007/s00436-008-0930-7; [Anonymous], 2021, WORLD MOSQUITO PROGR; Anyanwu GI, 1997, ANN TROP MED PARASIT, V91, P649, DOI 10.1080/00034989760752; Basseri HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075413; Carter TE, 2018, ACTA TROP, V188, P180, DOI 10.1016/j.actatropica.2018.09.001; Chavshin Ali Reza, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P47, DOI 10.1016/S2221-1691(14)60207-0; COLUZZI M, 1973, Parassitologia (Rome), V15, P129; Dash AP, 2007, CURR SCI INDIA, V92, P1571; Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003; Faulde MK, 2014, ACTA TROP, V139, P39, DOI 10.1016/j.actatropica.2014.06.016; Firooziyan S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2523-y; Gakhar SK, 2013, INDIAN J EXP BIOL, V51, P273; Gholizadeh S, 2015, ACTA TROP, V146, P101, DOI 10.1016/j.actatropica.2015.03.012; Gholizadeh S, 2018, IRAN J PARASITOL, V13, P161; Gholizadeh S, 2013, ACTA TROP, V126, P63, DOI 10.1016/j.actatropica.2012.11.003; Khan I, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-90; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MAHMOOD F, 1984, CAN J GENET CYTOL, V26, P538, DOI 10.1139/g84-086; Mishra S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253173; Nagpal BN, 2003, J MED ENTOMOL, V40, P747, DOI 10.1603/0022-2585-40.6.747; Oshaghi M.A., 2006, Pakistan Journal of Biological Sciences, V9, P294, DOI 10.3923/pjbs.2006.294.298; Oshaghi M.A., 2008, Bulletin de la Societe de Pathologie Exotique, V101, P429; Puri I. M., 1949, MALARIOLOGY, P483; RAO B. A., 1938, JOUR MALARIA INST INDIA, V1, P261; RUTLEDGE LC, 1970, ANN ENTOMOL SOC AM, V63, P1024, DOI 10.1093/aesa/63.4.1024; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Stone A., 1959, SYNOPTIC CATALOG MOS; Subbarao S K, 1998, TECHNICAL PUBLICATIO, V18; Subbarao Sarala K., 1996, Proceedings of the National Academy of Sciences India Section B (Biological Sciences), V66, P51; SUBBARAO SK, 1987, MED VET ENTOMOL, V1, P265, DOI 10.1111/j.1365-2915.1987.tb00353.x; SUGUNA SG, 1981, INDIAN J MED RES, V73, P120; SULEMAN M, 1990, J MED ENTOMOL, V27, P819, DOI 10.1093/jmedent/27.5.819; Surendran SN, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2601-y; SWEET W. C., 1938, JOUR MALARIA INST INDIA, V1, P149; Sweet W. C., 1937, Indian Medical Gazette, V72, P665; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vipin, 2010, INSECT SCI, V17, P335, DOI 10.1111/j.1744-7917.2010.01316.x; Wang G, 2017, MITOCHONDRIAL DNA A, V28, P769, DOI 10.1080/24701394.2016.1186665; World Health Organization, 2018, MALARIA; World Health Organization. Regional Office for South-East Asia, 2007, COMMUNICATION 1231; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089473; Zou YL., 2015, NCBI DIRECT SUBMISSI	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263836	10.1371/journal.pone.0263836	http://dx.doi.org/10.1371/journal.pone.0263836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192647	gold, Green Published			2022-12-26	WOS:000812552500030
J	Boumegouas, M; Raju, M; Gardiner, J; Hammer, N; Saleh, Y; Al-Abcha, A; Kalra, A; Abela, GS				Boumegouas, Manel; Raju, Manjunath; Gardiner, Joseph; Hammer, Neal; Saleh, Yehia; Al-Abcha, Abdullah; Kalra, Apoorv; Abela, George S.			Interaction between bacteria and cholesterol crystals: Implications for endocarditis and atherosclerosis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLAQUES; STATINS	Background The interaction between pathogenic bacteria and cholesterol crystals (CCs) has not been investigated. However, CCs are found extensively in atherosclerotic plaques and sclerotic cardiac valves. Interactions between pathogenic bacteria and CCs could provide insights into destabilization of atherosclerotic plaques and bacterial adhesion to cardiac valves. Methods Staphylococcus aureus and Pseudomonas aeruginosa were used to assess in vitro bacterial adhesion to CCs and proliferation in the presence of CCs compared to plastic microspheres and glass shards as controls. Ex vivo studies evaluated bacterial adhesion to atherosclerotic rabbit arteries compared to normal arteries and human atherosclerotic carotid plaques compared to normal carotid arteries. Scanning electron microscopy (SEM) was used to visualize bacterial adhesion to CCs and confocal microscopy was used to detect cholesterol binding to bacteria grown in the presence or absence of CCs. Results In vitro, S. aureus and P. aeruginosa displayed significantly greater adhesion, 36% (p<0.0001) and 89% (p<0.0001), respectively, and growth upon exposure to CCs compared to microspheres or glass shards. Rabbit and human atherosclerotic arteries contained significantly greater bacterial burdens compared to controls (4x (p<0.0004); 3x (p<0.019), respectively. SEM demonstrated that bacteria adhered and appeared to degrade CCs. Consistent with this, confocal microscopy indicated increased cholesterol bound to the bacterial cells. Conclusions This study is the first to demonstrate an interaction between bacteria and CCs showing that bacteria dissolve and bind to CCs. This interaction helps to elucidate adhesion of bacteria to sclerotic valves and atherosclerotic plaques that may contribute to endocarditis and plaque destabilization.	[Boumegouas, Manel; Raju, Manjunath; Abela, George S.] Michigan State Univ, Dept Med, Div Cardiol, E Lansing, MI 48824 USA; [Gardiner, Joseph] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Hammer, Neal] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Saleh, Yehia] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Houston, TX USA; [Al-Abcha, Abdullah] Michigan State Univ, Sparrow Hosp, Div Internal Med, Dept Med, Lansing, MI USA; [Kalra, Apoorv] Metro Infect Dis Consultants, Kansas City, MO USA; [Abela, George S.] Michigan State Univ, Dept Physiol, Div Pathol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Michigan State University; Michigan State University	Abela, GS (corresponding author), Michigan State Univ, Dept Med, Div Cardiol, E Lansing, MI 48824 USA.; Abela, GS (corresponding author), Michigan State Univ, Dept Physiol, Div Pathol, E Lansing, MI 48824 USA.	abela@msu.edu		Al-Abcha, Abdullah/0000-0002-9025-7453; Abela, George/0000-0002-8201-956X	Michigan State University; Jean P. Schultz Biomedical Research Endowment; Edward W. Sparrow Hospital, Lansing, MI	Michigan State University; Jean P. Schultz Biomedical Research Endowment; Edward W. Sparrow Hospital, Lansing, MI	All funds were from the institutional support. Support was provided in part from Michigan State University, The Jean P. Schultz Biomedical Research Endowment and Edward W. Sparrow Hospital, Lansing, MI. No external funding was obtained. No author was paid salary from those grants. Drs. Abela, Gardiner, Hammer and Kalra were paid salary from Michigan State University. Drs. Raju, Boumegouas, Al-Abcha are paid salary by Sparrow Hospital. None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2017, AM J CARDIOL, V120, P1699, DOI 10.1016/j.amjcard.2017.07.075; Abela GS, 2011, AM J CARDIOL, V107, P1710, DOI 10.1016/j.amjcard.2011.02.336; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Abela GS, 2006, SCANNING, V28, P1, DOI 10.1002/sca.4950280101; ABELA GS, 1995, CIRCULATION, V91, P776, DOI 10.1161/01.CIR.91.3.776; Al-Handawi MB, 2018, CHEM-EUR J, V24, P11493, DOI 10.1002/chem.201802251; Boumegouas M, INTERV CARDIOL; Chalmers JD, 2010, RESP MED, V104, P1081, DOI 10.1016/j.rmed.2010.04.005; Chhibber-Goel J, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/s41522-016-0009-7; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El-Khatib LA, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2020-001274; Farsaei S, 2012, INT WOUND J, V9, P238, DOI 10.1111/j.1742-481X.2011.00888.x; Frank RC, 2019, NEW ENGL J MED, V380, DOI 10.1056/NEJMc1901647; Garcia JL, 2012, MICROB BIOTECHNOL, V5, P679, DOI 10.1111/j.1751-7915.2012.00331.x; Holland TL, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.59; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; McGee DJ, 2011, ANTIMICROB AGENTS CH, V55, P2897, DOI 10.1128/AAC.00016-11; Miner MD, 2009, INDIAN J EXP BIOL, V47, P407; Molinero N, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00185; Nidorf SM, 2020, J CLIN LIPIDOL, V14, P619, DOI 10.1016/j.jacl.2020.07.003; Pervaiz MH, 2018, J NUCL CARDIOL, V25, P433, DOI 10.1007/s12350-017-0826-y; Pesonen Erkki, 2008, Ther Adv Cardiovasc Dis, V2, P419, DOI 10.1177/1753944708098695; RAZIN S, 1975, J BACTERIOL, V124, P570, DOI 10.1128/JB.124.1.570-572.1975; SHINE WE, 1993, INVEST OPHTH VIS SCI, V34, P2291; Sun HY, 2009, CLIN INFECT DIS, V48, P745, DOI 10.1086/597039; Vaca DJ, 2020, MED MICROBIOL IMMUN, V209, P277, DOI 10.1007/s00430-019-00644-3; Yazdi MT, 2000, WORLD J MICROB BIOT, V16, P103, DOI 10.1023/A:1008920105720; Zahn R, 2003, CIRCULATION, V107, P1253, DOI 10.1161/01.CIR.0000054613.57105.06	28	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263847	10.1371/journal.pone.0263847	http://dx.doi.org/10.1371/journal.pone.0263847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180238	Green Published, gold			2022-12-26	WOS:000796435800034
J	Smith, EW; Lattmann, S; Liu, ZB; Ahsan, B; Rhodes, D				Smith, Emmanuel W.; Lattmann, Simon; Liu, Zhehui Barry; Ahsan, Bilal; Rhodes, Daniela			Insights into POT1 structural dynamics revealed by cryo-EM	PLOS ONE			English	Article							MULTIPLE POT1-TPP1 PROTEINS; TELOMERASE PROCESSIVITY; DNA; CANCER; TRF1; SHELTERIN; RECRUITMENT; PROTECTION; RESOLUTION; COMPLEX	Telomeres are protein-DNA complexes that protect the ends of linear eukaryotic chromosomes. Mammalian telomeric DNA consists of 5'-(TTAGGG)n-3' double-stranded repeats, followed by up to several hundred bases of a 3' single-stranded G-rich overhang. The G-rich overhang is bound by the shelterin component POT1 which interacts with TPP1, the component involved in telomerase recruitment. A previously published crystal structure of the POT1 N-terminal half bound to the high affinity telomeric ligand 5'-TTAGGGTTAG-3' showed that the first six nucleotides, TTAGGG, are bound by the OB1 fold, while the adjacent OB2 binds the last four, TTAG. Here, we report two cryo-EM structures of full-length POT1 bound by the POT1-binding domain of TPP1. The structures differ in the relative orientation of the POT1 OB1 and OB2, suggesting that these two DNA-binding OB folds take up alternative conformations. Supporting DNA binding studies using telomeric ligands in which the OB1 and OB2 binding sites were spaced apart, show that POT1 binds with similar affinities to spaced or contiguous binding sites, suggesting plasticity in DNA binding and a role for the alternative conformations observed. A likely explanation is that the structural flexibility of POT1 enhances binding to the tandemly arranged telomeric repeats and hence increases telomere protection.	[Smith, Emmanuel W.; Lattmann, Simon; Liu, Zhehui Barry; Ahsan, Bilal; Rhodes, Daniela] Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore; [Rhodes, Daniela] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Smith, Emmanuel W.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Jupiter, FL USA; [Liu, Zhehui Barry] Francis Crick Inst, Struct Biol Cells & Viruses Lab, London, England; [Ahsan, Bilal; Rhodes, Daniela] MRC, Lab Mol Biol, Cambridge, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Scripps Research Institute; Francis Crick Institute; MRC Laboratory Molecular Biology	Rhodes, D (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Singapore, Singapore.; Rhodes, D (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Rhodes, D (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	rhodes@mrc-lmb.cam.ac.uk	Lattmann, Simon/G-2914-2010	Lattmann, Simon/0000-0002-4639-4602; Smith, Emmanuel/0000-0003-0985-6617; Ahsan, Bilal/0000-0003-1839-5023	Singapore Ministry of Education Academic Research Fund (AcRF) Tier 3 [MOE2012-T3-1001]; Singapore Ministry of Education Academic Research	Singapore Ministry of Education Academic Research Fund (AcRF) Tier 3(Ministry of Education, Singapore); Singapore Ministry of Education Academic Research(Ministry of Education, Singapore)	This research was supported by a Singapore Ministry of Education Academic Research Fund (AcRF) Tier 3 [MOE2012-T3-1001]. Funding for open access charge: Singapore Ministry of Education Academic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu T, 2020, COMPUT STRUCT BIOTEC, V18, P1939, DOI 10.1016/j.csbj.2020.06.040; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Chaires JB, 2020, NUCLEIC ACIDS RES, V48, P4976, DOI 10.1093/nar/gkaa202; Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14929; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; Corriveau M, 2013, J BIOL CHEM, V288, P16361, DOI 10.1074/jbc.M113.471896; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Dickey TH, 2014, NUCLEIC ACIDS RES, V42, P9656, DOI 10.1093/nar/gku680; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Gaullier G, 2016, NUCLEIC ACIDS RES, V44, P1962, DOI 10.1093/nar/gkv1531; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glousker G, 2020, EMBO J, V39, DOI 10.15252/embj.2020104500; Grill S, 2018, CELL REP, V22, P1132, DOI 10.1016/j.celrep.2018.01.012; Hu CY, 2017, CELL RES, V27, P1485, DOI 10.1038/cr.2017.144; Hwang H, 2012, STRUCTURE, V20, P1872, DOI 10.1016/j.str.2012.08.018; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y; Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Vilas JL, 2018, STRUCTURE, V26, P337, DOI 10.1016/j.str.2017.12.018; Maciejowski J, 2017, NAT REV MOL CELL BIO, V18, P175, DOI 10.1038/nrm.2016.171; Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Mullins MR, 2016, J MOL BIOL, V428, P2695, DOI 10.1016/j.jmb.2016.04.031; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nelson ND, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00025-18; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; Rice C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14928; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; Tegunov D, 2019, NAT METHODS, V16, P1146, DOI 10.1038/s41592-019-0580-y; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	55	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0264073	10.1371/journal.pone.0264073	http://dx.doi.org/10.1371/journal.pone.0264073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176105	gold, Green Published			2022-12-26	WOS:000777505200076
J	Jang, WS; Lim, DH; Choe, YL; Nam, J; Moon, KC; Kim, C; Choi, M; Park, I; Park, DW; Lim, CS				Jang, Woong Sik; Lim, Da Hye; Choe, Young Lan; Nam, Jeonghun; Moon, Kyung Chul; Kim, Chaewon; Choi, Minkyeong; Park, Insu; Park, Dae Won; Lim, Chae Seung			Developing a multiplex loop-mediated isothermal amplification assay (LAMP) to determine severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus	PLOS ONE			English	Article							REAL-TIME PCR; ORIENTIA-TSUTSUGAMUSHI; EARLY-DIAGNOSIS; SYNDROME VIRUS; BUNYAVIRUS	Severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus are endemic zoonotic diseases that pose significant public health threats in East Asia. As these two diseases share common clinical features, as well as overlapping disease regions, it is difficult to differentiate between SFTS and scrub typhus. A multiplex reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed to detect large segments and GroES genes for SFTS virus (SFTSV) and Orientia tsutsugamushi (OT). The performance of the RT-LAMP assay was compared and evaluated with those of commercial PowerChek (TM) SFTSV real-time PCR and LiliF (TM) TSUTSU nested PCR for 23 SFTS and 12 scrub typhus clinical samples, respectively. The multiplex SFTSV/OT/Internal control (IC) RT-LAMP assay showed comparable sensitivity (91.3%) with that of commercial PowerChek (TM) SFTSV Real-time PCR (95.6%) and higher sensitivity (91.6%) than that of LiliF (TM) TSUTSU nested PCR (75%). In addition, the multiplex SFTSV/OT RT-LAMP assay showed 100% specificity and no cross-reactivity for blood from uninfected healthy patients and samples from patients infected with other fever viruses. Thus, the multiplex SFTSV/OT/IC RT-LAMP assay could serve as a useful point-of-care molecular diagnostic test for SFTS and scrub typhus.	[Jang, Woong Sik; Moon, Kyung Chul] Korea Univ, Guro Hosp, Coll Med, Emergency Med, Seoul, South Korea; [Lim, Da Hye; Choe, Young Lan; Kim, Chaewon; Choi, Minkyeong; Park, Insu; Lim, Chae Seung] Korea Univ, Guro Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Nam, Jeonghun] Incheon Jaeneung Univ, Dept Song Do Bio Engn, Incheon, South Korea; [Nam, Jeonghun] Incheon Jaeneung Univ, Artificial Intelligence AI Bio Res Ctr, Incheon, South Korea; [Park, Dae Won] Korea Univ, Ansan Hosp, Div Infect Dis, Dept Internal Med, Ansan, Gyeonggi Do, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lim, CS (corresponding author), Korea Univ, Guro Hosp, Coll Med, Dept Lab Med, Seoul, South Korea.; Park, DW (corresponding author), Korea Univ, Ansan Hosp, Div Infect Dis, Dept Internal Med, Ansan, Gyeonggi Do, South Korea.	pugae1@korea.ac.kr; malarim@korea.ac.kr		Jang, Woong Sik/0000-0002-2910-0537; Park, Dae Won/0000-0002-7653-686X	government-wide R&D fund project for infectioMinistry of Health & Welfare, Republic of Korea [HR20C0021, HI20C0262030021, HG18C0012]; National Research Foundation of Korea [NRF-2016R1A5A1010148]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)	government-wide R&D fund project for infectioMinistry of Health & Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	This study was supported by a government-wide R&D fund project for infectioMinistry of Health & Welfare, Republic of Korea (grant number: HR20C0021 and HI20C0262030021).us disease research (HG18C0012), National Research Foundation of Korea (NRF-2016R1A5A1010148), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the	Augustine R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080182; Baek YH, 2018, J MICROBIOL BIOTECHN, V28, P1928, DOI 10.4014/jmb.1806.06016; Bhat IA, 2019, J APPL MICROBIOL, V126, P1332, DOI 10.1111/jam.13938; Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Bonell A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005838; Chakraborty S, 2017, INDIAN J DERMATOL, V62, P478, DOI 10.4103/ijd.IJD_388_17; Choi SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005264; Chrispal A, 2010, TROP DOCT, V40, P129, DOI 10.1258/td.2010.090452; Chung JK, 2020, VECTOR-BORNE ZOONOT, V20, P285, DOI 10.1089/vbz.2019.2463; Crecelius Elena M, 2020, J Spec Oper Med, V20, P120, DOI 10.55460/WCLB-0NKA; Ding F, 2013, CLIN INFECT DIS, V56, P1682, DOI 10.1093/cid/cit100; Elliott I, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3751-x; FDA, COVID 19 IN VITR DIA; Janardhanan J, 2014, EXPERT REV ANTI-INFE, V12, P1533, DOI 10.1586/14787210.2014.974559; Jang WS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238615; Jang WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213451; Jiang J, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3010011; Kala D, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02389-w; Kim DM, 2011, J CLIN MICROBIOL, V49, P607, DOI 10.1128/JCM.01216-09; Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108; Kim G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005408; Kim JH, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e257; Kirino Y, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020229; Li DX, 2015, CLIN MICROBIOL INFEC, V21, P614, DOI 10.1016/j.cmi.2015.03.001; Moehling TJ, 2021, EXPERT REV MOL DIAGN, V21, P43, DOI 10.1080/14737159.2021.1873769; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Yen NTH, 2019, AM J TROP MED HYG, V101, P1096, DOI 10.4269/ajtmh.19-0392; Viet NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005397; Paris DH, 2008, T ROY SOC TROP MED H, V102, P1239, DOI 10.1016/j.trstmh.2008.04.040; Park SW, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3773-1; Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953; Pradutkanchana J, 1997, T ROY SOC TROP MED H, V91, P425, DOI 10.1016/S0035-9203(97)90266-2; Ra SH, 2019, AM J TROP MED HYG, V101, P1259, DOI 10.4269/ajtmh.19-0242; Rajapakse S, 2017, T ROY SOC TROP MED H, V111, P43, DOI 10.1093/trstmh/trx017; Sano S., 2021, VIRUSES-BASEL, V13, P693, DOI 10.3390/v13040693; Seo JW, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071213; Silvas JA, 2017, AM J TROP MED HYG, V97, P992, DOI 10.4269/ajtmh.16-0967; Sui X, 2019, PEERJ, V6, DOI 10.7717/peerj.6068; Sun YL, 2012, J CLIN VIROL, V53, P48, DOI 10.1016/j.jcv.2011.09.031; Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902; Tantibhedhyangkul W, 2017, J CLIN MICROBIOL, V55, P1377, DOI 10.1128/JCM.02181-16; Watthanaworawit W, 2013, AM J TROP MED HYG, V89, P308, DOI 10.4269/ajtmh.12-0600; Wi YM, 2016, EMERG INFECT DIS, V22, P1992, DOI 10.3201/eid2211.160597; Yoo IY, 2020, ANN LAB MED, V40, P317, DOI 10.3343/alm.2020.40.4.317; Yoshikawa T, 2014, J CLIN MICROBIOL, V52, P3325, DOI 10.1128/JCM.00742-14; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Yun JH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017701; Yun SM, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.129531	48	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0262302	10.1371/journal.pone.0262302	http://dx.doi.org/10.1371/journal.pone.0262302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1G5LQ	35171943	Green Published, gold			2022-12-26	WOS:000795889700004
J	Kim, J; Bae, E; Kim, Y; Lim, CY; Hur, JW; Kwon, JS; Lee, SH				Kim, Jinyoung; Bae, Eunseong; Kim, Yeonhwa; Lim, Chae Young; Hur, Ji-Won; Kwon, Jun Soo; Lee, Sang-Hun			A robust multivariate structure of interindividual covariation between psychosocial haracteristics and arousal responses to visual narratives	PLOS ONE			English	Article							EMOTION RECOGNITION ABILITY; PICTURE SYSTEM IAPS; INDIVIDUAL-DIFFERENCES; AFFECTIVE STYLE; PERSONALITY; DIFFERENTIATION; EXPRESSION; APPRAISAL; ALCOHOL; STRESS	People experience the same event but do not feel the same way. Such individual differences in emotion response are believed to be far greater than those in any other mental functions. Thus, to understand what makes people individuals, it is important to identify the systematic structures of individual differences in emotion response and elucidate how such structures relate to what aspects of psychological characteristics. Reflecting this importance, many studies have attempted to relate emotions to psychological characteristics such as personality traits, psychosocial states, and pathological symptoms across individuals. However, systematic and global structures that govern the across-individual covariation between the domain of emotion responses and that of psychological characteristics have been rarely explored previously, which limits our understanding of the relationship between individual differences in emotion response and psychological characteristics. To overcome this limitation, we acquired high-dimensional data sets in both emotion-response (8 measures) and psychological-characteristic (68 measures) domains from the same pool of individuals (86 undergraduate or graduate students) and carried out the canonical correlation analysis in conjunction with the principal component analysis on those data sets. For each participant, the emotion-response measures were quantified by regressing affective-rating responses to visual narrative stimuli onto the across-participant average responses to those stimuli, while the psychological-characteristic measures were acquired from 19 different psychometric questionnaires grounded in personality, psychosocial-factor, and clinical-problem taxonomies. We found a single robust mode of population covariation, particularly between the 'accuracy' and 'sensitivity' measures of arousal responses in the emotion domain and many 'psychosocial' measures in the psychological-characteristics domain. This mode of covariation suggests that individuals characterized with positive social assets tend to show polarized arousal responses to life events.	[Kim, Jinyoung; Kim, Yeonhwa; Kwon, Jun Soo; Lee, Sang-Hun] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Bae, Eunseong] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Lim, Chae Young] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Hur, Ji-Won] Korea Univ, Dept Psychol, Seoul, South Korea; [Kwon, Jun Soo] Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea	Seoul National University (SNU); University of California System; University of California Davis; Seoul National University (SNU); Korea University; Seoul National University (SNU)	Lee, SH (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	visionsl@snu.ac.kr		Kwon, Jun Soo/0000-0002-1060-1462	National Research Foundation of Korea (NRF) - Ministry of Science and ICT of South Korea [NRF2017M3C7A1047860, NRF-2018R1A4A1025891]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT of South Korea(National Research Foundation of Korea)	JK and SL were supported by the Brain Research Programs and Basic Research Laboratory Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT of South Korea (https://english.msit.go.kr).Grant numbers are NRF2017M3C7A1047860 for the Brain Research Programs and NRF-2018R1A4A1025891 for the Basic Research Laboratory Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Aluja A, 2015, PERS INDIV DIFFER, V77, P143, DOI 10.1016/j.paid.2014.12.058; BABOR TF, 1992, ARCH GEN PSYCHIAT, V49, P599; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P266, DOI 10.1037/0022-3514.87.2.266; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell M, 1997, PSYCHIAT RES, V73, P73, DOI 10.1016/S0165-1781(97)00111-X; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carvalho S, 2012, APPL PSYCHOPHYS BIOF, V37, P279, DOI 10.1007/s10484-012-9201-6; Castellano F, 2015, NEUROSCI BIOBEHAV R, V59, P147, DOI 10.1016/j.neubiorev.2015.11.001; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COOPER ML, 1992, J ABNORM PSYCHOL, V101, P139, DOI 10.1037/0021-843X.101.1.139; COX WM, 1988, J ABNORM PSYCHOL, V97, P168, DOI 10.1037/0021-843X.97.2.168; Daudelin-Peltier C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01053-3; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; Deng YL, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01941; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Emery NN, 2014, ADDICT BEHAV, V39, P1459, DOI 10.1016/j.addbeh.2014.05.004; Erbas Y, 2019, COGNITION EMOTION, V33, P258, DOI 10.1080/02699931.2018.1465894; Erbas Y, 2014, COGNITION EMOTION, V28, P1196, DOI 10.1080/02699931.2013.875890; FISH LJ, 1988, MEAS EVAL COUNS DEV, V21, P130, DOI 10.1080/07481756.1988.12022895; Gendron M, 2014, PSYCHOL SCI, V25, P911, DOI 10.1177/0956797613517239; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gray J.A., 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Gross JJ, 2000, PERS SOC PSYCHOL B, V26, P712, DOI 10.1177/0146167200268006; Hanggi Y, 2004, SWISS J PSYCHOL, V63, P113, DOI 10.1024/1421-0185.63.2.113; Harley JM, 2016, USER MODEL USER-ADAP, V26, P177, DOI 10.1007/s11257-016-9169-7; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Herring DR, 2011, INT J PSYCHOPHYSIOL, V79, P211, DOI 10.1016/j.ijpsycho.2010.10.007; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Hofmann SG, 2012, DEPRESS ANXIETY, V29, P409, DOI 10.1002/da.21888; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kleiner M, 2007, PERCEPTION, V36, P14; Kohler Christian G, 2010, Schizophr Bull, V36, P1009, DOI 10.1093/schbul/sbn192; Kring AM, 2013, ANNU REV CLIN PSYCHO, V9, P409, DOI 10.1146/annurev-clinpsy-050212-185538; Kring AM, 2012, EMOT REV, V4, P182, DOI 10.1177/1754073911430140; Kuppens P, 2007, COGNITION EMOTION, V21, P689, DOI 10.1080/02699930600859219; Kuppens P, 2007, EMOTION, V7, P262, DOI 10.1037/1528-3542.7.2.262; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; Kuppens P, 2009, COGNITION EMOTION, V23, P1249, DOI 10.1080/02699930902985605; LARSEN RJ, 1987, J PERS SOC PSYCHOL, V52, P1195, DOI 10.1037/0022-3514.52.6.1195; Lewis MD, 2005, BRIDGING EMOTION THE; Lopes PN, 2003, PERS INDIV DIFFER, V35, P641, DOI 10.1016/S0191-8869(02)00242-8; Luminet O, 2000, COGNITION EMOTION, V14, P661, DOI 10.1080/02699930050117666; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Lyusin D, 2016, LEARN INDIVID DIFFER, V52, P129, DOI 10.1016/j.lindif.2015.04.010; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Mesquita B., 1992, EUROPEAN REV SOCIAL, V3, P225, DOI [DOI 10.1080/14792779243000078, 10.1080/14792779243000078]; Nook EC, 2017, NAT HUM BEHAV, V1, P881, DOI 10.1038/s41562-017-0238-7; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Revelle W., 2009, OXFORD COMPANION EMO, V1, P304; RIME B, 1991, COGNITION EMOTION, V5, P435, DOI 10.1080/02699939108411052; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; ROSENBERG EL, 1994, COGNITION EMOTION, V8, P201, DOI 10.1080/02699939408408938; Rosenberg M., 1965, ACCEPT COMMIT THER M, V61, P18; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Rutter LA, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1282; Sander D, 2005, NEURAL NETWORKS, V18, P317, DOI 10.1016/j.neunet.2005.03.001; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Scherer KR, 2011, J NONVERBAL BEHAV, V35, P305, DOI 10.1007/s10919-011-0115-4; Smidt KE, 2015, CURR OPIN PSYCHOL, V3, P48, DOI 10.1016/j.copsyc.2015.02.007; SMITH CA, 1993, COGNITION EMOTION, V7, P233, DOI 10.1080/02699939308409189; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Stouten J, 2005, EUR J SOC PSYCHOL, V35, P767, DOI 10.1002/ejsp.276; Sturmer M, 2018, INT J BIOMETEOROL, V62, P1663, DOI 10.1007/s00484-018-1566-7; Thompson B, 1994, WHY MULTIVARIATE MET; Tok S, 2010, PERS INDIV DIFFER, V49, P461, DOI 10.1016/j.paid.2010.04.020; Tourangeau R, 1984, COGNITIVE ASPECTS SU, P73; Tracy JL, 2008, P NATL ACAD SCI USA, V105, P11655, DOI 10.1073/pnas.0802686105; Tracy JL, 2008, J PERS SOC PSYCHOL, V94, P516, DOI 10.1037/0022-3514.94.3.516; Van der Waerden B, 1952, INDAGATIONES MATHEMA; Verduyn P, 2009, EMOTION, V9, P83, DOI 10.1037/a0014610; Wang HT, 2020, NEUROIMAGE, V216, DOI 10.1016/j.neuroimage.2020.116745; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Zhou TH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16060953	98	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2022	17	2							e0263817	10.1371/journal.pone.0263817	http://dx.doi.org/10.1371/journal.pone.0263817			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1G5LQ	35171958	Green Published, gold			2022-12-26	WOS:000795889700038
J	Grandjean, D; Gallet, C; Julien, C; Sarkis, R; Muzzin, Q; Roger, V; Roisse, D; Dirn, N; Levert, C; Breton, E; Galtat, A; Forget, A; Charreaudeau, S; Gasmi, F; Jean-Baptiste, C; Petitjean, S; Hamon, K; Duquesne, JM; Coudert, C; Tourtier, JP; Billy, C; Wurtz, JM; Chauvin, A; Eyer, X; Ziani, S; Prevel, L; Cherubini, I; Khelili-Houas, E; Hausfater, P; Devillier, P; Desquilbet, L				Grandjean, Dominique; Gallet, Capucine; Julien, Clothilde; Sarkis, Riad; Muzzin, Quentin; Roger, Vinciane; Roisse, Didier; Dirn, Nicolas; Levert, Clement; Breton, Erwan; Galtat, Arnaud; Forget, Alexandre; Charreaudeau, Sebastien; Gasmi, Fabien; Jean-Baptiste, Caroline; Petitjean, Sebastien; Hamon, Katia; Duquesne, Jean-Michel; Coudert, Chantal; Tourtier, Jean-Pierre; Billy, Christophe; Wurtz, Jean-Marc; Chauvin, Anthony; Eyer, Xavier; Ziani, Sabrina; Prevel, Laura; Cherubini, Ilaria; Khelili-Houas, Enfel; Hausfater, Pierre; Devillier, Philippe; Desquilbet, Loic			Identifying SARS-COV-2 infected patients through canine olfactive detection on axillary sweat samples; study of observed sensitivities and specificities within a group of trained dogs	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; PROSTATE-CANCER; SNIFFING URINE; COVID-19; SCENT	There is an increasing need for rapid, reliable, non-invasive, and inexpensive mass testing methods as the global COVID-19 pandemic continues. Detection dogs could be a possible solution to identify individuals infected with SARS-CoV-2. Previous studies have shown that dogs can detect SARS-CoV-2 on sweat samples. This study aims to establish the dogs' sensitivity (true positive rate) which measures the proportion of people with COVID-19 that are correctly identified, and specificity (true negative rate) which measures the proportion of people without COVID-19 that are correctly identified. Seven search and rescue dogs were tested using a total of 218 axillary sweat samples (62 positive and 156 negative) in olfaction cones following a randomised and double-blind protocol. Sensitivity ranged from 87% to 94%, and specificity ranged from 78% to 92%, with four dogs over 90%. These results were used to calculate the positive predictive value and negative predictive value for each dog for different infection probabilities (how likely it is for an individual to be SARS-CoV-2 positive), ranging from 10-50%. These results were compared with a reference diagnostic tool which has 95% specificity and sensitivity. Negative predictive values for six dogs ranged from >= 98% at 10% infection probability to >= 88% at 50% infection probability compared with the reference tool which ranged from 99% to 95%. Positive predictive values ranged from >= 40% at 10% infection probability to >= 80% at 50% infection probability compared with the reference tool which ranged from 68% to 95%. This study confirms previous results, suggesting that dogs could play an important role in mass-testing situations. Future challenges include optimal training methods and standardisation for large numbers of detection dogs and infrastructure supporting their deployment.	[Grandjean, Dominique; Gallet, Capucine; Julien, Clothilde; Muzzin, Quentin; Roger, Vinciane; Jean-Baptiste, Caroline] Univ Paris Est, Alft Sch Vet Med, Maisons Alfort, France; [Sarkis, Riad] St Joseph Univ Beirut, Beirut, Lebanon; [Roisse, Didier; Dirn, Nicolas] Serv Dept Incendie & Secours Oise, Fire & Rescue Serv, Tille, France; [Levert, Clement; Breton, Erwan; Galtat, Arnaud; Forget, Alexandre; Charreaudeau, Sebastien; Gasmi, Fabien; Petitjean, Sebastien; Hamon, Katia; Duquesne, Jean-Michel; Coudert, Chantal] Serv Dept Incendie & Secours Yvelines, Fire & Rescue Serv, Versailles, France; [Tourtier, Jean-Pierre] Begin Mil Hosp, Hop Instruct Armees Begin, St Mande, France; [Billy, Christophe] Francois Quesnay Hosp Ctr, GHT Yvelines, Mantes La Jolie, France; [Wurtz, Jean-Marc] Grp Hosp Mulhouse Sud Alsace, Site Altkirch GHRMSA, Altkirch, France; [Chauvin, Anthony; Eyer, Xavier] Great Paris Hosp, Hop Lariboisiere, AP HP, Paris, France; [Ziani, Sabrina] St Maurice Hosp, St Maurice, France; [Prevel, Laura; Devillier, Philippe] Foch Hosp, Suresnes, France; [Cherubini, Ilaria; Khelili-Houas, Enfel; Hausfater, Pierre] Great Paris Hosp, Pitie Salpetriere Hosp, AP HP, Paris, France; [Desquilbet, Loic] Univ Paris Est Creteil, IMRB, INSERM, Ecole Natl Vet Alft, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ecole Nationale Veterinaire d'Alfort (ENVA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Grandjean, D (corresponding author), Univ Paris Est, Alft Sch Vet Med, Maisons Alfort, France.	dominique.grandjean@vet-alfort.fr		GRANDJEAN, Dominique/0000-0002-8408-8358	World Health Organization [202605592]; German Federal Ministry of Health (BMG) COVID-19 research and development funding	World Health Organization(World Health Organization); German Federal Ministry of Health (BMG) COVID-19 research and development funding	Dominique Grandjean received funding in the form of a grant from the World Health Organization, Grant No: 202605592. This research has been supported by German Federal Ministry of Health (BMG) COVID-19 research and development funding to World Health Organization. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Qader A, 2015, BIOMED CHROMATOGR, V29, P1783, DOI 10.1002/bmc.3494; Aksenov AA, 2014, CHEMBIOCHEM, V15, P1040, DOI 10.1002/cbic.201300695; Aksenov AA, 2012, CHEMBIOCHEM, V13, P1053, DOI 10.1002/cbic.201200011; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Amann A, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/034001; Arevalo-Rodriguez I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242958; Axell-House DB, 2020, J INFECTION, V81, P681, DOI 10.1016/j.jinf.2020.08.043; Bjartell AS, 2011, EUR UROL, V59, P202, DOI 10.1016/j.eururo.2010.10.033; Boedeker E, 2012, INTERACT CARDIOV TH, V14, P511, DOI 10.1093/icvts/ivr070; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Buszewski B, 2012, ANAL BIOANAL CHEM, V404, P141, DOI 10.1007/s00216-012-6102-8; Campbell LF, 2013, BMJ CASE REPORTS, V2013; Centers for Diseases Control and Prevention, 2021, CALC SARS COV 2 LAB; Cohen Andrew N., 2020, FALSE POSITIVES REVE, DOI [DOI 10.1101/2020.04.26.20080911, 10.1101/2020.04.26.20080911]; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Eskandari E, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05939-6; Essler JL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250158; Grabowska-Polanowska B, 2017, BIOANALYSIS, V9, P1465, DOI 10.4155/bio-2017-0128; Grandjean D, 2021, J VET SCI RES, V6; Grandjean D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243122; Guirao A, 2019, LUNG CANCER, V135, P230, DOI 10.1016/j.lungcan.2019.06.008; Hantz Sebastien, 2020, Rev Francoph Lab, V2020, P48, DOI 10.1016/S1773-035X(20)30313-0; Hielm-Bjorkman A, 2020, INT K9 WORKING GROUP; Jendrny P, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05281-3; Johnen D, 2017, APPL ANIM BEHAV SCI, V189, P1, DOI 10.1016/j.applanim.2017.01.001; Kanji JN, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01489-0; Kirton A, 2008, EPILEPSY BEHAV, V13, P499, DOI 10.1016/j.yebeh.2008.05.011; Kitiyakara T, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa7b8e; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Pirrone F, 2017, J VET BEHAV, V19, P105, DOI 10.1016/j.jveb.2017.03.004; Ren SY, 2020, WORLD J CLIN CASES, V8, P1391, DOI 10.12998/wjcc.v8.i8.1391; Rooney NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210092; Rooney NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069921; Sarkis R, 2017, J CHIR VISC, V154, P22; Sarkis R., 2020, INT K9 WORK GROUP CO; Skittrall JP, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.10.003; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Surkova E, 2020, LANCET RESP MED, V8, P1167, DOI 10.1016/S2213-2600(20)30453-7; Taverna G, 2015, J UROLOGY, V193, P1382, DOI 10.1016/j.juro.2014.09.099; Vesga O, 2020, BIORXIV; Walczak M, 2012, J VET BEHAV, V7, P283, DOI 10.1016/j.jveb.2012.01.001; Wells DL, 2008, J ALTERN COMPLEM MED, V14, P1235, DOI 10.1089/acm.2008.0288; Willman D, 2020, CONTAMINATION CDC LA; Wilson C, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00091; World Health Organization, CONS US TRAIN DOGS S; Zhang Z, 2021, LANCET MICROBE, V2, pE79, DOI 10.1016/S2666-5247(20)30200-7	49	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0262631	10.1371/journal.pone.0262631	http://dx.doi.org/10.1371/journal.pone.0262631			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157716	Green Published, gold			2022-12-26	WOS:000788004500007
J	Ratnasari, N; Lestari, P; Renovaldi, D; Ningsih, JR; Qoriansas, N; Wardana, T; Hakim, S; Gumilas, NSA; Indrarti, F; Triwikatmani, C; Bayupurnama, P; Heriyanto, DS; Astuti, I; Harjana, SM				Ratnasari, Neneng; Lestari, Puji; Renovaldi, Dede; Ningsih, Juwita Raditya; Qoriansas, Nanda; Wardana, Tirta; Hakim, Suharno; Gumilas, Nur Signa Aini; Indrarti, Fahmi; Triwikatmani, Catharina; Bayupurnama, Putut; Heriyanto, Didik Setyo; Astuti, Indwiani; Harjana, Sofia Mubarika			Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EXPRESSION; INFECTION; MICRORNAS; TIME	This study evaluated differences in the clinical appearance of patients with hepatocellular carcinoma (HCC) based on plasma level and regulation of microRNAs (miRNA-29c, miRNA-21, and miRNA-155). The observational-analytical study with a cross-sectional design was conducted on 36 HCC patients and 36 healthy controls. The blood samples were collected from 2 Province Hospitals (Dr. Sardjito Hospital and Prof. Dr. Margono Soekarjo Hospital) for HCC and the Blood Bank Donor of the Indonesian Red Cross for 36 healthy controls. These blood samples were treated as follows: plasma isolation, RNA isolation, cDNA synthesis, quantification by qRT-PCR using a sequence-specific forward primer, and normalization of miRNA using housekeeping-stably miRNA-16. There were only 27 HCC patients with complete clinical variables (neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), platelet count, albumin, C-reactive protein (CRP), and cholinesterase (ChE)) that were able to analyses for regulation miRNAs based on its fold change expression miRNA target. All 27 HCC subjects were follow-up until 3-years of monitoring for their overall survival. The miRNA plasma expression was analyzed by Bio-Rad CFX 96 Manager software to determine the cycle of quantification, followed by the calculation of expression levels using Livak's methods. Data were analyzed using STATA 11.0, with a significant value of p<0.05. The miRNAs expression of HCC subjects were lower than that healthy control subjects in miRNA-29c (down-regulation 1.83-fold), higher than that healthy control subjects in miRNA 21 and miRNA-155 (up-regulation, 1.74-fold; 1.55-fold) respectively. NLR, CRP, ChE, and platelet count showed a significant difference in miRNA-29c regulation, though neutrophil count showed a significant difference in miRNA-21 and miRNA-155 regulation (p<0.05). Conclusion: Plasma biomarkers: miRNA-21 and miRNA155 might be potential biomarkers as onco-miR in HCC subjects, while miRNA-29c might act as a tumor suppressor. Significant evidence was identified with clinical progression based on the regulation of miRNAs, which was consistent with miRNA -29c.	[Ratnasari, Neneng; Indrarti, Fahmi; Triwikatmani, Catharina; Bayupurnama, Putut] Univ Gadjah Mada, Dr Sardjito Gen Hosp, Fac Med Publ Hlth & Nursing, Gastroenterol Hepatol Div,Internal Med Dept, Yogyakarta, Daerah Istimewa, Indonesia; [Lestari, Puji; Renovaldi, Dede; Ningsih, Juwita Raditya; Qoriansas, Nanda] Univ Gadjah Mada, Grad Sch Biotechnol, Daerah Istimewa Yogyakar, Indonesia; [Wardana, Tirta] Jenderal Soedirman Univ, Fac Med, Sch Dent, Dept Biomed, Jawatengah, Indonesia; [Hakim, Suharno] Univ Jendral Soedirman, Fac Med, Internal Med Dept, Dr Margono Soekarjo Hosp, Jawatengah, Indonesia; [Gumilas, Nur Signa Aini] Univ Jendral Soedirman, Histol Dept, Fac Med, Jawa Tengah, Indonesia; [Heriyanto, Didik Setyo] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Anat Pathol Dept, Yogyakarta, Daerah Istimewa, Indonesia; [Astuti, Indwiani] Univ Gadjah Mada, Pharmacol & Therapy Dept, Fac Med Publ Hlth & Nursing, Yogyakarta, Daerah Istimewa, Indonesia; [Harjana, Sofia Mubarika] Univ Gadjah Mada, Histol & Cell Biol Dept, Fac Med Publ Hlth & Nursing, Yogyakarta, Daerah Istimewa, Indonesia; [Lestari, Puji] Dharmais Canc Hosp, Dept Res & Dev, Jakarta Barat, Indonesia; [Renovaldi, Dede] Univ Muhammadiyah Jakarta, Fac Med & Hlth, Dept Biomed Sci, Banten, Indonesia; [Ningsih, Juwita Raditya] Univ Muhammadiyah Surakarta, Fac Dent, Jawatengah, Indonesia	Gadjah Mada University; Gadjah Mada University; Universitas Jenderal Soedirman; Universitas Jenderal Soedirman; Universitas Jenderal Soedirman; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Dharmais Hospital; Universitas Muhammadiyah Surakarta	Ratnasari, N (corresponding author), Univ Gadjah Mada, Dr Sardjito Gen Hosp, Fac Med Publ Hlth & Nursing, Gastroenterol Hepatol Div,Internal Med Dept, Yogyakarta, Daerah Istimewa, Indonesia.	nenengratnasari@gmail.com	Indrarti, Fahmi/GLV-5614-2022; Renovaldi, Dede/GPF-3319-2022; Ratnasari, Neneng/GLN-5795-2022; Heriyanto, Didik Setyo/AAR-3209-2021	Heriyanto, Didik Setyo/0000-0001-9728-5046; Wardana, Tirta/0000-0002-1926-1345; Gumilas, Nur Signa Aini/0000-0002-9904-2133; Ningsih, Juwita Raditya/0000-0002-1036-6220; Ratnasari, Neneng/0000-0003-1323-2233				Abd-Elmouttaleb AT, 2015, RES CANC TUMOR, V4, P25, DOI [10.5923/j.rct.20150402.01, DOI 10.5923/J.RCT.20150402.01]; Ali R, 2018, CARDIOVASC INTER RAD, V41, P260, DOI 10.1007/s00270-017-1791-1; Bayupurnama P, 2009, INTERNET J GASTROENT, V9, P3; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chen W, 2015, CANCER EPIDEM BIOMAR, V24, P386, DOI 10.1158/1055-9965.EPI-14-1038; Demerdash HM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1806069; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; EL Zwahry E, 2013, RESEARCHER, V5, P33; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Garcia-Ayllon MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044598; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Guan CN, 2016, ONCOL LETT, V11, P1574, DOI 10.3892/ol.2015.4048; Han JG, 2017, ANN SURG TREAT RES, V92, P55, DOI 10.4174/astr.2017.92.2.55; Hayes CN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030280; Huang GQ, 2017, J CLIN TRANSL HEPATO, V5, P35, DOI 10.14218/JCTH.2016.00035; Huang YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00631-9; Hung CH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/486407; Jin Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46872-8; Kalra A, 2017, LIVER TRANSPLANT, V23, P155, DOI 10.1002/lt.24702; Klingenberg M, 2017, J HEPATOL, V67, P603, DOI 10.1016/j.jhep.2017.04.009; Kwon JJ, 2019, MOL THER-ONCOLYTICS, V12, P173, DOI 10.1016/j.omto.2018.12.011; Lanza E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227711; Lee JS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011138; Lestari P, 2016, J MED SCI, V48, DOI [10.19106/JMedScieSup0048042016019], DOI 10.19106/JMEDSCIESUP0048042016019]; Liao QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130677; Liu XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170605; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35378; Mao BJ, 2015, ONCOL REP, V34, P2811, DOI 10.3892/or.2015.4275; Markus S, PLOS ONE, V16, DOI [10.1371/journal.pone.0247917, DOI 10.1371/JOURNAL.PONE.0247917]; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Meng FP, 2013, BIOMED REP, V1, P265, DOI 10.3892/br.2013.60; Morishita A, 2021, CANCERS, V13, DOI 10.3390/cancers13030514; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Oh BS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-78; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pieri G, 2014, ANN GASTROENTEROL, V27, P113; Rapado-Gonzalez O, 2018, J CANCER, V9, P638, DOI 10.7150/jca.21180; Shen SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38311; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Szabo G, 2012, J HEPATOL, V57, P462, DOI 10.1016/j.jhep.2012.01.030; Tang B, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0371-6; Wu H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1281-7; Xie QY, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0179-4; Zhang HG, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/4394650	48	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263298	10.1371/journal.pone.0263298	http://dx.doi.org/10.1371/journal.pone.0263298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157721	gold, Green Published			2022-12-26	WOS:000788004500011
J	Tashima, Y; Iwakoshi, S; Inoue, T; Nakamura, N; Sano, T; Kimura, N; Inoue, T; Adachi, K; Yamaguchi, A				Tashima, Yasushi; Iwakoshi, Shinichi; Inoue, Takeshi; Nakamura, Noriyuki; Sano, Taichi; Kimura, Naoyuki; Inoue, Takashi; Adachi, Koichi; Yamaguchi, Atsushi			Aortic Agatston score correlates with the progression of acute type A aortic dissection	PLOS ONE			English	Article							FALSE LUMEN; CALCIFICATION; ARTERIAL; RISK; ACCUMULATION; OUTCOMES; SURGERY; EVENTS; IMPACT	Aortic calcification in the tunica media is correlated with aortic stiffness, elastin degradation, and wall shear stress. The study aim was to determine if aortic calcifications influence disease progression in patients with acute type A aortic dissection (ATAAD). We retrospectively reviewed a total of 103 consecutive patients who had undergone surgery for ATAAD at our institution between January 2009 and December 2019. Of these, 85 patients who had preoperatively undergone plain computed tomography angiography (CTA) for evaluation of their aortic calcification were included. Moreover, we assessed the progression of aortic dissection after surgery via postoperative CTA. Using a classification and regression tree to identify aortic Agatston score thresholds predictive of disease progression, the patients were classified into high-score (Agatston score >= 3344; n = 36) and low-score (<3344; n = 49) groups. Correlations between aortic Agatston scores and CTA variables were assessed. Higher aortic Agatston scores were significantly correlated with the smaller distal extent of aortic dissection (p < 0.001), larger true lumen areas of the ascending (p = 0.009) and descending aorta (p = 0.002), and smaller false lumen areas of the descending aorta (p = 0.028). Patients in the high-score group were more likely to have DeBakey type II dissection (p = 0.001) and false lumen thrombosis (p = 0.027) than those in the low-score group, thereby confirming the correlations. Aortic dissection in the high-score group was significantly less distally extended (p < 0.001). A higher aortic Agatston score correlates with the larger true lumen area of the ascending and descending aorta and the less distal progression of aortic dissection in patients with ATAAD. Interestingly, the findings before and after surgery were consistent. Hence, aortic Agatston scores are associated with aortic dissection progression and may help predict postoperative residual dissected aorta remodeling.	[Tashima, Yasushi; Nakamura, Noriyuki; Sano, Taichi; Adachi, Koichi] Yokosuka Gen Hosp Uwamachi, Dept Cardiovasc Surg, Yokosuka, Kanagawa, Japan; [Tashima, Yasushi; Nakamura, Noriyuki; Sano, Taichi; Kimura, Naoyuki; Adachi, Koichi; Yamaguchi, Atsushi] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan; [Iwakoshi, Shinichi; Inoue, Takeshi] Nara Med Univ, Dept Radiol, Nara, Japan; [Inoue, Takashi] Nara Med Univ, Inst Clin & Translat Sci, Kashihara, Nara, Japan	Jichi Medical University; Nara Medical University; Nara Medical University	Tashima, Y (corresponding author), Yokosuka Gen Hosp Uwamachi, Dept Cardiovasc Surg, Yokosuka, Kanagawa, Japan.; Tashima, Y (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan.	tyasushi42@gmail.com		Tashima, Yasushi/0000-0002-9000-3410				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aizawa K, 2016, GEN THORAC CARDIOVAS, V64, P403, DOI 10.1007/s11748-016-0648-x; Akiyoshi K, 2019, GEN THORAC CARDIOVAS, V67, P501, DOI 10.1007/s11748-018-1051-6; Akutsu K, 2019, GEN THORAC CARDIOVAS, V67, P271, DOI 10.1007/s11748-019-01066-x; Akutsu K, 2015, CIRC J, V79, P567, DOI 10.1253/circj.CJ-14-0828; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Badi I, 2018, ARTERIOSCL THROM VAS, V38, P2079, DOI 10.1161/ATVBAHA.118.311298; Bhat O, 2020, J CELL MOL MED, V24, P539, DOI 10.1111/jcmm.14761; Blumenthal Herman T., 1944, AMER JOUR PATH, V20, P665; de Jong PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102036; Dudink EAMP, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2018-000893; Elsayed RS, 2017, CARDIOL CLIN, V35, P331, DOI 10.1016/j.ccl.2017.03.004; Hendriks EJE, 2017, ATHEROSCLEROSIS, V259, P120, DOI 10.1016/j.atherosclerosis.2017.01.029; HICKLER RB, 1990, CLIN CARDIOL, V13, P317, DOI 10.1002/clc.4960130504; Ichii M, 2013, KIDNEY BLOOD PRESS R, V38, P196, DOI 10.1159/000355768; Iribarren C, 2007, J INTERN MED, V261, P235, DOI 10.1111/j.1365-2796.2007.01768.x; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; Jacobs PC, 2011, EUR RADIOL, V21, P1577, DOI 10.1007/s00330-011-2112-8; LACHMAN AS, 1977, AM J MED, V63, P615, DOI 10.1016/0002-9343(77)90207-8; Leontyev S, 2017, THORAC CARDIOV SURG, V65, P90, DOI 10.1055/s-0036-1571813; Li ZY, 2008, J VASC SURG, V47, P928, DOI 10.1016/j.jvs.2008.01.006; Lombardi JV, 2020, ANN THORAC SURG, V109, P959, DOI 10.1016/j.athoracsur.2019.10.005; MEEMA HE, 1986, RADIOLOGY, V158, P671, DOI 10.1148/radiology.158.3.3945736; Narumi H, 2009, INT J CARDIOL, V135, P150, DOI 10.1016/j.ijcard.2008.03.044; O'Leary SA, 2015, J MECH BEHAV BIOMED, V42, P154, DOI 10.1016/j.jmbbm.2014.11.005; ORR DP, 1978, INVEST RADIOL, V13, P110, DOI 10.1097/00004424-197803000-00002; Osada H, 2013, EUR J CARDIO-THORAC, V43, pE82, DOI 10.1093/ejcts/ezs640; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Philip JL, 2017, J THORAC DIS, V9, P2966, DOI 10.21037/jtd.2017.08.06; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Qing KX, 2016, EUR J VASC ENDOVASC, V51, P656, DOI 10.1016/j.ejvs.2016.01.006; Saremi F, 2018, RADIOGRAPHICS, V38, P1949, DOI 10.1148/rg.2018180025; Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x; Shi N, 2019, ARTERIOSCL THROM VAS, V39, pE247, DOI 10.1161/ATVBAHA.119.312581; Therneau TM., 2015, INTRO RECURSIVE PART; Tohno S, 1998, CELL MOL BIOL, V44, P1253; Tohno Y, 1996, BIOL TRACE ELEM RES, V54, P23, DOI 10.1007/BF02785317; Yang CJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219461	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0263881	10.1371/journal.pone.0263881	http://dx.doi.org/10.1371/journal.pone.0263881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148346	gold, Green Published			2022-12-26	WOS:000800108800039
J	Levesque, AA; Pappalardo, RM; Puli, P; Enzor, LA; Angeles, C				Levesque, Aime A.; Pappalardo, Rebecca M.; Puli, Pawan; Enzor, Laura A.; Angeles, Clara			p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor	PLOS ONE			English	Article							WILD-TYPE P53; CHILDHOOD-CANCER SURVIVAL; CYTOPLASMIC SEQUESTRATION; G(1) CHECKPOINT; 7-HYDROXYSTAUROSPORINE UCN-01; CISPLATIN; ARREST; CELLS; REPRESSION; ABROGATION	Neuroblastomas are one of the most common types of solid tumors in infants and children and are responsible for approximately 15% of childhood cancer deaths. Neuroblastomas rarely have mutations in p53, with less than 2% of NB containing mutations in p53, compared to up to 60% for other tumor classes. Previous studies on the therapeutic combination of a DNA damaging agent and checkpoint kinase 1 (Chk1) inhibitor have shown that DNA damage-induced cell cycle arrest can be specifically abrogated in p53-defective tumors. However, some p53-wildtype tumors have also been shown to be sensitive to this therapeutic combination, suggesting that these cells have other defects in the p53 response that can be exploited for therapeutic purposes. In the current study, we investigated the response to the combination of a DNA damaging agent (SN38) and a Chk1 inhibitor (UCN-01) of four p53-wildtype neuroblastoma cell lines: SK-N-SH, SH-SYSY, SK-N-AS, and Lan-5. When the cells were treated with concentrations of SN38 ranging from 0-30 ng/ml, all four cell lines accumulated p53 which was phosphorylated on serines 15 and 20. However, only the SK-N-SH were found to activate p21(waf1) and repress cyclin B. In order to assess sensitivity to UCN-01-mediated abrogation of cell cycle arrest, cell were treated with 10 ng/ml SN38 for 24 h, followed by 25 nM UCN-01 for 6 and 24 h. The SK-N-SH showed no sensitivity to UCN-01 treatment whereas the SH-SYSY, SK-N-AS, and Lan-5 abrogated G(2 )arrest within 24 h. Our recent studies revealed that cells that are sensitive to checkpoint abrogation lack p53 dimers and tetramers, so we analyzed the oligomerization status of p53 in all four cell lines using glutaraldehyde crosslinking. The SK-N-SH cells possessed levels of p53 dimers and tetramers similar to what has previously been reported in p53-wildtype MCF10A cells. The SH-SYSY, SK-N-AS, and Lan-5 however, had extremely low to undetectable levels of dimers and tetramers. Our study also showed no cytoplasmic accumulation of p53 in these cells contrary to some previous reports. The results of this study suggest that oligomerization status may serve as an indicator of sensitivity of p53-wildtype tumors to the therapeutic combination of DNA damaging agent and Chk1 inhibitor.	[Levesque, Aime A.; Pappalardo, Rebecca M.; Puli, Pawan; Enzor, Laura A.; Angeles, Clara] Univ Hartford, Dept Biol, Hartford, CT 06117 USA	University of Hartford	Levesque, AA (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	alevesque@hartford.edu	Levesque, Aime/GNM-9708-2022	Levesque, Aime/0000-0002-2907-229X				[Anonymous], 2019, LANCET HAEMATOL, V6, pE285, DOI 10.1016/S2352-3026(19)30083-3; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Bunch RT, 1997, CELL GROWTH DIFFER, V8, P779; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen L, 2007, CELL CYCLE, V6, P2685, DOI 10.4161/cc.6.21.4853; DEMARCQ C, 1994, CELL GROWTH DIFFER, V5, P983; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; FAN SJ, 1995, CANCER RES, V55, P1649; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; Gencel-Augusto J, 2020, GENE DEV, V34, P1128, DOI 10.1101/gad.340976.120; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Imagawa T, 2009, ANAL BIOCHEM, V387, P249, DOI 10.1016/j.ab.2009.01.030; IMAMURA J, 1993, CANCER RES, V53, P4053; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Kohn EA, 2002, J BIOL CHEM, V277, P26553, DOI 10.1074/jbc.M202040200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lacour B, 2014, EUR J CANCER PREV, V23, P449, DOI 10.1097/CEJ.0000000000000006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Lipski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042615; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McKenzie PP, 1999, CLIN CANCER RES, V5, P4199; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; POWELL SN, 1995, CANCER RES, V55, P1643; Ries LAG, 1999, CANC INCIDENCE SURVI, V99-4649.; RUSSELL KJ, 1995, CANCER RES, V55, P1639; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Wolff A, 2001, ONCOGENE, V20, P1307, DOI 10.1038/sj.onc.1204251; Zafar A, 2021, CANCER LETT, V496, P16, DOI 10.1016/j.canlet.2020.09.023; Zheng RS, 2015, CANCER LETT, V363, P176, DOI 10.1016/j.canlet.2015.04.021	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263463	10.1371/journal.pone.0263463	http://dx.doi.org/10.1371/journal.pone.0263463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143532	Green Published, gold			2022-12-26	WOS:000797657800048
J	Silva, TACC; Quigley, SP; Kidd, LJ; Anderson, ST; McLennan, SR; Schatz, TJ; McCosker, KD; Poppi, DP				Silva, Tiago A. C. C.; Quigley, Simon P.; Kidd, Lisa J.; Anderson, Stephen T.; McLennan, Stuart R.; Schatz, Timothy J.; McCosker, Kieren D.; Poppi, Dennis P.			Growth and reproductive performance responses to post-weaning supplementation of early and normally-weaned Brahman crossbred heifers raised in tropical rangelands	PLOS ONE			English	Article							CATCH-UP GROWTH; BONE METABOLISM; BODY CONDITION; BEEF HEIFERS; PHOSPHATASE-ACTIVITY; FOOD RESTRICTION; DAIRY-COWS; CATTLE; NUTRITION; AGE	This study investigated the effect of five post-weaning supplementation strategies and two weaning weight groups on long-term growth, puberty and pregnancy percentage of Brahman crossbred heifers. Early-weaned (118 +/- 6 kg liveweight) and normally-weaned (183 +/- 6 kg liveweight) heifers were allocated to group pens (n = 4 and n = 5/pen for early- and normally-weaned respectively) and offered one of five levels of post-weaning protein supplementation: 0, 1, 2.5, 5 and 10 g of supplement/kg liveweight.day with ad libitum access to a low quality sabi grass (Urochloa mosambicensis) hay during the first dry season (169 days) after weaning. After the post-weaning supplementation period, all heifers grazed the same pastures as a single mob until the end of the experiment and were exposed to fertile bulls from January to May 2016. During the first dry season, supplement intake had a positive linear effect on liveweight gain and hip width gain with no difference in the response between weaning groups. Overall, heifers with higher supplement intakes (i.e. 5 and 10 g/kg) had higher hip height gain (P< 0.005), hip width gain (P< 0.001), body condition score (P< 0.001), and concentration of insulin-like growth factor-1 (P = 0.001), triiodothyronine (P= 0.04) and insulin (P= 0.05) in plasma compared to unsupplemented heifers. These changes resulted in thicker proliferative and hypertrophic zones (both P= 0.03) of the tuber coxae growth plate, larger diameter of terminal hypertrophic chondrocytes (both P= 0.004) at the end of the post-weaning supplementation period when comparing the highest supplementation with unsupplemented group. Unsupplemented heifers from both weaning weight groups demonstrated compensatory liveweight gain over the first wet season while evidence of catch-up growth in skeletal dimensions was observed in the second wet season. The main determining factor for pregnancy status of two-year-old Brahman crossbred heifers was pre-mating liveweight (P < 0.001), the pre-mating liveweight was in turn affected by post-weaning supplementation (P= 0.02) or weaning weight group (P< 0.001). This study further demonstrated the positive relationship between premating weight and the occurrence of pregnancy, with an approximate 300 kg pre-mating liveweight required to achieve approximately 80% (67.1-90.3% for a 95% confidence interval) probability of pregnancy in two-year-old Brahman crossbred heifers mated for 4 months.	[Silva, Tiago A. C. C.; Quigley, Simon P.; Poppi, Dennis P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Australia; [Kidd, Lisa J.] Univ Queensland, Sch Vet Sci, Gatton, Australia; [Anderson, Stephen T.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [McLennan, Stuart R.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Dutton Pk, Australia; [Schatz, Timothy J.] Dept Ind Tourism & Trade, Darwin, NT, Australia; [McCosker, Kieren D.] Dept Ind Tourism & Trade, Katherine, Australia; [Silva, Tiago A. C. C.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Quigley, Simon P.] Cent Queensland Univ, Inst Future Farming Syst, Rockhampton, Qld, Australia; [McCosker, Kieren D.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Gatton, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of New England; Central Queensland University; University of Queensland	Silva, TACC (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Australia.	tiago.silva@une.edu.au		McCosker, Kieren/0000-0001-9442-0222; POPPI, Dennis/0000-0002-9116-1832; Silva, Tiago/0000-0001-6138-9863	Meat and Livestock Australia [MLA -B.GBP.0005]; Coordination of Improvement of Higher Education Personnel [CAPES -BEX 0727/13-0]	Meat and Livestock Australia(Meat and Livestock Australia); Coordination of Improvement of Higher Education Personnel	This study was funded by Meat and Livestock Australia (MLA -B.GBP.0005) and the first author received financial support from Coordination of Improvement of Higher Education Personnel (CAPES -BEX 0727/13-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida IL., 1994, PESQUISA AGROPECU RI, V29, P461; [Anonymous], 2022, NLME LINEAR NONLINEA; Arthington JD, 2003, J ANIM SCI, V81, P1136; Australian Bureau of Meteorology, 2021, HIST WEATH OBS STAT; Ayres H, 2009, LIVEST SCI, V123, P175, DOI 10.1016/j.livsci.2008.11.004; BERGE P, 1991, LIVEST PROD SCI, V28, P179, DOI 10.1016/0301-6226(91)90142-D; BLUM JW, 1985, J NUTR, V115, P417, DOI 10.1093/jn/115.4.417; Burns BM, 2010, ANIM REPROD SCI, V122, P1, DOI 10.1016/j.anireprosci.2010.04.010; Cardoso RC, 2019, J ANIM SCI, V97, P36; D'Occhio MJ, 2019, THERIOGENOLOGY, V125, P277, DOI 10.1016/j.theriogenology.2018.11.010; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; DeLaurier A, 2004, RES VET SCI, V77, P29, DOI 10.1016/j.rvsc.2004.02.007; DOOGAN VJ, 1991, AUST J EXP AGR, V31, P139, DOI 10.1071/EA9910139; Dyer R., 2003, NAP3211 MEAT LIV AUS; Ekelund A, 2006, LIVEST SCI, V99, P227, DOI 10.1016/j.livprodsci.2005.07.001; Entwhistle K., 1983, FACTORS INFLUENCING; Farnum CE, 2003, PEDIATR RES, V53, P33, DOI [10.1203/01.PDR.0000041518.63329.FF, 10.1203/00006450-200301000-00009]; Festing MFW, 2014, ILAR J, V55, P472, DOI 10.1093/ilar/ilu045; Foran B., 1985, RANGELAND J, V7, P107, DOI [10.1071/RJ9850107, DOI 10.1071/RJ9850107]; Forcinito P, 2011, J ENDOCRINOL, V208, P59, DOI 10.1677/JOE-10-0302; Fordyce G, 2019, ANIM PROD SCI, V59, P148, DOI [10.1071/an17305, 10.1071/AN17305]; Forster B., 1972, REPORT LAND UNITS VI; Gasser CL, 2013, J ANIM SCI, V91, P1336, DOI 10.2527/jas.2012-6008; Gat-Yablonski G, 2008, J PEDIATR ENDOCR MET, V21, P879; Ghosh JK, 2001, CURR SCI INDIA, V80, P1135; Hamrick MW, 2008, J BONE MINER RES, V23, P870, DOI [10.1359/jbmr.080213, 10.1359/JBMR.080213]; Heinrichs C, 1997, ENDOCRINOLOGY, V138, P5359, DOI 10.1210/en.138.12.5359; KEMBER NF, 1971, NATURE, V229, P428, DOI 10.1038/229428a0; Koppen W, 2020, KLIMATE ERDE GRUYTER; Kurosaki N, 2007, J VET MED SCI, V69, P265, DOI 10.1292/jvms.69.265; LASTER DB, 1973, J ANIM SCI, V36, P734; LESMEIST.JL, 1973, J ANIM SCI, V36, P1, DOI 10.2527/jas1973.3611; Lui JC, 2011, ENDOCR REV, V32, P422, DOI 10.1210/er.2011-0001; Marino R, 2008, ENDOCRINOLOGY, V149, P1820, DOI 10.1210/en.2007-0993; Marsetyo, 2012, ANIM PROD SCI, V52, P630, DOI 10.1071/AN11285; McCosker T., 1984, P AUSTR SOC ANIMAL P, DOI [10.1007/BF02011596, DOI 10.1007/BF02011596]; McLennan SR, 2017, ANIM PROD SCI, V57, P489, DOI 10.1071/AN15660; McLennan SR, 2017, ANIM PROD SCI, V57, P473, DOI 10.1071/AN15659; McLennan SR., 2004, NAP3122 MEAT LIV AUS; McLennan SR, 2014, BNBP0391 MEAT LIV AU; Montiel F, 2005, ANIM REPROD SCI, V85, P1, DOI 10.1016/j.anireprosci.2003.11.001; Moriel P, 2014, J ANIM SCI, V92, P3096, DOI 10.2527/jas.2013-7389; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; NUNEZDOMINGUEZ R, 1991, J ANIM SCI, V69, P3467, DOI 10.2527/1991.6993467x; Pando R, 2014, J ENDOCRINOL, V223, P227, DOI 10.1530/JOE-14-0486; PATTERSON DJ, 1992, J ANIM SCI, V70, P4018, DOI 10.2527/1992.70124018x; Poppi DP., 2018, REV BRAS ZOOTECN, P47; R Core Team, 2021, R LANGUAGE ENV STAT; Rossi L, 2001, J NUTR, V131, P1142, DOI 10.1093/jn/131.4.1142; Ryan W., 1990, COMPENSATORY GROW B; Sato R, 2013, VET J, V197, P358, DOI 10.1016/j.tvjl.2013.01.013; Schatz TJ, 2017, ANIM PROD SCI, V57, P2091, DOI 10.1071/AN16212; Schlink A, 1994, P AUSTR SOC ANIMAL P; Schlink A. C., 1988, Proceedings of the Australian Society of Animal Production, V17, P326; Schubach KM, 2019, J ANIM SCI, V97, P4171, DOI 10.1093/jas/skz262; Seibel M J, 2000, Osteoporos Int, V11 Suppl 6, pS18; Silva TACC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247718; Smith D., 2017, DEMONSTRATING EFFECT; Soyka LA, 1999, J CLIN ENDOCR METAB, V84, P4489, DOI 10.1210/jc.84.12.4489; STECKEL RH, 1987, ANN HUM BIOL, V14, P111, DOI 10.1080/03014468700006852; Sullivan RM, 1997, AUST J EXP AGR, V37, P279, DOI 10.1071/EA95097; Tyler R, 2012, WEANER MANAGEMENT NO; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; WALKER KVR, 1972, CELL TISSUE KINET, V5, P409, DOI 10.1111/j.1365-2184.1972.tb00379.x; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YAMBAYAMBA E, 1991, CAN J ANIM SCI, V71, P1021, DOI 10.4141/cjas91-123	69	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263786	10.1371/journal.pone.0263786	http://dx.doi.org/10.1371/journal.pone.0263786			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143577	Green Published, gold			2022-12-26	WOS:000797657800079
J	Ueda, C; Langton, M; Chen, JH; Pandelia, ME				Ueda, Chie; Langton, Michelle; Chen, Jiahua; Pandelia, Maria-Eirini			The HBx protein from hepatitis B virus coordinates a redox-active Fe-S cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; X-PROTEIN; 4FE-4S CLUSTERS; ESCHERICHIA-COLI; 2FE-2S; GENE; CARCINOGENESIS; CHEMISTRY; SCAFFOLD; BINDING	The viral protein HBx is the key regulatory factor of the hepatitis B virus (HBV) and the main etiology for HBVassociated liver diseases, such as cirrhosis and hepatocellular carcinoma. Historically, HBx has defied biochemical and structural characterization, deterring efforts to understand its molecular mechanisms. Here we show that soluble HBx fused to solubility tags copurifies with either a [2Fe-2S] or a [4Fe-4S] cluster, a feature that is shared among five HBV genotypes. We show that the O-2-stable [2Fe-2S] cluster form converts to an O-2-sensitive [4Fe-4S] state when reacted with chemical reductants, a transformation that is best described by a reductive coupling mechanism reminiscent of Fe-S cluster scaffold proteins. In addition, the Fe-S cluster conversions are partially reversible in successive reduction-oxidation cycles, with cluster loss mainly occurring during (re)oxidation. The considerably negative reduction potential of the [4Fe-4S](2+/1+) couple (-520 mV) suggests that electron transfer may not be likely in the cell. Collectively, our findings identify HBx as an Fe-S protein with striking similarities to Fe-S scaffold proteins both in cluster type and reductive transformation. An Fe-S cluster in HBx offers new insights into its previously unknown molecular properties and sets the stage for deciphering the roles of HBx-associated iron (mis)regulation and reactive oxygen species in the context of liver tumorigenesis.	[Ueda, Chie; Langton, Michelle; Chen, Jiahua; Pandelia, Maria-Eirini] Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA	Brandeis University	Pandelia, ME (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02254 USA.	mepandelia@brandeis.edu		Pandelia, Maria-Eirini/0000-0002-6750-1948; Ueda, Chie/0000-0001-7604-7065	National Institutes of Health [GM111978, GM126303]; Brandeis University Innovation SPROUT Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brandeis University Innovation SPROUT Program	This work was supported by the National Institutes of Health (Grant Nos. GM111978 and GM126303 to M.-E. P.) and the Brandeis University Innovation SPROUT Program (to C. U., M. L., and M.-E. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Bak DW, 2014, CURR OPIN CHEM BIOL, V19, P50, DOI 10.1016/j.cbpa.2013.12.015; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; DEMEDINA T, 1994, VIROLOGY, V202, P401, DOI 10.1006/viro.1994.1356; Funauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16497; Geng M, 2015, WORLD J GASTROENTERO, V21, P10732, DOI 10.3748/wjg.v21.i38.10732; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gtlich P., 2011, MSSBAUER SPECTROSCOP; Gu JM, 2008, VIRUS RES, V133, P167, DOI 10.1016/j.virusres.2007.12.014; Gupta V., 2009, J AM CHEM SOC; Ha HL, 2010, WORLD J GASTROENTERO, V16, P4932, DOI 10.3748/wjg.v16.i39.4932; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Jiang TY, 2016, P NATL ACAD SCI USA, V113, P2074, DOI 10.1073/pnas.1525616113; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kumar V, 1996, P NATL ACAD SCI USA, V93, P5647, DOI 10.1073/pnas.93.11.5647; Langton M, 2020, ACS OMEGA, V5, P16772, DOI 10.1021/acsomega.0c01762; Lee SH, 2012, MOL CELLS, V34, P165, DOI 10.1007/s10059-012-0060-z; Li D, 2015, INT J MOL MED, V35, P319, DOI 10.3892/ijmm.2014.2018; Li JH, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01967-18; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540; Lim W, 2010, J MOL MED, V88, P359, DOI 10.1007/s00109-009-0563-z; Ling LR, 2020, ONCOL LETT, V19, P2861, DOI 10.3892/ol.2020.11404; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Maio N, 2021, SCIENCE, V373, P236, DOI 10.1126/science.abi5224; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Mapolelo DT, 2012, BIOCHEMISTRY-US, V51, P8071, DOI 10.1021/bi3006658; Martin D, 2013, FASEB J, V27, P1074, DOI 10.1096/fj.12-217182; Nasta V, 2020, FEBS J, V287, P2312, DOI 10.1111/febs.15140; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7; Ramakrishnan D, 2019, J VIROL, V93, DOI 10.1128/JVI.00250-19; Rouault T. A., 2014, IRON SULFUR CLUSTERS; Saeed U, 2019, J VIROL, V93, DOI 10.1128/JVI.01840-18; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shimberg GD, 2018, METHOD ENZYMOL, V599, P101, DOI 10.1016/bs.mie.2017.09.005; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Tsang SH, 2016, J VIROL, V90, P1544, DOI 10.1128/JVI.02121-15; Ueda C, 2021, METHODS MOL BIOL, V2353, P281, DOI 10.1007/978-1-0716-1605-5_15; Urban S, 1997, HEPATOLOGY, V26, P1045, DOI 10.1002/hep.510260437; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Velkov S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100495; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Weiler BD, 2020, P NATL ACAD SCI USA, V117, P20555, DOI 10.1073/pnas.2003982117; Zamor PJ, 2017, J GASTROINTEST ONCOL, V8, P229, DOI 10.21037/jgo.2017.03.14; Zhang Y, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0366-3; Zheng BY, 2014, INT J ONCOL, V45, P1143, DOI 10.3892/ijo.2014.2499	59	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR	2022	298	4							101698	10.1016/j.jbc.2022.101698	http://dx.doi.org/10.1016/j.jbc.2022.101698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D1HZ	35148994	gold, Green Published			2022-12-26	WOS:000793560400006
J	Lee, J; Pandey, AK; Venkatesh, S; Thilagavathi, J; Honda, T; Singh, K; Suzuki, CK				Lee, Jae; Pandey, Ashutosh K.; Venkatesh, Sundararajan; Thilagavathi, Jayapalraja; Honda, Tadashi; Singh, Kamal; Suzuki, Carolyn K.			Inhibition of mitochondrial LonP1 protease by allosteric blockade of ATP binding and hydrolysis via CDDO and its derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BARDOXOLONE METHYL; TRITERPENOID CDDO; 2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OIC ACID; SEMIEMPIRICAL METHODS; SYNTHETIC OLEANANE; STAGE 4; CANCER; MECHANISM; PATHWAY	The mitochondrial protein LonP1 is an ATP-dependent protease that mitigates cell stress and calibrates mitochon-drial metabolism and energetics. Biallelic mutations in the LONP1 gene are known to cause a broad spectrum of diseases, and LonP1 dysregulation is also implicated in cancer and age-related disorders. Despite the importance of LonP1 in health and disease, specific inhibitors of this protease are unknown. Here, we demonstrate that 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO) and its -methyl and-imidazole de-rivatives reversibly inhibit LonP1 by a noncompetitive mech-anism, blocking ATP-hydrolysis and thus proteolysis. By contrast, we found that CDDO-anhydride inhibits the LonP1 ATPase competitively. Docking of CDDO derivatives in the cryo-EM structure of LonP1 shows these compounds bind a hydrophobic pocket adjacent to the ATP-binding site. The binding site of CDDO derivatives was validated by amino acid substitutions that increased LonP1 inhibition and also by a pathogenic mutation that causes cerebral, ocular, dental, auricular and skeletal (CODAS) syndrome, which ablated in-hibition. CDDO failed to inhibit the ATPase activity of the purified 26S proteasome, which like LonP1 belongs to the AAA+ superfamily of ATPases Associated with diverse cellular Activities, suggesting that CDDO shows selectivity within this family of ATPases. Furthermore, we show that noncytotoxic concentrations of CDDO derivatives in cultured cells inhibited LonP1, but not the 26S proteasome. Taken together, these findings provide insights for future development of LonP1-specific inhibitors with chemotherapeutic potential.	[Lee, Jae; Pandey, Ashutosh K.; Venkatesh, Sundararajan; Thilagavathi, Jayapalraja; Suzuki, Carolyn K.] Rutgers New Jersey Med Sch, Dept Microbiol, Biochem & Mol Genet, Newark, NJ 07101 USA; [Honda, Tadashi] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11794 USA; [Singh, Kamal] Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Singh, Kamal] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Singh, Kamal] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Pandey, Ashutosh K.] Rutgers New Jersey Med Sch, Dept Pharmacol, Physiol & Neurosci, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Karolinska Institutet; Rutgers State University New Brunswick; Rutgers State University Medical Center	Suzuki, CK (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol, Biochem & Mol Genet, Newark, NJ 07101 USA.; Singh, K (corresponding author), Univ Missouri, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA.; Singh, K (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Singh, K (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	singhka@missouri.edu; suzukick@njms.rutgers.edu	; Sundararajan, Venkatesh/H-3837-2014	Honda, Tadashi/0000-0003-0746-9453; Sundararajan, Venkatesh/0000-0003-4195-7776	National Institutes of Healths (NIH) [-1R21 NS067668-01, 1R01 GM084039-01A1]; NJ Health Foundation Research Award	National Institutes of Healths (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJ Health Foundation Research Award	This work was supported in part by grants from the National Institutes of Healths (NIH) -1R21 NS067668-01 and 1R01 GM084039-01A1 and a NJ Health Foun-dation Research Award to C. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad R, 2008, CANCER RES, V68, P2920, DOI 10.1158/0008-5472.CAN-07-3036; Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Baigent C, 2018, J AM SOC NEPHROL, V29, P357, DOI 10.1681/ASN.2017101062; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Besse A, 2020, MITOCHONDRION, V51, P68, DOI 10.1016/j.mito.2020.01.004; Bonner ER, 2021, NEURO-ONCOLOGY, V23, P542, DOI 10.1093/neuonc/noaa283; Bota DA, 2016, FREE RADICAL BIO MED, V100, P188, DOI 10.1016/j.freeradbiomed.2016.06.031; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Celentano S., 2019, G ITAL NEFROL, V36, P2019; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Cheng AN, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001372; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; Chin MP, 2018, AM J NEPHROL, V47, P40, DOI 10.1159/000486398; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Deng P, 2017, SEMIN CANCER BIOL, V47, P43, DOI 10.1016/j.semcancer.2017.05.002; Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Feng Y, 2021, CANCERS, V13, DOI 10.3390/cancers13092020; Gibellini L, 2020, INT REV CEL MOL BIO, V354, P1, DOI 10.1016/bs.ircmb.2020.02.005; Gibellini L, 2015, ONCOTARGET, V6, P25466, DOI 10.18632/oncotarget.4510; Graves PR, 2019, ACS CHEM BIOL, V14, P1020, DOI 10.1021/acschembio.9b00222; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Honda T, 2010, BIOORG MED CHEM LETT, V20, P2275, DOI 10.1016/j.bmcl.2010.02.007; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hsu SK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102518; Ishizawa J, 2019, CANCER CELL, V35, P721, DOI 10.1016/j.ccell.2019.03.014; Kabe Y, 2020, NPJ SCI FOOD, V4, DOI 10.1038/s41538-020-0064-6; Khan YA, 2022, CRIT REV BIOCHEM MOL, V57, P156, DOI 10.1080/10409238.2021.1979460; Kim W, 2013, MOL PHARMACOL, V83, P367, DOI 10.1124/mol.112.082578; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; Liao JH, 2013, ACTA CRYSTALLOGR D, V69, P1395, DOI 10.1107/S0907444913008214; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Maneix L, 2021, CANCERS, V13, DOI 10.3390/cancers13040843; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Mohammed I., 2021, BIORXIV, DOI [10.1101/2021.1107.1128.454137, DOI 10.1101/2021.1107.1128.454137]; Nimmo GAM, 2019, HUM MOL GENET, V28, P290, DOI 10.1093/hmg/ddy351; Nunes AT, 2017, SEMIN ONCOL, V44, P377, DOI 10.1053/j.seminoncol.2018.01.004; Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080; Place AE, 2003, CLIN CANCER RES, V9, P2798; Pujols L, 2012, J PHARMACOL EXP THER, V343, P184, DOI 10.1124/jpet.111.190710; Quiros PM, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.968505; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Samudio I, 2006, MOL PHARMACOL, V69, P1182, DOI 10.1124/mol.105.018051; Shin CS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20597-z; Shin M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23495-0; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003; Su SC, 2016, STRUCTURE, V24, P676, DOI 10.1016/j.str.2016.03.003; Tai TS, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/9401648; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Toto RD, 2018, J AM SOC NEPHROL, V29, P360, DOI 10.1681/ASN.2017121317; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Venkatesh S, 2020, MITOCHONDRION, V51, P46, DOI 10.1016/j.mito.2019.10.004; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Voos W, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020253; Wang HM, 2010, CANCER SCI, V101, P2612, DOI 10.1111/j.1349-7006.2010.01701.x; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Wong KS, 2019, ADV EXP MED BIOL, V1158, P119, DOI [10.1007/978-981-113-8367-0_8, 10.1007/978-981-13-8367-0_8]; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Yu L, 2015, HUM MOL GENET, V24, P4764, DOI 10.1093/hmg/ddv196	74	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101719	10.1016/j.jbc.2022.101719	http://dx.doi.org/10.1016/j.jbc.2022.101719			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	0X0GI	35151690	gold, Green Published			2022-12-26	WOS:000789394500004
J	Wong, BH; Mei, D; Chua, GL; Galam, DL; Wenk, MR; Torta, F; Silver, DL				Wong, Bernice H.; Mei, Ding; Chua, Geok Lin; Galam, Dwight L.; Wenk, Markus R.; Torta, Federico; Silver, David L.			The lipid transporter Mfsd2a maintains pulmonary surfactant homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; PHOSPHOLIPASE A(2); LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; CLEARANCE; PROTEIN; INFLAMMATION; MECHANISMS; MEMBRANES; FIBROSIS	Pulmonary surfactant is a lipoprotein complex essential for lung function, and insufficiency or altered surfactant composition is associated with major lung diseases, such as acute respiratory distress syndromes, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease. Pulmonary surfactant is primarily composed of phosphatidylcholine (PC) in complex with specialized surfactant proteins and secreted by alveolar type 2 (AT2) cells. Surfactant homeostasis on the alveolar surface is balanced by the rates of synthesis and secretion with reuptake and recycling by AT2 cells, with some degradation by pulmonary macrophages and loss up the bronchial tree. However, whether phospholipid (PL) transporters exist in AT2 cells to mediate reuptake of surfactant PL remains to be identified. Here, we demonstrate that major facilitator superfamily domain containing 2a (Mfsd2a), a sodium-dependent lysophosphatidylcholine (LPC) transporter, is expressed at the apical surface of AT2 cells. A mouse model with inducible AT2 cell-specific deficiency of Mfsd2a exhibited AT2 cell hypertrophy with reduced total surfactant PL levels because of reductions in the most abundant surfactants, PC containing dipalmitic acid, and PC species containing the omega-3 fatty acid docosahexaenoic acid. These changes in surfactant levels and composition were mirrored by similar changes in the AT2 cell lipidome. Mechanistically, direct tracheal instillation of fluorescent LPC and PC probes indicated that Mfsd2a mediates the uptake of LPC generated by pulmonary phospholipase activity in the alveolar space. These studies reveal that Mfsd2a-mediated LPC uptake is quantitatively important in maintaining surfactant homeostasis and identify this lipid transporter as a physiological component of surfactant recycling.	[Wong, Bernice H.; Chua, Geok Lin; Galam, Dwight L.; Silver, David L.] Duke NUS Med Sch, Signat Res Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Mei, Ding; Wenk, Markus R.; Torta, Federico] Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore; [Mei, Ding; Wenk, Markus R.; Torta, Federico] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Silver, DL (corresponding author), Duke NUS Med Sch, Signat Res Program Cardiovasc & Metab Disorders, Singapore, Singapore.	david.silver@duke-nus.edu.sg		Chua, Geok Lin/0000-0002-9763-0652; Galam, Dwight Lark/0000-0002-1158-1969; Silver, David/0000-0002-7289-9890; Wong, Bernice/0000-0001-8981-1376	National Research Foundation (NRF), Singapore [NRF-NRFI2017-05]; Khoo Postdoctoral Research Fellowship Awards; National University of Singapore via the Life Sciences Institute; National Research Foundation [NRFSBP-P4]; NRF; A*STAR Industry Alignment Fund-Industry Collaboration Project [I1901E0040];  [NRF2017_SISFP08]	National Research Foundation (NRF), Singapore(National Research Foundation, Singapore); Khoo Postdoctoral Research Fellowship Awards; National University of Singapore via the Life Sciences Institute(National University of Singapore); National Research Foundation; NRF; A*STAR Industry Alignment Fund-Industry Collaboration Project(Agency for Science Technology & Research (A*STAR)); 	This study was supported by a grant from the National Research Foundation (NRF), Singapore (grant no.: NRF-NRFI2017-05; to D. L. S.) and by Khoo Postdoctoral Research Fellowship Awards (to B. H. W.). Work in SLING (M. R. W., F. T., and D. M.) is supported by grants from the National University of Singapore via the Life Sciences Institute, the National Research Foundation (grant no.: NRFSBP-P4), the NRF, and A*STAR Industry Alignment Fund-Industry Collaboration Project (grant no.: I1901E0040), and the NRF2017_SISFP08.	Adams TS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1983; Agudelo CW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228279; Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; BAISTED DJ, 1988, BIOCHEM J, V253, P693, DOI 10.1042/bj2530693; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; Bernhard W, 2004, AM J RESP CRIT CARE, V170, P54, DOI 10.1164/rccm.200401-089OC; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; BURDGE GC, 1993, BIOCHIM BIOPHYS ACTA, V1166, P251, DOI 10.1016/0005-2760(93)90105-I; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cater RJ, 2021, NATURE, V595, P315, DOI 10.1038/s41586-021-03650-9; Chan JP, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006443; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; GRABNER R, 1991, AM J PHYSIOL, V261, pL472, DOI 10.1152/ajplung.1991.261.6.L472; Griese M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117985; GROSS NJ, 1988, J APPL PHYSIOL, V64, P2017, DOI 10.1152/jappl.1988.64.5.2017; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; HALLMAN M, 1981, J CLIN INVEST, V68, P742, DOI 10.1172/JCI110310; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Harel T, 2018, NEUROGENETICS, V19, P227, DOI 10.1007/s10048-018-0556-6; Helms My N, 2010, J Vis Exp, DOI 10.3791/1941; JACOBS H, 1983, J BIOL CHEM, V258, P4156; Kandasamy P, 2016, J LIPID RES, V57, P993, DOI 10.1194/jlr.M065201; Karnati S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203464; Koenitzer JR, 2020, AM J RESP CELL MOL, V63, P739, DOI 10.1165/rcmb.2020-0095MA; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lobanova ES, 2019, J NEUROSCI, V39, P9689, DOI 10.1523/JNEUROSCI.1142-19.2019; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madsen J, 2018, J LIPID RES, V59, P1880, DOI 10.1194/jlr.M085431; Mae MA, 2021, CIRC RES, V128, pE46, DOI 10.1161/CIRCRESAHA.120.317473; Martini WZ, 1999, AM J PHYSIOL-ENDOC M, V277, pE187, DOI 10.1152/ajpendo.1999.277.1.E187; McDonough JE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131597; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Munoz NM, 2009, AM J PHYSIOL-LUNG C, V296, pL879, DOI 10.1152/ajplung.90580.2008; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Numata M, 2015, J LIPID RES, V56, P578, DOI 10.1194/jlr.M055723; Numata M, 2013, INT J NANOMED, V8, P1417, DOI 10.2147/IJN.S39888; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OYARZUN MJ, 1980, AM REV RESPIR DIS, V121, P709; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Piccirillo AR, 2019, J IMMUNOL, V203, P117, DOI 10.4049/jimmunol.1801585; POST M, 1983, BIOCHIM BIOPHYS ACTA, V750, P68, DOI 10.1016/0005-2760(83)90205-9; Quek DQY, 2016, J BIOL CHEM, V291, P9383, DOI 10.1074/jbc.M116.721035; Richmond BL, 2000, GENE, V244, P65, DOI 10.1016/S0378-1119(00)00006-8; Rindler TN, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.97381; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Scala M, 2020, EUR J HUM GENET, V28, P1509, DOI 10.1038/s41431-020-0669-x; SCARPELLI EM, 1975, PEDIATR RES, V9, P195, DOI 10.1203/00006450-197504000-00011; Schmidt R, 2001, AM J RESP CRIT CARE, V163, P95, DOI 10.1164/ajrccm.163.1.9903029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinha Meenal, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2013; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wong BH, 2016, J BIOL CHEM, V291, P10501, DOI 10.1074/jbc.M116.721340; WRIGHT JR, 1990, AM J PHYSIOL, V259, pL1, DOI 10.1152/ajplung.1990.259.2.L1; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Yang R, 2019, METABOLITES, V9, DOI 10.3390/metabo9040080; Yoshida M, 2004, CELL MOL BIOL, V50, P639; Zepp JA, 2019, NAT REV MOL CELL BIO, V20, P551, DOI 10.1038/s41580-019-0141-3	67	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR	2022	298	3							101709	10.1016/j.jbc.2022.101709	http://dx.doi.org/10.1016/j.jbc.2022.101709			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2R4AJ	35150739	Green Published, gold			2022-12-26	WOS:000821054100009
J	Baussant, T; Arnberg, M; Lyng, E; Ramanand, S; Bamber, S; Berry, M; Hansen, IM; Van Oevelen, D; Van Breugel, P				Baussant, Thierry; Arnberg, Maj; Lyng, Emily; Ramanand, Sreerekha; Bamber, Shaw; Berry, Mark; Hansen, Ingrid Myrnes; Van Oevelen, Dick; Van Breugel, Peter			Identification of tolerance levels on the cold-water coral Desmophyllum pertusum (Lophelia pertusa) from realistic exposure conditions to suspended bentonite, barite and drill cutting particles	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSE; GROWTH; SEDIMENT; DEEP; SCLERACTINIA; TEMPERATURE; STRATEGIES; IMPACTS; RELEASE; STORAGE	Cold-water coral (CWC) reefs are numerous and widespread along the Norwegian continental shelf where oil and gas industry operate. Uncertainties exist regarding their impacts from operational discharges to drilling. Effect thresholds obtained from near-realistic exposure of suspended particle concentrations for use in coral risk modeling are particularly needed. Here, nubbins of Desmophyllum pertusum (Lophelia pertusa) were exposed shortly (5 days, 4h repeated pulses) to suspended particles (bentonite BE; barite BA, and drill cuttings DC) in the range of similar to 4 to similar to 60 mg.l(-1) (actual concentration). Physiological responses (respiration rate, growth rate, mucus-related particulate organic carbon OC and particulate organic nitrogen ON) and polyp mortality were then measured 2 and 6 weeks post-exposure to assess long-term effects. Respiration and growth rates were not significantly different in any of the treatments tested compared to control. OC production was not affected in any treatment, but a significant increase of OC:ON in mucus produced by BE-exposed (23 and 48 mg.l(-1)) corals was revealed 2 weeks after exposure. Polyp mortality increased significantly at the two highest DC doses (19 and 49 mg.l(-1)) 2 and 6 weeks post-exposure but no significant difference was observed in any of the other treatments compared to the control. These findings are adding new knowledge on coral resilience to short realistic exposure of suspended drill particles and indicate overall a risk for long-term effects at a threshold of similar to 20 mg.l(-1).	[Baussant, Thierry; Arnberg, Maj; Lyng, Emily; Ramanand, Sreerekha; Bamber, Shaw; Berry, Mark] NORCE Norwegian Res Ctr AS, Randaberg, Norway; [Hansen, Ingrid Myrnes] Ecotone AS, Trondheim, Norway; [Hansen, Ingrid Myrnes] Norwegian Univ Sci & Technol, Trondheim, Norway; [Van Oevelen, Dick; Van Breugel, Peter] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [Arnberg, Maj] Akvaplan Niva, Pirsenteret, Trondheim, Norway; [Berry, Mark] Marine Scotland, Fishery Off, Shetland, Scotland	Norwegian Research Centre (NORCE); Norwegian University of Science & Technology (NTNU); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Akvaplan-niva	Baussant, T (corresponding author), NORCE Norwegian Res Ctr AS, Randaberg, Norway.	thba@norceresearch.no		Baussant, Thierry/0000-0002-2760-2998	Equinor AS [4590073409]	Equinor AS	This study and the writing of the manuscript was financed by Equinor AS under contract #4590073409. We are particularly grateful for their role in the study design, discussions of the results, decision to publish, discussions and comments on the manuscript made by Tone K. Frost and Ingunn Nilsen from Equinor AS. The funders had no additional role in study design, data collection and analysis, or preparation of the manuscript.	Addamo AM., 2019, MEDITERRANEAN COLD W, P373, DOI [10.1056/NEJMoa1809798, DOI 10.1056/NEJMOA1809798]; Allers E, 2013, MAR POLLUT BULL, V74, P132, DOI 10.1016/j.marpolbul.2013.07.016; [Anonymous], 2016, ENV FATES EFFECTS OC; Arnberg M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35623-w; Baussant T, 2018, J TOXICOL ENV HEAL A, V81, P361, DOI 10.1080/15287394.2018.1444375; Baussant T, 2017, J TOXICOL ENV HEAL A, V80, P266, DOI 10.1080/15287394.2017.1297274; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Browne NK, 2015, J EXP MAR BIOL ECOL, V466, P98, DOI 10.1016/j.jembe.2015.02.010; Buscher JV, 2019, PEERJ, V7, DOI 10.7717/peerj.7586; Buscher JV, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00101; Buhl-Mortensen P, 2017, MAR BIOL RES, V13, P1027, DOI 10.1080/17451000.2017.1331040; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Cordes EE, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00058; DAVIES PS, 1989, MAR BIOL, V101, P389; DNV-GL, 2019, HANDBOOK; Dodds LA, 2007, J EXP MAR BIOL ECOL, V349, P205, DOI 10.1016/j.jembe.2007.05.013; Dodds LA., 2007, ECOPHYSIOLOGY COLD W; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Frost TK, 2014, SPE INT C HLTH SAF E; Georgian SE, 2016, MAR ECOL-EVOL PERSP, V37, P1345, DOI 10.1111/maec.12373; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Gomez CE, 2018, PEERJ, V6, DOI 10.7717/peerj.5671; Harris CA, 2014, ENVIRON SCI TECHNOL, V48, P3100, DOI 10.1021/es4047507; Huvenne VAI, 2016, BIOL CONSERV, V200, P60, DOI 10.1016/j.biocon.2016.05.030; Jarnegren J., 2014, NINA REP, V1028, P40; Jarnegren J, 2020, MAR ENVIRON RES, V158, DOI 10.1016/j.marenvres.2020.104996; Jimenez C, 2019, MEDITERRANEAN COLD W, V9, P435, DOI DOI 10.1007/978-3-319-91608-8_38; Jones R, 2016, MAR POLLUT BULL, V102, P9, DOI 10.1016/j.marpolbul.2015.10.049; Larsson AI, 2013, MAR ECOL PROG SER, V483, P169, DOI 10.3354/meps10284; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Larsson AI, 2011, MAR POLLUT BULL, V62, P1159, DOI 10.1016/j.marpolbul.2011.03.041; Lartaud F, 2017, DEEP-SEA RES PT I, V121, P70, DOI 10.1016/j.dsr.2017.01.004; Lartaud F, 2013, AQUAT LIVING RESOUR, V26, P187, DOI 10.1051/alr/2012029; Lindgaard A, NORWEGIAN RED LIST E; Maier C, 2016, J EXP BIOL, V219, P3208, DOI 10.1242/jeb.127159; Maier SR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66463-2; Maier SR, 2020, CORAL REEFS, V39, P173, DOI 10.1007/s00338-019-01886-6; Maier SR, 2019, LIMNOL OCEANOGR, V64, P1651, DOI 10.1002/lno.11142; Morato T, 2020, GLOBAL CHANGE BIOL, V26, P2181, DOI 10.1111/gcb.14996; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Murray F, 2019, J MAR BIOL ASSOC UK, V99, P1281, DOI 10.1017/S0025315419000298; Naumann MS, 2011, J EXP BIOL, V214, P3570, DOI 10.1242/jeb.061390; NEA, 2015, ENV MON PETR ACT NOR; Neff J.M., 1987, P469; Neff J.M.., 2010, FATES EFFECTS WATER; OSPAR, 2013, OSPAR LIST SUBST US; Provan F, 2016, J TOXICOL ENV HEAL A, V79, P647, DOI 10.1080/15287394.2016.1210494; Purser A, 2012, MAR POLLUT BULL, V64, P2309, DOI 10.1016/j.marpolbul.2012.08.003; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Reynaud S., 2019, MEDITERRANEAN COLD W, P391, DOI [10.1007/978-3-319-91608-8_35, DOI 10.1007/978-3-319-91608-8_35]; Ricardo GF, 2018, MAR POLLUT BULL, V135, P941, DOI 10.1016/j.marpolbul.2018.08.001; Rix L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18715; Roberts JM, 2014, CURR OPIN ENV SUST, V7, P118, DOI 10.1016/j.cosust.2014.01.004; Roberts JM, 2009, COLD-WATER CORALS: THE BIOLOGY AND GEOLOGY OF DEEP-SEA CORAL HABITATS, P20, DOI 10.1017/CBO9780511581588.003; Rogers A.D., 2008, SCI GUIDELINES SCI G; Rye H, 2006, ENVIRON MODELL SOFTW, V21, P190, DOI 10.1016/j.envsoft.2004.04.018; Rye H, 2014, SPE 170763 MS; Sundahl H, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00213; van Oevelen D, 2016, BIOGEOSCIENCES, V13, P5789, DOI 10.5194/bg-13-5789-2016; Weinnig AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58556-9; Wild C, 2012, AQUAT ECOL, V46, P335, DOI 10.1007/s10452-012-9404-1; Wild C, 2009, AQUAT BIOL, V7, P71, DOI 10.3354/ab00185; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Zetsche EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146766	68	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0263061	10.1371/journal.pone.0263061	http://dx.doi.org/10.1371/journal.pone.0263061			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192627	Green Published, gold			2022-12-26	WOS:000812552500015
J	Liu, L; Li, ZW; Jiao, PP				Liu, Lin; Li, Zhongwu; Jiao, Panpan			Hydraulic mechanisms of the uneven enrichment of soil organic carbon in sediments during rain-induced overland flow	PLOS ONE			English	Article							AGGREGATE STABILITY; WATER EROSION; NUTRIENT LOSS; NITROGEN; MATTER; IMPACT; DETACHMENT; TRANSPORT; LOSSES; RUNOFF	Organic carbon (OC) can be unevenly enriched in different-sized sediment particles under low-intensity, rain-induced overland flows, but its hydraulic mechanisms are not completely understood. Hence, in this study, the hydraulic transport mechanisms of unevenly enriched OC between different-sized sediment particles were investigated through simulated rainfall experiments at gradients of 5 degrees, 10 degrees, and 15 degrees and typical regional rainfall intensities of 45, 90, and 120 mm h(-1). Results showed that the critical flow velocity of aggregate transport through loess soil was approximately 0.08 m s(-1). When the flow velocity was larger than this critical value, the aggregate loss amount increased quickly and exponentially. Flow velocities lower than 0.08 m s(-1) were determined to be essential conditions for uneven OC enrichment between sediment particles. At such velocities, even when the runoff depth was greater than 0.0018 m, the enrichment ratio of soil organic carbon (SOC; ERoc) values in all size classes of sediment particles was larger than 1.0. Small runoff depths caused preferential OC enrichment in silt and clay, whereas large runoff depths promoted OC enrichment in the >0.25 mm size class of sediment particles. The critical flow velocity and transport way differ between these high-OC-concentration clay and silt and large light organic particles. The interaction between flow velocity and runoff depth on ERocs in <0.05 mm particles was larger than that of >0.05 mm particles. Under the transport limit erosion, the flow velocity and stream power positively correlated with uneven ERoc in different size sediment particles through distinct laws. Slope and rainfall intensity could not be ignored in predicting uneven OC enrichment in sediments by interacting with hydraulic factor and effecting aggregate stripping, respectively. Hydraulic factors mainly affected the uneven OC enrichment by controlling particle selective detachment and transport process. Owing to the different hydraulic mechanisms of OC enrichment in different size particles, the obtained regression functions for uneven OC enrichment could be divided into two types. One was for calculating the OC concentrations in sediment particles with sizes of <2 mm (R-2 > 0.844, P< 0.005), and the other was for calculating the OC concentrations in large macroaggregates (>2 mm; R-2 = 0.805, P< 0.005). The findings provide an important reference for understanding SOC transport mechanisms and its mineralization potential under the effect of water erosion and improving SOC dynamic models.	[Liu, Lin; Li, Zhongwu; Jiao, Panpan] CAS & MWR, State Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Liu, Lin] Shandong Normal Univ, Coll Geog & Environm, Jinan, Shandong, Peoples R China; [Li, Zhongwu] Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Shandong Normal University; Hunan Normal University	Li, ZW (corresponding author), CAS & MWR, State Key Lab Soil Eros & Dryland Farming Loess P, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.; Li, ZW (corresponding author), Hunan Normal Univ, Coll Resources & Environm Sci, Changsha, Hunan, Peoples R China.	lizhongwu_hn@163.com			"Hundred-Talent Project" of the Chinese Academy of Sciences; National Natural Science Foundation of China [41271294]; State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [A314021402-1905]	"Hundred-Talent Project" of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau	This study was financially supported by the "Hundred-Talent Project" of the Chinese Academy of Sciences (http://www.cas.cn/) and the National Natural Science Foundation of China (41271294; http://www.nsfc.gov.cn/) received by Dr. Zhongwu Li; the funds of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (A314021402-1905; http://www.iswc.ac.cn/) received by Dr. Lin Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata N, 2015, SOIL TILL RES, V152, P1, DOI 10.1016/j.still.2015.03.010; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Cai Q, 1998, PROCESS SEDIMENT YIE, P92; CAMBARDELLA CA, 1993, SOIL SCI SOC AM J, V57, P1071, DOI 10.2136/sssaj1993.03615995005700040032x; Chamizo S, 2017, CATENA, V148, P117, DOI 10.1016/j.catena.2016.06.017; Chen YZ, 1987, GEOGR RES-AUST, V6, P76; Comprehensive Scientific Expedition CM, 1990, SLOP CLASS DAT SET C; Du HQ, 2021, SCI TOTAL ENVIRON, V798, DOI 10.1016/j.scitotenv.2021.149189; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fang HuaJun, 2006, Acta Pedologica Sinica, V43, P730; Flanagan DC, 2000, T ASAE, V43, P573, DOI 10.13031/2013.2737; Fornes WL, 2005, EARTH SURF PROC LAND, V30, P1181, DOI 10.1002/esp.1269; Fox DM, 1998, SOIL SCI SOC AM J, V62, P717, DOI 10.2136/sssaj1998.03615995006200030025x; GILLEY JE, 1990, T ASAE, V33, P1900, DOI 10.13031/2013.31556; Guerrero-Campo J, 2008, J VEG SCI, V19, P457, DOI 10.3170/2008-8-18382; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Jin K, 2009, CATENA, V78, P81, DOI 10.1016/j.catena.2009.03.001; KINNELL PIA, 1993, AUST J SOIL RES, V31, P333, DOI 10.1071/SR9930333; Kuhn NJ, 2009, EARTH SURF PROC LAND, V34, P1033, DOI 10.1002/esp.1796; Lado M, 2004, SOIL SCI SOC AM J, V68, P1992, DOI 10.2136/sssaj2004.1992; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2005, SOIL TILL RES, V81, P137, DOI 10.1016/j.still.2004.09.002; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Li ZW, 2016, SOIL SCI SOC AM J, V80, P1341, DOI 10.2136/sssaj2016.03.0092; Li Zhong-wu, 2015, Journal of Hunan University (Natural Sciences), V42, P115; Liu C, 2018, AGR ECOSYST ENVIRON, V253, P11, DOI 10.1016/j.agee.2017.10.028; Liu HX, 2016, CATENA, V145, P180, DOI 10.1016/j.catena.2016.06.007; Liu L, 2020, SOIL TILL RES, V204, DOI 10.1016/j.still.2020.104752; Liu L, 2017, J HYDROL, V554, P600, DOI 10.1016/j.jhydrol.2017.09.010; Liu L, 2018, SOIL TILL RES, V175, P291, DOI 10.1016/j.still.2017.09.011; Liu L, 2019, EARTH SURF PROC LAND, V44, P1895, DOI 10.1002/esp.4618; Lugato E, 2010, GEODERMA, V157, P80, DOI 10.1016/j.geoderma.2010.03.017; Maiga-Yaleu S, 2013, CATENA, V107, P26, DOI 10.1016/j.catena.2013.03.006; Maiga-Yaleu SB, 2015, CATENA, V126, P60, DOI 10.1016/j.catena.2014.11.001; Nie XD, 2017, ENVIRON MANAGE, V59, P816, DOI 10.1007/s00267-016-0817-9; PALIS RG, 1990, AUST J SOIL RES, V28, P623, DOI 10.1071/SR9900623; Palis RG, 1997, AUST J SOIL RES, V35, P891, DOI 10.1071/S92060; Polyakov V, 2004, ENVIRON INT, V30, P547, DOI 10.1016/j.envint.2003.10.011; Rajan K, 2010, CURR SCI INDIA, V99, P823; Rimal BK, 2009, SOIL TILL RES, V106, P62, DOI 10.1016/j.still.2009.09.014; Rodriguez AR, 2002, LAND DEGRAD DEV, V13, P515, DOI 10.1002/ldr.543; Sajjadi SA, 2015, J SOIL SEDIMENT, V15, P710, DOI 10.1007/s11368-015-1072-z; SHARMA PP, 1995, SOIL SCI SOC AM J, V59, P727, DOI 10.2136/sssaj1995.03615995005900030014x; Shi ZH, 2010, CATENA, V81, P240, DOI 10.1016/j.catena.2010.04.007; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Stanchi S, 2015, SOLID EARTH, V6, P403, DOI 10.5194/se-6-403-2015; Starr GC, 2000, LAND DEGRAD DEV, V11, P83, DOI 10.1002/(SICI)1099-145X(200001/02)11:1<83::AID-LDR370>3.0.CO;2-W; Teixeira PC, 1997, CATENA, V30, P119, DOI 10.1016/S0341-8162(97)00023-4; Trigalet S, 2014, AGR ECOSYST ENVIRON, V196, P1, DOI 10.1016/j.agee.2014.06.011; Vaezi AR, 2017, SCI TOTAL ENVIRON, V583, P382, DOI 10.1016/j.scitotenv.2017.01.078; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang YX, 2018, CATENA, V167, P257, DOI 10.1016/j.catena.2018.05.005; Wuddivira MN, 2009, SOIL SCI SOC AM J, V73, P226, DOI 10.2136/sssaj2008.0053; Yoo K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002271	58	0	0	12	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2022	17	2							e0262865	10.1371/journal.pone.0262865	http://dx.doi.org/10.1371/journal.pone.0262865			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2E9PM	35192628	Green Published, gold			2022-12-26	WOS:000812552500013
J	Hou, CY; Protopopova, A				Hou, Cheng Yu; Protopopova, Alexandra			Rats as pets: Predictors of adoption and surrender of pet rats (Rattus norvegicus domestica) in British Columbia, Canada	PLOS ONE			English	Article							LENGTH-OF-STAY; ANIMAL SHELTER; UNITED-KINGDOM; CATS; DOGS; WELFARE; AGE; RELINQUISHMENT; PREVENTION; AUSTRALIA	Whereas much research has been conducted on rats in their roles as pests and laboratory animal models, little is known about rats in their role as companion animals. However, rats have become the third most common companion animal admitted to the British Columbia Society for the Prevention of Cruelty to Animals (BC SPCA) shelter system after cats and dogs. This paper analyses 5 years of province-wide rat admission and outcome data (n = 3,392) at the BC SPCA. Most rats that entered BC SPCA shelters were white, sexually intact, and pups less than 6 months old. Rats were mostly relinquished by their owners, and the most common surrender reasons were due to owner-related issues and housing issues. Reasons for euthanasia were primarily poor health and neonatal age. A multiple linear regression model found that rats that were either senior, albino, unhealthy, seized by humane officers, or born onsite tended to stay longer in shelters (F[12, 1466] = 9.565, p < .001, adjusted R-2 = .06). Time to adoption for albino rats was 79% longer than for white rats. These findings help us understand the preferences of rat adopters and why the rat-human relationship may fail. Results may also be useful to improve the quality of life for pet rats by identifying programs to reduce their length of stay in animal shelters. Finally, our study highlights new questions for welfare research in an understudied companion animal-the pet rat.	[Hou, Cheng Yu; Protopopova, Alexandra] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	University of British Columbia	Hou, CY (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	chengyuh@student.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)/British Columbia Society for the Prevention of Cruelty to Animals (BC SPCA) Industrial Research Chair [IRCPJ 554745-19]	Natural Sciences and Engineering Research Council of Canada (NSERC)/British Columbia Society for the Prevention of Cruelty to Animals (BC SPCA) Industrial Research Chair	The study was funded in-part by the Natural Sciences and Engineering Research Council of Canada (NSERC)/British Columbia Society for the Prevention of Cruelty to Animals (BC SPCA) Industrial Research Chair (IRCPJ 554745-19). The funders did not play any role in study design nor decision to publish. The BC SPCA provided the data and edited the final manuscript draft for accuracy. URL: https://www.nserc-crsng.	AFRMA Fancy Rat Standards, 2018, AM FANC RAT MOUS ASS; Alberthsen C, 2016, ANIMALS, V6, DOI 10.3390/ani6030023; American Society for Prevention of Cruelty to Animals (ASPCA), 2020, PETS POV STAT MEM; [Anonymous], 2020, SHELTERBUDDY 0615; [Anonymous], PETS AUSTR NATL SURV; [Anonymous], 2018, AVMA PET OWN DEM SOU; [Anonymous], ALL BRANCHES SUMMARI; [Anonymous], BC SPCA; [Anonymous], 2020, GUID EUTH ROD FET NE; [Anonymous], CARING RATS; Attard E., 2013, CANADIAN STANDARDS C; Beumer K, 2014, SOC ANIM, V22, P8, DOI 10.1163/15685306-12341316; Brown WP, 2021, J APPL ANIM WELF SCI, V24, P238, DOI 10.1080/10888705.2020.1733574; Brown WP, 2015, J APPL ANIM WELF SCI, V18, P169, DOI 10.1080/10888705.2014.971156; Brown WP, 2013, J APPL ANIM WELF SCI, V16, P2, DOI 10.1080/10888705.2013.740967; Care Rat., 2010, AM SOC PREVENTION CR; Casey RA, 2009, ANTHROZOOS, V22, P347, DOI 10.2752/089279309X12538695316185; Ceriaco LMP, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-8; Cook AJ, 2012, J APPL ANIM WELF SCI, V15, P297, DOI 10.1080/10888705.2012.709084; Diesel G, 2010, J APPL ANIM WELF SCI, V13, P15, DOI 10.1080/10888700903369255; Ellis CF, 2017, J APPL ANIM WELF SCI, V20, P230, DOI 10.1080/10888705.2017.1303381; Gordon E, 2016, BRIT COLUMBIA SOC PR; Gourkow N, 2006, ANIM WELFARE, V15, P371; Hemy M, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7090067; Incoming Shelter Data, 2021, BRIT COL SOC PREV CR; Janke N, 2017, PREV VET MED, V148, P44, DOI 10.1016/j.prevetmed.2017.10.007; Kay A, 2018, J APPL ANIM WELF SCI, V21, P375, DOI 10.1080/10888705.2018.1436917; Ledger R.A., 2010, J VET BEHAV, V5, P36, DOI [10.1016/j.jveb.2009.10.016, DOI 10.1016/J.JVEB.2009.10.016]; Lepper Merry, 2002, Journal of Applied Animal Welfare Science, V5, P29, DOI 10.1207/S15327604JAWS0501_3; Lockwood R, 2018, BEHAV SCI LAW, V36, P698, DOI 10.1002/bsl.2373; Marston Linda C., 2005, Journal of Applied Animal Welfare Science, V8, P25, DOI 10.1207/s15327604jaws0801_3; Marston Linda C., 2004, Journal of Applied Animal Welfare Science, V7, P27, DOI 10.1207/s15327604jaws0701_2; Marston LC, 2009, J APPL ANIM WELF SCI, V12, P189, DOI 10.1080/10888700902955948; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Mondelli Francesca, 2004, Journal of Applied Animal Welfare Science, V7, P253, DOI 10.1207/s15327604jaws0704_3; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Neville V, 2021, VET REC, V189, P246, DOI 10.1002/vetr.559; Neville V, 2019, J APPL ANIM WELF SCI, V22, P105, DOI 10.1080/10888705.2018.1438287; Ockenden EM, 2014, ANTHROZOOS, V27, P33, DOI 10.2752/175303714X13837396326332; Overview of capacity for care (C4C), KOR SHELT MED PROGR; Patronek GJ, 1999, PUBLIC HEALTH REP, V114, P81, DOI 10.1093/phr/114.1.81; Perrin T, 2009, CAN VET J, V50, P48; Prokop P., 2018, Ethnozoology: animals in our lives, P447; Protopopova A, 2017, ANIM WELFARE, V26, P35, DOI 10.7120/09627286.26.1.035; Protopopova A, 2016, ANTHROZOOS, V29, P469, DOI 10.1080/08927936.2016.1181381; Protopopova A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114319; Protopopova A, 2012, APPL ANIM BEHAV SCI, V142, P61, DOI 10.1016/j.applanim.2012.09.009; Richardson C, 2006, IN PRACTICE, V28, P70; Robin C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121526; Rowan A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8050068; Salman M. D., 2000, Journal of Applied Animal Welfare Science, V3, P93, DOI 10.1207/S15327604JAWS0302_2; Schuurman N., 2020, TRACE J HUM ANIM STU, V6, P2, DOI [10.23984/fjhas.86934, DOI 10.23984/FJHAS.86934]; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Vojtkovska V, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090595; White SC, 2012, JAVMA-J AM VET MED A, V240, P1160, DOI 10.2460/javma.240.10.1160; Zak J, 2015, ACTA VET BRNO, V84, P407, DOI 10.2754/avb201584040407; Zito S, 2015, ANIMALS, V5, P276, DOI 10.3390/ani5020276	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0264262	10.1371/journal.pone.0264262	http://dx.doi.org/10.1371/journal.pone.0264262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180270	Green Published, gold			2022-12-26	WOS:000796435800056
J	Sonko, I; Chung, MH; Hou, WH; Chen, WT; Chang, PC				Sonko, Ismaila; Chung, Min-Huey; Hou, Wen-Hsuan; Chen, Wei-Ti; Chang, Pi-Chen			Predictors of HIV testing among youth aged 15-24 years in The Gambia	PLOS ONE			English	Article							CARE; ADOLESCENTS; LINKAGE; SERVICES; STUDENTS; ACCESS; WOMEN; MODEL; MEN	Background Worldwide, an estimated 38.0 million people lived with the human immunodeficiency virus in 2019, and 3.4 million young people aged 15 similar to 24 years were living with HIV. Sub-Saharan Africa carries a significant HIV burden with West and Central Africa most affected with HIV. Among the young people living with HIV in West and Central Africa, an estimated 810,000 were aged 15 similar to 24 years. This study aimed to assess predictors that influence the uptake of HIV testing among youth aged 15 similar to 24 years in The Gambia. Methods The 2013 Gambia Demographic and Health Survey data for youth aged 15 similar to 24 years was used. The Andersen behavioral model of health service use guided this study. A cross-sectional study design was used on 6194 subjects, among which 4730 were female. The analysis employed Chi-squared tests and hierarchical logistic regression. Results Less than one-quarter of the youth 1404 (22.6%) had ever been tested for HIV. Young people aged 20 similar to 24 years (adjusted odds ratio (aOR): 1.98), who were females (aOR: 1.13), married youth (aOR: 3.89), with a primary (aOR: 1.23), secondary or higher education (aOR: 1.46), and who were from the Jola/Karoninka ethnic group (aOR: 1.81), had higher odds of having been tested for HIV. Those with adequate HIV knowledge and those who were sexually active and had aged at first sex >= 15 years (aOR: 3.99) and those <15 years (aOR: 3.96) were more likely to have been tested for HIV compared to those who never had sex. Conclusion This study underscores the low level of model testing on HIV testing among youth (15 similar to 24 years) in The Gambia. Using Anderson's Model of Health Service Utilization, the predisposing factors (socio-demographic and HIV knowledge) and the need-for-care factors (sexual risk behaviors) predict healthcare utilization services (HIV testing) in our study; however, only socio-demographic model explained most of the variance in HIV testing. The low effect of model testing could be related to the limited number of major variables selected for HIV knowledge and sexual risk behavior models. Thus, consideration for more variables is required for future studies.	[Sonko, Ismaila; Chung, Min-Huey; Chang, Pi-Chen] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Sonko, Ismaila] Minist Hlth & Social Welf, Banjul, Gambia; [Chung, Min-Huey] Taipei Med Univ, Dept Nursing, Shuang Ho Hosp, New Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ Hosp, Dept Educ, Ctr Evidence Based Med, Taipei, Taiwan; [Chen, Wei-Ti] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; University of California System; University of California Los Angeles	Chang, PC (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.	pichen@tmu.edu.tw						Aday L A, 1974, Health Serv Res, V9, P208; Adebayo OW, 2017, J ASSOC NURSE AIDS C, V28, P342, DOI 10.1016/j.jana.2016.11.006; Ajayi AI, 2021, J PUBLIC HEALTH-UK, V43, pE77, DOI 10.1093/pubmed/fdz152; Ajayi AI, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233368; Alem AZ., 2021, BMC PUBLIC HEALTH, V21, P1, DOI [10.1186/s12889-020-10013-y, DOI 10.1186/S12889-020-10013-Y]; Aluzimbi G, 2017, J PUBLIC HEALTH AFR, V8, P54, DOI 10.4081/jphia.2017.577; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ante-Testard PA, 2020, LANCET GLOB HEALTH, V8, pE808, DOI 10.1016/S2214-109X(20)30108-X; Asante KO, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-17; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Azfredrick EC, 2016, INT J ADOLESC YOUTH, V21, P523, DOI 10.1080/02673843.2015.1124790; Bekele YA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228783; Boyd D, 2018, CHILD YOUTH SERV REV, V90, P134, DOI 10.1016/j.childyouth.2018.05.025; Brima N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137055; Budu E, 2022, J BIOSOC SCI, V54, P558, DOI 10.1017/S0021932021000237; Chowdhury MZI, 2020, FAM MED COMMUNITY HE, V8, DOI 10.1136/fmch-2019-000262; Conserve DF, 2017, AM J MENS HEALTH, V11, P1322, DOI 10.1177/1557988316635247; Council NA, 2014, NAT POL GUID HIV AID; Diress G., 2019, INTERNAL MED SPECIAL, P1; Diress G, 2020, HIV AIDS-RES PALLIAT, V12, P963, DOI 10.2147/HIV.S280590; Gassama O., 2018, J AIDS CLIN RES, V9, P1; Giguere K, 2021, LANCET HIV, V8, pe284, DOI 10.1016/S2352-3018(20)30315-5; Hadish MT., 2017, J TRANSMITTED DIS IM, V1, P2; Kurth AE, 2015, J INT AIDS SOC, V18, P23, DOI 10.7448/IAS.18.2.19433; Lakhe NA, 2019, BMC INFECT DIS, V20, DOI 10.1186/s12879-019-4717-5; Langer W., 2016, P M GERMAN STATA USE; Leta TH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-438; Lo CC, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118783414; Ma ZQ, 2014, HEALTH EDUC RES, V29, P330, DOI 10.1093/her/cyt110; Makhema J, 2019, NEW ENGL J MED, V381, P230, DOI 10.1056/NEJMoa1812281; Mandiwa C, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4031-3; Meehan SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195208; Melesse DY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002231; Motshegwa GD., 2020, GENDER BEHAV, V18; Mwaba K, 2020, AIDS CARE, V32, pS183, DOI 10.1080/09540121.2020.1739214; Nall A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081450; Pharr JR, 2016, JAIDS-J ACQ IMM DEF, V72, pS154, DOI 10.1097/QAI.0000000000001051; Saint-Jean G, 2011, AIDS CARE, V23, P486, DOI 10.1080/09540121.2010.516339; Salazar-Austin N, 2018, AIDS BEHAV, V22, P569, DOI 10.1007/s10461-017-1807-5; Sam-Agudu NA, 2016, PEDIATR RES, V79, P838, DOI 10.1038/pr.2016.28; Seidu AA, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00512; Singh U, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1252-5; Snipes M., 2014, Wine Economics and Policy, V3, P3, DOI 10.1016/j.wep.2014.03.001; Somefun OD, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019851551; Ssebunya RN, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5544-0; Takarinda KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147828; The Gambia Bureau of Statistics & ICF International, 2014, GAMB DEM HLTH SURV 2; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2021, YOUNG PEOPL HIV GLOB; UNAIDS, 2019, GLOB HIV AIDS STAT F; UNAIDS UNICEF, 2017, STEP PAC AIDS FREE G; United Nations Children's Fund (UNICEF), 2019, AD HIV PREV; WHO, 2019, GAMB HIV COUNTR PROF; Wiwattanacheewin K, 2015, AIDS EDUC PREV, V27, P139, DOI 10.1521/aeap.2015.27.2.139; Yaya S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08618-4; Zanoni BC, 2018, ADOLESC HEALTH MED T, V9, P211, DOI 10.2147/AHMT.S153204	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2022	17	2							e0263720	10.1371/journal.pone.0263720	http://dx.doi.org/10.1371/journal.pone.0263720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1H3HL	35180256	Green Published, gold			2022-12-26	WOS:000796435800028
J	Dima, SA; Shibeshi, MS				Dima, Shamil Ahmed; Shibeshi, Mulugeta Sitot			Antiepileptic drug adherence in children in southern Ethiopia: A cross sectional study	PLOS ONE			English	Article							MEDICATION ADHERENCE; EPILEPSY TREATMENT; NONADHERENCE; ADOLESCENTS; PREDICTORS; RECOMMENDATIONS; PREVALENCE; SEIZURES	Background Epilepsy is one of the commonest chronic neurological disorders with serious health consequences. Treatment adherence is one of the determinants of seizure control. This study was designed to determine factors affecting antiepileptic drug adherence among children with epilepsy. Methods A cross sectional study was conducted on 192 children with epilepsy (<= 14 years of age) on follow-up at a pediatric neurology clinic in Southern Ethiopia from January 1st to August 30th, 2019. Medication Adherence was measured using the eight-item Morisky's medication adherence scale. Logistic regression analysis was done to determine factors associated with antiepileptic drug adherence. Result One hundred twenty-five (65%) of the study subjects were adherent to their medication. On multivariable analysis, factors predictive of good adherence included family size of <= 5 [AOR = 2.34, (95% CI: 1.07, 5.10); P = 0.03] and duration of epilepsy (< 1year [AOR = 5.83, (95% CI: 1.48, 22.92); P = 0.012] and 1-2year [AOR = 4.58, (95% CI: 1.12, 18.77); P = 0.035]). Monthly family income of <1000 Ethiopian Birr [AOR = 0.18, (95% CI: 0.06, 0.61); P = 0.005] and presence of seizure attack in the past 3months [AOR = 0.23, 95% (CI: 0.10, 0.55); P = 0.001] predicted poor antiepileptic drug adherence. Conclusion Adherence to antiepileptic drugs in children is low in our setting; low family income and occurrence of seizures while on treatment predicted poor adherence. Supplying free antiepileptic drugs to poor children and regular provision of information about expected treatment response to children with epilepsy and their caretakers may help improve adherence.	[Dima, Shamil Ahmed] Madda Walabu Univ, Dept Pediat & Child Hlth, Gobba, Ethiopia; [Shibeshi, Mulugeta Sitot] Hawassa Univ, Dept Pediat & Child Hlth, Hawassa, Ethiopia	Hawassa University	Dima, SA (corresponding author), Madda Walabu Univ, Dept Pediat & Child Hlth, Gobba, Ethiopia.	shaman.hang2@gmail.com		Ahmed Dima, Shamil/0000-0002-5842-8259; Shibeshi, Mulugeta/0000-0003-3339-9225				Almu S, 2006, SEIZURE-EUR J EPILEP, V15, P211, DOI 10.1016/j.seizure.2006.01.004; Alsous M, 2018, EPILEPSY BEHAV, V85, P205, DOI 10.1016/j.yebeh.2018.06.022; Asadi-Pooya AA, 2005, SEIZURE-EUR J EPILEP, V14, P393, DOI 10.1016/j.seizure.2005.05.003; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Belayneh Z, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00405-2; Boshe BD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247952; Brodtkorb E, 2016, EPILEPSY RES, V122, P1, DOI 10.1016/j.eplepsyres.2016.02.001; Chauhan S., 2018, SRI LANKA J CHILD HL, V47, P129, DOI [10.4038/sljch.v47i2.8478, DOI 10.4038/SLJCH.V47I2.8478]; Chew BH, 2015, PATIENT PREFER ADHER, V9, P639, DOI 10.2147/PPA.S81612; Cramer JA, 2002, EPILEPSY BEHAV, V3, P338, DOI 10.1016/S1525-5050(02)00037-9; Deresse B, 2012, ETHIOP J HEALTH DEV, V26, P101; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Faught RE, 2009, EPILEPSIA, V50, P501, DOI 10.1111/j.1528-1167.2008.01794.x; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gabr WM, 2015, SAUDI PHARM J, V23, P33, DOI 10.1016/j.jsps.2014.05.003; Garnett WR, 2000, PHARMACOTHERAPY, V20, p191S, DOI 10.1592/phco.20.12.191S.35250; Hasiso TY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163040; HAZZARD A, 1990, J PEDIATR PSYCHOL, V15, P543, DOI 10.1093/jpepsy/15.4.543; Heckman BW, 2015, CURR OPIN PSYCHOL, V5, P31, DOI 10.1016/j.copsyc.2015.03.004; Hovinga CA, 2008, EPILEPSY BEHAV, V13, P316, DOI 10.1016/j.yebeh.2008.03.009; Ibinda Fredrick, 2017, Epilepsia Open, V2, P226, DOI 10.1002/epi4.12052; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Kassahun G, 2018, NEUROL RES INT, V2018, DOI 10.1155/2018/5109615; Kyngas H, 2001, SEIZURE-EUR J EPILEP, V10, P549, DOI 10.1053/seiz.2001.0557; Loiselle K, 2015, EPILEPSY BEHAV, V50, P103, DOI 10.1016/j.yebeh.2015.06.040; Mbuba CK, 2012, LANCET NEUROL, V11, P688, DOI 10.1016/S1474-4422(12)70155-2; Mitchell WG, 2000, EPILEPSIA, V41, P1616; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Nazziwa R, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.44.3399; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Paschal AM, 2008, EPILEPSIA, V49, P1115, DOI 10.1111/j.1528-1167.2008.01645.x; Patel Samir, 2013, J Diabetes Sci Technol, V7, P630; SabatU E., 2003, ADHERENCE LONG TERM; SEDA T, 2019, ETHIOPIA, V3, P93; Shah NM, 2013, EPILEPSIA, V54, P1020, DOI 10.1111/epi.12126; Shetty J, 2016, DEV MED CHILD NEUROL, V58, P469, DOI 10.1111/dmcn.12942; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; Sweileh WM, 2011, EPILEPSY BEHAV, V21, P301, DOI 10.1016/j.yebeh.2011.04.011; Tan XC, 2015, NEUROL ASIA, V20, P235; TekleHaimanot R, 1997, EPILEPSIA, V38, P541, DOI 10.1111/j.1528-1157.1997.tb01138.x; TEKLEHAIMANOT R, 1990, EPILEPSY RES, V7, P230, DOI 10.1016/0920-1211(90)90020-V; Tesfaye W, J CLIN PHARM THER, V2021, DOI [10.1111/jcpt.13515, DOI 10.1111/JCPT.13515]; Tilahun M, 2020, NONADHERENCE ANTIEPI; Walters RJL, 2004, QJM-INT J MED, V97, P337, DOI 10.1093/qjmed/hch057	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263821	10.1371/journal.pone.0263821	http://dx.doi.org/10.1371/journal.pone.0263821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176045	gold, Green Published			2022-12-26	WOS:000777505200035
J	Wang, HW; Lou, SJ; Jing, J; Wang, YS; Liu, W; Liu, TM				Wang, Huanwei; Lou, Shangjie; Jing, Jing; Wang, Yisen; Liu, Wei; Liu, Tieming			The EBS-A* algorithm: An improved A* algorithm for path planning	PLOS ONE			English	Article							UNMANNED SURFACE VEHICLE; ENVIRONMENT	Path planning plays an essential role in mobile robot navigation, and the A* algorithm is one of the best-known path planning algorithms. However, the traditional A* algorithm has some limitations, such as slow planning speed, close to obstacles. In this paper, we propose an improved A*-based algorithm, called the EBS-A* algorithm, that introduces expansion distance, bidirectional search, and smoothing into path planning. The expansion distance means keeping an extra space from obstacles to improve path reliability by avoiding collisions. Bidirectional search is a strategy searching path from the start node and the goal node simultaneously. Smoothing improves path robustness by reducing the number of rightangle turns. In addition, simulation tests for the EBS-A* algorithm are performed, and the effectiveness of the proposed algorithm is verified by transferring it to a robot operating system (ROS). The experimental results show that compared with the traditional A* algorithm, the proposed algorithm improves the path planning efficiency by 278% and reduces the number of critical nodes by 91.89% and the number of right-angle turns by 100%.	[Wang, Huanwei; Lou, Shangjie; Jing, Jing; Wang, Yisen; Liu, Wei; Liu, Tieming] State Key Lab Math Engn & Adv Comp, Zhengzhou, Peoples R China	PLA Information Engineering University	Jing, J (corresponding author), State Key Lab Math Engn & Adv Comp, Zhengzhou, Peoples R China.	jingjing_cs@hotmail.com						Ab Wahab MN, 2020, ANNU REV CONTROL, V50, P233, DOI 10.1016/j.arcontrol.2020.10.001; Cai K., 2019, INSTRUMENTATION, V6, P92; Costa MM, 2019, IEEE INT CONF AUTON, P33; Tanishk D, 2020, 2020 59TH ANNUAL CONFERENCE OF THE SOCIETY OF INSTRUMENT AND CONTROL ENGINEERS OF JAPAN (SICE), P451; Elhoseny M, 2018, J COMPUT SCI-NETH, V25, P339, DOI 10.1016/j.jocs.2017.08.004; Fu B, 2018, ROBOT AUTON SYST, V106, P26, DOI 10.1016/j.robot.2018.04.007; Gunawan Syaiful A., 2019, 2019 International Conference on Information and Communications Technology (ICOIACT), P654; Guruji AK, 2016, PROC TECH, V23, P144, DOI 10.1016/j.protcy.2016.03.010; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hauer F, 2017, ROBOTICS: SCIENCE AND SYSTEMS XIII; Hirakawa T, 2019, INT CONF PERVAS COMP, P608, DOI 10.1109/PERCOMW.2019.8730688; Junfeng Yao, 2010, Proceedings of the Seventh International Conference on Information Technology: New Generations (ITNG 2010), P1154, DOI 10.1109/ITNG.2010.53; Karur K, 2021, VEHICLES-BASEL, V3, P448, DOI 10.3390/vehicles3030027; Kumar PM, 2018, COMPUT NETW, V144, P154, DOI 10.1016/j.comnet.2018.07.001; Liu CG, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061057; Maheshwari P, 2021, AD HOC NETW, V110, DOI 10.1016/j.adhoc.2020.102317; Mandava RK, 2019, ADV INTELL SYST, V817, P139, DOI 10.1007/978-981-13-1595-4_11; Nazarahari M, 2019, EXPERT SYST APPL, V115, P106, DOI 10.1016/j.eswa.2018.08.008; Ning JX, 2018, INFORM SCIENCES, V433, P142, DOI 10.1016/j.ins.2017.12.047; Peng JS, 2015, CYBERN INF TECHNOL, V15, P171, DOI 10.1515/cait-2015-0036; Qingji G, 2005, CHINA CIVIL AVIATION, V23, P42; Sedighi S, 2019, CONFERENCE PROCEEDINGS OF 2019 5TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND ROBOTICS (ICCAR), P570, DOI 10.1109/ICCAR.2019.8813752; Shang SP, 2020, MOL PLANT PATHOL, V21, P936, DOI 10.1111/mpp.12940; Singh Y, 2018, OCEAN ENG, V169, P187, DOI 10.1016/j.oceaneng.2018.09.016; Song R, 2019, APPL OCEAN RES, V83, P9, DOI 10.1016/j.apor.2018.12.001; Tang G, 2021, IEEE ACCESS, V9, P59196, DOI 10.1109/ACCESS.2021.3070054; Wang ZQ, COMPUTER SCI, V48, P19; Yang JM, 2015, INT J NAV ARCH OCEAN, V7, P87, DOI 10.1515/ijnaoe-2015-0007; Zhang X, 2018, J GEOMATICS SCI TECH; Zhao L., 2017, INT J VEH AUTON SYST, V13, P330	30	2	2	22	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2022	17	2							e0263841	10.1371/journal.pone.0263841	http://dx.doi.org/10.1371/journal.pone.0263841			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0F6ZJ	35176092	Green Published, gold			2022-12-26	WOS:000777505200038
J	Mu, E; Jabbour, S; Dalca, AV; Guttag, J; Wiens, J; Sjoding, MW				Mu, Emily; Jabbour, Sarah; Dalca, Adrian, V; Guttag, John; Wiens, Jenna; Sjoding, Michael W.			Augmenting existing deterioration indices with chest radiographs to predict clinical deterioration	PLOS ONE			English	Article							VALIDATION; RISK	Importance When hospitals are at capacity, accurate deterioration indices could help identify low-risk patients as potential candidates for home care programs and alleviate hospital strain. To date, many existing deterioration indices are based entirely on structured data from the electronic health record (EHR) and ignore potentially useful information from other sources. Objective To improve the accuracy of existing deterioration indices by incorporating unstructured imaging data from chest radiographs. Design, setting, and participants Machine learning models were trained to predict deterioration of patients hospitalized with acute dyspnea using existing deterioration index scores and chest radiographs. Models were trained on hospitalized patients without coronavirus disease 2019 (COVID-19) and then subsequently tested on patients with COVID-19 between January 2020 and December 2020 at a single tertiary care center who had at least one radiograph taken within 48 hours of hospital admission. Main outcomes and measures Patient deterioration was defined as the need for invasive or non-invasive mechanical ventilation, heated high flow nasal cannula, IV vasopressor administration or in-hospital mortality at any time following admission. The EPIC deterioration index was augmented with unstructured data from chest radiographs to predict risk of deterioration. We compared discriminative performance of the models with and without incorporating chest radiographs using area under the receiver operating curve (AUROC), focusing on comparing the fraction and total patients identified as low risk at different negative predictive values (NPV). Results Data from 6278 hospitalizations were analyzed, including 5562 hospitalizations without COVID-19 (training cohort) and 716 with COVID-19 (216 in validation, 500 in held-out test cohort). At a NPV of 0.95, the best-performing image-augmented deterioration index identified 49 more (9.8%) individuals as low-risk compared to the deterioration index based on clinical data alone in the first 48 hours of admission. At a NPV of 0.9, the EPIC image-augmented deterioration index identified 26 more individuals (5.2%) as low-risk compared to the deterioration index based on clinical data alone in the first 48 hours of admission. Conclusion and relevance Augmenting existing deterioration indices with chest radiographs results in better identification of low-risk patients. The model augmentation strategy could be used in the future to incorporate other forms of unstructured data into existing disease models.	[Mu, Emily; Dalca, Adrian, V; Guttag, John] MIT, Dept Comp Sci & Elect Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jabbour, Sarah; Wiens, Jenna] Univ Michigan, Div Comp Sci & Engn, Coll Engn, Ann Arbor, MI 48109 USA; [Dalca, Adrian, V] Harvard Med Sch, Martinos Ctr, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wiens, Jenna; Sjoding, Michael W.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Sjoding, Michael W.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mu, E (corresponding author), MIT, Dept Comp Sci & Elect Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	emilymu@mit.edu			NIH [K01 HL136687, R01 LM013325]; Quanta Computer (JG); MM Precision Health Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quanta Computer (JG); MM Precision Health Award	This work was supported by NIH grants K01 HL136687 (MWS) and R01 LM013325 (JW, MWS), and MM Precision Health Award (MWS). This work was also supported by the generosity of Quanta Computer (JG, EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltagy I, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P3615; Boonn WW, 2009, J DIGIT IMAGING, V22, P357, DOI 10.1007/s10278-008-9115-2; Robinson C, 2021, medRxiv, DOI 10.1101/2021.02.11.20196766; Cardenas DNP., 2018, DIFFERENCES ROTHMAN; Chen XC, 2021, PATTERN RECOGN, V113, DOI 10.1016/j.patcog.2021.107826; Churpek MM, 2014, AM J RESP CRIT CARE, V190, P649, DOI 10.1164/rccm.201406-1022OC; Cummings BC., 2020, MEDRXIV; Das D, 2020, PHYS ENG SCI MED, V43, P915, DOI 10.1007/s13246-020-00888-x; Dunnmon JA, 2019, RADIOLOGY, V290, P537, DOI 10.1148/radiol.2018181422; Iandola F., 2014, ARXIV14041869; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Kamran F, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2021-068576; Leslie A, 2000, BRIT J RADIOL, V73, P1052, DOI 10.1259/bjr.73.874.11271897; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Ozsahin I, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/9756518; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rothman MJ, 2013, J BIOMED INFORM, V46, P837, DOI 10.1016/j.jbi.2013.06.011; Rousan LA, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01286-5; Singh K, 2021, ANN AM THORAC SOC, V18, P1129, DOI [10.1513/AnnalsATS.202006-698OC, 10.17660/ActaHortic.2020.1297.1, 10.1101/2020.04.24.20079012]; Sriram A., 2021, ARXIV210104909; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260; Wiens JAM., 2012, PATIENT RISK STRATIF; Yasin R, 2020, EGYPT J RADIOL NUC M, V51, DOI 10.1186/s43055-020-00296-x	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2022	17	2							e0263922	10.1371/journal.pone.0263922	http://dx.doi.org/10.1371/journal.pone.0263922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1P8AU	35167608	gold, Green Published			2022-12-26	WOS:000802227200022
J	Elelu, N; Ola-Fadunsin, SD; Bankole, AA; Raji, MA; Ogo, NI; Cutler, SJ				Elelu, Nusirat; Ola-Fadunsin, Shola David; Bankole, Adefolake Ayinke; Raji, Mashood Abiola; Ogo, Ndudim Isaac; Cutler, Sally Jane			Prevalence of tick infestation and molecular characterization of spotted fever Rickettsia massiliae in Rhipicephalus species parasitizing domestic small ruminants in north-central Nigeria	PLOS ONE			English	Article							BORNE RICKETTSIOSES; IDENTIFICATION; ECTOPARASITES; WORLD; DISEASES; STATE	Ticks are of great menace to animal and human health. They serve as vectors to both animals and human pathogens including Rickettsia species. Tick-borne rickettsiosis in West Africa remains incompletely understood. We determined the prevalence of tick infestation among small ruminants and molecularly described a clinically significant spotted fever Rickettsia massiliae from Rhipicephalus ticks collected from North-Central, Nigeria. A total of 352 small ruminants comprising of 152 sheep and 200 goats that were brought for slaughter at the major small ruminant slaughterhouse in Ilorin were examined for the presence of ticks. The collected Rhipicephalus species were subjected to molecular studies to detect and characterize Rickettsia massiliae. Of the small ruminants examined, 21 sheep and 46 goats were infested with ticks representing 13.82% and 23.00% respectively. Eight and nine different species of ticks were detected in sheep and goats respectively, with Rhipicephalus (Boophilus) decoloratus being the most prevalent tick species in both sheep and goats. There was a significant difference (p <0.01) in the prevalence of the different tick species collected in sheep and in goats. Based on the PCR amplification of the 23S-5S intergenic spacer (IGS), only 2 of the 142 Rhipicephalus tick samples screened for R. massiliae were positive (1.41%; 95% CI = 0.39-4.99). Rickettsia massiliae was detected from Rhipicephalus turanicus collected from sheep. Sequences obtained from the PCR carried out by amplifying Rickettsia 23S-5S IGS showed 99-100% close identity with members of the R. massiliae group. This study has for the first time confirmed the presence of spotted fever group Rickettsia massiliae from feeding ticks in Nigerian small ruminants. Further investigations to determine the possible pathogenic role of human R. massiliae infection in Nigeria would be beneficial.	[Elelu, Nusirat] Univ Ilorin, Fac Vet Med, Dept Vet Publ Hlth & Prevent Med, Ilorin, Nigeria; [Ola-Fadunsin, Shola David] Univ Ilorin, Fac Vet Med, Dept Vet Parasitol & Entomol, Ilorin, Nigeria; [Bankole, Adefolake Ayinke; Cutler, Sally Jane] Univ East London, Sch Hlth Sport & Biosci, London, England; [Raji, Mashood Abiola] Univ Ilorin, Fac Vet Med, Dept Vet Microbiol, Ilorin, Nigeria; [Ogo, Ndudim Isaac] Natl Inst Vet Res, Vom, Nigeria	University of Ilorin; University of Ilorin; University of East London; University of Ilorin	Ola-Fadunsin, SD (corresponding author), Univ Ilorin, Fac Vet Med, Dept Vet Parasitol & Entomol, Ilorin, Nigeria.	olafadunsin.sd@unilorin.edu.ng		Ola-Fadunsin, Shola David/0000-0002-2265-2494; Bankole, adefolake/0000-0003-2621-9302	Africa Research Excellence Fund Fellowship [MRF-157-0022-FELELU]	Africa Research Excellence Fund Fellowship	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Africa Research Excellence Fund Fellowship. Grant Number: MRF-157-0022-FELELU. The grant recipient is Dr. Nusirat Elelu.	Abunna F, 2008, INTERNET J VET MED, V7; Adang K. L., 2015, Pakistan Journal of Biological Sciences, V18, P224; Alayande MO, 2016, NIGER J ANIM SCI, V18, P183; Aminu M., 2015, INT J AGR EARTH SCI, V1, P1; Berrelha J, 2009, CLIN MICROBIOL INFEC, V15, P251, DOI 10.1111/j.1469-0691.2008.02273.x; Garcia-Garcia JC, 2010, AM J TROP MED HYG, V82, P691, DOI 10.4269/ajtmh.2010.09-0662; DUPONT HT, 1994, AM J TROP MED HYG, V50, P373, DOI 10.4269/ajtmh.1994.50.373; Ebrahimzade E, 2016, J ARTHROPOD-BORNE DI, V10, P366; Eremeeva ME, 2006, APPL ENVIRON MICROB, V72, P5569, DOI 10.1128/AEM.00122-06; Ereqat S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004348; Essbauer S, 2018, TICKS TICK-BORNE DIS, V9, P288, DOI 10.1016/j.ttbdis.2017.11.002; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Hazihan W, 2019, EXP APPL ACAROL, V77, P73, DOI 10.1007/s10493-018-00337-1; Jensenius M, 2009, EMERG INFECT DIS, V15, P1791, DOI 10.3201/eid1511.090677; Kakumanu ML, 2016, J CLIN MICROBIOL, V54, P972, DOI 10.1128/JCM.02605-15; Kamani J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002108; Kaze PD, 2017, SAUDI J MED PHARM SC, V3, P206; Kedir M., 2015, EUR J APPL SCI, V7, P50; LawalAdebowale OA, 2015, INTECH, DOI [DOI 10.5772/52923, 10.5772/52923]; Lorusso V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1504-7; Lorusso V, 2013, EMERG INFECT DIS, V19, P1705, DOI 10.3201/eid1910.130389; Lorusso V, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-171; Mathison BA, 2014, CLIN MICROBIOL REV, V27, P48, DOI 10.1128/CMR.00008-13; Mathisson DC, 2021, J MED ENTOMOL, V58, P2030, DOI 10.1093/jme/tjab098; Matsumoto K, 2005, MED VET ENTOMOL, V19, P263, DOI 10.1111/j.1365-2915.2005.00569.x; Obi ZC, 2014, INT J FAUNA BIOL STU, V5, P27; Ofukwu RA, 2008, SOKOTO J VET SCI, V7, P22; Okorafor U.P., 2015, APPL RES J, V1, P153; Ola-Fadunsin S. D., 2017, Sokoto Journal of Veterinary Sciences, V15, P15, DOI 10.4314/sokjvs.v15i3.3; Ola-Fadunsin SD, 2021, TICKS TICK-BORNE DIS, V12, DOI 10.1016/j.ttbdis.2021.101653; Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000338; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Rehman A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2138-0; Reye AL, 2012, APPL ENVIRON MICROB, V78, P2562, DOI 10.1128/AEM.06686-11; Rolain JM, 1998, ANTIMICROB AGENTS CH, V42, P1537, DOI 10.1128/AAC.42.7.1537; Sertse T, 2007, SMALL RUMINANT RES, V69, P55, DOI 10.1016/j.smallrumres.2005.12.011; Seyoum Zewdu, 2015, J Vet Med, V2015, P216085, DOI 10.1155/2015/216085; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; Vitale G, 2006, EMERG INFECT DIS, V12, P174, DOI 10.3201/eid1201.050850; Walker A., 2014, BIOSCIENCE REP; Wei QQ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1242-2; Wesongah JO, 2003, PAK VET J, V14, P133; Yishak Israel, 2015, Journal of Veterinary Medicine and Animal Health, V7, P140	45	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263843	10.1371/journal.pone.0263843	http://dx.doi.org/10.1371/journal.pone.0263843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157723	gold, Green Published			2022-12-26	WOS:000788004500022
J	Castro, RDR; Braga, JCT; de Macedo, MP; Pinto, CAL; Fregnani, JHTG; Rezze, GG				Ramos Castro, Raquel de Paula; Tavoloni Braga, Juliana Casagrande; de Macedo, Mariana Petaccia; Lopes Pinto, Clovis Antonio; Tavares Guerreiro Fregnani, Jose Humberto; Rezze, Gisele Gargantini			Hotspot analysis by confocal microscopy can help to differentiate challenging melanocytic skin lesions	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; MELANOMA	Some melanocytic lesions do not present enough clinical and dermoscopic features to allow ruling out a possible melanoma diagnosis. These "doubtful melanocytic lesions" pose a very common and challenging scenario in clinical practice and were selected at this study for reflectance confocal microscopy evaluation and subsequent surgical excision for histopathological diagnosis. The study included 110 lesions and three confocal features were statistically able to distinguish benign melanocytic lesions from melanomas: "peripheral hotspot at dermo-epidermal junction", "nucleated roundish cells at the dermo-epidermal junction" and "sheet of cells". The finding of a peripheral hotspot (atypical cells in 1mm(2)) at the DEJ is highlighted because has not been previously reported in the literature as a confocal feature related to melanomas.	[Ramos Castro, Raquel de Paula; Tavoloni Braga, Juliana Casagrande] AC Camargo Canc Ctr, Dept Cutaneous Oncol, Sao Paulo, Brazil; [de Macedo, Mariana Petaccia; Lopes Pinto, Clovis Antonio] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Tavares Guerreiro Fregnani, Jose Humberto] AC Camargo Canc Ctr, Teaching & Res Inst, Sao Paulo, Brazil; [Rezze, Gisele Gargantini] Dermaimage Med Associates, Sao Paulo, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center	Castro, RDR (corresponding author), AC Camargo Canc Ctr, Dept Cutaneous Oncol, Sao Paulo, Brazil.	rprcastro@yahoo.com.br	Braga, Juliana/M-2997-2014	Braga, Juliana/0000-0002-1378-6992				Borsari S, 2018, BRIT J DERMATOL, V179, P163, DOI 10.1111/bjd.16364; Kutzner H, 2012, MODERN PATHOL, V25, P838, DOI 10.1038/modpathol.2012.35; Longo C, 2016, DERMATOL CLIN, V34, P411, DOI 10.1016/j.det.2016.05.004; Longo C, 2011, J AM ACAD DERMATOL, V65, P604, DOI 10.1016/j.jaad.2010.10.035; PEHAMBERGER H, 1987, J AM ACAD DERMATOL, V17, P571, DOI 10.1016/S0190-9622(87)70239-4; Pellacani G, 2014, BRIT J DERMATOL, V171, P1044, DOI 10.1111/bjd.13148; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellacani G, 2019, J AM ACAD DERMATOL, V81, P520, DOI 10.1016/j.jaad.2019.03.085; Pellacani G, 2012, J AM ACAD DERMATOL, V66, pE109, DOI 10.1016/j.jaad.2011.05.017; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Scope A, 2007, J AM ACAD DERMATOL, V57, P644, DOI 10.1016/j.jaad.2007.05.044; Segura S, 2009, J AM ACAD DERMATOL, V61, P216, DOI 10.1016/j.jaad.2009.02.014; Smoller BR, 2006, MODERN PATHOL, V19, pS34, DOI 10.1038/modpathol.3800508; Braga JCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081205	14	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2022	17	2							e0263819	10.1371/journal.pone.0263819	http://dx.doi.org/10.1371/journal.pone.0263819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0U9YZ	35157706	gold, Green Published			2022-12-26	WOS:000788004500019
J	Guo, XY; Liu, TT; Zhu, WJ; Liu, HT; Zhang, GH; Song, L; Zhao, RN; Chen, X; Gao, P				Guo, Xiang-Yu; Liu, Tian-Tian; Zhu, Wen-Jie; Liu, Hai-Ting; Zhang, Guo-Hao; Song, Lin; Zhao, Rui-Nan; Chen, Xu; Gao, Peng			CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis	ONCOGENE			English	Article							CIRCULAR RNAS; ANGIOGENESIS; PROMOTES; INVASION; VEGFA; PROLIFERATION; CELLS	Increasing studies have indicated that circular RNAs (circRNAs) play pivotal roles in various cancers. Here, we aimed to explore the roles of circRNAs in breast cancer. We identified a novel circRNA circKDM4B (hsa_circ_0002926) by whole-transcriptome sequencing and validated this by Real-time quantitative polymerase chain reaction (RT-qPCR) and Sanger sequencing. It was significantly decreased in breast cancer tissues compared with adjacent non-tumor tissues. Furthermore, circKDM4B, which is mainly localized in the cytoplasm, was more resistant to actinomycin D or ribonuclease R than its linear transcript KDM4B. In addition, the overexpression of circKDM4B inhibited cell migration and invasion in vitro, while knockdown of circKDM4B induced the opposite effects. In vivo, circKDM4B suppressed tumor growth and metastasis. Additionally, circKDM4B inhibited migration and tube formation of human umbilical vein endothelial cells (HUVECs) in vitro and angiogenesis in vivo. Mechanically, circKDM4B sponged miR-675 to upregulate the expression of NEDD4-like E3 ubiquitin protein ligase (NEDD4L), which catalyzes ubiquitination of PI3KCA, thereby inhibiting PI3K/AKT and VEGFA secretion. Collectively, these findings uncovered the tumor-suppressor role of circKDM4B in breast cancer, especially in angiogenesis and tumor metastasis, indicating that circKDM4B could be a potential therapeutic target for breast cancer progression.	[Guo, Xiang-Yu; Liu, Tian-Tian; Zhu, Wen-Jie; Liu, Hai-Ting; Zhang, Guo-Hao; Zhao, Rui-Nan; Gao, Peng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan, Peoples R China; [Guo, Xiang-Yu; Liu, Tian-Tian; Zhu, Wen-Jie; Liu, Hai-Ting; Zhang, Guo-Hao; Zhao, Rui-Nan; Gao, Peng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China; [Guo, Xiang-Yu; Liu, Tian-Tian; Zhu, Wen-Jie; Liu, Hai-Ting; Zhang, Guo-Hao; Song, Lin; Zhao, Rui-Nan; Chen, Xu; Gao, Peng] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pathol, Jinan, Peoples R China; [Song, Lin] Shandong First Med Univ, Dept Pathol, Shandong Prov Hosp, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Gao, P (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China.; Gao, P (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pathol, Jinan, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81872362, 82072665]; Taishan Scholars Program of Shandong Province [ts201511096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province	This study was supported by the National Natural Science Foundation of China (Grant nos. 81872362 and 82072665), the Taishan Scholars Program of Shandong Province (Grant no. ts201511096).	Barbagallo D, 2019, CANCERS, V11, DOI 10.3390/cancers11020194; Chen B, 2018, THERANOSTICS, V8, P4003, DOI 10.7150/thno.24106; Chen NF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1594-y; Cheng J, 2019, CLIN CANCER RES, V25, P3732, DOI 10.1158/1078-0432.CCR-18-3001; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Guarnieri AL, 2018, ONCOGENE, V37, P3879, DOI 10.1038/s41388-018-0239-7; Guo JP, 2021, ADV SCI, V8, DOI 10.1002/advs.202004303; Gyparaki MT, 2014, CANCER LETT, V354, P1, DOI 10.1016/j.canlet.2014.07.036; Hanniford D, 2020, CANCER CELL, V37, P55, DOI 10.1016/j.ccell.2019.12.007; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He QR, 2018, MOL THER-NUCL ACIDS, V10, P331, DOI 10.1016/j.omtn.2017.12.014; Karedath T, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5723-0; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Li QD, 2019, CELL METAB, V30, P157, DOI 10.1016/j.cmet.2019.05.009; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liang YR, 2019, ONCOGENE, V38, P6850, DOI 10.1038/s41388-019-0926-z; Liu G, 2016, ONCOL RES, V23, P99, DOI 10.3727/096504015X14496932933575; Lu J, 2020, CANCER LETT, V471, P38, DOI 10.1016/j.canlet.2019.11.038; Luo Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01203-8; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557; Protopsaltis NJ, 2019, ANGIOGENESIS, V22, P311, DOI 10.1007/s10456-018-9658-x; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Suhasini AN, 2016, LEUKEMIA, V30, P617, DOI 10.1038/leu.2015.302; Szabo L, 2016, NAT REV GENET, V17, P679, DOI 10.1038/nrg.2016.114; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Wang LQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0889-7; Wang ZX, 2016, J BIOL CHEM, V291, P17467, DOI 10.1074/jbc.M116.726083; Xiao MS, 2020, TRENDS CELL BIOL, V30, P226, DOI 10.1016/j.tcb.2019.12.004; Xu JZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1382-y; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zhang HY, 2019, ONCOGENE, V38, P2844, DOI 10.1038/s41388-018-0619-z; Zheng J, 2019, ONCOGENE, V38, P7073, DOI 10.1038/s41388-019-0934-z; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhuang M, 2014, BIOCHEM BIOPH RES CO, V448, P315, DOI 10.1016/j.bbrc.2013.12.126	41	7	7	4	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 25	2022	41	13					1895	1906		10.1038/s41388-022-02232-x	http://dx.doi.org/10.1038/s41388-022-02232-x		FEB 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0J9BT	35145234				2022-12-26	WOS:000754011900001
J	Ishtiaq, M; Hussain, I; Bhatti, KH; Maqbool, M; Ahmed, KS; Ajaib, M; Shah, AU; Mushtaq, W; Hussain, T; Ghani, A; Khanum, H; Mazhar, MW; Mazhar, M; Sardar, T; Nasif, O; Ansari, MJ; Ondrisik, P				Ishtiaq, Muhammad; Hussain, Iqbal; Bhatti, Khizar Hayat; Maqbool, Mehwish; Ahmed, Khawaja Shafique; Ajaib, Muhammad; Shah, Amin Ullah; Mushtaq, Waheeda; Hussain, Tanveer; Ghani, Abdul; Khanum, Humaira; Mazhar, Muhammad Waqas; Mazhar, Mubashir; Sardar, Tauqeer; Nasif, Omaima; Ansari, Mohammad Javed; Ondrisik, Peter			Study of impacts of brickkiln emanations on soil quality of agriculture lands in selected areas of District Bhimber, Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							HEAVY-METAL CONTAMINATION; BIOCHAR APPLICATION; LEAD; METHYLMERCURY; ACCUMULATION; ADSORPTION; PESHAWAR; PB; MN; FE	The pollution is hot issue of current era in world and the current study was carried to explore impacts of brickkilns' emanations on physiochemical properties of agricultural lands from District Bhimber of Azad Jammu and Kashmir (AJK) Pakistan. In this research, various edaphic characteristics: pH, soil organic matter, organic carbon, water holding capacity, cation exchange capacity and heavy metal contamination in soils nearby of brickkilns were determined. The pH of soil ranged from 5.55 to 7.50, soil organic matter was 0.35-0.90% and organic carbon content was 0.65-1.40%. The water holding capacity ranged from 2.10 to 3.20 mgL(-1) and carbon exchange capacity was 1250 to 4202 meq/100g. The contamination profile of heavy metal depicted that Pb showed highest conc. 0.065 mg/g followed by Co (0.053 mg/g) and Ni with 0.52 mg/g in the soil. Pb and Cr had high conc. in soil samples around brickkilns due to burning of coal and rubber tyres as fuel. The conc. of sulphate and nitrate ranged from 0.90 +/- 0.50 mol L-1 to 4.25 +/- 0.65 mol L-1 and 2.30 +/- 0.50 mol L-1 to 6.55 +/- 0.25 mol L-1, respectively. The fertility of agriculture lands was depicted that edaphic properties were directly related while nutritive features were inversely commensurate to distance from brickkilns. The research proved that emanations of brickkilns causes severe impact on quality of agriculture land, plant growth and its yield. Hence, reclamation measures should be taken to mitigate and/or eradicate nuisance of brickkilns emanations by using environmental friendly strategies.	[Ishtiaq, Muhammad; Maqbool, Mehwish; Ajaib, Muhammad; Mushtaq, Waheeda; Hussain, Tanveer; Khanum, Humaira; Mazhar, Muhammad Waqas; Mazhar, Mubashir; Sardar, Tauqeer] Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Azad Jammu & Ka, Pakistan; [Hussain, Iqbal] Govt Coll Univ Faisalabad, Dept Bot, Faisalabad, Pakistan; [Bhatti, Khizar Hayat] Univ Gujrat, Dept Bot, Gujrat City, Pakistan; [Ahmed, Khawaja Shafique] Univ Poonch, Dept Bot, Rawalakot, Azad Jammu & Ka, Pakistan; [Shah, Amin Ullah; Ghani, Abdul] Sargodha Univ, Dept Bot, Sargodha, Pakistan; [Nasif, Omaima] King Saud Univ, Coll Med, Dept Physiol, Riyadh, Saudi Arabia; [Nasif, Omaima] King Saud Univ, King Khalid Univ Hosp, Riyadh, Saudi Arabia; [Ansari, Mohammad Javed] Mahatma Jyotiba Phule Rohilkhand Univ Bareilly, Dept Bot, Hindu Coll Moradabad, Moradabad, India; [Ondrisik, Peter] Slovak Univ Agr, Dept Environm Sci & Biol, Nitra, Slovakia	Government College University Faisalabad; King Saud University; King Saud University; King Khalid University Hospital; Slovak University of Agriculture Nitra	Ishtiaq, M (corresponding author), Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Azad Jammu & Ka, Pakistan.	drishtiaq.bot@must.edu.pk	Ishtiaq, Muhammad/F-5152-2010; Hussain, Tanveer/GWQ-5172-2022; Hussain, Iqbal/B-2295-2013; Ishtiaq, Muhammad/GSN-4278-2022	Ishtiaq, Muhammad/0000-0003-2468-1413; Hussain, Iqbal/0000-0002-8449-0494; Mazher, Mubsher/0000-0003-4536-5364	King Saud University, Riyadh, Saudi Arabia [RSP2021/257]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project was supported by Researchers Supporting Project number (RSP2021/257), King Saud University, Riyadh, Saudi Arabia.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, DOI 10.1007/978-0-387-21510-5; Alam SA, 2013, J ARID ENVIRON, V89, P67, DOI 10.1016/j.jaridenv.2012.10.002; Alloway, 1995, HEAVY METALS SOILS; Bibi A., 2015, SCI TECHNOL DEV, V34, P122, DOI [10.3923/std.2015.122.129, DOI 10.3923/STD.2015.122.129]; Bisht G., 2015, APPL ENVIRON SOIL SC, DOI [10.1155/2015/409401, DOI 10.1155/2015/409401]; Bosco ML, 2005, ENVIRON RES, V99, P18, DOI 10.1016/j.envres.2004.09.011; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; Carmalt C., 1998, CHEM ARSEN ANTIMONY, P1; Chauhan A., 2010, N Y SCI J, V3, P45; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; De GC, 1997, HYDROMETALLURGY, V44, P53, DOI 10.1016/S0304-386X(96)00030-8; Debnath P., 2012, INT J AGR ENV BIOTEC, V5, P161; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; El Balkhi S, 2009, ANAL BIOANAL CHEM, V394, P1477, DOI 10.1007/s00216-009-2809-6; Ghosh AB, 1983, SOIL WATER TESTING M; Gupta P., 2000, SOIL PLANT WATER FER; Hussain I, 2006, J CHEM SOC PAKISTAN, V28, P232; Hussain I, 2006, J CHEM SOC PAKISTAN, V28, P241; Iqbal A, 2021, HUM ECOL RISK ASSESS, V27, P258, DOI 10.1080/10807039.2019.1706152; Ishaq M, 2010, ENVIRON MONIT ASSESS, V166, P409, DOI 10.1007/s10661-009-1011-9; Ishtiaq Ch. Muhammad, 2006, Asian Journal of Plant Sciences, V5, P390; Johnson CE, 1998, SOIL SCI SOC AM J, V62, P782, DOI 10.2136/sssaj1998.03615995006200030035x; Joshi S K, 2008, Kathmandu Univ Med J (KUMJ), V6, P3; Khattak JK, 1988, 1 NATL C SOIL SCI; Kipngetich TE, 2013, INT J PHARM LIFE SCI, V4, P2828; Laghari M, 2015, CATENA, V135, P313, DOI 10.1016/j.catena.2015.08.013; Li XD, 2001, APPL GEOCHEM, V16, P1361, DOI 10.1016/S0883-2927(01)00045-2; Lu XW, 2010, J HAZARD MATER, V173, P744, DOI 10.1016/j.jhazmat.2009.09.001; Markus J, 2001, ENVIRON INT, V27, P399, DOI 10.1016/S0160-4120(01)00049-6; Moller A, 2005, GEODERMA, V124, P63, DOI 10.1016/j.geoderma.2004.04.003; Muhammad Ismail, 2012, Sarhad Journal of Agriculture, V28, P403; Myers GJ, 2000, ENVIRON RES, V83, P275, DOI 10.1006/enrs.2000.4065; Myers GJ, 2000, ENVIRON HEALTH PERSP, V108, P413, DOI 10.2307/3454530; Nelson D.W., 1996, METHODS SOIL ANAL PA, V5, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Sanchez-Camazano M, 1998, SCI TOTAL ENVIRON, V218, P217, DOI 10.1016/S0048-9697(98)00212-5; SANCHEZCAMAZANO M, 1994, ECOTOX ENVIRON SAFE, V29, P61, DOI 10.1016/0147-6513(94)90030-2; Sikder A., 2016, DHAKA UNIV J BIOL SC, V25, P75, DOI [10.1016/j.toxlet.2010.05.004, 10.3329/dujbs.v25i1.28497]; Skinder B, 2013, J ECOL NAT ENV, V6, P1, DOI [10.5897/JENE2013.0423, DOI 10.5897/JENE2013.0423]; Tammeorg P, 2014, PLANT SOIL, V374, P89, DOI 10.1007/s11104-013-1851-5; Turer D, 2001, WATER AIR SOIL POLL, V132, P293, DOI 10.1023/A:1013290130089; Tuzen M, 2007, FOOD CONTROL, V18, P806, DOI 10.1016/j.foodcont.2006.04.003; Udosen ED., 2012, RES J ENG APPL SCI, V1, P64; Valerio ME, 2007, SCI TOTAL ENVIRON, V378, P63, DOI 10.1016/j.scitotenv.2007.01.007; Vijver M, 2001, ENVIRON TOXICOL CHEM, V20, P712, DOI [10.1002/etc.5620200404, 10.1897/1551-5028(2001)020&lt;0712:IOMPAS&gt;2.0.CO;2]; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Yaseen SA., 2015, J ENV ANAL TOXICOLOG, V5, P269; Zhang XF, 2013, ISRN SOIL SCI, P12; Zheljazkov V., 1996, Acta Horticulturae, P427	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2022	17	2							e0258438	10.1371/journal.pone.0258438	http://dx.doi.org/10.1371/journal.pone.0258438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M6VZ	35148326	gold, Green Published			2022-12-26	WOS:000800108800003
J	Chakraborty, PA; Talukder, A; Haider, SS; Das Gupta, R				Chakraborty, Promit Ananyo; Talukder, Animesh; Haider, Shams Shabab; Das Gupta, Rajat			Prevalence and factors associated with underweight, overweight and obesity among 15-49-year-old men and women in Timor-Leste	PLOS ONE			English	Article							BODY-MASS INDEX; BURDEN	Background Underweight and overweight both have a long-lasting significant effect on human health at the individual and population levels. However, in the context of Timor-Leste, a country that achieved independence around two decades ago, there is a severe scarcity of evidence regarding the underweight and obesity burden. We conducted this study to find out the prevalence of underweight, overweight and obesity and their associated factors. Methods This study used the nationally representative data of Timor-Leste Demographic Health Survey 2016 data. We conducted descriptive analysis followed by multivariable logistic regression analysis to find out the prevalence and investigate the associated factors. Both crude and adjusted odds ratio of covariates were reported with 95% confidence interval (CI). Results This study analyzed the data from a weighted sample of 16,488 Timorese aged 15-49 years. The prevalence of normal weight, underweight, and overweight or obesity were found to be 55.2% (95% CI: 54.2%-56.2%), 25.5% (95% CI: 24.4%-26.7%), and 19.3% (95% CI: 18.3%-20.3%), respectively. For underweight, age, sex, type of settlement (urban/rural), township, and wealth, marital, and educational status were found to have a statistically significant relationship (p < 0.05) with Body Mass Index(BMI). After adjustment for the covariates in the logistic regression model age, sex, township, and wealth and marital status were found to be statistically significant correlates (p < .05) of underweight. For overweight and PLOS obesity, all the background characteristics included in this study (i.e, age, sex, type of settlement, township, and wealth, marital, and educational status) were found to be statistically significant correlates, after adjustment for the covariates. Conclusion This study concludes that Timor-Leste has a significant underweight and overweight burden which needs to be addressed through appropriate interventions. Further studies are also warranted to delve deeper into the complex interplay of factors associated with underweight and overweight.	[Chakraborty, Promit Ananyo] North South Univ NSU, Dept Publ Hlth, Dhaka, Bangladesh; [Chakraborty, Promit Ananyo] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Talukder, Animesh; Das Gupta, Rajat] BRAC Univ, Ctr Noncommunicable Dis & Nutr, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Haider, Shams Shabab; Das Gupta, Rajat] BRAC Univ, Ctr Sci Implementat & Scale Up, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Das Gupta, Rajat] Univ South Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	North South University (NSU); University of British Columbia; Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of South Carolina System; University of South Carolina Columbia	Chakraborty, PA (corresponding author), North South Univ NSU, Dept Publ Hlth, Dhaka, Bangladesh.; Chakraborty, PA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	promitch@student.ubc.ca		Talukder, Animesh/0000-0003-4174-3903; Chakraborty, Promit Ananyo/0000-0002-1561-1301				Abrha S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3315-3; Al Kibria GM, 2019, GLOB HEALTH RES POL, V4, DOI 10.1186/s41256-019-0117-z; [Anonymous], 2018, GLOB NUTR REP; [Anonymous], 2018, LANCET, DOI [DOI 10.1016/S0140-6736(18)31310-2, 10.14257/ijgdc.2018.11.9.06]; [Anonymous], TIMOR LESTE NUTR PRO; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Begum F, 2012, J OBSTET GYNAECOL CA, V34, P637, DOI 10.1016/S1701-2163(16)35316-6; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Chan YY, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4772-z; Chowdhury TR, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0372-7; CIA, 2012, CENTR INT AG WORLD F, P58; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; General Directorate of Statistics Ministry of Planning and Finance and Ministry of Health Timor-Leste, 2018, 2016 DEM HLTH SURV K; Hashan MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241621; Janghorbani M, 2007, OBESITY, V15, P2797, DOI 10.1038/oby.2007.332; Jitnarin N, 2011, EAT WEIGHT DISORD-ST, V16, pE242, DOI 10.1007/BF03327467; Lipowicz A, 2002, AM J HUM BIOL, V14, P468, DOI 10.1002/ajhb.10062; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Nartea Roxana, 2019, J Med Life, V12, P178, DOI 10.25122/jml-2019-0015; Nugent R, 2020, LANCET, V395, P156, DOI 10.1016/S0140-6736(19)32473-0; Osuji T, 2006, WOMEN HEALTH, V44, P41, DOI 10.1300/J013v44n01_03; Pengpid S, 2017, AIMS PUBLIC HEALTH, V4, P633, DOI 10.3934/publichealth.2017.6.633; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Prentice AM, 2018, ANN NUTR METAB, V72, P47, DOI 10.1159/000487383; Provo A, 2017, MALNUTRITION TIMOR L; Rising food prices, 2008, CAUSES CONSEQUENCES; Statistics Timor-Leste, 2015, STAT TIMOR LESTE; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; Templin T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002968; United Nations, 2018, LDCS GLANC DEP EC SO; Vlassoff C, 2007, J HEALTH POPUL NUTR, V25, P47; WHO, 2018, STAT FOOD SEC NUTR W	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0262999	10.1371/journal.pone.0262999	http://dx.doi.org/10.1371/journal.pone.0262999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143506	Green Published, gold			2022-12-26	WOS:000797657800021
J	de Arias, AR; Messenger, LA; Rolon, M; Vega, MC; Acosta, N; Villalba, C; Marcet, PL				Rojas de Arias, Antonieta; Alexandra Messenger, Louisa; Rolon, Miriam; Celeste Vega, Maria; Acosta, Nidia; Villalba, Cesia; Marcet, Paula L.			Dynamics of Triatoma infestans populations in the Paraguayan Chaco: Population genetic analysis of household reinfestation following vector control	PLOS ONE			English	Article							DISCRETE TYPING UNITS; CHAGAS-DISEASE VECTORS; TRYPANOSOMA-CRUZI INFECTION; MULTILOCUS GENOTYPE DATA; GRAN CHACO; HEMIPTERA REDUVIIDAE; RURAL COMMUNITIES; ACTIVE DISPERSAL; ARID CHACO; REGION	Background Although domestic infestations by Triatoma infestans have been successfully controlled across Latin America, in areas of the Gran Chaco region, recurrent post-spraying house colonization continues to be a significant challenge, jeopardizing Chagas disease vector control and maintaining active Trypanosome cruzi transmission. Methodology/Principal findings To investigate the dynamics of triatomine reinfestation in a rural area of the Paraguayan Chaco, genetic characterization (based on 10 microsatellite loci and cytochrome B sequence polymorphisms) was performed on baseline and reinfestant T. infestans (n = 138) from four indigenous communities and adjacent sylvatic sites. House quality and basic economic activities were assessed across the four communities. Significant genetic differentiation was detected among all baseline triatomine populations. Faster reinfestation was observed in the communities with higher infestation rates pre-spraying. Baseline and reinfestant populations from the same communities were not genetically different, but two potentially distinct processes of reinfestation were evident. In Campo Largo, the reinfestant population was likely founded by domestic survivor foci, with reduced genetic diversity relative to the baseline population. However, in 12 de Junio, reinfestant bugs were likely derived from different sources, including survivors from the pre-spraying population and sympatric sylvatic bugs, indicative of gene-flow between these habitats, likely driven by high human mobility and economic activities in adjacent sylvatic areas. Conclusions/Significance Our results demonstrate that sylvatic T. infestans threatens vector control strategies, either as a reinfestation source or by providing a temporary refuge during insecticide spraying. Passive anthropogenic importation of T. infestans and active human interactions with neighboring forested areas also played a role in recolonization. Optimization of spraying, integrated community development and close monitoring of sylvatic areas should be considered when implementing vector control activities in the Gran Chaco.	[Rojas de Arias, Antonieta; Rolon, Miriam; Celeste Vega, Maria] Ctr Desarrollo Invest Cient CEDIC, Diaz Gill Med Lab, FMB, Asuncion, Paraguay; [Alexandra Messenger, Louisa; Marcet, Paula L.] Ctr Dis Control & Prevent CDC, Div Parasit Dis & Malaria DPDM, Entomol Branch, Atlanta, GA USA; [Alexandra Messenger, Louisa] Amer Soc Microbiol, Washington, DC USA; [Alexandra Messenger, Louisa] London Sch Hyg & Trop Med, Fac Infect Trop Dis, Dept Dis Control, London, England; [Acosta, Nidia] UNA, Dept Med Trop, Inst Invest Ciencias Salud, Asuncion, Paraguay; [Villalba, Cesia] Programa Nacl Control Enfermedad Chagas SENEPA, Asuncion, Paraguay	Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion	de Arias, AR (corresponding author), Ctr Desarrollo Invest Cient CEDIC, Diaz Gill Med Lab, FMB, Asuncion, Paraguay.	rojasdearias@gmail.com	Messenger, Louisa/HGD-0180-2022	Acosta, Nidia/0000-0003-2652-354X; Rojas de Arias, Antonieta/0000-0002-6207-1870; Marcet, Paula L/0000-0002-0676-3020; Messenger, Louisa A/0000-0002-3107-6214	"Programa Nacional de Incentivo a los Investigadores" (PRONII) from the "Consejo Nacional de Ciencia y Tecnologia" (CONACYT),Paraguay; UNDP/World Bank/WHO/TDR [A70596]; International Development Research Centre (IDRC) [103696-009]; Project Research, Education and Biotechnology Applied to Health -FOCEM/MERCOSURCOF [03/11]	"Programa Nacional de Incentivo a los Investigadores" (PRONII) from the "Consejo Nacional de Ciencia y Tecnologia" (CONACYT),Paraguay; UNDP/World Bank/WHO/TDR(World Health Organization); International Development Research Centre (IDRC); Project Research, Education and Biotechnology Applied to Health -FOCEM/MERCOSURCOF	Paraguayan researchers were supported by the "Programa Nacional de Incentivo a los Investigadores" (PRONII) from the "Consejo Nacional de Ciencia y Tecnologia" (CONACYT),Paraguay. This work was also supported by the UNDP/World Bank/WHO/TDR (Grant no. A70596), the International Development Research Centre (IDRC) (Grant no. 103696-009) and the Project Research, Education and Biotechnology Applied to Health -FOCEM/MERCOSURCOF No 03/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahan L, 2016, J VECTOR ECOL, V41, P90, DOI 10.1111/jvec.12198; Abrahan LB, 2011, MEM I OSWALDO CRUZ, V106, P232, DOI 10.1590/S0074-02762011000200019; Acosta N, 2017, PARASITOLOGY, V144, P884, DOI 10.1017/S0031182016002663; Almeida CE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004447; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Bacigalupo A, 2006, REV MED CHILE, V134, P1230; Bacigalupo A, 2010, MEM I OSWALDO CRUZ, V105, P633, DOI 10.1590/S0074-02762010000500006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnabe C, 2020, INFECT GENET EVOL, V78, DOI 10.1016/j.meegid.2019.104103; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bezerra CM, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008404; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bremond P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-164; BRENIERE SF, 1995, AM J TROP MED HYG, V53, P179, DOI 10.4269/ajtmh.1995.53.179; Breniere SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080786; Brisse S, 2000, MOL BIOCHEM PARASIT, V111, P95, DOI 10.1016/S0166-6851(00)00302-9; Buitrago R, 2010, AM J TROP MED HYG, V82, P574, DOI 10.4269/ajtmh.2010.09-0325; Canese J., 1978, Revista Paraguaya de Microbiologia, V13, P3; Cecere MC, 2013, J MED ENTOMOL, V50, P394, DOI 10.1603/ME12109; Casaccia Paz Sánchez, 2019, Rev. Soc. cient. Parag., V24, P218, DOI 10.32480/rscp.2019-24-1.218-229; Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Ceballos LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001365; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; CHAPMAN MD, 1984, J PROTOZOOL, V31, P482, DOI 10.1111/j.1550-7408.1984.tb02999.x; Cura CI, 2012, PARASITOLOGY, V139, P516, DOI 10.1017/S0031182011002186; Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006; de Arias AR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001822; de Arias AR, 2004, MEM I OSWALDO CRUZ, V99, P657, DOI 10.1590/S0074-02762004000600022; Fernandez MD, 2014, ACTA TROP, V140, P10, DOI 10.1016/j.actatropica.2014.07.014; DGEEC, 2002, AN EST; Dias J C, 1998, Rev Soc Bras Med Trop, V31, P373, DOI 10.1590/S0037-86821998000400007; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echeverria JE, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2663-5; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Enriquez GF, 2013, PARASITOLOGY, V140, P303, DOI 10.1017/S003118201200159X; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabre A., 2005, ENLHET ENENLHET CHAC, P503; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fraenkel S, 2020, PATHOG GLOB HEALTH, V114, P30, DOI 10.1080/20477724.2020.1716558; Garcia AL, 1998, J MED ENTOMOL, V35, P38, DOI 10.1093/jmedent/35.1.38; Giordano R, 2005, MEM I OSWALDO CRUZ, V100, P753, DOI 10.1590/S0074-02762005000700014; Gomez MB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004561; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Gurevitz JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002158; Gurevitz JM, 2012, J MED ENTOMOL, V49, P1379, DOI 10.1603/ME11157; Gurevitz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001349; Gurtler RE, 2005, AM J TROP MED HYG, V73, P95, DOI 10.4269/ajtmh.2005.73.95; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Gurtler RE, 2009, MEM I OSWALDO CRUZ, V104, P52, DOI 10.1590/S0074-02762009000900009; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002496; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Justi SA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-149; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; Lucero RH, 2016, INFECT GENET EVOL, V41, P84, DOI 10.1016/j.meegid.2016.03.028; Santo-Orihuela PL, 2013, MEM I OSWALDO CRUZ, V108, P790, DOI 10.1590/0074-0276108062013017; Lyman DE, 1999, AM J TROP MED HYG, V60, P377, DOI 10.4269/ajtmh.1999.60.377; Marcet PL, 2008, INFECT GENET EVOL, V8, P835, DOI 10.1016/j.meegid.2008.08.002; Marcet PL, 2006, INFECT GENET EVOL, V6, P32, DOI 10.1016/j.meegid.2005.01.002; Marcet PL., BIORXIV 512392; Arrom-Suhurt CM, 2019, J PUBLIC HEALTH-HEID, V27, P723, DOI 10.1007/s10389-018-1001-x; Messenger LA, 2015, EXPERT REV ANTI-INFE, V13, P995, DOI 10.1586/14787210.2015.1056158; Monteiro FA, 1999, MEM I OSWALDO CRUZ, V94, P229, DOI 10.1590/S0074-02761999000700037; Paula MN, 2018, INFECT GENET EVOL, V66, P229, DOI 10.1016/j.meegid.2018.10.001; Nei M., 1987, MOL EVOLUTIONARY GEN; Noireau F, 1997, MEM I OSWALDO CRUZ, V92, P583, DOI 10.1590/S0074-02761997000500003; Noireau F, 2005, TRENDS PARASITOL, V21, P7, DOI 10.1016/j.pt.2004.10.007; Noireau F, 2000, MEM I OSWALDO CRUZ, V95, P119, DOI 10.1590/S0074-02762000000700020; Olmos F., 2003, CALIDAD MATERIALES C, V13; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez E, 2013, INFECT GENET EVOL, V13, P116, DOI 10.1016/j.meegid.2012.09.014; Perez-Cascales E, 2020, ACTA TROP, V203, DOI 10.1016/j.actatropica.2019.105292; Piccinali RV, 2020, PARASITOL RES, V119, P3305, DOI 10.1007/s00436-020-06789-y; Pritchard JK, 2000, GENETICS, V155, P945; Provecho YM, 2017, J MED ENTOMOL, V54, P646, DOI 10.1093/jme/tjw224; Quisberth S, 2011, INFECT GENET EVOL, V11, P1006, DOI 10.1016/j.meegid.2011.03.014; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Risso MG, 2011, AM J TROP MED HYG, V84, P78, DOI 10.4269/ajtmh.2011.10-0177; Rojas de Arias Antonieta, 2016, Mem. Inst. Investig. Cienc. Salud, V14, P3, DOI 10.18004/mem.iics/1812-9528/2016.014(03)03-006; de Arias AR, 2017, AM J TROP MED HYG, V97, P481, DOI 10.4269/ajtmh.16-1013; Rolon M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001026; Salvatella R, 2014, MEM I OSWALDO CRUZ, V109, P122, DOI 10.1590/0074-0276140338; Samuels AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002358; Sánchez Zunilda, 2016, Mem. Inst. Investig. Cienc. Salud, V14, P96, DOI 10.18004/mem.iics/1812-9528/2016.014(03)96-101; Sanchez-Martin MJ, 2006, TROP MED INT HEALTH, V11, P1585, DOI 10.1111/j.1365-3156.2006.01717.x; Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; Gaspe MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003614; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x; Vicco MH, 2012, PARASITOL INT, V61, P735, DOI 10.1016/j.parint.2012.04.007; Cardinal MV, 2014, AM J TROP MED HYG, V90, P1063, DOI 10.4269/ajtmh.13-0251; Waleckx E, 2012, AM J TROP MED HYG, V86, P455, DOI 10.4269/ajtmh.2012.11-0205; Waleckx E, 2011, INFECT GENET EVOL, V11, P1045, DOI 10.1016/j.meegid.2011.03.020; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WHO, 2010, WHO TECH REP SER, V949, P1; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024	104	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2022	17	2							e0263465	10.1371/journal.pone.0263465	http://dx.doi.org/10.1371/journal.pone.0263465			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1J1AU	35143523	Green Accepted, Green Published, gold			2022-12-26	WOS:000797657800049
J	Kaine, G; Greenhalgh, S; Wright, V				Kaine, Geoff; Greenhalgh, Suzie; Wright, Vic			Compliance with Covid-19 measures: Evidence from New Zealand	PLOS ONE			English	Article							INVOLVEMENT; ATTITUDES	Governments around the world are seeking to slow the spread of Covid-19 by implementing measures that encourage, or mandate, changes in people's behaviour. These changes include the wearing of face masks, social distancing, and testing and self-isolating when unwell. The success of these measures depends on the commitment of individuals to change their behaviour accordingly. Understanding and predicting the motivation of individuals to change their behaviour is therefore critical in assessing the likely effectiveness of these measures in slowing the spread of the virus. In this paper we draw on a novel framework, the I-3 Compliance Response Framework, to understand and predict the motivation of residents in Auckland, New Zealand, to comply with measures to prevent the spread of Covid-19. The Framework is based on two concepts. The first uses the involvement construct to predict the motivation of individuals to comply. The second separates the influence of the policy measure from the influence of the policy outcome on the motivation of individuals to comply. In short, the Framework differentiates between the strength of individuals' motivation and their beliefs about the advantages and disadvantages of policy outcomes and policy measures. We found this differentiation was useful in predicting an individual's possible behavioural responses to a measure and discuss how it could assist government agencies to develop strategies to enhance compliance.	[Kaine, Geoff] Manaaki Whenua Landcare Res, Landscape Policy & Governance, Hamilton, New Zealand; [Greenhalgh, Suzie] Manaaki Whenua Landcare Res, Soc Culture & Policy, Auckland, New Zealand; [Wright, Vic] Univ New England, Fac Sci Agr Business & Law, Armidale, NSW, Australia	Landcare Research - New Zealand; Landcare Research - New Zealand; University of New England	Kaine, G (corresponding author), Manaaki Whenua Landcare Res, Landscape Policy & Governance, Hamilton, New Zealand.	kaineg@landcareresearch.co.nz		Kaine, Geoff/0000-0001-6747-7434; Wright, Vic/0000-0002-8284-3567	Manaaki Whenua Landcare Research Strategic Investment Fund	Manaaki Whenua Landcare Research Strategic Investment Fund	The funding for this research was allocated from the Manaaki Whenua Landcare Research Strategic Investment Fund. This funding does not have a grant number.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Aldenderfer MS., 1984, CLUSTER ANAL; Allington D, 2021, PSYCHOL MED, V51, P1763, DOI [10.1017/S0033291721000593, 10.1017/S003329172000224X]; Bridgman A., 2020, HARVARD KENNEDY SCH, V1, P1, DOI [DOI 10.37016/MR-2020-028, 10.37016/mr-2020-028]; BURBY RJ, 1993, J POLICY ANAL MANAG, V12, P753, DOI 10.2307/3325349; Carlough L., 2003, GENERAL DETERRENCE E; Carmines E.G., 2008, RELIABILITY VALIDITY; CHAFFEE SH, 1986, COMMUN RES, V13, P373, DOI 10.1177/009365086013003006; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Daoust JF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235590; Daoust JF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249914; Daoust JF, 2021, J EXP POLIT SCI, V8, P310, DOI 10.1017/XPS.2020.25; Davies A., 2007, 200737 ENV WAIK; Escandon-Barbosa D, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11030035; Gray L, 2020, J PRIM HEALTH CARE, V12, P199, DOI 10.1071/HC20089; Gunningham N, 2017, REGULATORY THEORY: FOUNDATIONS AND APPLICATIONS, P133; Hager E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236918; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Isch C., 2021, WHAT PREDICTS ATTITU, DOI [10.31234/osf.io/jvspx.34443996, DOI 10.31234/OSF.IO/JVSPX.34443996]; Jarynowski A., 2020, SSRN ELECT J, DOI DOI 10.2139/SSRN.3570609; Kaine G., 2020, LC3867; Kaine G., 2021, CONSERVATION, V1, P196, DOI [10.3390/conservation1030016, DOI 10.3390/CONSERVATION1030016]; Kaine G., 2020, LC3747; Kaine G., 2011, 0311 DEP PRIM IND SE; Kaine G., 2020, LC3734; Kaine G., 2019, LC3646; Kaine G, 2010, FOOD POLICY, V35, P531, DOI 10.1016/j.foodpol.2010.06.002; Kassarjian HH., 1981, N AM ADV CONSUMER RE, P31; Kim Y., 2003, CORP COMMUN INT J, V8, P255; Lan RR, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.599862; Lang R, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10790-0; LAURENT G, 1985, J MARKETING RES, V22, P41, DOI 10.2307/3151549; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Lieberoth A, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.200589; Lourey R., 2011, 0711 DEP PRIM IND SE; Miguel FK, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110346; Ministry of Health, 2021, US; Murdoch H., 2006, 3 NATL C RISK MAN NZ; New Zealand Government, 2021, HIST COVID 19 ALERT; Olsen SO, 1999, FOOD QUAL PREFER, V10, P483, DOI 10.1016/S0950-3293(99)00049-X; Oosterhoff B., 2020, PREPRINT, DOI [10.31234/osf.io/rpcy4, DOI 10.31234/OSF.IO/RPCY4]; PETTY RE, 1984, J PERS SOC PSYCHOL, V46, P69, DOI 10.1037/0022-3514.46.1.69; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Taylor S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246317; Travica B, CONTAINMENT STRATEGI, DOI [10.2139/ssrn.3604519, DOI 10.2139/SSRN.3604519]; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vally Z, 2020, PUBLIC HEALTH, V187, P67, DOI 10.1016/j.puhe.2020.08.002; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; Wilson S, 2020, LEADERSHIP-LONDON, V16, P279, DOI 10.1177/1742715020929151; ZAICHKOWSKY JL, 1985, J CONSUM RES, V12, P341, DOI 10.1086/208520; Zhang XJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010197	53	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2022	17	2							e0263376	10.1371/journal.pone.0263376	http://dx.doi.org/10.1371/journal.pone.0263376			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2S0NR	35139139	Green Published, Green Submitted, gold			2022-12-26	WOS:000821499100028
